<SEC-DOCUMENT>0001453687-26-000082.txt : 20260430
<SEC-HEADER>0001453687-26-000082.hdr.sgml : 20260430
<ACCEPTANCE-DATETIME>20260430070423
ACCESSION NUMBER:		0001453687-26-000082
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		101
CONFORMED PERIOD OF REPORT:	20260331
FILED AS OF DATE:		20260430
DATE AS OF CHANGE:		20260430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cartesian Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001453687
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37798
		FILM NUMBER:		26920014

	BUSINESS ADDRESS:	
		STREET 1:		7495 NEW HORIZON WAY
		CITY:			FREDERICK
		STATE:			MD
		ZIP:			21703
		BUSINESS PHONE:		301-348-8698

	MAIL ADDRESS:	
		STREET 1:		7495 NEW HORIZON WAY
		CITY:			FREDERICK
		STATE:			MD
		ZIP:			21703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SELECTA BIOSCIENCES INC
		DATE OF NAME CHANGE:	20090109
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>rnac-20260331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019cdd24-8f10-71f0-acfb-b8a76448289c,g:7ae85b19-6328-41a5-b0c0-99683dc813c6,d:de29ba22317341cdb83bdf79fbf2d493-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:rnac="http://www.cartesiantherapeutics.com/20260331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>rnac-20260331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-25">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-26">12/31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-27">2026</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-28">Q1</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-29">0001453687</ix:nonNumeric><ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" scale="0" id="f-607">1</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="rnac-20260331.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>rnac:segment</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-04-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rnac:OldCartesianMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rnac:OldCartesianMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">rnac:Descartes08ForMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rnac:OldCartesianMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rnac:A2022WarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rnac:A2022WarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rnac:A2022WarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rnac:A2022WarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rnac:A2022WarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rnac:A2022WarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rnac:A2022WarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rnac:A2022WarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">rnac:ProbabilityOfSuccessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">rnac:ProbabilityOfSuccessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">rnac:ProbabilityOfSuccessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">rnac:ProbabilityOfSuccessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">rnac:MeasurementInputRevenueVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">rnac:MeasurementInputRevenueVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">rnac:ContingentValueRightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">rnac:ContingentValueRightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">rnac:ContingentValueRightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rnac:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rnac:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rnac:LeaseArrangementAxis">rnac:FrederickLeaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rnac:LeaseArrangementAxis">rnac:FrederickLeaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rnac:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rnac:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rnac:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rnac:RestrictedStockUnitsUnvestedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:StockIncentivePlan2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:StockIncentivePlan2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:StockIncentivePlan2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:EmploymentInducementIncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:EmploymentInducementIncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:OldCartesianPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:OldCartesianPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rnac:OldCartestianMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:OldCartesianPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rnac:OldCartestianMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:OldCartesianPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:OldCartesianPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:OldCartesianPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rnac:SwedishOrphanBiovitrumABSOBIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rnac:SwedishOrphanBiovitrumABSOBIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rnac:SwedishOrphanBiovitrumABSOBIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GovernmentAssistanceTypeAxis">rnac:NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GovernmentAssistanceTypeAxis">rnac:NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GovernmentAssistanceTypeAxis">rnac:NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GovernmentAssistanceTypeAxis">rnac:NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GovernmentAssistanceTypeAxis">rnac:NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GovernmentAssistanceTypeAxis">rnac:NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">rnac:BiogenM.A.Inc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-08</xbrli:startDate><xbrli:endDate>2023-09-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">rnac:NationalCancerInstituteAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-16</xbrli:startDate><xbrli:endDate>2019-09-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">rnac:LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">rnac:LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:Descartes08ForMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:Descartes08ForMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:Descartes08ForDermatomyositisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:Descartes08ForDermatomyositisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:EarlyStageProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:EarlyStageProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:ResearchAndDevelopmentEmployeeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:ResearchAndDevelopmentEmployeeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:ResearchAndDevelopmentFacilitiesAndOtherExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:ResearchAndDevelopmentFacilitiesAndOtherExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ide29ba22317341cdb83bdf79fbf2d493_1"></div><div style="min-height:32.4pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.368%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric> </span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:545.25pt"><tr><td style="width:1.0pt"/><td style="width:28.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:513.25pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#254;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">March 31, 2026</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:545.25pt"><tr><td style="width:1.0pt"/><td style="width:28.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:513.25pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from _______ to _______</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-37798</ix:nonNumeric> </span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:24pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">Cartesian Therapeutics, Inc.</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.416%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">26-1622110</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction</span></div><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">of incorporation or organization)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">7495 New Horizon Way</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Frederick</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-11">MD</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">21703</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">301</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">348-8698</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number,&#160;including area code)</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.080%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.311%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-15">Common Stock, $0.0001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-16">RNAC</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-17">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Securities registered pursuant to Section 12(g) of the Act:</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Contingent Value Rights</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No&#160;&#9744;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No&#160;&#9744;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.142%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#254;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="f-21">&#254;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="height:32.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:32.4pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). Yes&#160;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-23">&#254;</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;23, 2026, the registrant had <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-24">29,381,514</ix:nonFraction> shares of common stock, par value $0.0001 per share, outstanding.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.368%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="height:32.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="ide29ba22317341cdb83bdf79fbf2d493_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:7.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:81.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.045%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_16">PART I. FINANCIAL INFORMATION</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_19">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_19">Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_19">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_22">Consolidated Balance Sheets as of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_22">March</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_22"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_22">1</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_22">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_22">6</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_22"> and December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_22">5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_28">Consolidated Statements of Operations and Comprehensive Loss for the Three</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_28"> Months</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_28"> ended </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_28">March</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_28"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_28">1</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_28">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_28">6</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_28"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_28">5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_28">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_34">Consolidated Statements of Changes in Stockholders&#8217; Deficit for the Three Months ended March 31, 2026 and 2025</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_34">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_49">Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_49">Three</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_49"> Months ended </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_49">March</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_49"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_49">1</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_49">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_49">6</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_49"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_49">5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_49">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_55">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_55">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_166">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_166">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_166">23</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_202">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_202">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_202">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_205">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_205">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_205">31</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_208">PART II. OTHER INFORMATION</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_211">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_211">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_211">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_214">Item 1A.&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_214">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_214">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_241">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_241">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_241">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_244">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_244">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_244">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_247">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_247">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_247">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_250">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_250">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_250">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_256">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_256">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_256">33</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_262">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ide29ba22317341cdb83bdf79fbf2d493_13"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">FORWARD-LOOKING STATEMENTS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q, or the Quarterly Report, contains forward-looking statements. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section&#160;27A of the Securities Act of 1933, as amended, or the Securities Act, and Section&#160;21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. All statements other than statements of historical facts contained in this Quarterly Report, including statements regarding our future results of operations and financial position, business strategy, prospective products, product approvals, research and development costs, timing and likelihood of success, the plans and objectives of management for future operations and future results of anticipated products, the impact of future pandemics or similar events on our business and operations and our future financial results, and the period over which we estimate our existing cash and cash equivalents will be sufficient to fund our future operating expenses and capital expenditure requirements are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;contemplate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential&#8221;, or &#8220;continue&#8221; or the negative of these terms or other similar expressions. The forward-looking statements in this Quarterly Report are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. These forward-looking statements speak only as of the date of this Quarterly Report and are subject to a number of important factors that could cause actual results to differ materially from those in the forward-looking statements, including the factors described under the sections in this Quarterly Report titled &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; as well as the following:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our future results of operations and financial position, business strategy, and the length of time that we believe our existing cash resources will fund our operations;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our market size and our potential growth opportunities;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our preclinical and clinical development activities;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our dependence on third-parties, including contract research organizations in the conduct of our pre-clinical studies and clinical trials;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the efficacy and safety profile of our product candidates;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential therapeutic benefits and economic value of our product candidates;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and results of preclinical studies and clinical trials;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential impairment of our goodwill and indefinite lived intangible assets;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expected impact of macroeconomic conditions, including inflation, increasing interest rates, volatile market conditions and current or potential bank failures;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of global events, including the ongoing conflicts between Russia and Ukraine, the ongoing conflict in the Middle East and geopolitical tensions with China;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of political uncertainty on our product development;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the receipt and timing of potential regulatory designations, approvals and commercialization of our product candidates;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to prevent or minimize the effects of litigation and other contingencies;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our status as a development-stage company and our expectation to incur losses in the future, and the possibility that we never achieve or maintain profitability;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">uncertainties with respect to our ability to access future capital;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maximize the value of our pipeline of product candidates;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our unproven approach to therapeutic intervention;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to enroll patients in clinical trials, timely and successfully complete those trials and receive necessary regulatory approvals;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to continue to grow our manufacturing capabilities and resources;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to manufacture our product candidates, which in some cases are manufactured on a patient-by-patient basis;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to receive or manufacture sufficient quantities of our product candidates;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain our existing or future collaborations or licenses and to seek new collaborations, licenses or partnerships;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to protect and enforce our intellectual property rights;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal, state, and foreign regulatory requirements, including U.S. Food and Drug Administration, or FDA, regulation of our product candidates;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain and retain key executives and retain qualified personnel;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments relating to our competitors and our industry;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any future payouts under the contingent value right, or CVR, issued to our holders of record as of the close of business on December 4, 2023; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to monetize any of our legacy assets.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, we operate in an evolving environment. New risks and uncertainties may emerge from time to time, and it is not possible for management to predict all risk and uncertainties.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">You should read this Quarterly Report and the documents that we reference in this Quarterly Report completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ide29ba22317341cdb83bdf79fbf2d493_16"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_19"></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements (unaudited)</span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_22"></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Cartesian Therapeutics, Inc. and Subsidiaries</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Amounts in thousands, except share data and par value)</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-30">118,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-31">125,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="f-32">261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-33">1,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-34">3,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-35">3,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-36">122,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-37">129,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-38">11,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-39">12,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-40">5,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-41">5,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development asset</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-42">93,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-43">93,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-44">48,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-45">48,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Long-term restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-46">1,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-47">1,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Long-term prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-48">5,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-49">5,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-50">288,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-51">296,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and stockholders&#8217; deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-52">1,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-53">1,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-54">10,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-55">9,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-56">4,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-57">4,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-58">15,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-59">14,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 13pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-60">7,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-61">8,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="rnac:WarrantsAndRightsOutstandingNoncurrent" scale="3" id="f-62">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rnac:WarrantsAndRightsOutstandingNoncurrent" scale="3" id="f-63">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value right liability</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="rnac:ContingentValueRightLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-64">405,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rnac:ContingentValueRightLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-65">392,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-66">6,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-67">6,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-68">436,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-69">422,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note&#160;14)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-70"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-71"></ix:nonFraction></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; deficit:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Series A Preferred Stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-72"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-73">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-74"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-75">134,904.563</ix:nonFraction></ix:nonFraction> shares authorized as of March 31, 2026 and December 31, 2025; <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="3" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-76"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-77"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-78"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="3" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-79">120,790.402</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March 31, 2026 and December 31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-82"><ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-83">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-84"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-85">437,927</ix:nonFraction></ix:nonFraction> shares authorized as of March 31, 2026 and December 31, 2025; <ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-86"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-87"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-88"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-89">437,927</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March 31, 2026 and December 31, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-92"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-93">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-94"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-95">9,427,168.437</ix:nonFraction></ix:nonFraction> shares authorized as of March 31, 2026 and December 31, 2025; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-96"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-97"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-98"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-99">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March 31, 2026 and December 31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-100">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-101">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-102"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-103">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-104"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-105">350,000,000</ix:nonFraction></ix:nonFraction> shares authorized as of March 31, 2026 and December 31, 2025; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-106"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-107">28,544,728</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-108"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-109">26,011,106</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-110">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-111">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-112">718,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-113">700,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-114">861,555</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-115">822,373</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-116">4,583</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-117">4,576</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; deficit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-118">148,118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-119">126,240</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-120">288,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-121">296,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ide29ba22317341cdb83bdf79fbf2d493_28"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Cartesian Therapeutics, Inc. and Subsidiaries</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Operations and Comprehensive Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Amounts in thousands, except share and per share data)</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration and license</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-122">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-123">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Grant</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueNotFromContractWithCustomer" scale="3" id="f-124">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:RevenueNotFromContractWithCustomer" scale="3" id="f-125">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Revenues" scale="3" id="f-126">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-127">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-128">19,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-129">14,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-130">7,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-131">8,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-132">26,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-133">22,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-134">26,499</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-135">21,889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Other (expense) income:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-136">1,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-137">2,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Gain on change in fair value of warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="f-138">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-139">1,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) gain on change in fair value of contingent value right liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rnac:FairValueAdjustmentOfContingentValueRightLiability" format="ixt:num-dot-decimal" scale="3" id="f-140">13,800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" sign="-" name="rnac:FairValueAdjustmentOfContingentValueRightLiability" scale="3" id="f-141">346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-142">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="f-143">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other (expense) income, net</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-144">12,683</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-145">4,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-146">39,182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-147">17,710</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive (loss) income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-148">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-149">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total comprehensive loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-150">39,189</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-151">17,678</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-152">39,182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-153">17,710</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net loss per share allocable to common stockholders:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-154"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-155">1.46</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-156"><ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-157">0.68</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-158"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-159">26,855,158</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-160"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-161">25,902,650</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ide29ba22317341cdb83bdf79fbf2d493_34"></div><hr style="page-break-after:always"/><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Cartesian Therapeutics, Inc. and Subsidiaries</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Changes in Stockholders&#8217; Deficit</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Amounts in thousands, except share data)</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.579%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.435%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.435%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.435%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.126%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:5.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.450%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Series A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Series B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; deficit</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Common&#160;stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-162">120,790.402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-163">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-164">437,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-165">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-166">26,011,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-167">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-168">700,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-169">822,373</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-170">4,576</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-171">126,240</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of options</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-172">93,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-173">304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-174">304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon vesting of restricted stock units</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="0" id="f-175">169,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock through at the market offering, net of commissions and expenses</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-176">2,270,712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-177">14,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-178">14,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-179">2,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-180">2,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-181">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-182">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-183">39,182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-184">39,182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-185">120,790.402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-186">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-187">437,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-188">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-189">28,544,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-190">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-191">718,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-192">861,555</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-193">4,583</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-194">148,118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited consolidated financial statements.</span></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="ide29ba22317341cdb83bdf79fbf2d493_40"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Cartesian Therapeutics, Inc. and Subsidiaries</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Changes in Stockholders&#8217; Deficit</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Amounts in thousands, except share data)</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.913%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.130%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:5.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.507%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Series A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Series B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; deficit</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Common&#160;stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-195">120,790.402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-196">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-197">437,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-198">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-28" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-199">25,767,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-200">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-201">689,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-202">692,071</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-203">4,621</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-204">6,802</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of options</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-33" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-205">55,690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-206">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-207">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of vested restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-33" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="0" id="f-208">113,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-209">2,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-210">2,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-211">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-212">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-213">17,710</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-214">17,710</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-37" decimals="3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-215">120,790.402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-216">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-38" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-217">437,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-218">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-39" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-219">25,936,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-220">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-221">692,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-222">709,781</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-223">4,589</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-224">21,789</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited consolidated financial statements</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="ide29ba22317341cdb83bdf79fbf2d493_49"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Cartesian Therapeutics, Inc. and Subsidiaries&#160;</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Amounts in thousands)</span></div><div style="margin-bottom:9pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.517%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-225">39,182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-226">17,710</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" scale="3" id="f-227">615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-228">1,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non&#8209;cash lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-229">235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-230">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock&#8209;based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-231">2,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-232">2,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Gain on change in warrant liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="f-233">94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-234">1,818</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on change in fair value of CVR liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rnac:FairValueAdjustmentOfContingentValueRightLiability" format="ixt:num-dot-decimal" scale="3" id="f-235">13,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" sign="-" name="rnac:FairValueAdjustmentOfContingentValueRightLiability" scale="3" id="f-236">346</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="f-237">854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="f-238">893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-239">246</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-240">5,830</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="f-241">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-242">1,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="3" id="f-243">850</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-244">2,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-245">22,135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-246">23,108</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-247">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-248">1,075</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="f-249">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-250">1,075</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Equity offering costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-251">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="f-252">454</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-253">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-254">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from at the market offering, net of commissions and expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-255">15,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-256">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of Contingent Value Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rnac:PaymentsForContingentValueRightsDistributions" format="ixt:fixed-zero" scale="3" id="f-257">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="rnac:PaymentsForContingentValueRightsDistributions" format="ixt:num-dot-decimal" scale="3" id="f-258">7,754</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-259">15,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-260">8,025</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-261">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-262">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-263">6,498</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-264">32,176</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-265">126,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-266">214,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-267">120,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-268">182,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Non-cash investing and financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property and equipment not yet paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="f-269">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="f-270">535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Equity offering costs in accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rnac:EquityOfferingCostsInAccruedLiabilities" scale="3" id="f-271">707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="rnac:EquityOfferingCostsInAccruedLiabilities" format="ixt:fixed-zero" scale="3" id="f-272">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;margin-top:3pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited consolidated financial statements</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="ide29ba22317341cdb83bdf79fbf2d493_55"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%">Cartesian Therapeutics, Inc.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> and Subsidiaries</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_58"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-273" continuedAt="f-273-1" escape="true">Description of the Business</ix:nonNumeric></span></div><ix:continuation id="f-273-1" continuedAt="f-273-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cartesian Therapeutics, Inc., or the Company, </span><span style="color:#231f20;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">was</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> incorporated in Delaware on December 10, 2007, and is headquartered in Frederick, Maryland. The Company is a late clinical-stage biotechnology company </span><span style="color:#231f20;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">pioneering cell therapy for the treatment of autoimmune diseases. The Company leverages its proprietary technology and manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell&#8217;s genetic material. The Company&#8217;s cell therapies are designed to be dosed repeatedly like conventional drugs, administered in an outpatient setting and given without pre-treatment chemotherapy, which is required with many conventional cell therapies.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">The Company&#8217;s Product Candidates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company aims to provide a personalized approach to treating patients that begins with the collection of a patient&#8217;s cells, which are then used to manufacture the Company&#8217;s cell therapy product candidates. Once a patient&#8217;s cells have expanded in the Company&#8217;s process, mRNA is introduced to deliver a chimeric antigen receptor into the cell. Once the manufacturing process is complete, the product candidate is sent back to the treating physician where they administer six weekly infusions of the Company&#8217;s cell therapy candidate to the patient. The Company&#8217;s product candidates are specifically designed to target and destroy the pathogenic, self-reactive cells that are the underlying cause of the autoimmune disease, with the goal of creating a precision immune reset for the patient.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Descartes-08, the Company&#8217;s lead cell therapy product candidate, is an autologous chimeric antigen receptor T-cell therapy, or CAR-T, product targeting B-cell maturation antigen, or BCMA, in clinical development for the treatment of generalized myasthenia gravis, or MG, and myositis, specifically, moderate to severe multi-refractory dermatomyositis and antisynthetase syndrome. In contrast to conventional DNA-based CAR T-cell therapies, the Company&#8217;s CAR-T administration is designed to not require preconditioning chemotherapy, to be administered in the outpatient setting and does not carry the risk of genomic integration associated with cancerous transformation. Descartes-08 has been granted Orphan Drug Designation and Regenerative Medicine Advanced Therapy Designation by the U.S. Food and Drug Administration, or FDA, for the treatment of MG, and Rare Pediatric Disease Designation for the treatment of juvenile dermatomyositis.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Management&#8217;s Plan</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026, the Company had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-274">861.6</ix:nonFraction> million. The Company anticipates operating losses to continue for the foreseeable future due to, among other things, costs related to research and development of its product candidates and its administrative organization. The future success of the Company is dependent on its ability to develop its product candidates and ultimately upon its ability to attain and sustain profitable operations. The successful development of product candidates requires substantial working capital, which may not be available to the Company on favorable terms or at all.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026, the Company&#8217;s cash, cash equivalents, and restricted cash were $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="rnac:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale" scale="6" id="f-275">120.4</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalents" scale="6" id="f-276">1.7</ix:nonFraction> million was restricted cash related to lease commitments. The Company believes the cash, cash equivalents and restricted cash as of March 31, 2026 will enable it to fund its current planned operations for at least the next 12 months. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Further, the liability associated with the CVR Agreement (as defined below) will be settled solely through cash flow received under the Company&#8217;s License and Development Agreement, or as so amended, the Sobi License, with Swedish Orphan Biovitrum AB (publ.), or Sobi, and any other Gross Proceeds (as defined in the CVR Agreement) net of certain agreed deductions. Under the CVR Agreement, <ix:nonFraction unitRef="number" contextRef="c-44" decimals="INF" name="rnac:ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed" scale="-2" id="f-277">100</ix:nonFraction>% of all milestone payments, royalties and other amounts paid to the Company or controlled entities under the Sobi License, and any other Gross Proceeds will be distributed, net of specified deductions, to holders of the CVRs. There is no obligation to the Company to fund any amount related to the CVR liability. See Note 5, &#8220;Fair Value Measurements&#8221;.</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-273-2"> If the Company is unable to obtain additional funding on a timely basis, it may be forced to significantly curtail, delay, or discontinue one or more of its planned research or development programs or be unable to expand its operations or otherwise capitalize on its commercialization of its product candidates.</ix:continuation> </span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_64"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-278" continuedAt="f-278-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-279" continuedAt="f-279-1" escape="true"><ix:continuation id="f-278-1" continuedAt="f-278-2"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Basis of presentation and consolidation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Selecta (RUS), LLC, or Selecta (RUS), a Russian limited liability corporation, and Cartesian Bio, LLC, a Delaware limited liability </span></div></ix:continuation></ix:nonNumeric><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="f-278-2"><ix:continuation id="f-279-1"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">company, which is a variable interest entity for which the Company is the primary beneficiary and have been prepared in conformity with accounting principles generally accepted in the United States of America, or U.S. GAAP. Any reference in these notes to applicable guidance is meant to refer to the authoritative United States generally accepted accounting principles as found in the relevant Accounting Standards Codification, or ASC and Accounting Standards Update, or ASU, of the Financial Accounting Standards Board, or FASB. All significant intercompany accounts and transactions have been eliminated.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements for the three months ended March 31, 2026 and 2025 have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission, or the SEC, for interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. These consolidated financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and the notes thereto for the year ended December 31, 2025 included in the Company&#8217;s Annual Report on Form 10-K that was filed with the SEC on March 9, 2026. The unaudited interim financial statements have been prepared on the same basis as the audited consolidated financial statements. In the opinion of management, the accompanying unaudited interim consolidated financial statements contain all adjustments that are necessary for a fair statement of the Company&#8217;s financial position as of March 31, 2026, the consolidated results of operations for the three months ended March 31, 2026, and cash flows for the three months ended March 31, 2026. Such adjustments are of a normal and recurring nature. The results of operations for the three months ended March 31, 2026 are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2026.</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Significant accounting policies</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company disclosed its significant accounting policies in Note 2, &#8220;Summary of Significant Accounting Policies&#8221; included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2025. There have been no material changes to the Company&#8217;s significant accounting policies during the three months ended March 31, 2026.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-280" escape="true"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Not Yet Adopted</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Statement Reporting- Comprehensive Income- Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (ASU 2024-03), which requires public companies to disclose, in interim and annual reporting periods, additional information about certain expenses in notes to financial statements, including purchases of inventory, employee compensation, depreciation, amortization of intangible assets, and selling expenses. This guidance will be effective for the annual period beginning the year ended December 31, 2027 and for interim periods beginning January 1, 2028, with early adoption permitted. The Company is currently evaluating the impact of the standard&#8217;s adoption on its consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2025, the FASB issued ASU 2025-10, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (ASU 2025-10), which establishes authoritative guidance on the recognition, measurement, presentation, and disclosure of government grants. Under ASU 2025-10, government grants are recognized when it is probable that the entity will both comply with the conditions of the grant and the grant will be received. The ASU provides specific accounting models for grants related to assets and grants related to income, including options to recognize government grants as deferred income or as a reduction of the asset&#8217;s cost basis. The ASU also requires enhanced disclosures regarding the nature of government grants, significant terms and conditions, accounting policies applied, and amounts recognized in the financial statements. ASU 2025-10 is effective for fiscal years beginning after December 15, 2028, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-10 on its consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2025, the FASB issued ASU 2025-11, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interim Reporting (Topic 270): Narrow-Scope Improvements</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (ASU 2025-11), which clarifies the guidance in Topic 270 to improve the consistency of interim financial reporting. The ASU provides a comprehensive list of required interim disclosures and introduces a disclosure principle requiring entities to disclose events since the end of the last annual reporting period that have a material impact on the entity. ASU 2025-11 is effective for fiscal years beginning after December 15, 2027, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-11 on its consolidated financial statements and related disclosures.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><div id="ide29ba22317341cdb83bdf79fbf2d493_67"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="f-281" continuedAt="f-281-1" escape="true">Goodwill and Indefinite-Lived Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="f-281-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026, the Company has goodwill of approximately $<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-282">48.2</ix:nonFraction>&#160;million and an indefinite-lived intangible asset of $<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="f-283">93.9</ix:nonFraction>&#160;million related to Descartes-08 for MG.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="c-47" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="0" id="f-284"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="0" id="f-285">no</ix:nonFraction></ix:nonFraction> changes to the carrying value of the Company&#8217;s goodwill or in-process research and development asset related to Descartes-08 for MG during the three months ended March 31, 2026 and 2025.</span></div></ix:continuation><div id="ide29ba22317341cdb83bdf79fbf2d493_82"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-286" continuedAt="f-286-1" escape="true">Net Loss Per Share Allocable to Common Stockholders</ix:nonNumeric></span></div><ix:continuation id="f-286-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-287" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss per share allocable to common stockholders for the three months ended March 31, 2026 and 2025 (in thousands, except share and per-share data):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-288">39,182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-289">17,710</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding - basic and diluted</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-290"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-291">26,855,158</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-292"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-293">25,902,650</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net loss per share allocable to common stockholders:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-294"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-295">1.46</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-296"><ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-297">0.68</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-298" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the potential dilutive shares of common stock excluded from the computation of the diluted net loss per share allocable to common stockholders for all periods presented, as the effect would have been anti-dilutive: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options and restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-49" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-299">4,278,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-50" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-300">3,047,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-51" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-301">692,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-52" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-302">692,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Series A Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-53" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-303">4,026,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-54" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-304">4,026,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-55" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-305">437,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-56" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-306">437,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-307">9,435,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-308">8,204,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="ide29ba22317341cdb83bdf79fbf2d493_85"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-309" continuedAt="f-309-1" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="f-309-1" continuedAt="f-309-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="f-310" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2026 and December 31, 2025 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds (included in cash equivalents)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-311">117,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-312">117,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-313">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-314">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-315">117,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-316">117,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-317">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-318">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liability</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" scale="3" id="f-319">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="3" id="f-320">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="3" id="f-321">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" scale="3" id="f-322">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value right liability</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="rnac:ContingentValueRightLiability" format="ixt:num-dot-decimal" scale="3" id="f-323">405,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="rnac:ContingentValueRightLiability" format="ixt:fixed-zero" scale="3" id="f-324">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="rnac:ContingentValueRightLiability" format="ixt:fixed-zero" scale="3" id="f-325">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="rnac:ContingentValueRightLiability" format="ixt:num-dot-decimal" scale="3" id="f-326">405,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-327">405,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-328">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-329">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-330">405,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds (included in cash equivalents)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-331">122,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-332">122,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-333">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-334">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-335">122,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-336">122,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-337">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-338">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liability</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" scale="3" id="f-339">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="3" id="f-340">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="3" id="f-341">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" scale="3" id="f-342">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value right liability</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rnac:ContingentValueRightLiability" format="ixt:num-dot-decimal" scale="3" id="f-343">392,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="rnac:ContingentValueRightLiability" format="ixt:fixed-zero" scale="3" id="f-344">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="rnac:ContingentValueRightLiability" format="ixt:fixed-zero" scale="3" id="f-345">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="rnac:ContingentValueRightLiability" format="ixt:num-dot-decimal" scale="3" id="f-346">392,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-347">392,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-348">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-349">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-350">392,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" format="ixt:fixed-zero" scale="0" id="f-351"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="0" id="f-352"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="INF" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="0" id="f-353"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="INF" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" format="ixt:fixed-zero" scale="0" id="f-354">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> transfers within the fair value hierarchy during the three months ended March 31, 2026 or the year ended December 31, 2025.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026 and December 31, 2025, money market funds were classified as cash and cash equivalents on the accompanying consolidated balance sheets as they mature within 90 days from the date of purchase.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026, the Company had restricted cash balances relating to secured letters of credit in connection with its real estate leases. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="f-356" continuedAt="f-356-1" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="f-355" continuedAt="f-355-1" escape="true">The Company&#8217;s consolidated statements of cash flows include the following as of March 31, 2026 and 2025 (in thousands):</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="f-356-1"><ix:continuation id="f-355-1"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-357">118,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-358">180,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Long-term restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-359">1,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-360">1,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-361">120,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-362">182,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrants to Purchase Common Stock</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, the Company issued warrants in connection with an underwritten offering, or the 2022 Warrants. Pursuant to the terms of the 2022 Warrants, the Company could be required to settle the 2022 Warrants in cash in the event of an acquisition of the Company under certain circumstances and, as a result, the 2022 Warrants are required to be measured at fair value and reported as a liability on the balance sheet. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded the fair value of the 2022 Warrants upon issuance using the Black-Scholes valuation model and is required to revalue the 2022 Warrants at each reporting date, with any changes in fair value recorded in the statements of operations and comprehensive loss. The valuation of the 2022 Warrants is classified as Level 3 of the fair value hierarchy due to the need to use assumptions in the valuation that are both significant to the fair value measurement and unobservable, </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="f-309-2" continuedAt="f-309-3"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">including the stock price volatility and the expected life of the 2022 Warrants. Generally, increases (decreases) in the fair value of the underlying stock and estimated term would result in a directionally similar impact to the fair value measurement. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the 2022 Warrants was determined using the following inputs to the Black-Scholes simulation valuation:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Estimated fair value of the underlying stock. The Company estimates the fair value of the common stock based on the closing stock price at the end of each reporting period.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk-free interest rate. The risk-free interest rate is based on the U.S. Treasury at the valuation date commensurate with the expected remaining life assumption.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Dividend rate. The dividend rate is based on the historical rate, which the Company anticipates will remain at <ix:nonFraction unitRef="number" contextRef="c-72" decimals="INF" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" format="ixt:fixed-zero" scale="0" id="f-363">zero</ix:nonFraction>.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expected life. The expected life of the 2022 Warrants is assumed to be equivalent to their remaining contractual term which expires on April 11, 2027.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Volatility. The Company estimates stock price volatility based on the Company&#8217;s historical volatility for a period of time commensurate with the expected remaining life of the 2022 Warrants.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="f-364" continuedAt="f-364-1" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Black-Scholes pricing model assumptions used to record the fair value of the 2022 Warrants liability is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-73" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-365">3.68</ix:nonFraction></span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-74" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-366">3.48</ix:nonFraction></span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-75" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" format="ixt:fixed-zero" scale="0" id="f-367">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-76" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" format="ixt:fixed-zero" scale="0" id="f-368">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-77" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear" id="f-369">1.03</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-78" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear" id="f-370">1.28</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-79" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-371">89.14</ix:nonFraction></span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-80" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-372">87.36</ix:nonFraction></span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="f-373" continuedAt="f-373-1" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects a roll-forward of fair value for the Company&#8217;s Level 3 warrant liabilities (see Note 9, &#8220;Equity&#8221; to these unaudited consolidated financial statements) for the three months ended March 31, 2026 (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Warrant Liability</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fair value as of December 31, 2025</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="f-374">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="f-375">94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fair value as of March 31, 2026</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="f-376">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Value Right</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Company entered into a contingent value rights agreement, or the CVR Agreement, pursuant to which each holder of common stock or a 2022 Warrant in December 2023 was distributed a CVR by the Company. Each CVR entitles its holder to distributions of milestone and royalty payments under the Sobi License, net of deductions. See Note 6, &#8220;Fair Value Measurements&#8221; to the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2025 for further discussion of the terms related to the CVR Agreement. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The CVRs represent financial instruments that are accounted for under the fair value option election in ASC 825, Financial Instruments, or ASC 825. Under the fair value option election, the CVRs are initially measured at the aggregate estimated fair value of the CVRs and will be subsequently remeasured at estimated fair value on a recurring basis at each reporting period date. The estimated fair value of the CVR liability was determined using a Monte Carlo simulation model to estimate future cash flows associated with the legacy assets, including the expected milestone and royalty payments under the Sobi License, net of deductions. Changes in fair value of the CVR liability are presented in the consolidated statements of operations and comprehensive loss. The liability value is based on significant inputs not observable in the market such as estimated cash flows, estimated probabilities of success, and expected volatility of future revenues, which represent a Level 3 measurement within the fair value hierarchy. <ix:continuation id="f-364-1" continuedAt="f-364-2">The significant inputs used to estimate the fair value of the CVR liability, which represented a financial instrument being accounted for under the fair value option, were as follows:</ix:continuation></span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="f-309-3"><ix:continuation id="f-364-2"><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Estimated cash flow dates</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026 - 2038</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026 - 2037</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Estimated probability of success</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-84" decimals="3" name="rnac:ContingentValueRightLiabilityMeasurementInput" scale="-2" id="f-377">95.0</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-85" decimals="3" name="rnac:ContingentValueRightLiabilityMeasurementInput" scale="-2" id="f-378">100.0</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-86" decimals="3" name="rnac:ContingentValueRightLiabilityMeasurementInput" scale="-2" id="f-379">95.0</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-87" decimals="3" name="rnac:ContingentValueRightLiabilityMeasurementInput" scale="-2" id="f-380">100.0</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility of future revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-88" decimals="3" name="rnac:ContingentValueRightLiabilityMeasurementInput" scale="-2" id="f-381">23.0</ix:nonFraction></span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-89" decimals="3" name="rnac:ContingentValueRightLiabilityMeasurementInput" scale="-2" id="f-382">23.0</ix:nonFraction></span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><ix:continuation id="f-373-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects a roll-forward of fair value for the Company&#8217;s Level 3 CVR liability for the three months ended March 31, 2026 (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">CVR Liability</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fair value as of December 31, 2025</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="f-383">392,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="f-384">13,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fair value as of March 31, 2026</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="f-385">405,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div id="ide29ba22317341cdb83bdf79fbf2d493_91"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="f-386" continuedAt="f-386-1" escape="true">Property and Equipment</ix:nonNumeric></span></div><ix:continuation id="f-386-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-387" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consists of the following (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-388">9,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-389">8,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-390">417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-391">417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-392">6,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-393">4,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-394">307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-395">269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-396">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-397">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Construction in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-398">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-399">3,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-400">16,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-401">16,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-402">5,348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-403">4,733</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-404">11,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-405">12,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-406"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-407">0.6</ix:nonFraction></ix:nonFraction> million for each of the three months ended March 31, 2026 and 2025, respectively.</span></div></ix:continuation><div id="ide29ba22317341cdb83bdf79fbf2d493_94"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" id="f-408" continuedAt="f-408-1" escape="true">Accrued Expenses</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="f-409" escape="true"><ix:continuation id="f-408-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of the following (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and employee related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-410">1,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-411">3,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration and licensing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="rnac:AccruedCollaborationandLicensing" scale="3" id="f-412">385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rnac:AccruedCollaborationandLicensing" scale="3" id="f-413">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued patent fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="rnac:AccruedPatentFeesCurrent" scale="3" id="f-414">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rnac:AccruedPatentFeesCurrent" scale="3" id="f-415">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued research and development costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="rnac:AccruedResearchAndDevelopmentCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-416">4,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rnac:AccruedResearchAndDevelopmentCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-417">2,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional and consulting services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="rnac:AccruedAuditFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-418">2,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rnac:AccruedAuditFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-419">2,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued equity offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="rnac:AccruedEquityOfferingCostsCurrent" scale="3" id="f-420">707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rnac:AccruedEquityOfferingCostsCurrent" scale="3" id="f-421">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="f-422">510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="f-423">378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-424">10,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-425">9,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="ide29ba22317341cdb83bdf79fbf2d493_97"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-426" continuedAt="f-426-1" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="f-426-1" continuedAt="f-426-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains operating leases for manufacturing, laboratory and office space located in Maryland and Massachusetts. In Frederick, Maryland, the Company occupies over <ix:nonFraction unitRef="sqft" contextRef="c-105" decimals="0" name="us-gaap:AreaOfRealEstateProperty" format="ixt:num-dot-decimal" scale="0" id="f-427">35,000</ix:nonFraction> total square feet of integrated space under a lease agreement, or the Frederick Lease Agreement, and subsequent amendments entered into between February 2024 and June 2025, or the Amended Frederick Lease Agreement. The Amended Fredrick Lease Agreement is set to expire in 2031, carries an aggregate annual base rent of approximately $<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="rnac:LesseeOperatingLeaseAnnualBaseRent" scale="6" id="f-428">1.4</ix:nonFraction>&#160;million and is subject to annual increases in accordance with the terms of the </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="f-426-2"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Amended Frederick Lease Agreement. See Note 9, &#8220;Leases&#8221; to the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2025 for further discussion of the Company&#8217;s leases.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-429" continuedAt="f-429-1" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2026 and 2025, the components of lease costs were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="f-430">583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="f-431">584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="f-432">431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="f-433">406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="f-434">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="f-435">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-436">1,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-437">1,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-438" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The maturity of the Company&#8217;s operating lease liabilities as of March 31, 2026 were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026 (remainder)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="f-439">3,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-440">4,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-441">2,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-442">1,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-443">1,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="rnac:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" scale="3" id="f-444">852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-445">14,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-446">2,960</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-447">11,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><ix:continuation id="f-429-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to operating leases was as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities (in thousands)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-448">1,169</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="f-449">317</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-450">3.7</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-43" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-451">4.4</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-3" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-452">12.2</ix:nonFraction></span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-43" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-453">11.8</ix:nonFraction></span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the Company&#8217;s right-of-use assets and lease liabilities for the three months ended March 31, 2026 and 2025 are reflected in the non-cash lease expense and accrued expenses and other liabilities, respectively, in the consolidated statements of cash flows.</span></div></ix:continuation><div id="ide29ba22317341cdb83bdf79fbf2d493_109"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-454" continuedAt="f-454-1" escape="true">Equity</ix:nonNumeric></span></div><ix:continuation id="f-454-1" continuedAt="f-454-2"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Equity Financings</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;At the Market&#8221; Sales Agreement</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On December 13, 2024, the Company entered into a Sales Agreement, or the Sales Agreement, with Leerink Partners LLC to sell shares of the Company&#8217;s common stock, from time to time, through an &#8220;at the market&#8221; equity offering program under which Leerink Partners LLC will act as sales agent. The shares of common stock sold pursuant to the Sales Agreement will be issued pursuant to the Company&#8217;s shelf registration statement on Form S-3 (File No. 333-283803), filed on December 13, 2024 with the SEC and related prospectus supplement, filed on January 8, 2025 with the SEC, for aggregate gross sales proceeds of up to $<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="rnac:SaleOfStockAggregateMaximumGrossSalesProceeds" scale="6" id="f-455">100.0</ix:nonFraction>&#160;million. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2026, the Company sold <ix:nonFraction unitRef="shares" contextRef="c-108" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-456">2,270,712</ix:nonFraction> shares of its common stock pursuant to the Sales Agreement for net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="f-457">14.6</ix:nonFraction> million after commissions and expenses. There were <ix:nonFraction unitRef="shares" contextRef="c-109" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:fixed-zero" scale="0" id="f-458">no</ix:nonFraction> shares sold pursuant to the Sales Agreement during the three months ended March 31, 2025.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="f-454-2"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2026, there were <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="rnac:ClassOfWarrantOrRightOutstandingWarrantsIssued" format="ixt:fixed-zero" scale="0" id="f-459"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="rnac:ClassOfWarrantOrRightOutstandingWarrantsCancelled" format="ixt:fixed-zero" scale="0" id="f-460"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="rnac:ClassOfWarrantOrRightOutstandingWarrantsExercised" format="ixt:fixed-zero" scale="0" id="f-461">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> warrants issued, exercised, or cancelled. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="f-462" continuedAt="f-462-1" escape="true">The following is a summary of the Company&#8217;s warrants as of March 31, 2026:</ix:nonNumeric></span></div><ix:continuation id="f-462-1"><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Equity<br/>&#160;classified</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Liability classified</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average<br/>exercise price</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-110" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-463">6,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-83" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-464">685,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-465">692,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-466">46.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11, &#8220;Equity&#8221; to the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2025 for further discussion of the terms related to the Company&#8217;s warrants.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026, the Company had <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="3" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-467"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-468">120,790.402</ix:nonFraction></ix:nonFraction> shares of Series A Preferred Stock and <ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-469"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-470">437,927</ix:nonFraction></ix:nonFraction> shares of Series B Preferred Stock issued and outstanding, respectively, which are convertible into <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:PreferredStockConvertibleSharesIssuable" format="ixt:num-dot-decimal" scale="0" id="f-471">4,464,273</ix:nonFraction> shares of common stock. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Reserved Shares</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfStockByClassTextBlock" id="f-472" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has authorized shares of common stock for future issuance as of March 31, 2026 as follows:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of warrants</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-110" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-473">692,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for future stock incentive awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-111" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-474">3,641,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-112" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-475">736,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding common stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-113" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-476">3,542,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Series A Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-114" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-477">4,026,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-115" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-478">437,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-479">13,076,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="ide29ba22317341cdb83bdf79fbf2d493_118"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-480" continuedAt="f-480-1" escape="true">Stock Incentive Plans</ix:nonNumeric></span></div><ix:continuation id="f-480-1" continuedAt="f-480-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Company&#8217;s stockholders approved the 2016 Incentive Award Plan, or the 2016 Plan, which initially authorized <ix:nonFraction unitRef="shares" contextRef="c-116" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-481">40,341</ix:nonFraction> shares of common stock for future issuance under the 2016 Plan. Pursuant to the terms of the 2016 Plan, the Board of Directors is authorized to grant awards with respect to common stock, and may delegate to a committee of one or more members of the Board of Directors or executive officers of the Company the authority to grant options and restricted stock units. The Board of Directors established a Stock Option Committee which is authorized to grant awards to certain employees and consultants subject to conditions and limitations within the 2016 Plan. In January 2026, the number of shares of common stock that may be issued under the 2016 Plan was increased by <ix:nonFraction unitRef="shares" contextRef="c-117" decimals="INF" name="rnac:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="f-482">1,040,444</ix:nonFraction>. As of March 31, 2026, <ix:nonFraction unitRef="shares" contextRef="c-118" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-483">3,044,044</ix:nonFraction> shares remain available for future issuance under the 2016 Plan.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In September 2018, the Company&#8217;s 2018 Employment Inducement Incentive Award Plan, or the 2018 Inducement Incentive Award Plan, was adopted by the Board of Directors without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Stock Market LLC listing rules, which initially authorized <ix:nonFraction unitRef="shares" contextRef="c-119" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-484">39,166</ix:nonFraction> shares of its common stock for issuance. As of March 31, 2026, there are <ix:nonFraction unitRef="shares" contextRef="c-120" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-485">502,296</ix:nonFraction> shares available for future grant under the 2018 Inducement Incentive Award Plan.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 2023, the Company assumed the 2016 Stock Incentive Plan, or the Old Cartesian Plan, of the then private company that merged with the Company in November 2023, or Old Cartesian. . The Old Cartesian Plan permits the granting of options or restricted stock to employees, officers, directors, consultants and advisors to the Company. The unvested common stock options and Series A Preferred Stock options assumed by the Company generally vest over a <ix:nonNumeric contextRef="c-121" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-486">four-year</ix:nonNumeric> period. Additionally, the stock options granted have a contractual term of <ix:nonNumeric contextRef="c-121" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="f-487">ten years</ix:nonNumeric> and only full shares can be exercised as per the individual award agreements. As of March 31, 2026, there are <ix:nonFraction unitRef="shares" contextRef="c-122" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-488">49,149</ix:nonFraction> shares available for future grant under the Old Cartesian Plan. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The outstanding stock options to purchase Old Cartesian common stock were converted into stock options to purchase <ix:nonFraction unitRef="shares" contextRef="c-123" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-489">776,865</ix:nonFraction> shares of common stock and <ix:nonFraction unitRef="shares" contextRef="c-124" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-490">14,112.299</ix:nonFraction> shares of Series A Preferred Stock of the Company. The replacement awards that were issued as a part of the assumption of the Old Cartesian Plan resulted in $<ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="f-491">2.6</ix:nonFraction>&#160;million attributed to post-combination </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="f-480-2" continuedAt="f-480-3"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">service to be recognized as stock-based compensation expense over the remaining terms of the replacement awards, of which $<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-492">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-493">0.2</ix:nonFraction>&#160;million was recognized during the three months ended March 31, 2026 and 2025, respectively as research and development expense in the consolidated statements of operations and comprehensive loss. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="f-494" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense by classification included within the consolidated statements of operations and comprehensive loss, was as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-495">949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-496">1,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-497">1,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-498">1,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-499">2,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-500">2,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-501" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The estimated grant date fair values of stock option awards granted under the 2016 Plan and the 2018 Inducement Incentive Award Plan were calculated using the Black-Scholes option pricing model based on the following weighted-average assumptions: </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-131" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-502">3.93</ix:nonFraction></span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-132" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-503">4.46</ix:nonFraction></span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-131" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="0" id="f-504">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-132" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="0" id="f-505">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-131" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-506">5.97</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-132" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-507">6.20</ix:nonNumeric></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-131" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-508">92.71</ix:nonFraction></span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-132" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-509">97.44</ix:nonFraction></span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average fair value of common stock</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-131" decimals="2" name="rnac:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue" scale="0" id="f-510">6.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-132" decimals="2" name="rnac:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue" scale="0" id="f-511">17.46</ix:nonFraction></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The expected term of the Company&#8217;s stock options granted has been determined utilizing the &#8220;simplified&#8221; method for awards that qualify as &#8220;plain-vanilla&#8221; options. Under the simplified method, the expected term is presumed to be the midpoint between the vesting date and the end of the contractual term. The Company utilizes this method due to lack of historical exercise data and the plain nature of its stock-based awards. Expected volatilities are based on the Company&#8217;s historical volatility.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant date fair value of stock options granted during the three months ended March 31, 2026 and 2025 was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-512">5.25</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-513">14.03</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026, total unrecognized compensation expense related to unvested common stock options was $<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="f-514">15.5</ix:nonFraction> million, which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="c-134" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-515">3.0</ix:nonNumeric> years.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-516" continuedAt="f-516-1" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the stock option activity under the 2016 Plan, the 2018 Inducement Incentive Award Plan, and the Old Cartesian Plan for options for common stock:</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="f-480-3"><ix:continuation id="f-516-1"><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number&#160;of Common Stock Options</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average Exercise Price ($)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average Remaining Contractual Term (in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in&#160;thousands)</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-135" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-517">2,463,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-135" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-518">13.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-136" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-519">6.41</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-520">2,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-137" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-521">1,304,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-137" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-522">6.81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-137" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-523">86,132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-137" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-524">3.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-137" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-525">139,658</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-137" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-526">15.90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-138" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-527">3,542,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-138" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-528">11.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-137" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-529">7.74</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-530">2,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested at March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-137" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="f-531">1,204,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-137" decimals="2" name="rnac:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" scale="0" id="f-532">11.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-137" name="rnac:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm" format="ixt-sec:duryear" id="f-533">5.11</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="rnac:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-534">1,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at March 31, 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-138" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-535">3,139,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-138" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="f-536">11.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-137" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-537">7.64</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-538">2,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2026, the Company granted <ix:nonFraction unitRef="shares" contextRef="c-139" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-539">420,650</ix:nonFraction> restricted stock unit awards with a weighted-average fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-139" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-540">6.76</ix:nonFraction> per share based on the closing price of the Company&#8217;s common stock on the date of grant under the 2016 Plan, which generally vest over a <ix:nonNumeric contextRef="c-139" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-541">four-year</ix:nonNumeric> term. Forfeitures are estimated at the time of grant and are adjusted, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company has estimated a forfeiture rate of <ix:nonFraction unitRef="number" contextRef="c-139" decimals="2" name="rnac:ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate" scale="-2" id="f-542">10</ix:nonFraction>% for restricted stock unit awards based on historical experience.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized compensation expense related to the restricted stock units was $<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="6" id="f-543">6.4</ix:nonFraction> million as of March 31, 2026, which is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="c-139" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-544">3.1</ix:nonNumeric> years.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="f-545" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s restricted stock units under the 2016 Plan and the Old Cartesian Plan:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:74.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.666%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Grant Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value ($)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-141" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-546">522,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-141" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-547">18.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-139" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-548">420,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-139" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-549">6.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-139" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-550">169,278</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-139" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-551">18.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-139" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-552">37,598</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-139" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-553">16.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-140" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-554">736,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-140" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-555">11.82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="ide29ba22317341cdb83bdf79fbf2d493_124"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-556" continuedAt="f-556-1" escape="true">Revenue Arrangements</ix:nonNumeric></span></div><ix:continuation id="f-556-1" continuedAt="f-556-2"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Collaboration and license revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Swedish Orphan Biovitrum AB (publ.)</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the Company and Sobi entered into the Sobi License, which was subsequently amended in October 2023. Pursuant to the Sobi License, the Company agreed to grant Sobi an exclusive, worldwide (except as to Greater China) license to develop, manufacture and commercialize the Nanoecapsulated Sirolimus plus Pegadricase, or NASP, formerly known as SEL-212, drug candidate , which is currently in development for the treatment of chronic refractory gout. The NASP drug candidate is a pharmaceutical composition containing a combination of a pegylated uricase known as SEL-037, or the Compound, and nanoparticle-encapsulated form of rapamycin, known as ImmTOR. Pursuant to the Sobi License, in consideration of the license, Sobi agreed to pay the Company a one-time, upfront payment of $<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-557">75.0</ix:nonFraction>&#160;million. Sobi has also agreed to make milestone payments totaling up to $<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="rnac:RevenueRemainingPerformanceObligationVariableConsiderationAmount" scale="6" id="f-558">630.0</ix:nonFraction>&#160;million to the Company upon the achievement of various development and regulatory milestones and, if commercialized, sales thresholds for annual net sales of NASP, and tiered royalty payments ranging from the low double digits on the lowest sales tier to the high teens on the highest sales tier. A more detailed description of the Sobi License and the Company&#8217;s evaluation of this agreement under ASC 606 can be found in Note 13, &#8220;Revenue Arrangements&#8221; to the consolidated financial statements in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2025. Any proceeds received from milestone payments or royalties relating to the Sobi License would be required to be distributed to holders of CVRs, net of certain deductions.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="f-556-2" continuedAt="f-556-3"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On June 28, 2024, Sobi initiated a rolling biologics license application to the FDA for NASP for the potential treatment of chronic refractory gout which resulted in the achievement of a development milestone and a $<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-559">30.0</ix:nonFraction>&#160;million payment obligation from Sobi to the Company. As a result, the development milestone was no longer constrained and $<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-560">30.0</ix:nonFraction>&#160;million was recognized as revenue during the year ended December 31, 2024 as there were no remaining performance obligations under the Sobi License. The proceeds from the achievement of the development milestone were received from Sobi in July 2024 and were included, net of deductions as specified in the CVR Agreement, in the distribution to holders of the CVRs in March 2025.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Grant revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">National Institute of Neurological Disorders and Stroke of the National Institutes of Health</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In June 2024, the Company received funding approval from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health, or NINDS, for an award of $<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:GovernmentAssistanceAwardAmount" scale="6" id="f-561">1.5</ix:nonFraction>&#160;million granted for the budget period, which ran from June 2024 through May 2025. In June 2025, the Company received funding approval from NINDS for an additional award of $<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-5" name="rnac:GovernmentAssistancePotentialAdditionalAwardAmount" scale="6" id="f-562">1.5</ix:nonFraction>&#160;million granted for the budget period that runs from June 2025 through May 2026. The funding was provided by NINDS to further the Company&#8217;s use of RNA-based CAR-T cells to combat autoantibody-associated autoimmune disorders. Grant funding is to be used solely for manufacturing of RNA-based CAR-T cells and analysis of samples to inform mechanism of action. The award period runs through May 31, 2026. The Company will recognize grant revenue when expenses reimbursable under the grant have been incurred. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026 and December 31, 2025, the Company recorded a <ix:nonNumeric contextRef="c-71" name="rnac:GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" id="f-563"><ix:nonNumeric contextRef="c-1" name="rnac:GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" id="f-564">receivable</ix:nonNumeric></ix:nonNumeric> of $<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-5" name="us-gaap:GovernmentAssistanceAmountCumulativeCurrent" scale="6" id="f-565">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-5" name="us-gaap:GovernmentAssistanceAmountCumulativeCurrent" scale="6" id="f-566">0.9</ix:nonFraction>&#160;million, respectively, that is subject to reimbursement by NINDS. The Company recognized grant revenue of $<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-5" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="f-567">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-5" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="f-568">0.7</ix:nonFraction>&#160;million during the three months ended March 31, 2026 and 2025, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Transaction Price Allocated to Future Performance Obligations</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-556-3">Remaining performance obligations represent the transaction price of contracts for which work has not been performed, or has been partially performed. As of March 31, 2026 and December 31, 2025, there were <ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:fixed-zero" scale="6" id="f-569"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:fixed-zero" scale="6" id="f-570">no</ix:nonFraction></ix:nonFraction> unsatisfied performance obligations from contracts with customers.</ix:continuation> </span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_136"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="c-1" name="rnac:CollaborationAndLicenseAgreementsTextBlock" id="f-571" continuedAt="f-571-1" escape="true">Collaboration and License Agreements</ix:nonNumeric></span></div><ix:continuation id="f-571-1" continuedAt="f-571-2"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Biogen MA, Inc.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On September 8, 2023, the Company entered into a non-exclusive, sublicensable, worldwide, perpetual patent license agreement, or the Biogen Agreement, with Biogen MA, Inc., or Biogen, to research, develop, make, use, offer, sell and import products or processes containing or using an engineering T-cell modified with an mRNA comprising, or encoding a protein comprising, certain sequences licensed under the Biogen Agreement for the prevention, treatment, palliation and management of autoimmune diseases and disorders, excluding cancers, neoplastic disorders, and paraneoplastic disorders. The Company is not obligated to pay Biogen any expenses, fees, or royalties.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company may terminate the Biogen Agreement for any reason or no reason, and Biogen may terminate the agreement after a notice-and-cure period of <ix:nonNumeric contextRef="c-151" name="rnac:CollaborativeArrangementWrittenNoticePeriodForTermination" format="ixt-sec:durday" id="f-572">30</ix:nonNumeric> days if the Company fails to pay a fee owed to Biogen or for any other material breach of the agreement. The Biogen Agreement will otherwise expire when all claims of all issued patents within the patents and patent applications licensed to the Company under the Biogen Agreement have expired or been finally rendered revoked, invalid or unenforceable by a decision of a court or government agency.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Biogen Agreement encompasses patents and patent applications in the PCT/US2010/026825 patent family, which was filed March 10, 2010. In general, all patents that issue in this family have an expected expiration date of March 10, 2030, subject to potential patent term adjustments and/or extensions. For the U.S. patents and applications in this family, U.S. Patent 9,034,324 was awarded 677 days of patent term adjustment, which would extend the expiration date of this patent to January 16, 2032, absent any challenges to the patent term. The other issued patent in this family was not awarded any patent term adjustment, so its expected expiration date is March 10, 2030.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">National Cancer Institute of the National Institutes of Health</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Effective September 16, 2019, the Company entered into a nonexclusive, worldwide license agreement, or the NCI Agreement, with the U.S. Department of Health and Human Services, represented by the National Cancer Institute of the National Institutes of Health, or NCI.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the NCI Agreement, the Company was granted a license under certain NCI patents and patent applications designated in the agreement, to make, use, sell, offer and import products and processes within the scope of the patents and applications licensed under the NCI Agreement when developing and manufacturing anti-BCMA CAR-T cell products for the </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="f-571-2"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">treatment of MG pemphigus vulgaris, and immune thrombocytopenic purpura according to methods designated in the NCI Agreement.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s entry into the NCI Agreement, Old Cartesian paid to NCI a one-time $<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="rnac:LicenseAndOptionAgreementRoyaltyPayment" scale="6" id="f-573">0.1</ix:nonFraction> million license royalty payment. Under the NCI Agreement, the Company is further required to pay NCI a low five-digit annual royalty. The Company must also pay earned royalties on net sales in a low single-digit percentage and pay up to $<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="rnac:LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum" scale="6" id="f-574">0.8</ix:nonFraction> million in benchmark royalties upon the Company&#8217;s achievement of designated benchmarks that are based on the commercial development plan agreed between the parties. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the NCI Agreement, the Company must use reasonable commercial efforts to bring licensed products and licensed processes to the point of Practical Application (as defined in the NCI Agreement). Upon the Company&#8217;s first commercial sale, the Company must use reasonable commercial efforts to make licensed products and licensed processes reasonably accessible to the United States public. After the Company&#8217;s first commercial sale, the Company must make reasonable quantities of licensed products or materials produced via licensed processes available to patient assistance programs and develop educational materials detailing the licensed products. Unless the Company obtains a waiver from NCI, the Company must have licensed products and licensed processes manufactured substantially in the United States. Prior to the first commercial sale, upon NCI&#8217;s request, the Company is obligated to provide NCI with commercially reasonable quantities of licensed products made through licensed processes to be used for in vitro research.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company must use reasonable commercial efforts to submit a BLA with respect to a licensed product by the fourth quarter of 2026 and make a first commercial sale of a licensed product by the fourth quarter of 2028.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The NCI Agreement terminates upon the expiration of the last to expire of the patent rights licensed thereunder, if not sooner terminated. The NCI Agreement encompasses patents and patent applications in the PCT/US2013/032029 patent family, which was filed March 15, 2013. In general, all patents that issue in this family have an expected expiration of March 15, 2033, subject to potential patent term adjustments and/or extensions. For the U.S. patents and applications in this family, only two patents were awarded patent term adjustments. U.S. Patent 9,765,342 was awarded 297 days of patent term adjustment, which would extend the expiration date of this patent to January 6, 2034, absent any challenges to the patent term. The other patent, U.S. Patent 10,876,123, was awarded three days of patent term adjustment, but this patent is subject to terminal disclaimers filed against other family members, so this patent will not extend beyond the March 15, 2033 date. The other issued patents in this family were not awarded any patent term adjustment, so the expected expiration date for these patents also remains March 15, 2033. There is also a pending patent application which, if issued, will expire on March 15, 2033, but could also be subject to patent term adjustment and to any potential future terminal disclaimers. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">NCI has the right to terminate the NCI Agreement, after giving written notice and providing a cure period in accordance with its terms, if the Company is in default of a material obligation. The Company has the unilateral right to terminate the agreement in any country or territory by giving NCI <ix:nonNumeric contextRef="c-152" name="rnac:CollaborativeArrangementWrittenNoticePeriodForTermination" format="ixt-sec:durday" id="f-575">60</ix:nonNumeric> days&#8217; written notice. The Company agreed to indemnify NCI against any liability arising out of the Company&#8217;s, sublicensees&#8217; or third parties&#8217; use of the licensed patent rights and licensed products or licensed processes developed in connection with the licensed patent rights.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Shenyang Sunshine Pharmaceutical Co., Ltd</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In May 2014, the Company entered into a license agreement, or the 3SBio License, with Shenyang Sunshine Pharmaceutical Co., Ltd., or 3SBio. The Company has paid to 3SBio an aggregate of $<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="rnac:AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid" scale="6" id="f-576">7.0</ix:nonFraction> million in upfront and milestone-based payments under the 3SBio License as of March 31, 2026. The Company is required to make future payments to 3SBio contingent upon the occurrence of events related to the achievement of clinical and regulatory approval milestones of up to an aggregate of $<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="rnac:AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform" scale="6" id="f-577">15.0</ix:nonFraction> million for products containing the Company&#8217;s ImmTOR platform.</span></div></ix:continuation><div id="ide29ba22317341cdb83bdf79fbf2d493_142"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-578" continuedAt="f-578-1" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="f-578-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026, the Company has not recorded any U.S. federal or state income tax benefits for either the net losses the Company has incurred or its earned research and orphan drug credits, due to the uncertainty of realizing a benefit from those items in the future.</span></div></ix:continuation><div id="ide29ba22317341cdb83bdf79fbf2d493_151"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-579" continuedAt="f-579-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-579-1" continuedAt="f-579-2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026, the Company was not a party to any litigation that could have a material adverse effect on the Company&#8217;s business, financial position, results of operations or cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Other</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As permitted under Delaware law, the Company indemnifies its officers, directors, consultants and employees for certain events or occurrences that happen by reason of the relationship with, or position held at the Company. Through March 31, </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="f-579-2"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2026, the Company had not experienced any losses related to these indemnification obligations, and no claims were outstanding. The Company does not expect significant claims related to these indemnification obligations and, consequently, concluded that the fair value of these obligations is negligible, and no related reserves were established.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, as permitted under Delaware law, the Company indemnifies its directors for certain events or occurrences while the director is, or was, serving at the Company&#8217;s request in such capacity. The term of the indemnification is for the director&#8217;s lifetime. The maximum potential amount of future payments the Company could be required to make is unlimited; however, the Company has directors&#8217; insurance coverage that limits its exposure and enables it to recover a portion of any future amounts paid. The Company also has indemnification arrangements under certain of its facility leases that require it to indemnify the landlord against certain costs, expenses, fines, suits, claims, demands, liabilities, and actions directly resulting from certain breaches, violations, or non-performance of any covenant or condition of the Company&#8217;s lease. The term of the indemnification is for the term of the related lease agreement. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited. To date, the Company had not experienced any material losses related to any of its indemnification obligations, and no material claims with respect thereto were outstanding.</span></div></ix:continuation><div id="ide29ba22317341cdb83bdf79fbf2d493_157"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-580" continuedAt="f-580-1" escape="true">Segment Reporting</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-581" escape="true"><ix:continuation id="f-580-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents selected financial information with respect to the Company&#8217;s single operating <ix:nonNumeric contextRef="c-1" name="rnac:NumberOfReportableSegmentsNotDisclosedFlag" id="f-582">segment</ix:nonNumeric> for the three months ended March 31, 2026 and 2025 (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration and license revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-583">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-584">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:RevenueNotFromContractWithCustomer" scale="3" id="f-585">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:RevenueNotFromContractWithCustomer" scale="3" id="f-586">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:Revenues" scale="3" id="f-587">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-588">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Descartes-08 for MG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-589">12,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-590">7,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Descartes-08 for dermatomyositis</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="f-591">227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:fixed-zero" scale="3" id="f-592">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Early stage programs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="f-593">355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="f-594">990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development employee expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-595">3,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-596">3,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="f-597">949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-598">1,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development facilities and other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-599">1,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-600">1,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-601">7,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-602">8,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income), net </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" sign="-" name="rnac:NonoperatingIncomeExpenseAdjusted" format="ixt:num-dot-decimal" scale="3" id="f-603">12,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="rnac:NonoperatingIncomeExpenseAdjusted" format="ixt:num-dot-decimal" scale="3" id="f-604">4,179</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-605">39,182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-606">17,710</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> Includes interest income; gain on change in fair value of warrant liabilities; (loss) gain on change in fair value of contingent value right liability; and other expense, net.</span></div></td></tr></table></div></ix:continuation></ix:nonNumeric><div id="ide29ba22317341cdb83bdf79fbf2d493_163"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-608" continuedAt="f-608-1" escape="true">Subsequent Events</ix:nonNumeric></span></div><ix:continuation id="f-608-1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated subsequent events through the date on which the consolidated financial statements were issued. The Company has concluded that no subsequent events have occurred that require disclosure.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="ide29ba22317341cdb83bdf79fbf2d493_166"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited consolidated financial statements and related notes appearing elsewhere in this Quarterly Report and with our audited financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2025, which we filed with the Securities and Exchange Commission, or the SEC, on March 9, 2026. In addition, you should read the &#8220;Risk Factors&#8221; and &#8220;Information Regarding Forward-Looking Statements&#8221; sections of this Quarterly Report and our Annual Report on Form 10-K for the year ended December 31, 2025 for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.</span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_169"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are a late clinical-stage biotechnology company pioneering cell therapy for the treatment of autoimmune diseases. We leverage our proprietary technology and manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell&#8217;s genetic material. Our cell therapies are designed to be dosed repeatedly like conventional drugs, administered in an outpatient setting, and given without pre-treatment chemotherapy, which is required with many conventional cell therapies. </span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_175"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Financial Operations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">To date, we have financed our operations primarily through public offerings and private placements of our securities, funding received from research grants, collaboration and license arrangements and a credit facility. We do not have any products approved for sale and have not generated any product sales.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We incurred net losses of $39.2 million and $17.7 million for the three months ended March 31, 2026 and 2025, respectively. As of March 31, 2026, we had an accumulated deficit of $861.6 million. We expect to continue to incur significant expenses and operating losses for the foreseeable future as we:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue to advance Descartes-08 for myasthenia gravis, or MG, through Phase 3 development;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">advance Descartes-08 for myositis into Phase 2 development;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue to develop our preclinical and clinical-stage product candidates;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek regulatory approvals for any product candidates that successfully complete clinical trials; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain, expand and protect our intellectual property portfolio, including through licensing arrangements;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">hire additional staff, including clinical, scientific and management personnel; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incur additional costs associated with continuing to operate as a public company.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Until we can generate substantial product revenues, we expect to finance our cash needs through a combination of equity offerings, debt financings, and license and collaboration agreements. We may be unable to raise capital when needed or on reasonable terms, if at all, which would force us to delay, limit, reduce or terminate our product development or future commercialization efforts. We will need to generate significant revenues to achieve profitability, and we may never do so.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash, cash equivalents, and restricted cash as of March 31, 2026 will enable us to fund our operating expenses and capital expenditure requirements for at least the next 12 months. We have based this estimate on assumptions that may prove to be wrong, and we could use our capital resources sooner than we currently expect.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Components of our Results of Operations</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration and license revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">To date, we have not generated any revenue from product sales. Our revenue consists primarily of collaboration and license revenue, which includes amounts recognized related to upfront and milestone payments for research and development funding under collaboration and license agreements. We expect that any revenue we generate will fluctuate from quarter to quarter because of the timing and amounts of fees, research and development reimbursements and other payments from collaborators. We do not expect to generate revenue from product sales for at least the next several years. If we or our collaborators fail to complete the development of our product candidates in a timely manner or fail to obtain regulatory approval as needed, our ability to generate future revenue will be harmed, and will affect the results of our operations and financial position. For further </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">descriptions of the agreements underlying our collaboration and license revenue, see Note 11, &#8220;Revenue Arrangements&#8221; to our unaudited consolidated financial statements included elsewhere in this Quarterly Report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Grant revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We generate grant revenue, which consists of funding received to perform specific research and development services under grant arrangements.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development expenses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development expenses consist of internal and external research and development costs, which primarily include fees paid to contract research organizations, internal manufacturing and quality related expenses, process development costs, internal research and development expenses, as well as fees paid to contract manufacturing organizations. These costs are primarily associated with compensation expenses for our research and development employees, capital equipment and supplies for our process development and manufacturing process, and other related expenses. Our internal research and development employees as well as our indirect costs are shared across multiple development programs and are not solely dedicated to individual programs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We expense research and development costs as incurred. Conducting a significant amount of research and development is central to our business model. Product candidates in clinical development generally have higher development costs than those in earlier stages of development, primarily due to the size, duration and cost of clinical trials. The successful development of our clinical and preclinical product candidates is highly uncertain. Clinical development timelines, the probability of success and development costs can differ materially from our expectations. For example, if the FDA or another regulatory authority were to require us to conduct clinical trials beyond those which we currently expect will be required for the completion of clinical development of a product candidate, or if we experience significant delays in enrollment in any of our clinical trials, we could be required to expend significant additional financial resources and time to complete any clinical development.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and administrative expenses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of salaries and related benefits, including stock-based compensation, related to our executive, finance, business development and support functions. Other general and administrative expenses include facility-related costs not otherwise allocated to research and development expenses, travel expenses for our general and administrative personnel and professional fees for auditing, tax and corporate legal services, including intellectual property-related legal services.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest income</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists primarily of income earned on our cash, cash equivalents and marketable securities.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gain on change in fair value of warrant liabilities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Common warrants classified as liabilities are remeasured quarterly at fair value with the change in fair value recognized as a component of earnings.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(Loss) gain on change in fair value of contingent value right liability</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The contingent value right liability is remeasured quarterly at fair value with the change in fair value recognized as a component of earnings.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other (expense) income, net</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other (expense) income, net consists of non-operating income and non-operating expenses.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="ide29ba22317341cdb83bdf79fbf2d493_178"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Three Months Ended March 31, 2026 and 2025</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Increase (Decrease)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration and license revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(622)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,022)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,201)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">26,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">22,989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,588&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(26,499)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(21,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,610)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Other (expense) income:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(989)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Gain on change in fair value of warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,724)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) gain on change in fair value of contingent value right liability</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(13,800)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(14,146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other (expense) income, net</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(12,683)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,179&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(16,862)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(39,182)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(17,710)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(21,472)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">NM - Not meaningful</span></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2026, we recognized $0.1 million of grant revenue, compared to $0.7 million for the three months ended March&#160;31, 2025, a decrease of $0.6 million. The decrease was primarily due to decreased expenses reimbursable under the grant from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health, or NINDS, incurred during the three months ended March 31, 2026.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Research and development expenses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following is a comparison of research and development expenses for the three months ended March 31, 2026 and 2025 (in thousands, except percentages):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Increase (Decrease)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Descartes-08 for MG</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,099&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Descartes-08 for dermatomyositis</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Early stage programs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(635)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development employee expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(326)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development facilities and other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,463&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,789&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">NM - Not meaningful</span></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2026, our research and development expenses were $19.5 million, compared to $14.7 million for the three months ended March&#160;31, 2025, an increase of $4.8 million. The increase was primarily due to an increase in expenses for Descartes-08 for MG, primarily related to the expenses for the ongoing Phase 3 AURORA trial. This increase was partially offset by a decrease in expenses for early stage programs, primarily related to our decision to no longer pursue development of Descartes-08 in systemic lupus erythematosus.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">General and administrative expenses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2026, our general and administrative expenses were $7.1 million, compared to $8.3 million for the three months ended March&#160;31, 2025, a decrease of $1.2 million. The decrease was primarily the result of lower professional and consulting fees.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest income</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Interest income for the three months ended March 31, 2026 was $1.0 million, compared to $2.0 million for the three months ended March&#160;31, 2025, a decrease of $1.0 million. The decrease in interest income was due to decreased cash and cash equivalents balance.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gain on change in fair value of warrant liabilities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2026, we recognized $0.1 million of income from the decrease in the fair value of warrant liabilities, compared to $1.8 million of income from the decrease in the fair value of warrant liabilities for the three months ended March&#160;31, 2025, a decrease of $1.7 million. Fair value of warrant liabilities was determined utilizing the Black-Scholes valuation methodology. The decrease in warrant value was primarily driven by a decrease in the per-share price of our common stock and a decrease in the remaining expected life of the warrants.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">(Loss) gain on change in fair value of contingent value right liability</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2026, we recognized $13.8 million of expense associated with the increase in the fair value of the CVR liability, compared to $0.3 million of income from the decrease in the fair value of the CVR liability for the three months ended March&#160;31, 2025, an increase of $14.1 million. The fair value of the CVR liability was determined utilizing a Monte Carlo simulation model. The increase in the fair value of the CVR liability was primarily due to the passage of time. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other expense, net</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2026, we recognized immaterial other expense, net, compared to no other expense, net for the three months ended March&#160;31, 2025. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net loss</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net loss for three months ended March 31, 2026 was $39.2 million as compared to net loss of $17.7 million for the three months ended March&#160;31, 2025, an increase of $21.5 million. The increase in net loss was primarily due to higher expense from </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">the change in the fair value of the CVR liability, an increase in research and development expenses and lower revenue and interest income the three months ended March 31, 2026.</span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_187"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred recurring net losses since our inception. We expect that we will continue to incur losses and that such losses will increase for the foreseeable future. We expect that our research and development and general and administrative expenses will continue to increase and, as a result, we will need additional capital to fund our operations, which we may raise through a combination of equity offerings, debt financings, third-party funding, potential royalty and/or milestone monetization transactions and other collaborations and strategic alliances.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalents, and restricted cash were $120.4 million as of March 31, 2026, of which $1.7 million was restricted cash related to lease commitments.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our existing cash equivalents, we from time to time have received and may receive in the future research and development funding pursuant to our collaboration and license agreements. Currently, funding from payments under our collaboration agreements represent our only source of committed external funds. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The liability associated with the contingent value rights agreement, or CVR Agreement, entered into on December 6, 2023, will be settled solely through cash flow received under the Sobi License (as defined below) and any other Gross Proceeds (as such term is defined in the CVR Agreement) net of certain agreed deductions. Under the CVR Agreement, 100% of all milestone payments, royalties, and other amounts paid to us or our controlled entities under the Sobi License, and any other Gross Proceeds, in each case net of certain agreed deductions, will be distributed to holders of the CVRs. There is no contractual obligation for us to fund any amount related to the CVR liability.</span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_190"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Collaboration and License Agreements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In-licenses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In September 2023, we entered into a non-exclusive, sublicensable, worldwide, perpetual patent license agreement, or the Biogen Agreement, with Biogen MA, Inc., or Biogen, to research, develop, make, use, offer, sell and import products or processes containing or using an engineering T-cell modified with an mRNA comprising, or encoding a protein comprising, certain sequences licensed under the Biogen Agreement for the prevention, treatment, palliation and management of autoimmune diseases and disorders, excluding cancers, neoplastic disorders, and paraneoplastic disorders. We are not obligated to pay Biogen any expenses, fees, or royalties. For further description of the Biogen Agreement, see Note 12, &#8220;Collaboration and License Agreements&#8221; to our unaudited consolidated financial statements included elsewhere in this Quarterly Report.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Effective September 2019, we entered into a non-exclusive, worldwide license agreement, or the NCI Agreement, with the U.S. Department of Health and Human Services, represented by the National Cancer Institute of the National Institutes of Health, or NCI. Under the NCI Agreement, we were granted a license under certain NCI patents and patent applications designated in the agreement, to make, use, sell, offer and import products and processes within the scope of the patents and applications licensed under the NCI Agreement when developing and manufacturing anti-BCMA CAR-T cell products for the treatment of MG, pemphigus vulgaris, and immune thrombocytopenic purpura according to methods designated in the NCI Agreement. In connection with our entry into the NCI Agreement, we paid to NCI a one-time $0.1 million license royalty payment. Under the NCI Agreement, we are further required to pay NCI a low five-digit annual royalty. We must also pay earned royalties on net sales in a low single-digit percentage and pay up to $0.8 million in benchmark royalties upon our achievement of designated benchmarks that are based on the commercial development plan agreed between the parties. For further description of the NCI Agreement, see Note 12, &#8220;Collaboration and License Agreements&#8221; to our unaudited consolidated financial statements included elsewhere in this Quarterly Report.</span></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Out-licenses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, we entered into a License and Development Agreement, or as so amended, the Sobi License, with Swedish Orphan Biovitrum AB (publ.), or Sobi. Sobi paid us a one-time, upfront payment of $75 million, and upon the closing of a private placement of our common stock to Sobi at a price of $138.468 per share, we received an additional $25 million from Sobi. We are eligible to receive $630.0 million in milestone payments upon the achievement of various development and regulatory milestones and sales thresholds for annual net sales of Nanoecapsulated Sirolimus plus Pegadricase, or NASP, and tiered royalty payments ranging from the low double digits on the lowest sales tier to the high teens on the highest sales tier. Sobi has agreed to fund the Phase 3 clinical program of NASP, which commenced in September 2020. In July 2022, we received $10.0 million for the completion of the enrollment of the DISSOLVE II trial. In July 2024, we received $30.0&#160;million for the milestone associated with the initiation of a rolling biologics license application to the FDA for NASP for the potential treatment of chronic refractory gout by Sobi. Proceeds from milestone payments and royalties on sales of NASP, if any, are </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">required to be distributed, net of certain agreed deductions, to holders of the CVRs. For further description of the Sobi License, see Note 11, &#8220;Revenue Arrangements&#8221; to our unaudited consolidated financial statements included elsewhere in this Quarterly Report. </span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_193"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Financings</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;At the Market&#8221; Sales Agreement</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On December 13, 2024, the Company entered into a Sales Agreement, or the Sales Agreement, with Leerink Partners LLC to sell shares of the Company&#8217;s common stock, from time to time, through an &#8220;at the market&#8221; equity offering program under which Leerink Partners LLC acts as sales agent. The shares of common stock sold pursuant to the Sales Agreement will be issued pursuant to the Company&#8217;s shelf registration statement on Form S-3 (File No. 333-283803), filed on December 13, 2024 with the SEC and related prospectus supplement, filed on January 8, 2025 with the SEC, for aggregate gross sales proceeds of up to $100.0&#160;million. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2026, the Company sold 2,270,712 shares of its common stock pursuant to the Sales Agreement for net proceeds of approximately $14.6&#160;million after commissions and expenses. No shares were sold pursuant to the Sales Agreement during the three months ended March 31, 2025.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Future funding requirements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this Quarterly Report, we have not generated any revenue from product sales. We do not know when, or if, we will generate revenue from product sales. We will not generate significant revenue from product sales unless and until we obtain regulatory approval and commercialize one of our current or future product candidates. Our primary uses of capital are, and we expect will continue to be, compensation and related expenses, third-party clinical research and development services, laboratory and related supplies, clinical costs, legal and other regulatory expenses, milestone and royalty payments for in-licenses, and general overhead costs. We expect that we will continue to generate losses for the foreseeable future, and we expect the losses to increase as we continue the development of, and seek regulatory approvals for, our product candidates, and begin to commercialize any approved products. We are subject to risks in the development of our products, and we may encounter unforeseen expenses, difficulties, complications, delays and other unknown factors that may adversely affect our business. We expect that we will need substantial additional funding to support our continuing operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026, we had an accumulated deficit of $861.6 million. We anticipate operating losses to continue for the foreseeable future due to, among other things, costs related to research, development of our product candidates, conducting preclinical studies and clinical trials, and our administrative organization. We will require substantial additional financing to fund our operations and to continue to execute our strategy, and we will pursue a range of options to secure additional capital.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We regularly evaluate various potential sources of additional funding such as strategic collaborations, license agreements, debt issuance, potential royalty and/or milestone monetization transactions and the issuance of equity instruments to fund our operations. If we raise additional funds through strategic collaborations and alliances, which may include existing collaboration partners, we may have to relinquish valuable rights to our technologies or product candidates, or grant licenses on terms that are not favorable to us. To the extent that we raise additional capital through the sale of equity instruments, the ownership interest of our existing stockholders will be diluted, and other preferences may be necessary that adversely affect the rights of existing stockholders.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash, cash equivalents, and restricted cash as of March 31, 2026 will enable us to fund our operating expenses and capital expenditure requirements for at least the next 12 months. We may pursue additional cash resources through public or private equity or debt financings, by establishing collaborations with other companies or through the monetization of potential royalty and/or milestone payments pursuant to our existing collaboration and license arrangements. Management&#8217;s expectations with respect to our ability to fund current and long-term planned operations are based on estimates that are subject to risks and uncertainties. If actual results are different from management&#8217;s estimates, we may need to seek additional strategic or financing opportunities sooner than would otherwise be expected. However, there is no guarantee that any of these strategic or financing opportunities will be executed on favorable terms, and some could be dilutive to existing stockholders. If we are unable to obtain additional funding on a timely basis, we may be forced to significantly curtail, delay, or discontinue one or more of our planned research or development programs or be unable to expand our operations, meet long-term obligations or otherwise capitalize on our commercialization of our product candidates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our future capital requirements will depend on many factors, including:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope, progress, results and costs of our clinical trials, preclinical development, manufacturing, laboratory testing and logistics;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of product candidates that we pursue and the speed with which we pursue development;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our headcount growth and associated costs;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs, timing and outcome of regulatory review of our product candidates;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and timing of future commercialization activities, including manufacturing, marketing, sales and distribution, for any of our product candidates for which we receive marketing approval;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the revenue, if any, from commercial sales of our product candidates for which we receive marketing approval;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending any intellectual property-related claims;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of competing technological and market developments; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which we acquire or invest in businesses, products and technologies, including entering into licensing or collaboration arrangements for product candidates.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Cash Requirements due to Contractual Obligations and Other Commitments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are under agreement to lease approximately 32,294 square feet of laboratory and office space in Watertown, Massachusetts through May 2028. Remaining lease payments from March 31, 2026 through the end of the lease term total approximately $6.1 million. Payments made and remaining obligations on this lease liability are subject to potential reimbursement through deductions to CVR distributions as described in Note 5, &#8220;Fair Value Measurements&#8221; to our unaudited consolidated financial statements included elsewhere in this Quarterly Report and were reimbursed in the March 2025 CVR distribution. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023 we acquired two leases for office and laboratory space in Gaithersburg, Maryland, which expire in January 2027. Annualized rent is approximately $0.3 million and remaining lease payments from March 31, 2026 through the end of the lease term total approximately $0.3 million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In February 2024, we entered into an agreement to lease approximately 19,199 square feet of integrated manufacturing and office space in Frederick, Maryland. In May 2024, we entered into an amendment to lease an additional approximately 7,842 square feet at the same site. In August 2024, we entered into a second amendment to lease an additional approximately 2,009 square feet at the same site. In March 2025, we entered into a third amendment to lease an additional approximately 6,439 square feet at the same site. The leases expire coterminously in June 2031. Annualized base rent under the leases is approximately $1.4 million and is subject to annual increases in accordance with the terms of the lease agreement. The leases provide for a tenant improvement allowance of $0.8&#160;million. Remaining lease payments total $8.4 million through the end of the lease term.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are also party to certain license and collaboration agreements with Biogen, NCI, and Shenyang Sunshine Pharmaceutical Co., Ltd., or 3SBio. We may be obligated to make certain future payments which are contingent upon future events such as our achievement of specified regulatory and commercial milestones, or royalties on net product sales under these agreements. As of March 31, 2026, we were unable to estimate the timing or likelihood of achieving these milestones or generating future product sales. Payments made and remaining obligations on the license agreement with 3SBio are subject to potential reimbursement through deductions to CVR distributions as described in Note 5, &#8220;Fair Value Measurements&#8221; to our unaudited consolidated financial statements included elsewhere in this Quarterly Report. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="ide29ba22317341cdb83bdf79fbf2d493_196"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Cash Flows</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash (used in) provided by:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(22,135)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(23,108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,075)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8,025)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6,498)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(32,176)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating activities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities for the three months ended March 31, 2026 was $22.1 million compared to $23.1 million for the three months ended March&#160;31, 2025. The decrease in cash used in operating activities of approximately $1.0 million was primarily due to $22.2 million of net loss, adjusted for non-cash items, and $0.1 million of cash provided by changes in operating assets and liabilities, in each case during the three months ended March 31, 2026 compared to $16.0 million of net loss, adjusted for non-cash items, and $7.1 million of cash used in changes in operating assets and liabilities during the three months ended March&#160;31, 2025.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing activities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities for the three months ended March 31, 2026 was immaterial compared to $1.1 million for the three months ended March&#160;31, 2025, a decrease of approximately $1.1 million. The net cash used in investing activities for the three months ended March 31, 2026 and 2025 consisted of purchases of property and equipment. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing activities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities for the three months ended March 31, 2026 was $15.7 million compared to net cash used in financing activities of $8.0 million for the three months ended March&#160;31, 2025, an increase of approximately $23.7 million. The net cash provided by financing activities in the three months ended March 31, 2026 was primarily from $15.4 million in proceeds from sales of our common stock pursuant to the Sales Agreement, net of commissions and expenses. The net cash used in financing activities in the three months ended March&#160;31, 2025 was primarily the result of payments for the CVR distribution.</span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_199"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of recently adopted or issued accounting pronouncements refer to Note 2, &#8220;Summary of Significant Accounting Policies&#8221; to our unaudited consolidated financial statements included elsewhere in this Quarterly Report.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026, we did not have any off-balance sheet arrangements as defined in the rules and regulations of the SEC.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Use of Estimates</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our management&#8217;s discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America, or U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities in our consolidated financial statements. Actual results may differ from these estimates under different assumptions or conditions. During the three months ended March 31, 2026, there were no material changes to our critical accounting policies from those described in our Annual Report on Form 10-K for the year ended December 31, 2025.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Smaller Reporting Company</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We qualify as a &#8220;smaller reporting company&#8221; under the rules of the Securities Act and the Exchange Act. As a result, we may choose to take advantage of certain scaled disclosure requirements available specifically to smaller reporting companies. We will remain a smaller reporting company until the last day of the fiscal year in which the aggregate market value of our common stock held by non-affiliated persons and entities, or our public float, is more than $700 million as of the last business </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">day of our most recently completed second fiscal quarter, or until the fiscal year following the year in which we have at least $100 million in revenue and at least $250 million in public float as of the last business day of our most recently completed second fiscal quarter.</span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_202"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The market risk inherent in our financial instruments and in our financial position represents the potential loss arising from adverse changes in interest rates. As of March 31, 2026 and December 31, 2025, we had cash, cash equivalents, and restricted cash of $120.4 million and $126.9 million, respectively, consisting of non-interest and interest-bearing money market accounts. Our primary exposure to market risk is interest rate sensitivity, which is affected by changes in the general level of U.S. interest rates. Due to the short-term and the low risk profile of our money market accounts and marketable securities, and our current policy to hold marketable securities to maturity, an immediate 100 basis point change in interest rates would not have a material effect on the fair market value of our cash equivalents or short-term marketable securities.</span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_205"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated, as of the end of the period covered by this Quarterly Report, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of March 31, 2026.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Inherent Limitations on Effectiveness of Controls</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There are inherent limitations to the effectiveness of any system of internal control over financial reporting. Accordingly, even an effective system of internal control over financial reporting can only provide reasonable assurance with respect to financial statement preparation and presentation in accordance with U.S. GAAP. Our internal controls over financial reporting are subject to various inherent limitations, including cost limitations, judgments used in decision making, assumptions about the likelihood of future events, the soundness of our systems, the possibility of human error, and the risk of fraud. Moreover, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may be inadequate because of changes in conditions and the risk that the degree of compliance with policies or procedures may deteriorate over time.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="ide29ba22317341cdb83bdf79fbf2d493_208"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PART II. OTHER INFORMATION</span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_211"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Legal Proceedings</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_214"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">See the risk factors previously disclosed in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025. There have been no material changes from the risk factors previously disclosed in such filings.</span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_241"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_244"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. Defaults Upon Senior Securities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_247"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. Mine Safety Disclosures</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_250"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5. Other Information</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal quarter ended March 31, 2026, no officer or director, as defined in Rule 16a-1(f) of the Exchange Act, informed us of the <ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-609"><ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-610">adoption</ix:nonNumeric></ix:nonNumeric>, modification or <ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-611"><ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-612">termination</ix:nonNumeric></ix:nonNumeric> of any &#8220;Rule 10b5-1 trading arrangement&#8221; or a &#8220;non-Rule 10b5-1 trading arrangement,&#8221; as those terms are defined in Item 408 of Regulation S-K .</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_256"></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;Exhibits</span></div><div id="ide29ba22317341cdb83bdf79fbf2d493_259"></div><div style="-sec-extract:summary;margin-bottom:9pt;margin-top:6pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:49.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.747%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.996%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">File No.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Filing<br/>Date</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.1*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1453687/000119312523275461/d869185dex21.htm">Agreement and Plan of Merger, dated November 13, 2023, by and among Selecta Biosciences, Inc., Sakura Merger Sub I, Inc., Sakura Merger Sub II, LLC, and Cartesian Therapeutics, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-37798</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11/13/2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.1(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1453687/000110465916129891/a16-14002_1ex3d1.htm">Restated Certificate of Incorporation of Selecta Biosciences, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-37798</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6/29/2016</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.1(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001453687/000145368722000109/exhibit31_charteramendment.htm">Certificate of Amendment to the Restated Certificate of Incorporation of Selecta Biosciences, Inc., dated June 21, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-37798</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6/21/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.1(c)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1453687/000119312523275461/d869185dex33.htm">Certificate of Amendment to the Restated Certificate of Incorporation of Selecta Biosciences, Inc., dated November 13, 2023</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-37798</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11/13/2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.1(d)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1453687/000145368724000048/exhibit32certificateofamen.htm">Certificate of Amendment to the Restated Certificate of Incorporation, as amended, of Cartesian Therapeutics, Inc., dated March 28, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-37798</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/28/2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1453687/000114036125039793/ef20057980_ex3-2.htm">Amended and Restated By-laws of Cartesian Therapeutics, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-37798</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10/30/2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.1(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1453687/000119312523275461/d869185dex34.htm">Certificate of Designation of Preferences, Rights and Limitations of Series A Non-Voting Convertible Preferred Stock</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-37798</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11/13/2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.1(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1453687/000145368724000048/exhibit31certificateofamen.htm">Certificate of Amendment to the Certificate of Designation of Series A Non-Voting Convertible Preferred Stock, dated March 26, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-37798</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/28/2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1453687/000114036124032080/ef20031962_ex3-1.htm">Certificate of Designation of Preferences, Rights and Limitations of Series B Non-Voting Convertible Preferred Stock</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-37798</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7/2/2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="employementagreement_mil.htm">Employment Agreement, date</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="employementagreement_mil.htm">d</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="employementagreement_mil.htm"> as of March 26, 2024, by and between the Registrant and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="employementagreement_mil.htm">Milos Miljkovic</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="employementagreement_mil.htm">, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="employementagreement_mil.htm">M</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="employementagreement_mil.htm">D.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311_3312026.htm">Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312_3312026.htm">Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321_3312026.htm">Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document (the Instance Document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">* Certain annexes, schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted attachment to the SEC on a confidential basis upon request.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"># Indicates management contract or compensatory plan.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="ide29ba22317341cdb83bdf79fbf2d493_262"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ide29ba22317341cdb83bdf79fbf2d493_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant in the capacities and on the dates indicated.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:27.785%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.920%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.152%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:42.743%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">CARTESIAN THERAPEUTICS, INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date: April&#160;30, 2026</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Carsten Brunn, Ph.D.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Carsten Brunn, Ph.D.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President, Chief Executive Officer and Chairman of the Board</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date: April&#160;30, 2026</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Blaine Davis</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Blaine Davis</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>employementagreement_mil.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>employementagreement_mil</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- employementagreement_mil001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="employementagreement_mil001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Employment Agreement  This Employment Agreement (this &#8220;Agreement&#8221;), dated as of March 26, 2024, is made  by and between Cartesian Therapeutics, Inc., a Delaware corporation (together with any  successor thereto, the &#8220;Company&#8221;), and Milos Miljkovic (&#8220;Executive&#8221;) (collectively referred  to as the &#8220;Parties&#8221; or individually referred to as a &#8220;Party&#8221;), and effective as of March 26, 2024  (the &#8220;Effective Date&#8221;).    RECITALS  A. It is the desire of the Company to assure itself of the continued services of Executive following the Effective Date (as defined below) and thereafter by entering into this Agreement. B. Executive and the Company mutually desire that Executive provide services to the Company on the terms herein provided. AGREEMENT  NOW, THEREFORE, in consideration of the foregoing and of the respective covenants  and agreements set forth below, the Parties hereto agree as follows:  1. Employment. (a) General.  Effective on the Effective Date, the Company shall continue to employ Executive and Executive shall continue to be employed by the Company, for the period and in  the positions set forth in this Section 1, and subject to the other terms and conditions herein  provided.   (b) At-Will Employment.  The Company and Executive acknowledge that  Executive&#8217;s employment is and shall continue to be at-will, as defined under applicable law, and  that Executive&#8217;s employment with the Company may be terminated by either Party at any time  for any or no reason (subject to the notice requirements of Section 3(b)).  This &#8220;at-will&#8221; nature of  Executive&#8217;s employment shall remain unchanged during Executive&#8217;s tenure as an employee and  may not be changed, except in an express writing signed by Executive and a duly authorized  officer of the Company.  If Executive&#8217;s employment terminates for any reason, Executive shall  not be entitled to any payments, benefits, damages, award or compensation other than as  provided in this Agreement or otherwise agreed to in writing by the Company or as provided by  applicable law.  The term of this Agreement (the &#8220;Term&#8221;) shall commence on the Effective Date  and end on the date this Agreement is terminated under Section 3.  (c) Positions and Duties.  Executive shall serve as the Chief Medical Officer of the Company with such responsibilities, duties and authority normally associated with such positions  and as may from time to time be reasonably assigned to Executive by the Chief Executive  Officer of the Company.  Executive shall devote substantially all of Executive&#8217;s working time  and efforts to the business and affairs of the Company (which shall include service to its  affiliates, if applicable), provided that Executive may engage in outside business activities  (including serving on outside boards or committees) following approval by the Board of  Directors of the Company or an authorized committee thereof (in either case, the &#8220;Board&#8221;) to the  DocuSign Envelope ID: 812750BB-25CE-4A4C-8C11-641E280F51C4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- employementagreement_mil002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="employementagreement_mil002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   2     extent such activities do not materially interfere with the performance of Executive&#8217;s duties and  responsibilities under this Agreement or violate the terms of the Restrictive Covenant Agreement  (defined below).  Executive agrees to observe and comply with the rules and policies of the  Company as adopted by the Company from time to time, in each case as amended from time to  time, as set forth in writing, and as delivered or made available to Executive (each, a &#8220;Policy&#8221;).  2. Compensation and Related Matters.  (a) Annual Base Salary.  During the Term, Executive shall receive a base salary at a  rate of $400,000 per annum, which shall be paid in accordance with the customary payroll  practices of the Company and shall be pro-rated for partial years of employment.  Such annual  base salary shall be reviewed (and may be increased) from time to time by the Board (such  annual base salary, as it may be increased from time to time, the &#8220;Annual Base Salary&#8221;).  (b) Bonus.  Executive will be eligible to participate in an annual incentive program  established by the Board. Executive&#8217;s annual incentive compensation under such incentive  program (the &#8220;Annual Bonus&#8221;) shall be targeted at 40% of Executive&#8217;s Annual Base Salary (the  &#8220;Target Bonus&#8221;). The Annual Bonus payable under the incentive program shall be based on the  achievement of performance goals to be determined by the Board. The payment of any Annual  Bonus will be made on or before March 15 of the year following the calendar year in which it is  earned, subject to Executive&#8217;s continued employment through the last day of such year.  (c) Benefits.  During the Term, Executive shall be eligible to participate in employee  benefit plans, programs and arrangements of the Company (including medical, dental, vision,  and 401(k) plans), consistent with the terms thereof and as such plans, programs and  arrangements may be amended from time to time.  In no event shall Executive be eligible to  participate in any severance plan or program of the Company, except as set forth in Section 4 of  this Agreement.  (d) Vacation.  During the Term, Executive shall be entitled to paid vacation in  accordance with the Company&#8217;s Policies. Any vacation shall be taken at the reasonable and  mutual convenience of the Company and Executive.   (e) Business Expenses.  During the Term, the Company shall reimburse Executive for  all reasonable travel and other business expenses incurred by Executive in the performance of  Executive&#8217;s duties to the Company in accordance with the Company&#8217;s expense reimbursement  Policy.   (f) Key Person Insurance.  At any time during the Term, the Company shall have the  right to insure the life of Executive for the Company&#8217;s sole benefit.  The Company shall have the  right to determine the amount of insurance and the type of policy.  Executive shall reasonably  cooperate with the Company in obtaining such insurance by submitting to physical examinations,  by supplying all information reasonably required by any insurance carrier, and by executing all  necessary documents reasonably required by any insurance carrier, provided that any information  provided to an insurance company or broker shall not be provided to the Company without the  prior written authorization of Executive.  Executive shall incur no financial obligation by  executing any required document, and shall have no interest in any such policy.    DocuSign Envelope ID: 812750BB-25CE-4A4C-8C11-641E280F51C4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- employementagreement_mil003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="employementagreement_mil003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   3     3. Termination.  Executive&#8217;s employment hereunder may be terminated by the Company or Executive, as  applicable, without any breach of this Agreement under the following circumstances:  (a) Circumstances.  (i) Death.  Executive&#8217;s employment hereunder shall terminate upon  Executive&#8217;s death.  (ii) Disability.  If Executive has incurred a Disability, as defined below, the  Company may terminate Executive&#8217;s employment.  (iii) Termination for Cause.  The Company may terminate Executive&#8217;s  employment for Cause, as defined below.  (iv) Termination without Cause.  The Company may terminate Executive&#8217;s  employment without Cause.  (v) Resignation from the Company with Good Reason.  Executive may resign  Executive&#8217;s employment with the Company with Good Reason, as defined below.  (vi) Resignation from the Company without Good Reason.  Executive may  resign Executive&#8217;s employment with the Company for any reason other than Good  Reason or for no reason.  (b) Notice of Termination.  Any termination of Executive&#8217;s employment by the  Company or by Executive under this Section 3 (other than termination pursuant to Section  3(a)(i)) shall be communicated by a written notice to the other Party hereto (i) indicating the  specific termination provision in this Agreement relied upon, (ii) setting forth in reasonable  detail the facts and circumstances claimed to provide a basis for termination of Executive&#8217;s  employment under the provision so indicated, if applicable, and (iii) specifying a Date of  Termination which, except in the case of a termination pursuant to Section 3(a)(iii), shall be at  least thirty (30) days following the date of such notice, but no more than forty (40) days  following the date of such notice (a &#8220;Notice of Termination&#8221;); provided, however, that the  Company may deliver a Notice of Termination to Executive that specifies any Date of  Termination that occurs on or after the date of the Notice of Termination (but no more than forty  (40) days following the date of such notice) and, in the event that Executive delivers a Notice of  Termination to the Company, the Company may, in its sole discretion, change the Date of  Termination to any date that occurs on or following the date of the Notice of Termination and is  prior to the Date of Termination specified in the Notice of Termination, provided, in either case ,  that if the Company selects a Date of Termination that is less than thirty (30) days after the date  of the Notice of Termination the Company will pay Executive the base salary Executive would  have earned during the period commencing on the Date of Termination selected by the Company  and ending thirty (30) days after the date of the Notice of Termination.  The failure by either  party to set forth in the Notice of Termination any fact or circumstance shall not waive any right  DocuSign Envelope ID: 812750BB-25CE-4A4C-8C11-641E280F51C4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- employementagreement_mil004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="employementagreement_mil004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   4     of the party hereunder or preclude the party from asserting such fact or circumstance in enforcing  the party&#8217;s rights hereunder.  (c) Company Obligations upon Termination.  Upon termination of Executive&#8217;s  employment pursuant to any of the circumstances listed in this Section 3, Executive (or  Executive&#8217;s estate) shall be entitled to receive the sum of:  (i) the portion of Executive&#8217;s Annual  Base Salary earned through the Date of Termination, but not yet paid to Executive; (ii) any  unpaid Annual Bonus earned by Executive for the year prior to the year in which the Date of  Termination occurs, as determined by the Board in its good faith discretion based upon actual  performance achieved, which Annual Bonus, if any, shall be paid to Executive when bonuses for  such year are paid to actively employed senior executives of the Company but in no event later  than March 15 of the year in which the Date of Termination occurs; (iii) any expenses owed to  Executive pursuant to Section 2(e); and (iv) any amount accrued and arising from Executive&#8217;s  participation in, or benefits accrued under any employee benefit plans, programs or  arrangements, which amounts shall be payable in accordance with the terms and conditions of  such employee benefit plans, programs or arrangements (collectively, the &#8220;Company  Arrangements&#8221;).  Except as otherwise expressly required by law (e.g., COBRA) or as  specifically provided in a benefit plan or herein, all of Executive&#8217;s rights to salary, severance,  benefits, bonuses and other compensatory amounts hereunder (if any) shall cease upon the  termination of Executive&#8217;s employment hereunder.    (d) Deemed Resignation.  Upon termination of Executive&#8217;s employment for any  reason, Executive shall be deemed to have resigned from all offices and directorships, if any,  then held with the Company or any of its subsidiaries.  4. Severance Payments.  (a) Termination for Cause, or Termination Upon Death, Disability or Resignation  from the Company Without Good Reason.  If Executive&#8217;s employment shall terminate as a result  of Executive&#8217;s death pursuant to Section 3(a)(i) or Disability pursuant to Section 3(a)(ii),  pursuant to Section 3(a)(iii) for Cause, or pursuant to Section 3(a)(vi) for Executive&#8217;s resignation  from the Company without Good Reason, then Executive shall not be entitled to any severance  payments or benefits, except as provided in Section 3(c).  (b) Termination without Cause, or Resignation from the Company with Good  Reason.  If Executive&#8217;s employment terminates without Cause pursuant to Section 3(a)(iv), or  pursuant to Section 3(a)(v) due to Executive&#8217;s resignation with Good Reason, then, subject to  Executive signing on or before the 60th day following Executive&#8217;s Separation from Service (as  defined below), and not revoking, a release of claims (which Executive will receive no later than  ten (10) business days following Executive&#8217;s Separation from Service) substantially in the form  attached as Exhibit A to this Agreement (the &#8220;Release&#8221;), and Executive&#8217;s continued compliance  with Section 5, Executive shall receive, in addition to payments and benefits set forth in  Section 3(c), the following:  (i) an amount in cash equal to the Annual Base Salary, payable in the form of  salary continuation in regular installments over the 12-month period following the date of  DocuSign Envelope ID: 812750BB-25CE-4A4C-8C11-641E280F51C4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- employementagreement_mil005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="employementagreement_mil005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   5     Executive&#8217;s Separation from Service (the &#8220;Severance Period&#8221;) in accordance with the  Company&#8217;s normal payroll practices, commencing on the Company&#8217;s next regular  payday following the effective date of the Release (with the first payment including all  amounts accrued to date) (the &#8220;Payment Date&#8221;);   (ii) a pro-rata portion of the Annual Bonus, payable in the form of a lump sum  payment, in an amount equal to the product of (A)(i) the Target Bonus, if the Date of  Termination occurs during the first quarter of the calendar year or (ii) the Annual Bonus  amount based on actual performance as determined by the Board, if the Date of  Termination occurs after the first quarter of the calendar year, multiplied by (B) a  fraction, using the number of full months of the year elapsed prior to the Date of  Termination as the numerator and 12 as the denominator, payable in either case by the  later of March 15 of the year following the year in which the Date of Termination occurs  and the Payment Date; and  (iii) if Executive elects to receive continued medical, dental and/or vision  coverage under one or more of the Company&#8217;s group healthcare plans pursuant to the  Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;COBRA&#8221;), the  Company shall directly pay, or reimburse Executive for, the COBRA premiums for  Executive and Executive&#8217;s covered dependents under such plans during the period  commencing on Executive&#8217;s Separation from Service and ending upon the earliest of (X)  the last day of the Severance Period, (Y) the date that Executive and/or Executive&#8217;s  covered dependents become no longer eligible for COBRA or (Z) the date Executive  becomes eligible to receive medical, dental or vision coverage, as applicable, from a  subsequent employer (and Executive agrees to promptly notify the Company of such  eligibility).  Notwithstanding the foregoing, if the Company determines in its sole  discretion that it cannot provide the foregoing benefit without potentially violating  applicable law (including, without limitation, Section 2716 of the Public Health Service  Act) or incurring an excise tax, the Company may alter the manner in which medical,  dental or vision coverage is provided to Executive after the Date of Termination so long  as such alteration does not increase the after-tax cost to Executive of such benefits.   (c) Change in Control.  Notwithstanding anything to the contrary in any applicable  Company equity plan or equity agreement, in the event Executive&#8217;s employment terminates  without Cause pursuant to Section 3(a)(iv), or pursuant to Section 3(a)(v) due to Executive&#8217;s  resignation with Good Reason, in either case, within 60 days prior to or on or within 12 months  following the date of a Change in Control, subject to Executive signing on or before the 60th day  following Executive&#8217;s Separation from Service, and not revoking, the Release (which the  Executive will receive no later than ten(10) business days following Executive&#8217;s Separation from  Service) and Executive&#8217;s continued compliance with Section 5, Executive shall receive, in  addition to the payments and benefits set forth in Section 3(c) and Section 4(b), immediate  vesting of all unvested equity or equity-based awards held by Executive under any Company  equity compensation plans that vest solely based on the passage of time (for the avoidance of  doubt, with any such awards that vest in whole or in part based on the attainment of  performance-vesting conditions being governed by the terms of the applicable award agreement).  DocuSign Envelope ID: 812750BB-25CE-4A4C-8C11-641E280F51C4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- employementagreement_mil006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="employementagreement_mil006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   6     (d) Survival.  Notwithstanding anything to the contrary in this Agreement, the  provisions of Sections 5 through 9 will survive the termination of Executive&#8217;s employment and  the termination of the Term.  5. Restrictive Covenants.  As a condition to the effectiveness of this Agreement, Executive  will execute and deliver to the Company contemporaneously herewith the Employee  Nondisclosure, Assignment of Intellectual Property and Restrictive Covenant Agreement (the  &#8220;Restrictive Covenant Agreement&#8221;) attached hereto as Exhibit B.  Executive agrees to abide by  the terms of the Restrictive Covenant Agreement, which are hereby incorporated by reference  into this Agreement.  Executive acknowledges that the provisions of the Restrictive Covenant  Agreement will survive the termination of Executive&#8217;s employment and the termination of the  Term for the periods set forth in the Restrictive Covenant Agreement.  6. Assignment and Successors.  The Company may assign its rights and obligations under this Agreement to any of its  affiliates or to any successor to all or substantially all of the business or the assets of the  Company (by merger or otherwise).  This Agreement shall be binding upon and inure to the  benefit of the Company, Executive and their respective successors, assigns, personnel and legal  representatives, executors, administrators, heirs, distributees, devisees, and legatees, as  applicable.  None of Executive&#8217;s rights or obligations may be assigned or transferred by  Executive, other than Executive&#8217;s rights to payments hereunder, which may be transferred only  by will or operation of law.  Notwithstanding the foregoing, Executive shall be entitled, to the  extent permitted under applicable law and applicable Company Arrangements, to select and  change a beneficiary or beneficiaries to receive compensation hereunder following Executive&#8217;s  death by giving written notice thereof to the Company.    7. Certain Definitions.  (a) Cause.  The Company shall have &#8220;Cause&#8221; to terminate Executive&#8217;s employment  hereunder upon:  (i) Executive&#8217;s substantial failure to perform (other than by reason of  Disability), or substantial negligence in the performance of, Executive&#8217;s duties and  responsibilities to the Company or any of its affiliates;  (ii) Executive&#8217;s commission of, or indictment or conviction for, any felony or  any crime involving dishonesty by Executive;   (iii) Executive&#8217;s participation in any fraud against the Company or any of its  affiliates;  (iv) Any intentional material damage to any property of the Company or any  of its affiliates by Executive;  (v) Executive&#8217;s misconduct which materially and adversely reflects upon the  business, operations or reputation of the Company or any of its affiliates, which  DocuSign Envelope ID: 812750BB-25CE-4A4C-8C11-641E280F51C4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- employementagreement_mil007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="employementagreement_mil007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   7     misconduct has not been cured (or cannot be reasonably cured) within thirty (30) days  after the Company  gives written notice to Executive regarding such misconduct; or  (vi) Executive&#8217;s breach of any material provision of this Agreement or any  other written agreement between Executive and the Company or any of its affiliates and  failure to cure such breach (if reasonably capable of cure) within thirty (30) days after the  Company gives written notice to Executive regarding such breach.    (b) Change in Control.  &#8220;Change in Control&#8221; shall have the meaning set forth in the  version of the Selecta Biosciences, Inc. 2016 Incentive Award Plan in effect on the Effective  Date.   (c) Code.  &#8220;Code&#8221; shall mean the Internal Revenue Code of 1986, as amended, and  the regulations and guidance promulgated thereunder.  (d) Date of Termination.  &#8220;Date of Termination&#8221; shall mean (i) if Executive&#8217;s  employment is terminated by Executive&#8217;s death, the date of Executive&#8217;s death; or (ii) if  Executive&#8217;s employment is terminated pursuant to Section 3(a)(ii) &#8211; (vi) either the date indicated  in the Notice of Termination or the date specified by the Company pursuant to Section 3(b),  whichever is earlier.  (e) Disability.  &#8220;Disability&#8221; shall mean, at any time the Company or any of its  affiliates sponsors a long-term disability plan for the Company&#8217;s employees, &#8220;disability&#8221; as  defined in such long-term disability plan for the purpose of determining a participant&#8217;s eligibility  for benefits, provided, however, if the long-term disability plan contains multiple definitions of  disability, &#8220;Disability&#8221; shall refer to that definition of disability which, if Executive qualified for  such disability benefits, would provide coverage for the longest period of time.  The  determination of whether Executive has a Disability shall be made by the person or persons  required to make disability determinations under the long-term disability plan.  At any time the  Company does not sponsor a long-term disability plan for its employees, &#8220;Disability&#8221; shall mean  Executive&#8217;s inability to perform, with or without reasonable accommodation, the essential  functions of Executive&#8217;s positions hereunder for a total of six months during any twelve-month  period as a result of incapacity due to mental or physical illness as determined by a physician  selected by the Company or its insurers and acceptable to Executive or Executive&#8217;s legal  representative, with such agreement as to acceptability not to be unreasonably withheld or  delayed.  Any unreasonable refusal by Executive to submit to a medical examination for the  purpose of determining Disability shall be deemed to constitute conclusive evidence of  Executive&#8217;s Disability.   (f) Good Reason.  For the sole purpose of determining Executive&#8217;s right to severance  payments and benefits as described above, Executive&#8217;s resignation will be for &#8220;Good Reason&#8221; if  Executive resigns within six months after any of the following events, unless Executive consents  to the applicable event in writing:  (i) a material reduction in Executive&#8217;s Annual Base Salary or  Target Bonus, (ii) a material diminution in Executive&#8217;s authority, title or duties or areas of  responsibility, (iii) the relocation of Executive&#8217;s primary office to a location more than 40 miles  from the Company&#8217;s office in Maryland on the Effective Date, or (iv) a material breach by the  DocuSign Envelope ID: 812750BB-25CE-4A4C-8C11-641E280F51C4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- employementagreement_mil008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="employementagreement_mil008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   8     Company of this Agreement or any other written agreement with Executive.  Notwithstanding  the foregoing, no Good Reason will have occurred unless and until Executive has:  (a) provided  the Company, within 60 days of Executive&#8217;s knowledge of the occurrence of the facts and  circumstances underlying the Good Reason event, written-notice stating with specificity the  applicable facts and circumstances underlying such finding of Good Reason, and (b) provided  the Company with an opportunity to cure the same within 30 days after the receipt of such  notice.  8. Parachute Payments.  (a) Notwithstanding any other provisions of this Agreement or any Company equity  plan or agreement, in the event that any payment or benefit by the Company or otherwise to or  for the benefit of Executive, whether paid or payable or distributed or distributable pursuant to  the terms of this Agreement or otherwise (all such payments and benefits, including the  payments and benefits under Section 4(b) and Section 4(c) hereof, being hereinafter referred to  as the &#8220;Total Payments&#8221;), would be subject (in whole or in part) to the excise tax imposed by  Section 4999 of the Code (the &#8220;Excise Tax&#8221;), then the Total Payments shall be reduced (in the  order provided in Section 8(b)) to the minimum extent necessary to avoid the imposition of the  Excise Tax on the Total Payments, but only if (i) the net amount of such Total Payments, as so  reduced (and after subtracting the net amount of federal, state and local income and employment  taxes on such reduced Total Payments and after taking into account the phase out of itemized  deductions and personal exemptions attributable to such reduced Total Payments), is greater than  or equal to (ii) the net amount of such Total Payments without such reduction (but after  subtracting the net amount of federal, state and local income and employment taxes on such  Total Payments and the amount of the Excise Tax to which Executive would be subject in  respect of such unreduced Total Payments and after taking into account the phase out of itemized  deductions and personal exemptions attributable to such unreduced Total Payments).  (b) The Total Payments shall be reduced in the following order:  (i) reduction on a  pro-rata basis of any cash severance payments that are exempt from Section 409A of the Code  (&#8220;Section 409A&#8221;), (ii) reduction on a pro-rata basis of any non-cash severance payments or  benefits that are exempt from Section 409A, (iii) reduction on a pro-rata basis of any other  payments or benefits that are exempt from Section 409A, and (iv) reduction of any payments or  benefits otherwise payable to Executive on a pro-rata basis or such other manner that complies  with Section 409A; provided, in case of clauses (ii), (iii) and (iv), that reduction of any payments  attributable to the acceleration of vesting of Company equity awards shall be first applied to  Company equity awards that would otherwise vest last in time.  (c) The Company will select an accounting firm or consulting group with experience  in performing calculations regarding the applicability of Section 280G of the Code and the  Excise Tax (the &#8220;Independent Advisors&#8221;) to make determinations regarding the application of  this Section 8.  For purposes of such determinations, no portion of the Total Payments shall be  taken into account which, in the opinion of the Independent Advisors, (i) does not constitute a  &#8220;parachute payment&#8221; within the meaning of Section 280G(b)(2) of the Code (including by reason  of Section 280G(b)(4)(A) of the Code) or (ii) constitutes reasonable compensation for services  actually rendered, within the meaning of Section 280G(b)(4)(B) of the Code, in excess of the  DocuSign Envelope ID: 812750BB-25CE-4A4C-8C11-641E280F51C4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- employementagreement_mil009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="employementagreement_mil009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   9     &#8220;base amount&#8221; (as defined in Section 280G(b)(3) of the Code) allocable to such reasonable  compensation.  The costs of obtaining such determination and all related fees and expenses  (including related fees and expenses incurred in any later audit) shall be borne by the Company.  (d) If Executive incurs legal fees or other expenses (including expert witness and  accounting fees) in an effort to determine the applicability of this Section 8 or establish  entitlement to or obtain any portion of the Total Payments that have been reduced under this  Section 8 (collectively, &#8220;Legal and Other Expenses&#8221;), Executive shall be entitled to payment of  or reimbursement for such Legal and Other Expenses in accordance with this Section 8(d).   Subject to Sections 9(1)(iv) and 9(m) and the other provisions of this Section 8, the Company  will reimburse all Legal and Other Expenses on a monthly basis reasonably promptly after  presentation of Executive&#8217;s written request for reimbursement accompanied by evidence  reasonably acceptable to the Company that such Legal and Other Expenses were incurred.  If the  Company establishes before a court of competent jurisdiction that Executive had no reasonable  basis for a claim made by Executive hereunder, or acted in bad faith, no further payment of or  reimbursement for Legal and Other Expenses shall be due to Executive in respect of such claim,  and Executive shall refund any amounts previously paid or reimbursed hereunder with respect to  such claim.  (e) In the event it is later determined that to implement the objective and intent of this  Section 8, (i) a greater reduction in the Total Payments should have been made, the excess  amount shall  be returned promptly by Executive to the Company or (ii) a lesser reduction in the  Total Payments should have been made, the excess amount shall be paid or provided promptly  by the Company to Executive, except to the extent the Company reasonably determines would  result in imposition of additional tax under Section 409A.  9. Miscellaneous Provisions.  (a) Governing Law.  This Agreement shall be governed, construed, interpreted and  enforced in accordance with its express terms, and otherwise in accordance with the substantive  laws of the State of Maryland without reference to the principles of conflicts of law of the State  of Maryland or any other jurisdiction that would result in application of the laws of a jurisdiction  other than the State of Maryland, and where applicable, the laws of the United States.  (b) Validity.  The invalidity or unenforceability of any provision or provisions of this  Agreement shall not affect the validity or enforceability of any other provision of this  Agreement, which shall remain in full force and effect.    (c) Notices.  Any notice, request, claim, demand, document and other communication  hereunder to any Party shall be effective upon receipt (or refusal of receipt) and shall be in  writing and delivered personally or sent by facsimile or certified or registered mail, postage  prepaid, as follows:  (i) If to the Company, to the General Counsel of the Company at the  Company&#8217;s headquarters,  DocuSign Envelope ID: 812750BB-25CE-4A4C-8C11-641E280F51C4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- employementagreement_mil010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="employementagreement_mil010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   10     (ii) If to Executive, to the last address that the Company has in its personnel  records for Executive, or  (iii) At any other address as any Party shall have specified by notice in writing  to the other Party.  (d) Counterparts.  This Agreement may be executed in several counterparts, each of  which shall be deemed to be an original, but all of which together will constitute one and the  same Agreement.  Signatures delivered by facsimile or PDF shall be deemed effective for all  purposes.  (e) Entire Agreement.  The terms of this Agreement, the Restrictive Covenant  Agreement incorporated herein by reference as set forth in Section 5, and the Indemnification  Agreement (defined below) are intended by the Parties to be the final expression of their  agreement with respect to the subject matter hereof and supersede all prior understandings and  agreements, whether written or oral, including without limitation any prior employment agreement  or offer letter between Executive and the Company.  For the avoidance of doubt, this Agreement  shall not supersede any equity awards held by Executive. The Parties further intend that this  Agreement shall constitute the complete and exclusive statement of their terms and that no  extrinsic evidence whatsoever may be introduced in any judicial, administrative, or other legal  proceeding to vary the terms of this Agreement.  (f) Indemnification.  The Parties acknowledge that they have or will enter into an  Indemnification Agreement in substantially the form attached as Exhibit C hereto.  (g) Amendments; Waivers.  This Agreement may not be modified, amended, or  terminated except by an instrument in writing, signed by Executive and a duly authorized officer  of Company.  By an instrument in writing similarly executed, Executive or a duly authorized  officer of the Company may waive compliance by the other Party with any specifically identified  provision of this Agreement that such other Party was or is obligated to comply with or perform;  provided, however, that such waiver shall not operate as a waiver of, or estoppel with respect to,  any other or subsequent failure.  No failure to exercise and no delay in exercising any right,  remedy, or power hereunder preclude any other or further exercise of any other right, remedy, or  power provided herein or by law or in equity.    (h) No Inconsistent Actions.  The Parties hereto shall not voluntarily undertake or fail  to undertake any action or course of action inconsistent with the provisions or essential intent of  this Agreement.  Furthermore, it is the intent of the Parties hereto to act in a fair and reasonable  manner with respect to the interpretation and application of the provisions of this Agreement.  (i) Construction.  This Agreement shall be deemed drafted equally by both the  Parties. Its language shall be construed as a whole and according to its fair meaning.  Any  presumption or principle that the language is to be construed against any Party shall not apply.   The headings in this Agreement are only for convenience and are not intended to affect  construction or interpretation.  Any references to paragraphs, subparagraphs, sections or  subsections are to those parts of this Agreement, unless the context clearly indicates to the  contrary.  Also, unless the context clearly indicates to the contrary, (i) the plural includes the  DocuSign Envelope ID: 812750BB-25CE-4A4C-8C11-641E280F51C4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- employementagreement_mil011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="employementagreement_mil011.jpg" title="slide11" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   11     singular and the singular includes the plural; (ii) &#8220;and&#8221; and &#8220;or&#8221; are each used both conjunctively  and disjunctively; (iii) &#8220;any,&#8221; &#8220;all,&#8221; &#8220;each,&#8221; or &#8220;every&#8221; means &#8220;any and all,&#8221; and &#8220;each and  every&#8221;; (iv) &#8220;includes&#8221; and &#8220;including&#8221; are each &#8220;without limitation&#8221;; (v) &#8220;herein,&#8221; &#8220;hereof,&#8221;  &#8220;hereunder&#8221; and other similar compounds of the word &#8220;here&#8221; refer to the entire Agreement and  not to any particular paragraph, subparagraph, section or subsection; and (vi) all pronouns and  any variations thereof shall be deemed to refer to the masculine, feminine, neuter, singular or  plural as the identity of the entities or persons referred to may require.  (j) Enforcement.  If any provision of this Agreement is held to be illegal, invalid or  unenforceable under present or future laws effective during the Term, such provision shall be  fully severable; this Agreement shall be construed and enforced as if such illegal, invalid or  unenforceable provision had never comprised a portion of this Agreement; and the remaining  provisions of this Agreement shall remain in full force and effect and shall not be affected by the  illegal, invalid or unenforceable provision or by its severance from this Agreement.   Furthermore, in lieu of such illegal, invalid or unenforceable provision there shall be added  automatically as part of this Agreement a provision as similar in terms to such illegal, invalid or  unenforceable provision as may be possible and be legal, valid and enforceable.  (k) Withholding.  The Company shall be entitled to withhold from any amounts  payable under this Agreement any federal, state, local or foreign withholding or other taxes or  charges which the Company is required to withhold. The Company shall be entitled to rely on an  opinion of counsel if any questions as to the amount or requirement of withholding shall arise.  (l) Section 409A.  (i) General.  The intent of the Parties is that the payments and benefits under  this Agreement comply with or be exempt from Section 409A and, accordingly, to the  maximum extent permitted, this Agreement shall be interpreted to be in compliance  therewith.    (ii) Separation from Service.    For purposes of any compensation or benefits  payable to Executive under this Agreement, all references to &#8220;termination of  employment&#8221; and correlative phrases shall be construed to require a &#8220;separation from  service&#8221; (as defined in Section 1.409A-1(h) of the Treasury regulations after giving effect  to the presumptions contained therein) (a &#8220;Separation from Service&#8221;).  (iii) Specified Employee.  Notwithstanding anything in this Agreement to the  contrary, if Executive is deemed by the Company at the time of Executive&#8217;s Separation  from Service to be a &#8220;specified employee&#8221; for purposes of Section 409A, to the extent  delayed commencement of any portion of the benefits to which Executive is entitled  under this Agreement is required in order to avoid a prohibited distribution under Section  409A, such portion of Executive&#8217;s benefits shall not be provided to Executive prior to the  earlier of (i) the expiration of the six-month period measured from the date of Executive&#8217;s  Separation from Service with the Company or (ii) the date of Executive&#8217;s death.  Upon  the first business day following the expiration of the applicable Section 409A period, all  payments deferred pursuant to the preceding sentence shall be paid in a lump sum to  DocuSign Envelope ID: 812750BB-25CE-4A4C-8C11-641E280F51C4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- employementagreement_mil012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="employementagreement_mil012.jpg" title="slide12" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   12     Executive (or Executive&#8217;s estate or beneficiaries), and any remaining payments due to  Executive under this Agreement shall be paid as otherwise provided herein.    (iv) Expense Reimbursements.  To the extent that any reimbursements under  this Agreement are subject to Section 409A, any such reimbursements payable to  Executive shall be paid to Executive no later than December 31 of the year following the  year in which the expense was incurred, the amount of expenses reimbursed in one year  shall not affect the amount eligible for reimbursement in any subsequent year, other than  medical expenses referred to in Section 105(b) of the Code, and Executive&#8217;s right to  reimbursement under this Agreement will not be subject to liquidation or exchange for  another benefit.  (v) Installments.  Executive&#8217;s right to receive any installment payments under  this Agreement, including without limitation any continuation salary payments that are  payable on Company payroll dates, shall be treated as a right to receive a series of  separate payments and, accordingly, each such installment payment shall at all times be  considered a separate and distinct payment as permitted under Section 409A.  Except as  otherwise permitted under Section 409A, no payment hereunder shall be accelerated or  deferred unless such acceleration or deferral would not result in additional tax or interest  pursuant to Section 409A.  Notwithstanding anything to the contrary contained herein, if  the period to consider, return and not revoke the Release crosses two calendar years, any  payments or benefits described in Section 4(b) will be paid in the later calendar year.  10. Executive Acknowledgement.  Executive acknowledges that Executive has read and understands this Agreement, is fully  aware of its legal effect, has not acted in reliance upon any representations or promises made by  the Company other than those contained in writing herein, and has entered into this Agreement  freely based on Executive&#8217;s own judgment.  [Signature Page Follows]  DocuSign Envelope ID: 812750BB-25CE-4A4C-8C11-641E280F51C4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- employementagreement_mil013.jpg -->
<DIV style="padding-top:2em;">
<IMG src="employementagreement_mil013.jpg" title="slide13" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   [Signature Page to Employment Agreement]    IN WITNESS WHEREOF, the Parties have executed this Agreement on the date and  year first above written.               CARTESIAN THERAPEUTICS, INC.    By:__________________________  Name:  Carsten Brunn   Title:  Chief Executive Officer           EXECUTIVE      ______________________________  Milos Miljkovic            DocuSign Envelope ID: 812750BB-25CE-4A4C-8C11-641E280F51C4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- employementagreement_mil014.jpg -->
<DIV style="padding-top:2em;">
<IMG src="employementagreement_mil014.jpg" title="slide14" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">        EXHIBIT A  Separation Agreement and Release   This Separation Agreement and Release (&#8220;Agreement&#8221;) is made by and between Milos  Miljkovic (&#8220;Executive&#8221;) and Cartesian Therapeutics, Inc. (the &#8220;Company&#8221;) (collectively referred  to as the &#8220;Parties&#8221; or individually referred to as a &#8220;Party&#8221;).  Capitalized terms used but not  defined in this Agreement shall have the meanings set forth in the Employment Agreement (as  defined below).   WHEREAS, the Parties have previously entered into that certain Employment  Agreement, dated as of _____________, 2024 (the &#8220;Employment Agreement&#8221;); and    WHEREAS, in connection with Executive&#8217;s termination of employment with the  Company or a subsidiary or affiliate of the Company effective ________, 2024, the Parties wish  to resolve any and all disputes, claims, complaints, grievances, charges, actions, petitions, and  demands that Executive may have against the Company and any of the Releasees as defined  below, including, but not limited to, any and all claims arising out of or in any way related to  Executive&#8217;s employment with or separation from the Company or its subsidiaries or affiliates  but, for the avoidance of doubt, nothing herein will be deemed to release any rights or remedies  in connection with Executive&#8217;s ownership of vested equity securities of the Company, vested  benefits or Executive&#8217;s right to defense or indemnification by the Company or any of its  affiliates pursuant to contract or applicable law (collectively, the &#8220;Retained Claims&#8221;).    The  Company agrees not to contest Executive&#8217;s application for unemployment benefits; provided that  nothing herein shall prohibit the Company from responding truthfully to requests for information  from, or require the Company to make any false or misleading statements to, any governmental  authority.     NOW, THEREFORE, in consideration of the severance payments and benefits described  in Section 4 of the Employment Agreement, which, pursuant to the Employment Agreement, are  conditioned on Executive&#8217;s execution and non-revocation of this Agreement, and in  consideration of the mutual promises made herein, the Company and Executive hereby agree as  follows:   1. Severance Payments; Salary and Benefits.  The Company agrees to provide  Executive with the severance payments and benefits described in Section 4(b) [and Section 4(c)]1  of the Employment Agreement, payable at the times set forth in, and subject to the terms and  conditions of, the Employment Agreement. In addition, to the extent not already paid, and  subject to the terms and conditions of the Employment Agreement, the Company shall pay or  provide to Executive all other payments or benefits described in Section 3(c) of the Employment  Agreement, subject to and in accordance with the terms thereof.   2. Release of Claims.  Executive agrees that, other than with respect to the Retained  Claims, the foregoing consideration represents settlement in full of all outstanding obligations  owed to Executive by the Company, any of its direct or indirect subsidiaries and affiliates, and    1 To be included if applicable.   DocuSign Envelope ID: 812750BB-25CE-4A4C-8C11-641E280F51C4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- employementagreement_mil015.jpg -->
<DIV style="padding-top:2em;">
<IMG src="employementagreement_mil015.jpg" title="slide15" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  2  any of their current and former officers, directors, equity holders, managers, employees, agents,  investors, attorneys, shareholders, administrators, affiliates, benefit plans, plan administrators,  insurers, trustees, divisions, and subsidiaries and predecessor and successor corporations and  assigns (collectively, the &#8220;Releasees&#8221;).  Executive, on Executive&#8217;s own behalf and on behalf of  any of Executive&#8217;s affiliated companies or entities and any of their respective heirs, family  members, executors, agents, and assigns, other than with respect to the Retained Claims, hereby  and forever releases the Releasees from any matters of any kind, whether presently known or  unknown, suspected or unsuspected, that Executive may possess against any of the Releasees  arising from any omissions, acts, facts, or damages that have occurred up until and including the  Effective Date of this Agreement (as defined in Section 7 below), including, without limitation:    (a) any and all claims relating to or arising from Executive&#8217;s employment or  service relationship with the Company or any of its direct or indirect subsidiaries or affiliates and  the termination of that relationship;    (b) any and all claims relating to, or arising from, Executive&#8217;s right to  purchase, or actual purchase of any shares of stock or other equity interests of the Company or  any of its affiliates, including, without limitation, any claims for fraud, misrepresentation, breach  of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under  any state or federal law;    (c) any and all claims for wrongful discharge of employment; termination in  violation of public policy; discrimination; harassment; retaliation; breach of contract, both  express and implied; breach of covenant of good faith and fair dealing, both express and implied;  promissory estoppel; negligent or intentional infliction of emotional distress; fraud; negligent or  intentional misrepresentation; negligent or intentional interference with contract or prospective  economic advantage; unfair business practices; defamation; libel; slander; negligence; personal  injury; assault; battery; invasion of privacy; false imprisonment; conversion; and disability  benefits;    (d) any and all claims for violation of any federal, state, or municipal statute,  including, but not limited to, Title VII of the Civil Rights Act of 1964; the Civil Rights Act of  1991; the Rehabilitation Act of 1973; the Americans with Disabilities Act of 1990; the Equal Pay  Act; the Fair Credit Reporting Act; the Age Discrimination in Employment Act of 1967; the  Older Workers Benefit Protection Act; the Employee Retirement Income Security Act of 1974;  the Worker Adjustment and Retraining Notification Act; the Family and Medical Leave Act; and  the Sarbanes-Oxley Act of 2002;    (e) any and all claims for violation of the federal or any state constitution;    (f)  any and all claims arising out of any other laws and regulations relating to  employment or employment discrimination;    (g) any claim for any loss, cost, damage, or expense arising out of any dispute  over the non-withholding or other tax treatment of any of the proceeds received by Executive as  a result of this Agreement;   DocuSign Envelope ID: 812750BB-25CE-4A4C-8C11-641E280F51C4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- employementagreement_mil016.jpg -->
<DIV style="padding-top:2em;">
<IMG src="employementagreement_mil016.jpg" title="slide16" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  3    (h) any and all claims arising out of the wage and hour and wage payments  laws and regulations of the state or states in which Executive has provided service to the  Company or any of its affiliates; and    (i) any and all claims for attorneys&#8217; fees and costs.  Executive agrees that the release set forth in this section shall be and remain in effect in all  respects as a complete general release as to the matters released.  This release does not release  claims that cannot be released as a matter of law, including, but not limited to, Executive&#8217;s right  to report possible violations of federal law or regulation to any governmental agency or entity in  accordance with the provisions of and rules promulgated under Section 21F of the Securities  Exchange Act of 1934 or Section 806 of the Sarbanes-Oxley Act of 2002, or any other  whistleblower protection provisions of state or federal law or regulation, Executive&#8217;s right to file  a charge with or participate in a charge, investigation or proceeding by the Equal Employment  Opportunity Commission, or any other local, state, or federal administrative body or government  agency that is authorized to enforce or administer laws related to employment, against the  Company (with the understanding that Executive&#8217;s release of claims herein bars Executive from  recovering monetary or other individual relief from the Company or any Releasee in connection  with any charge, investigation or proceeding, or any related complaint or lawsuit, filed by  Executive or by anyone else on Executive&#8217;s behalf before the federal Equal Employment  Opportunity Commission or a comparable state or local agency), claims for unemployment  compensation or any state disability insurance benefits pursuant to the terms of applicable state  law, claims to continued participation in certain of the Company&#8217;s group benefit plans pursuant  to the terms and conditions of COBRA, claims to any benefit entitlements vested as the date of  separation of Executive&#8217;s employment, pursuant to written terms of any employee benefit plan of  the Company or its affiliates and Executive&#8217;s right under applicable law and any Retained  Claims.  This release further does not release claims for breach of Section 3(c), Section 4(b) or  Section 4(c) of the Employment Agreement arising after the Effective Date.   3. Acknowledgment of Waiver of Claims under ADEA.  Executive understands and  acknowledges that Executive is waiving and releasing any rights Executive may have under the  Age Discrimination in Employment Act of 1967 (&#8220;ADEA&#8221;), and that this waiver and release is  knowing and voluntary.  Executive understands and agrees that this waiver and release does not  apply to any rights or claims that may arise under the ADEA after the date Executive executes  this Agreement.  Executive understands and acknowledges that the consideration given for this  waiver and release is in addition to anything of value to which Executive was already entitled.   Executive further understands and acknowledges that Executive is hereby advised by this writing  that:  (a) Executive should consult with an attorney prior to executing this Agreement; (b)  Executive has [21/45]2 days within which to consider this Agreement, and the parties agree that  such time period to review this Agreement shall not be extended upon any material or immaterial  changes to this Agreement; (c) Executive has 7 days following Executive&#8217;s execution of this  Agreement to revoke this Agreement pursuant to written notice to the General Counsel of the  Company; (d) this Agreement shall not be effective until after the revocation period has expired;  and (e) nothing in this Agreement prevents or precludes Executive from challenging or seeking a    2 To be determined by the Company at the time of separation.   DocuSign Envelope ID: 812750BB-25CE-4A4C-8C11-641E280F51C4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- employementagreement_mil017.jpg -->
<DIV style="padding-top:2em;">
<IMG src="employementagreement_mil017.jpg" title="slide17" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  4  determination in good faith of the validity of this waiver under the ADEA, nor does it impose  any condition precedent, penalties, or costs for doing so, unless specifically authorized by federal  law.  In the event Executive signs this Agreement and returns it to the Company in less than the  [21/45] day period identified above, Executive hereby acknowledges that Executive has freely  and voluntarily chosen to waive the time period allotted for considering this Agreement.   4. Restrictive Covenants.  (a) Executive acknowledges and agrees that the restrictive covenants and  other post-termination obligations set forth in the Restrictive Covenant Agreement, including  without limitation Executive&#8217;s obligations relating to confidentiality, non-use and non-disclosure  of Confidential Information (as defined in the Restrictive Covenant Agreement), [non- competition,]3 non-solicitation, cooperation, and return of property, are hereby incorporated by  reference and shall remain in full force and effect pursuant to their terms to the maximum extent  permitted by applicable law. Executive represents and warrants that Executive has complied with  all provisions of the Restrictive Covenant Agreement at all times through the Effective Date.   5. Severability. In the event that any provision or any portion of any provision  hereof or any surviving agreement made a part hereof becomes or is declared by a court of  competent jurisdiction or arbitrator to be illegal, unenforceable, or void, this Agreement shall  continue in full force and effect without said provision or portion of provision.   6. No Oral Modification.  This Agreement may only be amended in a writing signed  by Executive and a duly authorized officer of the Company.   7. Governing Law.  This Agreement shall be subject to the provisions of Sections  9(a) and 9(c) of the Employment Agreement.   8. Effective Date.  If Executive has attained or is over the age of 40 as of the date of  Executive&#8217;s termination of employment, then each Party has seven days after that Party signs this  Agreement to revoke it and this Agreement will become effective on the eighth day after  Executive signed this Agreement, so long as it has been signed by the Parties and has not been  revoked by either Party before that date (the &#8220;Effective Date&#8221;).  If Executive has not attained the  age of 40 as of the date of Executive&#8217;s termination of employment, then the &#8220;Effective Date&#8221;  shall be the date on which Executive signs this Agreement.   9. Voluntary Execution of Agreement.  Executive understands and agrees that  Executive executed this Agreement voluntarily, without any duress or undue influence on the  part or behalf of the Company or any third party, with the full intent of releasing all of  Executive&#8217;s claims against the Company and any of the other Releasees.  Executive  acknowledges that:  (a) Executive has read this Agreement; (b) Executive has not relied upon  any representations or statements made by the Company that are not specifically set forth in this  Agreement; (c) Executive has been represented in the preparation, negotiation, and execution of  this Agreement by legal counsel of Executive&#8217;s own choice or has elected not to retain legal    3 To be removed if a termination by the Company without Cause and the non-compete will not continue.  DocuSign Envelope ID: 812750BB-25CE-4A4C-8C11-641E280F51C4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- employementagreement_mil018.jpg -->
<DIV style="padding-top:2em;">
<IMG src="employementagreement_mil018.jpg" title="slide18" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  5  counsel; (d) Executive understands the terms and consequences of this Agreement and of the  releases it contains; and (e) Executive is fully aware of the legal and binding effect of this  Agreement.    IN WITNESS WHEREOF, the Parties have executed this Agreement on the respective  dates set forth below.       EXECUTIVE  Dated:           Milos Miljkovic       CARTESIAN THERAPEUTICS, INC.  Dated:    By:       Name:   Title:     DocuSign Envelope ID: 812750BB-25CE-4A4C-8C11-641E280F51C4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- employementagreement_mil019.jpg -->
<DIV style="padding-top:2em;">
<IMG src="employementagreement_mil019.jpg" title="slide19" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">       EXHIBIT B  Employee Nondisclosure, Assignment of Intellectual Property and Restrictive Covenant  Agreement  [attached] DocuSign Envelope ID: 812750BB-25CE-4A4C-8C11-641E280F51C4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- employementagreement_mil020.jpg -->
<DIV style="padding-top:2em;">
<IMG src="employementagreement_mil020.jpg" title="slide20" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">     EXHIBIT C  Form of Indemnification Agreement  [attached]      DocuSign Envelope ID: 812750BB-25CE-4A4C-8C11-641E280F51C4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>exhibit311_3312026.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i5d90b868e91c41c2b9a86de1026a5faf_1"></div><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">I, Carsten Brunn, Ph.D., certify that&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this Quarterly Report on Form 10-Q of Cartesian Therapeutics, Inc.&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#2c2c2c;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">April 30, 2026</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Carsten Brunn, Ph.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Carsten Brunn, Ph.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President, Chief Executive Officer and Chairman of the Board</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>exhibit312_3312026.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i25cbe4415bea43e3915e8af749bab013_1"></div><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">I, Blaine Davis, certify that&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this Quarterly Report on Form 10-Q of Cartesian Therapeutics, Inc.&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:44.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.822%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#2c2c2c;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">April 30, 2026</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Blaine Davis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Blaine Davis</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>exhibit321_3312026.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i863ca50f5e724c9ebd38aaacc392e1aa_1"></div><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center;text-indent:63pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q of Cartesian Therapeutics, Inc. (the &#8220;Company&#8221;) for the period ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, that to his knowledge&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The Quarterly Report on Form 10-Q of the Company for the period ended March 31, 2026 (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#2c2c2c;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">April 30, 2026</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Carsten Brunn, Ph.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Carsten Brunn, Ph.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President, Chief Executive Officer and Chairman of the Board</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:50.659%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.303%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#2c2c2c;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">April 30, 2026</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Blaine Davis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Blaine Davis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>rnac-20260331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019cdd24-8f10-71f0-acfb-b8a76448289c,g:7ae85b19-6328-41a5-b0c0-99683dc813c6-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rnac="http://www.cartesiantherapeutics.com/20260331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cartesiantherapeutics.com/20260331">
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rnac-20260331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rnac-20260331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rnac-20260331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rnac-20260331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.cartesiantherapeutics.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets">
        <link:definition>9952151 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>9952152 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperationsandComprehensiveLoss" roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss">
        <link:definition>9952153 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofChangesinStockholdersDeficit" roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit">
        <link:definition>9952154 - Statement - Consolidated Statements of Changes in Stockholders&#8217; Deficit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>9952155 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusiness" roleURI="http://www.cartesiantherapeutics.com/role/DescriptionoftheBusiness">
        <link:definition>9952156 - Disclosure - Description of the Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.cartesiantherapeutics.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>9952157 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIndefiniteLivedIntangibleAssets" roleURI="http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssets">
        <link:definition>9952158 - Disclosure - Goodwill and Indefinite-Lived Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareAllocabletoCommonStockholders" roleURI="http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholders">
        <link:definition>9952159 - Disclosure - Net Loss Per Share Allocable to Common Stockholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurements">
        <link:definition>9952160 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipment" roleURI="http://www.cartesiantherapeutics.com/role/PropertyandEquipment">
        <link:definition>9952161 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpenses" roleURI="http://www.cartesiantherapeutics.com/role/AccruedExpenses">
        <link:definition>9952162 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.cartesiantherapeutics.com/role/Leases">
        <link:definition>9952163 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Equity" roleURI="http://www.cartesiantherapeutics.com/role/Equity">
        <link:definition>9952164 - Disclosure - Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlans" roleURI="http://www.cartesiantherapeutics.com/role/StockIncentivePlans">
        <link:definition>9952165 - Disclosure - Stock Incentive Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueArrangements" roleURI="http://www.cartesiantherapeutics.com/role/RevenueArrangements">
        <link:definition>9952166 - Disclosure - Revenue Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicenseAgreements" roleURI="http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreements">
        <link:definition>9952167 - Disclosure - Collaboration and License Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.cartesiantherapeutics.com/role/IncomeTaxes">
        <link:definition>9952168 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.cartesiantherapeutics.com/role/CommitmentsandContingencies">
        <link:definition>9952169 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.cartesiantherapeutics.com/role/SegmentReporting">
        <link:definition>9952170 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.cartesiantherapeutics.com/role/SubsequentEvents">
        <link:definition>9952171 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.cartesiantherapeutics.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareAllocabletoCommonStockholdersTables" roleURI="http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersTables">
        <link:definition>9955512 - Disclosure - Net Loss Per Share Allocable to Common Stockholders (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsTables">
        <link:definition>9955513 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTables" roleURI="http://www.cartesiantherapeutics.com/role/PropertyandEquipmentTables">
        <link:definition>9955514 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesTables" roleURI="http://www.cartesiantherapeutics.com/role/AccruedExpensesTables">
        <link:definition>9955515 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.cartesiantherapeutics.com/role/LeasesTables">
        <link:definition>9955516 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityTables" roleURI="http://www.cartesiantherapeutics.com/role/EquityTables">
        <link:definition>9955517 - Disclosure - Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansTables" roleURI="http://www.cartesiantherapeutics.com/role/StockIncentivePlansTables">
        <link:definition>9955518 - Disclosure - Stock Incentive Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.cartesiantherapeutics.com/role/SegmentReportingTables">
        <link:definition>9955519 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusinessDetails" roleURI="http://www.cartesiantherapeutics.com/role/DescriptionoftheBusinessDetails">
        <link:definition>9955520 - Disclosure - Description of the Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIndefiniteLivedIntangibleAssetsDetails" roleURI="http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssetsDetails">
        <link:definition>9955521 - Disclosure - Goodwill and Indefinite-Lived Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareAllocabletoCommonStockholdersScheduleofComputationofBasicandDilutedNetLossPerShareAllocabletoCommonStockholdersDetails" roleURI="http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofComputationofBasicandDilutedNetLossPerShareAllocabletoCommonStockholdersDetails">
        <link:definition>9955522 - Disclosure - Net Loss Per Share Allocable to Common Stockholders - Schedule of Computation of Basic and Diluted Net Loss Per Share Allocable to Common Stockholders (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails" roleURI="http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails">
        <link:definition>9955523 - Disclosure - Net Loss Per Share Allocable to Common Stockholders - Schedule of Potential Dilutive Shares of Common Stock Excluded from the Computation of the Diluted Net Loss Per Share Allocable to Common Stockholders (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails">
        <link:definition>9955524 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>9955525 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofCashCashEquivalentsandRestrictedCashDetails" roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofCashCashEquivalentsandRestrictedCashDetails">
        <link:definition>9955526 - Disclosure - Fair Value Measurements - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails" roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails">
        <link:definition>9955527 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques for Warrants Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofRollForwardofFairValuefortheCompanysLevel3WarrantLiabilitiesandCVRLiabilityDetails" roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofRollForwardofFairValuefortheCompanysLevel3WarrantLiabilitiesandCVRLiabilityDetails">
        <link:definition>9955528 - Disclosure - Fair Value Measurements - Schedule of Roll-Forward of Fair Value for the Company&#8217;s Level 3 Warrant Liabilities and CVR Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails" roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails">
        <link:definition>9955529 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques for CVR Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentScheduleofPropertyandEquipmentDetails" roleURI="http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails">
        <link:definition>9955530 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNarrativeDetails" roleURI="http://www.cartesiantherapeutics.com/role/PropertyandEquipmentNarrativeDetails">
        <link:definition>9955531 - Disclosure - Property and Equipment - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesDetails" roleURI="http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails">
        <link:definition>9955532 - Disclosure - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.cartesiantherapeutics.com/role/LeasesNarrativeDetails">
        <link:definition>9955533 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofComponentsofLeaseCostsDetails" roleURI="http://www.cartesiantherapeutics.com/role/LeasesScheduleofComponentsofLeaseCostsDetails">
        <link:definition>9955534 - Disclosure - Leases - Schedule of Components of Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails" roleURI="http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails">
        <link:definition>9955535 - Disclosure - Leases - Schedule of Maturity of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails_1" roleURI="http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails_1">
        <link:definition>9955535 - Disclosure - Leases - Schedule of Maturity of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofOtherInformationRelatedtoOperatingLeasesDetails" roleURI="http://www.cartesiantherapeutics.com/role/LeasesScheduleofOtherInformationRelatedtoOperatingLeasesDetails">
        <link:definition>9955536 - Disclosure - Leases - Schedule of Other Information Related to Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityAttheMarketSalesAgreementNarrativeDetails" roleURI="http://www.cartesiantherapeutics.com/role/EquityAttheMarketSalesAgreementNarrativeDetails">
        <link:definition>9955537 - Disclosure - Equity - &#8220;At the Market&#8221; Sales Agreement - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityWarrantsNarrativeDetails" roleURI="http://www.cartesiantherapeutics.com/role/EquityWarrantsNarrativeDetails">
        <link:definition>9955538 - Disclosure - Equity - Warrants - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityScheduleofWarrantyActivityDetails" roleURI="http://www.cartesiantherapeutics.com/role/EquityScheduleofWarrantyActivityDetails">
        <link:definition>9955539 - Disclosure - Equity - Schedule of Warranty Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityPreferredStockNarrativeDetails" roleURI="http://www.cartesiantherapeutics.com/role/EquityPreferredStockNarrativeDetails">
        <link:definition>9955540 - Disclosure - Equity - Preferred Stock - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails" roleURI="http://www.cartesiantherapeutics.com/role/EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails">
        <link:definition>9955541 - Disclosure - Equity - Schedule of Authorized Shares of Common Stock for Future Issuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansNarrativeDetails" roleURI="http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails">
        <link:definition>9955542 - Disclosure - Stock Incentive Plans - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansScheduleofStockBasedCompensationExpenseDetails" roleURI="http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockBasedCompensationExpenseDetails">
        <link:definition>9955543 - Disclosure - Stock Incentive Plans - Schedule of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansScheduleofWeightedAverageAssumptionsUsedDetails" roleURI="http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofWeightedAverageAssumptionsUsedDetails">
        <link:definition>9955544 - Disclosure - Stock Incentive Plans - Schedule of Weighted Average Assumptions Used (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansScheduleofStockOptionActivityDetails" roleURI="http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails">
        <link:definition>9955545 - Disclosure - Stock Incentive Plans - Schedule of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails" roleURI="http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails">
        <link:definition>9955546 - Disclosure - Stock Incentive Plans - Schedule of Restricted Stock Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueArrangementsDetails" roleURI="http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails">
        <link:definition>9955547 - Disclosure - Revenue Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicenseAgreementsBiogenMAIncNarrativeDetails" roleURI="http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsBiogenMAIncNarrativeDetails">
        <link:definition>9955548 - Disclosure - Collaboration and License Agreements - Biogen M.A., Inc. - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicenseAgreementsNationalCancerInstituteoftheNationalInstitutesofHealthNarrativeDetails" roleURI="http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsNationalCancerInstituteoftheNationalInstitutesofHealthNarrativeDetails">
        <link:definition>9955549 - Disclosure - Collaboration and License Agreements - National Cancer Institute of the National Institutes of Health - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicenseAgreementsShenyangSunshinePharmaceuticalCoLtdNarrativeDetails" roleURI="http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsShenyangSunshinePharmaceuticalCoLtdNarrativeDetails">
        <link:definition>9955550 - Disclosure - Collaboration and License Agreements - Shenyang Sunshine Pharmaceutical Co., Ltd - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingNarrativeDetails" roleURI="http://www.cartesiantherapeutics.com/role/SegmentReportingNarrativeDetails">
        <link:definition>9955551 - Disclosure - Segment Reporting - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" roleURI="http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails">
        <link:definition>9955552 - Disclosure - Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="rnac_WarrantsAndRightsOutstandingNoncurrent" abstract="false" name="WarrantsAndRightsOutstandingNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_ContingentValueRightLiabilityNoncurrent" abstract="false" name="ContingentValueRightLiabilityNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_FairValueAdjustmentOfContingentValueRightLiability" abstract="false" name="FairValueAdjustmentOfContingentValueRightLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_PaymentsForContingentValueRightsDistributions" abstract="false" name="PaymentsForContingentValueRightsDistributions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_EquityOfferingCostsInAccruedLiabilities" abstract="false" name="EquityOfferingCostsInAccruedLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_CollaborationAndLicenseAgreementsTextBlock" abstract="false" name="CollaborationAndLicenseAgreementsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rnac_OldCartesianMember" abstract="true" name="OldCartesianMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale" abstract="false" name="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed" abstract="false" name="ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rnac_Descartes08ForMGMember" abstract="true" name="Descartes08ForMGMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_ContingentValueRightLiability" abstract="false" name="ContingentValueRightLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_A2022WarrantsMember" abstract="true" name="A2022WarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_ContingentValueRightMember" abstract="true" name="ContingentValueRightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_ProbabilityOfSuccessMember" abstract="true" name="ProbabilityOfSuccessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_MeasurementInputRevenueVolatilityMember" abstract="true" name="MeasurementInputRevenueVolatilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_ContingentValueRightLiabilityMeasurementInput" abstract="false" name="ContingentValueRightLiabilityMeasurementInput" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="rnac_LaboratoryEquipmentMember" abstract="false" name="LaboratoryEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_AccruedCollaborationandLicensing" abstract="false" name="AccruedCollaborationandLicensing" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_AccruedPatentFeesCurrent" abstract="false" name="AccruedPatentFeesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_AccruedResearchAndDevelopmentCostsCurrent" abstract="false" name="AccruedResearchAndDevelopmentCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_AccruedAuditFeesCurrent" abstract="false" name="AccruedAuditFeesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_AccruedEquityOfferingCostsCurrent" abstract="false" name="AccruedEquityOfferingCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_LeaseArrangementAxis" abstract="true" name="LeaseArrangementAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="rnac_LeaseArrangementDomain" abstract="true" name="LeaseArrangementDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_FrederickLeaseAgreementMember" abstract="true" name="FrederickLeaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_LesseeOperatingLeaseAnnualBaseRent" abstract="false" name="LesseeOperatingLeaseAnnualBaseRent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_AtTheMarketOfferingMember" abstract="true" name="AtTheMarketOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_SaleOfStockAggregateMaximumGrossSalesProceeds" abstract="false" name="SaleOfStockAggregateMaximumGrossSalesProceeds" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_ClassOfWarrantOrRightOutstandingWarrantsIssued" abstract="false" name="ClassOfWarrantOrRightOutstandingWarrantsIssued" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rnac_ClassOfWarrantOrRightOutstandingWarrantsExercised" abstract="false" name="ClassOfWarrantOrRightOutstandingWarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rnac_ClassOfWarrantOrRightOutstandingWarrantsCancelled" abstract="false" name="ClassOfWarrantOrRightOutstandingWarrantsCancelled" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rnac_ClassOfWarrantOrRightRollForward" abstract="true" name="ClassOfWarrantOrRightRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" abstract="true" name="ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rnac_RestrictedStockUnitsUnvestedMember" abstract="true" name="RestrictedStockUnitsUnvestedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_StockIncentivePlan2016Member" abstract="false" name="StockIncentivePlan2016Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_EmploymentInducementIncentiveAwardPlanMember" abstract="true" name="EmploymentInducementIncentiveAwardPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_OldCartesianPlanMember" abstract="true" name="OldCartesianPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_OldCartestianMember" abstract="true" name="OldCartestianMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="rnac_A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember" abstract="true" name="A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_SwedishOrphanBiovitrumABSOBIMember" abstract="true" name="SwedishOrphanBiovitrumABSOBIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember" abstract="true" name="NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount" abstract="false" name="RevenueRemainingPerformanceObligationVariableConsiderationAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_GovernmentAssistancePotentialAdditionalAwardAmount" abstract="false" name="GovernmentAssistancePotentialAdditionalAwardAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" abstract="false" name="GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rnac_BiogenM.A.Inc.Member" abstract="true" name="BiogenM.A.Inc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_CollaborativeArrangementWrittenNoticePeriodForTermination" abstract="false" name="CollaborativeArrangementWrittenNoticePeriodForTermination" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rnac_NationalCancerInstituteAgreementMember" abstract="true" name="NationalCancerInstituteAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_LicenseAndOptionAgreementRoyaltyPayment" abstract="false" name="LicenseAndOptionAgreementRoyaltyPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum" abstract="false" name="LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember" abstract="false" name="LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid" abstract="false" name="AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform" abstract="false" name="AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rnac_NumberOfReportableSegmentsNotDisclosedFlag" abstract="false" name="NumberOfReportableSegmentsNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rnac_OperatingSegmentMember" abstract="true" name="OperatingSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_Descartes08ForDermatomyositisMember" abstract="true" name="Descartes08ForDermatomyositisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_EarlyStageProgramsMember" abstract="true" name="EarlyStageProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_ResearchAndDevelopmentEmployeeExpensesMember" abstract="true" name="ResearchAndDevelopmentEmployeeExpensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember" abstract="true" name="ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_ResearchAndDevelopmentFacilitiesAndOtherExpensesMember" abstract="true" name="ResearchAndDevelopmentFacilitiesAndOtherExpensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rnac_NonoperatingIncomeExpenseAdjusted" abstract="false" name="NonoperatingIncomeExpenseAdjusted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>rnac-20260331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019cdd24-8f10-71f0-acfb-b8a76448289c,g:7ae85b19-6328-41a5-b0c0-99683dc813c6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="rnac-20260331.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019cdd24-914a-73e8-be0e-769a2065aa5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019cdd24-914a-7eef-8a57-6ff6e56c561f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019cdd24-914a-73e8-be0e-769a2065aa5a" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019cdd24-914a-7eef-8a57-6ff6e56c561f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019cdd24-914a-7b23-9ebb-2dab0b64ded5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019cdd24-914a-73e8-be0e-769a2065aa5a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019cdd24-914a-7b23-9ebb-2dab0b64ded5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_019cdd24-914a-7e23-a0de-19b9e13ea5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019cdd24-914a-73e8-be0e-769a2065aa5a" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_019cdd24-914a-7e23-a0de-19b9e13ea5e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019cdd24-914a-7846-bc06-e20eec165075" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019cdd24-914a-7237-bfb9-ae2966269a76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019cdd24-914a-7846-bc06-e20eec165075" xlink:to="loc_us-gaap_CommonStockValue_019cdd24-914a-7237-bfb9-ae2966269a76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019cdd24-914a-78f9-aec3-5f0b53400492" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019cdd24-914a-7846-bc06-e20eec165075" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019cdd24-914a-78f9-aec3-5f0b53400492" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_019cdd24-914a-7a9b-817c-161ef0c22681" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019cdd24-914a-7846-bc06-e20eec165075" xlink:to="loc_us-gaap_PreferredStockValue_019cdd24-914a-7a9b-817c-161ef0c22681" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019cdd24-914a-7535-a2f2-88bd6eb511f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019cdd24-914a-7846-bc06-e20eec165075" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019cdd24-914a-7535-a2f2-88bd6eb511f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019cdd24-914a-7a9a-8008-a4b50b311376" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019cdd24-914a-7846-bc06-e20eec165075" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019cdd24-914a-7a9a-8008-a4b50b311376" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019cdd24-914a-7cce-855e-87cfa3262feb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019cdd24-914a-7783-9cad-7d25a9fb1df2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019cdd24-914a-7cce-855e-87cfa3262feb" xlink:to="loc_us-gaap_LiabilitiesCurrent_019cdd24-914a-7783-9cad-7d25a9fb1df2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019cdd24-914a-723c-bf14-ceaa6edd80c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019cdd24-914a-7cce-855e-87cfa3262feb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019cdd24-914a-723c-bf14-ceaa6edd80c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_WarrantsAndRightsOutstandingNoncurrent_019cdd24-914a-7c67-8f3d-a8ea7f1cce1a" xlink:href="rnac-20260331.xsd#rnac_WarrantsAndRightsOutstandingNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019cdd24-914a-7cce-855e-87cfa3262feb" xlink:to="loc_rnac_WarrantsAndRightsOutstandingNoncurrent_019cdd24-914a-7c67-8f3d-a8ea7f1cce1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightLiabilityNoncurrent_019cdd24-914a-7477-b5af-86319167d1e9" xlink:href="rnac-20260331.xsd#rnac_ContingentValueRightLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019cdd24-914a-7cce-855e-87cfa3262feb" xlink:to="loc_rnac_ContingentValueRightLiabilityNoncurrent_019cdd24-914a-7477-b5af-86319167d1e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_019cdd24-914a-7eca-9cfe-47e7d6e104d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019cdd24-914a-7cce-855e-87cfa3262feb" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_019cdd24-914a-7eca-9cfe-47e7d6e104d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019cdd24-914a-7f89-b9cf-86d2053a0a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019cdd24-914a-72a0-9af8-252b7d879f59" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019cdd24-914a-7f89-b9cf-86d2053a0a6e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019cdd24-914a-72a0-9af8-252b7d879f59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_019cdd24-914a-7680-a0be-0c78c53ed26a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019cdd24-914a-7f89-b9cf-86d2053a0a6e" xlink:to="loc_us-gaap_Goodwill_019cdd24-914a-7680-a0be-0c78c53ed26a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_019cdd24-914a-7ae8-96dc-b5988b72c7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019cdd24-914a-7f89-b9cf-86d2053a0a6e" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_019cdd24-914a-7ae8-96dc-b5988b72c7eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019cdd24-914a-7a61-a4db-c828fe6028f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019cdd24-914a-7f89-b9cf-86d2053a0a6e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019cdd24-914a-7a61-a4db-c828fe6028f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019cdd24-914a-7329-b590-506eb2364759" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019cdd24-914a-7f89-b9cf-86d2053a0a6e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019cdd24-914a-7329-b590-506eb2364759" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019cdd24-914a-77c9-9ea7-c5a958ecc105" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019cdd24-914a-7f89-b9cf-86d2053a0a6e" xlink:to="loc_us-gaap_AssetsCurrent_019cdd24-914a-77c9-9ea7-c5a958ecc105" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_019cdd24-914a-701d-a49b-d8d18cfab96e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019cdd24-914a-7f89-b9cf-86d2053a0a6e" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_019cdd24-914a-701d-a49b-d8d18cfab96e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019cdd24-914a-72b0-9cd1-849508131e79" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019cdd24-914a-73d5-95ba-3582cedf589e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019cdd24-914a-72b0-9cd1-849508131e79" xlink:to="loc_us-gaap_Liabilities_019cdd24-914a-73d5-95ba-3582cedf589e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019cdd24-914a-7c42-8c8c-91eeae1e347c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019cdd24-914a-72b0-9cd1-849508131e79" xlink:to="loc_us-gaap_StockholdersEquity_019cdd24-914a-7c42-8c8c-91eeae1e347c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019cdd24-914a-7bb7-95d6-9ac69b7c29a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019cdd24-914a-72b0-9cd1-849508131e79" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019cdd24-914a-7bb7-95d6-9ac69b7c29a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019cdd24-914a-7ae9-9947-6caf3b3ff8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_019cdd24-914a-72d7-a848-3af723ec5db8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019cdd24-914a-7ae9-9947-6caf3b3ff8f2" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_019cdd24-914a-72d7-a848-3af723ec5db8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019cdd24-914a-758e-a653-4daec7a6e418" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019cdd24-914a-7ae9-9947-6caf3b3ff8f2" xlink:to="loc_us-gaap_AccountsPayableCurrent_019cdd24-914a-758e-a653-4daec7a6e418" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019cdd24-914a-7f22-b44d-d6783d54342d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019cdd24-914a-7ae9-9947-6caf3b3ff8f2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019cdd24-914a-7f22-b44d-d6783d54342d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="rnac-20260331.xsd#ConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019cdd24-914a-72b9-8605-042992855347" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019cdd24-914a-7622-8ca3-dbb6413da1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019cdd24-914a-72b9-8605-042992855347" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019cdd24-914a-7622-8ca3-dbb6413da1eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019cdd24-914a-7fba-b568-e66872b406e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019cdd24-914a-72b9-8605-042992855347" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019cdd24-914a-7fba-b568-e66872b406e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019cdd24-914a-7aca-8c2b-99f416bf6af9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019cdd24-914a-781b-8659-55b79d777c34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019cdd24-914a-7aca-8c2b-99f416bf6af9" xlink:to="loc_us-gaap_OperatingExpenses_019cdd24-914a-781b-8659-55b79d777c34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_019cdd24-914a-7f98-9ee3-262b0adec0e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019cdd24-914a-7aca-8c2b-99f416bf6af9" xlink:to="loc_us-gaap_Revenues_019cdd24-914a-7f98-9ee3-262b0adec0e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_019cdd24-914a-761f-a019-19cb62cb591f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019cdd24-914a-7509-a7ac-7d80ba45b38f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_019cdd24-914a-761f-a019-19cb62cb591f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019cdd24-914a-7509-a7ac-7d80ba45b38f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_019cdd24-914a-7169-8e64-4baaafcd2094" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_019cdd24-914a-761f-a019-19cb62cb591f" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_019cdd24-914a-7169-8e64-4baaafcd2094" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019cdd24-914a-764d-a0ee-4e66db311228" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019cdd24-914a-756a-b521-72dbf4f086e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019cdd24-914a-764d-a0ee-4e66db311228" xlink:to="loc_us-gaap_NetIncomeLoss_019cdd24-914a-756a-b521-72dbf4f086e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_019cdd24-914a-72dd-a0a4-cdc35666b75f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019cdd24-914a-764d-a0ee-4e66db311228" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_019cdd24-914a-72dd-a0a4-cdc35666b75f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019d0bff-611f-7ba3-b170-550dc84ab9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_019d0bff-611f-7de0-a15b-f3ccb5640c15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019d0bff-611f-7ba3-b170-550dc84ab9a6" xlink:to="loc_us-gaap_InvestmentIncomeInterest_019d0bff-611f-7de0-a15b-f3ccb5640c15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_019d0bff-611f-72d3-9796-ef45c2aaf727" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019d0bff-611f-7ba3-b170-550dc84ab9a6" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_019d0bff-611f-72d3-9796-ef45c2aaf727" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability_019d0bff-611f-7806-85a6-d53bb23457c3" xlink:href="rnac-20260331.xsd#rnac_FairValueAdjustmentOfContingentValueRightLiability"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019d0bff-611f-7ba3-b170-550dc84ab9a6" xlink:to="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability_019d0bff-611f-7806-85a6-d53bb23457c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019d0bff-611f-7f8e-a9b8-71fd9ca90e75" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019d0bff-611f-7ba3-b170-550dc84ab9a6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019d0bff-611f-7f8e-a9b8-71fd9ca90e75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019cdd24-914a-715b-b361-a9c2a106c89b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019cdd24-914a-725e-bebb-8693f430686f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019cdd24-914a-715b-b361-a9c2a106c89b" xlink:to="loc_us-gaap_OperatingIncomeLoss_019cdd24-914a-725e-bebb-8693f430686f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019cdd24-914a-7973-a16f-c527d2f72b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019cdd24-914a-715b-b361-a9c2a106c89b" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019cdd24-914a-7973-a16f-c527d2f72b3f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="rnac-20260331.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019cdd24-914a-71d8-b033-bcf63cb2a9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019cdd24-914a-7c56-9748-d2b3b73c8f18" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019cdd24-914a-71d8-b033-bcf63cb2a9c4" xlink:to="loc_us-gaap_NetIncomeLoss_019cdd24-914a-7c56-9748-d2b3b73c8f18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_019cdd24-914a-7bf5-9e23-ce765e1b715c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019cdd24-914a-71d8-b033-bcf63cb2a9c4" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_019cdd24-914a-7bf5-9e23-ce765e1b715c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_019cdd24-914a-724a-9dee-aa334f248a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019cdd24-914a-71d8-b033-bcf63cb2a9c4" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_019cdd24-914a-724a-9dee-aa334f248a0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019cdd24-914a-7121-8c89-9812852e8867" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019cdd24-914a-71d8-b033-bcf63cb2a9c4" xlink:to="loc_us-gaap_ShareBasedCompensation_019cdd24-914a-7121-8c89-9812852e8867" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_019cdd24-914a-7ec1-85d0-88c032be93b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019cdd24-914a-71d8-b033-bcf63cb2a9c4" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_019cdd24-914a-7ec1-85d0-88c032be93b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability_019cdd24-914a-72a7-8219-acdfc10bf095" xlink:href="rnac-20260331.xsd#rnac_FairValueAdjustmentOfContingentValueRightLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019cdd24-914a-71d8-b033-bcf63cb2a9c4" xlink:to="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability_019cdd24-914a-72a7-8219-acdfc10bf095" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019cdd24-914a-7dce-9c28-7418b31774d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019cdd24-914a-71d8-b033-bcf63cb2a9c4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019cdd24-914a-7dce-9c28-7418b31774d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019cdd24-914a-7760-afbb-80610cbef791" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019cdd24-914a-71d8-b033-bcf63cb2a9c4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019cdd24-914a-7760-afbb-80610cbef791" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019cdd24-914a-799a-b892-5d76e33dcc44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019cdd24-914a-71d8-b033-bcf63cb2a9c4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019cdd24-914a-799a-b892-5d76e33dcc44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019cdd24-914a-7bfd-a1df-ae73089a6691" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019cdd24-914a-71d8-b033-bcf63cb2a9c4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019cdd24-914a-7bfd-a1df-ae73089a6691" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019cdd24-914a-7a38-9cc1-b85a92953e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019cdd24-914a-786e-a84a-c185a8bb71f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019cdd24-914a-7a38-9cc1-b85a92953e5a" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019cdd24-914a-786e-a84a-c185a8bb71f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019cdd24-914a-77ad-8fbc-068f6fd9dfa3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_019cdd24-914a-75c3-8978-8b7bbb9a1257" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019cdd24-914a-77ad-8fbc-068f6fd9dfa3" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_019cdd24-914a-75c3-8978-8b7bbb9a1257" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019cdd24-914a-78ad-a8f1-48749951c109" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019cdd24-914a-77ad-8fbc-068f6fd9dfa3" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019cdd24-914a-78ad-a8f1-48749951c109" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019cdd24-914a-7c58-988f-3d53a6e37197" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019cdd24-914a-77ad-8fbc-068f6fd9dfa3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019cdd24-914a-7c58-988f-3d53a6e37197" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_PaymentsForContingentValueRightsDistributions_019d96e8-880a-725e-9e56-458ad125b2de" xlink:href="rnac-20260331.xsd#rnac_PaymentsForContingentValueRightsDistributions"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019cdd24-914a-77ad-8fbc-068f6fd9dfa3" xlink:to="loc_rnac_PaymentsForContingentValueRightsDistributions_019d96e8-880a-725e-9e56-458ad125b2de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019cdd24-914a-7d43-8a48-2f79aad3d051" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019cdd24-914a-766d-812c-58b868e9914c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019cdd24-914a-7d43-8a48-2f79aad3d051" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019cdd24-914a-766d-812c-58b868e9914c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019cdd24-914a-79ee-a3d1-f0573d681e64" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019cdd24-914a-7d43-8a48-2f79aad3d051" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019cdd24-914a-79ee-a3d1-f0573d681e64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019cdd24-914a-7dc4-a140-f28db99b509b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019cdd24-914a-7d43-8a48-2f79aad3d051" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019cdd24-914a-7dc4-a140-f28db99b509b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019cdd24-914a-78f9-a491-de8401904246" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019cdd24-914a-7d43-8a48-2f79aad3d051" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019cdd24-914a-78f9-a491-de8401904246" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_019cdd24-914b-7f6b-8011-9d36b44f3a60" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019cdd24-914b-72a9-af65-108efe058f90" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_019cdd24-914b-7f6b-8011-9d36b44f3a60" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019cdd24-914b-72a9-af65-108efe058f90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_019cdd24-914b-71ef-9921-4a11773d529b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_019cdd24-914b-7fad-abb3-f251d6dbe9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_019cdd24-914b-71ef-9921-4a11773d529b" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_019cdd24-914b-7fad-abb3-f251d6dbe9b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightLiability_019cdd24-914b-733c-99c8-07c248d12859" xlink:href="rnac-20260331.xsd#rnac_ContingentValueRightLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_019cdd24-914b-71ef-9921-4a11773d529b" xlink:to="loc_rnac_ContingentValueRightLiability_019cdd24-914b-733c-99c8-07c248d12859" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#FairValueMeasurementsScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019cdd24-914b-723f-a575-741ac05c3478" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_019cdd24-914b-7efb-bb64-3f191348100f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019cdd24-914b-723f-a575-741ac05c3478" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_019cdd24-914b-7efb-bb64-3f191348100f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019cdd24-914b-7093-830c-7ae7ac0c4809" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019cdd24-914b-723f-a575-741ac05c3478" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019cdd24-914b-7093-830c-7ae7ac0c4809" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#PropertyandEquipmentScheduleofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019cdd24-914b-72bc-b792-471546e96cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_019cdd24-914b-7826-b8fc-865f5bad3cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_019cdd24-914b-72bc-b792-471546e96cc6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_019cdd24-914b-7826-b8fc-865f5bad3cd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019cdd24-914b-787a-8777-463192fd462f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_019cdd24-914b-72bc-b792-471546e96cc6" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019cdd24-914b-787a-8777-463192fd462f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#AccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019cdd24-914b-7e47-bd30-9c0cac4ccb2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019cdd24-914b-7fa7-b9f1-b65979a9cfba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019cdd24-914b-7e47-bd30-9c0cac4ccb2a" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019cdd24-914b-7fa7-b9f1-b65979a9cfba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedCollaborationandLicensing_019cdd24-914b-7e29-951e-2fd918d13198" xlink:href="rnac-20260331.xsd#rnac_AccruedCollaborationandLicensing"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019cdd24-914b-7e47-bd30-9c0cac4ccb2a" xlink:to="loc_rnac_AccruedCollaborationandLicensing_019cdd24-914b-7e29-951e-2fd918d13198" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedPatentFeesCurrent_019cdd24-914b-7e4e-b7fe-ba9d5fe701dc" xlink:href="rnac-20260331.xsd#rnac_AccruedPatentFeesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019cdd24-914b-7e47-bd30-9c0cac4ccb2a" xlink:to="loc_rnac_AccruedPatentFeesCurrent_019cdd24-914b-7e4e-b7fe-ba9d5fe701dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedResearchAndDevelopmentCostsCurrent_019cdd24-914b-7d80-8195-1bff79c86a5f" xlink:href="rnac-20260331.xsd#rnac_AccruedResearchAndDevelopmentCostsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019cdd24-914b-7e47-bd30-9c0cac4ccb2a" xlink:to="loc_rnac_AccruedResearchAndDevelopmentCostsCurrent_019cdd24-914b-7d80-8195-1bff79c86a5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedAuditFeesCurrent_019cdd24-914b-75b6-b925-ea457bccb895" xlink:href="rnac-20260331.xsd#rnac_AccruedAuditFeesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019cdd24-914b-7e47-bd30-9c0cac4ccb2a" xlink:to="loc_rnac_AccruedAuditFeesCurrent_019cdd24-914b-75b6-b925-ea457bccb895" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedEquityOfferingCostsCurrent_019cdd24-914b-75a1-86ae-1c34393ab46b" xlink:href="rnac-20260331.xsd#rnac_AccruedEquityOfferingCostsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019cdd24-914b-7e47-bd30-9c0cac4ccb2a" xlink:to="loc_rnac_AccruedEquityOfferingCostsCurrent_019cdd24-914b-75a1-86ae-1c34393ab46b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019dbeb6-d178-7143-94f9-6896cb058290" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019cdd24-914b-7e47-bd30-9c0cac4ccb2a" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019dbeb6-d178-7143-94f9-6896cb058290" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/LeasesScheduleofComponentsofLeaseCostsDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#LeasesScheduleofComponentsofLeaseCostsDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/LeasesScheduleofComponentsofLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_019cdd24-914b-7d72-b1f9-3ac34e316c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_019cdd24-914b-7594-a093-64c8e99cf3ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_019cdd24-914b-7d72-b1f9-3ac34e316c2f" xlink:to="loc_us-gaap_OperatingLeaseCost_019cdd24-914b-7594-a093-64c8e99cf3ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_019cdd24-914b-7db0-849a-7d2056a9485c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_019cdd24-914b-7d72-b1f9-3ac34e316c2f" xlink:to="loc_us-gaap_VariableLeaseCost_019cdd24-914b-7db0-849a-7d2056a9485c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_019cdd24-914b-7ad9-93cb-8f5b122e7a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_019cdd24-914b-7d72-b1f9-3ac34e316c2f" xlink:to="loc_us-gaap_ShortTermLeaseCost_019cdd24-914b-7ad9-93cb-8f5b122e7a3d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019cdd24-914b-7b5c-bce6-5f110192e50d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019cdd24-914b-7947-9198-327cac92f3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019cdd24-914b-7b5c-bce6-5f110192e50d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019cdd24-914b-7947-9198-327cac92f3fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019cdd24-914b-7a04-8e6f-eabc8b41c1f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019cdd24-914b-7b5c-bce6-5f110192e50d" xlink:to="loc_us-gaap_OperatingLeaseLiability_019cdd24-914b-7a04-8e6f-eabc8b41c1f5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="rnac-20260331.xsd#LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019cdd24-914b-734c-9a1c-d7fdb1a4dc1b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019cdd24-914b-79d5-9af4-e6f3dd0639df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019cdd24-914b-734c-9a1c-d7fdb1a4dc1b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019cdd24-914b-79d5-9af4-e6f3dd0639df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019cdd24-914b-713a-9a85-8de1fa8403c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019cdd24-914b-734c-9a1c-d7fdb1a4dc1b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019cdd24-914b-713a-9a85-8de1fa8403c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019cdd24-914b-725e-8feb-cce4d16f2b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019cdd24-914b-734c-9a1c-d7fdb1a4dc1b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019cdd24-914b-725e-8feb-cce4d16f2b9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019cdd24-914b-7ba9-bc83-fbd92636bf8a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019cdd24-914b-734c-9a1c-d7fdb1a4dc1b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019cdd24-914b-7ba9-bc83-fbd92636bf8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019cdd24-914b-7c9e-b185-efbc711c7a88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019cdd24-914b-734c-9a1c-d7fdb1a4dc1b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019cdd24-914b-7c9e-b185-efbc711c7a88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_019cdd24-914b-75de-ab56-04dc076c36d2" xlink:href="rnac-20260331.xsd#rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019cdd24-914b-734c-9a1c-d7fdb1a4dc1b" xlink:to="loc_rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_019cdd24-914b-75de-ab56-04dc076c36d2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019cdd24-9221-7e8f-887d-559643691629" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019cdd24-9221-7047-a29c-eed77f876075" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019cdd24-9221-7e8f-887d-559643691629" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019cdd24-9221-7047-a29c-eed77f876075" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_019cdd24-9221-7fe9-95f3-3a687252bc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019cdd24-9221-7e8f-887d-559643691629" xlink:to="loc_us-gaap_Revenues_019cdd24-9221-7fe9-95f3-3a687252bc0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019cdd24-9221-70cc-88f3-b9a69090da25" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019cdd24-9221-7e8f-887d-559643691629" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019cdd24-9221-70cc-88f3-b9a69090da25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_NonoperatingIncomeExpenseAdjusted_019d1aa9-15f5-70d9-85ca-97ea69a37fc1" xlink:href="rnac-20260331.xsd#rnac_NonoperatingIncomeExpenseAdjusted"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019cdd24-9221-7e8f-887d-559643691629" xlink:to="loc_rnac_NonoperatingIncomeExpenseAdjusted_019d1aa9-15f5-70d9-85ca-97ea69a37fc1" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>rnac-20260331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019cdd24-8f10-71f0-acfb-b8a76448289c,g:7ae85b19-6328-41a5-b0c0-99683dc813c6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="rnac-20260331.xsd#ConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019cdd24-9084-7601-a0de-d9740463ffc0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019cdd24-9084-725a-8185-68d86f201f29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-9084-7601-a0de-d9740463ffc0" xlink:to="loc_us-gaap_StatementTable_019cdd24-9084-725a-8185-68d86f201f29" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019cdd24-9084-726a-a297-e7be5d1bf7da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019cdd24-9084-725a-8185-68d86f201f29" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019cdd24-9084-726a-a297-e7be5d1bf7da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cdd24-9084-726a-a297-e7be5d1bf7da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cdd24-9084-726a-a297-e7be5d1bf7da" xlink:to="loc_us-gaap_ClassOfStockDomain_019cdd24-9084-726a-a297-e7be5d1bf7da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cdd24-9084-72a0-ab84-9a7476f3625d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cdd24-9084-726a-a297-e7be5d1bf7da" xlink:to="loc_us-gaap_ClassOfStockDomain_019cdd24-9084-72a0-ab84-9a7476f3625d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-9084-7a44-be86-b3e3daf12e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019cdd24-9084-72a0-ab84-9a7476f3625d" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-9084-7a44-be86-b3e3daf12e4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-9084-7479-9c48-302efa1b8c29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019cdd24-9084-72a0-ab84-9a7476f3625d" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-9084-7479-9c48-302efa1b8c29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_019cdd24-9084-7004-b7d6-d48aa78ef2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-9084-7601-a0de-d9740463ffc0" xlink:to="loc_us-gaap_AssetsAbstract_019cdd24-9084-7004-b7d6-d48aa78ef2c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_019cdd24-9084-7241-80ef-7241e902cfe9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_019cdd24-9084-7004-b7d6-d48aa78ef2c2" xlink:to="loc_us-gaap_AssetsCurrentAbstract_019cdd24-9084-7241-80ef-7241e902cfe9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019cdd24-9084-74ad-a7fd-86b13f302aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019cdd24-9084-7241-80ef-7241e902cfe9" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019cdd24-9084-74ad-a7fd-86b13f302aa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_019cdd24-9084-7a15-b5c9-4f1d32516e73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019cdd24-9084-7241-80ef-7241e902cfe9" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_019cdd24-9084-7a15-b5c9-4f1d32516e73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019cdd24-9084-7796-98e3-f09430aa10a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019cdd24-9084-7241-80ef-7241e902cfe9" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019cdd24-9084-7796-98e3-f09430aa10a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019cdd24-9084-743c-a1c8-23090e1980f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019cdd24-9084-7241-80ef-7241e902cfe9" xlink:to="loc_us-gaap_AssetsCurrent_019cdd24-9084-743c-a1c8-23090e1980f8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019cdd24-9084-73a3-95f9-df34bb4e72c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_019cdd24-9084-7004-b7d6-d48aa78ef2c2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019cdd24-9084-73a3-95f9-df34bb4e72c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019cdd24-9084-7021-a97e-aa3abba97b97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_019cdd24-9084-7004-b7d6-d48aa78ef2c2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019cdd24-9084-7021-a97e-aa3abba97b97" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019cdd24-9084-73f3-bcaf-9c7506daf507" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_019cdd24-9084-7004-b7d6-d48aa78ef2c2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019cdd24-9084-73f3-bcaf-9c7506daf507" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_019cdd24-9084-740e-8a3b-0edb5f7550da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_019cdd24-9084-7004-b7d6-d48aa78ef2c2" xlink:to="loc_us-gaap_Goodwill_019cdd24-9084-740e-8a3b-0edb5f7550da" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_019cdd24-9084-74ca-a8ed-cce620e7a836" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_019cdd24-9084-7004-b7d6-d48aa78ef2c2" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_019cdd24-9084-74ca-a8ed-cce620e7a836" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_019cdd24-9084-73cb-a9d6-582984f939ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_019cdd24-9084-7004-b7d6-d48aa78ef2c2" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_019cdd24-9084-73cb-a9d6-582984f939ac" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019cdd24-9084-78e0-a5ae-57bc3207863d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_019cdd24-9084-7004-b7d6-d48aa78ef2c2" xlink:to="loc_us-gaap_Assets_019cdd24-9084-78e0-a5ae-57bc3207863d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-9084-7601-a0de-d9740463ffc0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_019cdd24-9084-704f-b0b5-f67f85fd0bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_019cdd24-9084-704f-b0b5-f67f85fd0bfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019cdd24-9084-776f-b0d7-8219e01e8a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019cdd24-9084-704f-b0b5-f67f85fd0bfb" xlink:to="loc_us-gaap_AccountsPayableCurrent_019cdd24-9084-776f-b0d7-8219e01e8a4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_019cdd24-9084-735b-bb00-791d520c0229" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019cdd24-9084-704f-b0b5-f67f85fd0bfb" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_019cdd24-9084-735b-bb00-791d520c0229" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019cdd24-9084-74d1-8e8b-e3f6d78a3cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019cdd24-9084-704f-b0b5-f67f85fd0bfb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019cdd24-9084-74d1-8e8b-e3f6d78a3cf2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019cdd24-9084-722d-bbac-b16e2776ae56" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019cdd24-9084-704f-b0b5-f67f85fd0bfb" xlink:to="loc_us-gaap_LiabilitiesCurrent_019cdd24-9084-722d-bbac-b16e2776ae56" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019cdd24-9084-707d-9711-a637aadc2db4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019cdd24-9084-707d-9711-a637aadc2db4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_WarrantsAndRightsOutstandingNoncurrent_019d0bcf-753b-7e85-8a66-86191051365a" xlink:href="rnac-20260331.xsd#rnac_WarrantsAndRightsOutstandingNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:to="loc_rnac_WarrantsAndRightsOutstandingNoncurrent_019d0bcf-753b-7e85-8a66-86191051365a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightLiabilityNoncurrent_019cdd24-9084-7e03-b284-6b96246209c8" xlink:href="rnac-20260331.xsd#rnac_ContingentValueRightLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:to="loc_rnac_ContingentValueRightLiabilityNoncurrent_019cdd24-9084-7e03-b284-6b96246209c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_019cdd24-914a-73d0-b488-dea2d2aa1675" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_019cdd24-914a-73d0-b488-dea2d2aa1675" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019cdd24-914a-7b89-844c-24efc390aa41" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:to="loc_us-gaap_Liabilities_019cdd24-914a-7b89-844c-24efc390aa41" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019cdd24-914a-7924-bb6d-2ee1f42bd100" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019cdd24-914a-7924-bb6d-2ee1f42bd100" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_019cdd24-914a-73b0-b6e4-116565373b91" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:to="loc_us-gaap_StockholdersEquityAbstract_019cdd24-914a-73b0-b6e4-116565373b91" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_019cdd24-914a-706d-b6f8-67f0566068c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019cdd24-914a-73b0-b6e4-116565373b91" xlink:to="loc_us-gaap_PreferredStockValue_019cdd24-914a-706d-b6f8-67f0566068c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019cdd24-914a-7f3e-9db8-fe05f985b9f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019cdd24-914a-73b0-b6e4-116565373b91" xlink:to="loc_us-gaap_CommonStockValue_019cdd24-914a-7f3e-9db8-fe05f985b9f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019cdd24-914a-71f8-ab04-6f6b9db2d690" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019cdd24-914a-73b0-b6e4-116565373b91" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019cdd24-914a-71f8-ab04-6f6b9db2d690" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019cdd24-914a-7f10-ba2c-1ceee750c071" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019cdd24-914a-73b0-b6e4-116565373b91" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019cdd24-914a-7f10-ba2c-1ceee750c071" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019cdd24-914a-7f7a-bfce-79eff62731af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019cdd24-914a-73b0-b6e4-116565373b91" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019cdd24-914a-7f7a-bfce-79eff62731af" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019cdd24-914a-74ea-9a7c-ed659ac9d814" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019cdd24-914a-73b0-b6e4-116565373b91" xlink:to="loc_us-gaap_StockholdersEquity_019cdd24-914a-74ea-9a7c-ed659ac9d814" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019cdd24-914a-7e11-8f8b-58ec6349f918" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_019cdd24-914a-7e11-8f8b-58ec6349f918" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="rnac-20260331.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019cdd24-914a-7b7c-82c9-7134623a0ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019cdd24-914a-7233-a241-2be006326769" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-914a-7b7c-82c9-7134623a0ec5" xlink:to="loc_us-gaap_StatementTable_019cdd24-914a-7233-a241-2be006326769" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914a-7659-af21-3eaa210238e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019cdd24-914a-7233-a241-2be006326769" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914a-7659-af21-3eaa210238e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cdd24-914a-7659-af21-3eaa210238e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914a-7659-af21-3eaa210238e0" xlink:to="loc_us-gaap_ClassOfStockDomain_019cdd24-914a-7659-af21-3eaa210238e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cdd24-914a-7efb-bac5-b8549d65a577" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914a-7659-af21-3eaa210238e0" xlink:to="loc_us-gaap_ClassOfStockDomain_019cdd24-914a-7efb-bac5-b8549d65a577" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-914a-7135-8145-f343712ed806" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019cdd24-914a-7efb-bac5-b8549d65a577" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-914a-7135-8145-f343712ed806" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-914a-751b-8c15-f1674cab8e25" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019cdd24-914a-7efb-bac5-b8549d65a577" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-914a-751b-8c15-f1674cab8e25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019cdd24-914a-795f-8cd4-b5fec2b91765" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-914a-7b7c-82c9-7134623a0ec5" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019cdd24-914a-795f-8cd4-b5fec2b91765" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_019cdd24-914a-745b-945e-0b84351b09bd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-914a-7b7c-82c9-7134623a0ec5" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_019cdd24-914a-745b-945e-0b84351b09bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_019cdd24-914a-7b8c-b11b-d6fb3b69e74b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-914a-7b7c-82c9-7134623a0ec5" xlink:to="loc_us-gaap_PreferredStockSharesIssued_019cdd24-914a-7b8c-b11b-d6fb3b69e74b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_019cdd24-914a-73bf-b842-2ca8afd329c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-914a-7b7c-82c9-7134623a0ec5" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_019cdd24-914a-73bf-b842-2ca8afd329c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_019cdd24-914a-7e88-b7f9-dbf49f5969f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-914a-7b7c-82c9-7134623a0ec5" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_019cdd24-914a-7e88-b7f9-dbf49f5969f2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_019cdd24-914a-71b2-9b32-73fb49b3c87f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-914a-7b7c-82c9-7134623a0ec5" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_019cdd24-914a-71b2-9b32-73fb49b3c87f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_019cdd24-914a-76c7-8564-c1d04280098f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-914a-7b7c-82c9-7134623a0ec5" xlink:to="loc_us-gaap_CommonStockSharesIssued_019cdd24-914a-76c7-8564-c1d04280098f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019cdd24-914a-7cc5-ba88-515feda0b9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-914a-7b7c-82c9-7134623a0ec5" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019cdd24-914a-7cc5-ba88-515feda0b9bc" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit" xlink:type="simple" xlink:href="rnac-20260331.xsd#ConsolidatedStatementsofChangesinStockholdersDeficit"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019cdd24-914a-7d7a-8424-ebf19aaf4879" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019cdd24-914a-7111-97d0-6a8184dac4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-914a-7d7a-8424-ebf19aaf4879" xlink:to="loc_us-gaap_StatementTable_019cdd24-914a-7111-97d0-6a8184dac4b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914a-79c3-b5cb-2f0fad1a5d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019cdd24-914a-7111-97d0-6a8184dac4b2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914a-79c3-b5cb-2f0fad1a5d9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019cdd24-914a-79c3-b5cb-2f0fad1a5d9c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914a-79c3-b5cb-2f0fad1a5d9c" xlink:to="loc_us-gaap_EquityComponentDomain_019cdd24-914a-79c3-b5cb-2f0fad1a5d9c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019cdd24-914a-7dc9-9202-8a5ba67b2230" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914a-79c3-b5cb-2f0fad1a5d9c" xlink:to="loc_us-gaap_EquityComponentDomain_019cdd24-914a-7dc9-9202-8a5ba67b2230" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_019cdd24-914a-7b9c-b794-24616afc17c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019cdd24-914a-7dc9-9202-8a5ba67b2230" xlink:to="loc_us-gaap_PreferredStockMember_019cdd24-914a-7b9c-b794-24616afc17c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019cdd24-914a-7589-90f2-ca4b8e2a55ae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019cdd24-914a-7dc9-9202-8a5ba67b2230" xlink:to="loc_us-gaap_CommonStockMember_019cdd24-914a-7589-90f2-ca4b8e2a55ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_019cdd24-914a-76ab-a3e1-42a4fe6cf261" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019cdd24-914a-7dc9-9202-8a5ba67b2230" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_019cdd24-914a-76ab-a3e1-42a4fe6cf261" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_019cdd24-914a-7a88-bdf6-b312c4571d81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019cdd24-914a-7dc9-9202-8a5ba67b2230" xlink:to="loc_us-gaap_RetainedEarningsMember_019cdd24-914a-7a88-bdf6-b312c4571d81" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_019cdd24-914a-723d-8921-13c9829e6677" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019cdd24-914a-7dc9-9202-8a5ba67b2230" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_019cdd24-914a-723d-8921-13c9829e6677" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914a-7831-8eeb-76456b593594" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019cdd24-914a-7111-97d0-6a8184dac4b2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914a-7831-8eeb-76456b593594" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cdd24-914a-7831-8eeb-76456b593594_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914a-7831-8eeb-76456b593594" xlink:to="loc_us-gaap_ClassOfStockDomain_019cdd24-914a-7831-8eeb-76456b593594_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cdd24-914a-73df-8578-096ebf6f9859" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914a-7831-8eeb-76456b593594" xlink:to="loc_us-gaap_ClassOfStockDomain_019cdd24-914a-73df-8578-096ebf6f9859" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-914a-7501-a0da-5a967f15258d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019cdd24-914a-73df-8578-096ebf6f9859" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-914a-7501-a0da-5a967f15258d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-914a-7283-b1b9-f35a74c26feb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019cdd24-914a-73df-8578-096ebf6f9859" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-914a-7283-b1b9-f35a74c26feb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-914a-7d7a-8424-ebf19aaf4879" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_019cdd24-914a-747d-9fb0-ba62321e1bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_019cdd24-914a-747d-9fb0-ba62321e1bb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019cdd24-914a-7b6d-9847-5e62e3a9491c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_StockholdersEquity_019cdd24-914a-7b6d-9847-5e62e3a9491c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019cdd24-914a-7ead-b660-d469f3aa61a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019cdd24-914a-7ead-b660-d469f3aa61a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019cdd24-914a-7325-94f2-17cd34422236" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019cdd24-914a-7325-94f2-17cd34422236" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019cdd24-914a-7adb-a772-2dde9152f888" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019cdd24-914a-7adb-a772-2dde9152f888" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_019cdd24-914a-753f-886c-bb4c887fa56d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_019cdd24-914a-753f-886c-bb4c887fa56d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019d6aba-3958-7649-bf9d-b0f3acb1e466" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019d6aba-3958-7649-bf9d-b0f3acb1e466" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_019d6aba-3958-7c44-9e9a-9fd148ff87e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_019d6aba-3958-7c44-9e9a-9fd148ff87e0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019cdd24-914a-70fe-91f1-9ce049fa8323" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019cdd24-914a-70fe-91f1-9ce049fa8323" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_019cdd24-914a-7339-a06b-732438628bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_019cdd24-914a-7339-a06b-732438628bb5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019cdd24-914a-74d4-8932-6348b045f3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_NetIncomeLoss_019cdd24-914a-74d4-8932-6348b045f3c2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_019cdd24-914a-7baa-ba98-ca3c12d600c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019cdd24-914a-758a-b55f-c9bc80f8323e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019cdd24-914a-7b2d-8336-68f8b6780300" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/DescriptionoftheBusinessDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#DescriptionoftheBusinessDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/DescriptionoftheBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_019d1a10-6f5a-710d-a571-957642f3b67d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019cdd24-914b-7781-8a6d-00832a67c955" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_019d1a10-6f5a-710d-a571-957642f3b67d" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019cdd24-914b-7781-8a6d-00832a67c955" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_019d1a10-6f5a-7c7b-9b60-cba97e8ddac5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019cdd24-914b-7781-8a6d-00832a67c955" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_019d1a10-6f5a-7c7b-9b60-cba97e8ddac5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d1a10-6f5a-7c7b-9b60-cba97e8ddac5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_019d1a10-6f5a-7c7b-9b60-cba97e8ddac5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d1a10-6f5a-7c7b-9b60-cba97e8ddac5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d1a10-6f5a-7a45-9e82-6c6c8f8f6ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_019d1a10-6f5a-7c7b-9b60-cba97e8ddac5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d1a10-6f5a-7a45-9e82-6c6c8f8f6ae6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_OldCartesianMember_019d1a10-6f5a-7b54-94f4-7a6198cb3d91" xlink:href="rnac-20260331.xsd#rnac_OldCartesianMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d1a10-6f5a-7a45-9e82-6c6c8f8f6ae6" xlink:to="loc_rnac_OldCartesianMember_019d1a10-6f5a-7b54-94f4-7a6198cb3d91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d1a10-6f5a-7010-a616-f1095b67dfea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_019d1a10-6f5a-710d-a571-957642f3b67d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d1a10-6f5a-7010-a616-f1095b67dfea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale_019d1a10-6f5a-7bc0-9f40-b27af25c163d" xlink:href="rnac-20260331.xsd#rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_019d1a10-6f5a-710d-a571-957642f3b67d" xlink:to="loc_rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale_019d1a10-6f5a-7bc0-9f40-b27af25c163d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_019d1a10-6f5a-7727-b7b8-59245c0714e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_019d1a10-6f5a-710d-a571-957642f3b67d" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_019d1a10-6f5a-7727-b7b8-59245c0714e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed_019d1a10-6f5a-763d-b8e9-aeace04769b4" xlink:href="rnac-20260331.xsd#rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_019d1a10-6f5a-710d-a571-957642f3b67d" xlink:to="loc_rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed_019d1a10-6f5a-763d-b8e9-aeace04769b4" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#GoodwillandIndefiniteLivedIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_019d1a25-a18b-7892-a90f-55009d00d72b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019cdd24-914b-79c6-b13f-9e31cdf1a9df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019d1a25-a18b-7892-a90f-55009d00d72b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019cdd24-914b-79c6-b13f-9e31cdf1a9df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_019d1a25-a18b-7a4b-8a35-03df72ed541f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019cdd24-914b-79c6-b13f-9e31cdf1a9df" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_019d1a25-a18b-7a4b-8a35-03df72ed541f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d1a25-a18b-7a4b-8a35-03df72ed541f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_019d1a25-a18b-7a4b-8a35-03df72ed541f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d1a25-a18b-7a4b-8a35-03df72ed541f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d1a25-a18b-742a-b61d-d4a82a269485" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_019d1a25-a18b-7a4b-8a35-03df72ed541f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d1a25-a18b-742a-b61d-d4a82a269485" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_OldCartesianMember_019d1a25-a18b-7c41-8c0e-18e4766d375e" xlink:href="rnac-20260331.xsd#rnac_OldCartesianMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d1a25-a18b-742a-b61d-d4a82a269485" xlink:to="loc_rnac_OldCartesianMember_019d1a25-a18b-7c41-8c0e-18e4766d375e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_019d1a25-a18b-70e4-842d-36d6e04bdf75" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019cdd24-914b-79c6-b13f-9e31cdf1a9df" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_019d1a25-a18b-70e4-842d-36d6e04bdf75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_019d1a25-a18b-70e4-842d-36d6e04bdf75_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_019d1a25-a18b-70e4-842d-36d6e04bdf75" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_019d1a25-a18b-70e4-842d-36d6e04bdf75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_019d1a25-a18b-7176-8317-8550c06aa8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_019d1a25-a18b-70e4-842d-36d6e04bdf75" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_019d1a25-a18b-7176-8317-8550c06aa8ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_Descartes08ForMGMember_019d1a25-a18b-7a4a-9dd5-64e8bdd2b860" xlink:href="rnac-20260331.xsd#rnac_Descartes08ForMGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_019d1a25-a18b-7176-8317-8550c06aa8ca" xlink:to="loc_rnac_Descartes08ForMGMember_019d1a25-a18b-7a4a-9dd5-64e8bdd2b860" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_019d1a25-a18b-7785-9bbc-9f24ad75ae35" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_019d1a25-a18b-7176-8317-8550c06aa8ca" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_019d1a25-a18b-7785-9bbc-9f24ad75ae35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_019d1a25-a18b-7e8f-a9a4-63b96d4b774c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019d1a25-a18b-7892-a90f-55009d00d72b" xlink:to="loc_us-gaap_Goodwill_019d1a25-a18b-7e8f-a9a4-63b96d4b774c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019d1a25-a18b-711f-a62b-6299a1a6afe4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019d1a25-a18b-7892-a90f-55009d00d72b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019d1a25-a18b-711f-a62b-6299a1a6afe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_019d1a25-a18b-7c9a-891e-dd538a6dcaec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019d1a25-a18b-7892-a90f-55009d00d72b" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_019d1a25-a18b-7c9a-891e-dd538a6dcaec" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019cdd24-914b-78c1-bf65-a41ef39dc282" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019cdd24-914b-7c98-b20c-54893e4aaf9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019cdd24-914b-78c1-bf65-a41ef39dc282" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019cdd24-914b-7c98-b20c-54893e4aaf9e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019cdd24-914b-73fe-bd99-7db3fa026ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019cdd24-914b-7c98-b20c-54893e4aaf9e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019cdd24-914b-73fe-bd99-7db3fa026ae1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019cdd24-914b-73fe-bd99-7db3fa026ae1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019cdd24-914b-73fe-bd99-7db3fa026ae1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019cdd24-914b-73fe-bd99-7db3fa026ae1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019cdd24-914b-7e59-8ffe-d0952e16d175" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019cdd24-914b-73fe-bd99-7db3fa026ae1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019cdd24-914b-7e59-8ffe-d0952e16d175" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_019cdd24-914b-7284-8288-d891a9a0f1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019cdd24-914b-7e59-8ffe-d0952e16d175" xlink:to="loc_us-gaap_StockCompensationPlanMember_019cdd24-914b-7284-8288-d891a9a0f1fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_019cdd24-914b-7242-8049-05acdb6a2dde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019cdd24-914b-7e59-8ffe-d0952e16d175" xlink:to="loc_us-gaap_WarrantMember_019cdd24-914b-7242-8049-05acdb6a2dde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_019cdd24-914b-762b-8e8f-bcc72702592e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019cdd24-914b-7e59-8ffe-d0952e16d175" xlink:to="loc_us-gaap_PreferredStockMember_019cdd24-914b-762b-8e8f-bcc72702592e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914b-7dc3-bdda-e48aa194354d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019cdd24-914b-7c98-b20c-54893e4aaf9e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914b-7dc3-bdda-e48aa194354d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cdd24-914b-7dc3-bdda-e48aa194354d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914b-7dc3-bdda-e48aa194354d" xlink:to="loc_us-gaap_ClassOfStockDomain_019cdd24-914b-7dc3-bdda-e48aa194354d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cdd24-914b-770c-a5c7-353300b1cb8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914b-7dc3-bdda-e48aa194354d" xlink:to="loc_us-gaap_ClassOfStockDomain_019cdd24-914b-770c-a5c7-353300b1cb8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-914b-7724-bc9b-8d85ec30ad55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019cdd24-914b-770c-a5c7-353300b1cb8e" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-914b-7724-bc9b-8d85ec30ad55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-914b-7e8e-9271-ef4cad916de4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019cdd24-914b-770c-a5c7-353300b1cb8e" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-914b-7e8e-9271-ef4cad916de4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019cdd24-914b-79db-80ca-1644b296fd88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019cdd24-914b-78c1-bf65-a41ef39dc282" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019cdd24-914b-79db-80ca-1644b296fd88" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019cdd24-914b-7ec3-a554-dc84e2741326" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019cdd24-914b-7f0e-bef8-85f95ae4db2e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019cdd24-914b-7ec3-a554-dc84e2741326" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019cdd24-914b-7f0e-bef8-85f95ae4db2e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019cdd24-914b-772f-8e3f-78e4337a8557" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019cdd24-914b-7f0e-bef8-85f95ae4db2e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019cdd24-914b-772f-8e3f-78e4337a8557" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-914b-772f-8e3f-78e4337a8557_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019cdd24-914b-772f-8e3f-78e4337a8557" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-914b-772f-8e3f-78e4337a8557_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-914b-7aa8-be16-d924c841fd33" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019cdd24-914b-772f-8e3f-78e4337a8557" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-914b-7aa8-be16-d924c841fd33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_019cdd24-914b-7225-8e2f-def611784a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-914b-7aa8-be16-d924c841fd33" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_019cdd24-914b-7225-8e2f-def611784a8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_019cdd24-914b-7b8f-a5f0-254230bf0169" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-914b-7aa8-be16-d924c841fd33" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_019cdd24-914b-7b8f-a5f0-254230bf0169" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_019cdd24-914b-7946-aaad-741e5fc6869f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-914b-7aa8-be16-d924c841fd33" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_019cdd24-914b-7946-aaad-741e5fc6869f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_019cdd24-914b-72d1-8f7d-4c1d05ae8cee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019cdd24-914b-7f0e-bef8-85f95ae4db2e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_019cdd24-914b-72d1-8f7d-4c1d05ae8cee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019cdd24-914b-72d1-8f7d-4c1d05ae8cee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_019cdd24-914b-72d1-8f7d-4c1d05ae8cee" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019cdd24-914b-72d1-8f7d-4c1d05ae8cee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019cdd24-914b-733c-9b7a-dbdf4759c029" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_019cdd24-914b-72d1-8f7d-4c1d05ae8cee" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019cdd24-914b-733c-9b7a-dbdf4759c029" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_019cdd24-914b-76d5-87b4-d0db181217c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019cdd24-914b-733c-9b7a-dbdf4759c029" xlink:to="loc_us-gaap_MoneyMarketFundsMember_019cdd24-914b-76d5-87b4-d0db181217c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_019cdd24-914b-7cd3-93fc-dd87793fb3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019cdd24-914b-7ec3-a554-dc84e2741326" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_019cdd24-914b-7cd3-93fc-dd87793fb3e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019cdd24-914b-7ebf-b8eb-1204d3efdbde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_019cdd24-914b-7cd3-93fc-dd87793fb3e8" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019cdd24-914b-7ebf-b8eb-1204d3efdbde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_019cdd24-914b-78a2-b7a8-70b35c541b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_019cdd24-914b-7cd3-93fc-dd87793fb3e8" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_019cdd24-914b-78a2-b7a8-70b35c541b8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_019cdd24-914b-741b-9f3a-63605929d6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019cdd24-914b-7ec3-a554-dc84e2741326" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_019cdd24-914b-741b-9f3a-63605929d6dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_019cdd24-914b-7f8c-a58e-a7cb667f9aae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_019cdd24-914b-741b-9f3a-63605929d6dd" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_019cdd24-914b-7f8c-a58e-a7cb667f9aae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightLiability_019cdd24-914b-7f72-8d32-255faa47fa2d" xlink:href="rnac-20260331.xsd#rnac_ContingentValueRightLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_019cdd24-914b-741b-9f3a-63605929d6dd" xlink:to="loc_rnac_ContingentValueRightLiability_019cdd24-914b-7f72-8d32-255faa47fa2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_019cdd24-914b-73b5-93a6-d0bd507dc553" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_019cdd24-914b-741b-9f3a-63605929d6dd" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_019cdd24-914b-73b5-93a6-d0bd507dc553" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019d9b4e-3552-73ab-a884-898151834d32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-7985-9f1e-2518063d9229" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019d9b4e-3552-73ab-a884-898151834d32" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-7985-9f1e-2518063d9229" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_019d9b4e-54a4-7133-963a-3c00ae88dd10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-7985-9f1e-2518063d9229" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_019d9b4e-54a4-7133-963a-3c00ae88dd10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_019d9b4e-54a4-7133-963a-3c00ae88dd10_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_019d9b4e-54a4-7133-963a-3c00ae88dd10" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_019d9b4e-54a4-7133-963a-3c00ae88dd10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_019d9b4e-54a4-7755-a1e3-2720280da1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_019d9b4e-54a4-7133-963a-3c00ae88dd10" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_019d9b4e-54a4-7755-a1e3-2720280da1c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_019d9b4e-54a5-7fb4-98d5-e65071f0e20f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019d9b4e-54a4-7755-a1e3-2720280da1c5" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_019d9b4e-54a5-7fb4-98d5-e65071f0e20f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_019d9b4e-54a5-74e2-a74a-e94604fc939c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-7985-9f1e-2518063d9229" xlink:to="loc_us-gaap_ValuationTechniqueAxis_019d9b4e-54a5-74e2-a74a-e94604fc939c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_019d9b4e-54a5-74e2-a74a-e94604fc939c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_019d9b4e-54a5-74e2-a74a-e94604fc939c" xlink:to="loc_us-gaap_ValuationTechniqueDomain_019d9b4e-54a5-74e2-a74a-e94604fc939c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_019d9b4e-54a5-7257-9faf-c1796335fe05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_019d9b4e-54a5-74e2-a74a-e94604fc939c" xlink:to="loc_us-gaap_ValuationTechniqueDomain_019d9b4e-54a5-7257-9faf-c1796335fe05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_019d9b4e-54a5-7965-a6ee-e5120df25574" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_019d9b4e-54a5-7257-9faf-c1796335fe05" xlink:to="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_019d9b4e-54a5-7965-a6ee-e5120df25574" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_019d9b4e-3552-7e1f-b892-cc95fca60d32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019d9b4e-3552-73ab-a884-898151834d32" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_019d9b4e-3552-7e1f-b892-cc95fca60d32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_019d9b4e-3552-746f-9a27-b8d23559ed36" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019d9b4e-3552-73ab-a884-898151834d32" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_019d9b4e-3552-746f-9a27-b8d23559ed36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_019d9b4e-54a5-77db-990a-6e910092b1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019d9b4e-3552-73ab-a884-898151834d32" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_019d9b4e-54a5-77db-990a-6e910092b1f8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_019cdd24-914b-746d-b96f-c73789969e94" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019cdd24-914b-7250-b1a4-0d9cc1d53788" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_019cdd24-914b-746d-b96f-c73789969e94" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019cdd24-914b-7250-b1a4-0d9cc1d53788" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_019cdd24-914b-71ed-be25-b24b3967a7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019cdd24-914b-7250-b1a4-0d9cc1d53788" xlink:to="loc_us-gaap_ValuationTechniqueAxis_019cdd24-914b-71ed-be25-b24b3967a7a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_019cdd24-914b-71ed-be25-b24b3967a7a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_019cdd24-914b-71ed-be25-b24b3967a7a0" xlink:to="loc_us-gaap_ValuationTechniqueDomain_019cdd24-914b-71ed-be25-b24b3967a7a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_019cdd24-914b-7f4b-956e-037b8f15b5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_019cdd24-914b-71ed-be25-b24b3967a7a0" xlink:to="loc_us-gaap_ValuationTechniqueDomain_019cdd24-914b-7f4b-956e-037b8f15b5ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_019cdd24-914b-72a0-bdb3-305209c98383" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_019cdd24-914b-7f4b-956e-037b8f15b5ab" xlink:to="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_019cdd24-914b-72a0-bdb3-305209c98383" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_019cdd24-914b-7b68-87b3-65daac7cfc43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019cdd24-914b-7250-b1a4-0d9cc1d53788" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_019cdd24-914b-7b68-87b3-65daac7cfc43" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-7b68-87b3-65daac7cfc43_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_019cdd24-914b-7b68-87b3-65daac7cfc43" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-7b68-87b3-65daac7cfc43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-7fa9-87a6-4418ef2338dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_019cdd24-914b-7b68-87b3-65daac7cfc43" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-7fa9-87a6-4418ef2338dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_019cdd24-914b-748c-a3f7-b9b31926c31c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-7fa9-87a6-4418ef2338dc" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_019cdd24-914b-748c-a3f7-b9b31926c31c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_019cdd24-914b-7096-8354-70f858a14df7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-7fa9-87a6-4418ef2338dc" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_019cdd24-914b-7096-8354-70f858a14df7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_019cdd24-914b-7385-9be9-eed943548935" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-7fa9-87a6-4418ef2338dc" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_019cdd24-914b-7385-9be9-eed943548935" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_019cdd24-914b-7ec0-82b6-25e473c627e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-7fa9-87a6-4418ef2338dc" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_019cdd24-914b-7ec0-82b6-25e473c627e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019cdd24-914b-70bc-bee2-03c289e5bd41" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019cdd24-914b-7250-b1a4-0d9cc1d53788" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019cdd24-914b-70bc-bee2-03c289e5bd41" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019cdd24-914b-70bc-bee2-03c289e5bd41_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019cdd24-914b-70bc-bee2-03c289e5bd41" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019cdd24-914b-70bc-bee2-03c289e5bd41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019cdd24-914b-7a0d-bd72-4e906ebdeb62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019cdd24-914b-70bc-bee2-03c289e5bd41" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019cdd24-914b-7a0d-bd72-4e906ebdeb62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_A2022WarrantsMember_019cdd24-914b-7ac8-a9ed-67a542db10b4" xlink:href="rnac-20260331.xsd#rnac_A2022WarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cdd24-914b-7a0d-bd72-4e906ebdeb62" xlink:to="loc_rnac_A2022WarrantsMember_019cdd24-914b-7ac8-a9ed-67a542db10b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_019cdd24-914b-7f3e-b851-30dc6136aa85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_019cdd24-914b-746d-b96f-c73789969e94" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_019cdd24-914b-7f3e-b851-30dc6136aa85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019cdd24-914b-7221-a4ca-0f19cd2d0dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_019cdd24-914b-746d-b96f-c73789969e94" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019cdd24-914b-7221-a4ca-0f19cd2d0dcf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofRollForwardofFairValuefortheCompanysLevel3WarrantLiabilitiesandCVRLiabilityDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#FairValueMeasurementsScheduleofRollForwardofFairValuefortheCompanysLevel3WarrantLiabilitiesandCVRLiabilityDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofRollForwardofFairValuefortheCompanysLevel3WarrantLiabilitiesandCVRLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019cdd24-914b-7479-b6d7-b2f708a5e614" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-79fd-afaa-159275e0adbf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019cdd24-914b-7479-b6d7-b2f708a5e614" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-79fd-afaa-159275e0adbf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_019cdd24-914b-72f4-aa20-7030c3375abf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-79fd-afaa-159275e0adbf" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_019cdd24-914b-72f4-aa20-7030c3375abf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019cdd24-914b-72f4-aa20-7030c3375abf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_019cdd24-914b-72f4-aa20-7030c3375abf" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019cdd24-914b-72f4-aa20-7030c3375abf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019cdd24-914b-7546-8feb-50d123361739" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_019cdd24-914b-72f4-aa20-7030c3375abf" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019cdd24-914b-7546-8feb-50d123361739" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_019cdd24-914b-7f65-be86-5b9215fc7dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019cdd24-914b-7546-8feb-50d123361739" xlink:to="loc_us-gaap_WarrantMember_019cdd24-914b-7f65-be86-5b9215fc7dcf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightMember_019cdd24-914b-7255-931f-2284ef0386e7" xlink:href="rnac-20260331.xsd#rnac_ContingentValueRightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019cdd24-914b-7546-8feb-50d123361739" xlink:to="loc_rnac_ContingentValueRightMember_019cdd24-914b-7255-931f-2284ef0386e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_019cdd24-914b-7ff1-a585-8249d363c587" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019cdd24-914b-7479-b6d7-b2f708a5e614" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_019cdd24-914b-7ff1-a585-8249d363c587" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_019cdd24-914b-723e-8fd4-c6c62e2c923f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_019cdd24-914b-7ff1-a585-8249d363c587" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_019cdd24-914b-723e-8fd4-c6c62e2c923f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_019cdd24-914b-7af9-b5d2-9593e0782dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_019cdd24-914b-7ff1-a585-8249d363c587" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_019cdd24-914b-7af9-b5d2-9593e0782dc6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_019cdd24-914b-7ac0-a8ed-e254f3440cec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019cdd24-914b-7752-b000-9a48dbe59edb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-7772-8775-e101c598e6f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019cdd24-914b-7752-b000-9a48dbe59edb" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-7772-8775-e101c598e6f8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019cdd24-914b-77d9-b55f-7d1a456fc703" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-7772-8775-e101c598e6f8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019cdd24-914b-77d9-b55f-7d1a456fc703" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-914b-77d9-b55f-7d1a456fc703_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019cdd24-914b-77d9-b55f-7d1a456fc703" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-914b-77d9-b55f-7d1a456fc703_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-914b-7e56-8b34-817526c91491" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019cdd24-914b-77d9-b55f-7d1a456fc703" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-914b-7e56-8b34-817526c91491" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_019cdd24-914b-731b-85fc-9827e0cdbc85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-914b-7e56-8b34-817526c91491" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_019cdd24-914b-731b-85fc-9827e0cdbc85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_019cdd24-914b-7c80-a8b5-87933e82bcd4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-7772-8775-e101c598e6f8" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_019cdd24-914b-7c80-a8b5-87933e82bcd4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-7c80-a8b5-87933e82bcd4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_019cdd24-914b-7c80-a8b5-87933e82bcd4" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-7c80-a8b5-87933e82bcd4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-78d1-ac9c-42a80824c982" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_019cdd24-914b-7c80-a8b5-87933e82bcd4" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-78d1-ac9c-42a80824c982" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ProbabilityOfSuccessMember_019cdd24-914b-722b-a1f9-fe6a480a1a07" xlink:href="rnac-20260331.xsd#rnac_ProbabilityOfSuccessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-78d1-ac9c-42a80824c982" xlink:to="loc_rnac_ProbabilityOfSuccessMember_019cdd24-914b-722b-a1f9-fe6a480a1a07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_MeasurementInputRevenueVolatilityMember_019cdd24-914b-7d79-b8b2-1f4cf44a23df" xlink:href="rnac-20260331.xsd#rnac_MeasurementInputRevenueVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-78d1-ac9c-42a80824c982" xlink:to="loc_rnac_MeasurementInputRevenueVolatilityMember_019cdd24-914b-7d79-b8b2-1f4cf44a23df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019cdd24-914b-7d63-820b-191fc029d5c9" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-7772-8775-e101c598e6f8" xlink:to="loc_srt_RangeAxis_019cdd24-914b-7d63-820b-191fc029d5c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019cdd24-914b-7d63-820b-191fc029d5c9_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019cdd24-914b-7d63-820b-191fc029d5c9" xlink:to="loc_srt_RangeMember_019cdd24-914b-7d63-820b-191fc029d5c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019cdd24-914b-7158-8a64-363db5bccfc4" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019cdd24-914b-7d63-820b-191fc029d5c9" xlink:to="loc_srt_RangeMember_019cdd24-914b-7158-8a64-363db5bccfc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019cdd24-914b-7316-859c-363a75257707" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019cdd24-914b-7158-8a64-363db5bccfc4" xlink:to="loc_srt_MinimumMember_019cdd24-914b-7316-859c-363a75257707" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019cdd24-914b-73ad-ae19-d53664469252" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019cdd24-914b-7158-8a64-363db5bccfc4" xlink:to="loc_srt_MaximumMember_019cdd24-914b-73ad-ae19-d53664469252" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightLiabilityMeasurementInput_019cdd24-914b-7982-9fa4-61992abbd40f" xlink:href="rnac-20260331.xsd#rnac_ContingentValueRightLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019cdd24-914b-7752-b000-9a48dbe59edb" xlink:to="loc_rnac_ContingentValueRightLiabilityMeasurementInput_019cdd24-914b-7982-9fa4-61992abbd40f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#PropertyandEquipmentScheduleofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019cdd24-914b-78a3-ac69-6422199b6ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019cdd24-914b-7fd0-98cd-f193aad141b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019cdd24-914b-78a3-ac69-6422199b6ed5" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019cdd24-914b-7fd0-98cd-f193aad141b7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019cdd24-914b-7390-8322-2bc79706c630" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019cdd24-914b-7fd0-98cd-f193aad141b7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019cdd24-914b-7390-8322-2bc79706c630" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019cdd24-914b-7390-8322-2bc79706c630_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019cdd24-914b-7390-8322-2bc79706c630" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019cdd24-914b-7390-8322-2bc79706c630_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019cdd24-914b-7b40-b51c-75395bc98e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019cdd24-914b-7390-8322-2bc79706c630" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019cdd24-914b-7b40-b51c-75395bc98e5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LaboratoryEquipmentMember_019cdd24-914b-7514-baab-798edbecdd71" xlink:href="rnac-20260331.xsd#rnac_LaboratoryEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019cdd24-914b-7b40-b51c-75395bc98e5e" xlink:to="loc_rnac_LaboratoryEquipmentMember_019cdd24-914b-7514-baab-798edbecdd71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_019cdd24-914b-7519-964d-95721d9bf5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019cdd24-914b-7b40-b51c-75395bc98e5e" xlink:to="loc_us-gaap_ComputerEquipmentMember_019cdd24-914b-7519-964d-95721d9bf5dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_019cdd24-914b-79d6-bb7e-b111e735948d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019cdd24-914b-7b40-b51c-75395bc98e5e" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_019cdd24-914b-79d6-bb7e-b111e735948d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_019cdd24-914b-7342-b7d3-c2ce27b77142" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019cdd24-914b-7b40-b51c-75395bc98e5e" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_019cdd24-914b-7342-b7d3-c2ce27b77142" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_019cdd24-914b-7f0e-88ce-7b12ed9dc3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019cdd24-914b-7b40-b51c-75395bc98e5e" xlink:to="loc_us-gaap_OfficeEquipmentMember_019cdd24-914b-7f0e-88ce-7b12ed9dc3bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_019cdd24-914b-7a50-9e51-48efd105299a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019cdd24-914b-7b40-b51c-75395bc98e5e" xlink:to="loc_us-gaap_ConstructionInProgressMember_019cdd24-914b-7a50-9e51-48efd105299a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_019cdd24-914b-73ce-9e33-a67e15189e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019cdd24-914b-78a3-ac69-6422199b6ed5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_019cdd24-914b-73ce-9e33-a67e15189e3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019cdd24-914b-7fec-a8a9-dff3a874ccd3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019cdd24-914b-78a3-ac69-6422199b6ed5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019cdd24-914b-7fec-a8a9-dff3a874ccd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019cdd24-914b-7ee1-a693-9f00bf8ffec2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019cdd24-914b-78a3-ac69-6422199b6ed5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019cdd24-914b-7ee1-a693-9f00bf8ffec2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_019d1a79-3342-7c4c-a2ef-2e3170064757" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_019cdd24-914b-75d4-87fd-419298a086a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_019d1a79-3342-7c4c-a2ef-2e3170064757" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_019cdd24-914b-75d4-87fd-419298a086a9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LeaseArrangementAxis_019d1a79-3342-7e9a-ab7f-877a37a52602" xlink:href="rnac-20260331.xsd#rnac_LeaseArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_019cdd24-914b-75d4-87fd-419298a086a9" xlink:to="loc_rnac_LeaseArrangementAxis_019d1a79-3342-7e9a-ab7f-877a37a52602" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LeaseArrangementDomain_019d1a79-3342-7e9a-ab7f-877a37a52602_default" xlink:href="rnac-20260331.xsd#rnac_LeaseArrangementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rnac_LeaseArrangementAxis_019d1a79-3342-7e9a-ab7f-877a37a52602" xlink:to="loc_rnac_LeaseArrangementDomain_019d1a79-3342-7e9a-ab7f-877a37a52602_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LeaseArrangementDomain_019d1a79-3342-763d-b2ae-6e5846a5867e" xlink:href="rnac-20260331.xsd#rnac_LeaseArrangementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rnac_LeaseArrangementAxis_019d1a79-3342-7e9a-ab7f-877a37a52602" xlink:to="loc_rnac_LeaseArrangementDomain_019d1a79-3342-763d-b2ae-6e5846a5867e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_FrederickLeaseAgreementMember_019d1a79-3342-75c2-adb8-e8814bf722db" xlink:href="rnac-20260331.xsd#rnac_FrederickLeaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rnac_LeaseArrangementDomain_019d1a79-3342-763d-b2ae-6e5846a5867e" xlink:to="loc_rnac_FrederickLeaseAgreementMember_019d1a79-3342-75c2-adb8-e8814bf722db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_019d1a79-3342-7630-8f9d-81690c9f8d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_019d1a79-3342-7c4c-a2ef-2e3170064757" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_019d1a79-3342-7630-8f9d-81690c9f8d1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LesseeOperatingLeaseAnnualBaseRent_019d1a79-5157-7b3f-9f13-369a5f2fdb32" xlink:href="rnac-20260331.xsd#rnac_LesseeOperatingLeaseAnnualBaseRent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_019d1a79-3342-7c4c-a2ef-2e3170064757" xlink:to="loc_rnac_LesseeOperatingLeaseAnnualBaseRent_019d1a79-5157-7b3f-9f13-369a5f2fdb32" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/EquityAttheMarketSalesAgreementNarrativeDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#EquityAttheMarketSalesAgreementNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/EquityAttheMarketSalesAgreementNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-7380-b29f-deaa0b64bbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-793b-ae90-22f6652bd57d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-7380-b29f-deaa0b64bbb4" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-793b-ae90-22f6652bd57d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019cdd24-914b-7c9f-ae28-88b4d7f3e71d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-793b-ae90-22f6652bd57d" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019cdd24-914b-7c9f-ae28-88b4d7f3e71d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cdd24-914b-7c9f-ae28-88b4d7f3e71d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019cdd24-914b-7c9f-ae28-88b4d7f3e71d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cdd24-914b-7c9f-ae28-88b4d7f3e71d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cdd24-914b-745c-8aa8-a49072795ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019cdd24-914b-7c9f-ae28-88b4d7f3e71d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cdd24-914b-745c-8aa8-a49072795ab6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AtTheMarketOfferingMember_019cdd24-914b-79be-a00f-04a0c6289a0c" xlink:href="rnac-20260331.xsd#rnac_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cdd24-914b-745c-8aa8-a49072795ab6" xlink:to="loc_rnac_AtTheMarketOfferingMember_019cdd24-914b-79be-a00f-04a0c6289a0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_SaleOfStockAggregateMaximumGrossSalesProceeds_019cdd24-914b-7e30-bef4-d9b12f87d81e" xlink:href="rnac-20260331.xsd#rnac_SaleOfStockAggregateMaximumGrossSalesProceeds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-7380-b29f-deaa0b64bbb4" xlink:to="loc_rnac_SaleOfStockAggregateMaximumGrossSalesProceeds_019cdd24-914b-7e30-bef4-d9b12f87d81e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019cdd24-914b-77a4-8b15-5e2985b2377b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-7380-b29f-deaa0b64bbb4" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019cdd24-914b-77a4-8b15-5e2985b2377b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019d1a96-097e-7ce5-95c4-e7cca26d0b69" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-7380-b29f-deaa0b64bbb4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019d1a96-097e-7ce5-95c4-e7cca26d0b69" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/EquityScheduleofWarrantyActivityDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#EquityScheduleofWarrantyActivityDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/EquityScheduleofWarrantyActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_019cdd24-914b-7b5e-b890-d82c611e561e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_019cdd24-914b-7bab-baec-5baa0558c396" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019cdd24-914b-7b5e-b890-d82c611e561e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_019cdd24-914b-7bab-baec-5baa0558c396" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914b-7d8c-8a97-8ca22e79e39e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019cdd24-914b-7bab-baec-5baa0558c396" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914b-7d8c-8a97-8ca22e79e39e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019cdd24-914b-7d8c-8a97-8ca22e79e39e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914b-7d8c-8a97-8ca22e79e39e" xlink:to="loc_us-gaap_EquityComponentDomain_019cdd24-914b-7d8c-8a97-8ca22e79e39e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019cdd24-914b-7fd6-aff4-b7ca99d23ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914b-7d8c-8a97-8ca22e79e39e" xlink:to="loc_us-gaap_EquityComponentDomain_019cdd24-914b-7fd6-aff4-b7ca99d23ec7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_019cdd24-914b-7ad3-95fe-7db1f30697f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019cdd24-914b-7fd6-aff4-b7ca99d23ec7" xlink:to="loc_us-gaap_WarrantMember_019cdd24-914b-7ad3-95fe-7db1f30697f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_019cdd24-914b-7322-9419-7dd593743ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019cdd24-914b-7bab-baec-5baa0558c396" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_019cdd24-914b-7322-9419-7dd593743ab6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019cdd24-914b-7322-9419-7dd593743ab6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_019cdd24-914b-7322-9419-7dd593743ab6" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019cdd24-914b-7322-9419-7dd593743ab6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019cdd24-914b-7800-9ec5-348e465317a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_019cdd24-914b-7322-9419-7dd593743ab6" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019cdd24-914b-7800-9ec5-348e465317a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_019cdd24-914b-7b94-9d0a-a3b467a74169" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019cdd24-914b-7800-9ec5-348e465317a7" xlink:to="loc_us-gaap_WarrantMember_019cdd24-914b-7b94-9d0a-a3b467a74169" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ClassOfWarrantOrRightRollForward_019cdd24-914b-7a24-98cb-45e2b4cef143" xlink:href="rnac-20260331.xsd#rnac_ClassOfWarrantOrRightRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019cdd24-914b-7b5e-b890-d82c611e561e" xlink:to="loc_rnac_ClassOfWarrantOrRightRollForward_019cdd24-914b-7a24-98cb-45e2b4cef143" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019cdd24-914b-705d-bb46-f1386b7b9461" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rnac_ClassOfWarrantOrRightRollForward_019cdd24-914b-7a24-98cb-45e2b4cef143" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019cdd24-914b-705d-bb46-f1386b7b9461" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_019cdd24-914b-7f34-ac2a-e77cf5b842fb" xlink:href="rnac-20260331.xsd#rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019cdd24-914b-7b5e-b890-d82c611e561e" xlink:to="loc_rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_019cdd24-914b-7f34-ac2a-e77cf5b842fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019cdd24-914b-75b9-ae70-67765aa49d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_019cdd24-914b-7f34-ac2a-e77cf5b842fb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019cdd24-914b-75b9-ae70-67765aa49d0e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/EquityPreferredStockNarrativeDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#EquityPreferredStockNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/EquityPreferredStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-7e00-b82d-a5231224ef49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-76b5-9ae8-8898b12c28ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-7e00-b82d-a5231224ef49" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-76b5-9ae8-8898b12c28ef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914b-702e-8ceb-78eaa51af6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-76b5-9ae8-8898b12c28ef" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914b-702e-8ceb-78eaa51af6e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cdd24-914b-702e-8ceb-78eaa51af6e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914b-702e-8ceb-78eaa51af6e5" xlink:to="loc_us-gaap_ClassOfStockDomain_019cdd24-914b-702e-8ceb-78eaa51af6e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cdd24-914b-7be8-9d8d-7a12a25ee1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914b-702e-8ceb-78eaa51af6e5" xlink:to="loc_us-gaap_ClassOfStockDomain_019cdd24-914b-7be8-9d8d-7a12a25ee1c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-914b-7b94-853d-644d2d02482e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019cdd24-914b-7be8-9d8d-7a12a25ee1c8" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-914b-7b94-853d-644d2d02482e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-914b-7a07-ac00-26567d2fdd7c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019cdd24-914b-7be8-9d8d-7a12a25ee1c8" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-914b-7a07-ac00-26567d2fdd7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_019cdd24-914b-75ea-addf-777a34e7250b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-7e00-b82d-a5231224ef49" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_019cdd24-914b-75ea-addf-777a34e7250b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_019cdd24-914b-7e3f-8771-a6d299b8eddc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-7e00-b82d-a5231224ef49" xlink:to="loc_us-gaap_PreferredStockSharesIssued_019cdd24-914b-7e3f-8771-a6d299b8eddc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleSharesIssuable_019cdd24-914b-7772-b363-ec75f40126b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockConvertibleSharesIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-7e00-b82d-a5231224ef49" xlink:to="loc_us-gaap_PreferredStockConvertibleSharesIssuable_019cdd24-914b-7772-b363-ec75f40126b0" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-784c-bea8-787c1e30117a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-7486-b35f-47ee6b57cd80" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-784c-bea8-787c1e30117a" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-7486-b35f-47ee6b57cd80" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914b-7702-b5dd-0f552860e787" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-7486-b35f-47ee6b57cd80" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914b-7702-b5dd-0f552860e787" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019cdd24-914b-7702-b5dd-0f552860e787_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914b-7702-b5dd-0f552860e787" xlink:to="loc_us-gaap_EquityComponentDomain_019cdd24-914b-7702-b5dd-0f552860e787_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019cdd24-914b-758e-a6ef-9133864fdc75" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914b-7702-b5dd-0f552860e787" xlink:to="loc_us-gaap_EquityComponentDomain_019cdd24-914b-758e-a6ef-9133864fdc75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_019cdd24-914b-70a4-90c5-faa6dc71b2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019cdd24-914b-758e-a6ef-9133864fdc75" xlink:to="loc_us-gaap_WarrantMember_019cdd24-914b-70a4-90c5-faa6dc71b2ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019cdd24-914b-717a-bc20-16c35c8853fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-7486-b35f-47ee6b57cd80" xlink:to="loc_us-gaap_AwardTypeAxis_019cdd24-914b-717a-bc20-16c35c8853fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-914b-717a-bc20-16c35c8853fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019cdd24-914b-717a-bc20-16c35c8853fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-914b-717a-bc20-16c35c8853fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-914b-7d57-a072-506b1a96492d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019cdd24-914b-717a-bc20-16c35c8853fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-914b-7d57-a072-506b1a96492d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_019cdd24-914b-74e4-846c-bbe924ba0a10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-914b-7d57-a072-506b1a96492d" xlink:to="loc_us-gaap_StockCompensationPlanMember_019cdd24-914b-74e4-846c-bbe924ba0a10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_RestrictedStockUnitsUnvestedMember_019cdd24-914b-7860-a465-562474420b82" xlink:href="rnac-20260331.xsd#rnac_RestrictedStockUnitsUnvestedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-914b-7d57-a072-506b1a96492d" xlink:to="loc_rnac_RestrictedStockUnitsUnvestedMember_019cdd24-914b-7860-a465-562474420b82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019cdd24-914b-7c81-a1c1-261e48d99733" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-914b-7d57-a072-506b1a96492d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019cdd24-914b-7c81-a1c1-261e48d99733" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-914b-7929-83ab-40aecb8bf7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-914b-7d57-a072-506b1a96492d" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-914b-7929-83ab-40aecb8bf7a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-914b-7b89-9f21-344476ae62c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-914b-7d57-a072-506b1a96492d" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-914b-7b89-9f21-344476ae62c5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019cdd24-914b-765a-96a4-f850a9cfafec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-784c-bea8-787c1e30117a" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019cdd24-914b-765a-96a4-f850a9cfafec" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#StockIncentivePlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-743c-a552-91a5826cdf95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-743c-a552-91a5826cdf95" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019d87c1-d1d5-760d-9f67-a38191ba3162" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-743c-a552-91a5826cdf95" xlink:to="loc_us-gaap_PlanNameAxis_019d87c1-d1d5-760d-9f67-a38191ba3162" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019d87c1-d1d5-760d-9f67-a38191ba3162_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_019d87c1-d1d5-760d-9f67-a38191ba3162" xlink:to="loc_us-gaap_PlanNameDomain_019d87c1-d1d5-760d-9f67-a38191ba3162_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019d87c1-d1d5-7b8a-82c8-4306195d03e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_019d87c1-d1d5-760d-9f67-a38191ba3162" xlink:to="loc_us-gaap_PlanNameDomain_019d87c1-d1d5-7b8a-82c8-4306195d03e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_StockIncentivePlan2016Member_019d87c1-d1d5-715d-8de5-4bf23a720f57" xlink:href="rnac-20260331.xsd#rnac_StockIncentivePlan2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019d87c1-d1d5-7b8a-82c8-4306195d03e6" xlink:to="loc_rnac_StockIncentivePlan2016Member_019d87c1-d1d5-715d-8de5-4bf23a720f57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_EmploymentInducementIncentiveAwardPlanMember_019d87c1-d1d5-791c-aebf-4c58dd7dc9ce" xlink:href="rnac-20260331.xsd#rnac_EmploymentInducementIncentiveAwardPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019d87c1-d1d5-7b8a-82c8-4306195d03e6" xlink:to="loc_rnac_EmploymentInducementIncentiveAwardPlanMember_019d87c1-d1d5-791c-aebf-4c58dd7dc9ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_OldCartesianPlanMember_019d87c1-d1d5-7321-8f62-cb9398934517" xlink:href="rnac-20260331.xsd#rnac_OldCartesianPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019d87c1-d1d5-7b8a-82c8-4306195d03e6" xlink:to="loc_rnac_OldCartesianPlanMember_019d87c1-d1d5-7321-8f62-cb9398934517" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_019d87c1-d1d5-7ca8-8170-942d9daf1e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-743c-a552-91a5826cdf95" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_019d87c1-d1d5-7ca8-8170-942d9daf1e3c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d87c1-d1d5-7ca8-8170-942d9daf1e3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_019d87c1-d1d5-7ca8-8170-942d9daf1e3c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d87c1-d1d5-7ca8-8170-942d9daf1e3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d87c1-d1d5-77fe-a87c-562993b644e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_019d87c1-d1d5-7ca8-8170-942d9daf1e3c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d87c1-d1d5-77fe-a87c-562993b644e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_OldCartestianMember_019d87c1-d1d5-7f4e-8961-5a7214a7d758" xlink:href="rnac-20260331.xsd#rnac_OldCartestianMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d87c1-d1d5-77fe-a87c-562993b644e0" xlink:to="loc_rnac_OldCartestianMember_019d87c1-d1d5-7f4e-8961-5a7214a7d758" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019d87c1-d1d5-7a50-90c3-fb98e376d8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-743c-a552-91a5826cdf95" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019d87c1-d1d5-7a50-90c3-fb98e376d8e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019d87c1-d1d5-7a50-90c3-fb98e376d8e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019d87c1-d1d5-7a50-90c3-fb98e376d8e9" xlink:to="loc_us-gaap_EquityComponentDomain_019d87c1-d1d5-7a50-90c3-fb98e376d8e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019d87c1-d1d5-7175-a39a-95d75242e57c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019d87c1-d1d5-7a50-90c3-fb98e376d8e9" xlink:to="loc_us-gaap_EquityComponentDomain_019d87c1-d1d5-7175-a39a-95d75242e57c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019d87c1-d1d5-7f73-b7b2-778e90c85a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019d87c1-d1d5-7175-a39a-95d75242e57c" xlink:to="loc_us-gaap_CommonStockMember_019d87c1-d1d5-7f73-b7b2-778e90c85a6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_019d87c1-d1d5-71c3-93a0-251ff37fb9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019d87c1-d1d5-7175-a39a-95d75242e57c" xlink:to="loc_us-gaap_PreferredStockMember_019d87c1-d1d5-71c3-93a0-251ff37fb9a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019d87c2-0607-703b-8205-0c56138c20ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-743c-a552-91a5826cdf95" xlink:to="loc_us-gaap_AwardTypeAxis_019d87c2-0607-703b-8205-0c56138c20ff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d87c2-0607-703b-8205-0c56138c20ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019d87c2-0607-703b-8205-0c56138c20ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d87c2-0607-703b-8205-0c56138c20ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d87c2-0607-7318-a25e-d1093cb495ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019d87c2-0607-703b-8205-0c56138c20ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d87c2-0607-7318-a25e-d1093cb495ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019d87c2-0607-7c40-91bb-2c769a4a117f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d87c2-0607-7318-a25e-d1093cb495ca" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019d87c2-0607-7c40-91bb-2c769a4a117f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019d87c2-2105-783b-ac67-4dbded613e26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d87c2-0607-7318-a25e-d1093cb495ca" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019d87c2-2105-783b-ac67-4dbded613e26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019d87c1-d1d5-7abb-adfd-dba6096bb20e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019d87c1-d1d5-7abb-adfd-dba6096bb20e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease_019d87c1-d1d5-78b3-ae3c-e26041331ffd" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease_019d87c1-d1d5-78b3-ae3c-e26041331ffd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019d87c1-d1d5-7e65-b4d8-3df024c55c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019d87c1-d1d5-7e65-b4d8-3df024c55c1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019d87c1-d1d5-783a-82e7-1f1d1205b01d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019d87c1-d1d5-783a-82e7-1f1d1205b01d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019d87c1-d1d5-79f4-9265-ed6c0b4ad4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019d87c1-d1d5-79f4-9265-ed6c0b4ad4e1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019d87c1-d1d5-7b28-af0a-d612ff4343f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019d87c1-d1d5-7b28-af0a-d612ff4343f8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019d87c1-d1d5-7173-bee6-2b49914b2015" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019d87c1-d1d5-7173-bee6-2b49914b2015" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019d87c1-ebb4-7245-9e3b-d9f8c0f7046a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019d87c1-ebb4-7245-9e3b-d9f8c0f7046a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019d87c2-0607-77ec-9837-10979c0cbfe0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019d87c2-0607-77ec-9837-10979c0cbfe0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019d87c2-0607-7125-b43e-0cbad5d5709e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019d87c2-0607-7125-b43e-0cbad5d5709e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019d87c2-2105-7ad6-b9d3-9d77cee58b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019d87c2-2105-7ad6-b9d3-9d77cee58b5b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019d87c2-2105-77a4-a984-7a2968449d98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019d87c2-2105-77a4-a984-7a2968449d98" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate_019d87c2-2105-78fe-841b-36dfb32c34e4" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate_019d87c2-2105-78fe-841b-36dfb32c34e4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_019d87c2-2105-7a9e-8362-77adbcb714cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_019d87c2-2105-7a9e-8362-77adbcb714cd" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#StockIncentivePlansScheduleofStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019cdd24-9220-773f-ba71-a4ee67073414" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019cdd24-9220-7566-abde-6741c9060405" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019cdd24-9220-773f-ba71-a4ee67073414" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019cdd24-9220-7566-abde-6741c9060405" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_019cdd24-9220-7d34-b901-57d0daaa3e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019cdd24-9220-7566-abde-6741c9060405" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_019cdd24-9220-7d34-b901-57d0daaa3e8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_019cdd24-9220-7d34-b901-57d0daaa3e8c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_019cdd24-9220-7d34-b901-57d0daaa3e8c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_019cdd24-9220-7d34-b901-57d0daaa3e8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_019cdd24-9220-7478-9b22-da5e83af5e51" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_019cdd24-9220-7d34-b901-57d0daaa3e8c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_019cdd24-9220-7478-9b22-da5e83af5e51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_019cdd24-9220-72a9-875d-a0265229454c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019cdd24-9220-7478-9b22-da5e83af5e51" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_019cdd24-9220-72a9-875d-a0265229454c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_019cdd24-9220-79c6-bd81-a476a6c0b592" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019cdd24-9220-7478-9b22-da5e83af5e51" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_019cdd24-9220-79c6-bd81-a476a6c0b592" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019cdd24-9220-7cd1-8bc1-af7a6f9be510" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019cdd24-9220-773f-ba71-a4ee67073414" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019cdd24-9220-7cd1-8bc1-af7a6f9be510" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofWeightedAverageAssumptionsUsedDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#StockIncentivePlansScheduleofWeightedAverageAssumptionsUsedDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofWeightedAverageAssumptionsUsedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7ac1-815f-71f715ec37e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-70dd-a15a-48c0a8b92292" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7ac1-815f-71f715ec37e5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-70dd-a15a-48c0a8b92292" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019cdd24-9220-7acf-a356-f9606b125e90" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-70dd-a15a-48c0a8b92292" xlink:to="loc_us-gaap_AwardTypeAxis_019cdd24-9220-7acf-a356-f9606b125e90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-9220-7acf-a356-f9606b125e90_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019cdd24-9220-7acf-a356-f9606b125e90" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-9220-7acf-a356-f9606b125e90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-9220-7792-9f0e-d7c8e29c18ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019cdd24-9220-7acf-a356-f9606b125e90" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-9220-7792-9f0e-d7c8e29c18ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019cdd24-9220-77c3-b134-d23b33917fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-9220-7792-9f0e-d7c8e29c18ea" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019cdd24-9220-77c3-b134-d23b33917fa1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_019cdd24-9220-7c3c-bf80-6c91d1f5f2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7ac1-815f-71f715ec37e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_019cdd24-9220-7c3c-bf80-6c91d1f5f2e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019cdd24-9220-7ac0-8d0c-d55374208c48" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7ac1-815f-71f715ec37e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019cdd24-9220-7ac0-8d0c-d55374208c48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019cdd24-9220-775d-8e49-8f014da22a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7ac1-815f-71f715ec37e5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019cdd24-9220-775d-8e49-8f014da22a5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_019cdd24-9220-78b1-b3b2-1f7e0c23cb04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7ac1-815f-71f715ec37e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_019cdd24-9220-78b1-b3b2-1f7e0c23cb04" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue_019cdd24-9220-75d4-8c0a-ceffd5f5331c" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7ac1-815f-71f715ec37e5" xlink:to="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue_019cdd24-9220-75d4-8c0a-ceffd5f5331c" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#StockIncentivePlansScheduleofStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7603-9dfd-627e925539c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-7f5c-a8b8-87f3c06b487b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7603-9dfd-627e925539c2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-7f5c-a8b8-87f3c06b487b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019cdd24-9220-74d5-9494-b4695d97924d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-7f5c-a8b8-87f3c06b487b" xlink:to="loc_us-gaap_PlanNameAxis_019cdd24-9220-74d5-9494-b4695d97924d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019cdd24-9220-74d5-9494-b4695d97924d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_019cdd24-9220-74d5-9494-b4695d97924d" xlink:to="loc_us-gaap_PlanNameDomain_019cdd24-9220-74d5-9494-b4695d97924d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019cdd24-9220-73e2-85f4-65a5a67f0bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_019cdd24-9220-74d5-9494-b4695d97924d" xlink:to="loc_us-gaap_PlanNameDomain_019cdd24-9220-73e2-85f4-65a5a67f0bbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember_019cdd24-9220-7b86-a59d-bbbb25e10a93" xlink:href="rnac-20260331.xsd#rnac_A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019cdd24-9220-73e2-85f4-65a5a67f0bbf" xlink:to="loc_rnac_A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember_019cdd24-9220-7b86-a59d-bbbb25e10a93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019cdd24-9220-7784-8a63-30086f92adc2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7603-9dfd-627e925539c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019cdd24-9220-7784-8a63-30086f92adc2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019cdd24-9220-73c9-9210-22d311409e26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019cdd24-9220-7784-8a63-30086f92adc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019cdd24-9220-73c9-9210-22d311409e26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019cdd24-9220-7e23-a5e1-94c2beb7061a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019cdd24-9220-7784-8a63-30086f92adc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019cdd24-9220-7e23-a5e1-94c2beb7061a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019cdd24-9220-73ff-b8f1-bd9be7ffedac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019cdd24-9220-7784-8a63-30086f92adc2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019cdd24-9220-73ff-b8f1-bd9be7ffedac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_019cdd24-9220-7871-8b2f-35ee125ba2f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019cdd24-9220-7784-8a63-30086f92adc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_019cdd24-9220-7871-8b2f-35ee125ba2f4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019cdd24-9220-7b77-b8aa-362ae0ccd03d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_019cdd24-9220-71ad-9184-f7f614f60a55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7603-9dfd-627e925539c2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_019cdd24-9220-71ad-9184-f7f614f60a55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_019cdd24-9220-7a2f-bfad-b3283e5bef4e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7603-9dfd-627e925539c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_019cdd24-9220-7a2f-bfad-b3283e5bef4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019cdd24-9220-7264-a4b6-1dfea72df327" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7603-9dfd-627e925539c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019cdd24-9220-7264-a4b6-1dfea72df327" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019cdd24-9220-755c-ae72-db44062ab7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019cdd24-9220-7264-a4b6-1dfea72df327" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019cdd24-9220-755c-ae72-db44062ab7d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019cdd24-9220-72e2-8a46-bb8db8d4860d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019cdd24-9220-7264-a4b6-1dfea72df327" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019cdd24-9220-72e2-8a46-bb8db8d4860d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019cdd24-9220-7905-8d74-f02e015a5052" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019cdd24-9220-7264-a4b6-1dfea72df327" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019cdd24-9220-7905-8d74-f02e015a5052" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_019cdd24-9220-7df1-9809-117cadb6ebf0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019cdd24-9220-7264-a4b6-1dfea72df327" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_019cdd24-9220-7df1-9809-117cadb6ebf0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019cdd24-9220-70a8-8c14-e2a9938527ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice_019cdd24-9220-7e2b-ad88-5df329af92d3" xlink:href="rnac-20260331.xsd#rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7603-9dfd-627e925539c2" xlink:to="loc_rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice_019cdd24-9220-7e2b-ad88-5df329af92d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_019cdd24-9220-75b5-8968-6d4d62dd92cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7603-9dfd-627e925539c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_019cdd24-9220-75b5-8968-6d4d62dd92cb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_019cdd24-9220-7dd1-9456-e5005f7a479a" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7603-9dfd-627e925539c2" xlink:to="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_019cdd24-9220-7dd1-9456-e5005f7a479a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_019cdd24-9220-754e-8e69-efd07c9aaf6f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_019cdd24-9220-7dd1-9456-e5005f7a479a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_019cdd24-9220-754e-8e69-efd07c9aaf6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm_019cdd24-9220-72d7-8caf-392eac6a9b7a" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_019cdd24-9220-7dd1-9456-e5005f7a479a" xlink:to="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm_019cdd24-9220-72d7-8caf-392eac6a9b7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_019cdd24-9220-7a3a-98d7-2ed61249da62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_019cdd24-9220-7dd1-9456-e5005f7a479a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_019cdd24-9220-7a3a-98d7-2ed61249da62" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract_019cdd24-9220-7bbb-859f-a81dc66a9987" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7603-9dfd-627e925539c2" xlink:to="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract_019cdd24-9220-7bbb-859f-a81dc66a9987" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_019cdd24-9220-7c15-8135-82656388bffd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract_019cdd24-9220-7bbb-859f-a81dc66a9987" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_019cdd24-9220-7c15-8135-82656388bffd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue_019cdd24-9220-7567-9a11-fa15c374baea" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract_019cdd24-9220-7bbb-859f-a81dc66a9987" xlink:to="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue_019cdd24-9220-7567-9a11-fa15c374baea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_019cdd24-9220-7850-9361-924c83c62623" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract_019cdd24-9220-7bbb-859f-a81dc66a9987" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_019cdd24-9220-7850-9361-924c83c62623" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-781f-9e77-a77122f2c86a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-78af-bf70-058b4434a33b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-781f-9e77-a77122f2c86a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-78af-bf70-058b4434a33b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019cdd24-9220-75fd-a024-d7b97be6a6cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-78af-bf70-058b4434a33b" xlink:to="loc_us-gaap_AwardTypeAxis_019cdd24-9220-75fd-a024-d7b97be6a6cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-9220-75fd-a024-d7b97be6a6cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019cdd24-9220-75fd-a024-d7b97be6a6cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-9220-75fd-a024-d7b97be6a6cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-9220-7fe3-a599-0017d2465314" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019cdd24-9220-75fd-a024-d7b97be6a6cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-9220-7fe3-a599-0017d2465314" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019cdd24-9220-7bf9-88a6-7eb7d4693975" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-9220-7fe3-a599-0017d2465314" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019cdd24-9220-7bf9-88a6-7eb7d4693975" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019cdd24-9220-70fb-b3cf-dda8d41daa62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-781f-9e77-a77122f2c86a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019cdd24-9220-70fb-b3cf-dda8d41daa62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019cdd24-9220-7f17-909e-5f791afa0b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019cdd24-9220-70fb-b3cf-dda8d41daa62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019cdd24-9220-7f17-909e-5f791afa0b7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019cdd24-9220-735e-a869-1ee0128e52fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019cdd24-9220-70fb-b3cf-dda8d41daa62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019cdd24-9220-735e-a869-1ee0128e52fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_019cdd24-9220-7b9f-9aa0-c799e3488782" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019cdd24-9220-70fb-b3cf-dda8d41daa62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_019cdd24-9220-7b9f-9aa0-c799e3488782" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019cdd24-9220-79d5-82b9-18a54ca9a03a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019cdd24-9220-70fb-b3cf-dda8d41daa62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019cdd24-9220-79d5-82b9-18a54ca9a03a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019cdd24-9220-76ee-88fb-3202e7a41fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019cdd24-9220-7ea1-9a43-c2efa7187b72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-781f-9e77-a77122f2c86a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019cdd24-9220-7ea1-9a43-c2efa7187b72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019cdd24-9220-71af-b109-a8ab8a080a91" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019cdd24-9220-7ea1-9a43-c2efa7187b72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019cdd24-9220-71af-b109-a8ab8a080a91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019cdd24-9220-7bec-84dc-56a4ecec580b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019cdd24-9220-7ea1-9a43-c2efa7187b72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019cdd24-9220-7bec-84dc-56a4ecec580b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_019cdd24-9220-7d2a-b6a2-44112dc6814d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019cdd24-9220-7ea1-9a43-c2efa7187b72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_019cdd24-9220-7d2a-b6a2-44112dc6814d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019cdd24-9220-7b06-a038-4b8205c8acee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019cdd24-9220-7ea1-9a43-c2efa7187b72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019cdd24-9220-7b06-a038-4b8205c8acee" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019cdd24-9220-723b-884c-f680ccb09908" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#RevenueArrangementsDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_019cdd24-9220-7d5b-b243-b095921301bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_019cdd24-9220-7d5b-b243-b095921301bc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_019d1ac9-ed54-714d-9e0b-eb21746c4a9f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019cdd24-9220-7d5b-b243-b095921301bc" xlink:to="loc_srt_CounterpartyNameAxis_019d1ac9-ed54-714d-9e0b-eb21746c4a9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d1ac9-ed54-714d-9e0b-eb21746c4a9f_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_019d1ac9-ed54-714d-9e0b-eb21746c4a9f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d1ac9-ed54-714d-9e0b-eb21746c4a9f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d1ac9-ed54-77f6-a443-1e77338556b7" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_019d1ac9-ed54-714d-9e0b-eb21746c4a9f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d1ac9-ed54-77f6-a443-1e77338556b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_SwedishOrphanBiovitrumABSOBIMember_019d1ac9-ed54-7ac5-ae29-04d47baa9500" xlink:href="rnac-20260331.xsd#rnac_SwedishOrphanBiovitrumABSOBIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d1ac9-ed54-77f6-a443-1e77338556b7" xlink:to="loc_rnac_SwedishOrphanBiovitrumABSOBIMember_019d1ac9-ed54-7ac5-ae29-04d47baa9500" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019d1ac9-ed54-71d3-a71d-f376f8bdd2db" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019cdd24-9220-7d5b-b243-b095921301bc" xlink:to="loc_srt_ProductOrServiceAxis_019d1ac9-ed54-71d3-a71d-f376f8bdd2db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019d1ac9-ed54-71d3-a71d-f376f8bdd2db_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_019d1ac9-ed54-71d3-a71d-f376f8bdd2db" xlink:to="loc_srt_ProductsAndServicesDomain_019d1ac9-ed54-71d3-a71d-f376f8bdd2db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019d1ac9-ed54-7305-8f28-d76be57c21ce" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_019d1ac9-ed54-71d3-a71d-f376f8bdd2db" xlink:to="loc_srt_ProductsAndServicesDomain_019d1ac9-ed54-7305-8f28-d76be57c21ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_019d1ac9-ed54-708d-b358-effb114a4b24" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LicenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019d1ac9-ed54-7305-8f28-d76be57c21ce" xlink:to="loc_us-gaap_LicenseMember_019d1ac9-ed54-708d-b358-effb114a4b24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceTypeAxis_019d1aca-0ea9-7828-b5f3-46c561e6b468" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019cdd24-9220-7d5b-b243-b095921301bc" xlink:to="loc_us-gaap_GovernmentAssistanceTypeAxis_019d1aca-0ea9-7828-b5f3-46c561e6b468" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceTypeDomain_019d1aca-0ea9-7828-b5f3-46c561e6b468_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GovernmentAssistanceTypeAxis_019d1aca-0ea9-7828-b5f3-46c561e6b468" xlink:to="loc_us-gaap_GovernmentAssistanceTypeDomain_019d1aca-0ea9-7828-b5f3-46c561e6b468_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceTypeDomain_019d1aca-0ea9-7844-850c-90737f66c4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GovernmentAssistanceTypeAxis_019d1aca-0ea9-7828-b5f3-46c561e6b468" xlink:to="loc_us-gaap_GovernmentAssistanceTypeDomain_019d1aca-0ea9-7844-850c-90737f66c4f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember_019d1aca-0ea9-7f8f-9024-85eb6cd09943" xlink:href="rnac-20260331.xsd#rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GovernmentAssistanceTypeDomain_019d1aca-0ea9-7844-850c-90737f66c4f4" xlink:to="loc_rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember_019d1aca-0ea9-7f8f-9024-85eb6cd09943" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_019d1ac9-ed54-70ee-b5ff-9040dbaefe01" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:to="loc_us-gaap_ContractWithCustomerLiability_019d1ac9-ed54-70ee-b5ff-9040dbaefe01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount_019d1ac9-ed54-7596-9681-51876182945a" xlink:href="rnac-20260331.xsd#rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:to="loc_rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount_019d1ac9-ed54-7596-9681-51876182945a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_019d1aca-0ea9-7c4d-bc57-b6ac25ad68d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_019d1aca-0ea9-7c4d-bc57-b6ac25ad68d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceAwardAmount_019d1aca-0ea9-7019-b5ba-515f3ffcce6d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceAwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:to="loc_us-gaap_GovernmentAssistanceAwardAmount_019d1aca-0ea9-7019-b5ba-515f3ffcce6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_GovernmentAssistancePotentialAdditionalAwardAmount_019d1aca-0ea9-7316-a8ab-5eb37ff8a587" xlink:href="rnac-20260331.xsd#rnac_GovernmentAssistancePotentialAdditionalAwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:to="loc_rnac_GovernmentAssistancePotentialAdditionalAwardAmount_019d1aca-0ea9-7316-a8ab-5eb37ff8a587" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_019d1b0d-f4b6-7732-8754-c95470eb4e75" xlink:href="rnac-20260331.xsd#rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:to="loc_rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_019d1b0d-f4b6-7732-8754-c95470eb4e75" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceAmountCumulativeCurrent_019d1aca-0ea9-797e-8204-fa0cfe648aed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceAmountCumulativeCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:to="loc_us-gaap_GovernmentAssistanceAmountCumulativeCurrent_019d1aca-0ea9-797e-8204-fa0cfe648aed" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_019d1aca-0ea9-701d-8a26-7bb6948bb80b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_019d1aca-0ea9-701d-8a26-7bb6948bb80b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_019d1aca-0ea9-74df-bd81-4455ceb5fbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_019d1aca-0ea9-74df-bd81-4455ceb5fbbd" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsBiogenMAIncNarrativeDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#CollaborationandLicenseAgreementsBiogenMAIncNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsBiogenMAIncNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-72ac-a0ee-6b8d23e4e0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-78d8-87a1-5b886df85b20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-72ac-a0ee-6b8d23e4e0b1" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-78d8-87a1-5b886df85b20" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-7874-b931-6d507c8f6c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-78d8-87a1-5b886df85b20" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-7874-b931-6d507c8f6c4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-7874-b931-6d507c8f6c4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-7874-b931-6d507c8f6c4f" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-7874-b931-6d507c8f6c4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-7894-b3cd-0b9c4e412687" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-7874-b931-6d507c8f6c4f" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-7894-b3cd-0b9c4e412687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_BiogenM.A.Inc.Member_019cdd24-9220-7861-b4ff-5f8f61dd87a0" xlink:href="rnac-20260331.xsd#rnac_BiogenM.A.Inc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-7894-b3cd-0b9c4e412687" xlink:to="loc_rnac_BiogenM.A.Inc.Member_019cdd24-9220-7861-b4ff-5f8f61dd87a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination_019cdd24-9220-7396-9ce2-e1e903758e28" xlink:href="rnac-20260331.xsd#rnac_CollaborativeArrangementWrittenNoticePeriodForTermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-72ac-a0ee-6b8d23e4e0b1" xlink:to="loc_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination_019cdd24-9220-7396-9ce2-e1e903758e28" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsNationalCancerInstituteoftheNationalInstitutesofHealthNarrativeDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#CollaborationandLicenseAgreementsNationalCancerInstituteoftheNationalInstitutesofHealthNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsNationalCancerInstituteoftheNationalInstitutesofHealthNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-77e4-806f-a3ca2cedd749" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-728d-9597-ee0ae4aa8ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-77e4-806f-a3ca2cedd749" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-728d-9597-ee0ae4aa8ecf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-7724-9178-721db081b92f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-728d-9597-ee0ae4aa8ecf" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-7724-9178-721db081b92f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-7724-9178-721db081b92f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-7724-9178-721db081b92f" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-7724-9178-721db081b92f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-7bd6-9502-e380652a4aef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-7724-9178-721db081b92f" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-7bd6-9502-e380652a4aef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_NationalCancerInstituteAgreementMember_019cdd24-9220-7922-96e8-4867ff07fc16" xlink:href="rnac-20260331.xsd#rnac_NationalCancerInstituteAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-7bd6-9502-e380652a4aef" xlink:to="loc_rnac_NationalCancerInstituteAgreementMember_019cdd24-9220-7922-96e8-4867ff07fc16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LicenseAndOptionAgreementRoyaltyPayment_019cdd24-9220-721b-8956-d324770ac681" xlink:href="rnac-20260331.xsd#rnac_LicenseAndOptionAgreementRoyaltyPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-77e4-806f-a3ca2cedd749" xlink:to="loc_rnac_LicenseAndOptionAgreementRoyaltyPayment_019cdd24-9220-721b-8956-d324770ac681" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum_019cdd24-9220-753e-b7de-277ff32bb1a9" xlink:href="rnac-20260331.xsd#rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-77e4-806f-a3ca2cedd749" xlink:to="loc_rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum_019cdd24-9220-753e-b7de-277ff32bb1a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination_019cdd24-9220-76f2-93af-9903153881b5" xlink:href="rnac-20260331.xsd#rnac_CollaborativeArrangementWrittenNoticePeriodForTermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-77e4-806f-a3ca2cedd749" xlink:to="loc_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination_019cdd24-9220-76f2-93af-9903153881b5" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsShenyangSunshinePharmaceuticalCoLtdNarrativeDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#CollaborationandLicenseAgreementsShenyangSunshinePharmaceuticalCoLtdNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsShenyangSunshinePharmaceuticalCoLtdNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-777b-b29b-1ef3fb17eecc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-7629-a611-cc624c71b4ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-777b-b29b-1ef3fb17eecc" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-7629-a611-cc624c71b4ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-76d1-b725-701f1174a4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-7629-a611-cc624c71b4ee" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-76d1-b725-701f1174a4dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-76d1-b725-701f1174a4dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-76d1-b725-701f1174a4dc" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-76d1-b725-701f1174a4dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-72fa-813c-60b798a07e87" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-76d1-b725-701f1174a4dc" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-72fa-813c-60b798a07e87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember_019cdd24-9220-74a5-ae66-f214dc8ca41c" xlink:href="rnac-20260331.xsd#rnac_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-72fa-813c-60b798a07e87" xlink:to="loc_rnac_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember_019cdd24-9220-74a5-ae66-f214dc8ca41c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid_019cdd24-9220-70ec-85f1-bc7af4aff7a4" xlink:href="rnac-20260331.xsd#rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-777b-b29b-1ef3fb17eecc" xlink:to="loc_rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid_019cdd24-9220-70ec-85f1-bc7af4aff7a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform_019cdd24-9220-712d-9ecc-d7856675031d" xlink:href="rnac-20260331.xsd#rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-777b-b29b-1ef3fb17eecc" xlink:to="loc_rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform_019cdd24-9220-712d-9ecc-d7856675031d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_019cdd24-9221-7734-8261-cb882bed4976" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019cdd24-9220-7632-94ca-11d0a6ccc70d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019cdd24-9221-7734-8261-cb882bed4976" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019cdd24-9220-7632-94ca-11d0a6ccc70d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_019cdd24-9220-70dd-8d7c-996ec5a7906f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019cdd24-9220-7632-94ca-11d0a6ccc70d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_019cdd24-9220-70dd-8d7c-996ec5a7906f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_019cdd24-9220-70dd-8d7c-996ec5a7906f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_019cdd24-9220-70dd-8d7c-996ec5a7906f" xlink:to="loc_us-gaap_SegmentDomain_019cdd24-9220-70dd-8d7c-996ec5a7906f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_019cdd24-9220-7516-bf0f-16e554ef8104" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_019cdd24-9220-70dd-8d7c-996ec5a7906f" xlink:to="loc_us-gaap_SegmentDomain_019cdd24-9220-7516-bf0f-16e554ef8104" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_OperatingSegmentMember_019cdd24-9220-7da1-a32a-fcdd988b0e42" xlink:href="rnac-20260331.xsd#rnac_OperatingSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_019cdd24-9220-7516-bf0f-16e554ef8104" xlink:to="loc_rnac_OperatingSegmentMember_019cdd24-9220-7da1-a32a-fcdd988b0e42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_019cdd24-9220-7f4f-9e21-d39aeef406dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019cdd24-9220-7632-94ca-11d0a6ccc70d" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_019cdd24-9220-7f4f-9e21-d39aeef406dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_019cdd24-9220-7f4f-9e21-d39aeef406dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_019cdd24-9220-7f4f-9e21-d39aeef406dd" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_019cdd24-9220-7f4f-9e21-d39aeef406dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_019cdd24-9221-7c70-badb-82e2e3d966a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_019cdd24-9220-7f4f-9e21-d39aeef406dd" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_019cdd24-9221-7c70-badb-82e2e3d966a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_Descartes08ForMGMember_019cdd24-9221-7a2c-8346-d0c72ae99df0" xlink:href="rnac-20260331.xsd#rnac_Descartes08ForMGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_019cdd24-9221-7c70-badb-82e2e3d966a4" xlink:to="loc_rnac_Descartes08ForMGMember_019cdd24-9221-7a2c-8346-d0c72ae99df0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_Descartes08ForDermatomyositisMember_019d9b54-fe1c-7e40-b509-664083548301" xlink:href="rnac-20260331.xsd#rnac_Descartes08ForDermatomyositisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_019cdd24-9221-7c70-badb-82e2e3d966a4" xlink:to="loc_rnac_Descartes08ForDermatomyositisMember_019d9b54-fe1c-7e40-b509-664083548301" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_EarlyStageProgramsMember_019cdd24-9221-730b-9456-e8751fd5744d" xlink:href="rnac-20260331.xsd#rnac_EarlyStageProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_019cdd24-9221-7c70-badb-82e2e3d966a4" xlink:to="loc_rnac_EarlyStageProgramsMember_019cdd24-9221-730b-9456-e8751fd5744d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ResearchAndDevelopmentEmployeeExpensesMember_019cdd24-9221-72b9-ad06-c7e4bc72468b" xlink:href="rnac-20260331.xsd#rnac_ResearchAndDevelopmentEmployeeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_019cdd24-9221-7c70-badb-82e2e3d966a4" xlink:to="loc_rnac_ResearchAndDevelopmentEmployeeExpensesMember_019cdd24-9221-72b9-ad06-c7e4bc72468b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember_019cdd24-9221-7989-9c3b-e3585633192b" xlink:href="rnac-20260331.xsd#rnac_ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_019cdd24-9221-7c70-badb-82e2e3d966a4" xlink:to="loc_rnac_ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember_019cdd24-9221-7989-9c3b-e3585633192b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ResearchAndDevelopmentFacilitiesAndOtherExpensesMember_019cdd24-9221-7e16-a3cb-7f644ae29025" xlink:href="rnac-20260331.xsd#rnac_ResearchAndDevelopmentFacilitiesAndOtherExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_019cdd24-9221-7c70-badb-82e2e3d966a4" xlink:to="loc_rnac_ResearchAndDevelopmentFacilitiesAndOtherExpensesMember_019cdd24-9221-7e16-a3cb-7f644ae29025" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_019cdd24-9221-7f74-9519-cd0d38d807bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019cdd24-9221-7734-8261-cb882bed4976" xlink:to="loc_us-gaap_RevenuesAbstract_019cdd24-9221-7f74-9519-cd0d38d807bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019cdd24-9221-7e06-8420-08ea864fc7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_019cdd24-9221-7f74-9519-cd0d38d807bb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019cdd24-9221-7e06-8420-08ea864fc7cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_019cdd24-9221-7a85-981f-e62c0f61119b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_019cdd24-9221-7f74-9519-cd0d38d807bb" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_019cdd24-9221-7a85-981f-e62c0f61119b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_019cdd24-9221-77fd-ad93-7a142088c8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_019cdd24-9221-7f74-9519-cd0d38d807bb" xlink:to="loc_us-gaap_Revenues_019cdd24-9221-77fd-ad93-7a142088c8c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_019cdd24-9221-7a32-bffc-f73575e0227e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019cdd24-9221-7734-8261-cb882bed4976" xlink:to="loc_us-gaap_OperatingExpensesAbstract_019cdd24-9221-7a32-bffc-f73575e0227e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019cdd24-9221-7360-b40b-e16fcbdc6572" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019cdd24-9221-7a32-bffc-f73575e0227e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019cdd24-9221-7360-b40b-e16fcbdc6572" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019cdd24-9221-753a-add4-7d926ba200d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019cdd24-9221-7a32-bffc-f73575e0227e" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019cdd24-9221-753a-add4-7d926ba200d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_NonoperatingIncomeExpenseAdjusted_019d1aa3-8c7c-7909-8e88-961ee7ef864c" xlink:href="rnac-20260331.xsd#rnac_NonoperatingIncomeExpenseAdjusted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019cdd24-9221-7734-8261-cb882bed4976" xlink:to="loc_rnac_NonoperatingIncomeExpenseAdjusted_019d1aa3-8c7c-7909-8e88-961ee7ef864c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019cdd24-9221-7e40-8cd0-502d3945af77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019cdd24-9221-7734-8261-cb882bed4976" xlink:to="loc_us-gaap_NetIncomeLoss_019cdd24-9221-7e40-8cd0-502d3945af77" xlink:type="arc" order="3"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>rnac-20260331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019cdd24-8f10-71f0-acfb-b8a76448289c,g:7ae85b19-6328-41a5-b0c0-99683dc813c6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_019cdd24-9221-7774-9a9c-e8e9ae722301_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_019cdd24-9221-73db-8d80-3ee6f8f9ca94_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_GovernmentAssistancePotentialAdditionalAwardAmount_019cdd24-92d8-7d4c-8f2d-a5bc00872297_terseLabel_en-US" xlink:label="lab_rnac_GovernmentAssistancePotentialAdditionalAwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government assistance, potential additional award amount</link:label>
    <link:label id="lab_rnac_GovernmentAssistancePotentialAdditionalAwardAmount_label_en-US" xlink:label="lab_rnac_GovernmentAssistancePotentialAdditionalAwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Assistance, Potential Additional Award Amount</link:label>
    <link:label id="lab_rnac_GovernmentAssistancePotentialAdditionalAwardAmount_documentation_en-US" xlink:label="lab_rnac_GovernmentAssistancePotentialAdditionalAwardAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Government Assistance, Potential Additional Award Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_GovernmentAssistancePotentialAdditionalAwardAmount" xlink:href="rnac-20260331.xsd#rnac_GovernmentAssistancePotentialAdditionalAwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_GovernmentAssistancePotentialAdditionalAwardAmount" xlink:to="lab_rnac_GovernmentAssistancePotentialAdditionalAwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019cdd24-935e-7432-a585-66040d68ab71_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026 (remainder)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_019cdd24-92d8-7513-8764-1b71967c8ee8_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_019cdd24-92d8-7a20-8a94-51232f620825_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_019cdd24-9221-7b2e-96e3-fe459cb49bb4_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_019cdd24-92d8-7f0b-a970-e4ab8cb4c3bc_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_019cdd24-935e-7314-b48b-483b0da27cab_terseLabel_en-US" xlink:label="lab_rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, After Year Four</link:label>
    <link:label id="lab_rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:href="rnac-20260331.xsd#rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_019cdd24-92d8-767f-81b9-0bb68eba7c51_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_019cdd24-935e-7b44-9f79-fe7291b7fa9c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share allocable to common stockholders:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019cdd24-92d8-7a0e-86b7-40e378b12a2c_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_019cdd24-9221-7a16-b5c2-68dd2df6d3e6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_NonoperatingIncomeExpenseAdjusted_019d1aa3-8c7c-74d3-8e2d-a77fae83e5b6_negatedTerseLabel_en-US" xlink:label="lab_rnac_NonoperatingIncomeExpenseAdjusted" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other expense (income), net</link:label>
    <link:label id="lab_rnac_NonoperatingIncomeExpenseAdjusted_label_en-US" xlink:label="lab_rnac_NonoperatingIncomeExpenseAdjusted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense), Adjusted</link:label>
    <link:label id="lab_rnac_NonoperatingIncomeExpenseAdjusted_documentation_en-US" xlink:label="lab_rnac_NonoperatingIncomeExpenseAdjusted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense), Adjusted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_NonoperatingIncomeExpenseAdjusted" xlink:href="rnac-20260331.xsd#rnac_NonoperatingIncomeExpenseAdjusted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_NonoperatingIncomeExpenseAdjusted" xlink:to="lab_rnac_NonoperatingIncomeExpenseAdjusted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicenseMember_019cdd24-92d8-770c-95d5-1278cafb59fb_terseLabel_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License</link:label>
    <link:label id="lab_us-gaap_LicenseMember_label_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LicenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseMember" xlink:to="lab_us-gaap_LicenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_019cdd24-92d8-7bc1-95b0-82e20d1d3725_verboseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock options and restricted stock units</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_019cdd24-92d8-735a-9e67-a987becbc6c7_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for future stock incentive awards</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_019cdd24-92d8-73e7-9e13-7d534a6f0672_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive (loss) income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_019cdd24-935e-7040-9ba5-c19971585351_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of warrants, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_019cdd24-92d8-7916-b051-80daedcb6b58_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-935e-7d46-b2dc-3c994d2baf70_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_019cdd24-92d8-7f12-9c5c-0846974ddfa4_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019cdd24-92d8-7f9d-8717-8ff768659f00_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_019cdd24-9221-7354-b814-77b25115bd05_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Arrangements</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_019cdd24-92d8-74fa-9e5a-b3e3b3737d9a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_019cdd24-935e-7718-8407-4e8eb2b26d5e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_019cdd24-92d8-7a7b-bca0-ec8eaf4f3ed7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_019cdd24-935e-799b-8385-7677a0811054_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unsatisfied performance obligation</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AreaOfRealEstateProperty_019cdd24-92d8-7a5a-bd04-266155381387_terseLabel_en-US" xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Area of office space leased</link:label>
    <link:label id="lab_us-gaap_AreaOfRealEstateProperty_label_en-US" xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Area of Real Estate Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AreaOfRealEstateProperty" xlink:to="lab_us-gaap_AreaOfRealEstateProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_019cdd24-9221-731d-9f40-16762882bf62_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease_019cdd24-92d8-79f2-92af-9cadfdd72ff2_terseLabel_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares authorized, increase (in shares)</link:label>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease_label_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant, Increase (Decrease)</link:label>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease_documentation_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease" xlink:to="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_019cdd24-9221-78d1-909d-0fde41e22423_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_019cdd24-9221-752a-9158-c01b8470e69f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock&#8209;based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_019cdd24-92d8-781a-b2e5-441b18024b2e_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Outstanding common stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_019cdd24-92d8-7306-bf82-57cd23ef7078_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Series A Preferred Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_019cdd24-92d8-769f-be04-4dac980536d6_netLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019cdd24-92d8-7722-971c-739ee3d3b8c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019cdd24-92d8-7479-9b24-3a9b64a9c0cf_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_019cdd24-935e-70c2-aa3d-d8b28eaf3910_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_019cdd24-935e-7a13-869f-75ff10b4981b_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_019cdd24-935e-73fd-96b9-4b5085452db1_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_019cdd24-92d8-73cf-84d4-78fd90b0d464_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock&#8209;based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_019cdd24-92d8-7150-8371-4e37ae2cbace_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_019cdd24-935e-7e2d-9ca3-9b1b25f38367_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_019cdd24-9221-7457-96da-2c8b89754778_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019cdd24-9221-71e4-8560-ad60a28f4355_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019cdd24-92d8-7815-9c84-b663d2bf1158_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock through at the market offering, net of commissions and expenses (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_019cdd24-92d8-75c9-b8ae-989f62b76133_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_019cdd24-92d8-7854-8b1e-60e2fc8c1e1c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_019cdd24-92d8-7649-88f7-0f6f6f36cfb6_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue_019cdd24-92d8-7a2e-856e-9857ae2f6f3e_terseLabel_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average fair value of common stock (in dollars per share)</link:label>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue_label_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Weighted Average Fair Value</link:label>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue_documentation_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighed-average fair value relating to the share-based payment award.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue" xlink:to="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019cdd24-92d8-7523-b08c-195e712932f6_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Potential common shares</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019cdd24-92d8-75aa-9aed-ad0450966770_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number&#160;of Common Stock Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-92d8-7d69-b83f-a360a06b4058_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_019cdd24-9221-7cde-969a-dbda514ba75f_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019cdd24-92d8-7f6a-b9f5-fd821063e3e5_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market funds (included in cash equivalents)</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_CollaborationAndLicenseAgreementsTextBlock_019cdd24-9221-79e1-a6cd-9282bb77f1d9_terseLabel_en-US" xlink:label="lab_rnac_CollaborationAndLicenseAgreementsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaboration and License Agreements</link:label>
    <link:label id="lab_rnac_CollaborationAndLicenseAgreementsTextBlock_label_en-US" xlink:label="lab_rnac_CollaborationAndLicenseAgreementsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaboration And License Agreements [Text Block]</link:label>
    <link:label id="lab_rnac_CollaborationAndLicenseAgreementsTextBlock_documentation_en-US" xlink:label="lab_rnac_CollaborationAndLicenseAgreementsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaboration And License Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_CollaborationAndLicenseAgreementsTextBlock" xlink:href="rnac-20260331.xsd#rnac_CollaborationAndLicenseAgreementsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_CollaborationAndLicenseAgreementsTextBlock" xlink:to="lab_rnac_CollaborationAndLicenseAgreementsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_OldCartesianMember_019cdd24-92d8-7033-a868-c54024004b9e_terseLabel_en-US" xlink:label="lab_rnac_OldCartesianMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Old Cartesian</link:label>
    <link:label id="lab_rnac_OldCartesianMember_label_en-US" xlink:label="lab_rnac_OldCartesianMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Old Cartesian [Member]</link:label>
    <link:label id="lab_rnac_OldCartesianMember_documentation_en-US" xlink:label="lab_rnac_OldCartesianMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Old Cartesian</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_OldCartesianMember" xlink:href="rnac-20260331.xsd#rnac_OldCartesianMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_OldCartesianMember" xlink:to="lab_rnac_OldCartesianMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_019cdd24-935e-7e3d-bbf8-48d286e37d85_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_019cdd24-92d8-70f9-aab2-662dddc7ec71_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_019cdd24-92d8-736c-a2e1-23e5c0c314f9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_019cdd24-9221-7c7b-bcad-22784b04cd24_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Maturity of Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-92d8-70a9-8618-75126947f6fc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_SwedishOrphanBiovitrumABSOBIMember_019cdd24-92d8-7260-87c0-e1d311eb09a9_terseLabel_en-US" xlink:label="lab_rnac_SwedishOrphanBiovitrumABSOBIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SOBI</link:label>
    <link:label id="lab_rnac_SwedishOrphanBiovitrumABSOBIMember_label_en-US" xlink:label="lab_rnac_SwedishOrphanBiovitrumABSOBIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Swedish Orphan Biovitrum AB (SOBI) [Member]</link:label>
    <link:label id="lab_rnac_SwedishOrphanBiovitrumABSOBIMember_documentation_en-US" xlink:label="lab_rnac_SwedishOrphanBiovitrumABSOBIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Swedish Orphan Biovitrum AB (SOBI)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_SwedishOrphanBiovitrumABSOBIMember" xlink:href="rnac-20260331.xsd#rnac_SwedishOrphanBiovitrumABSOBIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_SwedishOrphanBiovitrumABSOBIMember" xlink:to="lab_rnac_SwedishOrphanBiovitrumABSOBIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_019cdd24-9221-77c6-beb8-ec2611cc3de1_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum_019cdd24-92d8-7c34-9373-c746620b69d2_terseLabel_en-US" xlink:label="lab_rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License and option agreement, benchmark royalties, maximum</link:label>
    <link:label id="lab_rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum_label_en-US" xlink:label="lab_rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License And Option Agreement, Benchmark Royalties, Maximum</link:label>
    <link:label id="lab_rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum_documentation_en-US" xlink:label="lab_rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License And Option Agreement, Benchmark Royalties, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum" xlink:href="rnac-20260331.xsd#rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum" xlink:to="lab_rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_LicenseAndOptionAgreementRoyaltyPayment_019cdd24-92d8-71d6-b938-7ef6d01eb636_terseLabel_en-US" xlink:label="lab_rnac_LicenseAndOptionAgreementRoyaltyPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License and option agreement, royalty payment</link:label>
    <link:label id="lab_rnac_LicenseAndOptionAgreementRoyaltyPayment_label_en-US" xlink:label="lab_rnac_LicenseAndOptionAgreementRoyaltyPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License And Option Agreement, Royalty Payment</link:label>
    <link:label id="lab_rnac_LicenseAndOptionAgreementRoyaltyPayment_documentation_en-US" xlink:label="lab_rnac_LicenseAndOptionAgreementRoyaltyPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License And Option Agreement, Royalty Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LicenseAndOptionAgreementRoyaltyPayment" xlink:href="rnac-20260331.xsd#rnac_LicenseAndOptionAgreementRoyaltyPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_LicenseAndOptionAgreementRoyaltyPayment" xlink:to="lab_rnac_LicenseAndOptionAgreementRoyaltyPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_019cdd24-9221-794d-8c6f-3bf14c487331_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_019cdd24-92d8-7d95-a9f6-bee03262eda3_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series B Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_us-gaap_SeriesBPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_019cdd24-935e-7f4b-b9a4-ea56b40580b5_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non&#8209;cash lease expense</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_019cdd24-92d8-7f82-8716-9538f966eec7_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform_019cdd24-935e-79d7-bab5-7392a28814aa_terseLabel_en-US" xlink:label="lab_rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate amount for future payments upon achievement of clinical and regulatory approval milestones for products containing ImmTOR platform</link:label>
    <link:label id="lab_rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform_label_en-US" xlink:label="lab_rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Amount For Future Payments Upon Achievement Of Clinical And Regulatory Approval Milestones For Products Containing ImmTOR Platform</link:label>
    <link:label id="lab_rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform_documentation_en-US" xlink:label="lab_rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Aggregate Amount For Future Payments Upon Achievement Of Clinical And Regulatory Approval Milestones For Products Containing ImmTOR Platform</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform" xlink:href="rnac-20260331.xsd#rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform" xlink:to="lab_rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_019cdd24-9221-70da-ba25-02dc8e4cb7a7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_019cdd24-92d8-755e-9aa5-a1d0d6980896_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019cdd24-92d8-7d60-836b-14d95b5b77b9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_019cdd24-935e-751f-837a-229e639bf541_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_OldCartesianPlanMember_019cdd24-92d8-7796-9cfe-68b72bdef916_terseLabel_en-US" xlink:label="lab_rnac_OldCartesianPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Old Cartesian Plan</link:label>
    <link:label id="lab_rnac_OldCartesianPlanMember_label_en-US" xlink:label="lab_rnac_OldCartesianPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Old Cartesian Plan [Member]</link:label>
    <link:label id="lab_rnac_OldCartesianPlanMember_documentation_en-US" xlink:label="lab_rnac_OldCartesianPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Old Cartesian Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_OldCartesianPlanMember" xlink:href="rnac-20260331.xsd#rnac_OldCartesianPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_OldCartesianPlanMember" xlink:to="lab_rnac_OldCartesianPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_019cdd24-92d8-7d14-9a99-a603572e9291_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_019cdd24-92d8-7232-9392-4c06a0d9c2c4_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_019cdd24-92d8-7b20-8220-f5fd0dde9622_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Roll-Forward of Fair Value for the Company&#8217;s Level 3 Warrant Liabilities, CVR Liability and Forward Contract Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember_019cdd24-92d8-7402-8316-ec985081a126_terseLabel_en-US" xlink:label="lab_rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">National Institute of Neurological Disorders and Stroke of the National Institutes of Health Funding</link:label>
    <link:label id="lab_rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember_label_en-US" xlink:label="lab_rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">National Institute Of Neurological Disorders And Stroke Of The National Institutes Of Health Funding [Member]</link:label>
    <link:label id="lab_rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember_documentation_en-US" xlink:label="lab_rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">National Institute Of Neurological Disorders And Stroke Of The National Institutes Of Health Funding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember" xlink:href="rnac-20260331.xsd#rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember" xlink:to="lab_rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_019cdd24-92d8-7d64-b5d4-dc2ab564565f_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_019cdd24-92d8-7924-9f60-412ebbc8ed1c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_019cdd24-92d8-78ac-a20b-fdcf9ca97704_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_LeaseArrangementDomain_019cdd24-92d8-7281-a2cb-27f5b30b38fa_terseLabel_en-US" xlink:label="lab_rnac_LeaseArrangementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Arrangement [Domain]</link:label>
    <link:label id="lab_rnac_LeaseArrangementDomain_label_en-US" xlink:label="lab_rnac_LeaseArrangementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Arrangement [Domain]</link:label>
    <link:label id="lab_rnac_LeaseArrangementDomain_documentation_en-US" xlink:label="lab_rnac_LeaseArrangementDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Lease Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LeaseArrangementDomain" xlink:href="rnac-20260331.xsd#rnac_LeaseArrangementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_LeaseArrangementDomain" xlink:to="lab_rnac_LeaseArrangementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_AccruedEquityOfferingCostsCurrent_019dbeb6-15b9-786b-ba5c-db664e7211da_terseLabel_en-US" xlink:label="lab_rnac_AccruedEquityOfferingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued equity offering costs</link:label>
    <link:label id="lab_rnac_AccruedEquityOfferingCostsCurrent_label_en-US" xlink:label="lab_rnac_AccruedEquityOfferingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Equity Offering Costs, Current</link:label>
    <link:label id="lab_rnac_AccruedEquityOfferingCostsCurrent_documentation_en-US" xlink:label="lab_rnac_AccruedEquityOfferingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Equity Offering Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedEquityOfferingCostsCurrent" xlink:href="rnac-20260331.xsd#rnac_AccruedEquityOfferingCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_AccruedEquityOfferingCostsCurrent" xlink:to="lab_rnac_AccruedEquityOfferingCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_019cdd24-92d8-71e0-9336-10c3b44f9a8b_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ContingentValueRightLiability_019cdd24-935e-7c46-bf9b-53972a9101dd_terseLabel_en-US" xlink:label="lab_rnac_ContingentValueRightLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent value right liability</link:label>
    <link:label id="lab_rnac_ContingentValueRightLiability_label_en-US" xlink:label="lab_rnac_ContingentValueRightLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Value Right Liability</link:label>
    <link:label id="lab_rnac_ContingentValueRightLiability_documentation_en-US" xlink:label="lab_rnac_ContingentValueRightLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Value Right Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightLiability" xlink:href="rnac-20260331.xsd#rnac_ContingentValueRightLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ContingentValueRightLiability" xlink:to="lab_rnac_ContingentValueRightLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_019cdd24-92d8-71b8-a20a-0c64cf89affd_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_019cdd24-935e-7289-aca0-09983057cf65_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-92d8-7feb-8238-df944d25d43d_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice_019cdd24-92d8-7fa2-a37d-381322da7006_verboseLabel_en-US" xlink:label="lab_rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice_label_en-US" xlink:label="lab_rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Exercise Price</link:label>
    <link:label id="lab_rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" xlink:href="rnac-20260331.xsd#rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" xlink:to="lab_rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_019cdd24-92d8-78a3-a6da-919fc31d7a76_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Continuing Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_019cdd24-92d8-7c2d-af15-59cf18ff1118_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019cdd24-92d8-7e40-adb4-410540f074d2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2030</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_019cdd24-9221-7363-924a-d37fc0b7caa1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_019cdd24-935e-77b4-80c8-d30b3adcd994_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities and Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_019cdd24-9221-7209-8bb5-db67e9cfb383_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019cdd24-92d8-7c07-8313-5a6e5ef5d6eb_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_019cdd24-935e-79c5-bf19-6f4fe8aadcb4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_019cdd24-92d8-7e2f-aea2-0aa4fd610d9f_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_019cdd24-92d8-7a0c-a4a3-bd0b21c8eb5e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_019cdd24-92d8-7a8a-98b8-2e4c3ef03cc9_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_019cdd24-92d8-7ba4-b42b-06936f37e0c0_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants to purchase common stock</link:label>
    <link:label id="lab_us-gaap_WarrantMember_019cdd24-92d8-7641-9024-9a9590c02d82_netLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Warrant Liability</link:label>
    <link:label id="lab_us-gaap_WarrantMember_019cdd24-92d8-76d2-8762-95ac0443d7ca_verboseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Exercise of warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_019cdd24-92d8-71a1-a5d2-60a6ed7e20e5_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019cdd24-935e-795b-89ab-dc99f4ea1ba4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, options, outstanding, number (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019cdd24-935e-763d-bae9-a575715cf2fb_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019cdd24-935e-7054-bc3d-3c5d07244512_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_019cdd24-935e-7b0d-a8f6-b1ea57155d68_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_NationalCancerInstituteAgreementMember_019cdd24-92d8-7be0-b84b-c308877ee9a4_terseLabel_en-US" xlink:label="lab_rnac_NationalCancerInstituteAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NCI Agreement</link:label>
    <link:label id="lab_rnac_NationalCancerInstituteAgreementMember_label_en-US" xlink:label="lab_rnac_NationalCancerInstituteAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">National Cancer Institute Agreement [Member]</link:label>
    <link:label id="lab_rnac_NationalCancerInstituteAgreementMember_documentation_en-US" xlink:label="lab_rnac_NationalCancerInstituteAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">National Cancer Institute Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_NationalCancerInstituteAgreementMember" xlink:href="rnac-20260331.xsd#rnac_NationalCancerInstituteAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_NationalCancerInstituteAgreementMember" xlink:to="lab_rnac_NationalCancerInstituteAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_019cdd24-935e-7716-a5df-20a27158561f_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_019cdd24-92d8-7182-89c3-434b9be8b9f7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019cdd24-92d8-77ba-bad4-9450ac5d9e54_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">In-process research and development asset</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019cdd24-92d8-77cb-abf0-d6b6c891ae65_netLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember_019cdd24-935e-7a6d-95b6-defcc213454d_terseLabel_en-US" xlink:label="lab_rnac_ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development stock-based compensation expense</link:label>
    <link:label id="lab_rnac_ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember_label_en-US" xlink:label="lab_rnac_ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development, Share Based Payment Arrangement, Expense [Member]</link:label>
    <link:label id="lab_rnac_ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember_documentation_en-US" xlink:label="lab_rnac_ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Development, Share Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember" xlink:href="rnac-20260331.xsd#rnac_ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember" xlink:to="lab_rnac_ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_019cdd24-935e-72b8-89f8-6b9ad2b911b9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_019cdd24-935e-7080-bd6f-8d62720dfdf8_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Common stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_019cdd24-935e-70db-ac3e-22470eaf96fe_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Common stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_019cdd24-92d8-7e62-a7c9-6e2355821c62_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gain on change in fair value of warrant liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_019cdd24-92d8-73fe-b06c-f45b3bf3a858_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on change in warrant liability</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_label_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Adjustment of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:to="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_019cdd24-935e-7951-a307-f498c1b7c05e_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_PaymentsForContingentValueRightsDistributions_019cdd24-92d8-762a-ba5c-ff13f12b311b_negatedTerseLabel_en-US" xlink:label="lab_rnac_PaymentsForContingentValueRightsDistributions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Distribution of Contingent Value Rights</link:label>
    <link:label id="lab_rnac_PaymentsForContingentValueRightsDistributions_label_en-US" xlink:label="lab_rnac_PaymentsForContingentValueRightsDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments For Contingent Value Rights Distributions</link:label>
    <link:label id="lab_rnac_PaymentsForContingentValueRightsDistributions_documentation_en-US" xlink:label="lab_rnac_PaymentsForContingentValueRightsDistributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments For Contingent Value Rights Distributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_PaymentsForContingentValueRightsDistributions" xlink:href="rnac-20260331.xsd#rnac_PaymentsForContingentValueRightsDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_PaymentsForContingentValueRightsDistributions" xlink:to="lab_rnac_PaymentsForContingentValueRightsDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_019cdd24-92d8-7e5d-92a6-e8bb12f9cf01_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash investing and financing activities</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_019d0bfa-ffa3-730c-8321-ef3cb7234486_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019cdd24-92d8-7166-8e64-462dfc496e3c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019cdd24-92d8-7b50-851a-22a80dc8a8f7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon exercise of options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_019cdd24-935e-76ab-bdb0-11fa7d647edc_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_019cdd24-92d8-761f-9d05-f3b5ba633f1f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019cdd24-92d8-79de-8dab-c4b18fdcba38_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019cdd24-92d8-72e6-98eb-ccf3348a2077_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_019cdd24-935e-72b7-9e1b-a190b32c9c48_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_019cdd24-92d8-73c0-b5b8-b6542ee37501_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember_019cdd24-92d8-76bf-9b81-8e1ea5cb6b57_terseLabel_en-US" xlink:label="lab_rnac_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3SBio License</link:label>
    <link:label id="lab_rnac_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember_label_en-US" xlink:label="lab_rnac_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement With Shenyang Sunshine Pharmaceutical Company Limited [Member]</link:label>
    <link:label id="lab_rnac_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember_documentation_en-US" xlink:label="lab_rnac_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to License agreement with Shenyang Sunshine Pharmaceutical co., ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember" xlink:href="rnac-20260331.xsd#rnac_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember" xlink:to="lab_rnac_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019cdd24-92d8-788a-9c11-009d4e86632f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019cdd24-9221-72ae-9d61-a736e8f209c2_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019cdd24-9221-7b22-9692-9ec489af743e_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019cdd24-9221-7e5c-8b39-1b9c546568da_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_019cdd24-92d8-730a-8f41-f239d058856c_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_019cdd24-9221-78ff-a0d9-1f31d72b4ac8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_019cdd24-92d8-7116-ab76-4542670338d7_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_019cdd24-9221-76af-bf71-e8374f5cbb2d_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_019cdd24-9221-7c1b-af69-113593e80c64_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_019cdd24-935e-72e0-a25f-ce274c61b8eb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ResearchAndDevelopmentFacilitiesAndOtherExpensesMember_019cdd24-92d8-72d0-9e53-f34754092eda_terseLabel_en-US" xlink:label="lab_rnac_ResearchAndDevelopmentFacilitiesAndOtherExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development facilities and other expenses</link:label>
    <link:label id="lab_rnac_ResearchAndDevelopmentFacilitiesAndOtherExpensesMember_label_en-US" xlink:label="lab_rnac_ResearchAndDevelopmentFacilitiesAndOtherExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development, Facilities And Other Expenses [Member]</link:label>
    <link:label id="lab_rnac_ResearchAndDevelopmentFacilitiesAndOtherExpensesMember_documentation_en-US" xlink:label="lab_rnac_ResearchAndDevelopmentFacilitiesAndOtherExpensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Development, Facilities And Other Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ResearchAndDevelopmentFacilitiesAndOtherExpensesMember" xlink:href="rnac-20260331.xsd#rnac_ResearchAndDevelopmentFacilitiesAndOtherExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ResearchAndDevelopmentFacilitiesAndOtherExpensesMember" xlink:to="lab_rnac_ResearchAndDevelopmentFacilitiesAndOtherExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm_019cdd24-935e-70b0-88b9-b4a42b843045_terseLabel_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested, term</link:label>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm_label_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm_documentation_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm" xlink:to="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_019cdd24-92d8-74ed-a7b6-2ff502c51d34_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019cdd24-9221-74fa-8926-2948844722ee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019cdd24-935e-7b2b-a415-b5e80b9a9127_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_019cdd24-9221-7bac-b725-6f460d54408b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_StockIncentivePlan2016Member_019cdd24-92d8-7455-893d-92195d9c4ffd_terseLabel_en-US" xlink:label="lab_rnac_StockIncentivePlan2016Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2016 Plan</link:label>
    <link:label id="lab_rnac_StockIncentivePlan2016Member_label_en-US" xlink:label="lab_rnac_StockIncentivePlan2016Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Incentive Plan 2016 [Member]</link:label>
    <link:label id="lab_rnac_StockIncentivePlan2016Member_documentation_en-US" xlink:label="lab_rnac_StockIncentivePlan2016Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the information pertaining to the 2016 stock incentive plan, which provides for the granting of stock based awards to employees, directors, and consultants under terms and provisions established by the board of directors.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_StockIncentivePlan2016Member" xlink:href="rnac-20260331.xsd#rnac_StockIncentivePlan2016Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_StockIncentivePlan2016Member" xlink:to="lab_rnac_StockIncentivePlan2016Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_019cdd24-92d8-7724-979e-af36e1dc556e_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_019cdd24-92d8-77d4-8c2c-8123ae03a289_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested and expected to vest, term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_019cdd24-92d8-742c-a3b1-40d24d9b40f0_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsExercised_019cdd24-92d8-7933-89fa-7adfea150f7a_terseLabel_en-US" xlink:label="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants exercised (in shares)</link:label>
    <link:label id="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsExercised_label_en-US" xlink:label="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant Or Right, Outstanding, Warrants Exercised</link:label>
    <link:label id="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsExercised_documentation_en-US" xlink:label="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant Or Right, Outstanding, Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ClassOfWarrantOrRightOutstandingWarrantsExercised" xlink:href="rnac-20260331.xsd#rnac_ClassOfWarrantOrRightOutstandingWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ClassOfWarrantOrRightOutstandingWarrantsExercised" xlink:to="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019cdd24-92d8-7080-ade3-802e8f8fa52e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unvested at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019cdd24-92d8-7141-af18-d4107c3ebc82_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unvested at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019cdd24-935e-728d-9b2f-9aaf0518d0b5_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_019cdd24-92d8-76df-a5a6-59228b769bb4_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_019cdd24-935e-73ba-9975-29be187e20d4_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019cdd24-9221-7d08-9262-41eae1ac0ab5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation expense related to unvested employee stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_019cdd24-935e-7fe6-8ce5-39806274b480_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_019cdd24-92d8-7862-9d44-323b4dca067c_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_019cdd24-9221-734c-9f5b-7b2500b45512_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Weighted Average Assumptions Used</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_019cdd24-92d8-7965-b73a-a9aa24ee98f5_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_019cdd24-935e-7031-b235-4b644a54c91e_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_019cdd24-9221-7b89-b4ae-e87c953670ae_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Lease Costs and Other Information Related to Operating Leases</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_019cdd24-92d8-7e92-b725-f8e3f6f78e2d_verboseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_019cdd24-92d8-7581-bd8c-890615d8afa0_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Vested and expected to vest (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_019cdd24-92d8-7996-a026-42d2b7e8cdc4_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market funds (included in cash equivalents)</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_019cdd24-9221-78bb-b53e-e3b5dca7ce30_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_019cdd24-9221-749c-a5f6-9f3ac0c4a3ca_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_WarrantsAndRightsOutstandingNoncurrent_019d0bcf-753b-7fca-992c-d84758cc41ed_terseLabel_en-US" xlink:label="lab_rnac_WarrantsAndRightsOutstandingNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant liability</link:label>
    <link:label id="lab_rnac_WarrantsAndRightsOutstandingNoncurrent_label_en-US" xlink:label="lab_rnac_WarrantsAndRightsOutstandingNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants And Rights Outstanding, Noncurrent</link:label>
    <link:label id="lab_rnac_WarrantsAndRightsOutstandingNoncurrent_documentation_en-US" xlink:label="lab_rnac_WarrantsAndRightsOutstandingNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants And Rights Outstanding, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_WarrantsAndRightsOutstandingNoncurrent" xlink:href="rnac-20260331.xsd#rnac_WarrantsAndRightsOutstandingNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_WarrantsAndRightsOutstandingNoncurrent" xlink:to="lab_rnac_WarrantsAndRightsOutstandingNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_019cdd24-92d8-7719-a430-3fa4b2f4570d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_019cdd24-935e-7d44-ba0b-5695da2a8dc4_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants and rights outstanding, term</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination_019cdd24-92d8-7bad-95b3-f3efd408937f_terseLabel_en-US" xlink:label="lab_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written notice for agreement termination</link:label>
    <link:label id="lab_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination_label_en-US" xlink:label="lab_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Written Notice Period For Termination</link:label>
    <link:label id="lab_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination_documentation_en-US" xlink:label="lab_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Written Notice Period For Termination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination" xlink:href="rnac-20260331.xsd#rnac_CollaborativeArrangementWrittenNoticePeriodForTermination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination" xlink:to="lab_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019cdd24-92d8-7cdd-8723-70c2b4e620ba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average Exercise Price ($)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_019cdd24-92d8-7a84-849f-3beeb40b531d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restricted Cash</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_019cdd24-935e-7b2f-93de-02fd6ca070e4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019cdd24-92d8-7bb9-b760-2a53d59a63fb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_019cdd24-935e-781c-949b-e191009c9913_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_019cdd24-92d8-7f2a-b0a9-30fd00bffc8e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_019cdd24-9221-7e52-a1d0-820bdd63e748_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon vesting of restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ResearchAndDevelopmentEmployeeExpensesMember_019cdd24-935e-7e86-97e4-b6c97f68e8f9_terseLabel_en-US" xlink:label="lab_rnac_ResearchAndDevelopmentEmployeeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development employee expenses</link:label>
    <link:label id="lab_rnac_ResearchAndDevelopmentEmployeeExpensesMember_label_en-US" xlink:label="lab_rnac_ResearchAndDevelopmentEmployeeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development, Employee Expenses [Member]</link:label>
    <link:label id="lab_rnac_ResearchAndDevelopmentEmployeeExpensesMember_documentation_en-US" xlink:label="lab_rnac_ResearchAndDevelopmentEmployeeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Development, Employee Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ResearchAndDevelopmentEmployeeExpensesMember" xlink:href="rnac-20260331.xsd#rnac_ResearchAndDevelopmentEmployeeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ResearchAndDevelopmentEmployeeExpensesMember" xlink:to="lab_rnac_ResearchAndDevelopmentEmployeeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_019cdd24-935e-7187-8839-f49b1187f37f_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_019cdd24-92d8-7d3b-833e-a887b1f2f363_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ProbabilityOfSuccessMember_019cdd24-92d8-73c5-8448-a0ce16fd44d5_terseLabel_en-US" xlink:label="lab_rnac_ProbabilityOfSuccessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated probability of success</link:label>
    <link:label id="lab_rnac_ProbabilityOfSuccessMember_label_en-US" xlink:label="lab_rnac_ProbabilityOfSuccessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Probability Of Success [Member]</link:label>
    <link:label id="lab_rnac_ProbabilityOfSuccessMember_documentation_en-US" xlink:label="lab_rnac_ProbabilityOfSuccessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Probability Of Success</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ProbabilityOfSuccessMember" xlink:href="rnac-20260331.xsd#rnac_ProbabilityOfSuccessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ProbabilityOfSuccessMember" xlink:to="lab_rnac_ProbabilityOfSuccessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_019cdd24-935e-7655-8b21-8bae3e4d8ec4_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_019cdd24-92d8-75fb-b4af-e7e015b9853f_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_019cdd24-9221-7aaa-9225-2daab778705d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_019cdd24-92d8-796e-a51d-685a20e62383_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDepreciationAndAmortization" xlink:to="lab_us-gaap_OtherDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_019cdd24-92d8-7077-ad87-9f21b5902be6_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember_019cdd24-935e-77e3-b4e8-55cb58e6b082_terseLabel_en-US" xlink:label="lab_rnac_A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2016 Plan, 2018 Inducement Incentive Award Plan and Old Cartesian Plan</link:label>
    <link:label id="lab_rnac_A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember_label_en-US" xlink:label="lab_rnac_A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2016 Plan, 2018 Inducement Incentive Award Plan and Old Cartesian Plan [Member]</link:label>
    <link:label id="lab_rnac_A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember_documentation_en-US" xlink:label="lab_rnac_A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2016 Plan, 2018 Inducement Incentive Award Plan and Old Cartesian Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember" xlink:href="rnac-20260331.xsd#rnac_A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember" xlink:to="lab_rnac_A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_019cdd24-935e-798a-a128-9b65d8c01219_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GovernmentAssistanceTypeAxis_019cdd24-92d8-7aae-9761-c87d02a9cacf_terseLabel_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government Assistance, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_GovernmentAssistanceTypeAxis_label_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Assistance, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GovernmentAssistanceTypeAxis" xlink:to="lab_us-gaap_GovernmentAssistanceTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_019cdd24-9221-7bed-8c86-249dc5c4bbcd_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Continuing Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_019cdd24-92d8-7d8e-83fa-9e3f21ae1405_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019cdd24-935e-764b-9736-9d7903276fae_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019cdd24-9221-76b4-8d15-fb2dffef1b1b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon exercise of options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019cdd24-9221-72aa-8ef4-75bf0066afac_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_019cdd24-9221-7744-8050-28508a164f8c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_019cdd24-92d8-7876-b106-0ba0ca4bbe6e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_019cdd24-9221-7168-a77c-89414742b97b_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restricted Stock Units Activity</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_019cdd24-92d8-7b43-b075-0b72facd4763_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsIssued_019cdd24-92d8-7753-bcd5-e15782287b66_terseLabel_en-US" xlink:label="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants issued (in shares)</link:label>
    <link:label id="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsIssued_label_en-US" xlink:label="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant Or Right, Outstanding, Warrants Issued</link:label>
    <link:label id="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsIssued_documentation_en-US" xlink:label="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant Or Right, Outstanding, Warrants Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ClassOfWarrantOrRightOutstandingWarrantsIssued" xlink:href="rnac-20260331.xsd#rnac_ClassOfWarrantOrRightOutstandingWarrantsIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ClassOfWarrantOrRightOutstandingWarrantsIssued" xlink:to="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_019cdd24-9221-7194-9724-8ac53e7581a4_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019cdd24-92d8-7485-9153-2420291278d3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019cdd24-92d8-7569-8912-9c79f12de2fd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_019cdd24-935e-72c8-9872-dcf8221760f0_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-92d8-7e55-9d3e-6c497c48bff8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019cdd24-92d8-7c6f-804a-ea14ce458cb7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate_019cdd24-92d8-7928-abe5-30c826705837_terseLabel_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated forfeitures rate</link:label>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate_label_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award Forfeitures Rate</link:label>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate_documentation_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the percentage of forfeitures rate of the stock options based on the historical trends.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate" xlink:to="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_019cdd24-92d8-72f1-846f-1dd3adfd86ac_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_019cdd24-92d8-7e4b-98f3-9b6a7e71c66e_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_019cdd24-92d8-7d40-aee5-65e76097e0ae_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_019cdd24-92d8-7561-ad09-99addf6216d6_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_019cdd24-92d8-72e9-9fa9-27e50f1e1e10_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueOptionPricingModelMember_019cdd24-9221-7eee-9194-09151ad0e14b_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation technique, option pricing model</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueOptionPricingModelMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Technique, Option Pricing Model [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:to="lab_us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019cdd24-92d8-754e-8a9e-385a27acbb1c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_019cdd24-92d8-70d0-b485-7cb7bbc90408_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_019cdd24-9221-7247-850b-14e9b1f32315_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019cdd24-935e-7928-8f81-b5d5c6c66b42_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019cdd24-9221-7eed-abc5-b6d0417b991e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019cdd24-92d8-7175-b239-31022c22f8f4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_019cdd24-92d8-7176-bc3d-edd4958bfed4_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_019cdd24-92d8-7d27-aa7b-da67f0424b5a_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_019cdd24-9221-7419-90e9-c8f0c1788de6_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9221-7a79-ab0a-55f4bd5a4e63_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_019cdd24-92d8-723b-a335-839095c3f418_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019cdd24-92d8-7f58-a757-426833505172_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Incentive Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_019cdd24-935e-76b5-b9ec-4a56783785fa_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue_019cdd24-935e-7646-98f8-df09038b6ecd_terseLabel_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested</link:label>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue_label_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested, Outstanding, Intrinsic Value</link:label>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue_documentation_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue" xlink:to="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_019cdd24-92d8-73ad-9574-a94d47ef8950_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019cdd24-9221-7252-ab54-f50909c4d3ce_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_019cdd24-92d8-7aca-8987-baebdcedbfa0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_019cdd24-92d8-70ba-bb76-309dc8b5aefa_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_FairValueAdjustmentOfContingentValueRightLiability_019cdd24-92d8-7958-8984-66ef970d65a8_negatedTerseLabel_en-US" xlink:label="lab_rnac_FairValueAdjustmentOfContingentValueRightLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">(Loss) gain on change in fair value of contingent value right liability</link:label>
    <link:label id="lab_rnac_FairValueAdjustmentOfContingentValueRightLiability_019cdd24-92d8-778f-bfda-b613f7c79059_terseLabel_en-US" xlink:label="lab_rnac_FairValueAdjustmentOfContingentValueRightLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss (gain) on change in fair value of CVR liability</link:label>
    <link:label id="lab_rnac_FairValueAdjustmentOfContingentValueRightLiability_label_en-US" xlink:label="lab_rnac_FairValueAdjustmentOfContingentValueRightLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Adjustment Of Contingent Value Right Liability</link:label>
    <link:label id="lab_rnac_FairValueAdjustmentOfContingentValueRightLiability_documentation_en-US" xlink:label="lab_rnac_FairValueAdjustmentOfContingentValueRightLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Adjustment Of Contingent Value Right Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability" xlink:href="rnac-20260331.xsd#rnac_FairValueAdjustmentOfContingentValueRightLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability" xlink:to="lab_rnac_FairValueAdjustmentOfContingentValueRightLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_019cdd24-9221-77e6-b93d-1bdca042e3fc_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; deficit:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_019cdd24-9221-71c9-a9c1-f085acac2e3f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_019cdd24-92d8-77b6-8021-0cca38aebbab_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_019cdd24-9221-7d31-8bb3-c51530dba7da_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019cdd24-935e-7b2f-a2a0-29aaf3fae54e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_019cdd24-9221-7b29-993c-0d1c6533316d_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_FrederickLeaseAgreementMember_019d1a6e-510d-79a9-9aa1-9ef027fc8cea_terseLabel_en-US" xlink:label="lab_rnac_FrederickLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Frederick Lease Agreement</link:label>
    <link:label id="lab_rnac_FrederickLeaseAgreementMember_label_en-US" xlink:label="lab_rnac_FrederickLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Frederick Lease Agreement [Member]</link:label>
    <link:label id="lab_rnac_FrederickLeaseAgreementMember_documentation_en-US" xlink:label="lab_rnac_FrederickLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Frederick Lease Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_FrederickLeaseAgreementMember" xlink:href="rnac-20260331.xsd#rnac_FrederickLeaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_FrederickLeaseAgreementMember" xlink:to="lab_rnac_FrederickLeaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_019cdd24-9221-7c26-8556-b9c810303d84_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Authorized Shares of Common Stock for Future Issuance</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_Descartes08ForMGMember_019cdd24-935e-7589-b573-5e8d34286632_terseLabel_en-US" xlink:label="lab_rnac_Descartes08ForMGMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Descartes-08 for MG</link:label>
    <link:label id="lab_rnac_Descartes08ForMGMember_label_en-US" xlink:label="lab_rnac_Descartes08ForMGMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Descartes-08 For MG [Member]</link:label>
    <link:label id="lab_rnac_Descartes08ForMGMember_documentation_en-US" xlink:label="lab_rnac_Descartes08ForMGMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Descartes-08 For MG</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_Descartes08ForMGMember" xlink:href="rnac-20260331.xsd#rnac_Descartes08ForMGMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_Descartes08ForMGMember" xlink:to="lab_rnac_Descartes08ForMGMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_019cdd24-92d8-7e5f-bb16-65df57863eea_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_019cdd24-9221-70e5-9c7b-96d5f4c9da89_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsCancelled_019cdd24-92d8-7cf3-9a7c-65395226678e_terseLabel_en-US" xlink:label="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsCancelled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants cancelled (in shares)</link:label>
    <link:label id="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsCancelled_label_en-US" xlink:label="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsCancelled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant Or Right, Outstanding, Warrants Cancelled</link:label>
    <link:label id="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsCancelled_documentation_en-US" xlink:label="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsCancelled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant Or Right, Outstanding, Warrants Cancelled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ClassOfWarrantOrRightOutstandingWarrantsCancelled" xlink:href="rnac-20260331.xsd#rnac_ClassOfWarrantOrRightOutstandingWarrantsCancelled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ClassOfWarrantOrRightOutstandingWarrantsCancelled" xlink:to="lab_rnac_ClassOfWarrantOrRightOutstandingWarrantsCancelled" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_RestrictedStockUnitsUnvestedMember_019cdd24-9221-731b-a4d5-dab744c6df9e_terseLabel_en-US" xlink:label="lab_rnac_RestrictedStockUnitsUnvestedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested restricted stock units</link:label>
    <link:label id="lab_rnac_RestrictedStockUnitsUnvestedMember_label_en-US" xlink:label="lab_rnac_RestrictedStockUnitsUnvestedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units, Unvested [Member]</link:label>
    <link:label id="lab_rnac_RestrictedStockUnitsUnvestedMember_documentation_en-US" xlink:label="lab_rnac_RestrictedStockUnitsUnvestedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restricted Stock Units, Unvested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_RestrictedStockUnitsUnvestedMember" xlink:href="rnac-20260331.xsd#rnac_RestrictedStockUnitsUnvestedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_RestrictedStockUnitsUnvestedMember" xlink:to="lab_rnac_RestrictedStockUnitsUnvestedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale_019cdd24-9221-7f1f-a662-11e80dff234b_terseLabel_en-US" xlink:label="lab_rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents, restricted cash and marketable securities</link:label>
    <link:label id="lab_rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale_label_en-US" xlink:label="lab_rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents And Debt Securities, Available-For-Sale</link:label>
    <link:label id="lab_rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale_documentation_en-US" xlink:label="lab_rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents And Debt Securities, Available-For-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale" xlink:href="rnac-20260331.xsd#rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale" xlink:to="lab_rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_019cdd24-92d8-7aaa-92b2-7b2e782ebfca_terseLabel_en-US" xlink:label="lab_rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average exercise price</link:label>
    <link:label id="lab_rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_label_en-US" xlink:label="lab_rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_documentation_en-US" xlink:label="lab_rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:href="rnac-20260331.xsd#rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:to="lab_rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_019cdd24-92d8-7d60-baae-78c5f9c3593f_terseLabel_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_label_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_documentation_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">n/a</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract" xlink:to="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019cdd24-9221-728e-bce3-f8723f023c85_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019cdd24-935e-7cd1-a702-8c3e2a145fd8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ContingentValueRightLiabilityMeasurementInput_019cdd24-92d8-7619-9b3f-8448543a6646_terseLabel_en-US" xlink:label="lab_rnac_ContingentValueRightLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent value right liability, measurement input</link:label>
    <link:label id="lab_rnac_ContingentValueRightLiabilityMeasurementInput_label_en-US" xlink:label="lab_rnac_ContingentValueRightLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Value Right Liability, Measurement Input</link:label>
    <link:label id="lab_rnac_ContingentValueRightLiabilityMeasurementInput_documentation_en-US" xlink:label="lab_rnac_ContingentValueRightLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Value Right Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightLiabilityMeasurementInput" xlink:href="rnac-20260331.xsd#rnac_ContingentValueRightLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ContingentValueRightLiabilityMeasurementInput" xlink:to="lab_rnac_ContingentValueRightLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_019cdd24-9221-78a5-8308-9400a5e555e2_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_019cdd24-92d8-701e-9065-d6879c31a25a_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_AccruedAuditFeesCurrent_019cdd24-92d8-7538-8333-5ccb30174ab2_terseLabel_en-US" xlink:label="lab_rnac_AccruedAuditFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued professional and consulting services</link:label>
    <link:label id="lab_rnac_AccruedAuditFeesCurrent_label_en-US" xlink:label="lab_rnac_AccruedAuditFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Audit Fees, Current</link:label>
    <link:label id="lab_rnac_AccruedAuditFeesCurrent_documentation_en-US" xlink:label="lab_rnac_AccruedAuditFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Audit Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedAuditFeesCurrent" xlink:href="rnac-20260331.xsd#rnac_AccruedAuditFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_AccruedAuditFeesCurrent" xlink:to="lab_rnac_AccruedAuditFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_019cdd24-9221-7552-902e-c9d1dea8499e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value Measurement Inputs and Valuation Techniques for 2022 Warrants Liability and CVR Liability</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_019cdd24-92d8-7584-967d-8ff677e9afdf_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_019cdd24-92d8-7cc2-a822-53904718949e_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019cdd24-92d8-755c-87a0-fe4360dfd0d5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_019cdd24-92d8-71fe-bbcc-ac8fe56379fc_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding, term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019cdd24-935e-7ec4-b811-75bb829cbc93_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ClassOfWarrantOrRightRollForward_019cdd24-935e-7cf6-b0b4-22cbf7d2dd42_terseLabel_en-US" xlink:label="lab_rnac_ClassOfWarrantOrRightRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Warrants</link:label>
    <link:label id="lab_rnac_ClassOfWarrantOrRightRollForward_label_en-US" xlink:label="lab_rnac_ClassOfWarrantOrRightRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right [Roll Forward]</link:label>
    <link:label id="lab_rnac_ClassOfWarrantOrRightRollForward_documentation_en-US" xlink:label="lab_rnac_ClassOfWarrantOrRightRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ClassOfWarrantOrRightRollForward" xlink:href="rnac-20260331.xsd#rnac_ClassOfWarrantOrRightRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ClassOfWarrantOrRightRollForward" xlink:to="lab_rnac_ClassOfWarrantOrRightRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_019cdd24-9221-71f0-91f3-95300da32efe_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_019cdd24-92d8-73b2-9115-b3355fc24b4f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_019cdd24-9221-7d66-b5f9-a82112d1d2cc_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-9221-7f14-9b4b-31b41f2804f5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019cdd24-92d8-7ee5-b22e-89efbbb220ff_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_019cdd24-9221-701f-8d62-8e2739683bac_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_019cdd24-92d8-727b-9d58-271444d1219e_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_019cdd24-92d8-7ea0-9f84-52701537f6b3_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants and rights outstanding, measurement input</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019cdd24-92d8-74df-9c5c-2eeabb3eca7d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_019cdd24-92d8-7a94-aa96-166ef83c7745_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_019cdd24-935e-7e0d-b1c9-cd11f64abaa8_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ContingentValueRightMember_019cdd24-92d8-75d0-bd35-086483651561_verboseLabel_en-US" xlink:label="lab_rnac_ContingentValueRightMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">CVR Liability</link:label>
    <link:label id="lab_rnac_ContingentValueRightMember_label_en-US" xlink:label="lab_rnac_ContingentValueRightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Value Right [Member]</link:label>
    <link:label id="lab_rnac_ContingentValueRightMember_documentation_en-US" xlink:label="lab_rnac_ContingentValueRightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Value Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightMember" xlink:href="rnac-20260331.xsd#rnac_ContingentValueRightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ContingentValueRightMember" xlink:to="lab_rnac_ContingentValueRightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_019cdd24-92d8-77f7-8747-1f541a6a8081_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_019cdd24-935e-78f7-983c-bc6b60df7a63_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ContingentValueRightLiabilityNoncurrent_019cdd24-9221-7903-ad63-0ed77ee4d4a4_terseLabel_en-US" xlink:label="lab_rnac_ContingentValueRightLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent value right liability</link:label>
    <link:label id="lab_rnac_ContingentValueRightLiabilityNoncurrent_label_en-US" xlink:label="lab_rnac_ContingentValueRightLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Value Right Liability, Noncurrent</link:label>
    <link:label id="lab_rnac_ContingentValueRightLiabilityNoncurrent_documentation_en-US" xlink:label="lab_rnac_ContingentValueRightLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Value Right Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightLiabilityNoncurrent" xlink:href="rnac-20260331.xsd#rnac_ContingentValueRightLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ContingentValueRightLiabilityNoncurrent" xlink:to="lab_rnac_ContingentValueRightLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_OperatingSegmentMember_019cdd24-92d8-7e06-9b6a-aaf949e67ce6_terseLabel_en-US" xlink:label="lab_rnac_OperatingSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Segment</link:label>
    <link:label id="lab_rnac_OperatingSegmentMember_label_en-US" xlink:label="lab_rnac_OperatingSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Segment [Member]</link:label>
    <link:label id="lab_rnac_OperatingSegmentMember_documentation_en-US" xlink:label="lab_rnac_OperatingSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_OperatingSegmentMember" xlink:href="rnac-20260331.xsd#rnac_OperatingSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_OperatingSegmentMember" xlink:to="lab_rnac_OperatingSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019cdd24-935e-721e-8901-67e31b2437c5_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unvested at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019cdd24-935e-7fb0-9bd3-f29ce71fc0fa_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unvested at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_019cdd24-935e-7d56-83bf-f03519717bf0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_Descartes08ForDermatomyositisMember_019d9b54-fe1c-7436-8510-113727f8b790_terseLabel_en-US" xlink:label="lab_rnac_Descartes08ForDermatomyositisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Descartes-08 for dermatomyositis</link:label>
    <link:label id="lab_rnac_Descartes08ForDermatomyositisMember_label_en-US" xlink:label="lab_rnac_Descartes08ForDermatomyositisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Descartes-08 For Dermatomyositis [Member]</link:label>
    <link:label id="lab_rnac_Descartes08ForDermatomyositisMember_documentation_en-US" xlink:label="lab_rnac_Descartes08ForDermatomyositisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Descartes-08 For Dermatomyositis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_Descartes08ForDermatomyositisMember" xlink:href="rnac-20260331.xsd#rnac_Descartes08ForDermatomyositisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_Descartes08ForDermatomyositisMember" xlink:to="lab_rnac_Descartes08ForDermatomyositisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019cdd24-935e-74a1-86ba-c0a4c4b12b20_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_019d1a25-a18b-7850-acba-1ce79fd4daf9_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">In Process Research and Development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019cdd24-9221-7919-ad4d-58f91411ee3a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_019cdd24-92d8-77d8-bc9a-8789a8ff477f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Vested and expected to vest</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_019cdd24-92d8-7ca8-9743-b774611c6118_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_019cdd24-92d8-72b6-bd21-66cb5e3d254c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_019cdd24-92d8-761c-b115-97c987d2ac98_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019cdd24-92d8-7e6d-9c6f-62579a99fc8f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalent [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-92d8-73e1-b748-d19215f4564d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_019cdd24-92d8-7464-8afa-3be98b0dd03d_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019cdd24-935e-7179-80a2-6e90ab65e0e8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_019cdd24-92d8-77ec-91b5-acfc23d0bc8d_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_019cdd24-92d8-7c71-9488-3fc50770bb86_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, value, issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_019cdd24-935e-7e3d-8d75-8dadab3ec5db_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_019cdd24-9221-7514-8ab2-8208a5aef5dc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_019cdd24-92d8-76f5-8008-57ba6a8dc0f7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.0001 par value; 350,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 28,544,728 and 26,011,106 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019cdd24-92d8-7320-9df7-833ed996509d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019cdd24-935e-7911-b0db-b05a3ae2420d_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019cdd24-935e-712d-9307-f97bf1a444ca_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average common shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_019cdd24-9221-7210-9d50-22a29719dbac_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies (Note&#160;14)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_AccruedCollaborationandLicensing_019cdd24-935e-77e3-9dcf-f8c5c973a6dd_terseLabel_en-US" xlink:label="lab_rnac_AccruedCollaborationandLicensing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaboration and licensing</link:label>
    <link:label id="lab_rnac_AccruedCollaborationandLicensing_label_en-US" xlink:label="lab_rnac_AccruedCollaborationandLicensing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Collaboration and Licensing</link:label>
    <link:label id="lab_rnac_AccruedCollaborationandLicensing_documentation_en-US" xlink:label="lab_rnac_AccruedCollaborationandLicensing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Collaboration and Licensing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedCollaborationandLicensing" xlink:href="rnac-20260331.xsd#rnac_AccruedCollaborationandLicensing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_AccruedCollaborationandLicensing" xlink:to="lab_rnac_AccruedCollaborationandLicensing" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_019cdd24-92d8-724a-ad8b-e056d0149fe4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_019cdd24-92d8-7b10-a3e3-51ba172bb5b5_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Smaller Reporting Company</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_019cdd24-92d8-7ab3-8513-7a54d1249255_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Equity offering costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_019cdd24-92d8-7784-b8b5-63bee39ba7c5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_019cdd24-9221-711d-b8b9-6108032b118f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_019cdd24-9221-7459-8acd-7facf593e1a7_periodStartLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_019cdd24-9221-7e63-a4f0-f895dda186b7_periodEndLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_019cdd24-92d8-775b-8eab-9afe220044ce_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_019cdd24-92d8-7cf3-bdc6-156376bff86e_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_019cdd24-92d8-72f0-9c8d-60f612695971_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_019cdd24-92d8-771f-b3d9-4e3ba91b7260_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_LesseeOperatingLeaseAnnualBaseRent_019d1a79-5157-72d3-ad41-ed3fe2271925_terseLabel_en-US" xlink:label="lab_rnac_LesseeOperatingLeaseAnnualBaseRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate annual base rent</link:label>
    <link:label id="lab_rnac_LesseeOperatingLeaseAnnualBaseRent_label_en-US" xlink:label="lab_rnac_LesseeOperatingLeaseAnnualBaseRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Annual Base Rent</link:label>
    <link:label id="lab_rnac_LesseeOperatingLeaseAnnualBaseRent_documentation_en-US" xlink:label="lab_rnac_LesseeOperatingLeaseAnnualBaseRent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Annual Base Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LesseeOperatingLeaseAnnualBaseRent" xlink:href="rnac-20260331.xsd#rnac_LesseeOperatingLeaseAnnualBaseRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_LesseeOperatingLeaseAnnualBaseRent" xlink:to="lab_rnac_LesseeOperatingLeaseAnnualBaseRent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019cdd24-92d8-7d5b-a6d4-becd7e08b846_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_019cdd24-9221-799e-a9c6-661f16fb038e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_NumberOfReportableSegmentsNotDisclosedFlag_019d1b18-bda5-780e-a433-eb9fa4df5061_terseLabel_en-US" xlink:label="lab_rnac_NumberOfReportableSegmentsNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments not disclosed flag</link:label>
    <link:label id="lab_rnac_NumberOfReportableSegmentsNotDisclosedFlag_label_en-US" xlink:label="lab_rnac_NumberOfReportableSegmentsNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Reportable Segments Not Disclosed Flag</link:label>
    <link:label id="lab_rnac_NumberOfReportableSegmentsNotDisclosedFlag_documentation_en-US" xlink:label="lab_rnac_NumberOfReportableSegmentsNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Reportable Segments Not Disclosed Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_NumberOfReportableSegmentsNotDisclosedFlag" xlink:href="rnac-20260331.xsd#rnac_NumberOfReportableSegmentsNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_NumberOfReportableSegmentsNotDisclosedFlag" xlink:to="lab_rnac_NumberOfReportableSegmentsNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_LeaseArrangementAxis_019cdd24-9221-7793-a635-6348cd095f03_terseLabel_en-US" xlink:label="lab_rnac_LeaseArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Arrangement [Axis]</link:label>
    <link:label id="lab_rnac_LeaseArrangementAxis_label_en-US" xlink:label="lab_rnac_LeaseArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Arrangement [Axis]</link:label>
    <link:label id="lab_rnac_LeaseArrangementAxis_documentation_en-US" xlink:label="lab_rnac_LeaseArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LeaseArrangementAxis" xlink:href="rnac-20260331.xsd#rnac_LeaseArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_LeaseArrangementAxis" xlink:to="lab_rnac_LeaseArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_019cdd24-92d8-77e2-93ef-12e23d8e70de_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_019cdd24-92d8-7cca-aa39-190dbc82bb92_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_MeasurementInputRevenueVolatilityMember_019cdd24-9221-7fd1-844f-74772bd6f499_terseLabel_en-US" xlink:label="lab_rnac_MeasurementInputRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility of future revenues</link:label>
    <link:label id="lab_rnac_MeasurementInputRevenueVolatilityMember_label_en-US" xlink:label="lab_rnac_MeasurementInputRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Revenue Volatility [Member]</link:label>
    <link:label id="lab_rnac_MeasurementInputRevenueVolatilityMember_documentation_en-US" xlink:label="lab_rnac_MeasurementInputRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Measurement Input, Revenue Volatility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_MeasurementInputRevenueVolatilityMember" xlink:href="rnac-20260331.xsd#rnac_MeasurementInputRevenueVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_MeasurementInputRevenueVolatilityMember" xlink:to="lab_rnac_MeasurementInputRevenueVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_019cdd24-92d8-781b-9fc8-0550f030ef2e_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_019cdd24-935e-7093-bf84-d7a3a23bf54a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_019cdd24-92d8-747b-a1a0-45740e5cc7b5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss Per Share Allocable to Common Stockholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_019cdd24-92d8-75da-b9dd-75bf74e832ae_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_019cdd24-92d8-7b5b-b86f-58de01fd1344_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_019cdd24-9221-7ff8-98ec-6f0be1f1fdfd_terseLabel_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Office equipment</link:label>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_label_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficeEquipmentMember" xlink:to="lab_us-gaap_OfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_019cdd24-92d8-7533-9ec5-49782b79bc87_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from at the market offering, net of commissions and expenses</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_019cdd24-92d8-782c-8176-ca5b435e7888_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net proceeds from issuance of common stock- at-the-market offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_019cdd24-9221-7482-b34f-a014e9d885e1_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019cdd24-935e-7e33-afd4-3ad5892e7d2c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaboration and license</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d1aa7-eee3-73bb-8ea8-9744541fc1a8_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Collaboration and license revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_019cdd24-9221-7a25-b9c9-d0003680edc1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers, net</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_019cdd24-9221-75fe-ba7b-2a59b5d31a0d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019cdd24-92d8-7336-9c5b-1979a4050794_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_019cdd24-9221-7a30-9f39-a52c81e5bc4a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019cdd24-92d8-7b36-9a94-d937408953e5_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award expiration term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_019cdd24-935e-7db0-ad1e-59f396eacd1f_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_019cdd24-935e-771a-9d40-775c95ec20aa_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_019cdd24-92d8-7698-ae26-e49f68a27de9_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_019cdd24-92d8-7657-87ff-5d19f4b80ef4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GovernmentAssistanceAmountCumulativeCurrent_019cdd24-9221-71a7-9d82-93c185efaa3e_terseLabel_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceAmountCumulativeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government assistance, asset, current</link:label>
    <link:label id="lab_us-gaap_GovernmentAssistanceAmountCumulativeCurrent_label_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceAmountCumulativeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Assistance, Asset, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceAmountCumulativeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceAmountCumulativeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GovernmentAssistanceAmountCumulativeCurrent" xlink:to="lab_us-gaap_GovernmentAssistanceAmountCumulativeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_019cdd24-92d8-72a5-a975-9c3e3bda9008_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_019cdd24-92d8-7e21-838a-d5bdb6b7d430_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_019cdd24-92d8-704c-a536-17c8ce496fcb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019cdd24-92d8-7655-86f0-3f360d37e6ad_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_019cdd24-935e-7e04-95a9-a2235b261aa6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_019cdd24-92d8-73ea-b4a9-d71fb2cf24ce_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_019cdd24-92d8-7a37-9ba2-21dfc75eaeca_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockConvertibleSharesIssuable_019cdd24-92d8-7e8b-982c-18f477ffb337_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockConvertibleSharesIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock, common stock issuable upon conversion (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockConvertibleSharesIssuable_label_en-US" xlink:label="lab_us-gaap_PreferredStockConvertibleSharesIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Convertible, Shares Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleSharesIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockConvertibleSharesIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockConvertibleSharesIssuable" xlink:to="lab_us-gaap_PreferredStockConvertibleSharesIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019cdd24-92d8-7309-b76b-0208d744f54c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019cdd24-935e-768b-b883-9c23dbe3973a_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GovernmentAssistanceAwardAmount_019cdd24-935e-7e37-88d9-8ad6f40cebca_terseLabel_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceAwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government assistance, award amount</link:label>
    <link:label id="lab_us-gaap_GovernmentAssistanceAwardAmount_label_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceAwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Assistance, Award Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceAwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceAwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GovernmentAssistanceAwardAmount" xlink:to="lab_us-gaap_GovernmentAssistanceAwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_019cdd24-92d8-74b0-b7f4-46f4512df533_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share allocable to common stockholders:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_A2022WarrantsMember_019cdd24-92d8-79ca-8ded-0f4287ca9422_terseLabel_en-US" xlink:label="lab_rnac_A2022WarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022 Warrants</link:label>
    <link:label id="lab_rnac_A2022WarrantsMember_label_en-US" xlink:label="lab_rnac_A2022WarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2022 Warrants [Member]</link:label>
    <link:label id="lab_rnac_A2022WarrantsMember_documentation_en-US" xlink:label="lab_rnac_A2022WarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2022 Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_A2022WarrantsMember" xlink:href="rnac-20260331.xsd#rnac_A2022WarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_A2022WarrantsMember" xlink:to="lab_rnac_A2022WarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_019d0bff-0c26-78c6-8afc-5e3c2b3128f9_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other (expense) income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_EmploymentInducementIncentiveAwardPlanMember_019cdd24-92d8-7cb6-9ea8-1cd9eaaa6e52_terseLabel_en-US" xlink:label="lab_rnac_EmploymentInducementIncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employment Inducement Incentive Award Plan</link:label>
    <link:label id="lab_rnac_EmploymentInducementIncentiveAwardPlanMember_label_en-US" xlink:label="lab_rnac_EmploymentInducementIncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employment Inducement Incentive Award Plan [Member]</link:label>
    <link:label id="lab_rnac_EmploymentInducementIncentiveAwardPlanMember_documentation_en-US" xlink:label="lab_rnac_EmploymentInducementIncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employment Inducement Incentive Award Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_EmploymentInducementIncentiveAwardPlanMember" xlink:href="rnac-20260331.xsd#rnac_EmploymentInducementIncentiveAwardPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_EmploymentInducementIncentiveAwardPlanMember" xlink:to="lab_rnac_EmploymentInducementIncentiveAwardPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_019cdd24-92d8-7081-89b8-b74fa022447f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Potential Dilutive Shares of Common Stock Excluded from the Computation of the Diluted Net Loss Per Share Allocable to Common Stockholders</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GovernmentAssistanceTypeDomain_019cdd24-92d8-743e-b784-5b72cd51adbf_terseLabel_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government Assistance, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_GovernmentAssistanceTypeDomain_label_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Assistance, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GovernmentAssistanceTypeDomain" xlink:to="lab_us-gaap_GovernmentAssistanceTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019d1a5b-863d-7029-9e6d-812ef2bd6ed0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: Imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_019cdd24-9221-757c-8e1d-eeb3b5bd2476_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:to="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019cdd24-92d8-7ca4-864a-a1480e1ccdca_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-92d8-7548-a6f0-b7a9d0b3ddf8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019cdd24-92d8-7f7a-b4a5-d059e9e51baf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_019cdd24-9221-7dbe-959a-55df16295213_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payroll and employee related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_019cdd24-9221-747d-b75b-e40a9ffc423f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019cdd24-9221-7037-b8f8-8c37b9b57206_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019cdd24-935e-7546-96ba-1a2333eac41e_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_019cdd24-935e-79f9-a47d-9cee084779af_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_019cdd24-935e-7ffc-9b06-3d8afb7158b9_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_019cdd24-935e-7022-91c7-2c9c375e343e_netLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_019cdd24-92d8-72e4-852d-a403afc538cc_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Construction in process</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_019cdd24-92d8-7254-868f-69e42fe8a998_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019cdd24-92d8-7ebf-8b44-0c58c7442fba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award vesting term</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_019cdd24-92d8-7455-a355-777da963e367_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_019cdd24-92d8-70a5-9fa8-9ad073d3bdda_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_019cdd24-92d8-7137-887c-800d4891284b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_019cdd24-935e-734c-bec8-a4f858e2a0e6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant</link:label>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_019d1aa8-229d-78d4-b9d8-ef14633a719a_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Grant revenue</link:label>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_label_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Not from Contract with Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:to="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_019cdd24-92d8-7a40-aa47-06881cd011f3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_019cdd24-92d8-7a04-aa89-2fa547dc29af_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed_019cdd24-92d8-7aa3-9f0a-9549fe99754d_terseLabel_en-US" xlink:label="lab_rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent value right, percentage of milestone payments, royalties and other amounts to be distributed</link:label>
    <link:label id="lab_rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed_label_en-US" xlink:label="lab_rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Value Right, Percentage Of Milestone Payments, Royalties And Other Amounts To Be Distributed</link:label>
    <link:label id="lab_rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed_documentation_en-US" xlink:label="lab_rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Value Right, Percentage Of Milestone Payments, Royalties And Other Amounts To Be Distributed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed" xlink:href="rnac-20260331.xsd#rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed" xlink:to="lab_rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_019cdd24-92d8-7ef6-9c8d-93b317a7f033_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series A Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_us-gaap_SeriesAPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_019cdd24-9221-744b-aea9-5c98398178e6_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_019cdd24-92d8-798d-9ae9-4e3e64a60dd2_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:to="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_019cdd24-92d8-71a2-8fe8-1f1a98d04fc0_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Continuing Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_019cdd24-935e-7c10-841a-72aecbef33d1_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_019cdd24-9221-7a62-a4c8-b137dccd51d4_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_019cdd24-935e-7c31-8624-5290c6ac8217_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_019cdd24-935e-74ce-86e1-2d858c7805cc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_AccruedPatentFeesCurrent_019cdd24-92d8-7fad-8417-9154dc4cf7b9_terseLabel_en-US" xlink:label="lab_rnac_AccruedPatentFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued patent fees</link:label>
    <link:label id="lab_rnac_AccruedPatentFeesCurrent_label_en-US" xlink:label="lab_rnac_AccruedPatentFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Patent Fees Current</link:label>
    <link:label id="lab_rnac_AccruedPatentFeesCurrent_documentation_en-US" xlink:label="lab_rnac_AccruedPatentFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying value as of the balance sheet date of patent fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedPatentFeesCurrent" xlink:href="rnac-20260331.xsd#rnac_AccruedPatentFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_AccruedPatentFeesCurrent" xlink:to="lab_rnac_AccruedPatentFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_LaboratoryEquipmentMember_019cdd24-92d8-7434-89b9-917fe58651d2_terseLabel_en-US" xlink:label="lab_rnac_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_rnac_LaboratoryEquipmentMember_label_en-US" xlink:label="lab_rnac_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Laboratory Equipment [Member]</link:label>
    <link:label id="lab_rnac_LaboratoryEquipmentMember_documentation_en-US" xlink:label="lab_rnac_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to laboratory equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LaboratoryEquipmentMember" xlink:href="rnac-20260331.xsd#rnac_LaboratoryEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_LaboratoryEquipmentMember" xlink:to="lab_rnac_LaboratoryEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_019cdd24-92d8-773d-b3fe-c001c72fb742_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_019cdd24-92d8-7b53-8a9f-7f919ae3e796_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019cdd24-9221-74e3-81c8-51b676eb0983_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_019cdd24-92d8-7779-a29c-6a4dd2feffd3_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment to goodwill</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of Intangible Assets, Finite-Lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount_019cdd24-92d8-7127-bb25-beaa43d48038_terseLabel_en-US" xlink:label="lab_rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Future contingent additional payments</link:label>
    <link:label id="lab_rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount_label_en-US" xlink:label="lab_rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Variable Consideration Amount</link:label>
    <link:label id="lab_rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount_documentation_en-US" xlink:label="lab_rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Variable Consideration Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:href="rnac-20260331.xsd#rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:to="lab_rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_019cdd24-935e-7826-8e65-fd086909f88f_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019cdd24-92d8-7ce2-b57f-196cad71d4eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average Grant Date Fair Value ($)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019cdd24-9221-78f3-8e7d-bfd539c2c3f4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares authorized for grants (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_019cdd24-92d8-7035-a1dc-9c5608272568_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_019cdd24-9221-7518-8055-8a88281f5172_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019cdd24-935e-72ad-ba0f-987407b9095c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019cdd24-9221-75ba-97e1-cb054804de34_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value of stock options (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_019cdd24-935e-7756-a337-eb95e5883fdb_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_019cdd24-92d8-7f52-b2a2-0482cd1746ab_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_019cdd24-92d8-7f3f-b97b-f924594bbb43_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_019cdd24-9221-7c66-8ce0-6bcc7bdcef95_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Description of the Business</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid_019cdd24-92d8-703d-9814-bf04f2ec06ab_terseLabel_en-US" xlink:label="lab_rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate amount of upfront and milestone-based payments</link:label>
    <link:label id="lab_rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid_label_en-US" xlink:label="lab_rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Amount Of Upfront And Milestone Based Payments Paid</link:label>
    <link:label id="lab_rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid_documentation_en-US" xlink:label="lab_rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Aggregate Amount Of Upfront And Milestone Based Payments Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid" xlink:href="rnac-20260331.xsd#rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid" xlink:to="lab_rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019cdd24-9221-71de-b9d8-82aae12513b3_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019cdd24-92d8-721c-87cf-372f58c003a9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019cdd24-92d8-7d3b-a3ff-5442acae357c_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_019cdd24-935e-7296-ab0a-f0af67a76b69_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_019cdd24-9221-7b61-83b3-c179534c4ae6_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_EarlyStageProgramsMember_019cdd24-92d8-7a5c-aa2c-c72519318725_terseLabel_en-US" xlink:label="lab_rnac_EarlyStageProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Early stage programs</link:label>
    <link:label id="lab_rnac_EarlyStageProgramsMember_label_en-US" xlink:label="lab_rnac_EarlyStageProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Early Stage Programs [Member]</link:label>
    <link:label id="lab_rnac_EarlyStageProgramsMember_documentation_en-US" xlink:label="lab_rnac_EarlyStageProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Early Stage Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_EarlyStageProgramsMember" xlink:href="rnac-20260331.xsd#rnac_EarlyStageProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_EarlyStageProgramsMember" xlink:to="lab_rnac_EarlyStageProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_OldCartestianMember_019cdd24-92d8-7637-b1ab-4d65e8080cca_terseLabel_en-US" xlink:label="lab_rnac_OldCartestianMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Old Cartestian</link:label>
    <link:label id="lab_rnac_OldCartestianMember_label_en-US" xlink:label="lab_rnac_OldCartestianMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Old Cartestian [Member]</link:label>
    <link:label id="lab_rnac_OldCartestianMember_documentation_en-US" xlink:label="lab_rnac_OldCartestianMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Old Cartestian</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_OldCartestianMember" xlink:href="rnac-20260331.xsd#rnac_OldCartestianMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_OldCartestianMember" xlink:to="lab_rnac_OldCartestianMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_019cdd24-92d8-7ea8-a22e-fcd3fa5a9da4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_019cdd24-935e-768c-9d93-5338e4065b93_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_019cdd24-9221-7163-ad35-eb3991558926_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_019cdd24-9221-773f-b620-8304d36ab145_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_019cdd24-92d8-7ed4-b3db-4bfcddce4b29_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Options Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_019cdd24-935e-789e-a4c4-ebc27aa07c98_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Warrant Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_019cdd24-935e-73f0-8546-de6e162d3115_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019cdd24-92d8-7ba3-8dfe-6062744d53b4_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019cdd24-92d8-7ee0-ad9e-4d5a1230b17a_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average common shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019cdd24-9221-7be5-9eed-92ab125ad57a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_019cdd24-935e-7d87-be9c-2ffccca9329e_verboseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Warrant liability</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019cdd24-9221-7834-b1cc-71568fbc9da4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Computation of Basic and Diluted Net Loss Per Share Allocable to Common Stockholders</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_019cdd24-92d8-73e4-a2c0-69b44fbf8eb4_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Long-term restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_019cdd24-92d8-7e3e-ab70-c595ce40d953_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Cash Equivalent, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_AccruedResearchAndDevelopmentCostsCurrent_019cdd24-9221-77b6-90c2-79657e0a95cc_terseLabel_en-US" xlink:label="lab_rnac_AccruedResearchAndDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued research and development costs</link:label>
    <link:label id="lab_rnac_AccruedResearchAndDevelopmentCostsCurrent_label_en-US" xlink:label="lab_rnac_AccruedResearchAndDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Research And Development Costs Current</link:label>
    <link:label id="lab_rnac_AccruedResearchAndDevelopmentCostsCurrent_documentation_en-US" xlink:label="lab_rnac_AccruedResearchAndDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying value as of the balance sheet date of research and development costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedResearchAndDevelopmentCostsCurrent" xlink:href="rnac-20260331.xsd#rnac_AccruedResearchAndDevelopmentCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_AccruedResearchAndDevelopmentCostsCurrent" xlink:to="lab_rnac_AccruedResearchAndDevelopmentCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_019cdd24-9221-75cc-a4da-92c4d7b7e09d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_019cdd24-92d8-7948-abfc-7340aa775022_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_AtTheMarketOfferingMember_019cdd24-9221-7f5b-b27d-7cd1c94b2fc2_terseLabel_en-US" xlink:label="lab_rnac_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-The-Market Offering</link:label>
    <link:label id="lab_rnac_AtTheMarketOfferingMember_label_en-US" xlink:label="lab_rnac_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At-The-Market Offering [Member]</link:label>
    <link:label id="lab_rnac_AtTheMarketOfferingMember_documentation_en-US" xlink:label="lab_rnac_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At-The-Market Offering [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AtTheMarketOfferingMember" xlink:href="rnac-20260331.xsd#rnac_AtTheMarketOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_AtTheMarketOfferingMember" xlink:to="lab_rnac_AtTheMarketOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_019cdd24-9221-7a58-974e-e009af44c731_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_019d0bfe-3eef-731d-a6aa-ccc0fb5d8fcc_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other (expense) income:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_019cdd24-9221-75e7-9afa-bed4434338be_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_SaleOfStockAggregateMaximumGrossSalesProceeds_019cdd24-92d8-70b6-b52b-513b0b0822cc_terseLabel_en-US" xlink:label="lab_rnac_SaleOfStockAggregateMaximumGrossSalesProceeds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate maximum gross sales proceeds</link:label>
    <link:label id="lab_rnac_SaleOfStockAggregateMaximumGrossSalesProceeds_label_en-US" xlink:label="lab_rnac_SaleOfStockAggregateMaximumGrossSalesProceeds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Aggregate Maximum Gross Sales Proceeds</link:label>
    <link:label id="lab_rnac_SaleOfStockAggregateMaximumGrossSalesProceeds_documentation_en-US" xlink:label="lab_rnac_SaleOfStockAggregateMaximumGrossSalesProceeds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Aggregate Maximum Gross Sales Proceeds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_SaleOfStockAggregateMaximumGrossSalesProceeds" xlink:href="rnac-20260331.xsd#rnac_SaleOfStockAggregateMaximumGrossSalesProceeds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_SaleOfStockAggregateMaximumGrossSalesProceeds" xlink:to="lab_rnac_SaleOfStockAggregateMaximumGrossSalesProceeds" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_019d1b0d-f4b6-78f1-a37e-bc544e9b7fee_terseLabel_en-US" xlink:label="lab_rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government Assistance Current Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</link:label>
    <link:label id="lab_rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_label_en-US" xlink:label="lab_rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Assistance Current Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</link:label>
    <link:label id="lab_rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_documentation_en-US" xlink:label="lab_rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Government Assistance Current Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:href="rnac-20260331.xsd#rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:to="lab_rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019cdd24-92d8-7077-9b98-5a25cb6e695e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019cdd24-92d8-7b18-9991-98ba8b398e4a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9221-73e5-b5a2-c42f0f11d5ec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_019cdd24-92d8-76d2-8b29-2a5b57928b55_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_019cdd24-935e-7964-b49b-7a8e9f713002_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_019cdd24-935e-78a9-957c-26cc380bfe95_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019cdd24-92d8-76ce-88a2-3def9406d4a7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_019cdd24-935e-70f8-bc50-888389f292a8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_019d1a24-c165-782a-b471-3da7fdeedcad_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_019d1a45-200e-739d-bb14-af8f44df724f_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_019cdd24-9221-708c-9672-b3db20f50e0a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_019cdd24-92d8-7792-a214-7433a3a65fb1_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_019cdd24-92d8-7f16-a096-a95d21589938_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_019cdd24-92d8-7f17-a8b5-639f6aa5d199_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_019cdd24-92d8-7303-969b-71813640a1f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_019cdd24-92d8-753a-8deb-57d40b578740_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_019cdd24-92d8-75a8-82c1-48408155ca5c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_019cdd24-9221-7d46-972a-58fdc345a052_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_BiogenM.A.Inc.Member_019cdd24-935e-78eb-93f0-dacd6a655512_terseLabel_en-US" xlink:label="lab_rnac_BiogenM.A.Inc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Biogen M.A., Inc.</link:label>
    <link:label id="lab_rnac_BiogenM.A.Inc.Member_label_en-US" xlink:label="lab_rnac_BiogenM.A.Inc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Biogen M.A., Inc. [Member]</link:label>
    <link:label id="lab_rnac_BiogenM.A.Inc.Member_documentation_en-US" xlink:label="lab_rnac_BiogenM.A.Inc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Biogen M.A., Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_BiogenM.A.Inc.Member" xlink:href="rnac-20260331.xsd#rnac_BiogenM.A.Inc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_BiogenM.A.Inc.Member" xlink:to="lab_rnac_BiogenM.A.Inc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_019cdd24-92d8-7951-bd12-6ba230c9b970_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase of property and equipment not yet paid</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_019cdd24-935e-7a2f-adb9-507c48873ad5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_019cdd24-9221-7d6d-a508-223dd6b55a9e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_EquityOfferingCostsInAccruedLiabilities_019d9b49-eaec-753a-bc0c-1cc9c7e5cde2_terseLabel_en-US" xlink:label="lab_rnac_EquityOfferingCostsInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity offering costs in accrued liabilities</link:label>
    <link:label id="lab_rnac_EquityOfferingCostsInAccruedLiabilities_label_en-US" xlink:label="lab_rnac_EquityOfferingCostsInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Offering Costs In Accrued Liabilities</link:label>
    <link:label id="lab_rnac_EquityOfferingCostsInAccruedLiabilities_documentation_en-US" xlink:label="lab_rnac_EquityOfferingCostsInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Offering Costs In Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_EquityOfferingCostsInAccruedLiabilities" xlink:href="rnac-20260331.xsd#rnac_EquityOfferingCostsInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_EquityOfferingCostsInAccruedLiabilities" xlink:to="lab_rnac_EquityOfferingCostsInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_019cdd24-92d8-70ec-a2d6-c54ce9ce0ca5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock through at the market offering, net of commissions and expenses</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_019cdd24-92d8-7a98-94c1-60fb7cf156bb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_019cdd24-9221-7c5a-82fc-0bcee11d8858_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_019cdd24-9221-77fa-b251-65bcf3fc21f5_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019cdd24-92d8-7356-acb9-0ecac5d928bf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_019cdd24-9221-7da8-9140-5f76b69e8558_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract_019cdd24-92d8-7fc5-8b69-9582e7d298fb_terseLabel_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract_label_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Intrinsic Value [Abstract]</link:label>
    <link:label id="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract_documentation_en-US" xlink:label="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">n/a</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract" xlink:to="lab_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_019cdd24-935e-784c-b6d1-ab5d5e57b107_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common&#160;stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_019cdd24-92d8-7a5d-b549-fd2dbf131717_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_019cdd24-92d8-7fcc-a8a9-18f1876c42e2_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019cdd24-935e-7482-a69e-c38b2c4ad995_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net change in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_019cdd24-92d8-71c3-b3c7-c6f0966cbf9f_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>rnac-20260331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019cdd24-8f10-71f0-acfb-b8a76448289c,g:7ae85b19-6328-41a5-b0c0-99683dc813c6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/CoverPage" xlink:type="simple" xlink:href="rnac-20260331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019cdd24-9084-7804-93fc-6313633393e7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_DocumentType_019cdd24-9084-7804-93fc-6313633393e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_019cdd24-9084-7088-b5cf-556cc57acf97" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_DocumentQuarterlyReport_019cdd24-9084-7088-b5cf-556cc57acf97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019cdd24-9084-790f-8f7f-de984ade55fa" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_DocumentPeriodEndDate_019cdd24-9084-790f-8f7f-de984ade55fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_019cdd24-9084-74af-abcc-d6bd4bc74fe3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_DocumentTransitionReport_019cdd24-9084-74af-abcc-d6bd4bc74fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019cdd24-9084-742d-8b7a-3f3e3795f336" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_EntityFileNumber_019cdd24-9084-742d-8b7a-3f3e3795f336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019cdd24-9084-7dac-ba61-d7c26ce438ab" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_EntityRegistrantName_019cdd24-9084-7dac-ba61-d7c26ce438ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019cdd24-9084-7943-a1fc-a9a110e9d9d5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019cdd24-9084-7943-a1fc-a9a110e9d9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019cdd24-9084-7a8f-8c9b-8ee71692b933" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_EntityTaxIdentificationNumber_019cdd24-9084-7a8f-8c9b-8ee71692b933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019cdd24-9084-7929-b8f7-cda6cafa42a5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_EntityAddressAddressLine1_019cdd24-9084-7929-b8f7-cda6cafa42a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019cdd24-9084-7100-80e0-373e2088da78" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_EntityAddressCityOrTown_019cdd24-9084-7100-80e0-373e2088da78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019cdd24-9084-73da-99b7-833e44a3e3ed" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_EntityAddressStateOrProvince_019cdd24-9084-73da-99b7-833e44a3e3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019cdd24-9084-7cd3-be3c-03a523202732" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_EntityAddressPostalZipCode_019cdd24-9084-7cd3-be3c-03a523202732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019cdd24-9084-786d-a9a8-48dee25fcb7a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_CityAreaCode_019cdd24-9084-786d-a9a8-48dee25fcb7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019cdd24-9084-7b2e-8f66-d869a42c257c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_LocalPhoneNumber_019cdd24-9084-7b2e-8f66-d869a42c257c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019cdd24-9084-7468-b8d2-dc1b2d8f81e0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_Security12bTitle_019cdd24-9084-7468-b8d2-dc1b2d8f81e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019cdd24-9084-7984-9759-4d719f4fbfe1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_TradingSymbol_019cdd24-9084-7984-9759-4d719f4fbfe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019cdd24-9084-7485-ae19-ed464831c9bb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_SecurityExchangeName_019cdd24-9084-7485-ae19-ed464831c9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_019cdd24-9084-76c1-bdcf-9423a1356a0a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_EntityCurrentReportingStatus_019cdd24-9084-76c1-bdcf-9423a1356a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_019cdd24-9084-7fea-8f7a-abe5c0c6268a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_EntityInteractiveDataCurrent_019cdd24-9084-7fea-8f7a-abe5c0c6268a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_019cdd24-9084-7058-9eb8-5588400954c1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_EntityFilerCategory_019cdd24-9084-7058-9eb8-5588400954c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_019cdd24-9084-7afc-9710-153afb152dd4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_EntitySmallBusiness_019cdd24-9084-7afc-9710-153afb152dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019cdd24-9084-7c03-b8b6-eaea8a31df62" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_EntityEmergingGrowthCompany_019cdd24-9084-7c03-b8b6-eaea8a31df62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_019cdd24-9084-7f00-b7a7-f61d31b2efbf" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_EntityShellCompany_019cdd24-9084-7f00-b7a7-f61d31b2efbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_019cdd24-9084-7035-aeea-f54321a05205" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_019cdd24-9084-7035-aeea-f54321a05205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019cdd24-9084-7727-8801-b02a26b2ea23" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_AmendmentFlag_019cdd24-9084-7727-8801-b02a26b2ea23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_019cdd24-9084-773b-a098-4412ed9c9044" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_CurrentFiscalYearEndDate_019cdd24-9084-773b-a098-4412ed9c9044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_019cdd24-9084-7135-8505-6b215e7f4621" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_DocumentFiscalYearFocus_019cdd24-9084-7135-8505-6b215e7f4621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_019cdd24-9084-7e8c-be4c-236c18138144" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_DocumentFiscalPeriodFocus_019cdd24-9084-7e8c-be4c-236c18138144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019cdd24-9084-71b4-949c-97315666fe7d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019cdd24-9084-7059-baa8-06f8ae5b9a5f" xlink:to="loc_dei_EntityCentralIndexKey_019cdd24-9084-71b4-949c-97315666fe7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="rnac-20260331.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_019cdd24-9084-7b99-a83d-e64648d7b066" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019cdd24-9084-725a-8185-68d86f201f29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019cdd24-9084-7b99-a83d-e64648d7b066" xlink:to="loc_us-gaap_StatementTable_019cdd24-9084-725a-8185-68d86f201f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019cdd24-9084-726a-a297-e7be5d1bf7da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019cdd24-9084-725a-8185-68d86f201f29" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019cdd24-9084-726a-a297-e7be5d1bf7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cdd24-9084-72a0-ab84-9a7476f3625d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cdd24-9084-726a-a297-e7be5d1bf7da" xlink:to="loc_us-gaap_ClassOfStockDomain_019cdd24-9084-72a0-ab84-9a7476f3625d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-9084-7a44-be86-b3e3daf12e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019cdd24-9084-72a0-ab84-9a7476f3625d" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-9084-7a44-be86-b3e3daf12e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-9084-7479-9c48-302efa1b8c29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019cdd24-9084-72a0-ab84-9a7476f3625d" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-9084-7479-9c48-302efa1b8c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019cdd24-9084-7601-a0de-d9740463ffc0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019cdd24-9084-725a-8185-68d86f201f29" xlink:to="loc_us-gaap_StatementLineItems_019cdd24-9084-7601-a0de-d9740463ffc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_019cdd24-9084-7004-b7d6-d48aa78ef2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-9084-7601-a0de-d9740463ffc0" xlink:to="loc_us-gaap_AssetsAbstract_019cdd24-9084-7004-b7d6-d48aa78ef2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_019cdd24-9084-7241-80ef-7241e902cfe9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019cdd24-9084-7004-b7d6-d48aa78ef2c2" xlink:to="loc_us-gaap_AssetsCurrentAbstract_019cdd24-9084-7241-80ef-7241e902cfe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019cdd24-9084-74ad-a7fd-86b13f302aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019cdd24-9084-7241-80ef-7241e902cfe9" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019cdd24-9084-74ad-a7fd-86b13f302aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_019cdd24-9084-7a15-b5c9-4f1d32516e73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019cdd24-9084-7241-80ef-7241e902cfe9" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_019cdd24-9084-7a15-b5c9-4f1d32516e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019cdd24-9084-7796-98e3-f09430aa10a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019cdd24-9084-7241-80ef-7241e902cfe9" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019cdd24-9084-7796-98e3-f09430aa10a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019cdd24-9084-743c-a1c8-23090e1980f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019cdd24-9084-7241-80ef-7241e902cfe9" xlink:to="loc_us-gaap_AssetsCurrent_019cdd24-9084-743c-a1c8-23090e1980f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019cdd24-9084-73a3-95f9-df34bb4e72c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019cdd24-9084-7004-b7d6-d48aa78ef2c2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019cdd24-9084-73a3-95f9-df34bb4e72c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019cdd24-9084-7021-a97e-aa3abba97b97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019cdd24-9084-7004-b7d6-d48aa78ef2c2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019cdd24-9084-7021-a97e-aa3abba97b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019cdd24-9084-73f3-bcaf-9c7506daf507" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019cdd24-9084-7004-b7d6-d48aa78ef2c2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019cdd24-9084-73f3-bcaf-9c7506daf507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_019cdd24-9084-740e-8a3b-0edb5f7550da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019cdd24-9084-7004-b7d6-d48aa78ef2c2" xlink:to="loc_us-gaap_Goodwill_019cdd24-9084-740e-8a3b-0edb5f7550da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_019cdd24-9084-74ca-a8ed-cce620e7a836" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019cdd24-9084-7004-b7d6-d48aa78ef2c2" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_019cdd24-9084-74ca-a8ed-cce620e7a836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_019cdd24-9084-73cb-a9d6-582984f939ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019cdd24-9084-7004-b7d6-d48aa78ef2c2" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_019cdd24-9084-73cb-a9d6-582984f939ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019cdd24-9084-78e0-a5ae-57bc3207863d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019cdd24-9084-7004-b7d6-d48aa78ef2c2" xlink:to="loc_us-gaap_Assets_019cdd24-9084-78e0-a5ae-57bc3207863d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-9084-7601-a0de-d9740463ffc0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_019cdd24-9084-704f-b0b5-f67f85fd0bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_019cdd24-9084-704f-b0b5-f67f85fd0bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019cdd24-9084-776f-b0d7-8219e01e8a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019cdd24-9084-704f-b0b5-f67f85fd0bfb" xlink:to="loc_us-gaap_AccountsPayableCurrent_019cdd24-9084-776f-b0d7-8219e01e8a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_019cdd24-9084-735b-bb00-791d520c0229" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019cdd24-9084-704f-b0b5-f67f85fd0bfb" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_019cdd24-9084-735b-bb00-791d520c0229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019cdd24-9084-74d1-8e8b-e3f6d78a3cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019cdd24-9084-704f-b0b5-f67f85fd0bfb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019cdd24-9084-74d1-8e8b-e3f6d78a3cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019cdd24-9084-722d-bbac-b16e2776ae56" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019cdd24-9084-704f-b0b5-f67f85fd0bfb" xlink:to="loc_us-gaap_LiabilitiesCurrent_019cdd24-9084-722d-bbac-b16e2776ae56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019cdd24-9084-707d-9711-a637aadc2db4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019cdd24-9084-707d-9711-a637aadc2db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_WarrantsAndRightsOutstandingNoncurrent_019d0bcf-753b-7e85-8a66-86191051365a" xlink:href="rnac-20260331.xsd#rnac_WarrantsAndRightsOutstandingNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:to="loc_rnac_WarrantsAndRightsOutstandingNoncurrent_019d0bcf-753b-7e85-8a66-86191051365a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightLiabilityNoncurrent_019cdd24-9084-7e03-b284-6b96246209c8" xlink:href="rnac-20260331.xsd#rnac_ContingentValueRightLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:to="loc_rnac_ContingentValueRightLiabilityNoncurrent_019cdd24-9084-7e03-b284-6b96246209c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_019cdd24-914a-73d0-b488-dea2d2aa1675" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_019cdd24-914a-73d0-b488-dea2d2aa1675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019cdd24-914a-7b89-844c-24efc390aa41" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:to="loc_us-gaap_Liabilities_019cdd24-914a-7b89-844c-24efc390aa41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019cdd24-914a-7924-bb6d-2ee1f42bd100" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019cdd24-914a-7924-bb6d-2ee1f42bd100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_019cdd24-914a-73b0-b6e4-116565373b91" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:to="loc_us-gaap_StockholdersEquityAbstract_019cdd24-914a-73b0-b6e4-116565373b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_019cdd24-914a-706d-b6f8-67f0566068c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019cdd24-914a-73b0-b6e4-116565373b91" xlink:to="loc_us-gaap_PreferredStockValue_019cdd24-914a-706d-b6f8-67f0566068c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019cdd24-914a-7f3e-9db8-fe05f985b9f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019cdd24-914a-73b0-b6e4-116565373b91" xlink:to="loc_us-gaap_CommonStockValue_019cdd24-914a-7f3e-9db8-fe05f985b9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019cdd24-914a-71f8-ab04-6f6b9db2d690" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019cdd24-914a-73b0-b6e4-116565373b91" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019cdd24-914a-71f8-ab04-6f6b9db2d690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019cdd24-914a-7f10-ba2c-1ceee750c071" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019cdd24-914a-73b0-b6e4-116565373b91" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019cdd24-914a-7f10-ba2c-1ceee750c071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019cdd24-914a-7f7a-bfce-79eff62731af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019cdd24-914a-73b0-b6e4-116565373b91" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019cdd24-914a-7f7a-bfce-79eff62731af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019cdd24-914a-74ea-9a7c-ed659ac9d814" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019cdd24-914a-73b0-b6e4-116565373b91" xlink:to="loc_us-gaap_StockholdersEquity_019cdd24-914a-74ea-9a7c-ed659ac9d814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019cdd24-914a-7e11-8f8b-58ec6349f918" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019cdd24-9084-78a8-a6c5-bd89d953afe3" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_019cdd24-914a-7e11-8f8b-58ec6349f918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="rnac-20260331.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_019cdd24-914a-75af-807a-0c9d8cbfc824" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019cdd24-914a-7233-a241-2be006326769" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019cdd24-914a-75af-807a-0c9d8cbfc824" xlink:to="loc_us-gaap_StatementTable_019cdd24-914a-7233-a241-2be006326769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914a-7659-af21-3eaa210238e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019cdd24-914a-7233-a241-2be006326769" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914a-7659-af21-3eaa210238e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cdd24-914a-7efb-bac5-b8549d65a577" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914a-7659-af21-3eaa210238e0" xlink:to="loc_us-gaap_ClassOfStockDomain_019cdd24-914a-7efb-bac5-b8549d65a577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-914a-7135-8145-f343712ed806" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019cdd24-914a-7efb-bac5-b8549d65a577" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-914a-7135-8145-f343712ed806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-914a-751b-8c15-f1674cab8e25" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019cdd24-914a-7efb-bac5-b8549d65a577" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-914a-751b-8c15-f1674cab8e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019cdd24-914a-7b7c-82c9-7134623a0ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019cdd24-914a-7233-a241-2be006326769" xlink:to="loc_us-gaap_StatementLineItems_019cdd24-914a-7b7c-82c9-7134623a0ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019cdd24-914a-795f-8cd4-b5fec2b91765" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-914a-7b7c-82c9-7134623a0ec5" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019cdd24-914a-795f-8cd4-b5fec2b91765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_019cdd24-914a-745b-945e-0b84351b09bd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-914a-7b7c-82c9-7134623a0ec5" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_019cdd24-914a-745b-945e-0b84351b09bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_019cdd24-914a-7b8c-b11b-d6fb3b69e74b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-914a-7b7c-82c9-7134623a0ec5" xlink:to="loc_us-gaap_PreferredStockSharesIssued_019cdd24-914a-7b8c-b11b-d6fb3b69e74b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_019cdd24-914a-73bf-b842-2ca8afd329c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-914a-7b7c-82c9-7134623a0ec5" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_019cdd24-914a-73bf-b842-2ca8afd329c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_019cdd24-914a-7e88-b7f9-dbf49f5969f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-914a-7b7c-82c9-7134623a0ec5" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_019cdd24-914a-7e88-b7f9-dbf49f5969f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_019cdd24-914a-71b2-9b32-73fb49b3c87f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-914a-7b7c-82c9-7134623a0ec5" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_019cdd24-914a-71b2-9b32-73fb49b3c87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_019cdd24-914a-76c7-8564-c1d04280098f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-914a-7b7c-82c9-7134623a0ec5" xlink:to="loc_us-gaap_CommonStockSharesIssued_019cdd24-914a-76c7-8564-c1d04280098f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019cdd24-914a-7cc5-ba88-515feda0b9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-914a-7b7c-82c9-7134623a0ec5" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019cdd24-914a-7cc5-ba88-515feda0b9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="rnac-20260331.xsd#ConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_019cdd24-914a-748c-8abf-9d869d43b197" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_019d0bfd-564a-7102-bdaf-20769b17f03e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_019cdd24-914a-748c-8abf-9d869d43b197" xlink:to="loc_us-gaap_RevenuesAbstract_019d0bfd-564a-7102-bdaf-20769b17f03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019cdd24-914a-7455-b06a-a6184ab1f7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_019d0bfd-564a-7102-bdaf-20769b17f03e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019cdd24-914a-7455-b06a-a6184ab1f7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_019cdd24-914a-7773-8aec-e1056a882a56" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_019d0bfd-564a-7102-bdaf-20769b17f03e" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_019cdd24-914a-7773-8aec-e1056a882a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_019cdd24-914a-7785-a92f-83cb8b43f491" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_019d0bfd-564a-7102-bdaf-20769b17f03e" xlink:to="loc_us-gaap_Revenues_019cdd24-914a-7785-a92f-83cb8b43f491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_019cdd24-914a-763d-bfa3-449bfc08ed00" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_019cdd24-914a-748c-8abf-9d869d43b197" xlink:to="loc_us-gaap_CostOfRevenueAbstract_019cdd24-914a-763d-bfa3-449bfc08ed00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019cdd24-914a-70e6-bd58-4b18808c399d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_019cdd24-914a-763d-bfa3-449bfc08ed00" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019cdd24-914a-70e6-bd58-4b18808c399d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019cdd24-914a-72b8-bf86-dbd72000fb25" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_019cdd24-914a-763d-bfa3-449bfc08ed00" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019cdd24-914a-72b8-bf86-dbd72000fb25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019cdd24-914a-73fb-ae08-c60eb54804c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_019cdd24-914a-763d-bfa3-449bfc08ed00" xlink:to="loc_us-gaap_OperatingExpenses_019cdd24-914a-73fb-ae08-c60eb54804c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019cdd24-914a-7c43-9c41-3ef9503c31b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_019cdd24-914a-748c-8abf-9d869d43b197" xlink:to="loc_us-gaap_OperatingIncomeLoss_019cdd24-914a-7c43-9c41-3ef9503c31b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_019d0bfe-3eef-716a-a67c-c78bcf29650f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_019cdd24-914a-748c-8abf-9d869d43b197" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_019d0bfe-3eef-716a-a67c-c78bcf29650f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_019d0bfa-ffa3-7827-9d44-5e60d53d244e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_019d0bfe-3eef-716a-a67c-c78bcf29650f" xlink:to="loc_us-gaap_InvestmentIncomeInterest_019d0bfa-ffa3-7827-9d44-5e60d53d244e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_019cdd24-914a-707f-b9ad-9cd8cd85b5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_019d0bfe-3eef-716a-a67c-c78bcf29650f" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_019cdd24-914a-707f-b9ad-9cd8cd85b5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability_019cdd24-914a-75de-8f8a-b4694a29e58b" xlink:href="rnac-20260331.xsd#rnac_FairValueAdjustmentOfContingentValueRightLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_019d0bfe-3eef-716a-a67c-c78bcf29650f" xlink:to="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability_019cdd24-914a-75de-8f8a-b4694a29e58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019cdd24-914a-7fb6-8120-9ec5f7522136" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_019d0bfe-3eef-716a-a67c-c78bcf29650f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019cdd24-914a-7fb6-8120-9ec5f7522136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019d0bfa-846f-701b-8598-06e2a6e81fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_019d0bfe-3eef-716a-a67c-c78bcf29650f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019d0bfa-846f-701b-8598-06e2a6e81fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019cdd24-914a-74b5-be6e-e5cd9edfdefa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_019cdd24-914a-748c-8abf-9d869d43b197" xlink:to="loc_us-gaap_NetIncomeLoss_019cdd24-914a-74b5-be6e-e5cd9edfdefa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_019cdd24-914a-7e32-b70c-59fe7bc3da86" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_019cdd24-914a-748c-8abf-9d869d43b197" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_019cdd24-914a-7e32-b70c-59fe7bc3da86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_019cdd24-914a-7256-8070-d297f5a7322f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_019cdd24-914a-7e32-b70c-59fe7bc3da86" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_019cdd24-914a-7256-8070-d297f5a7322f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019cdd24-914a-700a-8618-79ae87716d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_019cdd24-914a-748c-8abf-9d869d43b197" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_019cdd24-914a-700a-8618-79ae87716d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019cdd24-914a-757e-914b-5b92aaf857bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_019cdd24-914a-748c-8abf-9d869d43b197" xlink:to="loc_us-gaap_EarningsPerShareAbstract_019cdd24-914a-757e-914b-5b92aaf857bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019cdd24-914a-7db0-af08-a52cb84ac9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019cdd24-914a-757e-914b-5b92aaf857bc" xlink:to="loc_us-gaap_EarningsPerShareBasic_019cdd24-914a-7db0-af08-a52cb84ac9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019cdd24-914a-7eed-bb46-6256ad266a00" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019cdd24-914a-757e-914b-5b92aaf857bc" xlink:to="loc_us-gaap_EarningsPerShareDiluted_019cdd24-914a-7eed-bb46-6256ad266a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019cdd24-914a-7849-8493-93db757418fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_019cdd24-914a-748c-8abf-9d869d43b197" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019cdd24-914a-7849-8493-93db757418fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019cdd24-914a-7d68-ae29-53265ac8ed94" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019cdd24-914a-7849-8493-93db757418fd" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019cdd24-914a-7d68-ae29-53265ac8ed94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019cdd24-914a-7f91-8bd0-efa53586ec85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019cdd24-914a-7849-8493-93db757418fd" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019cdd24-914a-7f91-8bd0-efa53586ec85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit" xlink:type="simple" xlink:href="rnac-20260331.xsd#ConsolidatedStatementsofChangesinStockholdersDeficit"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_019cdd24-914a-7d26-90f8-3d5628d8cb2e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019cdd24-914a-7111-97d0-6a8184dac4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_019cdd24-914a-7d26-90f8-3d5628d8cb2e" xlink:to="loc_us-gaap_StatementTable_019cdd24-914a-7111-97d0-6a8184dac4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914a-79c3-b5cb-2f0fad1a5d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019cdd24-914a-7111-97d0-6a8184dac4b2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914a-79c3-b5cb-2f0fad1a5d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019cdd24-914a-7dc9-9202-8a5ba67b2230" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914a-79c3-b5cb-2f0fad1a5d9c" xlink:to="loc_us-gaap_EquityComponentDomain_019cdd24-914a-7dc9-9202-8a5ba67b2230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_019cdd24-914a-7b9c-b794-24616afc17c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019cdd24-914a-7dc9-9202-8a5ba67b2230" xlink:to="loc_us-gaap_PreferredStockMember_019cdd24-914a-7b9c-b794-24616afc17c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019cdd24-914a-7589-90f2-ca4b8e2a55ae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019cdd24-914a-7dc9-9202-8a5ba67b2230" xlink:to="loc_us-gaap_CommonStockMember_019cdd24-914a-7589-90f2-ca4b8e2a55ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_019cdd24-914a-76ab-a3e1-42a4fe6cf261" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019cdd24-914a-7dc9-9202-8a5ba67b2230" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_019cdd24-914a-76ab-a3e1-42a4fe6cf261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_019cdd24-914a-7a88-bdf6-b312c4571d81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019cdd24-914a-7dc9-9202-8a5ba67b2230" xlink:to="loc_us-gaap_RetainedEarningsMember_019cdd24-914a-7a88-bdf6-b312c4571d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_019cdd24-914a-723d-8921-13c9829e6677" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019cdd24-914a-7dc9-9202-8a5ba67b2230" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_019cdd24-914a-723d-8921-13c9829e6677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914a-7831-8eeb-76456b593594" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019cdd24-914a-7111-97d0-6a8184dac4b2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914a-7831-8eeb-76456b593594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cdd24-914a-73df-8578-096ebf6f9859" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914a-7831-8eeb-76456b593594" xlink:to="loc_us-gaap_ClassOfStockDomain_019cdd24-914a-73df-8578-096ebf6f9859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-914a-7501-a0da-5a967f15258d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019cdd24-914a-73df-8578-096ebf6f9859" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-914a-7501-a0da-5a967f15258d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-914a-7283-b1b9-f35a74c26feb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019cdd24-914a-73df-8578-096ebf6f9859" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-914a-7283-b1b9-f35a74c26feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019cdd24-914a-7d7a-8424-ebf19aaf4879" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019cdd24-914a-7111-97d0-6a8184dac4b2" xlink:to="loc_us-gaap_StatementLineItems_019cdd24-914a-7d7a-8424-ebf19aaf4879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019cdd24-914a-7d7a-8424-ebf19aaf4879" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_019cdd24-914a-747d-9fb0-ba62321e1bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_019cdd24-914a-747d-9fb0-ba62321e1bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019cdd24-914a-7b6d-9847-5e62e3a9491c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_StockholdersEquity_019cdd24-914a-7b6d-9847-5e62e3a9491c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019cdd24-914a-7ead-b660-d469f3aa61a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019cdd24-914a-7ead-b660-d469f3aa61a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019cdd24-914a-7325-94f2-17cd34422236" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019cdd24-914a-7325-94f2-17cd34422236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019cdd24-914a-7adb-a772-2dde9152f888" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019cdd24-914a-7adb-a772-2dde9152f888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_019cdd24-914a-753f-886c-bb4c887fa56d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_019cdd24-914a-753f-886c-bb4c887fa56d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019d6aba-3958-7649-bf9d-b0f3acb1e466" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019d6aba-3958-7649-bf9d-b0f3acb1e466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_019d6aba-3958-7c44-9e9a-9fd148ff87e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_019d6aba-3958-7c44-9e9a-9fd148ff87e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019cdd24-914a-70fe-91f1-9ce049fa8323" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019cdd24-914a-70fe-91f1-9ce049fa8323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_019cdd24-914a-7339-a06b-732438628bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_019cdd24-914a-7339-a06b-732438628bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019cdd24-914a-74d4-8932-6348b045f3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_NetIncomeLoss_019cdd24-914a-74d4-8932-6348b045f3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_019cdd24-914a-7baa-ba98-ca3c12d600c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_019cdd24-914a-7baa-ba98-ca3c12d600c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019cdd24-914a-758a-b55f-c9bc80f8323e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_StockholdersEquity_019cdd24-914a-758a-b55f-c9bc80f8323e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019cdd24-914a-7b2d-8336-68f8b6780300" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019cdd24-914a-792f-bf1c-3321fc14bfde" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019cdd24-914a-7b2d-8336-68f8b6780300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="rnac-20260331.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_019cdd24-914a-708b-9be9-f79f61d674be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_019cdd24-914a-79cb-8e77-20642631f3bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019cdd24-914a-708b-9be9-f79f61d674be" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_019cdd24-914a-79cb-8e77-20642631f3bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019cdd24-914a-7e23-a700-73feb5d8c833" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_019cdd24-914a-79cb-8e77-20642631f3bb" xlink:to="loc_us-gaap_NetIncomeLoss_019cdd24-914a-7e23-a700-73feb5d8c833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019cdd24-914a-769c-9695-1f5c99e22786" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_019cdd24-914a-79cb-8e77-20642631f3bb" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019cdd24-914a-769c-9695-1f5c99e22786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_019cdd24-914a-703f-bf75-93a1aee9e914" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019cdd24-914a-769c-9695-1f5c99e22786" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_019cdd24-914a-703f-bf75-93a1aee9e914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_019cdd24-914a-7505-a384-ca59971c7f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019cdd24-914a-769c-9695-1f5c99e22786" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_019cdd24-914a-7505-a384-ca59971c7f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019cdd24-914a-79c1-a05d-0c60156c7039" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019cdd24-914a-769c-9695-1f5c99e22786" xlink:to="loc_us-gaap_ShareBasedCompensation_019cdd24-914a-79c1-a05d-0c60156c7039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_019cdd24-914a-71d7-b0dc-59988e548939" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019cdd24-914a-769c-9695-1f5c99e22786" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_019cdd24-914a-71d7-b0dc-59988e548939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability_019cdd24-914a-73ed-82fa-ce81e1263039" xlink:href="rnac-20260331.xsd#rnac_FairValueAdjustmentOfContingentValueRightLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019cdd24-914a-769c-9695-1f5c99e22786" xlink:to="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability_019cdd24-914a-73ed-82fa-ce81e1263039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019cdd24-914a-77a1-9fc7-64e207b906ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019cdd24-914a-769c-9695-1f5c99e22786" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019cdd24-914a-77a1-9fc7-64e207b906ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019cdd24-914a-7c5d-b2ca-9d261815e74f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019cdd24-914a-77a1-9fc7-64e207b906ef" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019cdd24-914a-7c5d-b2ca-9d261815e74f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019cdd24-914a-71d8-9b50-fdd92f1a89dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019cdd24-914a-77a1-9fc7-64e207b906ef" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019cdd24-914a-71d8-9b50-fdd92f1a89dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019cdd24-914a-73e9-ba63-1a619693a618" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019cdd24-914a-77a1-9fc7-64e207b906ef" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019cdd24-914a-73e9-ba63-1a619693a618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019cdd24-914a-76f7-9af5-bb308e6253a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019cdd24-914a-77a1-9fc7-64e207b906ef" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019cdd24-914a-76f7-9af5-bb308e6253a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019cdd24-914a-7247-88a9-d1d7eb12ec73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_019cdd24-914a-79cb-8e77-20642631f3bb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019cdd24-914a-7247-88a9-d1d7eb12ec73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_019cdd24-914a-7d2f-a51e-8779ab2d65d6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019cdd24-914a-708b-9be9-f79f61d674be" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_019cdd24-914a-7d2f-a51e-8779ab2d65d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019cdd24-914a-7d38-8e69-566c35bfa4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_019cdd24-914a-7d2f-a51e-8779ab2d65d6" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019cdd24-914a-7d38-8e69-566c35bfa4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019cdd24-914a-74c3-b9c1-d2d3ce1f4e73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_019cdd24-914a-7d2f-a51e-8779ab2d65d6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019cdd24-914a-74c3-b9c1-d2d3ce1f4e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_019cdd24-914a-7f96-b417-2d43286f4119" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019cdd24-914a-708b-9be9-f79f61d674be" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_019cdd24-914a-7f96-b417-2d43286f4119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_019cdd24-914a-7463-a1ab-a80d43e71f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_019cdd24-914a-7f96-b417-2d43286f4119" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_019cdd24-914a-7463-a1ab-a80d43e71f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019cdd24-914a-7187-81dd-7aea757761d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_019cdd24-914a-7f96-b417-2d43286f4119" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019cdd24-914a-7187-81dd-7aea757761d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019d96e8-0211-7ed4-ad30-154b02fdb303" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_019cdd24-914a-7f96-b417-2d43286f4119" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019d96e8-0211-7ed4-ad30-154b02fdb303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_PaymentsForContingentValueRightsDistributions_019cdd24-914a-73b0-90ec-2a56603f6159" xlink:href="rnac-20260331.xsd#rnac_PaymentsForContingentValueRightsDistributions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_019cdd24-914a-7f96-b417-2d43286f4119" xlink:to="loc_rnac_PaymentsForContingentValueRightsDistributions_019cdd24-914a-73b0-90ec-2a56603f6159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019cdd24-914a-7518-a798-23a624f70a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_019cdd24-914a-7f96-b417-2d43286f4119" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019cdd24-914a-7518-a798-23a624f70a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019cdd24-914a-79c8-bd40-51dbf7187228" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019cdd24-914a-708b-9be9-f79f61d674be" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019cdd24-914a-79c8-bd40-51dbf7187228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019cdd24-914a-7dc6-b7a1-959d97e31f99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019cdd24-914a-708b-9be9-f79f61d674be" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019cdd24-914a-7dc6-b7a1-959d97e31f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019cdd24-914a-76e8-a975-b9a6f73117dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019cdd24-914a-708b-9be9-f79f61d674be" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019cdd24-914a-76e8-a975-b9a6f73117dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019cdd24-914a-7b46-a4c0-761ef1adf7be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019cdd24-914a-708b-9be9-f79f61d674be" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019cdd24-914a-7b46-a4c0-761ef1adf7be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_019cdd24-914a-758d-82f0-dd0fb5890f79" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019cdd24-914a-708b-9be9-f79f61d674be" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_019cdd24-914a-758d-82f0-dd0fb5890f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_019cdd24-914a-71b4-9272-97b90b8b82e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_019cdd24-914a-758d-82f0-dd0fb5890f79" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_019cdd24-914a-71b4-9272-97b90b8b82e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_EquityOfferingCostsInAccruedLiabilities_019d9b49-eaec-72ff-917b-7115a56d88ef" xlink:href="rnac-20260331.xsd#rnac_EquityOfferingCostsInAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_019cdd24-914a-758d-82f0-dd0fb5890f79" xlink:to="loc_rnac_EquityOfferingCostsInAccruedLiabilities_019d9b49-eaec-72ff-917b-7115a56d88ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/DescriptionoftheBusiness" xlink:type="simple" xlink:href="rnac-20260331.xsd#DescriptionoftheBusiness"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/DescriptionoftheBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019cdd24-914a-733e-85e6-3b7f9a118cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_019cdd24-914a-7c53-bfdf-7db81f94da91" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019cdd24-914a-733e-85e6-3b7f9a118cdc" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_019cdd24-914a-7c53-bfdf-7db81f94da91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="rnac-20260331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019cdd24-914b-7b7e-ae8c-42b1abff9a41" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_019cdd24-914b-7b4b-89fd-aebaf20bc752" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019cdd24-914b-7b7e-ae8c-42b1abff9a41" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_019cdd24-914b-7b4b-89fd-aebaf20bc752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_019d1a1a-9db9-7fdb-b325-1c32829ae61c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019cdd24-914b-7b7e-ae8c-42b1abff9a41" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_019d1a1a-9db9-7fdb-b325-1c32829ae61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssets" xlink:type="simple" xlink:href="rnac-20260331.xsd#GoodwillandIndefiniteLivedIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019cdd24-914b-7414-99fe-bffddabdc93e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_019cdd24-914b-7f91-bc56-d51fd94e2f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019cdd24-914b-7414-99fe-bffddabdc93e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_019cdd24-914b-7f91-bc56-d51fd94e2f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholders" xlink:type="simple" xlink:href="rnac-20260331.xsd#NetLossPerShareAllocabletoCommonStockholders"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholders" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019cdd24-914b-717a-8334-452be9e33ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_019cdd24-914b-7806-a564-bc19a060751b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019cdd24-914b-717a-8334-452be9e33ed6" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_019cdd24-914b-7806-a564-bc19a060751b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="rnac-20260331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-795e-b870-7bcc63738fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_019cdd24-914b-7b98-a20e-b8506bcb6f41" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-795e-b870-7bcc63738fe2" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_019cdd24-914b-7b98-a20e-b8506bcb6f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="rnac-20260331.xsd#PropertyandEquipment"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/PropertyandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019cdd24-914b-71cb-8f42-3b05757d4193" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_019cdd24-914b-74a5-85fa-cc442e834c63" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019cdd24-914b-71cb-8f42-3b05757d4193" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_019cdd24-914b-74a5-85fa-cc442e834c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/AccruedExpenses" xlink:type="simple" xlink:href="rnac-20260331.xsd#AccruedExpenses"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/AccruedExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_019cdd24-914b-7b68-920d-5e7202a76dca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_019cdd24-914b-713f-b615-58d155b88614" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019cdd24-914b-7b68-920d-5e7202a76dca" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_019cdd24-914b-713f-b615-58d155b88614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/Leases" xlink:type="simple" xlink:href="rnac-20260331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_019cdd24-914b-7504-84f1-d86a2446ac5d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_019cdd24-914b-7b0b-97eb-cf6ac90ac38e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019cdd24-914b-7504-84f1-d86a2446ac5d" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_019cdd24-914b-7b0b-97eb-cf6ac90ac38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/Equity" xlink:type="simple" xlink:href="rnac-20260331.xsd#Equity"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/Equity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019cdd24-914b-7bb7-b964-c8885980f9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019cdd24-914b-7754-b083-e20233632c51" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019cdd24-914b-7bb7-b964-c8885980f9b8" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019cdd24-914b-7754-b083-e20233632c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/StockIncentivePlans" xlink:type="simple" xlink:href="rnac-20260331.xsd#StockIncentivePlans"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/StockIncentivePlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019cdd24-9220-7411-baeb-1c6a204bffc8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019cdd24-9220-7f63-8849-2eb039ba2dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019cdd24-9220-7411-baeb-1c6a204bffc8" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019cdd24-9220-7f63-8849-2eb039ba2dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/RevenueArrangements" xlink:type="simple" xlink:href="rnac-20260331.xsd#RevenueArrangements"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/RevenueArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019cdd24-9220-7013-a576-01310e44bd26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_019cdd24-9220-7e4e-9d04-28f4966e6785" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019cdd24-9220-7013-a576-01310e44bd26" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_019cdd24-9220-7e4e-9d04-28f4966e6785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreements" xlink:type="simple" xlink:href="rnac-20260331.xsd#CollaborationandLicenseAgreements"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019cdd24-9220-7715-b58a-45dc506711f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_CollaborationAndLicenseAgreementsTextBlock_019cdd24-9220-713a-bc71-c5a7f3dce64f" xlink:href="rnac-20260331.xsd#rnac_CollaborationAndLicenseAgreementsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019cdd24-9220-7715-b58a-45dc506711f8" xlink:to="loc_rnac_CollaborationAndLicenseAgreementsTextBlock_019cdd24-9220-713a-bc71-c5a7f3dce64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/IncomeTaxes" xlink:type="simple" xlink:href="rnac-20260331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019cdd24-9220-7220-b79c-512f6aba9cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_019cdd24-9220-7f99-9c62-6ff2df805e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019cdd24-9220-7220-b79c-512f6aba9cc6" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_019cdd24-9220-7f99-9c62-6ff2df805e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="rnac-20260331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019cdd24-9220-7212-9307-c79873b103fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019cdd24-9220-7f62-a894-cad2776398c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019cdd24-9220-7212-9307-c79873b103fd" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019cdd24-9220-7f62-a894-cad2776398c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/SegmentReporting" xlink:type="simple" xlink:href="rnac-20260331.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019cdd24-9220-7f9e-a23b-953076033ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_019cdd24-9220-75e5-bc52-e8f8075f6680" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019cdd24-9220-7f9e-a23b-953076033ea0" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_019cdd24-9220-75e5-bc52-e8f8075f6680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/SubsequentEvents" xlink:type="simple" xlink:href="rnac-20260331.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_019cdd24-9221-7881-b1db-9585ec0a039f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_019cdd24-9221-7c2b-9b55-4e15eeb5c772" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_019cdd24-9221-7881-b1db-9585ec0a039f" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_019cdd24-9221-7c2b-9b55-4e15eeb5c772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="rnac-20260331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019cdd24-914b-704f-b174-efda91686f93" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_019cdd24-914b-72a8-976b-247b6328d239" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019cdd24-914b-704f-b174-efda91686f93" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_019cdd24-914b-72a8-976b-247b6328d239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019cdd24-914b-793b-b237-692a9147d710" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019cdd24-914b-704f-b174-efda91686f93" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019cdd24-914b-793b-b237-692a9147d710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersTables" xlink:type="simple" xlink:href="rnac-20260331.xsd#NetLossPerShareAllocabletoCommonStockholdersTables"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019cdd24-914b-7b15-93fe-7b398d48f926" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019cdd24-914b-76d4-a68d-30f2fbc47e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019cdd24-914b-7b15-93fe-7b398d48f926" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019cdd24-914b-76d4-a68d-30f2fbc47e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_019cdd24-914b-7ebc-b8d8-c41b9f6d3a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019cdd24-914b-7b15-93fe-7b398d48f926" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_019cdd24-914b-7ebc-b8d8-c41b9f6d3a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="rnac-20260331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-7874-abea-136a4e692aad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_019cdd24-914b-738a-a508-3d62de3bc221" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-7874-abea-136a4e692aad" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_019cdd24-914b-738a-a508-3d62de3bc221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_019cdd24-914b-7856-a2b9-0e1f1a9ccb31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-7874-abea-136a4e692aad" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_019cdd24-914b-7856-a2b9-0e1f1a9ccb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_019cdd24-914b-7d30-9598-a04c07524460" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-7874-abea-136a4e692aad" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_019cdd24-914b-7d30-9598-a04c07524460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_019cdd24-914b-7e7f-bfed-c5e3f79ca658" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-7874-abea-136a4e692aad" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_019cdd24-914b-7e7f-bfed-c5e3f79ca658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_019cdd24-914b-7c3a-a6b8-96557998d6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-7874-abea-136a4e692aad" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_019cdd24-914b-7c3a-a6b8-96557998d6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="rnac-20260331.xsd#PropertyandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019cdd24-914b-793d-985e-5b943c1d76d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_019cdd24-914b-7831-9555-e632bbd75ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019cdd24-914b-793d-985e-5b943c1d76d2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_019cdd24-914b-7831-9555-e632bbd75ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="rnac-20260331.xsd#AccruedExpensesTables"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/AccruedExpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_019cdd24-914b-7759-9bb9-9968789aafee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_019cdd24-914b-72a1-ba30-a0eb47dcc15e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019cdd24-914b-7759-9bb9-9968789aafee" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_019cdd24-914b-72a1-ba30-a0eb47dcc15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/LeasesTables" xlink:type="simple" xlink:href="rnac-20260331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_019cdd24-914b-74ac-8934-cfc01427a78a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_019cdd24-914b-7e97-b95f-a6809bdf744d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019cdd24-914b-74ac-8934-cfc01427a78a" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_019cdd24-914b-7e97-b95f-a6809bdf744d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_019cdd24-914b-7197-b971-e1083089a75d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019cdd24-914b-74ac-8934-cfc01427a78a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_019cdd24-914b-7197-b971-e1083089a75d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/EquityTables" xlink:type="simple" xlink:href="rnac-20260331.xsd#EquityTables"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/EquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019cdd24-914b-7d56-99dc-5889f9356410" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_019cdd24-914b-7077-ba2e-ac00a9a1b06f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019cdd24-914b-7d56-99dc-5889f9356410" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_019cdd24-914b-7077-ba2e-ac00a9a1b06f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock_019cdd24-914b-7073-841b-92e84eb8938a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019cdd24-914b-7d56-99dc-5889f9356410" xlink:to="loc_us-gaap_ScheduleOfStockByClassTextBlock_019cdd24-914b-7073-841b-92e84eb8938a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/StockIncentivePlansTables" xlink:type="simple" xlink:href="rnac-20260331.xsd#StockIncentivePlansTables"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/StockIncentivePlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019cdd24-9220-7bbf-a5a1-46afa5e5d222" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_019cdd24-9220-7bcd-a892-b48b9619fe29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019cdd24-9220-7bbf-a5a1-46afa5e5d222" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_019cdd24-9220-7bcd-a892-b48b9619fe29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_019cdd24-9220-77f9-b708-174b48931b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019cdd24-9220-7bbf-a5a1-46afa5e5d222" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_019cdd24-9220-77f9-b708-174b48931b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_019cdd24-9220-717a-83b4-aa749e76ad58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019cdd24-9220-7bbf-a5a1-46afa5e5d222" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_019cdd24-9220-717a-83b4-aa749e76ad58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_019cdd24-9220-7f3f-9f33-bbdfce0d2e76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019cdd24-9220-7bbf-a5a1-46afa5e5d222" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_019cdd24-9220-7f3f-9f33-bbdfce0d2e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="rnac-20260331.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019cdd24-9220-7cc9-925e-be8727ba7cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_019cdd24-9220-700d-b45f-05f98a7ac24d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019cdd24-9220-7cc9-925e-be8727ba7cc5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_019cdd24-9220-700d-b45f-05f98a7ac24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/DescriptionoftheBusinessDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#DescriptionoftheBusinessDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/DescriptionoftheBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019cdd24-914b-708c-9126-199f35a0934d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019cdd24-914b-7781-8a6d-00832a67c955" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019cdd24-914b-708c-9126-199f35a0934d" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019cdd24-914b-7781-8a6d-00832a67c955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_019d1a10-6f5a-7c7b-9b60-cba97e8ddac5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019cdd24-914b-7781-8a6d-00832a67c955" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_019d1a10-6f5a-7c7b-9b60-cba97e8ddac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d1a10-6f5a-7a45-9e82-6c6c8f8f6ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_019d1a10-6f5a-7c7b-9b60-cba97e8ddac5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d1a10-6f5a-7a45-9e82-6c6c8f8f6ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_OldCartesianMember_019d1a10-6f5a-7b54-94f4-7a6198cb3d91" xlink:href="rnac-20260331.xsd#rnac_OldCartesianMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d1a10-6f5a-7a45-9e82-6c6c8f8f6ae6" xlink:to="loc_rnac_OldCartesianMember_019d1a10-6f5a-7b54-94f4-7a6198cb3d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_019d1a10-6f5a-710d-a571-957642f3b67d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019cdd24-914b-7781-8a6d-00832a67c955" xlink:to="loc_us-gaap_CashAndCashEquivalentsLineItems_019d1a10-6f5a-710d-a571-957642f3b67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d1a10-6f5a-7010-a616-f1095b67dfea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_019d1a10-6f5a-710d-a571-957642f3b67d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d1a10-6f5a-7010-a616-f1095b67dfea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale_019d1a10-6f5a-7bc0-9f40-b27af25c163d" xlink:href="rnac-20260331.xsd#rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_019d1a10-6f5a-710d-a571-957642f3b67d" xlink:to="loc_rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale_019d1a10-6f5a-7bc0-9f40-b27af25c163d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_019d1a10-6f5a-7727-b7b8-59245c0714e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_019d1a10-6f5a-710d-a571-957642f3b67d" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_019d1a10-6f5a-7727-b7b8-59245c0714e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed_019d1a10-6f5a-763d-b8e9-aeace04769b4" xlink:href="rnac-20260331.xsd#rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_019d1a10-6f5a-710d-a571-957642f3b67d" xlink:to="loc_rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed_019d1a10-6f5a-763d-b8e9-aeace04769b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#GoodwillandIndefiniteLivedIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019cdd24-914b-70f8-8bf5-07b987a4062e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019cdd24-914b-79c6-b13f-9e31cdf1a9df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019cdd24-914b-70f8-8bf5-07b987a4062e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019cdd24-914b-79c6-b13f-9e31cdf1a9df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_019d1a25-a18b-7a4b-8a35-03df72ed541f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019cdd24-914b-79c6-b13f-9e31cdf1a9df" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_019d1a25-a18b-7a4b-8a35-03df72ed541f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d1a25-a18b-742a-b61d-d4a82a269485" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_019d1a25-a18b-7a4b-8a35-03df72ed541f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d1a25-a18b-742a-b61d-d4a82a269485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_OldCartesianMember_019d1a25-a18b-7c41-8c0e-18e4766d375e" xlink:href="rnac-20260331.xsd#rnac_OldCartesianMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d1a25-a18b-742a-b61d-d4a82a269485" xlink:to="loc_rnac_OldCartesianMember_019d1a25-a18b-7c41-8c0e-18e4766d375e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_019d1a25-a18b-70e4-842d-36d6e04bdf75" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019cdd24-914b-79c6-b13f-9e31cdf1a9df" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_019d1a25-a18b-70e4-842d-36d6e04bdf75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_019d1a25-a18b-7176-8317-8550c06aa8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_019d1a25-a18b-70e4-842d-36d6e04bdf75" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_019d1a25-a18b-7176-8317-8550c06aa8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_Descartes08ForMGMember_019d1a25-a18b-7a4a-9dd5-64e8bdd2b860" xlink:href="rnac-20260331.xsd#rnac_Descartes08ForMGMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_019d1a25-a18b-7176-8317-8550c06aa8ca" xlink:to="loc_rnac_Descartes08ForMGMember_019d1a25-a18b-7a4a-9dd5-64e8bdd2b860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_019d1a25-a18b-7785-9bbc-9f24ad75ae35" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_019d1a25-a18b-7176-8317-8550c06aa8ca" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_019d1a25-a18b-7785-9bbc-9f24ad75ae35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_019d1a25-a18b-7892-a90f-55009d00d72b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019cdd24-914b-79c6-b13f-9e31cdf1a9df" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_019d1a25-a18b-7892-a90f-55009d00d72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_019d1a25-a18b-7e8f-a9a4-63b96d4b774c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019d1a25-a18b-7892-a90f-55009d00d72b" xlink:to="loc_us-gaap_Goodwill_019d1a25-a18b-7e8f-a9a4-63b96d4b774c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019d1a25-a18b-711f-a62b-6299a1a6afe4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019d1a25-a18b-7892-a90f-55009d00d72b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019d1a25-a18b-711f-a62b-6299a1a6afe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_019d1a25-a18b-7c9a-891e-dd538a6dcaec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019d1a25-a18b-7892-a90f-55009d00d72b" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_019d1a25-a18b-7c9a-891e-dd538a6dcaec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofComputationofBasicandDilutedNetLossPerShareAllocabletoCommonStockholdersDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#NetLossPerShareAllocabletoCommonStockholdersScheduleofComputationofBasicandDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofComputationofBasicandDilutedNetLossPerShareAllocabletoCommonStockholdersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019cdd24-914b-7606-a62a-4a18d7cfee49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_019cdd24-914b-7111-bc6e-a57a49272362" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019cdd24-914b-7606-a62a-4a18d7cfee49" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_019cdd24-914b-7111-bc6e-a57a49272362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019cdd24-914b-746d-b512-1ff83410c2bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_019cdd24-914b-7111-bc6e-a57a49272362" xlink:to="loc_us-gaap_NetIncomeLoss_019cdd24-914b-746d-b512-1ff83410c2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019cdd24-914b-74a6-bb49-336eea80c7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019cdd24-914b-7606-a62a-4a18d7cfee49" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019cdd24-914b-74a6-bb49-336eea80c7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019cdd24-914b-704e-a1f3-c0f087ea5d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019cdd24-914b-74a6-bb49-336eea80c7d5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019cdd24-914b-704e-a1f3-c0f087ea5d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019cdd24-914b-7dd7-aea0-99f2ac80e535" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019cdd24-914b-74a6-bb49-336eea80c7d5" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019cdd24-914b-7dd7-aea0-99f2ac80e535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_019cdd24-914b-7786-a845-8a0fdc8983f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019cdd24-914b-7606-a62a-4a18d7cfee49" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_019cdd24-914b-7786-a845-8a0fdc8983f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019cdd24-914b-7dd7-8d9c-b86e2977c408" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_019cdd24-914b-7786-a845-8a0fdc8983f4" xlink:to="loc_us-gaap_EarningsPerShareBasic_019cdd24-914b-7dd7-8d9c-b86e2977c408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019cdd24-914b-736d-9ee3-cf87cfd6bb8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_019cdd24-914b-7786-a845-8a0fdc8983f4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_019cdd24-914b-736d-9ee3-cf87cfd6bb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019cdd24-914b-74af-9f1d-c134ce986579" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019cdd24-914b-7c98-b20c-54893e4aaf9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019cdd24-914b-74af-9f1d-c134ce986579" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019cdd24-914b-7c98-b20c-54893e4aaf9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019cdd24-914b-73fe-bd99-7db3fa026ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019cdd24-914b-7c98-b20c-54893e4aaf9e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019cdd24-914b-73fe-bd99-7db3fa026ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019cdd24-914b-7e59-8ffe-d0952e16d175" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019cdd24-914b-73fe-bd99-7db3fa026ae1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019cdd24-914b-7e59-8ffe-d0952e16d175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_019cdd24-914b-7284-8288-d891a9a0f1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019cdd24-914b-7e59-8ffe-d0952e16d175" xlink:to="loc_us-gaap_StockCompensationPlanMember_019cdd24-914b-7284-8288-d891a9a0f1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_019cdd24-914b-7242-8049-05acdb6a2dde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019cdd24-914b-7e59-8ffe-d0952e16d175" xlink:to="loc_us-gaap_WarrantMember_019cdd24-914b-7242-8049-05acdb6a2dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_019cdd24-914b-762b-8e8f-bcc72702592e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019cdd24-914b-7e59-8ffe-d0952e16d175" xlink:to="loc_us-gaap_PreferredStockMember_019cdd24-914b-762b-8e8f-bcc72702592e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914b-7dc3-bdda-e48aa194354d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019cdd24-914b-7c98-b20c-54893e4aaf9e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914b-7dc3-bdda-e48aa194354d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cdd24-914b-770c-a5c7-353300b1cb8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914b-7dc3-bdda-e48aa194354d" xlink:to="loc_us-gaap_ClassOfStockDomain_019cdd24-914b-770c-a5c7-353300b1cb8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-914b-7724-bc9b-8d85ec30ad55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019cdd24-914b-770c-a5c7-353300b1cb8e" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-914b-7724-bc9b-8d85ec30ad55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-914b-7e8e-9271-ef4cad916de4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019cdd24-914b-770c-a5c7-353300b1cb8e" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-914b-7e8e-9271-ef4cad916de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019cdd24-914b-78c1-bf65-a41ef39dc282" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019cdd24-914b-7c98-b20c-54893e4aaf9e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019cdd24-914b-78c1-bf65-a41ef39dc282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019cdd24-914b-79db-80ca-1644b296fd88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019cdd24-914b-78c1-bf65-a41ef39dc282" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019cdd24-914b-79db-80ca-1644b296fd88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-70c9-89ce-db19edccfa87" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019cdd24-914b-7f0e-bef8-85f95ae4db2e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-70c9-89ce-db19edccfa87" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019cdd24-914b-7f0e-bef8-85f95ae4db2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019cdd24-914b-772f-8e3f-78e4337a8557" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019cdd24-914b-7f0e-bef8-85f95ae4db2e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019cdd24-914b-772f-8e3f-78e4337a8557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-914b-7aa8-be16-d924c841fd33" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019cdd24-914b-772f-8e3f-78e4337a8557" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-914b-7aa8-be16-d924c841fd33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_019cdd24-914b-7225-8e2f-def611784a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-914b-7aa8-be16-d924c841fd33" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_019cdd24-914b-7225-8e2f-def611784a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_019cdd24-914b-7b8f-a5f0-254230bf0169" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-914b-7aa8-be16-d924c841fd33" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_019cdd24-914b-7b8f-a5f0-254230bf0169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_019cdd24-914b-7946-aaad-741e5fc6869f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-914b-7aa8-be16-d924c841fd33" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_019cdd24-914b-7946-aaad-741e5fc6869f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_019cdd24-914b-72d1-8f7d-4c1d05ae8cee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019cdd24-914b-7f0e-bef8-85f95ae4db2e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_019cdd24-914b-72d1-8f7d-4c1d05ae8cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019cdd24-914b-733c-9b7a-dbdf4759c029" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_019cdd24-914b-72d1-8f7d-4c1d05ae8cee" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019cdd24-914b-733c-9b7a-dbdf4759c029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_019cdd24-914b-76d5-87b4-d0db181217c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019cdd24-914b-733c-9b7a-dbdf4759c029" xlink:to="loc_us-gaap_MoneyMarketFundsMember_019cdd24-914b-76d5-87b4-d0db181217c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019cdd24-914b-7ec3-a554-dc84e2741326" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019cdd24-914b-7f0e-bef8-85f95ae4db2e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019cdd24-914b-7ec3-a554-dc84e2741326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_019cdd24-914b-7cd3-93fc-dd87793fb3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019cdd24-914b-7ec3-a554-dc84e2741326" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_019cdd24-914b-7cd3-93fc-dd87793fb3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019cdd24-914b-7ebf-b8eb-1204d3efdbde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_019cdd24-914b-7cd3-93fc-dd87793fb3e8" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019cdd24-914b-7ebf-b8eb-1204d3efdbde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_019cdd24-914b-78a2-b7a8-70b35c541b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_019cdd24-914b-7cd3-93fc-dd87793fb3e8" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_019cdd24-914b-78a2-b7a8-70b35c541b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_019cdd24-914b-741b-9f3a-63605929d6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019cdd24-914b-7ec3-a554-dc84e2741326" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_019cdd24-914b-741b-9f3a-63605929d6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_019cdd24-914b-7f8c-a58e-a7cb667f9aae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_019cdd24-914b-741b-9f3a-63605929d6dd" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_019cdd24-914b-7f8c-a58e-a7cb667f9aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightLiability_019cdd24-914b-7f72-8d32-255faa47fa2d" xlink:href="rnac-20260331.xsd#rnac_ContingentValueRightLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_019cdd24-914b-741b-9f3a-63605929d6dd" xlink:to="loc_rnac_ContingentValueRightLiability_019cdd24-914b-7f72-8d32-255faa47fa2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_019cdd24-914b-73b5-93a6-d0bd507dc553" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_019cdd24-914b-741b-9f3a-63605929d6dd" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_019cdd24-914b-73b5-93a6-d0bd507dc553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-7b3e-88f2-535920539d87" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-7985-9f1e-2518063d9229" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-7b3e-88f2-535920539d87" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-7985-9f1e-2518063d9229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_019d9b4e-54a4-7133-963a-3c00ae88dd10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-7985-9f1e-2518063d9229" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_019d9b4e-54a4-7133-963a-3c00ae88dd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_019d9b4e-54a4-7755-a1e3-2720280da1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_019d9b4e-54a4-7133-963a-3c00ae88dd10" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_019d9b4e-54a4-7755-a1e3-2720280da1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_019d9b4e-54a5-7fb4-98d5-e65071f0e20f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019d9b4e-54a4-7755-a1e3-2720280da1c5" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_019d9b4e-54a5-7fb4-98d5-e65071f0e20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_019d9b4e-54a5-74e2-a74a-e94604fc939c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-7985-9f1e-2518063d9229" xlink:to="loc_us-gaap_ValuationTechniqueAxis_019d9b4e-54a5-74e2-a74a-e94604fc939c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_019d9b4e-54a5-7257-9faf-c1796335fe05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_019d9b4e-54a5-74e2-a74a-e94604fc939c" xlink:to="loc_us-gaap_ValuationTechniqueDomain_019d9b4e-54a5-7257-9faf-c1796335fe05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_019d9b4e-54a5-7965-a6ee-e5120df25574" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_019d9b4e-54a5-7257-9faf-c1796335fe05" xlink:to="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_019d9b4e-54a5-7965-a6ee-e5120df25574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019d9b4e-3552-73ab-a884-898151834d32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-7985-9f1e-2518063d9229" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019d9b4e-3552-73ab-a884-898151834d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_019d9b4e-3552-7e1f-b892-cc95fca60d32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019d9b4e-3552-73ab-a884-898151834d32" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_019d9b4e-3552-7e1f-b892-cc95fca60d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_019d9b4e-3552-746f-9a27-b8d23559ed36" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019d9b4e-3552-73ab-a884-898151834d32" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_019d9b4e-3552-746f-9a27-b8d23559ed36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_019d9b4e-54a5-77db-990a-6e910092b1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019d9b4e-3552-73ab-a884-898151834d32" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_019d9b4e-54a5-77db-990a-6e910092b1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#FairValueMeasurementsScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-71b8-aecd-1b0af4a199ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019cdd24-914b-74db-9f4d-eec514efb17d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-71b8-aecd-1b0af4a199ef" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019cdd24-914b-74db-9f4d-eec514efb17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_019cdd24-914b-7477-aaa7-3b72b4bb0f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-71b8-aecd-1b0af4a199ef" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_019cdd24-914b-7477-aaa7-3b72b4bb0f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019cdd24-914b-7e42-9e5e-cb6e4177a710" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-71b8-aecd-1b0af4a199ef" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019cdd24-914b-7e42-9e5e-cb6e4177a710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-7f6f-b46a-4d3857d5c861" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019cdd24-914b-7250-b1a4-0d9cc1d53788" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-7f6f-b46a-4d3857d5c861" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019cdd24-914b-7250-b1a4-0d9cc1d53788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_019cdd24-914b-71ed-be25-b24b3967a7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019cdd24-914b-7250-b1a4-0d9cc1d53788" xlink:to="loc_us-gaap_ValuationTechniqueAxis_019cdd24-914b-71ed-be25-b24b3967a7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_019cdd24-914b-7f4b-956e-037b8f15b5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_019cdd24-914b-71ed-be25-b24b3967a7a0" xlink:to="loc_us-gaap_ValuationTechniqueDomain_019cdd24-914b-7f4b-956e-037b8f15b5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_019cdd24-914b-72a0-bdb3-305209c98383" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_019cdd24-914b-7f4b-956e-037b8f15b5ab" xlink:to="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_019cdd24-914b-72a0-bdb3-305209c98383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_019cdd24-914b-7b68-87b3-65daac7cfc43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019cdd24-914b-7250-b1a4-0d9cc1d53788" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_019cdd24-914b-7b68-87b3-65daac7cfc43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-7fa9-87a6-4418ef2338dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_019cdd24-914b-7b68-87b3-65daac7cfc43" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-7fa9-87a6-4418ef2338dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_019cdd24-914b-748c-a3f7-b9b31926c31c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-7fa9-87a6-4418ef2338dc" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_019cdd24-914b-748c-a3f7-b9b31926c31c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_019cdd24-914b-7096-8354-70f858a14df7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-7fa9-87a6-4418ef2338dc" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_019cdd24-914b-7096-8354-70f858a14df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_019cdd24-914b-7385-9be9-eed943548935" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-7fa9-87a6-4418ef2338dc" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_019cdd24-914b-7385-9be9-eed943548935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_019cdd24-914b-7ec0-82b6-25e473c627e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-7fa9-87a6-4418ef2338dc" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_019cdd24-914b-7ec0-82b6-25e473c627e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019cdd24-914b-70bc-bee2-03c289e5bd41" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019cdd24-914b-7250-b1a4-0d9cc1d53788" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019cdd24-914b-70bc-bee2-03c289e5bd41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019cdd24-914b-7a0d-bd72-4e906ebdeb62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019cdd24-914b-70bc-bee2-03c289e5bd41" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019cdd24-914b-7a0d-bd72-4e906ebdeb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_A2022WarrantsMember_019cdd24-914b-7ac8-a9ed-67a542db10b4" xlink:href="rnac-20260331.xsd#rnac_A2022WarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cdd24-914b-7a0d-bd72-4e906ebdeb62" xlink:to="loc_rnac_A2022WarrantsMember_019cdd24-914b-7ac8-a9ed-67a542db10b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_019cdd24-914b-746d-b96f-c73789969e94" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019cdd24-914b-7250-b1a4-0d9cc1d53788" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_019cdd24-914b-746d-b96f-c73789969e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_019cdd24-914b-7f3e-b851-30dc6136aa85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_019cdd24-914b-746d-b96f-c73789969e94" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_019cdd24-914b-7f3e-b851-30dc6136aa85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019cdd24-914b-7221-a4ca-0f19cd2d0dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_019cdd24-914b-746d-b96f-c73789969e94" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019cdd24-914b-7221-a4ca-0f19cd2d0dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofRollForwardofFairValuefortheCompanysLevel3WarrantLiabilitiesandCVRLiabilityDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#FairValueMeasurementsScheduleofRollForwardofFairValuefortheCompanysLevel3WarrantLiabilitiesandCVRLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofRollForwardofFairValuefortheCompanysLevel3WarrantLiabilitiesandCVRLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-70ee-aed8-feb9f376e543" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-79fd-afaa-159275e0adbf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-70ee-aed8-feb9f376e543" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-79fd-afaa-159275e0adbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_019cdd24-914b-72f4-aa20-7030c3375abf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-79fd-afaa-159275e0adbf" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_019cdd24-914b-72f4-aa20-7030c3375abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019cdd24-914b-7546-8feb-50d123361739" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_019cdd24-914b-72f4-aa20-7030c3375abf" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019cdd24-914b-7546-8feb-50d123361739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_019cdd24-914b-7f65-be86-5b9215fc7dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019cdd24-914b-7546-8feb-50d123361739" xlink:to="loc_us-gaap_WarrantMember_019cdd24-914b-7f65-be86-5b9215fc7dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightMember_019cdd24-914b-7255-931f-2284ef0386e7" xlink:href="rnac-20260331.xsd#rnac_ContingentValueRightMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019cdd24-914b-7546-8feb-50d123361739" xlink:to="loc_rnac_ContingentValueRightMember_019cdd24-914b-7255-931f-2284ef0386e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019cdd24-914b-7479-b6d7-b2f708a5e614" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-79fd-afaa-159275e0adbf" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019cdd24-914b-7479-b6d7-b2f708a5e614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_019cdd24-914b-7ff1-a585-8249d363c587" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019cdd24-914b-7479-b6d7-b2f708a5e614" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_019cdd24-914b-7ff1-a585-8249d363c587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_019cdd24-914b-723e-8fd4-c6c62e2c923f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_019cdd24-914b-7ff1-a585-8249d363c587" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_019cdd24-914b-723e-8fd4-c6c62e2c923f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_019cdd24-914b-7af9-b5d2-9593e0782dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_019cdd24-914b-7ff1-a585-8249d363c587" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_019cdd24-914b-7af9-b5d2-9593e0782dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_019cdd24-914b-7ac0-a8ed-e254f3440cec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_019cdd24-914b-7ff1-a585-8249d363c587" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_019cdd24-914b-7ac0-a8ed-e254f3440cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-7418-8828-2ea8032a6f11" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-7772-8775-e101c598e6f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019cdd24-914b-7418-8828-2ea8032a6f11" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-7772-8775-e101c598e6f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019cdd24-914b-77d9-b55f-7d1a456fc703" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-7772-8775-e101c598e6f8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019cdd24-914b-77d9-b55f-7d1a456fc703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-914b-7e56-8b34-817526c91491" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019cdd24-914b-77d9-b55f-7d1a456fc703" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-914b-7e56-8b34-817526c91491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_019cdd24-914b-731b-85fc-9827e0cdbc85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019cdd24-914b-7e56-8b34-817526c91491" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_019cdd24-914b-731b-85fc-9827e0cdbc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_019cdd24-914b-7c80-a8b5-87933e82bcd4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-7772-8775-e101c598e6f8" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_019cdd24-914b-7c80-a8b5-87933e82bcd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-78d1-ac9c-42a80824c982" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_019cdd24-914b-7c80-a8b5-87933e82bcd4" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-78d1-ac9c-42a80824c982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ProbabilityOfSuccessMember_019cdd24-914b-722b-a1f9-fe6a480a1a07" xlink:href="rnac-20260331.xsd#rnac_ProbabilityOfSuccessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-78d1-ac9c-42a80824c982" xlink:to="loc_rnac_ProbabilityOfSuccessMember_019cdd24-914b-722b-a1f9-fe6a480a1a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_MeasurementInputRevenueVolatilityMember_019cdd24-914b-7d79-b8b2-1f4cf44a23df" xlink:href="rnac-20260331.xsd#rnac_MeasurementInputRevenueVolatilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019cdd24-914b-78d1-ac9c-42a80824c982" xlink:to="loc_rnac_MeasurementInputRevenueVolatilityMember_019cdd24-914b-7d79-b8b2-1f4cf44a23df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019cdd24-914b-7d63-820b-191fc029d5c9" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-7772-8775-e101c598e6f8" xlink:to="loc_srt_RangeAxis_019cdd24-914b-7d63-820b-191fc029d5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019cdd24-914b-7158-8a64-363db5bccfc4" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019cdd24-914b-7d63-820b-191fc029d5c9" xlink:to="loc_srt_RangeMember_019cdd24-914b-7158-8a64-363db5bccfc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019cdd24-914b-7316-859c-363a75257707" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019cdd24-914b-7158-8a64-363db5bccfc4" xlink:to="loc_srt_MinimumMember_019cdd24-914b-7316-859c-363a75257707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019cdd24-914b-73ad-ae19-d53664469252" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019cdd24-914b-7158-8a64-363db5bccfc4" xlink:to="loc_srt_MaximumMember_019cdd24-914b-73ad-ae19-d53664469252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019cdd24-914b-7752-b000-9a48dbe59edb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019cdd24-914b-7772-8775-e101c598e6f8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019cdd24-914b-7752-b000-9a48dbe59edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightLiabilityMeasurementInput_019cdd24-914b-7982-9fa4-61992abbd40f" xlink:href="rnac-20260331.xsd#rnac_ContingentValueRightLiabilityMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019cdd24-914b-7752-b000-9a48dbe59edb" xlink:to="loc_rnac_ContingentValueRightLiabilityMeasurementInput_019cdd24-914b-7982-9fa4-61992abbd40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#PropertyandEquipmentScheduleofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019cdd24-914b-7816-b50d-d8625c097eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019cdd24-914b-7fd0-98cd-f193aad141b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019cdd24-914b-7816-b50d-d8625c097eb7" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019cdd24-914b-7fd0-98cd-f193aad141b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019cdd24-914b-7390-8322-2bc79706c630" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019cdd24-914b-7fd0-98cd-f193aad141b7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019cdd24-914b-7390-8322-2bc79706c630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019cdd24-914b-7b40-b51c-75395bc98e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019cdd24-914b-7390-8322-2bc79706c630" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019cdd24-914b-7b40-b51c-75395bc98e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LaboratoryEquipmentMember_019cdd24-914b-7514-baab-798edbecdd71" xlink:href="rnac-20260331.xsd#rnac_LaboratoryEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019cdd24-914b-7b40-b51c-75395bc98e5e" xlink:to="loc_rnac_LaboratoryEquipmentMember_019cdd24-914b-7514-baab-798edbecdd71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_019cdd24-914b-7519-964d-95721d9bf5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019cdd24-914b-7b40-b51c-75395bc98e5e" xlink:to="loc_us-gaap_ComputerEquipmentMember_019cdd24-914b-7519-964d-95721d9bf5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_019cdd24-914b-79d6-bb7e-b111e735948d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019cdd24-914b-7b40-b51c-75395bc98e5e" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_019cdd24-914b-79d6-bb7e-b111e735948d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_019cdd24-914b-7342-b7d3-c2ce27b77142" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019cdd24-914b-7b40-b51c-75395bc98e5e" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_019cdd24-914b-7342-b7d3-c2ce27b77142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_019cdd24-914b-7f0e-88ce-7b12ed9dc3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019cdd24-914b-7b40-b51c-75395bc98e5e" xlink:to="loc_us-gaap_OfficeEquipmentMember_019cdd24-914b-7f0e-88ce-7b12ed9dc3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_019cdd24-914b-7a50-9e51-48efd105299a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019cdd24-914b-7b40-b51c-75395bc98e5e" xlink:to="loc_us-gaap_ConstructionInProgressMember_019cdd24-914b-7a50-9e51-48efd105299a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019cdd24-914b-78a3-ac69-6422199b6ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019cdd24-914b-7fd0-98cd-f193aad141b7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019cdd24-914b-78a3-ac69-6422199b6ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_019cdd24-914b-73ce-9e33-a67e15189e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019cdd24-914b-78a3-ac69-6422199b6ed5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_019cdd24-914b-73ce-9e33-a67e15189e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019cdd24-914b-7fec-a8a9-dff3a874ccd3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019cdd24-914b-78a3-ac69-6422199b6ed5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019cdd24-914b-7fec-a8a9-dff3a874ccd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019cdd24-914b-7ee1-a693-9f00bf8ffec2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019cdd24-914b-78a3-ac69-6422199b6ed5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019cdd24-914b-7ee1-a693-9f00bf8ffec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/PropertyandEquipmentNarrativeDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#PropertyandEquipmentNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/PropertyandEquipmentNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019cdd24-914b-71f1-a0b1-81712df2ab8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_019cdd24-914b-73bc-967f-751dc37efae8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019cdd24-914b-71f1-a0b1-81712df2ab8f" xlink:to="loc_us-gaap_Depreciation_019cdd24-914b-73bc-967f-751dc37efae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#AccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_019cdd24-914b-7535-8e37-8da6bdd7b806" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019cdd24-914b-72c5-ad4b-295e469c7fae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019cdd24-914b-7535-8e37-8da6bdd7b806" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019cdd24-914b-72c5-ad4b-295e469c7fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedCollaborationandLicensing_019dbec2-1c6a-75fe-bfd8-7f6c5975ef31" xlink:href="rnac-20260331.xsd#rnac_AccruedCollaborationandLicensing"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019cdd24-914b-7535-8e37-8da6bdd7b806" xlink:to="loc_rnac_AccruedCollaborationandLicensing_019dbec2-1c6a-75fe-bfd8-7f6c5975ef31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedPatentFeesCurrent_019cdd24-914b-76c6-9184-b6a5432a195d" xlink:href="rnac-20260331.xsd#rnac_AccruedPatentFeesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019cdd24-914b-7535-8e37-8da6bdd7b806" xlink:to="loc_rnac_AccruedPatentFeesCurrent_019cdd24-914b-76c6-9184-b6a5432a195d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedResearchAndDevelopmentCostsCurrent_019cdd24-914b-7724-b02c-3c790027fab3" xlink:href="rnac-20260331.xsd#rnac_AccruedResearchAndDevelopmentCostsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019cdd24-914b-7535-8e37-8da6bdd7b806" xlink:to="loc_rnac_AccruedResearchAndDevelopmentCostsCurrent_019cdd24-914b-7724-b02c-3c790027fab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedAuditFeesCurrent_019cdd24-914b-7049-a687-4d65ec632bb4" xlink:href="rnac-20260331.xsd#rnac_AccruedAuditFeesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019cdd24-914b-7535-8e37-8da6bdd7b806" xlink:to="loc_rnac_AccruedAuditFeesCurrent_019cdd24-914b-7049-a687-4d65ec632bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedEquityOfferingCostsCurrent_019dbeb6-15b9-7edd-99ce-68e157f83db3" xlink:href="rnac-20260331.xsd#rnac_AccruedEquityOfferingCostsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019cdd24-914b-7535-8e37-8da6bdd7b806" xlink:to="loc_rnac_AccruedEquityOfferingCostsCurrent_019dbeb6-15b9-7edd-99ce-68e157f83db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019cdd24-914b-7602-b2e2-f5582170dda8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019cdd24-914b-7535-8e37-8da6bdd7b806" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019cdd24-914b-7602-b2e2-f5582170dda8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019cdd24-914b-7223-b79b-e64295c5972a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019cdd24-914b-7535-8e37-8da6bdd7b806" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019cdd24-914b-7223-b79b-e64295c5972a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_019cdd24-914b-7ec6-8755-673e5fa69ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_019cdd24-914b-75d4-87fd-419298a086a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019cdd24-914b-7ec6-8755-673e5fa69ddc" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_019cdd24-914b-75d4-87fd-419298a086a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LeaseArrangementAxis_019d1a79-3342-7e9a-ab7f-877a37a52602" xlink:href="rnac-20260331.xsd#rnac_LeaseArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_019cdd24-914b-75d4-87fd-419298a086a9" xlink:to="loc_rnac_LeaseArrangementAxis_019d1a79-3342-7e9a-ab7f-877a37a52602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LeaseArrangementDomain_019d1a79-3342-763d-b2ae-6e5846a5867e" xlink:href="rnac-20260331.xsd#rnac_LeaseArrangementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rnac_LeaseArrangementAxis_019d1a79-3342-7e9a-ab7f-877a37a52602" xlink:to="loc_rnac_LeaseArrangementDomain_019d1a79-3342-763d-b2ae-6e5846a5867e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_FrederickLeaseAgreementMember_019d1a79-3342-75c2-adb8-e8814bf722db" xlink:href="rnac-20260331.xsd#rnac_FrederickLeaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rnac_LeaseArrangementDomain_019d1a79-3342-763d-b2ae-6e5846a5867e" xlink:to="loc_rnac_FrederickLeaseAgreementMember_019d1a79-3342-75c2-adb8-e8814bf722db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_019d1a79-3342-7c4c-a2ef-2e3170064757" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_019cdd24-914b-75d4-87fd-419298a086a9" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_019d1a79-3342-7c4c-a2ef-2e3170064757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_019d1a79-3342-7630-8f9d-81690c9f8d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_019d1a79-3342-7c4c-a2ef-2e3170064757" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_019d1a79-3342-7630-8f9d-81690c9f8d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LesseeOperatingLeaseAnnualBaseRent_019d1a79-5157-7b3f-9f13-369a5f2fdb32" xlink:href="rnac-20260331.xsd#rnac_LesseeOperatingLeaseAnnualBaseRent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_019d1a79-3342-7c4c-a2ef-2e3170064757" xlink:to="loc_rnac_LesseeOperatingLeaseAnnualBaseRent_019d1a79-5157-7b3f-9f13-369a5f2fdb32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/LeasesScheduleofComponentsofLeaseCostsDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#LeasesScheduleofComponentsofLeaseCostsDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/LeasesScheduleofComponentsofLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_019cdd24-914b-7d69-a073-f2bcb35d545a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_019cdd24-914b-7f95-8e19-e07b22d4145d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019cdd24-914b-7d69-a073-f2bcb35d545a" xlink:to="loc_us-gaap_OperatingLeaseCost_019cdd24-914b-7f95-8e19-e07b22d4145d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_019cdd24-914b-7ab2-9d5d-e9223e464e39" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019cdd24-914b-7d69-a073-f2bcb35d545a" xlink:to="loc_us-gaap_VariableLeaseCost_019cdd24-914b-7ab2-9d5d-e9223e464e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_019cdd24-914b-7d9d-9798-83799f9ffed2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019cdd24-914b-7d69-a073-f2bcb35d545a" xlink:to="loc_us-gaap_ShortTermLeaseCost_019cdd24-914b-7d9d-9798-83799f9ffed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_019cdd24-914b-7924-a77c-a6dd0100108c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019cdd24-914b-7d69-a073-f2bcb35d545a" xlink:to="loc_us-gaap_LeaseCost_019cdd24-914b-7924-a77c-a6dd0100108c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_019cdd24-914b-7280-9761-30adfc40acdf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019cdd24-914b-72ce-96e4-43c2d229c4d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019cdd24-914b-7280-9761-30adfc40acdf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019cdd24-914b-72ce-96e4-43c2d229c4d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019cdd24-914b-7417-92a6-e9b8a297ce8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019cdd24-914b-7280-9761-30adfc40acdf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019cdd24-914b-7417-92a6-e9b8a297ce8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019cdd24-914b-7aec-81c0-c9916495114f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019cdd24-914b-7280-9761-30adfc40acdf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019cdd24-914b-7aec-81c0-c9916495114f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019cdd24-914b-7857-8429-fe9f81b1fada" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019cdd24-914b-7280-9761-30adfc40acdf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019cdd24-914b-7857-8429-fe9f81b1fada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019cdd24-914b-7dbd-bb99-b1c943ab6b06" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019cdd24-914b-7280-9761-30adfc40acdf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019cdd24-914b-7dbd-bb99-b1c943ab6b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_019cdd24-914b-73f0-8094-af6389a8ddd2" xlink:href="rnac-20260331.xsd#rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019cdd24-914b-7280-9761-30adfc40acdf" xlink:to="loc_rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_019cdd24-914b-73f0-8094-af6389a8ddd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019cdd24-914b-7d87-a586-60ce04d47d23" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019cdd24-914b-7280-9761-30adfc40acdf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019cdd24-914b-7d87-a586-60ce04d47d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019cdd24-914b-73c5-a847-42d72907dc19" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019cdd24-914b-7280-9761-30adfc40acdf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019cdd24-914b-73c5-a847-42d72907dc19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019cdd24-914b-7c43-a372-5187b202c921" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019cdd24-914b-7280-9761-30adfc40acdf" xlink:to="loc_us-gaap_OperatingLeaseLiability_019cdd24-914b-7c43-a372-5187b202c921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/LeasesScheduleofOtherInformationRelatedtoOperatingLeasesDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#LeasesScheduleofOtherInformationRelatedtoOperatingLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/LeasesScheduleofOtherInformationRelatedtoOperatingLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_019cdd24-914b-7170-acdd-aa46de707de8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_019dbeb9-403e-7629-af0c-cf4be80c7256" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019cdd24-914b-7170-acdd-aa46de707de8" xlink:to="loc_us-gaap_OperatingLeasePayments_019dbeb9-403e-7629-af0c-cf4be80c7256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_019cdd24-914b-7793-a3d8-e9a14f2421a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019cdd24-914b-7170-acdd-aa46de707de8" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_019cdd24-914b-7793-a3d8-e9a14f2421a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_019cdd24-914b-7f90-bea1-61981c559eba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019cdd24-914b-7170-acdd-aa46de707de8" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_019cdd24-914b-7f90-bea1-61981c559eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/EquityAttheMarketSalesAgreementNarrativeDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#EquityAttheMarketSalesAgreementNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/EquityAttheMarketSalesAgreementNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019cdd24-914b-7e7b-8b00-f93e222a6f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-793b-ae90-22f6652bd57d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019cdd24-914b-7e7b-8b00-f93e222a6f5c" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-793b-ae90-22f6652bd57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019cdd24-914b-7c9f-ae28-88b4d7f3e71d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-793b-ae90-22f6652bd57d" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019cdd24-914b-7c9f-ae28-88b4d7f3e71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cdd24-914b-745c-8aa8-a49072795ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019cdd24-914b-7c9f-ae28-88b4d7f3e71d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cdd24-914b-745c-8aa8-a49072795ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AtTheMarketOfferingMember_019cdd24-914b-79be-a00f-04a0c6289a0c" xlink:href="rnac-20260331.xsd#rnac_AtTheMarketOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cdd24-914b-745c-8aa8-a49072795ab6" xlink:to="loc_rnac_AtTheMarketOfferingMember_019cdd24-914b-79be-a00f-04a0c6289a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-7380-b29f-deaa0b64bbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-793b-ae90-22f6652bd57d" xlink:to="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-7380-b29f-deaa0b64bbb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_SaleOfStockAggregateMaximumGrossSalesProceeds_019cdd24-914b-7e30-bef4-d9b12f87d81e" xlink:href="rnac-20260331.xsd#rnac_SaleOfStockAggregateMaximumGrossSalesProceeds"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-7380-b29f-deaa0b64bbb4" xlink:to="loc_rnac_SaleOfStockAggregateMaximumGrossSalesProceeds_019cdd24-914b-7e30-bef4-d9b12f87d81e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019cdd24-914b-77a4-8b15-5e2985b2377b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-7380-b29f-deaa0b64bbb4" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019cdd24-914b-77a4-8b15-5e2985b2377b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019d1a96-097e-7ce5-95c4-e7cca26d0b69" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-7380-b29f-deaa0b64bbb4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019d1a96-097e-7ce5-95c4-e7cca26d0b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/EquityWarrantsNarrativeDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#EquityWarrantsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/EquityWarrantsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019cdd24-914b-70ee-84ae-4926d3168e52" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ClassOfWarrantOrRightOutstandingWarrantsIssued_019cdd24-914b-733a-8dbc-f8e70966336d" xlink:href="rnac-20260331.xsd#rnac_ClassOfWarrantOrRightOutstandingWarrantsIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019cdd24-914b-70ee-84ae-4926d3168e52" xlink:to="loc_rnac_ClassOfWarrantOrRightOutstandingWarrantsIssued_019cdd24-914b-733a-8dbc-f8e70966336d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ClassOfWarrantOrRightOutstandingWarrantsExercised_019cdd24-914b-76bb-987f-18422abae162" xlink:href="rnac-20260331.xsd#rnac_ClassOfWarrantOrRightOutstandingWarrantsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019cdd24-914b-70ee-84ae-4926d3168e52" xlink:to="loc_rnac_ClassOfWarrantOrRightOutstandingWarrantsExercised_019cdd24-914b-76bb-987f-18422abae162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ClassOfWarrantOrRightOutstandingWarrantsCancelled_019cdd24-914b-7c4a-93d2-7d8601bd8663" xlink:href="rnac-20260331.xsd#rnac_ClassOfWarrantOrRightOutstandingWarrantsCancelled"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019cdd24-914b-70ee-84ae-4926d3168e52" xlink:to="loc_rnac_ClassOfWarrantOrRightOutstandingWarrantsCancelled_019cdd24-914b-7c4a-93d2-7d8601bd8663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/EquityScheduleofWarrantyActivityDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#EquityScheduleofWarrantyActivityDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/EquityScheduleofWarrantyActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019cdd24-914b-76e5-bc88-ab934401c20f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_019cdd24-914b-7bab-baec-5baa0558c396" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019cdd24-914b-76e5-bc88-ab934401c20f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_019cdd24-914b-7bab-baec-5baa0558c396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914b-7d8c-8a97-8ca22e79e39e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019cdd24-914b-7bab-baec-5baa0558c396" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914b-7d8c-8a97-8ca22e79e39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019cdd24-914b-7fd6-aff4-b7ca99d23ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914b-7d8c-8a97-8ca22e79e39e" xlink:to="loc_us-gaap_EquityComponentDomain_019cdd24-914b-7fd6-aff4-b7ca99d23ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_019cdd24-914b-7ad3-95fe-7db1f30697f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019cdd24-914b-7fd6-aff4-b7ca99d23ec7" xlink:to="loc_us-gaap_WarrantMember_019cdd24-914b-7ad3-95fe-7db1f30697f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_019cdd24-914b-7322-9419-7dd593743ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019cdd24-914b-7bab-baec-5baa0558c396" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_019cdd24-914b-7322-9419-7dd593743ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019cdd24-914b-7800-9ec5-348e465317a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_019cdd24-914b-7322-9419-7dd593743ab6" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019cdd24-914b-7800-9ec5-348e465317a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_019cdd24-914b-7b94-9d0a-a3b467a74169" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019cdd24-914b-7800-9ec5-348e465317a7" xlink:to="loc_us-gaap_WarrantMember_019cdd24-914b-7b94-9d0a-a3b467a74169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_019cdd24-914b-7b5e-b890-d82c611e561e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019cdd24-914b-7bab-baec-5baa0558c396" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_019cdd24-914b-7b5e-b890-d82c611e561e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ClassOfWarrantOrRightRollForward_019cdd24-914b-7a24-98cb-45e2b4cef143" xlink:href="rnac-20260331.xsd#rnac_ClassOfWarrantOrRightRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019cdd24-914b-7b5e-b890-d82c611e561e" xlink:to="loc_rnac_ClassOfWarrantOrRightRollForward_019cdd24-914b-7a24-98cb-45e2b4cef143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019cdd24-914b-705d-bb46-f1386b7b9461" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rnac_ClassOfWarrantOrRightRollForward_019cdd24-914b-7a24-98cb-45e2b4cef143" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019cdd24-914b-705d-bb46-f1386b7b9461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_019cdd24-914b-7f34-ac2a-e77cf5b842fb" xlink:href="rnac-20260331.xsd#rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019cdd24-914b-7b5e-b890-d82c611e561e" xlink:to="loc_rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_019cdd24-914b-7f34-ac2a-e77cf5b842fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019cdd24-914b-75b9-ae70-67765aa49d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_019cdd24-914b-7f34-ac2a-e77cf5b842fb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019cdd24-914b-75b9-ae70-67765aa49d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/EquityPreferredStockNarrativeDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#EquityPreferredStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/EquityPreferredStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019cdd24-914b-7840-a396-e21672a7ee33" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-76b5-9ae8-8898b12c28ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019cdd24-914b-7840-a396-e21672a7ee33" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-76b5-9ae8-8898b12c28ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914b-702e-8ceb-78eaa51af6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-76b5-9ae8-8898b12c28ef" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914b-702e-8ceb-78eaa51af6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cdd24-914b-7be8-9d8d-7a12a25ee1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cdd24-914b-702e-8ceb-78eaa51af6e5" xlink:to="loc_us-gaap_ClassOfStockDomain_019cdd24-914b-7be8-9d8d-7a12a25ee1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-914b-7b94-853d-644d2d02482e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019cdd24-914b-7be8-9d8d-7a12a25ee1c8" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-914b-7b94-853d-644d2d02482e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-914b-7a07-ac00-26567d2fdd7c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019cdd24-914b-7be8-9d8d-7a12a25ee1c8" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-914b-7a07-ac00-26567d2fdd7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-7e00-b82d-a5231224ef49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-76b5-9ae8-8898b12c28ef" xlink:to="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-7e00-b82d-a5231224ef49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_019cdd24-914b-75ea-addf-777a34e7250b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-7e00-b82d-a5231224ef49" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_019cdd24-914b-75ea-addf-777a34e7250b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_019cdd24-914b-7e3f-8771-a6d299b8eddc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-7e00-b82d-a5231224ef49" xlink:to="loc_us-gaap_PreferredStockSharesIssued_019cdd24-914b-7e3f-8771-a6d299b8eddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleSharesIssuable_019cdd24-914b-7772-b363-ec75f40126b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockConvertibleSharesIssuable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-7e00-b82d-a5231224ef49" xlink:to="loc_us-gaap_PreferredStockConvertibleSharesIssuable_019cdd24-914b-7772-b363-ec75f40126b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019cdd24-914b-71b9-a8aa-6ff64fad3998" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-7486-b35f-47ee6b57cd80" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019cdd24-914b-71b9-a8aa-6ff64fad3998" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-7486-b35f-47ee6b57cd80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914b-7702-b5dd-0f552860e787" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-7486-b35f-47ee6b57cd80" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914b-7702-b5dd-0f552860e787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019cdd24-914b-758e-a6ef-9133864fdc75" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019cdd24-914b-7702-b5dd-0f552860e787" xlink:to="loc_us-gaap_EquityComponentDomain_019cdd24-914b-758e-a6ef-9133864fdc75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_019cdd24-914b-70a4-90c5-faa6dc71b2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019cdd24-914b-758e-a6ef-9133864fdc75" xlink:to="loc_us-gaap_WarrantMember_019cdd24-914b-70a4-90c5-faa6dc71b2ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019cdd24-914b-717a-bc20-16c35c8853fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-7486-b35f-47ee6b57cd80" xlink:to="loc_us-gaap_AwardTypeAxis_019cdd24-914b-717a-bc20-16c35c8853fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-914b-7d57-a072-506b1a96492d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019cdd24-914b-717a-bc20-16c35c8853fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-914b-7d57-a072-506b1a96492d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_019cdd24-914b-74e4-846c-bbe924ba0a10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-914b-7d57-a072-506b1a96492d" xlink:to="loc_us-gaap_StockCompensationPlanMember_019cdd24-914b-74e4-846c-bbe924ba0a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_RestrictedStockUnitsUnvestedMember_019cdd24-914b-7860-a465-562474420b82" xlink:href="rnac-20260331.xsd#rnac_RestrictedStockUnitsUnvestedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-914b-7d57-a072-506b1a96492d" xlink:to="loc_rnac_RestrictedStockUnitsUnvestedMember_019cdd24-914b-7860-a465-562474420b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019cdd24-914b-7c81-a1c1-261e48d99733" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-914b-7d57-a072-506b1a96492d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019cdd24-914b-7c81-a1c1-261e48d99733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-914b-7929-83ab-40aecb8bf7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-914b-7d57-a072-506b1a96492d" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_019cdd24-914b-7929-83ab-40aecb8bf7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-914b-7b89-9f21-344476ae62c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-914b-7d57-a072-506b1a96492d" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_019cdd24-914b-7b89-9f21-344476ae62c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-784c-bea8-787c1e30117a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cdd24-914b-7486-b35f-47ee6b57cd80" xlink:to="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-784c-bea8-787c1e30117a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019cdd24-914b-765a-96a4-f850a9cfafec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cdd24-914b-784c-bea8-787c1e30117a" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019cdd24-914b-765a-96a4-f850a9cfafec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#StockIncentivePlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019cdd24-9220-766a-a420-47c20f86cba1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-743c-a552-91a5826cdf95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019cdd24-9220-766a-a420-47c20f86cba1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-743c-a552-91a5826cdf95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019d87c1-d1d5-760d-9f67-a38191ba3162" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-743c-a552-91a5826cdf95" xlink:to="loc_us-gaap_PlanNameAxis_019d87c1-d1d5-760d-9f67-a38191ba3162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019d87c1-d1d5-7b8a-82c8-4306195d03e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_019d87c1-d1d5-760d-9f67-a38191ba3162" xlink:to="loc_us-gaap_PlanNameDomain_019d87c1-d1d5-7b8a-82c8-4306195d03e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_StockIncentivePlan2016Member_019d87c1-d1d5-715d-8de5-4bf23a720f57" xlink:href="rnac-20260331.xsd#rnac_StockIncentivePlan2016Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019d87c1-d1d5-7b8a-82c8-4306195d03e6" xlink:to="loc_rnac_StockIncentivePlan2016Member_019d87c1-d1d5-715d-8de5-4bf23a720f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_EmploymentInducementIncentiveAwardPlanMember_019d87c1-d1d5-791c-aebf-4c58dd7dc9ce" xlink:href="rnac-20260331.xsd#rnac_EmploymentInducementIncentiveAwardPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019d87c1-d1d5-7b8a-82c8-4306195d03e6" xlink:to="loc_rnac_EmploymentInducementIncentiveAwardPlanMember_019d87c1-d1d5-791c-aebf-4c58dd7dc9ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_OldCartesianPlanMember_019d87c1-d1d5-7321-8f62-cb9398934517" xlink:href="rnac-20260331.xsd#rnac_OldCartesianPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019d87c1-d1d5-7b8a-82c8-4306195d03e6" xlink:to="loc_rnac_OldCartesianPlanMember_019d87c1-d1d5-7321-8f62-cb9398934517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_019d87c1-d1d5-7ca8-8170-942d9daf1e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-743c-a552-91a5826cdf95" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_019d87c1-d1d5-7ca8-8170-942d9daf1e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d87c1-d1d5-77fe-a87c-562993b644e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_019d87c1-d1d5-7ca8-8170-942d9daf1e3c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d87c1-d1d5-77fe-a87c-562993b644e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_OldCartestianMember_019d87c1-d1d5-7f4e-8961-5a7214a7d758" xlink:href="rnac-20260331.xsd#rnac_OldCartestianMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019d87c1-d1d5-77fe-a87c-562993b644e0" xlink:to="loc_rnac_OldCartestianMember_019d87c1-d1d5-7f4e-8961-5a7214a7d758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019d87c1-d1d5-7a50-90c3-fb98e376d8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-743c-a552-91a5826cdf95" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019d87c1-d1d5-7a50-90c3-fb98e376d8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019d87c1-d1d5-7175-a39a-95d75242e57c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019d87c1-d1d5-7a50-90c3-fb98e376d8e9" xlink:to="loc_us-gaap_EquityComponentDomain_019d87c1-d1d5-7175-a39a-95d75242e57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019d87c1-d1d5-7f73-b7b2-778e90c85a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019d87c1-d1d5-7175-a39a-95d75242e57c" xlink:to="loc_us-gaap_CommonStockMember_019d87c1-d1d5-7f73-b7b2-778e90c85a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_019d87c1-d1d5-71c3-93a0-251ff37fb9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019d87c1-d1d5-7175-a39a-95d75242e57c" xlink:to="loc_us-gaap_PreferredStockMember_019d87c1-d1d5-71c3-93a0-251ff37fb9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019d87c2-0607-703b-8205-0c56138c20ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-743c-a552-91a5826cdf95" xlink:to="loc_us-gaap_AwardTypeAxis_019d87c2-0607-703b-8205-0c56138c20ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d87c2-0607-7318-a25e-d1093cb495ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019d87c2-0607-703b-8205-0c56138c20ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d87c2-0607-7318-a25e-d1093cb495ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019d87c2-0607-7c40-91bb-2c769a4a117f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d87c2-0607-7318-a25e-d1093cb495ca" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019d87c2-0607-7c40-91bb-2c769a4a117f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019d87c2-2105-783b-ac67-4dbded613e26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d87c2-0607-7318-a25e-d1093cb495ca" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019d87c2-2105-783b-ac67-4dbded613e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-743c-a552-91a5826cdf95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019d87c1-d1d5-7abb-adfd-dba6096bb20e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019d87c1-d1d5-7abb-adfd-dba6096bb20e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease_019d87c1-d1d5-78b3-ae3c-e26041331ffd" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease_019d87c1-d1d5-78b3-ae3c-e26041331ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019d87c1-d1d5-7e65-b4d8-3df024c55c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019d87c1-d1d5-7e65-b4d8-3df024c55c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019d87c1-d1d5-783a-82e7-1f1d1205b01d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019d87c1-d1d5-783a-82e7-1f1d1205b01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019d87c1-d1d5-79f4-9265-ed6c0b4ad4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019d87c1-d1d5-79f4-9265-ed6c0b4ad4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019d87c1-d1d5-7b28-af0a-d612ff4343f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019d87c1-d1d5-7b28-af0a-d612ff4343f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019d87c1-d1d5-7173-bee6-2b49914b2015" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019d87c1-d1d5-7173-bee6-2b49914b2015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019d87c1-ebb4-7245-9e3b-d9f8c0f7046a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019d87c1-ebb4-7245-9e3b-d9f8c0f7046a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019d87c2-0607-77ec-9837-10979c0cbfe0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019d87c2-0607-77ec-9837-10979c0cbfe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019d87c2-0607-7125-b43e-0cbad5d5709e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019d87c2-0607-7125-b43e-0cbad5d5709e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019d87c2-2105-7ad6-b9d3-9d77cee58b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019d87c2-2105-7ad6-b9d3-9d77cee58b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019d87c2-2105-77a4-a984-7a2968449d98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019d87c2-2105-77a4-a984-7a2968449d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate_019d87c2-2105-78fe-841b-36dfb32c34e4" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate_019d87c2-2105-78fe-841b-36dfb32c34e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_019d87c2-2105-7a9e-8362-77adbcb714cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d87c1-d1d5-7ed4-92ba-3ad029412a85" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_019d87c2-2105-7a9e-8362-77adbcb714cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#StockIncentivePlansScheduleofStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019cdd24-9220-7d3c-bce3-175f1c74df46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019cdd24-9220-7566-abde-6741c9060405" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019cdd24-9220-7d3c-bce3-175f1c74df46" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019cdd24-9220-7566-abde-6741c9060405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_019cdd24-9220-7d34-b901-57d0daaa3e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019cdd24-9220-7566-abde-6741c9060405" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_019cdd24-9220-7d34-b901-57d0daaa3e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_019cdd24-9220-7478-9b22-da5e83af5e51" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_019cdd24-9220-7d34-b901-57d0daaa3e8c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_019cdd24-9220-7478-9b22-da5e83af5e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_019cdd24-9220-72a9-875d-a0265229454c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019cdd24-9220-7478-9b22-da5e83af5e51" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_019cdd24-9220-72a9-875d-a0265229454c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_019cdd24-9220-79c6-bd81-a476a6c0b592" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019cdd24-9220-7478-9b22-da5e83af5e51" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_019cdd24-9220-79c6-bd81-a476a6c0b592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019cdd24-9220-773f-ba71-a4ee67073414" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019cdd24-9220-7566-abde-6741c9060405" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019cdd24-9220-773f-ba71-a4ee67073414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019cdd24-9220-7cd1-8bc1-af7a6f9be510" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019cdd24-9220-773f-ba71-a4ee67073414" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019cdd24-9220-7cd1-8bc1-af7a6f9be510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofWeightedAverageAssumptionsUsedDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#StockIncentivePlansScheduleofWeightedAverageAssumptionsUsedDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofWeightedAverageAssumptionsUsedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019cdd24-9220-7e89-80bf-10d296765d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-70dd-a15a-48c0a8b92292" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019cdd24-9220-7e89-80bf-10d296765d9c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-70dd-a15a-48c0a8b92292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019cdd24-9220-7acf-a356-f9606b125e90" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-70dd-a15a-48c0a8b92292" xlink:to="loc_us-gaap_AwardTypeAxis_019cdd24-9220-7acf-a356-f9606b125e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-9220-7792-9f0e-d7c8e29c18ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019cdd24-9220-7acf-a356-f9606b125e90" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-9220-7792-9f0e-d7c8e29c18ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019cdd24-9220-77c3-b134-d23b33917fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-9220-7792-9f0e-d7c8e29c18ea" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019cdd24-9220-77c3-b134-d23b33917fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7ac1-815f-71f715ec37e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-70dd-a15a-48c0a8b92292" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7ac1-815f-71f715ec37e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_019cdd24-9220-7c3c-bf80-6c91d1f5f2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7ac1-815f-71f715ec37e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_019cdd24-9220-7c3c-bf80-6c91d1f5f2e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019cdd24-9220-7ac0-8d0c-d55374208c48" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7ac1-815f-71f715ec37e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019cdd24-9220-7ac0-8d0c-d55374208c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019cdd24-9220-775d-8e49-8f014da22a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7ac1-815f-71f715ec37e5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019cdd24-9220-775d-8e49-8f014da22a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_019cdd24-9220-78b1-b3b2-1f7e0c23cb04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7ac1-815f-71f715ec37e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_019cdd24-9220-78b1-b3b2-1f7e0c23cb04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue_019cdd24-9220-75d4-8c0a-ceffd5f5331c" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7ac1-815f-71f715ec37e5" xlink:to="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue_019cdd24-9220-75d4-8c0a-ceffd5f5331c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#StockIncentivePlansScheduleofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019cdd24-9220-71d6-98d2-abe16c19e9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-7f5c-a8b8-87f3c06b487b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019cdd24-9220-71d6-98d2-abe16c19e9ec" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-7f5c-a8b8-87f3c06b487b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019cdd24-9220-74d5-9494-b4695d97924d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-7f5c-a8b8-87f3c06b487b" xlink:to="loc_us-gaap_PlanNameAxis_019cdd24-9220-74d5-9494-b4695d97924d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019cdd24-9220-73e2-85f4-65a5a67f0bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_019cdd24-9220-74d5-9494-b4695d97924d" xlink:to="loc_us-gaap_PlanNameDomain_019cdd24-9220-73e2-85f4-65a5a67f0bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember_019cdd24-9220-7b86-a59d-bbbb25e10a93" xlink:href="rnac-20260331.xsd#rnac_A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019cdd24-9220-73e2-85f4-65a5a67f0bbf" xlink:to="loc_rnac_A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember_019cdd24-9220-7b86-a59d-bbbb25e10a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7603-9dfd-627e925539c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-7f5c-a8b8-87f3c06b487b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7603-9dfd-627e925539c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019cdd24-9220-7784-8a63-30086f92adc2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7603-9dfd-627e925539c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019cdd24-9220-7784-8a63-30086f92adc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019cdd24-9220-73c9-9210-22d311409e26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019cdd24-9220-7784-8a63-30086f92adc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019cdd24-9220-73c9-9210-22d311409e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019cdd24-9220-7e23-a5e1-94c2beb7061a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019cdd24-9220-7784-8a63-30086f92adc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019cdd24-9220-7e23-a5e1-94c2beb7061a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019cdd24-9220-73ff-b8f1-bd9be7ffedac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019cdd24-9220-7784-8a63-30086f92adc2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019cdd24-9220-73ff-b8f1-bd9be7ffedac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_019cdd24-9220-7871-8b2f-35ee125ba2f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019cdd24-9220-7784-8a63-30086f92adc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_019cdd24-9220-7871-8b2f-35ee125ba2f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019cdd24-9220-7b77-b8aa-362ae0ccd03d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019cdd24-9220-7784-8a63-30086f92adc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019cdd24-9220-7b77-b8aa-362ae0ccd03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_019cdd24-9220-71ad-9184-f7f614f60a55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7603-9dfd-627e925539c2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_019cdd24-9220-71ad-9184-f7f614f60a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_019cdd24-9220-7a2f-bfad-b3283e5bef4e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7603-9dfd-627e925539c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_019cdd24-9220-7a2f-bfad-b3283e5bef4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019cdd24-9220-7264-a4b6-1dfea72df327" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7603-9dfd-627e925539c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019cdd24-9220-7264-a4b6-1dfea72df327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019cdd24-9220-755c-ae72-db44062ab7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019cdd24-9220-7264-a4b6-1dfea72df327" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019cdd24-9220-755c-ae72-db44062ab7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019cdd24-9220-72e2-8a46-bb8db8d4860d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019cdd24-9220-7264-a4b6-1dfea72df327" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019cdd24-9220-72e2-8a46-bb8db8d4860d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019cdd24-9220-7905-8d74-f02e015a5052" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019cdd24-9220-7264-a4b6-1dfea72df327" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019cdd24-9220-7905-8d74-f02e015a5052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_019cdd24-9220-7df1-9809-117cadb6ebf0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019cdd24-9220-7264-a4b6-1dfea72df327" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_019cdd24-9220-7df1-9809-117cadb6ebf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019cdd24-9220-70a8-8c14-e2a9938527ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019cdd24-9220-7264-a4b6-1dfea72df327" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019cdd24-9220-70a8-8c14-e2a9938527ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice_019cdd24-9220-7e2b-ad88-5df329af92d3" xlink:href="rnac-20260331.xsd#rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7603-9dfd-627e925539c2" xlink:to="loc_rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice_019cdd24-9220-7e2b-ad88-5df329af92d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_019cdd24-9220-75b5-8968-6d4d62dd92cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7603-9dfd-627e925539c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_019cdd24-9220-75b5-8968-6d4d62dd92cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_019cdd24-9220-7dd1-9456-e5005f7a479a" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7603-9dfd-627e925539c2" xlink:to="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_019cdd24-9220-7dd1-9456-e5005f7a479a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_019cdd24-9220-754e-8e69-efd07c9aaf6f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_019cdd24-9220-7dd1-9456-e5005f7a479a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_019cdd24-9220-754e-8e69-efd07c9aaf6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm_019cdd24-9220-72d7-8caf-392eac6a9b7a" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_019cdd24-9220-7dd1-9456-e5005f7a479a" xlink:to="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm_019cdd24-9220-72d7-8caf-392eac6a9b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_019cdd24-9220-7a3a-98d7-2ed61249da62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_019cdd24-9220-7dd1-9456-e5005f7a479a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_019cdd24-9220-7a3a-98d7-2ed61249da62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract_019cdd24-9220-7bbb-859f-a81dc66a9987" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-7603-9dfd-627e925539c2" xlink:to="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract_019cdd24-9220-7bbb-859f-a81dc66a9987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_019cdd24-9220-7c15-8135-82656388bffd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract_019cdd24-9220-7bbb-859f-a81dc66a9987" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_019cdd24-9220-7c15-8135-82656388bffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue_019cdd24-9220-7567-9a11-fa15c374baea" xlink:href="rnac-20260331.xsd#rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract_019cdd24-9220-7bbb-859f-a81dc66a9987" xlink:to="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue_019cdd24-9220-7567-9a11-fa15c374baea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_019cdd24-9220-7850-9361-924c83c62623" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract_019cdd24-9220-7bbb-859f-a81dc66a9987" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_019cdd24-9220-7850-9361-924c83c62623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019cdd24-9220-7b07-8241-5ebce06397cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-78af-bf70-058b4434a33b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019cdd24-9220-7b07-8241-5ebce06397cb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-78af-bf70-058b4434a33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019cdd24-9220-75fd-a024-d7b97be6a6cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-78af-bf70-058b4434a33b" xlink:to="loc_us-gaap_AwardTypeAxis_019cdd24-9220-75fd-a024-d7b97be6a6cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-9220-7fe3-a599-0017d2465314" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019cdd24-9220-75fd-a024-d7b97be6a6cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-9220-7fe3-a599-0017d2465314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019cdd24-9220-7bf9-88a6-7eb7d4693975" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019cdd24-9220-7fe3-a599-0017d2465314" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019cdd24-9220-7bf9-88a6-7eb7d4693975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-781f-9e77-a77122f2c86a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019cdd24-9220-78af-bf70-058b4434a33b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-781f-9e77-a77122f2c86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019cdd24-9220-70fb-b3cf-dda8d41daa62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-781f-9e77-a77122f2c86a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019cdd24-9220-70fb-b3cf-dda8d41daa62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019cdd24-9220-7f17-909e-5f791afa0b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019cdd24-9220-70fb-b3cf-dda8d41daa62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019cdd24-9220-7f17-909e-5f791afa0b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019cdd24-9220-735e-a869-1ee0128e52fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019cdd24-9220-70fb-b3cf-dda8d41daa62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019cdd24-9220-735e-a869-1ee0128e52fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_019cdd24-9220-7b9f-9aa0-c799e3488782" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019cdd24-9220-70fb-b3cf-dda8d41daa62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_019cdd24-9220-7b9f-9aa0-c799e3488782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019cdd24-9220-79d5-82b9-18a54ca9a03a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019cdd24-9220-70fb-b3cf-dda8d41daa62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019cdd24-9220-79d5-82b9-18a54ca9a03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019cdd24-9220-76ee-88fb-3202e7a41fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019cdd24-9220-70fb-b3cf-dda8d41daa62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019cdd24-9220-76ee-88fb-3202e7a41fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019cdd24-9220-7ea1-9a43-c2efa7187b72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019cdd24-9220-781f-9e77-a77122f2c86a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019cdd24-9220-7ea1-9a43-c2efa7187b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019cdd24-9220-71af-b109-a8ab8a080a91" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019cdd24-9220-7ea1-9a43-c2efa7187b72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019cdd24-9220-71af-b109-a8ab8a080a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019cdd24-9220-7bec-84dc-56a4ecec580b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019cdd24-9220-7ea1-9a43-c2efa7187b72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019cdd24-9220-7bec-84dc-56a4ecec580b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_019cdd24-9220-7d2a-b6a2-44112dc6814d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019cdd24-9220-7ea1-9a43-c2efa7187b72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_019cdd24-9220-7d2a-b6a2-44112dc6814d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019cdd24-9220-7b06-a038-4b8205c8acee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019cdd24-9220-7ea1-9a43-c2efa7187b72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019cdd24-9220-7b06-a038-4b8205c8acee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019cdd24-9220-723b-884c-f680ccb09908" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019cdd24-9220-7ea1-9a43-c2efa7187b72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019cdd24-9220-723b-884c-f680ccb09908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#RevenueArrangementsDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019cdd24-9220-7b37-bd3e-8eb370c2fc50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_019cdd24-9220-7d5b-b243-b095921301bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019cdd24-9220-7b37-bd3e-8eb370c2fc50" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_019cdd24-9220-7d5b-b243-b095921301bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_019d1ac9-ed54-714d-9e0b-eb21746c4a9f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019cdd24-9220-7d5b-b243-b095921301bc" xlink:to="loc_srt_CounterpartyNameAxis_019d1ac9-ed54-714d-9e0b-eb21746c4a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d1ac9-ed54-77f6-a443-1e77338556b7" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_019d1ac9-ed54-714d-9e0b-eb21746c4a9f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d1ac9-ed54-77f6-a443-1e77338556b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_SwedishOrphanBiovitrumABSOBIMember_019d1ac9-ed54-7ac5-ae29-04d47baa9500" xlink:href="rnac-20260331.xsd#rnac_SwedishOrphanBiovitrumABSOBIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d1ac9-ed54-77f6-a443-1e77338556b7" xlink:to="loc_rnac_SwedishOrphanBiovitrumABSOBIMember_019d1ac9-ed54-7ac5-ae29-04d47baa9500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019d1ac9-ed54-71d3-a71d-f376f8bdd2db" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019cdd24-9220-7d5b-b243-b095921301bc" xlink:to="loc_srt_ProductOrServiceAxis_019d1ac9-ed54-71d3-a71d-f376f8bdd2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019d1ac9-ed54-7305-8f28-d76be57c21ce" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_019d1ac9-ed54-71d3-a71d-f376f8bdd2db" xlink:to="loc_srt_ProductsAndServicesDomain_019d1ac9-ed54-7305-8f28-d76be57c21ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_019d1ac9-ed54-708d-b358-effb114a4b24" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LicenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019d1ac9-ed54-7305-8f28-d76be57c21ce" xlink:to="loc_us-gaap_LicenseMember_019d1ac9-ed54-708d-b358-effb114a4b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceTypeAxis_019d1aca-0ea9-7828-b5f3-46c561e6b468" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019cdd24-9220-7d5b-b243-b095921301bc" xlink:to="loc_us-gaap_GovernmentAssistanceTypeAxis_019d1aca-0ea9-7828-b5f3-46c561e6b468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceTypeDomain_019d1aca-0ea9-7844-850c-90737f66c4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GovernmentAssistanceTypeAxis_019d1aca-0ea9-7828-b5f3-46c561e6b468" xlink:to="loc_us-gaap_GovernmentAssistanceTypeDomain_019d1aca-0ea9-7844-850c-90737f66c4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember_019d1aca-0ea9-7f8f-9024-85eb6cd09943" xlink:href="rnac-20260331.xsd#rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GovernmentAssistanceTypeDomain_019d1aca-0ea9-7844-850c-90737f66c4f4" xlink:to="loc_rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember_019d1aca-0ea9-7f8f-9024-85eb6cd09943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019cdd24-9220-7d5b-b243-b095921301bc" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_019d1ac9-ed54-70ee-b5ff-9040dbaefe01" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:to="loc_us-gaap_ContractWithCustomerLiability_019d1ac9-ed54-70ee-b5ff-9040dbaefe01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount_019d1ac9-ed54-7596-9681-51876182945a" xlink:href="rnac-20260331.xsd#rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:to="loc_rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount_019d1ac9-ed54-7596-9681-51876182945a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_019d1aca-0ea9-7c4d-bc57-b6ac25ad68d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_019d1aca-0ea9-7c4d-bc57-b6ac25ad68d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceAwardAmount_019d1aca-0ea9-7019-b5ba-515f3ffcce6d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceAwardAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:to="loc_us-gaap_GovernmentAssistanceAwardAmount_019d1aca-0ea9-7019-b5ba-515f3ffcce6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_GovernmentAssistancePotentialAdditionalAwardAmount_019d1aca-0ea9-7316-a8ab-5eb37ff8a587" xlink:href="rnac-20260331.xsd#rnac_GovernmentAssistancePotentialAdditionalAwardAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:to="loc_rnac_GovernmentAssistancePotentialAdditionalAwardAmount_019d1aca-0ea9-7316-a8ab-5eb37ff8a587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_019d1b0d-f4b6-7732-8754-c95470eb4e75" xlink:href="rnac-20260331.xsd#rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:to="loc_rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_019d1b0d-f4b6-7732-8754-c95470eb4e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceAmountCumulativeCurrent_019d1aca-0ea9-797e-8204-fa0cfe648aed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GovernmentAssistanceAmountCumulativeCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:to="loc_us-gaap_GovernmentAssistanceAmountCumulativeCurrent_019d1aca-0ea9-797e-8204-fa0cfe648aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_019d1aca-0ea9-701d-8a26-7bb6948bb80b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_019d1aca-0ea9-701d-8a26-7bb6948bb80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_019d1aca-0ea9-74df-bd81-4455ceb5fbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d1ac9-ed54-7004-9e0c-cb33cb4a5273" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_019d1aca-0ea9-74df-bd81-4455ceb5fbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsBiogenMAIncNarrativeDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#CollaborationandLicenseAgreementsBiogenMAIncNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsBiogenMAIncNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019cdd24-9220-79b8-b9a9-2dbaa787e6ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-78d8-87a1-5b886df85b20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019cdd24-9220-79b8-b9a9-2dbaa787e6ad" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-78d8-87a1-5b886df85b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-7874-b931-6d507c8f6c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-78d8-87a1-5b886df85b20" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-7874-b931-6d507c8f6c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-7894-b3cd-0b9c4e412687" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-7874-b931-6d507c8f6c4f" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-7894-b3cd-0b9c4e412687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_BiogenM.A.Inc.Member_019cdd24-9220-7861-b4ff-5f8f61dd87a0" xlink:href="rnac-20260331.xsd#rnac_BiogenM.A.Inc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-7894-b3cd-0b9c4e412687" xlink:to="loc_rnac_BiogenM.A.Inc.Member_019cdd24-9220-7861-b4ff-5f8f61dd87a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-72ac-a0ee-6b8d23e4e0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-78d8-87a1-5b886df85b20" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-72ac-a0ee-6b8d23e4e0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination_019cdd24-9220-7396-9ce2-e1e903758e28" xlink:href="rnac-20260331.xsd#rnac_CollaborativeArrangementWrittenNoticePeriodForTermination"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-72ac-a0ee-6b8d23e4e0b1" xlink:to="loc_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination_019cdd24-9220-7396-9ce2-e1e903758e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsNationalCancerInstituteoftheNationalInstitutesofHealthNarrativeDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#CollaborationandLicenseAgreementsNationalCancerInstituteoftheNationalInstitutesofHealthNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsNationalCancerInstituteoftheNationalInstitutesofHealthNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019cdd24-9220-79cf-a070-083fa0482b11" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-728d-9597-ee0ae4aa8ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019cdd24-9220-79cf-a070-083fa0482b11" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-728d-9597-ee0ae4aa8ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-7724-9178-721db081b92f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-728d-9597-ee0ae4aa8ecf" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-7724-9178-721db081b92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-7bd6-9502-e380652a4aef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-7724-9178-721db081b92f" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-7bd6-9502-e380652a4aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_NationalCancerInstituteAgreementMember_019cdd24-9220-7922-96e8-4867ff07fc16" xlink:href="rnac-20260331.xsd#rnac_NationalCancerInstituteAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-7bd6-9502-e380652a4aef" xlink:to="loc_rnac_NationalCancerInstituteAgreementMember_019cdd24-9220-7922-96e8-4867ff07fc16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-77e4-806f-a3ca2cedd749" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-728d-9597-ee0ae4aa8ecf" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-77e4-806f-a3ca2cedd749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LicenseAndOptionAgreementRoyaltyPayment_019cdd24-9220-721b-8956-d324770ac681" xlink:href="rnac-20260331.xsd#rnac_LicenseAndOptionAgreementRoyaltyPayment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-77e4-806f-a3ca2cedd749" xlink:to="loc_rnac_LicenseAndOptionAgreementRoyaltyPayment_019cdd24-9220-721b-8956-d324770ac681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum_019cdd24-9220-753e-b7de-277ff32bb1a9" xlink:href="rnac-20260331.xsd#rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-77e4-806f-a3ca2cedd749" xlink:to="loc_rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum_019cdd24-9220-753e-b7de-277ff32bb1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination_019cdd24-9220-76f2-93af-9903153881b5" xlink:href="rnac-20260331.xsd#rnac_CollaborativeArrangementWrittenNoticePeriodForTermination"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-77e4-806f-a3ca2cedd749" xlink:to="loc_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination_019cdd24-9220-76f2-93af-9903153881b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsShenyangSunshinePharmaceuticalCoLtdNarrativeDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#CollaborationandLicenseAgreementsShenyangSunshinePharmaceuticalCoLtdNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsShenyangSunshinePharmaceuticalCoLtdNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019cdd24-9220-716d-8c0a-7a40d8bdef98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-7629-a611-cc624c71b4ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019cdd24-9220-716d-8c0a-7a40d8bdef98" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-7629-a611-cc624c71b4ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-76d1-b725-701f1174a4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-7629-a611-cc624c71b4ee" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-76d1-b725-701f1174a4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-72fa-813c-60b798a07e87" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019cdd24-9220-76d1-b725-701f1174a4dc" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-72fa-813c-60b798a07e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember_019cdd24-9220-74a5-ae66-f214dc8ca41c" xlink:href="rnac-20260331.xsd#rnac_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019cdd24-9220-72fa-813c-60b798a07e87" xlink:to="loc_rnac_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember_019cdd24-9220-74a5-ae66-f214dc8ca41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-777b-b29b-1ef3fb17eecc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019cdd24-9220-7629-a611-cc624c71b4ee" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-777b-b29b-1ef3fb17eecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid_019cdd24-9220-70ec-85f1-bc7af4aff7a4" xlink:href="rnac-20260331.xsd#rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-777b-b29b-1ef3fb17eecc" xlink:to="loc_rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid_019cdd24-9220-70ec-85f1-bc7af4aff7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform_019cdd24-9220-712d-9ecc-d7856675031d" xlink:href="rnac-20260331.xsd#rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019cdd24-9220-777b-b29b-1ef3fb17eecc" xlink:to="loc_rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform_019cdd24-9220-712d-9ecc-d7856675031d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#SegmentReportingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/SegmentReportingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019d1b18-bda5-76bc-9001-a70922f5f25f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_019d1b0f-4ccd-77c3-941c-870c08710c21" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019d1b18-bda5-76bc-9001-a70922f5f25f" xlink:to="loc_us-gaap_NumberOfOperatingSegments_019d1b0f-4ccd-77c3-941c-870c08710c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_NumberOfReportableSegmentsNotDisclosedFlag_019d1b18-bda5-7161-aab8-68d6166b919c" xlink:href="rnac-20260331.xsd#rnac_NumberOfReportableSegmentsNotDisclosedFlag"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019d1b18-bda5-76bc-9001-a70922f5f25f" xlink:to="loc_rnac_NumberOfReportableSegmentsNotDisclosedFlag_019d1b18-bda5-7161-aab8-68d6166b919c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="simple" xlink:href="rnac-20260331.xsd#SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019cdd24-9220-7607-9522-023689004a72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019cdd24-9220-7632-94ca-11d0a6ccc70d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019cdd24-9220-7607-9522-023689004a72" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019cdd24-9220-7632-94ca-11d0a6ccc70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_019cdd24-9220-70dd-8d7c-996ec5a7906f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019cdd24-9220-7632-94ca-11d0a6ccc70d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_019cdd24-9220-70dd-8d7c-996ec5a7906f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_019cdd24-9220-7516-bf0f-16e554ef8104" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_019cdd24-9220-70dd-8d7c-996ec5a7906f" xlink:to="loc_us-gaap_SegmentDomain_019cdd24-9220-7516-bf0f-16e554ef8104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_OperatingSegmentMember_019cdd24-9220-7da1-a32a-fcdd988b0e42" xlink:href="rnac-20260331.xsd#rnac_OperatingSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_019cdd24-9220-7516-bf0f-16e554ef8104" xlink:to="loc_rnac_OperatingSegmentMember_019cdd24-9220-7da1-a32a-fcdd988b0e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_019cdd24-9220-7f4f-9e21-d39aeef406dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019cdd24-9220-7632-94ca-11d0a6ccc70d" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_019cdd24-9220-7f4f-9e21-d39aeef406dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_019cdd24-9221-7c70-badb-82e2e3d966a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_019cdd24-9220-7f4f-9e21-d39aeef406dd" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_019cdd24-9221-7c70-badb-82e2e3d966a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_Descartes08ForMGMember_019cdd24-9221-7a2c-8346-d0c72ae99df0" xlink:href="rnac-20260331.xsd#rnac_Descartes08ForMGMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_019cdd24-9221-7c70-badb-82e2e3d966a4" xlink:to="loc_rnac_Descartes08ForMGMember_019cdd24-9221-7a2c-8346-d0c72ae99df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_Descartes08ForDermatomyositisMember_019d9b54-fe1c-7e40-b509-664083548301" xlink:href="rnac-20260331.xsd#rnac_Descartes08ForDermatomyositisMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_019cdd24-9221-7c70-badb-82e2e3d966a4" xlink:to="loc_rnac_Descartes08ForDermatomyositisMember_019d9b54-fe1c-7e40-b509-664083548301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_EarlyStageProgramsMember_019cdd24-9221-730b-9456-e8751fd5744d" xlink:href="rnac-20260331.xsd#rnac_EarlyStageProgramsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_019cdd24-9221-7c70-badb-82e2e3d966a4" xlink:to="loc_rnac_EarlyStageProgramsMember_019cdd24-9221-730b-9456-e8751fd5744d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ResearchAndDevelopmentEmployeeExpensesMember_019cdd24-9221-72b9-ad06-c7e4bc72468b" xlink:href="rnac-20260331.xsd#rnac_ResearchAndDevelopmentEmployeeExpensesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_019cdd24-9221-7c70-badb-82e2e3d966a4" xlink:to="loc_rnac_ResearchAndDevelopmentEmployeeExpensesMember_019cdd24-9221-72b9-ad06-c7e4bc72468b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember_019cdd24-9221-7989-9c3b-e3585633192b" xlink:href="rnac-20260331.xsd#rnac_ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_019cdd24-9221-7c70-badb-82e2e3d966a4" xlink:to="loc_rnac_ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember_019cdd24-9221-7989-9c3b-e3585633192b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ResearchAndDevelopmentFacilitiesAndOtherExpensesMember_019cdd24-9221-7e16-a3cb-7f644ae29025" xlink:href="rnac-20260331.xsd#rnac_ResearchAndDevelopmentFacilitiesAndOtherExpensesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_019cdd24-9221-7c70-badb-82e2e3d966a4" xlink:to="loc_rnac_ResearchAndDevelopmentFacilitiesAndOtherExpensesMember_019cdd24-9221-7e16-a3cb-7f644ae29025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_019cdd24-9221-7734-8261-cb882bed4976" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019cdd24-9220-7632-94ca-11d0a6ccc70d" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_019cdd24-9221-7734-8261-cb882bed4976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_019cdd24-9221-7f74-9519-cd0d38d807bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019cdd24-9221-7734-8261-cb882bed4976" xlink:to="loc_us-gaap_RevenuesAbstract_019cdd24-9221-7f74-9519-cd0d38d807bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019cdd24-9221-7e06-8420-08ea864fc7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_019cdd24-9221-7f74-9519-cd0d38d807bb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019cdd24-9221-7e06-8420-08ea864fc7cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_019cdd24-9221-7a85-981f-e62c0f61119b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_019cdd24-9221-7f74-9519-cd0d38d807bb" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_019cdd24-9221-7a85-981f-e62c0f61119b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_019cdd24-9221-77fd-ad93-7a142088c8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_019cdd24-9221-7f74-9519-cd0d38d807bb" xlink:to="loc_us-gaap_Revenues_019cdd24-9221-77fd-ad93-7a142088c8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_019cdd24-9221-7a32-bffc-f73575e0227e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019cdd24-9221-7734-8261-cb882bed4976" xlink:to="loc_us-gaap_OperatingExpensesAbstract_019cdd24-9221-7a32-bffc-f73575e0227e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019cdd24-9221-7360-b40b-e16fcbdc6572" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019cdd24-9221-7a32-bffc-f73575e0227e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019cdd24-9221-7360-b40b-e16fcbdc6572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019cdd24-9221-753a-add4-7d926ba200d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019cdd24-9221-7a32-bffc-f73575e0227e" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019cdd24-9221-753a-add4-7d926ba200d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_NonoperatingIncomeExpenseAdjusted_019d1aa3-8c7c-7909-8e88-961ee7ef864c" xlink:href="rnac-20260331.xsd#rnac_NonoperatingIncomeExpenseAdjusted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019cdd24-9221-7734-8261-cb882bed4976" xlink:to="loc_rnac_NonoperatingIncomeExpenseAdjusted_019d1aa3-8c7c-7909-8e88-961ee7ef864c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019cdd24-9221-7e40-8cd0-502d3945af77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019cdd24-9221-7734-8261-cb882bed4976" xlink:to="loc_us-gaap_NetIncomeLoss_019cdd24-9221-7e40-8cd0-502d3945af77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>employementagreement_mil001.jpg
<TEXT>
begin 644 employementagreement_mil001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M\0RV=R@N$REK$AEE+$D! %')X^@[G'-6M#N-9N_M=SJMHEE$\@^R6I96EC0
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MA^[N-2L88O"UOIUU;:M]LEU6 QB-X@Y9L$-YA:13M*D8Y/. * .DLO%5O?\
MBRXT*"UN/]'MVE:YD0HC,KA"J9'S8)Y8<9&!GG&<GC#5+NQ?6--\./>:*K-M
ME6YQ<3(IP7CAVG<."0"P)'0<BM)]-N6\=KJ/E?Z'_9;6YDW#[YE#8QG/0=>E
M8&E_\)1X=\-Q^&K+07N+FU0V]GJ)GB%L8P<))("V\$#&5"G)'!YH W=>\66V
MB7NDV?D27%QJ-S%$$7Y?*1W"^8^1P 6 QU)^AQT%>>:]X+\03W@O;/65FFGU
M*UGE#6B9B2-AC!+?=3EMO<D]R:]"&0H!.3CDT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4KK2-,OKJ&ZN].M+BXA_U4LT"NZ=_E)&1^%7:* "BB
MB@ HHHH **** "F0PQ6T"001)%%&H5(T4*J@=  .@I]% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+2K(LD3*0'1UZX/!]#7(O>-HFO\ PQGN;2X98-#D6=(X6>2(>3$"=@&XX/4
M9QGTK3CD;Q/XWUWQ#I]O<G3(/#S:;'-) \?GRLYD.P, 2 ..G4T )X&\4?V)
M\)/"[O!<:AJ-^[V]K;(XWS2>8YY9C@  $DGH*VYO'\]C;ZQ'J.@7%OJFF6@O
MC9K.D@FM\X+HXX.,'((%<9X>LKW2/ _P\UN>PNVBTB>X^VPI"S2Q1R^8GF;
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH YKQ%X<UG6+Z*?3O%=[I$21[&AMX4<,V2=Q+#.>0/PK'_X0;Q1_P!%&U;_
M ,!8?\*[VB@#@O\ A!O%'_11M6_\!8?\*/\ A!O%'_11M6_\!8?\*[VB@#S:
M;X8ZW<:K:ZG+X_U-KRU1TAE-K%E%?&X#MS@5<_X0;Q1_T4;5O_ 6'_"N]HH
MX+_A!O%'_11M6_\  6'_  H/@;Q3CCXCZK_X"P_X5WM% 'FUE\,=;TZ>\GM?
M'VJ1S7DOG7#_ &:(F1\ 9)/L  .@JY_P@WBC_HHVK?\ @+#_ (5WM% '!?\
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MYEO.@DC?:5RI&1P<$?C5B@ HHJMJ%_;Z7I]Q?71<6\"&20I&SD*.IVJ"3^5
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MU:R>WAG24M'/)Y<)"$^:>?NC'(P"<CC )SCF@"[16?KFMV/AW1Y]4U&4QVL
M&XJI8DD@  #DDD@8I=%UFR\0:/;:KITOFVERNZ-B,'K@@CL001^% %^BBB@
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MR"H4GYMW.3Z#TJQ#X<N9[_2[O6+^.]?3 QM]EOY6Z0KM\Q_F;+;<],#+$^F
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M:NU67<#L;;QD>@]*EO?"=X9X9=(\2:CII6V2UD7"7 D5,[6_> X?DY8=>^:
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M;]8X5>.Y"_=;:V=K#H#SQVZY *'PC#K\.[19'#R"ZNPS 8R?M$F3BNIUO_D
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MQLH/M\]C+9WD=[#/ JLRR(#MX8$?Q9_"J$'A/Q!%<1R2>.]5E1'#-&UM;@.
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M5F6&/.X2"1 AW$\Y '6J6H^"I9]1O[G3=?O]*AU,@WT%ND9$C!0I9&8$QL5
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MG)(=9B*>(+JZ13(#<A&14#;C%@E -H&.?>@#V^LQ-:AO;75&TM#>W.GR/ T
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M-@YZ@]>]9Z:[XCF^#VC>*H]3N#=6^VYU!8XXR;B 2$2#E3M(7D$8Z&@#U0G
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MHYI4VGY5<L%YZ<[3Q7G/AOPO9^,M!N?$6H7-S!KD]_.T5_',PDM!',RHB#.
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MLPG^V7#KYR2*049"  NTJ",#'7.<FK%OX=\J^N]2EOI9=5GMA:K=[$!AC!)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8B\^WB;"7LFX/,K>H6/CV-=AXRUDO\+M4UK2;IX]^GFXMIXFVL 5R"".AYH
MZVBL7P?<37G@K0KFYE>6>;3X)))'.6=C&I))[DFN;^(&J&UUO0;'4-8NM&T*
M[\[[3>6\GE$RJ%\N-I?X <L<\9QUH [ZBN7\+Z5/I]W<36GB.;5]#GC4P+<S
M_:'BD!.[;+W0C'!SS744 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,UFT&S[XD93G=GC&WICO7)CX;ZU)X:M_#<_B6(Z792Q/:A++$C!) RK*V_#
M $< <X/;! ,K6=;N-4\1>)$>[\4PR:?-]ET]=(MYGA1UC5BTFQ2KDLWW6_A
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MVLXA#>66652Z@)\XQ@8&&Z<4O@Z\E&NZ?;:QKFNV7B0E_MEAJ.XV]YP<^1_
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M!P!SP.PQ5V@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MWP?4T =U17-:5H?B#3KT7-]XLN]4@1&S:-9P1ASCCYE .?QIO_">Z+_PB_\
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M2Z3.,QC/;J=VW ZU*/B+H:^&YM<G6\MK>WO!97,4T.V6WEW!<.N>VX'@G@T
M=;17-Z5XUL=3UH:3+8ZEIUW)$9X%O[?RA.@ZE.3TR,@X//2J^G?$+2M2O[2"
M.TU&*UOI6AL[^:WVV]PX!.%;.>0IQD#..* .LHKC;OXDZ7;MJ(AT[5[P:9-)
M#>M:VH<0;.K,=P&.IXR< G%:UAXLTO4M:CTJW>0S36":A Y7"30L<!E/MD9&
M!UH W**R[/7[._U_4M&MQ*UQIRQFX?;\BF0950<\G'/2M2@ HKB)?BEHD5M-
M=BRU62RMIVM[NZCM<QVS*^P[SGUYXR<$$XS6A8^.M-OM=M=+%IJ,!O5=K*YG
MM]D-T%&3Y;9STY&0,B@#IZ*P(O%^FS>&+_Q JS_8K'SQ*"@W_N20^!GGE3CF
ML6?Q]*/'NFZ';Z5?2VES8_:6D6#).XQ[6!W?<4,P8XZ_2@#N:*PH?%FG3^']
M3UI%G^R:<UPLX*#=F$D/@9Y^Z<55O_'%C:-916]AJ6HW-W:B]6WLH [I"<8=
MLD <G&,Y)!H Z>BO-/&OBE[JR\#:CH>H3QVFI:W;(YC8H9(V)W(P_#!!]*E/
MB"\L?B_X@AGGNYM-L]"6Z%G&=PW!ER57.-V,T >C45AS^+=)@\&_\)4TK'3/
MLRW(95^8J<8&/[V2!CUK8MYOM%M%-Y;Q^8@?9(,,N1G!'K0!)163XA\167AN
MQBN;M9Y6FF6""WMX]\LTC=%5>YX)[=*Y33O%IOOB7=I,U[86-KH7G7%I>CR_
M)D$Q)<C)'W"/F!(QWH ]!HKF-(\=:=J]_:VHLM2LQ>HTEE->6_EQW2J,DH<D
M_=^;# ''--TOQ[INJWUK!%9:G%;WK,EG>S6VV"X(!.%;.>0I(R!G'% '4T5P
MFE^+M&TS1/%&KF]UB\MM-U*6.Z%V0[1."H*1#C]V,C /O6E_PGNFC3'U V6I
MK"UPMO: VI#7S-RIA&?F! )R<<#/2@#J:*Q]!\1VNOBZ2*"ZM+JT<)<6EW'L
MEB)&5) )!!'(()!K8/ H **\HNOB#J.L^$?'#16.H:?+IWGI;7'E>7Y6Q$^5
MF#'$NYF.!VQ73Z3X\L+F[TO3YK34X3?(%M;V>WVP7+A=Q"MG/(!() SVS0!V
M%%<E=_$+2K/4+B![347M+:Y%K<ZC';YMH920-K-G/!8 D @$]:@@\;7$WQ*N
MO#7]E7GV:&VC;SA#T<LV7)W<1D 8.,YS0!VE%%<#KL^OZC\38O#^F>()M*M!
MH_VUO*MHI2S^=L_C4]B/RH [ZBN:TW2]<T1[B]U'Q'>ZW"D#;;3['#&Q88.5
M*@$G ( )QS0WCK1CH&FZO"TUQ'J4JP6L$29E>0G!3:2,%<'=D\8- '2T5RVJ
M^/--TF_N[9K/4KJ.Q"F^N;6W\R*UR-WSG.>%()V@X'6IM7\9V&F7=O9P6E_J
MEW/!]I6#3H1*RPYP)#D@ $\#G)[4 ='17/6'C31]3GT:*SDED_M>.:2W;9@+
MY6-ZOGE2"<8QU!K/\3^.X=&TSQ(;.UN+B^T:%"X$>4#21ED8\@[1CYJ .QHK
M@;KQ1:WEGX2N]1?7-+GOKZ.**&$",32$#B09.8CGZUU.C>(+/7)M2AMA*DNG
M736EQ'*NTAP <CDY4@Y![T :M%<DOQ#TB;3H;NTM[^[:YNI;6T@@A#27)C)W
MN@SC8,'YB16UH6O6GB"Q>YM5FB:*5H)X+A-DD,B]49>QY!^A% &G117#0_%;
M0I["'4DLM6_LMW"27YM?W$#$[<.V?7&2 0,]<T =S17+ZSX[TW1];;1C9ZC>
MZCY*3K;V5OYK.C%AD<]MIR3@#CUINI>/+"PU"]M(=.U7438 ?;);&V\Q+<D;
ML,21DXY(7)% '545A6/B_2=1UBTTVUD=WO+ :A;3;?W<L6<<'KN&1D8JAXB\
M5:6D/B'3)9]0A;3;$7%W<V0 >%7SM",3]_ )''2@#K**Y/\ X2_3M)T'P]Y:
M:IJ<VI6R-9PH@DNIT$:L7?D#(!!8DCDUCZ#XSA;7?&VI7]U=0Z78"T(@N58-
M;GRR'4)V8L,8'4XQG(H ]$HK T7Q9:ZSJ$FGO8ZAIUZL(G6WOX!&TD6<;UP2
M" 2 1G(R,BM^@ HKEM2\>Z;IFH7=L]EJ<\-DRI>7EO;;X+8D!L.V<\!@3@'
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MV&M)$=(TO591'KEY9^<T*H<%E5?,P0,#!/K6LD$,9S'$B'U50*>54L&*C<.
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M2@#P03QR>!_AS ),SVWBE(IXV8%XG\Z0[7 Z-@@_C7;:< ?VA-:!&0=#B_\
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MD7<MO#?Q1[%NXU(Q* ..>1QQ\O%=%>*7L;A5!+&-@ ._%2JJHH55"J!@ #
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MZ5&Y_P"$PM%L4*CB.\#",.?3]TY/U2O3])TVWT;1[/3+5=L%I"D,8]E&/SH
MYR^^(-G:7.H+;Z1JVH6FFN8[V\M(4:*%E&6'+!F*CKM!Q4]_X[TRTO;"SMK:
M]U"?4+/[99K9QAO.3(X!+#!P<\X& >>U<AI'B/2_"6A^)M$UJ=8-36^O)(K9
MP?,NUE):-HQ_'NR!QT(YIWA#3+G2O%G@^QO4*W-OX6D616ZHWF1?+]1G% '=
M^&_$MMXEM;F2&VN;2>TG:VN;:Z0+)%( #@X)!&"""#6)?^-+VT^)MKX;CTB]
MFM7LS*\D<:'<2Z 2 EQ^[7+!N,YZ TO@L8\5^-^/^8I'_P"B(ZS]:U&TT?XU
MZ3<ZC.MM!<Z+):PR2<*\IG4A ?7% %#P]X_;2=%U::_LM9U.&SU.[%S=Q*)$
MMHQ*VT$LP) 7!PH.!CI78:IXQM;&\@L[+3[_ %:[FMQ=^58(K%(2<!V+,HY.
M<#.3@\5QNG+CX/>-N.3-JW;K\TE9WEVFF^(;:[UCQ%J&@VE[H5E]GN;>58XY
M&C5@\;,R,-PW*0..IZT >L:/JUIKNDVVIV+E[:X7<I9=I'."".Q!!!'J*Y'0
M_'\U]XA\2V^H:;=V>G:6^?M$L:!8%6(,_F$.3DG)& >,5M>!K2QL_"=J-->_
MDM)FDG1[\ 2MO=F+$ # ))(XZ$5YY>[;J\^)_AR.4+J]_B6TM3P\ZBW!^4=\
MXQ0!WVC^-[;5=1M;.72]3TYKV-I;*2]B55N549.W:Q(..<, <52L/B5INIV]
MW=6FEZL]G9Q3R7-QY*A(VBW90G=RQ"Y '9ESC-8'AL^'-8\0:$]MXHUW5KZW
M#7"6TLB.EH?+*MYP$8*?>*X)R33?"J;?@CXBPN"PU0GCKS)0!N_\+1TI183S
M:7J\.GZ@ +2]>W!CFD*[A&H#%MQP0.,$]"1S5VT\?:?(=634;&_TJ;2[87<\
M5[&H8PG.'78S ]",9SGBN9U)!_PAGPO&W@:CIO&.G[AJL:]]C'Q(UTZC:375
MB?"J"XAA0L[IY\FX #!SCTYH ZG1/%::OJ!L9M'U33)VA^T1"^B51+'D D%6
M89&1E3@\]*Q_&^MS:+XI\(.LEV;>6YN%EM[;)-P?).Q=H.&.XC&> >>.M9W@
MS5D7Q5'I.B>)IO$.AM9/*YG(D>R964(IE !.X%OE;D;:U?%BY\?^!>,@75W_
M .D[4 6[#QWIUQ!K#W]K>:3+I$:RWD-ZBAEC8$JPVLP8'!Z'J,5+H_C&#5-3
MCT^XTK4M+N9X3/;+?1*OGH,9*[6.",C*G!&>E<+XST^ZU/6_'EM9QR23-H]B
MZI&/F?9([$+ZDA2!6GX;_P"$<U;Q9I=S8>*M;UV[M899D6:1'BMPR["),(I5
MCNX7.<K[4 :^D?$S2-9T^;4XK+4H-+@MWGFOIX0L494\QY#'+XYP,^F<\5H:
M/XQ@U74X].N-*U+2[F>$SVRWT2KY\8QDKM8X(R,J<$9Z5Y_HFFW.H_LS_9+.
M*1[AHII D0^=]MRSD#U)"D"MGPW_ ,(YJWBW3+FP\4ZWKMW:PRS(LTB/%;AE
MV$2812K'/"YSE?:@"UH/C;0=,\$MK(N-;N+#^TC:M)?N)IE=G"_WON GMSCM
M6YI/C*#4M>_L:XTK4]-NW@-Q +V)5$T8(!*[6.",C(.#S7E'A]"?A';*5SGQ
M5%D$?]/"5Z1K /\ PMOPN<?\P^^_G%0!M>)?%%AX4M+2YU!+AX[JZ6U001[V
MWL&(XSD_=(XR<D<52TWQO:WM_>6%UIFI:;?6UL;S[/>1H&EA!P60JQ!YX(R,
M$UD_%*YCLK7PM=2QN\</B&UD<(I8X"R$D <DCK@>E9MUJECXH\?M>Z+<QWEG
MIVA7*7-S"=T8>0C;'NZ;L*3B@#=TSXDZ1J6D7&LBTU&VT>"U^T-?7$(6-CQF
M-<$EG!.,#C((S5BP\<PW.I6MA>:+JVF37J,]G]MB11<;1N*@JYVMCG#8KC$T
M^YO?V<-/AL[=YI8[6WN# BY:14E61@!W.%/'>M35]?TOQGXD\(VWAZ\2^>VO
M_M]R\.2+>)8W&'_NDE@,'F@#J],\7:7JGA!O$T9EBL$BDED690LD8C)#!@"<
M$;3QFL6'Q+IFI^+_  PP?7+:YU*PDN;:U+A8#'M)S,@8Y;'(ZXXKCM;M+FV\
M1ZI\/8$D6U\1:E#?1LH.$MGRUT >WS18 _VZW];C6/XZ^$$C0+&FG7*@ < ;
M6P* )/%7Q BD\,>)1IMEJPAM8+BV75H4 A2X"D#:P;?PV!N"X![]ZU8_&"Z?
MI^D6*6&I:OJ<NG174L5HJNZQ[0-[EV4<G.!G)(-<%%K^G:/\(_$/A6\DQKT"
MW\#66TF5][R,) .Z[6#;NF!5EH[33?$5M>:QXBU#0;.]T*S%O<V\JQQR-&&W
MQLS(PW#<I XZGK0!WESX]TM-+TF\LK>\U"75F9;.TMHQYSE0=^0Q 7;@ALGB
MLWPAKT^M>/O%*/\ ;888(+,"RNL@V[D2;AMR0"< Y'!&#DUS5N=*\+ZGX+UP
M3WRZ ZWZ->:DN&CDF8.K/@ *'(;!P."*U?#7B'3I?''CO7D=O[,ALK.;[0$.
M)(T27<ZC&6'! QUQQ0!Z714%E=PW]C;WENQ:"XB66,D8)5AD<'IP:GH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD\Q%++T)4JV1_7%6]7D^('A_2+O5VU;0]0BLHFGEMC8O"711E@'$AP< XXH
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MLPT;?)@#YU&WKS77W_Q \-Z;?7%I<WLN;9Q'<RQVLLD,#'M)(JE5//<\=\4
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M'D$5;H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_&<@4!V\2W89NY "8_F?SKAM+N+6X^"6A67G0R31:U"L\&X%DS>MPR]1D>M
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M_%,EXPTF0*4E$;%CEMH&W&<Y]NQK0N=>TZTNM,MI)B9=38K:*BEO,PN\GCH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/=]=H&:>-,L%@G@%C;"&X8O-&(EVRL>I88Y)]ZM44 5;C3+"[L18W-C;36@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM?V
M<-_8RVT_F>4ZD,$D9"1]5(-6:ANVG6UD-O$LLN/E1GV@GW.#C\J /*OV=B3\
M.[PDDDZI+DG_ *YQUZW7G?PL\'Z]X)\)WVD7WV(W$D\EQ!-%*SIED50&!4'J
MN:Z7P=#XF@T!4\67-K<:IYCDO; !=F?E!P ,]>@]* -^BBB@ HHHH *\P^(E
MS%:?$GP3--I=QJ:+%?YM;>%97?\ =IT5B <=>O:O3Z\Z\<_:%\:>']6TW4="
M6YTE+E9;;4;_ ,@GS44#H">@)_*@#2T;5]/O=6MX$\"ZMI[L25NKC3HHTC(!
M.2P8D=,#CJ163;7_ (M\0ZEXKM[378].ATJ]:*V9;2.1G^0,%;<,;1Z]3NZC
M',]KXSUYKR%;N;P:EL9%$K1ZT694SR0"@!.,\4_P]-I>E7OBF:X\0:,5U2^:
MX@V7J$A3&J_-SP<CWH Y^7Q7XO/PUM/'S:K;Q*@B:33$M5,<J&01L2Y^8,<E
MN" .G/6NAU+4_$E_\3;CPUINIQV%BFEQW;S?9UD=&,C+A=W&3QUR  >,FL&;
M3;23X)1^#QXAT+^TEAC0M]O7RLK,'//7H/2FW_B 0_&2[U'2-2T:=%T6*-X[
MF]6*.7]ZQPL@W ..#T/!/3K0 W7]9U6?P5\0_#NM7,=Y=Z/#'LNTB$9FBE7<
MNY1P&&"#BM>QU35KJ#P?X7T>]73WFT2.]NKOR5E=8U5$545OER6;DD' %9$V
MG1:EX>\937WB#P_'K?B,(HBCOU,,"1KMC4OU)QG)Q5]Q#I;^&]6TG7- GU+3
M--&G7=M-J*QI/'M7[KC."&7(R.0>U ":AXG\4Z38^)+3[6E[>^')K:[:86ZJ
M;NS<%G5E'"L 'Y7'0=*Z/5O$=S=^(/"VF:%<+LU'-]<RA W^AHH/?IO+* :S
MO#<VF1WVNZOKVMZ$;W63&DEM!>H\<4,:%53<<%C\S$G ZUSWPIGTG3WU.^O=
M?L)$@=M+TQIKA%;['%(Q4X)Z,6_\=% $T6N>,]2\&:]XABUZ*U_LF>[\F!;.
M-Q<)"S'#DCC@;1MP>,DG/%ZXU[Q386OA?Q%<:K"]KK%[:P3:6MLH2*.<<;9/
MOEEXZG!/8#BF:=;V-K\//$6@R>(-#-WJ+WS0D7R;!YV[9N/4=1G@_C4NK1Z?
M>^%/"NF1>(-$$^E7=C-<%KY I6$#?M/<^G3\* *&N^/YO[6U\0^+M/T=M*E,
M%KI\\2,;MT0,Q<MR%9B5&W&,9K27Q-KWB+Q=I.G:1?1Z?8ZCX?CU-W:!97A+
M/CY<]3R!SQU.,U!+?3Z-JFL_\(_JWABXM=5G^U)+>:BJ-:3,BJY*@'S%^4,!
MD<Y'O6A#-IR?$6#7Y?$6BO;)HGV!R+M%9I?-#DA<X"X]Z ,U]6\1OI/CW0[K
M6O,O-#A66'4%MD5Y(WA,FUE'R@\8R!WS6S\)K6]@^'ND27.H-<Q2VD;01&%4
M\A<'Y01RW;D^E9HATR36?'4\GB/14M]?MX8+9A>H63; T;%AGU/&":D\%R>(
M[7P0NC6$GAV>^TU(88)(;XSQR)N^=G"@%#M'R\G)]* /1J*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N>U3P
M+X6UO4)+_4]#L[J[D #RRIEC@8'Z 5T-% ')?\*O\#_]"QI__?NC_A5_@?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBL3Q'X
M@.B)906]N+O4=0N!;VEMOVACU9F.#A54%B<'I[T ;=%5WO;6*YCM9;J!+F09
M2)I &;Z#J:R[7Q 6\5W?A^\MA!.L(N;20/N6YASACT&&5N".>"#WH W****
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M_L7^V?[2M?[,V;_M?FCR\9Q][IUX^O% &C17*W_Q#\-VOA6]U^VU.UO+:V#
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M;[-]LTG4;BVML1_+L0IC<,\GYC7H>AWDNH>']-O9]OG7%K%*^T8&YD!./Q-
M%^BL?6/%6@>'YH8=7U>TLI9AE$FE"DCIG'I[]*DU3Q)HNB6<-WJ6IVMM!/\
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MRWM+0J]DMHDB2S1F$@QKN8@@J=Q '\.:Z+XG-<K\,_$)M=WF_8WSMZ[?XO\
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M/X9T:Y\.#P_-81OI(14%J2=NU2&4=<\$ T <9KJ:LWQ(\.KIC:<DBZ1.UO\
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M=I")"6+!)EC"EMH.PMD?> S[UTT.BZ=;ZS<ZO%:HNH7,:QS3@G<ZKT![<8H
M\PUB.R3]GO1FT]8Q,L-@UF4 W?:3)'DK_M;M^>_6KGB#5_\ A7?C#6[U5_T7
M7+ W-LF.#?1 )L _VPR'W(KL;;P+X8L]474K?1[=+E)#*A!;8CGJRIG:I]P
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M:R21$:'N^Q8C'RXC=OF]>5%='X%U>[U[P/I&JWS*UU=6XDD*KM!.3T':O/\
M2/\ CZ^,/_ __1,E=E\+/^27^'O^O0?S- &[K7B#2?#ULEQJU]%:QR-L3?DE
MV]% Y)^@J+_A*=!_L$:[_:MK_99_Y>?,&W.<8^N>,=<US^H,J_&?1?M9 B;1
M[D6>_IYWF)OV^^S]*Q=:DT!O%'APZ;Y7]GKXCF&H%01']N\D[<YX+;L=.,^]
M '<:=XLT'5K*[N['4X98;-2UR>5:( $Y92 0, GIVJ"W\<>&;O5(--@UFUDN
MYP/*C#'YR1D '&,X[9S7'^+=I\>ZY]FQE?"%R+O;Z[_W>[WQNQ[5%J%M#;_#
M'X?"&-4"7^E.N!T9BN3]3DY^IH ZC2_B!I&L^)=6T*VN(TGLL+'(23YIV%GP
M,<;<8//-3:)XDLHO"FGZAJ?B*RO4N)6B74$C\F*5MS8 &3C 4CK_  DUB>'"
M/^$X^(XSSYEJ<?\ ;M7$>&X(KGX/?#N&=%DB?Q&@9&&0P\Z?@^U 'KNE^,?#
MVLI=MI^JP3_8T\R<#(*+C.[! ...HXJX^N:9'IEKJ3WL0LKHQB"8GY9#)@)C
MZY'YUQ'B5/\ BY%]L7YY/"-R#@<MB48_F?SK*U&[MQ\'? R><FZ6?2T09Y8J
MR;A^&#F@#T#4_&/A[1M173]1U:VM[I@I,;M]T-P"QZ+GMG%;E>0PV>M7LOCZ
M :GHEI9O?S+>_;[5WD6(Q+M8L'4!=G3CL:].T&W:T\/:9;/=+=-%:11FX7I*
M0@&\?7K^- &)I_C_ $?4?&NH>&8Y4%S:A%1MQ_>R?/O0#'&P(.<\Y]N;<'CG
MPQ<ZJ-,AUJU>[:0Q*H8[6<?PAONEO8'-<G']H/CCXFK:$_:SIMIY(7KO\B3&
M/QQ69JQLF_9UTE;'R_.:WLEM0F-WVKS$SM_VMV[/XT >OUP&B?$C2X4U"/Q%
MJ]K;7$>J7-O$I&-L22%$+8Z#C&XXS@UW_:O*?#1TL>"?B'YWDX_M/4OM>[&<
M<XS[8Z?C0!W^L^*-$\/QP/JFHPVXGR8@<L7 Y) &20.YZ"M&TN[>_M(KNTGC
MGMYE#QRQL&5U/0@BO'O"\7B-M?T=;.[T^WO/^$4LMG]H6[RDIEMX7:ZX.=N[
MKVKT#P#I_P#9GA=;==1M+]#<SR++9KMB7=*Q**,G 5BPZ]J -+6O$NC>'4A;
M5K^*U\XD1JV2SXZX4 D@=SVI)_%&AVUE:7DVJVJ6MXK-;S&0;) %+$@].%!/
MX5Q^KQZW)\7V&E7>G6\QT1/*-];O*&7SGWA-KK@YV9Z\8K$BTB.TN_!%K+?6
M6I1-K]Y.K6B8A1MLCE%!)P%?/?M0!W0^(?A(Z>]\-<MO(23RF^]O#8SC9C=T
MYZ5?F\5:#;V%I?S:M:I:7BLUO,7^20!2QP?8 G\*YS0[:#_A<?BR?RD\T6-D
M-^.<$/G\]J_D*X;11:+H7PW2[V"W77;Q5#_=#!YM@_[ZVT >I+XNTO5M U:]
MT+48;F2R@D9@ <QL$)7<IP>WXUG^$_&"3_#73/$GB.^M[<S1DS3-A%+;R  /
M7@<"L;6@A^)'B4V^-H\*$76W_GIO?9N]]N?PKG/#&T>'/A,UUC[ +JXW[_N^
M=LD\G/ONSCWH ]/@\;>&[G2KO4XM7MS:6947+G(,.3@;E(R,Y[BM/4=5L-)T
M]K^_NHX+12H,K'CYB /KDD5P^H:;:ZU\6=3TUE#6USX:,%^$[,TV(\_[6W<1
MWQ7/Z%=W/B:?PSX-OSON- N9)=6_VOLQV09]0Y96]]IH ](O?&/AW3M772KO
M5[:&])53$S?=+?=#'HI/8$C-/U?Q9H.@W<5KJFJ06T\J[UC<DG;G&XX'RK[G
M KS*#3]8U'0O&UM+JVAV6G2ZI>I?->VSM+&"WRL7\P 8385XXP*Z3PDH@^(O
MBR.^G26Y2ST\)*_\<0A.YAG^'?N)_"@#=\#:W=>(-#N+R[DCD=;^Y@1HP "B
M2LJ]/8#FJWB3Q6/#_C#1;6[NX;;2KBUNI;EY!_$GEA,'KU<C ZY%4/A";<^"
M)#9[?LIU&[\G;TV>:VW'X8I/$_V3_A;O@C[5LSY%]Y.__GIM3'XXSB@#H;;Q
MGX=O-.COX-6MWM7N5M!)DC$QZ(01E2??%:5_JECI?V;[;<I#]IG6WA#?\M)&
M^ZH]S@UYM=:!%XG\3_$?28"JI/;60#KT2Z5&96SZC"9H\+ZO)\0?$N@W,ZD+
MH-B9KU".E^Y,6TCU4)(P]-PH ]-O+NWL+.:[NI1%;PH7D<]%4=37GC?$^'5O
M"VFZMI,L4$DFK6UK=1.=_E1/,4Y)  RJY]J]);[I^E>':;#%=? SP7!,JR12
M:S;QR(>00;I@0: /6-&\6Z#X@NIK;2M4@NIX5WO&A(.WIN&1RON,BFV'C'P[
MJ>JMI=EJ]M/> L!&K?>*_>"GHV.^"<5ROC!)E^(%L;($73^'=02,IU)!0J/S
M-9&@:9JE[X;\#R3ZYH$&G036LUFD5JZ3.RKS&&,A!8KO#<=<T >N]*X"Q\2^
M+O%HGO\ PO;:/;:,DK16]QJ7F.]WM)!=50C:F00,Y/%=U=1&>TFA5MID1E#>
MF1C-<1\)]2MO^$&M='D=(=1TC?:WMLQ >)U8\D>A'.>E &UH?B&\DT>]N/$M
M@NCSV$C)<2._[AU !\R-SC*'/X'BK&B^+=!\0SR0:5J<-S-&N]HQE6V_W@&
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[:RVMS"DT$R%)(Y%RKJ1@@CN*Q;3P3X:L%MA:Z+:1?9IOM$+*GS))C&[=UZ
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MFC.'T[3+:V<1&'=&F"4+;B">_//-0:QXS\/:!<O;ZIJ<=O.B(YC*LS$,2%P
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M\,:%X@\DZMI-I>&'B,S1!BH] ?3VJ=]$TIY+"1M/MBVGY%F?*'^CY 'R?W>
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MG>U"QVD^@6ATD,I3_1PS;@H;D#.WCZ5U^J^%/#^N7<5WJFC65Y<1#"230AF
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M 9E]X=T74[""QOM)LKFTMP!##+ K)& , *"....*DN=#TF\TM=+N=,LY=/4
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MTW$9JW!<0W4"3V\T<T+C*21L&5AZ@CK0!)1110 4444 %%%% !1110 4444
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M!)%-?+!RY7!!P?[I[4 7?"]SX?N]68:=X.N])N$B+BYN-'%J,9 *A\=3GIZ
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MB&LW<1C%ML)D5@"^[<< @?=QQZUZ+7GWA>UU_0CXHLK6TT^X^T7=UJ-A<?;
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M8VC *^4\F,%RK'Y@ ,X'O21:!K^M>,I]9URTMK"PFT6;3OL\=P)7CW.IW,V
M"2-W3@8'K0!E7?B;QM8^!K/Q8]WI\D6H-;O]C%J1]ECE==I#[OG.& ((ZMD=
M.;.N>.+LZYK=O:>)M$T==)(CBMKX*7O9=@=LY<%4Y"@@9SD^U<]K3:^/A7IF
ME2_V7)I]O/9VT%]:7?G?;PLR*@10OR\#).3]SISQU]YH.MZ3K^M7&E:'IFJP
M:K(MQ')=3",VLVP(VX%260[0W'/4>] '7:!JR:]X>T[5HTV+>6T<^S.=NY0<
M?AG%:-0644D%A;Q3>3YJ1JLGDIL3=CG:O89Z"IZ //?BI_:?_%++8:BEJDVN
MVT+!H-_SDED8\C(4K]WOGJ,53@M?$$_Q/UZUT_5+>VG&F6/VF^>U\PEAY@^6
M/< -Q)/). ,<YR.B\?:+J>L:?I$VDPQ3W6F:K!J'D2R^6)5CW94-@X/S4[0]
M)U./QGJVN7UO';QWUC:1B)9?,*2)OWKG R!N'/>@#%M/%6MWW@:&\FU#2=,N
MXK^6ROM0N<+%&L;LI=$8@%CM7 )QR:YSQ!XHU+6?AAXPAAUNRO#IDBQ'4+2(
M;+N"1%)7 8A6!8@D9^[TYK73P;KNGP:;=+I]KJ$ECK-[>M8R3A5D28OL<,01
MN7<#@^IIM]X-\3:GI?C2TN8+%)-=BBF@>*;Y(Y$55\DC )P%'S]#UP* /0M#
MAO8-'MH]0O$N[@+EIDA\H$=AMR>@P.M:%9VA2ZC-I$#:I8)8W8&UH4G$H&.,
M[@!UK1H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ J*>ZM[5 UQ/%"I. 9'"@_G4M<?\5%5OA?XA#*
M"!:$\COD4 =(FK:;(ZHFH6C,QP%$RDD^G6KE<+87&E7=AX?TZ70;C-T(P)WL
M]BQLD1D#;R.N4&/K5G6/&MUH?B0Z3>:2@CN+9Y-.G2X)^UR@@"#&SY7.1W(Q
M0!V-%<]J7B5M)33+:\CM(-2OPY$;W.(HP@!<E]N2!E1PO)(Z#)&59?$$36EP
ML^G[=0CU!-/ACCE+0W+ORCI(5'R8#$G&1M/!XR =M17(ZAXIUG2;/7IKS05Q
MI=K]KCF2<B&Y3:2RJQ3(<8QC![<BIY?%DL6I>%[;[ ABUU&(D\\[H6$1DQC;
M\P[9R/I0!TKND4;22,J(H+,S'  '4DU3EATSQ#I(606]_I]RJNI!#HXSD$$>
MX!!%<?X>\0:[>0^+Y[^SL[F.QOYX4A6X8#"1Q_NP"F,$9)8]23Q3D\:/I_A#
MPQJUOHEM#INHM;PR*L_EK9"3 4X"8*@X';J* .\ P /2JRZ?:)J4FHK;I]LD
MC$338RQ0$D+GL,DG%9.I^)5TF;5);F!/[.TVU6>:=9,N7.<1A<8S@ _>_B7U
MK/LO&DLOB>PTBXM+9X[^-VCN+*X,XA=!DI+\HQD=#W(Q0!U4%U;W7F?9YXIO
M+<QOY;AMK#JIQT/M4M<JUEIW@33?$7B"*T15DW7<L-LNT':"<]_F)))/Z<5H
MZ+JUUJ<I=HK.2Q>%)8+RSN#+'*22"OW1@C ]<Y[4 ;-%8NO>(8-$ELK9C#]I
MO798A/+Y: *NYF9L'@<# ')(]R.7NOB5<VGAW7-0;1DEGTB>.*01W!\F9)"
MLD;E?FZ\C'&#S0!Z%6.WA/PVS%F\/Z423DDV4?/Z5CS^*]:MO%,6ARZ#!YE[
M;23V+B]X.P@,)?D^3A@?EW^@S5"?XBW=IX0U;5Y]%0W>DWYL+NWCN<INW(H9
M&VY(/F*<8!ZT =-_PB/AK_H7M)_\ H__ (FJ]IX?\'WZ.]GH^A7"1N8W:&VB
M<*PZJ2!U&1Q5"#Q?J$7C"TT#6]#6QCU*.1K"=+D2B0H,LC@ !6V\\$CMD]:Q
M/"NM6OAGP[XIO)(BRKXFNX8((\ R2/*JH@[#)(^@Y[4 =E_PB/AK_H7M)_\
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M  C!M-!E/]NB8!)YO*>&2-6)5@5Z9'WO3D \ @'0_P#"(^&O^A>TG_P"C_\
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M^*E^P6\]UX>C65Q!=9CF0QE^&VY5AM8$8/(ZT ;G_"(^&O\ H7M)_P# */\
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M=!TZ4 >N_P!MZ:=>.A_:E_M,6_VG[/@Y\K.W=G&.O'6M"O-U_P"3C'_[%O\
M]KUZ10 45Q7C/6+O3]3MH3XKTWP]9- 6#RHDL\TN<8"-QL [CG)QQ7/MX\U&
M^T'PK=7&KVVA6^IQ3?:=3^SB2/SHV"J@W?*@;YFRW]W% 'JM%9N@/?R:+;MJ
M5U:7=R<_Z3:?ZN9<G:X'8E<$@9&<X.*YA-0\1^(?%>NV^DZK#I]EH\D=ND;6
MJR_:92@=MY)RJC('RX/?- '7:9JEEK.GQW^GSK/:R%@DB@@$JQ4]?<$?A4MU
M=06-I+=74R0V\*%Y))&PJ*.22>PKQGP[XKDT?P!X1TS^U;31&U&2]DGOKD*P
MA2.9R54-\I8LR@9[9XIWB/Q!>^(_AAXLMX]>MKP:4X22\M85*7L+*K+T.$8$
MD';W6@#TBW\=^&;JSM[N'5HWM[B[6RBD"/AYF&0HX[COT]ZZ*O*;O5]>\)^#
M_!034X[G^T-1LK5MUJB[('CY08[\?>ZUM->^)];\;>(]%T_5XM-L].6V:.86
MJRR9DCSMPW&,@DDY/0#% '>45Y/_ ,+$OIO#/AA;W5;'1[S4Y+E+K4944I&M
MNQ1BBL<;F.W&>!D\4L?Q"U"31KS3[#5+'4M2&K6VF6FIQ(#$ZS@,)&53C<H#
M@@<944 >F2ZI90:I;:;).JWERCR0Q8.75,;CZ<;A^=6Z\U6UUBR^+?AZ#5-2
M745&G7C17'D+$^28]RL%XXP"",=?;-=+XYUF\T/0H+NQ=4E>_MH"64-\CRJK
M=?8F@#I:*YK5-9O+7Q]X>TF)U%I>V]W),I4$DQB/;@]OO&N%B\4>,C\-(?'$
MNKVP6 AGT\6B[9XQ+L8L_56/)&W ''N: /7ZJ:?JEEJL,LUC.LT<4SP.P!&'
M0X9>?0BN4N-0U[7O'&J:/I.JQZ7::1! TKFU69IY906 .[HH4#I@\]:XS1?%
M-UH7A.&VEO[+2KS4_$%[%/>S@&*V"NSR$!C@G("KG^]0![317D=S\0[^V\)>
M+6L=;LM6NM'6WEMM1AC3;(DK8*LJ_+N4AAQV(XKT7P_!K,5I)+K6H1W4\["5
M8HH!&ML"/]6#G+X_O'DT :]%<%XSUR]TW5C%_P )=I>@VZVP>".2-)9KB3)S
MN5ONH, <<G)YXJ@GBWQ%KUQX-@TVXM[$ZWILMS=2&$2>4RA#N0'KR2 "<?,"
M<XQ0!Z917E6J>,/$F@:'XPLY[N&\U31&M)+:[\A4\Z*=EX9!P"/F&1[5M/J'
MB;P]XIT*+5M5M]0LM8E>VDA2U$7V:78778P.67@CYN>] '1Q^*M$ELM4O$U!
M#;Z5*\5Z^UOW+I]X'CG'MFM&SO(-0L8+VUD$EO<1K+$X!&Y6&0>?8UY!X;U.
MYT;PQ\4M2LV5;FUUF]EB9E# ,.F0>M=&GB37-8M?"&E6%[%9W^K:8+^\O3 )
M#&JHA.Q#\N69^_  /% 'H=5-3U2RT;3IM0U"=8+2$ R2,"0N2 .G/4BN2OKS
MQ3I'AJ==4UG2;.2.]6,:O. @-L>=_E_=\W/R[>AZ^U<9KWB>?6?AQXWL7U6#
M68].-L8;^&,1^:LC*=K!>,@J1D=>* /:ZS]-UO3=7FO8K"Z6=[&<V]R%!'ER
M#JIR/Y5R4NH^)_#OB/0?[7U2WOK+6)VM9;=+41_992A==C Y9<J1\WUKD]"\
M0OX7TSXDZK%Y7G)XADCB,QPBN[A S?[(W9/L* /::H:SK>G>'M,DU'5;I;:S
MC*AI6!(!)P.@)ZFN*\+^+VF\7P:(?%-AXBAN[6299K>-$>"1"N5(0XVL&)&>
M?E/6F?'3_DE.H_\ 7:#_ -&+0!TMKX%\+V>JKJ=MHMM'=*YE1@#M1SU94SM4
M^X KHJXKQCJ]UI]_9Q'Q5IOAZR> MYDJ)+/-+GA0C\; .21SDXXK-\,^-=5U
M.^\)S7CPFRUFTNH7$287[3"Y^<'J RJV!0!Z/17F_AOQ[>W%[XAN-5:/^S8[
M:74--*J%/V:*66-LGN?D5O\ @8KK/!UUJ=]X/TJ\UAU:_N;=9Y=J!0-_S 8'
M3 ('X4 ;E%9?B.ZO++P]>W%A/96]RD>4FOGVPQ\C+,?0#)]R *X/2?&MV;S7
M+"#Q):Z^EOH\FH0WD4"1F*1204(7Y6'*D?CUH ]0I&8(A9CA0,DUYA'KWBVT
MT3POXEO-5MY;?4Y[.&XTY;50H2; W!_O;N0?3G&.*OIJ/B7Q%?>)+K3=3@M+
M'2KF2RALVME<7+QH"Y=SRH); VXQUY[@';Z;J-IJ^G0:A83">TN%WQ2 $!AZ
M\\U:KD?A;_R3#P]_UYK_ #-==0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7.>.])OM>\&:GI&G1Q
MM<WD1B4RR;%7)').#_*NCHH Y:+_ (2>'0[:Q@TJRCN8X4B$[WFY8R %+@;.
M<<D#C/2JGB?PSJ'BB*^6?,#VBJ^C213_ #)..1,W'!R ,<_+N[MQU)U.P&IC
M3?MD'VXH9!;>8/,VC&6V]<<CFK= '!:MH_BZ]A\/Z];QV">(M*$B3VK2GR+I
M) H<!L94DJ",C@^O=VO:!XG\2:#;W4CV5AK=E>Q7UE;+(9(4:/(VN^ 6W!FR
M0,#@>I/=T4 <E-I_B/Q+X8U>SUB&STV2\LI;6*W@F,P#.I&]VVCVP .!GDYX
MQX-"\5W5[X.N;FPT^W&B%TF3[66+@P^7N!"<>H7!]R*[B[UC2["417FI6=O(
M1D)-.J'\B:+36-,U"4Q66HVES(%W%(9U<@=,X!Z<C\Z .6TS0=;TR3Q;;B"T
MEMM3NIKNVE$Y#EI$5=C+MPH!7).3]*FTWPE)<?"R'PGJZ1I*+$6CM&V]0P'R
MNIXZ$ CZ5V%% ''+X0N]1^'%SH>K7@.JW\&;NZ3G]_@8/N%VH/<+4_AQO&DK
MP0^(;?3K>.V&)+BUF,C79Q@$*5&P=SSG(Q@"NJHH I:NMZVE7"Z<D,EV5_=I
M.<1N<\AC@\$9'2N8\+^$O[%\4WVIV5D-)TZZME233DE#(T^[)E"CY5&WCC&<
MG@=^TJM>ZA9Z<D3WMU#;K+*L,9E<*&=CA5&>I/I0!SGC+0]8O;K2-:\/R6_]
MJ:5*[)!<DB.>.10KH2.AX&#[5G^)-(\4^*/ NHV-S;6-O?WAB6*U2X+1PJCA
MB6DVY9CCL,# ]S7>44 <G?:3JEWX^T/6EM8UM+.UGAF!F&_=)MZ#&"!M]>]<
M7XLT?4](^'OC:2\AA3^T-6CO;?;+NPK2PJ W'!^7MGK7K=Q<P6EO)<7,T<,$
M:EGDD8*J@=R3P!5'4M*TKQ/I2V]ZBWEA+MD 29@D@X*G*D;AP"/SH R9](OM
M:\4Z/JU]:K:0Z0LSI'YH=I9I%V<8X" 9Y/))' QSSI\!ZO?^%]=T^=H+2^GU
MN35["42;T5C('17X![$'&>N>:])CC6*)8U+%5& 68L?Q)Y/XTZ@#DVTC4=>\
M0:'JFJV<=BNDB67REF$ADF==G! X0#)R>2<<#'-&70HKOXHI?V=T#:26D=SJ
M-NF"LDL;%;=B?7ES_P!LA7<NBR(R.H96&"#T(K-T3P]I'ANR-GH]A#9P,Q=D
MB'WF]2>IH R#I&IK\3'U\6\;6']DBQ&)?G+B4R9VXQCG'6N;G\&Z_-\,==\.
M?9[5;V_O)IHF^T?NPLDWF<G&<@<=*].IDTT5O"\TTB11(-S.[!54>I)Z4 <1
M?:7XJTKQ=/X@T&ULKN'4X(H[ZPNK@Q&.2,$*Z.%(Q@X(Q_\ 6GU#1-=NO$7A
M3495MYSILEQ+>,LFP9E0J%C!'(7/4XR!ZFNLLKVUU&TCN[*XBN+:4926)@RL
M,XR".M3T >>77A#6+^W\>0.EO"->4&T8R[MI$03#X'&2,\9KLM#6_31K9-2@
MA@N4C56CAD,BK@ ?>(&>F>GY]:T:* .0?1M97Q_J6MP10K;S:2MG YERPE5F
M<,5Q]W+8Z]NE4]'\)36WC&UUZ'38=&<V\B:G%;3;HKR0XVD*..#N.X@'IP>M
M=W10!S?C;3-7U71K>'2#$[QWD4MQ;2R&-;J%3EXBP!P&X]CC!X-<XWA;Q%]I
M\8NMEIT<6N:=%;P1Q7!Q"ZQ/&%^X.!NSGCIP.>/1Z* ."D\.:TT7@=1:P9T,
MJ;O]_P!<0F+Y..>N><5GKX5\3Z7X>\3>&+*VL[O3M1%T]E=/<F-HO.!S&Z[3
MD@DX(..><5Z;10!G:!:W5CX>TZTO5B6YM[>.*00N77*J!P2 >WI7'ZAX1O=5
MU^SU1M/@L-7M=1\S^U;:8#S;02$A'48+,4PI!!'?/:O0:K6VH6=Y/<P6UU#-
M+:N(YT1P3&Q&<,.QP: .)3PUK8L?',)M8-VNM(;7]_PNZ$1C?QQTSQFDMO#_
M (EM=0\.2-:V-W:6.E)9R6TUR0MO<+C]^ORG?D# X!'MDUVMSJ=A9W5O:W-Y
M!#<7+;8(GD >0^BCJ?PJW0!Y=;^#/$D/PZTCP^\%DUU8ZFER66X.UHTG,N<E
M>"<X Y]<]JZ"X\-:A/\ %?3_ !./)6QATIK1U+_O!(7+=,8QSUS78U4.IV"Z
MDNFF\@^W,AD%MY@\PJ.K;>N.>M &;XQT!_$WA>[TR&=8+ABDL$K#(21'#J3[
M94 ^QK'_ +-\5^)A=6GB!;+3-+EL9;62WM)?/:XDD&WS-S("BJ,X YR>:[6B
M@#SAO#GBS5]&TKPSJ\&G1:=92P&YOH;EG>ZCA(*JL94;2Q5<DDXYQ71Z#H5W
MINK>)[J<Q&/4[P3P;6R0HB5/FXX.5-=)6>->T<WILAJMB;H-M,'VA-^[TVYS
MF@#@(?!?B+2M!\$-9PV5UJ'A]I/.MWN#&D@="IVOM/3/I6K;>$]47QUXFUR7
M[.MOJFG16\*K(2P=4 .>.F>]=Q'(DT22Q.KQN RLIR&!Z$'N*=0!P=QX/U.7
MX6Z/X<5K?[=:?8_,)<[/W4B,V#CT4XXJ0Z1XGTGQ=KMWI%OI]Q9ZTT,GG3W#
M(UHZ1B,DH%.\< @ CTR.M=Q10!YGIG@G6]!T/PO-;16-YJ>CQ3V\]M+*5CGB
ME;=\K[3A@54\C'45VWA^/5DLI9-9BLH+B64ND%IDK#'@!5+$#>W4DX'7VK6H
MH X[7=%UH>/M)\1:5;VMU%%:26=Q%-.8BJLRMO4[3G&#Q64OAWQ9H^D:MX:T
MB#3IM.O99VMKZ:Y9&M4F)+*T84[BI9L$$9XS7HU% %'1M,BT70[#2X&+16=O
M' K'J0J@9/Y5P%OX=\::7HFNZ-9V^ESQ:O=W4L=Q)=,AM%F8]5V'?P<\$<DC
MFO3:* . 'A/5/#-_97>@V=EJ<2Z7#IT]O=3>2<PYV2JVUAT9@1]*[#18;^#2
M($U1K4WV"9OLJ%8P22<+GG &!GOC/%7Z* /.[SPOXD%WXIL;&+3_ +)K[M(=
M2EF/FPJT2QF/R]OS8P=IW8&[/M3;?P[XGLM7\+:O'8V$D]CIK:;>6YNRH497
M$BMLYX7.,#KCWKT:B@"G%I6G071NH=/M8[@DDRI"H?)Z\@9YKB/#/@"ZT[6]
M<.HO ^E2PS6FG11L24@FE>60,"..64?05WUS<V]G;O<74\<$$8R\DKA54>I)
MX%%K=07MI#=6LR36\R"2.1#E74C((/<$4 <!X3\%:SI?A'7;;5IK>;5]0@%J
MDD;DIY<< BB!)'7@D_[U4KCX?:S+\./"6@JUK]LTG4(+FX)D.PHA<G:<<GYA
MV%>HT4 <>/#-^/BXWB?,/]GG1_L6-QW^9YN[ICICOFM;PQJ5_JNFW$^H1VZ2
MQWD\"FWSL9$D* \GKQS[UM44 <9J.C^(+3QQ=:UI%KI]TM]916OFW4Q1K,HS
MDD *=RG<#M!&2.HZUFZ-HOB_P]X;M-)&GZ5JMK;M/#+;S7&PW"L^])=Q0@'E
M@4(/KGM7HM% '/>"M"N/#WAQ;*Y$$<C3S3^1;DF*W$DA<1ID#Y5!QT%9!T?Q
M-H?BG6KK0[;3[JRUEXYBUS<-&;28($9BH4[U. < @]O>NXJM8:A9ZI91WEA=
M0W5K)G9-"X96P2#@CW!'X4 >=Z7X&US0O#_AF2!+*]U71FNDE@ED*QW$4SEC
MA]IVL,(>F.HK5UC0?$/B#X?ZYIMW#IUM?WX*V]O Q\N%/EPK/@;CP23@=<5W
M%% '!>)?!VIZMH/@^RMFMQ+I%_:7%SO<@%(E(;;QR?3I6WH^B7=CXS\2ZM,8
M_LVI?9?("MEAY<95MPQQR>*Z*B@#S6Q\$ZUI&C:!<6\5C<ZII-Q>,UM+*5CG
MAGD9BH?:<,/D(XQD$5>U7P[XCUWP\)9TTRSU:UU*'4+"VB):*/RR,)(^ 6)^
M;) &,UV5YJ=AIS0+>WD%NUQ((H5ED"F1R<!5!ZG)' JRS!5+,0% R2>@H X>
MTT?Q-J/CS2_$6K6UC96UK:3V_P!DAN#,RE]IW;MH!SCIV ')SQK>.-"O/$/A
MB6ST]XDO8YH;F#SB0A>.17 ;'.#C'XULV.HV6J0&>PNX+J$.4,D+AUW#J,CC
MBK5 '#V^D^)M4\;Z-X@U6UL;*WLK>XA-K#<&9E+A?FW;0#DCIC@ <G/%/_A"
M=5_X4JWA+=;?VD8BF=Y\O)FW]<9Z>U>B44 <3=:1XBT?QGJ.M:%:6-]!JT$,
M=Q%<W)A,,L0*JX(5MR[3R.O%9%AX$U[3M$LIM]C=:SI^KW-\BR,5BN8Y=P92
M<'82&R.#@@=:]$O]0L]+LI+V_N8K:UBQOFF<*JY.!DGW(%6<C&<\>M ' :]X
M?\2^)_ NO:=<VVF65U?>6MI;0R%A$JLI.^3:-Q.">%X]Z[Y!M10>H&*K6.IV
M&IK,UA>072PR&*1H9 X1P 2I([X(X]ZM4 <1=:'XAM?&&LWVF06$D&L0PQF\
MGF*R6>Q2IPFT[QSN R.>M<E:Z9XBT'Q!X'TY(+)]1T[3KR(1&X;R[F-?+'W]
MN4)!ST."!Z\>R55ETVSFU*WU&2W1KRW1XXI3U16QN ^N!^5 'E'C'0]5B\$>
M,]=UA8+:_P!6>S1;>WD,JV\4<B*HW$#<Q+,3QBNJ.C^)=<\3Z+<ZW;6%K9:/
M(\^ZWN&D-W,4**0I4;%&2<$D]O>MW6+SPW?6\VEZM?:<\;$"6WFN%4Y!!&1G
M/4#\JV(Y$EC62-U=&&593D$>QH \VM? >KP^%_'NG,UMY^NWMU/:8D. L@^7
M<<<'\ZN?\(KK>EV?A+4-,2TN-4T73Q8W-K+*42="B!@K[3@AD!&1SS7?T4 >
M>W^@^+]0CT_5KX:?>7UGJAO(]*,NV&.+RV0()-F6<%MVXCKTK-U?P7XKU>V\
M5QSC3A)KUO;%6CG;%L\38\OE?F&WG=QR#QSQZI10!P[Z/XFUWQ%HDFMV]A;V
M.CS-<F6WN&D:[EV%%(4J-@&XD@D^GO69;_#S4VTKQE:SSVT4NJZL=1L9 2P4
MJX=-XQZJ 0,\$UZ710!S>A+XCFU,S:MINEZ;:1PE!%;2F:260D?/NVKM4 'C
MDG/M53XF>&K_ ,7>!KO1]-,(NI9(F4S,57"N&/(!["NOHH XO4M'U^T\;RZW
MI%II]VMU81V>^ZF*&T9'9MP 4[E.[E0025ZUAMX'\21_#ZUTFWDM%UG2-1:Y
ML+HRG;,ID<EFPOR$K(PQSR.OIZA10!YEXA^'%_=Z#X<TS29H(A:6O]G7[LQ4
MO;/Y9DQ@<G,><?[1KL;K4+VT\5:1I=M%;?8+BWG>7@^8GE[ NWG 7Y@#GU%;
ME% '.^-]$N]?\-/9V0A>X2>&X6&<D1S>7(KE&.#P=N.E<Y<^'_%>I:[<:K=6
MNG0I>Z//IAM8[DM]ES\R-NV#>2V0< 8&.N.>\O-0L].2)[VZAMUFE6&,RN%W
MR-PJC/4GTJS0!Q-[X4U&X\"^&-&1H/M6F2V#SDN=I$)7?M..?NG%5TT+Q3HV
MI:_::/#I\NG:S<O=I=33LCVDDBA9,H%._D9 !'N:[ZB@# \$Z/=>'_!>DZ3>
MF,W-I (Y#&V5R/0UOT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5R'Q)U75-(\)FXTMXHY'N8(9
M'<D,%>14.W'0G/7L,]ZZ^N<\<Z%>>(O"L]A8/"MWYL,T7G$A&,<BO@D D9VX
MSB@#G=6?4H_BKHCPVEK)J#Z/<@J92L0/F1\EMN[ ]@3D_C6GIGC#4]1\/2W$
M>C"35(-3;2[B&&0M%&ZOM:4MC/E@'<>,]O>GMHVNS^.M+UZ>&P6&WL);:9$N
M&+!G96^7*<@;<9.,]<#I6$W@WQ,FC:A!$=/+S^(6U5K9KA_+N8&;)@D.SCMV
M(.* +\OC:_N-(\8I9"P>_P!!A\Q+B.0O#*#$9 0.H(P05R>1UKHO!\]]<^$=
M*GU QM-):0MO5RQ<&-3EB0/F/.:YR'PCKDU_XP:Z;3H8-?L8X4\EW8PNL+1[
M<%1D#.=W&<?=&>.E\*VFI:?X:L+'54M4N+6!(,6TC.I"*%SD@<G&<8XSCGK0
M!RGQ#D$/C3P'+]G><K?3_NXU!9OW709Q71V%U'J.O7;)H\UG=V5JHBEN8PF\
M2ELCY2<KF):S_%F@ZUJOB;PYJ6G0V3PZ3/),ZSW#1M)N3;@81L=S6JK>(YM0
MB>2ST^VM8T=G$=VTCS/C"(<Q@*N223R>!QUH Q-'\9ZKJFISZ*^DP6^L6MV8
M[J!IF*1V^W(G#[>0V0%&,G/;!Q8UCQC-!=:K;:5!!/-IBCS$F+YFD*!_+3:I
MP=I7D]SC'>J%UX5U]=1TKQ)8M9CQ$LK#40]PXAFMVZP@A"<+A=O P02<DG,D
M^B>+-'\6:AJOA[^S+BRU;RWNK6]E=/(F5 F]&53D$ 9&.U %^R\6SZU/9V>F
MV7D7LU@M].E\&7[,K':J%0,EBP;TX7/H#7'C#58!X<&H:&+.75;QK.:&2;+0
ML YW+@892$R.G6J^I>'/$UCXFL_$FB7%E>WC60LM0M[MFA28!BX="H;:021@
MYX]:L:_H&OZA9Z)?1R6=QJ^G:@+UX6=HX74JRF-6P2,!A@D<D$X&<4 ,U'Q;
MJB_\)I:6MK:QW6A6L<\,SNS+('C=^5QP0%Z9Y]JICQ#J%AX)\)76HZ?9W[7T
M]C 9'F)9/,"8EP5Y?.3U&#CDU-!X5UVXU/QA/?-81QZ]91VZ>3([&%EB9.ZC
M</GZ\$XZ#-17/A?Q)=^#?#>ER1:8MUI5W:2OMN7V,D&.AV9W-CIC ]30!NIX
MBNT\?-X<N[2"*"2S-W:W D),P#!67&,!AD$\G@BJ[^+Y(;2P,L-NMQJ4\J6>
M'8H84R?-; S@J 0!_?7D<D/\8^%[CQ$FEW%E<_8]0LKD,)U/(A<;)E!]2IR/
M=14?BWPWJ5W_ &-J'AN6VM]2T:1C;Q7 (ADC9=KQMCD9 &#VQ^( %T?5I?%E
MMK>D:II42FV81;Y(F>VND<95E# $CC!7L1UIM[J-EX$TW0M&CDM[>&=S;1W-
MT=D,9"EN<< DC &0.>O&#L:&-;>&2XUT6D5Q)@+;6C%TB SSN8 LQSSP!P/<
MF'Q%87.HK!;C3['4=-<.MY:W38W XVE<J1D$'KCKUSB@"_I-Q>75@);^WC@N
M/,D4K$Y=2H<A6!('#* WXUE:SXE^Q:PFCVODB\-L;EWGW%$3=M7A0222&],
M'V!/!7AZ7PQH+:=))F/[1+)!")#(+>)FRL08\D =_<UG^(]#\01>*[7Q-X:>
MSDN1:_8KNSO&9$FBW%U*L <,"3VZ&@"D/B%J1TK1;IO#YCFOM4&F312RLA1^
M2&3*C<A"Y!XZ]#5JW\3^);C7-5T :/IHU*TCCN(Y?MC^0T3[L9.S=N!7'3!Z
MY'<UO0?$>KP:!)*U@]U9ZK'J-RHE9(T559?+C^4D\-U.,G/3.!;M-&U:V\?:
MMKIAM&M+JRBMXE$[;]T98Y(V8 .[U.,4 92_$6[F\.>&=5MM%60ZS=_8VA-S
MM:*7+@@?+@C,;<DCMQ5[1_%&H7GB+4O#'B#3+>TOXK3[7"UO,98IX"=I()4'
M(;@Y%<A>:+JWAGPOX%TJYCLY+ZW\1JR^7,QC?=Y[XW%01]['0UW$.B7TWB>\
M\27,,,=S_9XL+2V$I("[B[,[8X); P <!>^> #G/ NO#2/AGX-LX8EFO]2'D
M6T;-M7C<S,QP>%4$\=3@=\UOIXHU)=<U'P[+8VQUF&S%[9[92L-W'G:>2"48
M-P1SU!K!LO >LV?A+PK$DEFNM^')B\6)6,,Z-D.A;;E=RGK@X(KH[72)CXKE
M\5:L(+1HK 6<,0EW!$W[W=V( R3@8'0#KS@ %?3?&-SJWA+2M5M;2#[=?W*V
MWV1I&'EON(D4G&<H%=CQ_":A?Q7K]QK'B32[#1[$SZ.(65YKM@DH="_9,@X
M&.@YYZ99X;T*"/QWKVIV=UYNFB0/%"N"B74B*9F![G:$Y]7<59L="UBT\3^*
M]3,5FT.K) MLHN&W QQE/G^3C.<\9H SX/'^HS:=X<UIM(@CTC6)X+8YN29X
MWEX#;0NTJ&XZY(YP.E6]7\;W$ U9M)M(;HZ7(8WA<OON'50S+'M4@$ X&<Y;
M(P!R<M/!FOQ^!?"^AA-/-UI%[;W$S&X<(ZQ-N^4[,Y/N.*N)H?B[0?$FIS:"
M=+N=+U6?[5)'>R.KVLQ #D;1\ZG ../PZD L'QEJMWXCL])T_1HLWND_VC"]
MW.T93YE&V1=A*XW'@;B3CIR1BZQXUUJ]\ "_M(+>RODU5=-O%\QF"L)Q&WEM
MCH?4] 3WYKH5T'5X_'UGK9:WN+6#26L'=Y2LLCEU<OM"X ^7IGO6$_@?79/!
MNJZ:38+>S:T=4M\3L8V!G$NQCL!!XQD T >C6YG,"&Y6-9L?.(R2H/L2 :Y4
M^*M276_$.DO8VD=QIMJEW:EYR%NHVW<D[?E *[3UYKJ+4W!MHS=K$MP1EUB8
MLJGT!(!./7 SZ#I7-^(_"<FL^(M(U."<0K")+:_7O<6S8;R_IO51]&:@!FB>
M+KC7=!\/:A:6UN9=58^9%YC8@50Q<YQR5*[>@Y(K+NO%6H+HOCF>QTZQLK_1
MV;]X'+B4B$/O;Y1EL8 !].M:_AKPF^@Z_K5X9P]I<W#2V4/_ #[B3:TP_P"!
M. <?[(K.C\(ZM-!XXM[@VD2:^'^SNDK.8\PB,;QM'IGC- &/K$^H/9_#FZN(
M8I[UKZ,IME/SYMFY9F'!SR>OXUU_AKQ#?:GJ^M:1JEG;V]]I<D6XVTIDCD21
M-RD$@'/!!X[5BR>&_$ES:^$!-#IBR:+<)),J7+D,JQ&/Y3LY)R6[8Z<]:UM$
MT34K'QOXCU>Y2V%IJ8MA"(Y2SKY2%3N!4#G.>": (/B5JNIZ/X.FNM+>*.0S
M0Q.[DA@KR*AVX[_-U[?6LK67U&/XI>'GBM+:34&TJ[&WS2L0.^/DMMW8'L"?
MYUT7CG0KOQ)X2NM-L'A2Z:2&6(S$A"8Y5?!(!(SMQT[U2DT;7;GQQH^O3PV"
MQ6ME-!,B7#DAI"I^7*<@;0,G&>N!TH @L?'K-X?FNK^SCAU&'56TAH(Y2T;3
MAL9#8SMQ\W3. >#5_0?$UYJ'B&]TB[LL"&%9X;V!'\F52<%3N PX..,G(YKG
M&\":[-HVK1K<6=IJ3:\VMZ=*DC2(KY&$D!4<8R#C/6NMT#_A)9B9_$*6%LRI
ML2WL7:16.1EV9@/3  Z9.2<\ &#\6=7O-,\)6]M8SO;S:I?PZ>9T.&B60G<0
M>QPI&?>NKBT/2XM$&C+8P?V:(O*^SE 4*XZ$=_K5+Q?X8M_%WAR?2IY6@=F6
M2"X09:&53E6'X_H346GS^+A;);7^GZ8;E1M:\CNF\M_]OR]F0>^W./\ :% $
M,5^=*OM.\':2L<MU;:<LK2W#';'"F(U) Y9F(Z<="<] <>_^(UU9>%]<OCI,
M1U/1+E;:\M6N"%^9E"R(VWYE(8$ X/7\=&]\.:G:>,;+Q-IDD=W,+$V%]!._
MEF9-V]74@$!@V>,8(/:LG6_ NIZCX;\3)";,:MK]S%+)OE810I&4"+N"DL<)
MUP.6/I0!J7'BC7K7Q7#H<NC69:_MI)[)UNSA2A7<)?DXX8'Y=W/'/6LZX^(>
MHV?@[6=5GTBW:^T?4/L%U"ER=C'<@#H2N2/WBG!QWYK7OM&U:[\=Z'K8AM%M
M;*VGAF4SMO)DV_=&S! V]R,YKC/%^B:IH_P\\;27JVH&HZI%>P>5*S[0TL*A
M6RHY^7/&>M '6P^+=6M/&=EH>N:/#:0:HDC6$\%QYIW(-S)(-H ;;SQD=@3U
MJ&/QO?1:EH4&HZ?#:_VO</ +1I2+FVX8HSKW#!>>F,CDU>N=$U'6_$6EZG?1
MPV2Z7',85CE\TO-(FS=T VJ,X[DGH,<\Q:>#/%D>G^'8IET@W.DZE]JGG\^1
MFO,JZF5CLR&^8<'.?5<8H TKCQMKY'B<6>B6).@O^\,MXV)4$8D^7"9W$'H0
M /4U>E\9W"7OA:06,2Z3KZKMNI)2&AD:/>B%<8);H#GK56+PSK:#QKF.QSKF
M3;8N&^3]R(OG^3CIGC/I46LZ3'#\*(M U2X@AU.SL(EM_L\NYO/B"B)H\@$D
MN% X[XH ZO3M2N+[5=3@\F(6EG(L*3*Q+2/M#,,8Q@;@,Y/.?2J'BWQ'=>'%
MTEK>PCNUOM0ALFS-L9/,/! Q@]#U([5I:#ISZ5HMM:32>;<A2]Q+C'F2L2TC
M?BQ8UD^,]$U+6X]&73EMC]BU2"^E\^4IE8R3M&%/)S0!2A\3^(Y/$>H>'3I&
MG#48;>.[@E%XY@,3%E^8[-VX%<<#!]N[],\8WVL>%]*U*UTG%Q>7+VUP"^Z*
MTV%P\C,!RN4..F<CD5/%HVK1_$2[U\Q6ALY=-2S1?/;S-RNSY(V8P=V.O:N;
ML_!GB>Q\/:-9A=-G-CJ<UW<6;W+B&ZCD9V4%O+SE"X(!4C(!["@#3C\=:C=>
M%]?U&PTVUO;O1;IX9(XK@^7<(JA]Z, >=K?=YY!&:VXO$,EZ= ^P);W"ZG$;
MB1@Y 2$*"77CGED7!QRP]*S_  QI.H^']1\07.L3:<EIJ-Z+F-HY&'S,B+M(
M8 #&W'4YST'2H/A[H$>E)J=Q!<F>Q-U+!IH/2*V5V8JOMYC/SW"K[4 =)XC5
M7\,:LK $&SFR#_N&O/O#WBS5_#G@WPA-?:/!_8$]M:6C7*7),T3,BJLC)MQL
M)]"3@\X/%>E:E:F_TN[LU<(9X7B#$9QN4C/ZUQEIX3U>[\+:)X9U6*TALM-:
MW\^:&<R&Y6'!0*I4;=Q52<GCD#.<@ FU;QU<01:G/I5E%>+IL[0/;DOYMPRX
MWA-JD @D@9SD@].">QL[E;RR@ND21%FC60)(NUE!&<$=CSTKB;?0O%_A[7]4
M70WTNXT?4[IKS_3&=9+25_OX"CYU)Y R/J.M=Q!&T5O'&\C2LBA3(W5B!U..
MYH X33/$^IVVO^-+G6'M_P"S='9,B)F)CC$/F *".2=W)XY_"KD'C+4#K6F6
MDFF)+;ZBK 26_F'[(X7($I*XVGIN'0]C4,O@V_NM6\7V\[VO]D>((U_>J[>=
M$PA$>-F,=0&SN[8QSD6/#=KXWMX[>QUR32S;V:A?M5L[F6["C"@J1A,\%CSZ
M <YH IZ5XR\2:M:7-]!X?L1:6D]U!<;[\AMT60-O[LY!(QG Z].,F&/Q_K/]
MD^&M9ET.V-AK,L-N$2Z/G)+*#M."NW;D8ZYYSQTK1\-^']9TGPUK5A<Q61N+
MNZN;B#R[ABN)6) 8E 1C/8&LW_A#]>7P;X1TA4L#<:+>VUQ.QN&"NL.>%.S.
M3GN!B@#:TKQ'JUQXCU30=0TZSCOK:VCNX#!<LT<B.67#,4!!!7K@_2L2U\>7
M$/@'0-<L]!MD34+Y;1K2*;8(=\S(-OR@,>.^WDUM0Z-J\7Q"OM?\FT-I-IT=
MHB?:&W[D=FR1LP =V.IZ5SUOX(\00?#[0= *Z<UWIVI1W<C_ &E]C(DQDP#L
MSDYQTH Z"Q\4ZF/$6J:+JFEPK=6UBNH6ZV4QE\Z,EEV?,J_/N7'H<U!8^,KY
MO$6D:1?V=I'<:I:27 @CF)DM'15;RY01Z-UP.0>*9J7AO7KSQ=JFJVLUM:)=
M:&=-@F69C)%+N=EDQMQ@%O7/&:S]-\*>)(=3\)7DMOH]NND1SPW$<4TCF3S$
M53*#L&6)7.#Z\L<\ "^'O%^IVV@Z_J^N?9Y5M]5FM(UA=@3()%B1 ".%SCGK
MR3BM.#QK-;ZU<6FJ6J"Q2R>\&H6RR&*,)RZ/N48.!D'OZ"LP^!-8N- \1Z)+
M<VEO%=ZE+J-A=Q,S2+(TJRIN4@ !2N#@G.>V.=2WTOQ3X@T:\TWQ4=.M89K6
M2V;^SW9S,SJ5WG<!M !)"\Y/<8P0#GO%NI:EJ^D^#]3ELK>&RN]<L)HTWDS1
M*SY0MQ@D@\@="<<]:]2(R,&O,W\,>,KGPYH6BW,6D,VC7UK,MV+IQ]HCA/RY
M39\I( !Y/->EKG:-V-V.<4 >0^']>USPYX6UO4=/T2WO--LM7OI;K=<[)2@E
M8MY:A2/E'/)'3@5V</B^:7Q7I.GFUA72]7LC=V-X9#ND( 8Q[<8#;6W=>@K,
MM?"VO6NA:[X>467V;5+JYD6^$S$QQ3L2P\O;RX!('S8/KVJ7QGI%H?"^G:3I
MEXEMJNG3VHTLA@TD<@(1<KU*E=V>V 3VH Z;1=2N-3%[+)#$EO'=206[HQ)E
M5#M9B"./F##OTSWJMKOB)-*OK'3H_+-W>+(Z&7=L1$QN8A02>64 <9SU&*U-
M.L8=,TVVL8,^5;QK&N3DD 8R?4US?B[0=9NM4TG7O#LULNIZ=YD9@NR1%<0R
M8W*2.0<J"#ZT 8^I^.[M/ ^N:C>>'HI9-,N!#+#.S+!<(6 66,LGS#D'! Q@
M\UHZAJNMK\4].TFW-M_9[:;+<%&9@6(>-23@=1DX'N<GTC\2:#XF\3> M2TV
MY.G1ZE?;%6)97$$"JP;[VTEF.#DX'4#MDW-0T36)?&VD^(+1++;'92V=U%+*
MP\L.RMN3"_/C;C!V_44 <CIFMZIX<L/'>I:=IMM<VUEKUS<7'G3F,E!'$6"
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M3;6*N9#$@#R'K(_5G/N6))]S0!5UK4[VQGL8+.T#K<._G7<IQ#:HJEMSX]2
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M81O;S(5Z%44;6#' YP5ZUJ_$;5]8TJU\/IHETMO<W^LPV3,\8==KI)U!'0$
M\8/'6@#M*HZKH^GZY9&SU.V6YMF(+1.QVL0<C(!YP0#S7G_B#7+C0-4TKPSJ
M/BZZM(S:RW=UJ@MT,\QW[4C4!"JCEB3MZ*!WJI:>,]8UC2],T>RU7_3+O6I=
M/_M9;<*TEO&GF^8J,-H<J5'3&<\4 >KQQK%&L:[MJC W,6/YGDTZO,KG4O$6
MA>)M=TN76YKRWM?#<M_:22Q1B02!B 7VJ Q&#V QC(SR=#4?$.J0>!O!^H1W
M96[U"ZTV.YDV+^\67;Y@QC SD],8[8H ZVWUJRNM9O-)B:0W=FJ-,#$P4!AD
M88C#<>A.*2XT'2;O6+?5[C3K:74;9-D-R\8+QC). >W4_F:XVW\2:O)\0?'&
MF->$V>FV$,MI'L7]T[1;B<XR>>><UCVGB3Q)I_POC\8:EKGFW5];P0PPM;H(
M;=G=4\T[1EFP2Y'3G '% 'K=%>7:)XN==<N--LO$T^NVTNFS7 GGME1[:>/'
M&0B@JP8D @XVUG#6/&,/@KPSXI_X2$RW=_-;6\EG);Q_9V64[ QPH;=DAB00
M.H  H ]BHKSEM8U?PEXKU&SO]7GU>R70IM5'VB*-'22)@"JE%'RD'H<XQ6-H
M/CB<ZCX>F_X2J35;C4YTAO\ 3C:!(X/,4D&)@@("-M4Y8Y!S0!ZCJVCZ=KMB
M;+5+.&[M2P8Q2KD9'(-6(A;6JPV<0BA 3$4*X7"K@?*OH,CITXKRP7_BO4?"
M?B77E\2S6KZ1=7PM8(K>(K(L+,0),J2>!M&,=,G)-2.-0UGXJ>&KP:Q=6JW.
MB&[$421E8P3'O0;E)PV!DGGT(H ]5HKS'P_KNHZAXE$%YXJ:TUA+V1;C0;NV
M1(S '8 1':&8[ &#!CGN,5UGCK7;GPWX/OM2LD1KQ=D4 <9422.J*3[ MG\*
M .BK"_X3#1#XE;P\ET\NIICS(HH)'6+(R-[A=JY'J:YRZ?7O"6N: MUXBN=5
MM-5N38W"W$,2F.5D9D>/8HP,J1M.>#6)\.]*OX_B/XS9M>O9!;7D G#10_Z7
ME&P7PG&/]G;0!ZI>7MKIUG+=WMQ%;VT2[I)97"JH]2363HWC/PWXANFM=*UB
MUNKA5W>4C88KZ@'!(]Q5;QWH=[KWAY(=.6"2ZMKN&[2WN#B.X\MPWEL?0X_/
M%8]KXCL-3\3:1;^)O#%[HVM1._\ 9\L^'B9RI#(DR'#$KGY3P?KB@#OJ*\3E
M^)$S6=QKZ>)Y!>1W;>7H2VH,36ZR[=A;9NWE06W;L9.,5UAE\0^+-;\0KI>O
MRZ3!I,XM+6.*&-Q+,(P[-*64DKE@,#' H [TRQK*L1D42,"RH3R0,9('MD?G
M5+3M:LM4NKZWM6D,EC+Y,X>)D ;V) ##W&17GLEEK=Q\8=%6]UF6WN1HC3RQ
M6JHT2L)(Q(B%DSL8KG)^;T(J./QYK%AIWQ$OIYA='1[[R+"-T4*FX[5!P 2,
MD=>?>@#U:BO/KM_$/A#4/#UQ>^(;C58-2OH["\@GAB55>13M>+8H*@,.A)R#
M64+SQ5JN@>*]73Q+-9G1[V^2SAAMXBKK"20)"RDD8&W QTR2<T >K5S]UXX\
M+V.K_P!DW6NV,5]N"&)I0-K'H">@/L36AH5^^J>']-U"10KW5K%.RKT!9 Q
M_.N \>6UKX>\':CX?T_P_.;#4$DEN=2<&2&V:1R6ED(W2$K][H<<<C% 'H&K
MZS8Z%8?;-0F\J'>L:X4LSNQPJJH!+$GL!19:Q9:A?W]E;2EKBP=([E"A&QF4
M.!D\'@CI7%.J:G\3O#6E&?[39:3HS:G&^<B:1F$*.?4@;B#[U3T[2]7U7X@>
M.(['7)])A2YMCOMHHW>20VZ8W;P1M&.@P3GKQ0!Z#<ZS8V>KV>EW$QCNKQ7-
MN&0[9"O+*&QC=CG&<XJ%-)T-O$DNII9VAUE8U1Y]@\T(1@<]<$9&?;':O/=5
MU*]\2_ ]M=NBB:SI;-<K-&,;9[>4J7 [;@IX_P!HUN^-M8.G^'=&\7P#8]M<
M6[R8_BMYBJR(?;YE/U4'M0!W5%%% &3<^*?#UG<R6UUKVEP3QG:\4MY&K*?0
M@G(IJ^+?#;P33)K^EO% F^5DNXV"+ZG!XKE/B[9V]E\)/$(MXE3S9(Y7('+.
MUPA)/K6WXWL;9O!>OWQB7[2NBW<(DQSL,9)'YJ* .DM[B*[MHKF!Q)#*@DC<
M=&4C(/Y5!;:G97EW=VEM=12W%FRI<1JV3$Q&0#]17$Z#XBU;3?\ A#M.O+*T
M&G:K9K#"\<K&:-T@#@L,;<$ \#IZFK(\93VB^,YY]*A5]#9/EMV+&<&(,&8[
M0> 1GC@ ]: .XICS11O&CR(KR'"*3@L<9P/7BL7P]J\^L&2=+K3[[3FB1X+R
MRR S$MO0J6;!&%[_ ,708I=2T.\N_$FEZM::O):):*\=Q;"%76XC8@[<GE.5
M'(ZXH V8YHIBXBD1RC;'VMG:WH?0T^N/M[+6_"6F/##>/K N=0 B::)8UL8'
M)+,Y!RX7DDY!)/;K6/J/C;4[GPEXR:QELA>Z(I"7D.6BE0QAPZC)PV"1U(R,
M\]* /2**Y2+Q7IOAS0=*/B;5K.TFN8 8BQ8;P%7/7//(S]:&\4W#>+=+TZ+[
M*VEZO9/<V-X-Q,CJ =F,@?=;?GN 1[T ;4F@Z3+K<>M2:=;/J<<?EI=-&"ZK
MSP#VZG\ZE.JV U*33C>0B\B@%P\);#+'DC>?;(KD]&\:7VKZ!J%PL5D-3MM2
M_LX6Z%F0OO"@YSDJ0V[(' !ZXK2M-<N9/B'=Z%/96R"+38[I;J-B7D!D*X.0
M-HR&.,GZT 7V\4Z"NCOJ[:Q9#3D<QFZ\X>66!P0#W.?2K;:KIRZ@+!KZV6\,
M7GBW,H$AC_O;>N/>O(YP/^%">*Q@8%[>_P#I2:]/D\/6-YK5CK$T$!N+:$HC
M^2/,.Y2N"_4KAF^7IDYH T+#4;+5;-+O3[N"[MGR%F@D#H<'!P1QUJS67H.A
M6GA^P>ULXH8DDE:9EAB$:!F_NH.%& !CV[FN;F\5>([C6_$NEZ?IFFA](2&1
M))[ARL@=&?! 4')P!CH.>30!W%9^KZ'I>O6J6VK6$%[!'()5CG0, PS@X_$_
MG6!;>+;W4]#T#4K.TAM;;4K<W%S=W+;H;,!0<-RNXEC@<CH3[5SNK>--7U7P
M!;ZE8&VM9SJZ:?<E2S*P$X0E#Q@-[]B1[T >H*JHBHBA548"@8 %+7,PZ]J*
M^-T\.7,=J?,TMKX3QAAM82!-N">1SG.16%/\0=4A\(SZPFF6LLUOJ[:;)&)F
M4$"81!E!'))/0D8]: /0Z*Y";Q)K&GSV^GZI:V46HWLTQMC:^;<(ENBJ2[*%
M#%LL%P,#G.15[PKKNH:RNH0ZEILMI/9W'E++Y,D<5RA&5= X!]B.<'O0!T-(
MS!5+,0% R2>@KGY]=N;OQ-<Z!I/V=;BSMDN+F>X4LJ%R0B!0022%))SP,<'/
M'(>)_%-YKWPF\3RQ0QV=]8>?8ZA"6+;67AMC#&00002.AH [ZPU_2=4NY;2R
MOX)[B)0[Q*WS!3T8#NI]1Q6E67H]F5M[>[N[>S^W" 1":&/!\O@A<GG&><=*
MU* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *Y_P ;Z#<>)_!FIZ+:2Q13W<81'E)"@[@>< GM7050
MUC6=.T#3GU#5;I+6T0A6E?. 2<#I[T <]JOA;4F3PYJ&E3VJZOHD9B"W&[R9
MT= CJ2!D?=!!P>G2J$_@O6=6L_$]YJMQ8KJ^L6'V"". N8;:,!L#<1N;+,23
MCZ"M"+XI>"9I4BC\06S.[!5 5^2>G\-=?0!3TBS?3]%L+*1E:2WMXXF*]"54
M X]N*YF[\/>((/%FJZAI-QIZ6NKQ0QSRS[_.MC&"N8P!AN#D D8/K7944 >?
M^&_!.KZ5=>%GO+BR:/0[:ZM286<F5)-FQL%1@_*<C\LUMV.C?V3XD\3ZS?W%
MJ++5/L^T.V-HCBV-OSQS]>E=+574--L=6M&M-1L[>\MF()BN(PZ$CD'!XH \
MZ^$.B"&+4M7$[7%EYKV&D2..?L4<CE2/8LQ_!179^+O#Y\2^'Y+&*X%M=))'
M<6TY7<(Y8V#*2.XR,'V-:W^CV%F<"."V@CZ*-JHBCL!T  IFGW]KJFGP7]C,
MLUK<()(I%Z,IZ&@#EK70?$.J^)]+U?Q&^F11Z4LAMK>P>1_,E==I=RX& %SA
M0#UZU?\ !'AZY\,>'!IMW+%++]IGFW1$E</(S <@<X-='10!S^MZ%<:GXD\.
M:E%+$L6EW$TLJN3N8/$R#;QZGOBL_4O!3:OKGB*>[FC%CJ^EQV("9\Q&4OEL
M8Q_$".>U='I^KZ=JWVC^S[ZWNOLTIAF\F0-Y;CJIQT-7: .!7PQXIU8:-8:_
M<Z5_9NEW$5PTEH9#+=M%]S<K !!G!."W3C%=1XHTJ;7/"FK:5;NB37EI) C2
M9V@LI )QSCFM:B@#E=4\+7=WX2T>QMKF&+5-):WGMY7!:(RQ+C#=]K L/7FJ
M>I^'_%'B;PYK5AK-YIMLUW"D=K;V@:2.-E;=N=V4,VXX!&, #N37;44 <%+X
M=\87_B'3-;NKS2;:>VAFM3!;%W2)) O[Q"R_,^5'RD!< #/6GP^&?$.K:[I=
MYXE_L?9IJ2KYMEO,MUOC,9#;E 1<,6(!/(%=U5'3]9T[5I+I-/O(KDVLGE3^
M4V0CXSC/3/- '!_\(1XGE\+Q^#)KW3#H"%8C>*9/M36ZMN$>S&T-@!=V[IVK
MJ=)T"?3O&&OZNTD1M]1CM4AC7.Y/*5E.>,?Q#&*Z&B@#G_!F@W'AOPZNG74L
M4DHN9YMT1.W$DK.!R!SAA6+!_P 2#XOWQG^6V\1V<30R'H;B %3']2AW#UP?
M2NZJO=V-I?K$MW;0SB*198_,0-L=>C#/0CUH XRY\-^*=7O-.MM8N-(FL["_
M2\2_16%TX1]RKLVA4)P%)#=,\53F\&^*8K#Q'H=C>:4NDZO/<SK<2&3SXO.R
M6CV@;<9)&[/ .<'I7H]% ' #PCXBT_7-'U?2[G3FEL-$339(+AG"S,&!/S!2
M5' (.">,8YKG?&^D3Z%\*_%]WK5Y:-J^LS)/(L#$(N&C58TW8+84=<=Z]AK/
MU'0M)U>:WEU+3+.\DMR3"UQ LAC)QG;D<=!^0H Y9=#UJ*71M?T%K(W@TJ.R
MN;:^9T1T&&4AE!(96+=CD'M4NI>&?$-]8Z-J#:E92>)-+N9+A':,K;LKAE:'
MCY@NT@!N3\N3UKM*HKK.FOK3:.EY$VHK#Y[6ZMEE3(&X^G)'6@#CM8\(^)O$
MWA+Q!8ZOJ=FEYJ7E?9K>#<UM:B-@P&X@,2Q')Q]!79Z4=2.FQ'5TM$ON?,6T
M9FBZ\8+ 'ICM5RJNI:A;Z3I=WJ-VQ6VM(7GE*C)"J"3QWX% '##P%J<Z>+='
MNI[(Z)KMQ+=I,A?[1#*X3 *XVE05!ZY./?BT/#OBG6[[1AXDGTI;+2KA;O-D
MTC274R A"P8 ( 3N(!;FMB7QKHL.G:'?/-*(-;FBALCY1RS2?=R.WXUT- &3
MXGT=O$'A;5-(241/>6TD*R,,A2P(!/MFN>T[PSK[W_A.\U9]-231$GBD6U>1
MA(KQ*BD;E'.02?ZUV]% '$:KX%GU;4/%<LEW'%%J\%HMLZ EX9(-S!F'3&XJ
M>#V/2M;1HO%KZB)M=GTN*UCA*""PWOYTA(^=F=05  .%&?O<DX%=#10!S_BC
M0KC7)=">WEB0:?JL5[)YA/S(JN"!@=?F'6JFJ^$6U?Q9=7]Q)'_9]UH<FE21
M@GS,O)N)'&,8SWZUU=9]MK%O=:S>Z6D=P)[-4:1GA98SN&1M<\-[XZ4 <8/"
M/BG4-*TOP[K%WI3:-8RPM)<0>9Y]TD)!160C:F2JY(8].*U++P[K.G?$#6M6
M@DL)-)UA83.LC.)XFCB*#: -I!.#R177T4 >::1\.-4TSX=Z-HZWUHNLZ1?&
M^MI@&:%GWL=K<!MI5R#BM*[\+>)?$>G:HFO:G:6TL\<0LK>QW/#;R1OYBR$L
M 68L%SP.!BNYHH Y_18_%CZB9]=FTN*V2'8MM8;W\QR1^\9G4%< $!1GJ<DX
M%,\6^'KG7Y- :VEBC&G:O#?R^83\R('!"X!Y^8=>*Z.J&L:S9Z%8"]OG9(3+
M'#E5+'<[!5X'N10!CZ]HFK'Q#9>(-!>S-]#;O:307K,L<T3,&'S*"5967/0Y
MR:S]4\,^)-2TW2KV34;!_$.G7S7D68V6VVL"IAR!NV[3C=C/%=O10!Y=;Z;J
MFH_$_5+37IK99[[PRT12SW-'"C3%< L 6/4Y('7&.*G7P=XON]'\/Z3J%WH\
M=KHMW:2HUN9"]RL+#&[*X4[1T&<G'( Y]#^Q6OV_[?\ 9XOMGE>3Y^P;_+SG
M;GKC/.*GH XJ#P=?1>-/%FM&XMS!K-G%;P("VY&6/82W&,9],TZ+P5<-\,++
MPO+=QQWUI#%Y=S&"R+-$P=6P<$C<H_#-=G10!S%G:>+;W[6-;GTN&%[1H(K:
MQWN&D;_EHSNH(QT"C/4Y)XK-;P3?MX"\.:!]HMOM.EW%I++)EMC"%@6V\9YQ
MQD"NKO\ 6=-TN>T@O;R*":[E$-O&S?-(YZ "KU '+:KX4?5O%[:E/)'_ &?)
MHT^FRQ@GS"9'4Y'&,8![U!H&E^,; Z9IU[?:7_9E@HC:>!7,]VBKM0,K#;'V
M)()Y'&,UT6J:SINBP)/J5Y%;1R.(T,C8W,3@ #J35Z@#C;3PA>V_@GQ'HC3V
MYN-4EOGB<%MJB<L5W<9XW#. ?QJM)X2URSUSPUJNF3:=))IVF_V==1W+.H9?
MERR%5.3E3P<5W=4[K5;&ROK*RN;E([F]9DMHVZR%5W,!]!S0!R%SX;\4ZO>:
M=;:Q<:1-9V%^EXE^BL+IPC[E79M"H3@*2&Z9XKHO%>@)XH\,WND-,8&G53',
M!GRW5@R-COAE'%;-% '%1Z!XEUK6]'N_$LFE1VVDR&XCBL&D<W$VTJ&;>!L
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MKTRB@#DO%GA[6-3N='UK0[FUMM:TQGVQW&YH)DD #QL0,X^48..W;MLZ)%K
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M2TNK>.S;[!Y3N4Q&_E@97Y>=Y)(/6N]U?P[+J?BS1=6$Z)#80W44B<[F\U5
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MGKD8Y[^YMH[RRFM9QNCFC:.0#C((P?YT >6^,]6U37_AO:ZR$M(M-O+VTD2
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MX;_[!5K_ .BEK?K)\,:9<Z+X7TS2[N:*::SMH[<O$I52$4*.I]JUJ "BBB@
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M'?TVXZ  =\T >NU%<W,%G;M/=3QP0IC=)*X51DX&2?<UY]%J&I>,?$ECI?\
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MOG7;Z PRWMO:6<;*+<11 KM=,?,6P<G.1GC&*[CP+_R3_P .?]@NV_\ 12T
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M$E\;F0Z39S+IUI#GY3(@S,_N=QV@^QJ#XN?\DJU__K@O_H:T /\ ^%K>"_\
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M'T2NCUSQOX3LH3!J\^^VE+("]G)+%,R-AE4A2K$$=!GH?2NHB2..)$B14C4
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MLVYR"0#@'' /)XJ[0!R]SX3DU3Q#97FL7:WVGZ?;;+>UDC'[R9AM>:3L3C(
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MI_AR2R\;:OKWGH8KZV@@6$+@IY>[G/OFN@HH X>+P5JEE?>-+W3]6B@NM?\
M+^SR>62;8JK*2>>3\W'I4_A/P_XCT"TLM)N+C0FT>WC,;1VUI*LK\'G<TA&2
MQR21SDUOZQKEIH@L#=+*?MMY'91>6H.)'SMSSTXK2H XK1O#'B71DL=(@URU
M70K*4-&5MC]J>('*PLQ)7'8L!D@=JKR^"]>MY-<L-*UBS@T;69Y;B42V[-/
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M5--\:VWAS4)8)TU*UDFL;M(2I22/[Z.N[!&""""/3WK'\ 0:K-!XJS?6A/\
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ML;F,(2'SC V@CY<YQSQS-X>T'Q1IXAAU?Q%#J%O:*5MPEL8GE."%,S;CG [
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M?N_+W88G=S]XY&!61#X!U&#PGX:T1=3M2=$OHKL3&W;]\(R2%QNXSNY.3TH
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ME4"8R2<@@#L*R=!\%Z[H!_LFV\1(WAI)"\5NUM_I,:$Y\H2;L;><9QG'3'4
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MOG!+;NN>U6H+2Y\7^,_$%KJ.JZC!::1]GMH(;"Z>V!D:,.\C;3DG)  )( %
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M]>U71XHYEN-,$)F9@-C>:I9=ISD\#G(%<9\3M,2^UOP:'NKV(2ZNL)$%R\8
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M5<MM4L?X06X&: , ?#F_.CKX:;Q#N\+K(#]D^R?OS$&W"$S;ONYXSMSCBN_
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M*UJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW%C%>2W2RW<MSYDH^;YSG!/<^_>@#D]5T6UN_CKISR2W@+:2]QB.[D0!TD0
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M7[]8]Q^0@],CKCUIVK>%;F\\7V'B.PU8V-Q;VYM9HS;B59H2X<KR1M.1UYH
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M4AE/0@@BN(U>.;4/BCX5N(-3O(([G3[J6-52+]T,1<#<AZ]\Y]L5V?B+SO\
MA&]2-O=2VLRVTC)-#MWH0I.1D$=O2@"/5_$EAHK:<+GSG&H74=I T,9==[G
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M*G# 'H<9P?P(_.N"@U;7[/Q3X5AN]56YM=<MYA+ +=$$+I") R,!D]P<DCT
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M:B)9+<C4?,NI)!?!TP=V6^4Y.0RX(K@=-L8M*^!GB?4K*2YAO&FN8_-%S(2
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M?:KZ80PF1(@Q!/S.P51@<\E@* ,71_"DNE^)[_7)-8N+F6_ABCGB>)%5FC#
M$8' PQP!^)-0/\/]*>Q\36A+[->=GDSSY)*_PC_?+/\ 4^U:J:_&_C"7P[Y#
M>9'8)>^=NX(9V3;CU^7-:] &-<:',OA9=&TK4IM.ECB2**\5!(Z[2,DAN"2
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M@C)/'H?QJY+X.O[[PYJ.FZKXBGOKJ^@-L]V]LB".(]0D:X )[DY)X] !UU%
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M 5RWCZ:S308+:\?4"MW=Q0I;:><2W;9W>5G(PI"G)R. >:ZFL7Q)X>'B"UM
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M7KBZO&U'3]0OGL9A<NOV;RY20% ..N<DCV["O1='\%SZ5<6*/XCU*YTW3O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 445S'BK6+V'4='T#291#J&J2L3<;0WV>",!I' ((+<A1D
M8RWM0!T]%<WJGCC0]&OY;.[FN6:V"FZFBM9)(K;=]TRNJE4SUY[<]*CCUF\L
M/'BZ/>SB>PU6W:XTV3:H,;QX\R+('S#!#@GGJ,GB@#J**** "BBB@ HHKSFR
ML=8\2^)_$Z_\)5JVGPV%\L$$-KY6P+Y2-SN0GJQ[T >C45P&B>-Y=/\ #%W+
MKLDFH7EGJTND0M:P@27TBMA-J# #$=>0!M-:UIXYM#-?VVK:?>Z/=V-HU])#
M=!&W0#.71D9@P&,$9SF@#J:*YO1O%IU:\2UN-#U333/ ;BWDND3;*@QGE&;:
MWS [6P:XI/':Z7\,-+U3PY:ZQ>175\($EU"1)94_? ,&+/R6&X+UQQG% 'K-
M%<9/K5E)X\\.6UU#K%IJ5W:S216QF40J IW"558@L.V,T7?Q%MH#?W%OHNJW
MFEZ=*T5WJ-NB&.-E^_@%@SA>Y4'&#UH [.BN6U#QS9VFKV^E6=A>ZG>75DM[
M;):*A$L98C.YF '3.3@<CN0*BB^(-A-H7V]=/U#[7]O.F_V=L7S_ +2.2GWM
MO0;LYQB@#KJ*R="US^VHKCS-/O-/N;:3RIK>[4!E. 005)5@0>H-&OZ]'H-M
M;N;.ZO;BYF$%O;6J@O(Y!/<@   DDD 4 :U%<A)\0M.M?#NHZM?65[:-IES'
M;7MI*J^;"SL@!X8J5Q(K9!Z?E4^G>-([OQ!!H]WH^I:;+=Q/+9R7:(%N%3&[
M&UB5(!!PP!QZ4 =117E7C7X@F]\ ZW=:78:M!9;7AMM83:L;2!]N5PV\ D$!
ML8S7J4))@C).25'\J 'T5YNT>L>(?B;XCTI/$NIZ;9V$%J\,=GY>,NIW9W(W
M<5:MM2U[PGXOTS1-:U/^U]+U??':7DD*QS03*-VQ]N P(Z'&<T =]17/0^,+
M"?POJFOK!<"UTYKA94*KO;R2P;;SCG:<9(_"L.?QW?-X\TC2;31KR6QN[ W3
M,HCRP8Q[7&7&%3+!N^>@- '>T5P^D>)M$L[GQC>-<:FL>F7)^VF\E\Q%(!XA
M7)POMQSBM#3_ !M!/=M:ZGI6H:/*;9[R(7JIB6),;B-C-AER"5.",T =117,
M:)XS76;RUA?1-4L8KV(S6=Q<QILF4 '^%B4)!R P&173T %%%<#XUN-0F\;^
M&M&MM=NM)M;R"[>>2V* L4"%>7!'<_G0!WU%<II&AW.GWXNCXOU75_+1C]CF
MD@*R<8'W5!_44G_"P=)/AF/6%ANVDDNOL2Z>$'VG[3NVF+;G 8=>N,<T =91
M7+:KXUCT[4+FRMM&U+4I+*%9KXVBH1;*PR =S#<V!G:N3BG7_C>RA&FQZ79W
M>L76HV_VJW@LPN?)X_>,7*A5^8#DYR<4 =/17+6/CS2]0?2(XH+M)=2N9K3R
MI$"M;S1*6=)!G@C;CC/:C7O&<>EG7+6VL+JYO=+L%O65 FUE8L!C+#IM)/L.
M,GB@#J:*\RG\71WO@'PUJOB"VUFRENKRTC5K.5(C/*\>X/\ *_\ J22?E//
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M'5[]+2XT/5-->:$W%N]VB;94!&>49MK?,/E;!YJ]XFU:70_#6H:I!:R74EK
MT@BCVYX'7D@8'4]\ XR>* -6BO)[CQEJ-QI?@+5[RUU"V>XN@)X8\9O2UL2"
MBHQ!5F(P&QSU KK]/\=6<YU:/4[&\T>XTJ 7-S%>!"?)()#J49@P^4CCOQ0!
MU-%<QH_C./4M3MK&ZT?4=+DO8FFLFO%0"X50"<;6.U@"#M;!Q6]J%[%IFFW5
M_/D0VT+S28Z[5!)_04 6:*\YT/2/$OB_1H/$&I>*=2TN2^03VMEIPC6*WC;E
M VY29#C!.2.N*A\1ZAXBT+PWX?DU^\#747B""*2>PW W4&6QN1?XF Y09&<?
M2@#TRBN:T;Q>FJ:W<:-=Z3J&EW\=O]J2*["?O8=VW<I1F'!P".V:Q/#'C#1K
M3X>6>JV8UF[@N+EK:UANW$UW/*7(" EL=B>3@ >U 'H%%<9=>-Y7T'6G@T;4
M8-7TZ+,ME((C)&&4E)<[]C)P>02?E(Q67\'9KR]\,+J%^-:EN;J-9)+K4+KS
M8ICN;_5+O.T#H>%[=: /1Z*X#XLZAKECH>D1>'[Y[._O=4BM5= #NW(^%.1T
M+!:V]%\76FH> H?%%P1%"MHT]RO_ #S9 ?,7ZAE84 =)17E/PY\6ZLZ>++_Q
M9?,(;-+>\",!BVCDC:78 !G@%1CKQ77Z3XSCU#4H;&]TC4=)ENH6GM#>J@$Z
M+C=C:QVL 02K8.* .GHKR?QG\07U'P#?7>F:?J]I:321QV>JC:B2D3*#C:V]
M00&P2 #T[XKK%U/3O^%J2:9YFI_VB-)\\H9O]$\OS ,[,_ZS/?'3O0!UE%<9
M!\1[">>VE_LO4DT>ZN1:P:LR)Y$DA;:.-V\*6& Q7%27_P 0+6PO+H/I&I/I
MEG<BUNM25$\F*0D \%@Y4%@"P4@4 =?17GT=]>'X_2V!NI_L8\/>:+?S#Y>_
MS@-VWIG'&:[?4K^'2]+N]0N,^3:PO/)CKM52Q_04 6J*\ZT/1_$GBW1[?7]3
M\4ZEIDEZ@GMK+31&D5O&W*!MRDN<8)SCKBH8_&&O:=X>\5:=?PO?ZYH(*_:;
M5$021O$SQ3LK$ 8P=P&>G - 'I=%>"1>(M<TCX+WNK0P>)&U"\MXF?5+J[26
M-2S8+Q@R%D&&QPH.=OID=3:7MEI6E^%8M33Q5;SW>J1I#]HOA(TLI5?FD(D.
M8C_=^O% 'J5%<GJ_CN#3=1OK2UT?4]3&G('OY;-$*VX(W8.Y@6;;SA<\4Z[\
M<VHEMH='TZ^UJ6>T6^*V00>7 WW68NRC)P<+U.#Q0!U5%<A??$71[/3]%O4A
MO;J/6-ZVJP1 N75<["I((8GY<>O7'6NETV[EOM.@NIK.:SDD7<UO/C?&?0X)
M'ZT 6J*YK5?%ZV6M/H^GZ1?ZO?PQ+/<1VGE@0(V=NYG91DX.%')Q7'?$;Q[/
M+\+FU3PZFH0_:G$3W2!8WLV$BJR."VY7/*_*#]1P: /5J*P_"=N;;08XFMM5
MMR';Y-5N!-/]2P9N#V&?RK%NO&.HP_%*'PU'I%W+9FQ\YY$$?),B*)<EP=BY
M8$8W9Z T =M17E/AKQ]+I'AB]N;W3M8U*VM-0NA=WT>UUMT\YL#YF#-A<'"@
M@#'TKLM5\8166H1V&GZ7?:Q=FW%U)'9!/W4).%8EV49.#A1R<&@#I**HZ/JU
MIKND6VIV+EK:Y3>A88([$$=B#D$>HJ]0 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5Q.H_N/C+H<LW^KN=(NH(2?^>BR1N1]=M=M6/XAT!-=@M62X:UO
MK*X6YM+I5W&)QP<CC*L"5([@T <5:^(-,\)WWB^PUV-WNKO47NK:T\HNU_%)
M&BJD8QASE2I';O6GXC/G>// 4,41BE22ZG:/C,48@*D'''5E%=R!P,X)]<5C
MVF@+#XFO=>N;@W%U-$MO "FU;>$<E%Y.26Y)[\=,4 ;-%%% !1110 5YAI'A
M&QU_Q=XQGO9]2B*ZDJ*MM>RP*P\F/J$8 _6O3ZY]M U@L2/&&J*"> +:TX_\
M@T <WXMT:S\,6/A6ZT^R,6D:-J8EN(XE9_+C974RGJ3AF!)Y/)-4[S4]-\4>
M-9=5L(9-6T73M#N8KQ[6,L)VD(_<IG 9MJDX![CO77_\(_K/_0Y:K_X#6G_Q
MFD'A_60,#QCJ@_[=K3_XS0!R/A'4K>+Q-:Z9X:\0WFLZ'):2O/;W69#8%=OE
M@2$!AG)78V2,>U<?I"M!^SQH\\B.([;5XYICM)V(MR26(]!7KW_"/ZR.GC'5
M/_ :T_\ C-'_  C^L_\ 0XZK_P" UI_\9H Y'4KRWU7XS^"=0L91/:2V%VR3
M(#M8;6JAINOV'AKP#K7A74F==<CDO88K+RV,EV97=HVC 'S!MXY'XUWO_"/Z
MS_T.6J_^ UI_\9H_X1_6<Y_X3'5,_P#7M:?_ !F@#EO"FFW&E>/-%LKI3Y]K
MX/A@D/4!UE4$9^HK-4:,MGXI&OB]@M&\52,E]:DJUG((D*R[ARHS\N[!&6YX
M-=Y_PC^L_P#0Y:K_ . UI_\ &:3_ (1_6?\ H<=5_P# :T_^,T 9OP^U.ZOT
MU:$ZK+K&F6LZ)8ZE+&%:92@+*2  ^T\;@.<^U-^(.J2:?/H<$^J7&E:/=7+K
M?7T!VLF(R43?@[ S=_;&16I_PC^L@8'C'5/_  &M/_C-!\/ZR>OC'5/_  &M
M/_C- 'DU[-;-H?C:TAEO93/?:;<VYOF9YIX/,@7S,MR5)''H,5Z+XIB:7XC^
M"PN1E=0&X#IF$5J_\(_K/_0Y:K_X#6G_ ,9H_P"$?UG_ *'+5?\ P&M/_C-
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MQ+A;TZ<=.VJ9S=!MOE#G!/?.<8YJII5U#J?Q8EU*T+26<WAZ+RYMA4-^_?U
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MQRH&=N5P3VW"KVLR_P#"2W'C;7],CEDTQ?#;:?#,8F47$O[QSL!&6 R!GU-
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MV_%B3^->;>)[E]2U'Q9I^I7FMMJ8#0Z3I=E)+''+$81ASLP'!8ON+$@ 8]J
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M<UX$O=1O_"T4VI2RSN)I4AN)HO*>>$.1'(RX&"R@'H/7O72T %%%% !1110
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MNV@#K.982&P4*=3E2,>N* .KHKC[#QK>SWT%G?\ ANZT^>]M9+FP62='\_8
M2C;?N/AAP??TJS!XXTZ?X?-XP*.EHEL\SPL1O5ER#'_O;AMH Z>BJVGW,EYI
MMK=2V[6\DT2R-"YRT9(SM/N.E>;_ !EU+58+/0]-M+6Y^QWVJ6\,TT%T(C-N
M+Y@ZAAG .[I0!ZC17GZ>+9/#UU8^%;'PK>R:BUA]JALA>*^T>8RD-*S$<8)R
M2>H%:-UXTO&U.^LM&\.W6J'3MHO9$GCC5'*[O+3<?G8 \@8ZXS0!U]%<9/\
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M].LR*$$;8)4$Y<X^; Z CFKMMX\:75]*AGT2[M],U=BEA?R2)B5MI9=T8.Y
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M%@&W*<.G&>"0<T >@T5RVI>+YX/$,^C:3H=UJL]I"D]XT4J1B%7SM4;B-SD
MG''UK.3XGV4N@Z?JT.F7DL=_J3Z=#$F/,9QOVG!Q]XIC!QC//0T =U7-7GA:
M?5/$]MJ>IZJUQ864HGL].6 (D<NW =VR2Y&21TQFJ]CXX O=4LM=TN71[C3[
M/[>X>99E>WY!<,O<%2"*-*\:3WFHZ?;:EH-UID6J(S6$TTJ/YN%W[7"G*-MR
M<'/0\Y% '6T5Y+XT\<W6K_#G7+VRT:\CT>1'AM]469/F(?;OV [@A88#?3(
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M=:)IDFY]=_LR1FDCZI,%*@-_ST 8 _P^W%:4VKVA^(VDVMSI-U'KDVDO.O\
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M%W<CI6<J6,?B34IM*M]8DT^^\.W5M;75X;B7[1,"&(7S,E1CIG )!Q[^TT4
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M_<EX\3Q^=-G)B1&4%B%&<^I Q4-]X@@\3Z_X*?2[2^D@MKXO<S26LD:PL8'
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MY%<%;7DDG@;P)IRZ;JANM*U:T%\GV&7,.S>&_A^;U^7/'7&10!Z%IWC*&_\
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M#S(%8,RCZ@$?C7-:CX@A\0:_X(O;/3]3"V]Y(UTC6$H-N3"R[6^7L3@XR.]
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MT%;.,VMN\R"=9MQC^13C@\$X'%<Q!!>#X96Y?3;]7L_$HNYHC;.7$7VHN64
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MBBB@ HHHH **** "BBLS7M3NM*TT36.F3:E=/*D45O$=H)8XRS8.U1U+8XH
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M<'GB@#JZ**\_U-+OQC\0+WP\U_=V>C:1;12W<=I*8GN9I<E59QR$"J>!C)H
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M:3;Y0VGYQP<D<''?UK+B\8:O;:5H-I)HT=QK^J(3#;B\_=^6B M*\FSY1R.
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M'MSXEMM,N]2TG5+:.&^CLD\R:"6/(1PG5EVD@XY'7Z]ZDB2+NC=7&<94YIU
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MM8+ZTFM+J)9;>=#')&PR&4C!!_"J>@Z0-"T:WTQ+J>YBMQLB><@N$_A4D#G
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M+#>O&5P:]4HH YCP$NI+X:VZDU\RBYE%H=0_X^#;[OW?F9YW8]><8S73T44
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MLP(X4XP$)'J>..M8N@>+_$2>$?"\,UC9W.KZO$!;237K!)$6(.TDC;,AS_=
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M,2%51]6('XUA0^)O$&F:SI-IXETS3X+?59##!+97#.89MI8)(&49R 1E>XH
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MB00C()],US%QXH\3ZCXJ\$MI\=E%;ZIITEXT$EQ(JN3&C,'PI^[N^7KD]<4
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M!W=%-CWF)#*%$FT;@IR >^*Q?%7B!O#NEPS0VWVJ]N[F.SM("^P23.<*"W.
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M>,S@9,>\;@/7'6I:\,^'U])H.E>*O&&JZ;IDHM[^[\Z[1F:[:3*@1(2OW"2
M.1UZ5WT?BCQ%I>I:1'XDTJPM[35IA;1/:7#.]O,REE20,H!S@C*]Q0!O:WI^
MF>(M*NM.N[@B-"&=X)MDD#*=P8,/ND$9YJEH'A6RT[4&UDZI?:O>RP>0EW>3
M+(4BSG:FU0H!(!)QDXK@-*Z_&+ZR_P#HF2M/PKXBNM)^'?@G2]+M(KK5M4@*
M6Z32%(T5%+.[D G &. ,G- 'J%<??_#O3[^XOC_:FKP6.H2&6\T^"Y"P3,?O
M9RI8!L<A6&:R]0^(&K:%;ZQ!JVE6O]I:7'!=.+:9FBGM7?8TB9 (*\Y!].M:
MFN>-_P"R?&6BZ)':K-;WH4W%QOQY/F,4BP.^Y@10!U6;>QM%!:."WB4*,D*J
M < >U2@AE#*001D$=Z\Y\9>,432O&4,^C6NH:=HJ6R.D[$K<22%6*D8Z*"I^
MM:-SXJU.+6-(T+1])M9)K[2_M<;2S%(X-I48; )V@'L,YP..H .VHK@!\0KV
MU\/ZH]_I<1UNPU%-,6UMYB8YYI-OEE6(R%(?/(SP:MVOBK7K;QAI7AS6M+LH
MY;Z&:;[3:3L\9" ' #*#NR><\8((ZX !VE%%86OW^O075K::'IUK,TJN\MU>
MRLD,(7&%.T$EFSQ]#0!NT5Y]-\1+U=#T:Z@T=);^^U1]*EM1/\J3+O4D/C[N
MY!SC@'VJ<>,]8TRZUG3=<TZR34+/2I-4MFM)F>*>-<@J=R@@AL#\: .ZHKSR
M'QUKT5CHFN:CHMG#H6J20192Y9KB'S<!)&4KMVDD< Y (^E7K'Q9KFK>,=3T
M73]*M/LNEW:1W5U-,P_=,H;Y% .7Y;C@# ]: .UHKSQO'>OW&B7OBC3]&LIO
M#MJTI >Y9;F>*-BKR*-NT#Y6(!/(%;FC^+/[3\67FC/ B1?8H-0L9@QS<0/P
MQ([8; _&@#IZ;)(D4;22.J(HRS,< #U)KC+?QAK&JVVJS:-HT=TL&I_V=:.\
MQ5'V\23.<'"*<C@$G%96O:_?:GX%\<Z7JMM;0ZAIMBWF-:2EXI$DB+*RE@".
MA!!]* /2$D26-9(W5T895E.01Z@TI( ))  ZDUSW@#_DG?AO_L&6_P#Z+6M?
M5/\ D$WO_7!__030!9CD2:-9(G5T895E.01[&G5Y#X6\5Z[X?^&N@:M/I-F?
M#T,,$$S_ &AOM(0L$\T+MV[=QZ9R1SQV[S0O$KZCK>OZ1>P);76E3KC#9$D#
MKNCDY]>0?0B@#HJ*P/!WB";Q1H7]KO:K;V\T\HM &)+PJQ57.>A."<>F*VKH
MW M)C:+$UR$;REE8JA?' 8@$@9QG - #I)8X5#2R(BD@99L#)Z"GUX:=:U[5
M/A!#J>KK%<AM8A> Q2L\TA%Z<J0P  & JX)XQTKT"U\4ZS9>*(-)\1V%A;17
MEK+=6TUI<-)L\K&]'W*.0&!R.* .RHK@['QMK,D6DZO?:3:P:#JUQ'#;LD[&
MXB$AQ$\B[=N&.. >-PZUWE !17G/QEDMX_#VA_;9&CLFURU6Y(9E_='?OR5Y
MQC/2N6GF\))X@T&'X>ZC/'J\E_'YR)<S^4]N/]8'$IVD8Z <YZ4 >WT5R6H>
M(]9NO$]WH/ARQL99;"&.6\N+Z9DC0R9*1J%4DD@$YZ 5%:>+]5U?PY'<:7HJ
M-JPOGL+JWFFQ%:2(2'9W R5&!C R=PH [*BO/KWX@W^E>%?$=Y?Z?:G4]"FB
MCFC@F9H95DV%65B 1\K]".HJS>>+/$-C8V2S:/9+J>KW@@TVU^T-A(RI8M,=
MO!4 Y"Y[8H [7S8_.\GS$\W;NV;ANV],X]*?7G.B7&IS?&6Y35[6""[BT!%)
MMI"\4B^>2&4D CJ1@CJ#UKT:@ I"0H))  Y)-<IJ?B/6)_$\WA_P[964UQ:6
MZ7%W<7TK)''O)V( H)+$*3Z >M<1\0_%&J:Y\']9FAM(+.2VN#8ZK$T[%XI%
ME08C(7#JV><XX/>@#U^"XAN8_,@FCE3.-T;!AGZBI*P/!NF2:3X>BMI--TS3
MSG<(M-R8R-H^8Y526..>/3FM^@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N(^*\,A\$/?1(TATV[
MM[YD49)2.0%OR7)_"NWIDL4<\+Q2HKQNI5T89# \$$>E '!_$/3KS7F\&W.E
M6[W<,.N6MW(\7(6$<ES[8-:GA_3KRV\>>,+V:W=+:[>T-O(1Q)MAVMCZ'BMK
M0M%M_#^E1:9:2SO:PD^2LS[C&A.0@.,[1T&<G'>K=Q=VUIY7VFXBA\UQ''YC
MA=['HHSU/M0!Y3H^AZUH.C>#]8;2;JXETF:_CN[*(#SO*GD;#JI(SC"G&<D&
MK?C<>)/&/PT\10IH,]N)98%TZT=<7,B+(A=G7) Y!P.N!S7J-% ' :@NH:%X
M[T[71H]_?V<FC?V?(+*,2/%*) XW*2.",C/J*Y_^P/$4NC:EJ;Z/*M];^*TU
MJ*QW*6EB"H"JG."V"PZXRIQGBO7Z* //K:75==^)>CZQ_8=_8Z7;V-S#OO$"
M/YC%#RH)P. !GK@^V>:TGPOKD/PPN=.DTRX6\;Q"ER(2OS&(3QMN^F 3^%>S
M44 <?XCT>[U'QWX=GC@D-G%:7\4\RCB,R(@7/UP?RKS[7[C6].^"D_AF[T&Z
M@GL(H[>>\<I]G9%E4*T;!LL6^48QQDYZ<^XUQT?PVT6.9%^T:DVG1W'VE-+:
MZ)M5?=N'R=<;N=N<9[4 =C6+XJ+_ -A2+_8@UJW=U6YL_E+-$3\Q56X9AP0,
MC..N:VJKW5_9V.S[7=P6^\X3SI FX^@R>: /(Y/"%WJ.AZS#I>B7\&BQW%G=
M66D:D^#*\;EIE4,Q**RX !/7T%:^FZ'ITEMK;Z)X&GTC=I<L*7%R@BFED<']
MVJ9.5X'S9'. ,]:]-J-[B"*:*&2:-)9<B-&8!GP,G [X'- ',:#H!NOA9I_A
M_5(&B:32DM;B-A\R$QA3^(/\JP?AUH^O/JLFK>);1X+G3["+2+3?_P M%3F2
M4?[QV\^U>DT4 >,Q^%]<'@#QY9'3+C[3?:^]Q:Q;>98S+$0P]L*3^%=WXCTZ
M[N_''@Z[AMWDMK2:[:XD4<1AK=E7/U)Q75TFY2Q4,,CJ,T >*:DVM:!\&]7\
M*3Z'="2R@GC-^Q3[,\&\L'#;LEBIQMQG)YQ7L>G C3+0$8(A3_T$5S$OPVT6
M::56N-2&G37'VF72Q=$6KN6W'*=<%N=N<9[5V% '-^/M$N_$/@N_T^PVF\/E
MRP*QP&>-U<*3[[<?C6%=S:EXTUWPX@T'4=-M=,O!?W<M\BH ZHRK&F"=^2QR
M1Q@5Z#10!YS9:)J<?PK\5::]E*+RZDU(P0D?-()&<ICZY&/K7;Z'#);^']-@
MF0I+':Q(ZGJI" $5?HH P?&NAR^)/!>K:/ RK/=6[+$6.!O'*@^V0*Y:^FUC
MQDWA[37\/:CIS6=_!>ZA/=HJQ)Y7.V-@3O+-@ CMR:]'HH \M5-;TFS\9:!'
MX>O[FXU.\N[FSNHU7[.4F48+/G@KSD8R>W6D^P:MHUS\.]2;1KZZCT[2GM+N
M*U0-)#(T48&5)'&5()[8KU.B@#RO5=/N+[Q#'<V'A/4-+\3)?INU*V8+:R0"
M0;FD<$!PT8/RE=V3BC_A$=5U'7/B?"]L\,6L6\$=E-)PDK")AP?0,0#7JE%
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M9+FY=P!&ZDL,+U?^[VX.:I7/CW5TL[WQ#!9Z<WAVSN7A=6E;[5)&C['E7^$
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MANUT73[9WUS36O4:Y=@L! 1OFQR1AB.!DG'3K3]+T748+7QVLMJZMJ-Y-):
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MTUR 1^[18G5B?H2!QZT 4+OQYK"6NHZ];66GOX?T^Y>&1'E;[5,D;[))4_A
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MWNS!&0'=4<%@N2!G%)I=M?W?Q&EUZ73KFTLY]$BA N-H99!,[%" 3S@@_C0
M_0?&;W>A3W&K6R1:C;:C)IDD%JVX2SJV (]V.".><8&23@9K2TCQ1;:KK%_H
M[V\]IJ5DJ/)!-M.Z-ONNK*2".WJ#U%<'>^%==&D:E=6^F)<W-KXJFU6&RF9=
MMW 05(&> 2&)&?2NS\+RM>/)=KX7.A1;-FV>*-)I&SSPA.%&._))Z#'(!-J=
MOKI\5Z3<6:6DNE*CI=+-(RO$3T= .&...>F3ZFO/?'L.L6OPSNXO$J6O&L0G
MS;=W<SQ&099AU!/(P.@  Z5[#7&?%#3-0U;P@L&F6<EY<1WMO-Y,9 8JC@G&
M2!T% 'G>L-X'2738_ ;R6/B&2]B$$RF>WC"[AO#F7"L-N?EY)["O2]7\0ZQ+
MXJ_X1WP];V37,-J+NZN;YG\N-68JB!5Y+'!/4  =ZP?%5YXA\9^'+OP_:^"[
MVV>]41FYU&:%8H!D'?\ *[$D=L#-7);'5/"GC#^V(M.O-8LKO3(;.X-KM,R3
M1$X8JS#*L&/0\$4 6;+Q;K6HZ#>BUTBW.NV.H?V?<Q&?$$;#!,VX_,8]I#8Q
MGM[U3?QWJECHOBIKVWTZ;4M"@CN ]H[&"975BO7D$%6!&:Q;KPSK,NDRZGJ&
MC37$>H>(!J%]I$3JTAM1&41&&=KD$(Q7.#^%5KCPWJIM?&L%AX3.G6^MZ7"+
M&WMUB4(T?F I(%. [;PW&1@XSD4 =+/XP\1VNA6M]/IFGBYUBZ@M](MA*^5\
MP$[ISCC"C=A<^GO5&'^UKOXM066NPVZ3'P_<*);"1@DB-+&/ES\RL.>_H<^F
MIXHT?4Y/#GAJ[L+-KF]T6[M[J2T5@&D54*.JDG&[#$CGM46FKK.K_$ZVUZ?1
M+K3]+329;6/[44\S>94;YE5CMS@XY_A/3(H EM_ DD.DZ%:B]O5FTR]-Q%)]
ML8^7&9-QC;_GI\HV<\#)[<&];:B='\??\(\2?L5_9F\M%/\ RRD1L21K_LD%
M6 [?-VP!U=<3?VCZC\8=(EC'[O2=,FEF8= TS!$7ZD*Y_"@!GQ5U'6=,\*12
MZ1-%"TEY!%)(797 ,JX"E>Q/!]B:FNO$/B.37+?PYIUMI9U6.S%Y?7$S2&WB
M!8JJH!\Q)P3SC %2?$O2[_5O!SQ:;:M=7,-U;W @0@,ZI(K$#/&< UG/)JFG
M>+QXLB\/:E/9:EIZ6UQ:1B/[3;R1NQ4E=^""&/0G% &_X3\0W&NV]_#?VT=M
MJ6FW;6EU'$Y9"P (=">=K!@1GFN?U34O$H^,6GZ;9S68L/[.>?RI'D 9/,C#
MLP'!<$';VP3ZUJ^"-+U"U.M:MJ=L;2YU>_:Y%L6#-#&%5$#$9&["Y.#WJEKE
MMJ5C\4-(UV#2KJ^L6T^2QD:VV$Q.TBL&8,P^7 ZB@#F-!UGQ+H_AKQ+J.E6.
MG26&G:KJ$\XNI'$DX61F81[1A<+W.<G/'&3UEUXMU/4M3M]/\.0Z>LAL([^>
M;478(BR9\M %Y+'#$GH .^:I6&@ZI%\./%^FO9NMY>S:FUO%D9D$I?9CG'.1
M61<^$TLM2T_4M6\(MKUM+H]M:R11QQRRVL\0/\+L!M8-@D'JM 'H'A?7?^$C
M\/P:BT'V>8L\4\.[=Y<J.4<9[C*G!],5L5C>%;+[!X=M83H]MH['<[6-L04B
M)).,C@G&,XXSGK6S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %9VLZ+::[:P6]YYFR&YBN4V-@[XV#
M+^&16C10 4444 %8>K>%=.US5;2^U![J9;4JT=H9V%N74DJ[1CAF!/4^@K<H
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $=%D1D=0RL,%2,@CT
MK/T31;7P_IBZ=8F7[)&S&*.1]WE*3G8IZ[1G@'.*T:* "BBB@ HHHH ****
M"BBB@ HHHH **** "HQ;PBY:X$2"=D"-(%&XJ"2 3UP"3Q[FI** "BBB@ HH
MHH *SM4T/3]9,1OHGD\K.S;,\>,XS]TC/0=:T:* .>_X0C0/^?2?_P #)O\
MXNC_ (0C0/\ GTG_ / R;_XNNAHH Y[_ (0C0/\ GTG_ / R;_XNC_A"- _Y
M])__  ,F_P#BZZ&B@#GO^$(T#_GTG_\  R;_ .+J:U\):+974=S!;2K+&VY2
M;J5@#]"Q!K;HH *K6EC!9>:8E)DF?S)9&.6D;&,D_0  =   ,"K-% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
G %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>employementagreement_mil002.jpg
<TEXT>
begin 644 employementagreement_mil002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M\0RV=R@N$REK$AEE+$D! %')X^@[G'-6M#N-9N_M=SJMHEE$\@^R6I96EC0
M9,C*2NXG)P"<#')JOX0TZ[TOP;86%Y%Y5U%$5=-P.#DGJ#CO0!>T#5AKOA[3
MM66$PB]MTG$1;=LW*#C/?K61%XLN+K53#::29[!;LVC7"W \TLK;'=8L<QJV
M06W \$X(%1:'X<U)/!?AW3Y=4OM)NK&RCBGCM#"VY@J@ABR.#@@_=]3UKG4\
M'75M=264&A 7AUO^T(M<#QXCA,WFL,[O,W;2T>T+M.<YP30!V%QXJMHO&-GX
M<B@>6::-WEF!PD)"[@I]6(YQV&#W%%GXJ@OO%L^@P6MQ^XMWE:YD0HC,KA"J
M9'S8)Y8<<8YYQSMOX,UW3O$VB7,>L"[MH;BXGNI6M45R9 ,[CNRQ;[H('R@#
ML!72-I]T?'L6I"+_ $-=,>W,FX?ZPRJP&,YZ \]* ,W1O$_B'7+."_M?#EH+
M*9V"N^ID/M#%2=OE>QXS4U]XLO+"XDGFT25-)BO$LVNI)MLA9G5 ZQ%?F3<P
M&=V2.0"*Y/PWX<?2+6U6]\ 7T^H03,YNX[NWVD^865@#,#P,=NU;$XU[4/%Q
MGU7PU?SZ=9W/_$OCAN+;R1C@7$@,H9FZD#'RCL6Y !H+XU<ZJ(O[,QIQU(Z6
M+G[0/,\\9&?*Q]S(QG=G'.,<TZU\9O<7=K*VF%-(O+Q[*WO?/!9I%+*"8\<(
MS(0#DGID#-<ZGA?41K*R_P!C2#6AJYNFU[SDV-;>9G;C=O\ ]5^ZV;<=\]ZN
M66AZPMMI/AZ339$MM.U0W;:@98S')"DC21A0&W[R2H(*@##')XR :NC>)M>U
MN)+NU\/6HL'N)(O-?4B'VI(T;-L\K_9)QG\:?IWBN\U37)[.UTN VL-S);M.
MU\HD(C8JS"+;G&X$=>U5/!W@FSTVQAN]0TU8]66ZN)2_FDD;IG*'@X^Z5J@W
MA^[N-2L88O"UOIUU;:M]LEU6 QB-X@Y9L$-YA:13M*D8Y/. * .DLO%5O?\
MBRXT*"UN/]'MVE:YD0HC,KA"J9'S8)Y8<9&!GG&<GC#5+NQ?6--\./>:*K-M
ME6YQ<3(IP7CAVG<."0"P)'0<BM)]-N6\=KJ/E?Z'_9;6YDW#[YE#8QG/0=>E
M8&E_\)1X=\-Q^&K+07N+FU0V]GJ)GB%L8P<))("V\$#&5"G)'!YH W=>\66V
MB7NDV?D27%QJ-S%$$7Y?*1W"^8^1P 6 QU)^AQT%>>:]X+\03W@O;/65FFGU
M*UGE#6B9B2-AC!+?=3EMO<D]R:]"&0H!.3CDT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4KK2-,OKJ&ZN].M+BXA_U4LT"NZ=_E)&1^%7:* "BB
MB@ HHHH **** "F0PQ6T"001)%%&H5(T4*J@=  .@I]% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU2=(7O;95E@8IO4SJC*V0&'\0(XYZU275/L]SX1MIK:>WMI-(VG4+>S:6;S
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M*HVENFXL..@Q6C<^,=>MK+58KOPN]IJ-M8M>0 70EAD0'#?O H 9>NTCG'%
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MXU*T%K<N@+1B829'8Y '7KCM6G0 4444 %%%% !1110 4444 %%%% !1110
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MY 649(#>QJAK-GJ/B?\ X3+7K;2[^&WET$Z9913V[)-<MEW9A&1N RP R.:
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MTU_38H;[1%A=DLYC(EP)?]6$+*""6&WD4 =S17*Z7XBUA=?MM'\0Z7:V<U[
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MM%,L@!5E8J".">".U7(O%VLVNN:3;ZUHL%II^L.8K26*Z,DD4FTLJ2J5 !8
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MC8P^:3((4RK <J/NX)XZ],5ZE67I6A6ND7FJ75N\S/J5S]IF$A!"MM5<+@#
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MB$<,2[F;$J$X'T!-1V6F7R?$+1[Q[646T7AYK>24K\JR>9&=A/K@'CVKMJ*
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M,$^A]O0FJ'B5-:OM>UO3Y])OKK3Y=."Z:;8A86D*MO\ ..X9()& <C&<#)H
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M1P>A!(XSSP#535+6YT/Q]JE_=^%)M?TO5DA:*2V@CFDMI40(596(PI !SG%
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M=5N;6X"[U##*L"I*E2.A!_*L[5O%%Y8^.-)T&'2YYH;J"6=Y4:/YMN!@!F'
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M^$(T3^[J'_@TNO\ XY70T4 <]_PA&B?W=0_\&EU_\<H_X0C1/[NH?^#2Z_\
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M,I ZG/2@!U%("& *D$'H10&4L5##<.HSS0 M%(64,%+ $]!GK02 "2< =2:
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M :.< %U)(#+@G(RI'X4OCKQ_IO@*SM9[^"XN'N7*I%;@;L <L<D< E1_P(4
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M-*:21+35/$!M;O:Q4O%ND8ID<@,5 ^E=K)I5CX5^)&FV>AVR6=GJFFW0NK6
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M/0@8KVJO );OPY=:3'I5[!\1;JP@*&U@ELUQ;[2"N,#YL ;?FS@$XQUKO/\
MA;^F?]"WXI_\%9_^*H X;PAGPYH_AKQBGRVPO;G2]3(Z>1)<-L<^RR8_[ZIW
MQ$_XJ30O&OB=OFM+$P:3IWH=MQ&9G'U?"@^BUI6GB7PK:^"[GPK_ ,(YXQET
MZX$H<RZ=EQYC%B01@9!.1QQ@5'<^(?"EQX"'@[_A'O&<>FA$4NFG?O25</N)
M/&2PR>.YH ZCQ=#IVL^-8; Z#<^(;RTLO,>SEG2.T@5V(#MNZR':0.O K@=:
MMH[KX#^(Q=VJA])U>6"RC>3S3:+YZ#8K]P Q7/I6WJWBW1=2UW^V+>P\>:9=
MO +:<V5@%$T8)(#;@<$9.",'FJ*ZGX170=9T,:%XW_LO57$KVWV#(@?(.Z,_
M>R2JGYBW3ZT 7_B)X2\/V6E^"4MM)M8EFUVT@D"IC=&X8NI]B0,U=US38YO'
MG]AQ>$QK.E:;I436^GB>.**%I'?=)M<@$X4 $=,'UK&O=>T+4_#EMI%_:_$"
MY>TNDN[:]>P43PR(,+@@ 8'/4'K4UUXITFX>SND@^($&IV\+6[:A%IZ>;/&6
MW;7!!4@'I\HQ0!6\:V6M6/PS\+V.I+-97<7B...W+3++)%%^]\K+ D$JI4?\
M!KL_$'P]M+/0$@\.:1%/_ID5Q?6<MPRG440,-CNQ.3E@WS<$CFN4U#7_  KJ
M6@:7H\VA>-Q!IUXM[')]AW222KN.79LYR78GI[8K5U[X@Z-KMM C:-XTLY[:
M4307-II^V2-\%>,D@@AB"""#F@#J/ #Z2MMJ=KING7FDR0W(^TZ7<XQ;.4'W
M "1L8?,,'!YZ5V%>9^$X],\3Z=K%A"_BNVNKB2&>ZU&_C%O/*5(VA& V@ )C
M  X)]:],H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH ***Y7Q7JEZ=6T;PYI<[6]WJ<C237"@%H+>( N1GC<V54''\1/:@#JJ*YB_
M\=:5IFH3VDL%_)#:2)#=7D<!:"W=\8#OGT9<X!QD9Q3/[3O-)^(4>DW<[3:?
MK$#S66_&89H@/,C![J5(89Z$-0!U5%%% !1110 445Q?Q U2]"Z3X;TFYEM]
M3UJZ$8FA;#P0)\TL@/8A1C\: .THKCOAUK%Y>Z-=:3JTS2ZQHMR]E=.Y^:4
MYCD_X$N.>^#6>?B>[:)-K<'AJ^ETJTE>.\N!+&#%L<J2JDY?  )QQSC.0< '
MH-%<GJ'C1X?$3Z%IFC7&I7WV..\3RY4C0QLS#)9N%QM'J3N&!UQ':_$"UN=*
MTR[;3[B&:[U;^R);=V7=;SY8-DC@@;>WJ* .PHK%G\1P6_BDZ&\$A<:<^H&5
M>1M5PA7 Y)YS67I7C:XO-4TVUU#P_>:9#JJN;":>1&,A5=^UT!S&Q4$X/IB@
M#KJ*\[^%T\T^J>.!++)((_$%PJ!V)VC/0>@JQ\5K^XL=$T80:E<:<EQK5M;W
M%Q!-Y3+$VX-\W88YY]* .\HKR6_N/[&U;1?^$6\:ZAK=[<7\<4^GS7J7BO 3
M\[$ 90*.=V<5V>N>*;[3=0GM-.\.WFIBU@%Q<RI(D2(ISA5+??;"DX'MSS0!
MT]%<E/XX-PVG1Z#I%QJTU[8KJ 03)"$@8@ DN?O$G&!Z&G7/C20KID&G:'>W
M6J7\#7(L92L#01J0&,A;A?F( ZY/3CF@#JZ*RO#VNP^(-,^UQP2V\L<KP7%O
M-C?#*APR'''![CJ"#7)>.-36+Q=I&F:MK=UHFA3VTK_:;>;R/.N R@1M+_"
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M0W,MO&QD9T/VC**?, 3A023\O&*EUOQ#?Z?J4>G:7H%UJMRT)N)"DBPQHF<
M;VX+$_PCZ\4 =!16=H.LVWB'0K35K19%AN4WA)!AE.<%3[@@C\*T: "BBB@
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M&C7?^_L/_P ;H \ZB2>TA\6ZIX"L+VRTA].C$2K;O&)+G>=\D$; 'B/C@#)
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ML%U92S07$4JL"C^8QQD_>X8<C.<UVE%% !1110 4444 %%%% !1110 4444
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M974<GQ"+VTR_:+MVAS&1YH^SJ,KZ\\<4 =CI&IP:UHUEJEMN$%Y D\88<A6
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M0APH9EC0C,A4$9&1SP,UC#7+Y/B?J;Z1I<VI2W.CVDL<+RB!47=(269@=IY
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M2W[:8NF"12YN@Q!3?TP,$[O2J7A,2W/CI]16VN4M9/#]I&LDT#Q_.LDFY?F
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<_XO\
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M!0/(3"J=K;F.#Q@ =SR* /4*"<=:Y&/QC>ZIH6B7_A_0I;Z358S*!-+Y45L
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M?&&94V<A3G&<;MO8&IM2UT&R\#2^(_#\<]]>:C#';LMZ3Y+D#$W"C)[[?UH
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M=) I(4\$?>&TG@#K4TOBWQ ;Y=,M/#4$^J0V:W=Y VHA%C#,RJJ-L.]CL)Z
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M/<")57(X?Y3@8.<C/.!CG- ':=**\G\<>)9-?^$OBZ"[L3I^IZ<Z6]U;>:)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD73P7$?F;AL W+)G ^5EY_ U8\(Z[-XF\-6NLRV7V-;K<\41?<?+W$*QX'4
M''O7!?$73K^W\601:0=O_"6VPTF[VG!0JP/FX[XB,B^W%>I6MK#96<%I;H(X
M((UCC0=%51@#\A0!A^)/$%YI=]I>EZ9907.HZDT@B%S.88E6-0S$L%8D\C
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M_#J6,Q\-7^J1:U-<!<Q#:I,D)/\ M2HAQZ&MV_TN_D^..DZFEG,UA'H\D3W
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M?6$]M#OA<O&JE7?I'AEYW=N:VOAG87>F?#G1;*^MY+>YAA*R12*593O;J#0
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M+A&Y&,Y7IS0![17%ZGJ=A%\6=#TV32(I;Z:QFDBU R$-"HSE N.0?KWKM
M .@K@M7TN_F^-7A[4H[.9[&'3IXY;@(2B,=V 3T!- %5_B'KLNA:EKEGX;@?
M3M+GGCNC+>E7=8G(8Q#80<*,G)'.0,XS6S?^+;^XU>#2O#6FP7UTUDM]-)=7
M!ACBC<X09"L2S8/&.,5AV6CZDGPD\4Z>UC<"\N&U(PP&,[Y-[2%,#OG(QZYH
MM5O_  CXCAU>;1]2O;*_T:VMI/L5N9I()X@?E9!R 0W7U'- %Z_^(.H6=MX?
M \-7*W^KRS6_V.>3RVBE0'')7!0D?>Z;3GVJU+XF\127Z:18:+8S:M!:)<Z@
M)+UDAAW%@D:L$)9FVL>0  *S+J/7M:U[P+JE]H\EJT5Y=23Q("WV>-HV$?F'
MH&(QGW.*K>)_#]C#X[O-6UCP_J.K6%]:0K$]@DDC0RQE@594(.&#*03QP>E
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ME13 K;MA)^;=MW<;MN/?'- '35DZ%X?M=!CNS#)-/<7D[7%S<SD&25SZD
M#     %:4LICMWECC:8A2RI&1E_89('/N0*\\7QC9ZY\*[S6O$FEW\>G2^:)
M%MR"63S650I1LC 502=HS]: /1Z*YZ^\66&EZO9:,;:^ENKJW:6!8H2P<(!D
M9)Y/(]AW(K-_X63IO]DWFH+I>L,MA*\=_$+8;[0I]XO\V,8.?E)..: .SHK)
MGU^V7[.EG#/?SW$'VF*&VV[C%Q\Y+LJ@'( R<GMT.':!K]CXETI=0T]G\HNT
M;I(NUXW4X9&'8@T :E%4=8U!M)T:\U!;62Z-M$TODQLH9L#/5B /\]:\WUO7
M+C5?"G@/7;N&ZM9IM6L'E"M\LJNI8X1&.X$XP",\=* /5J*Y_3?&&GW\^JP3
MPW6G3:6BRW*7J!,1,"1(""05PI]QCD"B+Q=9G6;#3+JSO;*7449[*2X10D^T
M9(&&)5L'.&"G\>* .@HK \5)KIMK%]"MX;IX[M6N;>6<Q"2+##[P]&*MCOC'
M/0FEKKJ>*=8^WVT)TQ]C6=RLY+$8 *;/X<'<<]R>_8 WZ*\4UZXU77-2UOQW
MI<TQMO#5U'#90(Y"7,<1)NB1T((8@'T6O0O$7C)-)\+:?KNGVWV^&]GMDC16
MVETE( (]\'H>] '4T5Q]AXFUR#Q4NAZ]IUC US9R7=K+9W#2#Y" R/N5>?F!
MR.*P[?XB^()/"EAXMET*RCT25HEG4W3&X 9Q&75=NW:&/ )R1SQF@#TRBL/2
M]??4?%6OZ.T"HFEFWVR!LF3S8]YR.V.E8VG^+=;USPMINH:3HT$EY>W,T+>;
M,5@MUC=UWNP!)SL& !U:@#LIIHK>)I9I$CC7J[L !^)IP(8 @@@\@BO)/'VO
M7.M_!SQ;#?VT5O?Z=<QVEPL$A>-B)(F#(2 <%6'49%>H:3_R!['_ *]X_P#T
M$4 7**\(T^7P&_B+Q<?&%XRWB:W<+"#<7"D1<8P(SCKN]ZZ[X>ZC?0>#=<U"
MS%YJ^G1W<S:-#)+OFDA &U<MR 3G&[D#M0!Z317%6_B[5].U.>P\2:=9QR#3
MI=1A;3YVD!6/&^-@RCYOF&".#4FB>)]=N;:#4]5TRPCT:YM&NUNK*[,IMU"A
MML@*C)(SRN>0?K0!U5Y;M=V4UNEQ-;-(A430D!XR>ZY!&1[@UG>'O#=GX;M9
MX[:2XN)[F4S7-U=/OEG<\98X'8    "N>T_QEK3-HU_JFD6MMH^M2I%:M'<,
M\\)=2T7FJ5 ^;&.#P2*U_':ZJW@C5AHGG?V@8?W8@.)",C?L_P!K;NQ[XH Z
M*BO*O#EKX!U+5;"3PMJDNEZS;2J\L$DLBSSJ/OQ21R'Y\]SSCJ#70>(O%7B/
M1O[3U&/0[4Z+IA!E:>X9)[A  7>)0I7 R>IYP>E '8F>$3B RH)F7<(RPW$>
MN.N*DKS6^=9/V@=$D4Y5M!D(/L7:M.7Q;XAL;RSNM2T2UMM(N]06Q13<,;I-
M[[$D9=NW:3@X!R PH [>BN'C\6Z_J7B_5]"TC2+-DTN>)9[FYG95\MT## "G
M+\MQT&WGK4MGX^BE^&]UXJNK8036<<JW%INY2="5\O/NV /]X4 =G17'VNA:
MAJ.K)K=W-?6;WFE>3>6D5V?+5V P(Q_"R_-\W')&.]4[JQO_  9X _M".ZN;
MB[T@/<8GF\QI;?>6,+M_$1&< ]F (XX(!WE%0VEU%?64%W VZ&>-98V]589!
M_(U-0 4444 %9-CX?M=-UW4-4M))HSJ 4W%N"/*:1>/, QD,1@'!P<#(SS6M
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7'_$2RNKW2=.6.RNKZPCU"-]1M
M+7F2: !LC&1N&XH2O<"NPHH \3N_#MZMGXTM]*\)3Z=:ZQI</V&"&%5^:,N"
M) IPKG<"!SQC/.:[SQ+IE[=ZCX-DM[:21+/41+<%1_JU\EUR?;) _&NPHH \
M]T[1=2B^'OC.Q>SE6ZO+G4VMXB.9!(7V$?7(Q52W@U/PUXA\/ZO+HNH7EL?#
ML>FS)9QB22&965OF7(XZC/J*]-HH \>?1M>DT'59+_1;WR+KQ1]MO+"!MTDU
MF8U^48/S_-MR >=I[4^TT.XMKGQ<NF^$Y],L=7T,QV44<*K\ZK*") I^5V+
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MUGP;X<\'R^'M0MKJ)K,7ES(BB".*$JQ8/GECM VXSDD=JKW?A6RT_6=>34/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'X,P_&NB\5:?:Z-\0?AKI^G0BVM$N+W;$A.!E5)_4F@#U*@D 9)P*\J@UQO
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MVSL=GF2.VZ3 /WL*!GM7%:K&]E\&?B';K=2S?9]>>))9'+.562 #+=2<<$T
M>NKXA/\ PE\'A^2SV22::U^TOFY"$.J%,8Y^]G.>W2CQAXC'A/PG?ZZ;7[4+
M15;R1)LWY8+][!Q][/2N)NM%LM>^)FAVFHJ9;4>&S(\!8A9L2H & ZC)SCU
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MEH$7&[)Z#U[UZB2!U-% 'G.C65CI$U]<RZ!XIU.]OHO)N;K4$CED>/\ N<,
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MXFB96.0-N$8G/)/X5O$@#)(Q0!S>O>!]+\1>(-+UF[>X6?3R,)&P"3 .'59
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M]G2*ZL^\>9AW+GG&.I/:M"UT&TL]?O-9C:4W-U!%;R*S#:%CW;<#&<_,<\T
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MN&N3%KDBRW.' *LJJ 4XXQL4\YYIO_"$6<EWH-Y=ZCJ5Y=:*\KV\UQ*A:0R
M [\*,X &,8_&@#CTUD_#Y/'.E@8\@_VGI:8^\+CY0BCT$W'XUFGP_/I>J^'/
M"TN@+K\%EHSWDUG)<(D;W+R@22MOX?!) SG&^O1]<\%:3XAUW2]8O?/%SIS9
M18W 24!E<"08^8!E! XYJ;7?#%OKES:W@O+W3[^U#+%=V4BK(%;&Y3N!5E.
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:.GQ-T_3;:*ULCI-K.+>% D:N1("0HX&0!G'I0![0TB+MW.HW'"Y/4^U,%S
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MU=V\#2G;&LL@4N?09/- ''>'8YO#%M=P:?X-U_9=W<EW)YES9L?,?&<?O^G
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M0 [5!& H&21@#DYJO9?#W3+74=/U":_U6^N]/<M:R7EUYAC&TJ5 P!C!Y[G
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M,9K2BU&QGLS=PWMO);+G,R2J4&/]H'%$>H64UV]I%>6[W,8R\*RJ74>ZYR*
M,6V\$Z5;C68F,\UIK#O)=VDK+Y19NK*  5)]0??KS4?A_P #:?X?X2]U.^B1
M#'!%?W1FC@0C!5%P ..,G)QQG!-6+3Q9I^KKK$.DW$$EWIS/%B:10CN$5MV0
M2=F6 +8[&KVDW\EQI]I]OELA?RQ[WCM9MZ'U*$\D>] &+H?@#2O#]TKV=WJ3
M6D;F2WT^:Z+6T#'G*)^)QDG!Y'/-,O?AUI-[_;$;W>I1VFK.TMS:1W&(O,8
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M/4<&NA5E=%=&#*PR"#D$5D2>*-*B\41^'GN%%^]N;C!90H&Y5"GG.XE@0,=
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MKB1%/4*7E.W\* ,32-$TG6/A%KVLZI:6\NJ7'V^XN+N1 98Y4>0+ACRNT*N
M.E6-#LH?$?CS0Y];MTNY#X0MKAXYU#*93(<L5/!/S-UZ9JW>>%_MMU=2/X2U
MN.VO)?.NK&'5XDMIW/5FC$F.<#., ]ZVD-_'KW]LIX,OENQ:"R&+VW"B(,6
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M['91L/F"EMSR$=BQ"@#J O/7 T=%TB#0],2PMYKF6-&9@]S,97)9BQRQY[T
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M\)+<,DPW*[[X^6!X;[Q//?!ZBLJ\@AL-)\1V-K&L-I!XPM#%"@PD89H20!T
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M;\V5DZ20V+W;M;^8O1RF<$YY]"<G')K9B\-:;#XEN]?6-S?W=NMM*6;*E!C
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M+@%SDF;._![=3]*JWW@G2[R.P\N6^LI[&W%K#<V5RT4OD@#Y&8?>' //?D4
M-\!Z;J&C^%(+#45B1X991%'%-YJQQ%R43=@9V@A>G:NEJEI.E6>B:7!IVGQ>
M5;0@A%W%CR<DDGDDDDDGJ35V@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HY[B&U@>>XFCAAC&YY)
M&"JH]23P*DKD_'TUM_9FFV4VF)J<]YJ$45K:RS&.)I1EP9" <H A)&#G XH
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MV^DQ_%&VTHB"V\S38Y%A.!$DA_>@8Z##-QVR: /9['6M*U.62*PU.RNY(O\
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MD6\IF2"*TG:2<Q?9F.V0E &_A).3S^=-\,:?;VO@3QMKMO;1MJ\5SJGV>Y*
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M\*:O-K_A/2M7N(TCFO+9)G2/.U2PS@9[5L5R_P -_P#DFOAS_L'Q?^@BNHH
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M[N_NX+6V3[TL\@1!]2>* ,&?P#H%QJ<E[)#<8EG%S+:K=2"WEF!!WM$#M)R
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MJ@U*X2ZBNC$(97M;J2#SHQT1]A&X?6MJ"]M+F>>""ZAEFMV"S1QR!FB)&0&
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MN72GO1<0/O)D654P&!QC!/&,Y[UL6/B'1=4O);.PU:QNKF'_ %D,%PCNG8Y
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MA0, 9/)JW3(9HKB%)H9$DBD4,CHP*L#T((ZBGT %%%% !1110 4444 %%%%
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MNYTZ]@\]K>*UF$<LX*@/ANHP.N.<&I=9^'WAKQ!J+W^IV<\UPS*Q(O)D4%0
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MGE60882,6R_ &-V<8&,8% %#X6Z796/P\T*>WMHDGGLHWEE"C>Y(SRW4^@]
M!Z5D?%^WADB\).\,;.WB*TC+%025^?Y?I[5Z!ING6ND:;;:=8Q>5:VT8BBCW
M%MJ@8 R>3^-0:OH6FZZMFNI6_GBSN4NX/G9=DJ9VMP1G&3P>* .2L;*TG^,.
MK175M"1::3;BQC9!M1&=_,*CH,L "17GWBQ$@^%GCVTME"V%OXBV6Z+PJ?-$
M651V 8MP/4U[+K?A32-?N(+F^AE%U I2.XM[B2"55/5=R$$@^AXJ*?P5X>N?
M#'_".2::G]DY#&!79<D-NR6!W$YY))YH Y37O^2Z^#?^P?=?^@-6?H6GZ;??
M![Q'=ZG;P/=SOJ,E]+(H+B57DQDGD%0%QZ<5Z1/H&F7.NV>MS6V[4+*-XH)M
M[#8K###&<'KW%9=[\/\ PUJ%_/=W%@Y-Q();B%+B1(9W'\3Q!@C'CN.>] 'G
M;:Q=^%(+?6IRXN-;\)Q')^])?0JH7/N1*/RJ"XTYO#ND:E\.H6*MJD^GI 1U
M*3*$G;Z?N)"?]ZO7-8\-:1KYL?[3LEG^PSK/;_,R[''0\$9'L>*+KPWI-[XA
MLM>N+-7U.R1HX)RS?(I!!&,X/WCU'&: .$LHTA^.VN11J%1/#T:JHZ !EP*P
M%TNQMOV<].O(K6);M3:7 GVCS!(;E!NW=<X./IQ7KB^'M+37[C7%ML:C<6XM
MI9M[?-&#G;C.!TZXS4)\*Z,WAF/PZ;/_ (E4815@\Q^ C!U^;.[A@#UH Y;0
M;#3]3\:^/6U:W@G=9H(&$Z@[+?R%('/0'+&K'P>V?\*OTKRW+Q^9<[6)R6'V
MB3!JKXIT=I/%4U]-X*EU>.2W1(I[*]$1D(SF.X0NH9<XP2&&.,=JZ+P)H=SX
M<\&:?IEZ8_M48>281G*J[NSE1[ MC\* ,'3+6W/QLU]C!%N72[9P=@R&+/D_
M7WKBX]+L8/V:C>1VL0NRHN//V#?Y@N  V[KD  #VXKUNZ\*Z1>>(H->EMY!J
M4*"-9HYW3<H.0&52 P!/<&D_X1/1/^$7_P"$:^Q?\2C;L^S^:_3=N^]G=UYZ
MT <*UEK.J>/?&:6VGZ%>)_H]NXU.20,L)A!"KM1OE)+GMSGTKN/!UG<Z=X-T
MBRN[N"[F@MDC,\#ETD & 58@9&,<TS6O!FAZ_>?;+ZVE^T&/R7>"YDA,L?78
M^QAN7D\'-;5M;PV=K%;6T2100H(XXT&%50,  >@% 'F_AS3=$U;0_&<WB*&W
M</J]XE]--@-'&A 3YNJA4"D8Z=15?6'34KCQ0^CZ9I#VMI81P7NHZG-)(TJ>
M3O4(.< *X.<C)/?K78:GX!\-ZOJ<M_>:>SS3%3.JSR)'.5^Z9$5@KX]P:EN_
M!6@7VLMJEQ9%KAPGF*)G6*79PA>,':Y';(/;TH \W\QY=8^"\DC%G:Q<LQ/)
M/V:.EBTC6]=T[QK&EMX>,-QJEW%->7\\B30[#A#D(0 BA"O/O7HUKX(\/V;:
M0T-D^[2#(;$O<2/Y.\88#+'(P  #D#MBFZEX$\.ZMJ4M_=V3M+,5,Z)<2)%.
M5^Z9(U8*^,#J#0!SFA:9%<_%/5'U.."[NK?1K)2Y&]2QWAF&?7'7T)]:Y:QA
MB.F^'M,E1?[+'C*ZB,)'R85I3&F.F-W:O8H=(L;?5KC5(H-MY<Q)#+)N/S(F
M=HQG QN/05G3^#= N='N-*EL UG/<M=NOF.&$S-N+JV<J<G/!&* .,U=])T/
MXK:M>FW411^$YKB[B@^4N%E'IC#%5QGV%4[*"]LO%7P^$VG:-IMO(9UMK>R=
MWF6+[,QVNQ W ?+D^M=W8>!O#NG333PV!>:>W>UGEGGDE::-R-RN78[L[1U[
M#'2H+;X=^&K5;?R[.<O;2I+!*]Y,TD10$*JL6R% 8C:#CGD4 87PITNR6SUK
M43;1->-K5XHG90751(0%!Z@<G@?WCZUJ?$O3YY?#2:S8INU'0YTU& #JP3_6
M)]"F[COQ72:5HUAHEO-!I\'DQS3O<.-Y;,CG+'DGJ>W2JGB34-1L--(TO1)=
M5NILQI$KHB*2.#(6(^7UQDT <!>7[>*;WQ/XJTQV>VTC0WM=-D7O/)%YLCK_
M +0!C7\Z70M UIX/!ETL/AJQM+-HI()K:>3SIXFB(9!E &+*=Q&>HS7:>!_"
MT7A'P=9:+^[>1$+7#*/E>1CEOPR<#V HTOP+X>T?48[ZRLG66'=]G5[B1X[?
M=][RT9BJ9R>@% 'FFKS2W7A./6;#2])T_2KC7(IK>1Y'>]DD^U &3<1@$X8X
MR<+D5U'A[2[*\^,/CB[NK:*::V^P"$R*&\LM!DD9Z'Y5Y]JW'^''A:072OIS
MM'<EF,1N9=D;,VXM&N[$9+#.5P:V-/T'3M+OKR]M(66YO%B6XE>5G,@C78F=
MQ/('?OWS0!0\>_\ )._$O_8+N?\ T4U>>Z796]_;_"*WNHEEA-K,YC<94E;<
M,,COR ?PKUN_L;;4].N;"\C\RUN8FAF3)&Y&!!&1R.">E4+?PQI%K_9'DVFW
M^QT:.Q_>,?*5EV$=?F^7CG- '/>&X(;3XI^,(;>)(HGMK&1D1< L5D!.!WX%
M'C1X]%\5^%O$LC!((YY=/NG_ .F<R$J3[!T7\ZZN#2;*VU:[U2*';>7:1QSR
M;B=ZIG:,9P,;CT]:CUS0]-\1Z3+I>K6PN+.4J7C+%<E2".5((Y Z&@#QRQU.
M?PC83^(Y0R7'B;1KF] ];KS2\(^NRX _X#6_HGA>STWX@^&](N;>.7^SO##$
M!P"/-$R!FQ]68_C7>:EX4T35X--@OK!)8M-D26T7<P$;*,+T/(X'!R*N'2;(
MZVNLF'_3UMC:B7<>(BP8KC..H!SC- 'C/B6*.V^'/Q0MH$6.!-84I&@PJY\@
MG [<UUEA##>_$S2H+Z*.:*#PPDMJDJAE#M(!(P![X"#Z&NKN_"&A7UAJMC<6
M.^VU683WB>:X\UQMP<@Y'W%Z8Z4:OX1T76X;..\MGW68VVTL,[Q2Q#&" ZD-
M@@#(SS0!P^L:1X<.N^$M-TQ(9=/77;HS0*^]$F$3LZ8/  ;^'I[5MZ/;PV?Q
M?U^*VB2&.72K65UC4*&8/(,D#OCBM^U\):'8Q:9%;6"Q)IDC2V@5V^1V!#,>
M?F)#');/6KL>DV46LS:ND.+Z>%8))=QY122HQG'5CVH X3XU_P#(HZ;_ -AB
MV_FU68;6W;X[W;&"(L- BD!*#.[SV&[Z^]=;K>@:9XBLXK35;;[1!%,LZ+O9
M<.O0Y4CUJ"_\*Z1J6OVFN7%O)_:-JH2.:.=XR5#;@K!2 RYYP<B@#,^)O_),
MO$7_ %Y2?RKFK/2-0N-(\(:MHZZ7?7MMH$4,FFZ@V-\3I&=Z$ [6RN,D8/2O
M1M3TVTUG3+G3K^+S;2Y0QRQ[BNY3U&00163>^"-!O[>PA>VFB^P0"VMY+:ZE
MAD2( #9O1@2.!P2: %\$W=C>>$[.73]/.G0*TD9LRV[R761E=0>X#!L8XQZ=
M*Z"JNFZ;9Z/IT&GZ? L%K NV.->@'7OR3DDDGDDU:H **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J"
M\O+73[26[O;B*WMHEW22RN%51ZDGI4]<)\3A=R6OAR&U%LPDUN!66[SY+':Y
M0/CG&\+^.* .LTG6]+UVU-UI.H6U[ &VEX) X!]#CH:OUY;J-I?:6WBC5=>U
MC3].^TZ;#%.NBEO/5M[*DFUOXFW% >.G48S5O2+>2W^)]SIAM1IUG<Z LS6E
MM<$#<)BH<E<8DP2"5_,T >CT5XMHVB6\OP/F\1R7-^VJKH]V!/\ ;91P&=@,
M!@.JCMSSG.:V+>R32O$GP]O+66X$^HP217CO.S><HMMX# G'# $8 Q0!ZC4%
M[+-!93S6\22RHA94=R@8@="0#C\C7EMA8W'C/PQ=ZLVN6VFZI;7TS27GV=FG
MLC'*?W>?, "[ !MQ@@Y()YK5TLP^*]8\9)JP\V73YQ:6\1)'V>,1@B1!_"S,
M6.X<\ 9XH ZKPCKDGB3PGINLRPK ]Y")3&IR%Y/&:VJX_P"%K*/AAX=!(!-J
M .>O)K8\4V]W>>&;^VL+R.TNYD$<,TA(4.2  2.1DG;D<\T ;%!S@XZUY'/?
M12>'?&=E=Z%)H>N6^C-.]K&P: A%EV3PLO'WCST/ ZD&M.XE8:Q\,91(PDGC
M=96#',B_92<-_>&>>>YH ZCPGXAN?$":Q]JM(K:33]3EL=L4A<,$"_-D@==Q
M["M2ZDU)=3L4M;>W>Q<R?:Y7D*O'A?DV+CYLG@Y(Q7EMGX:L-:T?QW=W4]U#
M/:ZU?26\T5R\8MW5$8. I SZDYX%7K.[O[S6OA=?7\LXN[NTN&N4,C!7;[-D
M,4SC/)/3O0!ZC17EEO83^.+/Q"TFK6UCJ%GJD\*W!A8SV*QO^[VL)%VJ5 /0
M Y.<U?TWR/%GBCQ+HVLS_:6M+:VCM>-F$DAW-.BGHQ<GYNHPHH [N?4+6VO;
M2SEE47%T6$,?=MJ[F/T [^X]:DN+B&TMI;FXD6*")"\DCG 50,DG\*\UN]'T
M\^/_  /$\K:EBPO(FNYSN>?RQ&%+'OSDY]\]ZZ;XDV\-S\-O$2S1JX2PFD4'
MLRJ2#^!YH Z2VN([NUAN8B3',BR(2,<$9%2UYH7BM]6\">'_ "Q%I5_:RSSQ
MCA;B5(5*HWJ.2VT\$@>E:?AP3Z9\1_$&B6Q8Z.MK!=Q0YRMM(Y92B?W0VW=M
MZ#MB@#2\6>*+KPW<:/%#IL-V-3OH[%&>Z,6R1\X) 1OEX^OM5^&^UM=1MH;S
M2;1+:8LK3VUZTIC(4D;E,2\'&,YZX]:Y7XI(TLW@R-)7A9O$=L!(@!93M?D9
M!&?J#720:=<6&KFYOM:FO;>:$6Z0W*1C:Y;/RA$4'(ZY_N^F: -VBO)?LMMH
M_CUM'N)I'\,ZC>K)'(V2([U5S]FWD\(>& '&<IW85LW:GQ'X]UO0+N6T$5K9
MP&VMKF%GRKAM\J .N&!P-W48&,9.0#T&BO,M-\R#Q-X>\):UJ_\ :]HFG7+K
M-*FU;RX24*%=23N*(&X).2,GD"D\0Z7;Z!9:!;66H7,_E>*;9,R29:!)&W&
M$8^0 C@Y[4 >FD@ DG '4FLJ?4[B^\/?VAX=2WO990&MQ-(4CD&X G< 3C&2
M..>*Y&YAAG^(GBJQD4/:R:%$\D!/R%BTF21TR0!GUKF[BTAM?V;[6ZM3)!.;
M6UD9X960L3(BG.#R,$C!XH ]HHK@O& C\.>+]"\5N=MBTAL-0W-\B"08CF(Z
M JP"EO1JIZY=/IFCZ5=%TLDU_68_M<DBD+'$ZN8T8 @@';&&Y R7_O&@#T2Y
M>6.UFD@A\Z948QQ;MN]@.%SVR>,UF^&=7N];T..\OM/.GW7F212V_FB0*R.5
M.&'##(ZUE^'_  Z^A^(M0;^TX&M;V%7&EP6YCBB9>#(H+MMW9P0  3]*?XRL
M;^31+.#14M&EBND86$[>7%=HJL3#QP.!N';Y.>* .HHKD_ 6I6=_8ZDMOI]S
MIES#>%;O3[CG[-)L7Y5(X*$8(QQST%9\?V;Q/X[\4Z'J_P Z6=O;I9PL?N)(
MA+RH/[VXXW=1@=,\@'>45YS Z/XWT'PM=WLNHZ5%H\LR27)W?;)TD"?/V?:H
M8^G.>>#7-^)#=V7AOXDZ/%<7(T[2S;RV#+,X,1E0,\0(/*C(PIX :@#VJLYM
M2-[IU_)HQANKFW,D**[[4:91]TL.@W<'\:XV73H=(^)_A]+62XQJEA=K>^9.
MS^?L$94D$XR,GIC X'%86BZ;:6WPD\8S6R-;S12ZF$D@D:-E",Y494C@8'%
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MA616:20#^]NPN[J,<8R: .ZHKR"'3]6UGX?ZD5DFNM0\.:Q<+ITDCDM=PP2
M^6Y_C# ,G/4@5TMA=67C..^\16K2"R73Q;VSQNR-O9?,D.5(.5RJ>Q#CN: .
MZHKQ2WL0G@'X?ZS'<WB:E/?65O)<BX?<8I"5=.N,$>W7GKFMYM_A7QKXH@T<
M2B)?#PU!;=Y&D#7"M( WS$\G !]: /3:*\UT713J5CX9\36VOVT!_=-/-# _
MF7P<!6BE;S.26/4CY2. ,5S5UIL;?#_QSJ+7-ZUWIFL7C64K7<A,!1EVD<\G
MMDY.* /9GU"UCU.'3FE7[7-$\R1]RBE0Q_-U_.C4+^VTO3KB_O)5BMK>,R2.
MW0*!DUP3V%I=_&32[F>WC>63P^\S,1U<31X/X5>^+]O#<?"[6C+&KF*-73/\
M+;UY_4T :VI^(KFP\8Z!HRVD36VJB<F<R'>ACCW8VXQSD<Y]>*Z*O._$FEVG
M_"<^!+"-&AMC]ORD+E#@P@D9'(S[5S>I1&R\"?$C3K:>YBMM.O";15N'!B#1
MQL5!SG;DGY3QS0![117FFMV4'A^\\.VUO)=);Z_J42:E-)<.WFE8R53DX7>V
M,@8R!CIQ4E[:G2_'U]H]C'C2+[0Y+J:T7_5PS(^U70=%SG&!C)&>HH ]'HKR
M*.>1OA_\,KIIG-S)J=C&\N\[G5@VY2>I!P,@^E:6L075YK7C2UO+>ZO)FM8O
M[(>V5G\AC&<*K+_JG\SYLDC((.<"@#JM8\0W6F>+/#^D+:1/;ZJ\R-.93NC,
M<9? 7&.<#G/KQ70UY=?Z--;:I\-M,U&>X>ZS<"[D^TN[-)]E._#DEL$YZ$<'
MC%;'@.(:?XA\8:1;LXL;._B-O$SEA'OA5F R20,Y./>@#L)]0M;>]M;.651<
M71;R8^[!1EC]!Q^8K'\->(;K6M1UZTNK2*W;3+P6R^7*7#C8K;LD#^]TQ6!X
MDTRRN?B[X5>>W1VDLKS>3WVB,K^63^=<_=:3;:A;?$^YG,WF6MQ)-;[)F01R
M+;*P<!2,D$#DY_4Y /8**\RM]1N-=USP]I%_<6S1W/AZ.]6.\B,B7,S$!_E#
M+N90 1G.-Q/O76>#M*FT/2)M,FU<ZGY%RX1RA4PH<,(N68G:#P2>A [4 %IX
MAN9_'=_X>EM(HXK:RCNHYEE+,X=F7D8&W[IXY^M=#7 R3Q6WQ6\07$TYMXHO
M#T+O,!DQJ))26_ <UB:3NM/$_@":S22*VOX+E7N)9?W]^GD;Q),!QDG##)8C
M/;I0!ZS5:TU"UOI;N.VE61K2;R)MO\+[58C\F%>;65Q-I'B;3H?$&G^:EWJ#
MMI^OV<FX7!DW[(IQU'#8'4?*,=,UI?#/3;*UN/%<D%O'&Z:_=0J5'1,1G;0!
MZ!7/>&_$-UK6I:]:75I%;MIEX+9?+E+[QL5MV2!_>Z8K*UF\%]\4-*\.WN#I
MQTV6]$+?<N9@X4*P_B"KN;'3)SV%<M;1V&E67CVT:[N[*V;6H8H_LAS*Q98L
M1)D\!L[.H ![ 4 >OT5YQHECYOCWQ)HES:Q6EA<:9;2FRMI241BSJ67 &UL
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M6&=O[SQ!MC$XYR.>^:ROL>HZ]XOT74KG2I]-AT9KL'SI(V$V]0B%-K'@C)Y
MQTYKL:* .<O_  %X8U/7/[9N])BDOCC>X=E63'3>H(5_^! U)K7@KP]XAU"&
M_P!3TY9;N%=BS)(\;%?[K%2-R^QR*WZ* ,F_\,Z-J;V#75A&QT_/V7:2@B!
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M** "BBHK>Y@N[=)[::.:%QE9(V#*P]B.#0!+114$MY:P7,-M-<PQSSY\F)Y
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MM+RUOX!/9W,-Q"20)(9 ZY'49% $]%%% !1110 4444 %%%% !1110 4444
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M_J$>K_$;X6:E$I2.\ANKA5;J \", ?SI^M>'+R[\2^)%N/"RZM<ZDJ)INHW
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MCTN]'Q6GU8P'[ VBI;";(P9!,S%<=>A!KA-8TW5M'\.VP:T"WDOC<75M'(X
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M6KVEI%%)]CFC)/R+(5&PAL9']T9% ';^%==/B/0(;]X1!/ODAGA#;@DL;E'
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MV$_)C<<G!Z<=:E'A2;2KO5+(> M,UJ:ZOI;BTU*X2 QJDC;L3%OWGR$D< Y
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MPZ<$=: /.4\#ZGJ&K_$J.ZB%O:Z[' EE.SJ0Q6-P20"2 &*]0*UM.OO&E_\
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MX\T.YU[PI/#IX!U.VD2\L22!B>-@RC)X&<%?^!5T<<:11K'&BHB *JJ,  =
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MJRW.MVTZ!9HESN55!\PAQQAQQGK6AIW_ !-OC+JNH0?-;:3I::<SCH9G?S6
M/LH7/IF@#NJ*Q_"VK76N>';;4+VU2UN9#(KPH^]5*NR\-W!VYS[UL4 <7>ZS
MXCU?Q1JFD>')=.M4TF.(SS7L+R^=+(I94 5EVJ%QD\GG@5#+XC\3:AJFE>'[
M6UM-*U>:P-_J#72_:%ME#; J!& 8LV>K< >M+=6?B'PYXPUG5='T4:Q:ZQ'"
MS(MTD+031KLYW]5(V\C)&#Q4#:5XJTS7-*\3/:0ZQJ!TTV&I6]M(L/\ 'YBM
M'O(4X.5.2,CF@"K?^/=<TGP_KZ7-M9S:WHM]:V[^4K+%<1S,FU@"<J2K$8R0
M"._2M6WUKQ+I?C/3-)UN33KFWU:"=XOL<+QM!)$%8J2S'>"&ZX!SV%8=_P"$
M-?U71?$-_/9QQ:KK.H64RV2S*WDPP/'@,_W2VU6)QQZ5U.N:/?WGCCPQJ=M&
MIMK".\$\C,/D,D:A.,Y.2#TH R?!_B;Q#XD:TU$7>BSV4SLMUI\*LEQ8#G&Y
MBQW," ""J]<BLJR\=WT'ASQ;J"6>FP26&O-8)(L3+&JF1$\Z;!RV Q)(QG':
MK4.B:UJ?BG1M1NO"MKI&HV=QYE]JUO<1[;I-C*455.]@Q(/SCY0.II?#F@>)
M?#VF^*WCTRUN)[[7);N*UGE7;<6SD9 (.%8KG&[C/44 1>)]1\4K\-_$5P=4
MTBYB6T+P:C8QL!+&RL'4*'.UAQA@2.>G%32>)-9TVU\/Z))JVCV]_>6K7,M_
M<Q%8HH5"A0$,GS.2P'W@."<52_X0O4K[2/%ZV6A1:!#JE@L,&F^>C!YUWDR$
M(2B9!5>#VR:L7&AZQ=MH.MW?A*&ZGLK5["ZTJXG@D9D.PK*C$[,AE/!(.#0
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M003HGE0K(&!QGS-VP;2O()]J]*H Q_%4M];^%-4GTZ:*&[BMGD1Y4+J-HR>
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M"ZD6L+1.J(3_ !L,C)'KZ5K6NCWL?Q*U#66B L9M,@MTDW#)D61V(QUZ,.:
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M)(C(-H!R,;AR1WSQ[T 2:7XCT76[BX@TO5+2]EM\><MO*'V9SC./H:TZ\/\
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MP,V?G&Q!N XR>M '<T5A>#?$#^)_"MGJLT"P7$F^.>)3D+(C%& ]LJ<>U;M
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M![9/X]:YKQ-I&J'QEINN6>C0:S!#9RVOV>:=8_(D9E82C<".0I4XYQZUVE%
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M<S)-=)ODGD3[ID=R[8]LL0/85OUF:+XBTCQ';R3Z/?PWD43['>(Y ;KBM.@
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M3EO[N[>W$S?,VU$520!T8DGVK.\0^)/$^A:5X7748K)+^[UV*PN'1 R2Q$L
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M+7 3]Q.N7 D !R 0%;@^N*WM%U'7K'QY-X<UC48-2BETW[?#.EL(&C(D",A
M)!'((/6L2S\&^(TBM;:[2T<V_B==7:XCEP)8VWE\+C*D%@ ,G-=6VBW9^)4>
MO )]B71WLR=WS>89E<<>F >: &^--=O=%T^PATQ8O[1U.^BL+=Y@62)GR2[
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M!5T!(.&4=.QJ-?$WBFQ\&6FN7=S93WNN-:6^FV8M]J6\DQP&=@<OD'<1Q@C
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MGSRF1QA<8QG/.  >NT5YGKGC@R^(VTP>*;+PU!!90W!DGCCD>>24$A0'XVJ
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M !1110 4444 5-,TRRT;3XK#3X%@M8L[(U)(&26/7W)-6Z** "BBB@ HHHH
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MMM4>U-N%8EAY<6QMPQQSTZU9LO!GAK3=5.IV6AV,%[DD31P@%2>I'H3[5NT
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M '?0S17$$<T,B212*'1T;*LIY!!'44^N,^&%S&OPS\-)-,BR26H6-68 MC/
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MJM- &&] WW21Z&H9M=TFW>^2;4;6-K!%>[#R@>0K#*E_[N1TS7)>*9(_#7Q
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MQ?PE_P"28:*,\*LJCV E< ?E7:4 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ9P:K7UU!+\:=&MXY5:6+2+EI%!SMW/'C/Y&N(TZ6-/@3H$C.H2#6HFE)/W
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M9?*<-L<=5;'0C/(H GHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC###;3VR*LNB2QM'(JNC JRL,@@]013J* ,;3_"?A_2EB6PT>SMQ#,;B,1Q
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M::!+'''<79E^:*)6YBCB"]<*H#9P,].*["""*VMXX(4"11($1%Z*H& !4E%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD6;WFHWD%I;)@-+/($49Z<F@"U15>QO[34[**]L;F*YM91F.6)@RL.G!%6*
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M*6=]@RWLBH&<9WKL'.T$ Y(-6KGPMJLOPIT/05BC.H6GV'SD\Q<#RG0OST.
MIJ"Z\/ZGI.LZXUCX7TS6H]3N#=V]U<R1K]GD955ED##<5#+N&W)Y(XH =<>-
M-3U?6+6TTC4]*TA9],@O[5=2B+M>M+N.Q3O7 7 !QD_-TJ;5/$NOMXCBT2/4
M-'T6\6PBN1'>QF47<S%@T<;;E^52H!(R?FZ5)XET_5;N Z7/X1TK7-.:V1(/
M+D2#[-+C#<.3A>A!3D#CGK5.\T778] LM"U/PWI_B>UCL(H5F:=8WCF"[7+&
M3D@G!#+\W'3- 'H-D]S)8V[WD21731J9HXVW*KX^8 ]QG/->)^$;CP?'87ZZ
MSX2FU*\_M.ZW7"Z(UR"/-; WA#G'IGBO7O#=C<Z3X8TO3[ZY%Q=6UK'%++G.
MYE4 G)Y/U-<1X:'C/PK8W>GQ^$H;V-KZXN$G_M6./<KR%A\I4XX- &K<Z@VB
M^#K76?"FC);Z;!*9KO3C9&"5H02)&1.-KC&[D<@?2F6WC&^UJ+7M8TCR#X?T
M^SD^RSO&2;NX52S,O(_=KPO3DYYXJ756\5^(] 33CIBZ++>7!ANYEO4F,%M@
M%F0@#YVY4#''7TK-?P_=^$M-\2:;I\8?PO<:;/-;J906LYO+.Y "<E&^\,=#
MGUS0! GBSQ;9^'-#\6:B^FMIEZULMS8QV[!XHY2JB02;N3E@=NW !QGC-&K>
M/=1%SKUU8:QH5I!HTSPIIUX1Y]ZT8!D^;>-F3E5PIR1S5+3K#Q)XD\!>%_#\
MNF0Q:=Y=E-/J7VI2K01A'"B/[V\X4'MG/-:,WAW5=(U/6H['PMI6L+J-V]W;
M7MT\8%NT@&Y958;BH;)&W.0<<4 7/^$EU_7O%3:3H4UE:6<FE6^H+=7$!E9/
M,+?+M# $G"]^,'KD5GGQ[K \.V@NKC3=/O3K$VDW>I2QL;:$Q[_GV[AC=M &
M6QDUTFFZ)=VGC^]U1HX4LI-*M[6,QD*-Z.Y("YR!AABL>RTGQ!HNEZE&FC66
MIP7>M7=S/8S2J&EMY&)0J6.T'."5;MZ4 2:GXIUO1=$L8;R]T;[?J%_]EMM2
MR5MO)V%S,REN" "-N[!..<&L^3X@ZA8:7KT+7VE:G=Z=]F>+4;93Y!BF?87D
M16;'ED,2 W(QTJM%X&U&/3%O8=&LH6M]8.H6VA23*\2PM%Y;Q[L%59CN<8^4
M'%=#:0Z_#INH75EX7T73Y6>,0V!9=\T0/[P/(GR@D$[>H'?.> #4\+76KW*S
MM?:EI>JV1"M:W]@NP/G.Y67<PXXP0><^U=%7GV@:/JVF7VOZSI_ARUTAKBT1
M;?2EN$*S7"[SYC;/E3.Y5X],FN\M6F>TA:YC6.=HU,B*<A6QR >_- '+?%+_
M ))AXA_Z\V_F*K6OPZ\(ZGX:LDET"QBEDMHV^T6T*Q2JVT?,'4 YSS6MXZTF
M[UWP-K&EV"*]U<VYCB5F"@GZGI6%#?\ Q!_LB#3;/PM86,Z0K"+RZU-9$3 Q
MNV(N3]* ,CPWXPUFV\/Z+9W$ZW=PGB-M#N+F8$M+&H<ALY^]@*,\]*ZK4O$=
M]:^,[O2(UA^S1:$^H*64EO-$FT<Y^[CM6)=^!+W1?"&A6NC :CJ&E:HFI3"5
MQ&;Q_F\SYCPI.\XSZ"IHM(\1ZIXOOM<O]-BLH)]"DL(8!<+(ZN9-PW$<9.3T
MR  .<T 9UMXH\477PPOO%VH#3/)?3#+;V7V=F^<=6<EN0V"=HZ CG.:OR^*=
M=:W\"VNEQ6$<^NV322F2(^7"5A1\JH(X&6^7// R.M2#PMJO_"D?^$9\E/[4
M_LS[-Y?F#&_'3=T_&I+/PSJD-Y\/I'A0+HUC)#>_O!\C&W1 !Z_,#TH HR^-
M]9\/6/BZ#5_LNH7NB);O;S01&%9_/R$#+N.,,,'!Z59FUGQAH6O^&].U6?3+
MR'5KDQRS6]NT1A(C9B@!8YY PW'0Y'(JIXH\)7=_)XZN)Y[:RM=0M;$VMS/*
M%020%F._^Z-VT9/K5?5KW7M3\8>!FU33;?3E%](RP1W(G:5A Y9P5& @'U)W
M<XQR ;?Q<GO[;X9ZQ/I]RMNRQXE)0DM&QVE5((VGD<\]#QSQBZG%XA3QUX1@
M2\L9=4?3[Q6NS;LL4:DQG=Y>\DD# QN&2<\#BNM\?:)=^(_ NKZ38[#=7,.(
M@YP"P8-C/;.,5FVFG:WJ/BSP[K=]I8L%M+*Y@N(C<)(49C'MY7KG:>G2@#,D
M\=:OHNE^([75&L+C5=+O;>T@N IAAE\\(49P2=H7<2V#T'XUH^&O%-W+XI.@
MWNLZ3K'FV9NH;K3U";"K!7C=0[?WE(.1WJAK/@G4]3O?%\Z16^Z\O+&\T\3,
M"DK01IE7'. 2I7GUS6YX:MK\ZK+<W'A33="MEAV*$,;SR2$\_-'P$P.AY)],
M4 ;.J>'=%UMXWU72+&^:($1FYMUD*@]<;@<5Y[\*O"OAZZ\/7%W<:'ILMS%J
MMR(YGM49T"R': 2,C';TKU2N3^'NA7_A_P /W-IJ,:QS27]Q.H5PWR.Y*G(]
MJ .5O/B/?);7^O0ZMH:6%E=/$ND2$?:9X8WV,^[>"KG#,J[2,8]:VKC7_$NI
M?$"_\/:1+806EM;V]T;F>%G(5L[E ##);C![ 'KQ6=:>&=7T8W.DVOA31[^-
M[V26WU6Z,95(I)"Y$B8WLR[B!C@\<BNCTS0[VU^(^N:P\2K8W5E;0PL&&2R;
MMPQU'44 <[-XF\87MGXLO=/GTRW@T"\N(T66V:1KE8T#["0XV\?Q<Y)[8YFC
M\5>)H3X7UJ[;3_[*UZYAM_L"0MYMN)4+(WF[OF/ R-H'./>KMCX:U.#P_P".
M+22%!-JUY>36@WCYUDB55R>W(/6DO/#.J3>&/ UBD*&?2;RQFNU\P818HBKX
M/?!/:@#NJ\Y\8/KQ^)_A*UT_4[:WAFCNV19+9G 98QN+8<;L@\=,')YKK=)U
M6[OM<UNQN+>..&PFC2&1&R9 T8<[O0C/3T(K$\7Z7K+>+?#.OZ3IRZ@NF_:8
MY[?SUB;$J*H8%N.".: .<TAO$RW?CF70[JPM8K;5YYB;F!I3.XBC.SAEV# '
M/)^;MCF]+X_NM3A\/6]KJ&EZ+-J.F#4;FZOP&2,' "(I9=Q+%NIX"UMZ%H.H
M6,/BY;B)5.I:C/<6V'!W(T2*"?3E3UKF[3P=JFD6GAF^;0K36)[/21IM[82R
M1@J00RNC/\I(.X'D<'B@#K_!7B*3Q'HT\MP]M)=6=W)9S2VC9AE9",.G)X92
MIQDXS7.6NEVGC+XF>(9-;@2]L]#\BULK2<;HE9TWO(4/!8Y !/85UWAFVN[;
M2!]NTZPTZ>21Y#:V0&R-2?E#$<,VT#)&!Z5S^IZ-K^A>,+OQ)X<M(-1AU**-
M-0TZ2<0L7C&$DC<C&=O!!_\ U &A!X2T3PWK-QXBTY&TY%M76ZM;4*D$P'S!
MF0#&X8.",=:YEO%GBVW\'1>.;A]..EN$N'TI;=O,2V9@ 1+OY?:0WW<5NV-M
MXI\0:C-/KD,>CZ2;62W738IEGDF9Q@O(X&!@= OJ<GUYU_#WBV[\#P^ Y],@
M2V54M)-8%TI0VZ,/F6/[^\J ,'C/>@#8EUGQ/K'C+7M"T>YT^TM]/BMI4N9[
M=I6)D0G;M##J1U[ =#GC"C\<>+9? MIXU?\ LR&R22..XL!"S/,/-$3N)-WR
M_-DA<'@<D]*[#1-$O+#QUXFU.6-5LKZ*S2W8,"3Y:.&R.HQD5S?_  ANM?\
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MML<%^""&((SGO6'/X)URX\/F26*#^U+[Q'%J]S"DH*P1AE^0,<;BJJ/J<XH
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M\4*DX!D<*#^= 'G4OAOQ/=S>+99[&RC&O:-]GBCBN,BVD5)56,G W9W@EA@
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MXF0:Z%3["FCR69.[YO,,RN./3 /-=+10!YE=>"]9&GZBR6MM=.?%!UB.SDE
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MH-/MH7QOCB56QZ@ 5/1UHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M36ML[Q C(WXPN?;)%4? >CV]MX+T^:95N+S4+9+F]N)1N>>210S%B>HYP/0
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MO%+6UW"T,@'7##''O7,^&[?Q1X;TJ#0[FQM]3@M$$-K?1W(C+1#A1(C#*D#
MRN[I0!8+V7@F&ST?3+=7EU.^D%E:[MBH6S(^3@X1<,>!W  IH\87-OJ>JZ/>
M:=&NJV5G]OA2.?,=U!G!96*Y4@C!!'IR:C\1^'-7U&71-9M9K=]7TF[:X6%B
M5B>-UVO$&QD';T8CKV . D^@7^H:YJ/B&:U2&Z?2CIMI:F4$X9BS,[#@<[0
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M&79@@]!N)('M5RBB@ K+UGP[H_B)+=-7T^&\2WD\V)91D*W3.._T/%:E% "
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MH SW.:AT/Q-8P^%+#4-3\26=^EQ*T*:@L/D1RMN; "Y.W 4C.?X2:O:3XO\
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M27C0-<")CR(E."Y[  ]S5/1O%V@>(+J2VTK4X;F9%WE%R"5SC<N0-RY[C(H
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M-J1[OXB!DD]R37521I+$\<B*\;@JRL,@@]0:P+7QUX8O-473;?6;:2Z>0Q(
M3M=QU57QM8^P-= 65<Y8#')R>E '/0>!/#%MIRZ?%I$*VBW"W2Q;F($J]&&3
MQCTZ5KQZ991:G/J4=NJWD\:Q2S#JRKG:#],G\ZM;@"!D9/0>M!95!+, !ZF@
M#+/AO1SHDVC&PB_LZ<LTEOSM8LVYN^>2<U%K/A'0/$$L4NJ:9%<2Q)Y:N2RM
ML_NDJ02OL>*V68*I9B !U)-&X;=V1CKF@!D$$-K;QV]O$D4,2A(XT4!54#
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M?SJCI'A+P_H-U)=:5I%I:3R#:TD4>#MSG ]!GL.* ,+XO?\ )*=?_P"N*_\
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M4D#DO]I!W?6O4+3P7X;L%M1:Z+9Q?99O/A98_F23 &[/7. !^ ]*M_V!I/\
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M;B>.-TU'5$*LV#N?.P8]3D8]<U-X8BCD\<>$G= S1^#U9"1]T[HQD?@2/QH
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M[.OP[6@!N$EC>%HP02"5< XX//2H]'\9^']?O39Z;J*S3[#(JF)T\Q <%D+
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M/M$D"2K?(\QD('[D0K@G/8'=^= %KQ=XJN[+5?!?]CWL;66KZ@L<KJJN)8B
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MF=IXA& LI?[Y8=\Y.?6J6H>$?#NK"V&H:)87(M4$<'FP*WEH.BCCI[=*J_\
M"=^'?[9_LO[<_G_:/LOF?9Y/)\[IY?F[=F[/&,]>.M)#JT \;ZE9-KSR-;V:
MS/IAML+ O'[SS,9;/IGO0!?U3PSH>M0V\6IZ197<=O\ ZE9H581CT7C@<#CV
MIY\/Z,;26T_LNS^SRRK-)%Y*[6=<;6(QC(VK@^P]*QH/B1X5N9K..'479+QD
M2&?[-*(B[C*H9"NT,<C@G([U8AU6'_A.KZP.NO(\-BLS:7]FPL0R/WOF8R<]
M-N>] &GJVA:3KUND&K:=;7L4;;T2XC#A6]1GI47_  C.A><TW]CV/F/Y6YA
MN3Y>/+[?PX&/3 K(A^)/A6XELUBU)VCNV1(I_LTHBWO]U3)MVJQR."0?6KNJ
M^-= T;5/[.O;UEN5022K'!)((4/1I&52$'NQ'K0!KR6-K+>PWLEO$UU"K)%,
M4!=%;&X ]0#@9^E4$\+:!'K1UE-&L5U(DL;H0+YF3U.<=??K5K2=7L=<TV/4
M--G$]K(S*D@4C)5BIX(!Z@UE7'CGP]::NVF37KK.DRP/(+>0PQR-C"-*%V*W
M(X)[T 7+KPMH%]JT>JW6C6,VH1D%;F2!2X(Z'..H[>E:U4;/6+&_N+^WMI]\
MMA+Y5RNTC8VT-CD<\$'C-9LWC;P_!H=EK!OF:TOCBT\N%VDG//"Q@;CT/:@"
MU+X8T&?59-4ET>QDOY$,;W#P*792-I!..>./IQ4UAH>E:6R-8:=:VS)"(%,,
M04B,,6"\=LDG'J37)>(O'5J=&T75='U-8[.36X+2]=X]I2/YO,1U<90@ 9X!
M%=#HOB_1O$%[/96%Q+]J@02/#/;R0OL)P' =02N>XH N2Z%I,UE=64NFVCVM
MW(TMQ"T2E97)R688Y)(!S[5'IGAO1-&:-M,TFSM&C1D5H854A6(+#('<@9^@
MJCXPU*+3-/LI9==?1Q)?11"5+;SO-)S^ZQ@XW8^]VQ3M3\:Z#I-]<6%S=2M>
MP*C/;06TDLF&!((55)(PIR1TXSC(H WV4.I5@"I&""."*R;'PKX?TU46QT:Q
MMQ'-]H01P*NV3&W>..#@D9]*K2>-_#Z:)9:PM\9K2]8I;>1"\DDK#.0J*"V1
M@YXXQS4D'B_0KFQL;R*^S#>W8LH<Q.&,_/R,I&5/RG[P% &I]AM/M[7WV:+[
M6T0A:?8-YC!R%SUQDDXJCIGA?0=%O);O3-'L;.XF&'E@@5&(ZXR!T]JFGUS3
MK?5'TV6XVW:6C7K1[&.(0VTMG&.O;K639?$#PQJ$-S/;:D&M[:V%U-.876-$
M(!^\1C=@CY>O/2@#IJY>]T:?P_8SKX*T'2H;R]?]\[MY"(<'#L%4[\$_=XZU
M8TWQKH6JI>&WN9D:SA^T31W%M)"XBY^<*Z@E>#R :KVWQ#\,7=[96T&H.QO6
M5+>8VT@BD=AD()"NW=_LYSGCKQ0!)HGA:/P]X$7P]:,)'6VD1I"-OF2N"6;V
MRQ/T%5/"?@;2])TC19K[1[ ZW9VD44ETL2LX=4"Y#8YZ8S5S5_'7A[0]0DLK
MZ]=9HE5Y_+MY)5@5NAD95(0'W(XYJ75_&>A:)+#%=W;O)-%YZI;023D1?\]"
M(U.$]SQ0!8U+POH.L7L5[J6CV-W<Q !)9X%=@!R!DCI6MTJ&TN[>_LX;NTF2
M:WF021R(<JRD9!%<!I7Q&LK"X\0Q:_?RLUIJ\\48BM7D\BW4+M+^6IVKG=\S
M=<'TH [#5_#.A:^\3ZOI%E>O%PC3PJY4>@)[>U6+K1],O;".PN=/MIK.,J4@
M>)2B[?NX7&!CM4-KXATJ]U4:9;7BR79M5O%15.'A8X#JV,,,^AJ2#6;"YUF[
MTB&???6:))<1A&_=A\[<MC&3@\9S0!?KC;CP7;ZKXVU:_P!8T^TO-,N;.VBB
M290Y$D9DR<$<<,.?<UJ:WXQT3P_=K:ZA<RB?R_.9(;:28QQY(WOL4[5R#R<=
M#5VWU[3+O4H]/M[M9;F6S6^14!(:!CM#AL8P3[YH >=%TMM(_L@Z=:G3=FS[
M(85\K;Z;<8J/2?#^CZ%;26^E:9:V<4AS(L$07>??'7\:YGQ=XRCM-)2ZTK4%
MB^RZY;V%](R8"#>OF*=PQC:W4?@:V='\9Z'KM]+8V5S+]JCC\[RI[>2%FCSC
M>H=1N7/<4 6_^$;T/^R$TC^R++^S4;>MIY"^4K9W9"XQG))I=8\.Z-X@2--7
MTNTOEB.8_M$0?;ZXSTK%B^)GA*9K39JA\JZ*K'<-;RK"&;HK2%=JL?0D&K^C
M^,M#UW4Y-.L+J1KI(O.$<MO)%OCSC>F]1N7/<9H H>+-)UC4=('AO0[2PM=,
MNX/L]Q=.^/L\1X98X@N"=O Y %;\6CV$6B1Z-]FC?3T@%MY$BAE,8&W:0>HQ
M7#W'C^UT#P)J.MKJ\NO/%>O!$[6;1!7R!Y9VKP%S]X]>F<XJ]??$W2K77]%T
M^..[>'4$E=Y&L9U9 O"X79DY;.>. ,G (H [6**.&)(HD5(T4*JJ,!0. !3Z
MY>RUZSAUSQ09_$#W,6F)'+/9FUVBP78S'#!<R;@">^,8IUK\0/#5YJ-K8P7[
ML]VVRWD-O(L4KXSL60KM+>V<YXZ\4 7=2\(^'-8O#=ZEH6G7ER0%,L]LKL0.
M@R144'@GPM:Q3Q0>'M,BCN$"3*EJ@$B@@X88Y&0#CVJ.^\=>'=.U:73;F_*W
M$&T3LL$C1PEONAY I5"?<BMC3=2M-7TRWU&QE\VTN8Q)%)M*[E/0X(!% !>:
M;8ZA%%%>6D$\<,BRQ+(@8(Z_=89Z$=C5*[\+:!?ZM'JMWHUC/?QX*W$D"LX(
MZ'..W;TK$\-?$/3?$-[K4.)+>/3YG"RRP21J8D5"SNS* IRQ^4D' SBKVE^/
M/#VL7\%E:7<HEN06MC-:RQ+< #),;.H#\<\&@#0U?PWHFO\ E'5]*L[XPG]V
M;B%7*_0GM[4:EX;T36+*"SU'2;.ZMH,>3%+"I6/ Q\H[<<<5/JVK66AZ9-J6
MHS^1:0X\R3:6VY( X )ZD5EZ;XW\/ZMJZZ7:7KFZD5GA$D$D:SJO4QLRA7 _
MV2>.>E &C'H.D0VUS;1:79I!=($GB6%0LBA=H##&" H ^E0VWA?0;.*SCMM'
MLHDLG:2V"PJ/)=NK+QP3ZUQWASXEZ=;Z-(WB+4I#<+>W$3RK:NR0H)F2,2,B
M[4X ^]@]_>NWM-;TZ^U6^TNWN ]Y8B-IXMI&T.,J02,,"!U&: )+S2M/U"YM
M;F\L;>XGM'\RWDEC#-$W'*D]#P.GI3=5T73-=M!:ZK86][ &W".>,. ?49Z&
MLV\\:^'[%KU9KX[[*=+:5(X9'8S.NY44*IWMCG"YQWQ6=K?B[2KOP3>:M9^(
MI-)@@E6*6\^QL\EN^Y<HT3KD$Y Y'\6: .IL;"TTRSCL["VAMK:(82*% JJ/
M8"JVKZ!I'B"!(=7TVUOHXSN19X@^T^HSTJKK/BO1_#QMHK^YD,]PI:.&"!YI
M'4=6V("0!ZXQ4=QXU\/V^CV6J_;_ #K6^;;:_9XGE>9N<A44%B1@YXXQSB@#
M1AT72[<60AT^UC%B&%H$B4>1N&#LP/ER"0<4LVD:;<273S6%M(]W&(;@O$"9
MD&<*WJ!D\'UKB?'WC9HOA7?^(O"^H;)8Y8XUE\KYHV\U5=61QP>2,$9KT")B
MT*,>25!- &3:>$_#UBEJEKHEA"+24S0;(%!C<\%@<<$X'/L/2IAX<T0:3+I0
MTFR_LZ5M\EKY"^6[9!R5Q@G(!_"J%OXZ\/76KKID5\QF>9K=)#!((9)1G*+*
M5V,W!X!J];>(M)NTU)H[Q0-,=H[WS%*&$J-Q)# <8Y!Z'L: --55$5$4*JC
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M=P3:BE]'(P#-(SN1D'DE@5QZU%X8>/3/'OA6'5W6&[_X0^*%?..")-XRO/\
M%@-^1KTFY\.:'>ZDFI76CV$]\F-MS);(T@QT^8C/%8]_X375/'C:IJ%K9W>E
M/I'V)H)U#YD\[>#M(QC'?UH \WU,O<76KZCI][%:Z:/&%LWVPQB2*-A#L:0C
M(! E*9.<9K7U[3W73O&=[=>*;?5]07P^\$T-O9B$1H=[(6*L03]_CK@UZA%I
M.FP:9_9D5A:I8;2GV585$6T]1MQC%0VGA_1;#3YM/M-)L8+*<$2V\=NBQR9&
M#N4#!X]: ..U&\.D_#[PA:V<=E$UU+96L4]U")([4F/<)=IP"PV\<CDBN8NY
MG:;XE0S:RNJ3CP^@,ZQ)&&*K/D +P=N<$]CD=J]?NM*T^^T[^S[NQMI[+:%^
MSR1*T>!T&TC'&!BH8M T:!HFBTFQC:&$V\96W0%(CU0<<*<GCIS0!YI?22W
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MTJ&584B"D,Q* +P2 P/J-U:&IQ)%\,?A^L:!0M]I!&!T)*Y/ZFN_C\-:%%'
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MCF:(0-(D*AC&.B$@9VC XZ4 >431)%^SEHH1 N!8N,#^(W,9)^N2?SK5M_\
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M>TBTVS2VMI!+!"L"A(G'1E&, C)Y'-6#:6QO5O#;Q&Z6,Q"?8-X0G)7=UQD
MX]J //?C1_R+FA?]AVU_]GK2T2-#\7?%<I4;UL;%0V.0#YF1^@_*NMO-/LM1
MC2.^M+>Z2-Q(BSQAPKCHP!'!'K3TM+:*ZENH[>)+F8*LLRH [A<[0QZD#)QG
MIF@#R30+2UN=$L%BUT:-K$.LZDVG3-&'1OWC!T*MP05(XR#W'0TZ_P!;EOM.
MT.XU(6$<FG^,(H+J[L_E@F(1OWO/3.X Y)P0>:]-N/#VBW=@;&YTBQEM#(93
M ]NA3>226VXQN)).>O-/.B:2=)_LDZ99_P!G8V_9/(7RL9S]S&.O- '"W]_:
MWOQ6U);6=)O(\+2I(8VW!6\X';D=\$''N*HZ3>KHG[/VDS0VMG)YD,$>+N,-
M"K2S &1QW +;OPKT>ST'1]/55L]*LK<+$80(K=%Q&3DKP.A/)'<U+_9>G_V9
M_9OV&V^P;/+^R^4OE;?[NW&,>U 'E5S-,GCK58+S7X]6G7PO=*9$@2)4;>AV
M#:3DXYQDD CUJQ?1)%\&_ X1 N)])<8'\19"3]<D_G7H<7AG088K>*+1=.2.
MVWB%1:H!'O&&V\<9'7'7O5MM-L'LX;-K*V:V@*&&$Q*4CV?=VKC Q@8QTQ0!
MP/A[4]*TFX\?0Z_/;QLNIRW$\<Y&7MFB39P?O J" /PK-LQ<-XZU632M=M?#
M]K/I=C-:17-BK;K8(PPH9EV!3G([9%>D7_A[1=4NXKO4-)L;NXA_U<L]NCLG
M?@D9%.U/0M(UH1#5=+LKX1',?VF!9-A]MP.* ,SP'8V^G>"M-MK341J-L%=X
MKI8O*$BL[,,+DX S@>PKD_"FIZ/9)\0UO9[>)TU>ZDG61@"T110#SU'##ZYK
MTU$2*-8XU5$4 *JC  '8"LNZ\+^'[YP]WH>FSL)6FS):HQ\PXRW(ZG R>^!0
M!YA9P3^'/!/@#Q?.&C.FQ);7Y(_Y<Y^,G_=)0@?6NR^'%M)-H]YXCN4*W6OW
M37N&ZK#]V%?H$ /_  (U/XQT76_$D(T*U^Q6^B7*J+VY9V,^P-EHXTVXY  W
M$\9/' KJ888[>"."% D4:A$1>B@#  H X3Q%$8?$]_J.A>)+*PU>*SC%[9:A
M$&@GB!<QDDD%>KC<I/N*S?#VM6UU\0=(U.>.'3H[[PG&\4+$(JGSMQ5>G0$'
MZ5WVI>'M%UF6*75-)L;V2+_5O<VZ2%?H2.*=J.@Z/K"0IJ>E65XL!S$MQ L@
M3Z9''04 >,7]]8W/A77;YG673V\;QR,_57CS%DCU!'/N*[C6KFVO_BKX5^P3
MQ3O!8WTMR8F#8B94"$D=BW2NR_L;2_+,?]FV>PS"X*^0N#*,8?&/O# YZ\"F
M:=H.CZ.\SZ9I5E9M.<RFW@6,O]<#F@#R%;>$_LW:+&8D*--;%EQP<W8S^>37
M<:L /C!X;(&"=,O ?INCKJO[(TT:<FG_ -G6GV&,@I;>2OEJ0=PPN,#!Y^M3
M/9VTEW'=O;PM<Q*4CF* NBG&0&Z@' S]* / H./V?_%Y[#6F)_\  B&O0?$5
M]:?\+4\$W7VJ#[.UOJ 67S!L)V)P#TKM$T;2X[&>QCTVS2SG+--;K HCD+=2
MRXP2>^:KR>%O#\MA;V$FAZ:]G;,6@@:U0I&2<DJN, D^E 'F,/\ R,?QF_Z\
M8O\ TFEK4U:*.+X>_#Q8T"JNHZ3M '3@?XFO1!I.FB2\D&GVH>]4+=-Y*YN
M 0 YQ\PP2.<\&GOIUC)!;P/9V[0V[(T$;1*5B9?NE1C ([8Z4 >:Z-J.EV&A
M_$&UU6:%)_[5O6E@D8;Y$D4>7A>IW*0!ZUU7PV_Y)IX<_P"O"+_T&LO7O#OB
M.YUF_N+/3_#=V;A-EIJ%W&4N;(%=I&0AW@<D<CK@UUF@:1'H/A[3M(B<R)9V
MZ0!R,%MH S^/6@#R2[+S^"_BI96S@W9U:XD\E6^<QA8RQQUQM#5TWB[4-.U2
M+P/#I%Q!-++K-K/;)"P)$**Q=L#HH3(/UKN$T72X]4DU2/3;1=0E78]TL*B5
ME]"V,D<#\JBL/#FB:5=R7>G:/86EQ)P\L%LB,WU(&: .<^+V/^%5Z[D$CRX\
M@=_WJ52\2WNGZEXB\ QZ3/!-)]N,\8A8';;B%MQXZ#!45T/CK0[OQ)X+U'2;
M$Q"YN @0RL0O#JQR0#V!K1L]!T?3[Z:^LM*LK:[GSYL\,"H[Y.3E@,GF@#S.
MQBC7X%>+"$4%WU-F..I$C@$_@!^56]=O(_!U_P"&O&D@;[%)IXT[4MO)*E-\
M3?7>I&?]H5Z.NEZ>MC+8K8VPM)=WF0"%?+?<26RN,'))SZYKF?$WAW5?$UU;
M:-)'86_AB.6*6?:Q::<(0PB";0JKN R<G@4 <[8:!%#X.T234M8_L;Q%J&H-
MJD5V4# 7<B.Q1@WRD>62N"1G'%87CW5KS4/A1XNM=0%A->6-_;0RWM@NV.YR
M8F#$<X8 A2,G&*]FO]-L=5M&M-0L[>[MFP3%/&'4XZ<'BH%\/Z*ND_V4-(L/
M[.SG[)]G3RB<YSLQCKSTH Y*WNH-/^+UT^H31PBYT.$6CRL%!"2,9%!/?)4D
M>G-49]=T^_U+0[3PO)IVEVUTU].NIRV:G!C8+)Y(; RY8DMW [UWNIZ)I6M0
M)#JFFVE[%&<HES"L@4^H!'%-O- T;4+."SO=)L;BUMR###+;HR1XX&T$8''I
M0!X9KUPL_P &_'9^WB]8Z^&\\($\T$P8<*. #U!'!ZU[X0[:?MB.)#%A3Z''
M%59O#VB7 N1-H^GR"Z""</;(WFA/N;LCYMO;/2M(    8 H \2\-Z?->^!/#
MMK>^,[2UMTNH$2Q&GJ9DN4E!\O<'W;MX.3CH23Q4_CZ+^UO%5_=:1:37&GZ9
M#$OB18)-HO(U=7$(&/F=%#,>1P=N><5ZHGA_18]6;54TFQ746SF[%N@E.>OS
M8S5JUL;2QCDCM+6"W21VD=8HP@9SU8@=2>YH X;5-<74?$NDVVC:EINFVKZ4
M]\FJ26Z2,T6Y5\N/<0%'\3?0<5QNFR17FB>&PTXNO^*YD<NR!2V3,P8J/NYX
M./>O79?"_A^>VMK:70]->"U8M!$UJA6(DY)48P,GGBIQH>D"Y:Y&EV0G:9;A
MI?LZ;C* 0'SC.X D ]>30!RUK%'_ ,+OU*38N\:#  V.>9GS_(?E7G.OC'PB
MNE' 'BN4 >G^D-7O L[9;QKP6\(NF01M.$&\H#D*6ZXR2<>]5I-$TF6T-I)I
M=D]L93.86MT*&0G)?;C&[/.>M ',6<:'XU:K(5!==#MU#8Y ,LF1^@_*N2T_
M4)K6"73[5K*WEO?&-_%'>7<(D6U*[VW*"0-YQM'/<UZZMI;+>/>+;Q"Z=!&T
MP0;V4$D*6ZD D\>]5+C0-'N[.:SN=*L9;::4SRPO;J4>0G)<C&"Q/?K0!Y2L
MYEL/BLCZJNIRC3ES<K&J"3%O(IP%X(!&W([K3_%5Q#<^$?A>T$T<JKJVG*2C
M X/E]..]>JQ:)I,$HEATNRCD$'V8.D"@^3_SSSC[O^STJ*#PSH-K;Q6\&BZ=
M%!#.+F.-+5 J2CI(!CAN!SUH Y;PY=VNG?$'QNFHW$4%Q)+;W"-,X7?;B$ $
M$]5!# ^AKC_#D*RCP*YC_P!$FU[4)[16' B(E9"!Z=Q^%>N:GX?T;6GB?5-)
ML;YHO]6US;K(5^F0<59:PLW>V=K2!FM3FW)C!,/&WY/[O''':@#S?7X-+N/&
M_BV#6+EK33YM$M%FG3K'F60*W0]#CD\>O%:F@:Q?V/BF;2M:U/3=52/36O(]
M4@B$4D<:NH*R@$C!SD$8!VGBNS?3K*6:::2SMWEGC$,KM$I:1.?E8XY7D\'C
MDU4L_#FCZ9:7-OIFE6%DERI$BPVR*K\$?, !N'/0T 7K2ZM[ZTAN[69)K>9!
M)'(ARKJ1D$'TJ:J6CZ;%HVBV.EP,6BL[=($9NI"J!D_E5V@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "N2^(.MSZ!I6EWD-W]EC;5K6*XD.,>2S_.#GMC-=;7!?%B6"#P]I$UT,V\
M>MV;2C&?E$F3Q]* -6V\?Z%<F^7=>P2V=LUY)#<V4L4C0#K(BLH++]*T[CQ)
MI5KX9/B*6Z TOR%N//"DY1@"#CKDY''6N4U&ZL=:^+'AM-/G@NUM]/O'NS"X
M=1$X14#$<<MGBN4L;>:74+7X6RJ[06&JM=R%@2&TY,31*3WR[JG_  &@#VB&
M59X(YD#!9%# ,N#@C/(/0USMIX[T*]U6.PAFN<S2M!#</:R+!-(N<HDI7:QX
M/0\XXS72UY3I>HQ:%<Z,N@^(+75M!OM0$$6EW$0^T6I=F)9&X;Y#DE77(&>:
M .^C\4:3+H-]K23L;&R,PGD\MLKY1(?C&3C:>G6J=_XZT+3[F"UDEN9;JXM4
MNX+>WMI)9)8V) *JH))^4Y'8#FO/HM8TZQ^$?C*PN+N%+T7.IP?9BX\S>SOM
M&WKT(/TR>U:6EW]A8?%#1FOIHH#+X2ACBDE8*-WFD[<GN0"?P- '7#Q[X<_L
M&/6FOS'8O<BT9Y(F5HI<XVNI&5(/7/2IM&\8Z1KFI2Z=;-=0WB1><(;NUD@9
MX\XWJ' RN:\HU:YM'T_6M5RLFD2^,[5U=?F214V"1ACJ"0>1UQ7;WU[9ZM\6
M_#!TRYAN3:V%Y+=/ X<+&X14R1ZMTH J?#OQN\WA2TN/$5_))<WNK2V-O*T?
M!;/R(2HP.AQFNYOM;L-.U+3M.N)6%WJ+NEM&J%BY5=S'CH .YKR7P3H+^(_@
MEJEC =MXM_<3VCCJDZ.&0@]N1CZ$UT/@74SX[\3OXLDC*P:?81V,*$8"W#@2
M7!&>XRB?@: -;0_%VCV?A>?5;OQ!<7]FNH&V:[N8/+,;E@H3  ^4$CYOUK4T
MCQGH^M:JVF6YNXKORO/C2ZM)(/.CSC>F\#<,D5Y#HJ+)\()T=0R-XJC# ]"/
MM$=>@>+8Y9?B/X<2#B9]-U)4(XYVQX_6@"[)\3_"T44T[W=P+6-S&MU]DE\F
M9@<%8WV[7(.> >QQTKL:\*U/6M%;]G>QTU9X&OEB@A^RAAYL<J2KO)7JN,,2
M3Z^]>ZT <S+X^T"'5FT]YKG*7 M'N1:R&W2<G'EF7&T-D@=>O%9EGK>I2?&K
M4=$>Z8Z;%HZ7"6^!@2&106SC/0GO7">(]:FU+P7?WMQKT%J)=3*#0[:WB!41
MW(!,AP7SA=Y;('(]:ZK3'63]H35'1@R-X?C*LIR"/,3D4 :/PKUO4M>\-WUS
MJ=TUS-'J<\*.P PBD8' '3-:OBW4K?3FT43ZS<:;]HU**%!#")/M+'.(FX.U
M3Z\?6N;^"G_(HZE_V&+G^:T?%O\ UO@K_L9+7_V:@#H]2\=:)IFHW>G.UW/?
M6FWSK>UM))G4,H;=A0?EP1D].<=:YCXA_$7[%X*L;[PW=3;]3DC$%[':-(J1
MEL-U7:'XQM//7CBM;PRB_P#"S_'3[1OS8#/?'D&O.[_CX$Z !T&NX'_@5+0!
MZ39^+=.T71-.BO+W6-0O+KS/)CFT]_MDH5CDF)4! 'J0.,=:OCQQH!\//KGV
MQEL8YQ;REHF5XI2P78Z$;E(+#.1WSTK%NKFWTSXT)<:C-'!#=Z$(;669@JEU
MF+.@)XS@J?I7#>)C#J/AKQ_?VQ672[O6K*.%UY25D:%9"IZ$;N,CKB@#TP?$
M/P[]D@NY+BXB@N9WM[=Y+61?.94W_(,98$="!\QX&34*?$GP_(DZH-1:[@?;
M+8BPF^TKQG<8]NX+@@[NG-5O&L:-XO\  J%05&I2D#' Q Y'\J70XT_X6_XL
M?:-XL;$;L<\B3/\ (?E0!K2^-M"CT&QUE+F2XM;]@EHMO"\DD[<_*J ;LC!S
MQQ@YK*U_XCZ?IW@6]\1:?'/<-!(;?R9+>13%./X95QE .,DXZCU%<9X;U*>V
M\+^$=,M[ZUTP7=WJ3'49HD<P".5_E3?\H9MQ&3V!K.U&Y2X^&_Q*1=2;4)/M
M\<GGLJJTJ;8,2;5 &TXX(&"!F@#TJ\\1V5UJGA=QJNH:<;^698K)[-D-T5 R
MKAUW(!U!XSFK6J>/-#TF_N;.9KR:2T4-=M:V<LR6P(R#(R*0O'/KBN4\97=M
M?>/OAK<6EQ%<0M=7.V2)PRGY$[BK/A75]+T(^-K?6KNWMIX]8N;J5)W"L\+J
MIC8 ]05X'TQ0!U.H>--"TS[#YUVTAOX6GM!!$TIG4;?N!0<D[UP!_0U8T#Q)
MIWB2WGEL'F#VTIAGAGA:*6)\9PRL 1P17F?@NSFMM0^&D5Y$5F32;YU5QR@8
MH5^GRL!77>%N/B1X\ Z>=9'_ ,EQ0!OZ]XDTKPS;V]QJUS]GAGF\E'*%ANVL
MW.!QPIK/E\=:/%I]C=%-09[XO]GM$LI6N'"'#-Y0&X =<D=QZUD_$R-)KCP6
MDBAE/B2VR#T.%D-4_$Z7<7Q5LI4U]-$2?1VBAN)(8Y%D=9=SH-_ ."A_"@#J
M)O&NA1:%:ZNMS)-;7<GE6Z0P.\LLG.4$8&[<-IR,<8.:;'XWT)]"EU?[1,L$
M4_V:2)K=Q,LV0!%Y6-V\Y'&.]<+;W":<FDV>F>);:1-6U6]N)-;FM$ B=5^=
M8@WR99MWS#(/S8S5+2Y-'OAXE@U+Q/*DIURVDL]5V(C><(4\N3 79L.T@$@*
MPQSDB@#TBW\;:%/I-_J4ES):0Z>0+M+N!X9(20"-R, W.1C YSQ2Z/XRTG6M
M0_L^(7EM>&/SD@O;22W:2/IN3>!N'TKSC7=5O[G2;^VU.[LM4@T75=.N+K4;
M.(*)H"^6$B@D;DP"<'&".E=1K-_9ZO\ $SP8FEW4%U);"[N)V@D#B.%HMH+$
M= S%0/I0!>'Q/\+M%#.MS=-:2.(VNA9RF&%BVT+(^W"DG'!]1ZU?UOQKHV@W
MK6=VUW+/'$)YEM;22;R(SGYY"@.T<'KZ5YRD:+^S#=;5 S#,QXZG[2W-;&N:
MQ<7&N>)K;^W8=&BL+>&,116T3W%\7BW#EP2PRVQ0HSG- &KK7C*/3/&VB?Z;
M))I-[IDTZ16\1E-P^Z/RRBJ"S'#'IVR>U)XE\:PWGPUU_5_#]W-#=V*,C"2$
MQRV\H(X9'&0<'N*Y/PUJ>G6VM?#>:ZN853_A'I(5E9QM23$8P3T!ZK]3CO3/
M$<T5]IGQ9U"SD66QDCM84EC.4>5(P),$<'&5!H ]'\.>);:]ATK2[FX9M7ET
MF&_=60CS$8 %@<8/S=0*TX-;L+G7;O1H96>]M(DEG4(<('SMRW3)P3BO/]70
MZ1X6\$>,8@1_9$-NEV0.MI+&J2?7:2K?@:WOAS;O<:5>^)+A"MSK]TUX-PY6
M#[L*_@@!_P"!4 ;^N^(M+\-6L%SJUS]G@GG$".5)&\@D9QT&%/-9LGCO1H]-
ML[PI?EKUG6VM5LI3<2[/O$18W8'7)&,$>M9/Q0C2:+PE'(H9&\2V893T(^>J
MGBM+J+XH:7,FNKHL<^E2PPW,D*2*T@E5FC^?@$K@_P# : .FF\;:##X>AULW
M;O:3RB")4A=I7ER1Y8CQNWY!&W&>#45KX]T*ZEO(EEN8IK*S:]NHI[9XWAC4
M\[E8 @]\=P01UK@!%8:5J/AO5FUU=3TV3Q'=275\T0BB6=X2@QCY=N]3\PXR
M3S5K6;RSU?QWXO&F21W)'A*2%GA(8-)N<X!'4X91^E 'HT_B/3+?3=-U"6=A
M;:E+#%;-L)WM+C8",<9SWZ5EVFM6:>+O$D+ZU<SM8012SV+08CM%,>[*L!EM
MPY/)Q7%:CKNEW?@OX=VEK?03W#:AI9,43AF0*5#%@.F#@<]SBI;7_DIWQ1_[
M!MM_Z3T =EI_C_P[J5K<WEO=R?8K:V%S+=/ ZQ!2 <;B,%AD94<CIUJSH_C#
M2=:GFMX6N;>>&(3M%>VSV[&(\>8 X&5]QT[UY_/;./V<=+%L3$D=O:7$I1-V
MU!*CNVWO@98CV-3:II[:G)?NGC)=;U9-!O1;6]M:QKE)$ R6CX^\$P#UYQWH
M O>(OB19W6EV3:%<WD+SZC;1Q7$EH\<=S&9E5Q&[KM;@GISCFO2J\<UK7=$O
M/AGX+M;2[MY9S=::$AC<,\11D#9 Y7'*G/<@=Z]CH \T\-?$JQMM$E;7KN[E
MEBO;B.>Y2T=XK=!,RH)'5=J\ =><8)ZUW-EKVG7^KWVE6\Y:\LEC>9"I VR#
M*LIZ,#ZBO*]&UK1;;X0>+;6XNK>.X\W44>%V >1W9PF!U.<J ?4>U7M4DD\"
M1^$?%UVCA(M,32]64#YB/+#1D^XD4C/^U0!Z/8:W8:GJ&HV5I*TDVG2+%<?(
M0JN5W;0>A(!&<=*@USQ-IWA\VT=W]HEN+HL(+:UMWFEDVC+$*H)P 1D].:SO
MA[I,^E^$8)+T8U'4'?4+T]_-E.X@_0$+_P !K/\ %6J3KXST_2H]6M=$C^P3
M73:A+%&TC8=5\M#)\J]=QZ]!0!KR>.?#T.B66L27^RQO)C;QR-&P(D 8E67&
M5(V,,$=1BJ\7Q"T&2VU*:1KVW;381<7,-Q92Q2K$3@2!&4$K[CI7F^ES0W>D
MZ&IN3=L/'3.SR*%=L^:RNR@ *3][&!7<75M#>?&26VGC#PS^&6CD0]&4W&"#
M^!- '3:GXBTS2- .MW=SMT_:CB5%+[@Y 7 ')R6'3UK3!RH.",CO7C.@)=:E
MJNC?#Z\WN/#=]+<7;L/]9!%@VOL0WF+Q_P!,Z]GH XS1_%6E6>AZUJEUK]S?
M6EIJ;V\TT]OL^SL611$  ,J"P^;GKUXK1TSQMHNK:PNEV[W27,L;2P?:+62)
M;A!U:-F ##D=.W/2O([=5?X3>/4< JWBE@0>X\^"O2?$X ^)7@4XZ-?CCT\B
M@#0L_'>A7VJ16$,USF:5H8+A[618)I%SE4E*[6/RGH><<9J['XHTF70+W6TG
M8V%D9A/)Y;97RB0_&,G!4].M<#I6H1:%<Z)'H/B"UU?0+^_$$6F7$8^T6F\L
M2R-PV$.<AUR!GFL^/6=.L?A!XQT^XO(4O5N-2@-L7'F;V=\#;UZ'/TR>U 'H
M.I^/- TF:""YN)VN+BU6[AABMWD>6-FVC: .3GMUP">@INJ>/M"TBZ>WN7NV
M:&-);EH;.21;5&&5,K*I"<<\]JYG2(TD^*WA]F4$Q^$@R$]CYJ#(_ D?C5#Q
M1J]Q>KXV1M<ATF.TW6B6$%M$T]Z3 ""Q8%CNW;1M P!UH [S5/&>BZ3?1V,\
MTTMW+;BYA@MH'F>9"2!L"@[CP3QV&>E$'C;09_#D^O?;#'8V\ABF,L3*\<@(
M!C*$;MV2!C&3D5R'A)X;GQYH$\;)*!X.BVNI!Y\U0>?TK#O&%NFJWLORV-EX
M]BN+MOX4C"1@LWL&*DT >E:=XVT/48;YS/-9M81^=<Q7T#V\D<>"0Y5P#MX/
M(IVB>,-)UZ\:TM3=17'E>>D=W:R0-+%G&]-X&Y<D<CU%<C\0]5T?6_#_ (@L
M](\JZU.WL(II[NVC679;B96*%QUX5FV>G-6M)@AOO&>CW<_C>/6;J"VGEM[>
M"UC4&)PJL6:/H,[,9ZD<4 =[=74%C:37=U*D-O"ADDD<X"J!DDUA:/XXT36[
MT6=O)<PS/$9X1=VLD GC'5T+@;AR.E4OBG;SW/PSUR.W1I'$*NR+U**ZLX_[
MY#4S5/&/AIQ!)8K:ZMJ"V%S=V@A193&BQY;)',8;A??I0!>TKQYH6LZC!96D
MMR&N0QM99K62.*YV\MY;L &P.>.U.MO'.AWNMMH]K-<37B7$EO*L=NY$3IUW
MMC"C((!/4]*\ZCU)I-3\ W%WXGM[SS;I)C:6T$4<%H&@D  *C<.3M 8\X/''
M'5_#6-%G\:R!0';Q)=AF[D )C^9_.@"Y'X_T#7=+OSINH7:)'82W+WL=H^VW
M51R<E<;P/F"]<=JGM/%>EZ;X2TB^GU*ZU$7B*MM(MLS3W;$$Y$:C.< D\<5R
M/@^-(_V;;C8H7=IE^S8[G,O-9&FI<II/PRN4U==)B.G3P+>/$DB)*RH0IW\
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M=5877E_V2[)>B92AAPN[)!_A(Y!'![53G\;Z-!IFG7V;R4:DI>SMX;21YYE
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MXH?M BOK5X"\6<;UW#D9J#2O'VC:QJ-M:6Z7T:WF[['<3VCQPW6T9/EN1@\
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M;S/(@BB\US))Y:!=[GJQQU)]:YRV\>:5.;R.:WU&SN;6U:\:UN[1HI7A7JR
M_>QZ#FM"?Q1I-OX3_P"$FDN/^)7]F6Y$H7DH0"./7D#'K0!H1V-I%9&RCM8$
MM"I7R%C 3!ZC;TP<G\Z9+I>G3Z>-/FL+62R  %L\*F/ Z#;C%8%CK%G=>/I;
M1-3U#[2=+2Y.G2QA88T+#Y^F=_.",^M<WXP^)-I-X0O9M#EU"!S+'':ZA]E9
M89F$RAQ'(1@_*'^N#B@#T-=+T];!;!;"U%FN-MN(5\L8.1A<8Z\U%JNDP:N+
M,3G"VMU'=+A0260Y7D].<=/IWK,UGQMI6B7\MG-'?7$MO&)KHVEJ\RVT9SAI
M"H^7@$XZX&<5)JOC'2M+_L]1]IOIM00R6L%C"9GDC !+@#^'!')]: -^L_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MEY##YTL'AZ^D6+'^L*M&0OXGBN435HY[[P)>W7BQ=0:2\CFFMXD@CMK/=#(
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MNG53PGS ')%>H&&)IEF,:&5055RHW 'J :@MM-L;*626ULK:"27F1XHE4O\
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M'ID^M '+_#'_ ))EX=_Z\DKK*9%%'!$L4,:QQJ,*B#  ]@*?0 4444 %%%%
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MKX8TO4K^ROTO+_;'#9QVQ\VXDV!F,:9Y3J=Q.,=35[Q^C2?#OQ&B*68Z;<8
M&2?W9KAH=:TQ+OX=Z\;^W?2;6TEL;BZ60&.VG>"/:'/12<$<XQGF@#T'0?$]
MEX@DNX(8;JUO+-E6XM+N+RY8]PRI(Y!!&<$$CBL_X@>*Y_!_AIM0MK.2XG:6
M.),1ET7<Z@[L$8X)QZG%9GAVZM];^*6N:OI<R7&FQ:=;V37,3;HY)@[N0K#A
MMJD XZ9IWQ@.SX<W<A^Y'<VKN<?=43IDF@"M=^,I;3XA68>WU4VUSHC21Z8L
M!,K3>?C/EYP#M#<D@8[UNP>/-&F\.W&M-]JBCM[@VDMM) 1<+/D 1;!DER6&
M /6LFUO;/4_C%:WMC<P75N_AR0QS0N'5O])4'!'!Y!%<=JL,C0Z]="ZFL[>R
M\:1W%S=0J&:"/R44R8((PI92<@],T >J:'XFM-=GNK5+:\LKVU"M+:WL/ER*
MK9VMC)!4X/()Z&H_&7B(^%O#%SJ<<'VBX!6*W@SCS)78*@^F3S[ U@^$(-+N
M/%M]?VGBJ[\07<5FEO+,PB:%$+EE4/&H4L""<9. U7?B5I=[J?@Z1M-A,][8
MW$-]% .LIB<,5'N1G'O0!2?0?B!'IYOD\812ZH%\S[";"(6K-U\O/WP.V[.>
M];%[XM31[;3(=2L+E]9O8]PTZQ3SY 5 +X.0-H)^\2*S3\5_")T?[='J:27!
M7Y=/49NC)_SS\O[V[/'I[XK-FU4:=\2-&U[Q!&NDV^H:$ULOVF4;(+CS5D,;
M/P 2OTSMH W_ /A/]$7P[>:U,;F"&QG6WNX)HMDT$C,J@,IZ?>!SG&*K_P#"
MR=(6_P#L4MAJ\-S)'YMI%)9,&O%R!^Z'4GD'!Q@<G !KS_Q))%JNB?$+6K-E
MFTJ\OM-A@F7E)FB>-9&4]QDXR.#BNZU]0?BUX-) R+6_Q[?+'0!<3XAZ+_PC
MM_K4Z7EK%IUPMM>07$.R6%V95&Y<]/G4Y!QBI=,\<:;J6M0Z4;34;.>YC:2T
M:\M3$ETJ\DQD]<#G! ..U>;^+B%TCXG$QF11J>GDH!DM_J./QKIM9US3?$GC
M?P='H5Y!?S6LL]W/]G<,88A"5P^/NDLP7!P<T ;MM\0M(NM1@MTM]06UN;DV
MEOJ#VQ%M-*"1M5\]R" <8)'6F7OQ#TNUN=1MH;'5;V;393'=I:6OF>4 H;<3
MD#;@\=S@\<5YK<:_'J.C>'-5U#Q1-/>G5K6XO=.C\I+?3T$XSYBA=R!3A<LW
M).:[OPCL>_\ 'KKM8-JC?,.<C[/'C^= &_8>+](U+5++3[:61GOK :A;2%,)
M+%D#@_WAD9'45:@UZRN?$=WH4/F/=VD"3SL%^1 Y.U2?[Q )QZ5Y=;0O8_"?
MP3XLMU)GT%8YI=HR6MG^29?^^3G_ (#79_#FW>XTJ]\27"%;G7KIKP;NJP?=
MA7\$ /\ P*@#H+[7+/3M8TO3+CS!/J32+;L%RFY%W$$]B1G'KBJUGXJTR^\5
M7_AR%Y#J%C&LLH*?+@A3P>Y&]<^F161\2HC#X>M=;C!,FBWT%_QU**VV0?38
MS?E7!S:D_AW0-,^(A1M]]=W\LHQR8[A28 ?;]S /QH [34?%VC:C<:)*FHZO
M:H^LM8P_90%2YE1MI5\YS$3GIBF1>.KF^\5^)="73;V*/3X%$4X@(V.4D8L[
M9X4[5V<<URNN:,WA_3?A5ID@/G0ZM 9L]3*V&<_]]%JV;>_L[/XE^/[.YN8H
M;F]L[0VL4CA6F"P/NV _>QWQ0!-X1^(MJ/"_AT:I'JDK744,$FJ/;DP&=@!M
M:3UW<$XQGC/!KH]4\;6&FZK<:;#8:GJ5S:HLETNGVWFBW##*[SD<D<@#)QVK
MA[I0O[/_ (=P /\ D''CU\Z.M?1-;TOPKXL\96^O7]O82SWBWT+W,@3SH3$H
M&PG[V"K# YS0!U-OXOT>\ET-;6=IEUI9'LY$7Y2$7<V[/(..,>O%4O$/C:VT
M>T\0""VN+B]T>U6XD1(MR_.K%#U^Z-IW'L*\\T-UT&W^'FIZL186+7>I/ON/
MD6%9P[1!B>%R/7UJ[>:A;:W=_%.XTY_M$#Z'$D4L?*RXBG!*'^(9R,CKB@#T
M;PIK<OB'PW9:C-:3VTLL2%UEB,89BH)9 2<H2>#6-K'C>;3?B!IOAV/2[R:&
M>"2262.W+$G*!2AS]T9;<<<<5H^!-2L=3\$Z0]C=P7*PV<,,IB<-LD$:Y5L=
M&&1D'FN?\17]GI7QA\.7.H7,5K!)IMS$DLSA%+EDPN3QGVH IZ)\05TN'Q$=
M3BU;4%L]8NQ)+;VYE2T@5\+N.1@  G R0.<8KK=3\9:=I[V<4$%[J5Q>0?:8
MH-/A\US#Q^\/( 7D#D\GIFN2T50/ 7Q"P!SJ.K$^_!K#LT%IJ^@7-[XFG\/V
MUUX7LT@NE,2I(T>2\9:52 0'5L#&<T >N:1JUGKNE0:E82&2VF!*EE*D$$@@
M@\@@@@CU%7JYCP%:V-OX8$FFWUW?6UU<37 N+I C2,[DLP 4#:3DC Y!KIZ
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M$&6; S@>] "2VEM/ ()K>*2(8Q&Z J,=.#3I((9H3#+$CQ$8*,H*D?2N8O\
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M\1>)+#POI\-]J/FB"2XCM]T:;BK.< D>GTR?8T :D,,5O$L4,:1QKT1%  _
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M5(X,5PH$(_!9Y?RJ7P/+<:Z=2O[U6\S0M$&BG<.LZ[C*WUPD?YU[#@9SCFC
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MO2"-%"A44!1A<#H/:@#Q^]\4Z1K&@_#^QTV\2ZN(M4TXW"1<^1M&TA_[IW<
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M\DDT;ZS_ /HYZ]!P,YP*4  8 P* "O M+ ;X1Z\",@^*U!!_Z^(:]]I-HQC
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M%&RE612K')!'!I< '( H \5FUW3KKX*1>$(G4^(VMX]-_LK_ );K.&"DE.H
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MPRR6F[RI59 ZL V2#@\C)Q73T & >HZ4444 %%%% !WS1@#M110 48 [444
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M-&\/+,NCZ9:V(F(,@@C"[\9QG'ID_G6I0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
2%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>employementagreement_mil003.jpg
<TEXT>
begin 644 employementagreement_mil003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M\0RV=R@N$REK$AEE+$D! %')X^@[G'-6M#N-9N_M=SJMHEE$\@^R6I96EC0
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MA^[N-2L88O"UOIUU;:M]LEU6 QB-X@Y9L$-YA:13M*D8Y/. * .DLO%5O?\
MBRXT*"UN/]'MVE:YD0HC,KA"J9'S8)Y8<9&!GG&<GC#5+NQ?6--\./>:*K-M
ME6YQ<3(IP7CAVG<."0"P)'0<BM)]-N6\=KJ/E?Z'_9;6YDW#[YE#8QG/0=>E
M8&E_\)1X=\-Q^&K+07N+FU0V]GJ)GB%L8P<))("V\$#&5"G)'!YH W=>\66V
MB7NDV?D27%QJ-S%$$7Y?*1W"^8^1P 6 QU)^AQT%>>:]X+\03W@O;/65FFGU
M*UGE#6B9B2-AC!+?=3EMO<D]R:]"&0H!.3CDT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4KK2-,OKJ&ZN].M+BXA_U4LT"NZ=_E)&1^%7:* "BB
MB@ HHHH **** "F0PQ6T"001)%%&H5(T4*J@=  .@I]% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>'I],N;Z&26RS<I*LI0 LA*_=8 @^G7FL?P/XO\ $.O^(/$-MJ&E,EG:WK0
M^='_ *)M3[AQRY)&<\]?2L&$:5!X^\*:MI%OKDVEQO/!<:A>&ZE#2R1$( LF
M2.>K  9(YX.-3P-=#2?&GC'2+Z"ZAN[_ %66YM=UM(4EC*D[@X&T# [D>G6@
M"QX7\8Z-I_PTTW4]+TN\6&[NFM;+3S.9999FD8!=[GN03DG@"M[3O%\\FJSZ
M3J^C2Z9J*6AO(HS.LJ3Q X.UU[@XR".^:\U\+:7J-C\*O!^H/IUVS:/K#W5U
M;"%O-$)>168)C)(W X';-=8UTOBWQS#JNEPW+:;INE7,37,EN\0EEEVXC4.
M6P%).!@9% #E^*-Q+X7B\3P^%KU]#"!Y[DSQJR#.&*H>7"GC/'0XXYKT**5)
MX4FC;='(H93Z@\BO++>QNQ^S:;(VLXNO[*=?(\L[]V3QMZYKN=,U1+8Z/H\E
MK=>=-8"7S1%^[3:J@JS=FYX'L: -VBBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MUG6=1O=8:Y.K6:6L\:VXC VJPRO)P/G.!^9- '/6^K:UH/PJ\*7UM?QR-/\
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M44$>9QP3GW]* *5WXA\2ZO:ZK=>'()6FL;V2UMX/+A,4YB;:XD9F##)#8QC
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MU<=,Y.<Y H ]FHKR9K*;Q#XX\/:5=:A?)83>&%GN8H;AX_.(=>I!R#DC)')
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF5CDAXB<$C P<Y'/K78T4 9'AW0AH%A-"UW)=W-S</=7-Q(H4R2OC)VCA1@
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M&"_8[Y$5BI";&#*>"K+U'ZU'9>"RBZS<:EJLM_J>JVWV26[,2QB.+:0%1!P
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M&24<O@,?3)Y.:Z#2M/NK WQN=2FO?M%T\\0E4#R$;&(EQU48_6M"B@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$-V-><>&O%$=E\*/#>FVVLKIS1WPM-6N$V^98QL\Q&[<"$+%0H8CC-5M1O+
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M,JPR#@].#4]<YH/B=;NST*UU53;:UJ-@+LVWEL ,!=_^[@L."<UT= !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %8OB+P^-<BLY8;G[)J%C<+<
M6ET$W^6PX8%<C<K*2I&1U]JVJ* &"-=V\JI<C!;'45CVGAX1>*+O7KJY^T7#
MPK;6J"/8MM".2HY.2S<EN.@&!BMNB@ HHHH **** "N>ET+6Y@RMXHF*,?N&
MQ@(_5:Z&B@#G5T/744*OBJ<*. !8P8'_ ([1_8>NX _X2J? Z#[#!_\ $UT5
M% '.OH6N2(4?Q5.RGJ#8P$'_ ,=H_L+7/+\O_A*9MF,;?L,&,>F-M=%10!SB
MZ#KB*%7Q3,H P +& 8'_ 'S2_P!AZ[@#_A*I\#I_H,'_ ,37144 <]_8FO9S
M_P )7/GU^Q0?_$TU- UN,L4\43*6.6*V, R??Y:Z.B@#FSX?UHJZGQ/*0_WA
M]@@^;Z_+S3O["USC_BJ9N!@?Z#!T]/NUT5% '/?V)KQQ_P 57/QT_P!"@_\
MB::=!ULR"0^*)BZC 8V,&1^.VNCHH YQM!UMV5G\43,RG*DV,!(^GRT/H&MR
M%2_BB9BIRNZQ@.#[?+71T4 5[*">WM(X[JZ-W.N=T[(J%N?1>!Z?A5BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !165>>)=$T^]%E>:K:6]T5W"&64*Y'J ><5-8:WI>JS2Q6&H6US)$
MTB12!B@.<$@=,X/Y4 7Z*** "BBB@ HHJG>:K8Z?=65K=7"Q37LABMT(.9&
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ML': -9G*QY&  ,[<@X)[UU_AHWND^/M8\/2:I>ZA9+8P7D)O9/,DB9F=6 ;
M)!V@X/2@#N**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *@O+&TU&V:VO;:&Y@?[T4R!U/U!XJ>B@"*VM;>RMDM[6".
M"",82.)0JJ/0 <"I:** "JMGIMCIWG?8K*WMO.<R2^3$J;V/5FP.3[FK5% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 13VMO=>7]H@BF\
MJ02Q^8@;8XZ,,]"/6I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>6^)?^2&^"/^NVF_^@U[30!P_B'4_$<_C^T\.Z)J5I81R::]Z\D]IY^2L@3
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MG^)],LD\3WUWK\]Y;:;=LMPLEL5%GC_EFN%RX'KS5VQ\<Z#J&M0Z5!<3BXN
MQMGDMI$BN-HRWEN5"O@<\'Z5Y5+_ ,BG\8/^PE+_ #KO?%<:1:UX!6-0JIJ6
MU0!C ^SOQ0!J77Q \.6>J26,UW*#%,+>:X6VD-O%*< (\H78IY'4\=ZV;/5[
M*^U'4-/MY2]SI[HERFTC874,O)&#P1TKSKPKK>@:/\/;^Q\1M;RSVVH7,5]9
M2JLDDTC7#%1Y9Y?(9<<<_A6CH>K:?I'C[QT=0NX;0;[2<+,X4E/LZC(!Z\@C
MCO0!NR^/_#<&DV&J2Z@4L[\R"VD,+_.8PQ88QD'Y3CU[9S4=S\0O#ME#;/<S
MW,4EU;FXA@:TD\UU#A,!-N=V2..O?I7FV@1I/X?^%0DCR/[2N7VL.A!E(_$$
M"NUU.))/C?H+.H)CT>Y9">QWJ,_D3^= &QJ/CS0=+F6*YENBX@6XF$5I+)]G
MC89#2[5.P?7'2I]6\8:-H\EG%---<37B&6"&RMWN'>,8R^U 3MY'-<(R74'B
M_P :I-XKM]%1IHYY([BUCD\V P* P+D$@89<#H1[T_PN+#P[X[TZ"XU)7M7\
M+P16%W<CRO-1)"2 &Z'!4XZXH Z?P'X@E\1'Q%<->?:;6'5GAM&V@;8O+C8+
MT!ZL>O-;^LZW8:!IYO=1F,<6]8U"HSN[L<*JJH)8D]@*Y'X7W-K>/XON;(JU
MM+X@G>-UZ.#''\P]0>H/?-:'CO4I[)=#M();2U>^U%81?742R+;81VW*&XWG
M;M&?6@#9T/Q%IWB&&=[%Y0]N_ESPSPM#+$V,@,C $9!R/6JOC;5[K0?!6KZK
M9%!<VMNTD9=<C(]17+^ +E9/'7B^-]8_M23;9XN2B)YNU9%)4( " ?ER.XK:
M^*'_ "3'Q%_UYO0!GV\?Q%_LF#4K;6=%U!Y(5F%G-8-"&R =H<2'![9(Q3;K
MQO9:M\/(M=?5+GP_FX6"=D@$TD,H;:T1&#G)[XZ$'BKUIXZ\+Z1X3LI[O7M/
M_=6D>8X[A7D)"#Y0@.2?;%>9^(M.O;+X(75Y?V[VUQJNNC43;N,-$LDN54CL
M< ''O0!Z]K?C+1] O!:7DER\XB\]TMK62<Q1Y(WOL4[5R#R?0TW4O&VAZ8+3
M=//<O=P?:84LK:2X9H>/WF$!PO(Y-8/B18X/$][?Z-XHM=*UF*SC^V6E_&&@
MN(@7*$YP1C+C<I..XK(M?%%QK-[:R#4++PM%'H=O>/(;:-I9!(6^1"_ C7;T
M ZM0!M:_XVM[/6/!]];:E_Q)-1^TO*T<>_SE$.8P!@MG<1@#G/'M6M%XOTG6
M="UJ:TOKBRDL('-T9;9DFM/D+!S&XR>!D<$'%>8^'[^QM[3X837TR+%%=ZBD
MC2X7RW.\+N'\)R5^E;NM3PW_ (E\?W5A*DMM#X8\BXDC8%3-ME8#(ZD+0!9\
M1^)[ZR\,>"+O2-:FN4U'5K6WFNWA5&N8GW9RI'RYP.@%=-)K5K;>.;VU?6KI
MWM]+-R^E):EE5 P_>JP7+-VV@GKTKS*__P"27_"O_L,6/_LU=;:?\G%W_P#V
M+J_^CEH N^&OBAI6LZ=#<7BSV;7%^;.$M:RB-F:1UC&\KMR0G//!X.*ZO4-;
ML-,O=/L[J8K<:A*8;:-4+%V W'H.  ,DGBO,?">DP^*/@O>:'#/&-02>Z>-0
MXWPS+.[QDCJO('X&M#P1JC^/?%,/B.>-EBTC3TM%1EP%O)0&G(_W0%7\: /3
MJSM:UW3_  _8K=ZC*R1O(L4:QQM(\CMT554$L3Z 5/8:E9ZI;M<6-S'<1+(T
M9=#D!E.&'U!&*YGQQJ4]K=^'["WGM+)[Z\9/[0N85D%MMC9OE#<!VQM!/J:
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M2_M*U>266.Y\GR@^^1F.%[#)..V.G%=+0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 445R/BO7]5CUO3?#/AX0+JE^CSR7-PI=+6!, OM&-Q). .F>M
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M6%G-8_89;2![/:$^SM&#'M'0;<8P,#BJ]YH6D:A-#->Z58W,L'$+S6Z.T?\
MNDCC\*SM/\6Z3X@BU:+2]4M5ELW>'SBZL 5529-N>4#-C/0X/-6K'5;6VTW3
MH]0UNPGNIH4(G$B1BY.!\Z+GH3Z9H N:AI6G:M (-2L+6]A!W".YA610?7#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "HY+B"&2*.6:-))25C5F +D#. ._'-25Q.@?\ $\^(GB'59_GC
MTEDTRR4](R4#S,/<EE&?1<4 =7_:NG&U6Z%_:_9V?RQ+YR["V<;<YQG/:G2Z
MC902R137EO')''YSH\J@JG]X@GA??I7D\?B\GX5V6K?V#H@,FM"V^RBT_<+^
M]*[PN>'[Y]:ZX:FEQ\6[O09=-L&B.AB=KDPYG<&7:8RW=.^W'6@#LE974,K!
ME89!!R"*6N,^'LLEI'K?AQW9TT6_:"V+')%NZB2-2?\ 9#%?H!79T %%%% $
M-U=6]C:RW5W-'!;Q*7DED8*J*.I)/05@_P#"PO!O_0TZ/_X&Q_XUT4D:2QM'
M(BNC##*PR"/<5Y\VEZ?_ ,+NCA^P6OE?\(XS[/)7;N^TJ,XQUH [VTO+:_M(
MKNSGCGMY5W1RQ,&5QZ@CK4U>;^*/%D5AXL_X1]?$MMX9L[6R2<R^3&S2R.S!
M44." JA<G R=PZ5E7?Q U^[\,^$KK2KFU-]J&JMIT[B,&&8AF0.,\A3@-QS@
MXH ]=HKS[4I?%6E:KX:T)/$8N;C4Y;H3WDEE&NU%C##:@XR,''N1G(%9?V_Q
MF]AXKB'B54D\.NYBN!91%KO]T)0L@QA0 <94 G/MR >BW.MZ?9ZQ9:3/<;+Z
M]#M;Q>6QWA!EN0,# ]2*T*\\D\7ZI-XT\!6D4JQ66M6,MS=0A <L(=ZX)&1@
M^AK/&J>+]4T3Q5JL'B!+)=&OKV.VA6TC?SEA)($A(X&,+Q@]22>@ /4Z1G5%
M+.P51U). *\^UGQ+=S:=X>O)?$UCX=L[^R6XE(19;F21E4A8T=2-@R<GD]!7
M)^(?$.J>(O@[KLQU<2-I^J"R>YB@51>Q>9'M8J1\APX)QC[OH: /7KS6]/L-
M4L--N;C9=WY<6T?EL=^P9;D# P".I%:%<!J^LZWH?C7P/H1U0W46H-=B]D>"
M-3-L4,G0?+C/;&:AM[[Q3XGBUW5M,UQ=.@L;N>ULK1;6.19O)X+2,PW?,P/"
MD8'K0!Z+17F=MXKU[Q1J?AF#3+V/3H=6T>2[N6$*R&)U9 2F[J<DJ,\8.<$B
MM_P5J>J7%UK^D:M>"^GTJ]$*77E+&TD;1JZ[E7C(W$<8H ZVLS7/$.E>&[..
MZU:\6VBDD$4>59B[GHJJH))X/05IUYI\2+'4+GQCX,-MJTEHKWS)&JP(_ER"
M-SY@W#DXXP>.,T >D12I/"DL9RCJ&4XQD'D=:?7G]G<>)O%.IZVNG^(3IEKI
M-S]@BV6D<AN)D12[R;@<#+ 87'%8MYX]\17V@>";K3&M[:]UB\>SND:,-'O4
ME">>=H92V <XXS0!ZU16?HMEJ%AIRP:GJK:G<[B3<- L60>@VKQQ6A0!1U36
M=,T2U^U:K?VUE!G DN)0@)]!GJ?:H](\0:/K\+RZ1J=I?(APYMY0^WZ@=/QK
MC].LK?Q#\7/$=QJ<27(T2&UM[&*4;EB\U#([@'C<3@9ZX%=2OA728_$D6OP6
MPM[](6A9H/D656Q]\#[V,<9_PH V:*\=U3QQJ6CH^H2>,].O;^*\5)M&LX%D
MM_+,H4H)=H?<%.<D]01BN\TC5[V[\?>)=+FE#6=C#9O FT#:9%<MSU.=HZT
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M]=/ATF^DBM=EI'(SXC5@K[A]T9[<G<>>!3]&\8ZK/J?A"[OY$&F>(=.V%%0
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MPS!\XQC&!Z]>U='10!R6K:1KEEXJDU_0(;&Z-U:):W5K=S-#RC,4D5@K=-[
MC'I5/6?"VO:TGA*6[NK*2\TO4DO;UD#(A49^6,8.<9 &<9QGBNW=UC1G=@J*
M,LS'  ]37.6WQ"\(7FHK86_B/3I+EFV*@F&&;T!Z$_0T 2ZOHEU?^+?#FJQ/
M$+?36N3,&)#'S(MB[1CGGKDBJ"^%[Y8O&JF2#.MLQMOF/RYMUC^?CCY@>F>*
MZ^B@#@4\%:FOB7P-J)EM?)T&PDMKH;VW,S0[!L^7D9]<<5=T_P *W]KX7\4Z
M;));F?5;J^F@*L=JK-G9NXX//.,_C78T4 >=V_A7Q'H>K:/J>FPZ9>S0:'#I
M4\=S.\8B9#G>C!&RI/48!X%4;CX?^))_"GBO1);K3Y9-4O5U&"[W,N9=T;,C
M)M^5<QX!!/!%>I44 <+?^&]>UOQ5X.UZ]CL+9]):Z-Y#%.S_ .L4*NPE!GIS
MG&/>HAX?\5Z(-:T[05TN:PU.YEN8;BYG='LVE^^-@0AP#DCD=>:[^B@#B]'\
M%2Z)KWA^:VFC>QTO2)+!BQ(D=RR'=C&,':2>>]:>@:%=:7X@\27\[Q&+4[J.
M:$(Q+!5B5#NXX.5/3-=#534]2M='TRYU&^D\JUMHS+*X4MM4#).!R?PH MUS
M7B7P_=ZQKWAJ^MWA6+3+UKB<2,02IC*_+@')R>^*Z*&5)X(YHSF.10RG&,@C
M(K/UWQ!I?AK3OM^KW:VUMO$88JS%F/10J@DG@\ =J .:_L7Q/X?UC6I?#L6F
M75GJT_VH"\G>)K:<J%8X5&WJ=H..#VJE_P *[N[2R\$V=I=0RIH=X;F[DE)4
MRELLQ4 'JS'@X^M=9:>*=*O;RQM(9+CSKZ%IX%DM94RBD@YW*-IX/!P:V: "
MBBB@#C-:\-ZU:^*6\3^%Y[/[7/ MO?65Z66*Y5?N,&4$JXR1T(Q^K]/TGQ5J
M>K_VCX@OK>Q@C@DB@T_39792SC!>5V W$=AC ZUT5MJ]E>:K?:9!,6N[$1FX
M3:1L$@)7DC!R >E$FKV46M0Z.\Q%]- ]Q''M/**0"<XQU8<9H \V?P/XOG^'
MJ>#Q_8UK!9JOEW$<KL;LHX=0R[!Y8) +'+'/UK>.D>++#Q7=ZWIMMI,AU6T@
MCNX9[IP+:6,,,J0GSKAO12<=J[FHYYX[:WEN)6VQ1(7<XS@ 9- '":+X=\6>
M&/#5I9V<FFZA+'=73W5O.[1I<))(64A]IVL,\C!!R>>!5:T\#:SI]K;:G9KI
ML6KV^J3:@EBK,+58Y4$;PAMN1P V[;C=GC%=SHNLV'B'2+?5=,F,UG< F*0H
M5W $@\$ CD&K] '-P#Q@VC:E/+_9,6J2G-C;!G>&$  8=\!F).2< 8KH8O,\
MI/-V^9M&_;TSWQ[4^B@ HHHH *YB[\/7D_Q(T[Q"CPBSMM/EM74L=Y=F!! Q
MC''K73T4 <]JNAW5[XU\/:Q$\0MM.CNDF5F.XF54"[1C!^Z<Y(K%U7P->ZI?
M^+9OM,$/]J?8I+*3EC'+;C(+C'3<!T)XS7=T4 <_HI\53ZB9M;ATRSM$AV+!
M:2M,TLF1\Y9E7:H ("\]>3Q70444 8WBGP[;^*O#MUI%Q(\(F ,<R?>BD4AE
M<?0@5SA@^)D]@=+DFT&%F7RVU>-Y#)MZ;UBV@;\<_>QFN\HH XF\\,:QI6LZ
M7K>A2Q:A=6NG_P!FW46HSLK7,88,K^8%;#ALDY&#D]*S;SP'K.I>'M=>ZFLA
MK6LWUM<R*CMY,,<+IM0-MR2%0\X&2>W6O2** .=U'0KJ[\=Z)K<;Q"UL;:YA
ME5F.\F39MP,8Q\ISS7#^._#][IWA?QA=231*NJZK936[1DLR 20IE@0.<C/>
MO6JK7^GVFJ6AM;ZWCN(&96,<@R"58,I_ @'\* .1.@^(]=\3Z7?:ZNGVEKI*
M3&+[%,\C3RR)LWX91L !) R3GN:Q(O!WC"/PUHNCJFC1QZ#=07$.R=Q]N,;Y
M^?Y/W>1DG&XEO0=?4J* .7T/P[>Z</$YN'@)U6^DN80C$[5:)% ;('.5/3-<
MMXETC_A'?@M865[<PIJVD);R6;Q$MNNHV&P(, G<<KTZ$UZC6==:#I-[JUOJ
MMUIUM/?VR[8;B2,,\8SGY2>G)- %+P9HDGA_PI8V,YW7FTS7;]WG<EY#GO\
M,3^ %;U%% '.ZSH5UJ'C'PSJ\+Q"WTMKDSJS$,?,BV+M&,'GKDBC1]"NM/\
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M5'=GX4LIQD8SD'[O&,DUS&OW^MZOX(M8KS691<6/B<:9+-'#&/M&R<!)&&W
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MY=*\':YKFG>+(?$%M#%$L)N8E6:VG=]G[Q45?E^8'! /!K6L?#'BNUU#Q'K
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!7N+&UNIK>:XMXI9;9S)"[J"8VP1E3V."1^-6*** "
MH;NSMK^TEM+R".XMY5VR12J&5QZ$'K4U% $%E96FG6D=I8VT-M;1C"10H$11
M[ <"IZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***P
MFU^2?QBN@6,"R"W@^T7\[-Q"&R(T '5FP3ST ]Z -VBL?1=7:[LX#J%SI@NY
MY)%B2SNO-20*?X2<$D#J .*?KNISZ?I\YT](+K44B,T=D\FUYE7[P7OG'0XQ
MG&: -6BJ6CZK::YH]IJEB^^VNHA+&3UP>Q]".A]Q5V@ HHHH **KWWVS[#/_
M &>8!>;#Y)N 3'N[;L<X^E>?'7OB(/&"^&_^*7^T&P-_YOE7&S8) FW[V<Y.
M: /2:*Y^[\3V7ARPLQXGU&SM[^9"66W5RK$?>*KRVT>IZ5:N?$VB6=I8W5QJ
M=LEM?'%M,7^23C=PW3&!G- &M17.1>/?"TUA%?)K,'V:5I%CD(8!R@!8#(YZ
MCZY&,U$WQ&\()917C:[;""1V0'#94J0#N&,KC(Y8#J* .HHKG[_4]GBS1+6/
M7;>".ZCE86!@WM> +D%9,_*%Z^]1WOQ \*Z?(T=UK5O&Z2M$XPQV,K;3NP/E
M&01DX'!H Z2BLC6/%&B:!%;R:GJ,4 N,^2HR[28&255021R.0.]9'B#XB:)H
MW@[_ (2.WN(KZWD8);K&Y E?."N<':1SG([4 ==17+S>(;:]UCPZ]AXAMX;6
M^,VVU:V+->[1_"QP4VG)/'-6-3\<>&M'U!["_P!7@AN4QYBG)$6>F\@$)G_:
M(H Z"BLC4O%&B:.RK?ZE! SPF= Q)WID+E<=>648')S4VC:[IGB&Q-[I-Y'=
M6X<QLR9!5AU4@\@].#ZT :-%5=1U&STC3YK^_G6"UA&Z25LX49QDX^M1W6LZ
M=9:C8Z?<W<<=W?[Q:Q,>9=HRV/H* +U%<OXI\16MKI>I1V_B*VTF[L6A$]S+
M;^<L&\Y4%>,EA[\9J.Y\?Z1:>.H/"TL@$\D <R_-Q*S($CQM_B#9SG Q[T =
M917GWA[XDZ6NFG_A(]8MH+PWMQ$H*D!469D3=@87A<9;&<5U6M>*-%\/&%=4
MU".!Y\^5'@N[@=2%4$D#UQB@#7HK*C\2Z+-I]E?Q:E!):7TRV]M*C9621B0%
M&.^01@^E27VO:7IMP]O>7B13);-=,A!)$2D!FX'0$C\Z -&BN;\%>,[#QKHH
MO[,".121+!DDQ_,P7)(&<A<\=,UM:EJ%MI.F76HWC[+:UB::5O15&3_*@"U1
M7 6.K?$/7--36-/LM!LK2=/-MK*]\UIGC/*[W4A5)'.,'&>:W;;Q;;P>%K?6
MO$,+Z&SGRY+>Z^\LF2-J\9;.,C Y% '145AVGC#P_?:1=ZI;ZI"]G9Y^TN00
M8<#/S*1N''J*T+C5K&T^Q>?<I']ME$-MG/[QR"P _ $_A0!<HK"3QGX<DUO^
MQEU:W-_YAA\K)P9!U3=C;N_V<YHO/&7AVPU@:5=:M;Q7NY4,9SA6;[H9L84G
ML"1F@#=HHHH ***X?QEJWC70+'5-8L/[ ?2[.(S)'/',9BH'()#!<YS0!W%%
M<7I%_P".)M-74[__ (1YK:2S\^..W697W%=R@DDC'K6QX/UN;Q#X2TK5KI8H
M[B\MUF>./(4$^@))Q0!N44A95(!8 GH">M+0 45A^)O$L/AV"T00-=7]_.+:
MRM$;:99#ZG^%0.2W856U*_\ $VDZ7)?O:Z=>[ &D@@+QM&O=@QSOP.<87('X
M4 =+12,RKC<P&3@9/4TI('4XH **;O3:6W+M'4YZ4[('>@ HI%8,,J01TX-"
MNK9VL#@X.#T- "T4F]<@;ADG YZTM !1103@9- !12!E)P&!.,XS0K!AE2"/
M4&@!:*175QE6##ID'-+0 4452DU:SCUJ#2#*/MLT#W"QCJ(U*J2?3E@!Z\^E
M %VBD+*&"EAN/(&>3064'!8#\: %HI"ZCJP'..O>C<-VW(W8SC- "T51LCJ?
MVV^%\;/[,)!]C\C=OV;1GS,\9W9QCC%70RDX# G&>#VH 6BDWKOV;ANQG&>:
MIQ:M9S:Q<:5%*'N[:))ID'.Q7)"Y]SM)QZ?6@"[12;EW%=PW 9QGFEH **Y+
M5_$FK6?CC3O#MI;V3K?VTLZ32LP*;,9! SG.>M;-A/K']H2P:C;V@@\H-'-;
M.QRV>58$<<8(]>?2@#4HHI"RJ0"P!/0$]: %HI&94&68 9QR:6@ HJGJNJ6>
MBZ5=:E?S+%:VT9DD<GL.P]2>@'<FF7CZD;BP:P^QBV:7_2_M&[?Y>TX\O'&[
M..O&,T 7Z**0L%4LQ  ZDF@!:*R?$E]J.G>'[J]TF&UGNHE#JMU+Y<>W(W$M
M],FKME=/<:=:W-Q";:2:)'>%SS&S $J?<$XH LT49STHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N)\#_-XG\;R2_P#'
MR=65&SU\L0Q[/PP37;5SBZ'=V'CF76K QFSU&!8M0B9L,)(Q^[E7UX)4CCC!
M[4 >7>';:5/@W:Z[:H6N]"U:;4$"]6C65A*OT,9;\A7>>$WC\1>,M=\4HPDM
M8@NE6#]BB?/*P]C(V,_[%=59:-ING:<^GV=E!#9ONW0(F%.[[V1[Y-4[K2Y=
M)\+RZ;X5M+2TE"%+9#\D418\O@ ],EL=S]: ,/X6\>%+F-/^/:/5+U+?T\OS
MVQCVSFNVK,\/:);^'/#]EI%J6:*UC";VZNW5F/N22?QK3H **** "N';_DNL
M?_8M-_Z4K7<56_LZS_M,:G]FC^W"'[/Y^WY_+W;MN?3/- ' WT6MR?%W4!IE
M]IUK,=(@,7VVV:;=&))-^S:ZXPV,]>JUR^L:-;PZ+X!TZ2^M-4M)/$A.^W3$
M+*TCED R?E!)7&3TQ7K6M>&M%\1+$NKZ;;WGDDF,RIDKGK@]<'N.]2/H.DR1
M6$3:=;>7I[K):((P! R]"H[8H YOQ1#%+\1? JNBLJ2WK*". 1!P?PK$BM8!
M%\5G$*;I&=6..H^R*?YL3^->D36%I<7EM=S6\;W%KN,$C#YH]PPV#VR.*C&D
MZ>!? 6D6+\DW0V_Z[*[?F]?E 'TH \JC);QY\)23DG2)B3_V["K^BVT'_"!_
M$9O*3=-J.J^8<?>P"!FO0AH6E"ZL+D6$'GZ?&8K239S A7:0OH,<4^/2-/AM
M;NUCLX5@O'D>XC"\2L_WRWKGO0!YQI%[?WM]X:TO2AIMG?0>&;>ZEU.\MS-(
M(VPNQ%#+QE<DD^E<O<3^;\(/'3M=Q77_ !46XSQ1^6DF9;<EE7)P#R>IZ]:]
M@U#P=X<U6.SCOM&L[A+.,16X>,'RT P%'^SQTZ5(_A30'^W;M'LR+]%CNAY0
MQ*J] 1[8'Y4 <=XV.?BY\.2/[]]_Z*6E\)/91>&/&PU,QAUU2_-_YF/NG.,Y
M[%,8]J[&U\+:%9#3A;:5;1_V;O\ L>U/]1O^_M],]ZBU+P;X;U?41J&H:+97
M-V,9EDB!+8Z;O[V/?- 'G?@JVD?7_ !OH]T\/AJ5TWCE?FC"G_ODX_&NK\&
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MD^A_ ?E0!Y=IME!XO\*WE[J&L6EAJ=G?RR7-RMMF\M)4F8J Y?(&T!0,8VG
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MCC% 'D>L6]G)X ^)ZI# \<.K.T0"@B-MD7*^AY/3WKK/$UA8VGB/P']CMX8
MNI.FV%0J@&%V/ XZ\UUL7A?088;V&/2+-8[X;;E1$,2C&,'VQVZ"FCPMH8CL
M8UTV!4L#FU"@CR3ZKCH??K0!QFH>7X)^(=W-;6<1A\2VFRW39Q]MCX"<=%<,
M"?<$TNHV]OH_BKPUX8>6RATYM/F,/VNWWQ7%T&3)*[E&_;N(S_>/<BO0[BRM
MKJ6WDN($D>VD\V%F&2C[2NX>^&(_&JFM:!I/B*R%GK&GP7L ;<$E7.T^H/4'
MZ4 9?@[0[;0[+4-.AU 7L*WKR"(1[8[4MAO*09.%!((&>,U0\:66JS:O87ND
MVUAJLEI;R^=H]Z=HGC<K\\;$$!QMQDC&&/KSU>G:;9:1816.G6L5K:Q#"11+
MM5?PJ*^T73]1NHKJY@S<Q*4CF1V1U4]0&4@X.!D=\4 9_@F]L=0\':;<:;;S
M6UH8RB03??BVL5*'Z$$?A6_45K:P65K';6L*0P1+M2.-<*H] *EH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *R=;\3:1X=\@:G=F)YR?*B2)Y7?'4A4
M!.!W.,"M:O.=;AU5_BZGV#5K337DT0"%[JT\\28F8R*OSK@\H3UXQZ4 =7/X
MP\/V^G66H2ZI MG?;OLTW)63"EB,@<$!3P>XQUXJ@OQ'\*/:RSKJA/DR>7)%
M]FE\Y3C/^KV[\8YSC%<0NF06T_@V,:I;:O%+XDN;CSH(/+B5RLC,JKN;@.#T
M-=1H\,7_  N7Q--Y:^8--LQNQS@E\_\ H(_(4 ;DOC/P[!I=CJ<FJP+97V?L
MTW.V3"EB.G!PIX..1CKQ4$/C#2M9TC5IM%OO,N;&!F='B:-XVVDJ2C@'!QQQ
M@UY?IDEG!X?\ ->%$MH_$EV 7X53YDVWZ8;%=7JS1S?$[7'MF5EB\*NET4.0
M',C% WOMW'Z4 :/@[QDK_"_2_$?B;4(TDF5A+,4"[V\QE4!5')X' &:U8?'?
MAN?3;[4%U';!8!3="2"1)(0W0M&5# 'UQBO,?"[)#X0^%5Q=D+I\=].)&?[J
MRL)1$3_P+I[UU]Y:6FM_%R\LL+-;/X<>VU (<@;Y?D5O1L;R/:@#L]3UK3M'
MTIM4O[I(K)=O[W!8'<0%P "3DD=/6LG4/B!X8TN6XBN]4"26TABG18)',1 !
M.X*IP,,/FZ<]:\^\/RW6O7GA[P/?$O+X<NY9=2)'#I;D+;?4-O0^^TUN:)#$
M9?B:YC4L]W(C''51;K@'VY/YT =1'XZ\-3:M;Z9%JL;W-PP6$JC&.1B,A1)C
M86QVSFG:CXV\.Z3JATZ]U)(KE"HD'ENR1;ON^8X!5,_[1%<"\4<7PG^'0C15
MQJ.EN,#HQ8$GZDD_G445EJ%S:>.[:X\3:9IEBVI70O8KJP\V18G4;7W>8O!0
MKMX[<9H ]'U7QAH.BW;VE_?B.Y1%D,*Q.[E6W8*JH);[K=,XQS6/KOQ+T32O
M#MAK-I.+V"^N$AA**^"-X60G"D@J"3M(!)&*H>'K-;?XIS(\HN9;?PW:1"X*
MX+_O'RV.V=H.*Y*^*Q>$;XDA(X_'9.3P%'V@?D* /8O[7L1HK:P9B+!8#<&4
MQL"(P,D[<;NG;&:K7WBC1=-TNRU*\U".*SOGC2VE()$A<97&!W'/-:4L<-W;
M21.%DAE0HPZAE(P17B&FZ;+XIM(/!4Q+3>';#4(9&/\ SVW&&W/_ 'QN84 >
MP:IK5C93#3Y;Y;:]GMY9H?W9<JJ#+/C&,#(Z]>E<E/\ $.PT#PQX>NKG5?[:
M;4KE81>K:M$)$+D/)L53@J.-O4XXK%\.ZF?&,FN>)WY6UT"/3U]!*\9EG'U!
M*#\*Q],98_A+\,G=@J+X@MBS$X 'F34 =JOC^UL_&&JPZA?E=+6RM)[.-;=F
MD)D#EB%52YX4$Y''M72-XNT!?#L>OG4X?[+EQY=P,G>2<;0,9+9!&W&<CI6#
MHJ12?%_Q-.%5G&FV2HXY^4F0G!]#@?E7$Z44MSX8FNBJ:;#XKU!7+<(DA,HB
MSV'S9Q[T >I:=XPT'5+6^N+6^RMBADNDDB>.2)<$Y9& ;& >W.*M2Z_I<.G6
M.H27:K:WSQ);2;6Q(TN-@QC(SD=:X'Q05N_'VN"R(D:+PC<1W7E\X9GS&IQ_
M%C<0/2JNJ:E9O\./AY"ES$\LM[I01%8$G:5W<>QX/H>* .MT;Q]INL^,-4\/
M0[Q+9LB1N8W_ 'K;2SYRN%VXQR>>U6_&'B67P[8VJ65H+S5-0N%M;*V+;5:0
M\Y8]E4 DFL7PG(B_%'Q]&SJ)&EL2%)Y(^S^E)\19/[)U?PIXEG5CI^F7SK=L
M!D1)-&4$A]@<?G0 ^>Y^(FC)%?7,>D:S!O47%E80213(I."8V9B&QG."!D#M
M6WK/C3P_X?NQ:ZG?^3/Y?FLBPO(8TSC<^U3L'!Y..E)K/C70M%TN.^>]CNA,
MRI;P6CK++<,Q  C4'YCS7):[J-W=ZMXN%M>:;HUOI]O%%=.]FLMQ>%HMP#'<
M.!NVJ,$DYQZ4 =^NLZ=)J5OIZ72/=7%N;J)%R0\0(&X'IC+#OWJK<^*M$M(-
M1FN-0CC33I5ANB5;Y'8 JN,?,3N& ,]:\]\'W$<?B'P&\LJJLOA,Q(S-]Y@8
MB5'N *9;#3-;O/%V=96P+>(;<V-ZH#JMPD:;.#PPRI&#P?6@#T&T\8Z!>Z5>
M:G%J4:VEE_Q\M,C1-#QGYE8!AGMQSVJ71/$^C^(C.NF79ED@QYL;Q/$Z@]"5
M< X..#C!KS#Q-J&K36&HZ=J;Z4MYI^HZ9+=:I:P$Q20M(=IF0G/R%02N[&#Q
MBNLTBPN+?QU)J6K>*=/O;N'2VC>WM[/R-L)D#"1CYC< JV/J: .ZHJ&UNK>^
MM8KJTGCGMY5#QRQ,&5U/0@C@BIJ "BBB@ HHHH **** "BBB@ HHHH ****
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M=I#<?ZY(8542=L-CKU-:E% $-K:V]C:16MI!'!;Q*$CBC4*J*.@ '05-110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG,8>1CZ$Y1,]AGUKOJXKPO\ \2KQ[XKTB;Y6O)H]4MB?^6B.BH^/]UTP?J*
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M>V=F+R>")I%MS)Y9DP,D X//IQUH O5%<W,%G;27-U/'!!&NZ265PJH/4D\
M5R'_  GQ*>$YUL;<VGB':JS&\(\ARNX*1L^;^[VYX.*D\2>(VM?#OB2ZN=#M
M[_3].S&T;S@K<@*&?(*8 &<?Q<@^E '7JRN@=&#*PR"#D$5#!>6MU)-';W,,
MKPMLE6-PQC;KA@.A]C7':EKVLQ>,O"VFV%M9K8WMK-.8VG9"2B+\IPAP!OX'
M.2.V*P=.U6]\-ZCX_N]+T:*[AM+\7$RFX$"A%@1F"X5LMU., >] 'JU1SSPV
ML#SW$J11(,M)(P55'J2>E0Z??1ZGI=K?P ^5<PI-&&X.&4$9_.O-I=5U;7O
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M4K;_ (^+:REEB.,X8*<'\#BN8T?1?"/A?X?V=]K=K9R)<01R7EY=6_G//+(
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M&X YP#UQDXSC)JIJL.KW7QGDM])O8K%G\/QF6Z>$2E%%Q)PJD@9)(Y/0 \4
M>D5!>WEOI]C/>W<HBMK>-I99&Z*JC))_ 5YG+X_U33]#GL-1OK"WU:'6_P"R
M&U*9 D*IM\SSRA. =G\.<;L=JAN_%+ZGX7\;Z+)K=CK8MM%DN8+^T"C<K)(K
M(X4E0RE1TZAA0!ZC8WMMJ5A!?6<RS6UP@DBD7HRD9!%6*\MT+6-47PMX"\.:
M-/%:W6HZ:)9;N2+S/(BCC7.U20"Q+ #/ YHU;Q=XE\.QZ[8W-U!>W.CBUOQ<
MK;A#<6COMD5E!(#+AN1^E 'J5%<%K7C*_L_B%IFGVC1/HP,$=^VW)\RX\P0X
M;MRB_P#?0K7\.:S>ZSXB\2AF0Z98726=J N"9%0&4D]_F8#\* -#2_#.CZ+?
M7=[86*Q75V<SS,S.[\YQEB2!GL.*UJ** "BBB@ H(!!!&0>U%% '.6'@+POI
M>I1ZA9Z1#%<1L7B.YBD3'J40G:I^@%='110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %<9XTT;5]5UOPW=:;9QS1Z7>_:IC),$W#:5VKUYY[XK
MLZ* ,,7.NSZC ?[*BM;50S3R&X5Y), [8U&.,L0<D]O?(YJ^\.^(/[2T[Q39
M0H/$*S&.\MVN (7M#_RQS[85@<?>+$CG ]!HH X2YT[Q5HGC"^UG0K&TU"RU
M=(C=6ES<^0]O,B! P8!@5V@9')R*;JFB>*;'Q-I_BC2TM-2O?L1L=0LWE\A7
M0N9%,;$'&UB1R,D>]=[10!Q/B/1O$.J:3H]Z(;6;5+#58M0-FLVV/8H93$LA
M')PV=Q R<\ 8%0VOA[7[GQ'XGOKVWL[>#6-.BMDVW!=HG5'&#\OS??Y/'L#U
MKO** /-I_#?B2X^'.AZ&]A;+>:?-:;@ESE62 J2V2!RVW@8..YK?\9^';[7;
M?2[S2IA9ZM872R0S-C*1O\DJ_P#?#$^Y45U5% ''^*O#>HO::)=^&3 E_H<N
MZV@G)$<L10QM&3VRIX/M^-;.A2ZY=1R7.MVEO8NP"QV<$WG;,9RS/M&2<C@#
M  ZG/&O10!A>)["34K>"TDTBWU73I&87EM*5!VX^5DW<;@?<=^<XJOX'T"Y\
M.:'-8322>1]JDDM())?,:V@.-D1;OC!/4XSC)QFNEHH X1],\6>'?%NJ7FA6
M5EJ>EZO(L[Q7%R8&M9@@1FSM;<I"@X SQ^=I]&UD^/='U>6-+B"UT^6VN)E9
M5+22,K95/[HVXY.?K78T4 ><KX9UP^$O&NF&R07&MWEU-:_OUVA95"C>>Q&,
MG&:AS?6'Q(\,1_8#+/#X?ECFA25=PP\8)4D@'D#J1P?7BO3*S)= TV;78M:>
M&0ZA%&8DE$\@VH>2NT-MP2!D8YH XW5O!FJ7OA3Q:L<,7]K>(I@PB\P!(44*
MJ!F[D*N3CNV!P,UHW&AZK:>,-/\ %-E:B9CI_P#9]_9&55?:&WJZ$_*2&R""
M1P:[2B@#F=!\/&SO->U+4DB$^MW"M)!NW*D:H(T0GN2 2>V6QSC)SOAUHDFD
MZ3=RM<M>1)+):Z>QZBTBD?RUR>O);GN-O8"NEUOP_I7B2Q6RUBS2[MED658W
M) #C.#P1ZG\ZOPPQ6\$<$$:1Q1J$1$&%51P !V% 'F4GA#7W^%.H^&OL<0U"
MYO'E0^>OEA6N/-Y/7@<=.M=#J6CZCJ/CO1M5^Q;;"WLKBWN-TJ[P9=O0 \@;
M>>>_&:Z^B@#@/"NF^-=!M(/#4T%A)IEH?+AU83GS/(!X7RMOW\<9R /?'+HM
M UE&\<DV2_\ $ZR;3$R_\\1%\_IR,\9X]Z[VB@#SV/PUKUM'X$N8+2V>XT*U
M>TNH9+C:#NA6/>K '(!7.,9P:]"[<T44 >9R?#>[_P"$>UW3UN$W1SO)H&./
MLHWB<<]LR84^R"M[7_#U_<_#6]T&T"3ZA=6S1N[,$5I7)9W/H"Q8_C7744 <
M5?Z)K3ZYX3U>TM;=GTZWGMKF&:?;M\Q$ 8$ [@"G3KR*JIX>UH6WCJ,V2[M<
M+FT_?+QF$1#?Z<C/&>*[^B@#*\,VESI_A;2K&[C$=Q:VD4$BA@PW(H4D$=N*
MY$>&=?M]%\;Z2EK;21:Q-=S6LPN,$F= H#*1P%YR<GV%>AT4 <')H&LO/X&<
M62XT4'[7F9?^>)B^3UYYYQQ[U%HNE>,O#4UUH=C;Z?<Z/+<RS6FH2W!5[1)&
M+E6CVG>06.,$ ]R.WH-% %6_T^#4]+N=.NU,EO<PM#*.[*PP?T-<IX8M/$OA
M32X=!GT]-5M+0>7:7L-PL;&+^$2(V,$#C*D\"NUHH X[Q/X=UC5H-*U*WDMS
MJ^EWPO(H"Q$3)C:T.[&>5_B(Z]@#P\Z-?:AXH;Q)<V1@>WTY[.UM#*I=F=MS
M,Q!V@< #D]R<<"NNHH \RC\):]%\.O#.A?8XVO=,O;>>?]^NPI%)O.T]R1P.
M!W_':NM*U(^/KS76M0NGMHALMQD7>'#M)G:.V#CKU[5V=17-O'=VTEO-N\N1
M=K;'*''U!!'X4 >6>&=)O_%7P?T#09+,0V<J0-/=&52IA20/A1][>=H'( &2
M<G'-GQ%X3\3ZM;^+;,VMC=-J/_'A?37!#0PX7$ 3;\O*GG(!W9.:]!TG2+'0
MM-BT_3H6AM(N(XS(SA!Z L20/:KU '&0Z5K1\>Z?KEQ8Q+;Q:2]G*(IPQ$C.
MK\9QD +C/'/;%1:#X;D@\+^)=-\0PQP6NH7EY<LWFJRB&8D\GL5'7M[UW%9N
MM:!I7B*UCM=7LH[N".02+'(3C< 1D@'GJ>#Q0!Q?P?T^\/AR37M3E\Z[U 1Q
M12[2,VT*^7$<'GYL,_ONS72^-=%NM=\-2V]@8QJ,,T5U:-(<*)8W#C)[9P1^
M-;\44<,211(L<:*%5%& H'0 =A3J /+M5\ ZZW@#1;'3)K==>M3,;B5W(4_:
M$D$^#CGYI,C_ '16OXA\&75S>^"4TM8A9Z%=(TH=MI$:JJC [GBNZHH X)O#
M^O6WC/Q5<06EM/INOV\:^>;C8]N\<#1@%-IW9..XP#^%.NO"6IS?#7P_H*B'
M[;8M8F;+_+^Y9"^#CG[IQ7=T4 5[^Q@U/3KFPNDWV]S$T,J^JL""/R-</I4'
MCSPMIT6BV^G:;K=I;*(K2]DO3;N(QPHD38V2!@94]J] HH \Z?P!JUUX8U87
M5]9C7K[48]41HD86\,T>S8@S\Q7"8)Z\]*O1Z3X@\1>*-(U+7=/M--M-)$KI
M!%=>>T\KILSG: J@$^^37;T4 >8+X6\6VW@V;P+!;V)TYP]NFK-<G<MLS$D&
M+;DN%)7KCWK4.A:]X:\5WFH^'K"TU"RU"TMX)8KBZ,#020J45L[6W*5(R!SQ
M7=T4 <MX!T'4?#V@W-IJLD4EU)?W%P9(C\K!W+ X[9ST[4_3="O+7X@Z[K4G
ME_9+VUMHHL-\VZ/=NR.W45TU% ''V?A>[T[Q/K*6XC;P[K432SP[\-!<D;7*
MC^ZXY/N*I>'=(\3Z7%I6C3:7HZVFGE8Y-3W[WN(4&%VQ[05<_+DEB!@GFN]H
MH \IN?!WBIO"VK>&K:STU(Y;N6[&HM<'?=YF\U59=ORMT4L2< <=<C2\3Z/X
MH\2:?>:5=Z!H]Q'=H/LUY)<X;3RRC/&PEF1LD,I&>.E>B44 <,-(\1>&O$>J
M:AHME;:M;:JD+2)/=>0\4T:;"V=I#*P )[YJKIW@74M/3PL7F@FN+/4KC4-1
MD4D*7E1\[ >H!<#Z#->AT4 <K)I.H6GC;5_$$7V?R9-(C@A\Q\#S49V^;T7Y
MAS]:U_#FH7.K>&=+U&\B2*YNK6.:1$!"JS*"0,\XY[UIT4 >57W@[Q3+X=\0
M^'+6UTZ.*^NI[L:D\Y+SAW\Q4*;>&SA2Q. !Q6EXETOQ3XATZ\TN\\.Z-=PW
MD0^SSRW6#I[,@#9&PERK9(9<9XZ5Z'10!G7&E"[\-RZ/<3,XFM#:R2GJV4VE
MOKWKSRX\-^-M0\):7X:N+/388],EMMUVMV6^UI"ZXPFT;/E&3DGD8QSQZI10
M!P-QH?B#1]8UIM&TG2]0M]5G^U137<VPVDI15;<-I+IE0P (/4>]6M?\,:EJ
M7B?P7J$1MS%I$DK79'R [D51L7GC(/&>*[2B@#C(?#&H)\5]1\1GROL%QI*V
M:?/\_F!P>1Z8'6LYO!FK'X+V_A4"#^THXX5;]Y\F5F5SSCT!KT2B@#A+S1-=
MTGQ#K%YH^DZ;J<&K,DP-U-Y9M9@@0DC:=R$*IP,'.:6[T3Q%I7B>R\0Z9:6.
MHS/IBZ??6WF_9EW*V\2(<-@9+#![8ZUW5% ')>!M"U?1?[=EUEK=KC4=2>\'
MV=B5 9$&T9&>""/< 'O5;5=)\16OQ$;Q+I-K:WEM_9263VTMQY3.PE=\JVT@
M8RO7KD]*[:B@#S1? ^M/I4FIS)8MK[ZU_;'V5G)AQM\OR"^/^>>?FQ][VK5N
M-*\0:UX8\1VMUIFFZ:]]8O;6=K#)O8,48%I)  ,$D8 '&/>NVHH \[A\):WI
M.E^#KZQCM9]5T*S-K<6KS%$G1T4,%?!P05!&1CK5[3?"]_JM]X@U3Q%#!;R:
MO:+8):0R^:(8 &!W/@98ER>!@8%=M10!Y=I7@+7E^'VL6>I2VS>(+EX7@E1R
M5!MTC$.3CCF/)_WC70Z)I&O>'? J06<=E/KTL[7-QYSGRFDDEW2'(P3A6('T
M%=A10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MNE!^\JJI" ]MQ]ZZ?Q59SZAX0UJRM03<7%A/%$!U+-&P'ZFL[X>:G9ZE\/\
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M#%<W4,,DY81)(X4R;1N;:#UP 2?:L3PSXVT7Q7<7\&FWD$DMI.\6Q9E9I$7
M\T ?P$G -97BR6(_$'P'%O4NUS=L%SU7[.PS].147PNBC2W\4,L:*P\17RY
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M(8J0.?[P(^H(J>S\1Z)J&ISZ;9ZM97%]!GS;>*=6=,'!R <\'KZ5Y"=/M!\
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MTKF++@ARL9;:I()Y4 \UTU<MXF\47FGZM8Z#H=A'?:W>HTRI-(4B@B4X,DA
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MYS-")'_>_P"\V=S=!P3VH Y#4=#LK?QWX-$/GQ_VI;W45^5G<&Y585=0YSR
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MD<?2@#CO$%E;Z)JG@[4?#J+&UYJ,=E.L72ZMI(V9F?\ OD!=VXY/7GFJ3_\
M%(>(]=\.0Q*5\0*)])+KN D8B.2,Y_A0L)-O0+NKN]-\,Z1I+PO9VK*8%*0!
MYGD6%3U$88D(.V%QQQ6=IL.K:WKD.I:WHL>F+IWFI:(;A9WD9_E\S*CY1L!&
M.IWG/09 .?O]!L8/B1X:TI1-]B_LFYC>'SFVN%,8&1GODY]<G.:YX:%8OX$\
M?JRRE=&OKW^S5,SXM-D2R+L&>,,3_*O6)]"TZYUB#5Y8&:_@4I%,)7!13U
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MOA?0C(1W6^27 S[XM6_[[KWFLVPT#2M+FOYK*QB@DU"4RW3*/]:YSDG\S^=
M'F4]W%XGTCXA>*HOFMCHYT^S;T1;<RR?^/2 ?\!IEF!_8OPAR!]]1S_U[FO3
M+/PQHNGZ!+H5II\46F2JZ26ZYVL'^\#SGG-17OA#0-1T:TTBZTV*2QLRIMXM
MS#RMHP-I!R./>@#G_#-G;R?$[Q[.\*-*7LHMS+GY#;*2/H>_K@5/\)>/AEI
M[+YRCV F< ?E736.CZ?IMQ<SV=LL4MR(Q,P))?8H1,Y]% %/TW3+/1[".QT^
MW6"UBSLC7.!DECU]R30!7\1C/AC5O^O.;_T UYB+:"[^'WPL@GC22)]0L]R,
M,AL0R'!]>E>ONBR(R.H9&!#*1D$>E86G^"?#FEPPQ66EQQ1P7(NXE#L0DH!
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M#3++)<RO@!_E^ZH R ><X]*[>@#(\5 'P?K61G_0)_\ T6U>76:HWPT^&:7
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MJ$TFCVL6J:9?DY9%1F4JXSL+!FX88/6NPN/!GAV[U>75;C28);R48D=LD/\
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M&F76K6\UC86L;F:-7W'F0M@\-\V%'+=:]=GTRRNM0M;^>W1[JT618)#G*!P
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !5673;.?4;?4);:-KRW1DA
MF(^9%;&X#ZX%6J* *E[I=CJ,MK+=VL<TEI*)K=V',;^H/:L^]\'>'=1U==5O
M-'M)KX%3YSQY+%?NDCHQ'8G.*VZ* ,BZ\*Z#>ZU'K%SI5K+J" ;9W3)XZ$]B
M1V)Z52F^'_A.XM;>VET&S,-ON$2A,; QR0".<9[=*Z2B@#)U#POH>JZ?;V%[
MI=K+:VV/(CV8$6!@;,8V\<<4L?AG1(=%&CQ:7;)IP8/]G5,*6#!@Q]3N .?:
MM6B@"M-I]I<WUK>S6Z/<VF_R)2/FCWC#8^H%+>V-KJ5E+9WUO%<6TR[9(I5#
M*P]P:L44 9&C>%]#\/";^R=,M[4S8$C(OS.!T!8\X'I5W3M.L])L(K'3[>.W
MM801'%&,*H)SQ^)-6J* *=_I-AJ<EJ][:1SM:3+<6Y<9\N0=&'N*J:UX7T/Q
M$8FU;3(+MXLB-W7YE!Z@$<X/ITK7HH SCH&D&RLK+^SK<6MC*DUM"J +$Z'*
MLH'0@UHT44 48]'TZ&SO+2.SB6WO'D>XC XE:3[Y/U[U5U#PKH6JV%K8WVEV
M\UO:*%MU9<&( 8PI'(X '![5L44 5--TRQT>QCL=.M(;6UC^Y%$H51Z_C[TO
M]FV1U4:I]FC^W"#[.)\?-Y>[=MSZ9YJU10!B:KX0\/:W?)>ZGH]I=7* *))$
MR2 <@-_> ]#FI+_PKH6J:E;ZC?:5:SW=N L4KID@ Y ]P#R,]*UZ* .=N/ ?
MA6ZM5MI=#M#$LKS*H3&UWQN((Y&<#(''%7+KPOH5YHT.D7&E6KZ?!CRK?RP%
MC(Z%<?=/7D<\FM:B@#'@\*Z%:Z)-HT&E6T>G3Y,L 3Y9">I;N3P.3Z5>N-.L
M[N:TFN+>.22T?S+=F',;8*Y'X$BK5% %6STVST][EK2VCA:ZF,\Y08\R0@ L
M?? 'Y5:HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKB!KBW>*X29) OWE)7[KCKCD>A-4]3\,:IK'PWN=/DEBAUV\V7DCG[@N5=9
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M_#/.+-CIVJ6WQ(U/59-/F>RETR&VCG5XAYDB,S'Y=V1G<,9'Y5S/_",^(?\
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M>WK38-.U30?'VKZU#I\]]IVMP0&187C$EO-$NP AF *E3U!.#[<TND>"H_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKW_"">$/^A6T7_P B_\ B: ,.XL->\-^+-4U71-)@U6UU6& /"MTEN8)8E*
M_-P4*XZ<C'2JVI:5XKCU7PAKCV]MJ^H:=%<QW\<,RP#,J@ H6X(7&/4X]ZZ7
M_A!/"'_0K:+_ . $7_Q-'_"">$/^A6T7_P  (O\ XF@#EXO!-[>>(/B$;WRX
M;'Q!!##:S!PQ^6)E)*]1@D=>M)+IGBGQ!IFC>']5TJWLK:SGMY+V^6\619UA
M(($:#YAN*C[V,<]:ZG_A!/"'_0K:+_X 1?\ Q-'_  @GA#_H5M%_\ (O_B:
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M""*M4 <U\/\ 1[W0/ ^G:7J$:QW4 DWJK!@,R,PY'L172T44 %%%% !1110
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M0O+7Q]9WCQ01Z[=>=9R*V[;C)4L.WS8XH V8)O%^@R"]UN\LM3TS[++/=^1
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MK3X;&WELM?BFDM[O[2%*.T&P(R8S][OFM;5O#>H7FA>$;2)8_-TN_LI[G+X
M2)2&QZT <OJ?Q&NT_MK5+?Q%HEM'IES+#%HT^WSKM(CAR6+!E9B&V@#TZYKU
M:WG2ZMHKB,YCE0.I/H1D5Y]'X>\0:-<:G8:9H>D7L%Y>R75MJ%TX_P!'$K;F
M5X]NY]I+8P>01TKT15"H%   &, 8% '%W6IZ]KOC'5-$T74+?3+;28H3//):
M^>\LLH+!0"P 4*!GODUQ_B'7M=U[0- S>065[;^*(]+O5C@WH\\<GRR+EL[1
MM!V]\]1BNPNM,U[0?&.J:WHNG0:I;:M%")X'N1 \4L0*A@2""I4C/?(K%N_
MVN0^$K(PBUNM;CU]==N81*4CD<N6:-6(XP"!DCM0 L5KX@F^*&L6EAJEO;7
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M<?+TH ]4T*+1IXI=:TA4==4*SR7(W$S8&%/S<@ < < >E:U>:6/BO7=7\/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>:E.88&D6(,(V?YFZ#"@FM"@#S+4_A\EA/XGBLVLM.\,:OI?[]1\BVMP@.)
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M5SPAK'AC4;:Y@\+RH]M#(7<11.L89R22I8 $$@_=X_.NAFA2X@DAD!,<BE6
M)&01@\CF@#B/!?\ Q-O&/BSQ+'S93S16-H_:18%(=AZ@N2 ?]FNXD#-&X1@C
MD$*Q&<'UQ4-E8VNFV,-E901P6T"!(XHQA5 ["K% 'GR>'_$6LZ_HUUK>EZ1;
M2Z9*7FU*UF+278\MDV!=@*JV[)!8].*=H&A^*=#M[#0([/2#I]E*%_M-Y"TD
MEN&R%\K;Q)C"YW8'7FN]1UD7<C!E]0<BG4 <+:^'-;M/%GBC$-H^DZZ XN?/
M(D@80[,&/;\W/N./RK!NO!/BC4_A98^%KBVT^"ZT^> 1R+=%EFCC/+'Y!M/3
MCG\*]8HH YVUT2[A^(6H:XQC^R7&GPVR -\V]'=CD8Z885QVH>&+[1M/CO&O
M=.M]1C\3RZA8K<S%8YQ,6 B+8^5F4GL>17HNL:Q8Z#I<VI:E,8;2';YD@C9\
M9(4<*"3R1VIU]8:?KFFM:WUK#=V<Z@M%,FY6'4'!H X/16U6Y^-$T^JBUCG7
M0-K6UK(95MP9U*JSD#+'#'H.,>F3Z169HOAW1_#L,D6D:=;V:RD-)Y2X+D=,
MGJ?QK3) !). * .)T?P==0^(?&]QJ!B-CKQB6(1OE@@C9&R,<'YO>LEO"WBS
M4/"MEX+U"'3ETN#R89M2CN&+S6\3 JJQ;?E<A5!)8CKUKN]3UW3=&AM)KZY\
MN.[G2W@949P\C9VCY0<9P>3Q[UHT <SHN@WEAXZ\3ZS,8OLNIK:" *V6'E1L
MK;ACCD\5RL_@WQ(=&\;:#'!8M::S<W%[:W9N2&#RE,(R;> ,'YL_A7J%% ',
MZ]H-YJ5_X7G@,033+T3S[FP2OE.GR\<G+"NFHHH XZ'PQ?Q_%B\\3$P_8)M)
M%FHW'?Y@<-R,=,#UK,/@G53\%H?"6ZV_M)(HT)WGR\K,'/.,]!Z5U>N^*]$\
M-&V75KY;=[DD0QB-Y'DQUPJ DXR.U:Z.LD:NIRK $'&.* '5S.IZ#>7?Q T'
M7(S%]DL;:YBE!;YLR!=N!CGH:OZKXJT#0KE+;5M9L;*=T\Q8[B=48KDC(!/3
M(/Y4:5XJ\/ZY<M;:5K-C>SHAD:.WG5V"Y S@'IDC\Z ,'4=&US3/%.I:OHNG
M:=J46J11"6*[G,1AEC4J'!VMN4KC(X/%0W&A^)K/Q#I>MVUMI>I7::8;&X5Y
M#;I%(7#F1/E;Y3R".#@"N[HH \[TC1?&7A_39[6.WTK4XS?W$TL<LQC^UQS,
M6S]TB-E8_=.00>HQS7M_ FL6FGVVHV<6GVNK6NKR:G!IZ2'[/''(@1X X7C(
MR<A<;CTQ7IE% ' R>&M>UV_UC6=5@M+*YFT>72[&SBG,H0/DL[OM').T<#@"
MK-]X5U&Y\&^%M*1H/M.EW%A+<$N=I$.W?M..>AQ7:U6O-0L]/$!O+J&W$\RP
M1>:X7?(WW5&>I/I0!YU?^#_$\NE^*=!M(M.2UUBYN+H:D\S>81)R(BFWKG"[
MLX"]!GBKD.D>+[#Q3-XBM[#3IC/IL%K+8M>%3O0L25DV$<9'4<Y/3'/H5% '
ME>J_#O6]0^']UIQELSK&H:Q_:ET Y$2$MDJIQDX4*.E=!J6C:WIOBN^UG1=/
ML-2BU*"*.>"[G,)BECR%<':V5*G!'!X%=?<W5O96TES=3Q001C<\LKA54>I)
MX%.BECGB26)UDC=0R.AR&!Z$'N* *VDPWEOI-M%J#P/>+&/.:W39&7[[1Z5<
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ KEO'6LZAI>G:=;:5*D%]JFHPV$5PZ!Q#OR6?:>"0J
MG />NIKF_&F@7FO:99MILL,>HZ=>Q7UKY^?+9TS\K8Y ()'% '(7+:CX=^)E
MM<:KJ+:I#:Z!>7"3/$D<A"LA92$ 4_=&#@=?;-4=%^(4SWGA^XD\76FI3ZK<
M1P7>DQP(HM?-'R^6P&[Y&*@[B<\]*Z-/"_B#6O%JZSKXT^"U?2Y]/:SM9GD*
M"0J=VXJ,D_-G@8P.O-7/#^G^,M.32])NI-*73=/41O=Q,[374:KM1?+*@(?N
MY.X].* .8\%KKEG9^.[X>((7EM]4NH@;^-(X/-5(\3.RKD  8VCY<"M'PEXJ
MFN/&46CKXG'B&UN;&2X,IM5B,,B,@^4JH!5@Y]<8ZU%<^!O$,EEXNT>-M--A
MJ]\VHV\[R/O$A:-O*=-N-AV$$@]#TK5M]&\57'C'2O$-]'I<2002VDME#.["
M*-RAWJY0;F)7E<  8YZT <'K/B#4O$O[._B"_P!5N!/<B\\H.$5/E6XC &%
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M?#W6-/\ A?:: 9;&34K._6^569C!-MF\P(QVYP1QTZT 5[#Q_+IDGB #7/\
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M9&T^8A"DD9!!&!D8H P-2\?:W'\+(=8M;^-KZ/5_L#7:P*!/&LK+OV,,*64
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M6=O$5E:U=Y'NWQ@-AE'ECJ<9)SQ0!T]>3^,?&.H:#=ZO>#Q=9+<6,JM;Z+!
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MUTV^2[2_B5A<RA#E5V;0J$\!B"1C/%=W4<T\-M'YD\J1)N"[G8*,DX R>Y)
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M8YS<HT4%PDH&Y?D!*X(&.#TYJ+3M"\0Z+=>+O$-[>V#7^HV<;0B)7,<$D22
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MQ_8 OG"UVG=]I\L1;_3&P?G5[2?#,^G6OB:%[B-SJ]]/<QE0?D#QJH!]QMH
MY.7Q=K%S<_#"5;HQ+K2,U]&BC;*?*0^G R2>/6KELOB+Q?-K^H:?XBN-->PO
MYK+3[:-$,!,6 6FRI9@S9Z$8'2ID^']ZO_"!_P"FP?\ %-H5GX/[[**OR_\
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M5Q-%*T83']TKD9]: ,#2O$NNZQX0\#6"ZG)#J&O/+]IOU13(L<09FV@C:&(
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M/3]4BCAC1P%\LK$"AXY7+DX]<4 >TT54TRR.G:=#:M=W-V4!_?W3AI&R2>2
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M=6AO([")XH]/NY+!T*!0'CP#M _AZ8K1GGBM;>6XN)$BAB0O)(YPJJ!DDGL
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MMCE0<!NXST)'<=N]3T >=MX)\47]OH-IJNN6#VVBWEO<1?9[9U>X$1',A+$
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M .2<?"?_ +"]C_6NSB@O/&/C#Q'!/K.IV-CI,D5K;0V%P8"7,8=Y'(Y8Y8
M\8'2GW'PZDG\->$=(_M-0= O+>Y:7R?]?Y>> ,_+G/7FK][X8UFT\0ZAJ_AS
M5;2T;4UC%W#>6IF7>B[1(FUUP=N 0<@XH Y;PYXDUEM2\+W&HW\LT,MS>Z+>
M$G"231L3%)M'&XA",^]'ASQA?6VIZYJVIWDDVEWUE<ZEI\<C?+%';RNA5?\
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MEEDDCDTR9Y[<2\R+$^0N"2<94XSWJU>OHT.L:!J&@:]%9_V3:&Q\FYL)I5>
M[1QC:0PV]?\ ) *G_"8:OI:?$^\^UR3MID\:622MN6$L"HP#VR0<>U=3#H.J
M>&-NKIXBU"_@@M)7O[:_E,HF8)E6C_YYG<.@XP<5SL%GX79_&*7VMM-;>(W#
M%$M)5:  $<'!R02"..U3:=J"O?6C>(/& O;.SA>*.WMK": 7.Y=NZ?DACC/
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M\6^'K'3+6T.I%S!"D6[[-*-VT 9^[[59_P"$W\._\_[?^ \O_P 30!A^'/\
MDL?C;_KVL/\ T!JR_$FN&\\<ZGI=W>>([:ST^WA$*Z)!*Q:60%B\C1J>@V@*
M>.O!K0TW4] L/&FN:^=9WKJ<5O&(?LDH,?E*1G..<Y]*K:IJMJGB&?6O#WB.
MWLY[R!(+N*[TZ:9'V9V2+C:0P#$=P1CTH RVU/Q+K<O@"PN-0U#2[C4H[Z*_
M94,$KB(##["/E8A<@XXWY%:S:??WGQ$E\-_\)!J\6EVVB02-Y=R1-(_F.NXR
M=<D#)(P3@=L@M-UHSZUX6U*X\2RW,NBQW"RO+9R;[EI4"[LA<+@C.,'TJ[#J
M_A^+QQ=>(O[8)6>PCL_(^R2Y!5V;=G'^UC&.U ') Z])\-=9UV7Q1JWV[1)[
MB*T9)MJNL,A ,JX_>,>02>V/<GI[G6M0?XO^&K);N5+*ZTB2>6V5SL9^<$CU
M%9X701X&USPY_;_S:G-<RB?[%+B/S7+8VXYQGUYJ=YM ;QOHWB+^W?ETZP:S
M,'V.7,A.?FSCCKTQ0!CJFM7OP[UWQ))XEU:.]TZ>]>S6&XVQJL4CD!U_CS@C
MG@#  XYVM?U&/4M1L4GUK7ED?38Y_P"SM!AD\R-WY\V1TSQV"G X/7-10/H,
M/@/5_#7]NY;4#=D3_8I<)YS,WW<<XW>O.*A\^TL]6DNM)\516T5Y9V]K>[].
ME>0>4"H>(\!20QZ@@=>: ,B0W?BK_A6-]?ZE?QW%X9HYFMYC%\R1O^\ '1SW
M/IQ70+XBU#3OB5XQC>ZGGL=,T:.ZBMG<E P0,2!ZG%8T=E96>CZ!;V/BFV6[
MT&ZEDLI9=,F9&A<$;9%SDL,GD$?3O6O:OX>7QEK.NWFM+/%JEA'9RVPLI5QM
M #'.#P<'CMF@"C=_VQHWPZLO'1\0ZG<:GY=M>W$$D^;:1)67=$(ONJ KX!'/
M'6M>&QU#Q+X[\7V$^O:I::?926HMXK*X,15GMU).X<XSS@<$DYSQ6&D%K+I-
MGX;OO%L4_ANT>,B,:9*MS-'&P9(G?[NT84$A02!VKI=*UGP_IOB77]6.L&0:
MK) XC%I*/+\N(1]<<YQGM0!-X(\SQ7X$T"_UF4W%Q"Y=G*C,CQ2D(Q.,CE%;
MC&2!GC(/1?\ "/V+KJ@EB$G]I*4N,J "F" O _VFY/.2:R_A];6>G^$+;3;.
M^^VK:O(K3"%HLEG9\;6YZ,*W=3OTTW3IKIE:1E4^7$G+2O\ PHH[DG@4 <;X
M(U77]=\!:'/;W-K]K@NOL]_)=*S&6*)V1BN/XR IR>,YKO:\^L="U_PKX&T+
M3=*O8$U&.<27D;0>:+AG8LZ _P (!;[W8#->@T <+XS?4KCQMX2TBSU2ZL+:
M^%Y]J-N^UF5$1ACT/4 ]1DD<UAWM]JGAV#QYHD>KWUS'9:2+^PN+B8O- 61P
M1OZG#*",]*U?'%K=W7Q#\$K87:VEVJW[Q2O'YBY$:<,N1E2,@\@\\&K*^!KZ
M\T[Q.^JZI!-JVO6WV5IH+<I%;QA&5552Q)^\2<GF@#GUN=9T'X5'QE+KE_>:
MO>:;;B..:7-O"93&JLL>/O ,"2<Y.?6M/4;*^\%ZKX;GAU[5;^+4+]-.O8KV
MX,BR>8C$2*#]PAE_AP,&NAD\(V]W\/8?"5[,SQ)816C3QC:<HJ@.!S@Y4'%4
M;?PIKE]JNE7/B36K6]M]*D\ZWBMK0PF:7:5$DI+MR 3PH R: .=/B#5X?AY=
MZ+]NF;Q&FK'0X[EF_>,S2967/7_4MNS[5.->U#3/B9XGMFO+B>QTW05N8K>2
M0E=Z@$M]3CD^];TG@='^(J>*/MG^CA1(UEY?#7 0QB7=G^XV,8[9S4B^"U;Q
MSK&OSW2R6^I:>MB]KY>" ,9.[/.0/2@#S_7-*U%_A7INOW6O:C=75_)8W%W%
M/-NA822QL%1.B;25QMQP#GK6EKFNRZCXL\06LU_XFMETYDM[%='MIGC5S&'9
MY"BD,=S ;6XP.G-:$OPZUZY\.6OAVY\2P-I=A)$UKMLB)76-P565M^" HQP!
MS@]L';O_  SK<.N:CJ/AW6;:Q&J*GVN.YM3-LD5=@DCPRX;: ,'(X!H YW3[
M_6/&.OZ-I>I7>HZ2L6A)J%Y#:NUM+)<,Y3#'[P4;2<>]:7PU@GM;[QA!<7+W
M,D>M,OG.!N<"*/!;'&<8S[YJ]J'A+54UC3]:T768X]3M['[!</?P&9;F/(8,
MP5E(8-DY'K5 >&-<\,>%?$\FF:O)<ZUJ%Q]LAG6U!82D("NSD8)4^R@^V: .
M_K@_B9#-<R>$8+>X:VEDUZ)1,H!9,Q2Y(SQG&<9XS7>5B>(= ;7+G1)EN!#_
M &;J"7I!3=Y@5'7;UX^_U]J .*N]2OO ^O\ B*UAU*^U"UA\/-JD2:A.9BDR
MNRX#'G:<#(IE]#JOA?PUHOBC_A(=4O+QY[7[?#<3[X)DF95=5CQA,%_EVXQC
MO77:CX1AU3Q->:G=3!K6[T=M*EM@N"59RQ;=GT.,8K(A\#ZU<6^EZ5K&O6]U
MHNF2Q2QQQVA2>X\K_5K*Q<C P,X SB@#$NM5UM_#VH^&8-3N4UIO$#:?!=>8
M?-6%O](5L]?]5D4ZZ\:7]S:Z3J=K-(HL?#=QJ][""0LLNP(B..^'$A_X#74M
MX+!^(Z^*A>8B$&#:>7UFVE/,W9_N';C'XU7T'X>V^E?\)%%=77VNVU??$D>S
M;Y%NS2-Y8.3GF5^?I0!RFAZI?_VAH1M;SQ9>2WQ\G5?MMI,D 5XR?-C+(%CV
MOMQMQP:MKX@U>?X>6>B_;IE\12:K_8<ERK?O%9)"7DSU_P!4N[/O74:'X?\
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M &34>G6K6.FVMH\\MPT$2QM-*Q9Y"!@LQ/))ZU7\0?\ (MZI_P!><O\ Z :
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M,Q;[5Y'K/YOW-WX=??VJ2]\%WT^L:O+:ZX;73-9VF^MEM@920@C/ER;OE#*
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MQWC<ISNY!!XR1TKH]%T^ZTW3$@O=1EU&Z+,\MQ(H7<S$G"J.%49P!V K0HH
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M+RP:W^?/E>7E9-W QS]TUV-5I]0M+:\M;.:=4N+LL((SUDVC<V/H.: ./M_
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MI.H #J0V-F !LQT ^:NNM=1FN-7OK%]-NH8K8(4NI OES[AD[,'/'0Y K0H
MSM"L]0L-)AMM3OXKZYC&TS10>2"!T^7<>??-7Y$\R-TW,NX$94X(^A]:=10!
MQUIX1UE[_2VUGQ$NHV>E3>?;)]D$<TCA&13+)N.[ 8] ,GDUQW@SPGJNO_#:
M&P37Q;:-?37'VJW^RAY0OGN&6.3<-H8#G*G&3ZXKTN_\0V]GK^GZ(D4MQ?7@
M:39%C$,2]9')/"YP!W).!1X;UNUU_1Q?6<#P0B:6'8X .4D9">..2I- &5?>
M$]1AUB;4O#>L1:6]S;QV]S%-:>>C",$(ZC<NU@#CN",<<4V_\'7COI%]INN2
MPZSIL#6YO+J(3BYC;&X2+E<\@$$$8-==5:^U"TTRU-S>SK#"'1-[=-S,%4?B
M2!^- '&:E\.9]6\,#3+W7YIKR34EU&>[DAR&8?P(F["+C  R<?C6U?\ A47W
MCK2/$OVS9_9UO+#]G\O/F;QC.[/&/H:Z*B@#DH_ ENWB/Q3J=U=&>W\06\=O
M+;"/;Y:K'L/S9.<CGH,4[1_#6O64]FFH>)WN["RC,<,,-MY+R_+M!E?<=Q ]
M O.#75T4 <;;>$-9DO=+&L>(QJ%AI<XN+=#:!)I'"LJF63<=V QZ*,GK7944
M4 <]XE\/7>KW>EZAINH)8ZCILKO#)+!YT;*Z%&5EW*>F.0>U<_/\-KNX@UJ&
M;Q 95U:2VN)VDM06$T3HQ8$, %(3 7''')QSZ#10!B:KH2WOB/1=<>Z$2Z2+
M@F,ID2"1 O7/&,9Z&N(TNRTWQ9\7Y_$.DSFXTFRMXVGEC.89[T!T0J>C%8W.
M2.AQ7J76FHB1H$1551T"C H =5;4+7[=IMU9[]GGPO%NQG;N!&<?C0^H6B:E
M%IS3J+N6)IDB[E%(#-] 67\ZIZ!KT'B&RN+JWBDC6&ZFM6$F,EHW*DC'8D4
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M9E"A< Y##Y><]0Q%:NAZ/JEA<W-WJVNRZG<3*J*JPB"&)5S]V,$_,2>6)).
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M # !<#E>A[@U@V>@BZ\%^--8;4=1ANK+4-3FL_LUV\*PLC,V=JD!B2.2V>,
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MSV,=F8-G "NS;LY_VL8Q61J?P^L[_P >:?XJANY+::W8//;JF4N6565&//#
M,1GGC% &'I>DOXU7Q)JM_J>I0W,&HW-G8?9KV2%;1(OE4A5(!8D9)8'-<_;*
M/%^N_#34M2FO/M%_8W?VAH;J2++1QCYE"D;23DG&,]#P*[FZ\$:@EUJO]B^(
MY--L=5E::ZM_LJRD2,,.T;DC86QW!YY%.U#P$#_PCCZ'J;:7-H,;PVS- )PT
M;H%8,"1S@#GUS0!S*^(=0TSQ=\4[E;F:5=,LH)K6&1RT<;>0S<*>!D@$XK=T
M#PG-:6VC:[!KNI->&%9M0%Q.\\=X&3)&QFVH02"I4<8Q@UI6O@BUB\0^)]3N
M+@W$7B"**&>V*;0BK&4(SGG(/M532O ^H6=SI:7WB:YOM,TH[K.T\A8SD*53
MS7!S)M!XX'J<T <'HVJ:K?Z5I?B&TL?%4^OW%S'/--AS9RPM)\\07=M"!"<$
M+G(!S7J?C/5I]"\%ZSJEKC[1;6DDD1(R ^.#CV/-96G^"=0TQX+*U\2W,6@V
M]QY\5C' JR ;M_E&8')CSVQG'&<5U.HZ?;ZKIEUI]XF^VNHFAE7.,JPP?YT
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M8YK*0&)(D,4F.%5?NXYYY)W>P%=G6>E[>MKLMDVER+9+ )%OS*I5WR!LV9W
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MIRZ6]I?Z9JD<?FFSU"'RY&CSC>N"0PSZ&NDH I:OI=KK>CWFEWJEK:[B:&0
MX.",<'UKDX_A]=RSZ/)JGB>\OQH]S'-:(T"(,*,8?;RS$8&X^AXY-=S10!P5
MY\-/MFG:CI+Z_>)HUU-+<1V21(/*E=B^2^,LH<E@I[XSG%:2^#KE/%,.O)K<
MHF>TCM;^(VZ%+M4).?\ 8SD]*ZNB@#C]+\$76E2V=M%XDOSHMC+YEMIX55(
MSM1I1\S(,_=/8 '(KI]1T^VU73;K3[R/S+:YB:&5/56&#_.K-% '&6?@.X$^
MEIJGB&[U+3]*D66SM9(43#H,(TCJ,N5'3ISR<UJ6/A:&Q\9ZKXD6YD:7488H
M6A*C:@08!!]ZWZ* ,W7-*DU?3OL\&H7-A.LBRQ7%N1N1E.1D'AE[%3P17/2_
M#]=2T_6(M;UBXO[S5((X'N5B2'RDC8L@15X&&);G.:[.L74/$]A9:9KMW$QN
M7T6-GNH5R"&$?F;<D8R5(Z9ZT 95IX*NSX@TG6]7\0W.I7FF&41;H$B3:\90
MC:O?G)/.<#I57_A7&U7TZ/7KR/PZ]S]I;2EC3&2^\H),;@A;G;^M=AI]V+_3
M;6\5"BW$*2A2<D;@#C]:LT 8VE^'HM+N];N$G=SJMS]H<$ >6=BI@>OW<U)X
M:T./PWX<L-&BF::.SB$:R.,%AZD5JUEZ_P"(=.\,Z8;_ %.8I$7$<:(I=Y7/
M1$4<LQ]* (]*T"+2M3UJ]2=Y&U2X6=U( $9"*F!Z_=S6%#\/(K/1-!M-/U:X
MM=0T176UOEC5B5?[ZNAX93QQ[ YJ2W^(ME]NM;;5-&UO1ENY!%!/J-J$B=ST
M4LK':3Z-BNQH Y*'P) ^E:]!J6HW%]?:Y%Y5Y>LJHVT*50(H&%"@G YY)SFJ
M[^ );NR\/0:CKLUW)HE['=0R_9T3>$ "H0.W'7KS7:T4 <AJO@FXN=6U"^TC
M7[K21J:*M_%%"D@E*KM#*6'R-MXR/0<9IT_@?[/+87&@:M/I-U:68L/,\I9Q
M+"#D!U;JP.2&]SUS76T4 >>^+K&>/PI:>![*\NKW4M7;RI+FX;>Z0[MTTSGH
M!@E0.!\P Z5WUO!':VT5O$NV.) B#T &!4E% '!7?PS^V:=J&D/X@O$T:YFD
MN(K-(D'DRNQ?)?&64.2P4]\9SBNAT;PZ=+UG4M5EOGNKK4(K:.8F,(,Q*5W
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M'OGK61!X(NQ=627OB2]O=+L;E;JWM)HD+[U)*;Y?O.%)[\G R378TA(4$DX
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MI6H>)I7BC59(6 S'L"X49&<CG)//3$A\"69^'D?@[[9/]E1$03X&_P"60/\
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MB@ < 5HSPI<V\L$@S'(A1A[$8- 'B-IHEJOPT^'B6S36[W^K6K3RQRMNR8Y
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M^'7\* -^N4N/&4Y\<GPOINCR7DL$4<UY<-.L20(Y R <ES@YP,5R6K>'=/\
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M/M&T-\RDHVWC<I' %=2K*V=K X.#@]*ANYI8K2=[6)9[E8F>*$R!/,8#@9[
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M;V\N]:C$5Y?2E!(5 PJJ H50,G  [FM;4?#EKJ3:,TLLRG2KE;F':1\[*C(
MW'3#'IBK%Q=:C'K5G;0:<DMA*KFXNS<!3"0/E 3&6R>.O%8,'C*ZU#QW?^'=
M-T@30:;Y0OKV2Z";#(NX;$VDMQ[CI^8!TFHZ?:ZMIMSI][$);6YC:*5#W4C!
MKF[#P(EO?:?/J&N:GJD.F'=8V]T8]D38VAB54%V ) +$XK>T:[U&\L3+JFG)
M87 D91"EP)AM'1MP Z^G:KZLKJ&5@P/<'- &3HOAZVT2[U:YMY97;4[LW<HD
M(PK%0N%P.G'?-6M7TV+6=%OM+G=TAO+=[=V3&X*ZE21GOS5#7/$2Z/=Z+ L
MG_M*_%D6$F/*RC-NZ'/W<8XZUJWDD\-C<2VL N+A(V:*$OL$C <+N[9/&>U
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MC:%;FU"$O$Q!*,KJ01D9''!K-C^&VFPZ7J%G'J&H"6\O8]0^UM(K2QW";<2
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M&TUH"[WIN &23)PGEXR1C!SF@#.L_"-I:^+)O$;75S/>3V*6,BR[=C*I!W8
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M1TZTT+XC>*-*TR!;73_LUG<+;1\1I(PD#%1T&=HSCTK;LO!>FV*^'%BENB-
M1TM=SK\X:,QG?\O/![8YK0MM"M;7Q%?ZVCRFZO88H9%8C8%CW;<#&<_,<\T
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M;%;4OAFRF\80>)VDG^W069LU0,/+*%BV2,9SD^OX4 ;5<%9?\EUU7_L!0_\
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M6+5;Q([\)%'*25B)@3+*.S'CGKP*Z;X9W4]Y\-?#\]Q(TDK6B@NQR3C(&3]
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M<QMAAD8X/8T 2T5E>&;&ZTSPQIEE?2M+=P6R),[OO)< 9RW?GOWK5H ****
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M>V<UK=0QSV\J%)(I%#*ZGJ"#U%>$Z3H]C_PI3PJT-O';S7^LVJW,\"A))/\
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MPS$V\FXL1R21P3UQ71Q:78Z#\2-:L=)M(;*SN/#8N)(+= D9D$KJ&VCC..*
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MX?DF)+" Q@G^ZKLJ_H!6?;Z1IWB;XI>*4UNR@ODTZVLX;2*X0.L:R*SNR@\
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MIUKPG0O#FB2?!OQE?OI%DUW!/?)%.8%+H%P5 .,@ ]/2M_4=/CA_X031]/\
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M* "BBB@ HHHH **** "BBB@ K*\1>'[+Q/HD^E7YE$$I5M\+[71E8,K*>Q!
MK5I&944LS!5 R23@ 4 8FG>%[73]6AU0W=[=7L5D;+SKF4.7C\SS,M@#+9[^
ME4[KP'I5S;7D8FO8)+G4O[4$\,H62&XVA=R'& ,#&"#U-;\&HV-S \\%Y;RP
MQYWR1RJRK]2#@5R7A'QM>>+=;U)8+;3X=*L[F6U1C=%KF5DQ\X0+C8<^OYT
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M.35;QKXJ'@[05U/[!+?,T\<"P1-M9F<X&.#^56H_$=E=>$6\1V1^T6GV1KI
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M#S/L\^TEHFVNI5@RE3V((!JOIWA:UT_5+?4VO+Z[O8+-K+SKJ4.SQM)YA+8
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MD@C!'7BM:WO+6\@\^VN89X>1YD3AEXZ\BBVO+6]0O:W,,Z*=I:)PP!].* .
MUK2_^$T\=:)"VD7L=CH$[S7%[=PF-9F!&R.//^L!958G&,*/6O1J@M[VTNWD
M2VNH9FB.V18Y Q0^AQTJ8D*"20 .230!QMY8W6A_$>'7+:VFGT_5X$LKX0H7
M,,J$F*4@<[<$J3VX)HN_AII%S+=K'J&KVEC>R-+<Z?;7A2WE9OO97&0&[@$
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MD_:K^X,SK'G.Q<\ 9YX'/>K&@^'=/\-P7<.GK(J7=U)=R[WW?O'QNQZ#@<4
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M+%;'& 44]P. 3G':B[^'VC7FI7UV\M_'%?MON[.*Z9+>=\8W,@ZG@9[''(-
M'GY_X^?@K_U[-_Z(BK2TK1M+UO0_'>J:K:P37XU.^C^U2*#) L0Q&%;JNT $
M8KM_^$*T??X>;9-G0$*6/[SH"H7YO[W"BJU[\/M%OM2O+MI+^*.^;?>6D-TR
M07#8QN=!P20!GL<<YH D^'7_ "3?PW_V#H?_ $ 5TU4])TRVT72+33+,,+:T
MB6&(,<D*HP,GO5R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "L#Q7KT_A^TTZ:"*.0W6I6UFPDSPL
MCA21CN*WZX;XIV\=YH6CVTN?+FUNRC?!P<&3!Y[4 ==9ZII^HO*EC?VMRT1Q
M(()E<H?0X/%)#J^FW-W+:0:A:2W,.3+#',K.F.NY0<C\:X/4K?2_#7Q,L[FV
MM(K.V_L"[:Y6UC$>Y(V1APN.0,XK!LK:6SU#P%=0:#I6CVD]X!;>3<M+=O$\
M$A(E.P Y!!/S'G% 'L,%S!<VZW%O-'+"PRLD;AE(]B.*K3:UI5O:17<^IV45
MM*<1S/.JHY] Q.#7E$VH7'A7P]XK\%V?%X;Y8-(3I^[O"=H7_</F\^U6FT6Z
MLO'2:+I^B:9JMOI>A6\-O%J,YC5%9W#NHV."S%0">.GO0!ZTK*Z!E8,K#((.
M0156?5-/M;R*TN+^UAN9O]5#),JN_P!%)R?PK%\!Z9?:-X4AL+\VX>&:41);
MS&5(XS(Q1 Q SM!V].U>?'2=6\0MXV5="T:\,VI7%L;Z]O#'- $4"/:/+;:%
M&UAR.N: /6[[5-/TP(;^_M;02'"&XF6/<?09/-/GOK2VV>?=01;U9E\R0+N"
MC)(SU ')]J\ZN8)M2U[[)_86E:IJUAI%O'J5YJ=RP@3>&.V-=C9)(8EL#C&:
MYK3+.'6['X26E^HN()%NU=&.5=4B)"GU7Y0,'J.* /8VUO24M_M#ZI9+!Y8E
M\PW"!=A. V<XP3P#4Z7UI)9?;4NH&M-N_P \2 Q[?7=TQ[UP1T+2KCXRFWEL
M+9[:U\/1&&W,0\I#Y\@!"8QD D#CC)KDI(IHM%DTBQL[>:S/CB:W%E-)Y<#(
M 76(X!PF\#C!':@#VFTU"RU"V^TV5W;W,&2/-AD#KQUY!Q7/ZEXQMHM3T*VT
MNXLKZ*_OS:3O%,'\K$;O_">#E>]>?^*]-US2/#OB_4);+3=(MKVRMHI;;3KD
MR?-YVQI"-B[<QL5/KMKH/$^AZ/I7C'P&VGV=M:2"^>)5@0)OC$+=<=<<8)Z;
MCZT >D,RHI9B H&22> *YB]\86XU[P_8Z7<65[;ZE<S032Q2A_+V1,XP5.,Y
M'>J7Q8D>/X<Z@JNR1RR00S,IQB-YD5^?0J2/QK-\0:-I.E_$CP&UA9V]I*TU
MS'L@C"!T6W;&0.N,\>FX^M 'H O;0VKW0NH3;INWRB0;%QUR>@QCFHKC5=.M
M%9KG4+6%5C$I,LRJ A. W)Z9XS7EUHZI\!?$^Y@/FU)>3W,T@ _458CTBPUG
MXKZ-#J-M%=01>%4F$,RAD9A,%!*G@XW'KWP>U '?6]_>/XBO+>2?2SIT<"R1
MB.8FX!.,EUZ!?0U976M*>ZBM4U.S:XF4/%$)U+NI&05&<D8[BO.+=0OQD\9J
MH 4:'$ !T VBL@Z+IUE\$/#FIP6<*Z@DMA.MWL'FAS,@SOZ]#@#L !VH ]BG
MU.PM;J&UN+VVAN)O]5%)*JO)_N@G)_"IH)X;F%9K>6.6)LX>-@RG!P>1[UYY
MH6D:7KOB3QU/K5K!<3+>K;;YE!,,"PH5VD_=ZDY&.>:T/A"0?A9H9#%ALE^8
M]3^]?F@#1D\;:5)=:[86=Q%)?:5!YA1I%VR-L9\+@Y.-OS>E3^'/%%GK.D:3
M)/=V<6I7UG%<M9K,-XWH&.%)W8YKB;+3[*/Q7\4)4L[=9(H83&XB4%-UJQ;!
MQQDGGUK/DT33=/\ A3X*U&VLX8[X76F3?:@@\TL[)NRW4C!QCTP.U 'K5QJF
MGVEW%:7-_:PW,W^JADF57?\ W5)R?PJW7C1TK5?$,WC95T+1KTS:C/;&]OKP
MQRP*B*(]H\MMH488$$<G->L:/'=Q:)81W\BR7B6T:SNC9#2!1N(/<9S0 TZW
MI(F@B.J60EG)$*?:$S(0<':,\\@CCN*EOM3L-,5&O[ZVM%D.U#/*L88^@R>3
M7CFE:#HL_P #-?OY[6W>\'V^7[0R@R1R)(^S:W5<84@#U/K5ZU&L:UXPG>30
M]+U>6+1+$;-3N#&(Q(K,Y4>6^=S @GC[H% 'J\]]:6VSS[J"+>K,OF2!=P49
M)&>H Y/I6:=4N)]=T^.RNM)ETNX@:1C]H)G<\X,8'RLOJ<UYE)X=E6^^&FA:
MXMO.J3Z@K1Q2F6,Q*A9(]Q W *%4@CD#%;6J6\%I\=?"=O;0QPP1Z5<*D<:A
M54?-P . * /0)=8TR"^2QFU&SCO'QMMWG42-GIA2<FGWNIV&F(CW]];6BNVU
M&GE6,,?09/)KRG1](TK5/@UKNJZG:6\FI7 O[BZN9$!E29'DVG<>1MVK@=L5
M<\,1KXA\;V+Z]!'=31>%K.6..X0. TA/FN >Y( )_"@#M?#&OS:])KBRQ1(N
MGZI)91F,GYT548,??YC6K?:G8:9&LFH7UM:(YVJUQ*L88^@)(KB_A;;VUG#X
MLMK, 6T7B*Y2-5Z* D8VCV'3\*(;&SUKXM:]%J]K!=K9Z;:K9Q7$8=51RYD8
M \9) !/MB@#MKF_L[.T^UW5W!!;8!\Z60*G/3YCQ34U.PEL?MT=];/9XS]H6
M53'Z?>SBO-XM*T1O''A70[:2.^T*TLKV:UCDE$\9G615([@E 6 '\-8?B^"'
M3K;XGZ?81I#8BSLK@PQ#:D<S9W$ < L%4F@#V%=8TQY[B!-1LVFM@6GC$ZEH
M@.I89^4?6EAU;3;BQ:^@U"TELUX:X296C'U8'%>>>(/"VBP^.O =I'IUND,I
MNDG54 \]4AW@2?W_ )E!^;.3GUK"\2VL%A8_%FSM(8X+98+*188E"HK-'\Q
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MVFI6$LMO%'>VSR7"&2!5E4F5!U91GYA[BG2WUI!<);S74$<[HSK&\@#,J]2
M>2!W- '.W?P\\/WMY<S21W:P74OGW-E'=R);3R=2SQ@[23@9]>^:N:UX/TK7
M+RVO9C=6MY;1F*.XL;E[>3RSR4)0C*^U:&G:UI6L"0Z9J=E>B(XD^S3K)L/O
MM)Q5UF"J68@*!DD]!0!EZ#X<TOPS;7%MI-N8(9YS.Z;RWSE54GGV456USPAI
M>OWD5[<&[M[V*,PBYLKEX)#&3DH2I&5SS@U;M/$>AW\-S-9ZSI]Q%:@M.\-T
MCB(#NQ!^4<'K7"Z)\4EU*\UN^N[[0[71=.FFBCA-QF[G$8&)%RVTJV>,#D\9
MH ZNX\#Z#/I.GZ=';26L6G$FSDM9GBE@)ZE7!SSDYR3GOFFIX%T)= O]&:":
M6WU%MUY++.[S3MQRTA.XG@=ZM:?XLT6_\.0Z[_:-I#8NB,\DMP@6%F4'8[9P
M&&0"*NIJ^F26$=^FHVC6<I"QW G4QN2< !LX))XH 9=Z+97NJ:;J4\;-<Z:9
M#;,&("[TV-D=^/6J5]X/T;4?[:^TP.W]LI&E[B1AO$8PN/3CTK4LM1L=2BDD
ML+RWNHXY#$[02APKCJI(/!&1Q63KOC'1O#NJZ;I^H7D,,U\[*-\RH(E"LV]\
MD84E=H/J: +UUHEC>:CIE]-&QN-,9VMF#D!2Z%&R._RGO4,GAG29KK5YYK42
MMJ\20WJNQ*R(BE5&.W#'I619>-[--9U^VUF^TZPMK"\CM[:6:81>8&B5SDLV
M"<MV[5T5YJVG:=8B^O=0M;:T.,3S3*B'/3YB<<T 9&E>"=(TF=YT:]N9F@-L
MDEY=R3F*(]43<3M' Z<\"K#^$](D\,V_AYH'_LVW$0CC\PY'EL&7YNO516M;
M75O>VT=S:SQ3P2#<DL3AE8>H(X--O+VTTZU>ZOKJ&VMXQEY9I B+]2>!0!AZ
MWX'T;7;]KZX^V07$L0AG>SNY(/M$8Z))M(W#D]:L'PEHO]I:/?I:>7-H\3PV
M0C8JL:,NTC;T/'K5*Q\6)J?CC^R;&:SNM-.E+?)<P/O+.9FC(# [2,#\ZUK3
MQ!HM_//!9ZO87$UN"TT<-RCM&!U+ 'C\: ([?PYIMMI^IV,43"WU*6::Y4N2
M6:7[Y![9]NE<IXIT&WLYM#6'P[J=W96%L;:.ZTF\:.[@4!0J$!E+H0.3G@C\
M^A\/^,M%\2?;_L-[ QLIY(G'G(250X\P8/W#V-:6FZSI>L)(^EZE9WRQG:[6
MTZR!3Z':3B@#FOASH5QHVG:I//IYTX:A?M<0V;,&:&+:J('()^8A<GD]>N:V
M-;\*Z;KMU;W<[75O>VZE(KNSN'@E5#U7<I&5/H:VZS;3Q#HE_?/8V>L6%S=Q
MYWP0W*/(N.N5!R* *47@O0X=(MM+CM66VM[M+U?WK%WG5MP=V)RQ)Y.3S6A-
MH]E/KEMK#QL;VVA>")]QP$<@L,=#]T5Q<GQ#EO?B.WAS2[W0H[*W6(S7%U<;
MGG9F ,<6U@-XSC!SSVKOYYX;:"2>XE2*&-2[R2,%55'4DG@"@"AK^@:?XETI
M]-U*-W@9E<&-RC(RG*LK#D$&H].\-V&FZ@NH1&XEO!:+9F:>=I&:-6+#)8\G
M+'GK7-3_ !(M+SPQ;:OH;VTS/J4-G+#(X9HT><Q;B%.1D LN>U=;8:YI.JS3
M0Z=JEE>2P'$J6]PLC1_[P!./QH SYO!FB3Z=?6,ELYAO+QK^0B5@ZSD@[T8'
M*D$#&*L:'X;L- -R]J;F:XNBIGN;J=II9-HPH+,2< $X'09JQ!KFD76I2Z=;
MZI92WT6?,MH[A&D3'7*@Y%7Z ,/Q%X3TOQ0;-M1%P'LW9X)+>X>%D)&"05(/
M2J>F?#[P[IFIQ:DMM/=7T/\ JI[ZZDN&C_W=[$ ^XYJCH/Q"BU;QMJGAJZL3
M:/;320VDYDW+=&/!<#@88!E..>#[5L_\)"W_  GG_"-?9AM_LS[?]HW\Y\WR
M]NW'XYS0 S4O!FD:KK!U.X6Y6:2-8YTAN7CCN44DJLJ*0' R>#V.#D53D^'6
M@/IMG8H+Z&.RG>>T>&\D62W+<,J,#E5]NE;2^(=$?5#I::QI[:@#@VHN4,H/
MILSG]*HCQEHW_"7MX:^V0"]6 2\S)@L6*^6!G._C./0B@"#4O .AZI>S7,XO
M4^TJJW<4-Y)''=!1@>:JG#<<<]1UKI418XUC10J* %51@ #L*R-"U&YNK2_F
MU"]TF8074B*^GR%DCC4#"R$GB0<Y[=*MZ;K6E:RLC:7J=G?+$<2&VG638?0[
M2<4 83?#KP\]TTABN_LK3_:6T_[7)]E,N=VXQ9V]><8QGM6O=>'].O/$%AKD
MT3&_L$DC@<.0%#C#9'0\5+8ZYI&J7$UOI^J65W-#_K8[>X21H_\ > .15^@
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MXD+]1S735R'A[QS8WMK-_;.H:;8W7]H7%K!"\ZQF18Y"BD!FR2<=N] $^I>
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M.W,D=]JBHQC&5 B! !QQBO2;/P)H-E=V=Y%#=->6CEX[F2\E>4Y !5F+99<
M?*>..E7+#POH^FZ?J-A;686UU&:6:[C9V82-(,/U)P".PXH \VEMKLQ?#.UT
MRQTV8/I\ESY%XQCADF6"+#':IRP5G(X]?2JGBG1-1L/!?B!+\Z;;I>ZQ92K:
MZ9.S+;L6C#]54J6P&_'->BQ_#_P]%H<6D+!<_9H9A/ QO)3) X&T&-]VY  ,
M8! _.IE\$: NBMI)LW>UDN%NI-\[M)+*I#!V<G<QRHZGMCI0!L6&G66E6JVN
MGVD%K O2.&,(O3'0?05Q'C:TMKCXB> _.MXI-]Q=*V] =P$!(!SU&>:] K'U
M_P ,:5XECMEU*&1FM9/-@EAF>)XVQ@D,A!&10!R?AS1=-O\ QKX\EO+*"X8W
M44/[U P"&W0D#/3/?UP/2N.\-_VK>VWP^@M;;3[PQ:3=2PQ:E(RQ;UD5,C"M
MEE0X'' )KV6PT6PTRXO;BTA*2WKJ]PQD9M[*H0'DG'R@#BLV7P/H$FBV&DK:
MRQ6^GDFT>&XD26 G.=L@;<,Y.>>: *G@/2=0TBVU>.^_LY!-J#SQV^GRL\=O
MN5=R<JN/FRV,?Q53\>1QW7B;P597:J]A+J;M*CC*LZPN8P1W^;M74Z-HMAH%
MA]BTZ Q0[VD8L[.SN>K,S$EB?4FFZYH&F^(]/%EJ<!EB6194*NR/&Z]&5E(*
MD>H- 'G^H-I.@_$_Q)>"W MH_"_VB[BM_D+$2-G&,88J%Y^AJG96MW9^+/ 2
M3Z5HVF6\JW"06]G(TDHB^S,2LC%1N ^7)YYKO+'P-X>T^6XEBLFDENK9K2YD
MGGDE:>-CDARQ.XGID\XXZ5!;?#OPY:_9C';W1EM94E@F>]F:2+:"%56+9"88
MC;T.>10!YJ+<0_##Q1]DM[=6E\2R6TK,-B^2;I 59@,A,'!]B:[;1=$UNW\=
M6VI7EKH&GQBPDMY(-.G<O,NY2A*E%&%((SVW8K;B\#>'X9]5D6R8IJN_[7 T
M[M#(7(+-Y9.T,2!R #4VB>$=(T"ZDNK..X>Y>,1>=<W,D[K&#D(I=CM7/84
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M:W<ABNXJ0P.0P88((/((.:RX/ ^@P:5J.GFVFFBU)0EY)/<R22S # !D9BV
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M-%4&RA)VC&3L7FM>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/='<6\USU)!)Q]!Q69I_@+PSI>H17MIIH26!BT"M-(\<)/4QHS%4_ "NDHH
MI66D6&GWE]=VMN(Y[Z02W+AB?,8#:#R>.!VK('@'PR#J.--PFHR"2YC$\@1V
M#A\A=V%.Y0> .E=)10!3N=*LKS4;'4)X ]U8ES;2;B/++KM;@'!R..:=J6G6
MFKZ;<:??0B:UN$,<L9)&Y3U&1S5JB@#,A\/:5!+IDL5H%?2X6M[,[V_=1E0I
M7KSPJCG/2I[;2K*TU*]U&" )=WWE_:)-Q/F;!M7@G P/2KE% &3KWAK2?$L$
M$.K6IG6"3S8F61XV1L8R&0@C\ZL6&C6&F7-W<6=OY<UV4:=][,7**$7J3T4
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M19VZVL+0W$L3"$=$+(P++[$FNCHH P-0\$^'=3M=.MKC35$6F@BS$,CQ&$$
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M1QH,*B@8  ]*P;CP'X9NK^[O)]+626\W&=6E?RW9EVLVS=M#$'&X#/O71T4
M9>F>'=*T>X-Q8VQCF,"6QD:5W8QH254EB>FX\]:R]6M[GP_H]Q:^&?#WVV:^
MEED=3.JQI))RSR;VSM)))"Y],"NHHH P?!GAJ+PCX2T_18F5VMX_WLBC >0G
M+'Z9)Q[8K1U/2+#6$MDO[<3+;7"7,0+$;94.5;@CIZ=*NT4 9VI:%INKW5A<
MW]J)IK";S[9BS#RW]>#S^.:XCQ'HEVWBF^OE\#Q:K)*B?9;N"\$2NRC@7,;.
M VT]#AN,5Z110!R_A;P=;:-H'AVWO42?4-'MV2.96;".ZXDQZ@].1^5:TF@:
M5+<:E/)9H\FIPK!>%B2)HU# *1G'1FZ>M:5% &;H>@Z=X;TX6&EPO#;!MP1Y
MGDP< <%R2!@#CI6E110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
;!1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>employementagreement_mil004.jpg
<TEXT>
begin 644 employementagreement_mil004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)\2ZT?#WA
MZ[U46WVDVX4B+?LW$L%ZX..OI6M7/>.-/O-5\&ZC96$!N+J14\N(,JEB'4XR
MQ ' /4T 1P>)=1M]6LK#7-%6P%\[16UQ#=B>-I I;8WRJ5)"L1P0<5IVGB'1
MK[4)-/M-4LY[R/.Z&.9688X/ /8]?2N>O+?6_%6IZ4MSHT^CV-A<&[>6XGB>
M21PC*BH(V8 9?))(Z8[UDV?A[6KG2?#>@OI;Z<^C9$NI>;&4?$+Q9BVL7.\N
M&.X+CG.30!V4?BKP_,UTL>M6#FU0O/BX4^6H."3ST!X)[&EUSQ#8Z#IU]=7#
MB1[2V-R]NC#S"F< X/0$\9/%<5/H>M:EX*7PZ/#<-K<6FD268NYY(R&DV*H$
M)4DA7*Y)8+QCOTORP>(]3UK4-5@T-;,MI2VT,.HR1N)7$I9D8(S84J2 ?Q([
M$ V+/7]8^T+'J>A1V\4L#S0W-M>>?$-H!VR-L782#P>0<'FK+>*]&M;:R?4M
M4L+.:Z@6=8WNE(VD=0W&5SP&Z&N/L?#MW_:8ET;PS=>';;[/.M[ ]U'Y-RS1
MD(J1H[*"&(._"\ CO65=)<^'/#NOVES8PW<DV@VT=P#<Q VC);E"L@9LE<@E
M2@;))'O0!Z3<^*O#]G.D%SK5A#*^W:CW"@G< 5[]"".?<4>)M;?P]H4FH1VH
MNI!+#"D)D\L,TDBQC+8.,%L].U<>?#&I3^&_%D:V(,^IZ5!!:AF4&1UMMNWD
M_+ASWQ6]XYTF[U?P3+86UFUY.9;9VMU=5,BI-&S@%B!]U6ZD4 7;35=7C,\V
MN:79:;8PQ-(]RNH>:%QR<@QK@8R<Y[5-;^*- NA<&#6;&06[*LQ6=2$+-M7/
M/<\#WKCI-#:70->L=,\$7FEW-YID\"2RW4#*[,A"I\LK8R<<XQZFM:_\*-J6
MKK#-;B/3I-!DT^1T*C8Y="H SG@ D'H,4 =)=ZOIMAY_VN_MH/(C6:7S90OE
MH20&.>@)! ]2*SYO%5@8],FT^6&^AOKX67F0R@B-BK,2>O(V]..M<;+X5\27
M_A\:CJ,;#76U&WN9X+::/<T4"[%5&;*9SNE ;C+8..UBU\-:K->PWYM+^-I-
M8AN)&OKF%IO+2!T\QECPH.6 P"Q( SB@#M;;Q#HUYJ,FG6VJV<UY'NW0),I<
M;?O<9[=_3O3=/\2:)JUQ]GT[5K*ZFV>8$AF5R5XY&#R.1^=<;I>B:PMAX7T:
M;2&M?[#F$D^H&6,QS!8W3,>&+DR%LG<!C)SGBLKPWI6I^(_!?A*UM]-?3(K/
M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M\0RV=R@N$REK$AEE+$D! %')X^@[G'-6M#N-9N_M=SJMHEE$\@^R6I96EC0
M9,C*2NXG)P"<#')JOX0TZ[TOP;86%Y%Y5U%$5=-P.#DGJ#CO0!>T#5AKOA[3
MM66$PB]MTG$1;=LW*#C/?K61%XLN+K53#::29[!;LVC7"W \TLK;'=8L<QJV
M06W \$X(%1:'X<U)/!?AW3Y=4OM)NK&RCBGCM#"VY@J@ABR.#@@_=]3UKG4\
M'75M=264&A 7AUO^T(M<#QXCA,WFL,[O,W;2T>T+M.<YP30!V%QXJMHO&-GX
M<B@>6::-WEF!PD)"[@I]6(YQV&#W%%GXJ@OO%L^@P6MQ^XMWE:YD0HC,KA"J
M9'S8)Y8<<8YYQSMOX,UW3O$VB7,>L"[MH;BXGNI6M45R9 ,[CNRQ;[H('R@#
ML!72-I]T?'L6I"+_ $-=,>W,FX?ZPRJP&,YZ \]* ,W1O$_B'7+."_M?#EH+
M*9V"N^ID/M#%2=OE>QXS4U]XLO+"XDGFT25-)BO$LVNI)MLA9G5 ZQ%?F3<P
M&=V2.0"*Y/PWX<?2+6U6]\ 7T^H03,YNX[NWVD^865@#,#P,=NU;$XU[4/%Q
MGU7PU?SZ=9W/_$OCAN+;R1C@7$@,H9FZD#'RCL6Y !H+XU<ZJ(O[,QIQU(Z6
M+G[0/,\\9&?*Q]S(QG=G'.,<TZU\9O<7=K*VF%-(O+Q[*WO?/!9I%+*"8\<(
MS(0#DGID#-<ZGA?41K*R_P!C2#6AJYNFU[SDV-;>9G;C=O\ ]5^ZV;<=\]ZN
M66AZPMMI/AZ339$MM.U0W;:@98S')"DC21A0&W[R2H(*@##')XR :NC>)M>U
MN)+NU\/6HL'N)(O-?4B'VI(T;-L\K_9)QG\:?IWBN\U37)[.UTN VL-S);M.
MU\HD(C8JS"+;G&X$=>U5/!W@FSTVQAN]0TU8]66ZN)2_FDD;IG*'@X^Z5J@W
MA^[N-2L88O"UOIUU;:M]LEU6 QB-X@Y9L$-YA:13M*D8Y/. * .DLO%5O?\
MBRXT*"UN/]'MVE:YD0HC,KA"J9'S8)Y8<9&!GG&<GC#5+NQ?6--\./>:*K-M
ME6YQ<3(IP7CAVG<."0"P)'0<BM)]-N6\=KJ/E?Z'_9;6YDW#[YE#8QG/0=>E
M8&E_\)1X=\-Q^&K+07N+FU0V]GJ)GB%L8P<))("V\$#&5"G)'!YH W=>\66V
MB7NDV?D27%QJ-S%$$7Y?*1W"^8^1P 6 QU)^AQT%>>:]X+\03W@O;/65FFGU
M*UGE#6B9B2-AC!+?=3EMO<D]R:]"&0H!.3CDT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4KK2-,OKJ&ZN].M+BXA_U4LT"NZ=_E)&1^%7:* "BB
MB@ HHHH **** "F0PQ6T"001)%%&H5(T4*J@=  .@I]% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0I:VL2Q1@G)P!CD]S5VBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGJOM7@-E=7%E^SIXFN+6>6"=-3?;)$Y5ES/&.".1Q7<2VQ\3^.K#1=0N;O\
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MN)I8;97M_P#6*))%1BG^U@G'OBN6TP7=AJEXNE:1XBT_2)=*N/M(U.0LJSJ
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MI]1\2ZYI'@C2O&DEZ+B&46\U[8>4@C6*8J,1D#?N7>O)8@X/'H >C45P!O\
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M77!JFFZA_8\\[2%44"5@(]I#'?\ +QUZ"MR&TL_[3OKZ\O?$UU)J5BUE?AM
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MP5FW-&LOEY"$D\8S@XS7IEQ?7L6LV=G%I<DUI,KF:\$JA8"!D J>3D\<5H4
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MG^PKK=A2#G'EX[5IZCJ6EZCXBT36&M_$"/I1G*1C0[HB3S$V')\OC'6NYHH
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M12RK,& 5/+4D@COG% '')8:,NCQ6;GQ++<G58]6N;N30KG?<3*P;D",!1\H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[(<,N>X]P>: /-O#<9TGQWX?ALM&U?2K:_M+A9SJ%TLAO"BHRNR"1BK@YR2
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M[8W^JVKW$D3E68F*0$@Y^4D<9&,=J /<:*\CU:./P+XD\21^'HS:0GPO)?\
MDJQ*"X20J),$GG!Y]<4[PWI&HV6L^'KS2_"NIZ?SMU.]N+V)UNXFC.7<"0EF
MW[6!QZT >M45QWQ5=H_A?K[HQ5A;Y# X(^9:PM6T&S\)ZYX0U72VE6^O-22R
MO9C*S&\22-RS29."<J&'I0!Z=17CVG:#9>)/AYK'BS4C*VNR&]GBO/.97M#$
M[B-4(/RA=@X^N:4V_P#PF?BWP<FKO*T%]X:^T7D".468DHV#M(.-Q!_#'2@#
MU./5;.769M)27-[! EQ)'M/RHQ8*<].JGBF:1>:A>VDDFI:6=.F65D6(SK+N
M0='RO SZ=JX#0/#>D6_QGUTQ62J;2RM98/F8[&;>">O<>M<MH%[=M\,Q9+=3
M1+J?BL:?/,CD.L+R#< W49 Q^- 'O%%>=/H]CX/^(WAFWT*$V=KJL5W#=VZ.
MQ1_+C#H^"?O \9Z_-7%1:':P_ NV\5;IVUVV5)K>],S;XL3A0J\X"[>".^2>
MM 'O5%(QVJ3C.!G%>+VNBVNI_""Z\;7+R_\ "2/;3Z@NHB9A)%(C,51>>% 4
M+MZ4 >@>)O&$FAZWI6B6&DR:GJ>I"1HHA,L2JJ#+%F;^7M73!V$ DD38VW<R
MYS@XY&:\;U?1=+USXI^"KB^L$9M5TZ:XNUW,-[B$$=^,>U>Q.BQ6C1H,(L>U
M1Z "@#B-.^)O]K:?#?V'@[Q-<6LPW1RI;PD,,XX_>^U=CIEZ^HZ=#=O97-DT
M@)-O=*%D3DCY@"1VSU[UY=\-5\='X=Z*=+F\.+9>2?*%U%.9,;V^\58#KGI7
M0>.H[O3O#5EXGFN;>'7='*R#R=PBN2V%>  Y)#YP.I!Q[T =Y17CKZA=O\,_
M$/C-+F0ZWJDBV[)$V&L4\U8A N<;64$DGCYCGT-3VMIJ?AO4)-2T7PE?Z+8P
MZ;=&\%Q=12I,ZIOB<JLC$ON4@G&2&YH ];HKSKPEX+TZ31/#?B*.[N8=9DCA
MO+J]$Q9KLNFYXWR<%3NZ=L#%4+":3_A3/C&0R-O5]5PQ;D8:3% 'H\NJV<.L
M6^E/+B]N(7GCCVGE$*ACGH.6'^119Z@UW?7UL;&[@%JZH)ID 2?*@YC.>0,X
M/3FO,+;0]-OOBAX8EN;59)'\/+<,Q9N9$,85NO85T6EW&N:KJ?C;2EUF9)K.
M>..PG\J/]SNA#@8VX(W'G(SCO0!W5%<)X9UZ_P#$.A>'X?ML\6IAY!JAVIN!
MA^652-N!ER@  !PW'2J0U/Q3XET>YU30))8KN.^ECMHW>(6^R.4H5D4@L=RJ
M23U!(Q@4 =A=^)+.R\2V.A30W8N+U&>&80DPY 8["_0-A6./0?2MBJOV6*XF
MMKN=,S1+E!O)5&(P2!T)P2,^A/J:\O\ [.@T3Q0;CQ-I>HQ74VJ^9:^(K6?>
MC*\O[N*09S&N"(RI7;[CK0!ZU7+>)_'^C^$]5L-/U!;EY+O#,\*!EMXRZH))
M"2-J[F R,]ZZAW5$9W8*JC)). !7AMCJUCXJ?Q;J>J:-KMU#K2FRL9;73)9D
MCM4R$96 QDO\Q'J!0![G17C,_B2ZUK]GW43<M+!J^F^7978<%9$D25 "0>02
MNTG/<FMZ\T"Q\,?$3PA+I8EBFOY+F"^D:5F-T! 7!DR>3N7.: /2**\.C\/6
M5Y\)M=UZY,\FIVDU]+9W!F8-;&.9RH3!XY!)]<_2NTT*YEN?B?</*Y)?P[:2
M$9XW&1\G% '>UF>(=7&@>'-1U=H3.+*W><Q!MN_:,XSSBO,XI[2;0-7LKY=1
MNS=>+;J&&RLI K71#%O*8L0!'@$MR.!U[54VR6?ACXF:4NFR:5:6]A'+%I[3
MK*(2\+[MI4D ':#@&@#UK0M4&M^'].U98C"+VVCN!&6W;-ZAL9[XS6A7.^ ?
M^2=^&_\ L&6W_HM:Z*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "LCQ-H*>)M!NM'FNIK>WNEV2M"
M%W%?0;@0/RK7K%\6>)+?PEX=GUFYMYKB*%D4QPXW,7<*,9('4T 53X6NWTN/
M37\1Z@;146)E6*%6>,  J6"9&0,$C!YJ6_\ "EOJD6L17UQ)<1ZG +?:Z)B"
M, X5./4[N<G.#V%8]Q\1CI2I-KWA?6M*L6=8VO)5BDBB+' +[') R>N*[9G5
M1EF 'J30!R%]X AU#0],L9M9U'[=I3;K+4U91<1\8P2!A@1P<CGO4MYX#L]4
M\.RZ9JFHW]Y<R2)-_:#N%G21/N,FT +MYP ,<GN2:ZIF"C+$ >IH+!5+$@ =
MS0!SMIX27^R;ZRU?5;W5GO;=K66>X*J5B8$%4"@!>N2>I(&2<#%"V\ &.?0Y
M[GQ#J5S+HS'[,S")?E*;-I 3!^7@D\GU%=D"",@Y!JCK&K6FA:/=:I?R%+6U
MC,DA R<#L!W)Z#ZT 9%OX/CM+C7'MM3O(XM7=Y9(/D*1R.H5G7Y<DD <$D#T
MJYI/ANUTSPI%X=DD>[LH[<VO[X#<T>-N#@ =.*QH_'=Q#=60U?PQJFEV=],L
M$%U.T3J';[HD5&+)D\<CJ:[$LH8*6 )Z GK0!B67A33+/P<GA=HVGT\6QMY!
M(?FD!^\21W))/'>J7ASP8V@20B;7]4U*WM05LX+MU*P#&.H +$ D D\ \"I+
MWQ9]D^(&F^%OL6_[;:27/VGS<;-N?EVXYSCKFNDW+NV[ANQG&>: *FJ6']IZ
M9/9_:)K8R@ 30D!XR"""N01D$>E4;'P^MOKKZU=7)NM0-J+02>6J 1!MV,#J
M2>2?;@#G.R6"XR0,G'-+0!B>*/"]GXKTR.TNI9[>6"9;BVNK9]LL$J]&4_B:
MJ0>$IDTR2&?Q!J5Q?O)$_P!O?9O7RW#*JJ%VA<@Y&.<G)Z8Z:D9E52S$ #N3
M0!S-SX)LM0M]<6_GDEN-:@2WN9HU$>$0$+M'/(W$Y.<_0 5$W@@_VAIFHIK^
MIIJ%E UL]P!$3/$Q!*E2FT<J,$ ?B>:ZS( SGBD5@RAE((/0B@#C$^'%E'X:
MDT1-4U 1?;A?6\I9"]O()/,&W*X/S$YW9)S]*FU7P(M]JMMJ]EKFI:=JT4'V
M>6[@*$W,><XD4KM)R21@#'IP,=:&!) ()'4>E"LK9VL#@X.#T- ')^(M#-WX
M6_X12R>=C>X2XN9#N9(BVZ61V[LWS #N6Z8!QU4,,=O!'#$H6.-0B*.P P!3
M@RDD!@2.HSTK+\2:T/#_ (<U+51$)VLK9Y_)W[2^T9QG!Q]<4 9R^#U?^SXK
MW49[RVT^Z%W;)*BAED&=H+ <JN[@<'@9)JM_P@4)T37M*;5;LPZW<27%RVR/
M<K2 !@OR\# '7-=39S_:K*"XV[?-C5]N<XR,XJO=ZO9V6IZ?IT\A%SJ#2+;J
M!G=L0NV?3@4 8G_"%*NLV>J0ZQ?P7$-BMA-Y6P"XB4Y4'*G:<D\K@^F*IP?#
MBVM_#6E:''J]_P#9],O$O('81EMR,61?NXV@D^Y]:VM#\1#6+W6K=H! --OC
M9AC)GS?D5MW08^]C'/2MOH,F@##7PVH\8_\ "2&^G-Q]C%D8=J^68]V_TSG=
MWS5GQ!H=KXDT&[T>]:1;>Z0*[1-AA@@@@D'N!6B9$"!BZA3T.>*=0!B6OAXC
M4;34-3OY=0NK-&2V9XU18]PPS;5'+D<9],X R<X^F_#NWTF^D%GK6IQZ-),9
MSI =?(#$Y(!QN"9YV@X/?(XKLZ0,"2 02.H]* &S11SPO#*@>.12KJPX8'@@
MURVD^!QI5U99U[5;G3]/)-E8RN@CBX*@%E4,X4$@!B<5HZ9XA&H>(->TMH!"
M-*EAC\TR9\WS(P^<8XQG'4UMT <[!X/LH/#&JZ"MQ<&WU)KEI9"5WKYY8MMX
MQQN.,BJ]UX(ADU/1M1M-4O;*ZTRV%F'BV'SH>,JX92/X>HQU^E;FJ:O9Z-!!
M+>R%%GN(K6/ R3)(P51^9JE!XA$OC"_T%K<(MI9Q77V@R?>WLPQC'&-O7/>@
M"G:^!=-MD\31F:XDC\0N[72LP&S<I4A,#C@GKFJ3?#J"XT+1]*OM:U"[CTF^
MBO+:1Q&& B7:D9PHRN/Q]Z[/(QG(QUS0&# %2"#T(H YC5?!GVW5;O4+#6]1
MTI[Y%CO5M#'B<*,!OF4E6V\;EQP!Z4FI>"8;FZTZ]TW5+[2KZPMOL:7$!61I
M(./D<2!@W(SD\YYKH-1O4TW3+N_D5FCMH7F95ZD*I) _*N,L_B1<W>F0:HO@
MOQ VGS1B5)X4BE)0C(;:'W8Q[4 ;WAGPI:>%EU 6MS=7!OKG[3,]RX9C(5 )
MR .N,GW)J/Q'X337]0TO48M2N].O]-:0P3VVPG;(H5P0ZD'( [5I:+K>G>(=
M*AU/2[E;BUF!VN 001P00>00>QJX\\4=N\[2*(D4LS9X '6@#E;[P(L][J$V
MGZ[J>EP:FVZ^M[7R]LK8VEE+*2C$#!*D9KI-.T^UTG3;;3[*(16MM&L42#^%
M0,"FZ9J=MJ^DVNIVC$VMU"LT;,-IVL,@D=N*M@A@"""#T(H R=-\/6VF:_K.
MKQ2RM-JK1-,CD;4\M-@V\9Z=<YK'C\!10712WUO4X=)-U]K.EQNBQ>9NWD!M
MN\(6YVAL5U](&5B0K D<$ ]* .3U;P)'J&IWU[9:UJ6E_P!I(J7\5H4VW  V
M@_,I*MMXW+CBG7/@6W26TFT34KS19K:T6QW6H1A) OW58.K D<X;KR::/&-W
M=>/;KPSINC?:$L%B>^NY+H1B(2#(VKM)<XYZCI76T <M=>!-/N[?P]"]W>D:
M'=+=0N\@=Y7!S^\)!SD\G&/PI_BGP-IGBV\TZYOY)T-D^2L3 "=-RL8WR#E<
MHIK&U'XE7FDM:+?>"];A-W<+:V^7@/F2MG:HP_?!KI]!UB\U=)VO-"OM*,9
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M<FD"Z%V-,=D,>\/Y@&_;OV!N=NZNO!R,CI10!GZYI0US0[W2VN9K9+N(PO+
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M/.*6@"EH^F1:+HECI4#N\-G;I;HSXW,J*%!.._%7:** "BBB@ HHHH ****
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M\HNK6WDMD4$;"KE221C.?E'>LJ^\!:5J&DZ_ILL]V(=<N!<7)5U#*PV<)\O
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M=TC1G=E5%&69C@ >IH QM#\,6VB75S>&]OM0OKA5CDNKZ4.^Q<E4&   "Q/
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MGU+[0/M*AOO*6V[2I '!4]*TM \.67AV"X6V>XGGN9?.N;JYD\R69\8RS>P
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MN'?;LV.BX],?-U]J ':-X1TO0M;U;5[-9?M6J.'GWOE5.68A!C@$L2?>H?\
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MO+9)VC4Y"EAG -:U !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4:[TZ&WTV\&G7,$<%L5B%TFS)W+U<K@'/49YKF[]E'P.\(@D9+Z6![GS(_\
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MMVTK*K(4*\\8PQ^IZYQ0!YMH^D:[KWA)+^S\,Z>=5GOGNUUN2_"SB59SVV9
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MF,_F/P-7/"JIIOBN+3]4\,66D:PU@ZP76G29M[J)&3<-H (()4@,"0"<'GD
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M]0T:QO9%57N+>.5E7H"R@X'YUX?9_P#)#_B%_P!ABZ_]"BKV?PS_ ,BIH_\
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M-[\-N"A\*,'D\8Q5'6%F@^%_Q)M98;.W\G4H_P!Q9.6AC8B L$) [YSP.<T
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MWL^JV,=HDAB>=[A BN.JELXS[=:E;5=.33?[2:_M5L-N_P"U&9?*V^N[.,4
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MG]E_VG9?VAC/V7SU\WIG[F<]/:B]US2--NHK6_U2RM;B;_513W"HS]N 3DT
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M[_[=,][;731>1+)97;P&:/.=C[2-PY/YULV5E;:;8P65G"L-M!&(XHTZ*H&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6E<E6+;MP<G<#GD$'BGZ3X1TC1I+F:WBGEN;J/RIKBZN9)Y60=%WN20/88H
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MNYMH2ZZ1;R!B@R&\QOF^OO7&1:1I\7[-UQ?+:0_;"KS_ &@H/,#K<$*0W48
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M[5V>D:9IM_\ &#Q@][;P7$T=K9+&DR!@%9&W$ _1174?\(AH?_"+CPW]C/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"TVEPPI<17&G-8/&H#&1G3.".I(+9]>:MZ;;0'X_:T##'@:-"P&T<-O'/UH
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M0AP2.0NTMF@#UO2_$.BZXTRZ5JME?-"<2"WG60I]<&M%F5$9W8*JC)). !7
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MVGV^LW.KQ6X6_NHTBFFW'YE7[HQG QGL*EOM1LM,L7O;ZZAMK5,;II7"J,D
M<GU) _&K- &+K?A/1O$,T,^HVKO/"I1)H9Y(7VGJI9&!*GT/%21^&=&B?2FB
ML(XSI(86(0E1#N7:V #@Y'KFFR^*_#\&M+HTNLV*:DQ"BV:90^X]!CU/IUHU
M+Q9X?T9IEU+6;*U>%D6199@&4L,J".O(!/T% %L:38C6CK @']H&W%J9MQ_U
M0;=MQG'4YSC-5U\-Z0NEZCIHLP+/49)9+N/>W[QI?OG.<C/MCVJ%O&'AM;ZT
MLCKNG_:;M5:WC^T*3(&^Z1SW[>O:I-8\4:#X?DBCU?5[.R>491)I0K,/7'7'
MO0 [_A&](.J:=J7V,?;-.A,%K)O;]VA&",9P>/7-.B\/:5#I=]ID=H%L[]IF
MN8M[?O#+GS.<Y&<GIT[5/_:VG?Z$1?6Y%\<6I$@(GXW?)_>X!/':DGU?3K:6
MYBGOH(Y+6#[3.K2 &*+GYV]%^4\^QH R[SP/X=OY[2:XT[<]K MLFV:10T2_
M=1P& =1Z-FHY_ /AFXTW^SY-./V879O$1;B13',>K(0V4ZGA2!STJY;^+?#U
MWJPTJVUJQEOR,BW2=2YXSP/7'.*HZ'X\T3Q!X@U+1[*\MWGLW"IMF!,XVAF9
M1Z*3M/N* -*T\.:38ZPVK6]KMOWMEM6F,C,3$N,+@G'8<]:SXOA_X8AU);Z/
M3 )$F^T)%YTAA27.=XBW; V><A:Z.21(HVDD=4C0%F9C@*!U)-9>C^)]"\02
M31Z1JUG>O#_K%@E#%1ZX';WH M6^E65IJ=[J,$ 2[OO+%Q)N)W[ 0O!.!@$]
M*-+TJRT6P6QT^ 06RN[A Q;!9BS'))/))-4[?Q7X?N]9?1[?6;&744)!MDG4
MOD=1CU'<=J+GQ7X?L]832+G6;&+47("VSSJ'R>@QG@GL.] "ZWX8TCQ"8'U*
MU9Y;<DPS13/#)'GJ Z$, >XSBFQ>%-"A\/2:"FFP_P!F2Y\R!LL').2Q).2V
M>=Q.<CK3[SQ/H5A=M:7>K6<-RLL<)B>4!P\@RBXZY(Y%6DU;3I+.YO$O8&MK
M5G6>4.-L93[X8]L8.?2@#.TGP=H.B1W:65@/]+3R[AIY'G:1,8VEI"3MP3QT
MJ/1O _AWP_??;--T_P NX"&-'>:27RD/54#L0@]EQ5O4O%&A:/9VUWJ.K6=M
M;W(!@DEE $@QG*^HP0<^]27WB'1]-TJ/5+W4[2"PDQY=P\HV/GD;3WR/2@#&
M3X:^$D$JC21Y<C[_ "C<2E$;<&RB[L)R/X0/3I6[;Z186NKWFJPVX6]O$C2>
M7<3O" A1C.!C)Z"L+P_XJ&O>+M8LK6XM;G2[:UMIK:: [MQDW[LL#@_<'TYK
MIKFY@L[:2YNIHX8(E+R2R,%5%'4DGH* ,&+P)X;AU8:E'IV)UF-PJ>?(8EES
MG>(MVP-GG('7FK&DZ FF>(-=U1=@.IR1,57/\";<G/<DGIQ@#WJ33?%.@ZO9
M7-YI^KV=S;VH+3R1R@B( $Y;T& 3GVID'B_PY=:K'I<&MV$M](H9($G4LP(R
M,#/7'./2@!_BC08?$_AF_P!&G<HMU'M60=4<'*M^# '\*H6.DMXCT32CXLTL
M#4].G68#S?E\^/@2J5/*GJ ?7!%6M5\6Z'I=VVG3ZO90ZF8RT=M), Y)'RC&
M>_8=Z/!NKW.O>#=(U6\$8N;NV2601C"[B.PH MQZ%IL7B";74M0-3F@%N\^]
MLF,$$+C..H';-8&K>'Y-&\(7.B>#]/$,NH2M&7\PE;?S.))F+')P,X SSCBM
MS6?$>B^'DB?6-4M;$2DB/SY I?'7 [XI]QKVD6MM;7-QJ=I'!<J7@E:90LBA
M=Q*G."-H)^E #]&TJWT/1;+2K0$6]I"L*9ZD*,9/N>M4=7\(:'KNH17^HV7F
MW,<?E;A*Z!X\YV.%(#KGG#9'-5_^$@BOM9T,Z;KFEFPODF80-S+=!5.#$<]%
M(R>#Q5T>*M .M_V*-9L?[3SM^R^>OF;O3&>OMUH BL_!^@Z?=07-K8>7);W$
MMS#^]<K')("KE5)P 03P!CG.*EO;2'2YK[7;'2I;S4YHHXGCAD >95)V@;V"
MC&YCV_&K5M)J3:I?)<P6Z6"B/[)(DA,CY!W[QC P<8P3FKM '(>!O#MSICZQ
MK6IVL-KJNM77VB:")@PA0<(A8<,1R21U+&NO(R,&BB@#G=.\"^'-*U)+^ST[
MRYXRQB!FD:.$M]XQH6*IG)^Z!UJY;^&=&M=#N-&BL4_L^X\SSHG9G\PN26+,
M222<]2<TS7=<_LJ;3+.)%>\U.Y^S0;\[5(5G9FQU "GCN2!QU$^B3ZM/:2C6
M;."VN8YF13!+O25!]V0=US_=/(Q0!R5QX%MKSQW$T]A*=&M]$CM;>87+J\<J
MRL0%<-Y@.P]<]#C-=)'X/T"+PZ^@+IL?]F.2S0EF)9LYW%B=Q;/.[.?>MNB@
M#GK?P1X>MM+O].2P+V^H*%NS+/))),!P TC,6P.W/%:=WH]A?26,ES;AVL)1
M-;'<1Y;A2N>#SP2.<U>HH YRW\">&[755U&'3MLZ2F=$,\AB20Y)=8BVQ6Y/
M(%+=>!?#=[JSZE<::&N))%ED432"*1UQAGC#;&/ Y(-0:WXIO]+\7:/H%MI=
MM<-JB3-%-)>-&%\I0S!@(V]>,5JV5YJ[ZD;;4-,MX(3$9$GM[IIAN! *L#&N
M#SD=<X/I0!0U'P)X<U74I+^\T\O-,5,RK/(D<Q7@&2-6"OT'W@>E=&  ,#@4
M44 <U?> ?#.I:A->W6F[Y9W$DZ+/(L4S#H7C#!'/'<&M'5_#FD:\MFNIV27
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M"HHX  J:BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVD!(FE#X$6!D[L_=XYYIFD>*]!UX3G2]4M[KR%W2A&Y5>S8/./?I7E?CD/\
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MU[QE:O\ #W6/$'AR_M[IK2!RDB_,%=>S#L?8UQ'AO[,^L?"HW94L-$G\G?\
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MI]C!#NN+B: S-)/YFPPCY@ ??ZUO3>,+;1--\2:GJ.MV=]#I]PZ1P0Q^6T+
M$K QYRY(QFLRV_Y.'O/^Q<7_ -'BN6M?^1:^,7_7Y=?^@M0!ZWX>UZR\2:-!
MJ=A*DD4BC<$;.Q\ E<^HSBM2LOPV0?"VD$<@V4/3_<%:E &?J>NZ5HOE?VG?
MP6GFARAF?:&"#<WY"LJY\7:=?^$-:U;0-0M[M[&UF?*\[)%0L RGD=._6L;Q
MNMHWQ \ B\V>5]LN=N_IO\KY/QW;<>^*R=?"#Q?X^^S >6?"X^U;?^>V)=N[
MWV?I0!TOA_QE;#X>Z/X@\1WUO;/=PJ7<_*&<YX51R3QT%;,7B;1)])AU2+4[
M9K&:188YP_RERVT+['/&#7G'ANZN6\,?#S3=-MK#^TIK*:>&\OHVD6W5% ;:
MJE2S$.!U'&:R)E^V^$_$$%W/;7@?QE DSP1E(I,F -A26P"<]SF@#UO2/%N@
M:]=S6NEZM;74\*[W2-^0N<;AZCW'%-TOQ?X>UN_>QTW6+2ZND!8QQODD X)7
M^\!ZC-<WXFBM5^)6@^>RP0/I&H1S2 [=L8$??L!DGVJOH7V_P_JGAC2-272M
M6TV1'@T?4[=-D\06$L-R\@@QJ1N4_7K0!Z/145O<P7<7FVT\<T>2N^-PPR#@
MC(]#4M %/4=6T_2(HI=1O(;6.63RT>5MH+8)QGZ*3^%4M*\6:!KD=U)IFJVU
MRMJ-T^QN8QC.2#SC@\]*YKXI"T:+PF+[9]F/B*U\S?\ =QMDZ^WK5?Q$$'Q1
MS;@>:?#5U]JV_P!S>NS/X[L?C0!UEEXO\/:E--%9ZQ:3/#;BZEVR<)$0"'8]
M ,$'GL:32/&'AW7KMK72]7MKFX5=_EHV&*_W@#U'N,BO,GM8K7]FJR\F,)%)
M#;2710<M&TR&0G\,Y]JZWQB(/^$H\!_8A']J_M%O*\O'_'OY+>9C'\.-OMTH
M W+CQOX8M=0N;"?7+*.YME9IHS)]S:"6!/3( )(Z\5)J7B_P]HZYU#5[6V_<
M+<CS&P3&S;0P'<$\5YA%_9Y_9QU<W_E?:";LS[\;OM7GOMS_ +6=OX8K;TRU
M@N?B]HCS1JY@\)))'N&=K><%R/?#,/QH [*]\:>&]-U&.PO-9M(+J0*1&[]-
MWW=QZ+GMG%2ZKXJT+1)9(M3U2WMI4C61DD;YMK$@$#J<E6Z>AKS7Q9>7E]X9
M\>75F-'T[2XI9K2X$MNTEQ=RHBKG=O 4D[0O!Q@&MW1HHY_B['<2*'E3PO;E
M7/)&Z5\D?6@#HI/'WA.)+-WU^Q"7BAH&\W(8$E<D_P (R".<<@^E6=8\6^']
M N8K;5=6M;2:1=ZI(^#MSC<?09[GBO,[>RM8O@WX]"01J&OM1)PO]USM_+ Q
M6[<V>HPSW>L:#>:7>ROIEO'JNEW^?F18V*D./N%E9N&!!ZT >D(ZR(KHP96&
M0P.01ZTM9OAV\MM1\-:7>V=O]FM9[2*2&#&/+0H"%X]!Q6E0!E:UXFT7PZ(O
M[6U&"U,V?+1SEGQUPHY('K2_\))HITNVU,:G;&QN9%BAN!("CNQP%!]<\5S=
MAM_X73K'VK'G?V1;_8]W7RM[^9M_X%C/X5P.K00W/A[7+=%#:;+XVB2-5^Z0
M602;?;=NZ=\T >SZ1K6FZ_9&\TJ\BN[8.T?FQ'*[AU&:OTV.-(D5(T5$48"J
M, "G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5R_CC0[K7K#2K>V@2=8=6M;B='( \I'R_7KQV[U
MU%4]4U6QT73Y+_4KJ.VM8\;I)#P,G 'N2>,"@"CI/A+0-"EN)=-TNWMY+A=D
MK %BR_W><X7V'%58/ 'A2V@:"'0[5(S*LN #D,I)7!SD 9. ..3ZU8M/&&@7
MND7FJV^I1M9V6?M+E64PX&?F4@,..>E1Q^./#4R7#QZO R6T\=O*X#;5D<D*
MN<8))!''3OB@#5L=,LM,%P+*V2#[3.UQ-L_CD;[S'W.!62G@3PO':7]HFBVR
MVVH,KW40!VR%6W#C/&#SQBF_\)[X7_LI=3&KQ-9O,;>-U1R9) ,D*H&6XYR
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M'[$<@@CD$>HK/B\:>')M;_L>/58&OO,,(CPV#(.J!L;2P],YKG=(^(^FVO\
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MUNIWY"QQ, 0Q8C'0CCKSTK$?Q[::IXL\,V.A:C'-:WDLZW:&(JQ586=#A@"
M2.".#@T /U7P1;7OB?04&F0/H-C87%L\1(Q&28S& ,Y_A.".F*Z"U\*:%9Z)
M/HUOID":?<;C-" 2)2>I8]23ZDU OC;PV^M_V.NK0F^\TP;,-M,@_@WXV[O]
MG.:;J7CKPSI$T\-]JT44L#F.6,(S,A"ACD*"< ,ISTY'- %N^\,Z+J6DV^EW
MFG0365L%$$3#_5;1A=I'*D#C(-0_V='X5T&2+PSH44SA]PM8Y5A\QB>69VZG
MW.3Q4M_XHT/3-)M]4N]2@2RN=OD2J2_G;AD; N2V1SP*8GB[P_)H#:XNJVYT
MU6V-/D\-G&TCKNS@;<9]J *7@CPW/H&G7D]^(/[5U2[DO;WR!\BNYX13W"CC
M/<Y/>K1\&>'&UO\ MDZ/:F_\SS?-V_\ +3^_MZ;O]K&:MZ-KVE^(+9[C2[M+
MB.-_+D !5D;T96 (/U%37FJ66GW%G!=W"Q2WDODVZL#^\?!.T>^ : ,_4_!O
MAW6=174-1TBVN+H  R.OWP.@8=&Q[YK<  &!P*SQK>FG73H@O(_[3$'V@VW.
M[R\XW>G6L77O$EGY""S\26^G/!J<=G<2/;&8-(1DP=L,01SVH ZJL75/"6@Z
MU<27&HZ9!<3R*JM*V0^%SC# Y&-S=/4UFKX_TEO'DGA7?B9(5;S,-S*6(\O&
MWL #G..:R?"/Q*TJY\.Z5_;^L0)JMTS*XV$*"9&5 Q VH2 .I&>M '6'PQH;
M: NA'2[;^RU&!:[/D'.<_7/.>N>:BM_"'A^UT>XTF'2K=;&X8/-%@GS6!!!8
MDY)X'4]JVZXV+XAZ7=^*]6\.P.%NK*(>6Y#'S)<.77&W V[!R3SGCI0!U%QI
MUG=WEI=SVZ27%FS-;R'K&67:2/J"168_@SPY)K?]L/H]J;_S!+YNWK(.C[>F
M[_:QFL#PC\1M(O\ 0]#BU;5X!K-[#'O7854RL,A<@;58Y&%SGD5OZMXR\/:%
M?+9:EJD-O<%0Y0ACL4G +D A ?5L4 :"Z1IZZRVL"UC&HM!]G:XQ\QCSG;],
M\U%#X?TBW344BT^!4U)V>\7;D3EAABP/7()K15@RAE(((R".]<I<>/\ 2;;Q
M['X5D?$[0!S)AN)6=52/&WN&SG.!B@#;T70M,\/6'V'2;1+6VWE_+0DC)P,\
MGV%:-82^,_#KZW_8ZZK";[S3#LP=ID'\&_&W=_LYS[47?C+P]8:I_9ESJD4=
M]Y\=OY&&+>8X!48 [@CGH,\XH S_ !5X:?7_ !-X:EELXKG3;5[K[8LA& KP
ME5X/7YL=.G6M73_"NAZ5IUWI]EIL,-M>!A<(,DR@C!W$G)XXY-4;GXA>$[.4
M1W&M0(WFM$V0V$8,4(8XPOS C)P.#5JT\8^'K_6SHUKJD,E^-V(@#\VW[P5L
M;6(YS@G&#0 7?@WP]?:99Z;<Z5 ]I9?\>T?(\KC&%(.0/49YI5\'^'EDD=-(
MM4,C0LP1=H)BQY9P./EP,?04R#QIX<N=:_LB'587OO,:(1@-AG7JH;&TL,'@
M'/%;U %2?3+*YOX+Z:VCDN8$>.*1ADJKXW#Z' _*LW2O!GAS0[\WVFZ1;6US
M@J'0'Y >H4$X4'VQ3;?QMX;N]:_LB#5H7O3(T00!MK.O50^-I88/ .>*CU#Q
M[X7TMYH[S5XHWAE:&50CL8V4 G< #@#<.3QSUH O>'M$C\/Z6UE$RE6N)I_D
M7:H\R1GP!D\#=C\*U:Q]4\5:'HUG:7=]J,20WF/LQ0&0S9&<H%!+#!!R!WK*
M\)^)G\0^(O$L<5U%<:=:2VXLVC ^Z\*LW/4_,3UZ=* '^-] G\0+H,,5M'<0
M6^K17%TDA&WR0CJV0>OW@,>]:.E>$]!T1+I=.TR&#[4-LY&2SKC&"22<<GCI
M6AJ&H6>E6$U]?W,=M:PKNDED;"J*S](\6:#KD%S-I^I0RI:C=/N!C,0QG+!@
M"!@'GIQ0!=M]*L+724TJ&TB6P6/R1;E<ILQC;@]16?H_@[P]H%TUUI>E6]M.
MR[/,4$LJ_P!U22=H]A@5'I7C?PWK=^MEI^JQ37#J6C0JR>:!U*%@ X_W<U%>
M_$'PII\CI=:S#&R2M%(-K'RV5MIW8'RC<",G X/- '&ZYX-U?4I]9MD\):*M
MWJ+R1KK<4P14B?@NT1RWF[202.I/6O1[71+"UNX+U+=3>0V@LUN#]_R@0=OT
MR,U7UCQ5HF@BV.HZA'$;K)@55:1I !DD*H)(Y'/2N3MO%\VHZ!XMO_\ A(+:
MPM;+41#::C]G$R11%8B"5'WLER,^_M0!U$_@WPY<ZK/J<^CVLEY.I661ESOR
MNTDCIDJ2,XSBK.G>'M)TF:.6PL8X)([<6JLN<B(,6"<]LDG\:P=0^(6E:/XB
MTC0[FX$DMY 9)+@*P"<+L.T*<[R3WXQS6CI&IB?Q#K\#Z]!=I:-%FT%OY9L@
M5)PSY^?=C.>V* +PT#2AIEWIHL8OL=XTCW$./ED9SER?J:IZGX*\-ZS/%-J&
MD6\\D48B5B""4'13@_,/8Y%,TWQSX9U?44L+'5X9KB3=Y2[642XZ[&( ?_@)
M-,O_ !]X7TQY4O-8AC>&5H95".QC9<9W  X R.3Q[T =%'&D4:1QHJ1H JJH
MP% Z "G5B:KXOT#1([:2_P!3BC6Z3S(=@:0NG!W *"=O(YZ<UJVEW;W]I#=V
MDR3V\R!XY8VRKJ>A!H S]:\,Z+XB\DZMI\5RT.?+=LJZ9Z@,"" ?3-._X1O1
MAI=MIBZ;;K8VLBRPP*F%1U.0P [YY^M-UKQ-H_AT0_VI?) \Y(BC"L[OCKA5
M!) [G%8/BKXA:9I7@.Y\0:7>V]TSHRV9PS*\H[-CICN#CI0!VE%<G\/=8N-;
M\-K>76M1ZI.Y4R-':>0(6**3'C^+&>M=90 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7*>.KV2VMM
M'M;>VLI;N]U.*"WEO8R\=O)AG$FT$98;3@9')'-=75+5=(T_6[%K+5+.&[MF
M(8QRKD9'0^Q]Z /']5>Y\KXHQ7FI6^H7*:3;"26"#R5W!9>-NYN1P"<^W:MO
MQQ8VR_"/0;)8E%N9]/C* <$%ES^>:[<>#_#BH$71+$*+8VF!" /))R4^A))_
M$U?N=*T^\LXK.YLX9;:)D:.)URJE/ND#VP,4 <QXEN;IO%VAZ/I2:=:WAMKB
MX2_N[?S3!&NQ66)0R\MN&>>@KSZ$)?\ A]8Y[B&_23Q[&'E2/9',"5R0N3A3
MDGJ<Y]Z]AUCP[H_B!(4U?3;:]6%BT?G(&VD]<?7N.],7POH27+7":19K*\L4
MS,L0&7C&(V^J]J .+\8)-_PGT_V0'[2_A2^5"O4MO7:/S-8FNSZ.WP6\')&\
M#.9=.^S!2"1(&7S/Q'S@^YKUN33[9[Y;\01?;DB:&.X*994)!(^F0#CVKS-/
M VKWLD-E<>&] TW=>1SW^JV+X:Y2.02!4CVY0L57.3@8[T $5MK$_B?QW'%J
MVD64)G0W2W]FTK& VZA6W"10$QN'3J&J7PYIT5I\1/#5L;J._%IX3Q#=!<!P
M)44..N,J?R-=SJWA3P_KMW%=:KH]G>3Q#:LDT08XSG!]1GL>*O#3K(:@E^+6
M(7:0_9UF"C<(\@[ ?3(!Q[4 >9:9:P+X,^*;"% SZAJ08XZ@0@@?F2?Q-5M&
MCUJ7Q5HW]G:C86DS^%+/RFO;9IMZ@GS N'7!SL)Z\8KU--(TZ.VO;=+*%8;Y
MW>Z0(,3,XPQ;U)'!JKJ/A70=7L;:RU#2;2XM[4!8$>,$1 #&%]!@ ?A0!YO;
MZ3#:WG@>W;4+35(6UV]G62VCVQ*VV1RJC)P%<''/:M#7U"^+O'048W^%E9L=
MSB89_*O04T73(UL5CL+=%L"3:*L8 @R"OR@=."1^-2'3;$WDUX;2$W$\0AED
M* EXQG"GU')X]Z //-/L3J'A3P'+IFM6UAKMMIBO9K/'YD<Z^2BRJ5R#_=Y!
MR*Z'PEK\,VEW!U*+3M-O$U.2RF^SN%BN+G(^9"<%BV>AYR".U6O^$"\*#33I
MPT"P%H9?.\H1# ?&-P]#CCBI;OPGILNG:9I]I;V]G:6%Y%=Q1Q0C :-MWR],
M$GJ>>"?6@#=KQMH5'B:Y^'[+NAN/$*ZEY9^Z;0I]H9?IYJ;?QKV2J1TC3FU=
M=6-E =16+R1<[!Y@3.=N?3- 'EOA OJGB7P]X>F);_A$TN_M&>075S!!_P".
M9855BMX4_9EU$K&H,B7,CG'WF%RV"??@?D*]<M=(TZROKN^M;*"&ZO"IN)D0
M!I2.FX]\9-,_L+2AHS:/_9]O_9K AK78/+()W'CW))H X*XW']H#32#\Q\--
M@GU\UJ;X-NO#\/P?TQ?$!B,27'EW$;J7?[7YYXVK\V_?@^O?I7H9TG3SJJ:H
M;.'[>D/D+<;1O$><[0?3/:J/_"(^'?[<_MK^Q;+^TMV_[3Y(W[O[W^][]: .
M6\+6T+2_$20Q(7DU2:-R1RRB!, ^WS-^9K9^&I)^&GAPDY_T"(?I700:;96W
MVKR+6*/[7(9;C:N/-<@ EO4X 'X4^SL[;3[.&SLX$@MH5"1Q1C"HHZ "@#C-
M8OKVX\=W5IIT^EZ6]CIB37.I7=MYTC1L[81?G4!!L)))/)%<9X:2*ZT_X6B0
M+*HO[]AE,#*^:5..V"!QVQ7K&I>&=#UF]M[W4M*M+JYM^(I)HPQ49SCW&><&
MBW\-:):7*W%OI=K%,D[W*ND8!65QM9QZ$C@T <UX>MX?^%N>-9O*7S/LU@N[
M'."CY_/:OY"N+\+[(](^%[W6!IZ:A?H2_P!P3$RB'\<YQ7LL5A:07US>Q6\:
M75R$$TJKAI H(7)[XR<?6JK^'-&DT7^QGTNU;3>3]E:(&,$DMG'KDDY]: /.
MO&8$WBWQ>+3#!/!LR76SG$A9S&&_VMN[\*LZ]?6K^'?AO$D\;23:GI[QJK9+
M*$.3]!D#\17>Z5X?T?0[22TTS3;:U@E.9$CC WGI\WK^-4['P3X8TV3?9:%8
M0.)5F#)" 0ZG*D>F"3C% '+^&;:%K3XC2&)2\NJW4;DC[RB%, ^WS-^9K#T)
MP+_X/L[ ?\2RZ&2?^G=*]8ATRQMENUAM8HUNY&EN JX\UV !9O4D #\*H7OA
M+P_J6G6FGWFCV<]I9X%O"\0*Q #&%]!B@#B+UYO#D-]J5C=:7K7AF?5B]U8W
M$?[Z"=YP&\MNC%9#D*PSQP>E>H5B-X/\./K0UAM%LCJ(<2?:#"-V\=&_WO?K
M6W0!Y? TWAN/3Y+6ZTS7/"EUJRK!')'BXM999C@HW(?;(Q/(##\*31;:'_A!
M_B._E)NEU+5?,./O8! S7;1>#_#D&M'6(M%LDU$L7^T+$-VX]6^I]>M7X])T
M^&UN[:.SA6"[>22XC"C$K/\ ?+#N3WH \WT:^OKE]#L].GTS39[3PQ:W%QJ=
MY;>=(8V'W%^9<*"A))/4BN5N'$GPK\!,) __ !50^8+M!_?S_P /;Z=J]DN_
M"/AZ_-D;O1K*;["@CMM\0/EH,84>PP..E./A70""#I%G@W?VXCRACS_^>G^]
MR>: ./MO^3B[W_L7%_\ 1RUV_B#_ )%O5/\ KSE_] -2C2K!=6;51:0C4&A\
MAKG;\YCSG;GTSS5F6*.>%X94#QR*5=6&0P/!!H \=NGLG_9ZT".Q,9N&-BEL
M$QN^T^<F['^UG?\ K5B&SU:ZE\?0'6M(L;-K^87JWUFTD@A:)=K%O,7"[.G'
M8UZ!;^#/#5IJ,&H6^AV,5W JK%*L(!0 ;1CW  &>M2:GX2\/:S?QWVI:-975
MU& %EEB#' Y /J![T 6=!MS:>'=,MC="Z,-K%&;@# EP@&_\>OXUR&A/:+\9
MO%XD*"[-E9&+/79M;?CVSLS^%=_TKB3X'M=4\8^([[7--M;NPO4L_LOF@,0T
M:.K^Z_>'UH X[PW=S_9M+T[28M/1K[7=3ETV]NX?-2VA1FYC4$98[B!R!C-2
MV.C3^)M%\?V"7\-YJ,>I)/;74$7E+]HCAC*LJY./F7;G)SR:]+O?"V@ZCI=O
MIEWI-I+8VQ!@@,0"QXX&T#I^%5+[2_[#BDOO#'AZPEU.1$MR-XMU$:C"Y(!R
M%PHQZ?2@#D/#6N)XX\2P>)VC)M-"TH#RP.EY,N90/=44+_P*L=KJ]GTSP%>3
M7FDVME>ZM;3VFDV-IM,",2?]9OYQNPWR@9;%>D>"_#1\+^'ELYGCEO9Y7NKR
M6-=JO-(<L0/0< >P%">!?"L<-S"GA_3UCN6#3*(!AB#D?3!YXH Y/PC+I:6O
MQ&^U-""-7NS=[\9\K8,9_P!G[_ZUS5BLZ3_!@7&X2>3/][KM\I-O_CN*]3O/
M!'A?4)#)=Z#83.96F+/""6=B"2?7.!UK2N-(TZZN[*ZGLH))[$DVLC(,PY !
MV^G % 'E,%AJM[IGCJVEUS1[#3WU.\6^%Y9L\B(P&URWF+QLV[>.W>O6=,A>
MWTJSADG\]XX$1IL8\PA0-WX]:H7_ (2\/:IJ::E?Z-97%ZF,321 MQTSZX[9
MZ5LT >96W_)>]?\ ^Q?3_P!#6L3[/%#^S1IWEQJORVLN0/XS<H2?KR:]<&DZ
M>NJ2ZF+.$7TL7DR7&P;VCZ[2?2HSH6E'1TT@Z?;_ -G(%"VVP>6 I##CV(!H
M T*\9\77UY?^$_'-W!<:5I>FQ7,]I);BSWSW<J*%+,^\ ,<#'RG  ->S5C2^
M$O#T^J3ZG+HUE)>SH4EF:$%G!7:<_5>"?3B@#E_#<T:?$S7C>R()9-*L7M6D
M/6$*^\KGMOZ_A5'2KC0F^(?AF72?+31)-*O4TW"%$\_SE\S8&QR0&^HZ<5V5
MYX+\,ZA96EG=Z'936]H-MNCQ ^6/0>@]JLZAX;T75=,BTV^TNTGLH<>5 T0V
MQX&!M'\.!QQ0!P.NW&@2>(_#\NG>4+"/Q*ZZBZJ1&;WR3M))X)SCD<9]ZL>(
MRDGQ*U#[,06C\+7 NRO;+YC#>_WB/;-=N/#FBKHG]BC2K/\ LO&/LGDCR^N?
MN^N><^O--TSPUHFC6<]IINEVMM!<9$R1Q@>9QCYCU/![T >875O%;?LYZ,%C
M"VI2REN@!P4,R,Y/Y\UTGB>:QD^*O@)8WB:Y'VQAL()$9@..G8D<?0UVJ:78
M1Z4-+6S@%@(O)%ML!CV8QMV],8[5GZ9X.\.:-)%+IVBV5M)$YD1XX@&5BI4G
M/7H2/H: /+-1U"\OO!^CZK]JTK3],O-:@DMM+MK3$@(N@2QDW_>X);"]3CO7
M9^$K>%O&/CZ1HE+R7L,;$CJHMTX^G)_.MW_A"?"^^];^P;#=??\ 'R?)'[SD
M-S^(!X[@&M.STNQT]IFL[2* SE3*8UQO(4*,^N  /PH \@\"R+'/\-7NV @.
MEWL=N7/ FW+P/?8"!^-:OBV73KC5]+/AVXL[>6/Q$%OYY8&>$7?D-L+C*AC]
MT<'AB,\UWUQX7T*ZT6+1I])M)-.BYCMFB&Q#SRH['D\CUIR>&M#CT,Z(FDV8
MTQA@VOE#RSSG)'KGG/7- &%X7TV\MO%VN7FH:WI][?2P6\=S;V5N8O+V[]C,
M"[<D$CZ 4OQ,MW/@]M4@4M<:-<PZG$!_TR8%O_'-]=#I&A:5H%JUMI-A!9PL
MV]EA3&YO4^I^M7)X8KFWD@GC62&52CHPR&4C!!'IB@#Q\7\$6K+\1VDS:/KK
MV?FC[IL_+^SAOIYB!OQK,URSE@^%OA6]N5VW>J^)(-2GS_>F:1Q^2E1^%>R-
MX=T9M"_L-M,M3I0 'V3RQY>-V[[O3KS]:EO-&TS4+6WM;NQ@F@MG22&-T!6-
ME&%('8CM0!R5BRK\;]74L 3HEO@$]?WK5QRV\,?[+]T4C52\4LC$#JWVD\_7
M@?D*]9O/#NCZAJUKJMWIMM-?VN/(N'0%TP<C!]CS3O[!TG^Q3HW]GV_]FD%3
M:[!Y9!.XC'UYH T!T%>>Z:RCXF^/U+ ,;&R(!/7]U)7H=9=SX;T6\UB+5[C3
M+6348DV)<M&-X7!&,_0G\Z /+Y((H/V<M&\J-4(^PR @=&-S&2?J<G\ZN16N
ML7&N^/8DU?2+*!KK_2UO[-I6\@P(%;<)% 3;N XZ@UZ2=#TMM(CTDV%N=/C"
MA+;8-B[2&7 ]B ?PJMJOA/P_KEY%=ZIH]G=W$0"K)-$&.,YP?49['B@!WABU
M^P^%-(M!>+>K#9Q1K<J,"4!0 PY/48-<R[!?CP 6 +>&<+D]3]IKNP H
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M\+.MJ7/_ "U#Q[@OOL_2NC\"26DOCCQZ]D4,)OX,E.A?RAO_ /'MU=+>^$]
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M?^@"M6F0PQV\$<$*+'%&H1$48"J!@ 4^@ HHHH **** "BBB@ HHHH ****
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M>>&;[5DTRWU1'N7D:*,^6XCD<=520C8QXZ FN>T;XDZ=9QZNGB/5-LMOJUU
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MQLWCDEC\,2I</&01N\U2%)'< C\"*HZ+=QZ+^S]I$D5E9S><D,>V[3="'EG
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M<T :TGAG0I=875Y-'L7U)2"+IH%,@(Z'=C.?>KT-E:V]S<7,-O%'/<E6GD1
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MVM[+.UR\9F\FVMI)W6,'!=@BG:N>YIM]XTT*PL["Y:ZDN$OXS+:K:023O*@
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MD<US-IMVLZSH"94$:% ^?O8!'!K3%A/I7Q&UJST_7;3P];C3[1K:.2T1U>%
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M5I(SE78+(#@CKC&/J#7H%5;/3-/T_/V*QMK;*+&?)B5,JN=J\#H,G [9-6J
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MM8;:');RX8PBY/4X'%-O+.WN1'++9P7,UN?,M_-4'8^.""0=I]Q0!QVD?/\
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MCHQ8 J%!S]TY]._45R_QR_Y)P_\ U^V__H=:5JBGXUZBY4;AH, ![@&:3/\
M(4 =)H>NV'B/2TU'396D@9F0AT*,C*<,K*>001TI-<UZP\/6<=S?-+^]E$,,
M4,3222R'.%15!)/!_*N=^''$'B<#I_PD=]_Z&*D\<:I<6FH>'["&]M]-6^N9
M%?49XD?[/LC+ )O^4,W0$^_!H W="\06'B&UEGLC,K02F&>&>)HI87 !VLK
M$'!!_&L7XA:W/H&F:3>17?V6)M7M8[F3C'DE_G!]L5D?#>[BF\3>,$&K-J3M
M=0.MS(J(TRB%5W@( I7(P"!@@ \YJQ\5YH+?0M&GNAFWCURS>48S\H?)X^E
M&[H_C+2=:U&;3X1=VUY'%Y_DWMJ]NSQ9QO4.!E<U%IGCO0]6U&"SMI+H?:2R
MVMQ+:R)#<E<DB.0C#< GWQQFN3\63Q>(_&UC!H%S%=W$.AZB97MI X42(JQ
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M<N9FLH;J18%C1&21, %!M8[6&<=,#-=7\0H9;?6?"%Q%J0TFU@NIH3>>4CI
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M C;N,1(()! [UU&G:%X9UK4==>UU:35CJMFL-^8Y(GAQ@A"?+4 /C..^!]*
M.P.I6*Q02F]MA'.<0L95Q(?13GG\*;)JNG0WZ6,NH6J7C_<MVF42-]%SDUQ'
M@.>\U.*TTG4HV\[PNSVL[LN!+,H*1,I[_NB6/NZFN=TN30]?\*7ND>(]?N;7
M5(-1E:ZLD:%)_M F+(8LIO8GY0,$^G3B@#UFXU?3;61X[C4;2%T*AEDF52I;
M[H()XS@X]<4'5M-6^%BVH6@O"<"W,R^83C/W<YZ5PNG:+I%_\6?%<5YI]I<#
M['9/Y<L2L-QWDM@\9R%YKE]7U73;G0(;FQGMK.V'BE)?L\LF^X,@N,/(Y)^0
M=2%QP,<\XH ]AN=8TRS\[[5J-I!Y&TR^;.J^7NSMW9/&<'&>N*GDN[:&T^U2
MW$*6VT-YS. F#T.>F*\]TK3M)O\ XE^-&DM;2>)K*R<9164[TDRWIR,<USF@
MZPFF^'/A==:I-LT;;/'--(?W<<VTK"6/08^< GIU[4 >Q6^H65W:&[MKRWFM
MADF:.4,G'7Y@<<4EEJ5AJ4;R6%[;72(VUF@E5PI]"0>#7F_BRXT33](GU/19
M&_L^37+:XUFZM6\V/'\1&=RG!$98 8YK;TI_#%MXBU#Q);^(S>R/8#[;.)H3
M D:D%6?RU #]<9YP&]* .WHJ&UNK>^M(KJTFCGMYE#QRQL&5U/0@CK4U !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %0W5I;7UN]O=V\5Q _WHY4#JWU!X-35Q_P 1=9FT+2-*O([M
MK6+^U[1+B1?^>)?YP?;&: +/B/PJ-0TO2['28K2SBL]3MKPQA/+39&X9@ HZ
MFMRRTO3].,IL;"UM3*=TA@A5-Y]3@<UD:1XSTW5]4ETSR+^QO$A^T+%?VS0&
M2+."ZYZ@'KW'I4.F^/=&U34+:VA2^CBO&9+.[FM62"Z8 DB-SUX!(SC..,T
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MJXTEH[VZU!K=;F.WL[<RM)&Q897'IM.2< <>HH V;?2]/M+J6[M["UAN9O\
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M<C*"R9X.#VSWJ6N0C^)&A2RQL$OQI\L_V>/4VM&%J[[MH D]"W&[IGO5F_\
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M\44DS;I61 I<^K$=3]:(;2VMY9I8+>**28[I71 I<^K$=?QKGYO'6DQ^(Y-
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*X/XKS16^@:1/.I>&/6[-W4+N)429(QWX[5WE,DBCE"B2-7VL&7<,X(Z$>]
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MEECC?$R1GR@LH4<X#8.[&!C)XK<\,^(I;/7=0T^Y\2VVOZ5:Z=]M.HHJ&2W
M;'ER-'\K97+ X!X/%=W]AM/M+W/V6#SW78\OEC<R^A/4BHETRSALI[6UMX;6
M.96#>1$J\D8SC&"?J* );*\M]1L;>]M)!+;7$:RQ2 $;D89!YYZ&N.^+^/\
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M"&,0;=GE!1MV^F.F*9'86<-J;6*T@2V/6%8P$/X8Q0!QOBQ536O 2J  NIX
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M<_-(Q8Y+D +QP!FNJH Y3X@:M<:3H=FUO<Q68N=0@MI;V6-76U1FYDPWRY&
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MYRVU0-QQCGUH \>M87L/A3X(\6P*3-H2I+-M&2UJ_P DR_\ ?)#?\!KLOAU
M]UIM_P")KA2+C7KIKM=PY6W'RPK_ -\ '_@56O%/A_5M=LUT6QNK.PT2=/+O
M2L;>>4S\R1X^50PXR>F36CK6F7LWAJ32M#FAL9'C%NDK X@C^Z2H'5@O3ISB
M@#G?A/\ /X3N[E/^/>XU6\E@/8QF4@8]L@UU'B'[#_PC>IC5$D?3S:R"Y6-2
MS&,J=V .>F>E2Z/I-IH6CVFEV*;+6UB6*,'K@=S[GJ?<U=H \GM=6DM))M$L
M?%$'B32I](NI48[&GLE1!MWNGW@V['S '(HOE5?@GX."@#]YI1X]=\=>GV^G
M6-H)1;6=O")?]9Y<2KO^N!S4AMH#"D)AC,28VIM&U<=,#MB@#QSQ;K,FI:7X
MUBNO$4EC-;R3VEOHMI'"'N%$0P[AE+L&!))! "@\\5>BN(;OXN>!Y[>9)HGT
M*3:Z,&!^4]Q7J9LK0W1NC:PFX9=AE\L;ROIGKCVHCLK2%HVBM84,2[8RL8&P
M>@]!0!Y]\+O^0_X^_P"P_-_6O2*CC@AA9VBB1#(VYRJ@;CZGU-24 >4^$/$V
MA>'_ (>Q:+K1CGU2UNY+6?2@%>XEE:=B-L;$;L[@V>GOQ6:Z06D_C.RU?QI-
MHL;ZA<2RV'E0,9X95!5D#H7?<IVX7N,5[ ;&T:\%X;6 W0&!,8QO ]-W6B:Q
MM+BXCN)K6"2:+_5R/&"R?0GD4 >97&H?9=8NM%G\3SZ/::7IMHELD442W6H%
MD//[Q&+'(V[5'4UE>'9M&E\*^%7C\5C0-=MM,:-+EBAB= PWQ.'^5B& .W(8
M9S7LDEG:S7$=Q+;0O/%_JY60%D^AZBHI=*TZ:'RI;"UDBWF38\*D;CU;&.OO
M0!Y$FJ7VJZSX9US4==705N].NK1;^"./R9)$G&,>:"%$B*''<XP*[SP!;6,6
MF:C<V&L3ZNEWJ$DTEW+&J!Y %1BFT!2OR]1P3FNFGL[:ZM_L]Q;PRP<?NY$#
M+QTX/%21QI#&L<2*D:C"JHP /0"@#(\70R7'@O7884+RR:=<(BJ,EB8V  KS
M>^\1Z1J/A+X>V5C?P7-R-1TPR10N':(+@'>!]WYL#GO7L-58M,L(2QBLK:,N
MXD8I$HRPZ,>.OO0!YWX9\2:'HFO>.UU6]MK1QJCS'SW">:@B3A<_>(YX&?O#
MU%87@P?\(U<^!;[7'%I:3:-<6T<MP=J12O*)5#$\*3'P,]<8KT71?"D=E>:Y
M-J$=K=I?ZDU["K1[O+!1%YR.#\IZ5T-Q;07<+0W,$<T3=4D0,I_ T >*>*YH
M=6T_XE:M8ND^F2II]LD\9W1S21L-^T]#C<HS7=^*P!X_\!X &+J[ Q_U[/77
MBSMEM1:BWA%N!@1!!L ^G2GM%&[H[QHSQDE&(R5SP<>E #Z\^GOK2P^/"_;+
MF&W^T^'XX8/-<)YLGVEL(N>K>PYKT&H9K.UN)8I9K:&62(YC=T#%#Z@GI0!Y
M);*H_9TUHA1RM^3[G[1)_A4C;K#QSJSW7BY_#B76GV<T#LD&VX1(RK8:53RK
M9X'][->L?9;<6Y@\B+R6SF/8-ISR>.E,N;"SO%1;JT@G6,Y02QA@I]1GI0!C
M>![.SL/!FF0:?=3W5H8VDBFN(_+=U=B^2N!C[W''3%=#1THH **** "BBB@
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M+9X"QD3C+;_X-HS]20.:X(:CH@U;Q=X>\7:M/8/=7KR+ Y"K=6SJH38=I+'
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MJ=6#;U.0,<T >HV'B*PU'7=0T>$R"[L4BD?> %D2095D.?F'&/K65>_$/0[
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MH G\$^-;CQ3?ZS;S:7>6R6=[)#%))#M554(-CG<?WF68X],5#XI\12Z)\0=
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M LS,<!0.I)]* '45G7^MV>G/8++YTGVZ9886@B:1<MT)*@A5]SQ6C0 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJF0G8@4,ISA22<\<<'/&%J7@.^G\&WVE6T]J;_4M2&I7<TA98P_FK(54 $X
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MA/\ >([X].YQ7 Z%XEF3Q%=:;9>(-3U:TDT>:\$NH6AB:.9&490F--RD/TY
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MS$87\Z+V[:_^+_P^O'4*]QI=Q*P'0%HB?ZT =[H_B33]<O\ 5;*S:0S:9/\
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG_&/AV7Q-H\-C#<)
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M$\FL37<J2A"!&)EV@$=\4'P/?VV@>%TT_4((]9\/1A(9I8BT,H*;'5E!! 8
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MHPST(]: .0A\*Z]?ZY/K.LZK:17D=A)96/\ 9T+ 0%R"TIWDY;@<=,"I=/\
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MVQ2"W&#\P!8LS'/.3V J]JWAE]3C\.J+I8_[(O8KILIGS0D;)M'/&=V<\]*
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MNX#G;G&!SUK?O? VJSOK]C;ZU#;Z+K<KSW""V+7"NZ!&57W8VG:.V<9 QUH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ I&4,I5@"I&"#WI:* &111P1+%%&L<:#"H@P%'H!3Z** "HI[:WN@HN((I
M0C!E$B!MI]1GO4M% !1110 4444 %%%% $<T$-S"T,\22Q-]Y)%#*?J#3T14
M1410JJ,  8 %+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !112,RHC.[!549))P * %HK@_"7CZ7Q5X[
MU[2H8!'INGPQ&!V4B24MU<^BD8P,=.>^*[R@ HHHH **** "BBN0\3:QJO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOX?FQ.0;8Q7'EG)R?EZ=>: ,#Q?90+X"\;W7_"1+KES<3V$5TZ6ZQHCI+&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]X4YR3C/:M1M4\2ZQ\1M5T/3M5BLM-LX;6Y\S[,LCD,#E!GLW7)SC;QUH ]
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MW;L!3P,UJ7[3ZY\1_#5J8E231[>6_P!06-]ZQ/(GEQINP,G)<]!D+G%=T
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M!HW_ $";#_P&3_"@#CK*\U/5]5-]KOB'2=,M8[>2*#3]/OQ(&9Q@O*YQN([
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MH/@W2=)O-8TPW%I;)%(8[I2N0.QR*W/[ T;_ *!-A_X#)_A1_8&C?] FP_\
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M*/[ T;_H$V'_ (#)_A0!Y]XZUJ.Y^'2:C=W>EVNOZ=<17=I%:W8N )E?"@'
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M[>NQA$X9MIZ]!QD#\* -&WE\4^(_%'BFPM?$3:9::;<QQVS16L4C$M$K;6W
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M[T7$P>^0%E\IDPN#R<L.N*P?-N-)M-8T;0_$?A9M,U&>::&XN=1"RV8EY<;
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M=/;5C>:@-12S6U$H^Q&!F+F/ SYF>,YSTH T*X"Q4#X[ZNP4;O[#AY_[:G_
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MNBNB1')'N&]20K8RNX=#R:Q/"'A3_A'-3UBZ@@BL+*_:)H].@D+QQ,H.]QP
MI;(X''RCZ  MZUXD^PZO#I%MY0O)+=KEGF5V2- P4<*,DDY].AYZ \^?B#JB
MZ1I=T_A\QSW.L+I4\<LC)AB>)(]RC<A'0G&,]\5H>)M!U[_A)K'Q+X:ELS>Q
M6[6=S:7I98YX2VX8902K!LGIW_ Q:YH'B36;'16E?3GO+75H=1G3S72-%C_Y
M9QG:2?J<<YX'0 "P^)O$LOB+4?#QTK31J$-O'=PR_:G\CRF++AODW;@5QP,'
MV[TQ\1+Z3PQX>U:'1HY)-3U$:=+!]IP8Y-[J=ORX89C/)(QD=:UX=%U:+XA7
MNOF*S-I-IT=HB?:&W[D=FR1LQ@[L=>U<3J.B:OX;\)^$M-N5LGO(_%,4L?ES
M,8WWO*X!)0$?>QT/K[4 =CHGBG4YO%UUX8\0:9;6MX+7[9;26LQEBFBW;2,L
MJD,"1VY_GS_@+7ET7X6^$[:*)9KW49GM;:)FVKN\R0EF/.%503Q[#O74P:+?
M3>+)?$MW#!'/%8_8K2V64L,%M[,[;>"2%  !P ?7 YJQ\ :S:^"_#EH)K)-;
MT"[-S;LLC-#,"S%D8[05!5L9 .,4 = GB;4H_$5YX;N+2U.J"S^VV,BNRPW*
M [2ISDHP/UX.?:H=+\8W>J^$+'5(;2!=2NKL6ALF=OW<F\JZDXSE0K,>.BFK
M4&D3R>*?^$IU<6]H;:Q-K#$LV\(I;<[LY '8 #L 3GG S= T.V/Q!UK5;&[$
MNFY2584(,:WCIB5U([^6$_[^-0 ]O%7B"YUCQ)I=AI-@9]'6%E>:Z;9*'0OV
M3.> ,=!SR:K0>/\ 4IM.\-ZTVDV\>D:Q<06I!N"9XWEX#8V[=H;CKDCGCH-"
MRT'6;3Q-XKU,QV+1:LD"VRBX;<ICC*?/\G&<YXSBL=?!>OQ^!O"VB :<;G1[
MZWN97-RX1UB;=A3Y><GW''O0!I:OXVN81JS:1:171TN0Q/"XD+W+JH9E0JI"
MD9P,YR<C ')#XQU:[\26>D:?H\(^VZ3_ &C$]W.T;1_,J[9%VY7&X\#))QTY
M(A30O%V@^(]3GT"32I]+U6?[5)%>NZM:S$ .R[1\ZG ../PZF\- U>/Q]9ZW
MOM9[6#26L'>29EED<NKE]H3 &5Z9[T <]K'C36KWP M_:PV]E?1ZLNFWJAV8
M B<1MY9P.#ZGH">_->E6_GF!/M(C$V/G$9)7/MGFO.F\#:[)X.U73"VGK>S:
MR=4M\3.T9!G$NQCL!'3&0#7H=J;@VT9NUB6X(RZQ$E5/H"0"<>N!GT'2@#E_
M#GBV?Q*]O/9BRDM7FDBNH%<_:++:&V^8I[DJ >!C/&[K7':-XBU/PMX7\1:K
M;:=;3Z=9Z_>-<^9,5D9#/@^6H!'&<\D?2NA@\'ZA<>(=&URZM+"RU:S9C>WM
MG,W^FKL*[&78.I*DDYQC SVIS>"/$$W@#Q)H)&FK=:K?S7,3_:7*(LD@?!_=
MYR,8X'/M0!TNO>(-0TZYN$M[:WBM8+/[3]MO'*Q2R$D"%2.C<9)YQD<&N;\0
M:NGB'1_AYK*0F'[9K5I,(R<E-T<A(SWK2O?#_B.?Q1)J"?V;);7&G"U59Y7)
MLI.=S1@+APV1GE2<#G K.@\&^(X_"W@_3'&F--H=[#<2D3N%9(U9<*=AR3NS
MT '3GK0!I6  ^,^LX &=&MB??]Y)4WQ#U35=+TW2CI;PQ_:=5M;>5G)R5:1>
M!CH#C!/IGUXL6FB:G%\1;_79%M/L%Q8Q6JA9F,@*,S9*[<8.['7M4GC;0K[7
MM'M8].: 7=I?6][&MPQ5',;AMI(!(SZX- $&H>*;J*_N-+M4M/M]I;I+.9!(
MT9=\[47:,]%R2>F1P><9@\?:M<)X7^S>'O)FUOSD,-Y,T3P21HQ((V?=RN=W
M7'\/2I+W0O%FG^*7\0:$^ES/J%O'#J-E=2.B!TSM>-P"> <'(YZXYXL:CX?U
M^[USPOJ!DL9VTR6::Z9I&CW&1"NV-0K<+NXR<D 9]: (H/%'B9_$<7AZ?1=.
MBU!]+-\7%XS1JWF!,'Y,XZGC.<CD<FLY_B'KB>$+GQ"=$LUBTRX>WU&,W3;F
M*2;'\GY>1W^;'<8[G??1-4_X62/$"):&Q&EFQ"F9A(6,@DW8V8QQCK7/R^"=
M?E^'OB+P^1IRW6J7L\\;_:7*(LLF_D^7G(Z=.?:@#HKS7)(O'NEZ1_9ULZW5
MG//%=E_WB[=N5QM^4'([G..E<_/\0=>30-;UE=#LOL^BW\UM=(;MBSI&P#&/
MY.3R3DX[<&MJXT/6;CQMH>M>58K;V-G-;S)]H8N6DV\K\F"!M[D9S6+)X,U^
M3P9XLT8C3A<:U?7%S"WVE]D:RD'#?N\Y&.PY]J -_6_$=_92RFUMK>*SBL1=
M?;+URL4KDG;"N.C8&2><9'!K!OO%FKZI+X#N]+2"WMM9<RRPRNV2PA9MA('W
M1],D@=*N3>'/$C^(3>@Z;+;S:8MF!-*Y-E(,AFC 7YPV1GE2<#G JE9^#?$5
MGH/@U VF/?Z!*=T9F<1R1F,QY#["=W.?NX[>Y -+5?&MW"-6.E6D-S)I3>7)
M"PD+7,@0.R1E5(& P )SDY& .3U>FWHU+2[2^$,L N(5E\J9=KIN&=K#L1T-
M<:F@^+M!\2:E<:#+I5SINJRBYFBO3(C6\^T*[+M!W*=H."?;(ZGM[:*2&UBB
MEF,TB(%>4C!<XY..V: .,N/&]_8WFD_;K""W34=2^P+9R28N8U+,J3$="I*@
MXQP&')JU'XMGOM=O]-T\637%A>1V\ME-(5G:,[-TRC^Z Q(&#G;U&<5SB>"?
M%@TC3K25](EN;#6DU%[MYI-]Z%=CE_D^5@& Q\W0 8 YT]?\':CXBF5KJUT^
M._M[Q9;+6()62:&(.&P5VY)QD ;B.02<B@#N+R=[6RN+A())WBC9UAC^](0,
M[1[GI7)Z=XPO'\3:5HNHV]HD^HV;W!BAE)DM'0*QCD!Z\-UXY!XKH];M+N_T
M+4+.QNC:7<]O)'#<#_EFY4@-QZ&N+TWPIXCAU?PI>RPZ-;)I,$UO/%!+(VX.
MJ@R E1DDJ3@XQG[QSP =%XW\0W/A7PK=ZS;6<5V;?9NCDE*<,P7(P#GEAQQ]
M:IW'B?5=-ECMM4L+2WN;VY,=B(YVE'E!-[/)A<Y&,8'4D<@?-5CQ]H=_XE\'
M7NCZ;]F%Q<[ 'N)&15"NK9X4D_=Q4'BW0-8U>+2-4TB>UM=<TN8S1),S/#(&
M7:\;$ '!'?';MU !D7WC/7'\/>(/)T^2"^TV6%5O(;9Y(I(78;IHU8 L47<2
MO.".]9]]XFU*R^'WB#6M(\86^MQ011-:W/DQB:"0N ZNJJ%Q@@C*@]?:NL6#
MQC<:///)<:9::L6C,-O'NDMPJMEE9B-V7!() XXQGDGGKWP)JWB&V\23:DFF
MZ9=:K8QVL<5D[2)N1F<22,57))(' X [T =#XCU>]L/%/A2RMIMEO?W<T=RN
MT'>JPLP&2,CD \5YE&+G_A'?BZUK=O;.FH7#,R*I+KM;*\@X!'&1SZ5W/]A>
M+=8\1>'=5UDZ3;1Z3-([P6LLC^;NB9"^648.2,+Z$\G@57M? &H)IOCRSFN;
M9?\ A(;B:2V9"Q\L.I W\#G)'3- '2^#+:YM?".F)=7\EX[6\;J\D:(54H,+
MA0!@>O6MZL;PK;ZO9^'K6TUJ*SCNK=%A'V25G1E50 <LH()P>/UK9H ****
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M9"0P(R2S'\: /1(]:L9-<FT82E;^*%9S$Z%=\9.-RD\, >#CH>M:%<)\1?\
MB77/A?Q!#\MS9ZM%;NP_B@F^21?_ $$_A7=T %%<IXWU;4+,:-I>E7 M;S5[
MY;7[3L#F&,*SNR@\%L+@9XYK*%]K'AOQ1/H5QK%SJ5K=:5->6LUTD?G0RQD
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M1@O%B;;((S\R'MD'D?C2ZSI-CJ MKR[LFO)=.D-U;1!L9E"D#C(!/)QGH37
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M*#G!(Z@'!Q]#0!Q[^%M8OO'7A_Q-?2V*-86<T-S# SD%W! V$CD<CKBJVM>
M+C4_'D&KQ7<,>DRR6]QJ%J0=\TT&_P HCMCYESG^Z*[VB@#E-6T37+?Q.VO>
M'9-/::XM5M;JVOBZHP1BR.K("<C<P(QR/2M[2(-0MM*@BU2\2[O@"9IHXPBD
MDDX4=@,X'?CGFL-OB1X06]^R'7+</YGE>9M?RM^<8\S&S]:ZF@#E?%/A^[\0
MFZLKC3]+U#2YK95C2ZD9)()LMEU(1NQ7H01M]ZV]#T^32=!T_3I;E[J2UMXX
M6G?K(54 L?KBK]1SW$-K$9;B:.*,$+OD8*,DX R?4D#\: ,7QEX;7Q9X6O-'
M^T&WDE"M%,!GRY%8,IQW&0,^U89T+Q;J7B#PSJNIMH\3Z2T_G""21_.\R/9N
M *KM[G'./4UU4VL00:W:Z4T5R9[B-I$=86,0"]=S] >.AK0H X'1/#'BWP\\
MVBV&I::?#K3.\$LBO]KMD=BS(H'RG!)PQ/&<X/2JFM>!O$6HVOBVQCO-->'6
MG\R&YG\PS1@!<0D 8"#;P03C)XYKTFB@#D'\/ZX/&.FZ_'/IY9=-:QNXV#@
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M$EN[J1+6PLX]S'LJCH ._H!]!44.OVTVI6=A]FO4FNK;[2A>W8*B^C-T5O\
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MY95TB#2[DW43MM\K)$D8!&?O'Y3@<"@#!L_$GB#6M)\#I#JLEO<:C=WEK=7
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M2$G(;:> .!SUSP 9 E\1ZEX2\4ZZ?$]];2Z3=W_V**!8PA6%F($F5);IMQD
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MHN[D]223U)Z5F>,]22QUBRN;+Q;I^EZE;1L'L=0E/D7$;X^\H8$$%>&'/44
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M!22<XYQ4GPOU;3M8OO$6JQ7MN]YJM\]PEL) 9$MH\1QEEZC/7_@0H M?$?\
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M&..O3!(Q0![3<6T%W;O;W,,<T$@VO'(@96'H0>#5+0M8LM<TW[7IZNMNDLD
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ME+*P._YFSG@Y[5V5% %/2K6YLM+M[:]OGOKF-,2W+H%,C=S@< >@]/6KE%%
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M5$B^9G>-N0P(ZD8K=\,:%)H.GW$=Q="ZN[NZDN[F5(_+4R.>=JY.   .I]:
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M H'R@@!1R< =Z -JPM[OP]\3+32X]7U*]L=0TV::2.^N#-MEC= &4G[N0Q!
MX]J[#4=/MKU89IK..ZFLW\^V5SC;* 0"#V/)&?>N0N=8T"X\96&O_P!K2*+2
MTFMO(^Q3'=O93NW;>,;>F.]-\3ZQHVN6]H]CKUQIVH64XN+:X6RE=<X(*NFT
M;E()R,T 9VGZI?#QYK&K:]I_]E:M;Z&PM+%7$J2P*Y=G\T<,=V!MP, ]\U7T
MZ]N_#?P'LKZPEVZGJ B<W+#)\ZYE&Z0^I&_OZ"I]-N-.EUN?6?$GB$7]V]FU
MC%%;:;-#%%$QR_!#$L<#DFLOP_JFA:E\-Y_!&M7\T%U9$VPE2WD+%$?=#,HV
M].%Z]U- '?:/X8O]#UE)X/$&HWFGO"4N+?49C.QDR-KHQ^[W! XYZ5E_#[_0
M=9\8:)'Q;66JF6!>R+,@D*CT )/YUFZ;K\-IJBZOXD\8?:8[.W:..*WT^:VA
MYQNDD!SN; ]@.<5'X%FEUS3/$MW8W\FG:UK5U)=PO):EC;1#"19# *QVC.,_
MQ4 >H44R)72%%D?>X4!GQC<>YQ3Z "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *9)%'*%$D:N%8,-PS@CH?K3Z
M* "BBB@".&"&W0I#$D:DY(10!GUXJ2BB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "F+%&CNZ1JKN<NP&"QZ<^M/HH **
M** "BBB@!DD4<H DC5P"& 89P1T-/HHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "F>5&)C-Y:>:5VE]HW8],^E/HH 9+%'/&T
M<L:R1MU5QD'\*?110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA0IPH4$DG>N!_A6</B;H#6LTL<>IR36[,MS:)82&:WV@$M(F/E7!')Z\XZ'
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB=YHYGUK1FEB!$;G1F+)GK@^?QFA-(\3))+(FM:,KS$&1AHS O@8&3Y_/'%
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M- %^#XHZ!<6]G=QPZD=/N72,7_V1O(C=C@*[]CD@'&0#P3FNUKQEE5?V8[,
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M(],=,4):V\=J+6.")+<+M\I4 3'ICIBN/T;QM<ZIX^UO0'TJ]CM[+RE2;R0
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MM([IKI+6!;AQAI1& Y^IZUQO@GQ:EUH=Q<ZUK5M(6U:XM+6>1DC655?:@7&
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MLP E^=<]1G(SWV\<4 =Q:_$*PN;_ $V%M,U2WM-3<1V=_-"JP3.5+!1\VX9
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MDAC7<SQQRJS@#OP"?PK)O]<TSQAXX\))X?O([];&::\NIH#N6",Q%0&/8L6
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M#:G?ZQX3MKS49!-,SRHMP(O+%Q&KLJ2[?X=R@-CWKHZ "BBB@ HHHH ****
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MD.WG# ''ITKF?&'C\WG@GQ#/IFFZHEC'%-;PZQ&56/S5RN5PV\+NX#XQGTH
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M5X]P'#?,#CO7-ZC'-'X(O->EMYXK&Z\71ZHF^-@RVV]5$A7&0#MST[BO;Z*
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MQA8^7*!_P%R?PK@=0&H^&?".A>)(K>5M1U:VO8;@(I+>==@S19_W7 %>Y44
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MV5I)9V$LF JJ"3A5[#@#T%5M/U:/P[\3/$T6N>9"NJ?9Y=/G,;,DR)'M,:D
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M]J=R@0R..&R.><-\O3BNL\0ZLNC:<ES+;27$+3QQ2I'$9&",<%MHR3@')X/
M- &1I/FWUQI.IZ'XEFU/1I'<722-'("/+;:P8*&4AMN5]QP,'.I?^*M%TN5D
MO+SRE618I)?*<Q1N<85Y -B'D<,1U'K7G\>C:1I_Q!T>^\!72J;J=AJ]G9R;
MK80;22[J.(V!P .,D\#@U7L;C1H/[8\*>+;+59K^6_N)(K9&N&CU".24R(R!
M#L[@'. ,9)ZX /0-1\=>&=*GO(+S5HDFL]OGQHC.R;LXX4$G[I)QTQSBK?\
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M/"?VF#46DO+XQVA1G@".,<R(V"1[$5P=TLDW@#XC6<,%]),=6-RHEMW#M'F
M[CD#DA6..N!T%='XWF&K^)/A[?6,<TMM_:A?S/*887 ^8@C('N: .@OO&LRZ
MIJ%GH_A^^U==-(6]F@DC148KNV+N8%V Y('J!UIEQ\0]/$>@MI]E=ZB=<AED
MLD@"AF*!25;<0%/S'))P-IK%TG7;/P/J_BFRUM;F*2ZU.34+-DMWD%TDB+A4
M*@Y8%2N/I6=X6T6_TB^^&]O>VTD<T5MJ4DRE?]29-KA3Z$!L?A0!WGAOQ/\
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MPK,S=R> ,=CTH Z.UBE@MDBFG,[J,>:R@%AV)QQGUQ@>PZ5-7E^L^*Y+W7O
M^IVVG7XE:XOH7TY@%D,HB*;#D[<!N=V<8YK?M?'T45MKQUS3)M,NM%C26X@\
MQ9MZ."4*,O#$D$8]: .Q/3BJ.GZ9'8RW-R6\V[NV#SS$8+8&%4#LH' 'U/))
M)P].\83MJ:6&NZ--HTLUL]U;M).DJR(F-X)7[K*&!(]._%<;XO\ &=_K7@1;
MQ-#O++3;VZM?L=Z9U+.OGH070<H&4''7L.XH ]<HHKC?^$ZN8[VW>Y\.WEMH
M]Q>BQBOY9%#&0N45C$?F5"PP"?4''- '945R)\:7<FHW*V?AR]N],M;S[%/>
M0R*660$*Q$7WF52>2/0G'%==0 45XOX,33=:\*VFH:U\0]7MM0E:7S8?[<$6
MW$C*ORDY'R@5W;:U:>$M+T9#<7>I:3=3^2VK370F,3.3L+MW4L=N[H.* .MH
MK@?%?B8:GX;\;6-A!+Y.F:=-')?!\+Y_EDF->Y*C&3V)Q2Z/XUNK>+P[;W^A
M75OIVI+';6NH/,A+R&/*[H_O*&VG!//J!0!WM%>7:GJ>G3V?Q1@L+2YMKZTL
MC]IG:X9EE8PR%2BDX3&#TQFM'1/'%S;6/AU-0T*ZM],U!8;6VU%YD;?(R?(6
MC'S*&QP3ZC(&: /0**\^@\06EIKOCR32=(GDU33E@>Y+W1V3DHQ!4,<)M .<
M=:V?A[K.JZ]X,TZ_U>V,=Q+ C><70_: 5!WX7A<GM0!JZ[8ZI?V*1:1K']E7
M"RJ[3_9EGW(,Y7:W'/K[58TS3XM+TZ*SB=W"9+2.<M(Y)9G;W+$D^YK(\<^(
M6\,>$KW4(5WWA ALXP,EYW.U !WY.?H#7.^ [G5]!\17WA#Q#J4]_<FVBO[2
MYN)"[2*5"RJ">RN#@>AH ]$HIDK.D+M''YCA253.-Q[#/:O.?#?Q"O\ _A'=
M>UOQ%8216=E>SI&\;H[$B38L"JN"6!(&X]2>M 'I-%<G8^,+S^V['2]<T";2
M9-15_L<AN$F5V4;BC;?NMCG'(.#S6OXEU&ZTCPUJ.HV=M]IGMH&D6/>%Z#DY
M/' R<=\8H U:*\@G\3:Q=:#\/M6U*QN#=2WL9V0R(6O=ULQ# +A5W,>AP!WP
M*["S\6O?RZUI.L:+-IU[96?VEH/M"R":%@PRKKT.5(]J .OHKSWP_P"+K.V\
M$^'/[ T2YF?4S*EE8R70+*$+LY>5R>!@GN>0*[#0]4GU6P::ZTRYTZXCE:*2
MWGP<,.ZL.'4]F''Y4 :5%<[XX\0GPQX2O=0B7?>%1#:1@9+SN=J #OR<_0&N
M<\!W.KZ#XBO?"'B'4KB_N3;1:A:7-Q(79U*A94!/97' ]#0!U7B+0[O6/L,U
MAJLFGW=C,9HG\H2QL2I4AT)&>&..01FG:?I-^+F*[UG4HKZX@#>2(+;R(T)&
M"<%F)../O8P3Q69>^-)TUV_T[3-!NM2CTQ4-_/%*B>667<%16.9&V\X&/3K6
M<?BA:MX?T#5H=*NIQK4\L%O#&P+[U+!1S_>*@=L9YZ4 =[17(S>+]46XMM.M
M_#,T^LM;?:KFS%W&JVT>XJN9.A9B#@#T/2D;QY#<Z;I,NE:9<7NH:H9%ALF=
M8FC,1Q+YC'A0IX/7)(QG- '7T5Q5Q\1;>RT(W]WI=U%<PZDFFW=D&#20R,1R
M".'&&!&.N:8/'NI)K;Z%/X3NX]7DA%Q:VXNHV26+)!9I!PF".1SU&,YH [BB
MN-M_B#!+X<DU!]+N4U"/4#I9TT.K.UUG&P-]W&#G=TQDT2>/&L=-UR35='FL
MM0TBV%W):><KB6)L[61QP1E6!XX(H [*BN.M_'4[:MI4-YH%U9Z?JS^797LD
MR'>VTLH:,<IN .,\^H':OX%\4:[K^L^((-2TPPVUI?O!&_G1MY!5$_=87EN2
MS;N1SB@#N:*Q/%>O'P_HPGB19+RXGCM+2-NCS2,%7/L,Y/L#5#5_$L?A:]T/
M2IEO;R?4)BCS^0\G 1F8X4'DD<*HX!S@ 4 =517G=IXHCT7QWXN&J:A?2V4,
M-G+!!Y<DIB#([.5C120.F3CCC)KLCK^F'3K.^CN/.@O5#6WDHTC3 C=\J@$G
MCD\<=\4 :5%9^CZYI^O6TD^GSF18I6AE5D9'BD7JK*P!4CT(JA>7NKQ>,[&U
MCTV>;29;=BUS'(H6&4;L^8#R1@*!CNQZX& #?HKRG7M4\0W?A30(M274M#OK
MGQ%;V5T\5T%>1&R&9&3HA.0!_L@\]2_QA8W'@C1EUK2?%FM7%_'<1)%8WU[]
MHCN]SA3'L(SD@DY'(Q0!V.G^';JS\::IK[W\,D=_#%";<6Y4H(]VT[MYS]XY
MXKHJYC5O%=W;:S/I6CZ'/JUS:PK/=[)TB6)6SM4%OO.0I./3O7)>*=<BUGQ#
M\--2T^:5;2]O'?:25)&U?E8>H.01ZT >J45QVI^.9K2ZU,V.@W6H:?I)VW]W
M',B^6P4,P13RY52">GIS5G4_%=['<Q0Z'H%SJZM:K=M,LJPQB-L[0K-]YCC.
MT>V>M '445Q[>._ML.D_V!I$VIW.I69OEA,R0>5$"H)9FXSN8# SWJ2X\9S"
MWTJ*TT&]EU?45D==/F986A6,X=I&/ 4$@ C.[(QUH ZRBN)NK_4O%VAQ2Z/<
M7NCZG9:AY-S; (VV1/O)(>A3!#9'48XR0*T(-(U<^(M9D?6;TZ?<(AMU8*/L
M\H_YY^J@8R&&"3CG!H Z:BL/PIKS:_I$DDZHE[:7,ME>(GW5FC;:V/8\,/9A
M6Y0 45A-XPT-;I(#=MA[O[$LPA?RC/T\OS,;=V>.O7CKQ45YXY\/V5W?VDMW
M*US8!6N(8K:61U#9(.%4DC"DDC('&<9H Z*BLL^(M*&E6>I+=B2UO=OV4QJS
MM,6&0%4#<3C)QCC!SC!KF?!^K3:CX^\8P_;+R:UM_L8BAN0R>061RX"$#;S[
M<\=>* .ZHKA?BE=S6FC:,L6IW&G17&LVUO<7%O.866)BP;YNPQS^%0Z;H_A_
M^T[4VWQ!U>[F6562W;71()2#G:5_B!QR* /0**Y:3QSI]C/KT&K1/82Z0@G9
M78-Y\!^[)'ZY/RX[-@=Z9/XPNX[31XX]!GDUG5(VFCTXS*ABC7!9I'/"XW*,
M8)R<4 =917'GQ_;IH)O'TVZ&I"^_LS^S RF0W79-V=N,?-NSC;S[4^W\<QVT
M6H_\)'IEUHTNGHDLV0;B,QMG#J\8.0""#P,4 =;169+X@TR'4['3I)W%U?1M
M);)Y+XE55W-AL8R!SC.>:P+#QMI^NZ3X@DN#?:=:V4L]NT_V>5'C1% 9]VT@
M.&+$#J !D=: .RK#T3PZNEZGJFJ7%R;O4=1E#23%-@2->$B49.%4>_)))JO9
M^)=$T[3O#]LVHW<XU&",6,\T,LCW(* @LP7&XCDYP>IQ6K+K-A#>75K-.8Y+
M6 7$[/&RHD9SABY&W^%N_8^E %^BLBS\3:7?:K_9<<LT5Z8O.2&XMY(6DCSC
M<N]1N&>N.G>J&B)>Z!9ZQ<:YJUQ<V2W+2P2W:@.D>!D87MNR%&,^W(% '345
M0L-8M-1NKBUA\])[=4>2.:!XB%?=M/S 9!VMTSTJ:_U"UTRV^T7<HCCW!!P6
M+,3@*H'+$G@ #)H LT5CVOBG1[I-187@A.FX-ZEPC1- "NX%@P! (Y!Z&EMO
M$VEW6H+8"66&Z>(S1Q7-O)"9$'5EW@;L=P.1WH UZ*Y5_B-X6CA><ZBYACN#
M;2R"VE*PN"%_>';A!DXRV >?0U-<>+X(/'4/AHVUT6:R:Y>9;:1ESO15 (!X
M^9LMT& ,]: .DHKE+'Q#H-C!X@U,ZW>3VUM='[7]H#LMJP1<I&NW(7&#QGDG
MFKEEXST*_P!3M]/M[MVN+F(S09@D5)E RVQRNUB >0"2/P- &_16$?&.A#1[
M[53=R"RL)GM[J3[-+F%UQN#+MW<9&3C%6[S7;"R2,NTTKRQF9(K>!Y7*<?-M
M4$@<CD_3K0!#XBTK4=8L!::?K,FEJ^5GDB@5W9",$*2?D/\ M<U<TG2[31-)
MM=,L8_+M;6,11KUX'KZGN35./Q1HTVD6FJ07JSVMXP2V,2,[2MS\JJ!N)&#D
M8XP<XP:Y[P;JTVI>.O&47VR\FM;=K00Q7(93"2C%P$(&WGVYXZ\4 =S156_U
M&UTR!9KN78KN(T4*69W/154 EC[ =JH6WBK1KJTO[D7HB33VV7:SHT;0'&<,
MK 'GMZ]LT ;-%9-KXETNZOWL!++#>)%Y_D7$#PNT?]Y0X&X>N.G>LP_$7PN+
M5+K^T'-LTY@:<6TICC?=MP[;<)\W +8S0!U-%8EIXNT6]U:33(;I_M21&=0\
M#HLL8."T;,H5P/52:S7^)OA%$AD;5L0RRF$2^1)L1@Q7#MMPG(/WL9Z]* .M
MHKC;JZNX_BYIMJM[<&RFTF>5K;?^[W*Z -CUP3R<U:TK7="MK+7M376[F>TM
M[U_M3W98K;2;5S%&"H.T9& ,\MQF@#J**QX/%&E3RWL/G2Q3V4:S3PS0/&ZH
MV<,%(R0<'IGIBJ5IX_\ #5]+IZ6]^SKJ+!+:7[/((W<YPF\KM#''W20?;F@#
MI:*QM4\5:1HYN/MEQ(%M55KEHH'D6 'H7*@A?7GMSTJ:\U_3[)$8R23F2+SU
M2UA>=C'_ '\("=OH>_:@#3HJIIFIV6LZ;!J.G7*7%I.NZ.5.C#^GICM5N@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "N/^(D]U!I.G;)KZ#3WU"-=2EL0_FI;X;."GS ;M@)7G!KL
M** /%$LT(\>6FEZ=JJP:IHBMIWVI9Y'N0BRAB#)E@<L,*2"000.:O7^K03Z)
MX UB."]:STN\CBO3]CEW0D0;3E=NX@$XR 17KM% 'CFOO_;5WXGM]0BUVZU&
M9=NBV4!N(H#"T*E7^7"?>+;M_/&,=JLZ%JD7A[5M+U^^M[T:5>Z!;V9G6SE<
MP7$+$,CJ%++G)P<8)%>M44 >=27M_K_BOP-JLVCW-C$+F_(24$LL7DL$=Q@;
M"W!VGIG%9GBS0M0U?5_'D%K:SNTVG:>\.T%?-:-W<HK?WN,<=R*]8HH \JT_
M2] U^[DCT>/Q'<7:Z?<*+G4IKDQ6CR)LV$3'&X[C]W/W:R=0UI[[X4:7X:@T
MK4CJUE]B@O8#9R#[.(I(P6+$;2"5&,$G!ST!Q[710 '.#CK7@TS&[T33KV]@
M\07GB*TU."YU<R_:3%:HMP"VV/\ U9&,;0H)QD]J]YHH \BUJYM$UFYO/#L6
MNZ7XIDO%Q9QPR_9[\;@/,<8,>UDY+94COR*]=HJ&Z@-U:R0">6 NN/-A(#K[
M@D'F@#QCP/?^$-+\(V=GK_AJ634XWE\YI-!DE8YE<K\_EG/RD=ZZK7M3M]?\
M(VWA_P -Z8ZKK!:T436+11VD(_UDC(RC&!]T<9;&.E=%_P (M-_T,VO?]_X_
M_B*/^$6F_P"AFU[_ +_Q_P#Q% '#K97F@^ O%O@B2TFE>UT^YFL+I(2?MD4@
M8C) P90Q((ZG@UM>(K6XDT7P$L=O*S0ZM9-*%0DHHB<$GT ]ZWO^$6F_Z&;7
MO^_\?_Q%'_"+3?\ 0S:]_P!_X_\ XB@#SXZ?>_:_C$?L=QBZM5%N?*;]Z?(D
M'R\?-R1TJU=ZB?$6B^$O#=M87T>J07=E+>Q26LB+:QPX9V+D;2.,#!.<BNW_
M .$6F_Z&;7O^_P#'_P#$4?\ "+3?]#-KW_?^/_XB@#C]&TZ];QG\4<6LP%W%
M MNS(0)3Y+CY2>#R1TKH/A??Q7/@+2K18[B.XL+:.WN(YX'B*2*N"/F S]1F
MM#_A%IO^AFU[_O\ Q_\ Q%'_  BTW_0S:]_W_C_^(H Y?Q3I5]XU^(=EI$<]
MY8:;HD0OGO(HQ\UTQ_=A2P*DJN3G!QDU2\6>%=8\/2Z;XOMM:U;6[O2+A2UM
M,D99[=R%E50B DX(/?H:[7_A%IO^AFU[_O\ Q_\ Q%'_  BTW_0S:]_W_C_^
M(H WXY%EB21"2KJ&!(QP:\5AM;NZ\%^)M!@LKMM8LM;DU(6K6[J)HEN%<;6(
MVMN4' !R:]H@B,%O%"9))2B!?,D.6; QD^YJ2@#SJ\U6'QKXK\+KI%O>-!IU
MR][>3S6LD*PXC95C)<#+$MT&>AKLO$EO+=>%]7MX$,DTME,B(O5F*$ #\:TZ
M* /(M'N/[2T3X;16]M=^9IEU%!>+);2)Y3K:LISN XSW'%;^J6MPWQ$UZ98)
M3$_AA8U<(=K/YDOR@]SR./>N^HH \<T&VTVW^$GA2T\3:7J:1*96^UVT<BRV
M,@=]K'9\ZY!(SC'KUKM_A]/?SZ)=?:[B]NK5+R1-/N;^,I/-; +M9P0"?FW@
M$@$@ UUE% 'FWBK2[[QK\0K'1XY[RPTW1(A?27D48^:Z8_NPI8%25&3G!QDU
M2\6>%=8\/2Z;XOMM:U;6[S1[@%K:9(RSV[D+*JA$!)P0>_0UZM10!YOI>K_\
M(QXJ\31W.GZA-_:EQ'?:<T%I)(+D-$JE-P&%(*X.X@#.>E<WX7M;F?PU\,76
MW=A#J=TTIC4E8_FFY)[#->BZMX6U&[U6XOM,\3ZAI@NHUCGA5$E3Y1@-&'!\
MML'J.O7&:U]$T>T\/Z)::38*RVUK&(TW'+'U)/<DY)^M ' >*M.L;+X@SZGK
M<FLP:;>V$4<5SILMPH66-GRC^3SR&!&>.#67>Z!IUDOAG5VLO$%AHFV[6XV3
MS_:H&E97620QDOABISZ%AGFO8Z* /(;S2[*3P]:W6B:?K'EW'B2RD>6_:622
MX5'4>;AR7"8&/FQPOIBNMEMYC\9;6Y\F3R!H$J&7:=H;ST.,],X[5V-% 'C%
M[HEU/IFKW4MKJ'V>T\9R7LRVN])FMS&$+Q[<,<;L_+V!J>_T_2+WPGXNNM M
M==NY#I9MEO+Z2>3SLY;RXUE.X[3SP,9:O8** .&\3VL\O_"">7!(_DZK TFU
M"=BB"0$GT&2*@\"W(L/%?B[2;J&YBN[C5I;V'=;OL>%D0!@^-O;IG->@44 <
M-\3()/L_AF^ /D6/B"TGN#V5"Q3<?H7%.\=%K;7_  ?J+PSO:VNHOYSPPM(4
MW0NJDA03R2!TKL+RSM]0LIK.[A6:WF0I)&W1E/446<#VMJD#SO/L&!))]XCM
MN/<^_>@#A-+N(E^('C>XE5XXIK.T",Z$!RL;AP#T)!(! [URFF//H_AGP'J]
M[9:C+IME:3V6H);"19;5G*%795PV/DP?8CU%>VT4 <YX232I(;R_T?3Y[:VN
MY0YGN%D62Y;'+E9/FQV!/7![8)Z.BB@#A?BAI@U>P\.6<EHUU;OK]I]HC"%A
MY7S!MV.BX/)K)UWP9I/@O7-)\6:%H,)@M9/(O[:"#>PB<@"9!R0Z''3D@FN^
MU32'U*2-DU74++8"-MI(JAO<Y4U0_P"$6F_Z&;7O^_\ '_\ $4 <5KMCIVG^
M/=8U#7)==@L]1@MY;.?3);E4=D0HT;"'^+A2,]B:AU/1_LU]\,8].TF_M;2"
M\EE>&?,DEN'PQ\QN<')/4UW?_"+3?]#-KW_?^/\ ^(H_X1:;_H9M>_[_ ,?_
M ,10!YY>:9I>E:SXEM]=C\2-<7E[)<V<&G37(BO8Y%'RJ(SLW Y4[L=NU7K^
M&WMO$+:3JD&O"PM].M8M$T^SEG5)&"D.'>(X+@A02S8 Y]Z[7_A%IO\ H9M>
M_P"_\?\ \11_PBTW_0S:]_W_ (__ (B@#S?2O[$'@SPY9^(+/6M/NK""2%-3
MLX9TDMI@V&BRBD\C!&05./44Y[2\E;PYKOBI];%I]DNK.6ZMO.AGC'G!H'F6
M+##<B\C&,XS7HW_"+3?]#-KW_?\ C_\ B*/^$6F_Z&;7O^_\?_Q% %?P)9Z=
M!I-W<Z9::G!#=732;]2D=I;C "B3YR6 (48W8/'2NIK.TO2GTSS=^IW][YF,
M?:Y%;9C/3"CKG]!5NZBDGMWBCG:!G&/,0 LH[XST/OS0!YOX9UJU\,6'BS7]
M02Y-A=^(IQ$8(6D) PA? _ARK<^U>FJRNBNI!5AD$=Q5#^Q;)='CTF.,Q6*(
M(S"AP&3NI/4@]^Y]>36@!@8'2@#Q/5;^34-&1Y-/OK6YM/$44LVGVUBZQ6Z"
MXR9"57]XS##$Y.2> .:ZS2+J%?B/XPNI5>.&6RLPCR1E0Q59-X!(Y(W $>M>
M@44 >):#)=:+HWPZUB[M;HZ;IT5S;7ZK"Q>U>085V0#..V<< ^]=AX3NTN_B
M5XNN8H;G[/=161AF>VD1)-L; X8@#N/KVR*[VB@#@OBO$KZ+HDDMI)=6T.MV
MLMS%' 9LQ*6+Y0 Y&.V*@L?$7@&*_@:S\.R07.\".5/#\B%6)P#N\L8^M>B4
M4 >4^*M&U3QOXAGU33;1(T\-G%D+B'']HW 97=#G_ED-H4'IN.<\4OB"2UUK
M5/#GBJ^AUJTTJ6RFMKG[*9XIK24LC 2"/Y]N59>F,[3Z5ZK10!Y'+IEM:Z5I
MGB+1=+UE[2TUT7ER+LR2W%Q%Y9B,ZJY+D $$ @'"YQ6OXBUR?QIX.\56>CZ5
M=R6::>1!=21/&;F4@DHD;*&. !SW)QBO1:* /,#K$&K>,/ %W96]]);0PW:2
MR_9) $9H47!RN>#P3T'KUI-)E-IX=^(.G7%O<QW+7VHS*&@<*Z2#]WM;&&+9
MX R37J%% 'G,FC7&L?!?14LE9=6TRQM;FT!4ADN844[2#T)PRD>]2:Q8ZMKW
MPPU2^M[1TU;4UCO%M2V&"*R,L7J"43!']YF]:]"HH X/PSJ/A_Q'J]E?V.DZ
MG_:%JCB66_6<&SW+ADW2'!8G PN>,GM70^+XK&?PM?0ZE!/-92A4E6W!,@4N
MHW+MR<KG=QZ5MT4 <-X);5K?6]0TZ;5/[<TF*WB>VU1T E!);]R[CB0J.<]1
MNYZT_P"(AO;,:!K=O:3WEMI6HB>[@@7<_E%&0N%[E=V<5VU% 'FOBQ_^$P\%
MZO=>&-,ED=C;RM*]LT+WWE2!C& RAF 4=3P2<#O5O598?%OB+PC>Z27(L+A[
MNYE9"IMX_+(,;Y^ZS$@;>O!/05W]% 'C%R#)\*_'MND,IGN=6O'@B\IM\H>0
M%"JXR00,@CT/I73O<"W^*FCZ@T-P]K=:"]K%+%"[J9?.1MI('R\ GG &*] H
MH \DE?=X=^*,:I(7NIIS;KY;9FW0*@*<?-E@1Q6A<2H=9^&DBABENDOG,$.(
M@;8H-W'R_-QSCFO2Z* /&-0N&M/"7Q&T*2UO#J5S?W=S#"EL[!XI I5PV-N.
M#WZ\=<"M*\U"/0_%=IJVL6FK#1M0TFWMTN+=)U-O-&SDI(B889#Y&1U_&O5:
M* /*;N.'P]K7A/7K31KJS\-PO=I*@B=G@,P 69TY9=Q!SGD \X)Q6SX1NTNO
MB/XQN8H;D6]TMDT,SVTB)(%B(."0!W'U!R.*[VB@#A_'\MWI>J>&?$,=I/=V
M&F7<AO8H$+NB21E!(%')VY/3UK,\5R-XE\*W.J^'-*FD2*]M;R0_9C%+J"Q/
ME@%8!FP N">N"!TKTNB@#@K]H/$WC;PIJNE2%[?3%N9[JXVE1&CQA1&Q('S$
M\E>H"DG%<E<*TGP2\3VBPS&YFU"X,<'E-O<-<;E(7&2"O.?05[510!P>K7$4
MWQ/\(3PDO"MI>*\BJ2JEUCV GH"<' -<KI<UI?\ PE\0Z%''Y^HW=Y?0P6H3
MYY)&F;8P'=0<$MT&TY(Q7LCABC!"%?'READ ^XXS6'X2\.R^&-*EL9+U;M7N
M);@.(?+(,C%F'WCGD\4 <U% ]A\3/#=O,S2?9="DM99MI*^9NCP"W0$[2<&L
M9+Z6Q\.^/)X=+%\7UTS)#-;&56B/E#S@F/G"X+#'=:]<HH \OTR[BC^)&H7N
M[4Y[6YT% EY<VSJ)"LCDG[H"C&,# ![ YYR;8&+X6> 8&BE6>UU>S>>+RFWQ
M!)"7++C( !R2?7WKV:B@#S+3M9A\.>(/$^B^(-.O+B/5+Y[RR>.S>XCO(Y$5
M?+^4$9&W&&P,>U,U2[7PWXX-]KEA?PZ3J.G6\,4M@962UEB+YB81<X._@X^G
M>O4** ,;PO:65GH,,>G::^G6;,SQ6[@A@"Q.Y@>5)ZX/(SS@Y%;-%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %8NM^(5T34]%MI;8O#J=T;3SP^!$Y0LF1CG<5(ZBMJN6^(>G7%
M_P"#;J2QB:6_L'CO[54&6,D+AP !U) (_&@!;7QI!<^/[OPJ+1U,$)=;HO\
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M2!SCGJ"#VH\,Z;X>O=6TE+?0?$*ZA IDG>]FNA%8R!"/^6K;6))(&W/!STH
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M=XH_M-;1HBLD\:.I.T'&<C)'KCBNN%X?&'C_ ,.WVG6=]'8:.ES-<7%U:R0
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M]R]O,MM)96:13,A".0'R W0D<9KEYENK>W^)VC/IU^;O4/M-S:%+5VCF1K<
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ME<R*WEH K<@\Y'3FO2/^$/M/^@IKO_@VN/\ XNC_ (0^T_Z"FN_^#:X_^+H
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M,OIC-=::DZ^3(Q.6&2I=5/=0P'TKL$18XUC10J* %4#  ':@!U%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\ARTBQRR*I)[G  S[4 >\45X]JQDU_Q3XG6ZT/7M2>SF6TL)=/G6-+,B)6W
M&5/G+-NS@\8'M7IOAJ34I?#&F/K$;1ZD;:/[4K8SYFT;NG'6@"33[V]NKN^B
MNM+DLXH)=D$KRJPN%_O  Y4>QYK0KQ3[9=?V1\7C]IFS!/)Y1WG]W\K?=]/P
MK:O-&A\/:EX*U:SGNCJ-]?QVU[/)<.WVE9(79MRDXZJ"   .U 'I=U=0V5G/
M=W,@C@@C:21S_"JC)/Y"LBX\46L6I>'K6&-IH];\PP3 [0JK%Y@)!&>15/XD
MVD-W\./$"S*6$=C-*N&*X94)!X/KVZ5P[^'K+_BV>GP&>W@NEEEF,<[[FS:
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MC"@?.0C)@^V&JKHOA1M"\0:IJ%KJMP;/49VNI;!XT*"9@ 7#8W?P],XKHZ*
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M./?FN83P#(-&TRUD\07C:AI,F[3]0$4:O FP)Y97;AU*CG/)]:[.J7]JV?\
M;?\ 8_F_Z=]F^U>7M/\ J]VW.>G6@#-\/^&!HU[?:E=:A/J6J7VP3W4RJOR)
MG:BJH 51D_4GFD\4^%QXD33Y(]0GT^\T^Y%S;7$**Y5L$$%6!!!!KH** ,72
M/#R:5K&JZF;N6XN-2$'G%U &8H]F1CUZFL>+X?06FAZ596.J75K>Z5--+:7R
M*C.OFLS.K*1M93NQCV%=E10!E:%H\NCVLRW&I76HW,\IFFN+@CEB ,*HPJ*
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MZS@N[:026\\:RQ..C*PR#^1H XZZ\ 7^JV[6>M>,M9O;"3B6V5(81*O]UF1
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M$ZE;7852T4W/\)&",$C!]:<WP[6275)IM<OIIM6T]K*_=T3][D,%< #";0Q
M XP!GN3VU% &%=WNF>#?"]K'?RRM:V\26J;86D>4A, ;5!Y(7Z5A?"KPP_AW
MPO)-<6\MO=:A,;@PS'+P1=(HB?\ 90#CL217:W#RQ6LLD$/G2JA9(MP7>P'"
MY/ R>,U#I=Q>7>FP3W]B;&Z=<R6QE67RSGIN7@_A0!0\+V>HV.E2Q:G//-,;
MN=D:>0.XB,C; 2"?X<<=LXKE=7TB[U'XPB6SO[G3IXM 7R[J)%<9\]LJRL"K
M @YQUX!KT2L;Q!KZZ"=*W6YF_M#48K$8?;L+Y^;H<XV]* ,0?#R!-&2WBU:\
M75%U'^U#J95&D:YP5+%<;=NTE=N,8IT.AVO@W4+WQ3?ZY>RB>!(]0:6(/YS!
MB$?"+E<;]H51C&/K773S);V\D\AQ'&A=CZ #)KG/!?BRZ\8:=_:G]C26.FR@
MFUFDN%=I@&*G*#[O3U- &)\,_#ZVUQKGB,VD]JFK7;-9P3@AXK;<S#Y3]W<S
M,VWT(J6?X91SZ9<:2VOZ@-*\YI[2T58P+:0OY@.[;EP&)P&..>Y ([VN 3XG
MQO\ #K5/%W]DN$L+EK<VWGC+X=4SNV\?>ST[4 7&\"7<6KZCJ^G^)KZSU#45
MB6YD2&)E<)&$!V$8!X)!&,;CVIUQ\.=,DT'0-'AN;B*#1KV.^C;(9I9%+$[R
M?[Q8DXKJ[2?[59P7 7;YL:OMSG&1G%34 <KJ?@V:YU:]O]+UZ]TDZ@BK?);I
M&PEVC:&4L"4?;QD>@]*Z2TMDL[."UC:1DAC6-6D<LQ &,DGDGW-35GZM=ZA9
MP0/IVEG4)'G5)$$ZQ>7&<Y?+=<<<#DYH Y__ (5[9?9/%=O]MN-OB-V><X'[
MK((^7\^]:NI>&X-271!)/(G]DW4=U'M ^<JC( ?;#5MT4 4]6TV#6=&O=+N2
MP@O('@D*'#!64@X]^:Y[3/!#V3: ]YK5S?/HC2?9FDB1,HT7E!#M S@<YZDG
MFNMJEJ&JV>EM9K=R^6;RX6U@&TG=(P) X]E/Y4 9-[X,T_4M0UNYO'DDCU>T
MCM)HN %5-V"IZY^;/X"C1O#5]I^HQWFH^(]0U0P0F&".4)&BJ<9+! -[<#EO
M?CFK6G:^NH>)M:T86Y0Z6+<F7?GS/-4MTQQC'O6S0!D>*- A\4>&[W1;B:2&
M*[0(TD8!9<$'C/TJGJOA&+4;321!?7%E?Z3C['>PA2R?+L8%6!#*PZBNCHH
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MF<Y6 SK,=N 020 ._3VK3H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M\[\=:/+/XB@U*_\ #]SK^B)9^4;:UE_>6TN\DRK'N&\E2!D'(VUZ)7/:QX8G
MU#4_[1L->U'2KAH1!-]F\MDE0$D95U8!AN/S#!YH XJ\_L+7O[ LK6RU;Q2L
M>F>=%:RW")&L98*)9F8KF3*E1UZ-QGFN<U>XGN/A-X4%P9-T/B=8%$DF]E1)
MIE52W?  &?:O2/\ A7MI:R6+Z3JVI:8UM9BQD:W9&:>'<6^8LIPVYF.X8/S&
MH'^&&EMHT.D"_OEL+?4QJ5M$"G[E@6.P';DKEB><GWH PO&=KI^L:[KNS1-1
MUJZL;14>8W20P:<VPN#%E@=Y!#$C/;GM5*2V/BK6OAU;ZI/-)#?:'))>JLA4
MW'[N)B&(.<%L$^O([UW%]X&M[W6+^[&J7\%IJ6S[?81,@CN"JA!DE=R@J "%
M(R!1I/@6UTJZT.X_M&]N9-&MI;6V\[9S&^  VU1G:% !_/- &#:2VOP^\=:C
M9N3!H6H:=]NME))6*2W3;*BY]4"M^%;7PWL;F'PHNI7^[[?K$SZC.&.=GF'*
MJ/0!-HQ]:P_'UG;>.-9TKPQ;VEV\MI>K/?7?DO''!!L.]-Y #%PP7"D^_2O2
M54*H50 H& !VH \WM] L/&_BOQ8VN)),;"X2SLE\UE^RKY2L70 \,68G/7@4
MW^QH-<\?1>'M<N)=4T_2M%BDC2=^+B5G93*X& QPH'/J370:OX'34-5O-0L=
M:U+29+^-8KY;-DQ<*HP#\RG:V.-RX.*+CP'9H=.FT6^N]&NM/M?L44]KL;=!
MP=CJZL&&1G)YSS0!YYJ(FMM(U?P];7=Q':6'BBRALY!(2\$<AC;8K'G"ECC-
M=(?#>E:+\2[#3=/MC#8ZMI5TE]!YC%9]I3#-D_>^8C/7FM]/ &FIHR:>;F[=
MO[134Y[IW4RSSJX;+'&,':!@ <#BM:YT&WNO$MAKCRRBXLH)8$0$;&$A4DGC
M.?E'>@#Q2'3K73_V8]1O[2+R;NY)$TJL<OLO2J]^PXKL[O2X-<^(6@6%\9)+
M)O#KR30!RJS8DC #8/(R0<>PK37X8V0\)ZGX8;6-1;2+QPT<!\O_ $;][YI"
M';DY;^]FNAB\-VL/B"SUA9IC/:V!L$0D;2A96R>,YRH]J /++J,:5H'B/2+-
MY([&Q\3V:6T6\D1(S0L57/1<D\>]=OXAG$/Q0\)EY-D0L]09^>,!8N3^M7+W
MP'IE_9:[;33W0&L7*74CHP#0R(%"E#CC!0'G-1VO@2)=9M-7U/6-0U2^MX98
M-]QY:JT<@ *[44 8P>1R23DGC !Y_:)!;7WA?6])T;4X%O=6B0ZW?72>;?12
M[LAT#9PPY&0, #@5H^&M"TRSO/B-=6]JL<]M/-#"X8Y1# "0.?6NA7X90BPL
M[1_$.KNFFR1OIA8Q?Z'L.5P-F'.!MR^>.!C)SI1^"88-:UB^@U2^C@U=6^U6
M8V&,N4V;P2NX''.,XS^5 'G?A]I-4\#?#?0;F:7[#J<\YO LA4S+&)'$9(.<
M$@9'?%:>KV,'A?7O$>BZ.IMM,NO"MS>M:HQV1S(2@=03\N0W..N*ZR/X?:;#
MX2TO08;N\C_LN036=ZC*)HI 6.[.-I^\001@BI+;P/ (]6DU#4[W4;_5+0V4
MUY/L5DA((VHJJ%4?,3TY/6@#B)-"L]'\/^!/$%MYHUB>^T^.XO&E8O*DH =&
MYQMP< =@!BO2_%!*^$M9()!%C.01_P!<VJM=>$[.[T71=+>><0Z3-;30L"-S
MF#&T-QT..<8K6U"R34=-NK&5F6.YA>%F7J P()'OS0!XWI4#:EX.^%UK+<3J
MEQ<2I,8Y"K.GE2;ER.<$<?C77>&--M?#WQ-UO1]+C-OITFFV]W]F5B464NZE
ME!/&0!G'6M>P\"Z?I]CX<M([FZ9-!D:2W+%<R%E9?GX]&/3%:<6@V\7BBYU\
M2RFYGM$M&C)&P*C,P(XSG+'O0!R/Q(M/[1\1>#+!II8H;F_ECF\IRI:,Q'<N
M1R,C(]>:QM8TRV_X33_A'H_"]UJ^C:7ID36UA!<HD<3R.^9#YCKN/R@ \XYZ
M9KT75O#UMJ^JZ/J$TLJ2:7.T\2H1ABRE2&R.F#VQ576O"W]IZK%JUCJMYI6H
MI";=I[4(WF1$YVLKJP.#D@]1DT <!:Z?J6HWWA#PKXG@N4L_]/F>UGG#M/'&
M1Y"R,C$-M5QD9YQS574K%-&/Q2L;2>7[-!I%L8(VD+>0"DIV@DY ST] 0.@K
MI_%6B6.B:9X?._7@VGSR;-7L_P#2)[<N#O:12K%U<\'"X''0<54\&^'8-7O?
M&%Q-'J,NDZO##:"XOU:.:[VHXDDP0"!\X X ^7@#% %_Q1(RV_@##D%M7M@<
M'J/(DKGM)O+6P\0_%JYO;JYM;=&@WS6N/-3,;C*9_BR>/?%=9;?#R-9=)EOM
M?U74&TF=);,3F,",*I7:0JC=D$98Y/ P1SF=_A]I4K^)S+/=./$6PW(W >44
M!"E..#SGG/(% '*>&K3^Q/B#HD%GX>NM"M[ZQN1,D]TDC76SRRKNJL<.,G)/
M/S$5:^#N@V;>%[/Q#/YD^I,US#'+)(Q\J(3.-BC.,9!/3.3706_@4IK&G:S=
M:_J=WJ=D2HGE\H!XB,&(J$"@'KD#=GOTQK^&?#UMX6T"#2+2666"%I&5YB"Q
M+NSG. !U8T <A\4I'35O @1V4-XBMPV#C(ST-0V?AG3?$_Q \;1:S$]W;0S6
MHBMVD8(C-;KEL CYN!@]N<=377^(?"UIXDN='GNIIXVTJ^2^A$1&&=>@;(/'
MTQ5C3M!M]-UK5]4BEE:;5'B>56(VJ40(-O'H.^: /+].L=3USX=>$+V?3YO$
M%C:"X2\L/M&QY@&*1OR0'*!3\I/.:@UG3?#NK:9X+%I!>/;#Q#]C>WORPEMU
M/F%X",Y 4@8&3@8YKO8? ,5AI&F66E:UJ5A-IPE6&YC*,SK(VYE=64JPSC'&
M1BFW7P\LKC0[:Q74[^.[M]0_M-=0#(9FN><N05VGKC&,<"@#E?%NGZ7?:CKD
M=IH6HZM+IEFD/G&Z2*#32(RR^5E@2V"&)&>W/:HKVZFO_$WP=O+F0R3SVDLL
MCGJS-;QDG\S782^ (9KR[DDUO4S;7Z1C4;4&-4NV5 FYB%RNX ;@I /TXI;;
MX?6<$WAB634KZX?PZLB6ADV#<C*%"OA1G:J@#&#ZYH XF(E=<^,[*2"+*,@C
MM_H\E,O?#-G::/X U*WENHM2U*ZM;6]O$G<23Q2PL70G/ XP,?=[8KT >!=/
M%UXIN/M-UN\1Q"*Y&5Q& C)\G'HQZYJS<>$[.YT_0+-YYPFB3PSP$$9<QH4
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MV)A=PR#]Z7'F$E2&W*,9&!TKU2\\/VM[XBL=9E>3SK.":!8N-C+)MW;AC/\
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M" BA  @Y)X'4YJA!\.(O,THWWB#5K]-)N(YK&.=HP(PG0':@W9&!D\XZ8R:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5POBQ==F\6Z6T7AVZU31K!/M*K!<0IONLD*6#N#A!R/=@>
MU=U10!Y_\*;Z\NM-UE+C2I[1!JUW()))$8%FF8LF%).5/!/0]B:] JO9V-K8
M1R1VEO' DDC2NJ+@,['+,?<DYJQ0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
.1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>employementagreement_mil005.jpg
<TEXT>
begin 644 employementagreement_mil005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M\0RV=R@N$REK$AEE+$D! %')X^@[G'-6M#N-9N_M=SJMHEE$\@^R6I96EC0
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MA^[N-2L88O"UOIUU;:M]LEU6 QB-X@Y9L$-YA:13M*D8Y/. * .DLO%5O?\
MBRXT*"UN/]'MVE:YD0HC,KA"J9'S8)Y8<9&!GG&<GC#5+NQ?6--\./>:*K-M
ME6YQ<3(IP7CAVG<."0"P)'0<BM)]-N6\=KJ/E?Z'_9;6YDW#[YE#8QG/0=>E
M8&E_\)1X=\-Q^&K+07N+FU0V]GJ)GB%L8P<))("V\$#&5"G)'!YH W=>\66V
MB7NDV?D27%QJ-S%$$7Y?*1W"^8^1P 6 QU)^AQT%>>:]X+\03W@O;/65FFGU
M*UGE#6B9B2-AC!+?=3EMO<D]R:]"&0H!.3CDT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4KK2-,OKJ&ZN].M+BXA_U4LT"NZ=_E)&1^%7:* "BB
MB@ HHHH **** "F0PQ6T"001)%%&H5(T4*J@=  .@I]% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!XLU;6M6TW['?3O*$CF^SO LK(L10KL;Y0,D#<#GD5ZA)(D4;22,%11DL3@
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M89HY87B>-P <,C@,."#TK@(W7S/A9E7Q:PD7&4/[D_9=GS\?+\W'..:W/"+
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MYJDL4QE00I;!' 8>M 'I5OXPT2[LQ<P7,KJURUHD?V>02/*HR55"NXX'.<8
MYKF_"WB6-=:\;W=_JER=,L+B$JUYN3R%\H%QM(&WYLC&.>.M.\57<FD>/_#G
MB"XCFET1;:>UDFAC,@MY)-I5V"Y.&V@9KG[C4Y(Y/B1?6FBS:@DSVDD,5Q8R
M-%*OE1JS;2!NV\MMZD#\: /1[;Q1I5S<W-L)IHKBVA%Q)#/;R1OY1R X5E!(
MR".,\\=:HVOQ!\,WKZ>+?4&=-0<16TOV>01LY) 0N5VJQQPI()XXY%<MI5["
MOQ1&H^9J5S:7&@;!>W-LZ*["8L?X0$ 'L!]2><2T5HO@]X-MFAE6YM]5MGEA
M\IM\86<LQ9<9  .2?<>M 'J6J>*-)T<W O)Y +9!)<&*!Y1 IZ%RH.T=^>W/
M2I+KQ#IMI%%)YLEQYL/GHMK"\[-'_?P@)V^A[]JX>QUF'PWXG\3Z5K]A=SP:
MO=_:[*6*S>X2[C>-4,7R@\C;C!XY]*BU*ZC\-^-OMVN:?J%OI&H:;;PPR6!E
M*6DL1?,+"'M\_'!'IWH ]&TS4[+6=-@U#3KE+BTG7='*G1A_GC':H-6U[3=#
M:S74)GB-Y.MO 5A=P\C=%RH(!/;.*@\+VEE9Z##'IVFOIUFS,\5NX(8 L3N8
M'E2>N#R,\X.14/C71'\0>$K^Q@.V\"":T<=4G0[XR#V^8#\S0!;M_$.FW6M7
M>D0S2M?VB!YXC;R#:IZ'<5P0<'&"<XK*OM=T2_GT"3^U[ZU-Q=YM$B22(73
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M6'A^V@L--;3K0;FBM6R&12Q()!Y!.<D'IG%:] !1110 4444 %%%% !1110
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M)&1]X#.1R,9R*RM8^T^*M#L+SP]J6H6;"Y62.2)?+$@!(/F!P"8^^!UXQG-
M'5T5DZCXBL-,EN(Y1/(UK")[CR(6D\F,YP6P.^UN!D\=*U$<21JZ_=8 CZ4
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MN\44[0,PQYB@%E'?&>,^AY^AJ:N<\=Z_<>&?!U]J5FBO>#9#;*W3S)&"*3[
MMG\* -NQL;;3;&&RM(A%;PJ%1!V'U[GW/6K%<&/AO,VG^;)XKU\ZX4W&^6^<
M()/:+[FS/\..G>K]YXCU314T;17LX]8\27<+,ZPR""+" ;Y&8@[1DC P<DT
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M.: .XHK-T.^U+4+ SZGI)TN8N0D#3K*Q3 PQ*\ \GCG&.M:5 !1110 4444
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ML#<<'&0!D#/'%37O]K7X\6^)-/M=4MK#4+K3X 8H7CNGM8CB:1$QO&0YQQG
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MCL>E9FA>&M4T:_\ AA;75I*7LX]0>[9$+) TD>X*S#@<MM]R.*]9) ZD"EH
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MO3B94/6.!!LB7\@6_P"!5T?BF&6Y\(ZU!!&\DTEA.B(@RS,8V  '<DT >9>
M-1_X1'X?:??+X=A-_K#006IAN]TFH3-O.Z0E?W8 R<Y;C-=SI?B>_EU^3P_K
MNEQ6%^UJ;JW:WN?/BFC!VL 2JD,"1QCOFN3AT;5;3X=>!;U=-NI+K0YH9[FR
M$9$QCV,C[4/)8;LX]JV;)[CQ/\0K;6X-/OK73--T^6!9;RW:!II9&7A48!L
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M-K;-*T3LJ8W*HR!P>: ,W0M>UK2$\:3:7H2:A!::Y>3W$DMWY/ "DJ@VMN;
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MG7J#GTJ;7K.2\UR6XTSPOJVF^*A>*L>H6H(MIHA(/GE<$(RF/JK#<#Q7JU%
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MQZ9(R>U=G10!P.@_;?"_B3Q+'J&GWTMMJ5U_:%I/;V[SABR -$VP':5*@#.
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M=-O;F?P68+6606FI1R7!5<^4HA<$MZ#) _&M+_A#-*_Y^=:_\'=Y_P#':/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %9UQK=G;ZY::-EY+ZYC:81QKGRXUX+N
M?X5R0!ZGI6C7$^#O]-\9>--3EYF6^CL$S_!'%$I 'H"78_6@#;'B6,Z1'J/]
ME:N%>?R/(-DWG YQN*=0O?/I5JUUNSNM9O=(!>.]M%1WCD7&^-NCK_>7((SV
M(P:\>B\1:T?@[8:@=6O3>/KPA:?SVWF/SB-I;.<8XQ7>>*O]"^('@S4(N))I
MY["7'\<;Q%P#[!D!H [:BBB@ HHHH **K:E<PV>EW=U<3-!!#"\DDJ]8U"DE
MAUZ 9KR+1($TSQ+X/N].T+4M.BOY7BEOKV[1Y=01H'?,J*Q.XD!N0,>W2@#V
M:BN)^+32)\-=3:&9H9/,M]LBG!4^?'S69?Z%8^$/'/A.XT9987U"XFM+X&9G
M-TOE%@SY)RP9<Y]Z /2:*\8\,64=AX#\1>+P99]8L&U$64KR,1;JI?A5SCJ2
M3D?R%6=3T"Q\,>"M#\3Z895UI)K*2:\\YF>[\UT617)/S!MYX[=J /7J*Y^/
MQ+=/X@.EGPUK"Q>88_M[)'Y&!_%G?NP?I7#> M+TV+0]9\4ZG<3BXLKO4%BN
M?,8_980S[MB_=SRQR0>WH* /6:I:=JMGJOVK['+YGV6X>UF^4C;(F-PYZXS7
MDVBVD6G^*/"3V6@:CIMOJ7G0SW5[=H\NH1F!GS*BL3NRH;)QCVZ4SPWIVAZ/
MX+\97DBWEKG6+JP$E@Q^T%#*JI$F>,DD+GWZCK0![317F'@Z Z3\27T^VT&;
M0K.XT=IWLWNEE$CI,BB3"LP#8<@^M:7Q*MS>7?A&S,\L,=QK21R-$Y1F0Q2;
MER.1D<<>M '>T5Y#K07P!XBUZ'PXK6UM+X9FO_LZL62.XC<*L@!)QPW/KBGZ
MIX>L/"OA;P_XBTKS4U=;JS\^Z\YF>\$K*LBR9/S!MQ/MVQ0!ZW62-<2]TO4+
MK18#J,]G+);^0'$6^5#ADW-P.>_2N%\/^';'7_B#XPGU59+F.RU&(VL+2L$C
M<Q*6; (R> .>G/J:YS3-)L=.^$'CB]M(/)N?M%]!YBL<[%D^4=>U 'MMI+--
M902W-O\ 9YWC5I(2X?RV(Y7<.#@\9%35Y/9P)XBO/ N@:D7ETO\ X1X7TL!<
MA;B0+&JA\'Y@-Q.*RO$J-H6C_$/0=.DDBTZUAL;FUBWEA;-(WSJN3P"5!QT&
M30![;17F][H%CX8^(/A"?3!+'/?2W,%[*TK,UT!"S R9/)W+G-;'Q+O+FV\)
M+!:W$ENU]>VUF\\;;6C22158@]CC(S[T =A7*:3XRFUSQ9J.DV.CR-8Z;.;>
MZU!YU4+(%)PL?5AD8S[U@:AX?TSPIXT\,0:+;FUMM5:XLKZV21BDZ>46#,"?
MO C[W7D\U0^%OAW28/%GB^YBLU6:PUB2&V;<W[M"I&!SSP3UH ],U#5;/2VL
MQ=R^6;RX6U@&TG=(P) X]@?RJGI^OK?^)M:T46Y1M,6W8RE\B3S59NF.,;:Y
M#XHZ/8:CK'@TW=LLIDUA+=\DC,91R5X/J!4%EX4TC6_B3XMM-1MS/96T%@D=
MJ9&$?^J8 D \D 8&>F30!Z?17AEG>7EYX;\&Z)-9WNL6<ESJ(FM(YU1[A+>1
MEC5F=E!4 @X)YVCK7?\ @"RU+3FUBWGTBZTO2C.DFGVMS.DIC!3]XH*LV%W#
M(&?XJ .PN+B*TMI;F>01PQ(9)';HJ@9)/X5SW@[QOIGC6UN9M/ANK=K=E#PW
M2!'VNH9'P"?E8'@^U<]\7=8:/1[+PU;)=27&M3B*9;2)I95M5(,S*J\DXX_$
MUB#Q%9Z/\2M%U*RTG5M.TS4(%TF\^V6$EO&K#_CW8%A@G^'V% 'L-%>;0^'M
M/\2_$SQA!K$;W5G!'9%+5I&$>YHFRQ (R1CCTR:YO38YM4\/^ +"XO+DQG5K
MVU=Q*P=X4\Y0A8'.-JA?7% 'MM%>.ZSI]OX;N?'VDZ2K6M@WAP78MT<[4E(E
M4LH)XR ,X]*W_$<KKHGP_(=@7U>Q!P?O#RGH ]#KG5\5HWQ#;PE]C;>NG?;_
M +3YG&-X3;MQ[YSFO,O%S6SVGB#Q%I6DZG=75I>DIKL]TB"W>-U4QQ+N#&,$
M%?N\Y/7K731_\G&R_P#8M?\ M<4 =CXI\26GA/P]<:S>PSS6\!162!07)9PH
MP"0.K#O6#-\2;;3_ "Y-9\.Z_I5HSJAO+NV3RHR3@;BCL5&3UQ5?XT9_X59J
MFW&[S;?&>G^O2LGQSI_C.X\*W3:[-HUWHMN!<7]KIZ203311D.0KN7 ^[G&
M3C&10!ZI17FTPL/'/C^SL[U'GT2/0HM1M[1R521Y9" [*#SA0  >A)KFM6$U
MCH_B/P]:7=Q'9Z?XAL$LG$A9H%E,;%%)SPI)P/>@#VZBO.1HEAX6^*&BQ:/$
M]M%J5A=B[02LPF,?EE6;<3EOF//7FL$SR#]F6UE\U_,,$/S[CG_CY7O0![)1
M7E/B_2X[3Q'JVJ^(]'U&\TN58VM=6T^8F33%5 &^0'*@,&?< >O([5ZE Z26
M\<D<GF(R J_]X$<'\: )**X/XFP&[;PG:?:)8$N-=BBD:)RC%#')N (Y&1QG
MWK)GMM-\$>.;VVL99M.T>YT">[ND@<GRGC<#S4!SAMK$>Y H ]2HKQO1;"*P
M\7>&(K;P]?Z5::I#<P7,MY=(\E^GD%@955CAL@')QU(IT>KW^E_#[5_!BS.V
MN6U^-$M'8_,\<YS%)GMB(L<_[% 'L58UYKZVGBO3-"-N6:_@GF$V_ 3R]O&,
M<YW>O:N"UO1=(FU5]&@T34]>DTK388"ANDA@LA@E7!9E)E8<D\G '2LVPMO^
M$JOOALFKS2S+/HURUP/,(,^%BX8@Y() )]<<]30!ZIXDUI?#OAO4-8: SK9P
M-,8@VW?CMG!Q4VBZD-8T'3M4$1B%Y;1W C+9V;U#8SWQFO)M6MH]%TCXG>'[
M'<FEVUA!<6\!8LL#2QMO5<] 2H./K0SRZC%X(T:;1;K6=/3PY'>/8P3)&))-
ML2!GWLH8*">,]6!Q0![/6>]YJ"Z]'9KI9;3V@,CW_GJ DF2/+\O[QXP<].:P
MOA]:ZI8Z->6NHV%S8P1WLGV""YF65X[<A2JEE9N 2P&3T K&OI''[0FEQAV\
MLZ Y*YXSYK<XH ]&HKQ"/P[8WWPM\2:[=&>74K.?4);.<S,&MC'*Y4)@\<@D
M^N?85[!IY_M'P_:FZ'F?:;5/-'3=N09_G0!D:QXTL=.\+:EKMHAO8["X-M)&
M"4S()!&PR1V)Z]\5TU>!1:-8V?P4\5W5K (KE]1D@,@))V+=J%&"<<5VMWH-
MCX7^(OA*72EEBEOVNH;UVF9FN@L)<%\GD[AG- 'I%(2%4DG ')KPO0X-9U?0
MM/\ $-AX7U.3Q#/<K=G6#>1!9%,OSH5,F?+V93;M[#BO:-7TZTU72KBROH1-
M;R+\Z$D9P<CI[@4 87@OQA/XSM7U&'1I+327+"VNI9U9IMK%3\@Y7H>_:NJK
MY_\ "ME#8_!31KJR#VM[K.H1Z==7D3LKB%[IE;!SQP,9'K7=3Z-8>#OB#X6C
MT&$V<&IFYMKRWC=BDH6+>KD$GY@1][KS0!Z-17BGAG0[5OA+KOB&<RS:DMIJ
M4,$SRL?)C!D^51G YR<XSS["I;[PS9VFF> =1MYKJ+4=2N;:UOKM)W$D\4L#
M%U)SP.,#'W>V,4 >S45Y_P"&M-M?#WQ1UG2-+C-OI\NF6]V;<,2@E\QU+ $\
M9 &?6I_&T8U7Q=X4\.W3/_9E\]S-=1*Y43^5&"J,1U7+9([XH [>218HGD<X
M5%+$^PKF/!?BZX\96!U--&DLM+DW?9;B6=6:;#%3E!RO(/<US T/3K'Q?K_A
M2& G0[C1H]0^QEV\N&82,OR\_+G:IP.XJ;X(:186OPXTO4H;=4O+I)!-*"<N
M!*X'&<=J /2J*\Y\6VNG:YXO>R;0]1\07-K9)YEJMRD-M:!V8A\LR_O&P>F>
M%'2MSX;7EQ?_  ZT.YNI7FF:WVM([;F;:2HR>YP!S0!/I/BM-5\9:_X>%FT;
M:0("9S)D2^8F[ICC'U-='7CCL5\8_&%E)##2X2".W^BM6QK,KCP'X 82,&?4
M-*!.>6R!F@#TNBO(T\.6'B"\^(4NJ++<"UO'^S(96"P/Y"G>H!^]TY]O<YI)
MID5MX1\"^*A+.^NW-_8">^>9B\J2G#(><;=IQCV^M 'M-%>7:3X5TSQ3XL\:
MKK*R7446H(D$)E8+"3"F74 \,>.>VWCO71_#"_NM2^'.D7%Y,\\X62(RN<EP
MDC("3W)"CF@#KJ*\EN-.@T;Q1/=^)M+U&.6;5?-M/$5I/O5$:0>7%(,YC7!$
M9!4J<^^:VO#$CFP^(!9V.S6+L D_='D1T >@45XQI5BFLR_#*RO))FM9]$G-
MQ&)"HF 2([6(.2,XSZ].A-3Z5X.TB\N/&VEW,<LNG:;<8L+9IGV6I>$.S(,\
M')&/3''4Y /8**YOX?7<]_\ #W0+FZE:6>2QB+R,<ECMQDGN:Z2@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHH) !). .] !12 @@$$$'N*%977*L&
M'J#F@!:**1F5<;F R<#)ZF@!:*3<N[;N&[&<9YQ064,%+#<>@SR: %KD+&TN
M=!^(>I$6\LFFZZJ3K+&A98+F-=K*V/NAU"D$\9!'I77,RJI9B !U)-4M4U>S
MT>&WEO)"JW%S%:Q8&=TDC!5'YF@#F%^&>EKX1@\."\O/LL-\+Y9,KO+[R^#\
MN,9/I4US:7.N_$>RN&MY8]-T".1A+(A43W,J[<+G[RHF>1W;'8UU]% !16?H
MUUJ5YIZRZKIJ:?=%F!@2X$P !X.X =1VJ^&5L[6!P<'!Z4 +112!E+%0P)'4
M ]* (+^R@U+3KFPN5W6]S$\,J@XRK @C\C7(Q?#I0=,EG\1:K<7.ER*UC,_E
M?N4"E2FT)AMRG!8@G@<BNU+*I + $\#)ZTM '&?%:U>]^'.I6R0O,9)+<%$!
M)(\^//3VS5NP\%K;Z]:ZK?:SJ&IO8HZ6,=T4VVX888Y506;'&YLG'YUT[,JX
MW,!DX&32T 8>B>%K#1=#N=(4R7-K<RS22K/@[O-)++P!QR1619_#R&!M/@NM
M;U.]TO395EL]/G,?EQLOW-S!0SA>P)[#K78^8FP/O7:>ASQ2DA022 !U)H 6
MN?T[P?I^G^'-1T(O-/9W[W#S>81NQ,3N ( ]3BM\$, 000>A%+0!Q4/P\"S:
M7<W'B+5;F\TN139SR>5^ZC"E3'M"8.Y3@L1N.!R,4C?#>T:/6;==7U%++4KD
MW@MU*8M[@NLGFHVW=D,HP"2.3Q7:EE4@%@">!D]:I2ZO9PZW;:0\A^V7,,D\
M: <;$*AB3VY8?K0!AV'@D6?B&VUZ76]1NM3CB>">67R\3Q,00A4* J@J"-N#
MG.<YK/\ B-ICZK=^$[<?:%7^V%9I;?(:+$4F'![8..3Q7=4FY=VW<-V,XSS0
M!S.G>"[>"\U"]U6_NM9N[ZV^QR2W810(.<QJJ*H .23ZU4LOA]%!+IT=WKFI
MW^FZ9(LME8W!CV1LOW"S*H9]O;)XP.M=B64,%+ $]!GK0"&&001ZB@#)TGP]
M;:1JNL:A#+*\FJ3K/*KD80JH4!<#I@=ZPT^'5JFGZ]IJZOJ']FZP97>U_=[8
M'D.69#MS] 2179TBLK [6!P<'!H YB[\$6TNGZ)%::A>65[HT(@M+Z'89 FP
M(0P92K A1D$=1QBJ[_#VPGT#5]-N[^]N;C6'1[V_D*^=(5(V@87:% &  .,F
MK?@7Q7_PFGAB/639?8]\LD?E>;YF-K8SG Z_2M?5]7L]$L/MM](4A\R.($#)
M+.X11CZL* (-2T&WU/5](U*6659=+EDEB5,;6+H4.[CT/:I-=T2S\1:-<:5?
MJYMYP 2C;64@@JRGL00"/I6@S*B[F8*/4G%+0!S&F>#C:ZU;ZMJ>M7^KW=I&
MT5H;H1JL ;AB BKEB!@L<\5;T'PQ:>'[[6+NVFFD?5;LW<HD(PC'LN ./KFK
MVKZO9Z'8&]OI"D/F1Q9 R2SN$48^K"J7_"0C_A-9/#S6X"IIRWYN#)ZR%-NW
M'MG.?PH ;XH\,0^)[:R1KVYLKBQNEN[:XM]NY)%!'1@01@G@BI-)\.Q:5J^H
M:G]KN+BZOXK>.=I=O)B0J&P .3DD]L],5L @C((QUS0K!E#*00>A!H Y)?A_
M90Z+96-I?WMM<V%U+=VE]&5\V)Y&9F'*[2IWD$$<C%;&A:(=%@N!+J%WJ%U<
MR^;/<73#<S8  "J J@ #  K6I REBH()'49Z4 8J>&+4>,I/$\DTTMV;06D4
M;D;(4SN.T8SDGJ2:D\3>';/Q5X?N='OC(L,^T^9$0'C92"&4GH016L6 (!(!
M/0>M&]2Q7<-PY(SS0!CZ5X=ATK5]1U074\]SJ$=NDQEVX_=(5!& .3DD_P!*
MSK'P)I]A%HT<=S<L-*O)[R'<5^=I=^X-QT'F'&,=!74EE! + $]!GK6-X2U_
M_A*/"]EK/V;[-]I#GRM^_;M=EZX&?NYZ4 1WGA+3[_5M3O[EI7_M'3QIT\60
M%\L%CD<9S\Y[UCVWPYC5M)^W:_JM^ND3QRV23&,",(,!3M4;LC W')XXQDY[
M:D#*V=K X.#@]* .(O/AG97MMJ.GRZQJ0TF\EDG%@C((XI7)8L#MW'#'<%)(
M!YQ6K9^$(+7Q9'XEEO[JYU!=-&GN9 @5U#!MY"J/F)';CVK5T?5[/7=+BU*P
MD,EK*6",1C.UBI_4&KU &-XK\-VWBWP[<:+=SS00SE&,D)&\%7##&01U4=JP
M;CX=/J4)M=7\6>(-0L7_ -;:O-'&DH_NL40$CVR*[965QE6##U!S7)^%?&-W
MXKU+4/LVC>3I%I<RVHO9+H;Y)$(SB+;P.>NZ@"SJO@^"]O+*_P!-OKG2+^R@
M-M%/:*A!A./W;*ZE2H(!''!JNO@#3AH;::]W>222W\>H7%W(RF6>975LMQC'
MR@8 & .*ZF66."%YI75(XU+.S' 4#DDUD>%]>D\2Z3_:@LC;6<TC?8R[Y>:(
M' D*X&W=R0.>,'O0!+=Z#;WGB/3=;>643V$4T4:+C:PDVYSQGC:,5RK_  KL
MY-&DT1]=U4Z,'\RWL=T86 []_!V[F .<!B0/J :TM)^(.E:QXQO/#D$-PLL!
MD6.Y< 13O'M$BH<Y)7=S]#6AJGB/^Q_$.EV%Y:[;'4F,,-Z).%N.JQLN.-P!
MP<]1C'>@"CJW@DZG=7YCU_5+.QU'_C]LH3&4D^4*=I92R94 ':15VUTJ[MO%
MSW44LZZ4NFQV\=N9LQ"0.3E4SP0N 2>N1Z&E\1>(_P"Q9M.LK:U^V:GJ4_DV
MUMYFP$#EW9L'"JO)X/8=ZDGO]=2;5EBT2)X[:-6L7-X!]K;;EE(VDQX/ )SG
MVH Y_P").FMJK>%;8"X"G6XF:2#(:(".3#@CI@X.?7%6XO -K,^J3:QJ=[JU
MUJ-F;!YKC8AC@.3M0(H Y.2<=0*VO#VNVOB30[;5;/<L<RG=&XPT;@X9&'8@
M@@_2I]8U:TT+2+K5+^0I:VL9DD8#) 'H.YH YF/P"(KO3=1NO$6JW5]I;[K>
M>01_+%M*M'M"8(8'EL;C@<\"LC2=/MO%GQ3/BVVL[J+3K"T6&.:XA>$75Q\P
MWA& )"([+N(ZGCI77W/B$6_B[3M"^S[EO;2:Y\_?C9Y948VXYSNZY[5M*P90
MRD$'H10!S.H>"XKW7;O48M5O[2*_2.._M8"FRY" @9)4LO!P=I&16;#\,K2W
MCTCR-;U2.;1XY8["93'NA5RO'W,, %QR#D$Y[8[A65AE6!'J#5;4KN:QTZ:Y
M@LIKV6,96WA*AY.>@W$#\S0!SD?@&S.AZY87>H7EW<ZV,7M])L$K?+M4 !0J
MA1T&*EN?!,#6.BQV.I7EA>Z/;BVMKV'87,>U5*NK*58':IQCJ,C%9#?$J\76
MDT<^"M;&H/ ;E8-\&3&&VEL^9CKQ78Z7?RWVEQ7EW8S:=(^=UO<LN],$@9*D
MCGKU[T 1Z'HZZ)IYMA=W5Y(\C2RW%T^YY'8Y)X  'H  !52;PM:3>-K?Q2T\
MXNX+(V:Q CRRA8MD\9SSZUNTW>FW=N7;ZYXH YZ'P;8P^$M2\.K<7!MK\W!D
MD)7>OG,Q;'&.-QQQ6[9VRV=E!:H2R0QK&I;J0!CG\JFIOF)L+[EVC.3G@4 <
M4?AM:?V9K.E?VOJ']F:G,9S:_N\0.9!(2AVYZKC!)X/KS71:CH-OJ6MZ/JDL
MLJS:7)+)$JXVL70H=W'H>U6-(U6TUS2+;5+%V>UN4\R)F7!(^E9_BSQ/#X3T
MF*^FM)[OS;F.VCA@V[F=S@?>('6@#-M_ 45K<I'!K>IQZ0ES]K32T=!$K[M^
M-P7?LW<[-V*ZYU#HRGH1BN,/Q#^PW5K'KGAO6-(@NIE@CNIUC>(.W"ABCDKD
M]R*[-F5!EF"CU)Q0!REC\/M)LO 2>$&EN9K%-Q65G E5C(9 P(  (8Y'':IM
M+\'_ &36H=7U/6;[5[VVB:&U:Z$:K K8W%515!8@ %CSBNFI%96SM8'!P<'O
M0!SMAX-L=/\ !EWX8CN+AK2Y2X1I6*[P)BQ;'&.-QQQ4MSX4L[FRT"U>><)H
ML\4\!!&7,:% &XZ8/.,5O4FY0P7(R>@S0!EQZ#;Q>*KCQ )93<SVB6C1G&P*
MK,P(XSG+'O47B'PW;^($M'-S<6=[92^=:7EL0)(FQ@_>!!!!P01@UM5'</+'
M;2O!$)9E0E(RVW>V.!GMD]Z ,+1_"<.F2:A=7-_=:AJ6H(([B\N-H;8 0JJJ
M@*JC). .IYJSX6\.VWA/PW9Z'9RS2V]J&"/,1N.YBQS@ =6-9FO^,+CPOX(_
MMW5M)9+S*(;"*X#_ +QFVA?,QC'?.*W=)N-0NM.CEU2PCL;LD[H([CS@HSQ\
MV!G\J ,?4O!J7VNSZG!JU_8_:X4@OH+8H%N43.W)*EE.&(RI!P>W6KWAGP_%
MX7T9=*MKJ>>UBD9H!,%S$A.=@*@9 .>N3SUJU<:O9VVL66E2R$7=XDDD* 9R
ML>W<2>WWA5+P]XB&NC5"T M_L.I36 S)N\SRR!NZ#&<].?K0!7@\%Z=#KOB'
M5'DFE;78HX;J%R-@54V87 SR#SDUDV_PUA6'2[>[\0:K>VVDW$,]A#*8PL/E
MD%0=J MP-N3R!G&,UW#,J#+, /4FEH P[3PQ:6;:Z4FF/]LRM+/N(^0F,)\O
M'H.^:KOX+L7\-Z)HAN+CR-(FMYH7RNYS"05#<8P<<XQ3_%GBN/PK;V#M87-]
M+?7:V<$-N5#%V!(^\0/X:S#\18;">%/$&@ZOHD,KB-;NZC1H QZ!G1FVY]^/
M>@#&TKPQ>ZEXH\9SV^KZEI#3:@L;/;JF)H_)3IO4X();#+@\FN_T;2+/0=&M
M-*L$*6MK&(XP3DX'<GN2>3]:N%U5=S, /4FJ>HZO9Z5)8I=R%6O;E;6  9W2
M$$@?DIYH YZ;P&MQ</%)KNIMI$EU]J?3&*&,OO\ ,QO*[]F[G;NHNO ,,^IZ
MG/!K.I6MCJK>9?6$)01S-M"D[BI9<@#.",UUQ95(!8 G@9/6EH YK3O!5CIL
M_A^:*YN&;0[.2T@#%?G5PH);CK\HZ8JW9^&[6RN]<N$FF9M8D$DP8C"$1A/E
MX]!WS6RS*BEF( '<G%9^O:Q!H'A^^UBX1I(;.!IF5.K #.!]: #0='A\/Z#8
MZ1;2220V<*PH\F-Q [G&!FM&L/PIK.HZ_HL6I:AI*:<MPBRP1K="8M&R@@G"
MC:>>G-;E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7G7B+1[+7/C!I5
MGJ">;:?V+.[P,3LFQ*F%8=QDAL>JBO1:X#7]!FU?XJZ=*LM]9I#H\QCO;7@Q
M2>:F!D@J<J6^4@Y&>* .;*Z=HZ^,O"YCOGTE=3LHK*QLI K.\Z*Y@5FX5"P.
M1D8!:BT\-?VEJWBGPLNC1Z%!>:/!/'9Q7"R(DXDD"2C;PIRJY Z[:[4?#S31
MHLUB;[4&NYKQ;]]2:5?M'VA<;7SMV\ 8 QC':DC\,V'A>_D\3RZCJ]S=);^5
M=L0)FNAGY2R*F<KG@(!@#I0!RO\ ;,GC[2_!VAS ^?<3&XUF,]56U.'5AV#2
M[:IIX:TO6=(^)%]J-N+B:VU&]^S%R?W#+"C;T]&SC)_V173_  _T#;K?B'Q9
M+I\U@VKW'^C6TZ[9(X1U9E/W2[Y8CZ5T-OX4L+:QUVS26X,>M3S3W)+#*M(@
M1MG' PHQG- 'G1T>TL-'^'?B.%6.M7M_9"ZOF<F6=9HB75CW'8#L!Q5%].U7
MQ)'XCOH/"L]]K!U*YCLM7%]%&UH8G*Q*@9@RA=HR!UR>N:]1F\(Z?-I.A::T
MMR(=%FMYK8AEW,T*[5W\<C'7&/PJC>^ ;.[O;V2/5=4M+._E\Z\L+:95AG?C
M<3\I9=V!NVL,T <_:Z#:>(OB;K4>OVB7"II=B\EI(=T7FGS,DCH2/F ^IKD;
MG2K*\\&>'+6[MUN([/Q>=.A\WYBMN9W!CR>V% _ 5[/:Z#:6GB&^UJ-I?M-Y
M#%!(A(V!8]VW QG/S'/-8UU\/=+N=!;2ENKZ%?[1;4XKB.11+%.7+Y4[<8!)
MP"#Q0!U%K:P65I#:6T2Q6\*+''&HP$4#  ]@*EKGK31;VU\56]ZU_>7%K%I?
MV1S/,")9/,#!R@ &[ ;+8[@#H:Z&@#Y^\/1&Y^#/AZ'S9(S+XGA3S(V*LN9\
M9!['FN]L]%T[PU\6["VT:U2RM[W2)VN(HLA9&21-K$=V^8\]>:UM/^'6CZ;X
M=L=$AGO3;66H)J$;.ZES(K[P"=N-N>V,^];<VA6L_B2UUUGE%U;6TELB@C85
M<J22,9S\H[T 6=2N8;+2[N[N96A@@@>221.J*JDDCW %>1:-:1Z9XC\&7FG^
M')]*BO9WC:]N+M'N+Z-H';]\J]22%;D\'TKV"]LX-0L+BRN4WV]Q$T4JY^\K
M#!'Y&N2B^&]H@TYY=<UF>?39$:RGEFC+0*H*[ -F""#@D@DX'/% '"P^&-+O
M_AIXNU>\M_/O[:YU*2UG=CNMC'([+Y?]WYADXZYYKU_0YY+G0--N)F+2RVL3
MNQ[DJ"36=#X0T^#PUJ>@K+<FUU%KAIF++O!F)+[3C QN.,@_C6S96L=A86]G
M$6,<$2Q*6/)"@ 9]^* //_%=GIVO>,+BT/AV?Q!<V=DBS1SW*16UH'+$%=W/
MF-@Y(Z #D5S>F0_\)&GPKAU222XCGLKT3AG/[Y5C3"L>I!VC/KWZFO1M2\%V
MNHZY-J:ZCJ-H;J)(;V"VE58[I$SM#94L.&(RI!Q46D^ M-TB?1Y(;N^D&D-<
M?8XY70JBS !DX4$J,<<YYY)H X_1?!6@WGBCQMH]Q8K)I5E+ ;2R8GRK=I8
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M'< ?0XKWC2]*L-%L5LM-M(K6U0DK%$N%!)R:YZ?X>:1/X(L_";3W@L+5D=)
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M)@G&'P,\8-><^&M$TJV\2_$.X@TZUCFMYMD,B1 -&K0 L%/8$DDUS_AE%O\
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M9'/J]I::%-H-]')&]YII93$A93M>/9\NU@IY&,E>10!V,LT<$9DFD2-!U9V
M _$UBZ9XB^W^)M>TIH4CCTO[.5FWY\SS4+=.V.E<]XFL[;7/B?X>TC5(4N=.
MCL;F[%M*NZ.24%%!93PV 21GUKA_$.GVFE:=\5;*Q41VT0T[9$I^6,$ [1Z
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M1;ZUO()KJ6:VTY=-1II W[E6W#/ R>V?2M^LF;Q)ID'B6'0))P+Z6W:X W#
M 95P><[B6&!CG!H HR>"-)EM[N!FN=EUJBZK)AQGSE*D8X^[\@X_6M*YT.TN
MM?L=:D,GVJSAEAB ;Y=LFW=D8Y^Z*S?#7BN'6=/>>\:VM)?MMQ:Q1F4 R>7(
M4!&>I..U;MS>6MDBO=7,,"L=JF5PH)]!F@#C?^%5Z(=/;36OM6;31)YD%DUU
M^ZMVW;LH-OKG[Q.,G'K6C>^!-+O]6O+V6YOUAOBK7EC'/MM[AE4*"ZXST !
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M.US(-UQAR<EOW\G-=N<@' R?2L_0M#LO#FCPZ5IR,EI"7**QR1N8L?U8UHT
M>+6&B:5J/P*O_$-[:POK4UO=7\FH,@\];A7<J0_WA@J  #VQ6OI&FVOB/XC^
M?K=I%=M_PCEE,T,Z!T\QF?+%3P2,D#TR:Z2?X<:'//,&DOUL)Y_M$VFI=,+6
M1R=Q)C]">2,X]JW8M$LX=?GUI%<7<ULEL_S?+L0EA@>N6- ',_#"-+;1=9L8
M1LMK/7+V"WC'2.,2'"CV&37;UG:1HMGHD=VEF' N[N6\EWMG]Y(<MCT&>U:-
M 'AWB417&@:QX@TOPY:1P?VJ)$UJZN_]+,J7"H6C782%W*5"EQQVKK-/T72_
M%'C?QI_;UC!>M;R06D*W"!_(A,(;Y,_=RS,<CO6I<?#30+I+R&9[]K2Y=Y1:
M?:F\F&1R2SQK_"V22.N,G%3ZCX!TO49Q<->:I;W#VZVUS-;7C1M=QJ, 2X^\
M>3SP>>M ')_V%H1^)WA.&&.VU*V72)MES,$G:7RR@1B^/F(' /:I](95^'GQ
M"9B !J&K9)[?>KJKSP+H]U)I$D!NK!])C,-JUE.8B(SC*'U!P*KW7PZT2[O-
M0E>74$M]0=I;JRCNF6WED(P7*>O /ID#B@#E+:*WU0>&;&#PY;:WJ%MX>MY'
M&H7 2V@CD  (4H^78H>0.@ZUSE_(\GPC\$!RO[OQ,D:A7WJJK-.JJ">H   ]
M@*]3N/ 6D3O9.D^H6S6MFEB3;731^= O1),=1UY&#R>:C/PZT$Z;#IP6Z6S@
MU$:E! )CMAE!)PH[)EB=OO0!UE<5\7/^26:[SC]TG/I^\6NUKD_B;8W6I?#K
M6+.RMI+FXEC0)#$A9F_>*3@#KP#0!@Z[H6E>'/$7@B[T6SAMKJ34/LLDD*@-
M/"\3ERY'+\@')SSS7+:'I&NZ[X0MM0L_#.G_ -JS7IO!K<E^%G\T3DG(V9Q@
M%-N[&*].T_P/I>GZQ;ZD)K^XDM%9+.*ZNFDCM0PP?+4]...<\<5$?A]HQU!K
MCS+X6K7/VMM.%TWV4S;MV[R_][YL=,]J .=T#0=-U7XL>-;O4+2*Z>TN+,VZ
MS*&6)C"I+@'C=\J\]1CWKGM(TZQTO4OBG?6&F6<=WI8+V#I;H#;L('/[OCY>
M?2O6[#0K+3M7U35+<.+G4VC>X+-D$HNU<#MQ4.G>&=-TS4=7OH(W:75G62Z$
MC;E8@$<#L,$T >;ZOH6DZ+\*]!UO2K."+5;=[">&\C0":621T#[GZMN#MD'K
M6KX>T/3M3^+7C2]OK6.YDL[BS:V$JAA"YA4EU!Z-\J\]1CBMZR^'>BV5S:,)
MM0FM+*436EA/=L]O XZ%4/IGC)..U;=AH5EIVKZIJEN'%SJ;1O<%FR"47:N!
MVXH \=;0-+F^$?B_59K.*6_CO;UX;EU!DAV3$J$;JHSDX'<GUKIKO1=.T7Q9
M\/[G3[2*"YGDFCN)T4"2<-;LQ,C=7)89R<\UUX\':2/#>H:#MF^PW[RR3#S/
MF)D8LV#VY-6[K0+&\N])NI1)YFE.7ML-@ E"ASZ\&@#R+4A%-I%OX@TKPY:6
MUK+KD4T.KW%WF]E8W(4L%"9VGYAM+_=[5U&B^'-(UOQSXZ?5;""]"W4,:+<(
M'6,&W3<5!Z$\9(YX%:[_  QT"2VFM7EU$VC.98+<W;>7:.7W[HE_A.>_.,D=
M":WM+T&STFZO[FW,S37[H]P\K[BS*@0'\E&?>@#RCPHB:Y;_  XTO5D6ZT_[
M!=SB"<;DEDC(1-P/#;5)QFM7Q?I%AHUC9Z/H,$5U;W_B"'[7I1N52%28V<18
M /EJQ16VD8/XUUS^ =%.@Z;I,1NX%TQBUG<P3E)X2<YPX]<D$'@TZ/P'H::%
M/I3)<RK<3BZENI)V-PTX((E\SJ&&!@CTH S/!^C:KIWBC4[N71++1=.NK:+-
MG:7(E4S*S#S  JA<J0#QSM%=S6+H?AFST*:YN(Y[R[O+G:)KJ]G,LC*N=JY/
M0#)X '4UM4 >7^*;>UUCQ#XB6V\,V6J36=DD%Y>:G=;([<%&<+"NQR#AMQ(V
M\XYJE:Z1J.I:'X6\0'1K+Q-&-!A@GL+R11(I(#&6/>"I8C@YP3@<UW-]X(TK
M4-:GU*62\4W007=M'<,L%UL&%\Q!][CC'0@8.:I1_#?2;:"UCLM0UBS>WA^S
MI-;WK*YAR2L9/=5)..XSUH U?!UQIUSX1TR328YXK#R=L44Y)>,*2I1LD\J0
M1U[5:\0W,UGX9U6ZMB1/#9S21D==P0D?J*GTO3+31M,M].L8O*M;=-D:Y)./
M<GDDGDD^M6G19$9'4,K#!!&010!XIJWAW1+3X-^&]2M[2".^=M/E:Z50))GD
M>,ON;JV22<'/*CTJU<:=?>(M=\9A_"UAJ[F[-FEU=7HB>V18D*! 48KRQ?((
MR3[5UJ_"WP^+9+1IM3DLH9%EMK62\9HK9@P8>6IZ=,<YX)'>K^K^!M+U?4+B
M]>XU"U>[18[Q+.Z:)+I0, 2 =>.,C!QQF@#C;+1$;XH>&4URQL[C4E\.[[J1
MHUDWW"-&OF9(Y88X/45B:;I&N^(/"LU[9^&=/?5;B_EN4UN6_"SI,DYQQLR
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MO?[5^W'[1*2V9=P\ODN"P*[CUQVH ]@.J:>LZP&_M1*\AA6,S+N9P,E0,_>
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M!Y!'>EKD?A=*\WPRT%G<N1;;0<YX#$ ?D *ZZ@ HHHH **** "BBB@ HHHH
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M"F5(95<QAAE=P!XR.GK5N@#&T/PQI^@RW$]N]U<7=R%$MU>7#3RLJYVKN8G
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MZ GFG:CJ^F:1"DVIZA:643MM5[F98PQ] 6(S0!F7_ABW/@2Y\,Z>@2#[$UK
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M[M_'Z5J7UC;W'QN\._:[*W9YM%EDG5HE(9\G)(QR:ZP?#SPT+[[3]CEV>?\
M:?LGVF3[-YN<[_)W;,YYZ8K6FT#39_$-OKLEN3J5O"T$4N]AM1CDC;G!^N*
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M9(K:".&/&=L:!1GZ"LFY\&Z!=^%AX:DT]1I V_Z.CLO1MP.X'=G=R3GGO6X
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M06'DB5 P0M&V6 /0_*.>O7UKT>J%KHMA9ZQ?ZM!"5O;]8UN9-Y.\1@A."<#
M)Z5?H \^\06=K-\9/"QEMH9"]C=EMZ Y(V8S].U4?#.F:9JGA?QE=:O;037,
MVI7R7DDR L@0D*N3R J@8].M=KKGA72?$-U975_%-]ILBQ@F@N'A=0V-PRA!
M(.!Q5/4O /A[5;^XN[FVG5KH@W44-W+%%<D<#S$5@K?B.>] !\.Y[FY^'7A^
M:[9FF:QBRS=2-O!/U&*S_BY%')\+=>+HK%( R[AG:=PY'H>379Q11PQ)%$BI
M&BA511@*!P !Z57U/3+/6=,N=-OX1-:7*&.6,DC<I]QR/J* ."U32-/N/B%X
M'MI+. VR6-Y*(=@V%@(B"5Z'GGZ@&N:\20FSE\>V%A##%:RZGI2R0D^7%MD$
M>_=M'"L<!B!T)KU#3?"&CZ7+83017#S6"21V\D]S)*R+)C<,LQR/E&,],<8J
M:;PQH]P^K-/9++_:ZHMZ'9B)0B[5XSQ@>F/7K0!S6AZ'K=MXZBU.\M= T^/^
MSWMY+?3KAV:8!E*,5,:C"\C/^UBN\K#T3PEI.@74MU9I</=21B(SW5S).XC!
MR$!=B0N>PK<H X+P]_R67QG_ ->EC_Z U1>,)8]1^)?@O3+-A)?6D\UY<;.3
M#!LP=WH&) 'K6WJOP^\.:SK$^JW=M<_;9U599(;V:'<%&!D(X' J]H/A30_#
M*2C2-/CMVF.992S/))_O.Q+'\30!Y3JTCW/A>/6]/T?2K#3)]<BFMYY)GDO9
M)/M0!DR1@%L-QN.%R*V#"MKXO^*5W9V\:WMOI]O+;.J#<DAMI#E3V)/7UKJW
M^&_A>1+J.2RF:&X9G\DW4OEPLS;BT2[L1DMSE<'\*O)X.T:/7TUM(KA;]8EA
M=_M4F)E52J^8N[#D GELT <%X?\ #^M267@RZBL_#=A:VCPRQW-O=2>?/&T9
MWI@Q@,74DD9ZC->MUS>F^ _#^DZC#>VEK,'MRQMHI+F1XK<MG<8XV8JF<GH.
M_%=)0!PDUO!J'QJ,6H11S):Z$LEI'*H959IB)' /? 49]*X_6+2VB\(_%&S@
M@B^P6EUOME"#;%(T2&0)_=^8]O6O4M;\+Z7X@EMYKV.9+FVR(;FVG>"6,'J
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M%W9Z5K/A^;4Q]@U.V?%Q#++(VQG'1_F;;N4].HH ]/EEC@A>::18XHU+.[G
M4#DDGL*X#4/B?97/@_5M6T"XLYKNQNE@\EY!)E#.L7F;5(.U@25/TKT$@,I!
M (/!![UX:UO"WP+\0@(JE]8="5&#C[:G&: /8+'Q'HFJ7\UC8:M8W5W!GS8(
M9U=TP<'(!SP>*$\1Z)+K#:1'J]BVI+G-H)U,@(Y(VYSGVKE/$%C;:?\ $/P,
M+"UA@(2^A41(%&T09"\=@0*Y#PYH^OZK\/="D#>';6 745VM[++(MP)Q-ELG
M;C>S;D(SWQ0![;7-^(O&.E:19ZI!#JNG_P!LVUG+/'9R3+O++&6 *9SVZ=<5
MTE>0:?;6%S\&_&%SJ$4374D^I27+N!N$ZN^SGU&$Q^% '?V_BO3;7PSI.J:[
MJ-E8-?6T4F9I1&K.R!B%W'WK2FUG2[:&":?4K.**X1I(7>=0LBA=Q*DGD!>2
M1VYKRS2(]9N/%&DKIT&DS21>%;,Q+J1? 1BP<IM!Y)"@^V*(- ^RZCX#TO49
M+"[A75=0D1+1B\*#8[B,9'16XP>F,4 >HZ7KFDZW;/<:5J5I>PQMM=[>57"G
MT.#Q4.G>*- U>]>ST[6M/N[E,EH8+A'8 =3@&O+_ !J)+"^^(_\ 9R>2TFBV
MCR"(8SEG5FX_V,\UT7C"ST^Q@\#/I,,,;QZS:16K0J ?)8$.!C^$IDF@#J[O
MQ;X<L9!'=Z[IL+F5H-LET@/F+PR]>HR,CMFIHO$6BS:PVD1:M9/J2@EK59U,
M@P,GY<YZ<UYI::;93>"OBE<RVT4DS7^I NZ@D!(]R@'M@DD>YJQ>6%K9>'_A
MA-;01QR_VC: R*OS'? Y?)ZG<>3ZF@#N;'5W&IZZ+[5M':SL2C!(),26J;26
M\\DX'3(Z< U8@\3Z#=:H-,M]9L);\KN%NEPK.1C/0'/3GZ5Y9'_Q_P#QI_Z]
M5_\ 2>6M75-.L[#PI\.GMK>.*1-5T_#JH#'>AWY/4[LG/K0!W\_B70K75DTF
MXUBQBU&0@+:O<*)"3T&W.<GMZUGCQQH9\9/X8^W6PO%A5^9UYD+$>4!G._ S
MCK@BO-O%UQ/=^"_%FIV&GZ19:7]OD5Y9B[W4\\<BIYBGHAW*-HYP!VKJH(A_
MPN?67CB0S#0873*C[_F/S]: .L;Q3X?75_[);6]/&H[MGV4W*>9N_N[<YS[=
M:DO_ !%HNEN\=_JUE:R1A2Z33JK+N)"Y!.><''K@UY9%:Z<W[-DMU(D9G:T>
MX>8@;S=>8?F+==V_CU[5LZ5I\.H_&&YFU.VCFGBT"U;;*H8+(68$X/?J,^Y]
M: /3:@N[RUL+<W%Y<16\((4R2N$4$D #)]20/J:E62-W=%=69.& .2OU]*X?
MXPB,_#'4Q,VV+S;;>P.,#SX\F@#I]/\ $6B:M>3V>G:M8W=S!_K8H)U=DYQR
M ?7BDB\2Z%/J[:1#K%C)J*$AK5;A3(".HVYSD>E<EXFM;'3/'/@62P@A@=9+
MF+$* 9MQ 2PXZJ,*:Y1YKF71?"&HP:?I&F:3=Z[:RV<,;.]U\\I)+.>,D%B1
MSUQF@#V2SO[/48#/8W4%S"&*>9#('7<#@C([@U0N?%7A^TT]=0N-;T^.S=S&
ML[7*;&<'!4'/)&#D>U>=ZKJLW@'5_%NF6P.=7B&H:0@[W,K"%T'J=[(^/0FM
M"+23HNI>'?"^BZ;IT^IZ;I3S&]OV<QQHS*KE47JSODD\8'UH Z+Q#XK73AX<
MN+&XLY;'4[]8);@MN3RC&[EE8''\(YY&,UI6OB/2M6T^[N=&U.SO_LZ,6-O,
ML@4X)&<'VKQ^VCMKOPWX7M[XVTEJ?&<R;8A^X(W3850?X"3P#V-=G?PPVOQ:
MG6SC2/SO#4K7*Q@ '$H"$X[_ '@/:@#4\$>,3K/PXL?$^O3V=D91(9I,^7$F
MV5D'WB<< =^M=+INJ:?K%FMYIE[;WELQ($L$@=<CJ,CO7AOAA;Z;X=_#2WM(
M[.0/J-TP2]+"!I5,YCW;03G.2/<"O3/"&E:I8^(]?N]1ETA7O! SVNG2,1&Z
MJP+L& P67;]=M &_X@NY['0KNZMKRPLYHT!6XU D0)R.7((X_&F-KVFV-C!)
MJ>K:?#(UL)V<SJB,O +KD_<RPY]QZUS_ ,7/^25>(/\ K@/_ $-:Q;6SM[SQ
MQX%%S"DHB\/R2('&0& B ./;- 'HFFZKI^LV8O-,O;>\MB2!+!('7(ZC([U+
M=7=M8VLEU=SQ6]O$NZ265PJJ/4D\"N.\%Q1VWC'QS;PHL<*ZA"X11@!F@0L<
M>YJ/XGK=26?AV"V2V<3:W KI=D^2_P KE ^,G&\+^.* .C&OV&IZ!>ZAHNK:
M=,D44A%R90\,3A2<R$'@#@GD<5C77CW3-"T[0?[9U73);G4G5#-:SJL.TAB9
MAN/^KRN,YZD5S^HZ3J]K;>-M0U*31HGN= =);33I')+*DFV5@P'4$KGOM]JR
M+.**3PK\)=\:-FZC4[E!R/*?B@#MH?'=E;^)=?M=6U'3K/3;+[)]EGDD">9Y
ML9<_,3ANG&.U='<ZWI5GI2ZI<ZE:1:>P#+=/,HC8'IALX.>U<AH.G6=Q\5?&
MLT]M%*\<5C$A= =JM$=P&?7 S]!7$:$FHR:?X M=/CL9 ESJIABORPAWI*P3
M[H)R%+[: /98]>TB73(]3CU2S:PD8*ER)U\MF)P &SC.>,>O%2Z?JNGZM%++
MIU[;W<<4AB=X) X5QC*DCN,C\Z\?\6Z-?V7@OQ1_:$^F*;W5;*1K;3)&*V[E
MHPQ.0"K, K?CFO8[*QM-.MEMK*VAMH%X6.) JCC'0>P% $>IZOIVBVGVO5+Z
MVLK?.WS+B0(N?3)[^U1-K^CKHXU=M4LAII&1=F=?*/./O9QUXKF-72.Y^+^@
M07J*]NFF74MJL@R#/OC#$ ]PE9^KKH-K>6FD>'M.L;S4+K6I)?+GF<6]M=)$
M7=V49Y"X^0#&3GK0!V]OK^CW6DOJT&JV4FG("7NEG4QKCKELX'XT6&OZ/JEA
M)?6&J6=S:19\R:*=61,#)W$' XYYKR^STN?6+OQEIMSJ&DVMZ-4L98_+0_97
MN%16"%&.6W% &&<DYJ+Q1>7C:5K&FW^BZ=8:P;C33?2P2LUM=V[3[59C@,JY
M#*01G![T >K:5KVD:['))I.IVE\D1VN;:99-I]\'BJGC#5[C0/!^K:M:+&UQ
M:6SRQK*"5) [@$''XU@Z-H^MQ>/8M3U)M!MF_LY[=[;3Y'WRKO4JQ5E'"G(S
M_M8J_P#$O_DF?B/_ *\9/Y4 :.F>*-&U*X6PBU:PEU(1AI;6.=2ZG&3\N<\?
MI6C97]GJ-FEY8W4%S;/G;-#('1L'!P1QP01^%><:_9:?9:1\/)=+AA25=5LD
M@DB4!FB=#YG(Z@KDGUK+U&^N/"'_  EG@^S^6?4Y4FT1>G_'TWEN%] C[FH
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M,Z--)Y99QAF";MJL03\P //6ICX+T$ZG8:C]CD^V6$2PP3?:9=VQ3D*QW?.
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY5XQ;M/>:39_"RX=GN8-6-K<$GEM.BQ,K^VY2B"O:+B22*VEDBA::1$+)$K
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MX>:V%<203^,V 9#]Y3<+R#]*]#\1:'-_;.D7/ARXTJWU33X9O*T^[3$<L+[
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(++2-"DDDM,S"62ZD/RH_'W% &[!.<X]*ZR;3;.XU"UOYK='N[4.L$IZQAP
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***IVNK:=?6
M!O[34+6XLQN)N(IE>,8Z_,#CCO0!<HJIIVJZ=J]NUQIE_:WL*L4:2VF610PY
MP2I(SR./>K3,%4LQ  &23VH 6BJW]H67_/Y;_P#?T?XU85E=0RL&4C((.0:
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MA0!9HHJM'J-C-?S6$=Y;O>0*&EMUE4R1J>A9<Y /O0!9HHHH **** "BBB@
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MW'_HMJNZ7#);:3902KMDC@1'&<X(4 U!XBM9K[PSJMG;)OGGLYHHUR!N9D(
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MEF&",$DJ 3D>QKF+7XB:G):66ORSZ+_8UW=)%]@1C]KBA>38DA;=@G)#%=O
M/7BK/P]\+Z[:7=U?^*(56Z@LHM)L\2*^ZWCY9^"<;S@\\_+5#P]X4N='AT_1
M)/ >DW$UK.$?6ID@,;P!LB3'^L\S;@8(Z\YQ0!ZI7*>*_$EWINJZ9HVFSZ?;
M7=\LLKW5_DQ0Q1XR=H9=S$L !D=ZZNN)\:>'I+S7=(UQ-"@UR*TCFM[BPE$9
M9D?:0Z>9\NY2O<CAC0!Q?Q"\13Z[\'_$,-Z;5K[3K^&VFDM&)BE^>-E=,DD
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MR0JJ'.>,D$<XH 9=^-KW4+S2[+2+C2].DNM+CU.:?4LLJ+)PD:J&7+$ALG/
M'3FH$\?:IJ>G:+9:9!8IKNHWMQ92,Y:2WA\C)ED7!!8$ %1D?>'-4F\(W6GS
M:%J5WX5M]>6/0X-.NK-_):2"6,9#+YAVD?,RG![ \U;N] UFTB\,Z[8>'+&"
M\TRYN'GTBP=(QY4RE#AN%+@!">@)SB@"K976JVWC_P 52ZM%9RW=KH$1#1(P
MAG :1@=A)(!S@C)Z'FI]'\9ZC=>"O"::78:;;ZOKK2)#$(V2VMU3<SOL!R0
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M;AV(WA2><G=QD8(&<YH T=(\7ZNFN:/::Q=:)<Q:L&5$TYCOM)0A<*V6;>"
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M8@*,$D9(ZUH^%-$UF'Q)H^HW^FO9Q6_AM=.E#RQL5F65>/E8Y!"[@?0\X/%
M$ \>ZS#X=NXY[2QD\01:VNB0[-RV\DK;2LA&2P7:V2,]J;&=<3XN:!!K;64T
MB:;=M'<6D;1JX)CR"C,Q!&.N><CI4%]X0UUK;6;NVM$>\A\3IK-E"TJ@7*(B
M+C.?E)&\<XZ5-?1^+M1\50>(H_#TEI'::5=PV]O)<1-*9V"E<X; #$ #D_=)
M.,B@"O:>(9=.MO$GBFVMTN;W6-:32]-1VPCB,B&,DC^'=YC&N@L]<\0:5XLT
MW1/$+:=<IJD4K6MQ8Q/%LDC 9D969LC:2001TZ50N?!=]#\--"TO3UC;5='D
MMKU(Y'PLL\;;W4MVW$OSZFK,%KK7B3QIHVKZAHTND66CQSLB7$\<DD\TJA.
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M058>7CA2N7)R1G@5':^*7U"XF^P6*W%K!?FPG=9_WL3A]C,T>WA<^^2,'&*
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M/7O#?@R]BNK2QN;C7EL[E%A9U,R/(H8?."4^0DKU.1SQSZ];K,MM$MPZ23A
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M'IZZI')8_8+RR\]87"ARZR(S<<$D$?Y';TR::*WA>:>5(HD&6=V"JH]23TH
MXC6]&\07M[X=\3);1-J6EW$KOIR2C!@E0(R*YP"X !R< DD9QBM+3=&N;GQS
M=>*;NV>SSIZ:?!;R,K.5#F1G;:2!R0 ,GH>F:VM/UK2M6+C3=3LKPI]X6TZR
M;?KM)Q5Z@#C?"WA6[T/Q#JID=#I"7#S:7$.L9FPTHQV 8$+[,WK6?I5KXO\
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M&.E.;W3-1MY[A!/%@)'(7)!W<Y!X_I6HMMXK\->*]6FTO18M7TK5YEN@#=I
M]K-L5&#;L[E.T'Y<X]Z[^LB/Q1H<NGS7Z:G;M:07'V664-\JRY"[#[Y8#\:
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M8EFGSL[N2_SG"G'W>2!6DWQ&NM,TKQ%$-1TW7;O3X[=[*[M,".8SOY:JX5B
M5?K@\@CI4>F>$/$D7@S1=/N=)LC?>';I9;=)+D/%?H0ZNOW?DRK\9!Y Z5J:
MEX:UKQ+X5UFTETK3-$FF,3V$41#N'C8/F5U&,%@  !P,]: *6IV_B&S\>^!X
MM9U&UU!'NKAA+#;>08W^SOE<;B&4YX/!X.<YKJOB#K%SH'@'6M3LV*W,-L?*
M<?PLQ"AOPSG\*Q'L/%FO^*_#.JZCI-KIMKI<TK31+=B9W+Q,NX8   . !R>3
MG&.>QUO2+;7M#O=)NP?L]W"T+D=0".H]QU_"@# T;X>>&;/P]#8SZ/97CR1
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M98S$2%E'!RGS%3QU%8.@:!J6L^'M2NHA9WNI6/BNXO51_E@NB $D0$@X!W,
M2#R!0!+K'BO4KSPOXOTF'Q%INH366F_:H]1LHU(DA8.KQL%<A'!7@@]&!Q7H
M/@V*^A\)::-0O([J5K>-E=(?+PA084C)R1Z]_2L&?0]:UWPQXCLYM&TS1FO;
M-K>S@B8.^XJV3(ZC&"2N  <8)KH?"8U-/#EG;ZMIZ6-U;QK"8TG$H8*H&[(
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M3S#N0.W5)(P!M7OA<8'-=7\0M-UF_M["*#0;?7]*MPTEW9RW7DR3.!A2.,'
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MM&O;!5>YA .8PPRI/&.13M(UC3]>TR+4M+N5N;.;/ERH" V"0>ON"*\^T/\
MY+%\0_\ KSM/_1-7O@C_ ,DDT;ZS_P#HYZ /0:J7^IV>EI"][.L*SSI;QE@?
MFD<X5>/4U!X@U9="\.:EJS)Y@L[:2?9G&XJI('XXQ7F>OIXG;1O"5_J^JV]Y
M'>ZQI\DMNEJ(OLS,X8!&!RP'W3NYZ'/:@#T^WUK3KO5[S28+I'O[)4:XA .8
MPPRN>W(J_7 0>*=4?QSXWTLR1?9M)LH9K4",95FBW')[\^M95IXN\2V?PX3Q
MAJFHV1:]@@BM;5H D<,CNJ><\F<D<EBO  X]Z /5**\NLOB$-+O[^"?Q)8>)
M+:/2YM06:T5$>-XL;HV"$C# Y!//!ZULZ0OCF6/2]1GU2RNH+^/==6PM1']C
M#IN5HVSE]IP"&Z^U '7ZAJ%II>GSW][.L-K;H7ED;D*!U/%/M+J"^LX+RVD$
MEO/&LL3CHRL,@_B#7BEG'J;?"/QW<WNI_:8WN+Y3'Y 3]X)/F?(/?^[T%=5H
M.N7^C_\ "!6LSH=&U71XK8909CNEB5ERWHRY 'J* /1Z*Y?1-:O]8\:Z_"CH
M-&TP1VB (,R7)&^0[NOR@JN/>NHH **\FM?$'C:]\!WGBU-5LXQ8-<.+,V8*
MW,<4C;MS9RIPI V_W<]^-;Q'XGNP]I<Q^*]*\/V4]@ES;I.J2S3R-DX96Z(!
M@9'))/(H ZO6_"NB>(GADU73TGEA!$<@9D=0>HW*0<'TSBKVG:;9:1I\-AI]
MM%;6L(Q'%$N%4=?Y\UPVC^-=3NM2\(W5Z(DTOQ!IY7:JX\J\4;OO==K#< #W
M%;>A:U?ZSXQ\01HZ?V-IK1V<0"#,EQC=*<]?ERJXH ZBBBN:\:Z[>:)I=G'I
MHB_M#4KZ&PMGF7<D;2$Y<@=0%#''TH Z6BN*M-1UW0O&FG:%K&IQZI;:K;S/
M;S_9EADBEBVEE(7@J5;([Y%5OAEJGB;Q-H=GXAUC4;?[+/"\:6<5L%+,KX\U
MGSP?E8;0,8P>M '?445YQX?\0^(]1N-?U:^U""+1M#U"]@:V2V!DN4CSC+Y^
M4*-O09)!S0!Z/5"PUK3M3N[VULKI)I[&3RKE%!S&_H<_2O--'^(=R]UH%W<>
M*=(OVU:XC@N-(MU0/:>:/EVL#N)5MH;=ZGI5H>-=9%A\1YA+"'T.5ELCY0^4
M!6/S?WNG>@#U"J]]?6VF6$]]>2B&VMT,DLC=%4#)/%>=7FK^-+"^\..=4L95
MU]C";9K0!;-C'O#*P.7V@'(. <=L\5=<U/65T'X@^'M8OX]0-CI0G@NE@$3%
M9(WRK*O'!7@^] 'JD4J3PI+&P:-U#*P[@\@T^O-(M3\4>';;PMJ-_J-M<:?J
M,]M936"VP7[,)5PA63.6*G .>O. *U]+\2:C=>&_%U[+(AGTR^OH+8A  JQ#
MY,CO0!VE%>8R>)O%&I7G@[3M.O;:VFUK1OM5S<26X<1.%1BX7C/4@#.,D>E/
MO=?U[_A*+S1!XHT[3;ZSCA%G!>VH5=38Q@LY8G@%]RX3D8[T >ET5YEKOC2X
M/B?5=,3Q7I/A[^S(XE5+I4<W4SIO.2Y&(P"HX&<D\]J[7PIK?_"2>%=,UGRQ
M&UW;K(Z*<A6Z,![9!H T+V^M--M7NKZZ@M;=,;I9Y B+DX&2>!R0*RQXT\*L
MP5?$NC$DX %]%S_X]6!\8B%^&E\60NHN+4E ,EOW\?&.]0VNJZ!/=PPCX=:M
M"9)%422:&BJF3C)/8#KF@#T&BN&\1>+[WP7KD[ZM&UUI%[#_ ,2TPQ?.MRH_
MX]SCKOZJ3Z$50UCQ-K>A:9X?T_6M:T_3-4U5Y9+J^E1?*M$10Q1 3AFRR*"2
M>Y]* /2**\M@^(EX-#U2VM=0L-7U*#4;:PLK^)1Y,WVC&QF"G&5^<$#@[>V:
MUM2N/&/AG1M=NKO4K;4[:#2Y;FWNS;K"\4Z@G84!(92.<]>,<T =Y4<TT<$,
MDTKA8XU+.WH ,DUR>L^(=0LM)\(W$+H)-3U"TM[DE =R2(Q;'IR!7.>%CK5O
MXA\?7LVKB<6LY#1FV4>8RP+L;.>   ,=Z /1]+U2RUK38=1TZX6XM)P3'*H(
M# $@]?<&KE>6Z+XVUMO"_@?7KZ6%K/4KI[340L07#.S+$XQ]T!E /UK5\0>,
M[S3?$VKI;;'TS0M(:\O5VC,D[Y\J//;@$_C0!WM%>7Z#XXN/^$@T2UN/%>DZ
MV-5+1SVUHJ*UG)L+KMVL2R94J=W/(.>U>H4 9&M^*=#\-F :OJ4%HTY(B1R2
MSXZX R<>]:P((!'0UY'XAT_6)OCMI"P:VL,CZ;-);N;-7\A,D%<$_-GGGWK;
M@U'Q7XF.N7^D:O;V%MIUW-:6MLUHLOVAHN&:1B<@,V0-N,#UH [^2*.7;YD:
M/L8,NY<X(Z$>]/KR^3QIK^OW'@V'0YK>Q.O6,\LSRQ>:(&0*2P!QG'S #/)(
MS7I5I'/#9017-Q]HN$C599M@3S& Y;:.!D\X[4 34A8 $D]!DTM>:>&8=6;X
MI>-3-JXD@MS;*\7V91YBM"S( <_+MSVZT >@Z;J5GJ^G0:A83K/:3KNCE4'#
M#UYJU7B?AW4/$_A_X1:-XB@U.V6QM1$ITTVP;S8FF"$F3.0QW$C' X'/6MW7
MO&\Y\1ZU90>*])T)=*V1PP7:HS7DI0.=VX@JG(7Y><Y.>U 'I]%97AK6!XA\
M,Z9K C\O[9;),4!SM)'(_ Y%<]\4;B?_ (1NQTR"=X!J^IVVG32QG#+'(WS8
M/;(&/QH WH?%GARXU#[!#KVF27A;:($NXRY/IMSG/M6E=7=M8VSW-W<16\"#
M+RRN$51[D\"L&\\ ^%[S06T8Z-:16OE[$,,2K)&>S*V,AAUS^>:YS4=,@UKX
MH:3X;U(O>:7I.C"^6&X.\3S&3R@T@Z/@ GGN: .TTSQ%HFMNZ:5J]A?,@RRV
MUPDA4>X!-%_XDT+2KG[-J.M:=9S[0WE7%TD;8/0X)!Q7%_$_2+#1/#/_  E6
MEVD%GJNCS130S01B,NID56C;'52&(P:R]6NK2V^-&I-=^'KO6E;2( L5O:).
M8SO;DAB,>E 'J5CJ-CJ<'GZ?>V]W#G'F6\JR+GZ@UF-XS\+*Y1O$NCAP<%3?
M19!]/O5Q/@<V<OQ.UJZM=.?0%EL(T&DSP^1+.0V3<;!\N.=N5)[YQ6!X)\2>
M!])\%!=>T]7GBGN3-*^DO,I!F?&9-A4\$#K[4 >W0S17$*30R))$XRKHP*L/
M4$=:I-<Z2-=6 W-JNK&'(A$H$K1Y/5<Y*YSU&!S7)_#BV?1O#.K7EU;2:9I<
MM_<7EG:SC:;:U(!&5_@'#-M[9K@'=I]%F^*2S1_VPNIB^BMS( _V!?W7E8SW
M3+&@#WF2-)HGBE17C<%65AD,#U!'<5C?\(;X6_Z%K1__  !B_P#B:U+.[@O[
M&"\MI!);W$:RQN.C*PR#^1JCXGOI]+\*:QJ%JP6XM;&::(D9 94)''?D4 0_
M\(;X6_Z%K1__  !B_P#B:/\ A#?"W_0M:/\ ^ ,7_P 37&G7O%NEZ3X>\2ZC
MJ5K/9:A-;176GK:A1"DV &63.2P)!(/!R<8J[I.K^)-9\8Z];_VE;VFDZ+?A
M6'V8.\Z%%;R\Y&T#D[N3\P]* .E_X0WPM_T+6C_^ ,7_ ,31_P (;X6_Z%K1
M_P#P!B_^)KSFQ^)D\L&G:W)XGTF5;R[CCDT%%3S889'V A@=QD4$,<C'7@5J
M2ZUXNU./QA<6.K6UE#H=W,D -HLAF"1J^QB3P/<<G=[<@'9?\(;X6_Z%K1__
M  !B_P#B:H6NC>!;W5;W2[?1-$DO;'8;F$6$>8]XRN?EQR*YR/Q)XHBM?"?B
M*ZOK4V6N7=O;R:8EL (DF4E6$F=Q8<$]N?:K \7:L/$OQ#LQ)%Y.B64<UG^[
M&58P%SN/\7([T =5_P (;X6_Z%K1_P#P!B_^)J2W\*^';2XCN+;0-+AFC8,D
MD=G&K*1W! R#7/ZAXFU*W\&^$]2CDC%SJ5UI\5R2@P5FV[\#MU/TK.EU;Q;J
MVH^+H=/U:VL(-&GQ 3:+*TO[I7V-DX"YSSR3N[8Y /2*A@M8+6-DAC"AV+/W
M+,>I)/)/UKS.+Q1XJ&B^&/%5Q?6@L]4NK:";3$MAM5)3MWB0G=NS\V.G..V3
M;3Q'K5_XMU&Q@\0:;87EI>B*#1;R *;F ;?G$A.XE@6(V@@8&10!Z)%%'#$L
M<2+'&HPJJ, #V%5-6UG3M!T][_5;R&TM4(!DE; R>@'J?85>KROXT6M]-#X:
M:+4!%;OK5K$(3 &Q*2^),D\X'&WH: /2M.U&TU?3X;^PF$UK,"8Y " P!QWY
MZ@U:K@WO/$M_XG/A>SUN*!K"R6YO=1^Q*SRO([!$5"=J@*I)//X5CZAXZ\0V
M/A:\&;:76=-UV+3)7$>U+E&*D-CG:65AG'0YQ0!ZI16=HEKJEII_EZQJ4>H7
M9<L98[<0J ?X0H)X'/)YK1H **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\:LZC^%B.1^=87C/0+K7M*M3I\L4>HZ?>Q7UKYV?+:2,_=;'(!!(R/6NCHH
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M44 %%%% !1110 4444 %%%% !1110 5YW\2F6/Q#X'E:!IMNK'Y$4,S?NSP
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M:U!(]NT,S-)&\:!R'!&.0>V<'N>M '67-U;V<#3W4\4$*\M)*X51]2>*S/\
MA+?#>W=_PD.DX]?ML?\ C5G7 #H&I \C[++_ .@FO/\ P/JSQ?"OP_:2Z#>7
M-O/%#:R2$1F(I)($+'Y]V,,?X: /3@00"#D'H12UR/B3Q/=>$=2TP7-M%_PC
M]PWD27BAV>W?;\@91U#$8!]>WK9NO$5[I'AZSN]6M(DU"\G2"*VB+$*[] Q
M)X ). >A SU(!TM%<,?'ESI;ZS_;&G2M;6%LMS!>P6\D<=QDA?*Q(/E?<0.I
MR#GC%;$=]XE35X;2XTZU:VN+9I/M4+$K;2C'[MP3EP<\,,=.E '0T5P,7CZ]
MF\":'XE%C;@W]Y';2P%S\@>8QY5O;&<$58T[4]=N/B?KU@TEJUE:6ELT41W#
M <R'.>?F) R<= /Q .LL-2LM4A>:QNHKB..1HG:-L@.IPR_4&K5<#;^+]5?P
M#J^NV.C68NM/NKE9+-'.UQ$Y#D, ,MP3TYKH(==DO'T9K-[:6WO+8W<TN" L
M052&7GN6  /N>V* -ZJL>I6,VH3:?'>6[WL"AY;=9 9$4]"5Z@&N,'CV^F@T
MS5++2Y+O3;Z=4,,-M,9HHF/RS;MNTC&"5[9ZFNG30+)/$\FOB"!;QK<V^^.$
M*[J2I.]NK_<4#T&?6@#6I&940N[!549))P *Y'POXNG\3BUNK1K&2VD9UNK=
M&(N+%@#A9 3R<C!X'MD<UH>-]%O/$/@W4]*T^9(;NXC C9_NDA@VUO9@-I]B
M: +EIXBT2_E$5GJ]A<2$X"17",3] #[&M.O-=(\7:?KFO:5H_BC2)-"\3V,O
MF6T4J9CE.TJ?)DZ$$$\?3&<5I:KXVODBU2?1K 7@TV=H&M_)E9[EDQO",BD*
M020,YR1VH [BBN'D\7:_>^)'T72=&M%E?3(M0BDOIW3:'8C$BA<JPP1M&?J*
M-(\;ZEK.@1SQ:0(=1BU)].U!'?=%9,@)>1CP64#'IRP&>] '<45P'_"P+O\
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M<L%P".A-6;3Q%K_BK7]#L[/46TNVU#0!?W(CA1GCD\Q5.S>#@Y..<C&>,\T
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M1TR"1FNM/,8N%*D!=Z[EP>_% '$P?#>YETSQI8WMY"BZ]?M=VTD.6,/S;D+
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M)K<HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB-J?B&>:%[&]TL6!@YWYW DGMC -8_\ P@WB2;PW!X/NM2TYO#T3)&UPJ/\
M:I+=&#+&1]T' "EL].U %F"76/%7B_7X[;7KO3+/2&A@MH[9(R))&C#LTFY3
MN'S ;1C@5/\ "(R'X:::90HD\ZZW[>F?M,N<4^;PWXBTWQ1JNH^'KS34M=6$
M;7"7B.6@D1=F^,+PV0!P<<CK5?2-&UKP9X3\.Z+:7,=Q*FJ%+IQ&6\R"221V
M[?*0""3['U% '>5PNM?\37XO>']+EYMM.L9M4V'HTI81(3[KEB/K7=5POB@?
MV'\0O#WB:3BQFBDTF[E/2+S"&B8^@+C!/;(H /'FE76G7$'C?14']I:5&?M<
M.<"\M.KH?<#+*?4?2H?!%G-XGU1_'VJQE6N4,6D6S$'[-:_WCVWOU/H./:NQ
MUNQ?5- U'3XW5)+JUE@5FZ LI4$^W-5O"FCR^'_">EZ1/(DLMG;)"[IG:Q Q
MD9H YVU_XE7QIO+6'Y;?5](6[E0=//BDV;OQ1AGZ5W5<+HX_M[XJZMK</S6.
MEV0TF*3^&28OYDN/]WY5/OFNZH \/@T^ZB\)_%*>;6+ZZ$4]W;F.;R]LA$*8
MD;"@[L#'! QVKI%.N^'9?!]])KUS=1ZG<PV5U8O'&($5XF(\O"[AM*CDDD]Z
MLS>!]<\KQCIT%WIQTW7S-/&[AQ-%+(@7!QQM&/K6[J_AFXU&V\,Q1SQ*=)OH
M+J4MGYU2-E(7WRW>@#SW4O'5Q*VN:E#XDO;;4+"[FBL-)BLR\$J1-MVR'RSE
MGVGG<-N1Z5[%:SBZLX;@*5$L:N%/49&<5QR^'/%.E7&HVF@ZEIT&F7UV]T)I
MXF:>U:0YD"+]Q^<D;L8SSFNV P ,Y]S0!QGB6[U'4?&FD>&+'4I]-@EM9KV[
MGM@OFLJ%55%+ A?F;)..U<WITFHZ/JOQ',VN0074'V(+J=W&,*OE?*S*!@MM
M(' P6[<XKKO$GA_5;GQ!IGB#09[--0LXY+>2*\#>5-$^"02O((*@CBL"3X?:
MW=0^(I[O4[*34-4N;.\B(C;RDD@((1EZE. O7..?:@"GI&MW%WK.J:)8>)M8
MO+1](:\CN[NU\F>"57"G86B4,I##L<8ZUCZ)J]SX;^%OA.+^W;RW36)51[@P
MK(;.%5=F$2JA.3@ %@V,D]J[:#PSXCG\5Q:[J5[IQ,UA+87%M 'VQ1L0RF,G
MEFW Y+8X(P.*S]+\#>(K+POI6GO?:8+_ $&X6739XTD*R+AU99@>1N5\?+TZ
MT 7? ?B!]0U;5]+34[O5;&V6*:UO;J QR8?<&C8[%W;2H(..C>U=AJ4,EQIM
MS%%<RVTC1D+-#C>A]1N!&?J#5'0H-?1KJ?7KNS=Y67R;:S0^7 H'/S, S$GD
MYX&!@=:UG4/&R'HP(H \(TRSOD^$7@V:+4II9[K6[,P+<!6CMV\UP,  $C/)
MR3]17>64VK:#X_.C3Z[<:C9W6E2W@:_$8,,J.JY!15PA#=.V*IZ3X"UZU\,Z
M-H-Y>::\&CZI;W=O+$'#211R,[!P1@,<@#''7FM[7O",NM^(FOC=)%;2:/<Z
M:P .\&4K\P[8 !H Y#1?$\\?B/P_'%XLO=:;4IG@OD:S*6H/ENP:!_+48#+C
M&YL@UH_"RPNHK_Q9/-J]]="/7+FV,4WE[7*B/]Z<*#OP,<$+CM4J>$?%LJ>'
M6N;[2%;0ID\B"%9!',@C,;,Y/(;:1@ 8'/)R,:_A?P[J_A[7M=+3V,VD:C?2
MZ@F XG223;E3_#M&WZT =;7D'PT\0:U9> =.M[7P;?ZA C3;;F*X@57S,YX#
M.#P>.1VKU^O./#GAWX@>%]"M]'L;OPS);6Y<HT\<Y<[G9^<$#JQ[4 :WB74=
M<M/#UGXEM(9;0V&;C4-*D9&\V#'SKN&0'4?,"#CC'-8G_"8ZJ_A+Q#X[CFQI
MGDF/1[-E&,!MGG2=\L_\/91ZFMK4?#WB'Q+8:?I^O76G+9B<RZC'9"0"Y1>4
MC&[HI/+<\XP*AD\ L4\0Z3#<QQ>']8B,BVZ@[[2Y/WFC'382 V.Q''6@##T+
MQ9]E\3:=:P>)-0UVVNX)C>BZLS&()$3>'0^6N%.UEVDGJ*O^&X?%FNZ-I7BJ
M+Q"PGO9%GETV9$%J+=F_U:X3>&"XPV>3UK?TFR\6R7D?]O7VF&RBA:-HK*-B
M;IC@;G+CY,8/RKW/7'%8VE^$O%>EV=EH$&M6<6@V<X9+B)7%XT(;<(3_  C^
MZ6';M0!/HVMZE<^'O&ES-=,\UAJ-]#;,5'[M(U!0#CG'O7*[-2UOQ/\ #6ZF
MUR_BFO=(DGD:(1C:XAC+$ H?O9YSGVQ712>$/$MN_B+3].U#38])UJXEN6EE
M1S<0M*H#JH'RD<<$],]#1+X+URT7P9<Z7=:>U]H%DUG*MT'\N4-&B%E*\\;,
MCZT 9ZZMXDU;7_B1I5AJ<L<VGQ6[:8%13Y3F,L0,CG<0!SGK5O4O&%YK7A/P
MH-$N#;ZEXAGB3S$ +0HHW7# $$?*%*_C6WX?\*W.D>-O%&N2W$+PZPUN8HTS
MN3RT*G=VYSVK.\-> )M#\8W>J37<4NG1>=_9EJH.;;SG#R9[=1@8[&@#E-5\
M<3S3^(+V+Q+>V=_IUW-!I^F169D@E$1QB0^6=Q=@PSN&W(KUZQN?MNGVUWL*
M>?$LFQNJ[@#@_G7(GPYXITN[U2W\/ZCIL&GZC=/=>;<1,T]H\F/,V+]U^<L-
MV,$\YKM5!"@%BQ Y)[T <=XWU 6MUIMO-XDFT>UE\PO'8PF6[N" -H0!'(49
M))V^E<LGBO7[WPKH(L]587<OB5M*:\EM@K2PCS0&>,@8; 4D8'*\]Z['7-"U
MIO%=KK^AS:?YZV;V4L=\'VA"X<.NWG((Y'&1W%8EEX!U>W%G!/J-K<16OB'^
MV!,599)0RR;PPQ@-N?C'&,T 6=+O+_P]X\OM&U#6[K4=-_LC^TA+>A-\++(4
M8915^4CG&.,5B>,M5U37OA]I^L>7:Q:=>W]G+' 5;SDB,R%&+YP2>,KM&-W4
MXY[*\\+M?^,I]6GE0V4^C-ICQ#.\EI-Q/IC'%<N_@?Q6W@R'PJ;[29+6RGA:
MUNW\SS'BCD#*KH!@$ 8R"<XQQUH [&^D2X\2VD3L!!IT+7LQ/9F#1QY]L><?
MP%<]<>-]3C\&IXSBM+:31\^8UIM83_9]^WS ^=N['S;=O3C=74V&F2)_:,E^
M8I9;Z3YPF=HC"A%49YZ G'8L>M<G:^"-6@\&S>"Y+JUDT9F,4=YO87"VY?<4
M*;=I;&5#;O0XXP0">\\4^([KQ7=:)H5EI<F-.BO[>>ZED"LK.5PVT9!.#@#Z
MY['N%SM&[&<<XKE[3P]?6OC^76T%HNGMIL=@D2R-YBA'+!L;<?Q8QGMU[5U-
M 'G7BN>2V^+_ (/EBM)KIQ:7H\J$H&/RK_?91^M=/8W=UJ=WJ,W]EMIU[:@0
M0-=A6+JRJ^3Y;D%<\=<C!]Q6;KGA_6KSQUH_B"R%@8=-AFB$4TSJTOF  G(0
M[<8]\UIA/$TMT\\@TV&..!A#;QSR.'F.,,[;!\H&> ._L* ,7PSXLUK7[TZ=
M/9VUKJ-A/(FKQ,CE85S^[\LY^;>.0>F,GL-S=4\9ZF8]6ET.R-T=-G:#[.;*
M>5KITQO"R(-J')(&0W(YQFC_ (1#5;+7-)UW3)K1=2$;1ZN9I6VWJMSV7J&R
M5.!M&!C'%)'X:\5:)XAU*;P]J.F?V5JEP;J:&^C=GMI6 #M'M(# XS@D?X@%
M^+Q)J.M7MU9:-;Q6UQ9V<-Q.+^-B5DE4LD)4,I4@#YB3QD#!YQ%%XHUB/7/"
MVGZAIL-H^L0SM<0%MSV[Q(&P&!PP.?3BJ]WX6\0Z9XJ?7/#5_92&\MHK>_@U
M,.1(8QA)04YW8X(X']+&L^&M:FOO#NJV-Y:W&I:4\QE%WN2.83+A\;0Q7!QM
M'/'&: ,3Q%XMUN3P?XW-N]M;76C2FW2=(V.Y#&K$@%OE;Y^#D@8Z5LW^N:IH
M\OA6VG@L;E=1NUMY)@&4QYC9@54D\X!&<]^E4&\!ZO=:3XRLKO4+/.O.9(GC
MC8>6VQ5YR>F5Z<G'>KVI>'M?U(>&99GTWSM*NUNI@CNJMA"FU?E)_B)R<?2@
M"S9^)+U/&6KZ'JOV2"*VM$O;2558>="20S'+8&PC!'?.>*A;Q3?QKI5E+$D>
MIW]N]VVRTEE6")2H&Z-"6+$NHZ@#GG@ V?%'A(>(-5T:^CN/(>SE=+C'_+>V
M=</$?4$A?PS47BOPYJ][JVF:]X=O;:VU:P5XBEVK&&XA?&Y'V\CE0010 NCW
M=[XLT'4;+6])%K+%<-;YN+-O*N$!!65(Y1G![ YP1WJ/6-=M?"$VA:$EQ;:=
M:30-%#=WJL\2&((J1DAEPQ!)R2/NGKFM[1H-4BM&DUFX@EO96W,MLK+#$,8"
MINY/J2>23V& *>O:9>ZG-'#]DTZ_TN2%TN;.]8J&8D;6!"-TPW;N/2@#1TN6
M\GTV&2_2)+I@?,$)RG4\J>X(P:N5B>$=!;PSX7L](:<S&W#8;)(4,Q8*"><*
M#M&>PK;H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***XK7)K_6_'L'A
MB#5+O3;.'33?W$MFRK+*QDV(NX@X PQ..O% ':T5YUJ+^)+.X\.^$KC7'\[4
MKNYWZG"JB<VL2[P#D8$ARH+ =LU3U(^(M.U#7_"NG:W?7,W]CKJFG7$Y5IHW
M60JT18 ;@V!U'&30!ZC17G>I^*[GQ!HW@Z#1;EK:[\031RRO$?FB@C7?/@]B
M/N_C7-7WC*[NEUK58-;UF+5+2\FCL-.M[&1[5TB<J$<B,AB^TY.[C<.F* /:
M:*\V$NL^(_B3J&F)K5]IVEPV%K>&*W*K)O;=\N6!P#_%QD[0..:YZ^\97=TF
MM:K!K>LQZI:7DT=AIMO8R/:ND3E0CD1D,7VG)W<;ATQ0![56?HFM6>OZ:NH6
M)<P&22,%UVG<CE&X^JFN-M)-3\8>+];1-:U#2[/2EMX[>&U*KF22,2,T@93N
MQN VGC@U:^$GF_\ "O;7SRIE^U7>\J, M]HDSCVS0!W%9TVM6<&OVNBN7^V7
M,$D\8"_+M0@-D^OS"L3Q_J=]8Z7IEGIURUI<:KJ<&G_:4 +0J^2S+GC.U2!]
M:Y>\@N?"_P 2;*>;4KO4K:WT*]N(_MC!I5*E"R[@!D' QGD9/.,8 /4)X(;J
MWDM[B))H95*21R*&5U/!!!X(-,M+.UT^U2ULK:&VMTX2*% BK] .!7D>A>*[
MQYO#M_%K>M:AJ&H7$*:C92V$BVJ)+U,9,8"A"5P0W(!ZYJY8Q>(M=T7Q1JA\
M4:C:S:=J-['81P% @$;$KY@*DN/X<9P /4T >KT5Y!-XW.NWFDPZAJNJ:5:O
MHL%]+_95N[R23RYX)5'*HH4X'&2>^*EM]?\ $6KQ>#[-=3NK2:[O;VTN+DV_
MEO/%&C%9-C+\K%0",C 8].U 'K59VJZU9Z,U@+LN#?7:6<.U<_O'!(SZ#Y3S
M7GMUKVJ^#3XVM/[3NM2CTW3X;RR>^(>2-Y-ZD$@#<NX XJ+7]$U+2G\$S76O
M7VH^=K=K]I2[*L!*5<[H\ ;1]X;>1R/2@#UBBO%;[QE=W2:UJL&MZS'JEI>3
M1V&FV]C(]JZ1.5".1&0Q?:<G=QN'3%=+#_:OBCQSKVGG6]0T[3;>ULYDBM65
M)%>1&.-Q4X'!R.YQZ$$ ] GN8+8(9YHXA(XC0R,%W,3@*,]2>PJ6O$-1FU+7
M_"G@J6_UB]%TOB4:?)+"RIYFV255E(VGYP$&#TY/!K;U^_N=/\2W=EJ_BG5]
M$ACCA32+PQJ;68[!N:9MFUFWYR&*C&,8S0!ZI6?_ &U9_P#"1#0LO]M^R?;,
M;?E\O?LZ^N>U7H]WE)O96;:,LHP"?45YUK>G76J?&6"UM]1N+",^'RTTMJ0)
M2HN.%5B#MR<9.,X&.] 'H]%>/W?BS5M$TS4]"N=6NGEM]=BTY-3\GS;A+:2/
MS<[54[I H9<[>X..*D3QK<Z%8^)9+"]U35+"TTT7=I/JEK(CQ3[BAC+,B[UY
M1OS% 'KE%<=IVAZ[HES::C+XEN]0M_(=M2@O=I#-MR&A"J-F&SQTQ[UR@N?$
M4GPV;Q__ ,)#>KJ/E&_6R!3[((@V?*V;<XV<;LYSSF@#URBO.4DU3Q1X\U33
MDUR_T_2TTZTN52T95D#OOZ,0<#N<=2!VR#S?]H^)C\+9_%\WB6]^WZ9*R111
MA%AF2*;RSYJ[<LS ')R.WOD ]JHKRSQ!XE6[\9:OIMWKVLZ5!IT4*VZZ9:22
M[Y73>7D*QMD ,H"G ZUV_@[5+S6?"&F:AJ,317LL(\]6C*'>"5)VGD9(SCWH
M W**XOQI=:J/$OA33--U*6Q74+BXCG>, DHL);C((W#!P3T.#@]*YV^\0ZKX
M)_X36V_M*YU./3K"WN[)[XAWC>4LA!( W+N .* /5J*\YOX=9\&7/AV^?Q%J
M&I?;M0AL+^"[9&C8RY&^,!1LPV, =J]&H R+7Q)I]YXGO_#\32?;[&))9@4P
MNUP",'OUK7KR=-1_L?XM?$#4]@?['HT-QM/\6R,-C]*==2Z]H/@C3O&LOB*_
MNKMOLUQ>6<A3[,\<S*&1$"_+@/P0<\>] 'JU%>=6]MK'B;Q=XML'\1:C865A
M<0K;)9LJL&:!6.6(/R@\X&,DG/:LO2?$.M^+-/\ !.F/JD]G)J-K<7.H75KM
M6600D( I((7<QR<#Z4 >LT5Y'>^)-?\ "Y\=13:M+>_V;#81V$LT89D\]F7>
MRJ,,PW#/'.P<<U>\.ZY)'XIM["PUC7-6L;JTF-P^I6<D9@F0 JRLT:X##<-O
M."!0!Z=4-U:V]];26UW!%<6\@VO%*@96'H0>#7"?"H:QJWAG3_$FL:Y>W<UU
M;M&MJ2HA50^ Y&,ESM)SGHV,<5UOB756T/POJNJH@=[.TEG53T8JI(!_$4 :
M:JJ*%4 *!@ = *P+/QCIFH66M7-JEU,ND7$EK<QI 6<R)]X(HY;VKA?#WB.Y
MCUGP^;?6]<U:6_?RM3@N[&1(4W(2)(R8U"!7 & 3D'VS6?H5]<Z9X.^*M[93
M-#<P:S?/%(O56&,$4 >NZ0MFND6K6%F+.UDC$L< A\HH&^;!3^$\\CUS4M_>
M)I]A<7DD<LB01M(R0H7=@!G"J.2?:O.H=3U?7QX'T5=6NK,7VC#4=0NK<@32
MD1Q@*&(.W+.2>*K/JNOZ7;_$BTGUB>Y?2+&)[&=@H= T+L&. !NZ9..2N<4
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MQOM*GN86O'5Y8)HB,X8 94ANAZ$5-\,(]6U'PUI_B+5];O+RXO+4+]F8J(4
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MNQ:PA1PF(%X.YAS6CX#DD\2>)]5\;0V9L=-O[>.U@B=E,DQC9MTD@4D*0?E
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MK(CP3L&=^[.Z@#VZBO/A'J_C#Q!XC6WU^^TJ'2IUL[..T*A3+Y8=GERIWC+
M8X&!ZFKNEW^L+\1H])U*[239X?BGF2$8B:?SF5G4'D9 H Z^XN8+2!I[F:.&
M%<;I)&"J,G R3[D"JESJ\5MK-EIC6]V\MVKLLL<!:)-HR=[]%SVSUKR/Q=<W
M^K^"O$K7&IW@%IXH%K&B. /*\R':IXZ*3D>_K74ZE>ZEI'Q-\%Z#%JEY-97%
MO=FX\]@6G*H2I8@#D'TQ0!Z'17FNG^+[S0/!WBM-7N7N=3\/W$L2/+RTRO\
M-;D_[VX#\*R[G6+VRO\ 2_#GB#Q!K-J;;28[J[GT^!Y)I[F1F&"R(VU%VG'
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M2/8;1Q75T4 <?I6@>*C?V!US7+66QL(V18K*)XS>$KM#3Y8C@<[1QGFLG_A
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MYC%I Z27,J A&D+,0N,YP.IKMZ** ./C\$[_ !IXCUF[N$ELM9L4LVMPI#*
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M"$:1HAEVZLQ^IR?QJKH?A:30?%>MW]I/&NEZILF-H%P8IP,,P[88<GWKIZ*
M*&MZ1;Z]H=]I-WN\B\A:%RO4 C&1[CK7*1>$O$6HR:/:^(-5L)].TF>.X3[+
M Z2W4D8_=F0LQ"@'D@9R1VKNJ* .?\-^'9=#U#7[F2X24:GJ#7:*JD; 55<'
MU/RUT%%% '!:&)/#_P 0/$>C.5C&LG^U-.D<?*[[0LR^Y!"G'H<U2T#PAXZ\
M.QW?V;6= GN+R=KBYNKBSE:69S_>(<# '    %>BRVMO/)%)-!%(\+;XF= 2
MC8QE2>AQZ5+0!P7BF^UW3O -]8ZI-97>N:HS6%A'8Q-&':5=HX9B<KEV)SC
MKKM#TQ=%T#3M+1MRV=M' &]=JA<_I5I[6WEN(KB2")YX<^7(R LF>#@]1GOB
MI: .7\8^'+_7&T>[TJZMH+[2[P748N49HW^4J5.T@]^U3Z'H%UIOB'7-6NKB
M&1]4^S$I$I 1HXMC=3T)Y'M70T4 <#9^ ]1TK0="33]1MAJ^C3W,D4LL3&&5
M)G8NC $$<,O([K74Z%:ZQ;V\[ZWJ$-U=32[PEO%LB@7  1,Y8],DD]3VK5HH
M RO$NAP^)?#>H:-<.8X[N$Q[U&2AZAL=\$ _A7+MX2\4ZI?Z!<ZWK&G.NCW:
MS*EK Z^> I4LY8G#<C ' RWMCI-=\36'AV?2X;T3%M3O$LH/+4'$C=-W(P/>
MK,6JK+KD^E_8KU6AB$OVEX"('S_"K]"W/2@#AKGX?:_/X=OO#<>LV46DM<27
M-LPMV,S,TIE5)#G&T,>2!DX'3G.LGA;6$\93:U]JTY[;4;**VU*W>)\Y0')B
M.> =Q^]FNSHH XS0_#GBC2%T[2O[;L_[$T]@(V2W/VF:)1A(G))4 # + 9..
MU=G6;8:W::CJ^J:; )//TUXTG++A270.-ISSP:@U_P 36'AMM,6^$Q.HWL=E
M!Y2@_O'Z9Y&!QUH YZ?PSXJLO%^MZSH6IZ3%#JI@+Q7EM)(R^7'L&"K#KS5Q
MM.\<76D:A:76L:1%<3QB.WN+2UD4PY/S-AG.3CITP>:ZZB@#CK;P)%H>IZ+>
M^'94L_L</V2[C<$B[@Z_-C_EH&RP;U)SQ45AX7\2Z.!I6F:U9P:$+IIT8VY:
MZBC9][1*2=A&21N(R >E=M7.WOC/3K/Q1%X=2WOKO4619)%M;<NL",<!I&Z*
M* ,R^\+^(;/6]6O?#6J6-M%J^UKE+N!G,,H79YD15AR0!P>,BFS^$=<L-9T[
M5M$U:WFNX=-&FW+:JCR><H;>),J0=V[/MS7;T4 >=2_#B_D\&ZYH[ZO')?:A
MJG]II=/%A0^8VPR@]"4/3H".N*TY?"FJZAXO\,^(]1O+(7&EPW"7$5O&P20R
M*5&S<20!D=:[*B@#A]?^'[:SXUL]92]2&Q)A?4+383]I:%F:(YZ<%N<]@*T-
M:T'5_P#A(X]?\/W=G%>&U^QW$-[&S12QABRG*D$,I+?4-7444 4-&M;ZSTN&
M'4[_ .W7@W-+.(Q&"22<*HZ*,X'4X'-7Z** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "O.?$6G3ZI\7]+M8;^XLHVT6<S26S;)"@F3Y5;^'+;>1SC/K
M7HU<GKGA;4[WQ=9^(]+U2&UN;2S>V2*: R)(6<$[\,#MP.Q!S@]L$ XJ_P#$
MFK>';77_  Z=4OYS;:M9VD%^4,]S'!<('8# )=U 8#@G)%._X2V]\/6_B&;3
MI->O-.@TEKJ"76K:4&&Y#!=H>1064AE;'/W3BNE3X?W$^E:D]]JJG7KZ^BU#
M[=#!A()8MOE!4).54+C!.2":OKX;U?6+#5+7Q1JL%S!?6OV46UC 8HH@<Y<;
MF8ESD=\#'2@"K8:#J^@FUU?_ (234+Z)+=WU*WO9/,68[,@Q#'[LANPXQQ7*
MN^NQ_#%?'W_"0ZB=6\D:@;;S?]$V%L^5Y6,8V<9ZYYS77:7X8\1"]L!K?B&.
MZL-/C9(X+6!H3=97:#.=Y#8'\(&,\UF?\*^U@Z$OA1]=MSX8#@;?LK?:C"&W
M>3OW[<=MVW.* &1IJ'BCQ_KVGMK>I66F0V5G.D5G-Y;J[J_(;&0.#D#J<9Z5
MS(O/$'_"IQXRF\2:BVI6,NV*-) L,B1S^41(F/G+ $DGU%>H:=X>-AXNUC6Q
M.K1W\%O"L(3'E^4&'7/.=WZ5AGP!*?A?<>#_ .T4\R5G;[3Y1P-TYE^[GWQU
MH P]>UUK_P 9ZY87.I^(K.'35AAM%T>VE=?,:,2-)(40[OO* IXP#QS4-[KF
MK75CH%_XFFU_2M,ETW-S-IL;QF.[#8)F"J65=HR!C')S77:AX;UN#7K[5/#N
MJVEHVI1QK=QW=J9@'0;5D3#+AMN!@Y!P*ENM&\3V[6CZ1X@A<I:K;W":E;&5
M96'_ "V&QE(<Y.1T/'I0!K>'I#+X>L)#JB:INA4B^10HG'9L D9/?WKE_B'K
MDMA=Z#I:W.H6MOJ$TIN9M.B:2X\N-,[4"@L,L5R0,@ UTGAG0T\.>';/24F,
M_P!G4[I2H7>S,68@#H,DX'856\2Z!<:N^G7VG7B6>J:;,9;:66/S(R&4JZ.H
M()5@>Q!& : /,]=U*[N?AEXYLG?5I]/MDA:RN=4MY(YF5R-R$NH+;64\]<,*
MV[_5;^RUKX765K=S0VUY"ZW,2-A90L,9 8=\9-;NJ>$M9U[P=K.DZMK<4EYJ
M>-KQ6Y6&V4;<*BEBQ^[DDMU-.O?!,EWJO@Z]%\JCP\K*R^7GS\QJG!S\OW<]
M^M &%;#6?$47BK78]?O[2?3[VYM;"VAD MU6$8^=,?-N.<D\@'C%9Z>(=8,'
MPI)U*YSJ7_'Z=Y_?_NT/S^O)-,UBZL=$N?&%A!XNM=/LYY9+B[T^YMMMUYDB
M L(&+#<']0K8)..>:VM(\$75_HGP\NIY_LDNA0+++ \9+.6C4;>ORD8H I:'
MX>N]=USQMLUS4=.C35W$(L9?+_>F*/+.<98?=PO3KZ\8UQK5UXBB^$NJ7I#7
M4U\XE8#&YEPI./<KG\:[,>#_ !'IM_KMUHFO6</]L733.ES:,_D J%#(0X^<
M8/7(/' QR2?#F*./P;!9WOEP>')?,(>/+3\#/?@DY/?K0!RNJ>([O4+[Q)<1
MZEXD@U"PNY;;3+?3K.:2V!B  \S:A5RSYSN/ (Z5ZSI=U+?:197<\+033P)*
M\3 @HS*"5(/(()Q7+W'A77[2_P!4&@:Y;6-CJDQN)UEM3)+;R, ':)MP'S8!
M^8'!YKL8U*1JA=G*@#<W4^YH \W\=:4;_P")_@A/[1U"V6X^V*?LT^S84A+;
MEXX)R03W'%2Z?::AXUU+Q'=2:_JFGQV&H2:=90V4_EJGEJN9&&/G)8G@\8%;
MGBKPUJ&KZMH>KZ3?V]K?Z3)*T?VF$RQNLB;&! 8'ITYJG+X4U_3]1U67P[K5
MG:6^K2>?<1W-HTC0S%0K21$..3@'#9&10!H^ =;NO$7@;2M4O=INI8RLS*,!
MG1BA;'N5S^-9OQ-O]3L=*T4:3>O9W-SK5K;>8O0ARPPP[CID>U='X>T2V\-^
M'[+1[,LT%I$(U9^K'J6/N22?QJGXJ\.OXCBTI$N5@^PZG;WY)3=O$9)V]>,Y
MZT <9X@N'T/6=)\,3:UXDELC;37MQ<VPDGNYFWJJH6C7<J ECP!V%5K;Q!K=
M[I^G: +S5+;[;K<EG'J-S T-T]FL?FY&]1\_\&['8GK7<>(/#]_>:M8ZWHM[
M!::G:1R0'[3"9(IHG()1@"",%000?YU1OO"&J:CHUG]IUW?KMG>_;K>\^SCR
MHWY'EB/.?+VDK@MGOGM0!E>(O[:\#>%]7F@UR[O+>>2WALFN09[BU:1PCG.,
MOP<J,$Y&.:B\-:I<0^*/L5A<^)+S2Y[&5Y7UBVF4PSH5VE7D0<,"WRCC*C&*
MUI/!>J:QINK)X@UTRW=\(O)^R1LD%F8FW(R(S'+;@"23SC'%:>E:9XD^URW&
MN:S:SIY!@CM[.V,4>2>9&W,Q+<8P" .: /-] \1ZY'\+_"?BVZU2ZG6VU%TU
M/S)"1+;O*T99O7;\I'I73>(O$=_'XOU6:RGD%AX:T:6[N8E;"37#J3&CCN J
M[OQK2\.^ H])^&;>#;VZ6[C>*:)YECVY$C,<@9/(W>O:G^%_ XT?PSJ.F:K>
M?VE<:F7^VW.S89%*",+C)P H _.@#D?#VM7T>J>'9[:^\3ZA/>R+'JD=]93+
M;;70DR(60*@5]N,'!![UZ[7):'H'B;3YM/MK[Q#!-IFGKLC2"U*2W("[5$K%
MB.!S\H&2 :ZV@#S86FI^(_&?C.QD\0:G96=@UO\ 98[.;RRCO &)SUQGG;T)
M)SGBL*"^U[_A7GA_QK/X@U!]1>XMEDMUD"V\D;2B,J8P,$D<ENN2<8& /1],
M\.OI_B'Q%JAN5==7>%EC"8\K9$$Y.><XSVK''@*4?#C3?"G]H)OLY('-QY1P
MWERB3[N>,XQUH YC6/$$^I:[XD!U/Q):S:?.;73HM+M)9(5=8U;=)L0JY+M]
MUNB@>N:T[.]U7QGXFL-/O+W4=)AM]$@OKFWM)#!(US*2"&/7:NT_+ZGFMJ\\
M+Z];:KJEQX=UJUL;?56$EREQ:F5H9=H0R1$,!DA5X8$9&:=J/A75X_$%KKNA
M:M!%?+9"QNOM\!E2= =RN=K*0X)/L<]J //+R]U7P_\ ##XA7%OJ4RZA;:^5
M6\0A';YH%W'' )!YQZFNSNY+[Q)XRM] .JW]C96ND1WLS64OE2S2NY49?KM
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M7N,J,CTKF-0\+Z\+V7Q)?ZQ9S72:;<VEQ!%:LL0A8!@(\N2&W+DL<YSC P*
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M^DDDCR;A@Q=^_P NYF)[XK4B\' >/=5\137*2V^H:>MDUKLP0!C)+9YR!Z4
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MR6CR75MYJ7$;L&;*AEP=PR,'VJ"?X9276A:YIMQKLLDFKWT-[+<^0 R,A0L
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M2.JF@#2DC66-HW&48%6![@UYEX=T4ZAX(U/X=WMRUKJ&E2[8IMH8M%YGFP3
M'[R\ $?[)'%>GU4-W9#5ELS)%]O: RJF/G,08 GZ98?G0!R\/A#6G\26.OW^
MOPS7L,,EM-&EF4B:%]IVH-Y*MN7)8DYSC  %#> RWPQ@\&_VCS$D2?:_)Z[)
M _W-W?&.M=G10!R%WX2U6+Q+J&K:%KL>GIJBQB]BEM!,=R+M#QG<-K;<#D$<
M9P:TO!WAL>$O#%MHJW37*P/*PE9=I(>1GYY/(W8SWQ6[6"?%$+7>OVEO87ES
M<:-Y?F11*I:8N@<"/GDX..<<T 'C/PX_BOPO<Z/'>"S>9XG6<Q>9M*2*_P!W
M(S]W'6LO^PO'G_0ZV/\ X)5_^.5UEG.UU907#02P-+&KF&4 /&2,[6 [CH:F
MH YAO!T-_KU_JFN3IJ(GM?L=O;M%M2WA(_> <G+.>K<< "J">!]0@TC2H8=?
M)U+1IG.GWDUOOQ"PV^5*N[YQMP-P*G@'MSVU% '(W7@Z^U;P_<V>L:[)/J,M
MREW!=0PA$M)$(*>7&2> 5YR23D\\U&/!FI:G%JG_  DFO->M>V+6"QVL!@BB
M1NK["S;GSCD],8KJKB_M;2XM8)YTCENI#' AZR,%+$#\%)_"J>F:[;ZKJFK6
M$,<JR:9.L$K.!ABR!P5P>F&'7% '+Q>!M;N9-";5_$D=RNBW,<T"0V7EB0*I
M7Y_G.6((Y& .>#GBU!X+OK75/$;P:O&--UOS'DMFM<O'*T>S<'W<CC.,?C79
M44 <C:>!88OAD/!ES=^?']E:#[2(]N&))5PN3R#@]>U/T?P/;V7@V_T#4;M[
M]]2:>2^N]GEM,\I.6QDX(& /]T5U=<U;>-+6^\777AZQT[4+F2R94N[M$400
M,RE@"2P)Z8X!H ;HN@^(;2^M7U7Q*+VUM(S'%##:^29B1@-,=S;B!V  SS73
MT44 >>7OPXU"\TC5-"'B$1:+=SRW,4*6G[U)'<R ,^[YD#G.  3T)QUS]4G@
M\/>,+Z2?QE!HE[>V4#Z@;BQ BN2BE?,MRS_*P QM^;MP:]3IDD,4VWS8T?:<
MC<H.#0!YCX.\'R:I\/?"RO-+9BQU<ZK&LT99Y(Q+(R*<D$%E<'//TKKM>\.W
MMYK%IK6C:C'8:G;PO;LTT'G131,0=K*&4\, 00?7UKHZKWURUE87%TEM-<M#
M&SB"  O(0,[5!(&30!S-SX0U&XTW3Y&U^1]=L+E[J+4)( R;G!#1^7GB,JV,
M Y&!S4@\/>(7TR<R^*9!JKW*7"316^V",*,>6(MV2A&<Y;))SVKHK&Y:]L+>
MZ>VFMFFC5S!. 'C)&=K $\CO5B@#GO#WA^]T[4=1U75=0BO=1OUBC=H+?R8T
M2/=M4*68D_.Q))_E6S?VB:AIUS92,52XB>)BO4!@0<?G5BB@#@;7X?ZE#X;T
MK3Y=?B-]HLJ/IEY'9[?+55V;)%+G>"I(.".U;.A^&;RUUZYU_6M2CO\ 5)K=
M;5#!!Y,4,(;=M52S$DMR23V%=+6?::G)=:M?V3:=>0):[-MS*H$4^X9^0@Y.
M.AR!0!H5X_X0\+ZQKWP_EL8-?6UTK4+J[6ZA-KOE"^>ZLL;[@%# <Y4X))[X
MKN_"_C2U\723OIVG:@MA&S*E],BK%,RM@A/F+?F!T-=&D:1+MC147KA1@4 <
M_:^%8[/QFNO0W 6%-*33$M0GW0LF\-NSZ<8Q^-4+GPEK%IJVJ77AW7HM.AU5
MQ+<PS6?G;)=H4R1G>N"0!D$$9&:Z"YUNQMHM382B6338?-N8H^60;2P'U('%
M2Z3J,6L:-8ZG CI#>6\=PBOC<%=0P!QWP: .>LO EKIEUX5:RNF2WT"*XC6-
MTW-.95 +%LC!SECP<Y[5H:;X=_L_Q#X@U7[5YG]KM"WE^7CRO+CV=<\YZ]!6
M[10!Y+>>%KK1-8^'.@V>J[+JRBOQ%>>1D$A%/*9Y4@D$9Z'@@UTT7@2>ZLO$
M9UG55NM1UVW^S2SP0>6D$84JJHA8G@L2<GFNPF,,:FXF\M1$I8R/@;!CDY/0
M8KC6^*GAP(UPD>J2::I(;4H].E:V&#@G?MZ>_2@"&;P#J6H:;X9MM2UR&670
MM0ANTDBL]@E2( !"-YP3C[WOTK(^(%KIOC3Q7H6@Z==>;J$%PXU+[.V1#9D?
MO4D(Z%B$ ![UZ=;7,%Y:Q7-M*DT$J!XY$.592,@@]Q3EBC1F9(U5G.6(&"WU
MH <JA5"J % P .U8WB70/^$AM;&'[3Y'V6_@O<[-V[RG#;>HQG&,]JVJ* ,*
M_P##2:AXKL]9EG!B@LI[1[8IGS!(5).[/'W<8QWKG$^'FI-I%OX;NO$*S>&8
M)$(MOLF+AXD8,L32[L;1@#(4$@8KT"B@#E_^$7OH/'LWB.QU2.*"[@CAO+22
MVWEQ'G:5?<-O7T/^&9I_PY-C\/=7\*_VIO\ [1DF?[3Y&/+\S'&W=SC'J*[N
MB@#A?%SZ)H'PU/A_6;M)&DT[[';Q*/WMRZH%'EIR2V[:>^,C-:G@#0;CP_X/
ML[:^9GU*?==7TC'+-/(=S9/<CA?^ UT;11NZNT:LR?=8C)7Z4^@ KSVT^'%]
M;>''\/OKL;Z='?)=V@^QXDC G\XJS;_FR>,X&/TKT*LOPYKMOXFT"UUBTCEC
M@N Q5)0 PVL5.<$CJ* *^I^'%U+Q1I.L/. EA!<PM 8\^:)0HZYXQM]#G-9.
MC>$=;T@V&GIXE)T.PD#06Z6VV=T&=L3R[B"@X'"@D"NJOK^UTRT:[O9T@@4J
MK2/T!9@H'XD@?C5B@ KE=?\ "$]]KD.OZ)JSZ3K,<7D/+Y(EBN(LY"R(2,X/
M0@@C\JZJB@#D]*\(WW]N)K?B/6?[5O88FBMHXX!!!;JW#$)DDL1QDGI65_PK
MK4?[&/AG_A(%_P"$7\S/V;[)_I'E;MWD^;NQM[9VYQQ7H-9]SJ<EOK-EIZZ=
M>31W*N6NXU!A@VC.'.<C/08!H IV'AT6/BW4]<6X!6]MH(! (\>7Y6[G.><[
MNF!C%8Q\ $_#:[\(?VES</*WVKR/N[YC+]W=SC..OO7:T4 >:"PU:X^+/B.7
M1]3BLKF+3[-2)[?SHI%;S.JAE.1M&"#Z\'-7XOA[<V%CI<FG:RJZS97D]Y)>
M7%MO2XDG!$NZ,,, Y&,'C KNA&@=G"*'8 %@.3BG4 >>W/PWO;JUUZWF\0>:
M-9-O-.[VGS+-$Z'<N' "$)@+VXY..>GU;01J'B/0M9-T(ETEIW,93/F>9'LZ
MYXQUZ&MNL_3-2DU)KQ9-.O+,6]PT"FY0 3 ?QI@G*GL3CZ4 >>6-EIGBWXP-
MKFD7'VG2K&WCDNI8CN@FO%#K'@]&98W))'3Y:]3IL<4<*!(D5$'15&!3J .>
M\2>&YM7O--U/3K\6&JZ:SF"9XO-1E<8='3(R#@="""*JZ;X0N(1K=WJ>I+>:
MMJ\(@EGC@\N.*,*5543<3@;B3DY)K;U#4Y+&ZL84TZ\NA=2^6TENH*P#^\^2
M,+],U8BO[6>^N;**='N;8(TT8ZH'R5S]<&@#-\(Z!_PBWA33]$^T_:?LD93S
MMFS?R3G&3CKZU:UJPNM2TN2WLM0ET^ZW*\5S&NXHRL",J?O*<8([@FM"B@#A
MY_ =WK4.L/XBU:*YN]0L!8*]I:^2D,88L#@LQ9MQSR>V*6+P9K=UJNAZAK7B
M**[DTB8O%'!9>4L@*,A+?.?F.0<]!@@#G-=O10!P;^ =4B6\TW3O$CV6@WER
MUQ);QV_[^+<VYTCE##:I.?X21FNATCP__97B#7=4%SY@U22%Q%LQY7EQA,9S
M\V<9[4>+?$UIX/\ #ESK=]#/-;VY0,D !<[F"C&2!U/K6RC!XU<=& - &/X2
MT#_A%_#%GHWVG[3]GW_O=FS=N=FZ9./O8Z]JVJ** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "O-?&6IFX\>0Z+=PZ]/IL&FBZ,&C>8'>5Y&4%V0AMJA
M#@9QDUZ57.:WX:O+S6K?6M'U4:;J4<!M9'DMQ/'-$6W!67*\AN00>YZYH \R
M\3W&IS^ O#*:K%?++!XKABA>_0I/)"#)Y;.#_%M(!/<BNKEU6\@^.5W;&ZG:
MRB\.&X^R^8?+WB4?-MZ;L<9ZUIZOX$EUK0-(TZ\URXFGL-2349+N:,,TS*6)
M7&0%7YL #H !S5[_ (1)/^%A2>*VNR2^F_V>;4Q\8W[]V[/X8Q0!YIJ%MJG_
M  I>7QFGB#54UJZA6YF=;QQ&5>0#RU3.U  1@J <CK@D5U\M_>#X^0:>+N?[
M$?#YE-OYA\LOYQ&[;TSCC/6O/M82SN/!ESX2TWQ'>3M]I^SV7A^6T$=S&_F\
M+(P)+1KRP/ P!D\8KUY_"BO\1(_%OVPADT[[!]F\O@C>7W;L^^,8H \OT;1;
MB#X+/XEM]8U*#4;%+BYM!%=,L40CF<[#&#M8-@YW GYO05U4.LWMW\:=(A^T
MSI9W'AL7+6HD/E[S(?FVYQG'&>M/@^&-_;^&AX97Q1(=%E9FNH?L:^8X9RS*
MC[OD4YYX;OSSBNA;PA%_PG]KXI2ZV"WTW^SUM!'QC>6W;L^^,8H \WT2YGL_
MA]\4[FUFD@GCUB_9)8F*LIPO((Y!JQ>:<-:O/A1+>7FH&6\L2)GCO)$8D6N[
M<"&!#$L<L.2.":ZZV^':6_AOQ5H_]ILPU^[GN3+Y./(\T#C&[YL8Z\4^^\"7
M$FF^%H]/UG[)?>'HUC@N7MA*L@\H1ME-PZ@>O% %"PUZ3PCKOB[3M7NIY[:W
MA.LV+3R%V,!&'C!/97& /]JLO6=-U%/@-<76JW4TFL+&-5,LKEFAFWB157/W
M=HPN![T_Q?::;XX\;:%HUC<&YN=/E?\ MB2$81+<%2T4AZ99T4!>W-;GQ(=]
M5TRW\'V1S?:U(L;[?^6-LK!I93Z# VCU+8% '86-P;O3[:Y(P9HEDQZ9 -6*
MS1IMS'K5O=1:@Z6$-J8#8",;6;((?=UR ,8]ZTJ "LKQ/_R*>L_]>,__ *+:
MM6JNIV0U+2KRQ+^6+F!X=^,[=RD9QWZT >4^&B? ^G^&/$"?+H6LZ?:6^J#^
M&WN/+41S^P/W6/T-1QZE>V'A[Q/!I]P]K<:CXT>P%PGWHA*\89AZ'&<'MFO2
M;7PS9IX+M_#%[B[M([)+.0LNWS%5 N<<X/&?:N<TGX806'@N^\.W.KW%TUS>
M?;8[W8$EBE&S8PY.2"@.>^30!!=:9_PB_C/0-.L=1U-]/UM+FUNX;B^EE.Y8
MMZR(S,2C<$$J1U]JX[0K670_AROB6SOM15K'76ENHS>2,DD"W#(X*$XY5MQ.
M.<9->F:=X4U ^(+36M?UM=3N+&)X[-(K06Z1EP [D;F+,0,=0 ,\55TKP')I
M^CZWH<^K?:M'U'S_ "K<VP5X/-)+?/N^;&>.!0!BS:UJ!^*JZBM[-_8D=XFA
MM )#Y1E:%I=^WINWE$S^%<]X@UG5I/ USXAAU.]B&I>)E%J8YV7;:JQC51@\
M ["2!US7;1?#D1^ '\-_VO*;QKG[9_:?DC>)Q*) ^W/48"]>E3:O\/;?4O!&
MD>&8;UK:'3I('681;B_ECN,C&X\]: ,?^QH)OCY-(UQ? IHL=T%6[D"[O/(V
MX!QLX^Y]W/.*Y:QTF:W^#5YXD@U;4H+^RDNIK,073I'%MN'R"@.UMQ#9+ GG
M'05Z;?>%;J7QS;>)[#5A:NMJMG=6[VPD$T0DWX!W#8>2,\U7C\"HGPZN_"/]
MH,5N%G7[3Y7*^9(S_=SVW8Z]J .:\4S21Z[<7OB";Q!::5):0M87^ERR>39M
MM.]I5C/7<0<L",<4^+2;>[^.%K,=0O)P?#R7@ECNW59&$ZJ#A3C8P )3[I)S
MBNDU3PKK=S)<QZ?XG>ULKN!89[>:U$^S";"8B6&S(ZC!&>:8? \EIXCTC5M'
MU8V8L-/33)(9;<3":W5@P&<C:W'7GZ4 <1<:J(+RRUG3+WQ)?3RZS%$^I2%D
ML98GGV-$L9?;M . 0O49S6M9Z3/XDO/&K7VLZJD5EJ,J6<=O>R1"!A$C;AM(
MSU& >!SQR:N_\*SO_P"PX-&_X2=Q8V$R3Z:@LUS"R2;U\P[OWH'(Q\O7)Y Q
MTFC>&3I2ZYOO//?5KEKEV$6T1EHU0@#)S]W/XT <)I%_?>,Y_!NE:C?WB6\F
MAMJ-X;:=H6N9 R1J&9"&QDEL C)JG.EUH=C\5E@U"Z:>VCMS#<M*?-4?9P5^
M?J2 0,]3C)YKK4^'MQ86/AXZ3K9M-3T:V:T6Z>U$B3Q-C*O'N'< C#<4)\.G
M.E^*+6XUN6XG\0H@FN'@ ,;!-I( ."/0<8&!D]: ,0-J&KW/PXL7U:_AAO\
M1Y9+TPW#(\^(H6Y8'.<G[W7!.",YJEJ.I:EX9L?'&CZ;J5YY=M<V$5E+<3-+
M);"YVA\.Q)P,DCG@UW=IX.6TO/"]Q]M+?V#8O9A?*QYVY$3=U^7[F<<]:S/%
M'A.R&G>,-1OI;R:#5(H)'BM(<RP&!?E9.?F.0&[=* ,^\TB?PSX[\'6MAK&J
M26%Y/<+<V]U>/-YCK Q#98D\]2.F0" *]*KQ_2[@>(OB%X4N+?Q+_P )%)8"
MXEN)H+80Q6T31%1N49^=F(ZG/R]!W]@H \U^(&D0:C\0O!*RW%[&)Y;B)A!=
MR18"Q,P*[2-K9)!(Y(X/%0:7X:CU_P 8^-TN-0U&"&.\A6-+2Z>$A_LZ?.Q4
M@L1Q@'CKQS76>*O"]QKUWI%_8:I_9U_I<SRPRM;B92'7:P*DCMWS5K1?#QTC
M5-9OFNS.^J3I,P\O;L*QJF.ISG;G\: /+K7Q/?:SHO@NSU,ZU=P7&G375XNE
M;_/N&1UC3<R$,%Y).#R<5WOP^GU%]-U"WOH-42WM[QEL6U-&6=H"JL Q;EL$
MLN3G@"JMI\/IM+T708-+UHV^IZ-')#%>-;!TECD.61X]W(R%(^;@BNFT/3;O
M3+%X[_5)M2NI96EDGD78 3_"B#.U1C@9/?UH T74.C(20&!!(.#^=>*>&K"#
M0M>^(^K0SW\DNBN9H%>]E82$0N?W@+?O.G\6:]MKF-)\&V^G:GXFNIKC[5%K
MT@:6!H]H1=I4KG/.0?:@#BKZSN_#WP^TWQI'K.J3ZP/LES=&6\=HKA970/&8
MB=@7#G& ","M/3K&ZUWXJ^*H[O5M16PTJ>RFM[2&Y9$+M"K<@'[N5/R]"6.<
MU>A^'U\;.PT>_P#$;W?A^QEC>*S-HJR.L9S&DDN[YE! Z*,X%;^E>'%TSQ/K
M^M"Z,AU=K=C%LQY7E1[.N><]>@Q0!Y3IVMZKJ.DVWB*SM/%D^ORW0G#(DALF
MA\W!A"9V;/+R,XSN&<UU.GV5WXJU3Q5JDNL:C;7&G:A)8Z>D%RR10>4BG<4!
MVON9N=P.1Q6M9^"M3TZ1+*Q\2S6^@I=&X6RCMP)5!?>8A-NR(]Q/&W.#C-<O
MKEWI.A>)/$=LWB>YT>&\Q/=:?): M=,R %K:3.<L %. 2#TQ0!!X=O-0\2:=
MX&T*[U.^6WNM.GOKZ6.Y=);DHP55,@.[&6).#S@5;O[J^T"U^(&A6VHWLEM9
M:2+VQDEN&>6W+QN&42$[L J",G(J_P"'/!5\_@GPC/'=OI.NZ7:G9(\(D 60
M?/'(A(R.G<$$5K)X$>72/$46H:LUUJFO0&"XO1 $6-0A1%2,'@*"3C.23R:
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M^!N<'=GYNH()  SC(KHI/!SS2>&Y;C5[BYFT:=YVFG4,]RS*0<G(VCYN ,X
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MB^8"99"WSNT; \!0%!.,YK8U#X:1:AX%U+P])JLINM3NA>7>H/""TDN]6)V
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M- 'I%%%>:6&BGQS?>*+V]U+4+>ZL]2ET_3VMKJ2-;01JN'"*P#,6))W9SP*
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MM;-*(%F66%B&VLK8Z$9!S72T4 <*?AI _AKQ%H\FKW,IUR99Y[F1%+J^%W'
MP.2N<< 9P.E:5UX7U1&M'T?Q+<:>T-HEI(C0+/%($Z.$8X5^3R.O&0<5U%%
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M;(DWQAP0.V,XK7H X9_AK;2>%M>T235;J3^V+H7<ERZ@R)*-ASZ'YHP<<#G
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MVO$2W8L3Y.[*Y7/3&<_A7<CP'-'<:%>0>(+N*^TFW:T^T"",^?"2/E92, X
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M'AKSEAW':6$B\X]:=X/\*)JWAW0O%!U.]CUZX\N]N+P3NWG!CEHBA;;LP=N
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M+NU647$5Z)<LPW".-2G0]B3^=4-.\*:7K\WCV?4XI)S%JLX@4R,JPL(8SO4
MCYNG/^R/>@#UJBO%$U"]U^U\$V%_I=[KMLVAF]GM(IT3SY 40/(790P4$\9Z
MMG%=[\/K75+'2+ZUU"PN;&WCO7-A!<S+*\=N0I"[E9N Q<#)Z8H ZZBN$^)T
M37,?A6V6>:%9_$%O$[0N4;88Y0P!'(R._:L6V\&Z,OQ0U#05@D&B2:5%>R:>
M)G\IY_,=-Y&>>!TZ9YZ@4 >JT5XWITEHW@>WT*\74[]5U^YL[/3[68![I(G<
MB-V8C]V ,G)'W1]*H:@]S8>"OB#IT-G-I,-I+9O;V33B7[,7\LMM8$@ D;L
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M' /!P>#6U\,=)GT?P/;07%I)9M+//.MM)]^)'D9D5O?:1FNPI P8 J00>XH
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MUJ:;X2AM-8.K7U]<ZG>_9%LXWN53$<8^]M55 RQY)]L=*Z*F[T";]R[?7/%
M''R>#Y])\/PZ5H5_?I"FIQ7,2"8(((?-#21 \$QA=WR\GMTKLJ,T4 <U+X/C
M/BVYU^VU2\MFO(5AO+9 ACG"@A2<J2"-W8BFOX(L9/ UMX4-S<_8[<0A9<KY
MA\MU<9XQR5&>*U](NM1N[6235--2PF65E2-;@3;D'1L@#&?3M52]\0BT\5Z/
MHBVXD&HPW$OGB3[GE!>,8YSN]1C% %#5/!7VS5+V]L-<U'2O[055OH[3R\3[
M1M# LI*-MXW+C@"NEMK>.TM8;:+=Y<*+&FYBQP!@9)Y/UJ3<"Q7(R.HS535+
M\:;I=Y>;1(UM;O-Y>[&[:I./;I0!F>)?"5CXE^RS2S7-G?V;%[6^M)-DT)/!
M .""#W!&#5/3/ Z6^L6^K:OK.H:W>VH(M3>%!' 2,%E1% W8XR<FMS0M3_MK
MP_INJ>5Y/VVUCN/+W;MF]0V,X&<9ZXI8M7LY];N=(CD)O+:&.>5<<*KE@O/K
M\IX^E '-7?P\BG;4(+77-3LM*U*5I;S3X#'LD9_O[6*ED#=P#W/2MF#PQ8VO
MB*VUB O&UMIW]G10+CRUBW!AVSD;0.O2MG<N[;N&[KC/-+0!ST'A&S@TGQ!I
MRW$YBUN>XFG8D90S*%8+QT '&<UREQX7E_X6/I-G9WU]9KI_AORH+Z)5)#+*
MB@,&4HV5SD$>XQ@5J0_$.YO;F^CTWPCK-]%9W<MH\\+0A2\;;6QN<']*Z;1-
M3N=5L3<76E76F2!RH@NBA<@ ?-\I(QSZ]J , ?#RS&C/:C4[[^T'OQJ3:F2A
MF-R. V-NW 'R[<8Q4;_#FWFDU&:?6M2EGU.P>ROY'\O,X.X!\;<*5#$ +@8
MX/.>UI P)(!!(ZC/2@#$O_#%KJ%GHEM)-,JZ1=0W,)7&7:-2H#<="#SC%<A?
M6-IXX^)^D7MK:70L]#60W=W+"\232!@8XEW ;]K@OGI^=>E;EW;<C=UQGFEH
M *R;G0+>Y\3V.NM+*+BSMY8$C&-C"0J23QG/RBK%_J]GIMU86US(5EOY_(@4
M#.YMK-^ PIY^E-BN]1;7)[633D33DA#QWOV@$R/W7R\9&.><T 4[3PQ:V;:Z
M4FF/]LRM+-DCY"8PGR\>@[YK+_X0&*WAT<:9K.H:?<:99?8!<0B-FE@^7*L&
M4C.5!! X-=A2%E! ) )Z#/6@#A+C3](\ :%J=J?[3U&UU5W,6G+ T[-(RX=0
MRKGY^Y<_UK0^&_AB3PGX(LM/N?\ C^<>?=$MD^8W;/?: J_\!KK*0LH8*2,G
MH,T 5-6TRVUK1[S2[P,;:[A:&0*<':PP<'UKF8? )6_TO4;KQ%JEUJ&FR9MY
MY!%Q%M*M'M"8PP/+8W' YX%3>)/&-SI'B/3/#^EZ1_:6I7T<DP5[D0)&B=26
M(//7C%;MEK%I?ZA?V$+DW-@R)<+CA6= X /?@B@#GX/AWI<7A[Q#HK7%T]OK
MEU+=3L64-&\F,[<#H" 1G-.D\$RO;:<X\1:BNK:>'2'4@D7F&-L9C9=FQE^4
M=1G(SFNL# D@$$CK@]*-PR!D9/04 <N_@>TFTS3K2XU&_N)++4X]4-Q+(&>:
M96)^;C 7GHH& .*ZFJ.L:O9Z%ILFH7\ACMT9%) R<LP51CZL*I'Q"!XU_P"$
M=-N,?V:;_P"T>9_TTV;=N/QSG\* (/$GA--?U#2]1BU.[TZ_TUI#!<6P0G;(
MH5P0ZD'( [59T[PW;::NLK%-,W]K7+W,V['R,R*A"\=,*.M; ((R""/6A6##
M*D$>HH Y,^ [>'2M%MM/U.]L;S1H3!:WT01G*$ ,KJRE6!P#C'4#%;>AZ.NB
M6!M_MEU>2R2--+<73[GD=NIX  'H  !57Q9XG@\)Z,NHSVL]T&GC@6*#;N9G
M.!U('6L6;XBKIH677O#6MZ39E@&O)HDDBCSQES&S%1[XH Z#6] M]=?2VN)9
M8SIU]'?1^7CYG0, #D=/F-*F@VZ>+)O$(EE^TRV261CXV!%=G!Z9SECWK22:
M*2!9DD1HG4,KA@5(/0@^E5-5U>ST6UCN;V0I')/' F!DEY&"J/S(H YQ_A]:
MI:Q+9:I>VEY!J,VHP7<81GC>7=O7#*5*D,1@BH)OAE936^KP/J^I.FKQ1K>;
MV1FDD1@PESMX;C&!\N.W QVY95QD@9X&32T 96I:#;ZGK.CZG++*LNERR21*
MN-KEXRAW<>A[50B\%V,7@Z_\-"XN#:WOVC?(2N]?.9F;'&.-QQQ71LRK]Y@,
M\<FL'QEXIA\'>&KC6)K9[GRV1$A1@I=F8 #)Z#GK0!6OO!@EO(+W3-9OM*O$
MM5LY9K<1MY\2_=#*ZD;ADX88(R:E'@VQ6X\/2BYNV;0S(83))O:4NA5C(2,D
M\D\8Y]JU=(N=0N].2;5+".QNB3N@CN!,%';Y@!G\JY;Q'\0I_#$5[=7OA36#
MI]H^UKQ##Y;#<%# ;\X)([=Z .WK"N?"UI<^-++Q.T\PN[2U:U2($;"K$DD\
M9SSZTW0O$-_J]X\-UX:U/2XUC+B:Z:(JQR!M&QB<\Y_"MX,&S@@X.#@T <Y%
MX,LHO!^H>&A<7!M;W[1OD)7>OG,S-CC'&XXXK>M;=;2S@MD)*PQK&">I &*E
MW+G&1GKC-&Y2VW(R.<9H YWQ9X,T_P 8#3Q?2SQ_8I_-4PD#>/XD;(/RG S]
M*-3\&:?JOB_3/$<\LXN=/7"Q*1Y<F-VTL,9RI=B.>];T\KK:RR6\:S2JC%(]
M^T.P' SVYXS4&EW%[=:9!-J-DME=NN9+=9A*(SGIN  /% %:PT&WT_7]7UB.
M65IM3\GS4;&U?+4J-O&>0><UA2_#C3)?#^DZ,;R[$&F:E_:,3@KN9][OM;C&
MW+GISP*[%65AE2"/8T!E;.&!QP<'I0!R^K^"Q?ZQ<:II^M:CI%S>1+#>&S*$
M3JN0I.]3M8 D!A@XJ?2O!FF:-JEA>V)EC6QTXZ=%#D%?++A]QXR6RO7/<U8&
MOG4="N]0T"V&HS0RR0I"\@A$CHY1AN(.!D'GOBM6"21K6*2XC$,A0-(F_<$;
M'(SWP>] &?I&@V^CWNK74,LKOJ5U]JE#XPK;%7"X'3"CK2>(= M_$>GQ6=S+
M+&D=S%< QXR6C<,!R#QD5K9!&0>*0,I) ()'49Z4 9<V@V\WBFUU]I91<6]K
M):K&,;"KLK$GC.?E'>LN;P)IL]GJ]N]Q= ZC?C4?-1@KV\P"[6C..,% ><]Z
MZFD#!AD$'Z4 <U;^#8WM=3BUK5;[6'U&#[-,UP515BYX1$ 53\Q.<9S6?!\.
ME\_29;_Q#JNH?V3.DUDLYC 0*,;3M4;L\98\\<8R<]J&4D@,"1U /2E)P":
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M(K,ZGJDFBPS">/2'E4VZD-N"_=WE >0I;%=I0!Y+X+@\82?\)&VAWVC06?\
M;][\EY:R2/N\SDY5P,=.U=/XDTFYO/ LLOB'4K.VU/3R;R'4;6-HTMY$)*,
MQ)QC@CG.3[4Q/AM#;W-[-8^*/$=BEY=27<D-M<QJ@D=LM@&,_P ZN-X%M[G3
MHM/U+6M8U.V2[6Z=+R9&\TKC:CX090$9V]SUH XSPYK%WKFD>)/'%^HBUZPT
M]X;:P*D?8E$/F!MK=Y#\V?3 SUJ+PSHFJ13>%]2TSPE/93AXWO\ 5'OX7-Y"
MZ'S#( VYLDAQD9!'%>D3>&+";Q(=<#2QW$EJ;2YB0CRKF/L)%(Y(YP00><<C
MBL[2O EMI5W9.-7U:YL[ DV5C/.IB@X*CHH9L D#<3@4 <KX5\+:7XL\)_\
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M?Q3X9M/%FD#3KRXN;>-9DG62V95=60Y&"01U]JQ7^&UC>O&-9US7M8MD8/\
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M&836UK<>&+*R-YI2^+FMDL?/\M'B\GSO(W'@+OYQ^% 'N*3Q21"5)4:,]'#
MC\Z59HGE:)94,B?>0,,CZBO%_$.D:GI?@[QK*= AT/2;JQB:.SAN$D19U?#,
MJK@+E=N>.JUT.I^'],\.^,/!-UIEJEO=3W<L%S<*/WEPK0.Q\QNKDD Y.>:
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MPQJ'A]6G^Q7QG,I+C?\ OB2^#CCECCBMFUMDM+.&UCR8X8UC7=R< 8&:FHH
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M)[U18W378?SR6GE;<6,I_CR6)/O70444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:C'))92M<I*7V %E=5^XVTYQD_6O.K32-27X8>,K9M/NQ/-XE,L41A;<Z>?
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M\DID99L<[>W'.36;JFKGQL/#6EZ?IVHQ74&HVUY?BXLY(5M%B^9E+,H!8G
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M5R&*>9%M&S=M/<XXS5:7Q]J\RZY)I7AC[7%HMU-!<R27HB#B,9^3Y#EL<XX
MXY.> #O1T&3DUE6>@V]KKU]K322SWMVBQ!I",0Q+TC0 <+DECW)/TK*TOQM!
MJ>OZ?IPM&B@U+2UU*RN&?_6@XW1E<<,H(/4\5=TKQ'_:WB76M+AM"+?2S'&]
MUYF1)*R[B@7'\(QDYZF@#=HJO?WL&F:=<W]T^RWMHFFE;T5023^0KEM,\9ZC
M-?:4FK:!_9UGJ^193BZ$K;MA=4E7:-C%02,%N1B@#L:*\ZNOB7J,7AW4/$UM
MX:^T:#;F18;C[8%DFVL4W^7MX0L,9R2!SBNFT[Q*+_Q//HOV388K"&]\WS,Y
M\PL-N,=MO7/?I0!O]*Y]O"Q9BW]OZX,G.!=C _\ ':Y/Q=XPTR]\!ZM?:KH/
MVVTLM8:P-J;DIYC1R[1)N R.><?K5Z^\1^(X_BW!H=II\,MA_9AGVM=A-ZF1
M%,I^0D%?F4+WSG/:@#=_X14_]#!KO_@6/_B:/^$5/_0P:[_X%C_XFJ^E>-[:
M_P#!-YXCNK9K,V(G%W:L^YH9(B0R9P,G@8X[BMG0]0GU70K'4+FT-G+=0K,U
MN7WF/<,@$X'.".U &=_PBI_Z&#7?_ L?_$T?\(J?^A@UW_P+'_Q-,\5>*Y/#
M=UI%M#IDE_-J<[6\2)*$(<(6&<C&"0 3V&3SC%9,OBB\O[/Q)H6L:4NFZG;:
M8]RJ1W'GQS0LK ,K;5/# @@B@"]J'@?[?;",>)?$$4B.)(Y$O!\CCH<;<$>Q
MXJIIWPZ^RW[ZE>>)]<O-2:+R/M)F6,B+.[8 %Z9YK*\!ZMJ&F_"7PLNF:3+J
M=Y<J8U3?Y<<8W.2\DF#M7C'0Y) %:=Q\0VL/#.IZE?Z.\5[I=]'97=G'/OP7
M9,,C!?F&V0$< ]N* -C_ (14_P#0P:[_ .!8_P#B:/\ A%3_ -#!KO\ X%C_
M .)JG8^+-3_X2FTT76M!&G&_ADFLY4NQ-N\O!9' 4;6 8'@D>]=;0!SW_"*G
M_H8-=_\  L?_ !-'_"*G_H8-=_\  L?_ !-9]SXPU:YU/5+;P]X>74H-+?RK
MF:2\$&Z7:&,<8VMN(!&<D#)Q5:]^),*V'AJZTO2YM0&OB1;>,2"-D=5R%;((
M^]\I.<#!/.* -G_A%3_T,&N_^!8_^)H_X14_]#!KO_@6/_B:U].ENY]/@EO[
M5+6[9<RP)+Y@1O0-@9^N*R_$7B&;2)]/L+"P^WZIJ#NMO TOE(%1=SN[X.%
MQV))(% #/^$5/_0P:[_X%C_XFC_A%3_T,&N_^!8_^)K*F^()M-%O)+O2)$UJ
MUOH]/.FI,&\R>3:8]LF -K!@<D#H>.*DM/&6J+XJM/#^K:"EG<SVLMUYL5WY
ML>U,8"G8"223D$#&!US0!H_\(J?^A@UW_P "Q_\ $T?\(J?^A@UW_P "Q_\
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M\RFXFGW. #F1RY''INQ6&/%FLQP:3IZ:'%/KU[ \YMS>@11PIM!D>39W+*
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MC^'5S+)X'TJSN-/OK*XL+6*UECO(#$2Z(H)7/5<]Z (_B'JVH:?HUA8Z5/\
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MBW/D.AF9PR/T;*G  R<^V37<V6GWB?%R]U!K65;-]$AA6<H=A<2L2N?7'.*
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M^UVQNK9;.YTB[,+KYFX-$5#1R]!@,,\=L=:P/)_L?XRZ89C^ZO\ 0&LH7/\
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MJZ3!XDTJQM[;5I?(ADL[EI&@F*EE20,H!R 1E>XH T_^$-T__G_UW_P=7?\
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MA'[#;)*_B#$F&?'E1"+S';W(X'U- &KK6DV/BK2Q9R7+>3'<Q2EK=U)#QN'
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M(R 2 3L <]!G@#'- '=T5S7A7Q#?ZK>ZQI>KV<%MJ6E3(DOV:0O%(KH'1E)
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MDG 'TINDZ?<Z/JGB22U\!N-+U*VM7AT\1HH>)&=90XY42D-N"'J, D&O6J*
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M<QD-NF^>UE\PE?E!# %2?F4]AFO6Z* .;\"6NI6?A:&'4Q<JXFE,$=V^^:.
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M$4]">001^%<?HFAZYX:TWP3JC:1<7,VGP75I>V43)YRK*VY64%@&P5&1GH:
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M:%# ,>N#C^E$JZEX5\<:WJL>BWVJ:?K,<#@V(1GAFB4H5968<$8.: .5\?\
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MI::6^N2VKWEW*\DGV:"(/L7 QN8D\8XZ&IOB;I-]KGP]U2PTV W%VXB>.($
MOLE1R!GOA367/+JD'BVQ\9P^'M3DMKG3FL+JR"Q_:8"LN]'V[L$'D<'(!!H
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M!5)RVW(W8''/4@@ '3T5B6_B:"Z\07VBQV=U]JM+9+K)V!94<D+M.[.<J?O
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M/TC2+=+W7;R\NS#;L2$BC%P^Z64C[J#\R>!74/K)C^+MCHDVG:?)</HIN&U
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M\NM=\1^)/L4\8N=,6PM+8@"27&XEB,_+DL ,X/!)Q78B^M"<"Z@)/_3058H
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MRG60C\E-1^*TG\3>#--UKP_"+N\MY[;4[&,,!YF""5R>!E&85VG6L[1=$LM
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MZAM-$U^UA\>Z.='=XM7DN[JSO%GCV.9(@JQD%MP;(ZD8]ZE'@_5)?@SI^BF
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MF';L:N^%KCQ-,+2RU;PO#I\MJ MS?^=&Z3;1C,:K\V6XZXP,]^* -72_%/\
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M=Y'H-I  YYS7'77A_P 3K\/-5\*0Z!+).NHF>*X-Q$(YXS="4%?FSG'4,
M><\5UIL=6A^)Z:RFF/)8W>DQVDD@F0?9W65G.X9R?E;C:#SZ#F@""P\2Z=8Z
M3XJU;3_#UU&UAJ$OV^%2GFS2*BEY!AB#P1QGM701>(%N+;19K>V:8:J R!)%
M_=H4W[SZ@#CCN0.]9'@S3-0L[OQ1_:6FR6\-_JLEU#YCQN)(V1%Y"L<?=/!]
M:9X%\,W^@&[MKYP]K9226VE<Y(MF;S,D^O*K_P!LA0 :A\1],T^&.^>+?I37
M/V9KI)D+*=VS?Y><[-W&>O?&.:U'\,P-XXC\2(#'.MJ;>1A,Q\T$\*4^Z .N
M>I)'3'/*>&;'Q/X>MSX8D\.074,,KK::R9H_+\EF)#2(?FW+G& .<#D#FO2J
M .>TSQ3_ &L]G-:6+R:?=SRP)=)*IV% Y)=>J@E"!U/(SCI1XY@U>Y\%:I#H
M6[^T6B'E!'VLPW LJGL2NX ^IKE]/\,WT7B;3=9TS2[K0[V2X)UF)9D-I<1[
M6RP0,07+;2, $9.>:[;7Y-3BT=Y-'@$]\LL12)G"!U\Q=XR>F5W<T <+X6OO
M!WB74=/.CVR:)K>G3;[G36C\B4@*RLKJ,"3&<YY(QVR:Z#6O'MEI$6H7"6YN
MK;37V7;).BN" "VQ"<OM!YZ=P,D&LO7]"E\4^(?#]]!H-QIM_I]]'<3ZA.8U
M*PKDM%E&)?=P/0<\]C%:6?B/PUXAUBTA\-1ZSI^HWLE[:W8GCC\EI.620-SM
M!R<@'CL>@ -:?QZCZLVF:7HE_J-RUC'?P>4T:I-$YPK!F;"C@_>P?0&G6'C^
MRU30[*_L[&[:XNKTZ?\ 9'7:\,XR660\A0 "2>>,<9XK)6XN+#XQR!K26[;_
M (1R!9#;*HPPG?D*2."?3../K58>'_$>DZ>)[6REF34M=FU'5+"UN$240R#"
MH'+ '&U"P##/(SC- &QJ?CJ2+PAXFU*ULQ%J.AL\4L$YWH7 5@05(RI##T/M
M3HM5\8MX;?4VMM(6:Z:)[:-G9$M(6Y9YB6&XJ,'"XYX'K7-2>%=>?P]X^TV#
M0DMAJC>;8I'/&%;,:+L ! !&TYS@9Z9ZUT/B[1+^]\-Z!%'IO]HI8W4$UYIV
M]!Y\:HP*_,0K88JV"<';0!AZEXNURZ\*>,[-+_29K[2K,3"^L@WER12(^<#>
M2L@V-SN(Z'%.N]>U72/#G@3^TK?2M0GU#4;6W$CP,?*1E&'7<Q(D'][I[5%_
MPB^NW#^,(X_#\&GP:[I"Q6L<4D06"1%E41R;3]YMX.5!49QGC-/U'0_$>NZ'
MX&1M"EM)]'U6U>ZBDN(B1%&H#2 AL$9SQUXZ4 ;\VN>(]:\2:MIOAPZ9;V^D
ME(I9[Z)Y#-,R[]JA67:H! )Y.3TK,3X@ZOJ%EX8.G:?:+>ZK<W-G<PSLQ6"6
M)6R00?NAESZD<<'FK@M]=\*^*=>N[#0I=7L=7DCN8_L\\<;0S! C*^]A\IV@
MY&<>E4-'\&:OIDO@UYHXY9;2]O+S4GC<;8FF1^!DY8 L%XSTS0!O>&M<UF;Q
M)J_A_7?L4ES910W$5Q9QLBR1R;A@JS,005/?FN7^-L6I3:=H,43V1L9=7MHV
MBFB9F:4E\;L, 4QU7&3ZUUMAI-]#\2-9U:2#%C<6%M#%+N'S.C2%AC.1C<.H
M[U2^).@ZEK^G:'%IEMY[VVLVUU,-ZKMB3=N;YB,XR.!S0!GW&N>*[+Q/9>$-
M.M]#%U)IAO'G$$B0Q$3%20@;.,8&/[QSG'%7!KGBG7-8U:UT Z3!!I,BVTDM
MY%))]HN-@9E7:PV*-P&3DU=;1K\_%F/6Q!_Q+AHC6AFWK_K?/#;=N<].<XQ6
M;#!K_A+7M?;3] EU>RU6Y^VV[P7$<9BE**KK)O88&5!!&>#0!63X@ZMJEMX1
M.DV%JEQKAN8IH[DL1!)"#N.01D!E8X[@ <9S3K#7O'.HZMK7A^(:&FH:2T;/
M>M%+Y4JR)NC41[\@\-D[B!@<'-1:-X*U71[GP(KHD_\ 9KWTVH3(X"H\Z,>
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M"U;QIJDNL:Q!INJ:)IJ:2%3R-1(,EW*4#LH(==BC<%R ><U%XEU:.;2O"'Q
MLD,,@G@2<9Y-M<85XV]<,5(]"* /2Z**PO%5]J=CIT+:;/I]J7F"SWE^P$5M
M'@Y;&Y=QS@ 9'6@#=HKR^3XAZI;>$->NXIM-U.^TF_M[9+FT'[BZ21H^0-QP
MV'(/) (_"MJ+6O$FD>,M+TS7;C3;FUU:&=T^RP-&;9XE#%<ECO7!/. <CH.E
M '77M]:Z;9RWE[<1V]M$-TDLK!54>I)JP"" 1T->+>*=:\3^(?A#JWB&1M/7
M2;V)O+L%A831P^9M5_,W8+< D;<8Z&O9HO\ 4I_NB@!L]S!:Q>;<31PQYQND
M8*,_4U776=+=@JZE9LS'  G4DG\ZXSXPF >$;(W4)FMQJUIYL0CW[UW\C;_%
MD<8[U4TV3X>7&J6L5KX*>&X>51%*_A]XPC9X)8IA<'OVH ]+HKA=9\<77A/6
M-1M-;MUEBFB\[1FMT(:Z;(4VYY/[S<5QCJ#GM46I>)M=TZ/0='OK_1]/UF_A
MDN+N[G7]Q;(F/E52XW-E@OWNS&@#OZ*\XC^(-^VA201?V==ZW_:Z:1#-"2;:
M5G =9L DA=A)*@GE2,U/K.N>,O"WAW7KO44T^]%G:+<6E_%$8T9]V&C>+>6R
M.H(."#ZT >@5'<7$-I;2W-Q*L4$*&221SA44#))/8 5SVO:]>:;J7AFVMUB*
M:G>&"<NI)"^4S_+SP<J/6N+\,ZAXAM](^(6HW]]8WB6-U>J86M6 >:.%,'ES
MB/ QLQGK\U 'J5G>6VH6<5W9SQSVTRAXY8VW*X]0>]3UP.F>-IK3P9X5U*YT
MR'R]6,,#O;L(HK>23A<KSA.V:Z34/$<.F7&HF[C"66GV@N9[D/G&=V$VXY;Y
M3W[CUH VJ0,K9VD'!P<'H:Y*S\=VTWB:QT2YAACDU"-WM9+>[6<9099)-OW&
MQSW!YP:=;:9IO@.R\1ZX(C%:RN][+!"[/]T$EAN/WF[@8 X';) .LHK)TS5;
MJ^N?+FLHDA>!9XKF"X\Z*0$XP#M'(X/IR,$UK4 %%<OJ'B^2&#4[K3M*FU&V
MTN7R;HQ/B1G&"ZQ)@[RH(SDKSD#.*M2>(VGU.73=*LOM=Y!;)<SK-)Y*Q*^=
MBD[2=YP3C' ')'&0#>HKBI?B19C0[#4X--O)1<ZBNFS0_*'M9R^TJXSR0?3.
M>.F:M6_B^[FU#5]+ET5[74K&U6[AAEN%*SQMN .Y<[3E2".?;- '42S101F2
M:1(T! +.P Y.!R?>GUYH/%377PGL];\2Z&NHP7)A9XU=2I+R#:Q!Z ,5P!NK
MI+_Q;/:^+#X=MM%N;J[-B;R-Q*B(X#A,9)X&2<D^G .: .GHKBX_B%$_ARRU
MAM,E03:@--N(#*-\$QD\L]L, >X[8K6?Q1#;^*;O1+J#R1;Z?_:)N=^4\K<5
M.1C((P3]* -ZFR2)%&TDCJB*,LS'  ]2:XV+XC61U+2()88A;:O((K:6.Z62
M1'(RHEC'*;O8M@\'%8OQ$UL:]\-?$4UGIB7>F0B2$73R#<71MIDC7'*JV1G(
M/!P#QD ]-!# $$$'D$4M5M/_ .0;:_\ 7%/Y"J^M:S!HMG'-,KR233);P0IC
M=+*YPJC/ ]23T )H LW5E!>>49DRT3^9$X.&1NF01TX)'N"0>#5BN9?Q>-.;
M5QKFGRV$>F6ZW+W"$RPRH<_<?:N6R,;<=<8S2OXLDL=3TNUU?3&LHM5;RK68
M3"0++C(CD&!M8C.,%AD$9H Z6H+NTAOK=K>X4O"WWTS@./0^H]1T/0\5QLWQ
M"N!8:[=V_AN[E31;B2*[#3QJ0B(K,PY.3@D[1GIU&0*NQ>-]^K:-!)I%Q#I^
ML@BRO'D7+-LW@,@Y4%0<$_B!0!U8      Z 4UY8T=$>1%>0D(I."Q S@>O
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MMRW)RW3BHK;QMJOBG^PK+P_]DLKN_P!/;4+J>YC,RVZ*PC*JH9=Q+Y&2>@H
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M[MUD=%Z*W?'MG-;5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI7=75W;6-NUQ>7$-O GWI)G"*/J3Q4=AJ=AJD)FT^^MKR('!>WE610?3()H
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M-)]O*N;B:1=VP;F7" 8R0,\U9\9:7KNM#4-+?PUI>KV5Q'BRNI9Q&UHQ7!+
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M2(&,8"LSRJ(W*^GEN#^!H ]'HKSZW\8ZGJ.E>"4MC&FHZO<;;T% 0J0JWVC
M['<N!Z9K-F\:ZEIWB"Q2Y\4:-=7%QJB6<VB6JJQAC>38") =Q=?E)R,=1@4
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MM=:-M5T"6>&X"KL$I',3 =@X*@>] &[;>!/"5K;1P1>&M**1J%7S+1';'NS
MD_4FL[4O#OPZTF_ANM4T[P[93M&R1K<K%$K+D$D(V%)Z<XS[UO>'#J;>'-/?
M675]2>!7N=J!0'(R5P/3./PKA?'UQ:VWQ*\+27FD7&JP_8[P&U@M1<,3^[YV
M'T]: .TT?6_#$OE:9HNIZ0^U3Y=K97$1P!R<(IZ=^E;5<?X=O-(OM2>.Q\'W
M^C3K$S+=W&E+;@=!@-Z\]/8UB?\ "8>(_._X0_9'_P )=]IV?:?)_<?9,[OM
M6.F-OR[<_?XH ]+HKS;7_&$R>*K_ $5?%NF: NFP1?/>I&SW4SKNZ,0 @&W.
MWG+46'C+5_& \/V&CW,&FW-[ITFH7MSY0F\L(XBVQJ3@Y?/)SP* /2:*X2;6
M?%&D3>'K'57M6FNM8:SDGB0 7-OY;LK[>=C' R/;WI_B#6M7_P"$FUG1K*\2
MVCAT$7T4GDARLOF.">>N57'MUH UO$MOX2MHAJGB.QTME++"+BZM5D.2?E7)
M4GUJ;_A"_"O_ $+6C?\ @!%_\37FD&MZYX3^!VA:C;W\4TLS6J1![9<11-P5
MZ_,?>N]L-<OH_B+JGA_4'0V[VD=[IQ"@'9G9*I/<AL'Z&@"]_P (7X5_Z%K1
MO_ "+_XFC_A"_"O_ $+6C?\ @!%_\37#R?$'4CH#ZJU]965KJNM-8Z9=7" 1
MV]LF[=,V2-Q.QL G&2*W?!7BIM4US4]%?7++7%MH8KB"_M HW*Y8,CA"5#*5
M[=0PH V_^$+\*_\ 0M:-_P" $7_Q-'_"%^%?^A:T;_P B_\ B:A\>:Q=Z!X&
MU?5;!E6ZMH-\99=P!R!T_&HO$&MWNG:SX6MK=T$6HWK0W *YRHB=N/3D"@"W
M_P (7X5_Z%K1O_ "+_XFC_A"_"O_ $+6C?\ @!%_\37$?V[XRO\ PYXCURVU
M>TM(]&NKU8H#9B3[2D+,<.Q/RC V\<\$YYP-4^(-;\2^(;'2]'OH]*B&DQ:G
M<S&W$S%I3A(P&X X))Z]* ->R\/>"=1>Z6TT'1)6M)S;SA;"/Y)  2I^7K@C
M\ZM_\(7X5_Z%K1O_   B_P#B:\UTWQ+?>&M$\1/<7-C:ZA>>*WL6O)1B"$F-
M"TN">FU&(!/4@$UI+X]N[?3_ !1;6WB"PUR;3]*.H6E_;HG!^8%)%4E<@A2/
M9J .X_X0OPK_ -"UHW_@!%_\34%OX!\(6K3-%X:TO,TAD??:HXR?0,#M'L,"
MCP<VNW>EIJFMW\,WVZ&*:&UB@""V!7.TMG+D@C)XP0<<5:\4WE[8^'[BXL;N
MQLI04!NKYL10(6 9SZD#. 2,G% %>Z\!>$;RVDMY?#6E".08;R[5(VQ[,H!'
MX&KVG^'-#TEB^G:/86CLGELT%LB,R\<$@9(X'Y5Y[;>.[Y-+\71VNO6>MMI>
MFB]M-0AA50&(?*.JG:<% ?H:T3K'BG2[KPQJ.H:E:SVFLW4=K-8):A1 9(V9
M2LF<L05YSP>P% 'HE%<+H_C.XL_#_B9O$#HVH>'II5G*J$\V/&^)@.VY2!]1
M71>%9-5G\+:;/K;JVI30B6<*FP*6YVX]@0/PH U)[B&U@>>XFCAA0;GDD8*J
MCU)/ JAIOB/0]9E>+2]8L+V1!EDMKE)"!ZX!KDO%EM'XA^(_A[P[?CS-*CMI
MM1FMF^Y<.I54##N 23CH>];]]X)T&]O-/O8[)+*[L)EF@GLU6)^/X"0.4/0B
M@#H:*X*&_P#%'BG4->ET;5K?3+33+Q[&WB:T$IN)8P"Y=B>%W' VX/%9T'C;
M7?$)\%KI4EO8MKEK=-=-)%Y@A>+:"5!/.#N !/<9SB@#TZBO,K"^\;:A=>(]
M'&O6D4VARC;?"Q4M<[XPZJR9VJ .I')R.F.4C\8>(M;7P/%ILMM:2Z]93RW4
MCP^8L3(J'<JY]VP,]QG.* /3J*\^M-?\1V<GBG1+J^T^YU'3((KBTO[E!;Q-
M'(#S*!P-A4],9XZ54T+QG<R:UJ6EQ^);'Q!''I4E]'=6\*(89$8*4(4D$'<"
M._!H ],HKRN+Q'XO@\)^'_%MWJ=H]O=R6B7&G+: !HY65"PDSG=SNQT&<8..
M>ET3Q+<Q:YXHTK79HPVEN+N"4*%#6;KN4^Y4A@30!U]%<YX&U+5-9\*6VK:M
MM6:^9KB*)4"^7"QS&ON=N#GWKHZ "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *SM>TB#7] O\ 2;C_
M %5W \)./NY& ?J#@_A6C10!P7@WP=J=OI&L-XHDBEU358TM9G@?<!"D0C4
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M0J4="P!VDJ>#@\BLE?#VNZUJVJ:YJUM:V,\FDR:;96<5QYNW>=S.[[0,DA0
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M84@\>H-<?<>$/&2?#Z\\"VMOIQLU62.WU)KH[I(MY=4,>WANBDYP!GK7K-%
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M7AWQ%X?U?3-7TFSM+]_['ATV]M9;DPX>/E9%?:<CE@1CTKT*B@#S&W\"Z_\
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M6.7"Q[EW@''!X.#R!7L-5)M-L[C4;74)H%>[M%=8)3G*!P V/K@?E0!YY?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6D80$!#&L0?:3E5((8KU% %2U\;ZK_8_BN/3]676WTM+:6WOQ: .$E)#EHU
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MZ$X)^E7IO#WB75?$5GJVJ0:;!:_8KC3Y[*&X9C#%(%)=7V#<Q*D;<  8YZT
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M8'A#-R!DY//.:X!=2UOQ%:?#J\-\JZI<7U^ANFB4[% E7<% "DA!QQC(&<T
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M6WA7Q%KMAJ'DQ1ZXEC8 0QL%B0A)",J<[FW=<XQQB@#UTR()1$77S""P3/)
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M"@@@8  (''(H ](50JA5 "@8  X JA>:U8V&J6&FW$CK=7Y<6ZK$S!MHRV6
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M8;&_?@@YSC.>,4:UX\F?4?$,D?BQ=+N-+N'@L=-^S*ZW!C49,I*DG>V5&TC
M&: /7Z*IZ3?C5-&L=0"%!=6\<X0_P[E#8_6I+Z22'3[F6)X4D2)F1YSB-2 <
M%CV7U]J +%1_:(?+DD\Z/9'G>VX87'7)[8KR[0?%%Y+XGT?38O&#ZS_:D,Z7
M+"T5(X)5CWAX6V %<@C!+=C7,?9-6'P=\8WC>(;QA]NNUDB,46)/WI5R3LR-
MV<G!&,<8H ]\!! (.0>]9^L:U8Z#8_;=0D>.#>L>4B:0[FX'"@FN-UBYO-&T
MC0[6\\:&QAE5S+<F"-KN<X!1(T$97:,G)VYZ>M8&J>.]<B^%;ZK::ENOK?6#
M8?;?LZJ9XQ(0&*,N%)7&1@<^E 'L-%<+J%SK^J?$:]T"SUI].TZ+3(;HO##&
MTH<NZX4LI S@9SG[O&,YK!;Q7XF7PO8PQZC&VJ1^*3HLEV\"XF0.R[F7&!VS
MC'3J* /6**\VC7Q4GCR?PH?%5P]K+IRZC]L:VA\^+]X8S&F%VX)P<E3@# ZY
MK-?QSJMCX32VO]7CAO1K\VCR:JT"DK%&6)EV ;=VU0 ,8R<T >MT5X]<>/+Z
MU\/>+(],\0-JIT^TANK+47@0.NYRK1N-H5B, @[>C>U=#//XCT/Q5X=%YKSW
MD&LR2P7%J;>-4@?RF=3$0-V 5Q\Q.1UH [Y)$D+!'5BC;6VG.#Z'WIU>;_"N
MTOTN/%$]UK%S=HFMW4#121Q@.ZE!YI*J"&(&, [?05Z10 5#>7=O86<UY=S)
M#;P(9)9'. J@9)-<EK5]JVK>.XO#&G:G)I=O#I_VZZN8(T>5RSE$1=X(4<$D
MX/85R/B:]UF_\!^-M&O]7D:YT-BKW$<,:F[@>,.BN,8!YY*XZ#WH ]+T#Q)I
M?B>S:\TF:2:W5MN]X)(@W&<C>HR/<<5K5S'P_LKJS\%Z5]IU*:]$MG \8ECC
M7R5\M<(-BC('J<GWKIZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *YSQGX?N]?TRT.G3PPZCI][%?
M6K3@F,R(3\KXYVD$CBNCHH X2#PMK^J^+H];\0/IR6YTV:P>SM'=MH<J<AF4
M9)^;/3&%QGDU1/@OQ1=>&+;P;>W6EG0H3'$]XC/]HEMT8%4\O;M5B%"D[CQV
MKTFB@#BIM!\2Z=XPU?5-#DTMK75TA\XW;.'MWC39N55&'&,'!*\]ZR+3X?:_
MIVB^$K>TO['[9H5S=3N\I<K+YA<JO"@\AL$\8R2,XY],K!TWQCHVL:Y=:3I\
ML]Q<6KM'-(EO)Y*.O53)C;N'IF@##B\(ZQJUSXAU'79;*"]U/33IEO%:,TB0
M18;)+,%+$LV>@Z4:<OBOP]X9\.:9<+IAGAO+:QD^SF2026JIM9AE1M?Y=WH
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M@_A7+#PYXJUF71;3Q#-I2V&E7,=TTEH\C27<D0^3*LH"#/)&6Z8KNR0JEF(
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M5V'\F>-<$$%>5(8$CCD'M0_A/Q$(-,U/^V+>Y\165S//FX5A;,DPPT*@?,J
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M"&#93)5@VX]"#N/2D\1^#M<\2>&M)L[W5+674+75([^>7RRD>U2Q\M !G #
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M2"ZMV^]%/&'0_4$8JQ10!7LK"STVU6VL+2"UMU^[%!&$0?0#BK%%% !1110
M4444 %%%% !1110 54L-+T_2HGBTZPM;.-VWLEO"L89O4A0,FK=% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% "$!E*L 0>"#WJ*UM;>Q
MM8[6TMXK>WB&V.*) B(/0 < 5-10!#%9VT-S/<Q6T,=Q<;?.E5 &DVC"[CU.
M!P,]*FHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L^_T+1]5GCGU
M'2K&\EB_U<EQ;I(R?0L#BM"B@     & .U%%% !1110 4444 %%%% $%W9VN
MH6SVU[;0W-N^-T4T8=6P<C(/'4 U/110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%<AXGUOQ!!XHTG0_#_\ 9BRW=O/<2R7\<C!1&4 QL8==QH Z^BLO0UUY;63^
MWY-.DN-_[LV".J;<#KO).<YK4H **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
D@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>employementagreement_mil006.jpg
<TEXT>
begin 644 employementagreement_mil006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
MSC.!VSQGUK/USQ4NBWE[;FS,WV72)M4W"3;N$9QLZ<9]?TKG/"GA_5+?5-%:
M^LM4B&EVKQ%[FZMS"I*A=L2QC<RG&?FVXP.IK0\5Z#J6I:GJLUI;>9'/X<NK
M&,[U&Z9V!5>3W]>GO0!8A\6ZE;OI\FLZ$EG97\D<,=S!>"<(\GW XV*0"2!D
M9Y(KI[>[MKL2FVGCF$4C12;&!V.O53Z$>E<5+;Z]XAL=)T>XT"?3+2WGMIKJ
MXN;B%MPA97"HL;L22RJ,G&!FNRLY)9!/YMFUMMF95#,I\Q1T?Y2< ^AY]: .
M;L/&KWFI6<;:9Y=A?7D]E;7 N TADBW[M\6/E4^6^#DGID#-7;#Q9;ZCXDO]
M(@M+D)9VXF-P\;*)3O92$4C+ %2-PX)Z9KD]'\+ZC;:MIDAT:2#5X+Z2;4-;
M,R%+N([L@88NV[*84J N/89ZQK&\B\;7>JK;&2V.E)"A5U!>19';: 3QP1R>
M.>M %2U\6:C)=V,%YH#6G]I12/8J]R#(65-^R5=H\LE?0MCH>:;:^+M2.NS:
M;J.AQVJVUHUW<SQWHE$*<[0PVCEL-@9Z*35+PNFN7&O#4O$7AZ^CU"56C6=I
M[=K>RCZ^7&JR%N<#+8R3C. ,#0TO1KY=$\02W=K"VIZI<7+F*X;<C)S'"C%3
M]WRU3..FX]Z (=.\;SSZ'=:UJ.EQ6FGV]G]J8Q7RSR#@,$*!1AB#W/7BFWWC
MBZTBQU)]5T7[/>6EA]OB@2Z#K-&#M(W;1M8$@$8(^88)K!O/"-YKB3+8^'H_
M#H729K1U8Q!;B9BAC7$;'*(4/S'!^;@=:G\2:/KOBNTU:Z&BS6<W]C26$%M/
M-$6FED=6;!5BH4>6H!)&<G@4 =%!XFU&'6(=-UC14LY+F"6:W>"\$ZMY8!8-
M\JE>&&#@BJ.E^.-1NK71+^_T!+73]8:)()HKX3.K2+E-R%%X]<$XK,TWPW<+
MXDL[W2_"TV@0QQ3)>/-=1-]I1D(6,*DCCA]K9.,;?>LC0O!U_;6'AV&W\)3Z
M5J]B]N;C57NX2FU<";"I(Q;>NY<%0/F[8H ]/UC4+C3;-)+6PEOKB258HX8S
M@98_>9L':HZDX_,US\_CB6TLKU;C2E35+2]ALVM1=#RV:4*RL)2H^7:Q)RH(
MVGCO3]7M?$NBZ5=2:+=7^M7MS*J(EP;<"T3)W.HQ&&P. "QR<=LUFP:5*F@0
MQOX.GNC%?K<W46I302SW+%2&F4K(4+@D<,0,<#&!0!L2>*KFVTBVN+C2T:^O
M;D6UE:6UVLHG)4MGS, !0 Q)YP%[YQ4=QXJU32K'59M7T P/8V$E]&UM<&:"
M94!)3S"B[7Z<%>G(S@UA0>&-6MI/[=L-*6VD@U<WUMHYD1<0M!Y,@R"45VRS
MXSC/4\FM'6CXE\2Z'KMI'HSV%I-I5Q!#!=21&>XN'4A<;'944<CD\ENP% &Q
MI>I^(KR>W-YH-G;6DJ[FE343(RC&1\OE#/.!UK3U34K?2--FOKDMY<8&%099
MV)PJJ.[$D #N2*XSP]I$5E>6PB\#ZAI<_EF,WYN;=Q%E<%L"5B?^^36C=>#]
M4FFL95\57DSVDKS)]MMHI1O*A0<*$'RC=C(/WC[8 +">+T?P);>)?L3;[F*-
MH;/S!N>61@J1[L=V8#.*OZ;XBL[[PO%KTK"VMC 99A(?]25SO5O=2"#[BN+T
MKPAXBET7PKH]_=36<.G(;J:X@$.Z.90%BB .\-C<[%L$<#O5B#P3K*7%]I8U
M68:;]N35(+J>**3SI&R7C=%VC D D&% )/M0!JVWCJ.Y\,PZJ-,N5N;F^DL+
M:P9@)))5D9 "3PO"%CG[H!ZXK2TS5]7EU3[!J^B?8V>(RQ7%M.;B%L$ JS;%
M*MR" 1@\X/%<G9^%?$5GHL4\C1W>HV&NSZC!;D+$)D:24,-P) +I*6&>AP#7
M117/B'7;QXS8W.@Z<(&5I96A>Y>4D;2@5G554!N6SG(X[T 6-;\07&GZI::7
M8:>EY>7$$MSB6X$"+'&5#?-M.6RZX&/4D@51C\:-J4&E)H>FM=WNHV8OA%/,
M(4@AX&Z1\-U)P H.<'L,UF:WX8N&U&Q;5+*]\5Z;%;2Q^5*T D29F!WE3Y:$
M;?E!'*_B33=+T?Q!X<ETK59+*35)1IOV"\MH9T,L860O$59RJOM#%3D@G@\T
M =%;^))8M-O;C5])N[*XLY1$\,2-.)BV-IA95'F [@.@(.00,4VR\6P7/@^U
M\0RV=R@N$REK$AEE+$D! %')X^@[G'-6M#N-9N_M=SJMHEE$\@^R6I96EC0
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MA^[N-2L88O"UOIUU;:M]LEU6 QB-X@Y9L$-YA:13M*D8Y/. * .DLO%5O?\
MBRXT*"UN/]'MVE:YD0HC,KA"J9'S8)Y8<9&!GG&<GC#5+NQ?6--\./>:*K-M
ME6YQ<3(IP7CAVG<."0"P)'0<BM)]-N6\=KJ/E?Z'_9;6YDW#[YE#8QG/0=>E
M8&E_\)1X=\-Q^&K+07N+FU0V]GJ)GB%L8P<))("V\$#&5"G)'!YH W=>\66V
MB7NDV?D27%QJ-S%$$7Y?*1W"^8^1P 6 QU)^AQT%>>:]X+\03W@O;/65FFGU
M*UGE#6B9B2-AC!+?=3EMO<D]R:]"&0H!.3CDT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4KK2-,OKJ&ZN].M+BXA_U4LT"NZ=_E)&1^%7:* "BB
MB@ HHHH **** "F0PQ6T"001)%%&H5(T4*J@=  .@I]% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/L16@TI\,>,=*U[48+D:9<Z!'8//% \GD3(^\!PH) (8C..HH ;XH^(FH0^
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M'PC4V5SNMK@&<>4V8A@?>X^7\:T?$4UK!K=]<:!%KFE^+/M85;2&*1K?4,,
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M?,8NI&6#8&">!VK>AO)/!?A<O+J-QX@6>[$6EJ7#2R"0@1Q&0G#8.3O/;Z4
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MY%(;!QU\S<5YZ84^O-@^)=/^TB)?M#HUS]D$R0L8_.SM*[@,#!R">F1C.>*
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MU"US&]I( %-XS[E;&&&WDD=.]=]J]K<2?%'PU=);RM;Q65ZLDH0E$)\O )Z
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MR/F!VGI7)0072?!#0;%K"^%Y%?PM);_9)/,0+<[R2NW(&WG->ST4 </)(?\
MA<<%YY%Q]E_L%X3/Y#^7O,RN%W8QG:"<5QTD%TWP=U"R%A?&Z?63(L'V23>4
M-X)-VW;G&SG->TT4 <#J4TP^*=O>VUE<7"+H$\:MY+B-Y3(K+&7Q@$@'K7,V
M5S<7=[X$U%]-U82VUS(MY"EA)%#:,T+*(DCP %!.-W/'5J]DHH \ZT)Y=/E\
M=V5S97JR3:A/=1L+9RCQO$@4JV,,201@9/M6-IMKJ.GZ'\-]9:RNVMM'CD@U
M"W$#^;#YD7E^84QN(4YS@=#7KU% 'FNJV<E_K_B?Q%:13FQ?P\=/3;"V;F8E
MVRJXRV 57..IP.AJJZRC0?AC']DO/,LYK<W*_99,P!;=D;?\ORX8@<UZI10!
M4U2VEO=)O;6"7RIIH'C23^XQ4@'\":\M>VNM8^#D/@MK"YAUZ-(;%H'A8"-H
MY%_>[L;=FU=VX'!Z#GBO7:* .&NF:/XP:9*8;IH(]'EMWN! YC$C2(0"X&,D
M*3UKMY'6*-G<D*HR<#-.HH \I\"KI<6A:W;:YI-T#<ZI=R!9M+F8O$[<$?(>
M"*Z'67A\5^&X-#?3KF*/52T<;3V[@V\2'B5LCY'^4%0<')7/0UVM% 'ED4>L
MZO\ #/6_"1LYDUK3D:".4PO'%?*C AU8@ EP,'GJ2>]6].FTWQ;&HLO#NHV6
MKQVTT;7%_#(GV%GC*D*[]220,+VR3C&*](HH \Z\$ZXTFAZ-X;O?#U['K&F+
M%!*L]H1##Y8V^<)2-O*@D8.23@<<UAWSSV7AWXCZ$^GZ@]_>W=U=6Z1VKLLD
M4D2;6#XV]CQG.> ">*]AHH \X9YK;Q=X,U)["_-O_94UJVVTD+1RD1X5QC*9
MVGEL#CKBM#PJC-X\\;-);3K#<SVQB>6!E255A"-M)&& ((XKMZ* . \%:+J.
MFZG<Z+=PL-*T.YD;396Z2K,,H!_US5I$/^\/2L/3S;:==:QX:\1^&]3OKB:_
MGFM6CADD@O8Y9"ZY(.Q2"V#NP!CDUZW10!%;Q^3:Q1;%38@78GW5P.@]J\Q-
MM=6/B3[;X:FOHFN=8*:CHEW"S0R#S2'N8RP^3@>9N!P>!UX/J=% %35;62]T
MB]M(7\N6>"2-'_NLRD _K7FWA*>QO++1]$U+PKJ*Z[IC1+(MS#(8(7CP//60
M_)C )7'))P..:]4HH \IA68^#_B7#]CO/-O+R]:V0VLF9@\*JI0;?F!8$<5;
MNS(TWPV9;6[(M6!N"+:3]R/LY3Y^/E^8XYKTN@YP<=>V: /*M$O[5-,^(6GR
MP33SW&L7J1P)"S&<M&BA5P,$YZ^F<G YJ6#2KO1-7^&=A<13ROIMM/'=2QQ,
MZ1,T 4 L!@#=P,^E=EX;\.R>'Y-59KT7(U&^DOG'D[-CN "!R?E^48[^];U
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M.><5'#\1;V6#1=6/A\QZ!JMQ%;1W+W0\Y&DX5C'MQMW<9W9QSBI=%T^]BO\
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M8T <FWQ$U)M'G\26WAU9O#,+L#<_;,7#Q*VUI5BVXVC!."P) S7->/&O]?\
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MA#W(QS]16A0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M* /1:*\1)N;S1]$T:6]NC!9^,I=,282MYC6ZK* I?K]T[<]1CVK9L_!NC?\
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M)(7+!\G!Y ('0=L5@1V^KZ_INI:S9>&=3NO$+W\[6>K)>1(L)CF*I&JM("$
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*W!D@9&#Z4 <)JUMI?@OX=IX66VO]4$UK+:VMND#2/.3GAF5=J\N.3C]*V?
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ML".,YY]:R;WP)'<WM\]KK>IV%EJ,GFWME;,@25\ ,0Q4LFX ;MI&:ZZD+*"
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M0R#,<BE&'J",&N/TWX=V^GZ;I>G/K.H75KI=]'>6:2^7^[V!@$R%!*_.>O/
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M:(@-E'5Q@D$=5':@#E;W3O%OBRXTZUU?3-.TK3;:\BO)FBO3<22^6VY44;%
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M6%O"<NKS079L;.[6\BB^PJD2%!&&8%3EM^1US[5Z)IW@G2=,\7W_ (EMS/\
M;+P$-&S@Q1EMN]D7&06V+DY-0ZKX'MM1U*\O(-6U33OMZJM]#92JJ7&!M!.5
M)4[<#*D' H Y.VT1M=^(FG6GBB 3S)X6@>\MG8-&\XF8'=@X8 ECCD9P>PJA
M9KI]KX7UC0)K>]NK1?%,EE8:;:RA?- "R"$EN!%]XGD<"O3;?PW8VGB!-8A,
MJS1Z>NGK'NR@B5]P[9SD]<UEW/@'3I[>Y2*\OK>>;5#JR7,3KOAG*[3MRN-N
M,C!!ZF@#S:_CDL/#WQ*TU=*31[:.PM9TL(IQ(D3N'#,NW@;@BY ]*Z74O#VG
M>'O$O@J_T^'R[Z[O&M[RYW$O=*\+EO,/\1) //3M6U+\,],G74A+J>JN=4M!
M;7[M*A:X()*R,2G##) Q@ 8&.*Z#4?#]IJ=QI,\SS*VES_:( C !FV%/FXY&
M&/3% '$_"K0M*L-0\675K800SPZW=6<<B+@K"/+(0?[.1G%>DNZQHSNP5%!+
M,3@ >M8.D>$K?1->U+4[._OA'J$K3S63.I@$K8W.!MW _+ZXK1UK2H]<T6\T
MN:>>"*[B,3R0,%<*>#@D$#(R.G>@#QW3-6M_$S^*]6U+P]K][!K@-G9RVE@9
M$2T0%5*G(Y+98^X%6E\47^H? ^>UN))[75K.XATB^+926,&5$+'/()C;KZDU
MZYIFG6VD:7:Z=9ILMK6)88U]%48'XURWB/P;IQM_$NII97E_)JMJBW.GPRJ@
MF:/[KIQD2#'!SVZ4 8FI>&-(\-_$;P,NCVZV4,LUTLEM$3L<K;MAR/[PR03U
M.1GH*R_"VF6UIX9\7>*UB,VKZ?=ZH;&5B3Y 7><*.G))SQSGV%6-$T[^UO'7
MAR]M/^$CNUTQ9Y+J\UN%HC$&B*+$N54%LMDD YP,D\8]#T7PU8:)I][8P&2:
M"\N9KF59R&RTIRPX ^7VH \V\,Z'JD-QX8U'3/"4UC,KQO?ZFU_"YO(70^89
M &W.22'&<D$<5E:18:WK?A^#7;#PE-+X@FO#=IK9OX58D3'*8+!@FT%-G3':
MO3-)\"VVE7=E(-7U:YM+ DV5E<3J8H."HQA0S8!(&XG IB^ +)+PF+5-4CTU
MKK[6=+291;^9NW_W=P7=\VW=C/:@#EX/#&E>(O%OQ _M:V%VD4T0ACD)VQ,;
M9<NH[-P.>HQQU-84.D6L/PS\(^*,.^O?;+(F_=R92K2!-A;/W=IVXZ5ZW9^'
M;.QU#6;V*28R:NZO<!F&%*H$&WCC@=\\U1_X0C3/^$3T[PYYUU]CL)(9(GWK
MYA,;AEW';CJ.>!0!YY>V%[XFUCQ;*_A2;5KJ.]>SL[X7L41L@B+L\L,P*D$[
MR1UW5JP:)_;WQ&L+7Q/;B:5/"T$EW:LP:-YQ*P.X X8 EL=1G!["NIU3P+:Z
MAJ-[=0:MJFG)J  OH+.952XP-N3E25)4 $J02!6G!X=LK;Q"NLQ&59UL%T]8
M]P*")7+#MG.3US0!XWK&E6)^'^MV+VZO;Z9XL^S62/\ -Y$32191<]!\S#\:
M]SL;&UTRRBLK*!(+:%=L<48PJCT%<[>^ =*O=%U?2WGO%CU2_.H22)( \4V5
M(*'' !0=0>]=!IUH]A80VTEY<7CQC!N+@J9'YSD[0!^0H X_QQ_I/C+P)82\
MV\FI2W# ]"\43,GZFL[6-!TF]^.>E27-A!*[Z5)<,67.9$D0(WU X%;WC[2+
MR]TRQU32XC-J6C7:7T$(ZS*N0\8_WE)Q[@5+=^'K/Q/?Z1XFM[[4M/NH82$,
M.(V>-R"8Y%=3CD=.".: //K?PMI.I>"?'6J7UL+B]@O]4>VE=CFW*,S*8_[I
MW#)(Y/?@"I)9+OQ'X@TZ&_\ #K^(X8/#]I.+=[F.-%DEW;Y2'(#,=H /;!]:
M]'M_"=A;:'J^D)+<&WU66YEG8L-RF?._:<8 &3C(/XU5NO ]K(-.DL=3U'3;
MNQM%LDNK5TWR0C&%<,I4\C.<#!)Q0 _P'::KI_A2"SUB"2">"65(HY9EE=8=
MY,8+*2"0I Z]JZ6J.CZ5;Z)I4&GVS3/%$#\\TA=W))+,S'J223^-7J "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *IW^I0:>;9)23)<S"&% 0-S8+'DD# 56/X<9.!5RLS7/#VD^)+
M..TUBRCNX(Y5F1')&UQT(((/<_G0!6U3Q/::;INMWHC>==(B:2=58#<P3>5'
M.<X(YQCGV.,%?'FMC3EU*7P)JOV$Q"8R17-O(WED9R$#Y/';K2^.O#VDV?A7
MQAK=O91QZE>:5+'<3J3F10AQD9QV'..U<Y?ZUXZT3P)IMQ,-!@TR6&"WDO(E
MFDDM(G4*)64X!QD9Y/)Z$4 >G:=K%CJNC6VKVMPILKB(2I*WRC:?7/2K?FQ^
M5YOF)Y>-V_/&/7->4ZYHO]D77@GPI9Z8NN:=;VUQ*;2>=8TN70( [;LJ<;V;
M;[^U \(:_+H-Y:#0[2"RCU>._MM$FNU:*6+9B2'<!A5W_. 1C/:@#T;6-?T[
M0]'?5;R<?95*C='AMQ9@HQZ\D5?-Q J%S-&%"[LEAC'K]*\2\46N@W'P]UB&
M'P\VDWEIJEJ;C3IPK+;.[Q@F+;E0KK_=QGGBM_6/#&CWGQ7T/1WL85TN/1IF
M-FB[8F E4A2HXQN(;'J!0!Z!%>:@^OR6QM;?^S!;B1+E9\R-)D?+LQP,<YS5
MX3PM,81*AE49*!AN ^E>6[CIWQLUQ[2, VWA8&% .!M==HQ^ JUX0\(Z!<^$
M/#6OSL+?5G\F]DU-'59YIGY9'<@[E8L5*GZ#% ':V_B&UU$ZM!IK+/=:<YB9
M'8*K2; X&?3Y@">W-6=*NKJYTZWDU"&&WO73=)#%-YBJ<]FXR/?%>7>'=$TJ
MSL_B7<6VG6L,T%Q=V\4D<0#)'Y"G8#V7/.*HZ2G]D_#OX?>+DX&E.(;MO^G:
M9C&Y/K@E30![874,%+#<>0,\FF1SQ3%Q%*CE#A@K [3Z'TKR'Q)>75[-X\\5
M6CLHTFR_L:PD4X*MD-.X]""P&?\ 9K5\/^'-2T_Q5HMUI_A&WT*S@CDAO98;
MV.0W$93Y=X4 LP<*=QR>30!Z3//%;6\EQ/(L<,2EW=C@*H&22?3%<1#\0=3U
M"U.I:/X,U6^T?DI=B6*-Y5'\4<3'<P/;IFM#XFQW$OPS\0I:AC)]B<X7KM'+
M?^.YK:T":TN/#NFS6)4VCVL9AV=-FT8_2@!-%U[3]?T.#6+&;-G,I8,XVE,'
M#!@>A!!!^E7EN(7B$J31M&>CA@0?QKS[Q-<:;XF\3>#=)2:"\T.[N+QYXXV!
MBFD@3Y4;'! 8L<=#MK*U3PI:3^*_$OA'2H([6QU'08[P6\0VQQ72RLJ.%'"D
M[5)QC.V@#UEG5%W.P5?4G%,,\2S+"TJ"5AE4+#<1["O*O[9;X@6_@?2'!+3'
M^T=60_PBV.TJP]&FX_"L>/2M7\2:;KM[;>%HKK5YM2N?L^LO?1I+;/'*5C"@
MC<JIM P#SSZT >VR7$,*LTLT:*N-Q9@ ,],TKRQQQ&5Y%6,#)<G Q]:\WTWP
M_I^O_$WQ5_;EC#=^5:V'^CS*'C#M&^6VG@D8P#VR<=:PM&-I<^"?#6BSZ9-K
M,_\ :-ZMGI[SA(72&209E+ Y1%(P,'G'% 'LJS1M&LBR(4;[K!A@_C2+<0N9
M DT;&/AP&!V_7TKPZ[AE3P9XGTPVR:9'#XCLUCM;6?>EKO: D1L ,<DG  P2
M:ZV\\.:-HOQ+\.6NFZ;;6UOJ5A?6][%'& MPBK&0''\1^8\G).: .VT77+'7
M[1[JPEWQ)-)"2>#E'*$_3*G!]*TJ\Z^#6EV%IX-:[MK*"&XFN[A))4C 9U69
MPH)[@#@>E:?Q.\07&A>#9X]/5Y-5U%Q8V,<8R[22<9'N!D_7% #O#/Q#T[Q/
MXAO=)M[:>(PJ\EM/(1LNXTD,;.GL&'ZUULLT<*;Y9$C7.-SL *\/U:^/AS2_
M"VH:;X5\0V9\-,%GGN;1$22V88FW%7/)/S=, YKL-2M=.\5?%73[/4(H;_2H
M=":^MH)0'B>1Y0N_:>#A<8SZT >@&6,!B74!>O/2D^T0[9&\Z/;&<.=PPI]_
M2O"-<LH=-\#_ !-M+.1O)@U2U6++;O+ ,.%&>R_='L*ZCQ9H-KH]WX8T'2M#
MCOK.\NYKB[LVF$8O9(XL@RLV=W/S$'.=M 'J*2))&)$=60C(93D$?6FQW$,L
M1ECFC>,9RZL"./>O&-6T_7-(T>_L_P"P4T[2M6U>QBBTN"]3:0Q(F0,O$:N5
M0=,?,:NWFBZGIVF>+[I/#5OH&DS^';E)+:WN4='G56VN%0  [2P)QS@4 >M+
M/"TIB66,R ;B@89QZX]*(IXIU+0RI(H."48$ ^G%>.ZCX4TBWTCX>W,-L(KN
M^O+>"\ND)66YCD@8R*[CDAL8QV' Q2^((T\'ZMXYC\.P)I\1\/17 BMEV*DF
M^1-Z@< A>X]* /88YXI6=8Y4=D.&"L"5/H?2D-S '1#-'ND^XN\9;Z>M>:>'
M_#FI6'B;0KO3O"-OHEK CPWL\5]'(;F(H=N\* 7;>%;<<GKZURL?A[2U^ 5Q
MKQM8VU>(2S0WK#,L)2X8*$;JH&.@XY)[T >SG7K >(3H?FYOA;?:BG;9NVCG
MUSVK _X6);C0_P"U)-!UR-8[W[)<P/:8EMOE#^9(N>$VLIS[BL:WT72YOCM<
MSR:=:M*NBPW8<Q D3><P\P'^]@ 9Z\5W_P#9=EY @, ,?F^<5+$[GSG+<_-S
MZYZ#T% &;IGB)KGQ-J6@7ULMM>VJB>#:^Y;BW;@2#@8(;*L.QQR<UO5POB?_
M $?XK>!IXN))UOK>7'\48B#@'V# &NG\17MKIWAK4[R]DFCM8;61I7@.) NT
MYVG^]Z>] %]+B"1G5)HV,9PX5@=OU]*PV\::*N@ZGK/V@_8].DFCF( R6C)#
M;1GG)''K7GVD:6FG>,_"=NOA6UT2VO;:Z@E N5EENXO)W8F55 )R 226Y)K
M/A_1D^!_BN\72[,7,=]<A)1"NY0DVU<''& 2!Z9H ]Y%Y;FU6Y,T:PL 0[,
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M6ESVJN#+%'IK(SKW ;S#@^^*XCQ]>2^%/$UU'H=Y]F37( VK;$+"P7>L?VP
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M_"/>)["[BC2V=XKJT6*2(/NQ*HE)*@DDXYQZUWU027UI#-%#+=0)+-_JT:0
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M%Y?VJ7'V42C<,C/ /)% ',Z=IS::^B/'X4\3RG14FCL_.NK-L)( "I/G<@
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M FO>&[37Q:O+/=6EW:.7MKNTDV2Q$C# $@@@C@@@@U2'@;23H$VDRR7DWG7
MNWO))R;@S@@B4/V8;1C  P,8K>BO;6>>2"&YADFBXDC20%D^H'2LOQ)XB@T/
M0]5NXI+>:\L;.2Y%JT@#-M4MR.H''6@"BG@+3397\%Y>:E?SWPC$EW<W&9E$
M9W1["H 3:WS# Z]<U<T3PK;Z-?37[W^H:C?2Q"'[1?S!V6,'.Q<  #//3)K4
MT^Y-[IMK=,H5IH4D*CMD X_6L>7Q,MOXWGT.X$,-K%I:7QN9)-N"TK1[3GC'
MR_K0!;\1^'K+Q1HTFF7S3)$SI(LD#[)(W4AE93S@@BLV[\#VMT]G<C5M6@U*
MUA-O_:,-PHGEC)SMD)4JPSS]WCM71+=VSB(I<1,)AF(AP=_^[Z_A3WFBC=$>
M1%9SA%9@"Q]O6@#/T+0;'P[IOV*Q60JTC2RR2N7DED8Y9W8]6)[U4USPI:ZW
MJ%KJ'V[4+"]MXWA$]C,(V>-B"4;(.1E0?4'H:W68*I9B  ,DGM4,=Y:S2>7%
M<PO)L$FU7!.T]&QZ>] ')M\,- :T:S#WRV9ODOTMUN,+',JE<J<;AG=D\YR
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M#]JCMXKLWL,D<Q66*8N7W*W8Y8_G0!T<$$5M;QV]O$D4,2A(XXU"JB@8  '
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M<.3L7RV!W$$$\?= JKHNC3KXA\&^'_$:6UU#::=>30P[_.A9Q*%C&6'S%(B
M,CCF@#U1+^SDA@F2[@:*=@L+B0%9">@4YY/!Z43W]G:EQ<7<$12/S6$D@4JF
M<;CGMGC-><>(-,T71[OP_:Z-)&(SXLADGMXY 5MY6B?*A1]S/!V^_O5W5XX+
MKXKWEO,D<J'PL^^-P&!_?\9!^E &LOB]=;\'QZUX<N--5Y"N%U.?RUC!.,/M
M)PV.@KIX[F"6:6&.:-Y8L"1%8%DR,C([9KP76+2VM_V9=,EAMXHY)FMVE9$
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M))?R#O\ ;(I!&@/O^XE_[ZH ]C\0ZPFC:'J5W&\+7=M9374<#MR^Q">G7&0
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MCO+ZVMGF.(UFF5"Y] ">?PKQ2+1--M_V=;?58[*$:BHBN%NR@,JN+A0"'ZC
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M.8V:)PP5AU4XZ$>E59M>T>WLGO9M5L8[2.0Q/.]P@17'52V< ^W6@#&T_P
MZ5IM_#>07FL-+$=RB74YI%S[JS$'\:MQ^#M#C\,W/A_[)OT^Y+M.LCEGD9CN
M+LQY+9YSG(P/2MFVN;>\MH[FUGCG@D&Y)8G#*P]01P:R/$GBS2O"R61U*XCC
M-Y<I;QJTBJ?F8 N<D?*N<D]J (-0\$Z7J+6LKS:A!=6]N+875M>212R1#^!V
M4Y89YYYSD]Z=>>"=#N]+T_3UMY;5-._X\I;29HI8.,':X.>1USG/>J<?C:TC
M\4ZI9WM[I]OI-M9VUQ#>/,%#F7?_ !D[2,*,8_6NB?5-/CTW^TGO[5;#;O\
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MS,TDLP8-O=R<DY4?E6CKGA_3_$-I';W\<A\J030RQ2-')#(.C(ZD$'DUIT4
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M.Q+'CCKQVH YWX/6UO%\,-$FC@B266!O,=4 9\.V,GO2_&3_ ))-KW_7./\
M]&I76:/H]CH&DV^EZ;"8;.W4K%&7+;1DGJ22>2:AU[P_IWB;2Y--U6.26SDQ
MOB29XP^"",[2">0* **V&IVT^GWUSKADL;8-)<1/"D8*^6P!W#T)''X]JX[Q
MGYOA[Q7]IBU*\32-4A6WU3]](PTX,X"SISB/=RO;!&[G!%=NWA+3)%A6:349
MHXG218Y=1G="5(*[E+X89 X.14LWAG2[BSU6UGBEEAU4DW:O.YWY4+@$G*C
M P,4 <_X@NGA\4>'/#<,BI975O<2!9IG G>,)M0L#N;AF;!/.!GI6->_VEX4
MCL='N];,EGJ>NQQ?)(^^T@=680B0G=@L@ .00"<=JZV_\"Z!J>A6FCW=M+):
MV9#6K&XD,L!' VR9W#'UI[^"M F\.2Z#/9&>QE;?()I7>1WX^<R$[MW YSV
MZ4 8/B?1ET3PYXNN+35;M1+ISW-O9K,P%J\<;?/&0<C)P2.F14-S<W UOX;.
M+JX!NHY%N )FQ,!:EAN&<-SSD]ZZG3/">D:7IEUI\4,LT-VACN&NIGF>5,$;
M69B3C!( Z#)]:I6OP^\/VCZ<ZQ7DDFG,6M'EO97:(8V[02V0H'&WI[4 <QX3
MTNWBLO'SPO<Q/'JMVB/'<R*5'EQMD$-USWZ^]5IDOY/@[X:\1P7%Y+>:7!;W
MMPBW#C[5"N#*CX/S?+D\^GO7>+X1T>.[U.YCAFCDU+)N0ES(%8D ,P4-A6(
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MUO':6L5M"NV*)!&BYSA0,#DUE:AX5TG4]?L]<GBF74;10D<T-P\>4#;@K!2
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M:5I]RT-DEV\MW=-%PSLN!M1O2K'@72KW2H]96\FTUC/J#3B#3G9H[=BB[DY
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MFH-0\(Z'JFEV6G75CNM[$*MJ4E='A 7:-KJ0PX&.O/>MNB@#GW\$>''\.?V
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MC'I[SB21HAO+O(RL?F8N?XB?4UV,^@Z7<Z"-#GLTDTT0K +=R2 B@!1G.<C
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?TC_ *&#Q/\ ^#,_X4?\*?TC_H8/$_\ X,S_ (5Z'10!YY_PI_2/^A@\3_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M '>?O?3UI7D2, R.J G W'&30 ZBC(SC/-&1G&>: "BBFI(DJ[HW5UZ94Y%
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M?O 'D?6@!U%8GBOQ"OAKPSJ6K+$MS)90^:8/,VEN0.N#C\JUQ,GEQN[*F_&
M3U)[4 244A95&6( Z\FA6#*&4@J1D$'@T +169_;UD^IZAIL3E[RQ@2>5,8
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MXH Z_P +:%%X:\+Z;HT6"+6!49A_$_5F_%B3^-<AJ.B:?KOQHFM]3MTNK5-
MB<V\HS&[>>X!9>AQDXSZYZ@5Z-68NA6B^*)/$ :7[8]FMD5W#9L#EP<8SG)/
M>@#QV+POI3_"WQ?=RV_FW&E7=]%ITLC$M:)$Y*+&?X0#D\=<\UTFJ167B36K
M>*3PXWB*^M])A-PMU<I%;6PDR01D$^8V#R!P .178+X-TU?#VKZ()+G[+JLL
M\L[;QO!F)+;3C '/&0?QJO=>!+"XU!;N+4-2M=UM':W,5O.$2ZC3(42?+GH2
M,J5.#0!P.ESS:;X:\!>-I)&?[.O]FZA(S9)MI'**S'N$<(?QKK_"D?\ ;?C?
MQ'XH?YHHG&DV)_Z9Q',I'L9"?^^:H>(M)@\/^![KP;I6GZIJK:DDL=G$8B\5
MOO/ :0*%1$)W#<<^_IV/AG0XO#?AK3]'B;>+6$(S_P!]^K-^+$G\: ,_Q]-9
M)X4F@OH[R:.[FBMDM[-PDD[NX"QACP QX/MFN%LM'OF\0>)/#^FZ7;^&GOM
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M_M\-F;-5##R]A8MDC&<Y/K7E&N:&MSI.K^'K'1O$\5W<W$BV^FON?3HV9_\
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M==SW_EZGJMG9:C(9;VPMK@+#.S?>)RI9=W?:PS75P016MO%;P1K'#$@2-%&
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M[YI/F*X<%0%R<=,\$\<5CZ9ID+W7C[2[_0=-L;=+&WN1IT#B>".7RY?G V*
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M(QM9BH&<_>RIX]*U*\RBTK3X_C/K]VFF6CW,&DPW43&%21,6?+@X^\< 9ZT
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M]JNUB^SHT(<[ RG!+,QW#!^4>E=_X/M=3L?"&EVFLL&U"" 1RG?OSC@'=W.
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MW$GFND;4;);N.U:\MQ<R+N2$RKO8>H&<D4L^H65K-%#<7=O#+,<1I)(%9S[
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M^A:S:>(=#L]6L6+6UU&)%SU7U4^X.0?<4 6+"RBTW3K6Q@W>3;1)#'N.3M4
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M.PW$>PKM+N^M+"(2WEU!;1D[0TT@0$^F33WN8(]F^>-?,!*;G W #)QZ\<T
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MQQD8.*Z&TO[._1GL[N"Y5#M8PR!P#Z''>DMM1L;R66*UO+>>2(XD2*56*'W
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M7?A.RNO%4'B);F]MKZ*)87%O-M2>-6W!9%QR,D^E1_\ "%Z3_P (6_A3]_\
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M6\MXWWK'M>50=S?=7&>I[#O0!0T+PY:Z#]JDBN+N[NKME:>ZO)?,EDVC"@G
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M.-/GN?M4D?G-DR;@V<YSU4<5IR>(-&AU1-+EU:Q34'QMM6N$$K9Z87.>:T:
M"L]M$L6\0IKIB/\ :"6IM%DWG'EE@Q&.G4#FM"LSQ)J,VC^%]6U.W5&GL[*:
MXC60$J61"P!P0<9'K0!GZOX'T36M0EO;E+J.6X01W0MKN2%;E!P%D52 PQQS
MVXI-2\"Z)J=R)V2[M6,*V\@L;N2W66)>%1PA 8 $@>W%3:)XJTO5(K&V?4]/
M_M:>VCFDLXYU\Q2R!CA,[N_Y5=GU_1[74X],N-5L8K^7'EVTEPJR-GIA2<G-
M ''W?@J&]^(D3?9+BVTNUT*.VM;BTF:$PR+*WRHRD$?(>G3!KHHO!>@Q>&Y=
M %D6L)7,DH>1FD>0G=YA?.[?D [LYX%3F_N_^$O%A]MTG[&;/S?LI<_;-^[&
M_&<>7CC..O>IX/$&C7-Q';V^K6,TTB-(D<=PC,RJ2&8 'H"""?4&@"EIG@_1
M],BO5$<]V]]'Y5S+?3O</+& 0$+.3\N">.G-0Z+X%T/0K^.]M([J2:&,Q6YN
M;J286R'JL8<D*. ..W%:FFZ]H^LM*NEZK97K1'$@MKA9"GUVDXK0H Y-?AQX
M<31M1T<071TV_8-+:F[D,:$/O^09^3YN3CK6MK7AO2_$&A'1M1MS+9?)A0Y5
MAL(*D,#D'BM:JU_J-EI5H]WJ%W!:6R?>EGD"*/Q/% %6Z\/:5>>'QH4]HK::
ML20K#DC:JXVX(Y!&!@CD8J#1/"^FZ!-/<6QNIKJ=562YN[EYY65<[5W.20HR
M>!67;>+FU'Q/J5AI]SITNGPZ5'>V]V'W(79G4[F#8V#8.G/7FM&QU^WMO#%K
MJ>NZQHRAQA[NVG"VKMDXV,QYZ>O4&@"YK6AV.OV L[^-V19%EC>.1HWC=>C*
MRD%2/45F1^!=!&CW^F3P3W46H%3=RW5P\LLI7&TER=WRX&,'BC6O'6@:)::;
M<S:C:20ZC<)# Z7";2K'!DSG&Q>Y[5H7'B30K6+S+C6M/B38D@9[E -C_<;K
MT;L>_:@"AIO@C1M,U*VU*-;N>_ME=4N;JZDFDVL "I+$Y&!P.@R?4U#%\/?#
ML.J+?);3X2X^U):FYD-LDV<^8(L[0V>>E+?:[J%DWBB07FCSIIMGY]M;1,QN
M(F$9;]^-W )'&,<5/X?\6Z9J]GID4NIZ>-7NK.*>2RCG7>K,@8@(26QS^5 $
M&I_#_P /:MJ,][<V]P#<LK74$5U)'#<E>ADC4A6Z#J.>]6-8\&:/K5XMW,MU
M;W B\AY+.ZDMS)%_<?81N7D]?6MF*]M)S.(;J&3[.Y2;9(#Y3 9(;'0X(.#Z
MU@:IX]\.Z5J&DVL^J66-2W-'-]IC")&%9A(Q)^Z2NT'N30 Z]\#:)>"T\J.Y
ML6M(!:Q/874ENWDCI&2A&5^O]:9<> =!FBLT@CNK V</V>*2QNY('\K.=C,K
M L,Y/.>23W-:UUK^C6-_#87>K6-O>38\J"6X17?/3"DY.:74]=TC1?*_M35+
M*Q\TXC^TSK'O/MN(S0!G77@C0KG3-/L5MI+9-.S]CEM9WBE@SP=KJ=W/?).>
M](/ V@CP[>Z$;61[.^;?=,\[M+.^0=S2$[B>!WK3U'7-)TB"*?4M4LK.*4XC
M>XG6-7^A)YJY%+'/"DT,B21.H9'1@58'H01U% &9K7AS3M>@MX[M9T>V??;S
MV\[0RQ-C!*NI!&1P>QK)O? UA_8,6EV"E<:C#?233SN\CNLBLSLQR68JN!GC
MIV%=910 5R,GPU\-2QW,4EO<M!.S.L!NY/+@=FW%HEW81MW.1[]B:UM5\2Z5
MIDDMG)JEA'J?DM)%:2SJ)'."1\N<G-4M%\6VLO@C2-?UV]L=/-[;1R.TD@BC
MWLN<+N/Z9- $4_P\T"XN7ED6],<K*]Q;_;9?)N'4#YI$W8<G R3UQSFGWW@'
M0=0U">[FCN@MS();FUCNY$MYW&/F>(-M8\#/'..<UMQZMITKVJ1ZA:N]VA>V
M59E)F4#)*<_, .XI;J_MK>1;9KRUBNY8W>&*:0 OM&2<9R0.^.E %6/P[IL/
MB*YU^. C4KBW%M)(7.TH""!MZ=A7E<WA"?4;--$@\'ZAIUT]XC2S27OFV%I&
MLH=W@!<\L%Q@(#\Q' KTK2]?BB\*V^JZ[K&BX;<)+RSGVVC'<0-C,Q[#!YZ@
MUHC6M*.E?VJ-2L_[.QN^U^>OE8SC._..O'6@!+71[*RU;4-3@C*W5_Y?VARQ
M(;RUVKQT& >U9,G@/0FTRSL8HKFW6RDEEMIK>ZDCFB:1BSX<'."2<CIT]!6S
M9ZMINH6!O[*_M;BS )-Q%,K1C'7Y@<<4S3=<TG68I)=+U.SO8XCB1K:=9 A]
M\$XH Q+OP18C2M-L-/3RTM-4AU%I)IG=W='W,Q8Y+LW(^8]_85U59VG:_H^L
M2RQ:9JMC>R0_ZQ;:X20I]0I.*T: /,_"OPXL;KP[LUVTO899+RXDGM!=21Q7
M \]V0R1JVUOEV]1TP.U==K/A#2M;NXKN<75O=1Q>0)[*Y>W=HLYV,4(RN>QZ
M=JWJKWU_9Z9:/=W]U!:VR??EGD"(OU)XH SHO"FC03Z-+!9B(Z,LB6*HY C#
MKM;C/S9'KGUJMJ_@G1]:U"6]N/MD,T\8BN/LMY) MP@Z+($8!N"1ZXXK3AUS
M2;C31J4.J64E@6"BY6=3'DD*!NSC.2!CU.*;9:_H^I7LUE8ZK975U!GS88;A
M7=,'!R <CGB@"AJ7@S1M2:SD\NXLY[.'[/!/8W#V\B1?\\\H1E>!P:?%X.T.
M'2[#3HK/9;6-TEY"HD;/G*2P=FSECDDG).:SO%WCBPT30]8?3M2TV?6;"!I1
M9/,&8$?WD#!OY5U<+F2"-SC+*"<?2@"A<Z%I]WJPU.:)FNQ:O9APY \IR"PQ
MTZ@<]:KOX5TB3PW;: UNQTZV\KRH_,;(\M@R?-G)P5%;5<E?>*;VV^*.E^&$
MBMS97=A)=/(5;S RD@ '.,<>E %G5_ VB:UJ$U[<I=1R7"+'=+;7<D*7*C@"
M15(#<<<]N*NOX9TF37-/UC[-MO-/A:"V*,56-&&"-HXZ5,-?T<ZM_9(U6Q_M
M'_GT^T+YO3/W,YZ<TMSKND6>HPZ==:I907LV/*MY)U61\],*3DT 6KNU@OK.
M>TNHEEMYXVBEC;HRL,$'\#7-6WP[T"V-JZK?//:2I);SR7TK21!00$5BV0F&
M(V]#GG-;-QXAT6TTR/4[C5[&*PEXCN7N$$;_ $;.#T/2L_7O&VAZ!H]KJ<U_
M;2V]W*D=N8YTQ*&<*64YP54')/8"@"PGA72(_#=SX?6W8:=<^;YL?F-D^8Q9
M_FSD9+&J^J>"=&U6ZMKN5;N"YMX/LRS6EW) [1?W&*$%E^M7[OQ)H=C96]Y=
MZSI\%K<_ZB:2Y14E_P!UB<'\*GO-7TW3K 7][J%K;69P1<33*J'/3#$XYH @
MT/P_IGARSEM-*MA;V\DS3F,,2 S8SC/0<=*34_#VFZQJ.F7]["SW&FRF6U8.
M5V,0 20.O0=:E;6])32AJK:G9KIQ&1=F=?*(SC[^<=?>IK#4;+5+1;O3[R"[
MMG^[+!('0_B.* ,+4_ >@ZMJ,]Y<Q7*FY*FZ@ANI(X;DKP/,C4A6X '(Y[YK
M%\7Z5&WB6WO)?"VI7UN+3R1=:/=F*7[Q/E2('3,?<')[UZ!10!Y_X:\ PR>$
M8K76K5[*Z;4)M1BCLYS&]DSLV%5T(Z*<''%;"_#WPZL5]$MM.L=_;"VND^U2
M8F7.=S9;E^3\YYY//)K8U/7M'T7RO[5U6RL?-.(_M,ZQ[_IN(S2ZAKFDZ3;1
MW.HZG9V<$IQ')<3K&K_0D\T 3V-E!INGVUC:J4M[:)88E))PJ@ #)Z\"K%,A
MFBN8$G@E26*10R2(P96!Z$$=13Z "BBB@ HHHH **** "BBB@ HHHH ****
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M2.2'/7;(&W<YYYYH \]U:2PO],\-JNAQ:9<0>,8;>\M 1(BRG<S[6Z%6RIX
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MV<DLS +QDXX Z4 =71110!Y_K+/J/C75(M-TG2))[&PBCOK[59'*B-][+&J
M$8P&)/'7VKGO#&EZC>^%?"&KZ4VF7U_::4\+:=J+'#PLX^9#R58; N2",<5Z
M)J7@[0]6U==3O+1WN=BQOMG=$F53E5D12%< D\,#5)OAUX:^SQ0Q6EQ (6=H
MG@O9HWC#D%E5E?(0D9V]!V% %GP1=V5YX4MGL-..FQ))+$UGNW>3(LC!U!Z$
M;@V,<8].E=#533-,L]'TZ'3]/@6"UA&$C7)QSD\GDDDDDGDDU;H **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ JO>WUIIMG+>7US%;6T0S)+,X55'N35BN4\>7*1V6DVBZ?;7UW>:E%
M%:I=.RPQR@,X=\<D (3CN<4 :MKXGT*]TF;5;;5[*73X<B6Y692D?^\<\=1U
M]:6S\3Z%J&J2Z79ZQ8SW\6=]O'.K.,=> >W?TKR/7FO%M/BA%?RV#W0TZS,O
MV%&2,-B3J&).[&W)^E=1XDM;"UC^'CZ7'$LBZK;QV[1 9,#1-OP1V*X)H ZV
MY\9^&;.:.&YU_38I))&C57N4!W*=I'7C!!'UK,UKQ/?:?\2?#'A^!8#9:G%<
MO.S*2X,:%EVG.!S[&N4\.V6DR^ ?'[W$4#EM1U,7+. 2-I8KSVP,$>YS5*P>
M>3QI\)'N2QG.C3%RW4G[,.OO0!Z9H^HSW.J:S%/J>FW,5M,%2*USYEN,'Y9>
M3\WY=*ETOQ/H.MW4UMI>L6-Y/",R1P3J[*.F< ]/>O'[J2XBTWXQM:EA)YZ@
ME>H0@A__ !W->E7Z>$]+71[^2.!)[:UF.FB$E6>,19<*%P&&P9YX[]: -6S\
M4Z!J.J2:79:S8W%]'G?;Q3JSC'7@'MW]*Y_1/B#II%_'K^JZ;8W$>JW-G;QO
M*(R\<;[5)!/YGIFN2C-\G_"O9FM=&T^PGU".2QL[0.T\<;PN2&D8X888;L#D
MD<U>\-66DS>$_B(]S% Y?5=26Z9P"0HR0">P&<CW)- '3Z]XGOM-^(GA30K=
M8#9ZJMR9V927'EQ[EVG.!S[&MJ;Q/H5OK*:/-K%C'J3D!;5IU$A)Z#&>I["O
M*K%YY/%'P<:Y+&8Z9.6+=3_HPQG\*;9:5KVL^"=<A,_AZUMY]2NFN;N\:19X
M9EG;#,WW05PNWVQ0![91444JY$+RQM<*@+JIY^N/2I: "L7Q=K<GAOPGJ>LQ
M0K-)9PF58V. V.Q-;5<A\4O^27^(?^O1OYB@"_X.\3IXJT,7;P&UO87,%Y:$
MY,$R]1]#P0?0BE\&^()/%'AF'59H$@>26:,QHQ(&R1D!R?7;FN8UA6\&ZO8>
M,K=3_9EW%%:ZW&HX"X CN,>JD[3_ +)KF_#^IRV_@7P;8"1DL-3UV>"ZD1L;
ME\Z4K'D=F8 'U ([T >U45YW<6K:7\19](T\R0Z3J&C27$]M"[1K#*CA1(FT
MC82#@[<9QFN8TRU%MX(^'FO)<71U.;4K2"2=KASNBD9E=,9QM(]O?KF@#VNB
MO,5L9O'%WXLLYM0M[:\L[YK:!WA9IK- B^7)&1(NW)RV0.3G)(X'H6D[_P"Q
MK'S+P7K_ &=-UT$VB8[1\^.<9ZX]Z +E%<C\2]7N]$\#7EY:2/"YDBB>=#AH
M8WD578'L0"<'L3FL_6K4>'O&GA.70T\F._GDM+RWB/R3Q^67$C#NR[<[NO/)
MH U+[Q'JL^H:O9^'M/M[RXTDQ":*>7RS,SKOV(W12%(.3P2<<8S74J25!(P2
M.1Z5Y_X+TJP@\?\ C-XK9%:WN[<1$9^0&W7./S->@T <MK7BF_TWQ?I7A^WT
MJVN'U..9X9I+QHPOEJ"P8"-O7C&:U;*]U9]1:VU#3+>"(Q&1)[>Z:9200"IS
M&F#R".N>?2N/\7P27'Q;\$QQ74MJYM[_ !+$$+#Y%_O*1^E=/9Z8UM<WMOJF
MIOJ*WY'E)<*@8*JX9<(JC /.<=6^E &[17E'A&*&S\7IX?U"XDGT^"2>ZT&X
MES_I8)_>!G)RYC.0,]1\W0+5E;&;QQ<^*[2;4;>VO;._>WA=H6::S157RY(R
M)%V@\MD#DYR2.  >G45YUI,D/B'Q;J.A:W=KJ"6FE6C6I9=JSAU/FW"IS\Q;
M: >=O;J<QO:II?C#P!:6^HW-ZJB^MY;F9\O/Y<1P'(QNVG(&?2@#T.\N[>PL
MI[RZE6*W@0R22,<!5 R2:JW5S?N-/DTVW@F@FE4W#32%"D)4G<H .6SCBO*=
M<ABG\+_%.W=0\%M<!H8R<K&1"A^4=N23]:Z#Q#:0Z>W@+[&9(%;584>..5@C
M Q.QRN<'D#DB@#T:BO.=1N(_!?Q$GNWC:2RUVR98(R<XNXN?+7/"^8&''=A1
M?0-INO>&/"TL]JEO=6MQ+)]HB+Q75RNSY2NY<C#.0I)'3C@8 .UUZ]O].T2Y
MN],L$O[R)04MWG6$/R,Y=N!@9/X5-I5Z=2TBROS \!N8$F,+_>CW*#M/N,XK
M#\+: ='MM2TRYU*/4K=KDRQVQA(6T5L$1#<S?*.H&>,_2JGC>'5C>Z;=Z=86
MVL0VR3&YTB:0*TRG8!(F>"R8(Y_OG')H [*BN?\ !5]8:CX2LKG31<K:DR*(
M[K/FQD.P9&SW4Y'X5LWD*W%G-$Y<*Z$$QN48<=F!!'X4 +=-<+9SM:(DER(V
M,22-M5GQP">PSCFDL6NGL+=[Z..*[:-3-'$VY5?'S $]1G->5>%M#MIO@^/$
M$EQ?MJDFB3H9_MDH./F88 8 8*C]<YR:OK)>'PU\.'?S+C37BA%_;("[S9ML
MH2@Y=5;YB!GIG'% ';>*-6N-!\,:CJUM;1W,EG;O.8I)"@8*"3R ?3I^HJ[I
MEVU_I-G>.H5IX$E*CH"R@X_6O-+O1KJQ\'?$*]E6[AL9X+D:=;S2R 1P^5\V
M(B<("^[ P"![&I+>QBTGQ-\/KBTDG674;:6&\9IF83*+;>H()QP0", 8H ](
MM-0M;Z6[CMI5D:TF\B;;_"^U6(_)A5FO)_#NBJ=!\<Q:2\%A?OK=S:V\[$JJ
MY,>$)'(!/''/-;W@C4(WU[4]/N]#DT/64MX6GLT8-;R(&<"6(CC!+$'@=!U(
M- '=5DZOXGT+0)(H]7U>RLI)1E$GF5"P]<'M[UK5PGA>&&X^(7CE[R-)+I9K
M:("0 D6YA!4#/\).[/J: .MN-:TNT@MY[C4;2*&X!,,CS*%D 4ME3G!^4$_0
M5+I^H6>JV,5]87,5S:R@F.:)MRM@X.#]0:\0LK2"^T+P59RH)=-_X2>Y2W0\
MJT :7:/=>",=,<5[K%%'#&(XHUC1>BJ, ?A0 YF"J68@ #))[5D:;XL\/:S>
MO9:;K=A=W* DQ0SJS8'4@ \CZ5D?%-[B/X8>(&MBPD^S8)7KL+ /_P".[JS/
M&5M8VJ>!6TJ.)'CUFUCM#" #Y!5MX&/X2G7\* +>B_$'3<ZC'X@U73;&>+5K
MFSMDDE$9>.-]JD@G\STJ?Q!XGOM,^('A/0[98&L]6^T^>S*2P\M R[3G Y]C
M7->&++29O#?Q%>YB@<OJVHK=,X!(0<@'V&21[DUD6+SOX@^#37)8RG3[C);J
M1]G7&?PQ0!ZCI6HS7&LZU!/J>FW$-K(@2"VSYML""2)N3R<9' Z&EL_&'AO4
M'V6>O:=._G+!MCN58F1L[5'/).#CUQ7DUV\\?_"YVMRPDVPC*]=OEON_3-='
MXNL]'MU^'1LXX$D75K5+4Q@ F':2<8_ASL/UQ0!W-QXIT"UUA-(N-9L8M1<@
M+;/.HD)/08SU/8=ZH+XZT-O&DGAC[;;B\2%6R9EYD+$>4!UW@#./0BO./%MW
M=7?@CQ3J5C::/8:2VH2*S2AWNIYDE">8#D!267@8. *[#3XXS\;M8)1<_P!C
M6[ X[^8W- '0:!JKW&G7]U?ZOI5W';W4JF:S;;'"B@';(23AASGIVJ?2/$^A
M:_++%I&KV5[)$,ND$RN5'K@=O>O%=..?AAKJ2G%E)XPV7A[>298MV?;IFO1?
M$T,-O\1O S6D:)<E[J)A& ,P"$D@X_A!VX]Z -]O&?AE+BVMVU_31+<\0I]I
M7+_,5XY]01]1BIM2\3Z#HUY%9ZGK%C9W,P!2*>=49AT!P3T]Z\IAT^T7]F_5
M9A;Q^;+]IF=RHR76X8*<^H"@#Z5T6MV-]9WFN:WIT>DZU97%K&NK:;=/ME0)
M%T5QD#*'.UAWR#S0!Z54%Y>VNG6KW5[<16]NA :65PJC) &2?4D#\:BTFXM[
MS1K&YM$*6TUO')$C#!5"H(!_ BN4^+R[OA=K*G.#Y X_Z[1T ;D?C'PU+)>1
MIKVG,]DI:Y N5_= '!+<\ 'CZU9LO$&CZEI<FIV6J6D]A'GS+A)E*)CD[CT&
M!ZUQWB+2-.3XG^ XDLX%CCAO0J! !A(XR@QZ*>1Z'FL2^GM=/U+X@6KZ;#>1
M7.IZ?#%:2,8XGFECCP6(Z#<0Q]<>] 'HEIXO\.7VGW-_:ZY82VEKCSYDG4K%
MGIN.>,^]:-WJ-E86#W]Y=PP6B*&:>5PJ 'H23QW%>;VFGW6H_$O4M(UYM,D:
MZ\.F*>/3XV1=AEP VXG+ $X/'!%9.FW-QXAL?#WP_OFWW6FW[IJP_O6]H04R
M/1RT//?F@#V8$,H8'((R#7.>+O$$_A]]",30+#>ZG':W#S=%B*.S$'(P?E')
M]ZZ2N!^*,5K./",-Z$:V?Q#;*ZO]U@5DX/L3Q0!U>D>(M&U]96TC5+2^$)Q)
M]GE#[/3.*;IWB?0M7OIK+3M8L;NZAR9(H9U=E ."< ],UYWX\$EGXPU1]*7R
M[I_"-XTWE#!PK#8>.X^;!JUI&C:Q+)X-N99_#=I:695K3[(TBRS1-"P,:[N#
ME3N(_P!G- 'I]9^KZ[I.@6ZW&KZC;643MM5IY FX^@SUK0KB_$,]S<^.M.T_
M2;#3GU2"QEN?MFH;V2&)G5"J(I&68@9.1@#WH Z&Y\1:+9Z1'JUQJME%ITF/
M+NFF41OGIALX/?I3)/$^@Q:,FL2:Q8KIKG"W1G7RV/H&S@G@\>U>9^&=.N=3
MT"QGTW4=)35;#7-0FLX)E/V:X4LX<(H.X* ^01G;GWK1@@EUQ(7L+?2M&\2Z
M5J\[/8SMYMO=3>2-[#&&Y216W 94]1WH ZW6/$,4GAR+5-&UW1X899D5;RZ?
M? PS@J""/F[#GK6CJOB/1=">%-6U6SL6G.(Q<3*A;Z9/3WKR+QS?+=_#:_BD
MTF#3+^W\011WT-N^^-YOE8NIP,AE93T!]:[73(8+GXO^)OML:22QZ;:);"0
MXA;S-^,]BV,T =5_;VD"+S?[3L_+^T&UW^<N/.'5,Y^]P>/:F:3XDT37C,-)
MU6SOC <2"WF5]GIG';WKQNQL]/N?"FGV<")+IK^/#'&G57BW, /<%>/I70>/
M%DL_%NLR:>GE3MX.N^8A@G;(N#QW )Q0!Z'IOB?0M8O9K/3=8LKNYAYDB@G5
MV49P3@'IFL+Q=X^TS1]&UE=-U;3I=;L;=Y%M&E#,&7J"H.>.XZUA:7HVM23^
M#[J2;PW:VMG@V@M&D66:)H6!C7=P<@AC_NYKGC!82?LQ7$]TD1F>*2621@-Q
MN3.1DGKNW<?3B@#VRWD,MM%(V-SH&./<4LLL<$3RS2+'&BEG=S@*!U))Z"H[
M+_CQM_\ KDO\JY#XKD_\(',KDBU>[M4NCG'[DS(&S[8Z^U '0:3XHT'7II(=
M)UBRO98AET@F5V ]< ]/>G6_B70[N^BL;;5K.:[F#F.&.969MA(; 'H00?H?
M2N8\50P6_COP*UE'''=?:9X@(U S;^2VX<?PCY?I5?X2:?:1Z%J5Z((_M,NK
M7>Z4J"V!(0 #U Z\>Y]: /0ZYE_'6AQ^-1X7>]MUO/)#Y,RC]X6VB+'7>0<X
M]*Z:N"BCC/QXN247/_".QMT[_:&YH ZBW\2Z'=WL5G;:O937,JNR11S*S,$)
M#' /8@@_0^E)I?BC0=:NYK32]8L;RXA&9(X)U=@,XS@'IGO7G?@H:9H_PP\1
MZU=6*W!6XOWG X>10S#8&Z@$<>V2:?:QZE:>.O <-_'HUJAAN5M[73U?='%Y
M&=K,Q^8 A>PY% '=OXS\,QW%M ^OZ:);DXA4W*Y?YBO'/]X$?48J;4_$^@Z-
M>16FIZQ8V=Q,,QQ3SJC,.F<$]/>O*H-.LU_9SUF;[/'YLOVN9W*C)=;APISZ
M@*,?2NAUBQO[2[UG6]-32=:M+BSB75M-NWVRJ$BSA7&0,H<[6'N#S0 _QK\1
MO[(\5:9X=TS5=%M)9A(U[=W[;DM0JAE4J&7!;/&3W%==-XIT*QN[6POM;T^*
M^G12D33JI?/0@$]#V]:X*]>ROOBK\/;FUMPEK<:9<2QHRC(0PY4'Z#%4H=-U
MO5K3QW;K_P (^EG/J5U%=3:@9!+&@4!"2. %3:5].M 'I^I>)-$T=Y$U+5K.
MT>-5=UFF52%8D*<'GD@X^AHG\2Z';7JV4VK6:733K;B%IEWF5@"J;>N2"#CW
M%<)I>EQ7'Q@B74A#?3VWAFW_ 'A&]&D\QE+C/KS@^C'UJWX4T^UF^*7CN\EM
MXY+B*>T6)W4$Q@P*3M],D#/T'I0!UX\3Z$=:.C#6+$ZF#C[+YZ^9GKC;GKCM
MUJ/4O%.B:9>C3KG5[&#477,=M+,H=B>G&>_;UKRK0=)\0:M\.+$-<>';2!KT
M7)NYVD6X2Y%QDDMTWEQM_'%=+X;AL;FT^(DFJ)$SMJMRERTH&1 L2[,Y_A"Y
M(_&@#J_!6L7/B#P9I.K7@C%S=VXDD$8(7)] 2:T-:O)-/T'4;V$*9;>UDE0,
M,C<JDC/MQ7/_  N_Y)AX=_Z\U_K6QXI_Y%'6O^O"?_T6U &9X;\;:1J]CI%O
M<:MIXUJ[LH9Y+1)@&#M&&("YSWZ=<5T%EJ%GJ,3R65U#<)'(T3M$X8*Z\%3C
MH1Z5Y-?6MA!\#O"LUA'$+I)=.DMG0#=]H:1-^#_>Y?/XU;UK5Y/AYXC\410J
M?+UJU_M#34'0WN1$Z =RS-&WYT >G66H6>I0M-974-S$KM&SQ.& 93@C([@U
M9K%\):$GAGPIIND*0S6T($C#^.0\NWXL2?QK:H **** "BBB@ HHHH ****
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M:FEUIZ2KJA1KS+-^]* !#UX( &",=*K/X[\*Q3V\+Z_8+)<'$0,HY.XK^'S
MCGTJUK'BG0M FAAU;5;6SEF!,:2O@D#J<=A[GB@"BGA+1=#$>I:9HSRW]DDA
MA"7#>;*6'*LSM\Y.!]\G&!TQ5/PAH%['KVM>*M8L8K+4M59(TMD<.8(8U 4,
MPX+-C)QD<#TIWASQA%<:!JNK:U>VL%K::G<VRSDA4\M)-J<]R1CZUKP>*M!N
M=%EUF'5;5].A.V6X#_+&<@8;T/(X/J* -BL[5]"TO7X(8-5LX[N*&3S423.
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MJ6I6FD:=/?W\ZP6L"[I)'/"B@"U6/?\ A?1M3UNSUF[LM^HV8 AG61T( ;<
M=I 89YP<BLWP_P#$#0M<\.V>KM?6UJ+ATA:*28'RYF!(C)XYP#5N3QOX8BTB
M'57UNT%C.[1Q3;^)&4X(4=3C':@"[::!I5EI4^EV]E&MC<&0RP$EE?S"2^<D
M]<FLRU\ >&+(6_V?3-KV\RS12&>1G1E!"@.6W;0"1MSMY/%:)\2:*-.M=1.J
M6@LKMML%P91LD."< ].BM^1J/2?%>@ZY'<R:9JUK<K:C,Y20?NQZG/0<'GIQ
M0 X>&='7P]+H(LE_LN4.'M][8(=BS<YSR23UJIJ?@;PWK%Y]KOM-$DQ18W*S
M21B15Z!PK .!T^8&EM/''A>^@NI[;7;*6.T3S)V64?(N<;OIGOTKD_A]\09?
M%,VHW^HZUI4%M")F33TCVR0Q(P E>0MTP>>,<@\=* .[ET'2YM5L=3>S3[98
M1M':R D>4K#!  .,8XZ50U/P/X<UC4FU"_TQ);A]OFGS'59=OW?,0$*^/]H&
MK&E^*]!UJWN9]-U6VN8[5=TY1_\ 5KC.2.N, \].*AC\:^&I5N'CUNS=;:!+
MF9EDR(XVQM8GL#D?F* -%-(L(]9?5TME%^]N+9I@3DQ@[@N,XZD]J+32;&QO
M[Z^MK<1W-\R/<R D^857:IY.!@<<52'B[P\UM?W(UBS\C3W$=U)Y@VQ,?X2?
M7MCUXJ:P\2:+J>ES:G9ZG:RV4&[SIA( L>!D[L_=P.>: *7_  @WAO\ MG^U
MO[+3[7YWVC_6/Y?F_P#/3R\[-W?=C.>:6^\$>'-2UAM5N],22\?;YC>8ZK+M
M^[O0$*^/]H&LB3Q[9:CXG\-V6@ZE:7EK>W$\=WLY90L+.N.XR5Z]\&NWH JZ
M;IMGH^FP:?80B&TMTV11@DA5],GFI;FVAO+2:UN$WPS(T<B$XW*1@CCV-8]G
MXT\,W^J_V9::W937A8JL22@[F'4*>C$>@HU+QIX:TAY$U#6K.W>*3RG1Y/F5
ML!L$=>C*?Q% $%IX!\+V-]:WEOI2)+:8,"^:YCC8# 8(6V[L?Q8SWSFLO4-&
MU+Q5XWTN?4=(6STG0YWGAFEE1WNY>B%0I.U!@-S@DXXXI_B_Q9=:7?\ A :5
M-;RVNL:C'!))C>'B;!RI![YZUU=CJ5EJ:S-97,<X@F:"78V=DB_>4^A'I0!:
MHJK8:E9:I%)+8W,=Q''*T+M&<@.IPR_4&K5 !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<A\4O^28
M>(?^O1OYBNOJCJND6.N6+V.HP>?:R??B+LJO[$ C(]C0!SVG:7<6^F:%JEQX
MAO#:6,*W$T,XA6/9Y#+U2,-QN!Y/:N:\?VD>CZ^-<T]9/)FM3%KL<46[R[1V
M ,X!^[)U[$D G'RFNW_X0[0O*BA:TD>&(J4B>YE9!M(*_*6QQ@<8JX=#TX_V
MAF!C_: Q=9E<^8,;?7CCCC''% ''^(KFUM]7\'Z-:2V4.B7R3^7YL?FP2NJ(
M8E(#+NR&8C)Y.#R<5D:O;?\ "&6L=B=85]+O]>MEO((8S%%90R!BR [FVHS*
MN1D8#'LU=U-X,\.W/A]-"GTN*73$.Z.W=F81G_9).5[]".I]:EA\)Z#!X?DT
M*/2K?^RY,[[=EW!R>Y)Y)X').>!Z4 <KXL\/:1I7A[Q=/8.T<MSI,D_V&/ A
MB:-&"RJH'RL3WSSM]C4%RR?V_P##&0,/-FBD#L#RZ_92>?49.?QKLM)\*Z'H
M>FSZ?IVFPPVLX*S(<OY@QC#%B21CC!JK:>!/#%D;0P:1"#:.7@+LSF,XQQN)
MX Z#H.V* .0\*Z1IL>G^/O*LX8775+N)'A7RW5/*1MH9<$#/.!5233)+GX+^
M&=<MH1-J&C6UO?JIY,T: &2,^H*Y./4"O1?^$7T47=_=+81I/J"[;J1&93(,
M 'H>,@#.,9QS5O3M*LM*TV/3K* 16<:[4AW%E5?09)X]J .%UO5?/\(^(O&N
MD<LUD(;&X1?F$2_?D'OEF_"-:MZ7X?M4U[1/$%AK%C##-$\0BL;4HNH*R%AO
M)D;<5P6W'GKDUV-KIUG9:9%IMO;1I911"%(,94(!C;@]1BLK1O!/AOP[<3W.
MD:1;VLTRE69<G@\D#).T'T&!Q0!N1RQS('B=70]&4Y!KB_$%U]I^)GA_0[Y0
MVESV=Q.L3C*3SKMP&!X;:NXX/<Y["MOPMX;M?"^ER65G$D$,D[3""-F9(L@#
M:I;DCC)/<DG SBKNJ:-I^LQQ)?VPE\F02PN&*/$X_B5E(93[@B@#R?Q':?9M
M+^)>BK$LFC6=K#=6D3KN6UF>,LRIG[HR P ^[GC&:V]:TRQ_MKX=V4,"06\D
MTY=+?]WG-J2?NXZ]_K7>)H>F)IMSI_V1'MKH-]H20ES-N&"79B2Q(XR3G@53
MC\'Z#"; Q6 0Z?DVI65QY1(P2.>I'!)Y(XZ4 >;W5V_A73?B#:Z6S6MC9W]G
ML5-Q%O',L7G%0#D<,QX(QVQ756?A>U@U^'4X-5LXK>^LWA:STZW,,=VN-PD)
M$AY']X=CC/-=+#X;TB"?4)ELU9]1&V\\QV<3C&/F#$@\<?3BJNC^"?#GA]+E
M-)TN.T^TKMD:-WW%?0-G*CV!% ',_"70K >#M$U]DEDU1[-X6G>9SE#(3MVY
MV]0.WKZFK/Q5L[6ZT31VN+>*4KK-FJF1 V TH##GL1P:Z[2-'L-"L$L-,M_L
M]JA)2(.Q5<\G&2<<^E+JND6&N:>]AJ5JES;.06C?/4'(((Y!!'44 </>Z/IU
M[\7;73I;9#8KX=D'V=/EC(%PHVD#J/;I6-HLMJO@RRTFYEN9$3Q)-:65HL@V
MSA)7*Q2%L_N@!D]>% &>!7H\?AG2(=1CU"*T,=W'!]G21)74K%_<&#C&><>O
M/6JS^"/#DFGM8/IB-;&X^U;#(YQ-_P ] <Y#<G)!YH \[GB>+PW\4;%MD$5H
M?-A@M9&6.%C;AB%QCC/)X )[5J1:=;:3XQ\ 75F'CN-0MYXKR0R,3.HMPX#9
M/.& (].U=B?!/AO%Z%TB!!?(L=SLROFJ!@ X/3 &?7'.:L'PQI#3:?,ULYDT
MX%;1C/)F$$8.WYO3CZ<=* ->O*/ .BWFK>$-?AMM<OK'SM3OHU6%8=H)8C.6
MC+?D?IBO59(Q+&R,6 88.UBI_ CD5@VW@GP_91/%:6<D$;L7=(KJ50S'J2 W
M)/K0!C>.M,M]8T&WNM.D4ZW972C3W09\V=&YB;H&3Y6W9X&"3]TUBOK<5O\
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M!WAZWT6YT>+2X1871W7$1)/FGCEF)R3P.I[4 7+*.PT?2;2!3!:VZHD48)"
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M<9 (S_>J]\2_^29^(_\ KQD_E6-I7A"V?2;*0^-_$:%H(SL75% 7Y1P!MZ4
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M\<:YK7B33MS6^FZ+]ET['/\ I$T7F.1_M %$H [BP\9>'=3U4Z99:M;S7F6
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M;^PN$N+6==T<L9R&% '.^&/"*V?A.XTS7H+2[DO[F:[O(0FZ$/(Y;:H(Y X
M/MFM?1O#>C>'HY4TG3;>T$Q!D,:_,^.F3U.*7Q%KEKX:\/WNLWNXP6D9=E7J
MQZ!1[DD#\:Y6.;XF7&GC5%70(9&3S%TF2.0MMZ[&EW !\<?=QF@#J+?PUHMI
MI]K86^F6T=I:SBX@A5,+'("2& ['))JW)I]L]\-0$$0ODA:!+AERRH2"5^F0
M#CVK)?Q=8Z?X?L-3UU9-*ENPH%I*I>42$<H%4$L1[#IZ4^'QEX?GT.ZUF/4D
M^P6C;;ARC!H3QPR$;@>1P10!PD?@;5;R6WLIO#&A:63>13W^J64@_P!(2.0/
MMCCVY3<57.3@8[UZ):Z+%;>)-1UE67S+V"&%E5,8\LOR3GDG?CM@**S1\0O"
MINY[8ZQ$LL*%SNC=5< X.QB,2<D#Y2:FMO&_AV[T:]U>+4E^Q6+;+IWB=&A/
M'#(5##J.U &S>V5MJ-E-9WD"3VTRE)(G&593U!%<W_PK/P3_ -"QIO\ WY%7
M-/\ &OAW5-7&E6>II)>,&*(8W42A?O;&("OC_9)IO_"<>&_[;_LC^TT^V>=]
MGQY;[/-_YY^9C9N[;<YSQ0!I6.B:7IMP9[*Q@@F,*6^]%P?+085,^@]*BD\.
M:-+;W]O)IEJ\.H/YEW&T8*S/_>8=">!SUXJCJ?CKPWH]S<VU[J02XMF"S1)#
M)(Z94-G"J3C:RDGH,CFKEKXFT:^N[*UMK^.6:]MC=6P4'$L0."P.,<9Z9S[4
M .TOPYHVBV4UGIVF6UO;SY,T:H,29&/FS][CCFHM&\)^'_#T\L^D:1:6<LHV
MN\48!(ZXSV'L.*N?VO8?VV-&^T ZA]G^T^0%)(BW;=Q.,#GCK5V@#GK?P)X5
MM)998- L(WE8.Q6(=0P88]/F /'<"KLWAS1I]=AUR73;=M4A7:ET4^<#!'7Z
M$UR_C_QCK&AW=KIGANTMKO4C;37]PDX9@EO&OHI!W,W ]Q746.OV%]X9A\0+
M,%L)+7[47/.Q-NXYQW'.1[4 3Z9I.GZ-8BRTVSAM;4$L(HEPN3R3CWI-*T;3
M="L_L>E64%G;;R_E0H%7<>IQ61%X_P#"\UO<W$>K(T%LL332B)]J^:0$YVX)
M)8# Y&><4\>._#3:5+JBZHALXKC[+Y@B<[Y<9VH-N7X/&T'/X4 6+/PAX=T_
M5VU6ST:SAOF+'SDC (+?>(]">Y'6MHC(P>E8</C'0)]$DUA-13[!',())&1E
M,<A8*%92-RG++U'<=J;I7C/P_K>IMIVGZBLMVJ&0(8W3>@.-R%@ X]U)H ?I
MG@[PYHVHM?Z=HUG;73 CS8XP"H/7;_=S[8JV-"TI='DT@6$ TZ0,'MMOR-N)
M9LCW))_&L>;XB^$K>:ZBEUF)3:EEE?RW*!E^\H?;M9AZ D\&KFL^+]"\/RQ1
M:E?>5++&95C2)Y&"#JY" E5]S@4 2W7A70;[5+?4[K2;6:]MPJQ3/&"RA3E?
MK@],].U-@\)Z!;"U$&DVL8M)FGMPL>/*D;JR^A.!27_B[0=,BLY;O4X42]B:
M:V907$R#;DKM!S]]<#J<C&:SC\2O"*V'VW^UP8@[(RK;RF1"N-VY NY0,C)(
M Y% &_!I-A;:G=:E#:11WMT%6>=5PT@484$]\"I+ZQM=2LIK*]@2>VF79)%(
M,JP]"*SM0\5Z'IFG6E_<WZ?9[P VIB1I6GR-PV*@+-QSP*:?%_A]='M=6;5(
M%L+F7R8ISD*7Y^4\?*1M;.<8QS0 ZR\)>'].U9]5L]'M(+YLYF2,!AGKCTSW
MQUI)O"'AVXUH:Q-HUF^H!@_GM&-VX=&/8D=CUJM9^._#=_'?/;Z@6^PQB6=&
MMY%=4/1@I4%A[@&L[0/B9H>J^$XM=O)OL8+B-XC&[$.Q.U5^7+DA<_*#WH [
M2L6\\(>';_5UU:[T:SFOU*MY[Q@DE?ND]B1V)Z5:T;7--U^R-YIET)X5<QL=
MI5D<=596 *GD<$=ZT* *T6GVD%]<7T5O&EU<JBS2@?-(%SM!/MD_G5&Y\+:%
M>:0VE7&E6LE@TIF,#)\N\DL6]CDDY]S65XH\>Z;X6UW2-+N]VZ^9C(PC=O*C
M"L0PVJ=Q+*!@<C.:MZMXX\.Z)>&TO]1V3K&))$CADE,2'HS[%.P?[V* +]KX
M?TFRO(+RVT^"*Y@MA:12JN&2$<A ?3VJJ/!OAQ9=0D&C6@;401>$1_ZX$Y.X
M>YYK7MKF"\MHKFVE2:"5 \<B-E74C((/<56U;6+#0[!K[4KE;>W5@NX@DEB<
M  #))/H!F@"#4/#.B:MIMOIU_IEM/:6X AC=.(L# VGJ...*5_#>B/H7]AMI
M=H=+ VBT\H>6.<]/7/.>N>:KV_C'P_<Z+=:O'J4:V5HVVX>16C,3<<,K ,"<
MC QDY&*JR>+]/U/PUK5[HE[ON;"UD<J\3(\3!"RED< X.,C(P<4 7]+\+:%H
MCK)IFE6MK(L;1!XTPVUB"03U.2HZ^@I_AW18_#V@VNE1,K) &Y5-BY9BQPN3
M@9)P,GBN>\,>,HE^&^C:]XDOE6:[C 9Q'\TLA)P%1!DGCH!VK=M_%6AW6A3:
MW'J,(TZ#<)IGRGE$=58, 5;IP1GD>M $NM>'M(\16\<&L:=!>QQ/O19ESM;U
M'I5;4_!OAO6KJ.YU+1;.YGC4('DC!)4=%/J!Z'-9\GQ&\-G1-2U*VOC*+"+S
M)83#(DG/W?E90V">-V,>]:7A3Q);>*O#UKJEL"ID1?-C*L/+D*JS*"P&X#=U
M'!H V$1(HUCC5410%55&  .@ K-U;PYHVNRVTNJ:;;W<EJVZ!Y4R8SQT/X#\
MJMZAJ%II5A/?7UPEO:P+ODED. HK*T[QGH&JVM]<6E_E+&/S;E9(9(WC3!.X
MHRAL8!Y YQ0!HQZ1I\-K=VL=G"L%X\CW$87B5G^^6]<]ZIZCX3T#5K&ULK_2
M;6>WM%"VZ,G^J4 #"GJ!@ 8]JJ6WC[PQ>:E;:?!JJ//<D"#]VX21B,[0Y7;N
M_P!G.>V,T:OXWT'3+RYTV74E2_BCRRB-V6)F'R[W *IGC&XB@#>L[.VT^TBM
M+.".WMH5"QQ1*%51Z "IJY_P/J=WK7@?1M2OI!)=W-JDDKA0NYB.3@<"N@H
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MDOAKXL3VI#637=JJ,GW3*JQ"7'ONQFO53X-\,FT^RG0--\@1F(1_9DP$+;R
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M &4@;1N/?CCGM0!XOX8CU.1O !L]3MM/=]!GCMY;JV\]6DWH651O7#%<<YZ
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M;'5[)[+4;2"[MI/O13H'4^G!H \C\1:CJMS ]E?MI4%_INNZ>;O4[: M!(C
M^6\B$@Y5MF06P..<5M7>F7<5WXFO=1\26.H7X\/R0R6UK9^050[F1V_>-G^,
M#ZUW-IX=T6PTJ32K72K.&PESYELD*B-\]=PQ@_C2:=X;T32+&>RT_2;.UMK@
M$3110JJR C!W>O!QS0!Y%HD=^VA?"UK._M[ F"[C2XN8/.C$K*-HV[E^8J'
MY]:N:[8-86M[?WNNVFIQ-XCTZ35A;6WDQ0!"H;<-[#D>63SVYKU.;P]HUQHR
MZ/-I=F^FH %M6A4QKCIA<8%/M=#TFQTHZ7:Z;:0Z>P*M;)"HC8'KE<8.>^:
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MD$<%O$NV.*)0JH/0 =!4U !1110 4444 %%%% !1110 4444 %%%% !1110
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M$BM FJ0I)(0$25G.T9/ ) 8"F^)9;?4[WXG2Z2ZR)]DT\S2Q+O5]C-YA&/O
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MM@=21)DT =C;^*M+TWPII6H7NKR7ZW:*L%PMJWFW;$9RL2+G) S@#BISXUT
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M \X[=^@R:I77CO0+.ULYY9[DF\B,T4,=G*\OE@X+M&JEE ]2!6-XXBCF\>>
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M3-=S'1=.,MZ"MTYM4S.#R0YQ\W/K5NUTZRL6=K2SM[<R!0YBB";@HVJ#@<X
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MA@TUPEXD]L\<L#'& R$;N<CM3M/\<Z%J>L1:7!-<+/.K-;--;21QW(7EC$[
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M='M]+.F0Z58QV#'<;5;=1$3D')7&"<@'\*T:* (9;2VGN(+B6WBDFMR3#(Z
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MT!Z@-U&?:@#B?#L,?_"XO&4FQ=R6E@BG'0%&R/T'Y5RMB"T?QG !)*R@ ?\
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MB@#S#0(=/\/>*/!\CZF+G29=(NH;*^GC\E6E:59,8/W<H<#U XJY%-%?ZO\
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MMPB0L"8X%A??D#[HY4<_2N@\:^&6\0>$M9T[3H[6&^U"-%,T@VARI&-[ $G
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4\$U<^(T-MXG\/VL.EZSI(O+.^AO8TGNU5)-A/RDC..M7O\ A4_@3_H6K/\
M\>_QH_X5/X$_Z%JS_P#'O\: ,*XNM2_X2NR\4QGPY+=G3FL9K.35@%MSYI82
M))L.<@@,-H/UK*N=#OI_"WC'19=;T":36K@7D-T+T(/,;R]Z%,':HV'!R3C%
M=E_PJ?P)_P!"U9_^/?XT?\*G\"?]"U9_^/?XT 9\=M:IXJ\+ZD=9TGR-+TV6
MUG'VM=Q=E0#:.X^4^E6[+[%;_$75=>?6-+^QW5C#;Q@7:[]R,Q.1Z<CO4O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*WZ* .?U3P1X;UJQM+/4-*CFBM"3 =[*\>>N'!#<GD\\GDUL6-C:Z98PV5E
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MQR <DGH/2K3>'M-;5XM5:&4WT47DI,;B3(3NOWNAQD^IYK4HH \^\:^#X_\
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ME;1P?:9VN)M@QOD;[S'W.*SK'P;X<TW5CJEGH]K#>DL1*B?=+?>*CHI/? %
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M4 %%%% !1110 445Q>ENWB'XC:O>3DM9Z#LL[.//R^>Z!I9"/[P#*@]!GUH
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M,R$,/IZ9KA?#?B*3PGIWBJ2V\/7EYI]KK]X]Q):F-5@C!7[JD@M@#.%& .]
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MCZ5TU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%RCQ31)P"B#YMS  <@8R3[5V,=_:2W\UC'<1M=P(KRPAOF16SM)'H<'\JL4
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M':S<;AA2 2!P>:JQ:#K.OZKK^MZA8?V8]WI!TJRM995=PIW,7<H2HRS# !/
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MRUDM],MS&)9#+*[R-))*Y_B9V)+'ZF@#4J&[C:6SGC099HV4#W(J:@D $DX
M[T >=6O@O4KCX)VOABYABBU.*!#Y4K!T\Q)!(JL1D$$J >O6I+'1[V\%ZMKX
M*T[PTYL)HDNL0F;SW7:NPQ9P@YR3@GCCK7?12QSQ++#(DD;#*NAR"/8BGT >
M1V7AS7((O"LEKX,@L/[%N(S=*LT'FW)\MD9U8-@J"=QW'+9Z<<Z$VBZSJWB3
M2KN?PI;Z=JMI?)+<ZW;3QB.:%2=R@!O,;>O&UAQGK7I$L\4.SS94C\Q@B;V
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M0:[3;-&93( $ZACG'. .3D]* --EURY^+6O0:+<VEFSZ;:/+<W$!FV8,F%5
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M'Q3X6N=>M-(T:+4K;4KR6]M;DW:1"!Y0-RR*W) ;)&W.0: *<OCW6M8/@Y-
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M!#"\%]/;)Y+%E94;;G)[Y!!]P:W*0 *,  #VH 6BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5F 4*!G<3TQCG-<!X3^($_BKQ?J=K%?:'%IEI=2V\, E+75T$'^M0[L%#UR
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MCAFFCO8IQ$H7= L0(#8[!]N/<UQ$>F647[-,MVEM$+DJ9S-M&_>+C ;=UR
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M*K6^H6=W<7-O;W4,LUJP2>-'!:)B,@,.W'/-02:[I$,5[++J=FD=BVRZ=IE
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M,8SU!H /#_@CP_X8E>32K)HV92@\R=Y=B$Y*H')V@^@ZX%,TCP'X<T+4FO\
M3M/,,NYG1/.=HXF;J4C)VJ3D\@#@XZ5H:3XDT37GF32=6L[YX/\ 6+;S*Y7W
M.#T]Z@C\8^&I9YX8]?TUI;=@LJBY3*$L% //]X@?4@4 5+OP!X<OIM1DN+*1
MEU$EKJ(7,@B=B "^P-M#$ ?,!GWJY-X3T6>YTZXDM&,VGH8[=A/("$.,JV&^
M=>!PV16T2 ,G@5Q.M?$#3@VFQ:!JNFWT\NK6ME<I'*)"D<C[6( /7T/2@#H]
M-\/Z;I-]?7MG%*EQ?.)+EFGD?S& P#AF(!QQQVJ>TTJRL;V^O+:W6.XOI%DN
M''61E4*,_@/Y^M9]EJ4K^(]8MI]4TR2VM4C9;:(XGMP5R3-DXP>HX'%1/XOT
MB^T?5;G0]6L+ZXL;:24K#,LFTA21D ],B@"*X^'_ (9N=??6I--_TR1@\NV5
MUCE8="\8.UC]1735RWAOQOI.JZ?H\%UJVGKK5Y90SR6B3 -O>,,0%SGOG'7%
M:6J>*O#^B74=KJFM6%G/(,K'/.J-CUP3P/>@!D/A328)498IV2.X-TD,EQ(\
M:S$EMX4D@')) Z \@9K995=2K ,I&"",@BJ-[K>E:<D;WNI6ELLD;2HTLRJ&
M10"S#)Y R.?<4W3M?TC5]/DO]/U.TN;2/(DFBE!5,#)W'M@<\T 9FE^ O#>C
M:E'?V.G%)XMWD!IY'2#=][RT9BJ9_P!D"FS?#[PS/J$EY)IQ+23?:)(!<2"!
MY<YWM%NV$YYY%:6E>)-$UQ)GTK5K.\6#_6F"97V>YP>!P>:@MO&7AF\BNY;;
M7]-FCM%WW#)<H1&O3<>>![]* +R:18QZU+JZP8OY8%MWEW'F-22!C..I/.,U
M4_X1;1O[#O-&^Q?\2^\>1YX?,?YS(=SG.<C)/8U0\,^/M \3V%G/;7]K'<71
M94M&G4RAAD[<>N!G'I6]/J%G;7=M:3W4,=S=%A!$[@-*5&6VCJ<#DXH AAT7
M3[?5CJD5OMO3;+:&7>Q_=*20N,XZD\XS5<>%]&&C7VD"S'V&^>62YB\Q_G:0
MY<YSD9)[$>U4?%?B*;0+[0$5[>.VO;XP7,DW 2,1.Y(.0!]T<GM5NV\7^'+S
M3KC4+?7-/DL[8@3SK<+LB).!N.>,GIGK0!*WAS26UBQU8VF;ZQA,%M+YC?(A
M&",9P>/4&J%GX#\.6.IQW]O8NLD4AFBC-Q(T,3G.62(ML4\GH.,\5MWNH6>F
MV3WE]=0VUJF-TTSA4&2 ,D\<D@?C5;Q#JC:+X:U358XUE>SM);A48X#%%+8/
MY4 9MIX#\.66IQZA!8NLD4IFBC-Q(T,4ASEEB+;%/)Z#CM5ZT\-:/92ZI)!8
MH#JKE[T.S.LQ((.0Q(Q@G@<5S5AK'Q"U'3K6^AT;PZ(KF%)D#WTP(5@",_N^
MN#76VFHQ/-%I]U<6JZL+=9IK6*7)4'@L <$KNR <4 9>D^!?#VBW\5[9V4GG
MP*4MS-<RS"!3P1&'8A...,<<5?A\/Z7;Z?J%C%:[;;4))9;I-['S&E^^<YR,
MY[8QVJ4ZUI82]<ZC:A;$XNV,RX@.,X<Y^7CUINE:[I.NVKW.E:C:WL*':[P2
MA@I]#CI0!9L[2#3[&WLK5/+M[>-8HDR3M51@#)Y/ K"U3P'X=UB_FO;RQD,U
MP +@17,L27 ' \Q48*_X@U>TWQ1H&LW4UMIFLV-Y/""9(X)U=E'K@'I[U8_M
MK2_[)75?[0M?[.8 BZ\T>603M'S=.20* (;[P[I.HMIIN;-&_LR59K,*Q00N
MHP" I P!V/%1?V&O_"9_\)!\@?\ L_[%P3N8>9OY[ #MCGYCGH*IQ^.M#E\9
MS>&!>V_VR.)6R9E^:0LP,0'4L N2/<4[1-?C:S9M4US1[B26_:UMWM'VH6_A
MBY)S)UR!^5 &UJ&GVFJV$]A?V\=Q:SKLDBD&0PK+T;P=HF@WC7EC;2FZ,?E"
M:XN9)W6/.=BF1B57V&*U+K4+.RDMX[JZAA>YD$4*R.%,CGG:N>IXZ53A\3:%
M<:R^CPZQ8R:DA(:U6=3(".HQGJ.X[4 3Z1H]AH5@+'38/(M@[R!-S-\S,68Y
M))Y))IFN:#IOB32WTW5K;[3:.RLT>]ER5.1RI!ZU8AU"SN+VYLH;J&2ZM=OG
MPHX+Q;AE=PZC(Y&:LT 4ETFQ76FU@08OVMQ:F7<>8@Q8+C..I)SC-4+CP?H-
MUIM_I\^GJ]K?W+7=PA=LM,2"7!SE3P/ND8K<HH P=)\&:%HE^M_96;B]$;1&
MXEN))9&5BI(9F8D_=7KTQQBBW\&>'K;PW+X>CTU/[*E8LUN[LP))R3DDD'/(
M(/':MZB@# TWP5H&EVM];V]B76_C\JZ:XF>9Y4P1M+.2<8)XS2:;X)T#25L!
M:6D@_L^1Y;4R7,LGE,R;#C<QXV\8Z#L*Z"B@"E;Z38VFJWNIP0;+R^6-;B3<
M3O$8(3@G P">E9LG@KP_)H-MHIL"MC:R&6W5)G5X7)+%E<-N!RS=#WQTK?HH
M P8/!F@6^EKIJ6.;87*WAW3.SO,I#!V<G<QR!U)Z8Z5HS:38W&K6NJRP;KVU
MC>*&7<1M5\;AC.#G:.H[5=HH QM$\*Z/X<FNY=*MGM_M3EY$\]V3)))VHQ*K
MR3T J76_#NE^(888]2MS(8'\R&6.1HI(FQC*NA##\#6I10!@Q>"_#\6@7>B+
M89L+PEKE6E=GF8XR6<G<3P.<UN(BQQK&@PJ@ #T IU% &-KOA71_$;02:E;.
MTUOGRIH9GAD0'J Z$'![C.*BF\&>'IM!MM%.FHEC:L)($C=D:)^3O5P0P;D\
MYR<G-;U% &#;>#- M-(O],CLBUMJ (O#),[R3Y&/FD+%CQ[\=JO76B:=>KIZ
MW%OO&GS+/:_.P\MU4J#P>>">N:T** ,G4?#.CZKK&GZM?6*37VGDFVE+,-A/
M/0'!Y&1D'':I+S0=,U#6-/U:ZMO,OM.W_99=[#R]XPW .#D>H-:5% '-:AX!
M\-:IJDFHW>F[YI65YE$TBQS,O0R1A@KD8[@U<NO"NCWGB"WUV6U<:E;H(TFC
MF>/*@Y 95(# $]"#6S10!B6WA#0;31[[28M.C^P7TKS7,#LSB1WQN/S$D=!T
MZ8XINC>#M$T&\:\L;:4W31^4)KBYDG=4SG8ID8E5]A6[10!C?\(IHG_",-X;
M^Q#^R75E:W\Q^06+'YL[NI)ZUL@8  Z"BB@#.L="TW3=2U'4;2V\NZU%D>ZD
MWL?,*@A>"<# )Z8K*MOA]X9L]0BO(=.(:&4SPPFXD:"*3.=R1%MBG)[#CM73
M44 4;;1["SU:_P!4MX-EY?B,7,FYCYGE@JG!.!@$] *J:#H:Z+-K$B; -1U!
M[W:A)"EE13U[DIN/;+8'%;-% &/K?A;2/$,MM+J-O(TUMN$4L,\D+J&QN7<C
M D' R.E5H? WARVDWP:<(Q]JBO!&DT@C6:(81U3=M! ZX'.!G.*Z&B@#,O=/
MM8;Y]>2QDN=2M[1X8Q&^&="0Q0 D+DE1R?SKG?">A7DGBG6?%^K::NGWNH+'
M;P6Q=7>.% .79<C<Q . 3@*!7:T4 %9=AX<TG3$U*.ULD5-2GDN+Q68N)9'^
M^2&)X/H./:M2B@#G]&\$Z!H-ZMY86;K.B&*)I;B240H>JQAV(0<?PXJ6V\(:
M!:Z+>:/%IL?]GWLCRW$#LSAW;&3\Q)'0=.F.*VZ* ,+1O!^B:#>/>6-M*;IX
M_*\^XN))W5,YV*TC$JOL*D_X131/^$8/AO[$/[(*E3;^8_0MN^]G=UYZULT4
M <)XMT>_\9:SI^AS:,8M%LKR.\N;Z=T(F"+D1QJ"6Y)P20, 'UKNZ** ,;6_
M"ND>()H)[^WD^T0 K%<03O!*JGJN]"#@^F<4T>$-!71;?1UTY%L+>9;B.)78
M8D5MP8G.2<\\DY[UMT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !7$:Y/=77CZ*RTBPTS^T;;3/.EOM1WLL<+R%=B(I&22A).1P*[>L76/"6AZ
M_>0W>IV(FGA0QJXD=-R$Y*-M(W+G^%LB@#RG0H(-1T3X>0W"P3P?VY?$*B_N
MR%:<KM!_AX&!Z5U%YH5IK/Q%\5:-)&J0:AH,"R[5_BWR*'^HXQ]*ZRV\'Z#9
MW4=S;Z>L<D=T]Y'B1]J2N"K,%S@9!/ &.>E3WUG#87%WKMGI;WFJ- L)2.0*
M\J*Q(4;B%&"Q/:@#S31M1N/&4WA/PU?<W.CRR7&LH>?GMF\N,'UW.0WX5UOQ
M7>1/AIJY0L%(B64KU\HRH)/PVEL^U2>"O#UW87FM:_JMI#:ZKK-P)9+>)@P@
MC4;40L."W4DC@DUU=Q;PW=M+;7$22P2H4DC=<JRD8(([B@#F]5LO#=O?6<GE
MV\.J?8;B.P$1*EHM@+@!>&4#;UZ=JXK0=/M+3]FZZFA@C6:;1;AY90HW.2K=
M3U/0#Z >E=[I'@CPYH4TLVG::L<LD7DEWE>0K'_<4LQVK[# J[%X>TJ'PZ=
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY)';W#\99XP<$G SZ]Z .0ATB>0^%KZ]\,2>(-.'AVWMX+?$;)!<X!+,LA
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M<$C)!!/3]+6G:IXIUW7K:3^R)=$T2 ,9Q>F-I[IB,*JJI.Q0>2<Y/3UKKZ*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA4 >:VW_ "<-J?\ V+J_^C5KD8=!TRV_9ZL]:2SA_M:,03I?% 9D87"@8?J
M%X Z8KV%/#>G)XJF\1JLG]H36@LV;?\ +Y88-T]<CK5;_A#-(/@U/"NR;^RT
M54"^9\^%<./F^HH Y&/3K*'XO>)[R+3K1KJ#28;F%C I83$OE@<?>..3U-87
MAC0]9OO#_A;4++PWIMO<K/!>OK/]H SSACF7>/+!.]68%2QQQZ5Z=<^$["X\
M4Q>(EFO(+Y(UBD$$Y1)D4D@2+T8 DU2M/A_HME?P3Q/?&VMYS<6]@]TQMH9,
MD[ECZ#!)('0$\ 4 <=IGAO2-4T?XAW>H6$%U.-3OXXWF0.8@$!&S/W3DYR,'
MIZ"JMAI]CJGB+X7S7]E;74MQH<C3/-"KF0K#&5+9')!)(STS7I]IX<T^SM-5
MM85D$>J3RW%SE\DO( &QZ# K-N_ >D75KHD*2WUJ^C1>39SVMR8Y%3:%*EAU
M!"C- 'GKWEUI^N?&2[LF9+F*UMVC=>JGR7^8>XZ_A6GKN@Z1X?\ "/A34M&L
MK>WOX+ZQ$-Q"@62;S&"N&8<MN#'.>M=[:>%=*L]5UK44A9YM9""\61MR.%4J
M!CL,$YK.T_X?:-I]W9S";4;B&P;?96EU=O)#;-C **>X!P,YQVH Y?1_#FD:
MQ<?$"XU*P@NY!J4\2&= _ECR4.4S]TDGDCG@>@JEI$D>LZ-X*LO["AUW58M%
M^T!;^XV6T,9VIO8%6W.2,#C(YKTRRT"QL/[4\A9!_:<[7%QELY=E"G'H,**R
M'^'VC^1ID=O/J-FVGVWV2.6UNFB=X<@['8<D9&?6@#RO66<?!R*!DCC6W\3M
M#'%$Y>.)1.^$1B!E1T' X[5[_7(R?#;P])ID^F".Y2QEO%O1;K.0D<B_W!_"
M"3DBNNH \PL/#VE:UXW^(+ZG8P7FQX$C6= XCS;+DJ#T)P.1SP*YNWT>PM_@
M]X5UQ+:,ZL+VRD^W,N9O]<JXW]=H7"@9Q@"O8+30;&RU#5;Z%7$VJ,C7)+9!
M*H$&!VX%4O\ A#=(_P"$8LO#VR;[!9O&\0\SY@8V#KD]^10!Y[XQAM]5@\;7
MUCX:LKH6T;PW.J:A=;7BDCA!Q NQB-N0>JY;\ZO0:=8ZC\5?#=S>6-K<3S>'
M?M$DDL*L6E#1[7)(^\.QZBNKO/ &BWVH7US.;TP7S>9<V2W++;RR;0N\H.K8
M _$ ]10W@'2R^D2K=ZG'<:5$88+B.[99'B)!V.?XEX'% 'FNFZ1KOB#PI->V
MGAG37U2XOY;E-;EOPDZ3).<<>7D!=NS;NQ@>]=1H^AZ?JWQB\8W.H6L5RUF+
M!H$E4,L;F+.\ \;AM&#U'/K70S?#_19]0EN&>^6VFN/M4VGK=,+627(;>T?0
MY(!(Z$]16Q9Z%96&MZGJ\"N+O4O*%P2V0?+4JN!VX- 'E>D7EG8+\5Y]02=[
M7[>4D2W;;(^X%0JGL22!GWK2T.RGTGXF:)"?#^F:$L^EW*-!87'F&15,17S,
M(HR#G!YSD\UV'_"#:&8->A>&5X]<D\V\#2'EO5?[N.HJ.T\!Z7:ZC9:D;O4Y
M]1M&)6[GNV>1U( \MB>J<?=]<GJ3D Y_X)?\B3>?]A6Y_F*N^.8(M2\8>"M(
MOHUFTZXN[B6:&0921XX2T88=",DG!]*Z3P[X;T_POITECIJR+!),\["1]QW-
MUYH\0>'+#Q):0PWIGC>WE$]O<6\ICEAD' 96'0X)% 'G5]%HGACQOXQD$+0:
M<OAZ-YX+/]V5+.X(0# 4G@\8Y;/>I-'L)]'^(?A:+_A'=-T%9K*ZB\JSN?,D
ME150@2X102#@YRW)/-==!\/-!B_M RK=74FHVOV2\DN;AI'F3).23SNYP".@
M QC%%KX TJVO;&_-WJD]_9R!HKN>\9Y"N,>62>-F"<C'.30!Y6N@Z:O[/JZR
MMK&NJK<"2.^"CSHB+S8-K]5 '8<<GUKM[[2=*\,_$[PH^F6<%C'+8WR7)A0+
MYB(L;#?C[Q!R<GFNE_X0K1_^$/'A;9-_9@.=OF?/GS/-^]_O5H7NAV-_K%AJ
MEPC-<V*2I#\WRXD #Y'?A10!Y'%$J1^$=8T_PW9Z;9W6M0-!?R7>^^N%E9L[
M\)R'4DD%S@8]*UM,T32M;T3QWJNJV\,FH+J=Z@O)%'FVRPC$>QNJ[0 1BNE7
MX8Z"MK';>?JC1V[J]F&O7/V(JP8>3_=Y YY.!C-<UXBTI8]8UU%\*Z_+-><Q
M+8W+-97S[ %>9<@(0?O!N#C/S4 8^C)>7TG@RS30K/6X;?PREQ':7EP(HU=F
M56DP48,0 !TXW&O1O .EZCH^AW5IJ%M#:)]MFDM;6&?SE@A8A@@; X#%AC'
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^JZ=;7<5I<7]K%<S?ZJ&295=_P#=4G)_"B[U73K":*&\O[6WEE.(TFF5&?Z
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M;RR*&('*$L!QQ7:4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=)$#HRLIZ%3D&G4 %%%% !114;3PJ&+2Q@*<-EAQ]: )**** "BBB@ HHHH
M**** "BBB@ HHHH **:KJXRC!AG&0<TZ@ HHHH **** "BBB@ HHHH ****
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MW>QR0M/ R+*@B5"02,'D&H/ ^@:EI-]=Z;>QD:9HT\L>E.QSYD<N'!_X I*
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M>U2YNI+JY,,<:L2$0$*Q+-M8]@ />J;>/9+S3-#_ +(TP3:MJ[2I':7$WEI
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M) VRJ64'?_7O0!Z117&W'B77]2UW5-/\-:=I\T6E,L=Q/?3N@EE*[O+0*IZ
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M*"%!''&HP%4#  ^@KC[KQ)XF.M#0['3]'?4X+);RZ$UVZH^YF4)%\F3]SEB
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M!)8X/)P!QUSP >H45D>%]=3Q-X8T[6HX3"MY")#&3G8>A&>^"#S6O0 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH ***YGQ+KNI6VJZ;H6A1VK:I?B24RW08Q6\,>-SLJD$DEE &
M1R?:@#IJ*QO#TVOR6]Q%XAM;6.YAF*1SVC?NKB/ (<*264\D$'TXXK9H ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+"BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>employementagreement_mil007.jpg
<TEXT>
begin 644 employementagreement_mil007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M\0RV=R@N$REK$AEE+$D! %')X^@[G'-6M#N-9N_M=SJMHEE$\@^R6I96EC0
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MA^[N-2L88O"UOIUU;:M]LEU6 QB-X@Y9L$-YA:13M*D8Y/. * .DLO%5O?\
MBRXT*"UN/]'MVE:YD0HC,KA"J9'S8)Y8<9&!GG&<GC#5+NQ?6--\./>:*K-M
ME6YQ<3(IP7CAVG<."0"P)'0<BM)]-N6\=KJ/E?Z'_9;6YDW#[YE#8QG/0=>E
M8&E_\)1X=\-Q^&K+07N+FU0V]GJ)GB%L8P<))("V\$#&5"G)'!YH W=>\66V
MB7NDV?D27%QJ-S%$$7Y?*1W"^8^1P 6 QU)^AQT%>>:]X+\03W@O;/65FFGU
M*UGE#6B9B2-AC!+?=3EMO<D]R:]"&0H!.3CDT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4KK2-,OKJ&ZN].M+BXA_U4LT"NZ=_E)&1^%7:* "BB
MB@ HHHH **** "F0PQ6T"001)%%&H5(T4*J@=  .@I]% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHD0)*LS*!N)(4 9[T 7I_B-=&WUBYT_PS=WEKH]S/!>RB=$"B(G<4!Y<X&[
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M"%QEB< D#[H8<F@#M:*\A\7>+=3USP/;7DGA^6RTR_O+1K2Y^TJ[E?/1E,B
M#8&4''+=@>M=1;ZIIB_%/6;2/2V74X-+2:6]\]B)(\C";.@[<T =M17G=O\
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M0;KF8-M7!. H/).>@!ZUG:YXVU^R\-^(/-\.O8:M8V1N(S]I$L)C(8>8LFT
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M)M>-U.0>X(]000:I:'X5_LK5;G5[W5+O5=4GB6 W-PJ+LB!R$14  &3D^IH
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M1R5;!&""1P<U9TMO$VHVF@:Q#J=NT%[&LU]:NBA(XW3</)(7<64D#YB0>>E
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ML9=&8[([N- Y('10R$].N* ._P!8OKC3=+FN[73Y]0FCV[;: J'?+ '!8@<
MY_"KD;%XU9E*$@$J>H]J\2\0:CJ-W\)_&?BZ.^NHO[2O8_L!25E\JVCG2-"N
M#\I;#$XZYKH/%-O+_:=G?:S9:W?:!_9L:H^E3R!K6?)+R.B,&;*E<-SC:>*
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M:TJ)Y>W.W;M;&,<]3DDUWT?@69M8MM8N_$-[=:C'#);RRM%&JRPN!^[" 84
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MN_!5I=WWA>Z:[F5O#X(A4 8ERBK\W_?/:H9? &G7&I>*+N>XG=?$4$<%Q&,
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MF+5=6UVZU:YMH7@MO-ACB6)7*[CA -S':O)].E "^.KBU@\*S)=W%]"EQ+%
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MY;^*"1F8Y:,B0D=?4"NGLO"FDZW\2O%EIJ-N9[&VM[!([4NPC_U3 $@'D@#
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M$CZ 5S&NZ?%XX^(&BQ)IMXMIH4\DMY>3P-%'(01MB3<!Y@+HK$C(PO7FO2*
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M)W')] /2N"L;"TOO@#9R74"2O%K0",XR5#7"JV/J.*]VT/P_:: -1^R/,_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1R+-'\K#ID!!N'^R>#5+3OA[<V^HOJE_XNUB[U1H?L_VE!%%B+=NV!=A[\T
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M:.6)RK(?4$<@UD^"YKG4/'OB[57T^[M;.[CLOLK7,+1F5520%L$9'/8\@$9
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MMP =R$#Y7SZXXS61XQU74/$W@FXOX-#OH[.TU6VE@W1-YUQ"CJ6D\H@,HSG
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M*_N6!M\M,UMN+-YDS$DJ#C)YX+8KK:** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/'MW=\WHU7[/\W58$!$8'MC-=AK]W;:+I=[X@F@\R33K.9UQU*X#%?Q*+^5
M&M5>^O(]/L9[R99&CA0NPC0NV!Z <FN#U/7]<T/PIHOBN34#=13O;&^LS$@C
M\N; _=$#<"I88RQR.M63J=_XHA\6&UU&2QMM+FEL(8XXT;S)$C!=GW*202V
M 1P#SD\ '6Z+JUOKNBV>JV@D%O=Q++&)!AMIY&15;7_$NG>&H;6;4GE2*XG6
M!72)G"L<\M@<#CK7D]G>/<:%X"T6;3]3U'3FT9KN>STYPK3,NQ5W$NGRKN)Q
MGJ1Q7<>"["\N=&U#3]4LM2MM/BORUE!?R!I#;X5A&Y#-E0^X=>0 #QD4 =!8
M>)-.U'7=0T:!Y1>V&TS))$R@@]U)&&'TK7JO'90I?2WN"T\BJA9C]U1T4>@R
M2??/L,8OC/5-0T?1HKRQM[J:-;E!=FTC$DT<'.YD4@@D';G@\$T 7/$'B*R\
M-6,=Y?)<-%),D(\F,MAG8*,]@,D=36M7E'BC5HM;^&-Q>V6M)JMN^K6GV>9D
M"M&/.B^210JX8-GL#@BNBLM1UNQ^(=UH5UJ:W\$VDG4(?-A2,0R+*$*@J,[#
MD=<D8ZF@#M:P(/%^FW$>M2)'>8T=]ER# =Q.W=\J]3P?05RVF^)-83Q'X3M9
MM3-_'JBW$=ZR0J+;S$B+@P/M5F4$$9RP([YIVE?\?WQ,_P"N_P#[:K0!W.CZ
MI!K>C66J6H<6]W"L\8D&&VL,C(]>:NUS7P\_Y)QX;_[!L'_H K$\26/]K_%3
M1],N+BY6PDTJX>>"*9HQ-B1, E2#C)!X],="10!Z!17C=AX9MKS1?&T%S=ZA
M)!HUU<1:9']LD'V7$8D!4AN2"P^]G@>YRV35KC7;KPS9ZKIVKZS:_P#".07\
MMOI\@4R3R':7D^=,@!3CGJU 'LU%>4"2X'A"QTG7H-?#2:K)'9:=&X^UWMNH
M9T21P_"A3\QW#[@YK&O;N^L_!7C;3[5+_2DLK^Q^R6]Q.)9+42-"2 P9AM))
M(&X_>Q0![A17G4NCP>%_B3X6739[P#4TNXK[SKF27[04B#JS!B1NR.HQUKMM
M;M8;[0[ZVG#&)X6W!7*'IGJ""* ,R[\8Z?#IVBZA:;KRTU:^BLX)$^4 N6 ;
M!&<#::Z*O"=/T:W3X4^!/LLD]O-?ZS9F69)6+ YD&5R2%..F,<\UT.H*/ OB
MS65T1ITM_P#A&+G4#;RSO*IGB<!7^<GG!P?6@#U6BO(/#<%_#?\ AN]TS0O$
MD5S(Z#5;V^F5XKJ)T.YV'FMR&*LN%&!Q[5Z_0!B^'_$]AXE;4UL5F!TZ\>RF
M\U0,R)UQ@G(]ZVJ\)L)I;?X=_%6:&1XY4UJ[*NC$$'*]"*ZJ_P!%B\.^*/"%
M[:7-XUWJ%TUM?R27+N+H-"S$LI.!AER,  =N@H ]!LM3L]1DNTM)Q*UI.;><
M $;)  Q7GKPPZ>M6Z\,L+>/PUX/^(&JZ2+F*_AUJ?3X9$G=F2-I(5X#-@L-V
M0QY]ZZ7PY:W5AXKM/[*\/Z_IFERVLT>H?VE,'1W !CD'[QSOR&!/&=U 'IU%
M>&:1IIC^ UYXHEO;V;6)M,EC$[W+_NXQ)@*JYP/N@YQG)/-=->Z/'X<\1>#=
M1L[J\:]O[S[-?2R7+N+E6A=CN4G:,,H(   [=!0!Z;7/Q>*H9?'L_A06T@GA
ML!>F?<-I4L%VXZYYKS/Q)=0K%JOB'2K77KN[M]2&S6FN!';P[9E0Q(GF#=&.
M4X0Y)/7K726?_)Q6H?\ 8O+_ .CEH ] O[R+3M/N;V8,8K>)IGVC)VJ"3CWP
M*X^'XG6<]C'?)X:\3FSDC$JW TTLA0C(;(8Y&.>*Z'Q5_P BAK?_ %X3_P#H
MMJ\VTSQGXI\-_#'1;K_A%K3[!'8VT27TFI95%95597C6/(7D$@'B@#U72]4L
MM:TNWU+3KA9[2X3?%(O1A^/0]L=JMUY%J.FS^%O#W@[PDPO=3M[F>>6]33&"
M/<X#2E%)9<)N?)Y&56J]U9ZY;^&M?N=/T_5]-M-(N+?5-+M[Z7+_ " F>+(=
MB4PI.TGJU 'LM%>>:AJ__"3>-=!CT^:1M-L+ ZU<>6Q D+KB!#C_ ($V/:N2
MT"75;[2]%UZRT/Q')KT]Q%<W.HO,OV>>)W'F)M\WB/82%&SC:.E 'N%%>46?
MA^#Q$/',^IW-[+]DU.X2T1;J1%MR(D;<H4CG)'7.,<=3F?PMJE[J&O\ @6:Y
MN99'N/#DLDV6.)'S%\Q'<]>?>@#U"BO(=?UG4+$^/A:SW7F/J=A:1^0_SQK(
MD2MY>3@,03CIR<UK^$K:ZL?&"+IN@:YI>BS6;BZCU&4.GG*RE'7]XYW$;P>F
M>* /17=(HVDD941069F.  .I)KB3\4-,DCDNK+1M?OM,C)!U&VL"T! ZL"2&
M91SR :L_%-[B/X8>(6MBPD^R$';UV$@-_P".YKHM'CM(M$L([$*+-;>,0;.F
MS:-N/PQ0 [3-3L]8TVWU'3[A+BTN$#Q2IT8?T^G:K=>>^(X;.\\0>%/"UBZ6
M^AWCW<US%8/Y2R^4H/EY3& 68E@.N*Y[Q'?W/@27Q?IFBW%PEH-%BOK9'E:3
M[+*TIB8H6)(SPV,]10!Z9KFO1:)/I,4D#RG4KY+)"I V%E9MQ]OD_6M>O*M?
M\)V'AO5/!#6$US\VLQ).);AY!._E2?O"&)PWWN1C[WL,8DTVHZY#KNIVVB^(
M[G7EO[A-.O[:51!;^4Y6.,*91\OR_-E3G<>M 'N%%16SR26L,DL?ER,@+I_=
M)'(KS;2="M_&S^)]3U>XO#=0ZG<V5FT=U)&+-(L*I0*0 V?F)[T =;XL\60>
M%;:R9K.XO;J_NEM+6V@*AI)&Z9+$ #CK6S8S3W-C#-<VK6D[J"\#NKF,^A*D
M@_A7ANKQQ^*-#^&.L:H)9;V^OX+:YD$SKYB@L"< @ GKN&#SUKW.RLX-/LH;
M2V5EAA4*@9V<@?5B2?Q- &+J?C71=*\0V.A3322:A=RI$(X4W"(L"5\P]%R
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M/7KN6ZEDVC,1<@D+Z@8[UMZIX>AU2\T6XDG=&TJX^T1A0/G.QDP?^^LULT4
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ME$N8'A9EZ@,I&1^=4['P_:6GA2V\.S#[59Q6:V;>8/\ 6($V<_45K44 <B/
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MZ'G>3[1LC5U9MQ.6SGGWK0?X:6CP:I VKZ@\6IO!-<B38Q::)U;S,[>"=@!
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M;L\9M]-_LV.W7'EK%O5A[Y&T#Z4 >76WAFSN?!/C>2XFO)3H=W?0Z5NN9/\
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M# '2NTK#/AP)X,@\.6NHWEHL%K':QWD#[9E"  ,".A(7]:VU&U0,DX&,GO0
MM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 445R_BK6+V+4M'\/Z3-Y&H:I*Q:XV
MAOL]O& TC@$$;CD*,C&6]J .HHKD]?\ '&FZ8-3LHI+MKNSMR9IXK5Y(K9RF
M4\QP"JGH>>!WP*S-.\2:M9Q^#M1U&Z^T:?KMI!;S@QJIANWCWHX*@<.=RD=
M=N,4 =_1110 4444 %%%>:06VK>)?B/XNL3XGU?3[73&M!;PV3QA1YD.YL[D
M;N,_B: /2Z*X/3]3USPQXUL/#FMZC_:UAJL<IL+V2)8YHY(QN:.3;@,-O(;
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MK&\A1C'&[8VJ[@;4)R.&(ZCUJMJ/C;PUI,]Q!?:S:PRVVWSD+9*;C@9QWXH
MWZ*YZX\=^%[6*XDDUJVV6\GE3,A+A&P"<[0>!D9/09YJQ%XKT&;5X=*BU2W>
M\G4M%&IR'P,D*WW2<<XSG% &S17.VNL:5#JVOW+^(UFBMA$;FWD=?*L<*1P<
M=6P202>1VJ6T\9>';Z^L[*UU:"2XO(Q);H,_O!MW<'&,[><=<=J -VBLBX\4
M:+:736\]\J,DRV[OL8QI*V,(S@;58Y'!(/(]:J'QA8?\)F_AS$HFBMA-)(8F
MVY9L* <8QUR>G;/7 !T5%8&A:EIS66JWL?B#^T+2.\E:2>5U"6V "8PP &U1
MWYZ]:MVGB+2KV[>UBNPMPD7G&*9&B8Q_WP' RO\ M#(H U**YP^/?"P$3?VW
M:E99O(5E)*[\[>2!@#/&3P?6H[JU\0MXIO6M]8D32YM/=4C-FI%K-P$=6ZR$
M_.2O08 /44 =/16/X7CU6+P[;1ZU<FYOE+AIS$(VD7>VQF4<*Q3;D=CFM=F5
M%+,0% R23P!0 M%9,.MZ?JLGV*SO94N)8&FB<0LI:,$#S$+KM899>1D<BN5\
M >-[.Y\)Z##K6LI)K%]O7]YUD?S&V@D# ) &!QGM0!Z!161?^*-&TN::*\OE
MC,&SSVV,R0;ON^8P!"9[;B*Q]9O[^V^)7A:SBOI18WL-X9K;"[&,:*5.<9_B
M/?' H Z^BN0\(7]_<^)/%MI>7TMU'9WT<<'F!1L0Q*V!M '4UU] !16)>>+_
M  _8W-U;7&JP+/:*&GB4EV3.<< $YX/ YXS48\;^&F:Q5=9MF^W;1;LI)5RW
MW03C"D]@<&@#?HK,U/Q!IFC[OMUSY>Q/,DVQL_EI_??:#M7@\G X/I1<^(=*
MM4MV>[$GVB(S0K C3-)& "7 0$E>1\W3D>M &G16-+XL\/PVMC<R:O:+!?D?
M97,@Q+GN/;U/;O4VD>(=)U[[2-,O8[@VSA)E4$%"1D9! .".AZ&@#3HHK O-
M7>Y\5P^';20QLML;R\E7JD>[:B+Z%CGGL%..2" #?HK M)[2^\1:S;VWB"::
M>.*));.-E(LS\V&''WCCD'/3D8IWAO6WU/\ M"QN]HU'2[DVUSM& _ 9) .P
M92#CL<CM0!NT45@PW]B?%6HJFN//+;VB&;3EPRP $G?@#.X],9[=* -ZBO/M
M!U2[\97E]<6VM7=A-8ZM)''$D),3VT;!2C*P );DYSN!/' Q7H- !17"WM]K
M$OQ9CT"+6[JWTZ32&O=D44!99!+LP&:,G&#T/YUN6\[Z.VJ76H:Y+>V$"H&,
MT2;K=P"7SY:+\NUHSR#CF@#>HK+M?$>DWIL1;78E^WHTEJ51B)47&6''09'/
MN/6FW_B;1M,G,5Y?+#M=8WD*,8XW;&U7<#:A.1PQ'4>M &M16=J6O:;I)(O+
M@HRQF5E2-I&2,=78*"57_:/%)%X@TF>\M+2*^C>:\B,]L%R1-& "60]&&".A
M[T :5%<OK?CO2-)\,ZGK,<K7(L':!XDC;<)@!A&&,KU&2>F:FO-6TZZU/0U7
M79+.::9VBLU&TW>%8%65EW;1@G/'3Z4 =%16=:Z[IM[JEUIEO<[[VT ,\.Q@
M8P>F<COV]>U(-?TQK(78N"8FE:%,1/N>1<@JJXW,1@\ 'H?0T :5%8%WJ,?B
M'PQ>R>']8:"89C%S!;^;) ZD;E,3<[NV" 1FI[/49=.T73%UV;=J<D"B588B
M[22!07*H@)P#G.!@4 ;%%5[&_M=3LX[NSE$L$F=K@$9P2#U]P:L4 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %<3J/\ H_QDT.6;_5W.D74$)/\ ST5X
MW(^NW^5=M6/XAT"/78+4K.UK>V<ZW-I=(NXQ./;NI!*D=P: .!;6+/04\>:-
MJ0?^TKZ[GN+2W\IF:[CD@54V8'.""#Z8YQ3M3!;X8_#^S4$7,UUI2QCN"H5F
M/X*K5ZH,X&>M8\^@)=^*;;6KJX:464+):6^W"Q.W#R$]V(PH]!GUH V****
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MSD2H3@=3@<U?\1^+K&3P]=6VAR+K&IW4+0VUM8GS3O88!<KPBC.26(Z5V-%
M'D]A;0^!QX.\.7S1VLT=E.#JHB\QA(S!F@BR",L3U(.0N ,GC$M+F./X:6+-
MYP33O%2RW321,/*3[6Q);([ @GTSSUKW.B@#RW4==TO1_B!?W7B&:^MM*U:S
MMSI]Y&\T<9V!@T;;,<Y;<,CO[UW/A2QT_3O#5I:Z392V>GKO,$,I<L$+$@G>
M=PSG=@\C...E;.,T4 4=;@NKK0=1M[%]EY+:RI ^<;9"I"G/UQ7E=Q+#KWP:
MTWPW98C\1P_9+5;,\3V\\4B!G*]5 "LV[I@]>:]BHQSF@#@Y[VU3XWVRM<1
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M2-P<';Y>?7?\OUH ZFBN+?QS?R:O-H]CX:N+G5(K."[>$W"1J@D!RK.W *D
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M_"B5Y_AAHDKNSLT;DLQR3^\:NRH **** "BBB@ HHHH **** "BBB@ HHHH
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MCF$5FPV^6(S* 5;.X%02,#VKTZB@#A_BI%,WA:TN(H)IEM-3M;F988R["-9
M6.T<G%<[JJ:2WC.[UW5)->BTK5;*!K2YL/M47SQ[U:-UC 8,05*[AZXKUJB@
M#RV#2$MM=^'!T_2K^TLXY+^9XKK<\D/F1%LR,2<$DD\G/..M="EO/_PN>>Y\
MF3R#X?CC$NT[=WVASMSTSCG%=C10!Y7#8W8^%WCZ VL_G37VJ-%'Y9W2!F.T
MJ.ISVQUI[6-W_P +1\!S_99_)AT>5)9/+.U&\L\,>@/UKU&B@#S+3K*Z7X5>
M-+=K6832SZJ8XS&=S[B^W ZG/;UJC*P&HZ?9^(8]<-BNBV@TZTL#.BSSX(D#
M&+'SC"#YB  <^]>MT4 >'V+2Z7X7\"SW=E>QIHNKSQ:@HMI': GS,' &67YA
M\PR.?6KMU9:38:[XB?6D\2'^T;C[;8+I[W2)=H\:C9MCX#A@00V#@CM7L=%
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M$33*A,<1?:';' SVR>,UXO=^)]:UKX2W.IZO:E$75HFCFCE#LX%[@H$ &-H
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M7"RK%\WW<X!XSFJOV*]L_!HA_L3487TSQ7'?RVP@DD9;<RE@5//F8!Y*D^]
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M,PS([':ZP$-A@_!((R#0!MR?$$3:9I#:;I,MSJVISRVT>GR2B,Q/%GSM[X(
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M<,#VY&>U>D^!;'3K72KJ?3-)O].AN;EGQ?2R-+/@!1(1(2RY X!P< <4 'Q
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M110 4444 %%%% !1110 5DW^@PZAXAT?6'F=9=,\_P N, ;7\U0IS],5K44
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&$Q*L1_!CH/O<^DVN:EJ:7+)!K(5/[*\Z"+3T66:2;G,K[D*B+ &"2 23[4
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M '>45Y]8Z[JK^)M>TF.^NVMX]*CO;26]MT61&)=2=H5?E.W.&&<Y[5EV&O\
MB1- \#Z_<ZTT_P#:MW;VEU:?9XUC990WS9 W!@0#P0/;U /5:*** "F[T$@C
M+KO(+!<\D#J<?B/SKS7Q+XDUO2+?4K^+5/.FM-5BB6WM8E:WCMV=$V2LRY\P
MAB2%8D$CH*OVL-T_QHU('5+SRDTJ"40_NR@!D<%.5X7C/&#[T =[117#^+-3
MU6TN]6%MJK0BWTWS[2VLHUDE$@WDR3;U(5.% Y&?FZF@#N**\X;Q!K^H7O@
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M&B7$5Q!L*_.T8  ;(Z<=L5/;>%K.U\97OB=)IS=WELEL\9(\L*I&".,YX]:
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M2/H<UMREW+&\L<X/5"@'RE>H/0],4V3X?Z;=6VOVU]<W-U!K<@FN$;:OEN
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M03DL&\X8)'\&,C'7OS4NOZC?_:;E;;67=$TD3VT&G!6D\SYB9I&8;0F -N2
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M7^T+9;:]MX&39,J@A3DJ64@,1E2*;I7@Z31+/3;>PUR]_P!!MC;#SD1UD3C
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M%85'S>6""H'&>>M=+%X<TKQ#\6O%2:O;)=P0VED5MY>4+%7^8KT) ! /;<:
M.\U>ZU*TMH7TO3DOY6F5'C>X$(2,]7R0<XXX[UE2>+"GQ'B\)?8LB333?_:O
M-Z?.5V[<>V<Y_"O)M9=X_AK:Z?YCO!IOC$V5LSL6/DI(^T9/7 ./PKMI_P#D
MXNU_[%P_^CFH ZLZ_/IVC:IJGB"Q73K>Q>0J8YQ,985'#\ 8)Y^6MM'62-74
M\, 17S\UI;W?PA^(K7$*2-;^(+F6(L,['!C&X>^&(_&NXU'2K+P3XA\*Z[IE
MK'::=+_Q*KZ.)<*%F.Z-SZ8DZG_:H ]+H) &2<"N'\%1_P!L>)/$?BQ_FCN+
MC^S[$]OL\!*EE]FDW'\*I^*M)L]:^*WAVROU\VT;3KII("?EF :/"L.XS@X_
MV: .K\4:\/#GA74-;6 70M(3*(A)M#^V[!Q^56]*U)=2T*PU-T$ NK:.<H6R
M$WJ&QGC/6O(=;M8M&T+XI:#8+Y6EVL%M/;VX/RPM+'EPOH"5!Q[UKSQ6&J:?
MX.TR31)]=O(M&2X%@\R1VR(41?,DW=6SPO7JU 'JM(KJX)5@V#@X.>:\0BA>
M^\(>&=-N/,@AC\7R6@B2<L8H@9AY8<<D 94$=NE=?HND6'AWXNW&GZ/:QV5E
M<Z&MQ+;PC:C2K/M#XZ9P<4 ='XR\40>#O"]WK<]N]PL&T+"C;2[,P4#/;D]:
MO:1=ZA<Z8MQJ]A%IUR2=T*7(F51V._:O\JX#X[Z;97/PZGOIK:.2ZM98E@E9
M<M&'D0-@^X J2[\-Z/-\0]*\+-IT":%;Z9-J*V*KB&6<RHF67HV 2>?6@#TH
M$$ @@@]Z RDD @D<'!Z5X=XIA31_#?Q,T&Q!CTRS%C/;0 Y6!I2I=5]!E0<=
M!FO6_#WA[3O#UDT5C#M><B6XE9BSSR8Y=B>I- %A=8LVUU]&$A-ZELMTR8X$
M98J#GURIXJEX3\1+XG\-66KM MJUUOQ!YF_&UV7K@9^[GIWKD++0-)?X[:I<
M-I\!ECTV"Z1RG*RF1@7'O@#FN.A\.:;%\!3XC$&=9MPT]O>ECYD!6X(4(?X1
M[#@DD]30![VS*N-S 9.!D]32UY'JMK-XB\>>)(KSPH^OQ6:6]M;YNXXA:JT0
M=B@<C#%F)W#GY1SQ7H/A"'5K?PCI<&N C4XH!'/N<.21P"6!()( )- &T752
M 6 ).!D]:6O'='\(Z+KF@^-KW4H%GN8]6U%8)G8YM=K%@4_NG=\V1UXSP*O^
M"KZYU+QGX<O;MV>XG\'(\CMU=O.3+'Z]?QH ]3I RMG# X.#@]#7B'B4LW@W
MQ_Y4A1_^$GA"N.JG=;\_A6]XH\):/I^J^#-'LX#;V=SJDK7 61MTQ,#!MS9R
M2P7!]<T >HJRN,JP8>H.:0.K,5# LO4 ]*\;\1X\"ZQXKM?#4?V&VE\-B]\F
M#A(IQ*8O,4=%.TYX_NUI:UX:TGPC8^%=5T.V2WU :G:6\EQ&3ONTE.V02'^/
M=G/.>1Q0!ZGN7=MW#=C.,\T%E#!2PW'D#/)KR;^R+?P_XD^T^)-"G,DNK>=;
M>);28,?GE_=QRC[R+@K&1@KC\ZQQINK>)+/7=1MO"LMYK3ZC<"TUC[=$CVS1
M2%8U4,P957: 1WY]: /<J;O7?LW#=C.W/.*IW5S<VVA3731@74=LTA0<C>%S
MC\Z\AN-!TZU^"L7C")0/$:VT>H_VKD^>9BP8@MU(Y*[>F.U '?>(/&-WIOBJ
MP\-Z3HXU'4+JW:Z;S+H0)'&#C.=K9.0>,5UU>0:GX9T/4/CII\5WI%J\=WHS
MW4\;ID/+YA^8^]=E\3K^YTSX;:Y=6<K13B (LBG!0,RJ2#V(#&@#1USQ$NCW
MFBP+ +C^TK\61828\K*,V[H<_=QCCK6WN7>$W#<1G&>:\MU_PEHGAO7O YT>
MT2T)U5(I%CX\[$3X=_[S#GYCS\QKGK?3M9\0Z-?ZO9>%)+G7YK^>6VUHWT2/
M$T<S*B*&8,J*%V[>A&?6@#V6+6+.;6[G2(Y";RVACGE7'"JY8+SZ_*>/I5X,
MI8J&!8=1GD5Y-#I=A9_$WQIJL6FV_P!NLM-AO(&V E)F20LP]R>OK5'PQHNK
M/;>%M6T[PI+;WIE@N+W6&OXF>[AD'[XN-VY@P8L >F!B@#V<LH(!8 DX&3UH
MWJ&"[AN/(&>37E_@;P_I]]K_ (NUB[A\ZZM-?NDM2['$!*J691TR<@$^PKD8
M/#MA%\$] U^)7CUL3VWEZ@KD31AIPFU3V4*<8Z=^M 'OP96)"L"0<'!Z50T>
MZU*[M'DU33DL)Q*RK$EP)@R#HV0!C/IVKBK?1-.\,_%O28=&M4LXKW2[C[2D
M9.)2CH59O5N3R>>:X32D:7X+WR+(\;-XF11(APRYN(^0?44 >_AU8D*P)'!
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MP!8^@]: .8/P_P!)-IXDMO.O-GB&0R79WKE"?[GR\=>^:U=0\/6FI2:0\SS
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MJ5E:VDDV'CBM[GSL(5!&X[1AN3D<_6MN@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N"^,=A:7?PQ
MU>>XM899;:(/ [H"8F+*"5)Z'''%=[6;K^B6GB30KO1[XR"UND"2&)MK8R#P
M<'TH \Y?0M*;5? >@#3K6+2;RWFOKFU2(+'=3I#'M+J.&QDGGKBJGB*SMM#N
MOB!H^EPI;Z;+X=%XUM"NV.*8^8A*J.%RH!..N*]&U3PGI^JZ=I]K))<P2:<5
M-I=6\NR:$A=N0V.XX(((/I56#P+I<6E:O933WMU)J\9BO;RXFW3R+M*@;L8
M )P ,#- !X$T'3M'\,V4]I;JMU>VL,MW<'EYWVYRQ[\L<>F<"L3QYIUKJWCW
MP-8WRA[:66\\R,GB0"$':?4''([CBN[LK2.PL+>SAW>5;Q+$FXY.%&!G\JR?
M$'A/3_$=WI]U>274<^GF1K:2WE\MD9@!NR.XP,?KD<4 >8>*4_X16]\:Z=X?
MB%I:3Z;93-!;$1I%))-Y3E<<(2AZCTSVK;TWP_J6GZ]%>6?A*U\/Z>MA/;W@
MM[R.03C:#&2J@98,#\QR?F-=98^!M)MK/58+I[K4GU90E[/?2[Y)5 PJY
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MWQA%3*XY. 3GMCWK;O[.+4=.NK&?=Y-S$\+[3@[6!!Q[X- 'D<GA[2])\$^
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MP 'W$#'&:]:U[PU::\;262>ZM+NS9FMKNSD\N6+<,, 2""".H((X%9UQ\/\
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MWXD_$/5)[*"$:?!;7"SQ1*)(=\$C2LAQPS<DXZFNVE\(Z;-X8L/#[&?[%8F
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M>9N.2V,?P@  8 [4 <1<I<ZEX@\-V#>'H->M;;PY%<I9W,Z1QK(Q"&0A@0Q
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FR2)%&TDCJB*,LS'
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M25^'_P#KW/\ Z&U>>6,]W:?#KXCZIH][<6=F-7GFL)K9MN0& 8J?[IXZ8Z4
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MLP;[\<C ,J[3@@'K@UQF@PRZ?\ =0U&QOKZVNTAO9%D2Y<[2D\N-H)(7IR5
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M<@XYK2DO+6&*.66YA2.4A8W9P Y/0 ]R:<UQ"D\<#S1K-("4C+ ,P'7 [XH
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M@"E_PC=N/$LVOK=72WTML+4X92HC!+  %>S$G/\ 3BLW_A7^E#PXF@_:K_[
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M@@,>2?:N@O=1L=-B66_O;>UC8[5:>54!/H"3UH LT4BLKJ&5@RL,@@Y!%+0
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M[F-I6)9VP20<Y'*@C'I0!@>)+*W\)^+/#7B.QMXK:Q9SI-\D*!$$<IS&V!P
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MNK&Y>"0QDYV$J>5SS@].U6K#P]I>FZ$=%M;14L&1T>,DMO#9W%B>23DY)]:
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M9I&=8@0N23R?F.3U-4I?!.B2Z.=,\F9(?M;7L<D<S+)%.S%BZ.#E3ECT]<4
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MUS7'WPN(?"_Q4MKA+&)T$3/%8$^2KF%=V,@<G SQUS5K5?\ FCO^]%_Z)CH
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M'[P+!O ?^]\R@\YR: /1+'5]-U.T:[L-0M+NV0D--!,KHI'7)!P*;IVM:5K
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MVY[[: /2?[?T;9=/_:UALM IN&^T)B$-]TN<_+GMGK4UMJNG7M@;^UO[6>S
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M&8]/A\71PVZQG:(@7C+*F.@#,W3H:]ML-.LM+M5M=/M(+6!>D<$81?3H/H*
M'7-Y:V8C-U<PP"1MB>:X7<V"<#/4X!./8U#IVL:9K"2/IFHVEZD;;7:VG60*
M?0[2<5QWQ0MK6\/A"VO0K6TOB&!)%;HX*2?*?4'H1WS6#XVC_L7Q;K#Z)$EM
M-+X2NI)EMU"<HX"/@?Q#+ &@#TVRUO2=1NIK6QU.RNKB#_6Q03J[1]OF .11
M'KFD37,=M%JEE)/(&*1I<(68*2&(&<G!!SZ8->>Z+X>UD7GA&[2R\-Z=:V6-
MDEI=2&6>%HB"F#& V<ANO5<U6\$>'-,O_A_XBDF,-K<WMU?V[7[J-T"EF3AC
MT49)QD#D^M 'IFGZWI6K-*NFZG97C1'$@MIUD*?7:3BF6_B#1KO47TZVU>PF
MO4R&MH[E&D7'7*@YXKS2]EOM LM0L[_0+"RUQ-!O!IVI:4Y$<RQHI92F 58?
M(P!SWP?5VNZ9IFG?"?PW>:5;01WD$NG264T2 .TC.F>1R2P+9]: /2+SQ#HF
MGAC>ZQI]MMD\IO.N43#X!VG)ZX(./0U)?:SI>F6T=SJ&I6=I!)@)+/.J*V>>
M"3@UP_AS1=-U'Q5X]EO;*"Y=KU8?WR!\)Y"$@9Z9SSCK@>@K"\,:5J5]X1\'
M:QIJ:9J5Y9Z7)"^FZB^-\3./F0X.UAL"Y(Q@XH ]@BECGA2:&1)(G4,CHP(8
M'H01U%/KGO!%U87?A2V;3M/;3H4DEB:S9MWD2+(P=0>A 8-C'&,=.E=#0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !5#6M%T_Q!I<NG:G;B>VD()7<5((.001@@@]Q5^H+N]M;")9
M+RYAMXV=8U:5PH+,<!03W)X H Q=*\%:'H^HIJ-M!.]^L;Q&YN+F2:1E;;D,
M78Y'RC'IVZFH]/\  ?A[3-2BO;6UF#0.TEO"]S(\-NS9R8XRQ53R>@XSQBKY
M\4Z NER:F=:L!81R&)KG[0OEAQ_#NSC/M4ZZWI3:1_:RZE:'3=N_[6)E\K'3
M.[..O% &='X*T*+4M2OEM'+:FK+>0M,YAEW !B8\[<D#KC-+HO@S1=!NS=V<
M5P\XB\F-[FZDG,4?78F]CM7@<#TJU8^)M"U/9]AUBQN=Z/(OE3JV57&X\'H,
MC/ID59.K:<NG1ZB;^V%E+M\NX,J^6VX@+ALX.20!ZYH HP^$]&@\*'PQ':$:
M08FA,'FL3M8DD;L[NI/>K-QH6G74^F330%I-,<O:G>P\L[2GKS\I(YS5:'4+
MEO%MU8OJ&EM:QVJR+:(Q^UHV1EW&<;/3CTJ>T\1Z)?W M[/5[&XF,)N D4ZN
M?*!QOX/W<]Z &S>'-*GN=4N)+8F75+=;:[/F,/,C 90.O'#-R,'FHK;PIHUI
M#H\4-J531R38CS6/E94J>_S<$]<U8TOQ#HVN/,FE:K97S0G$@MYUD*?7!KG?
M%7C_ $_3=&O7T74],N]3M9H(WMO.$A4/,D;956!X#'Z'&: -R]\+Z/J-QJ$]
MY9B9]0MEM+G<[8>)22!C/&"QY'-4K3P'H-E=6=W'%=M>6DGF1W4MY*\O3&UF
M+99,#&T_+[<FND9@BEF("@9)/0"N<\.>.-$\3SZC#87ULSV4[QE1.K%T7;^]
M !^X2V,].* (E^'?AI--U+31:3_8=1;=/;?:I?+SOW_(N["?-S\N*O:KX3TC
M6(+*.YAF22Q&VUGMYWAEA&,$*ZD-@@#(SS4VF>)]!UJYDMM,UFPO)XQEX[>X
M5V ]< ]/>M.21(HVDD=41 69F.  .I)H PH_!>@Q:"^BK9'[%).MQ(#*Y>24
M,'#LY.YCE1R3VQTK1N=(LKS5;#4YX2UW8"06[[B-@D #< X.0!UJM%XJ\/3W
MT5C%KFG274T8DCA6Y0LZD;@0,\@CGZ<U+I?B#1M;:9=*U6SOC <2BWG639]<
M'V- &E7,7WP^\.ZC?7%U/:S@74@EN;>.ZE2"X<?Q21JP5CP,Y'/?-:=AXET/
M5;Z6QT_6+&ZNH<F2&"X5W7'!X!K*\)^)Y=7TK6;[5&MK>.PU*ZMO,'R(L438
M#,23SCJ>!0!K7OA[2]1U'3+^YMMUSI;,UHRN5$98 '@'!X ZUIUE7OB;0M-L
MK>\O=8L+>UN0#!-+<*JRCKE23R/I6E%+'/"DT,B212*&1T8%6!Z$$=10!F:M
MX:TG7+_3;[4;037&FR^=:OO8>6^0<X!YY53@YZ42>&M(E\3P^(WM =5A@^SI
M/O;A.>-N<9^8\XSS4FJ^(-&T,PC5=5L[$S'$8N9ECW_3)KEH?%VI7OAS7;V.
M^T6PDLM8FLH+B^++;^4C@ L=W+$'J"!G'% '66>CV-A<ZA<6T)274)?.N3O)
MWMM"YY/' '2LV7P1H,FB6&DBUEBM]/.;-X;B1)8#SRL@.X=3WYJ]J?B/1-%E
MAAU35[&REF_U:7$ZQE_< GI1JGB+1=#6%M5U:RLA-_JC<3JF_P"F3S0!1?P/
MX?D\-S: ]DS6,TGG2;IG,CR9#>89,[BV0.<]O2K6G>&M,TR^COK>.9KJ.T%F
M)IIWD8Q!R^"6)R=Q)R>:S==\5#2?$7ARW\^S73-16YDN+F5N%2.(.K*V< <]
M3GBM$:_8:GX?O=0T75M-F6&*0BY:4/#$X7.9"IX X)Y'% #)?".ASZ?J-C+9
M;K?4+DW=PID;)F./G!SE3\HQC&,5%:>"M$L].U*R$$\RZE&8KR6XN9)99DVE
M=ID9BV "<8/&:PO$'C#4]&TKPA-#+IEY)JVI6]G<SP!FA9'SN:+YO;@DFM]]
M7>V\37D-UJND1Z=;V7VAH"^VYBP1F1\G CQGG'XT ;%G:0V%E!9VZ;(((UBC
M7).%48 R?85#JNF6FM:7<Z;?Q&6TN4,<J!BNY3U&1R*Q/#GC[P_XDL8I[?4K
M2.66=H%MWN$\PL'95^7.<L$+ =Q6_<7UI:2V\5S=0PR7#^7"DCA3(V,[5!ZG
M'84 <HOPL\+*H58=1  P -4N>/\ R)6[8>&]+T[4O[1MX'-W]ECLQ++*\C+"
MG11N)QZGU/)S6J[K&C.[!4499B< #UKCM0\>6,NHZ';Z#J.G:@EYJ0M+HQ2B
M0QJ8W;C:>#E.IR.M &F_@O0)+"_L38_Z-?7'VJ6,2N )L@[TP?D;(!RN.:=I
M_@_1=.LKZU6V>X6_7;=O=S/.\XQ@!F<DD $X';-6I/$>B1:PND2:O8IJ38VV
MK3J)"3T&W.<^U9UKXWT2[\7W?AN.]M_MENB_\MU_>2$ONC49R64)DCMF@!VC
M>"-"T*[:ZM+>9YC%Y"O=7$DYCB_N)O)VK["J=O\ #3PO;*B+9SM%%(LL$4EY
M*Z0,KAQY:EL)R!TZ].E;=KXCT2^U.73+35[&>^BSYEM'.K2+CKE0<\=_2C_A
M(]$^V)9_VO8FY>5X5A$ZES(@RZXSG('4=J (&\*Z2?$__"1+%-'J10)(\=PZ
MI* "!O0':V 3C(J71/#FE>'=&&D:9:^58@L?*9V?.XY;EB3SFF1^+/#LU[;V
M<6NZ:]S<J&@B6Y0M(#T*C/.>U3:;XAT;69YX-,U6RO)H/]:EO.KE.W(!H C\
M/>&=(\*Z8=.T>T^SVK.9"A=GRQ !)+$GH /PJAI_@/P_I>I17MK:S!H'9[>%
M[F1X;=FSDQQEBJ'D]!QGC%2Z'K?F:0UWJNL:-/\ Z48%GL9,19) 5"68_/DX
MQGJ15W3?$6BZQ<S6VF:M97D\'^MCMYU=DYQR ?6@#3K/M-$L+%M0:WA*'4)C
M/<_.3O<J%)Y/'"CI4=MXET.]U632[76+&:_CSOMH[A6D&.OR@YX[^E9&G>/-
M&UVXUJRTS4K$7-AN"/).K)( @8R8!SL4M@GV- $T_@+P_-9:;:BWN($TV,PV
MS6]W+$ZQG&4+JP8J<#()J-OAWX:\J6.*SFMUDF6X7[/=2Q^3(J[=T>UAL)7@
M[<9XSG J_INM11>%K?5=7U72F39NEO;:7;;'DC*LQ/';KUJQ9>(=%U+3IM0L
MM6LKBS@!,T\4ZLD8 R=Q!XP.>: #1="T_P /V;VVGQ.JR2&65Y96DDE<X!9G
M8DL>!U/:G:UHMAX@TUK#48FD@+*XVN49&4Y5E92""".HJ*#Q/H-SJBZ9!K-A
M+?,NX6Z7"ER,9X .>G/TI6\2:&FL#2&UBQ&I$X%H;A?-SUQMSG/M0!4T[P9H
MNE:E#J-I#.M[%&T;3M=2.TP;D^82Q\PYZ;LXXQT%;]%4O[8TS^RAJG]HVO\
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M))YY4BBC4L\CL%50.I)/05R4GCBTO?%'AVPT2_T^_L]0DN8[F2&02%#'%O4
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M[R2]MDN9KR2/R3<7=U)<2"/.=@9V)"Y["G?\(EHO_"*KX9^R'^R54*(/-?.
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MQ(K+>7*@A0"!]G7CZ5T\?PV\)Q6Y@32V";E9/]*ES"5;<!&=V8QGG"X%7O\
MA#=!_M>^U06)6[OHS'<LL\@64%=IR@;;G'&<9]Z /+_#:)<>'?A/:WBJ^GO-
M<-(CC*-*J.8L^^<X]ZUO%T<=MXO\6I9HJ1S>#9Y+M8Q@&0,P0MC^+;N'TKNW
M\'Z _AR#0&TY#IEN088=[9C()(*OG<""3R#GFDL?!V@Z=I]_96]D3%J"&.\:
M69Y))U*E<-(S%CP2!SQGB@#A]2TZSL?!OPZ>VMHXI%U33B)%4!B77YR3U.[)
MSZT^[M9/#;75[<6>E:YX8N=7^U-<1OMNK69YQSW#[)"!P0P QVKT"?0=,N;/
M3[2:U#0:?+%+:IO8>6\?W#G.3CWS[UG-X#\-MJYU,Z<?/,_VDIY\GE&7.=YB
MW;-V><XZ\]: .B;E&^E>+/-&G[+\&YU&Z*-!D]6^TCCZ]:]JKE&^&OA)C<;M
M)RD[,[1&XE\M6)R2B;MJ$^J@=QWH S=(L+2Z^+_BN>>WCEDBLK)$+J#M#+)N
MQGUVBN-T"*)SX'T^=%.FIKVI@1,/D#H93$,=.#G%>QP:596VJW>IPP!;R\6-
M)Y=Q.\)G:,9P,;CT]:S;CP7X?NM&_LB73E-E]H:Z5!(X9)2Q8NK@[E.2>A'7
MTH \W\8K'9>*?';Z4JQW!\,*\_E#!#%VW'CH=F#6[IFAZU_;OA:\F_X1JSM;
M-'6!;&2023PM$1L4,H##[K?\!S76Z9X.T#1YY9[+3U6::#[/,\DCR&6/);#E
MB=QR3R<GMG%1Z/X)\/:%?+>:?8&.=$,<1DGDD$*GJL8=B$!_V0* .:^#FFV<
M/@P7RV\?VJ:\NB\Q4%\"9E SUQ@=/<^M6OC(BM\*=:+*"5$)!(Z?ODKK=)T>
MPT+3UL=-MQ!;*[N$#%OF9BS'))/))-.U32[+6],N--U&W6XL[A=DL3$@,/J.
M1]10!QNJ:=9S_&#P^DMM$T<&E7,L:%1M5O,C&<=.YKCM=BDA?Q78V4=NMM)X
MGT\2Q396 AUB)WXZ*6VYKU;3?"NC:3-:36=JZS6D+P0R23R2,J.P9AEF.<D#
MKTQQ3Y?#.C3QZI'-81R)JK!KU7)82D*%!P3Q@ =,=,]: .=T'2-:@\>2ZGJC
MZ% TFF^0]KITC[Y,2 I(RL!P/G7/OBF?&;_DDFO?[D7_ *.2NBT3PKH_AZ2:
M73K5TFF 62::>2:1E'1=SL3@9Z9Q5O6-'L-?TJ?2]4MQ<64X DB+%=V"&'*D
M'J!WH X;3HX[GXI:2EXBR)!X822T609"N9,2,N?XMH0?0UROB"VA^R^.+"!
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MXUBBC7HJ@8 YJE<>&](N]5GU.>R1[N>T-E,Y9L20DY*,N<'ZD9H K^"HXX_
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MUHJ68&GW7F^=#O;Y_,)+\YR,DGH?I5;5/!F@ZS]F-Y9OOMHO(BDAN)(7$?\
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M:/I(!U#4[6U!B,P\V4+E 0"PSU&64?B*XOP?%8S:/XX;4UB9WU>]6^,H&?+
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M[#;L2(.K*^< 9/7O7.Z?JYUO4;:7PSIVDZ>EOH5O)+<ZDCOY<$FXK"JJRC:
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M+M<FX4]8X^1ASVZ_2J5KX]T.[\9W?AE+R#[7;HN#YH_>29??&!ZJ%R?K7/\
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MOL,"M#3=*L='MFMM/MU@A:1Y2BDD%V.6//J33M0U&STJS:[O[A+>W5E5I'.
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ML1E?(9>=J \;@>3VKFO']C#I6O\ ]NZ=%)Y<EJ8M?CAB#%;-V ,P':3ANQ)
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M6MG68]'M5U N9?."='/5P.@;WQFM&TTRRL;B[N+6VCBENY/-N'4<R-C&3[X
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MP! P#TQQBI=#CT3Q1X6UI_$,_E:I;:I,UY.KA+BW:.4F((W50%"@ =>0.2:
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M*O>'/'^B:C:Z/976JPMJ]W;1%TV,%:8H&90V-F[.?E!SVQ7-6[J'^+*%AO\
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M^Q%=;\2/^1U^'O\ V%6_DM '3ZCX[\,Z3+/%>ZK''+;R&.5%C=V0@!CD*"0
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M<\@'ZC- &S7BWB_4KJ_\*>-[A=1T_3+**ZN+,V$-FK373H I=W)SN;&<@<*
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MU+;4&U?QW#)XFL-*@-XSW45W8B9F@:! K[BZ_+MR ,=0:]/_ +'TS^SH]/\
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MPM!_Z,EKN+S_ ).)T[_L7F_]'-7<'0=';3X-/.E61LK=P\-N8%\N-@2057&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBM7L;B2YM+FV:&0.ICV,5=0P&"<$<'GTKD]6MK:QM8M5?Q FK0#Q993:G<)
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M]/GNF#!KB(B..0AC]T$GIP#SUK2-U;BX6W,\7GL-RQ[QN(]0.M>4:#H+Z_\
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MR7]I&!:Q0S8E20IB4.H.3W+9],\YYY'4;BTA^#_CNTDEA24:S>*L)8!L^>"
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MR@G^=7JR_#//A31_^O&'_P! %:E !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5[VQM-1M7M;ZU@NK
M=_O13QAT;Z@\58K-US7M/\.6"WVIS&&W:5(=^TD!G.!GT&>] $L&D:9;:<VG
M0:=:16+ @VR0JL9!ZY4#'-)::+I5A8R6-GIEG;VDH(D@B@5(WR,'*@8.1Q6,
M?'FCC2X+_P K4,7,Y@M;?[%)Y]PP&[*1XW%<<YZ8IS^/?#\6B1ZO-=20VK70
MLW\V%E>&;NDBD94COF@#8FTC3+C31ILVG6DEBH %L\*F, =!M(Q3X=-L+?3_
M +!#96T=EM*?9TB41[3U&T#&*R-(\9Z5K&H3Z?&E[;7D4/VCR+VU>!WBSC>H
M8#(SQ5;2_B)X=U>">YM9[C['!:FZFNY+=UAC48RI<C&_!!V]<4 ;ECHVEZ7;
M26VGZ;9VD$F2\4$"HK9]0!@U$OAS0TTU]-71M/6P=M[VPM4$3-ZE<8)X'/M6
M?I?C?1]4EFB_TNSDBMS=;;ZV> O".LB[@,J._IFET;QMI&MWR6D"WL$DT1FM
MS=VDD*W$8QEHRP 8<@^N#F@#732M.BTW^SH["U2QVE/LRPJ(MIZC;C&*CLM$
MTG3?+^PZ796OE!A'Y$"ILW8W8P.,X&?7 K(T_P >Z'J>HP6D#W06Y=H[6ZDM
M72"Y9<Y$<A&&/!^N.,U6N_B5X>M/M9_T^9+*:2&\DM[*21;8HQ5C(0,*,@_@
M,T =?5"]T/2-2\W[=I=E=>;M\SS[='W[<[<Y'.,G'IDUS6I^/X;'QGI.BPV=
MU<P7MN\[3PVLDF1\FPH5&"OS'<>W'2KD_C_0K?57L7:[*1W(M);Q;5S;1S$@
M"-I<;0<D#T!/- %G7[/6UTF/3_"T>FVH=3$TD^Y1;)C ,:*N&(YP#@=*N>'M
M#M?#?A^QT>SSY%I$(U8]6/=C[DY/XU@V_CI;CXB7?A@6%YY<$"'SOLDG^L+-
MDDXP(\!<-T)SS4/A_P 7Z1;Z6DLNMWNH1W6KM81SW,&TI,>D? &%]"?7K0!V
M]4Y])TVZOX;^XT^TEO(1B*XDA5I(Q_LL1D=3TJ'4=<L=+U#3;"YD87.HRM%;
M1HA8L57<Q..@ ZFLNS\>Z'?:E#9PO=;+B5H+>[>V=;>>09RB2D;6/!QZXXS0
M!N?V98?V>-/^PVWV(  6WE+Y8 .1\N,=>:BO]$TG598I=1TNRO)(?]6]Q LA
M3Z$@XJ_39'$<;.02%!.%&2?I0 [H,"BN<N/'.@VO@^+Q3+=/_94H79((V+'+
M;<;>N<Y_(UH76O:?:7NEVDDI:;5&9;544MOVKO)XZ +SF@!&\-:$^H_V@^BZ
M<U[NW?:#:H9,^N[&<U;OM/LM3M6M;^T@N[=CDQ3QAU/X'BO.W\?V^A_#L:S8
MWM_KI>\\B.>YM6X)D"L&V@8 !./4X%6[KQO]D\?6RR_VB-/N-%,T5@+1S,\W
MGXXCQNSM!Z]AF@#M8]'TR+33IL>G6B6!&#:K HB(Z_=QC]*GDM+:6>&:2WB>
M6#)A=D!:/(P=I[9''%4= \0:?XDT]KW3WD*)*T,L<L9CDBD7[R,IY!'%:4CI
M%&TDC!44%F8G  '>@#F_&OAEM?\ "6M:?IT5K%?ZC"L9F<;=Y4C&]@"3@9QU
MK7M=$TJRO9;ZVTRS@O)A^]N(H%61_7+ 9/XUDZ3XZT;6;V*UMQ>Q&XC:6UDN
M;22*.Y11DF-F #<<_3FISXPT<>$H_$_G2?V6ZJRR>6=V&<(/EZ]2* +G_"/:
M)YEW)_8^G[[P8N6^S)F<9S\_'S<^M6[>QM+1W>VM8(6D"J[1QA2P484''7 X
M'H*Q-;\:Z3H5\UE.M[<W,<0FFCL[5YS!'S\[[0=HX/7GBL+5?&L-IXST*6&]
MEGTB^TN:>.&UB,K7#[H]FU5!8G!/';G/2@#H-5M=<M8[.S\+V^DVUJQD%PTR
MLODYY#1HHPQR6)!QDX]2:UM/L8=,TZVL;<$0V\:Q)GK@#'/O5+P_XCT_Q):S
M3V)F5K>4P3PW$31212#!*LK<@X(K6H *H7FB:5J-PEQ>Z99W,Z+M62:!78#K
MC)'3VK&M/'^A7NJ0V437>R>=K>"\>U=;::49RB2D;2?E/UQQFEO?'VA6&IW5
ME+)=-]C(6[N(K5W@MV(R%>0#:IY'TSSB@#;NM)TV^GBGN]/M+B:'_522PJ[)
M_NDC(_"KE<M=_$+P]966EW4L\Y35+<W%FJ0,SRJ-O 4#.X[UP/>G7WCO2+#R
M%DAU&2:2V6[D@@LI))+>)NC2J!\G?@\\'B@#?O+&TU&W-O?6L%U 3DQSQAU)
M^AXJ-](TV46HDT^T<6AW6VZ%3Y)]4X^7\*S-0\9:186]A*CSWK:A'YMI#8P-
M/)*@ )<*H^Z 1R?6HIO'?AZ#2+#5)+QA:7TQ@A81,6\P!B4*XR&^1AC&<\4
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MA&<$+C /)Z>M7JY#Q=XW'AC6]$TX6-U<&_F(D:*UDEQ&$8X3:.7R%XYP,G%
M'4VMG;6, @M+>*"($G9$@49/4X'>IJYK4_'.D:9?R61BU"ZN((UEN4L[.2;[
M.C#(,FT?+D<XZX[5N:?J%IJNGV]_8SI/:W""2*5.C*: *J>'-#C!":-IZ@S"
MX(6U09E&</T^\,GGKS3QH.CC[1C2; ?:?]?_ *,G[W_>X^;\:GU"_M=+T^XO
M[V98;6WC,DLC=%4#)-9.B>,=,UV]DLH8[VUNEA^T"*]M7@9XLXWKN RN<#\:
M +MQX>T6ZT]-/N-(L);*,[DMWMD,:GU"XP*GL]+T_3C(;*QMK8R8WF&)4W8&
M!G YP !6#8_$+0-0U&WM(9+L)=2&&UNY+5TM[AQGY8Y"-K'@X]<<9I+KXA:!
M9ZC+:RR77E03BVGO5M7:VAE) V/*!M!R0#V!/.* .JK,?P[HDC7+/HVGLUTP
M>X+6R'SF!R"_'S$'GFL[6/'&C:)?S6=Q]LE>V19+M[:U>9+5#R&D900O )]<
M<]*?JGC71=*OH+*66>>ZN;;[3;PVL#3-.F<?(%!R>_T!/04 :5[H>D:E<07%
M]I=E=36_^IDF@5VC_P!TD<4[4M'TS68DBU33K2]C1MR)<PK(%/J P.*Y#7_B
M;86/@B[U_2X9[B6&;[,T$MM(##-D K*O!3&>^,D@=ZU[OQQIEG#9EK75)+F[
M1Y(K*.PD:X"*<,S1XRHSCDXSD8H V[K3;&]L#8W5E;SV94*8)8E:/ Z#:1CB
MN9\9>%I-0\&#0= L+*&/SX9!%Q#$BI*KD8 /7:1T[U0\1^-K:(^$-6L-0<:1
M?7CB8I&295$3X3;C=NW@#:!G(Q6U9>+]+UJUU6*%[VQNK*$O<17-LT,T2E20
MX5AR.#CZ4 ;&GZ98Z>A:TT^VLWD \P0QJN<= 2!SBHWT#1GM[FW?2;%H+I_,
MN(S;IMF;KN<8^8^YKSKQ'XGNK7X9^'-3T37+NY%UJ<,)O9D"R31EG#!AC Z8
MZ=JZZZU>UM_B#]B;5;XW"Z4;G^S(X=T3('(\P$#)?C&W/X4 ;D&DZ;:S&:WT
M^UAE,0A+QPJI,8Z)D#[H].E,L=$TG3)6EL-,L[61\AF@@5"<G)Y ]:X_0/BC
M8:C92W6HVMW9Q?VDUE%*UI(L>#(5CW,1@-Q\WH3SBNNU37+'1Y]/@NY&$NH7
M MK=$0L6<@GMT  ))Z"@":#2M.M;N6[M["UAN9O]9-'"JN_U8#)_&HK#0M(T
MNXFN-/TNRM)I_P#6R00*C/\ 4@<UH5SVJ^--)TG59-+E%W/J*1),+6UMGFD=
M&+ %0H.0-IR>W'J* .AJM-I]E<W<%W/9V\MS;Y\F9XE9X\]=K$9'X5D1^-=!
MD\+GQ%]L*:>&*$O&PD$@;;LV8W;MW&,5'8^-]+OI+J 6^I07MM ;EK.XLI(Y
MWBZ;D0C+\\<9YH U7T329-0_M!],LVO<@_:# IDR.AW8SQVJ_7*^ ?&/_"9Z
M NH-9S6\FYL[H'2-AO<+L9N&X49P>#Z5TEU<+:6DURZ2R+$A<I$A=V &<*HY
M)]AUH ;>6%GJ,!@OK2"ZA)R8YXPZY^AXJ@OA3PZC*RZ!I:E2"I%G&,$=QQ7/
M>&/B18ZMX/GU_5(YK""W=][O;R+&R^:Z($)'SMA5!"YPQQ[5LZ/XPTS6=1;3
MDCO;.^$7G+;WUJ\#O'G&Y0PY&?3I0!JC3+ 27,@L;8/=#%PWE+F88Q\YQ\WX
MU$NAZ2FG2:<FEV2V,GW[9;=!&WU7&#5^O/SXT.E?$#Q+I]Z;Z[BBBM&M+.TM
MFG=04<R,%49 SMR3ZCUH [2TTK3K'3_L%I86MO9D$&WBB58R#U^4#'-)IND:
M9H\#0:9I]K91,VYDMH5C!/J0 *RG\;Z$/#]GK45S)<6MZXCM4@A9Y9I.?D5
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M#4\-K<QR7K65PRQ_;19R>1&[' 5WQA3DCZ9&<4 ;(\)>&@,#P]I.#V^Q1_\
MQ-7H]+TZ&>">*PM4EMX_)AD6%0T:?W5..%]AQ6-K7CC1]"OI;.X6]FEMXA-=
M&TM'F6VC.<-(5!"C@GUP,UC:OXQ73/B!IJ&YGGTR[T>2>*WM8C*UQ*9$VE%4
M$D[2Q],9/:@#L+?1],LWG>VTZT@>XSYS10*IDSUW8'/XTFFZ+I6C+(NEZ;9V
M2RMND%M L>X^IV@9KC/%GC6.[^%VNZSX?NI[>[LOW3"2(QRV\H=0596'!P?U
MKH="\1VMY)9Z1-,YU4Z;#>NKH1O1@ 6!Z'YNM &C::'I.GWL][9:99VUU/\
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M[[KU5;6W6Z:Z6"(7#KM:4(-Y'H3UQ1#:V]N\KP011-*V^0H@4NWJ<=3[T >
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M&PC(8\ #KP*ZJ_N[;5?B'K]WIL\5S;6OA9[>XEA8,@D:1F521QG:"?QKT/\
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M9=S1YD& <%3ZG;63;7<>G/I5GIWBJ/[/JVH7UU-KDUK$I61 H9(MPV#<=QW
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MY(IK338[2$,CQQG*-L7<H5=RDG ]>:Y^>&6;PG\5Q$C/LUWS751DF-)59_\
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M)"/.SL(X89.,CN".U8>OZC97_P 'O 8L[N"X-OJ&FPS"*0,8W$9RK8Z$>AH
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MG<3C'>M30?$UCX@-U%;I<V]U9L$N;2[B,4L1897*GL1R",@UP*:SIB:O\/\
M7&O[9])AL9K&2Z$H,=O<-%&0KMT4D*1S6WX;N8-9^*'B'5M-E2?3H[*VM&N(
MFW1R3 NQ"L.&VJP!QTS0!V>HZA:Z5IMSJ%[*(K6VC:65R,[5 R>G6N?MO'NE
MS17S7%KJ5B]G9O?-%>6C1/) H^9T!ZXXXZ\BM'Q4--;PKJ:ZPLC::UNPN?*4
ME@A&"1CGCKGMC->=2:E>26>N^';'Q)%XHL9] NY8IE"//;,%"HCNG#;MQQD
MY6@#T6Y\2Z=::?I5]*TGDZI-#!;83)+2C*9':N.TOQX-,U+Q7#J$>J:A]CU6
M3"VMNTPM;<1I@MCA5SOP.O!XXK)O_$FD:GX:^'EE87\%U<KJ6FM+'"X9H0H
M.\#[OS$#![_0U?\ #/B70M#U?QVNJWMO:L-6EE_?N%\U!$@PN?O$>@R?F'J*
M .KO?'>B60TLB2>Y.JP-/9+:PF1IU&WA0.<_../KG&#6>/B?HKVEQ+%8ZQ+-
M:,RWEHEBQFM0O),@Z*,=.><'&<'''^#;*>RO_AC!=QE)ETJ_?:XY4-L(^GRL
M*Z30%7^W_B.=HR;E 3CK_HR_XF@#2UCQ!I4]SX3N4U?4(8M2N%:S6T \NZW
M$++D9VX(]#3-#\<2:OXYUK0&TR\CAL6C2.8VS  E&9C(V< ' V^OXUYZO_($
M^#?_ %\I_P"@K79>&KZTMOB[XVLI[F&*ZNFLFMX7<*\P6W.XH#RV,<XZ4 =[
M=3BUM)K@QRRB)"_EQ+N=L#.%'<^@KB?#/Q)M=3\(76OZO;SV,%O(X,C6[!'7
MS61%3J7? 4$#^(UW=>#Z7>6Q^$^CJ)XY'T37UN]3MD;=)#"MVY)=!R!@@].@
M]J /5](\8V&K:I_9CVFH:??-$9HX+^V,+2H#@LO4'&1D9R/2NAKSV^U2P\1?
M$_PF=%O+>^73XKNXNY;:02+%&\81 S#C);''M7H#L5C9E4L0"0H[^U '+VOQ
M!T:[U*"UCBOQ;W%P;6WOWMF%M-*"1L5^YRI .,$C@UU5>$3Z\FHZ/X8U6_\
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M"G/(&<9]: -.2-)D*2(KH>JL,@U%%9VT$TL\-M#'-+_K)$0!G^I'6IZY6_\
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M#@5%<6MO>0F&Y@BGB)R4E0,/R-<ZWCS1CX<T_6H!=7,>H/Y5K;0P[IY9,D%
MGJ-K9R<#'6N;\;>-?MOPQ\276E/?Z7JFG>4DT4R^3<6[,Z8Z$\%3P02"* /1
MQ;P*8B(8P8AB,A1\@Z8'I2F&)I5E:-#(H(#E1D#TS6)I6OV[WFF:+*9GOYM,
M6^+D94J"JG)SG.6%0W/C?2K:+4F:.[D>QO4L##'%N>:9@I58QGG.X=<=Z -M
M-.L8HA%'9VZ1A_,"+$H&[^]C'7WJ3[-!Y+0^3'Y39RFT;3GKQ7':QXOTV\\'
M:W<78US2/L 0721H(KN$,05*')7GU!/>M?2_$NGSZG::$C79N7TV.^BDN /W
ML1PN=V>6SC/'>@#<:*-G1VC4LF=A(Y7MQZ4S[+;[)$^SQ;93ND&P8<^I]:PK
MWQOH^GWFL6\[3@Z1'$]TZQ[EW2_<C7!R7/'&.XJ;1/%5MK5]/8-8W^G7T,:S
M&VOH@CM&3@.N"01D8ZY!ZT ;311NR,R*S(<J2,E3[>E1?8+/=,WV2#=/_KCY
M8S)_O<<_C5BL;7O$EKH+6D+V]W>7EXS+;VEG&'EDVC+$ D  #&22!R* -+[%
M:F>.?[-#YT:[4D\L;E'H#V%/2WABA,,<,:1'.450%YZ\5S=OX]TB<Z8"EW$U
M_>/8;98MI@N%&?+E&?E8]L9S6G=^(+.S\0Z=H;K*][?I))&(U!5$0 EG.>!R
M /4T 7K:RM;.(Q6MM#!&3DK%&%!/T%/^SP& 0>3'Y0QB/:-HQTXKAO#OC'1+
M'X>P:S'>ZS?VCW#00F^Q+=SRERHC '4YX ]*CL_%<NH_$^UM674-.@CT>>:X
MLKT>7M821[9" 2IX+88$]QZT >@TPPQ-,LIC0RJ,*Y49 ]C7,:7X^TS5+ZS@
M6SU*W@OR18WES;[(;H@$X0YSR 2-P&0.*J7'Q.TF&&]GBT[5[FWL)Y(;V>WM
M0R6Q1BK%CNZ<9XR<8) R* .NFL;2YFCFGM8)98_N.\89E^A/2I&BC:1)&C4N
MF=K$<KGK@]JP-6\96&FS6EM;VM]JEW=P_:8K?3X1(_D\?O#D@!>0.3R>E0MX
M]T=M&L=0M8[R[>^E:"WLH(<W#2+G>I0D;2N#G) &.O(H ZBH9K2VN6C:>WBE
M:,[D+H&*GU&>E4-!U^T\06DLUM'/#)!*8+BWN4V2PR#!*L.>Q!X)!!%:M $8
M@A$;QB)!&^=R[1AL]<CWID]E:742Q7%K#-&A!5)(PP&.F :Q-7\86FEZL-*@
MT_4=3OQ$)Y(+"$.8HR<!F+,H&<' SDXZ5R/Q$^(3Q?#"35_#9O5DN3Y:W2PX
M^R,)%5UDSRC<E1P>?P- 'IX    P!T I:P?""-'H**QUDL';)UA@9STY.">/
M2MZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "N#^*\R6V@://+&TD<6MV3LBJ6+ 29( '4^U=Y6%X
MHT&3Q!;Z;%%.D)M-2M[UBP)W"-]Q4>YH Y*_U*P\6?$?1CH%W!?I8:;>O=36
MSAT3S5140L.-Q()QUXKE)?$FE2_!'2-%BNTDU.)[2*>T4YD@*7";C(O51D8R
M>I(]:]RCABAW>5&B;CN;:H&3ZFD%O K.PAC#.<N0HRWU]: .(\.JI^,'C5L#
M<+:P /L4?_ 5S6B^*M#T;0/'5IJ-W#;W+:MJ+)!*<-<[B5&P?QG(VX&<=Z]?
M"J&+!0&/4XZU@>&_#8T6+45N6AN&N=3N+^-MG^K$C;@.>X]: .!\-,G@SQ#X
M>G\1S)803^%X+-+BY;8D<R/O:)F/"G##KUVTQ'T34CXDUO4KJZL]%U#6H/[/
MU.W)012Q0A?/#] I8%=Q!!S7KTL,<\9CEC21#U5U!'Y4IC0Q^644QXQM(XQZ
M8H \6U34;_5=$E$GB"34]*T36[.;^W+.)-_E%3O/ *,8RRDL >.HXKKO!\.C
M7/BR\U"P\4:AX@NH;);>2>1HG@1&?<%#QHH+ @G&3@&NZ2*.*,1QQJD8& JC
M 'X410Q0)LAC2-.NU% 'Z4 /K@O$-W;Z#\4=&UK59DM],FTV>R6YE.V.*8NC
MC<QX7<H(!/I7>TV2-)HS'*BNAZJPR#^% 'E+SQ:M%\4-=L'$NEW&F"W@N$Y2
M=XK>3>5/< L!D<<5V'PW_P"2:^'/^P?%_P"@BNF6-%C$:HH0# 4#C'IBE"A0
M H  Z 4 +7FND>(-+\*^+_&5KK=W':W%Q>)=VZR'#7,;1* (Q_&05*X&3FO2
MJ8\,4DB2/$C.GW6*@E?H>U 'A&C0^5X2^'FHW6IW.BV$)O[>:]@*#[.\CG8&
M+JRJ#L9<D=QR*O\ B6VTP_#7Q;J6F:QJ&LB:\M/M%[<!"CF*2+)C**H90O!(
MS]WVKVAHHVB,31H8SP5(X/X4"*-8O*$:B/&-@'&/3% 'E6M7NFW/Q BUD^+I
M=)TF_P!)6*UU&UFB$,KQROOC+NK+D;@<<=#Z55FL].BMO TFG75[>VMUXE>Z
M$]Z@5Y&82$N %4;2PW#CH<UZZUK;M"(6@B,0Z(4&T?A4A13C*@[>G'2@#BKD
M _&S3B1TT"<C_O\ QUC:4H_X1?XH' R=2U#/_@.E>G;5W;L#=C&<<TFQ0&&T
M8;KQUH \<_YF/X,?]@Z7_P!)HZZ#PVH_L/XAG R=7OL^_P"Z2O0_+3*G8N5^
M[QT^E*$4 @*!GD\=: /%(_\ C[^"G_7K)_Z(BKJO#"C[#\0C@9.KW>?^_,=>
M@>6GR_(OR_=XZ?2E"J,X4#/)XZT >,^%M1M/#VH>"M6U>X2UTZY\+"SCN9CM
MC68.C[2QX7*CC/7%=-\/+V#4O%7C:\MD98);Z!HRRE=Z^2N' /9OO#V(KH_$
M&E:S=R6<^B:G;VK6^X/:W=OYMO.#C&X A@1C((--\+>'9]$74+J_O%O-3U*X
M^T74R1^6F=H541<DA54 #))H Z"O-/&>KZ?H?Q9\)WVJ7<5I:K97BM+*V%!(
M4"O2Z8\4<F-\:MCIN&: /+_&/B"P^(EA%X1\,2G43>7$1O;J%"8;6!'#EF?&
M-QV@ "GL8U^/>KF:)IHAX9R\:+N+KYJY '<GTKT]45%VHH4>@&*-B[]^T;L8
MSCG% 'DN@ZW%I6I:78^$O$;Z[IEQ!,?[)G*R2V*I$63YA\R@,%3:_P#>&*Q3
MKMI>6_@_5KSQ7<7]U_:-M<ZC"7C6UL,A@0ZJH\LACM&XY/)KW%((8G=XXD1W
M.695 +?7UI!;0!740Q@.=S */F/J?6@#RC0O%6AZ'I_CNWU.[AMIVUB_D2*4
MA6N0<* @/WSD8P,D<>M9]O8W.FZY\'+2[1DN(K6Y#HPP5/DH<'W&<5[0UO Y
M4O#&Q5MRDJ#@^H]Z>45F#%067H2.E 'E&@_\CI\6/^N<'_HF2L"QGBM/@S\.
M;RX<1VUMKUO+/*WW8T$LN68]ASUKW4(@+$*N6^\<=?K2-#$T1B:-#&>J%1C\
MJ /,_'&K)X8U?3/'VFXN[2[LY+"?R?G67<IDMV&.OSC;GT85V'@K0F\.^$=/
MT^8[KH)YMTYZO,YW2$GO\Q/X8JKJOAG4-=U^T:_OK9= L9DN8+&& AY9% V^
M:Y;!56R0 !VSTKJ: "O)?$FKV&A:IK6H^'O$<EAK<=P#/H5R%9+^7"@;(S\V
M7&T;T->M5&T$+3+,T2&51A7*C</H: .-\*<_$7QTQ7:QEL<_^ XXKB/#^L-9
M>$?!NGW.N'0M*NOM[SWRE$8NDS;(P[@A,[F/J=N!7M@5020 ">IQUICP0R1A
M'BC9 <A2H(!]: /G[6[JV?X1_$&V2[GGE&KQ3C[61Y[Q.UOLD88!PP&0<"NU
MUS_DL/P[_P"O.[_]$FO33%&Q8M&A+8W94<XZ9I2BE@Q4;EZ''(H =7#_ !?.
M/AAJO[LR?O+;Y ,EO](CX_&NXI&56&& (]"* /-]8UK3?%?C7PA;Z%?17<UM
M-/=7#0MN-M'Y++B3^X2S 8.#FN5\.V>DR^&=)T#5O%VKIJ$=S';2:'$82\<R
M2@CY/+WA 5#;LXQSFO<$ABC=W2-%9SEF50"WU]:3R(A,9O*3S2,%]HW8],T
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M['VKM9M0L]-^.K"^N8[?[9H<4-MYK;?-D\]OE7/5N>E=^MO BE5AC52VX@*
M,^OUI7ACD='>-&9.58J"5^GI0!X7+X@TRS^!>K>'I;I/[:A-W#)8 YF0^>[$
ME>H4*<[NE==)?VFF_&FS-[=1VHO/#B6]N\K;1)*;CA%)ZMR.*]%^SP^8\GDQ
M[W&&;:,L/0FE>&*1D9XT9D.5)4$K]/2@#P[P]9:2_A?3?#VK^+]7COX[I+67
M0X3"729)<C">7OV9 ?=G&.<U[I4?D1>=YWE)YN,;]HW8],U)0!R?Q-L+K4OA
MQK5M9Q-+.80XC09+A75F '<D*1BJ-UXPT3Q7!_8^@RKJ%[>V%PRRP ,+/,9
M\P]4))"XZYKNJCC@BB+F.)$+G+%5 W'U/K0!XU?:[IFJ_!:P\*64\;>()8+;
M3QIH/[^.9&0-N3JH7:S;B,<5VGAM0/BCXV/4^5IXS_VS>NQ$$(F,PB02D8+A
M1N(^M/"J&+  $]3CK0!XEH4\>DV'@K7;UO+TNSU35(;F8_=A,KR*C-Z#(QGH
M,UK?$3Q)IGB/X8^,6TE#+!;>1&U^@'E7#>8A(1A][;P">G/&:]6,49C,912A
MZKC@_A2+#$L0B6-!&. @48_*@#S1]3L=!\>^&]0U:ZBLK*?PXULEQ.X2,R!X
MWVECP#@5E6=YH.I6GBRZU6XN[33YO$,;07T.8VMV\J,QS;OX%X&&(Q\PSUKU
M^2"*9 DL2.H.0&4$ TXQHRLI12&^\".OUH \6\0ZQ=W_ ,-/'%B^M1Z[864<
M MM41%'F;F!:,E/E8KA>1_>YK>\0D:+H?@SQB,A=)6&*\(&?]%F14<GUP2IK
MTE((8XA$D2+&/X H _*GE%9=I4%>F".* /&9]*NYOA8?$5P;B"YU'5X=;O'A
M4-)#!YJE=H(.=D85L$'&#Q73>%(M%O/&+7UCXLU#Q!=V]B8VE=HI((XW=3M+
M1HHWY0'&<XS7H   P!QZ4V*&*!2L,21J3G"* ,_A0 ^O./'<2V_CG0=1O-;N
M=%L&M+BU-_"T:B.4LC!7:1650P4\\<KUKT>FR1QS1F.5%=#U5AD'\* /*I?#
M]GJWP_U^[\/ZI?ZI>"^_M"WO;I5_>7, 7#1E54,I";<@<\UI^ +Q?&'B'5O&
MVPBWDBBT^P#=5C4!Y?SD;'_ :]#5510JJ%4#  & *%147:BA1Z 8H ^?_"KB
MS^$O@[59P?L.G^(_/NWQD11[I%WGV!85T^KZC9^+/B%=0:%<1W>_PO>6R7,#
M!HVD9EPH8<$C(SCINKUCRHQ&8PB[#P5QP?PI(X8HE58XD0*,*%4# ]J /(/#
M*:'J<?A2UE\8:O>7T$D,BZ0/))MI8DY$BK&&15P5R2.O4YK0TI0/A;X^X'-W
MJY/OR]>G+!$DK2K$BR/]YPH!;ZFG;%"E=HP>HQUH \JT34[+PUXITK4-:N8[
M.QO_  S:0V]U.VV/S(R2T>X\ X8''>H]?U.SUG4O"WB..]OM T4R7MO_ &@J
M1QX9]NR0EE8*DFQL,0#R.F:]7D@BFC\N6)'3^ZR@C\J<\:21F-T5D(P589!'
MTH Y#P';Z63K&H:9K-]JXNKE5FO+G9ME=$"YC**H90,#([K78TU$6- B*%51
M@*HP!3J //(-6T_PM\3_ !/)KMY!80ZG;VDUG/<N$218T9'4,>-P/..OS5Q'
MB5'?X&>*M1\MTMM3UQ[VU#J5)A>X3:V#TS@G\:]VE@AG4+-$DB@Y =00#^-/
M9%==K*&7T(R* %'04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5R'Q+U/4-*\(&?3+Q[.Y>[MX
M1,BJ2JO*JG 8$=#77UP'QD\@?#Z3[5M^S?;;7S=W39YRYS^&: +L7A76UF1F
M\?ZK( P)0PV^&]N$K7C\5:<=7U33+DR6=QIL(N)3< *KPD']ZAR<J,$$\8/6
MO/[2_P#@E97D%U:OHT5Q!(LD4BH^593D$<=B*=X\TZX\>Z_+9:%##(V@Q,UU
M.Y(6YD;#?8\@C*D+EO0E>G- '7_\)Y9-HNFZC#INI2R:HY6QLEB7SYP 3O +
M8"[1NRQ'!'K6AI/BC3]4TRZOG\RQ%G*T-W%>@1O;N,$AN2.A!!!(((KSW7=7
MT_7KGPAXE&I7NC:4B75I<SVY5&LIF"8CD+*0HRC*<CT[&JE_]@L=%'B32;W5
MM8TZ+Q!;7&IW5R _G11)M+Q[5&]5)3G'5/;- 'J \4:(;>[G.I0I'9X^T[\J
M8<C(+@\J".03Q5AM:TQ;JSMFO81->J7MD+<S #<2OKQSQVKC-;O="\2^%_%=
M]X=BCO;F?2)8IKV!"0Y"-LCS_$W)X'(XSU%8P\0Z3?ZK\,WM+^&=(?,25XSN
M6-S:E=C$<!L_P]: .RT[QMH^M)K20Z@EHEA*\!N9"% "HI,GS< !GQSUQZ&K
M-AKVEV&D:1'>:_%=R7<:K;W4F%-X<=5 X)/H*Y+0-1LK2/XAV-U<1Q7 U*ZG
M:*0X(B:) KGT4] >]16&EOK_ ,"M$.F2*VI:?:07=DR')6XA (7ZG!4C_:H
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M"X;<\S')#$Y;JJ_-@ XS76Z;>:19_$?QL^K26L"7,%FR"[ 4RQ>3A\!N6&<
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ",H92K $'J#0  NT
M =,4M% #41(T"(JJHZ!1@"D6*-,;(U7&<8&,9ZT^B@!,#)..32T44 ( %
M '  I%C1"Q1%4L<L0,9/O3J* "FI&D0(C14!.2%&.:=10 4444 %,$4:R&0(
MH<C!8#DBGT4 -V+S\HY.3QU-#1H[*SHK%3E21G!]J=10 4444 ! (P1D&N?U
M71M6U35T1]3@CT HGG68M\R2,K9QOSPIX!&.F1WS7044 (RJZ[64,#V(S2T4
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%5[Z_M-,LY+N^N([>WCQNDD; &3@?J0* +%%9>H>)-%TJ\M[._U2
MUMKJYQY,$D@$DF3@87J<GCZU=L[RVU&SBO+.>.>VF4/'+&VY6'J#0!/1110
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MU"QF$UK<('BD (#*>_/- %JBBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-6T/E1,L<#!748!).W#CJ<D@GO@5_'^F26GPWT;2?M!66&\T^V\^,=")$7<
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MJ;^.K'7Y)[5XX-/>SD0!E9RS*Q<#D 97 &3QWI]QX2CE\>0>)$G*(+;R[BW
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M/L52)]TDK,JL3@G(5F(P!GY&]JL:]X8?7/!EQHL]ZSWCIOCO&&"LX;>K@#H
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M'H>:6>V@ND5+B".9%8.%D0, P.0>>X/>N+\;:Q?>$);+Q8TTK:9&HM]2T[S
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M=7:2*0M)"Z!V PW#8/7IP.*Z3Q'H:^(=&DT\WMS9.722.YMFVR1NK!@1^(H
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MDNO"<_VRU']A!@X\MOWY,?E\<_+QSWYKJ[>V@M(%@MH8X8E^['&@51] *EH
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M9#\F>O..M=W=7,%E:375S*D5O"ADDD<X5% R23Z 4^.1)8UDC8,C@,K#H0:
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M/AO=^$?[1R;A9U^U>3]WS)&?[F[G&['7G%=9%#Y5JD&XG:@3<.#P,9H \O\
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MY^7&[Y<YZY.* ((+2X\9>+O$D=WJVJ6EGI<T=I:P6%VUOAO+#M(Q7[QRW&>
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MD\XZ#%;GBNZEMO$U_+KNI^(-*TYXHO[,O[!G^RP';\WG!."=^?OC!7'2M\>
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MXP_X1Z:/Q-=Z7IVG1R)%ILTSR-+([_/+(&#' 4!<D]Z /5$18T"(H50,  8
MJC<ZE+!K-G8+IUW+'<JY:[C4>5#M&0'.<@GH, UY9<7'B*^L_!&G7E]JVGW%
MQJ-U:32.QBGF@"MM9A_?*8Y.<-SUK8U$3Z)\5/ NBVE]>_8#:W@DBDN7?S<(
M2"^3\Q!Z$T >EUA6_BFTN/&MWX76&<7=M:+=M*0/+*D@8'.<\^E>::[J@MVO
M-<TR\\27MY#JB*NH LE@B>>J-!L+[60 E<A3EN<UT&F?\G":W_V!(O\ T-:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB#.ZUB92))'/9?+8_4D5Z-9VD-A906=L@2""-8HT'\*J, ?D*EP,DX&3WI:
M.:UKPO=7>OPZ]HVJ_P!FZFMN;65GMQ/'-%NW ,N5Y!R00>YK-E^'44WAN;39
M=4EDN[K44U&[O7B&995=6P%! 5<* !V'K7;UF>(==L_#.@7FLW_F&VM$WN(Q
MECR  !ZDD"@#3HK+\/ZM<:UI:7MQI5SII<Y2&X=&9D(!#?*3C.>AYXZ5J4 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 <%X _Y&OQW_V%A_Z+6L'QM):W=_XDN+=/$6H7MA;X
MCFLIO)M],D6+=U\Q0S<AFX8X./:N_P!#\-Q:'J>MWJ7#RMJMT+EU90!&=H7
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M]8^VR;]#M7MDCV#$H:/9DGMZU-:>$8;70-=TD7;LFK3W4SR%!F,SYR .^,T
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MU/%WB1_ACI6M+?0?VA-JOV69S;C#H;IH@ .B\ =B?QYKU)PYC81LJOCY2PR
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M?<P5C\I&,@>I-K3M5U*Z\9>*]'DOF^SV5O:RVK"--T1D5RW.W!&5&,@U#:^
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M(JGRWW8!.W.2IP3D4 =/7.>(;V^@U?3[>/4!9V<T<I<6Z"2ZED&W:L:%&!4
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MC>1(8]PCW*00"2,X/05SVJ"3PQJ'B[0=.NKH:>_AB74H(Y+AY#;2C>AV,Q+
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MO@8J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTF[G_9H [6L6^\116WB2PT&WMWN;VY1IY0K8%O O!D8^[84#N?I6U7"^#O\
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M'("EC@ CWSSG-@U_Q1>?!NU\30:E(VI6S23W0C@B_?PI,P< %2%(121CT[T
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MPQ().=PXX(XJ32/#L/CA?$&JW]Y>Q:FFJ7%K97,-PZFR2)MJ;%!"]LG(YR:
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M;D18.?+#!2V>G4@53\.:_'XBL;BZC@:$07<UJ59LY,;E2?QQ7%S:'I]Q\?\
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MO.'U;0AH/Q+T_P /WUJ\1M(S:102 [H4M8T8KZ@<@FNV\=B-/ >B?9L;DO\
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M89YK@7$BSVCV7V*&UEBRD*8PV.<G=QG/]T=.^II]V+_3;6\";!<0I+MSG;N
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M/4CMDDD>7_6EPPVL&[C'88Z5NZ%I$FCVDL<^I76H7,\IFFN+DC)8@#"J,!%
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M\LONQLD9,YP.NW/XULT 97A_0H] TY[9;B:ZFFF>XN+B;&Z65SEF(  'L .
M!6K110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO$.J7>I6#_N[B7RN8B,-$5";<$=3C<?7@8L#P-IX\!2^$/M-S]BE21#+E?,
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M)*9[^*&&1#C8HCW8QQG^(YYHT#0;?P[82V=M++(DES+<DRD9#2.7(X XR>*
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MK#FW:U1;PH$2,XW#:BJ&8X&6.3Q5#3OAW:V-SIXEUC4[S3M,E\VPT^=T,<#
M$*<A0S;<_+N)Q0!PNCZ-I^G?#CXC7EI;"&XCN=2MDD5CD1+]U>O;\ZTK%Y-'
MTWX:^)_,?R9+.#2[[)X*31KY;'V$@'/^U75I\/K:.+Q#:IJU^-/USSVFM/W9
M6*27&]T.W=GC@$D<]*OS^#["Y\#1^$Y)9S9QVL=LDH(\P;,;7SC&X%0>G44
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M.4 /RDEB<]:]*KE=0\$_:-5O=0TW7-2TA]0"B]2T\LK,0-H8;U.QL<;EQT%
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MV.X$H:7*^8/,=G..,=6..*34?!HN=1&H:;K.H:3=O;K;7$EKY9\^-<[=P=2
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M<2'YV.0&^4'U4UUM !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
MS?C[6)]"\#ZI>VAQ=^6(;<CJ)9&$:G\"P/X5TE5K[3[34K?[/>V\=Q#O5]DB
MY&Y3E3]00#0!!H>DP:#H5CI5L,16D*Q _P![ Y)]R<D_6M"BB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
>**** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>employementagreement_mil008.jpg
<TEXT>
begin 644 employementagreement_mil008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M\0RV=R@N$REK$AEE+$D! %')X^@[G'-6M#N-9N_M=SJMHEE$\@^R6I96EC0
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MA^[N-2L88O"UOIUU;:M]LEU6 QB-X@Y9L$-YA:13M*D8Y/. * .DLO%5O?\
MBRXT*"UN/]'MVE:YD0HC,KA"J9'S8)Y8<9&!GG&<GC#5+NQ?6--\./>:*K-M
ME6YQ<3(IP7CAVG<."0"P)'0<BM)]-N6\=KJ/E?Z'_9;6YDW#[YE#8QG/0=>E
M8&E_\)1X=\-Q^&K+07N+FU0V]GJ)GB%L8P<))("V\$#&5"G)'!YH W=>\66V
MB7NDV?D27%QJ-S%$$7Y?*1W"^8^1P 6 QU)^AQT%>>:]X+\03W@O;/65FFGU
M*UGE#6B9B2-AC!+?=3EMO<D]R:]"&0H!.3CDT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4KK2-,OKJ&ZN].M+BXA_U4LT"NZ=_E)&1^%7:* "BB
MB@ HHHH **** "F0PQ6T"001)%%&H5(T4*J@=  .@I]% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R_CW7KW0O#T?
M]EA/[3O[N*PLVD&5265L!B.^!D_A745RGQ"T6_UCPY%)I2+)J6FWD.H6L3'
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M"PT;5=#A\.>*+O3+HB+5+^[O+.*,R36\5T"%.P<G;\I(&2,GTKU\D#J0,TM
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M*T6RD5'E:39NC8D(">Y/"CJ3@#I6]?>,=+TR?3H+Y+V";42PMXVM7).%+8.
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MEA;7/A37/!EUJ%^ES+Y%P;3S+6Z1I"Z.\A^5<9&<\C'<\5ZV!@ >GI0!0O\
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MYMW,AZ1#/)'7)Z#CKSBYX7\2W&N1V%O-X<U"RO;9-MV]Y:F.. A<$1L?OY.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ$&EB(W DO#'--O02 1+M(/RD<L1D\=J .MMK.WM/-\B()YTC2R8_B<]2?\
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M17'W/BC7+[7=3T[PWI-G=)I95+F:\NFB#RLN[RXPJ-R 1DG R:K#XA-J.E:
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M'5=$\:VWB[2M/EU*![/[#J%G 1YNP-O22,$@,0201GI^G.:MIL'C+6K&;2?
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M,JY6/?$H7)[9.<5YYK5SK&D_!&]\+76A7L5U80>1-=R*!;&-9!AT?/S%A@
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M&1)(V&5=&!!^A%/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\RV]O+.^=L:%SCT S7F'ACPQI7C#PS'XM\9DWMQ?[IP)[ETAM(MQ"H@#
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M0+&')&.^65>?6O/[KQ3J5Q\&[W5-#LM/T<C4_L\BV@:+ \Y%W+M_B)/)],T
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M[88A6V]8SCD=>!0!WU%<7)XA\2:EK][HVAV^E"72X8?MUQ>&0HTTB[@D87G
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M0@CJ*X?Q1XLEAG\46"Z=:7ECI.C?:KA;@%A)*^XK$PZ%2BDGZUA7^N>()O\
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MF+Y#SU^4^W%9/B+POK5YX:^(EM;V#O-J=Y%)9H&7]\H6($CGC[K=<=*]5HH
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MAI;"?(P9!,S%<=>A!KE+WPK%IVMZ]]I\!1>()M0NVN[&\*0E1O S'*SD% K
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M%EE"EAUY(P![$&@"]::%KUUXGM/$GBFXTV)=*@F6UMM/WLH,@ =W9P"?E&
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M_$2TO[&*.RM+>:)2MUN^SD6W"@;!NW?>)R,9Q0!ZO17FWA_QCJ6F:%X36]T
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M^K:C>3*J:*$$HM$0Q $EE(12'W%MW/3&>E>JV]O%:6T5M;QB.&%!'&B]%4#
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M=5@.<K^^ ,$?L49YC^ KU^L3PWX<M/#\%R\5U/>W5[+YUU>W+AI)VQ@9(
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M67_",16_G[#L\SSBVS/KCG%<S>>&[#3=9\0IJG@_4]9N;V]DNK&6U\SRIED
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MD]L;N9KF<Q101;MH)(5B23D  =LUCW?Q)?3_  KJ6IWFDF._TJ^CLKVS6;<
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M0S*8U(=LJ,,23D<X]37.:U>:E:_&:)-)L(KR\F\/[56:8Q1Q@7!)9V )QT&
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M7'Z=>WG@[6?$2S:%JU[;ZG>?VC9R65J9=Q>-0T;X^X05_BP.>M;_ ,/M%O-
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M 7.GQ1S136TKM;7"NX4@,R@AE[C'H: .\I'=41G=@JJ,EB< "L+6M?ETO7=
MTV.W23^U)I8B[,1Y>R)G!]\D8KC?#.O>(+O1O'%SKEO8W5G97-[&81.[_-&B
MYB *@>5@'GKDGB@#TV.6.:-9(G62-AE64Y!^AI]>>^&_&*Q6/@N&/2+>QTS6
MX)$C\ESMMI5!98P,=& ./<5H:SX\32-=U>U-IYMEI&FB\NYE;YA*YQ'"!ZL!
MG/TH [*BN2TWQ'KL.O6&F>(M,LK4ZG%(]J]I<-)L= &:*3<HYVDG(X^4UUM
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M.Y$N1&%+ $$L-ISZU?T[Q%K<&O6VD^(M.LK>6^MY)[22SG:1<I@O&^Y1\P#
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MD$>H-<0WB'66GU/0=?LK&&YDTF:\@DL9VD0JORLC;E!# LO/0YKGO#/BS7=
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M.<F-P2K*?HP(_"M>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+!?7$PGD0>3*KR%EV-GG@^E7/'&G7\DVA:UIUH]Y+I%]Y\EM&1ODB9&1]F2
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M:E>ZYXGE\)1IX9U.S6PU6WN+][F-5"%593LY.Y>22W3IZUZ?2$@ DD #J30
MDB"2-D;HP(->2Q6^OV?PWF\ +X?OY-2\J2PCO B_9&B9B!*9,\#8<XQG(QBO
M5[>Y@NX%GMIHYH6SMDC<,IQQP14M '$:/H5WIWQ,FN/(D-A'H-O:)<$?*SI(
M<CZXP:[>BB@#Q70M1U:;X5ZCH%GH%_=3ZA)?6UI<0JIAQ)-(I,C9^3:2W4=
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M7+30K+77TBY>Y/BA];GT^+#31PN&3 &<%@"IQFMFV@U;7/'FHZLVCW=C8SZ
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M08VXW$  G)Z\9KI/!6E7VFZAXLDO+=X5O-9EN("V/WD91 &'MD&N93PUK(^
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MT=5)&X9!!&<\]Z ,C6_$VO7W@[QAIK6UC;:SI%NXNRLKF-H'A9EDB.,AB <
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M^&H(D@B/W3<S*6,GU5,*/3)I-2\6^(M)N?MU]I=A!H_VY+3RFG/VLQM((UF
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M=\Q4[<\XKB+KPYJ/E>+XM,\(/IMIK.D(EE!!'$FUT,@*R!3A7;<".O&,G(-
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M$3Q,&S\I)(<;#CG&<4 >CT5YAI7B?Q'8^%?"%G-/I/V_5H 8;R[:3RQ&L*,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.62+YDB0AI%(8Y7]?:N];P1X909?3T49 R9G')X'\5._X0;PW_T#1_W^D_\
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M>"H8C 4YVC%=!;:!J,7QEO=:%F5TM]#6UCF#+CS!(IVXSGH/3%=W2%U5E4L
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M/<>';@>=8W30NE[&5=7\OYB"1N5ANQR*OZIX;GU+P%XGM]&\$V^BR7<4<5K
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M?N\],5RUWX6&FZSKHE\!6OB"74+Q[NQO7C@*J7 RDI<[E"MDY .0>.:]6HH
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MY'9RH/?&['X5TE%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %9NMZPFBVD$IMYKB2XN([:&*(=7<
MX&3_  J.I)Z 5I5S7C:/7)-+L_[%@EN +V(WL$$PBEEMN=ZHQ(P<[>XXSS0!
M%_PG%I;VVO-J%M);3Z(Z)=1APRMO4%"K<#!W#KC'>MC3M2N;N\N+:YL#;F*.
M.195E$D<H?=]TX'(V\Y'<5PMAHFKV.J>+I1X2A?3]3%HT5H9HMLB*@22,C.
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MU\2VTEM/YB$?:FN-Z^>)#]XC!DR&XQCVKWN@#GO^$%\+?] &Q_[]"J6I^'/
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M-;L&N+978JC[PYW$?*6&T#DUL:%XOF^Q^)5U_P F*[T">3S_ "E*AH-N^.0
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M"RD#/YUP+:+XCF\+>"K&31&2?1KZTDN%6YB;]W#&49@=P&23D#GCKCI7IE%
M'G]]X6U'6/$?BY9[5[>QUC2X[*&Y+H<.H<$E0V<?..W8]*O>&;SQF\5M8:UH
M=O:?9%"S7T=VD@N0HP/+0<J6XSNQCGOT[*B@#RJ?POX@E^%NO:$-)<:A>ZA+
M/"AGBVE'G$@).[C &/K7J43,\2,T;1L1DHQ&5]C@D?D:?10!Q=KIFLZ;XW\4
M7JZ;]HL=4C@>*9)T!#1Q%"FTD')./08SSVK!@\,:_#\/?"&D'2G-YI6HVUQ<
MJ)HL!(G+$@[N<@\#^5>I44 >?VUMXL\,>)-733M$AU;2M5NC>Q2->+"UK(P
M=7!R2N1GY0?QS7=VRS):Q+<2+).$ D=5P&;') [#-2T4 <=\4-'U+Q%X#O\
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M1B2<+^?)[G)K2HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KF_&FO7FAZ;91Z:D3:CJ5]%86QF!
M*([YR[ <D!58XKI*YKQKH5YK6FV4NFM%_:.FWT5_;),2$D9,Y1B.@*LPS]*
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M+2-9C5/L=K8W$$I+<AG9"N!W^Z: -#Q)8W>I^&-5L;";R;NYM)8H9,XVNRD
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MO9GO&MHIA((U5 D4>[^)N ,CNU8MS:RZ!\ ;/P^,2:IJ$"V,4 .29YV)9?\
M@(9B?I0!ZG8W:7^GVUY&,)/$LJCV8 _UKS72K[5M-^(7CS4;W5(Y;#2X8)9H
M%ML&2/R7=%4[OE*YY.#N]J])T^T6PTVULU.5MX4B!]0H _I7$OX9U8^-/%2R
M64<NB^)+:*&2Z6X"O;[(6C(V$9;)/8T 4I/$?BW2O#.G^,-2O+"73[AH)+G3
M8[4J8(9F4 K)NRS+O7.1@\UZ6X8HP1@K$<$C.#7FC^'_ !9JWAC3O!VI:?9P
M65NT$=UJ:76X3PPLI&R/&X,VQ<YX'->F4 >$2#69/AI\1IM0U2*ZB34+J%HU
MMMA,BO&-X;<<+@8"XX]:[L:KXGT;Q)X>CU2\LKBRUB1X&M8K8H;5Q&77:^X[
M_NX)('K@=*QKCPCXE/A[QMX>33[=H=5O+B]L[S[4!N,CH1&4QD$ 'G..*Z_Q
M!HE[J.M>%KJW5#%IUXTUP2V"%,3+QZ\D4 <2_P 3+D64GB(>(-$6T2[*#0R5
M^T-;B386W;]PDQE\;<8XKURO-]*\-Z[H<2Z':^']'N;9+MFBU6X96VP-(7(:
M/&XN 2HP<=#FO2* /)9/%_C%O!6H^*TN]/C@TRZF0V9M23=1I,5)+[OD..!@
M'E<YYP-^+6?$VF^+O#]MJMU97%GKBS#[/%;E#:.D?F !]QWC&020/7 Z53/@
MW5_^%3:UX=\N+^T+N6Y>)?,&TAYBZY/;@UO:QH5[>^)O"5]"J&#3))VN26P0
M&A*# [\F@#DU\<ZM#X9^(&HHEHL^BZE+!;;8< JK #?S\QYZUM'5O$^D>)]
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M,7[W*+'.VKWAD13D*WFG(!],T^ZTWQ#H?C?4]9T;3+?4[75X(5F22Z$#02Q
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M<-!)<Z;':E3!#,R@%9-V69=ZYR,'FKJ>#;Z\\<^++^]1(]-UG3([-61PS [
MK<>W-4G\/^+-6\+Z=X.U'3[.&RMV@CNM32ZW":&%E(V1XW!FV+G/ YH OC4O
M%FN^)_$NE:7J%CI]OI<T2Q326OG-(7B5]A&X #).3R>1CI6]X*UV;Q-X-TO6
M+F-(Y[F',JI]T,"5./;(-1:!HUYIWBCQ1?W"H(-1N89+<ALDJL*H<CMR#1X
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MEK+:E\C(Q]HCSQ0!TEAXBT359S#IVL:?>2@9,=O<I(P'K@$U-8:59:6;LV<
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M:@#O,@]**\9\/:GX@T3P;XIU@:HMPR:S/$Y:SW"$F=5DN"%.2 I+;.@Q7?\
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MC(KTI65U#*0RD9!!R"*6@#%\.QZN(;F;5[2QLWEES#;6AW^4@ &'? W,3D\
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MS 9"D4K2;P\:M@XP& !([5H6OASQ!J'B?5M8U9+.U2_T?[!'##*93 =['!;
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLDB,[;B,=,E>_8T 8>OV'B*ROO!+:OK8U))M:@:4-;)$8I?+?A-@&5P6ZY/
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M#8R!<%25Y.>G8]*O)HWBR[\3:!K=Y;:3;1Z=YENUC!<.0L<B@-(&V#)^483
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=17@<1NJD,'4KSG(/![&@#(N/%>MBTU>TAO=MW<>*AH]I.T:M]FC94.0,8)
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M>=:W\2I<V\V>I 52%(R,$'D<&K?CF_\ L<>FQ2>(7T>VFF82FVB,EU. O"Q
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M[O:R,SD1GY<[022,'//)-9>E>-=?D\":E/\ ;1)JD_B,Z39SRQJ1 '=%!P
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M<@XY'7FB_P##/B"WU^PU_1]0LKC44T\:?>C4$9$N%#;A(/+'RMNW<8Q@XXH
MJ_#2.ZAO/&$5[.+BX36F5I@H7S,11@,0. 2,$XXSFNH\4*I\)ZR2!G[#/V_Z
M9M6;X,\-W_AXZS)J-[#=SZE?F\+Q(5 +(H(P>@!4XY/&.:W-7LWU'1;^QC95
M>YMY(59N@+*0"?SH YOP+<1V'PGT6]=,K!I22L!U(5,_TKEI=0\36?P[A\?O
MX@N9+LQ1WTFF^7&+4PLP/E ;=P(0_>W9R*[[PYH1TGP9I^@WC),;>S6VE*9V
MOA<'&><5R7_""^))O#47@ZYU+3F\.QE8S<*C_:I+=6#",C[H. %W9Z=J &:1
M97,_QKUN?^V+XQ16-M*(OW>UD8N1&?ESM!)(P0>>2:S8O%5Q;:WI,T7BVYU6
MYN]56TNK:*S/V 1NQ7$<GE@97Y>=Y)P:ZV;PQJT7CZYUJQN++^S[^SCM;N*4
M.)4"%L&,CCH>]82>!O%:Z!H^E'4=)6+0KB":R")(/M)B;CSC_#\N>%SDG.>*
M )?!7_)8/B)_O6/_ **:K7Q%OX],USP=>S0W$T<6I2$QV\+2R-^X<<*O)ZUI
M^'_"MUI'C;Q/KL]Q"\6L&W,<:9W)Y:%3G/J3Q5W7="GU76O#]]%+&B:9=O/(
MK9RX,3)@>^6H YJUN'\3_$32-8L-'U"QM--MKA;J[O;5K?SO,"A(P&P6P06Z
M8'XUBV7BFXM]<T22+Q;=:O<7VHBTO($LR+'8VX#R9/+ RI"_QDGFO5[NW%W9
MSVS,56:-HRR]0",9%>=IX*\6?V+H5A)J&D*N@3P26B1I(%N?+^4&4_PG;GA<
M\G.: )]+\7W>B:%XMAUVX-Q?^'I9&5W !GA<;X"< #)SM_"J:R^+!J7@W0KK
M79X+G4-/N9M2F6./S PV-A<K@%=Q4''3G!-1>)=+L_$OQ8TBVTZ[25/LXDUN
M*(AD,4,@>$.1W,F1CKBNTU#0)[OQMHVN)-&L-A;W$+QG.YC)LP1VXVF@#BK"
M+Q-J'_"5::_BR_C30IF6TN(XXO-E)C$@$I*88+D#@#.3GM5>?QW-J%KX6MM1
MUJYT>.]TD:A>7-E!OEE?*JJ+A&V G<Q..P%=OIWAFXLKWQ3.\\3+K$PDB S\
M@\H)\WXC/%8]EX+UK0['P]<:1=V#:KIFGG3[A+D/Y-Q$2IX(&Y2&7(X[F@#!
M'BW7KSP[I4=CJC_:&\2C2Q?RVVTW$!1F5V0@<X*YP!DK[UJG^V=-\5:KX;;Q
M'J-S;S:(=0AN9A%YT$BR;"%(0#!!'!'%:]WX9UO5+/0SJ>I6TU[8ZNFHS%(R
MD80!QY48ZG&X8+<G!S5VY\-S7/C=];,Z"V?2'TXQC._<T@?=Z8Q0!YSH,VIZ
M+\)_#-RNKZK'IMTZF^N+>%)9+*':_P#JP$)"EPN6(8C-=:MG%XF^&>L6K:_'
MKUI/'+]DO,*)% 4% ^T ;U<9S@=LBF:!X<\:^'_#-AI=MJ.CEM-;9$A1_+NH
ML-Q(<;D8$@C;D<<YJ&_@N_!W@WQ%?7C6TFL:U.?)M;%"(S<2(L4:(#RQ.W<3
MQGD]J .F\#ZK-K?@;1-2N&+3SV<;2L?XGQAC^)!-3>+KRXT[P9KE[:2&*YM]
M/GEBD !*NL;$'GT(K'T^PU3PQI?@W1+)T:*,BVO_ -V6R!"S%@?X1O7K[@=Z
MW_$6FR:SX9U72X76.6\LYK='?HI="H)QVYH \YF\2:F_A'P=>ZIK&H:?IMY9
M&34=3LH%=Q-M78&.Q@BG+DG;U '%>@^&)99_#UK)+J\.K[MQ2^A4 3)N.TG;
MQNQ@''<'I6%8Z!XIT'P[H5CI%_ITK6-G]FN;>[5A%*<##JZC<",$8(P0:U_"
M.@R^'M$-K/+"]Q-<2W,OD(4B1I'+%44]%&<"@#FK27Q!XFUGQ)>V>N3V,6DW
MK65E9QQQF*1T168RY4LP8MC@C Z<U@6GB/Q/JNB_#N*WUAX+K6A<K>7'E(Q(
M5"=P&,9 !([9QG-:-S)_8GB'Q5;Z?XFTJSL[B07=_'=HRW%H[Q@,T62%?<H!
M!Y /KT)X*\+7MUX<^'6HLZ0KI,,TLL4@.YQ+&0N/S!YH CUG7S9^)7\.7_BW
M5-/M]-LHF^TP6XDGNIG+'<Y$; *H4<8&2WM3AXIN=4\*^'KC4_$<ND&=IX[D
MV=J3=7;1L55HTV,54XW-\O<#BNGU30]<MO$TVN^')]/\R\MDM[NWOPX1BA8I
M(I3G(WL".A'I52Y\-^)H=3TC6;34M/O=5M[*6SNGO8F2-P[J^] G0@KC'<=3
MGF@#A=:U+4/$/@*Q:36;T_9O$J6 G\E8GN$$R^6\B,F0ZC!Q@<]0:W_$'B'[
M)XI_X1V^\5:GIUK86$4C7-O;B2>ZF<M@N5C8!0%S@ 9+>U2S?#S76\/ZCIXU
M2RFN&U>/5[6XE1AOEW!G611T&1QMSQ6S<:'XG@UA->TV;2!J-S9I;:A;S^9Y
M#%&8HZ,/FR-S#!'(/:@#ECXJ\2:O8^"X;74C:W6HW=W9W4XMP/,6,,!*$8<'
M W@<#)].*]/L[&:UTA+*2_N;B58RANY-OFL?[QP,9_"N=G\+:M>:AX3OK[4X
M;FYTB::6ZD\O9YI="H"*. !G'/8=S77T >!_8[J+X/>,+J35+NZ9M4EC\J?9
ML+BZ3+\*#N/?G'H!7?,=;\/>.O#MO<:_=:C!K'VB.Z@GCC$<;I'YBM$%4%1D
M$8)/'<FJ3_#_ %X^&_$7AT7FFFPO[QKNUEPXE4M,LA5QC&  1QWQ76:SH$^I
M^)O#NJ1S1I%I<L[R(V=SB2(H-OT)S0!P,_BJXLM8L[F+Q;<ZC=RZQ':3V<%F
M38B%Y=FQ9/+P'4$<[\D@BM>W3Q!XDU[Q9:KXDO-/M=-NPEH+5(]VXPHV&+*<
MJ"<X&"=QR>E5T\!>*4\,V.A+J6E+;:1<Q7%DRH^ZX,<H=1-_=&,YVYR<'/&#
MUF@>'[K2]1\07=Q-"YU2Y6=5CS\F(E0@Y]U- "^!=8N=?\#:/JMZ5-U<6RM*
MRC 9AP3CMG&:Z&L+P;H<WAKP?IFC7$L<LUI#Y;/'G:QR3QGZUNT %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 445RGCW5;^PT_2[+3;C[+=:MJ4-@+D*&,*ODLR@\9VJ0,^M '5T5P
M<+:AX7\=Z9HS:Q?:CI^K6EPRB^=7DAFB"G*L #@JW3U%0?"D:QJ_AG3_ !)K
M&N7MW-<P/&MJ2HA50^ Y&,ESM/.>C8QQ0!Z'117BVH>,;JZ_MW4X-<UF'5+*
M\FBT_3K:QDDM76)MH5R(R&+E3D[N-PZ8H ]IHKSVUFU/QCXQUB%=8U'2K/2H
M;40PVA52TLL?F,TFY3NQE1M/'!K'T#Q#KLFG>$S>:C))/=:_=6UTPZ2(OG87
M_=!48'L* /6J*XF_UB]@\?:Q9C44M;2#P\MTAGYBAE\R0>8P]  ,\]!6#X9U
MZ6/QAH=G:Z[K>JVVI6\WVE]1M'BB9T0.LD!:->#\PP"1@CZT =[X?\2:?XEA
MO9=.:0K9W<EG+YB;?WB8SCU'(YK7KS;X-_\ (+\4?]C'=_R2O2&&Y2,D9&,C
MJ* (X;F"X:589HY3"_ER!&#;&P#M..AP0<>XJ6O$]&N[[PIX4\?:[;ZG>W5U
M:ZQ<6<,=RZM&7+Q(LK *,OR,]L#I74WT.K>"]4\.7!\0ZCJ<.HWZ:?>PWC*R
MLTBL0Z *-F&7H.,&@#T.J&LZQ9:!I4^I:A+Y=O"!D@99B3@*H')))  ]35^N
M%\6?\3+XC^#='EYM$:XU&5#T9XE C_)F)H Z>/6XI-8ATPV=\DTMJ+G>T!\M
M1G&UGZ!_]FL^Y\7:7'H][?7UI>Q6%O=&SN&N+4J ,@%R#UCY'S#(K'GUC4%^
M.%KHPNY!IS:&;AK?^$R>:1N^N.*A^'E[=>)](\5VNM3O>0KK-W9*LG.(<*-G
MTP30!WEK#;V]K##:1QQVZ(%B2( (J@<!0. ,>E2UQ?PJNY[GX?V4%S(9);&2
M6R+G^(12,B_^.A1^%=7?P-=:?<0+<36[.A F@(#I[J2",_A0!3O_ !'IFGVE
MG=/<"6"\NX[.&2 AP9';:!D=L\'TK5KP32K&Z3X.^$IX=1N'N+O6K0Q"X(>.
M!_M#@%1@'&>2"3FNSFO=1\&>+I[=]8O]4L9-$N=0:.^=69982O*E5& 03QTH
M ](HKQ[0?%-V;OP[>0ZWK>I7VH3QQZE:3V$BVR+(.6C)C 4(Q7!#<C/6O8:
M"BN&\1RZK>?$32=$M-6N+"RN=.N);CR-N\[73!4D$!N<9QT)[X(YNZ\3ZMX=
MTCQ%I3ZM=3R6NL6]A;7\T?G3113*C$D*OSLH+8XR3CZ4 >N$@ DG '4FF6]Q
M#=V\=Q;31S02J'CDC8,KJ>A!'!%>31ZK-=+KVD:?K>OW6FOH\ETMW>6[Q2P3
MQD90.\:Y5U/3!Q@XQFNM^%UDUG\.M$9KRZN//LX90)V!$0*#Y$P!A1Z'/UH
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MGOK:5E5&L(S.6W="-O4>]<U=>&M;TRSU$1^*=2N=/DL)#(;EU-Q',O(:-@F
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.!W5% '&Z/X?\5PWFEQZMKUL^GZ8N$6RB>*2\(7:IFRQ& .<#@FH/^$#N?\
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MODO$G%LPNWV/O12<[!V!8#D#H,UV]% 'GLW@?Q"EMX@T>RU>QBT;6)KBX+/
MQN(C,/F0'.W;GOC.">^,6W\'ZOIUQI&IZ%?V2:E9Z8FF7"7<3-#<1K@@_*05
M(;)'L<5V]% '&6W@[4A>^'KV_P!9-[=:==W%W<O(IPYEC9=D8R=J+N&!Z"M:
MTT"2W\;:EKQG0QW=G#;K$ <J49R23[[OTJ33?$UAJOB#5]%MQ,+O2C$+@NH"
MGS%++M.>>![5LT %<_H/AV72-=\0ZA).DJ:K<I.B!2"@5 N#Z]*Z"B@#B=(\
M+^)=%CM='L]:LX]!M9]\;"W)NO)W;A"23LQ_#NQG'8&HI/!VOVEUKEKI&K64
M&D:S/)<3"6!FG@>10)/+((7G&02.">A[]W10!P$?@?6-,L_"TVD:A9?VEHEH
M]F_VF)C#.CA0?NG((*@BD_X5U=WEEXEBU/5EDN=9E@N4N(8=OV>6)5VD*2?E
M#*,#.=HP3GFO0** .2LM"\2WE[)/XBUFV:$6CVL=KIT;QQN7ZRR!F.6P.!T&
M37/S?#G7+WX=VOA2\U/3\64\+6T\4+C,<9)^<$GYCQTXKT>UN[>^MUN+2>.>
M%B0LD;!E."0>1Z$$?A1=7=O8VLMU=SQP6\2[I)9&"JH]23TH YG5/#NL0>*)
M?$'AV[LHKBZMDMKNWOHV:.3824<%2"&&2/0CTJC#\/YXM-TZ-]126]375UJ^
MG,>U9I.=RJN?E&-H'/:NZHH PGT"1_'D/B+ST\J/37LC#@[B6D5]V?3Y<5NT
M44 <+./^$=^+2WLWRV/B&S2U$IZ+=1$E5)[;D)QZD8JNG@WQ1IT6OV^DZSIR
MV^M7MQ<O]HMW9K82G&4(8 G;C@\9&?:N]N+6WNXQ'<P13(&#!9$# $'(.#W!
MJ6@#AI?!.H:3=Z%>>&+RTCFTS3SIKQW\;,DL1*G/RD$-N7/OFJD_PXOKOPKX
MITJZU>.2ZUNZ6Z%P(2H1P(SC;G[NY..3@$=37HE% %+25U)=-B&KO:/?#/F-
M:*RQGGC 8D],50\6Z%+XB\/R6-O<);W*S17$,DB;D#QNKJ&'<$K@_6MRB@#C
M;#PWXA7QE:^)-0U*QEE-H]G<6T,+K&D9977RR23NW#DMUSTX%5-,^'DUG\--
M4\)S7\;27K3LMPB'">8<C@]<5WM% '#CPQXF1=(U-+_2EUW3X7M#B&3[/<6[
M;?E;YMP8% V1Q[5+J?A/6=:\/V=IJ>KPS7T>J17[R+#LC54?=Y2#K@ 8!8D_
MRKLZS=)UNTUF748[42!M/NVLYMZX_>*JL<<\C#"@#2HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ KE/'\NIPZ):O8?V@+<7:?;VTT9N1;X;<4[YW;,XYQG%=763KUCJMY;P/H^
MI)8W<$HD'FQ>9%,,$%'4$''.<@@@@4 <"^M>5X=TV;1/%-YJ5K+XCL[?=<9$
M\*,ZAX9"<,W<_, <''/6NBUF_NX_B-86"7$@M)='NY7A#?*SJR $CU )_.J=
MSX O]0TW49KO5K==<N[ZWOTN(+8K#%)!M$8"%B2,+R2<\^U6[3PEK,WBB'Q!
MK&KVTUREC-9^1;6QCB4.5(*Y8G.0<DGG(Z8Y . TRVU70O@MIOBVVU[4%N[&
M".9+,2@6K1!PIC,>.<KG+'G)[=*Z?1=,,GQK\07']I:B1%:6TRQF?Y&#[SL8
M8Y49X':EMOAQK:>%++PC<:_;3:#'L^T?Z(1<.JL',8;?@*2.N,@<<UT'_",Z
MC;?$";Q%8ZA;+:WEO%!>6TT!9B(\X*,&&.O<&@#DO \FJ7/PZ?Q9JWBR\BG-
MI<QQO.V^"W5791(R=7<%2<D],#%,T;Q!)I'B6V2WOO$5[8W&F7-Q-_;,4B"1
MX@C!XMZ@C(+ @<<CBNDL_ !@^%K>#)=0W,8Y%%TD6 &:4R*=I/(!(R,\XI#X
M1UZ^U[3=:U;6+&>>V26WEMHK1EA:"0 ,%RY(<XZDXZ#''(!2\+Z1K^IZ/H7B
M<>)KXWUX([N[MIGW6K0N,F-(P/E(! ##G(YS6'X8LI],TWXCZA#JNI//:75[
M%'YEQN!*PJ5D(QRXP!N]*Z72_!>OZ?'IVDGQ*!H&G3+)"D,+1W4B*<K$\@;!
M0< X ) Q4D'@K4[:?Q3;Q:I;'2]=,\OEM;GS8II(PA.[=@J,9QC- '-6>JZY
MJ7AGX<(FLW4-QJDCI=W"MEY%\IR>O&>."<X.#VJ34=9U/P1/XRM(-3O;^*TT
MF*^M#?R^<\,KLZ'YCR5R <'TKI--\"26%AX/MC?HY\/NS,PB(\_,;)QS\OWL
M]^E+XB\)6UY=>(]4U"XD-E?:.+.2*&(M(@0NQ=<?>/S<#'44 8>J6&M>&)_"
M+Q>)=4NDOM5MX+]+F;>)"RL<KQ\JG!!4<=/2O3Z\5^V2Z]J7@BW3Q79:[-#J
M$4\<%C!Y;+"B,6EG&YB'' Q\N"3P>WM5 'D^E:44\>?$68ZEJ#_9HH<1O/E'
M#V['##'(7/R^E9^GV^IZ%\-?"GB.#7=1\]38QFT$N+9H794V>7C&=I^]USD^
MF.W/A'4H?%VN:G::E;+8:U"B75O+;DR(R1&-2C!@,<@G(/I[TL_@F2;X?Z5X
M9^W*'L?LN9_+X?R75C\N>,[?7C- ''ZOXAN=1U?Q(W]I^)+:ZT^X:UTV'3+2
M62 ,B [I-B%7+.3D-T&.F<UZCHEY/J&@:=>W4#6]S<6T<LL+*5,;LH+*0>1@
MDBN=N_"VO6NIZI+X>UNVL;759!-<)/:F5X)=H5I(B& R0HX8$9&:ZV",PP1Q
MM(\I10I=\;FP.IQW- '$:^-1U'XF6&B0ZM>65A+I,L]PML^UF*RH!M/\)Y R
M.<9'&:YJY\1ZKH6B:WI!U6_G,.OPZ;!>E3/<QP2*KMC )=P-P'!/(]*]$ET!
MI/'%MXA^T )#I\EGY.WDEI%?=G/^SC&.]8]UX":Y77'74?)N;[4HM2M)EBR;
M:6-4"Y!/S#*<]."10!R<EY<W%AXFTRTO?$SZ2=%DNTN=1BFBEAG3JBR2*"58
M8R.>C8QFNU^&UC]A^'VB?Z5=7'GV4$W^D2;_ "\Q+\J^BC' J2#0==O[/5(O
M$&LP2B]M&M$@LK<QQ1 @@O\ ,S,6.?4#BK'@_2-4T'P[;:5J=[:W?V1%@@DM
MX6C_ '2J%7=ECEN.HQ0!#XXNUM-!3?K$^EK+<QQ&2VA,D\H)YBB"Y(=L8! .
M.>*\_E\0ZC:>&/'MO9W^M*FFVMO/9RZFKI=1&0-N&6 8C*9&?4UZ+XJT&[UJ
M+3I]/NX;:_TZ[6[@:>,R1L0K*58 @X(8\@YKF[WX>:O?IXA^TZ[;R/KUE'#=
M-]E($<D9;88QOX0*V,').,YY- %+4[+6]/\ $?A>&'Q/JA;73+#?AY R+B/S
M"85(Q&>" 1G&1U[U;S7M6\'VOCVSM]2NKX:9'9O827TGFO$UQE3ECU ;! -=
MWJ7AM[_6O#=^+E4&CR2.R%,^;NB,?!SQUSWJAJ'@2#5;WQ4]Y=$VVO6]O#L1
M<-"8@P#9SR<L"..U &5J%IJ'@K5/#=S'K^J:A'?ZA'I][#>S^8DGF*V'48^0
MAEZ+Q@TFG:QJ,GPU\87SWLS75K/J:P3%OFC"%]@![8P,5I0>%=>U#4])G\2:
MS:7EMI,OGP16MJT333!2JR2$NW(!)PH R:H3^ M;^QZ]HUIKMM#HNK2SSE3:
MEIXVER60-NV[,GTS@D<=: *=O)JVN^*]$TMM;O[6SF\,QWES]GEVO))O49#?
MPDYY(YP,=ZYOQ,;ZY^&_B6QN]7O[@:1KR6D,KS?/+$7A(60X^?&\X/J!Z5Z7
MI?A.33O$6GZHUVKBUT5-+,8CQN(=6WYSP..GZUF:G\/9-0\/^)M-&I+')K&H
MB_BE\K(A*^60I&?FYCZ\=: .QT^S_L^QBM?M-Q<^6,>;<R;Y&YSR>]<GXGN+
MW4_&NC>&+?4+FPM)K::]NY;5]DLBH5545^JC+9..>*ZK3$OX].A75)K>:] /
MFR6\9CC)R<84DD<8[UC>(_#EWJ.J:;K6D7L5GJNGB1$,\1DBFC<#<C@$'J 0
M0>"* ..OH[W[-XW\+7.L:C/;6%@M[:3M-^^VO&^Z)WQ\RY7OS@XS6U\(M-^Q
M_#W2KG[;>3_:K6-O*GEW)%C/$8Q\H.>?H*N67@ZZ%GXBFU+48KC5]<A\F::*
M$I%"@0HBHI).!N)Y.3FM?PIHC>&_"NFZ,\XG:SA$1E"[0V.^.<4 <_\ %VR^
MU_#76)/M-S#Y$#2;89-HD[;7'=>>E<M-=2:#HG@[2/[6U[[)JEL;JZDM=\]P
MJQQ1XBCV*61"SC.!P!UYKTCQ9H;>)?"NI:,DX@:\A,0E*[@N>^.,UF7WA*[.
MG^'WTW4(H-6T2(10S2PEXI5,81U900<-@'@Y! H XIO$>M#2)-'MKS5XX;O7
M+73[+4KZW>*Y6"5=SX+J"64JZAB,\BM&>QE\-_%#2W;4;V_M8]'O)D%Y+YLB
MD%"PWGD@X'!S@Y^@W=0\'ZOK.@-#J6NJVKI?1W]K<16^(;62/&U50DDKP<Y.
M3N)I+/PCJ\_BRU\0Z[JMK<RQ6<MHUK;6S1Q!'*],L3G@Y)ZY'3'(!Q>B>)=1
MFBT'6(;WQ+>:I>W,+7UM)93?8C#*<,$^38H0,"&!YV]3FNA\*1ZGK7BKQ'=W
MNNWZV6E:S+';6L<NV,C:I(DX^9 ",+P!R:U-%\+>(M(%AIB>(8?["L) 8D2U
M(N9(QG;$[EBNT<#(4$@=JOZ)X5_LS_A(UFN?.CUF]ENB%7:8U=%7;G)R>.M
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M\HX/ERJ_W<]]N.M %/[/J'C'Q3XDA&NZEIMOI,D=K:)8R^6/,,8=I)./GY8
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M#"Y(&3CM0 FF^(YO#FJ^,-.URZEGCT]3JMI)*V6:U=2=@/\ LNI7\16';?\
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MCO[674)[".=&NH$226(=45\[2?KM;\JL4 <7;Z#=Z'XA?Q;K/B.V8&T-O?\
MF6_E1! V4\LE_P!V 3SG=G)Z9XQOAUH]K=^+?$7BJR,C:3/</%IF\84AB&GD
M0?W6D P?8UZ6Z)(A1U5E/!5AD&N;\-^,K3Q-?7=OIFFWXLK5WA^WO&BP.Z$
MJOS;CU_N@<4 +9^$_LEKXG@^V[O[<N)9\^5CR=\:ICK\V-N>U03>"S+X:\,Z
M1]OQ_8EQ:3^;Y7^N\@8QC/R[OJ<>]=910!QD_@_68+S4DT7Q$-/T[4IS<3Q?
M9=\T3MC>8I-P"[L9Y4X))%;%IX>^R^+[[7?M1<75G#:^24Y7RRQW;L\YW>G:
MMNJNIW\>EZ5>:C,KM%:P/.ZI]XA5+$#/?B@#CKOX=R3>'I]/@U8171UIM8M[
M@V^Y8Y#(7"E=WS 9QG(_I5J^\-^*;E9TB\4P+%>P"*Z26PWJC;=K-"/,^3(_
MA.X9Y[UT^F7\>J:59ZA"KK%=0).BO]X!E# ''?FK5 %73+"'2M*L].MRQAM(
M$@C+')VJH49]\"L37O#FH7NO6.MZ/JD-C?6\$EJ_GVWGH\3E6/&Y<,"H(.:Z
M6B@#@;;X<W%N%B;7#-;IK<.LJ9+?]Z9%_P!8K,&P=QY& -O/![;NH>%8M2\4
M?VM<3Y@;2Y=-DMMGWED=6+;L\<#&,=ZZ&B@#SE_ASK5SHMAHEYXI633=-FAD
MM%6QVR,(F!59&W_-A05& .<$YQBO1J*R]*UVWU>_U6S@CE1],N1;2EP,,Q17
MRN#TPPZXH R]<\+WU]XKTOQ!IFJ1V=S:0O;R)+;>:LL3D$@?,N#QUY_Q+3P@
M;7PYXATG[=N_M>XO)O-\K'E>?GC&?FVY]1GVKJ** .-;P9J-@^F7>AZQ#:W]
MKIT>FSM<6OFQ7$:?=)4,"K [B.3UQ72:/8W&G:5#:W=_-?W"Y,ES* #(Q))X
M' '. .P %7J* ,3Q3H$GB'2X8;>[%I=VUU%=VTS1^8JR1MD;ER,CJ.HZUST_
M@+5+R^U"^O/$$<MQJ>ERZ==@6>$56#;#$-_RA2V2"6SSR,\=1H6NV^OP7DMM
M'+&MK>36;B0 $O&VTD8)XSTK(UOX@Z3X?NKJ&^L]7"VPS+/'I\KP@8!SO VX
MYZYH DNO"'VG2_"]G]MV_P!AW-O/O\K/G>5&4QC/RYSGOBG7W@ZWU/Q#J>HW
M<^^VU#2AIDML$P0NYB6#9_V\=.,4:'XWT[Q!>1V]G9:M'YB&19;C3Y8HR,9^
M^PQSV]:Z6@#AK?P/JTW]DV6L^(8[[2=*FCF@A2S\N69H_P#5^:^X@A>#P!G'
M-/F\$ZHFHZTNGZ^MKI6LRF:ZMS:;Y4=D"/Y<FX ;@!U4X[>M==#?VMQ>W-G%
M.CW%KL\Z,=4W#*Y^HJQ0!R.D>"#I5SX9F_M#S?[$T^2RQY./.W!!N^]\N-G3
MGKUIFI^ TU./Q=')?E%\0K$/EBY@,<80'K\W(![>GO6KX<\4V?B:35DM(9XS
MIE])8R^: -SIU*X)X^N*C\0>,--\.7MK9W<5]-<W2/)%%9VKSL57&XX4$C[P
MH OZ%::C8Z3#;:I?0WMS&-IFA@\I2!P/EW'GWS57Q1X='B/3X(DNFL[RTN4N
M[2Y5 _E2IG!*G[PP2".X-)H'BS2?$DEQ#8R3)=6V/.MKF!X98P>A*N <'UK<
MH Y?2/#.H1^(CK^NZI%?WZ6QM;=+>V\F*%"P9B 68EB0.<]!BI?!?A7_ (1'
M2;JQ^V?:O/O9;K?Y>S;O(.W&3TQUKHZ*  C(Q7GNF?#B^L?#UCH4VNQS6&G:
MC#>6>+/:ZJDID*,=_P Q.0,X&,=#7H5% &!J/AF/4O%%KJ\TP,,-C/9O;%,^
M8LI7)W9XX7&,=ZSM%\*Z[I3Z?9R>)C+HVG<00):[)I$ (1)9-Q#*HQT49P,U
MV%0W=W;V%G/>74JQ6\$;22R-T50,DG\!0!-7&:KX1UN7Q?<>(-%\0PZ=)<6D
M=K)%+8"?(1F(.2X_O>E=C'(DT221L&1U#*1W!Z4Z@#E+?1O&*V]Y'=>+;69I
M;=HX'32Q&89"1B3_ %GS8&>/4@]L5 /A];6-KH7]C79LK_2')6[:/S#<*W^M
M649&[>><YX/(KLJ* .'O/ ^K)=:M'HOB/^SM-U>9I[J'[+OEC=@!(T4FX;2V
M.X.#R*N#P2J>.8?$2:A($BTC^RQ 5)?&XMO\S.<\^GOFNLK+&NVY\5GP]Y<O
MVH6(O?,P-FPN4QUSG(]* ,&U\(ZU+?Z6VN>((]1L]+E\ZW46?ES2OL9%,K[C
MG 8] ,GDTFE>#]9T@VFG6_B0IH-I/YD-LEKB<H&W"%I=V"@Z?=!(XS79U3U7
M4[71=)N]3O7*6UK$TTK 9.U1DX'<T 7*S]=TS^VO#^I:5YOD_;;66W\S;NV;
MU*YQD9QGIFLW1?&%IJ^EVVHSV5YI<%W+'':?;E53<%QE"H5FZ^^*Z*@#$@\.
M1+X'B\,3SM)$--&GO,J[2R^7Y98#G'KWKG4\#:Z[Z)/=^)89+C195-H$L-L9
MCV%&WKOR7*D<Y &.!R:[VB@#BV^'EO>Z9K2:K>M=:IJDPF:_2/8T!3_4B,9.
MT1\8YYYSUKJ].ANK?3K>&^N5NKJ.,++.L?EB1AU;;DXSZ9I;"_M=3LHKVRG2
M>VE&8Y$Z,,XXJIXAUNW\-^'[W6+J.62"TC\QTB +$>V2!^M &?XP\,S^)+33
MOL=^ME>:=?1WT$KP^:NY 1AER,@ACWJC-X4UNWUB;6-'UVVM;Z^MXHM0$UB9
M(II(UVB5%#@HV"1C)&,>E=;!,MQ;Q3*"%D0. >N",U3T[4Y+^XOHGTZ\M!:S
M&)7N% 6<#^-,$Y7ZXH K^&?#\/AG1(].BFDN'WO+-<2 !II78L[G'3)/3L,5
M<U?38=8T:]TRX_U-W \#\9P&4C/ZU<HH X2W^'3P> )?#QUAFU"2Z%Y_:?D8
M83B0.KA-W8*J]>U7E\#11:'X5TR"[V)H-U#<[O*SYY1'4]_EW%RV>:ZVL_3-
M3DU%[U9-.O+/[-<-"IN5 $P'_+1,$Y4]B<4 49_#?G^+Y=>^U8\S2SIWD^7T
MS)OW[L_AC'XU@6'PV.G^!='T&'5V6_TBY-U::@L ^60N[<QECE2'*D9YKO:K
MVE_:WWG_ &6=)?L\S02[?X)%QE3[C(H XV]\":GK.B:U;:QXA,][J:11AX[<
MI!;I&P8!(MYY)SDDYZ>E=!JWA_\ M37]!U3[3Y?]E32R^7LSYN^,IC.>,9SW
MK:HH *XJ]\'Z\OBW4]=T3Q)!8?VC'"DL,NGB?'EJ0,$N/4]J[6B@#DET+Q?)
MIM_:W7BVW>6XA\N&:+3!&T!)Y88DY.,@>AYYZ4B^ [33Y]!N-"G_ +/FTE?(
M+>7O^TVYY>-^1DEOFW=FR<<UUU% '%Q^#M9LIKBTTOQ']CT6XNFNF@6US/%N
M?>Z1R[L!2Q/521DT_4O"&K+K>I:CX>UY-,&JJ@O(Y;3SOG5=HDC.Y=K;<#G(
MXS78T4 <5/X(O[/4=,U'0=<^SW=II_\ 9TKWT!N?/BW!@Q^93OW9.<]ZJR?#
M5Y/"&N:(^M2//J>H?V@+QX!E),QMRN<'YH\\8ZX'2N_JO:7]K?B8VLZ2B"9H
M)"O\,BG#*?<&@#F)/!]]>^)_#7B#4=6BEN]'2X658K78LYE4J,?.=N 1ZYQV
MIFO^ (=<\8Z?KIOFAAA\HW=H(LBZ,3%XLG/&&/H<CBNJFO[6WO+:SFG1+BZW
M>1&>K[1EL?053T;7;?6Y=3CMXY4.G7KV4OF ?,ZJK$K@GCYAUH SM;\.:A<Z
M[!KFB:G%8:BEN;67S[?SHIHMVX J&4@J<D$'N16MHUC<Z=I<5M>:A+J%R"S2
MW,JA2[,23A1PJC. .P J_10!2U?38=9T:^TRX_U-W \#G&<!E(S^M<C;_#J2
M'P!)X>.L,VH/="]_M/R,,)Q('5PF[L%5>O:N[K+U/7;?2]4TG3YHY6EU.9X8
MF0#"E4+DMD],*>F: ,.;P'$/"FAZ38WS6MYHICDM+T1!OWBJ0Q9,\ALMD9[]
M:=9^#;FXU#4-2\1:DE_>WEBVGJ+:#R(X8&)+!068DD\DD]A7744 >>Q_#W69
M=.T;3=0\31SV6C7-O-:)%8[&<0L-HD.\Y.T;1C YR036JG@:%O%/B75KF[\Z
MWUVTCM9+81[3&JIL/S9YR/88KK:* /.S\/-;N=-TK3-0\4)-8Z3<036JI8['
M<1,-HE;?\WR@KP!R<G.*]$HHH Y+5O">I7'C'_A)])UF.SNUL%L1#-:^;&RB
M1G);#*?XAC&"-O4YQ52+X>NFA/$VKN=;;4O[6_M$0# N>G^KS]S;\NW/3O7<
M57DO[6*_@L9)T6ZG1Y(HCU94QN(^FY?SH S="TW6+2:ZN=9UA;^>?:%CA@\F
M&%5S]U2S')SR2>P]*U;F'[1:S0"22+S$*>9&<,N1C(/8BI:* ./L?"FLOJVF
M7>O:]#J,6E[S;+'9^4\C,A3=(V\Y.UCP  2<UBO\,M5D\+'PNWB91HL3AK9%
MLOWH DWJLC;_ )@/8#) ],'I8/&EK>>+KKP[9:=J%U+9LJW=U&BB" LNX!B6
M!/3L#6KK&IR:5:)/%IUY?LTJQF*T4,R@_P 1R1P.] '/77A'5X?%6J^(-&UV
M&UN-0CAB:"XL_-C"QJ1DX=26R<@]!R"#GCAO'&G6&@:!X7\)V^H"]UEM>@O)
MDX\Z8NTA>4H.@W'_ #BO8OM]K_:0T[ST^V&'S_)_B\O.W=],\5*88C,)C$GF
M@8#[1NQ]: .7U'POJRZ[>ZKX?UN+3GU&-$O$GM//!9!M61/F7#!>.<@X''%-
MU+PA>O/I.HZ5K3P:QIUN;4W5W%YXNHVQN$@RISN4-D$8-=;10!PM[X!OKWP]
M#;R>()9-7BU5-6%[-#NC$RGA1%N^6,#@*#[UVEFEQ'9PI=S)-<J@$LL<>Q7;
M')"Y.![9-58M3DEUR?33IUXD<40D%XRCR9"?X5.<Y'TK0H YKQ-X3_X2+5_#
MU]]L^S_V1>?:MGE;O-Z?+G(V].O-6M'\/_V5JVNWWVGS?[5N5GV;,>5B-4QG
M//W<]NM;=% &-X3T'_A%_"NGZ+]I^T_9(]GG;-F_DG.,G'7UK9K+\.:[;^)M
M M=8M(Y8X+D,524 ,-K%3G!(ZBM2@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N(^*EW?V7A&&33;
MR2TNFU&U198V(QF0#!QU'J.]=O6'XJ\.+XGTJ*Q:Z-N([J&YWA-V?+<-C&1U
MQC- '$>)8O[ U+0O#:S^([ZPNA<7EY]EFDENIRH0!2X(94RQ) ([55#^(YO#
MMS;1V7B5]*M=61O+<M%?RV)CR45B=S;9#_>W%1C-=]XB\.S:O=:?J&GZ@=/U
M33V?R)S")4*N '1T)&0<#N"" :J'PSK8TU-OBNZ_M5;HW)NFA!A.5V^5Y.['
MEXY SG/.<T <3J%^K>$K./PYXBU91+XBM;;%VSBXLMY :)]_S$9.<-D<XY%:
M.IO-X \66XL+Z_NK.^TJ]GDM[VZ><"6!%<."Y)!.2#CBJ_C'PO-9:3:-?:I)
M<ZCJWB*P-Q=PQ"'9@B-=BY.-H'<GFNJL_!UU-KK:MXAU==5D2T>SMXDM1!''
M&^-Y(#'+, !G@8[4 <1X=O=2\[PUJ%G;>+9]0NIHO[4FO$D-I-%(/G8 DJH4
MD%2H' K6T#1[_P 9Z-<>)!K^I66K37TWV1HYW,-M''*46,P@A6!"<YY.>M;^
MB^$=7TJ33[:3Q1/-I&G'%O:K;B.1E *HDL@/SJH/3 S@9Z54F^'UZ/MMA8^)
M)[/0;VY:YFLH[<>:I9MSK'-G**QSV.,G% &=X;T:$?&;Q;<&XO2]O':2JINY
M-A,B2%@5W8*C/RJ<A>V*VO'UW=[M T:TNYK,:MJ2V\\\#;9%B",[!6ZJ3M R
M/>K,7A2YL_'-SXAL=5$-O>Q11WED]N'\SRP0I5]P*]?0U=\3^'4\1V-O&MU)
M9WEI<)=6EU&H8Q2KG!VGAA@D$=P: .633?[&\>1>&H+_ %-](U;3)96BDOI7
M>&6-U^9)"Q=<AN<'K6=\$=(@A\/7>H+->&7[=<P;'NG:+:''.PG;NX^]C-=?
MHWA>[MM?DU[6M6&I:E]G^RPF.W$$4,6[<0J[F))(&23VQ4O@SPLOA#1I=.6[
M-T)+J6XWF/9C><XQD]* .?\ ':W$>OVEQJ,6NR^'5M65CH\LBM#/NSOD6,AB
MNWH>0#GCFFZ3J+R^,_"T%KK=QJ5A+HEQ)Y[.0+@AXPKLO0L 2,D9ZUT>LZ-K
M5UJ27VC>(6T\F'R98)K;[1$V"2'5=R[7Y(SGD8R.*QS\/IK&+0Y-$UIK._TJ
M*6'SYK83+.LIW/N3*X^;D8/% '/ZUKVJVD_C2"VOYXY)-7L;&WDWD_9EE2,,
M4!X7JQX[G-;.K^%)- T'Q!<6>L7\NGR:/<I+9WD[W&9=A(D5W8E3C(('!SVQ
M4Z?#B&33M?M;[5KBZDUB:*Y:XV!'AF0+AUQQ]Y00,# XJ5?!>J7@OI-<\227
M\T^GRV$/E6H@CB6089R@8[GZ<Y ]* .4BTZ?0?#?@77+?5M2:]N;G3[>=6NG
M,+PRJ%,?E9V@ $8P,\9))YKO/'MQ/:?#_P 07%M-)#/%83/')&Q5D8*<$$<@
MU'>>$%N_#V@:2;TJ-(GM)A)Y>?-\C'&,\9Q[X]ZV=8TR#6M%OM+N2P@O('@<
MKU 8$$CWYH Y'Q%?7<.G>!6BNIT:XU:TCF*R$&53#(2&]02 <'TK!M]+N=>T
M[QM>WFM:LKZ?J=ZEBL%[)&("BA@<*1GDXP<@ < 9-;T/@+59FT/^U?$[7B:-
M<QS6R)9B(,$4K\_S'+$8^;MSQS6SI_A5;#3O$%H+PN-8N[BY+>7CRO-4+MQG
MG&.O&: .%:YU3Q-JO@&UFU>]MH=4T-Y[[[+,8S*=D;<8Z$GC/7!(&,TW4KG[
M5XIUG2KA?%DUOI,4%I8G26E/E-Y08RR,K#>^6'WLC ]Z[+3O!":??^&;H7[2
M'0].:P"^5CS@55=W7Y?N].>M.U+PKJ3:Y>:IH.O?V7)?QHEXCV@G#E!M5URP
MVL%X[@X''% '*:;+JWBWQ!H>C>(9=0LA!H(OKNWAF>V>:X,IBRY0AL *6QD<
MM6.6O-%TSQ='#J-TTT?B:SB%QYI$C(3",,PY/RG!/?G/6N^O_!EX;_3-3TC7
MIK34[*S^PR7-U"+G[3%D']X"5^;<-V0>I-4E^&BG0==T^;6KB6?5;M+[[68E
M#Q3+L(;&<$;DSCC@X]Z +NO7MQ;_ !(\*6Z3S+;RVU^TL*N0LA58RN1T.,G&
M>F:P?">BZAXG\-Z;XL_X2#4;;6KN7[43Y[O;K'YA_<^3N"[=HQZYYS6]9^#]
M2/B?3=?U?7_MUW8Q30B..T$,95P!P-QP<@DG)SQTQ5.#X>WEK$FE0>))XO#:
M7/VA=/2W"R ;]_E"8'.S=VQG'&: ./O=5U#5Y?$=_!#XKDUBVOKB#3'L$D-K
M#Y+;44J#M;<5^;<#U]JZ2VBN/&?CG4;;4[K4;.WTNPM&2TM;J2WQ-,K.SML(
M)*X"@'CKQ6K<>#-3CO-1&D>)9=-T[4IS<7,"6P:5';&\Q2Y&S=C/0X))%3:E
MX2OV\2/K>AZY_9EQ<6Z6UVLEJ+A9E0G8PRPPXR1GD>U %#X51R0Z!J\4TQGE
M36[U7E8 %R).6...>M:/Q*_Y)IXC_P"O"7^56_"/AA/">E7%@EY)=K+=RW/F
M2KAOG.<'U/OQGT%6_$FC#Q#X;U'1VG, O(&A,H7=LR,9QD9_.@#(FU271/A0
M=4@ ,UIHPFC!&1N6'(S[9Q7*:AI]SX6\+:)XI@UG5)]2,]H;TSWCR1W2RLJN
MOED[5'S\;0,8%>BIHUNWAM=$N?W]L;06DF1C>FS8?ID5R]OX"U!H],T_5/$;
MWVC:9+'+!:_9%CDD,?\ JQ+(&.X+@=%&<<T 8>@:?:Z?X[^(6H/J5Y;"Q,3B
M>6YDD2,-;EBSH3A]O4 ] ,#%0>';UK+Q?X82Q?Q*T.I),EW<:L[^7>8A+K(B
M,QV'*YX X.*Z>]\ R7>N>(+E=8:/3=>@$5[9_9P6W"(QJR29^7&0<8/2F1^!
M]8>_T74;WQ/]HO=)D_<$602,Q%"CJ4#<NP(^;/&!@=<@&?\ ";_CZ\<?]C+=
M?S%2^+M1N-,^)WARXM=+NM2D_L^\7R+8H'P6BY^8@8'UKH/"GA1?"\NMNMX;
MG^U-2EOR#'L\LO\ P]3G'KQ]*M76@"Z\6Z=KWV@J;*VFMQ#LSO\ ,*G.<\8V
M>G>@#E8EU.YUW5_&&JVK^'+2#1FLXFN&264?,9#,RH2,+@87.3SZUB:',8O%
M6A6-H_BA+;5K6XBNY]4E<"Y(BW++&&<E&R"> N :]-U[1X?$&@7^D7#LD-Y
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M,Y[U1\+^%;KPS?:GLU87&FWES+=1VK6P5H7D;<?WF[YAUXP.M '-^,-'@O\
MXN>$!+<7R">WO"PANY(\;$4C;M(VYSSCKQG-9VF^'AJZ^/;J34M1M_L^KW1M
MTM+IX1'((D.\[2-Q^Z,-D#'3DUVOB7PK=:SK6CZQIVK#3K[3/.5&:V$RND@
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M<,I!!5A[@@$?2L.S\(:G-K.G:AX@U_\ M0:86:TBCM! /,*[?,DPQW-@G&,
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M)9ON@OT&<]3Q795Y;>'Q/XP\%V_AQ/"LMA;W<,$<FH7-W"R1QC:2P16+$X'
MXY-,\:-:7FKZ[Y:^(]2N[&U4(=/F,,.FOL+!L^8@9SD,>&P,#VH ]4"@$D
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MG\Z[J@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4)2)=JQD _\ CW6M#4?"5XVO7>L:'KLFDW%]&B7B_9DG24H,*X#8VL!QGD8
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M^\ASD,/H0#6G10!QT'@O4/[>TS7+[Q)/=ZC9;HRQMD2-X6 R@0?=)(SNR3^
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFP8?S' 9@JC[F>>21UKT/M7FT6OZ5H7Q=\3/JUU#9Q2V-F%N)VV1@@2':6/
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MUO:I;:(7( S@":,D_@ 34,.I6&L_%C1K_3KJ&[M9-#NO+FB8,IQ-&#@_7(H
MU[;Q[I$V@7^K317EH+"?[-<6D\.)TFX"H%!.2VY<8)!S5O1/%-OK-]<6#V%_
MIU_!&LK6M]&J.T;$@.NUF!&01P>#UKS+7K669_&$Z27$45EXDLKJXEMAF2.)
M8X]SJ,'E0=W0_=KJO"$.AW?B^:_T[Q1J>OW4%CY+SRO')!&CN&V[D11ORF<9
MX&: .H\4:M-HGAN^O[>UN+F:*)BBP(&*G:<,02/E'4UY_P##[Q2-.\#_ -OZ
M]/X@N)[D1#==GS$N)79@J6R ]3P",#MZ5Z)XF_Y%36/^O&;_ - ->5V0:W^$
MGP^U5T9K/3+^"ZNRJEO+B_>*7('92P- 'H^C>+K;5M5DTJ;3]0TS45A\];:_
MB56DCSC<I5F! . ><C->4+XCUO\ X9RU'5O[7OO[22\VK=^>WF@?:%& V<XP
M2*[>/4['Q1\5-'NM#NHKVUTRPN#=W-NV^,&4H$3<."WRDX]J\T7_ )-;U/\
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M: -DQ(X&^-&(.[E>_K6/<^'_ +=XJL]9N[GS(;")A:6H3 25N&D8Y^8[?E'
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M['L4KMVC;Z8XH*AL9 ..1FN-M/B1IEUH5QKKZ?J5OI4<,<D=S+",7#.0/+C
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M$0YM8HPQ;S./D.2%P>I-=59>&[VQU26_E\3:M>1$.?L<YC\H9SCH@/';FNB
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M=WHMSF*X_>-9R!0(T\W /S9*[&R1BKOAD>'=6U3P]'%XA\0ZEJ%N1/\ 8I9
MR63K&0?-&P;,9*8SDD\5ZR !T &:, $D#KUH \7U"PN$\2WOPX2)_L&JZM'J
M88 [19L#),@/;]Y'M _VJT==BL-)^(FLW.M>(=3T*UOK:VDM)K241QS>6K*Z
M$[3EAP0O7#5ZQ2$ ]1F@#RBTT^TLO$_PQBL([X6@CU*6/[>H$PWQA_GP.#EC
M5OQ'JPD\:ZIINJZUJ=C%%;0G2[&PD,37K.&W$$#+G< N,X'4^M>FT8&<XY%
M'C?@66.?4/AXB'<]KI5]!,,<Q2+Y0*GT(I_B73[N_G^):6EO)/*EQIEP(D&3
M*L:1NP [G"GBO8:* //M6\6:?XVTG4]!\-^9J$UWI5SON(U*I;,4PB.2!AF)
MQMZC!S6'X87P]JE[X<@7Q!XAU#4;=EG.GR2!ELI$0@^:NP; ,E.O.1C->N
M=!BC !)QR>M %;4_^05>?]<'_P#037BBZ[I^J_ W3/"=HY.NWD-O;16.P^83
MYBGS,8^YM&[=TKW"ZA^T6DT&[;YD;)G&<9&*SO#&BGP]X9TW2&F$[65NL/FA
M-N_ ZXR<?G0!YQXGU,W^L>*=-U'6-5AO(D$.E:19.8_M*-""'X&7!<L"2<*
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MR >HS10!YQX_MX;?QCH6JZAJE_I6F?9KBUDOK239Y,C%&4.Q4@*P5A]0*V?
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M9UZ4C/?]U%2:IH7BI_&LFN:;/HTD26PM[6.^64F 'F0C;@98@9/HH'K7:T4
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MEG0 [>2.NX<]!R3@5!=>,KB*>WL;;P[?WFJ-:K=W-G%)$#:H20 S,P4L2"
M3G!JEXIA>3XH> G$;,B-?EF"Y"_N!C/I6'XDM['3/B)J-]KFK:OI5E?V<'V:
MYL9I(T=X]X:-B@.6Y4@>YQ0!T]QX^LFL-&ETNQN]2N]8#FUM(]J/A!^\+EB
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M75P\,R1I%&^=G+D99@"0/3O7.>"O%B6NB1331W,PU;Q+<VD.\X:(,[LNX'H
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MEN+_ $N73)V8C[/+*DC!>Q)4D<CMVK0H **** "BBB@ HHHH **** "BBB@
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M/X<M(;O5-4QXELYWDO93/(BYP><<*,9_$UZ310!Y_P"-[L1^*M+M]7NM5MM
M>TE;.GF93-<AEVH[1?-C;N('&37$E)+3P>Z-8:A#_9OBZ*^N(98Y))8K<R;E
M8DY+\=2"3FO=J* /+M8U6VU3Q9,=3GUUM-EL8)-'M; W$ NG8MOW%-IW9V##
MD  Y]ZW_ (6%D^'FFVDL<D5S9[[>>.1&4I(&.1R.>HYKLJ* .'^)XN!I&BS6
MUG-=O!K=I,884W,P5B3@5DZCJDWB?QG;:EX:AN)O[&TJ];SI+9XU-Q(JB.+#
M@9;*Y(KTZB@#Q"UFLFN_!^JQOX@OI[>\C;5KJ\-RZ02-$Z[?+;Y0=YQ\BX4
M#/(SJ6ES:6_B2P;PM_;>GZC/J(&I:)+%(;=8RQ\V0@@HG'S!D;!XQG->MT4
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MU67PAISZUYOV\QG>9DVR%=QV%QV8KM)'KF@#F[7Q-K]Y\0/$NC2Z<!IUG;1
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M;4[7$MPMY-="&QD5",GS&V-DY4!<\'TH ])UC5;70M&O-4O6*VUK$TLFT9)
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M2$=RH(49Z9)KJ="1H_#^FHZLKK:Q!E88(.P<$5RG@/\ T/Q1XWTR7B<:L+P
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M[H0$6_F#*^;(J#G';=GIVK 6]D\3_$NUO;"QO5TT:+<VZ7=Q:R0J\C.A( <
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MCN)TN@)MXV[BD6WY@N[^\"<' H [&BBN"F^(&HO8ZAK.G>'#=Z!8R2))=?;
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M6QM88;H2*])HH \TU/4=6.K^#_%>IZ#>P00&\CN+>WB:>6W250(F=%&>0O(
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MBW-O;)]B?8ZRROAV?&U  Q)W$'C/0@U[-YT7EB3S$V'^+<,?G3@RL2 P)7J
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M ,(A8?VR;@WN'R;D 2E-[>7YG^WLVY]\UT%%% !1110 4444 %%%% !1110
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M7:" IYVA5Z^IXS0!R,L-OH?PUTCQ_#JUY)K;&VN+B>2[=ENC(ZB2$H3MP S
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MMI/!QG!K'\&^'-8C\566FZG9SII/A87(L;B53MN3*Y$9![[(\CV)H WM//\
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M$PR\Y[<UBZ+I6K>'M#\!ZS+I-[-_9=M<6M]:0Q%IXUEQAPG4X*C('.#0!?\
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M.SI7A*V\(:I/J&FZC/:Z)]F8SZ;*S2QJXY\Q"S$IQG(&0: -?1?#]KH,M_\
M89)EM[N<W'V9B#'"[?>V<9 8\D9(STQ6M7G?_"?:[#H$'BRZT2TC\-S,C$"Y
M8W4<+L%65EV[3U!V@]#UJY<^+/$-UXAU_1]#TBRF?2/*9IKNX9%</&'"@*I.
MXG(]!CD\T =%HWA^UT:YU"ZCDFN+S4)_.N+B<@NV!A5X  51P!VK0MK2"SB:
M.WB6-&=Y&"]V9BS$^Y))_&O/(?B-K$^A:5XG_L.VBT"\FA@DWW)-PA=@A<*%
MV[0YP.<D<\9XTIO%7B*^\4:YH6A:18R/I1A+7%Y<LB,)(PX4!5)W9S[ #WH
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M&:YC4O$6MS>(+S2?#FFV=R^GPQRW<EY<-&"S@E8TVJ?F(&<G@9% '645PO\
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M=7<OD^7#&,LV)D)Q^ )_"JGC71]1O]?\"S6EG+-'9:@)+ED&1$N!R?:O0**
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MS\A!4<GC!ZUZ'10!S7@'1+OP]X+L-/OPHO!YDTZJ<A'D=G*Y[XW8_"NEHHH
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M-2*0;/(6W9BQV$'H@X/ [8H ZRZ\1>*;>\TG019Z0VOWRS3RL))#;00(1R>
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M20E?P!'YU2\=VFHKKGA;6;+3;G4(M-O)6N(;7:9-KQE00&(!Y]Z &66NQ_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBLS7-<M- LH[BZ661IID@@@A4-)-(QP%4$@9ZGD@
M F@#3HH'(!QCVK,L]=M;S6[[1]LL-[9A7:.50/,C;I(F"<KD$>H(P0* -.BB
MB@ HHHH ***X37OB)?>'EDFO?!VJBT6<0)<":':Y+;5(&_/)QU'>@#NZ*XC4
M/'6IZ9X=U+5KWPG>V0LUC*K<W$6)2TBI@%"V,;L\BNU$B,S*KJ67[P!Y'UH
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M>#0 M%-21)%W(ZLOJIR*%D1V95=69>& .2/K0 ZBDR,=1Q065026  &<D]J
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MB>Y(< HX"@%#CC&Q3SGFC_A";22_T&_O-1U&\O-%,Q@FGD0M)Y@P?,PHS@
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M^[\:?^N9_P#1,E>DZMX.M-5U'2]06^O[*\TU&BBEM)%4O&V,JV5((.!Z5&/
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M4]"#D&G$@#). *Y+X7_\DQ\._P#7FE0?$QV?1=*L&9EM=1UBTL[O:2-T+/\
M,N1T!P ?K0!U\%Q!<IOMYHY4SC=&P89_"B&YM[G?Y$\4NPX;8X;:?0XZ5PVN
MZ'X4\)V&MZA"LE@D^G>3/I^FNL7FKNVJZH!P^6V[NGS<UD:!92:/\2M&@3PW
M8Z EQIEPKPVER)3,J&,J9 J*-P)//.<GF@#K? OBR3Q?H,^I36J6IBNY;?8K
M[AA".<D"NBCN[::$S17$3Q+G+JX*C'O7A'AUFD^&-GI[LPM-1\6K9W84XW0M
M)EE)'8X /UKM/&?AC0=!\+>*KC25CL9KC1I%DL+<JD3JN<2^6!]X9V[O>@#T
M<R(NW<ZC<<+D]3[5S7AWQ7)KGBGQ-H[VB1)HTT,:R!R3+O5CDC'&,5B^*&'V
M;X>C(R=7MB!Z_N)*YW3KVST_7OBW<W[7 M5, D^S-B4@QNN$/9CG /O0!Z['
M=VTPD,5Q$XBXD*N#L^OI6(GB==7\-W.I^'E@NIHY'CCCN91$K%)"A);G ^4D
M'OQ7"Z5I*V'CW0K&3PKI^BVM[IEW!/;0W"S&ZC CXF4( 2,GG+9W'FN=CTVQ
MM/V:]9N[>SMX;B=Y%EECC"M(%NR%#$<G X&>E 'NHN5BLDGO'B@^0%R7&U21
MTR>V:D$\1A$PE0Q'!#[A@YZ<UYK'96NO>//#^EZM!'=:?:^&UO(;:90T;3%U
M0L5/#$+TSTW5SOB*W33= ^(^AV'[C3;6\T^2VBCX6!Y6C9P@[#.#@<#- 'M<
M=S!++)%'-&\D?WT5P2OU':A+F"29X4FC:5/O(&!9?J.U>?7^@:7X>^)'@LZ1
M90V37(O8+AX5PTZB#<-YZN=P!R<G-9OA[2(/"VLZ+9Z]X=CBO/M+QVOB&RD!
M%Y(P<XFZ."PSPVX9'% 'K%1/<V\1(DGB0A@N&<#D]!]34M>9Z5H.G:Q\9/&%
MQJ%LES]B%A) D@RJ2&(_/C^\-O![9/K0!Z.;F 7 MS-&)R-PCW#<1ZXZTKW$
M,<J1/-&LDGW$9@"WT'>O#]/TG7/$'AJXU&R\+6LNM3W\MQ%K<E\BS)*DY  !
M7<JJ%V;<XP/>NJT;0M+\3^(_&EYK=M'/=0WXM(99/OVL21(5,;?P'+%LC'/-
M 'HKW-O' 9WGB6$=9&<!?SZ4OGQ>4LOFIY;8VON&#GI@UXOX:^R7_@;P-IKZ
M-_;M\T=U<Q6DTPCMMJN5:27<&!QO&T8/)-5+Y)A\+=?L?*2Q%OXH2&*"VEWI
M:CS(CM1L#@,S$<#Z4 >XF\MA%)*;B$1QDJ[[QA2.Q/8U@IXEFN/$>L:1:V\+
MFRL(KJ&4RX65GWX!..!\HY]ZYC7/#>C6OBWP9X:ATZ"/19Y;RZFM-N8YY8XE
MV%P?O'DGG.<<UGMIECI'B;XB6NG1)!;C08V$$8PD1*2DA1T4=\#^\: /3=,N
M[B?3+6744MX+N5<O'#-O0'T5N,\5:@N(+F/S+>:.5,XW1L&&?J*\5TJP@U/P
MI\*K.Y4M!+-*)$S@.ODR$J?4'&".X)%3^)8T\*7WCV'0(4L(FT*WG\JV41JL
MA=T+J!P#M[CTS0!["EW;29V7$38;8=K@X;T^OM4U>4>(O"NA:!<>!)=)M8;1
MSK%M"WD@+]H78QW/C[Q!'WCD_,?6O5Z ,MO$&G+XC&@F8?;C;?:=N1@+N"XS
MGJ2>E4O"OBB/Q!H<%]<"&UFFGGA2'S<EO+E9.,XSG;G\:YAM%TN;X^O++IUH
M\@T%+H,T*DB87!429Q]\  ;NN *Y.'PWI,OP1UO6);**34D>\EANG7,D)2=]
MH1NJC(S@8Y)]: /;YKF"V"F>:.(,=J[V"Y/H,U+7D5S%=Z_XXU5;GPO:^(DM
MM/M(XTN[I(U@$B,[,JLIY8Y^88(VBN^\$V6IZ=X.TVRUCB]@1HV'F^9A0Q"?
M-W.S;S0!O,RHA=V"JHR23@ 5&EU;RP>?'/$\/_/17!7\^E<Q\0)+)M&LK&[L
M)M1:]OHH8+&.41K<2#+A9">/+PA)Z]*\WU2*6RT3XEV+:7::3&NGVDWV&SF\
MR)'8."PPJ@$A5R .PH ]O2Y@DF>%)HVE3ED# LOU':D:\MD9%:XA5G8JH+@%
MB.P]37FFM:#I?ARZ\#ZGH]M%#?RZK#:S7,8Q)<QRQOYAD;JY.-V3FLS1_"VA
MZMX.\;7NH6D%Q=+J.I".XE4%[;:S,NP_P8/S<=2>: .]U;Q7)IOCWP_X<6T1
MX]5CG=IBY!C\M"W QSFM73;O4;B_U&*\M[:*"&4+;/#/O:1><EQCY3[<UY;:
MW=Q?^.?A-=W;,]Q-I$TDC-U9C;Y)/UZU1DO[K3+/XP7=D[1W"7*!70X*Y!4D
M'L0"3F@#VV*Y@G=TAGCD:,X<(X)4^AQTH6YMWG:!)XFF09:,."RCW'6N4M?"
M/A3PY=Z;JEDL6FRVL$B VY5/M:;,GS!C,F -WKD9K@K6".VE\':MIWAJ+3;>
M[U:(Q:E-=J][=1RAR?- 7D,ISRQQ@4 >F:%XGCU276$NA#:_8=3DL(RTO^MV
MJISSCD[NGM5_4+O48-2TZ&TM[:2VF=A<O+/L>-0!@HN/F/7CBO//#WA30M?N
M_'<NK64%V_\ :]Q"IF4-Y"^6AW)G[I)/48/RCTK!M;RYOU^#=Q=NSS,TP9V.
M2P"JH)]> * /2M*\63:GXU\3>'Q9QH-'2!HY?,/[TR)NY&.,=*F'B?\ LSP_
M8WWB)+>UNKFX6W\JUF$J;WDV+ACC(P02>W-<CH/_ "5CXE_]>UG_ .B*XW3=
M.LKWX(^ 6NK2"=AKB1 RQAOD>ZD#KSV; R.^* /H".:*4D1R(^ "=K XSTI1
M(C.R!U+KC<H/(^M>?ZA;VW@OXC:1J-O'%::1JUM_9EPJ*$CBEC!: X' ^4,@
M]A5SX;P/=V&I>*9U(N-?NVN4W#E;=?DA7_O@9_X%0!VU0QW5O+,\,<\3RI]]
M%<%E^H[5@_$"^NM-^'^O7ED[)<Q64A1UZH<8W#W&<_A7':[X=T?PQH?A/4]#
MLH+:_BU&RB6XA0+)<+(0KJ[#E]P))SF@#H9/&]U<_$"3PSI=C:2QVJ127EU<
M7>S <CY8U"G<P!]1SQQ7:5Y/X?\ #NB#XX^)D_LBQVVMM:SP+]G3$4A )=>.
M&SSD<YKUB@#D[[Q??G6KW2]!\/3ZM)8;5NY?M,<$:.RA@@+?>;!!/&!D<UJZ
M!K\.O:.;_P"SSV31R/%<07("M#(APP/;CU'&*YZ\\.7TNO:CK/@[Q-#:74T@
M2_M)8EN+=YD4#Y@#NC?;MS@YZ<5R^N>(M6\1:;I>E7^DV\]W%X@:PU"SBN-D
M%TT<32* S _(WRG:<_=Q0!Z[#-%<1"6&5)(VZ.C @_B*C2]M9(Y)$N862,X=
MED!"GW]*\>URQUK0?#GBBX32(?#^F7XLXOL]I=*ZQNTPCE=0H 3<C ' [9KM
M+KP-X4T^5I+6SM;-Y+&6W:RC"+'=H #ET(^<J0#GJ,\YH T/^$G?5O"D6M>&
MXK:Z:8J8X[N;R1M+8.3S@\<"M^>Y@M8_,N)HXDSC=(P49^IKP'5=/L[3]F6P
MGMK2"&:Y:W>>2.,*TK"7&6(ZG'K7H<NG67B+XMZC;:U:PWEMIVEP&TMKE \8
M,COO?:>,_*!F@#O?-C"JWF+M<@*<\'/3%-AN8+@N(9HY2AVOL<-M/H<=*\2N
MK5/[*N=!C:1--M?&]O:VP1R/)C?:61#V +MC'3-=A:Z/IV@?%^R@TBR@L8+K
M19C-%;1A$<I*FUB!P2,GGK0!Z%7$7_Q N8I]4DTOPU>:EINDR-%>WD<T<>'0
M9<1HQR^T=>G/2NWKB_$NIW>NWEUX0T# G>/;J=^1E+*-QT']Z5ES@=LY- %J
M^\:Q[M)@T33Y=6O-5MOMEO$LBQ*L& =[LWW1\P&,$YJ.+Q_91Z#J^H:E97-E
M<Z3*(+NR.V1_,;&P(0<-NW+@\=>U8FK:6Z^-_#N@^&[@:7>Z9I+O]LD02C[*
M&6,1&,XWDL <Y&,>]<S>K+8QZO8:E(+G4+3Q+IMSJ5^!M6XBD9"AV_P!0 NW
MGIU.: /1=)\77=QKEOI&MZ#<:/=7<3RV>^=)EF"X++E?NN 0<>F>:KS^.;N\
MU.\LO#/ARZUI;*0PW-R+B.WA60=45G/S,.^!Q3/&&6\;^!HXO]?]NN''KL%N
M^[\.15'X5R3Q_"Y8+-(GU>UENHIHIF*C[2)7.)" 2,Y7GT- '2>&?%,?B(WE
MO)876G:E8N$NK.Y W1EAE2&&0RD="*WZX_P[XCUZY\6WF@:]I^GV\T-DEXKV
M4[R AG*X.Y1S\IKL* (7NK>.=('GB69_NQLX#-]!WKE_&7C.3PY?:1IEA9P7
M>HZI,T4:SW'E1Q!0"6<X)[CM7(:/X?TCQ#\/O$6N:Q9P3ZM<37TDEW*H,MN8
MV<($8\H%"K@#%9FI6%EK>J_"F^U33K6XNM3@)OGEA5C<8@0C?D?-UR,],T >
MU6CS2V<$EPL:S-&K2+$^] Q'(5L#(ST.!5&^\0:=I^LZ?I5Q,%NKX2&(9& $
M ))YXZC%:$$$-K;Q6]O$D4,2!(XT4*J*!@  = !7G?BS1=+O_B_X0^UZ=:7'
MG6UYYOFPJV_8J%,Y'.TDX],T =/H7B>/5)=86Z$-J+'4Y+",M+_K=JJ0><<G
M=T]JW9IX;:,R3RQQ1CC=(P4?F:\ITOPQHVLVWQ!NM2L(;N9=4NXXFF4-Y0$2
M'*9^Z<GJ.>!Z"LRPDOM:N_"-O/H</B&.'PQ%<BVN[A43S&8(TA# AF 4#D<;
MB: /; 0P!!!!Y!'>H;V\M].L9[V[F6&V@C:261NBJ!DFN=\ Z9J6D:!-9ZC:
MK:*EY*UI;+.)A# QW*FX=E)8#V JG\7(YI?A9KBPJS$1QNX7KY:R(7_\=#4
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M4@LQ &X<C;[T >P45SO@:PU/2_!]E8ZLFRZ@WH%\[S=L>]O+&[OA-H_"NBH
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M!XDN=>3S/MEQ;I;/EOEV*21@>N2:BM_#.GVL.LQ1^;MU>5YKG+_Q,@0[>..
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MFAM8[^Y,J6R,-K!!CNO&3DXXS51/ACHZ6EO;F_U=ULW1K%GN\FRVG($7& .
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M,DUZ%I]O'::?!!%/-.B( )9I3*[^Y8]<UGGPU9,FHI)+<2KJ$ MY1*X?$8!
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M97EO<&.XB3 &T..HP .: +?A&RU;3=(DLM8U&._GAN'$<BR%W6(X9$=B 68
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MJ7_"+Z[?7WE>2EQ?ZK!,\<><E5S)@ GKW- '.^!/!]EJWP>N)(1!;ZKJ$=U
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MI;Q^(X=/N()KW1[=I-C2*5E81&3Y<') Z'T.:ZB&"*VA2&")(HD&%1%"JH]
M!TKR>VL+.*?XKR1VD"21(XC98P"@-KD@''&3UH ] T+Q+8ZK8::);ZR74[JT
MBN'LTF7>NY QPF=V.:T)]6TVVOHK&XU"TBNYO]7!),JR/]%)R:\NNM&T[3?
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M1+_6IM5ECNEFN0HNHHKJ2.*YVC"^:@(5\#C!ZCKFI;7P=HMDFB)!;NJZ+O\
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M2:L=!\,ZGJZPB9K*VDG$1;;OVJ3C/;I5?1_$UG?^&])U6]FM[%M0M5N5BEF
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M ",/QG_[!\7_ *325=O]+L=/\&_#N:UM8HIQJFFDRJH#DN/G);J=V3GUKO\
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M;'3UAL=0:1KF(2.?,+KM;DG(XXX(QVQ0!P=_I5CI_@OX>36MK%%,-3TT^:J
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M.T,3M&><# Y/'-:- !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %9&O^(;+P]%9O>S0PK=W MTDGD$<
M:G:S99CTX4X]3@=\C7JO>6%GJ, AOK2"YB#!PDT8=0PZ'![B@"AI_B&RU'7-
M2TF&>#[38%5DB\T>9R =VSJ%^8#/<Y]LZ]<?\0M/M8?!/B34H(1;WYL'9KJ
MF.5MBDJ"ZX) ]"<5S-[I!T*^\$:YI=U>&_O[N"SO1)<.XN8I(R6)4G VA<C
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M:6]S?V%K'<R+<2%%<N6"QJ1T)"$Y/ R/4XL:UXB.AZ)9WES9D7EW+#;16AE
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M^6I26/\ NL6+MN[X Z "H+?3+";XO:7(3]LSX<\T74GWIF6:,+(2,<XY].:
M.]L9-1>XO5OK>"*%)L6K12%C)'@<L"!@YSQ5VO(I]5U#0/#?Q,O-.EG>YM+\
MB!I)&D:(&.,$@L2?EW$_A6OK]M'H5QX/U3P^SB2ZU&"SGVN3]L@E4EFD_OL
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MAFO)XG8@1VT2Y9N.Y/ ]\UT?VV76_"ZW^A7,:2W=L)K265-R@D97</3L?QH
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M/K'4/$/AVST#4K.\M[R[DAN]AW,JB%W7'IDKU[X-;W_"6^'QKG]B_P!L6?\
M:6[9]G\T;MW]W_>]NM %/6?#<:6^KZEH]HDFN7=HT -S<2&.3@@*RDE<<G Q
MCFN0TKP;:DVZ:=X6UW0KV$KBZEU7,41&,D*LS;_IL /0X%=;I^O7D/C:^\.:
MIY;&2+[;ITZ+M\R'.UD;_:1OS!!XKIZ (YX(KFWD@GC26&52CQN,JRD8(([B
MLO3?"^D:2]NUI;R?Z,I2W66XDE6!3P1&'8A...,<<=*BC\:>&9=8_LF/7+%K
M[S/*$(E&2_\ =!Z%O;K4M]XKT'3+I[6]U:U@N$DCC:)WPP:3)08Z\X/Y4 /M
M_#NF6FM7&L0PRK?W("S2FXD.\#H"I;&!V&.*GU71[#6[:.WU&W$\4<@E12Q&
M'&<,""#D9X]^:O5R>G^(;W6]?US[))#!HVDAK0S.F3+= 9<YSPB<#'<YYXH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\_W=Q.W\,4 >>0:=K>J:!XTMFO?#]KI\VJ7J7DM]')YL7S?*Q8,%&%V%21P
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M/L+72[""QL85@M8$"11KT51VK'UKP-X9\17XOM6TB"[N@@C$CEL[1D@<'W-
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M##3 %I"/3>V3CVS6?#H=[I7CN\O[. 3:3K40^W)O"F"=%PL@!/*LO! YR :
M//$BL%_9@@:V6/S/*1XV7&[[3YX&1WW;N/I79^-MP\8> F7_ (^O[1D''788
M6W_AC%;$'P_\*6UU:W,.B6R26I4PXW;5*C"MMS@L.,$C/ YJ&/1;[4_B!_;F
MI0B&RTN%K?3(BX8N\F/,F.#QP H!YQDG% &+X(GGMH/'UW#;-=7\6NW;) #A
MI=J)Y: GUZ#ZUR-S?:AIEOX:^V^%]<_M.77DO;R>1(1]IG,<@*)B0]!@*#@;
M4KTBWT6^T?Q]=:E8PB72]8C4WJAP#;SQC"R $\JR\$#G(!KH+S3K34'M7NH%
ME:UF%Q 6_@D (##WPQ_.@#C?&C%O%_@&5%9+DZC)A3]X(86WC\L9I?AZRC5/
M'$DQ F&O2ARW:,1IL_#&:T8]%OM3^(']N:E"(;+2X6M],B+AB[R8\R8X/' "
M@'G&2<5%+X<N;7QK?7D%L+G1]>MQ#J<6\*8I$4JL@Y&0RG:0.<X- ''^&K[Q
M)K?B+6O&6F^'[34K+4#]CL9+F_\ (VVT3$<+L;AF&X^]:WPKN;S2)=6\%ZK;
MK:W.G2?:K2$2^8!:RDL%5L#<%8D$X'45Z!86%KI=A!8V,"06L"!(HD'"J.U4
M-6TZ**:77K+2DO-<@M6@M\.$9P3D(6) VYYY_#F@#G?A]QKOCA8_^/<:XY7'
M3>8TW_K3OB&%;4/!Z7(!L&UR+S@WW2VQ_+!]MV/QQ6QX-\//X;\/I:W,PGOY
MY7NKV<=))Y#N<CV[#V K5U+3+'6+"6PU&UBNK648>*5<@]Q^.>] ')784?&O
M33; >:VBS?:]O]SS4\O=_P "W8_&J7P6_P"1+N_^PK=?^A5U^B^&=&\/><=*
ML([=Y\>;)DL[XZ99B20.PS5C2M'T_1+5K73;5+:!I&E9$S@NW)//K0!R?Q>.
M/AY<$]/M=I_Z/2EN+:&?XXVDDL:NT/A^1XRPSM;SPN1[X)'XFNMU32['6M-F
MT[4K:.YM)QB2*0<-SD?J :K:;X;TC2)8);&R2&2"W-M&^YB5B+[RN23QNYH
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M: /.?%UY>7WA/QU=V<>CZ?I27$UM<>="\EQ=3(%3=NW!5)( 7@] :Z.P<O\
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MR/,*GJ.2* .WM?&'A^\TF[U2#5(6L[/_ (^7(*F'O\RD9'Y4EGXR\.ZAK/\
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M.$D4D[8V/0,V-JGV)%=#7DVA/9)\#?$(U$QB=?[16_#XW>>7D^]_M?<QWZ4
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ME6-CKVLZ=ID.E7-Q%%+8J)!=6R2L%4EB=K,"1E=HKT.21(8GED=4C0%F9C@
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MNR(\89(^2K8W GOG:O7T%;%% '/0>!/"MM;M!#H-BD;2K,0(A]]<[2#VQDX
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M]O')+:.9('89,;$%21Z<$BLU_"'AV36QK+Z-9G40XD\\QC=O'1O3=[]:VZ*
M"JD6F6,$UY+%:Q))>L&N6 YE(7;EO7@8JW10!G?V%I1TRVTW[!!]BMF1H8-O
MRQE#E2![&JVI^$/#VLZ@E_J6CV=U=( !)+&"2!T!_O >AS6U10!DZAX7T+5=
M2M]1O]*M;B\MP!%+)&"5 .0/< \C/0TMGX9T33YXI[/3+:"6*266-D3&QI
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M7J/AS1M7O[2^U#3;>XN[-@UO,Z_-&0<C!^HS6I10!071-,32Y],6QA%C/O\
M-@"_*^\DOD>Y)S]:JZKX3T#7(K>/4])MKE;9=L.].47T!ZXXZ=*V:* ([>WA
MM+>.WMHDA@B4)''&H554=  .@J2BB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHKE?$6N:M'XDTWP[H@LXKN[@EN9+J\1G2.-"HPJ*068EAW&!0!U5%<SX3U[4
M-3NM8TO5HK8:AI-PL,DMJ&$4JL@=6 8DJ<'D9./6NFH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
(B@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>employementagreement_mil009.jpg
<TEXT>
begin 644 employementagreement_mil009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M\0RV=R@N$REK$AEE+$D! %')X^@[G'-6M#N-9N_M=SJMHEE$\@^R6I96EC0
M9,C*2NXG)P"<#')JOX0TZ[TOP;86%Y%Y5U%$5=-P.#DGJ#CO0!>T#5AKOA[3
MM66$PB]MTG$1;=LW*#C/?K61%XLN+K53#::29[!;LVC7"W \TLK;'=8L<QJV
M06W \$X(%1:'X<U)/!?AW3Y=4OM)NK&RCBGCM#"VY@J@ABR.#@@_=]3UKG4\
M'75M=264&A 7AUO^T(M<#QXCA,WFL,[O,W;2T>T+M.<YP30!V%QXJMHO&-GX
M<B@>6::-WEF!PD)"[@I]6(YQV&#W%%GXJ@OO%L^@P6MQ^XMWE:YD0HC,KA"J
M9'S8)Y8<<8YYQSMOX,UW3O$VB7,>L"[MH;BXGNI6M45R9 ,[CNRQ;[H('R@#
ML!72-I]T?'L6I"+_ $-=,>W,FX?ZPRJP&,YZ \]* ,W1O$_B'7+."_M?#EH+
M*9V"N^ID/M#%2=OE>QXS4U]XLO+"XDGFT25-)BO$LVNI)MLA9G5 ZQ%?F3<P
M&=V2.0"*Y/PWX<?2+6U6]\ 7T^H03,YNX[NWVD^865@#,#P,=NU;$XU[4/%Q
MGU7PU?SZ=9W/_$OCAN+;R1C@7$@,H9FZD#'RCL6Y !H+XU<ZJ(O[,QIQU(Z6
M+G[0/,\\9&?*Q]S(QG=G'.,<TZU\9O<7=K*VF%-(O+Q[*WO?/!9I%+*"8\<(
MS(0#DGID#-<ZGA?41K*R_P!C2#6AJYNFU[SDV-;>9G;C=O\ ]5^ZV;<=\]ZN
M66AZPMMI/AZ339$MM.U0W;:@98S')"DC21A0&W[R2H(*@##')XR :NC>)M>U
MN)+NU\/6HL'N)(O-?4B'VI(T;-L\K_9)QG\:?IWBN\U37)[.UTN VL-S);M.
MU\HD(C8JS"+;G&X$=>U5/!W@FSTVQAN]0TU8]66ZN)2_FDD;IG*'@X^Z5J@W
MA^[N-2L88O"UOIUU;:M]LEU6 QB-X@Y9L$-YA:13M*D8Y/. * .DLO%5O?\
MBRXT*"UN/]'MVE:YD0HC,KA"J9'S8)Y8<9&!GG&<GC#5+NQ?6--\./>:*K-M
ME6YQ<3(IP7CAVG<."0"P)'0<BM)]-N6\=KJ/E?Z'_9;6YDW#[YE#8QG/0=>E
M8&E_\)1X=\-Q^&K+07N+FU0V]GJ)GB%L8P<))("V\$#&5"G)'!YH W=>\66V
MB7NDV?D27%QJ-S%$$7Y?*1W"^8^1P 6 QU)^AQT%>>:]X+\03W@O;/65FFGU
M*UGE#6B9B2-AC!+?=3EMO<D]R:]"&0H!.3CDT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4KK2-,OKJ&ZN].M+BXA_U4LT"NZ=_E)&1^%7:* "BB
MB@ HHHH **** "F0PQ6T"001)%%&H5(T4*J@=  .@I]% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,:-)++;&..-%+,['H !R30!H77BO1-*NK73[J^<74T!EB0Q.[R* .1A>6Y'
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M_:G]IW%RL/V63YXFG0JRMC:V0<X!SCGI7H'BJWFE\;>"I8X9'CBO+@R.JDA
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MQ-OGT"?7X/"\TFE6<LD=Y*;M59 DA5C&I7YP  3TZD<X-:^H>,;]=5N[+0]
M?51901SW+BZ6(@2 LJHI!+L0,]AT&: .NHKE+_Q;?'4UTW0]!DU"[2T2[N4F
MG%L(%?.Q22#\YVM\O&,<FJP\>R:C%I2:!H[WUYJ%M)<F">X6W$"1L$<,Q!^8
M.=N #T- ':451T>_EU/2H+N>QGL9G!$EM./GC8$@CW''![C![U>H **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ KD/B%9WDNGZ1J5G:RW;:3JL%]+;PKNDDC7<K[1W8!LX]JZ^B@#S;
MQ-?ZAX_\+Z]IFC:1=K:I;1R07-W$\#7$ZR!_*5' )&$QNX&3CWIVI:HWCC5?
M#%IIVFZE#]BU&/4+Z2[LY(5MQ&K?NR7 #,68#"YZ$]*]&W+ZCKCK2T >70:;
M?#X9^/[8V5R)[B^U1H(O*;=*&)VE1C+ ]L=:TM7L;N1?A[LM9V^S7D33[8R?
M* MW!+?W1GCFN_I"0!DG H \?T7Q&-,T+QEI[:9J,]S<:QJ*V8MK1Y5G9G*[
M=R@A2#UW8XP>:B'A6W\/7NCR>([359;/^PK>S:;37N#Y-Q$265A <D$/P3D9
M!KU#0-!AT"&^CAF>47=]->L7 &UI6W%1CL*UJ /,;71TAO? TNFZ)?V-K_:-
MW<2Q7)>62+?%( \C,25+'!P3U;'6K>JVTL7C;Q1=SZ'<:G8R:-;1M L>1<#S
M)-ZKGAF"G.!ST]:]#R,XSS2 @]"#0!XZ@U*VL=>C\#G7_P"RUTIC'%>1R@PW
M&]<+;^: ^?+W\#(SM[U/I,&G0>/?#NI:/I6MKIQCGMIKV\CN79YG5=NX29*C
M@Y? 7)Z\<>N44 >&>1>R? ;7/#(TO4O[6M)'WP&SD^?==[QL.,/\O/RYKK)?
M.\-^+M&\0W=G>2:=+H2Z=.]O;O*UO(KAP7106P<D9QU'->CT4 >.ZMINHZOI
M'BS78M-O$CU74].^RV[P,)6B@>-3(4QD _,>1G R:[/7[6XE^)'@ZYCMY7@@
M2^$LJH2L>Z- NX]!G!QGK77T@((R""/:@"AH^JC5[22X%E=VFR:2'R[J/8QV
MMC<!G[IQD'N*T*** "N(\36=U-\4/ MU%;326]O]O\Z5$)2/=" NX]!D\#/6
MNWHR,XSS0!R'BVUN+CQ3X-EAMY9(X-0D>5T0D1KY#C+$=!D@<USWC#P[J.N>
M(O%EO:VTI^U>'H8H)"I"22K+(VP-TST[\9KU"CK0!YIX7LO#MWXCTZ>PT+Q"
MMY;(\LDVH3702S<KM*XF;:S'<1\N?6O2Z** /,=,UF[\$CQ!I,NB:E>7\VI7
M%WIRP6SO'=+*=R@R %4P20V[&,9YJU;W\WA'QMKU]K&GWOV;68K6>*6SMI+E
M5E2/8\1V*2#D @D $&O1** /([?2[:W\+I)XJ\/ZB8-3U6[U+?;)(9M-:1LQ
MY$?SJ2.XZ'@U#J$6LR> [.YFBU>^M;#Q'!<VS7,+-=M9(X(9UQN)R6ZC.,$U
M[%10!Y?XKN=%U.]^W2Z9XBL=1-HK:=J>G6TZRS @D1D*O!#?PR#O[UW^@-J#
M>'=-;5@!J1M8S= 8XEVC=TXZYK1) ZFB@#B?&$<^G>+?#?B46EQ<V-B+FWNQ
M;1-*\2RJNV0(N20"N#@=#5&P2XU_Q+XE\1P65W#8/I*Z?:&X@:)[AAO=F",
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MDL,;R X;Y3VQWK6NM%TZZ\)>+9/#WA?5K:2733;Q37?G^;=$Y)1(I"6P#CG
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M !1110 5QG_"N+)F6WEUC5YM(2X%RNER3*T.X-O )V[R@;G:6Q79T4 %%%%
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M** "BBB@ HHHH Y_Q!X4A\2W-N+_ %"]_LZ,JTFG1LJPW!5MP\SC<1G'&<'
MKH.E%% !1110 4444 %%%% !1110 5E6&@V^GZ]J^KQRR--JAA,J-C:GEIL&
MWCN.N:U:* "BBB@!DR-+!)&LC1,RE0Z8RI(ZC/&16+X>\+V^@2WET;NZO]0O
M65KF\NV!D<*,*OR@ *.< #O6[10 4444 %%%% !1110 4444 %%%% !1110
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M]JKG]-\)VFG>)/$&LB:29]:$(FA<#8HC0H /7(/.: /./#<&ILOAG5=/T'Q
M-3FE@EU+4KBX1H;J&0?O25\T_+\VY?E&-HZ52MI-5UG1Y]>L= U^X\227DDM
MMJ,<Z"!0DQ B"F4?N]J[2"O)S7HVD^")M*GL8AXBU*72=/?=::>=BA."%5G
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M>LS2,7MK6:U\G *.LA7.?^^?UK)TGP3-I4]C$/$>I2Z3I[;K2P.Q0G!"JSJ
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M8@K)C*G(_P!K%4] \*-X>UG5+JVU6X>QU"XDNVL7C3:DSD%F#XW=NF<<UT=
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M;Q!>:MIFNWNEMJ"(E]% D;";8-JL"P)1MO&1[4 4OA$&7X:Z<'D\QA-<@O\
MWC]HDYKN*Q_"WAVV\*>'K?1K2222W@:0HTG7#.SX_#=C\*V* "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT^S;V*[ HBW1H HY'S-[^F*W/ /AMO"G@RPTR8[KL*9;I\Y+3.=S<]\$XSZ
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MSC/-!95(!8 GH">M 'FTUA:W/A^/39]/\6R7,=U]MCU%H5\]+C.=XYVCJ1M
MQCC%0KH]I/INLV^J6'BO4;O6(5@N;R:UC5PBYVJ@7"J 23C')ZYKT\D $DX
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M')8\G.22<^N:T[JU@OK.>TN8UEMYXVCD1NC*PP0?J#4K,J#+, /4F@D*"6(
M'4F@#CK+X?102Z='=ZYJ=_IVF2++96-P8]D;+]PLRJ&?;VR>,#K6WIGAZVTO
M6]9U6&65YM5DCDF5R-J%$V#;@>GKFH[;Q!]I\8WV@"V %K9PW0GWYW[V88VX
MXQMZY[UMT %8.N^&!J]_:ZE::E=:9J=LC1)=6P1BT;8+(RN"K#(!Z<$5O4C,
MJXW,!DX&3U- '+/X*VZ?91VFO:K;WUI))*+[S%DDE:0Y?>K*48$XXP,8&,5!
M<_#RSN=!6P;4[\7@U!=4_M'*><;D='QMVXP ,8Q@"NP9E099@!ZDUC:-K_\
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M:\A6VN'C5I8O,#B-R!E=W?!XSWH I^'-#M_#7AZRT:UEEE@M$V(\N-Q&2><
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MJ!U*"YCD42Q3%V?(.W&,L1@CI746L#6UI# T\L[1H$,TI!=R!C<V !D]> *
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MZ'WKH: /-(]!TF7X]W<TEA TJ:/%=JQ7D3><R[_K@ 9]JY&'PWIA^!E[X@:
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M*0G$"-$'9E'9F9OO=>!5MOA5I;Z7)I+ZMK#:3O\ ,@L?/3R[=MV[Y?DR0#G
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M(IHH9+ET)99-N0VU1G&P8Z=\YH \\U*S@T?0_BKH^GQB#3K:&&6"W0_)$9(
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M!@N(Y'!V%E!*LO&#C![UQ=II6M>(M"U#4;/PK#/K<^H3RP:V]]&DL,D<S!
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M2RBN1((X),>:@*XVJ77.!C[Q% 'I%SXD6+Q9I&C0QQS1:A;W$WVA9,[?*V<
M#KG=Z]JUM0O[?2].N;^[?9;V\32R-Z*HR?Y5P$FA:5H?QA\.KI5I#9QRZ?=E
M[>W4(@(V#=M' )Z$]]H]*Z#XCVMO=_#CQ$MS!'*L>GSRH'4':ZH2K#W! (-
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M\>X'VBV(4*%1@H&W:,8((.3FM/0?#%GH$MW<QSW=Y?7A4W%Y>2;Y9 HPHR
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M\N3+*(2"-BD_=')/ Z\G-;>FZ?!I6EVFG6H86]K"D$08Y.U0 ,GZ"@!FK_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*R/$NOQ^&]'-\]O)<RM+'!!;Q$!II78*B@G@9)ZGH*UZPO%EAI&JZ.NF:S=&
MVCNYXX[>5)?+D$^=R>6?[^1D?2@"A9^)=?BUBRLM<\,?8X;UBD5S:7?VE8W
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M<J[D'?U!#* /I0![/7*:CXIU1O$%WHWA_0TU&:Q2-KN6XNQ;QQEQE4'RL6)
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MU&XLK.UTV>"*&:24)YGF1!^2QQGGC%>9:/;6^I:;\,C>V\5T/MUW;*\Z!S)
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M/K7BGBJWCL?#WQ*TNP40:?#J6GR0)$,+')(83)M X'..!77>(]!TFR\1>"=
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MKHC2JRS%(@^Y0K9* G:3Z@UN:1XETS4EM;;^TK$ZG);I+):1SJ9%)4,?DSN
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MJ_E6EKF@Z?XALDM=0C=ECD6:*2.1HY(I!T=&4@J1ZBK-WJ5A8$"\O;:V)1G
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M(WPKED8L[Z3.S,3DDFVY-=Y=^!] OM7GU*XM)'EN"&GB^T2"&5@,!FC!VLP
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M;+YT)(P=DF[<HQQ@''M4Z>"]!CTNVTY;(_9[:[6^3,SEFG4[A(S9W,<^I.:
M-BSL;33[9;:RM8;:!?NQPQA%'X#BIZ** "BBB@ HHHH **** "BBB@ HHHH
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MQQ-MD:WF5PA]\'BF:9XBT36IYH-+U:RO98?]8EO.KE?J >E>7^-%>QUGQ_\
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M8WEP@),<,RLV!U('<>XJ*Z\:^%[&5(KK7].AD>1HU5[A0=RMM8'GC!!'/<4
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MHG\4Z5:Z!::QJ=P-+M[E%95OOW3JQ&=I4\[O;VH 9-X-\/S^%T\-2:<C:.@
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M*LT9BR " 5(XP!QTXH \L\67EY=^!?$^HV5OH^GZ0^HNI$BR/=3S),$,F[<
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MF,YS7%IJ-IKWQ2\,ZAAFL9M$GN-/\^,J?-+IN(!_BV?I6O\ \*Q\%B]^U?\
M"/VV_?YGEY;RMWKY>=GZ5LZSX=TG7[>&#4[))DA;?$0S(T9QC*LI#+QZ&@#R
M3QDB+:_%.*V 6T)TUF"<*)B5\S&.^-F?>NM\1Z58+\3/ ,*VD*Q11WJH@0
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MS M,  '!!RK8 Y&*;;^#O#]KHUUI,>F1&RNSNN(Y"TAE/'+,Q+$C P2>,#%
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M_H:U@+96UO\ LU6$L4*+(/LL^\#YO,-RGS9]<''TXKUM="TQ=;FUE;11J,T
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M:+:9&(52>R@[?PKI*@L[.VT^SAL[."."VA0)'%&N%51T %3T %%%% !1110
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M.N* .JC\2Z)+I,6JQZG;/82R+&EPK@H79MH7/KGC%48O'WA.>.[DCU^R9;0
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MQ?X>\/W4=KJVKVMI/(-RQR/SMSC<?09[G K;K@/#OV-O%'Q 75?*W_:(_/\
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MC(VXSN_"N*TW3KZ;3O">H^']3T^/6[?0(8VLKY2R30,J'/RG<GS+C<,^E5-
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M997,@#'Z]1^)H ]%TK5M/US3X[_3+N*ZM9,A98FR,C@CV/M6)XI\=Z1X2O\
M2[._FC62^FVMN?;Y4>&)D/!R,J!CWJE\/%5)_%Z( J#Q%<X Z#*1D_J347CO
M \6>!2?^@JX_\A-0 1?$&PL/$WB*VUK4[6VL+22V%D6&&8/ )&/')Y.<]LUT
ME[XGT/3M(@U6ZU2VCL;C;Y,^_*RY&1MQ][CTKG/#-M WQ/\ 'D[1(TI>RCW$
M9.W[.I(^A_H*Y/PA=7+>'/!.EZ9;:>-1<7\T-Y?1M(MLB2LK!%4J2Q#@=1@
MT =QK_Q$T'1?"B>((KN"\MY7$< CDQYK;@",X.".2<CL:Z33]0M-4L8KVQG2
M>VE&8Y4Z,,XX_*O$;^5W^&?C,S75O<NOBB/?-;Q^7&QWVV2JDG SGN?6O=Z
M.&O/$/BR\\:ZKH6@P:*(M/A@E:2_,H9O,!/&S/3::U;'4==TNTO+[Q?+HMO9
M0H&66Q:4[>>2^\=.G2N2.B-K/Q<\4 :YJ>E^5:61S83+&9,J_P![<ISC''U-
M=AI^CVNB:7J U'7+[4[22,M.VJ3)(L<8!W=% "D$YS0!J76L:=9+:-<7D*"\
MD6*V^;/G.PR N.N15*?Q?X>MM:71YM7M4U!F">07Y#'HI/0,>P/)KS+X?;8_
M%FG'5ENET][:4>$_M1!"P[VW ]_,*;-N?X*CLM,UO5/ ^OVTVK:#8V,NI78O
M);N"3SHIO/.&9]X4,/D*G'3;0!ZCK/B[P_X>N8K?5M6M;2:4;ECD?G;G&XCL
M,]SQ5Z/5;"6_2QCNXGNGMQ<K&K9+19QO'MGO7&>&A;_\)CX\35C$TP>W$IEQ
M@VWV<8Z_PYW_ (YJMH#Z3_PLW3/[%(&EOX7Q9_> *"X&,;N>GKVH WO$_C_1
M?#6B7FH/<17#VUP+4P*^TF;Y<IG!P0&W'VJ1_$%O>ZUH#:?X@LEL[X3%;8Q;
MGO-H_P"6;9^7:02>.:\RUNXAN/A]\09H9%>(^)TPX.0</;@\_A75>,/^2S_#
MW_=OO_15 '?:=JECJ]BM[I]U'<6S%E$B'C*D@C\"#69<>-?#=KI=MJ<VL6JV
M=T66WEW9\W:<-M Y.,<D5YUK%_<>$9O&'A:RXN-9ECGT=?\ :NCY4@'IM8%J
MT/['U/1OB'IFDZ!-IL(L_#J16YOX7D# 2D2%0K+AC\A- 'IEG>6VH6<5Y9SQ
MW%M,H>.6)@RL/4$5R^L>+DT/QU!8:A>06VDG2I+J1Y!@^8)41<'Z,>!UJ?P%
MISZ9H5Q"VH65[OO[B7-B"(HBSDM&H).-K;N,\5G7MO#/\;=*>6-7:'0YY(R1
MG:WG(N1[X8C\: .BMO%&A7>A2:W!JMJVF1Y\RY\P!$(Z@YZ'D<'GD4[2?$VB
MZ[:SW.F:E;W$5N<3,K8\OC/S X(XYYKS:2Z6RN/%5K'86ES+>>*+>"WCN@?)
M29XXV$C@<G!7.!U.*S?$[ZJESX_BN;ZSNKY?#T F:Q@:%0-\F0078DA"><]"
M.* .UU3XAZ=<W.AP^'=5M+IKG5X;2Y5?F/E,KY(SVRH^8<5W=>:^,?[+#?#H
M6ODY_M:W^R;,?ZGRSG'^S_J_TKTEONGZ4 <ZOCWPH]U:VRZ]9&6ZV^2HD^]N
M^Z,] 3V!ZU:UGQ9H/AZ6.'5M4M[6612ZQN<L5_O8&3CWZ5Y6EK!#^S &CB56
M*+,6 Y+_ &D?-GUX'Y5VGAL)_P +1\;?:=OVG;9^5NZ^1Y7\/MOW9]Z .SM+
MNWO[2*ZM)XY[>50\<L;!E8'N".M4-6\2Z+H38U74K>T/E--B5L90$ G\V _$
M5SGPKQ_PC%]Y&/L/]K7GV+;]WR?-;;M]LYJOX@M8+KXS>$_/C6016-W(H89
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MX]\5Q^#_  G>:D&3[6(V%JDBL5>3' ..W?MTH 6/X?\ A.*":&/0K18YF5V
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MZ6,?G7(*.K1Q_P!_:0"5]P,4 .M/!'AFQU4:G;:+:Q7:N9$=5X1CU95Z*?<
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M,]0<$$'D$>AJ]0!B:SX/\/>(;F.YU;2;>ZGC78LC@@E<YVDCJ,]CD4NK>$M
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M3K+4XHXKZUBN8XY%E195# .IR&P>XH X3Q=>0VGQ'T2\AC$[VNCZA/=QIU:
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M, U%XO):Z"#S"G'RYZXX'Y54U?PIH&O7,5QJVD6=Y-$-J/-$&(&<X]QGL>*
M&>#[-=/\':/9I?+?QPVD:1W2# E0+\K 9/&,5A:##$WQ=\7SE%,J6EBBOCD
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MP,GCDG\S7>5AZMX6T_4M'O-.CAAMTO+E;F=EB!WN'5BV,CYB% SVX/.,5N4
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M&A^*L<^JQZE,NDQ!KB.$1*Q$4P( !(./ND^HQVKT+X>?\DX\-_\ 8-@_] %
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M8NM-U=W\.7D]MJ5M"(YA&J@%9%!( 8LI!! .T\5/J\,</@7X=)&BHJ:GI6T
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M('7:G49Z<5V&F:==2>.M.O=1\6V&H7<-C-Y5M:V(B9X7*98L)&^4,%QQZXH
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M1+B_>_FT?3Y+R1"CW#VR&1E(P06(R1CCZ5H111PQ)%$BQQHH5$48"@= !V%
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M^(7A]-3-F9KGRQ<?93>?99/LPFSCR_-QMSGCKC/>K_A#)\$Z#SS_ &=;\_\
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MC=%46YR37=0S1W$$<\+AXI%#HPZ$$9!H ?1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(YH M4444 %%4=0UBPTJUCN;VY6.&29(%< L#(S;57@'OQ5Z@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"!EFY.#TH [*BO*;GQ)XGTS3?B%%=:HLMUHD,)LIU@1<;HRVXC&"3QG/&<X
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M4\EM&))UC8QH3PS <#\30!,3@$GM5+2-6LM=TJWU/3IC-:7"[HI"I7<,XZ$
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M6VF7$<QGUW3[9'25PR^2"2K+&&4DDXP2,# H ]-HK+\.27,N@VLEWJ5MJ4C
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M["@##U3PO>7?A+1[*VN8(M4TEK>>WD<$Q&6)=I#=]K L/7G-07OA_P 0^*-
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M8P1-[ ;F/0#U/!XH X*\\'^(G;Q-IMG=:=%I>NRR3/=/O-Q'OC"-'MQM(^7
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M Y^;0;F3X@6FOB2(6T.FRVC(2=Y=I$8$<8QA3WKH*** .$7P3J"_#[Q#X?\
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M>-Q_US;^5>2>%?#7B+Q%\*]$T5[[3UT&YBB>:0J_VD1A]YC ^[U&-W''8]2
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M<R(V$7:<# SGOBNW\!ZK>ZQX5BFU RO<Q32P&:6 PM.J.0DA0@$;EVGH.<T
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M5KKFMZK:ZC;3&Y?4K1XHVD1599(2T:\'YA@9&"*Y:S_Y(C\1/^PS=?\ H45
M'NMG=Q7]C;WD&3%/&LJ9&#M89'Z&JMOK5G<Z[>Z/&7^UV<4<LH*_+MDW;<'O
M]TU'X8_Y%/1O^O&#_P!%K7$MI-WK'Q;\101:M>:=;#3[-I6LF5)7;]YM&X@X
M'WB<#GCGKD ]+HKQQO&>IQ:19Z)J.K7<4J:W=Z;=:G;6YDG>& %@555.';*
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M$@@AER/K5.'X=WS6.N"[UA'U"_OX=1@NHX<"">,*1\I/*[EP!G[O?/->@T4
M<D?#VNZYI^JV?B;4K1K>]M#:I;:?"52/.<RDN2Q;D8' &.]93>#?%.HC0(M8
MUK3G@T6]@N(Q;6[JUQY?&9"6.&QG@<9)/I7H59^CZJNL6CW"V5[:!96C\N\@
M,3G'\0!_A/8T :%>.>$?#WB+7?AJ=+M=5LH-(U&>Z2<R0,T\*&=U=8R#M(8
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MRX)]Z[G0O#\VE:MKFH3W,<KZI-%,52,J(RL2H1R3G)7/XUQOB+3M+\*_!_\
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MI)?!NLVVHZRFD:W;VNDZS,T]S%):EYH790KF)MP W8[@X- %OX8?\DQ\._\
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MBO/I+6X\'^-O#=O::KJ=W9:LTUM<PW]V]Q\ZQEUD4L25.00<<$'I7)HNKO\
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MAT;5?MF?[-T][+R_+_UF[9\V<\?<Z8/7K71T4 <W9>%#9IXF7[9O_MN=YO\
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MLLQ8[<CK@9-==10!QND>$-:T@V6GQ>)"-"L90\-NEMMG9 25B>7=@H.!PH)
MQ4-WX&U9+C5H=&\1G3M+U>9I[J$6N^6-W $ABDW#;NQW!P>17<44 <G_ ,(C
M=VOC6'7M-U58H39Q6=U;3P&5I41B05?<"&.<9(/K6?8_#2&W\):OH4^I.YOM
M1?4(KF.+8UO(2K)@$G.TH/3/M7>44 <G8>%M5F\0V.L^(M9@OY=.21;.*VM/
M(16<;6D;+,68KQV R:A7P&5^&5QX._M'F9)5^U>3TWRL_P!S=VW8ZUV5% $+
M6T4MF;6>-)H6C\MT=05=<8((/4'TKE]8^'>@:G-I;P:7IEH+.]6YE5+&/]^@
M5E,9QC@E@><_=Z5UU% '(:CX2U2/7+O5/#>MQ:4]]$D=W%+:"=&*#:DB#<-K
M!>.X.!QQ3O\ A#;C3O#>EZ9X?UJXT^XTZ0R+,Z^8MP6R7\Y,C<&+$]>#R*ZV
MB@#AIO >H76AZ]'<:]NUK6T6*XOUML+'"O CCCW<#:6&=V<L377Z9I]OI.EV
MNG6B;+>UB6&-?15&!_*K5% ''0^"[_3#XE&BZZ;!=7N%NH +8/\ 9)>/,89.
M&#XZ8&*[&BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "N/\ B1XSD\$^&X[VWACEO+JY2UMQ+G8K,"=S8Y( !X^E=A7-
M^./">E^,?#<FG:K,UO#&XG2X1@IA90?FR>,8)!SV- &/I?C"_MOB;=>"]7:*
M<M;"ZLKM(]C,,99&7)'9L$8X%=Y7CG@[2;K4OB-?^-K^^FN])TVS^RVE_+$(
MS=$+AY%51R@^?GOD8]O2O#'BG2_%^CC5-(E>2V,C1DNA0AAU&#]1^= &S111
M0 4444 %>;?%/Q9X@\,WV@1Z"T9^T?:IKB)XPWFI"BR%03R,J&''K7I-<!XR
M57^*/P^5@"IDOP0>A'D"@#JQX@T\^&/^$A\X?V=]E^U^9_TSV[OSQVK@?A]X
MQUWQ!;>*G\0S_9UM(HIX1#$ ]O'+$T@[<D+MZ]Q6$MI>+J)^$NR3[$=1^UB7
MG']F?ZW9GUW_ "9_"MS3U"^(_BPJ@!1#  !V_P!%:@#H=,\7Z58^$=&NA>ZG
MJYO@RVI%L9+FYP26)11V Y/ QBK[^.=$308]7,MP8Y)S:I;BW?[0TX)!B\K&
M[?D'C'OTKSWPS'I<GPW\$?:->DT+5$BG:PO@%V Y(=&WC8001\IP3CCH:D77
MY[C4/"VM:S<VDEAINLWEE-J4"[()BT16.;J0H+$J3G .>: .]M_'6AS:1?ZC
M++/:+I[!+N"Z@:.:%FQM!0C)+9&,9SGBHU\76FJZ5K$=HE[9:A9VC3&WO+=H
M954JVUP&ZC(/([CFN3\<:QI>N:9=SZ+,$&F:I82:AJEO"DB;0V<AN1)Y>02"
M"!4T%O:3ZGK-[_PF+Z_?PZ'-$P2"(1QQ.=PR\2A=V5. 3G!)Z4 8L_BO75^#
M/A+5UU.<:A=ZE#%//D;I$,D@(/X ?E7I&L^,=.T;4AIK07][?>5Y[V]A:O.T
M<><!FV] 2#[UX_<_\D!\#_\ 86@_]&2UV^K:[)+XZUNQNO$L7ARTTZW@9&CB
MA\Z[WJ6+;I%;(4_* HZT =-<>.O#UMH.G:Y)??\ $NU"98()@AQO(;AAU&-C
M YZ$8HTKQMI>JZT-($&H6=Z\1FACOK1X/.0=63<.<>G7VKRG3)89_ ?@RV:0
MR30^,T6>.7 D0F:8X=1]T]\8%=[XG!/Q9\#[3AC!J(S_ -LDH U8O'VB3:FE
MFIN_*DN#:1WIMG%L\V<>6)<8)R"/0D8S1JGCS2-+U"ZLC%J%W)9J&O'LK-YD
MM@1D;V48''..3BO,_#UG#<>"]+T;5?'$UNR7<=L^CI:PM*EPDV0N OF?> ;=
MZ<DXKJ_#&MZ5X;N_&EMKE];V=PNKSWC)<.%:2!U4HR@_>&!CC/(Q0!V \4:2
M]]HUI%<^:^L123631J2LB(H8G/;AA3I_$NEVNL76ESSF.XM;+[?,64[$AR06
MS^!XKR;00?#_ /PJFXUAA9P)!J"M)<'8L9E4-&K$]"1@#-;$^JZ)JWQ-\232
MS?:M)3PP8;F2 %PZ>8V_85SNP"1QW!'44 =MHOC/3-<OELX8K^VFEB,\ O+1
MX1/&,99"P^8?,/?D<50^(&JZMIMOH,&CWJV4^HZO%9/.T*R[4=')^4^ZBLCP
MOJDUCXGTW1+3Q-;>)-*N+262)\(;BS5 NW>Z<,K9QD@'(J?XJ6QO8O"5LMS/
M;&7Q#;H)H& DCS'+RI((!_"@!+Z^\5^#]2T:74];MM9T[4+^.PDC^PBWDB:3
M(5U*L00".01T_35U'XBZ!INKWVD.;R?4K-HU>UMK5Y9'+KO&P*/F^7DGH*++
MP%:0ZK:ZCJ&L:SK$MFWF6R:A<J\<3XQO"JJC=@G!.<5S?A:)#\??',I4&1;:
MT56QR 8DR/T'Y4 =7?>.-,L9X+46NIW5Y+;K<M:VMF\LL,;=#(H'R^F#SQTJ
M6T\::'?3:/';732#6%E-FXC(5S&,NIS]UASP>>#7/:9J5CH7Q/\ %XUB\@LC
M>QVEQ:R7,@C62)(BC;2>#M8'(]ZYB.PGF^&M[XFL8FWV.O7&N:<,8WP"4DC_
M '63>??B@#T_4O$&GVNIG19)Y4O9+.2[_=)DQQ+P7)Z#GIZFL31_%^DV7@O2
M+T7^IZN+UGCM7-N7NKE@S$_(H[!3S@# K)\-R)XB_P"$O\9#YH+R-['3V(_Y
M=X5(+#V9RQ_"N?\ ",>ER?"OP5]KUR31-15[EM/OUV[5??(&5MPV$%3]TXSC
MCI0!V>O>+=(N_"L6I+J^HZ7"+]+9VA@*SI*#@Q.C#*^_'I6SK/B[3M%U"/3F
MAO;R_DC,WV6QMFGD6/.-[!>@SQSU[5Y7XRUF\UCX:M]MN+6\>T\1Q6JWUHFV
M.[5<'S ,D9^8J<$C*FNSM;^ST+XL^(FU>ZAM%U"QM)+*6X<(K)'O610QXR"0
M2/?- &W+X\\/0Z!::V]Z5L+JY%JLAC(*2$D%7!Y7!!SGI1IGCC2M3UM-(\G4
M+.\FC:6W6]LW@$Z+U*;ASCKC@UYA,JW>A17R+NL-1\?QSVI(^66(N%W#V)5C
M7<>+./BEX /^UJ'_ *(% &I9>/-%OM3ALXA>K'<2M!;WDEHZV\\BYRJ2$8)^
M5L>N#C-=/7D^D:I;Z)?:+%X;\20ZGHU_?B :-<HIN+0,6+,AX=0ASE7' [UZ
M98ZK8ZF]VEG<+,UI.UM.%!^20 $J<^Q% %RBBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *AN+2VO$"7-O%.@
M.X+*@8 ^O/>IJ* $P,8P,=,5%:VEM90""TMXK>%22(XD"*,\G@5-10 4444
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M'IC%>BT4 >;Q:3\5(+<01:EX2CA ($:6L@4 ^V,5%)X>^)<MD+*2Z\'/:#I
MUDY3U^[C%>FT4 >9_P!@_$[[*EK]L\'_ &>/!2+[')L7'3 Q@47F@_$[48UC
MOKSP?<HIRJSV<C@'U (KTRB@#S=M'^*;QQQOJ/A)DB(:-3:2$(1T(&.,4KZ5
M\59)8Y7U/PFTD6?+=K64E,\'!QQFO1Z* /-K/P_\1H-66^>Y\(+([CSY8K)U
ME=<\C=C.<>M>BQP10ES%$B&1M[[5 W-ZGU/O4E% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1145Q<P6EN]Q<S1PPH,O)(P55'N3P* ):* 00"#D'O44-U;
MW#2K!/%*T+[) CABC8S@XZ'!'!H EHHHH **** "BBLS6?$6C>'H4EUC4[6R
M5^$\^4*6^@ZG\* -.BL[1]?TCQ!;M/I&I6M[&APQ@D#;3Z$#I^-:- !1110
M4444 %%(2 "3T%4=&UJP\0:9'J.FS--:R%@KM&T9."0>& /4>E %^BBB@ HH
MJI%J=C-J4^G17<+WMNJO+ K NBMT)'8&@"W1110 4444 %%%% !16)JGC'PW
MHMZ;/4]<L+.Y"AC%-,JL >AP:CL?''A;4[V.SL-?T^YN9,[(HIU9FP"3@#V!
MH WZ*IZ3JMEKFEV^I:=-YUI<+NBDVE=PSCH0".E1KK=@VO-H@F;^T%M_M)B\
MML>7G;G=C;U/3.: -"BBB@ HJCJ>M:9HL<4FJ7]M9I-((XVGD"!V/89[U>H
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M?6[#0K6.YU&9HHI)5A5EC9\NW084$]NO2M"@ HIKR)&NYW51D#+''). *=0
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M,3I,[+%<13.6(WA<AAA"#MZ@U?U;PYXFUW0(I+R[TZ/6K34H]1LHXPQMXMG
MC9L!F!!;+8ZMP,"@#.M[+4]/^,&D0:AJCZDG]DW+13RQ(D@R\>Y6V *0, @X
M!Y]J])KB=/T'Q+=>.[/Q+K+:=#'#8RVOV2UE=]FYE8-N91N)P<],8'7FMSPG
M?:EJ/AZ*YU80B\,TR,8%*HRK*ZJR@\X*J#[YH P_B?X@U/PYX=L;O2K@032Z
ME! [%%?*,3D88'TZU%<W/B'5_B#J^A6>M-IUA;65O.)(K>-Y5=BX(4L",'&3
MG/W1C&35[XA^%[WQ;H=G96$L$<L-_#<L9V(!5,Y P#SS5RQT*ZMO'6KZX[Q&
MVO+2W@C4$[PT9?.1C&/F&.: /-=<U+7-<\#Z(UUJ[1W4'B5-.GEB@0"=DN,)
M*00<$;0<#@GJ*V=<\626OB:YT&[\:C11IMI#FX:UC>2\G<$EF!4J% "\*!DL
M>:M7?@+63X2>RMI[(ZA%K[:O )';RW'G%PC$+D'!YP#S^=:3Z1XKL-;GUO3(
M=(DN=2MHH[ZUGN)%2.:/(5T<(2PPV""!T% '/?\ "9>(M>A\"QZ7>PV4VMK>
M17<@A5U#1#!D4,.VUB!G'(SD5I[_ !3=^-Y_#,7B22&UM=+@GEO%M8C,\A9U
M) *[1NQD\'&WC&<UJS^&M8N_$'@_5+R]MIY=(6Y^VN%*&1I8@HV*!C /J1Q6
M+<_VTGQAU:?14LYI4TBV62WNY&C5P9),$.H8@@CT(()Z4 9]WXS\2VO@Z4)=
M0RZSI_B-=(DG,2JMRNX8)7&%W*PSCIVJ]XCUW4/#$NC:%J?B_P A[TSSW.K/
M:QJR(FW$:)@J"6;J0< &I&\ :K+X92WENK-M4N->36;U@6$0.\$HG&3A5 &0
M,X[5T/B31=3GU?2]=T0VK7]@)8F@NF9(YXI NY=R@E2"JD'![T >:>(?$-]X
MA\ ZA!'KYNEL-8MK;[9# BB\B=XV1F&,!E)YVX!*^AKHM?\ %$VG>)$\.WWC
M,Z2EG9)-+?-;1&6ZE=FP,%2H50N3@#.:UM?\-^)O$G@FZL[VZTY=6>[CNK>.
M/=Y$2HZL(RV-S?=.6QU/3%/ETGQ5;:TOB&Q@TAKZ[LUMK^RDN)%B!1F,;I($
M). Y!!44 85CXQUGQ/:>%M,LM12SN]1DNQ>7\$*ME+<[=T:N"!ORIY!QFM#P
M?!?VWQ.\5P:C>?;)8[2R"W!C"-(G[T@L%X!Y(X !QG S5S4_#GB65O#VM0W6
MGW6OZ69A,DH:*"=)1AD! )7;A<''..:G\,>']<LO%FMZ]K,UDSZG#;HL-JS$
M0F/>-N6 R,$<]SG@<4 ;OB&YN;/P]?W%G=6=K<1PLT<]ZVV&(_WG/H.M<%H/
MBVY;7[S3;?Q,VNV[:1+>)<26BQ-#*C*,+M50RD/GOC'6NQ\9Z'<>(_"MWIEK
M)$EP[1R1^=GRV9)%<*V.=IVX/UK D\/>*[_Q)!K=Y_94>ZPGT^2TBF<K"C[6
M#JQ3YV++R"% &,9YR 8D6M^+;?P5X?\ &%UKPE^T26BW&GBUC$4D<CJA.[&X
M.=V[(( / &*W+>[\1>)?$GB Z=K7]GVFD7 M+>W6WC=9Y0@9S*6!;;E@,*1Q
MWS4EQX,U&7X8Z1X:6:V^V6?V/S'+-Y9\IT9L'&>BG''Y4O\ 8'B?2/$.M3:#
M)IC6&L2K<,]T[K):2[ C,JA2'!P" 2O- #_A&2?A;H9(P3')D?\ ;5Z[6N>\
M"Z#<^%_!>FZ+=R123VJLK/$25.79AC(!Z$=JZ&@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBN0^
M(?B*7P]H]B(;T6+7]]':->>5YA@0AF9PN#EL*0.#R: .OHKQZ;QM>VNA^+(-
M*U^YU1++3DO++4)[<+)$Y8J\;?(JMC"D';T;':MZ:?Q#H?B'PQ<76O37D6L7
M!M[NS>*-8HR8F=3%A0P"E<<DY[T =-)XPT5/$W_".K<2RZF-OF10V\CB+<,K
MO8*57(]36[7C/A6TN]*^(7Q OI==OYETS[--."D(-X!"[8?"<8 P-NWWS5^?
M4O$^F_#^V\>S^()YIFCAO)],\F,6Q@D9?W:_+O!"M][<>10!ZO17GL=SX@UO
MXFZ[I$.MRV6E:<MG.$BB0NQ922F2/NM@D]^!C'-0Z6_BOQ7IMQXDTO7S:R?;
M)4LM.DB3[,88Y"F)3M+DMM)R#QG@4 >D5#=6MO>VSVUW!%/!(,/%*@96'N#P
M:\LUWQD\WB+7K9_%4^B-IC+#96\%J)5FE\L.S2DQME=S;0 5X&>]7K'7M8\:
MZUI5A!J5SHT T6+4KLVJ)YC32-M"9D5L*-K'ISF@#O--U>QU22^BLY"S6-P;
M6<%"NV0 $@9Z\,.14%S?:7HFH6]N;?RKC59R T%L3YD@ RSLHXXQRWI7,?#)
M+J.3Q;'>S+-<IKLJO*J[?,Q'$-V.Q(P<>]2^-M=U+2O%W@RRLKHQ6^H7SQ72
M!5/F* N!DC(ZGIB@#N**\W@;Q)XBU/Q;%'XDN=/M],O6CM!;PQ%L^4C8<LIR
M@)Z#!.XY/2NJ\%:O<:_X*T?5;O;]IN;5'E*C +8Y..V3S0!O45YCXWUZXL-3
MU8IXPEL9[.V$MEI]C:>=\VPMFX_=M@,< #*C'-7&UC5O%>N:3H]IJ4ND0R:+
M'JMW-:HC2,TA"K&I<$*!\Q)QD\"@#T*JQTZR)R;.WS_UR7_"N&OKKQ3:S:!X
M6NM7B2_U*YN=^J6\2^8;:%=P.UEVK(VY0< @<D4FLW?BKPMHYL6U:*\FU#4[
M>PTR_FC4S1++]XRJ%"L5PV".O?TH [K^SK'_ )\[?_OTO^%']G6/_/G;_P#?
MI?\ "N/@FU;PSXYT;1[G6KK5K#6(9P/MB1B2&:)0^0R*N5()&".,=:YW0/$/
MB-? &H^--2UE[C['%=I!9>2BQR%'8*[D '.0!Q@8'J30!Z'J<^B:.+0WMO G
MVNZCM(<0!MTK_=' XZ=:O_V=8_\ /G;_ /?I?\*\MU[3-<L[;P7=:CK]QJ7V
MG6[%KF*>*-5CD.3F/8H(7J,'/8\4>,/%=WHUSK-]%XN<WMA,#;Z7:6OF6XC&
MW*3OY9(<_-D[QC(H ]2_LZQ_Y\[?_OTO^%']G6/_ #YV_P#WZ7_"N*EEUW7?
MB!K>BP:[<:=IMK:6LP-M'&90[[^ S*< XR>">!C'.<FP\4Z_J.AZ#HW]H^7J
MM_JEU83:BL*[O*MRY9U4C:'(51TQR3B@#TO^SK'_ )\[?_OTO^%']G6/_/G;
M_P#?I?\ "N$U[4/$7@CPUJ<EUK27D,D]O!IU[<1 S0>8P5S(JJ%8+G<N!D]"
M*;X0\3>=XP.CVWB&ZUVPFLFG$UU;A)()5905R$0%6#9 P<;: .]_LZQ_Y\[?
M_OTO^%9UOX0\-VNH/?V^@Z;%=ODM,EL@8YZ\X[UG^-M4O]$71-1MK@QV:ZG#
M!?IM!#0R'9DDC(PQ4\8K&M_%&J2?%1[9KC/A]Y9-+CCV# NDA68MNQGIO7&<
M<4 =5JUQHVBQVTEY9IMN+A;>/RK4R?.V<9V@X'!Y/%7?LFF^<8?L]IYH7>4V
M+NV],X].#7E6H^,?$(\,Z;K<&HLD6J>*Q;6X$:<66YT"<COLSGKSUK8L+&]D
M^.&L.=9O/+AT^"3RML>UD+OB,_+G:"21@YYY)H ['1IM$U[2;?5-.MX)+2X!
M,;F *2 2#P1GJ#5_^SK'_GSM_P#OTO\ A7BVB2:_H?P8L?$]IKTT0L1NCT]8
MHS \?G[6#DJ6+').01C@ =Z]RH Q+"[T/46OQ#:QJ+"9H;AIK;RU#+U(+  C
MW'%:D%M:1XEMX85W#AXU R#[CM7D&H:UK.M^"OB;'<ZI,JZ;?7,$'EH@Q"H(
M\L_+T(.,]?>M+4+V_P! T?PS;W_B34[/1I[5GN-4CMXW>.3:GEQ,1&0B8+<E
M<G')H ]4HK*\-R3S>'[62XU2WU1V!*WL  69-QVM@<9QC..,YK@?$/B[S?%^
MLZ9+XKN-!33$B2V2WM1+YTK('+R$HV5&Y1M&.] 'J=%>:R>,=6L_#GA_QM=N
MPTB2W6+5[(1C]TS':)TXW</P5R?E/3(S4&J:[XJMOAO>>)_M@@O;^ZMI+"U*
M(5MH'E150G')96RQ[9XQB@#U&BN"\W7/#/C;0+.[UZXU6RUGSH9DN(8U\F5$
MWJT>Q1A3@C!S]36%H/B'Q$O@;4_&>IZP]PM@EVD%B(D5)2CL%9R!G.<#C'"^
MI- 'K5%>4:%XNGC\0:/;6WB>XU]]062.\@FM1$L,HC+JT9"+M7<NW!)^\#5G
MP7KFH:G?6WG>*I9=8$;G4]"OK=(3&^T\1#:& 5L<Y8$=>: /3J;(R+$[2E1&
M%)8MT [Y]J\U\#ZW?:IJ=H+OQ7*VK;6.J:'>VR1&(X/$(VAL*V.<L".O-=#\
M2TF;X<:^T%W+;,EE*Y:,+EU"G*G(/!'!QSZ$4 :>E>&/#NE7+7^E:/IUM-*O
M^OMX$4L#SP0.A]JV*\EN=<FT#2O"FAW7B:\LX+VS-U<7_D(\R(J(%BCVQD 9
M;[Q4G"]>:AN?'&M+X*O9--U0W=S9:U!:6]]+ $^U0N4(W@J!GYBI( Z9% 'L
M%%><ZL/$NDZUX6T*'Q-/-+JD]U]INY+>+(58@WRKMP,88KUY/.1Q4.EV_B?4
M?$7B/PTWBR]2VTHPR0WBPQ?:',L>X*YV;=JD'H 3GJ ,4 >F45Y$/&.JWOA'
MPGJ.JZM=:5I]Y#-_:&IV5NKD3(P6,-E6"*V&)..HQP*]'\,RSS>'[:2?58-6
M+;BE]  %F3<=I(7C., XXR#0!K445Y';>++JVUS1W7Q=)JUQ>:F+2[M(;3_0
ME1RP'E2>6.5.WG><\T >N45YI#)XEU^7Q<T?B2YL(=*OY8K-;>&(DE8U8!RR
MG*C/08/)R3QAECXAUKQ?/X5TR'4I=,-YHYU2_N+5$\QR"J!4W!@H+$D\'TH
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MJ[,HX5/E+=.<@9KJO .NW&O^&1<7<PN)X+B6V-R(O+%P$8A9-N!C<NTX]2:
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MD*"<L?E]A0!Z#17GFH7GBNP.A>&)]7B_M#4[Z>,:I#$ID^R1H7R5*[1*1A>
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M0"]WOV1D+C!SN1NF.M4]2\2W$&NR:#J_C"YTE],L;??/;6JR/=W+J69V_=L
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MXRK8)'0BO0'=8T9W.%4$D^@K.T/Q!I/B6P-]HU]'>6RN8S)'G 8 $CGZC\Z
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M5>?7_@3Q'<Z+X@\/07^FPZ7J5S<727&US<%I&WB-AC:!NP"P))48P#R/2J*
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MRPR" W7!Q@$YP:Z"7PUXEUC3=>36]6M1-J&GO8V]K:*XMH=P;,AW'+,21SV
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MD,=+TX06<,0QM,VWS)&^HW(M8V@_#.33?"_B+1[V^CN6U.+[+!(%/[F!$*Q
MY[J2371^"_#UQX;T$VM]=)=ZA/<2W5W<("!)([$Y /MM'X4 9WBF]U"\\6:)
MX8L;^;3XKN*>ZN[FW"^;Y<>T!$+ @99N3C.!6%='4\>+_"EWKE_-%9V"7UI=
MY03F-E<-$YVX897KC.#UKJO$OAZ^O]5TO6]'N;>#5-.\Q%6Y0M%-%( &1MO(
MZ @CH1TYJII_A/4"/$-_JUY;2ZMK%N+;_1T80V\:HRJJYY/+$DGKZ4 9_P '
M-/DM?AYI5TVHWEPMQ;@K!,RF.##-]S"@C.><D]*J^*]-GN_B_P"%D35]0MDD
MM;IPL#(!&5"9VY4_>[YSTXQ76^#="E\,^$--T6>9)I;2+RVD0$*W)/&?K5#Q
M-X<U:^\3:)KVC7-E'<Z<LT3Q7B,4=) H)&WG(VT <=I>F:I=VOCN]M-?O=-6
MTUB\D@CM @#2JBMF3<I+#A1M&._KPZZ\;2:E)X=M=2UF^TF"YT.+4KF73;=G
MEEEDX"@JC[5&&/3G(%=II?A>>PTWQ-:O<1LVKWMS<QD XC$J*H!]QBLNV\&Z
MSHL.A76BWMB=2L-+33+E+I'\F>-<$$%>5(8$CKD,: -+P!K%WK/AQWO999Y+
M:ZEMEN98#"UQ&K?)(4(&"5(SQUS5/Q'IVO:?XQ@\4Z'IUOJN+$V,]E).(9 N
M_>'C8C&><$'&<#\.ET6VU&UTQ(]6ODO;TLSR2QQB-!DDA5']U0<#.2<<UD:S
MI'B1=<&K>'M5MUWPB&>PU$.\!P20Z;3E&YP<#!X]* ./UW5-.USP9XVEM;*_
MT'7H[+S-1@D4)+(!&P3)Y#(1N&1SCTXJS(QT?P=X8M;GQ;J-I!=1J[^5$);R
M8>4I$<(2,X53R3M)QCGFM4>"-1U*R\1S:YJ-L^J:U9?8@;6$K#;1A6"A0QRW
M+DDD_E5>#PKXLM_["OUO-%;4]+MY+':T<ODO PC ;KD.#']"#CB@#C]>U&^U
MWX77_FZOJ+K8:ZEFDLD8AEGB\R(KYJL@.Y=P[#E02*W]>UL67BA/#E]XGUFS
ML[&P29KFV@,MQ<S.S8WLD3 *JKTP,D^U6;CX=ZS/X<U_2GU>UEDO[^/4H+EX
MF!$X*,X=0<!,IQCD ]\5K3:#XHCU6+7K&ZTA=6FM!:W\$B2?9Y KLR.A!W C
M<1SUSVH O^!-7O-;\)V]U?EWN4DDA>5H3$9@CE5DVD C<H!Q@=:Z2J.D6U]:
M:5!#J5\+V]4$RSB,1AB23@*.@&<#O@<\U>H **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKD_'NJ7
M]CI^EV.FW)M;G5M3AL/M*@%H4;)9ESQNVJ0/K0!UE<]I/C+3-<UN\TS3HKV?
M[)(\,UT+=A;K(OWD\SINYKGVM[[0?&FG^'QKNJ76GZW97(#7$X>:WEB"G>CX
MR,ANG(R*RO@SI)B@UV[_ +1OW$6M7<'D/*#&^-OSL,<O[YH [_7?%&B^&1:G
M6;Y;1;N7RH2R,0S>F0#CZG K7KS7XJ:3!KVK>$M)N.(KRZN(6./N[H&&1[CK
M^%5/^$LU"?X4II^['B:2X_X1]ESR+G.QGS_N9DS0!WV@>)]&\407$^BWRW<5
MO*89'5&4!P,XY SU'(XK7KQ_PE!#X9\-^/+2TU./2H;'4?(CO9(]_E 11J&V
M_P 3'L.Y(ZU>T#6IX?$M_IEIJ.O7%D^BRWBMK,+I(LJ.J[HRZJ=I#].@(H ]
M2HKR#3+?Q3>?"E/%<7B/4I]9-FES';^8/)*QL"5VXRS,JG))Y+?2NCO_ !'-
MXBU3P=9:'=20Q:@/[4NGC/S"U11\C>FYV53]#0!TFB^)=/U^\U6ULO-\S3+H
MVMQO3 WCKCU%;%>1>%+HV2_%"Y748M-:/5IB+R5-ZPGGYMO?'8=SCK5KP_K4
MUOXJ_L^SU/7[NRN=*GN"VL0/&1+&4P\1=5."'.0.!Q0!ZG17C45QK]M\--$\
M:2^)-1EU#=:E[<N/L\D;RK&59,<DALEB<YSC' '2VL>I^*_%WB,C7=0T^WTF
M>.TLX;1PJ;_+#L\@(._EAP>,"@#K]"UNT\1:-!JECYGV:8N$\Q=K?*Q4\?53
M6C7$_"+?_P *PTCS,;\S[L=,^?)FJEG!J/C37O$<CZ]J6G6NFWAL+2&QE$8#
M*BLTC\'>26X!XP* /0:*\>3Q)XA\06'@.)-5DLKK4I[RTOIH !O\H,I<#&-W
MREAQ@$]*]8TZS.GZ?!:&ZN+KREV^=<OOD?W8X&30!9HKQZX\136NIV>H6?B/
M6=2N)-8CMIBEJZZ:8GF\LQJ2NW*@@;@Q)8=>:U[:TU?Q+K7B^&7Q'J=G;6%[
MY=HEG($*,84;YC@DJ#C"\#ELYXP >E45Y9HWB?6 O@37K^\=[#6+;^S[U#P@
MN#S%)CL6*E3VYKI/#NH7VM>-O$5Y]ID_LBP9-.MH0?D:51NF?'J"0N?8T =?
M4<\\-K;RW%Q*D4,2%Y)'8*J*!DDD] !7'^);F^U3QMI/A>VU"YT^UDM)KZ[E
MM6"2R*K*BHK8.T9;)QSQ7&^*I=0A\-^/?#=SJ]]<0Z9;0W5K/)(/-:.56#12
M,!\RY!]R#UXH ]3N-=LK;6-,TMF9I]2262W9!E2L84L2?HPQ6G7E%_HUR/$?
MP]T^#5[Y3):7S/=NX:94,<)*J2,#T!QP#ZU'?>(=6\*6?C338]5N[O[!-9)9
M7-T//FB^TX#=!E]O) P?3F@#UNJUMIUC9SSSVMG;P37#;YI(HE5I&]6(')^M
M>;Z'K4T&OR66G:AX@O\ 3I]/FDEDU6UE0V\Z8*LKNB\,"WR]BHZ5J?"Z'5+_
M ,,Z?XBU?6[Z\N;RU"_9W<>2B@\,%QDN=N2Q/\1% '6ZAJR:==V-L]I>3&\E
M\M7MX"Z1'UD(^Z/<UH5P?CS5]0T[Q7X)MK.[EAAO-1:*X1#@2K@<'VJYX:U*
M]N[_ ,9)/<R2+9ZBT5N&/^K7R4; ]LDG\: .PK/EU9(=<M]*-I>,\\32B=("
M85 [,_0'C@5Y;;:MX@U?3OAK:1:W=6\NL6]R+VX0@NX6,-GD8W 9P>Q.:WI;
MS4-+^+7AKP^FIWD]@=*E:59Y-S3.NX!W.!EN.M 'HE4]6U.WT;2+S4[O?]GM
M(6FEV#)VJ,G ]>*\X\,:E<R>(K6WU?Q)JMCXB-Q)]ITR^B_T:YCRWRP<!<8V
MD,K$\'(.:R[R/5?$GPHU_P 63:[?K+<PWA2R#C[,ENK.GE[,==JGYLYSC\0#
MU)->@DU#3[2.TO7%] 9XYU@)B1<9P[]%)["M6O,X]7U"#XA^!]+BNY4L+G1W
MDF@!^5V6/@D>U+HMMX@\7Z3-XFM/$EY9WLEY*+.UR/LB11RE CQXRV0IR<YR
M>,8H ]&2ZMY+J6U2>-KB)5>2(,"R*V=I(Z@':<?0U4T;5DUK3Q>1VEY:J79/
M+O(#%)P<9VGMZ&N%\-:7)_PN3Q?,VIZ@PMTM'$1F!1Q(DAVL,<JN3M';WK"\
M/^*]>N_AAI).IS?VEJVNC3/MKX9X49V)89XR%4@?6@#V>BN 'V_PIXWTO2EU
MC4-0L-7M+D[;Z42O#+"JMN5L X()&.E<M#=>((/A5I?C:7Q+J4FHQFW8P;Q]
MGDC:98RK)CYB0<EB<YZ8&* /:*R-0\2Z9I]A:WS3B>VN;J.TCDMR'!D=]@Y!
MZ!N#Z8K0O;<W5C/;B>: R(5\V%MKIGNI[&O"M+L;A/@KX;N(=0N7N+O6+4QB
MX8/' XNF *K@<$\D9YH ]\HK@+87_AOXAVNFG7;^^L;_ $V>>0:A*'$4D;)\
MZD ;1ACD#BN?TK7YK?7?#LUKXAUS5CJ%X;:\EN+1X[&961SF'<@5<,HQM)R,
M]: /6H;JWN'F2">.1H'\N548$QO@':WH<$''H14M>:_"[2WM]5\6W#ZGJ%QY
M6M3VVR>8,KX6/#L,<OCC/IVK<U/4KO2OB5I"2W3C2]2L9X?*8_(D\1$@;V)3
M</PH ZZBO(_#_C;5+/3/$>IZO=22I<:<VM:;')TCB+R*L8]N(?\ ONKFCQ:Y
MK>L6OAS4=<U*V73=(M[B\>VE\N:>YE)SN?&=J@$8&/>@#U"BO)AXBUJVMXM+
MEU.>::P\76VFFY. \]LY#!7P,$X;!XYQ777.H7:?%73].6X<6<FD3S-#GY2X
MEC ;ZX)'XT :?AKQ+I_BO2!J>F^;]G,CQ?O4VG<IP>*GFUNTA\06VB/YGVRY
MMY+B/"_+L0J#D^N6%>->#=1OK3X4:18Z?=/:3ZMXA-@;F,#?$C.Q=ESQNPI
M^M=;;:5/I'Q@TBW?4[R^MSI%RT1O'$DB'?'N&[ )'0C/(YYQ@  ])HKB_B=J
M6I:7X8MI])NC;7;ZC;1*XZ$,X!!]0>XK$\2W4WAJYT/P]<>(->DM[UKBZO+V
M)&FNF"! (T\M"44LV>!P!C/- 'I]%>1KKFNS>'+V"VFU^?3[358T:^%HR7K6
M+)N;:&4%F5_E+ 9V\U8DUMHO#5C<:+XJNM4M9?$%G;J\PQ/"C.H>&0D GN?F
M .#CGK0!ZI6%HGB_2-=T6?5X)S!903/!))<XC"LI /4XQDBJ-_J%W'\4-&T]
M+AULYM-N99(0?E9E>, GW&3^=>0PV[2_ /5I%NKB'R]<.5B?:) T\:X;CD#.
M1[@4 ?1-95G>6>JZK<@Z;.ESILAB2XN;7:#N')B<]0<<D>U7-/LS86,5J;FX
MNC&"/.N7W2-SGDX&:\K;Q'K/V'XJ/_:,^[3'(LCN_P!1\C'Y?3H* /7:*\UG
M76-"U'PCJ;Z_?W<FJWB6M[;2N# 1)$S91,?+M*C'.?4GFNS\4W9L?"^HW*ZG
M%I;)"<7LL>\0D\;MO<\\#UQUZ4 :]%>4Z/KEQ;>(+[3K+4M?N;*31)[M6UB%
MT=9D90&C+JIVD/R!P"!5/[1K^F?#32/',OB/49[Y$M99[9W7[/+$[JA4IC[V
MULELYSG\ #V*L+Q!K>CZ)?:,^I0;[F[NQ9V4BQ!VCDD&.IY4$<$BN5MK/5O$
MWC3Q=92^(M3LK"PG@6VCLI0C*S0JQR2"=H/.WH23G/%<MJ>L7NN>'/AO=ZC(
M)+U?$D<$T@&-[1RLF['OM!_&@#V"+5DEUR?2A:7BO#$)3<- 1 P/97Z%N>E:
M%><_\)'?V?Q6\36\MS+)IUAHBW:6I;Y0XP21[GFI?#&D^(=0TK0?$P\37;W=
MZ(KJ\M9R#:M#(-QC1 /D(!&#GJ.<YH ]!J);JW>ZDM5GC:XC17>(,-RJV0I(
MZ@':<?0UY'K?B*:QN[K5++Q'K5_>0:HD92"U<:<D9F5#"QV[,A206W9W?E6O
MX>TMS\9_%<QU/4&%O%:2"(S#8X=9#L88Y5<_*.WO0!W6C:LFM6'VN.TO+5=[
M)Y=Y 8GX/7:>WH:T*\8T'Q9KUU\,M/)U.4ZEJFO#3%O7PSPHSG+#/&0JD#ZU
MU<0OO"OCW1=)&L:AJ&GZQ!<!DOY1*T4L2JP96P#@@D$=* .\HKQ2WN_$*?"*
MP\;R^)=2?4H1%((-X\AT\X(5=<?,2"223G)XP!7K^KWW]EZ+?ZALW_9;>2?;
MZ[5+8_2@"Y7/:YXRTS0M6M-*EBO;K4;I#+';65NTS[ <%B!T&<_E7#74NNZ/
M\/++QV_B+4;C4#';WMQ:NZ_9GCE9=T0CQA<*_!'.13-4T(W/Q]MHAK&J1>=H
MSW&^*<!H_P!\?W:G;PGM^M 'K4TT5M!)//(D4,:EWD=L*J@9))/0 5GW&O6-
MMJNE:<SL\VJ+(ULR#*,$4,23]",5A_%&%IOAKKQ2XG@,=H[YA;;O 4Y5O53G
MD5R=UH]R-6^'-C;ZO?*TT%VS73N'E13 A*H2,#C@<'&<T >MT5Y+?>(-6\(V
MWC:PCU2[O!I_V(V,]W^^EA-R=C=LOM/(&/;FM#PMK$D?C&UL+#4/$&I:==6T
MAN6U:TE3R9DVE65W1<!AN&T<9 H [+Q-XET_PGHKZKJ?F_9D=4/E)N;+' XK
M8KS?XZ?\DPNO^OJ#_P!#%6/&-Y&_B-;.3Q#K4&RT#I8:';222JQ8_O9"BM\O
M  4X'!ZT >@45YAX7\4:K<:AX/O]2O&:UUK298I4/RH+F([_ #,=BR!ORJEX
M?\;:G9Z;XCU/5[J26.XTYM:TV.3I'$9)%6,>W$/_ 'W0!ZY17CMS<ZII8L8/
M%GB+7=,@_LR P:A;*3#]J;<9?/8*>02H ;"X%>LV3M_9EO)+<I=-Y*EKB-0%
ME.WE@ 3@'KC)ZT 6:P?$7B[3?#4UC;7:W4]W?,RVUK:0-++)M&6(4=@"*X&&
M;7M2^&USX^7Q#J$.HB&:_AM$=?LJ1HS$1&/'S JN"3SD]:@\26)UOXI^ KP:
MEJ5L-4MKF8"&8 V^+<'$?'RY[]<\T >P0R>=!'*$=-ZAMKKAAD=".QI]9^I2
M&P\/W3B^2V,%JQ%W<C<(R%/SOTSCJ?6O._#.M2P^,=#M+76-?U&UU*WG^TOJ
MEL\<4CHH99(=Z+@'YN!Q@B@#TC5M132-,GOI+>ZN5A )BM8C+(V2!\JCD]:L
MPRB:".4*ZAU#!7&&&1G!'8UR?Q1U*]TCX;:S?Z?<R6UW#&ACEC.&7,B@X_ F
MJ^G:K?R^/=%LWNI&MIO#IN9(R>&E\R,;S[X)_.@#MZS]7U9-'MX9I+2\N1+,
ML(6T@,K*6S\S =%&.3VKS3Q)XDUJS\->/KFVOYEGL-6MXK0[O]6A\C*CV.YO
MS-6_'!UCPAX5TQH/$&HW-Y=ZY;BXGE<?=<'<B  ;8\C(7MZT >H45Y?XIU*>
MU\6ZA'K'B'5] MBL0TB[@CS9Y*C=YIVD$[\Y#D#;CD9S6@BZCXI\=:W8MKM]
M96FC0VR1+I[B,2RRH7:1L@Y & %.10!OIXQL)M(.I6UIJ%S"+QK(I;VQD<.K
M%22H_A!!YKH:\*_M75M$^$T$]K?/#>MXFDAFEA^7>#.^X?0GM7=7*WWBOQUK
M.D#6=0TRQT>WM]JV$@C>664,VYFP<@  !>G6@#MI;JWAGA@EGC26<E8D9@&D
M(&2%'? !/'854MM62ZUB]TU;2\C>T"%II8"L4FX9^1^C8[XZ5YKKFB:K)XX\
M VFK:[>->O%>)-/9.(@2D>0ZC'RLP.&]>V*M_P#"5ZEIWC/XCO)<23VNCV$-
MQ:VSGY$;R"QQ]2.: /3Z*\KO!K?AOPGI/BY_$6I7EV\EJ]_;3.IMY4F95940
M#"8W\$>G>K=M::MXEU_Q?;R^(M3LK6PO EHEG($*L84;DX)*@]%X'+9SQ@ ]
M)HKG/ .K76N^ ]%U*^</=3VRF5\8W,."<>^,UT= !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8?BO
MP\?$>EPPQ71M+RUN8[RTN-F\1S(<J2O<<D$>AK<HH Y33/#FK3>)H?$'B*^L
MY[FUMWM[2"RA9(XPY!=R68DL< >@%2^"O"TOA2RU.WENDN#>ZE->@JA7:),?
M+]1CK735C:AXHTS3]-MM0\TW-M<W:6<;V^''F-)Y?J. V0?I0!!KWAV36=<\
M/Z@EPL2Z5=/.R%<F0,A7 /;K6:G@&%/B2WBK[3^X,9<6>W@7)41F7/\ N#'3
MJ<UV5% '"7'P_GFT[Q) FHQI-JFIIJ5NYB)6)D*,JL,_,,IS[&GKX2\03^(T
MUV_U>Q>YDL9K"X@BMV6)(F*LOEY8G=N7)+9R#C P*[BH+J\MK&)9;J>.%&D6
M-6=L NQ"JOU)( ^M &+H%E;>"O!-A8:GJ%LD-C (I+F5A'&?^^CQUKE/A+H4
M5NNK:W"TCV%Q.]MI'F+@I9+([KM[[2SL1[ 5VDFI:;J6NW7ANXMO.EAMH[J1
M9HU:(JS$+UZG*GMZ5KJJHH50%4#  & !0!Y__P *WF;3/%UHVI(&UR_^W0N(
ML^2P<.H89^8949Z<59_X13Q%=>(;/7=0U>P:YCMYK26"&V=8A"^T_)EB=^Y<
MDGC! QQSW%% '%R^!II/AG9>$_MT8EMEMP;CRSM;RY%<\9[[<?C3I_"VNV?B
M/5-0T#5K.UMM7V-=1W-LTCPR*NS?$0P&2 .&R,C\*ZN\O+;3[26[O)XX+>)=
MTDLC;54>I-4Y=<M8O$EOH3++]KN+9[I&"C9L1E4Y.<YRP[4 5/!?AUO"GA.R
MT1K@7!MO,_>@8W!I&8?^A8K+G\,:_IVM:K>>&M4L;>#57$MQ%>6S2>3*%"F2
M,JPSD 9#<9'X5V5% '%6GP_CTY_""6EY^YT!YW?S%RUPTJ$,?8[F)KM2,C%9
MFN>(-,\.VB7.IW!B61Q%$B1M(\KGHJHH)8_055T/Q=I'B"ZGM+.6>.\@4/):
MW5N\$JJ> VUP"1[B@#DA\/?$ \.VFAC7;);/2[B.XT_;:MND9) Z^>=W( R,
M+C)P<\8KJ=#\.SZ7=Z]<37,<K:K<BXPB$"/]VJ$<GGE<_C6U:7EM?VRW-I/'
M/"Q8"2-LJ2"0>?8@C\*DEEC@A>:5U2.-2SNQP% Y)- 'F'B;3].\,?!^+PO?
M:C'+JD5NBV"0\337"OF(QIG/W\9]LUVW@_1'\/>%;'3YFWW2H9+J3KOF<EI#
MGO\ ,36E'%87QM]12*WG8H&@N H8[6&05;T(/:K5 '->(O#M[?:QIVN:->06
MNJV*R1 7$1>*:)\;D< @CD @@]:RV\!7-_HOB9-5U*.35M?C6.:>"$K%"J+M
MC5%))(&23DY.:[FL[7M<L/#6B76KZE(8[2V4,[*NX\D  #N22!^- &!8>%]7
M;5/#>HZK?V4D^CQ7,+"VA9%D61$53RQP1L)/KGM3=1\"?VG>>*)9;[RUUD6I
MA:-/FMY(!\K<]?F ...F*Z'1-7&MZ:MZMA?62L<+%>Q".0C (.,G@YJM8^+-
M%U'Q)?>'[6\WZI8KNG@,;+M''()&#]X=">M %33]+\32RW#ZYJ]G)&ULUO';
MV5L8T+'_ ):.68DMQ@ 8 R>M6_".AOX:\)Z;HTDZSO9PB,RJNT-R><?C4GB+
MQ+I/A32_[2UJ[%M:^8(P^QG)8YP %!)Z'\JTH)DN((YXCNCD4.IQC((R* /,
M_B#>VMU\1? FGV]S%+>P:DTDT$;AGC7:IRRCD#'//:MJ3PEKEMKFM2:5J]I;
MZ;K,@EN5EMV::%M@1C$P8+R .6!P>Q[]<MA9K>M>+:0"Z<8:<1C>1TP6Z]JL
M4 </I7@*?3F\%%K^-_\ A'8IXY,1D>=YD>P$<\8ZUH7WA26[^(NF>*!=HL5G
M9R6Q@V'<Q;/(/;K6MK^MVOAS0KS6+U96MK1/,D$0!8C.. 2/7UJU87L6HZ=:
MWT(817,*3('&"%8 C/OS0!R*^%?$=Y=Z9#K.M65WIVFW:W<4JVK+=3,F=@=M
MVT=>2!SCMFLV?X>Z\/#^J>%[+7+.'0+MIFAW6S&XB$A+>7NW;=FX]<9QD<=1
MZ110!QY\%S'QAX<US[;'LTBP>T>+8<R$KMW YXJC_P (3X@LXKO2-)\0166A
M75TUQE(6%W;AVWO'%(&  )S@D9&>]=7K.N6NA1V3W2RL+R\BLX_+4'#R'"DY
M(X]:TZ .4M_#.IZ?X_OM=LKZU-AJ44*7=O-$S2 Q*RJ48-CG/.0:Q]+^&<MA
MX"@T ZHHOK2__M"TO4BXBE#[E)4GD=01GH:]#HH Y&Q\,ZO=^(8]<\17]G-<
M6MM);V<%E"R1Q[\;W)9B2Q  ] *KOX$G;X66_@_[='YL20J;GRSM.R59/NY[
M[<5VU9FMZY:Z!:V]Q=K*R3W45JGEJ"=\C!5SDCC)YH TR,C%><Z9\/-7L_#%
MEX>N-5LY++3M1@N[21+=ED*),9&5_F().0!@#'O7HU% '-:WX4_MKQ%;Z@]S
MY<":=<V+QA?F/G;?F![8VFL!/!'B9[/0HKC7-/+:#+$UFD=HZI*J*4S+\^=V
MT\;< <]<\=CK^N6OAS1Y=4O5E:")XT81*"V7=4'!([L*TZ .5\.^&M3T#Q%K
M4RWUK+I.I7;WWE&%A,DKA01NW8V_+Z9IWCSPI/XNT*.TL[T6-Y#,)8;@INVY
M5D88!'578?E7444 <+XC^'4>L_\ "/Q6MXMM:Z:B6UQ'LS]HME:)O+]N8E_,
MUH:OX<U0>)AXB\/WMI!>R6HM+F&\A9XID#%E;Y6!# D_4&NJHH X*7X>7+>&
MY(%U5#KDFJ+K#7K0_NS<JP(&S.0@ "XS[U>TSPQK7_"90>)=9U.UFG2QDLS;
MVL#)&@9U8%=S$D_*<D^HZ8KKZ* /.=/^&5S8>!+?1$U6-=0LM2_M*TNQ"2B2
MAMP#+GD8)!Y[UJ:=X6UMO&=KXFUK5+2:>*SDM/LUI R1JK,I!7<Q).0<D^H]
M.>RK%\1^)['PQ'I[WR3L+^]CL8O)4'$CYP3DC X- $/B_P .R>)M*MK..X6
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M:I'Y:?- \&2K^_S%3CVK0T:P\3IJ(N==U>SFACA,26]E;&-9&)'[QRQ)SQ@
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M7;@_A7$I\/\ 5I-(M?#5YK\,_AJV="(1:$7$L2,&2)Y-^W:, 9"@D"@##O-
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MI**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLDL=I(Y)^385P,%?F;<>@XZ5OZ1XBTW6]$_M>SG/V,;P[2*4*%"0P8'D8P:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5;_XAZAITJ3V,7AY;66:)@R/.!(V 1P2%(SZ9KTSPO&D7A+1HXU"HMC % Z
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MK#<, XP<'.,#&3Q7KL5I;P2RRPV\4<DQS*Z( 7/JQ'7\:1+.U1YW2VA5Y_\
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M@"I&""."*J6VDZ=9B,6NGVL C9F010JNTD8)&!P2.#0!YSK?&O?$[W\/1?\
MHJ>J>BQ:=+X(\#%_$+:#K,>GNUC=LJF-E(42(P?Y6S\IVY!XR.AKUAK2V=IF
M:WB9IDV2DH"9%YX;U')X/K4,^DZ==6:6=QI]K+:IC;!)"K(N.F%(P* ,;P-K
M%UK?A]Y[LVTDL5W-;FYM%Q%<A'(\U1SP?J>0:Z6F0PQ6\*0PQI'$@VJB* %'
MH .E/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ/>03ZG<7%BD5K$X,L!C96<LHY4*%;)/2M_P4BCQ]X^<*-QO;<$]R!",?S-
M'>5FZWKEEX?T\7EZ9"K2+%%'$A>261CA411R6/I6E7!?$Z.15\.7QU"33K6U
MU13/>1JK?9PT;HKG>"H&Y@"2.-U &NOCO2/[%U34IX[RU_LH WEM<0%)H@1E
M3M[@CD$'!YI+/QWI-YK-MIH@U"(W@8V=S-:LD-UM&X^6QZ\<CID=,UY_K]O8
M2>$O'-_;>)[C7KK^SHK>XG,<8B !9E"M&H5F&XYZD9&:ZSQ8JIK'@$*  -3
M '8?9Y* .?T#Q5J'B+XIZM'<R^(+:PL7@2VLX[;9$FY"6-SD$C)&1DBNL@^)
M&ASRPL(M133YYA!#J;VC"UD<G: ']"> 2,>]<UH=M->>-?BO:VW$\T=O''SC
MYC X'ZFLN_UO2]2^!NG^'+*YA;6Y;>UL$T]6'GK<(Z!LI]Y<%68DCM0!Z%>>
M.M*M/$,VA+!?W.I0O$KPVULTA"R#(<XZ(.,D],BH;OXBZ'9WT\,B7S6MM/\
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MN?[.C4- R!S\X&,F3/&,]*\NO/\ DB'P]_[#%K_Z%+7:/_R<8G_8M_\ M<T
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M1ZBKM<]X(U>[UWPG:7][Y33NTB&6%2J3!9&59%!Z!@ WXUT- !1110 4444
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M#;P6T A@ACBB7@(BA5'X"O/KSQDL/Q!TZ6V>_O=/O=!,]O9VJ%C-(95(8(2
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M;>?+\SSL;MO3..,U;^*'B.]\->!M0N].BN?M31E8[B&,,L!) W-D\=>#@\T
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M[8/.7C"N#N^]QNQC/>O0=/=GTNUDD8EFA1F8GJ=HYH ='96D-K]FBM84M_\
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M:/!P.F1S]#7HLL,4X EB20 Y =0<'UIVU2P; W#H<4 <9X5_Y*%X[_Z^;/\
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MS$].]=-X?_Y+GXP_Z\;3_P!!%>@B")9FF$2"5A@N%&XCZT\(H8L% 8]3CDT
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"RH2C%0 1D<'&>?:H- \83_VEX>E3Q+?:M<ZE,D6HV,ED4AAWJ2&B/EC:$;
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M&.M 'J]%>>1?\)#XOO\ Q%<Z=XAN-+&F7KV%C;Q1QF-Y(U4L\VY26!9L8&,
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M_$_AS6-/\0:C9PM>)&MK%8QDQVS(=P<LP#,2P7(X&%XZDUVE% 'EVJP>)?\
MA-O!$WB&XTXE+V6..*P5]K$P.2[%^_ P .,GDYXN3>"O$T=CXBT2QU'34TC5
MYKF<32(YN(_.R6CQ]W&21NZ@$\5W4J:?=:A%'*MK+>VH$T:N%:2$-E=X'5<X
M89[\BHM'U>'6K1[F&WNX%25HBMU"8F)'< ]O0T <P/"VNZ1<Z=J.AW.GM>1:
M7%IUY#>;Q%*(^5=649!!+=1R#VJ[+8>,[>ST^2UU?3[R\19%O(KN$QPRECE2
MA0%EV?=&<Y!YYYKJJ* /.9OA_J\6BZ6;&[T\:M9ZP^K,C1LML6<MNC4#+!1N
MX^GO74:?<ZTWBJYM;PPFR2P@D'E1D!9V9@X#'J/ESCL,9ZUO44 <YXK\/W>K
MMIE_I=S#;ZKI=P9[9IU+1N&4HZ/CD!E/4<C%8NJ>$O$OB#PKXALM6U6T^VZH
MD<<$$._[-:JI!XS\Q+<DG'I7>T4 <._A;7]/U;3=2T:YTTSQ:3'IEP+Q7*J%
M.X.FWKSGY3C.!S61=?#;6;CPF-!;4K218=:_M&&X<,'="[.P< 8W9;MQ7I]%
M '/V>@3VWCK5->::,P7=G!;I&,[E*%B2>V/F%83>!+T_##5/"WVNW^TWDD[I
M-\VQ?,F,@SQG@'%=[10!AI/JB>,XK/<C:2-,+L!&<K.) !\WH5SQ_LFH/&'A
MZZUZRL9-.N8K?4M.O([VU>928RZY!5\<[2&(XKHZ* .$A\':SJ?B>XUCQ'=V
M+1W6D3:6]K9A]L:NRG(+<DG#9)QU QQFKF@Z3XOL'TVQOM4TTZ78+L,EO$WG
MW:JNU X;Y4[$E222.V:Z^J]]=I86%Q>21RR)!&TC)"A=V &<*HY)]J ..7P/
M>#X?Z_X=^U0?:-2GNI(Y>=J"5RPSQGC/-:FI>&KB]U+PM<I/$JZ/,TDH.<N#
M$4^7\3GFMVQNTU"PM[R..6-)XUD5)D*.H(SAE/(/M4SNL:,[L%102S,< #U-
M 'FC^ O$Y\+_ /".1ZEID=C:7/VFTD"/YDY$WFJLW91G.2N22 ?7/5Z!H-WI
MOB#7]4NY8&.J/;R!(L_(4B",.1Z@X]JWX9HKB".>&1)8I%#HZ,"K*1D$$=01
M2NZ11M)(RHB@LS,<  =230!YU:> =9TC1O#+Z;>V)UC0VN%_?A_(GCF8EE)
MW CY2#CJ*O:?X?U_2+[Q3XAO-0LWO]1LH_*$,;&."2)9  %.2RC*^Y.>!G%=
M3HNLVNOZ9'J-B)3:RD^4\B;?,4'&X \[3V/<<UH4 4=%EO)]!TZ;4%VWLEM&
MUPNW&)"H+#';G-<5)X,\2VUIKNB:9J.FQZ+JLT\PDE1S<6_G9WHH'RD9)P3R
M,]#7H=% '"1^#M9TDZ!J.C75B=3T_2DTNZCN@XAN(U"D$,HRI# D<'(-1O\
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M],?*Q()/. &YYZ5VTCB*-I&^ZH+'Z"J>C:O:Z]HUIJMD7-K=1B2,NNTX/J*
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MM(BH5QM7Y7.,E0", 8Y)K3T+P_XJTL:;ILNMV;:/IV%1HK<BXN(U!"1R$DJ
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MWNX;E':7]WG!1@<9.><TWP?X)_X1_P *:AH6H3QW<5[<3R2;%(!27@KS[9H
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M@\0:D\Z.FJ3Q2H@!!C"1*F#Z],T 5OA[J]YKW@+1]2OW$EW-"1*X &]E8KG
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MKV:%C=-9;A-%;?O) X4-LVC^+!&![CUK@[R>_P!%^*'@O0(=6OY[&6TNS/\
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MQET="1E3E2"!Q@]*A^&D6J:Q;R:YJ>N:A.8;NZMH;7S<1%!(PRXQEF'0'/
MH ]&HIK[_+;R\;\';GIFO+/".J2)JEHFK>(-:MO$*1R/J&E:DA\JYPI+>0,!
M0 <$%"?E'(YS0!ZK17B>D>*=1NK+2==AO?$MUJ]U=1/<V?V*8V1@=P&1/DV
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M.U1?$O\ Y)IXC_Z\)/Y5U5,EBCGB:*:-)(W&&1UR"/0@T <-8^$]9U%O#_\
M:VL6UQI.E-'=6\4=L4FED5,1^:Y8@[<]@,GL*G_X1/7[&XOK71M>@L])OKIK
MIPUJ7N+=G;=(L3;MN"<D94XW'K7: !0   !P .U+0!@6WAQX/'5[XB-R&2YL
M8[00;.5*,6W9SWSTQ63J7A/Q#JOFZ9=Z[:S:'+=K<$26A-TJB02"(/NVX!
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M%G+;=O;(7) QQ7:44 8&A^'7TCQ!X@U-KE95U:>.98PF/+VQA,$YYZ9KGH_
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M>)?AUXG\4SZUJ274BWXAMUN&%O'#&701F+[IRJG)(SDYSFO2_"O_ ")^B?\
M7A!_Z+6N5N/AYJAT_6-$LO$:VV@ZD\TIM_L>Z6(R9+(K[@-FXDXQG!(R.M;=
MKI^JZ9JWAZP@NY'TRUT]X;I1" CN@C5&+<D$\X4>_I0 [QQ=1VOAP^9JUSIJ
MS3Q1>9:1&2>7+#]U$!R'8 @$9QR>U<1I]]KC1>+](T%]<$D5E;W%E%JK$W,;
M.7#A&<D\A/ER>#7?>*= FU^SL_LEXMG>V-XEY;2O%YB;U!&&7(R"&(ZBL-?
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$0MYC'A7R6.W@XQQ5_3?'VCZG?6EJ(M0M?MV?L4UW9O%'<\9^1B.I'(!QD4
M=1117)^.?&+>$8-+:.RGN7O;Z*W_ '<#2!5+@,/E_C*D[1W([XH ZRBO/#XV
M:S\>WT,Z:G-;R:7:SVVG0VK/,&8ON)C RI  SG&.!U-= OCG0W\-P:ZDTSVT
M\OV>*)8&,SS9*^4(\9WY!X]L].: .CHK)T/Q#9>(([@VJW$,]M)Y=Q;7,)BE
MB8C(W*?4$$'H:UJ "BN&O]7U_P 0^+[[P_X>OH=+M=+2,WVH/ )G:5QN6.-6
M^7A>23GK^>AH<?B[3=;>RUFZ@U;2GA,D>HK$D$D3@_<= <$$<A@.W- '4T5R
M,/Q'T">>+:+Y;&:;[/%J+6CBUDDSM $F,8)XST]ZGU+QYI&FZG?:;Y-_=7UD
M$::"SM&E8*R[MW'\(!&3ZG% '3T5QZ?$SPY*+.6%[R6RNGCC6^2T?[.COC:C
MOC ;D CL3SBK.H^.])T_5KS2A#J%WJ%H$:6WL[1YG"LN[=QVP1SZG% '3T5S
M<OCG0UT+3]6@EGNX=1;9:16L#22S,,Y4(!G(VMG.,8YI/^$[T)?#\FM33306
ML-R+2X6>$I)!*6"[74\KC<"?8YH Z6BN7M?'NDW5W<6AM]2MYXK9[N-+FR>(
MW$2]6C##YNW'!YZ5H#Q1I)\)_P#"3"X_XE?V;[5YNWG9C/3U[8]>* -BBH;.
MY2]LH+J-75)XUD4.NU@",C(['GI4U !17':]XY.C>-M)T!=-O)TNXY9)9(K5
MY#P%V[,=1DG=UQQ4^H_$#1M-O;RW:+4+E+$XO;BULWEBMCC)#L!U Y.,X[T
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MTK2]1N;'R-0O)K10]V;*T>9;8$9&\@<<<XY.*Y;XD^.IK71M#7P_<WJ)JUW
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MSM[A$.56:)7"GV!'% &+X#M+.S\'62:??37UI(9)H[B:+RV</(S$[<# R3C
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M/<06>I6=Q+;G$\<,ZNT7^\ ?E_&L;Q!J.I7>E6=YX3U*RF/VI58!//6X7D%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6%-Q<*J$J@7"C.![GGDGT'3%7Z* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ KC/%%@6\7Z/>Z5K5KIWB#[/-#%#=PF2.[@RI92 0<J<,,'-=G6;K
M.@:1XAMDM]7TZWO8D;<BS(&VGU![?A0!QWPYM[AO$WC+49K\:@)KN" W2($2
M22*/YP@R<*I8*.3]WJ37H=5K"PL]+LHK*PMHK:UB&$BA0*JCV JS0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
A44 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>employementagreement_mil010.jpg
<TEXT>
begin 644 employementagreement_mil010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M\0RV=R@N$REK$AEE+$D! %')X^@[G'-6M#N-9N_M=SJMHEE$\@^R6I96EC0
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MA^[N-2L88O"UOIUU;:M]LEU6 QB-X@Y9L$-YA:13M*D8Y/. * .DLO%5O?\
MBRXT*"UN/]'MVE:YD0HC,KA"J9'S8)Y8<9&!GG&<GC#5+NQ?6--\./>:*K-M
ME6YQ<3(IP7CAVG<."0"P)'0<BM)]-N6\=KJ/E?Z'_9;6YDW#[YE#8QG/0=>E
M8&E_\)1X=\-Q^&K+07N+FU0V]GJ)GB%L8P<))("V\$#&5"G)'!YH W=>\66V
MB7NDV?D27%QJ-S%$$7Y?*1W"^8^1P 6 QU)^AQT%>>:]X+\03W@O;/65FFGU
M*UGE#6B9B2-AC!+?=3EMO<D]R:]"&0H!.3CDT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4KK2-,OKJ&ZN].M+BXA_U4LT"NZ=_E)&1^%7:* "BB
MB@ HHHH **** "F0PQ6T"001)%%&H5(T4*J@=  .@I]% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,"IW8XQVJWX@M= TUH(#;>(-"U2STZ*+3[NQ661IU"_+$2@97*G@A_7@X.:
M.IO/&EW]M>UTCP[>ZC)!:17=TID2!X5D!*IM?DOA6^7C'3.:ZBTN!=V<%RL<
ML8FC60)*A1UR,X93R".XKRO69K22*SN=?BUS1O%2Z9"4O],BD/VB0KEH\1@J
MVU\@JP[\<5Z1X?DU";PYIDNK)LU%[6-KI<8Q(5&X8[<YH Y.T\4:[=_$?7=$
M?36&FVEM%AA-'^[W>81+_>.\!1M[8^M87@SQQ>:/\.] NKO0[R72%6.WGU-I
MTRK,^S<$)W,H8@$\=\ CFM>*X&F?%W7TNX;E!JEA;+9R+;NR2% X8;@"!C/<
MBL>2PO/^&<[&S%I/]J$5L#!Y9WC%PA/RXSTYH [+7?%M_I=[>0V/AN\U""PA
M$]W<"58E52"<1[O]8P )('L,YK'U+QKJS^-?#5IH^G-<Z9J-G)= ^;&AG0JA
M!^;E=F<X[Y]JR/$H.H>(O$EAJJ:W<7;(L>BV5J\\<$B&(9;,9"GYRVXN> /P
MJKI]^FGWOPXU6YM[U+.WTB2QG<6<K&*<1QKM90N1RI .,''I0!Z_.\D=O(\4
M1ED5"4C#!=YQP,G@9KQG4?%NMZW\)M>U#4[62V2+4D$5PDJ'"B]0>6 G/RCC
M/?WKVJO#T,K?"W7_  ]]CO!JEOJXE> VLG*&^1@RMC##'/!/ STH ]%L?&-T
M_B2TT?5= N=,^WQ2264LDR/YFP LK*I^1L'..:JVWQ!-PUK>MHES'H%Y="UM
M]3,J89F;8K&/[RHS<!O<$@9IWBBSFNOB!X.9(I#$@OUDD521'N@ &3VR:X;P
MWHNC1:=I7A_5+7Q-/K4$\<,]BL]S]G0H^1-R?*\L8##!],#- 'ME>:Z#97_Q
M$CN]?O\ 7-5LM->YEATZSTZY-N!$C%-[E>68D$]<#^7I5>8^'-9'PXANO#>O
MV=]'90W,LFG7T%K)/%-"[EPI* E7!8@@B@#=MI;[P'H>L7?B#6)-2TFT(DLY
M9!NNMIX\MS@!CN("GOGG':2R\8W@UC3].USP_<:2=2W"SE:X256=5W%'V_<;
M&2!R#@C-8/B&?7O&W@C7'M]$FM[:.6";389U*7%T(I%=RR'[H.W"CJ:EU#5X
M?&_B/PO!H]O>F.POOM][-/:20BW"QL A+@98EL8&>A[4 23?$^1=,OM5@\-W
MDVF:=<R6]]<"=%\O8^TE5/+\8)QC&>N0<:=IXXEEU_3+"[T.YL[/5@YT^\DE
M0^;M7?\ ,@Y3*\C//J <XY5+"\_X4UXPMOLD_GRW6H&.+RSN<&5L$#J<]JW]
M<M;A]=^'[)!*RPW#F4A"1&/LS#YO3GCF@"$_$NXET_4-2L_"][<Z?ID\T-[.
ML\:E/+8ABBGE\*-QZ=<9SG&OJ'BV[\ZWCT+0+G5UEM%O3,LJPQB-ON@,WWG.
M,[1[9ZUP.C^)8+'P-XGTE[*]DOKJ^U&*RCAM9)!<L[NH 900"&.""00!GN*G
M2T?3KVTT/Q(-:DCM-'LX--M-/DG2.XF"%9<M$0-P8*/F( '/3F@#K9_B';&+
MP\VGZ9=7TFO022VD2%58,@4E6SP/O')S@;3UJO+\2#9:9JUQJ6AW%K<Z/<01
MW]N)ED\N*7&V56'##!SC@\&N9\&V]S]I^'<3VES&^G0ZC;W8DA=?)DVKP21W
M['O73V.CKJ7C;Q[:WUO)]BO[:SAW,I"NIA=6VGOC/X4 ;^N^)(=&ETB!(&NI
M]4NUMH(XV X(+-(3_=4#)K3OB1I]R1P?*;^1KR_X<0:EJWB!/[71B?"5L^DQ
MNW22<L0T@_[9+&/^!&O4;T%K"Y !),3  ?0T >7>#O'%WI/@#P[<7>AW<FDE
M(;:;4VG3(=F";O+)W%=Q S^0(QGJ]=\8WNDW>H"U\-WM[9:;$);RZ$BQ *5W
M'RPW^L(7DXQZ=:Y.>PO#^SYI5F+2?[2J66Z'RSO&+B,G*]>!DU!XF1M3U'Q7
M8:I%KEUJK;H]'LK9[A+<PF$;7^0A#\Q;=N)Z8QVH [2^\9SF_%IH6B3ZPZV<
M=[,R3I$$CDW;,;OO,=K''ZUTEC="^L+>[6&:$3QK((IT*2)D9PRGH1W%>337
M.@7.DZ//>QZ_I.IPZ5#':ZG8P3J\I4$-"0JG)5U^ZXYSD<'->F>&)=3G\+Z7
M+K*%-2>UC:Y4KM(DVC.1V/J/6@##BU'2S\6[C3ULIQJJZ.)FNO/;RS%Y@&SR
M\XSGG=C-9D/Q2DFT"U\1#PW>+H3NJ3WC3H#$2^PD)U90QP3QWQG&:(;2Y'Q^
MO+LV\OV8^'A&)MAV%O.4[=W3/M6(=/O/^&;$LOLD_P!K\A1Y'EG?G[0#]W&>
MG- 'K]>?QZ_9VGB;QRVEZ1<2ZKIT5O)<E[H[)\QDKM5CA-JYSC&<5Z!7E^E:
M=>O\0/B:1:S!;JVMD@8H0LI\AAA2>#SQ0!;\/>.M8D\':!/>Z/+>:QJ@"6RK
M/$@N<1EVE)&!&, \8S[5V6AZI<:M9/+=Z9<Z;<Q2M%)!/@\C'*L.'4Y&&'OZ
M5YEI5]H-Y\-/#NGZWINK>78JD,]S#;3QR:?.J'#94!N>1N7(YYZUV7P^GOY]
M'O1<W-]=V4=XZ:=<W\92>:WVK@MD GYBX!(!( H L>(O%QT/7--T>#2[B_O=
M2CE>W2)U4$Q[<@EN ,,3GV[G JG!\0;>/3-9FU33+FQO](DCCN+$,LKNTF/*
MV,.&WD@#ISUK.\8:E'I'Q/\ "EY-#-);I9WHE:&)I&C4^7\VU020#C. < D]
MJYO5]-NO%8\7:_I]G?/923Z<;951X9;I+9MTIC!PV<,0IZDCB@#O+3QC<"XO
M+/6-$FTV^@LGOHHC.DJSQ+PV&7@,"0"#ZCK6=9?$B2\\/C71X=O$T^9(5M':
M:/=<SR,J",+G( 9L;C@<$^F<G3;/0+Z74[K18O$-[-!I4Z"\OY;AHT+CF)1,
M<EC@$X'&.3TJ]IL%K;_!71K;6M&NKRT^QVZ7=M'&QDC7C+[1\V5/S?+R,9%
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MN%C^(=Q_PC+Z_<>'IX;.<0+IJ?:%:2]DE. H7'R#.,$]1SCM69<:SJ,OQ/\
M#0UG2SIDL%C?2LJ7 GC="J<A@!DC:<C'''7- 'IM9,^@P2>);;78I9(+N.%K
M>4)C;<1$Y"N/]EN01R,GL:R/#_BW5-:ET^:;PW-;:7J,9EM;Q+A9<+MW+YJ@
M?N]PZ<GG JK\6-2U/3/AYJDVF0L6:$K+.D_EM IP-PXR3SCC'6@#MZR;708(
M/$=YKDLLD]Y/$L$9?&V"(<[$'NWS$GJ<>@KA_#6J-X2\+Z/I]KX:*ZKJS@VU
MHE]O^T8B5GG>1A\@QU&#V]:VQX\EMK'Q -4T=K35-%M/MDEH+@2)-$5)5DD
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]%\(S6,6K2R(UXQ">6FX(H*@N_\ =4%AS[UT=>'CQ!X<\3^)/%=]KDEVUI/
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M0X'0K\@ "UL>$]#7Q%X@\5W.JWVH30V>M7$%M MW)&D8*+N/RD=F 'ICC!-
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M)!#=!BL<A!9=K%><?[M<%H?_ "47XJ?]>]K_ .B'K;^#/_))=!_W)?\ T<]
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MT>BN.^%=S<7GPTT6XNIWGG=)"\CL6+'S'[FNQH **** "BBB@ HHHH ****
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MQ()4"G)[8 KF5^&MU_9=AI[^*+MX=*EBETL&V0" QL"I<#_6$#Y><#!/&:]
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF>2&^>"./;%LZL-SC=QD@#G Y R,];87L&I:?;7UJ^^WN8EFB;&,JP!!_(T
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M69R[MB5P,D\G@"@#M:*PM?\ %$.B75I8Q6-WJ.I789H;2T"[BJXW.Q8A549
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *XG4?W'QET26;_5W&D74$.?^>BR1N?QVUVU8WB'
M0$UV"U9+AK6^LKA;FTNE7<8G'!!&1E64E2,\@T <$=9L-!C\?:/J;$:E>W<]
MQ:VY0EKN.2!539Q\W((/ICG%.U,%_AA\/K51_I,UUI2Q#N"H5B?P56KU,#IG
M!/KBL>?P^MYXIM=:N[@RK91,EG;;,+$[</(3GYF(^4=,#/K0!LT444 %%%%
M!7FEIK%O\//%WB"WU[S+;2=6N_[0L]0\MFBWLH$D;D [2"N1GJ*]+KGWT'5V
M9C_PEVI@$_=^S6N!_P"0J ,&\\0R>/-)\0:7X?LY)M-?2YHDU-\QI+<,I CC
M##YASRW05SNI:_I_B7X?Z+X5TQF;7)7LH9+(1L)+0Q.AD:08^4*$/)_"N_\
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MRM/#WB^]/B#Q%JFB0W.GV?V>>TF\N.=HD*.A.TY8$ @=<-7L6!G..:" >HH
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MZBKM8?@ZRM+#PEI\%C;WMO;%#(D5\?WR[V+G?[Y8UN4 %%%% !1110 4444
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MMHK#\%NTG@7P\[L6=M,MBS,<DGREY-;E !1110 4444 %%%% !1110 4444
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ME-O8>?&<@8R>E>]T4 4])4KHUBK AA;Q@@]1\HKB=;U!=$^+MKJ=W;7)T_\
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M* ."\->-5GM=!T2UTF^?4EC2'4(I8'A6Q")AF9F7:>0  #SFN4@D9?AWX_\
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M>J4 .YHVW!3[&M>B@ HHHH *R- T&+0(K^.*=Y1>7TUZQ8 ;6D;<5'L*UZ*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MJEJNK66B6)O+^;RH=ZQC"EF=V.%55 )8DGH!0!=HH!R :HVFKV5]J%[803$W
M=DRK/$RE67<,J>1RI'0CC@^E %ZBBB@ HHHH ***Y&^^(>F66LWNE)INM7EQ
M9,J3FRT]YE0LH8#*^QH ZZBLC0?$,6OQSO%I^IV?DD B_M'@+9S]W=UZ5KT
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M%6;?@!FCD)RFX*,\'GD8J":&3Q!\2[*6-&%AX=BD+RD'$EU*H78/7:F23V+
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/THP^'-*T_PV-8M1::I#-<R7<;0R7"%RTQD+@%@P+9QWP.E=Y2$A5)/ ')H
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M2E0#['-;U% '$W7P]:2?5H;77[VTTG5I'FO+".-"&=QA]KD;E#=P/?D9J=O
MIMK;1CI.LW&GZAI=D+!;I8DD\Z$ ?*Z,,'E01CH<UU]4-9O+ZPTR2XT[3'U*
MZ4KMM4F6(OD@'YFX&!S^% &./!D;1:()]4O;F;2[UKTSSL&::1@P(/95^<X
MP!@"M"WT"*W\5WVOB9S-=VT5NT1 VJ$+$$>YW5K DJ"1@^GI2T <C9^ K2SM
MM)@6]F8:;J4NHH2H^=G+Y4^P\P_E6E<>&8+CQ%=ZRUQ()+G3?[.:, 8"[F;<
M/?YJW** .(E^&UE+\,H_!!O[@6J8Q<[5W\2^9TZ=>*U]=\*6^NZQH.I2W,L3
MZ/.T\:* 1(2 ,'\JZ"L/Q=XGM?!_ARXUF[AEF2(JJQ18W.S,% &?<T 9.I^
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MA$7.T(B *I!.<XSG%/TSPK=6EV;C4?$6I:HRV[6T*S[$6-&QDD(HWOP/F;-
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MN( P;8P8'&2.HYH \QTH:QK&AV_B&Q\-ZU-XCFNOM*ZH+J,1,HEYCVF7/E[
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M+*RD**L?RE0'95#2!0< ,:%^'^EOX;U'2+J6>YDU&9KFXOG($QF)RK@@8!7
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M"1R+.JYVDJZD!AD@,.U5K[X=:5>>"$\++/<Q6JRK,T^X-+(X?>68D<DMG/%
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M@)S\HX)/J2: />20.IHKR+58YO$?CG6X;[PM=>((+*WMHK=8[N*%;;S(][,
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M ^4'IUR>] 'I=%<9\56*^ +HJ2#]JM.0?^GB.CQ(Y'Q-\$*&(!6_R,]?W2T
M=GD9QGFC('?K7@D6@64?P)7Q.5D;6[8&:WO3(V^#;<$*J<\+@=.^2>IKL['1
M;#Q=\0/%<FMPFZ_LYK:VLD9V'V=3$'9DP?E8LV=PYX% '7>%O$ \3:"FJ"V^
MS!IIHO++[L>7(R9S@==N?QK:KP+13<7'A[P?HITVXUNREGU2>>T2=(_M+1SD
M*7+LH(&\MC/)QQQ5[6].UBP\)2V4MA=:)8OXALVTV%[F.5[=&*A@I1F  ?)
M[9H ]NR/453N]6L[+4;#3YY=MS?LZVZ;2=Q12[?3 %>?>(O!%MI5QIS67AEM
M9\/V\4HFTV.X.])G*GSP';]XV%(QG/.16+-H_AK6_$_P[,$$UW8W$5]"WVXL
M9=L2$K&^><HVX?AU- 'M&1G&>:"0!DG%>'^,_LLMCXF\0:7HM_=75G=,5UVX
MND3[-+&R@I"N0QC4C'3DD]:Z6T\-:9XE^(_C6/68#>6T+68CMY'/EJS6XRV
M?O<#![<XZF@#TLD 9/ KG1XEN)]:\0Z59:9]HNM)MX)8U\\)]I:57(7)&$^Y
MC)SUKS3PXG_"26O@+0M7>2ZT[R;^66&5R1.89#'$'_O!1SBI;[3;?1F^*]G8
MEDMXM)MC%'O)\H&*4[03R!D\#L#@<4 >PV4MQ/86\UW;?9;EXU:6#S _E,1R
MNX<'!XR.M3@@C(Z5X[I>FP:W>_#FROC)):2>&V:>$.0)@%APK8ZC.#COCGC-
M4]0B_LA?$OA?3I);32I?$&GV@CCD(\F*=$:55.<J#R,#U- 'MV<]*,UY=?\
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MI,;E& /EX[YK+TKP)#I=U9;=:U6?3[!B]GI\LJ^5"<$ 9"AF"@D ,3BNJ\Q
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MQMKIT*0DJ4R2JAG(4D L3C-=2KJZ!U8,I&00<@T)(DB;T=67^\#D4 >4>"/
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M&0.,%1C.>^<UU&1G&>:S]3NM1MY+)=/L(KM9+A8[DO<"/R8SU<#!W$?W>,T
M8P\$13:7J]IJ6L:EJ$VJV_V::YF= R1X( 154(OWB>G)/-7]0\,6.I>&X=$G
M>=88%B$,\;[98GCQL=6QPP(!Z4V\\46<":\D&9KK1K;SYXC\H.8RZKGW"_AF
MK>B:JFKZ+IU^56*2\M(KGR=^XH'4-CWQG&<4 9EGX.@6#44U;4;[67U"#[-,
MUXR@"+GY55 JK]XG.,Y[U5T_P'#;7NGS7NM:IJ<&F-NL;:[=-D+ ;0QVJ"[
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MD[6"R((TE?DN#MW'YOF"DE0><5N:)X:BT6_U"_\ MMU=W6H"'[1)<;/F,2;
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MO:PC;'%&,*HSGC\ZQ8O ^C6\.A0VZS0Q:+,TULJOG<[ ABY();.XD].3724
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MV<<EW8W-VEG/(-TELD4QV+&QY0 Y.!ZFNHL]'T[Q!\5K\ZO;0WJIHMI((+A
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MUG^#O#6A:]X L?$.L;+?5KBY:\FU8,J3QRB8X D8< 8";>F.,4 >HO<P1SI
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MK->6\5Q+_JXGE57?Z G)H KZ#HEIX<T6VTFQ\S[-;@A/,;<W+%CD_4FL;5?
M5AJFNSZP-3UFQNYXTBE-A>M"'5<[<@#GJ:Z*XU"RM!(;F[@A$:AG,D@7:"<
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MEMTF>V64%UW*#]W.<<U;?4+**\2SDN[=+J092%I '8>RYR: .8NOAQHUU-=
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M.+>9_"TNGB.2TUN0J[.XW0+Y)EP<$@,, $9XKIK2^M+^(RV=U!<Q@[2\,@<
M^F10!SNI> -*U*^O+AKK4K>&^8->V=M=&."Z. "74>H !P1D#FM>WT&RM=?N
M-9B5UNI[:.V89^0(A)7 [?>-6(-4T^Z69K>^M91!_K3',K>7_O8/'XU3T#Q)
MIOB6TEN=.F#I'-)"P)7=\CE=V 3\I*D@]Q0!5_X0O2?^$5O?#G[_ .P7CRO+
M^\^?,CEVP<<<FFZKX,L=3ODOH[W4M/NQ +>2:PN/*:6,<A7X(.,G!ZC/6M36
MM8L] T:[U2_DV6]M$TC8(W-@$[5R1ECC@5BS^,81KGARVMC!)9:M%<2R3M(,
MQ"*-7[''\7/IB@"];^$]*L[K1Y[:)XCI$$EO:HK_ "A'"ALYY)^4<Y]:9=>$
M-)O6UXW"2N-<C2.\7?@81-B[?0X_6KUQJ2SZ+<WNDW-E<.D;F)WF'D[P.-S+
MG SUI+?4UAT6UO-6N;&WDDC4R.DX\G>1R%9L9'I0 :'HZ:%I<=A'>7EVD?W9
M+R7S' Z 9P.!BM&FHZ21J\;*Z,,JRG((]13J "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y;QUHEU
MKFF6*6:64\UK>I="SO3B*Z"JV8VX/KN'!&5&:ZFLO7- LO$%K%#=F>-X)1-!
M/;RF*6%P"-RL.1P2/H: /*]:73KOP\^FIH;Z%>?\)'8+J%C'*"BLY3#QE/E
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M4M+\;:CI_AVPDCMVDBN-5O[HB<31(!^X4(Q 4@8&Y<FO:*Y6[^'NA7UW?RW
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MNI4-D<@$DC/0FO1+SP#HM[JUW?NU]&+TAKNUBNG2"X8# +H#@\ 9['N#1=^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR[;F"66;Y#*.K8=@N5;IP1VI?#UA9PI\2Y(K2!)([NXC1EC *KY"G:#V&>U
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MOK.]@O8HH@%EA5$*AU P0&XY]:I?"&PLT'BN=+2!9HO$5W%'((P&1/E^4''
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M?_)7OB#_ -@J#_T4*V?A'H]A9?#W1KV&UB%Y<VH::XV#S'R> 6ZD   #L *
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MSFNCUJ\M].T+4+V[#FVM[:2641DAMBJ2<$=\ T +:ZSI=]=RVEIJ5G<7,/\
MK88IU=T[<J#D5'+K^C0R11RZM81O,Q2)6N4!=@<$*,\D'CCO7E^GVMQ8>(?
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M!$WT;.#T/Y5@6OBZ;4M7\36UE<Z7]DT^Q@N+.\=R8B9$D):1@V"@*#ICC/-
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M^:+4.?M@?<!O(SCR\<9QU[T[_A*?#QN+:W&NZ:9KH9@C%VFZ7G VC//((XH
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M5V]K;Q> /BJ\<$2.NI:C&K*@!"^6GRCV]JF\=:79:9^SQ.+2VBB:2TLWE=5
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M2J/_  B6B?\ ",_\(Y]B_P")3G/D>:_7S/,^]G=][GK0!R4/_)QMQ_V+0_\
M1ZURD6E6,7[-<UXMK%]J*M.9]HW[Q<84[NO   ]A7L(T#3%\1MX@%M_Q-&MO
MLAGWM_JMV[;MSCJ.N,U7_P"$3T7_ (1<^&_L7_$I*E3;^8_0MN/S9W=>>M '
M&7.T_M"(9'V*?"YW/G&T><V3GM4>A6#^&KOPWI6L:3I=]8ES;Z7K5BV&),3$
M>:G?>@;)!()Y]Z[YO#VE/X@&NO:AM2%K]C\TNV/)W;MNW.WJ>N,UGZ7X$\/:
M/J$-[9VDHD@W?9TDN99([?<,'RT9BJ<$C@=.* /+9+>&/]G_ ,521Q1JYOKA
M2RJ <"Z&!FNX\0V.G:9:^'-$TW0K*YO+F[#6J7#&.%7CB9C+)M&7(&>"#DG-
M:Q^'WAHPZI ;"3[/JC%KJ$7,HC8E@Q(7=A22 ?EQ6EK?AW3/$%K!!J$,C"WD
M$L,D4SQ21, 1E70@C@D=: /'=>CE'A3XH0WB6'G12VKLEDI\E)"B E0>0WK[
MYKIO&L,4'C'X:QPQI&@O92%10!]Q.PKK4\!>&DBO(ETW$5[;"UN8_.DVRH#D
M%ANP7S_'][KS3X/!.@P+I0%K+(=*D:6S:6YE=HV;&3DL<]!P<@=J .'U'6'^
M'^K>-;.$'_3X%U73$'>>4B%U'OYI0X]#4,?A[4M"\2>$]!TZWTRYDL=%FD5=
M1=UC:<R)YKKM5LO\WIT8UZ1JWAC1]<U'3K_4;)9[K3I/,M9"S#RVR#T!P>5!
MP<]*=K?AS3/$,< U"%R]NQ>":&9XI8B1@[70AAD=1GF@#'\"Z9=Z)IVIPW\V
MFKYNI2RQPV$I:*WW!<QC<!@[MQQC^*NMKF+[P5IS^'K71]/MXX((+Z&[RSLQ
MW)*'9B2268@$98]_:NGH \Y\(Z?IVIP>-YM7MX)II-8NX;EYE!(A4 (N3T4)
M@CZURF@VHUJ;X31:M']H0V-ZQCF&0ZHJ&/<#U& I_ 5Z;JO@3P]K-_->W=I+
MYUP MR(;F6);@ 8 D5& ?CCD=*TGT#2WU#3;[[(JSZ9&\5F4)41(ZA6 4'&,
M*!R.,<4 :$<<<,211(J1H JHHP% Z "N!\)6-EJ7B+QS+JEM!/='4_L[B= Q
M%N(D\L<]%(+&O0*Y[5_!&@ZW?R7MY:S"XE01SO;W,L/GH.BR!& <?7- 'EVF
MQI<^#_AIYZ+,@UQH8FD&XM"&F"#GMM"_D*[+0]*L+KXK>,I;BTAE:*"QCC$B
M!@BM$V0 >F=H_*NEU3PEHFL:1:Z5=60%G9NCVR0.T1A91A2A0@C )'%6M.T+
M3M*N[FZLX&2>YCBCFD:1G+K$NU,[B>@[]3WS0!XYI*7TN@^ [&Q@LIHUU34?
M+@OG98"\;2^6#M!.0-Q48Z@59\8Z1JFF^ _'4]^VE0_;)+*3[+IDK,(9!(@9
MB&5=I8!#[XS7ILG@W09="31FL<64<QN(U65P\<I8L75P=RG+'D'OCI3%\#^'
MAH-WHK6+26=Y()+GS)Y&DF<$$%I"VXG*COVH UM-TNQTBS2TT^UBMX5 &V-
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MDTZ]2Y$:@9A4)LSCL&SBN*TNR2R_9AGN[&$)=SVCF>9%^=D,VU\GK@(,?04
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC:PK!:Q1B.../Y0B@8 &.E0Z1H^GZ#ID6FZ7;+;6D6=D:DG&22>3DGDFKU%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%&><=Z
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\F]?F8;\;?E)R">.V>* /3:\C74/$E[/\28;^>S>RMK>2,QHTA,?^C$KY8/
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MVV0X#?NLME6P.2<C/:@#V6BO-#XV\4CPI_PFIM-,_L+_ %WV#:_VG[-NQO\
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M!Y>[)P(R/EZ#!QDUR_BS7=2U[X8ZAK$MFD=A+J%HVF0A2LTL(N(\.Y)P"YY
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*/CP1VUM;W(M+8PW2PKO@DEBD#R*>H8YR2.O>@#TF"]M;F22."YAE>,X=8Y
MQ0^X'2I(IHIDWQ2)(N2,HP(S7FGA*P@\/>(='TS5?"]MIFJ"VD@M-3TZ0&&]
M"J"X< !MQ"[L.#R"0<UZ#I6D6&B69M-.MEMX#(TA122-S'+'GU- $M_<26FG
M7-S# 9Y(HFD2$'!D(!(7/;/2L6P\7V5]X"7Q:$*6GV-KIXRV2NT$LN>Y!!%=
M%7ASAK73]6^&ZY!G\1101*.JV4Q\\X]@J2 _6@#U'PQXLM?$?A--?,+6<8$G
MGPR'+0F-B&!_+-+X=\56^M>%++7[N--,AO 61+B8<#<0O)P.0,_C7FWB>[FT
M%?&_A:T^2;6;BWDT]/[QN_W4N/H4<_C71:SIMB/$&D:!8^'+?6KK3=*^2._G
M$=M!"6"!L%'RYV$<+T!YH [+6;V^MK6UDTQ+*5I+A$<W4_EKY9SDJ0#ENF!W
MK12:.4N(Y$<HVU@K [3Z'T->"ZB[M\)?"B.% B\5")$1RZHJS3 *K'&5 X!Q
MT KM[F_@\#?$36KJY.S3=7TUM0'8>?;C$BCW9"I]R* /0&N[9(Y9'N(E2$XD
M8N $^I[4+=VS6PN5N(3;GI*'&T\XZ].M>+)I>HP:;X-M[C2X=3NM;O+K5[^R
MN)O*CFF,>] Y*M]U3G:0>4IWBG2=5TKX;^-FN=,M=)LKF:SFM;*UN!*D+^9&
M)",*H7)"MC'4F@#V1M1LDBEE:\MUCA;9(QE4!&]"<\'V-3QR)-&LD;JZ,,JR
MG((]C7 >(/ T-K!I!T'1=,O([&9YI],NB$6]+)L\PL009!URP/4\UL^ YM-D
MT*>+3=,FTOR+R6.XL)&S]GFR"RK@E=OS C;Q@T =11110!6U&>YMM/GFL[,W
MERBYCMQ((_,/IN/ _&N&D^('B.+7X=#?P+,-0F@:X2+^U(>8U."<].IZ9KT*
MN"O_ /DNFC_]@.?_ -&B@#13Q9J$6MZ%I^IZ2FG/J,5W+,DERLAA$.TCYE^4
M@AL^U;EW?E]&N+S2I;2YD6-C"SS 1,P[,XS@>IKD/&&F6FK?$OP;:WT*SVQA
MOG>%QE),+$0&'<9P<'TKF]4L[;3+'XLZ=8P1VUE':0RI;Q*%1&>W.XA1P,X%
M 'JD&H+%I-K=:I-:6TDD:&0K,/*#D9(5CC(SG![U>5@RAE(*D9!'0UY1;Z#>
MWOA?P3JUMH]AKT5IHD<4FEWCJN=\<9\R/<"NX;<<]CUKM_!$^FS^$[3^R;6>
MTM(VDC%K.27@=9&#QGD_=8$#G& ,<4 =#7%Z[\1;+0O%]KH4EG++&YB6ZO%<
M!+5I21&''OC\ 175ZC?V^E:9=:A=OLMK:)II6]%49/\ *O$M,74=<\%^(&U'
MP?K=S>>)G:Z^U0K#L1< VX7=(#A %(X]: /=7=8T9W8*JC)8G  J&&]M;D(8
M+F&429*%) V['7&.N*\EN]?D\5_#GPS;:CN6:;7+;2M9A8X)9&(=6_WBJG_@
M5;+Z+I>C?&?0UTRVAM%ETRZ:2W@4(@(* /M' )'!/?:/2@#T&.]M)95BCNH7
MD=2ZJL@)*@XR!Z9XS1;WEK=EQ;7,,WEG:_ER!MI]#CI7A^AZ;;Z9^S[<Z]9P
M(-7N(986N^DBQ&X,957ZJNT9XXSSUKH%T;6]'U"/5M.\+:;H,-GIMU'-]CO%
MD,X$>8\J$7)5U7DY/S&@#U".\M9;F2VCN87GC^_$L@++]1U%-?4;*)D62\MT
M9W,:AI5!9AU4<\GVKR/PSH&KS:?X0O['PSIUD\4D%S+JR7X:>YB=?WN\; 6+
MAB<%C@X]*@_X1_2KWP%\1]1N[*&>\BU'4VAFE0,T.PEEV$_=^;)XZYH ]E6\
MM7NFM5N86N$&6B#@NH]2.M#7EJETMJ]S"MPXRL1D =AZ@=:\PN-&L-*G^'6I
M6=M''J%Q>(EQ=A?WL_F6[ES(W5B3SS6);Z1K7B/1=;N+;PS83ZE<:E<M'K,U
M^$GMY(Y2L> 4)4)M4 !N1]: /:9[^SM5=KB[@A5" YDD"A2>F<],U1UCQ)IF
MABP-Y. +ZX2WAVL.6;.&.3]WCDUQFDZ%I^M?$_Q:^LV-O>-#;V $4Z"2-6:)
MMQ"GC/&,]<9]37(0:=97?@WP#'=6D%PL?B9[-?.C#GR!+./+.>J_*O'3@4 >
M[JRNH96#*PR"#D$4UY8X]OF.J;CM7<<9/H/>B**."%(88UCBC4*B(,!0.  .
MPKA?B?:17R^$K2<$PS>(;=)%!QN4QRY'T(R/QH [(:II[6TERM]:F",[7E$R
M[5/H3G J8W5NMM]I,\0M]N[S2XVX]<],5YM;>%-!_P"%PW]D-)LQ8?V-#<FS
M$*^09?,= YCQM+!<@''<^M8VD_8O^$2L]!;2CJC?\)'>1:?I[3>7"1$\C?O"
M01Y:C)Q@Y..* /8$O;26&.:.ZA>*5ML;K("KGT![FI))8X0IED1 S!5W,!DG
MH![UXY;^'KK5['QYH\-E::;>VMQ;7ME:V,N^*"Y$0<%#M7!8J,_*/O&MBRU>
M/XB>)?"CQ@&ST^S&L7:=0MPV8XT/NK"0_P# : /3JAFN[:W#&>XBBVKO;>X7
M"],G/;WJ:O/M5TBQUCXT6L.HVT=S!'H+2^3*H9&83@ LIX.,DC/?![4 =[%<
M0S0">*:.2$C(D1@5(]<]*B@U"RN89)K>\MY8H_OO'*K*OU(/%>,SP1VVF:IH
M$*^3I%QXVALI8(_E1;=UC9D&/NJ6XP..:ZK4]%TO2/B9X:MM-TZTM[?5+2]M
MK^VAA58YHD167>@&#@G'([XH [#0/$.G>)-/-[ITN^(221D$C=\CLF< G@E2
M1ZBM6O/?@QI]G;?#ZVN8+2"*XGFN!+*D85I L\@4,1R<#@9Z5Z%0!S?A+Q7#
MXA\/6%_=-;6MU=F4+;^:,G9(R< \G[M;MQ>6MIL^TW,,/F':GF2!=Q]!GK7B
M6F>'-%D^ >H:P]K VI(EU<)>%1YL4D<K[ K]5 VC@>I]:TDCU'Q%XNUIKKPM
M8:\8[*RA O;H1?9U>'>VQ2C<LS-DC!^4>E 'L5-DECAC,DKJB#JS' 'XUB>#
M+/4M/\':79:NRM>P0^6[+)YF0"0OS=_EV\UD?%O_ ))9KV#@^2G/_;1: .L6
M_LWEFB6[@:2$9E02 F,?[0[?C3[>ZM[N$36T\4T1X#QN&4_B*\RU[PCH=OX]
M\%6L.G01PW2W<=VJH!]J5(PX$O\ ST^8 G=G/>L/7U70K;XE6&E 6-E]HTU=
MEN-BQ+,$64J!P,@G- 'LUO?V=X[I;7<$[1G#B*0,5/OCI69XD\0P:'H>JW<4
MEO->6-G)<BU:0!FVJ6Y'4#CK7*>(=$TOPSXE\%W&A:?;6-P^H_8G%M&$\V!H
MG+!L?>QM4\YP>:Y>+1=+U+X&ZYK]]:PMJ]PM[<RWC*/.$HD=0N_J!@!<=,$C
MO0!ZE;ZKJ-S?:24ALA97=KYTY><B96*Y 1,?,/4UB6/CFZUCQ[?Z#IMOIYL=
M.:);BZFNR'E+J6_=(%(;&,<FN=89^+'P_!Z?V)+_ .BS4G@30M(C^*?CGR]*
ML5^Q3VAM=MN@\C,;9V<?+GVH ] T2^OKG23<ZLMC#,KMN^RS^9&%'0[B!SCK
MZ5H6]U;W<(FMIXIHCT>-PR_F*\!\/M<O\)M"LH+1+R.\\3&&:UDE\M)U&]PC
M-@X!95['/3O6SXEL-<T/PYXMOTT>ST"QO+&")K:RNA(/,\T(T@ 50N8W(.!S
MMH ]'U;Q7%9ZCH=M9-;W::A?FTE=)0WE?NV?/'?Y>A]:Z.O,O$?AS1-#\6>!
M&TJQMK-_[0,16! GF((7P6Q]XCU//S'UKTV@ J#[;:?:_LGVJ'[3C/D^8-^/
M7;UJ>O#M3$4VCQ>(-*\.6EO;2ZY%-#K%Q=YO96-R%+!0F=I^8;2_W>U 'M$^
MH65L&-Q=V\05@K&20+@GD Y/6G&]M5NDMC<PBX<;EB,@WL/4#J17G%AX>TK6
M_'7Q ;5+&&\"/;I&LZ!Q'FV7)4'HQP.1SP*YFWT>P@^#GA?75MHSJZWEE(+Y
MES-_KE0#?UVA<*!TP!0![;->6MO-'#-<PQRRG$:/( SGV!ZTLUW;6P8SW$40
M1=[;W"[5SC)SVSWKR&XTV_\ $6L^,]WA:PU9VO&LTN[J]$4EJBQ)L" HQ7&[
M?D$9)]JTK/0_[2^)&DVOB6"&]N;?PM$UQ')B2-YQ+M+$'AN2Q&?7- 'IJ7,$
MEN+A)HV@*[A(K KCUSTQ6%-XH3_A+='TBT\BXMM0M[B4W$<F[:8MG QP<[OT
MKS&6"*'0K_08U$6DS>.4LI($X1;=BC&,#LI;M[UOZWIEAX?^)NESZ+9P6LQT
M:^D\BWC"(64+M;:.,GIGOM'I0!Z4EY:R73VJ7,+7"#+Q+("ZCW'453UG6K?2
M]/OI!- UW;VLEPENT@#/M4MTZXXKRGPQH6LW>C>$]0L?#.G6TZ36]Y+K OP9
M[A'YFWC8"=ZLV5+'''I5BQT72]7^'OC/6M2M89-4>YU!VNW4&6$QE@@5NJA0
MHP!_6@#U'0=1;5_#NF:F\8C>\M(KAD4Y"ET#8'YUH5A>"?\ D0_#O_8,MO\
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M6/[/MO*$8^VVN[]VP9<GS?514-[H\E]X@GUB3PEKJRW4'V>[@CU&V6&Y0*5
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MEEBL[ZVN)(3B5(9E<H?1@#Q^- &%<>!=,EMM-BMKG4;&73K5;."XL[DQR&$
M#8QZ,/E!Y'7I6SH^D6>A:7#IUBC+!%DC>Y9F9B69F8\DDDDGU-*=8TL33PG4
MK,2P<S)YZ[H^<?,,\<D=:NT 9?B#0;/Q-HLVDZ@9OLDY7S%B?86 (.,^F0*T
MHXTBB2.-0B( JJHP !T J.ZN[:QMVN+NXBMX5^])*X11]2>*R]9U6X30UOM$
MNM)=G=0DMY<%8&4G!PRYY]* ,+Q+X/T^#2=>N;31[C4I-2FBN;BSBN?*;>A'
M[R(_PR#[W4;B,5D^%M%DNO'MMK,.G:U;VMG8RQ27>M,3<7$KE<* Q)VJJGT&
M2?4FO1+O4K'3_+^VWMO;>:=L?G2JF\^@R>32_;K3&?M4&/-\G_6#_6?W/][V
MZT 9NF^%=)TSPJ/#<<!ETORY(VBF;<65V+,"?JQJMH_@O3M'ODO/M.H7TT4)
M@@-]=-,((SC*H#TS@ GDX'6MFRU.PU'S/L-];77E';)Y$JOL/H<'BBWU/3[N
MZEM;:^MIKB'_ %L4<RLZ?[P!R/QH P-/\ :/IM];3Q2W[V]I(9;2RENF>WMW
M.>40^F3C.<9XQ5U/">EQZ-K&E*LOV75I9Y;H;^2TWW\'MUXIGB7Q/::)HVK3
M075G+J5E9RW*VCS#>=J%AE0=V.*U=-NFOM*L[MU"M/ DI4= 64'^M %*X\-Z
M?<IHZ2+)C295EM</T94*#/KP369>?#_1KV_N;AY+]+>[F$]U8Q73+;7$G'S.
M@ZYP,XP#CG-+X8\8VVKZ7'-J-S96=W+=3P10&8*9!'*R#:&.23M[=ZZ2.Y@E
MFEACFC>6(@2(K E,\C([4 4[31;.RUG4=5A#BZU 1+.2V5Q&"%P.W!-8]QX
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MLKEX)0C=4+*1E3@'!H \_P!1T>;0?AA#+?R0VVKZ7?/)HOV.0SE)&D/EVZG
M+@@^61CH/:H(;J<?"_QGX@+NOBF<31ZD,8>T9?E$2\\*J'(.><YKT2W\&Z):
MMI/E6K!-)+M:1F1BJNWWG()^9^3\QR<DGO5C_A&M+_M>_P!2^S_OM0MQ;W:;
MCY<Z#@;DZ$X)&>N.* .=?P]X:T:QTK4-.BM;+4;:TD73S"RQM<DQ$[2/^6G
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M[2I4\ #D\9S7KVN>';'Q!% MV;B.6V?S(+BVF:&6)B,$JRD'D'!'0UFS> -
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M+[5=W3S2,C8X)8G@;1@=N?4T ><LZK^R]%N8#,"*,GO]I'%;MQ#'<?M#&"9
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ML.IVU];Q1RN(_+EF0.C%BJJPSP6QP.IK2M=:TJ],8M-3LYS*SI&(IU;>R?>
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MG:.IP.N*KPZWI-QJ4FFP:G92WT6=]LDZF1<=<J#D5YCX$N]0U"?6-2U_S?\
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M\/\ PUI&I1ZC;V#R7D6?*FNKF6=H\_W?,8[3[BLC4=)O/%_CO29[S19;/2]
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M%3:=X=TK2;.\M+&T$,%[-)/<('8[W<88Y))&<=J /%;Z*-/V4(I%C0.R1[F
MY/\ I7<UZ!:10W?Q=D2^C23R= A:T6100 TC"1E![Y"@GTQ70R>#?#\OA5?#
M#Z>#HR@ 6WFOCAMX^;.[[W/6GZUX3T7Q!]G.HV9>2V!6&6*9XI$!Z@.A#8/I
MG% 'G^HVMO%XI\+6'A!-,EM(I-1>.*[DD:!;D%-X&,X9=SX X&6Q6;XHT2]L
M_">K1:C-IF+WQ!9R-;:9(Q6W9B@<<@%2<!O^!9[UZ?/X-\/W&B6NCMIJ)96C
M![=(G:-HFY^974A@>3DYR<G-)'X,\/QZ.NE+IX^QK<+=;3*Y9I@00[/G<QR!
MR2>E &O:6=K86ZV]G;Q6\*](XD"J/P%<+X-M+&^O/',FJPPRSOK$T-P9E!/V
M=8T\L'/\.W./QKT&N>U;P-X=UN_DO;ZP9KB90DS17$D0F4=!($8!QV^;/'%
M'DUVK3_"'X<R7*[Y/[<M8U9QDF(/*$'TVA:]W6*-(O*6-5CQC:!@?E6=?^'-
M(U.SL;2[L8VM[":.>UB4E%B>,$(0%(Z ].E:E 'AC6\)^!GB4"-5+:Q(A91@
MX^V)QFNUU^QMM.^(7@46%K# 0+V%1&@4;!!D+QVR!6S_ ,(!X9_XF(&FD)J+
MB2ZC%Q*$=MX?(7=A3N4'@#I6S<Z597FHV.H7$ >ZL2YMI-Q'EEUVMP#@Y''.
M: /'?#FC^(-5^'NB2!O#EK#]KBNUO99)%N1.)LL2=N-[-E",]\5Z;X\LKG4?
M .O6EHK-<2V,JHJ]6.T_*/KT_&D3P+X;CU@:HNG 7(G^T!?.D\H2_P#/01;M
M@;OG&<\]:Z*@#!\':K8ZKX+TJ^LI8S;?9(P<$8C*J RGT(((/TKE->UC3/%&
MO^")()1=:+)JERKLR$1R31Q.(\9&&&X'!Z&MR\^&?A"_O9KN;1PLD[;IDAGD
MBCE/JR*P4_B.:V+[PWHVI:-'I%SI\)L(MOE0H-@B*_=*%<%2.Q&#0!P'BJ..
MW\;>)TM$5$F\'SR7:QC :0,PC+8_BV[A]!5/4M$TW_A!OAG']CAVR:C8"3Y1
MEQ)"Q<,>X8]?6O1+#P?H6FV-_:6]D?+U!#'=O+,\DDRD%<-(S%B,$@<\9XJS
M)X>TJ:STRT>T!@TR2.6S3>W[IHU*H<YR< D<YH \^\2016OC3Q<EO&D22^#F
MDD5%P&8/*H)QWP,54U&QT^V^$?@VYT^&%;M;G39+:1%&]IF9-_/4DY;-=]XE
M\/P7NGZU>VMIOU>ZTF6Q1PY!=2&*I@G;]YNOOUK-\,^ -&L+'1;VYTTIJ=K;
M1,4:=VCBFV ,PCW% V<_,!UYH XGQA//>^$O&U_8:?I%GIJW4L,\]RSO<W$\
M95-Z]D^8 */;.!FNITZSMKSXPZC<7,*321:):["XSM+/)DC/?CK[GUK<N/ 7
MAFZOKR\GTQ9)+S>9T:63RV9EVLWE[MH8@XW 9]ZT--\.Z5I%S]ILK9DG^SI:
MF1YGD8Q(254EB<XW'GK0!Y4NFRQ^!-6U/3(@+KPWXEO+VTC08'EQRG?&/12A
M;CV%=7X9N(?%WC[4?$\#>;IUA:QV%@_9G<"65A[_ #(OX&M?5;>X\.Z3<P>&
MO#S7T]_/+*Z>>JQK+)RSR%VSM)/(7/T%6/!7AF+PAX1L-%C97>!,S2*,!Y&.
M6/TR3CVQ0!A?$:UAO=4\&6]Q&LD+ZVFY&&0P$4AP1W''2H=.TJP/QIUR0V<)
M(TFV8#8,;F9P3CUPH&?2NUOM)L=2GLIKN 2R64WVBW;<1LDP1G@\\$]:(])L
M8M8GU9( +Z>)89)=Q^9%)*C&<<$GM0!Y-X=E4>&_#^CVFF6EW>OK5^;$7CLL
M%L(GD)<A?O$ D >ISQBI+;0KOQ#IOQ TW?9C4H;^*XMS8J5B2Z2%&!4')!++
M@^Y->@W'@?P[<Z=%8/8%8(;A[J(QSR(Z2N26975@PSN.0#CFH9-%LO"<<^I^
M'O#LMU?2QI UO;7 3S%7[I;>P7(P,M][ZT <QH&KI\0_%VAZBJC[)HVG"[G3
MLM[,"FP^Z*KGVR*V_B;$T7AF#6HE)FT2]@U  =2B-B0?38S?E5GP%X9D\-Z)
M.;N.%-2U&ZDOKQ8?N([G.Q?91@?GZUTEY:07]E/9W48EM[B-HI8ST96&"/Q!
MH \D2\BA\6KX_DD M)M:ETHR _*;41>6K9]/.CS^-+HJ3?V1X8VZ7:7.NZ]>
M7>M1R7SL(;?<,ERJ_>;RW10/QXQ7H<G@WP_+X67PR^G(='4#%MYCX&&W_>SN
M^]SUJ35/"FBZS:6=M>6A,=E_Q[&*9XGBXVX5D(8#'!&>: /']=,P^%_Q+BG:
MT,B:M'O%F"(@_P#H^[:#R.<Y]\UV6K :%K_@SQ0"$@FA72+YO]B50T1/H!(.
MO^U71OX \+R6E]:G2E%M?1QQW,232*D@CQLX#8!&U>1R<<DUIZGH.F:QHCZ-
MJ%HL^GNJJ82S#A2"O(.>"!WH \AO8KG4_!M_XGV1$^(M?M>+G(C^QI,(X5DQ
MR%. 3[-7;Z%I&MP^/6U/5'T*W9]-,#VNG2/OD D4H[*P'"_,N?\ :Q74/H>F
M2Z$-#DLHGTP0BW%LPROE@8 _# YZ\56T3PKHWAZ6:;3K5TFF4+)--/)-(5'1
M=SL2%'H#B@# \6)'/\1/!-M=JKV;/>2!'&4:98ALR#QD N16+XVL] @EAM+$
M0JMUXCL!K<",=F&!*[U^ZN["9QUZFO0-:T'3/$-DMIJEJ)XE<2)\S(R..C*R
MD%3[@U4M_!OAZUT*YT5-,C:PNF+W$<K-(96./F9F)8MP.<Y&!CI0!@:W##:_
M%GPLUE&D<TUC>I=>6 "T*JA3=CL'Z5PD>DV)_9RTB3[-&)7N+:1I0,/N-R%)
MW=<[3CZ<5ZYHWA'1- N);FPM'%S*@C>>>>2:38.BAI&)"^PXIP\*:(/#L.@"
MQ']EPE6CM_,?Y2K[UYSGAAGK0!SE]:6UC\7?#@M+>* /I5W&PB0*"JM&5''8
M5P]A8:4/V8Y+E8H?.\AYO. &\3B8A3GKD$*![8%>SS:38SZM;:K) &O;:-XH
M9=Q^57QN&,X.<#J.U<+X(^&VF0>%-&.NZ2RZG;@/-"UPWEF16.UFC5MC,!CD
M@]O2@""U,C?M PF88E/A=2X_VO.YKG/"US;P_#W7;>?3H]0:]\5O:PVTTA2-
MI6>/87(YV@C)]<8[U[!_86F?\)#_ &_]E']J?9OLOG[V_P!5NW;<9QUYSC-4
M1X)\.C1KO2!IJBRN[@W4T8E?)F)!WALY4Y4=",8H \[U(7\.N>-H=0.FK<GP
MFS2)IRLJ<>9MW;CDM@]?0BKVI:=9V/@WX=/;6T<4BZIII$BJ Q+CYR3U.[)S
MZUV"> ?#,?*Z<=Y@EMG<W$I:6.08<.V[+YSU;)';&*TY]!TRYL]/M)K4-!I\
ML4UJF]AY;Q_<.<Y./?/O0!P_ANQT;4M(\<2>(8H'1M7O$OI)N"L* ;/FZ@!,
M$8Z=15.WM]4OO'OB$:-!HMY;+8V441U1Y&/V9HB1MP#E2V[.>I'-=GJG@/PU
MK.IOJ%]I@DN)=OG8E=$FV_=\Q%8*^/\ :!J;6?!VA:_<1W&H63--''Y(DAGD
MA8Q]=C%&&Y?8Y% $?@:PGTOP5I=C<7EM=O!$4$UM(7C9-QV[6/4!<#\*XWPO
MIVD7.E?$62\@@D9]7OTN&D4$K&!D#GH!EC]2:]-M+2WL;2&TM(4AMX4$<<:#
M"HH&  *YR[^'7A:^EN))M,;=<RM-<>7<RH)V8Y.\*P##/.#P,G YH X;3FGT
M71/AYXQF)"K:1:9J+MWMY0/+9CZ*^T_\"KK/AY$=076/%DH/F:W=EX">HM8_
MW<(_$ M_P*E\<Z?JFLZ3_P (GI6C#[%>Q)'+?NZ+#:QAN0$SN+ *, #'(YXK
MK;&R@TW3[:QM4V6]M$L4:CLJC 'Y"@#B=;@A?XS>&=\2-G3KLG*@Y(*8K(T7
M2[&?PS\2)YK6*2674]11G= 3M5<@9/8$D_4UWNM>%M&\07-G<ZE:-+/9DF"5
M)GB9,XR,HP)!P.#Q4\&@Z9;6FH6L-J%AU"66:Z7>Q\QY!ASUXS[8H \KT0:W
M>:]X:.GQ:7<31^$;1XQJ;/@;CB1DV@_,<(#[8]:[WP%I=SH_AZ6TN;BQEQ>W
M#QI8.6BA5G),8R 1M8L,=JLWO@O0-0L=/LY[)ECTZ(0VC0SR121(%"[0ZL&Q
M@ $$\XK4TS3++1M.AT_3K=+>UA&$C3H.<GW)))))Y)- '&^$[:VO?&'CF34(
M8IKO[=' PE4-BW\E=@Y_A.6/O7$Z+&DNB_#D.BR0+K=U% 7&<P@RA!SVP!CV
MQ7JFL>"M UZ]-[?V3FY:,1220W$D)D3^Z^QAN'L<U)J?A'0=7TFTTR[T]/L=
MFRO;1PNT1A*C VE"".#V- '.>'M-LKCXH>.9I[6*5U^Q1*9$#;4-N,@9Z X&
M?7 KA_#Z:G+8?#RVT^.PE*#4VACU MY6])<+]T$[@A;'XU[-I^B:=I=U=7-G
M;^7/=",3N79BXC78F<D]%&/?O5&7P7X?FT.WT=M/Q96TAF@5)75XG)+%E<-N
M!RQZ'OCI0!YGXLT>_P!/^'_BP7T^FJ;S5+24V^F2,5MW+Q!NH!5C@-^.:]BL
M;"STVU6VL;6&V@0 +'$@4#C'0>P%9*^#/#ZZ#)H@T\&PDE$\D9E<M)(&#!F?
M.YCE1R3VK>H \QL[?Q+/\2/&G]@ZAIUJ@EM/-%W:O*2?LZXQM=<5+J>BKX;T
M*UL[F*'7=8UK6TE,EUF&$W)!8.RKG"*L?"\YP*[VUTJRL]0OK^W@"7-\R-<R
M;B?,*+M7@G P!CC%1:UH6G>(;$6>IVYFA6194VNR,CKT964@J1Z@T >3:C]L
M2+XI0WS:?]I&D6[2K8*RQABDO4,<[L;<_A6CXMTJPT_X.:4MM:0QDR:>SN$&
MYV,B$LQZDDDDD^IKM5\ ^&5255TS FM6M)L3R?O8F))#_-\QRQ.XY;D\UHZC
MX>TK5=!.B7UHLVG%%C\DLPP%QMP0<@C YSGB@#DO$I@\(^/-%\2_)!IU[&VE
M7Y PJ=7A<C_>#+GT-7?AM:2OH5SX@ND*WFO7+W[!NJQ-Q$GT"!?S-4?%7AR[
MU?2[?P1IVCRIHKO$UQJ5Q<AQ'&K[V5-S&1G)&,G@9ZUWT44<$*0Q($CC4*JJ
M. !P!0!Y;XSOY/"?BC7[BWRK:]HH%O\ [5W&XA4#WQ,GY5CW.G+I%K>_#2$G
MR[[4K$18X/V>1 TQ'MFWES_O>]>LZMX=TG7+BPN-2LTN)=/F$]JS,P\MP0<\
M$9Z#@Y'%$WAW2;CQ%;:_+9HVJ6T1AAN"S95#G(QG'\3=NYH X72HT/QR\61E
M%*?V3;C:1QC"\8KF]/LK:Z^"G@:"6%&CN-8M4F&/OJ9W!!]>.*]AAT'3+?7;
MK6XK4+J-U$L4TV]CO1>@QG Z=A679> ?#.G1>3:Z:8X1=1W:Q_:)2B2HQ965
M2V%P6)P, ]Q0!ES6T%I\9M+-M#'#YFAW"OY:A=P66/ ./3-6_'$ZE]"TZ/3;
M:^O[N_!M!=NRPQ/&C.9&V\M@ X7N3[5T3Z592:Q#JSP WT,+01R[CPC$$C&<
M=5';M4&M^'],\16L=OJ=N94BD$L3)*T;QN,@,K(0P.">A[T >.ZZ+D:!\3H+
MM[+SUEL#*+ ,L0<[,D G.[ &?<5V^OZ=9Z?X]\ I9VL,"K+=P 1H%_=_9F^7
MZ<"MD_#_ ,+F*XB&E@1W$"V\R+/(!(BOO&X!N6W<[C\W)YY-;%WI5E>W]C?7
M$'F7-@SO;/N(V%E*MP#@Y!(YH \BN)KC1=(USX:VSE+FZU%+;3#Z6=T2[$>H
M11,"?I7L$%G;:=I,=E#B"TMX!$G.-B*N!SVP!7(:3H^H:YX^'BS6-'_LQ;*T
M-I8P2R)),Q8DO(Q0D 8)4#)ZL>]=P0&4JP!!&"#WH \QT&UG\+W?AG3-3T_2
MM0T[S#!I&LV3;9%8QL5\Q>^Y V64D'J:P=+T_2&_9TU>X>& S%+N5Y"HW"99
M7V<]01A,?A7I>F>!?#FCZC'?6.GF.:'=Y(:>1TAW<'RT9BJ9!(^4#BN:\'?#
M;3%\,:>-?TEAJ$<LDDL)N&\MSYSLA=%;8YV[>H/&!VH R]-A\1:CXRUXQ6NB
MW,WV"QBE&JF3<(VARP4*#\I<R9]Q3_#.FM:^+_">EZK<VE_%::!<-9RQ-YD+
M2><HRA/4B+ SZ9KN];\'Z'XANDNM1LV>X6/RO-BGDA9H\YV,48;ESV.13M2\
M(:%JVGV=C=:>@@LL"U\EVA: 8QA&0@J,<8!YH \X^)5KH=GX-,.A&,(/$L)N
MHXG)6.<\N,'A>W P.:V/$%O _P =?"H:&-@^GW18%0=QP>OK75-X(\.-H<&B
MG3$_L^"<7"1"1Q^]!SO+9W,<GJ2<UH3Z'IMSKEIK4UL&U"TC:*";>PV*WWAC
M.#GW% 'E%W+<V_C#XOR699;A-+MS&4Z@BV/(]Z[+3=/\*6NA>$;J5+:&2&.,
MZ;)&2C,[1'(&W[V5W$@Y![UT=MH&EVFKZAJL-HJWNHJBW<I9CYH1=J@@G P.
M. *SM+\!^&M%U)-0L-,$=Q'N$.Z:1TAW?>\M&8JF?]D"@#S:2:YFT;PAJ4&G
MZ1INDW>OVLMG"C.]T=\V26<\98%B1SP<9K:T/_DJWQ+_ .O6T_\ 1!KJ%^&_
MA-89H1I7[N0Y"_:)?W7SA_W?S?N_F /R8Z5JVWAO2;34M0U""TVW>HHD=U)Y
MC$RJB[5!R<# XXQ0!Y%X?L9V^ /A[7;%"VH:#/)J$('5T2:3S$^A0M^0KM/#
M-Q#XM\>ZEXG@;S=/L+:/3[!^S,P$LK#W^9%_ UJ7MG+X4\+Q:/X3\.&\0AXX
M8//410EB3ND,C9*Y8G R>U6_!?AJ+PCX1T_18V5V@CS+(HP'D8Y8_3)./;%
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M]['M7/PVMO=_#/X8P3Q))#)JMH'0C(;Y).#ZB@#U+1_$NB>(/._LC5+6],!
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M1I]["<7%O+*[%&/59 &8C<I!QSBMSXL-(OPRUCRRP4K$)2O7RC*@?_QW=^%
M&UI7B[P]KMV]II>LV5W<("QCAF#-@=P.X]Q7/Z!\1-,>VF3Q!J^GV=X=0N;>
M&-Y A,:2LBD@GCIU/!-,\9Q6T.L> SIR1+<+JRI!Y0 Q;>2_F 8_AQM]NE8'
MAZVTI_AEX\:9(3NO=2^U%@,@@L5S]!@CW- '6:QXFO['XG>&_#\/D_8=1M[B
M2;*Y?*(2N#GCI6GH^IO/?ZVMSJ^G74-I/M$< VM:K@DK*2>OOQTKSBQ:=O'O
MPJ:ZW>>=#D,F[KN^S\Y]ZR;QIET'XP&$L&^W*&V]=A.'_P#'<T >O6/C+PUJ
M;JECKEA<,TP@58YU)9R"0 .^0K8]<&GR>+/#T.MKHTFLV2ZDS!!;&8;]QZ+C
MU/IUKD/&4&DQ>(?A[]E6!91J*K;", ?N/*.<8_ASL_.N:\17MY>>!=2U2U@T
M?3M'N-7W1Q&-WNII5N0IDW[@%8E"<8.%% 'HL?CS1)/&TOA<7< NXXE.XRCY
MI2S Q ?W@%!/UK0MO%6@7FLOI%MK%E+J*$AK=)@7R.HQW([CM7)J)!\6/%)M
MA_I T. Q8'.[+X_7%<]X<TG6K_P5X.9K[PY:Z?#<6MQ;R8D6=I V63).#(WS
MJ1W)- 'H6N>,M%TIKNP.KV*:M' [QVSRC=NVDJ"/4\<=35SPMJ4^L>$M'U.Z
MV?:+NRAGDV#"[F0$X'IDUP.C)8R> /B ^HK&7;4=1^UE\9!&=GY#;C\,5V?@
M'_DG?AO_ +!EO_Z+6@"'P]X^T/Q)J^IZ=97ENTME)M7$P)F0*I:11_=!8KGV
MJ[IOC#PYK&H-8:=K=C=78R?*BF#%L=<>N/:O-+KSX_"/Q8:T!$POYAE>H3RT
MW?\ CNZN@\7Q6,.B^!SI:Q*R:O8K8F(#/ED?,!C^$IG/:@#T8D 9)P!6-IGB
MSP_K5]+9:9K-E=W40):*&8,V!U(]1[BJ7Q$>Y3X<^(6M"PF%A+@KU VG=C\,
MU5,/AR/3/#4D2VZWJVY&BE"02QA.0NWJ-O7/% &H?&/AL:Q_9!URP&H;_+\C
MSUW;_P"[_O>W6IM3\4:%HK2KJ6K6EJ\2JSK+* P#9V\=>=K?D:\Q6+3_ /AF
M9I"$WFS,A<_>^U>9USUW^9QZUT6C6PF^+U]/>1*UW'H-J"6&2K,[[OY4 =))
MXV\+Q/9H^OZ<&O5#6_[]?W@)P".>A((^HJ?5/%.@Z*\B:GJUG:/$%9TEE"L
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M39]1L-4M;BSM]WG31R K'@9.[TXYYKC/$&E6 \5?#>V%K%Y,4LRHNT8 6W+
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M?388[>RN!=6Z+GY)1GY\YR6Y/)SUJ23Q)HL6FVFHOJ=L+*\=8[>X\P;)&.2
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M;H;W[.;;S3G/E%MVW'3&>:S-+\%>'-%U'[?IVE107(#!&#,PC#=0BDD)G_9
MK,U#Q'J-O\6=(\.QO'_9]UI\MQ(I3YBZD@8/X5U.H:A::78RWU].D%K"-TDK
MGA1TYH 9INE6.D020V%NL$<LKSNJD\NQRS<^II;[3+/4OLWVR!9OLTZW,.XG
MY)%^ZPQW&36?8^+_  ]J6L/I-GJUM-?INS"C<G;][!Z-COC.*CO/&_AC3]4;
M3;O6K2&[5@CHS\(QZ!FZ*?8D4 ;]<R?A[X4/VL'18"+K)E&YL#+!SM&?D^8
M_+CD"HM0\?Z-IOC2U\,W$\:W$T1=W+$>6Y*!$QCDL&)Z\8]ZZF21(HVDD=41
M 69F.  .I)H I66C:?IU[=7EI;+'<7:QK/)DDR"-=J9R>PXK,N-!L=#N[_Q#
MHV@_:M8N!^\CAG\LS$D9/S,$!XR3C)Q4FE>-/#>MW_V+3=8MKBY(++&K8+@=
M2N?O >V:BN_'WA2PF,-UKMG%()6B96?[C*VT[O[H!R,G XH K^!_#ESHT.IZ
MEJ4,$6K:Q=M=W4<!RL0Z)&#_ !8&<GN6-=763K'B;1= B@DU34H+99\^5N.2
M^!DD 9) [GH*=<>)-%M;&TOI]4M4M+O_ %$YD&R3Y2W#=.@)_"@".S\*Z'I^
MB76C6FFPQ:==;_.MUSM?>,-GGN*2;PIH=QX?BT*33HCID.WRH 2/+*G(*D'(
M(/<'-5YO'7AB#2K34Y=9MUL[PL+>3DF7:2&VKC) (Y.*I>(/B+H.@P:/.UY!
M/#JDR)'(DGRB(YS+D Y QT]Z +@\">%PNW^QK<K]G-LP)8[XRQ8AN?F.XDY.
M3DYS5K1/"VB^'6F?2[%89)@!)(SM([ =!N8DX&>F<5#J'C3PWI+6RWVL6L#7
M,8FC#-UC/1S_ '5/J<"MU65T#HP96&00<@B@"AK&AZ9K]F+35+1+F%7$BAL@
MHPZ,K#!4^X-5;3PEH-CH]WI5OIL265X&%RA9F,V1@[F)W'CCDTV]\9>'-.U=
M=)N]8M8;XLJ^4S?=+?=#'HI/8$BEU7QAX>T.^2RU/5[6UN7 ;RY&Y4$X!;^Z
M#ZG% &O!!%:V\5O"@2*) B*/X5 P!^55)M%TZXUFVUB6U1]0M4:.&<DY16Z@
M=N<U?!! (.0>A%8:^,O#CZY_8RZQ:G4/,,7DAOXQU3/3=[9S0!':^!_#5EJP
MU.WTF*.Z60RH0S%$<]65"=JGD\@#K6Y/!%<P203Q)+#(I1XW7*LI&""#U%1:
MAJ%II5A-?7\Z06L*[I)7Z*/4U#>ZUIFG264=Y>PPM?2B&V#M_K7/0+ZT 4-(
M\%>'=!O1>:;ID<-P$*)(79S&IZJFXG:/88JO<?#SPG=2;YM%A8F0RN-[@2,6
M+G> </\ ,2<-D<UL7&LZ;:7KV=Q>PQ7"6S7;H[8VP@X+GL%![U5T7Q7H7B*2
M6/2-3@NI(@&=$)#!3T.#@D>_2@"Q-HFFW&KV>JRVB-?6:,EO-R#&K## #IR*
MJ3^'K2TLM:;2;"S%[J:N\PN0S13R%2!Y@S]TYP<=C5+PYXDM9-+LOMWB*RU&
M>\N9(;>X@B\I)6'.P#)Y ]^:W;G5+&SO;.RN+F..YO&9;>(GYI2HRV![#DT
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MY&?<4 .T#2ET/P]INDK)Y@LK:.#?C&[:H&<=LXK1HHH **** "BBB@ HHHH
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MD1>4!ZA<_='L,5SVA_#O39O[4E\1:-:SSRZM=7,#/AMT+R;DW8/([[3TSTH
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M(U\]_$=U&TF.=J[2!],LQ_&NDLO!OAS3M6.JV>CVL-Z2S"5$^Z6^\5'12>^
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M^=+(CLY"CYE 1=I)SGDT :^L:W!N\/SVGB.WLK>^ND$8^SB87RMR(U;^'/\
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MX?T,PC4-22(S0&XBVHS^8F0,KM!SRRX Y.: -2UT^SL9+F2UMHH7N93-.R*
M9'( W'U. *ST\)>'HM;.LIHMBNI%BQN1"N_<>K9]??K6I;7,5U9Q74))AEC$
MB$J5)4C(X/(X[&N9C\=^'M9L[R/2M:VR)8R71N4MG80(!]\Y7&1D'8>2.V*
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MB7&H3:A-I%C)>31&&6=[=2[H1M*DXR01QCTXH X768HX?!7PZ2-%14U32]H
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M:IHFE:Y#'%JNFVE]'&V]%N85D"GU&13/^$>T7[0]Q_9%CYSM&[2?9TW%H_\
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MH OVMU!>VL5U:S)-;S('CEC;*NI&00>XKA_!L,?_  LKQ_/L'FFYM$W8YQY
M.*[#1M,BT71+'2X6+16=ND"L1@L%4#/Z5-#96EM<7%Q!;0Q3W)#3R(@#2D#
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MX59K6Y2RXAR!W'G)5/Q%J&GZMXL\!QZ3<P7$HO)+A?(<-L@$+!B<= <J/TH
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M;AE3*ZJ53/7DCCDUD>&/&T4'P]\/ZEKUU-<:AJ$7RI!;M+-.XR3MCC&3@#G
MP*H>'=4TW29_']OJ]Q!%<#59IWBE8!I(7B3R\ \D$ @ 5R?AJ.\2V^'\L6LQ
MZ0DFC7,,-S+ LJ^;YB,4PQ !*C.>ORD4 >KMXTT!/#G]O-?8L-_E9\MO,\S=
MM\OR\;M^>-N,UBZ;XP.M?$J#3K.>X2R&DRS36EQ;M#(DPEC +*ZAA\K''8YK
MDKRWM--CTK4VUZ/5;(^+DGOKH0"&**7RC'G@[<!@N6'&3720ZA87_P =8_L4
MT4[1>'Y$EDB8, ?/0A21W .<?[0]: -/QQX@E\/7GAN7[9]FM)]1\N[.T'='
MY3MCH3U Z<UI:-XOT?7'O8[:::&:R4/<17<#V[QH02&*N =IP>:QO'B))KO@
ME74,/[;!P1W$,A!_,5S_ (VM[BY\6^*X+-6:>3P>0JIU8^;+P/<CB@#M-'\;
MZ'KE_'9V<\XEF0R6YGMI(EN$'5HF=0' ]OK3=-\=^']7OQ9V-W)+)MD9V\AP
MD6PL&WL1A3E6P"><9Z8KD]&MX]1U#PE//XWM[WRS]HL;."Q1&($+!@2A)4!2
M0<\9 '6JOABSEF^"GBB*QC/VJX?4L!!\SMEU'XX % '<:1XXT+6]0CLK.XG\
MR96>W::VDB2Y5?O&)F4!P/8].>E4=+\4:99V/B+4;OQ#-?6MAJ+PSM):E/LA
MW!?*&%RX!(^;GZUS>B6\>I3>#Y9_&]O=B-EGL;*"Q17.V%@RDJ25 4D'/&<#
MK7+, WPZ^*H/0^()@?\ OZE 'K>G>-]"U368]*MKB<7,RL]N9;:2-+A5^\8W
M90' ZY!Z<]*U]3U.RT;39]1U&X2WM(%W22OT Z?B<\ #DURGBM%3QUX#"*%"
MW=RH &,#[,_%)\4?D\.:==2C-E::O9SWG&0(5D&XGV&03]* -G1O&.D:W?M8
M6[W4-X(_.6"\M9+=WCSC>H=1N'TJ/1?'&@^(;V.UTJYEN'=&<L+=PB;6*D,Q
M& V0>#SCGH16'K-Y:ZI\4?!JZ;<0W,EM'>3W#0.'\N%H@H+$=BQ7'TI?@Y$D
M?PXM610&DNKIG(_B/G.,G\ !^% %OQAXE?P]XH\+++=F#3KF2Z%THCWF3;#E
M   6)W8P%Y)('-6H_B%X<;3+V_DNIX(K&1(KM)[62.2 N0$+H5W '/7&*R/'
M5U9V?CWP'<7SHENMU= O(<*K&'"DGM\Q'-56L+'Q7\1O%5G&Z36$NB0V5U)$
M0P$K-(1R.-P4@^W% '<ZOK=AH=M#<7\QC2>=+>+:A<O(YPJ@ $DFL[QWJ-WI
M/@36]0L9C#=6]H\D4@ .U@.#@\5P7A&[N_%>NZ!I.HJQD\)Q2-J.1PUTK-##
M]3M5GS[UV?Q,_P"29^(_^O&3^5 #+'QC::=X/\.7>L3SSW^HV,4BQV]NTLL[
M^6K.0B G SD\8&:T;+QAH>H/I:6UX7;5/-%J#$PW-$,NIR/E8<\-@\&N&L=3
MN/LG@O2H-2L]''_".I=-J,\*/(0%B4QQE^!UW'KP!6-82HO@N7Q!'=FYET7Q
M3)>R3%0CO"\FUV*C&T,CEL8 XH ]:M?$>E7GB&]T&"Z#ZE91K)/#M(VJP!'.
M,'[PZ'C(J;2M9L=;@FGT^8RQ0SR6[ML*C>APP&1R,]QQ7D U3_A';"P^(D@P
M-3N-1,N1UCE4M;@_^ \8'^]7IO@;1WT'P3I.GR@^>EN'GSU,K_.__CS&@"'4
MO'_A[2[ZYM;BXN7-H0+N6"TEEBMB>?WCJI5?Q/'>I]8\:Z!H;VZ7MZ0]S 9X
M%BB:0S)E1\NT'))9< =<UQ_AO5-,TCPGXQM=7N8(;F#4;][N.9PK.')*M@\D
M,I7'K6=X8LIH/$WPVBOHR+B#0)SM<<H=J #V(4XH ];M[A+NSBN8]XCEC$B[
MU*L 1D9!Y!]JY'0?&&CVG@VSU6]\22:A:3W1MTU"XMO*+.6( *A1M P1DC'%
M=FWW#]*\#\+(DOPA\&QNH9&\4P J1P1Y[4 >OZ+XPT?7M1FT^TDN4O(8Q,8;
MJUD@=HR<!U#J,KGN*NZUKFG^'[);K4)61'D$4:)&TCRN>BHJ@EB?0"N;NQCX
MT:61U.AW /\ W^CJK\1$N5\0>$+F+4DTR)+N>,WDD2R)%(\)"9#$#G#*">YH
M Z"'QGH4NA7FLM>&"TLF*77GQ/')"PQ\K(P#!N1@8YR,9J+3O'6AZGJ=KID3
MW45]=!VCM[FTDA?:J[BQ#J/E(Z'H<'TKSKQ#9Q6UAJVJR^(TUK;J^F'5&CMA
M''$D3C.=I*M\K+GTVC-=+J^IZ;J'Q@\')97,%Q-%;7K2/"X8!6C7:"1]&/\
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M.8]IE)"C;(K') /93VK3M-%TJPO)KRSTRSM[J?\ ULT,"H\G?YF R>?6KU%
M$-M:6UG&T=K;Q0(SEV6) H+'DD@=SZU5MM!T>SU![^UTFQ@O9,[[B*W19&SU
MRP&36A10!7N+"SNYH)KFT@FEMVWPO)&&:-O52>AX[4MQ8VEW+!+<6L$TD#;X
M7DC#&-O52>A]Q4]% %&XT72KO4(K^YTRSFO8<>5<20*TB8Z88C(I)M$TFYTU
M=-GTRREL4^[;/ IC7Z*1@5?HH J?V5IW]F_V;]@M?L&W9]E\E?*V^FW&,?A3
M++1M+TWR_L&FV=KY:E$\B!4VJ2"0,#@$@$_2KU% $4UK;W#Q/-!%(\+[XF=
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ***9++'!$TLTB1QJ,L[G  ]R: 'T4R.:*5G6.5'*'#!6!VG&<
M'TX-"S1-*\2R(9$ +(&&5!Z9':@!]%%% !1110 4455BU*QGOY["*]MY+R !
MIK=)5,D8/(++G(SD=?6@"U14#WEK'=Q6CW,*W,RLT<+. [A>I ZD#(S]:GH
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MJ*=0 44V21(HVDD=41 69F.  .I)K(MO%WAJ]N$M[7Q#I4\\APD<5Y&S,?0
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M068[Y,;I'?"@<   #UH SXO$?B^'P;H/C"ZU6V>&YDM5N-.6T4*\<CJA;?\
M>#G=NXP!G&#CF_/XCUJ[\8:GIL'B+3],O+6Y6.STF]@ %Y%M4[_,/S'<2P&S
MICH:9<:2LOPLTCPXNJZ7]NM/L?F$W2[/W4B,V#]%..*C\61ZAXBAOM&F/ANY
MM)Y<VFIR7JI+9(<'_5[22ZX."&&>,XYH ]/HK-M)-4?5KGS1:-I/DQFTEC8F
M5V.=^[MCIC'O6E0!YM\9-(TV/X:ZS>)I]HMT7A8S+"H<DSID[L9YR:T/B)I.
MFV'PT\1R6>GVEM(UBZEH850D<<9 K1^(GA^]\4>!M0T?3S$+JX,10RMM7Y9%
M8Y.#V4U:\::/<Z_X+U;2;,QBYNK=HHS(V%R?4T <VNH>)M"UCPPU_JEO=66K
MS?99;)+8(+<F)G4H^=S8VX.>OH.W.W/Q/F6UN]?7Q1I<:P7;JF@,B>9) DFP
MDMG>)"H+C''08KO==T"\U&Z\+20&+;IE\MQ/N;'RB)U^7CDY85C:?H'B?0D?
M1-.L=(DT\W;RP:C/(2\4+R%V1HMOS,-S '<!TZ4 =?KI!\.:D1T-I+_Z :\;
MAU7P;J7PEM-&M=/2]\0R:7'##%;Z<YE^T^6 &#[,##<EL]C7M6IVSWFDWEK%
MCS)H'C7/ R5(%4_"NFSZ-X1T?3+HH;BTLHH)-ARNY4 .#Z9% '*>(-5U323I
M]I>>,-+T)5L$):5$FGN;CHV5;I&,=1R23TK/D\:>(M7M/ @TN6VM;GQ!%.+E
MFBWHC)&#O4'GCYB!GG@&MV\T;Q#9^-=2U32K:PGCU.VA@^TW,Q5[(Q[@2%VG
M>IW X!&2.<=:RM \%:Y8S^"A=K:"/P^]Y'*Z3%C*DD>U' VC!)/([8ZT 0+9
M:^GQGTZUG\1><T.A^:[_ &-%\Q?.02)@'C<5SD=.@I(?B#J=IHOCO4+IK>1M
M(U1K.R#J$107")O(Z@%@2?05T.JZ+K47Q(T_Q'IMO:W5L; Z?<QRSF)HU,H?
M>ORG=].*QK;X>:C)I7C6SN9[>)]8U-KZRD4E@A#AT+C']Y1D<\4 0:=XXNK?
M5VT^V\1V'BI[C3[BXA6UC1'CGB4,$PAY5P3C/.5ZUJ>!=:U+6Y8+K_A*=.U>
MWD@W7EHL AFLY>, *.<9W A^> 035^PB\774D[7%CH^D;+5XXC"YN"]P<;7^
MZNU!S\O).:IZ;H>N7WC'3]<U72=+TR6RAECFFL[@RO>EP  ?D7"#&[#$G./>
M@!/B?]J\GPJ++RQ='Q#;B(R@E%8I+@D#D@=<=\5'%K^L^&O$NJZ;K>I+JMK!
MHSZM'*+=8738Q5DPO!!X(/6MWQ7HEWK4N@-:F,"PU>&]FWMC]VJN#CCD_,.*
MJZIX5FU7QG<WTS(--N="ETR3#?/N>3)XQTVYYH Y+1/B!<-J&@2W'BO2M3;5
MIT@N=+MD0-9F125*$'<=K84[LYSVJ_H7B/Q'>CQ!KE]J,*:/H5[?1&T2V4O=
M+$&(R_\ "%&W&!DD'-:GA[3_ !79'2]-O+'1XK2P4)-?QR%Y+I57:NU-HV$\
M$DD]#BIO#OA*>TT#Q)I>IM'Y>K:A>3 Q-G$4W SQUQVH Y71_']T][H,DOBW
M2M2DU>98+C3;:- UDTBDJ4(.YMK84[LYSVJIX?UK6/#/A;QKKLVH+J#P:Q<6
M\=N\"H)+@R1QK(2#D#D?*.,=ZZ_P]I_BNS.EZ;>6.CPVE@H2:_CD,CW2JNU=
MJ;1L)X)))Z'%9*^!M:N-+\6^'KE;6.QU2^FU&SOTF)=)6='16CV] 5Y.?PH
MT);[Q+X6UG01J^LPZK9ZK="RF46BPF"5D9D*%>JY4@ALGWK:\;ZO>Z'X5N+^
MQ(21)(E>=HC*+>-G57E*#EMJDMCVK(.D^)_$>LZ)+K]EI]A9Z3<?:V%M<M,U
MS.%*J5!5=BC<3SD]![UT^N#5_P"S2VB&V-ZCJPCN<A)5!^9"0"5)&<'!P: /
M-O%=Y?7GPH\1SOX@L-?L"L!MKJV54DW>:NY'"_+Q\N#UY.1Q70_;_$VB>,]
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M?#=]K:7@U2RFEL[XV:))!+&5W JORLN&!'TQ527P+JQL=0E@EM4U&/Q(^MV
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M2+K$;1L^[9\G#$@8).3DC'/4>#-!O-!371>&(F^UFYO8O+;/[N0C;GC@\=*
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M4;[=/*$5L6:*&/4'&XLJ@UTNL3W%MHM[/:2VL5Q' [1R7;%848 X9R.BCJ:
M(?\ A'=#_P"@-IW_ ("I_A1_PCNA_P#0&T[_ ,!4_P *X'0?&DL'B2*T?Q2O
MB&SET^>YF=;5(O(DBVGY"J@,K MP<G@<UH^'G\::MIVC^)%UBWEBOV2>?2WM
MT2**W?GY) -Y=5(/)P3Z4 =-<:3X;M+6XN9M*TT16R,\I%JC% !D\ 9Z<XIF
MFZ=X9U?38-0L=+T^6UG7?&YLU7</HR@C\17 ^%3K.GV_Q#U-M<EGDL[N[4*]
MO& \J0H5E.!P0 !M^[QTJY8>+-?U?PUX)LX+Y(-6U]9'GOC K>7'$I9RJ8V[
MC\H&1CVH [S_ (1W0_\ H#:=_P" J?X4?\([H?\ T!M._P# 5/\ "N(U#Q!K
M_AN3Q/H]UJGV^>UT-]5L+UX$21<;E*NJ@*V& (X[\YI3JGBG2SX4U>]UM;F#
M6+N"UN=/%K&L<8E0D%' W94CG)P?0=* .V_X1W0_^@-IW_@*G^%'_".Z'_T!
MM._\!4_PJ76M231M"U#5'3>EG;27!4'[P12V/TKSZ?5O%FB>%=-\87^N+=13
M/;R7FF_9(UB2*9E7$; ;]R[QR2<XH [S_A'=#_Z VG?^ J?X4?\ ".Z'_P!
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M[J#X<:.]Q?O<I+;(\2-&J^2N/N@@9/U/- ';57OKZUTRQGO;V=(+:!"\DKG
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MG&,8Q[_A7.Q^!?$B^#]5\,,=-^SOJ N[2Y$S[G7[2LI#KL^4X!Z$\_G7J%%
M'/:OH5U?^,?#>KQ/$+?3/M7G*Q(9O,C"KM&,'D<Y(JQXMT:7Q%X1U71X)4BF
MN[9XD=_NAB.,X[9JWIFKV6L1W+V,QE6VN9+64[2NV1#AAR.<'OTJ]0!Q%AX?
MU^XU;PIJ.J1Z? ^D0W,,Z6\[OO#QHJ%<J.ZG([<=:CU7P->:K?\ BV4W4,*Z
MJMDUDXRS12V^6!<8Z;@O0GC-=W10!SVB_P#"5S:B9M;BTNTM(X2@@LY&E:60
MD?.695VJ #A>>O)XK&^*T<TOAS3([>413OK-DL<A7(1C*,''?!KN'DCC*AW5
M2[;5W'&3Z#WJ"]T^TU&...\MXYTBE69 XSM=3E6'N#0!RUGHGB#5/&5EKFOQ
M:?;1:9;RQ6L-G,\IDDDP&=BRK@;5P!SUZU7TCP',GPB'@S5)XA,UO+$\T!+*
MK-(SJPR 3C*^G2NZIOF1^;Y6]?,V[MF><>N/2@#ACH7BK7[O1(?$*Z7!9Z5=
M)>226DSR/=RQ@[/E90$7)W$9/3%0^)O -[K/C.&_MKBWCT>[-N=7MW)WSF!R
MT> !@YR <D<"O0:* .1\0^%[[5O'OA37()(%M=)-R9U=B';S$"KM &#R.<D5
MGZIX>\4:Y<6UCJ46CR6MM?I=1:JK,+A(TE#A5CV85\ *2&QC)Q7?44 >?Q?#
M^XN-4\>'4)X19>(TB2 Q$EX]J,I+ @#()!&">E+_ ,([XKUI=%TW7O[+BL-,
MN8KF:>UF=Y+QHON#85 0$X)Y/3BN],D:R+&74.P)52>2!UP/Q'YTDLJPPO*Y
M(1%+,0,\"@#F-&\-7NGV7BJ&:2 MJVH7%U!M8D*DD:* W'!RISC-9EIH?BS1
MO#NEZ1!;Z+JMI%IL5I<6MW(R*LJC!=6V-O4C'! Z<=378:3JMIKFEPZC8.[V
MTP)1GC:,G!(/RL 1R#U%7: ,;PGHLGAWPKIVD2S+-):Q!&=00N<DX7/.!G ]
M@*Y\:)XI\/ZGK1\.II=Q9ZM<M>*;R9XVM9F4!SA5;>I*@XR#U%=S10!P6G^
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M&?!8X'"@GK6G0!6TZW>TTNTMI"I>&%(V*],A0#BK-%% !1110 4444 %%%%
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M?*E5D*.C$9(R#U ."!Q0!E> ?$CZO>ZUIO\ :QUBWL6B>WOVB$;2)(I^5@
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M=G!;H@)WAHRY)/&,?,.])XRT.ZU_0DM[&2!;N"Z@NXEN,^5(T;A]KXYVG&*
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M.QU8GID$$Y[5#%X U6"PAO[:?3K?78-6DU2**-6^RKO01O#G&[:5&2V.I/%
M"76L:YX:U36]$GU>74%&A3:G8W<\48EB>/*E3M4*PR589'J.:JKJ?BBPTGPE
MXBNM?>X&J75G!=6'V>-81'. ,J0N[<,@YS@G/ '%:S>$]<UB[UG5=9DL(;^Z
MTF32[.WM7=XH4?)+,[*"26QT7@#O5N^\)7MUX3\,:4DUN)])N;&:9B6VL(,;
MMO&<G'&<?A0!S?C7Q1>Z1>:U<1^,([>ZL$$EII5M:B92 @8BX;82I8Y_B7 P
M:ED@U+6OBO<BPU*32XYM!MI9IH8T>3_6285=X('4Y.#T]ZM7W@OQ'+:^)]&M
M+K38M,UJ>>X-VQ<W"F10#&5QMQD8W9^[VS3X/#7BZQ\11Z_;/H[W']E0V$MH
M\T@C=D9B6#[,CJN.#U8>AH XWQSJ^HZC\(-?LM5N%N;W2M:6Q:Y"!/.571E<
MJ. 2&&<>E=5XH\7*OC.[T6;Q2WAZVLK6*0/% LCW$LFX\[E8!% ''!);K46K
M?#?5]3^'NIZ2UY9?VSJFI?VC<R980JQ93M7@M@*H R*Z+4M%UZQ\47.N>'3I
MTIOK>."[M[YWC :,MLD5E5NSD$8[#F@"YX'UR?Q'X/L-3NMAN) Z2LBE5=D=
MD+ 'H#MS^-=#5/2H;ZWTNWBU.Z2ZO53]],D>Q6;OA>P[?A5R@ HHHH ****
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MLY9]IYW#;D>E:FK^(;N3Q+=17OB>[\-ATA?1A);I]EGW1JS>8[*<G>2I7<N
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M3Q6Z!YI4C4L%#.P R3@#GN20*X7Q#))HUIHVGW?C*^M87\TRR1PK)?71X*A
MD9 5<\D+_=YKCM8U'4?$7@C1I)=9O=T'B=-/\]8EB:=!,-DCHR<.H ., 9SD
M&@#U^36+6+7(=(99_M4T)F4B%C'M!QR^, \=,YK0K@)=5U2P^+>A>'?[2GGL
M'TAY9A*J;I9%9@'8A1SQVP/:LFWO?$FM>!M0\<V_B&ZM9D6XN;/3TCC-N(HF
M8!'!7<Q8(<MN'7CI0!ZK17F\>J:QXJ\8VUC:ZO<:9IEUX?M]2<6RH90[NPPK
M,IQD8R<'[O&,YK<\ :CJ%]I>IVNI7;7D^FZI<6 N74*TJ(1M+  #.#CCTH Z
MRBO-_&NL/;:S>Q'Q==Z?);VBR6MEIMH9W#X8[Y\1O\I. !D#&:BAUO7O$FL>
M%+6#5'TZ#5=!-[>&WC0L&_=G*%@0#EL<YX)XS@@ ]-JA=:Q96>KZ?I<TC"[O
MQ*;=0I(81@%LGMP17FTWB77](T?7]'75'N;^WUFWTRRO[B-2Z+.$(+  !BH9
MN<>E7+C2[_2?BGX.AN=8NM3MVAOC&]V$\Q&\M=PRJJ"I^7 (R.>?0 ],HKGO
M&EZ]AX?,B:S%I"M/&DEVR;W"%OF6-<',A' X/TKS]_%^HVWAKQO'I^M7]VNE
MVL%Q97E[;>5.ADW;E(9%W %."5[^U 'L-%>=7<WB#PUJGAK4+O7KB^BU:]CL
MKVSDCC$2-(C%3%A05"E<<DY'6LVSD\5:UX>\2:POB>ZM9=,OKU+&&**+RV6)
MF($N5)8<;>", 9Y- 'H5YXBTZQ\0:=H<\K+?Z@LCVZ!"0P09;)Z#BI;#6+74
MKR^M8%G$EE((Y3)"R*2?[I(PPXZBO,Y=4;6_B5\,-5= CWFF7$[*.BEH,D#\
M34R>.=6TZ'XDWL\_VE=&N%2QB=1MCW @#@ D9(Z^E 'JU%<GI.A^)=*U.SN)
MO$DFIVDD3?VA#>(B[7QE6AV(-HW9!4G&/>N/L?%-S;ZYH<D7BRYUB>^U'[+>
M0):$6.Q@^/)?RP,J0O\ &<\T >J2WUO%#=2>8'^RJ3,L?S,N%W8P.<XP<>XI
MFF:C!JVFP7]L)1#,NY1+&8VQG'*GD?C7F'A:WO["7XAZ@-;OYI;2YN$59?+*
MNRP*5D;" [A@#C P.E2:7XFUW6/"?@:P34WAU'7VE-S?B-"ZQQ*SMM!&T,0
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M\@ X/6O0O!UG+9>$]-CEOKB\9K>-P]QMW*"@^4;5 P.W?W- &[1110 4444
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MLKA=2TR-;B.)67R7C8[5CSU3:W)/).3@9P/7JANK2VOK62UN[>*XMY!M>*5
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M=*ETB[U5+Q38V9E$\VUL(8R0_&,\8/2JVJ>,-!T:"TFOK\(+Q/,MU2)Y'D7
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M2:\W2")?@;XS81KF2\OW<XZD3$ _H/RKI=:AC@\2?#=(D5%CEF1 HQM7[*W
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M?"<$1^*WCZX* RAK% V.0OD9(_0?D* -T>./#;:U_9 U1/MGG?9\>6^SS?\
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M:UEEM87DM"3;NR F(D;25/;CCCM62_C70$T*WUG[<7L[B3R8?+A=I'DYR@C
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M37,2E(YB@+HIQD!NH!P,CVK.'A7P\+BXN/["TSSKGF=_LB9DY#?,<<\@'GN
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M=: .+T?4+'2_B9XW_M.Z@MGD2SFC:=PFZ!82"1GJ V[/N:D^$!A/@%#;QF.
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M85WFO;5\17^J^'O$UA::FEE']ML[Y ]O<1+O,;$Y!7JXW*2/45V)T+2#I/\
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M,36Q6V=Y+H +R%4?>.X':!W/8&LWQ!XT@OOAUXAU70;J:&\L(75EEA,<MO*
M#AD<9!Y[BN?AO;*P\4_#6:^ECB0Z'(B22$!5<QQ 9)X&>1]3CO5'Q!-#?6WQ
M8O[*1);)[2UA$T9RCRI$=^"."0&4&@#N[+Q=:Z=X1\.W6JRW%Q?ZC90ND5O
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M0--/!=(TK@>= 8%"E?[PX(XSSQWKF?"6IS0>#_!.F6UW;:.EV^H2?;KB%'>
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MTVVU"U+&WN8EEB+H5)5AD'!Y'%>/7]O/9ZGJ7PQB#K!J^I1W5J5&-EC)NDG
M] IC9?\ @=>T1QI%&L<:A40!54#  '04 <Y/X[T*VU9]/DEN<QSBVDN1:R&W
MCF) "-*%VALD#KP3S6!9>/H=,USQ3;ZM->7*VE_MABMK1YC!"(D)9MBG:N2>
M6]_2LW4M1B\/3ZEJF@>(+6ZM'U,B]T"\B!=IVE"R>43AU8GY@""#U'%;?A*-
M/[=\?-M&YM2VDXZ@0)@?J?SH W+[QGHMC8:?=B::Z74EWV<=G \TDZX#$JB@
MG !!)/3-<M\0?&<B_#1=>\-:@\3/=Q1"41X9?GVNK*PR""""",US_A?5+A=
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MZ#3SI\-A:QV1!!MDA41D'K\H&*H:)XIL=<NI[2."^M+R%%D:VOK9H)"C$@.
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MN);ZV-U:):PM*UPF1]P+U/S _3)Z T :UCH^F:6TK:?IUI:&4YD-O L>\^^
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M* J@=  .@I]5--OUU/3XKM+>YMUDS^[NH6BD&"1RK<CI^56Z "BBB@ HHHH
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M65%6-"[R.QPJ*HY+$G %:-<3\2B;:QT#4Y QLM-UJWNKM@,^7$-RES[*6!H
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MNTUI9Z+:")7N$\D$.P*EW5LDD@@!0:LZ)XBT6R^(EA>75_:Q6L_A6VCCNWD
MBW"5\J7Z G:>">JD=: -?Q+XXMKGPYHNLZ;>7-K;C7K>VO5="DD:ACYL4B]<
MX'([UOZ=XYTR]OKRSN+;4-,N+6V-XR:A;F(M #@R+R<@=^_M7FX9+VW_ +3@
MP^GW_CVWEM7Q\LJ JI<>H+*>?:NL\1FU'Q-C-["\UI_PC5YY\<:EF>/S$W
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MR2M#=1>5-'E&*..2".."#VK@-'U:QL;'P/)>3D"RUS45NQ/CS("3*090/ND
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M* "D(#*58 @\$'O2UE:]KUMX?LX9YX;BXDGF6W@M[9 \DTA!(502!T!.20,
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MB)_:47B.ZU>PNK"RTNZF7[1+$H2..,)F-L,29<DG &.G- '="")0@6) (_N
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MZ-DFGF#_ $EIQR4VYQT&<YQCG-:&@^(K;7UNECM[JTNK201W-I=H%EB)&1D
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M6!((UA7[L80!1WZ5SK>.]*_L*WU..&\E>XN3:1V*0_Z29P2&B*$X##:2<G
MSFHI/B!I5OH&I:K>6U]:'3)8XKRTGC430ERH4D;MI4[P<@D8S0!U1C1G5RBE
MESM8CD9ZXI@M;<7)N1!$)R-IEV#<1Z9ZUR)^)&GQZBMA/I&M0W,\9DL4DM0#
M>@$ B,;LYY!(;;@<G%6K3Q]I,^B:GJ=S#>6/]F2^3=VMS$!,CG&U0JD@EMPQ
M@\YH Z1[6WDG2>2")IH_N2,@++]#VI)K2VN61I[>*5HSE"Z!BI]L]*YZS\;6
M=P+]+O3M2TZZLK0WK6MY$JR20C.63:Q!Y&,9R"1G%5+7XDZ7=2:8XT[58K#4
MY(X;;4)+=1 TCCY4)W;LYXSC&>AQS0!V5%<5HGC2[U3X@:WH$FDWL=M9&)$F
M,2@1DJ[%I#NZ-A=N!]<5VM $26T$<DDD<,:O)]]E4 M]3WH@M;>U5EMX(H0Q
MR1&@7)]>*H^(-<M?#>AW&K7JRM;V^W>(E!;YF"C )'=AWHO]<M=.UC2M+F64
MSZF\B0%5!4%$+G<<\<#WH TZP?$^@RZ\-'\J9(OL&J07S[P3N6/.5'N<UB2?
M%+25L9K^/2]8FL+:5XKNZBME*6Q5RIW?-D],_*#@$9QTJOJFJW8^-/ANR@O9
MAI]QIL\KP)(?+D(W88KT)Z<T =Y!;06P8001Q!CN81H%R?4XIJV5HD9C6UA5
M&;>5$8 +>N/7WKF?^%A:9]MV?8M1_L_[5]C_ +5\D?9?-W;,;MV[&[Y=VW;G
MO3[SQ[86>HW-O_9VJ3VMI.+>ZOX;<-!!(<<,=VXXW#)"D#- '4)&D8(1%7<2
MQVC&3ZU$ME:)&8TM850MO*B, %O7'K[USE[X]L++4;JW_L[5)[:SF$%U?P0!
MH('.#ACNW'&X9(4XS754 <'J_A#Q-JJ:EICZ[8MI6H,RR3O9G[9'"QYA5@0I
M&. 2,X/>NVAM8+=(UBC5?+C$:G'(4=!GTKD-?\:W>D^/-'T&#2;VX@N8I9)7
MBB5B^ NW82PX4D[L^V,UC:-XZDTI_%7VRSUG55L]9N2[6T8E6U@ 7 )9A@##
M':N2!SB@#TG[- ;C[088_.V[?,VC=CTSUQ6"GA9!XTN=886[64NF1V0M3'T*
MR,^<=,?-27_C2PMETY;*UO=5GU"W^U6\%C&&<PX!\P[BH5?F Y/).!6IHFLV
MFOZ5%J-D7\IRRE)%VO&ZDJRLO9@001[4 7/(B"(GE)L3!1=HPN.F/2G>6AD$
MFQ=X& V.<>F:J:OJUGH>DW.IZA+Y5K;IOD;&3Z  =R20 /4UBZ;XYL;V]DL[
MVPU'1[A;9KM4U*)8_,A7[S*0Q''&0<$9Z4 =##:6UNSM!;Q1-(<N40*6/OCK
M4&E:9!H^G)96Q<QHSON?&69V+L3@ <EB>!7.6?Q%TZZEL6DTS5K2PU"58K/4
M+FW58)F;[F,,67=V+*,TMY\0K&WO-3M+;2=7U"?3)"EVEI K>6-H;=DL!@@\
M#J=IXXH Z^H6M+9[A;A[>)IT&%D* L!['K7#:S\1S;ZGX572=-O+^RUA6GWP
MQ*6DC$;$(F6&'!VD@]![UJZKX\L-+O;RW&G:G>1V"JU_<6L >.UR-WSDL"2%
MP2%#8% '2O;6\LR3201/+']QV0%E^A[4?9X-JKY,>%!"C:.,]<?6LJ/Q/I\G
MB"'1OWJS7%K]KM9F \JX3OL;/)&02,#@YZ5RWB+XF+;>%FU;1-.O+F,Z@MG%
M<F)3%)B159E^8$J?F53W;VH Z7Q/X=&L^#M2T*Q\FT-W T2$)A%)[X%:MK90
M6P5EAB$^Q4>54 9L#N>II;&Z:]LH;EK:>V,B[C#<*!(GLP!(S^-4-?\ $5IX
M=MH)+B*XN)KF40VUK:IOEF<@G"C('0$DD@ #K0!H_9+;?*_V>+=*,2-L&7'H
M?6GI#%&<I&BG 7*J!P.@KS;QKXT^W_#+Q-/IIU#2M5T[RDFAE'E7$!9T(.5)
MX92<$$Y&:Z)_%D6EV.CVGV/4-4U.ZLUG^SV:*\FP*NZ1BS* ,G')Y)XS0!TG
MV2V\R23[/%YDHVR-L&7'H3W%<WJVC>)?[6:ZT34]-6V:)42WO[0N+5AQOB*D
M'D=0?3\*DE\=:6N@V6JP0WET;Z8V]O:0P_OVE&[<A4D!2NULY( QUJ%_B#I4
M/AO4=:NK:^METV=;>\M9HU$T+L5 R-V"/G4Y!QB@#3\->';?PYX=L=(1S<_9
M03YTBC+R,2S-CMEF)_&M66W@G>-Y88Y&C.Y"Z@E3ZCTKR_Q_XNN[OP=9:AI2
M:KI8.LV\*RRJ8&N(CD[EP<E&]\=.E=]IWB&SU+6M5TB-)H[S3&C$RRJ &#KN
M5EP3E2,_E0!4UCPV=1\0Z#J4+0Q)IUQ+-,A7F7?$R=N_/>MN*TMH8#!%;Q1P
MG.8U0!3GKQ5#1?$%IKTFHBS2;987;V<DCJ KR)C=MYY )QGCFCQ/<V]EX6U6
MZNIKN&WBM9'DDLVVS(H4DE#V;T]Z -,Q1L%#(I"$%01]TCTJ/[);?:?M/V>+
M[1C'F[!NQZ9ZUR</C72=)T3PT@75;PZK:;[+<@EGFVHIP_/+D,.>G4D@#-6;
M/Q[I4VG:Q=WL%YIC:. ;VWO(PLD8*[E.%)!##I@\T ;EIID%G?W]Y&7,UZZO
M(6Q@;5"@# Z<9YSR35VO-]0\8W&H^*/"%M'9:QI'VF]=FANT$8N(O)<_PL00
M#MRIY&1Q6KHGB+1H+CQ==-J.IF+3;MOMIOY-T<) )(A Y"<=.O2@#K9[6WN@
MHN+>*8*<J)$#8/J,TL]O!<Q>5<0QRQYSLD4,/R-<WI?CNQU'48;&YT[4]+EN
M(6GM3J$ C6X11EBI#'D @D'!QVJ/2_B!I^JWUE NFZI;0:AN^P7=Q %BNMJE
ML*=Q(RH)&X#(% '5M%&T1B9%,9&TH1QCTQ3([:"&#R(X8TAP1Y:J N/ITKA?
M#?Q&_M"/Q'=:OI]W86.EW,R^?+$H6-$"#RVPQ)ER2< 8Z<ULZ=XWLKRYDMKV
MPU'295MFNT74(0GFPKC<R[6;ID9!P1GI0!T"6EM$L:QV\2+'DH%0 +]/2B6T
MMIY$DFMXI'C.49T!*_0GI7/Z+XUM=:OK>V_LO5;(7<1FM)KN *EPH .5(8X.
M"#A@#BNFH :8T+JY12ZY 8CD9I##$?,S&A\P8?Y1\W;GUKB?#GCR;5?$'B*U
MO=-N[.QTV7"SRQJJPJL89O,.X\DY(P.F*LV7Q%TZ[FL#)IFK6ECJ$BQ6=_<V
MZK#,S?< PQ9=W;<HS0!U<%O!:Q>5;PQPQYSMC4*/R%2T5Q6I>-;NS^)5GX;C
MTF]FMI+1I9)(XE.XED"N"6'R+E@W&<] : .QGMX+J(Q7$,<L9YVR*&'Y&E,,
M1B$1B0QC&$*C QTXKS#0/B =*TO6I=0M-9U**SU6\%Q=01^:EK$)3M#%F!P%
MYPN<#'3BNOU3QE9V%U;6EI8W^JW5Q;_:EAT^-798>@=BS* ">!SDXX% '1T5
M1T?5K37=)M]3L7+VTZ[E++M(P<$$'H0001ZBKU !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<IX]_
ML0Z59KKEU=6,/VM3#J%N^PVDP5MKE_X1U7)!'S8/6NKI&574JP#*>"",@T >
M,:CK5W=>&WGN=4_MG2=%\0V,J:ND0'F0AE9R=O#;"<%AUK;EU[3=>^*=C+I=
MREW;1Z)=J;B([HV;=&2H;H2!C..F17I8C18_+5%"8QM XQ]*$C2-0J(JJ.
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M^--(U;0O#3?VG=7&D7#?:;< I"67"HS=F<G&WKP<UZ#34C2,$(BKDY.T8R:
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.1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>employementagreement_mil011.jpg
<TEXT>
begin 644 employementagreement_mil011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M\0RV=R@N$REK$AEE+$D! %')X^@[G'-6M#N-9N_M=SJMHEE$\@^R6I96EC0
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MA^[N-2L88O"UOIUU;:M]LEU6 QB-X@Y9L$-YA:13M*D8Y/. * .DLO%5O?\
MBRXT*"UN/]'MVE:YD0HC,KA"J9'S8)Y8<9&!GG&<GC#5+NQ?6--\./>:*K-M
ME6YQ<3(IP7CAVG<."0"P)'0<BM)]-N6\=KJ/E?Z'_9;6YDW#[YE#8QG/0=>E
M8&E_\)1X=\-Q^&K+07N+FU0V]GJ)GB%L8P<))("V\$#&5"G)'!YH W=>\66V
MB7NDV?D27%QJ-S%$$7Y?*1W"^8^1P 6 QU)^AQT%>>:]X+\03W@O;/65FFGU
M*UGE#6B9B2-AC!+?=3EMO<D]R:]"&0H!.3CDT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4KK2-,OKJ&ZN].M+BXA_U4LT"NZ=_E)&1^%7:* "BB
MB@ HHHH **** "F0PQ6T"001)%%&H5(T4*J@=  .@I]% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK'6'81!^<9Q@9Z=:VO"_C%QIOA[P_!HM^VJQ)%:W\,L#Q)9JB8>0N5VL./E
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MT4$AEWY$GFACC&.,;?UKGY/B.JZ3IU\FCSS/?:I+ID<$<H+;T,@!R0!R4[X
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MZU#3)--N7+!K620.4PQ .1QR #^-+KFJQ:'H.H:K,-T=G;O.R_WMJDX_'&*
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M[ZX8-(4WDH'(X+!=H)'<=^M &Q167KGB'3?#EM%<ZG,T,4LJPHXC9AN8X )
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MV%H8U2*V+#!;@9=L< GIDU'9^/\ P_?S:8D%Q<%-2(6UG:VD6)W()";R-N[
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MBI(QN'45B>'_  _+HPDEO=6NM5OI%"&ZN0H(0$D* H  R22>I[]   ;E%%%
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M(U>U?MYD@(,7IA7#/CL=OK4WC6V?4/&'@FSA!,D=_)>N1_#'%'R3[$NH^I%
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MB:_I,$=W/:O=6CZ?<&5)PA&^/YU4AQD'G@YZBN3U_P 47'B7X1?V\\-W8/\
M;8F1EEV*4-T$V_*WS87@[AC/(H ];HK"T[Q98:CKEQH_D7EM=Q0?:5%U 8Q+
M%NV[USVSQS@\]*A/C33$N=.26*ZBM=3D$5E>N@\F=R,J 0=PW ?*6 ![9H Z
M.BN7L_'FEW^IO86EGJDTD=Z;*9ELWVPOM!RY/W5YQD^A[<UNZGJ5MI&GRWUV
MY6&+&<#)))  'N20!]: +=%<_>Z]:/INL1ZC9:C:QVMKON5V9<QN&&4,;-G[
MK<@\>U4X/%>AZ+H'AH(+[[)J44,=CNB>5L,FY0[<_-M'3))[9H ZRBN4C\?6
M$LM_;)INKMJ%B5,MB+3,Q5AD.!G&T@'DD>G7 J'5?$GAS5- T'49WO9+*_O;
M<V;6X=#YI?"AR", '@@GL>N* .QHKB07C^->P33>4_A]I#&TK% WGJ,A2<#@
M#I6C9>.-*OI]-$<=TMMJCO'8W;(/*G9<D@8.X9"G&X#.* .EHKEHO'NEW&K2
MZ;;6>J3SPWB6<QCLG*PLP!#/_=3GJ?Y<UT5[>6VG64][>3)#;0(9)9'. J@9
M)- $]%85MXKLIM:@TF>WN[.ZN8&N;<7*!1-&O4C!.",C*M@^U0'QOI216EU(
MERFF7<PA@U%D'D.Q.%YSN )& Q4*>.>10!TE%<W<^-=/AU;4-+BL]2NKZQC2
M22&"U)+!LXVYQD?*>>G3!)-58_B/H<UIIM[%'?/87\B1+>"V(BBD<[0KL>AS
MP<9 /4T ==17+7_CW2['4M0TU+35+N]L$1Y8+6S=V*MGE>F0,=>G(P235JV\
M9:-?:)I^J64SW,6HOY=I%&O[R63G*;3C!&ULYP!@Y- &_6+K_AX:XUE/'J-Y
MI]Y8R-);W%LR_*67:0RL"K @]Q4"^,=/\C5C)!=17.DIYEY:.B^;&FTMO'S;
M64@$Y4GICKQ4A\6:<HT)BEQY>MA?L<FP8)9-X#<Y!V\]* )]-T::UF6YO]4N
MM3ND4JDDZ1HL8/7:J*HR<#DY/O@UK5R%S\1M'@CU1UM-4G&ERF.\\JS;]T H
M8N<XPH![\G!P#BMFX\1647V!+<27D]_&9;:&W +21@ E_F( 4 CDD=0.IQ0!
MK45YOX(UR&SC\675TU[Y8U[[/##<.7E#LL2K&-Q/\1P.<=\XYKN=.U1=0ENH
M3:7-M-;.%D2=5!Y&005)!&#U!]NU %^BJ.IZM;:4D'G[WFN91#;P1C+RN03M
M4?0$DD@  DD53L?$UI?SW]I';72:C8;3/8R*HE ;E6'S;6!]0Q% &U17G/@.
M+_A+-+T_Q#?KJ$.IQ75Q+]I27:DR^;(HB(!.4"A1M('W>.^=_P 5^*)] O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN]1U!/#WA_4?#^G7>EW,%Y!>8CADG< 1[(PQ (^?+  8H ZN\\7S6OA7PYK
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M%EWHUE'X<F9&*+<,;J.!V"K*1MVGJ"5!Z'K6CXAT&ZU;QW92"%Q8OH]Y:2W
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M&Q\+/^27^'O^O0?S-=?7,?#O3[O2OA]HEC?0/!=06P22)^JG)X-=/0 4444
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M8^#[Z/86;SZ@8;91 I .59"W)..,&O0J* /.-<T:X?QJUW?^%3X@MI-/B@L
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M31+RREG&,(\A0 8Z] 3^%=K4,%W;7+S);W$4KP/Y<JQN&,;8!VMCH<$'!]:
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M_A77K[PWJ=Y)IS)J&JZ];WWV,2*6A@1D #$'&[:I)P3UKUFB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KF?''B.]\,Z39W6GVL5U//?P6ODR$C<)&QP1T/H>1[&NFKA/BH
M;@:'HQM%1KD:Y9>4'.%+^9P">PSB@"UI^O>(+'QC:Z#XB339%U"VDGM)[%77
M#1D;XV#DYX8$$8^E<1\/->N- ^&EC-;112-=>(Q9N) <!))0I(P1R!TKL+6V
MUGQ#X^TW6;[19]*LM(M9T07$L;O--+M!P$9AM"KU)YSTKE])\%^(['X7Q6;:
M</[5LM;74H[0S)^^1)0V P)4$C/4T >@7>NW%OXZTW0ECB-O=64]R[D'>&1D
M  YQCYCVKG/!WBSQ=XF\,?\ "1-IFFM;M:R_9[2)F26>=6(!W,=J)D$<Y/&?
M:K%G!KVK_$33=>NM$ET[3H-/GM]L\T;2AV9#E@K$ ''&"?NG.,BL[3?"NO0?
M <>'/LYAU@6\BF#SE&[,S,4W@X&Y3C.?XJ -30?%.KMXJM]$UBXT6Z:[M)+B
M-],9OW+H5#1N"S9X?AN.AXK/^"/_ "(US_V$[G_T(4S3=(OXO&NAZQ9>#4TC
M3(H)K22&,P+*A?81(X5L%/EP "6ZG'-:GPLT'4_#OA2>RU6V^SW#7T\H3>K9
M1B,'*DB@"UXFU?Q%97[)IS:+964<'F"YU20_Z1)D_NT57!7  RQS]X8'%9)\
M=ZCJR>'(M*.F:?-J^GF]\S4RS)N!4>4@4KN;+$]>@Z4W5]"OV\<:K=R>&8M9
M2^MX8K"[G,3166T,'#!SN R=WR@D]*H:?IFJVO@O1]#UWP*-7LK6W-O+$)(6
ME253@.NYP-C \$$,"#D4 >CZ1-J$^E6\FJVT=M?%2)HHGWH&!(RI]#U'<9YK
MR?[9XCO=$^*']I75G+;01W,+)&LF586P V98A4QU'7.37HG@C3+_ $CPA8V.
MHAEN(_,(B:7S3$A=BD9?^+:I5<^U<?-H>OQ#X@Z2FC2RQZTL\]G=I-&(V+0;
M0A!8,#N&.F/?% %G3O$/B;1K3PG)J%OIO]D:F\%BL,8?[1"7C)1F8G:?N\@#
MC. 3UIM_X_U9(M6UFS.C_P!D:9<R0M:3.WVJX2)MLCJ=V%Y#;05.<>]:NM:%
MJ5WHG@VW@MM\NG:C9SW2[U'EI&C!SR><$CIFN=7PG)I5UJ5C_P (!INLSW-]
M+/::G<1P&,1R/NQ*6_>93)& #D 8H ]4BE2:%)8SN1U#*?4'I7EGAWQW=R?#
M/1K[3M(TRVU+5=1-A:VT$9CMHW+MEV4'. %)..IKU2-%CC6-%554 !5&  .P
M%>/:#X+\2:3\,_#L9TT'6-%U8WYLC,F94W."H8$J"5?(Y[4 :9U#5-,^*:W'
MB+[(WV+P[<SF>R5E22,2H3\K$D,-I[D=/H+FE^-]9-QH=SJAT9K#695B2WM'
M8SVC.I:/>2Q#]-IP%P3WJ*71]=\5>,)[Z_TB72]+N-!N=-432QO*KR,O+!6.
M,C. "?N\XSBF>%] DM+C1[.;X>:79W5EM%WJK1P%6*+@/"5^<LS 'D#'.>:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %4-5T:SUJ.UCO49UMKF.[CVL5Q)&<J>.O/:K]% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6-KWA?3/$IMUU19Y
MH(&+?9UG=(I>0?WB @. 0.#G]:V:* $ "J   !P .U+110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !5#1=&L_#^D0:7IZ,EK!NV*S%B,L6/)
M]R:OT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!BZ;X6TO2]9NM7B2:74+D%7GN)WE94)W;$W$[5SV&!T]*VJ** "BBB@
M"&\M8KZRGM)P3#/&T3@'!*L,'GZ&F:=80:7IEKI]JI6WM84AB!.2%4 #GOP*
MLT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!@@$8Y/3GVKKX[^SENGM8[N![A/OQ+("Z_4=10!8HJ![VTC<(]U"KEQ&%:0
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M^M $]%0/>VL=TEJ]S"MPXRD32 .P]AU-%Q>VMJT:W%S#"TAVH)) I<^@SUH
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MWO+I]7NK1I;A S0PQ@*BJ3]T <\8ZYKJO^$(T19] EC@DC_L+?\ 8E60X7>
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M-+U:_NKI[K4K87H O(+2[:**YPNWYU'^R "1C(KI(88[>".&% D4:A$51@*
M, "@#RK6-;N=4^+*26VB:AJ^G>&XF3;9!"!>2#DG>R@[4X[D&G>!M7N='\5>
M(M!FTN\TV&]#ZMIEM=A0V3Q*@VL1C=R #TS7H&@>';#PW:3V]@)/](N'N9I)
M7W/)(Y^9B?RI=2\.V&JZMI>J3K(MYICL]O)&^TC<,,I]01VH \;U'0='?]G;
M^W'@B&JRP+<R7^!YTDKR@.&?J0=Q7!X_*NM?0M.UOXUZDNIVL=W!!I%O(L$R
MADW[W 8J>"0"<>F37.:KX7?4=*O/#]IX7UVSO+BY*QPR7+2Z;:@R9:9&R%^[
MD@8R"Q %>N0Z%90>(KC7$#_;;BW2V<EOEV*21QZY)H \D32-7\2:=XEEA\,V
M%S?SZG=+'J\U^(Y[9XY"L>T%"5";5P PS^-7Y++4M<\8^)X[WPKI^N211VUH
M3=7BQ_9U,"L1&"C8RS,=PQS]*[6_^'^C:A?74\DM_'!>2"6[LH;IDM[EQCET
M'7.!G&,XYS4^L>"M.U?4'OOM.H6-Q+$(;AK"Z:'SXQG"N!UQD@'@X/6@#A[+
M0I;GQCX-TWQ+'%>3V^@S"=&;S8Y65T"[L\/V//< ]J@TOPIH<^F?$1)M-MY(
M[6[N8K6-XP5ME\E7_= _<^9L_+CH/05Z5;^%]*L]2T^^MH#$^GV9LK=$;Y$B
M)7C'?[HYI;?PWI]M%K$4:R;=7E>6ZR_5F0(<>G % 'EMD^H:OJ7A.%]$M=>6
M'PK!<K;WUR(T$CD*\F&5@S851TXW>]277A^[@T[PIH^LVL<%L_B63R;2*X\U
M8[=HY&$6[ RHRRXQTXKT"Y\#:5-8Z5;PS7UG+I< MK6ZM+@QS+%@ J6_B!VC
MJ.HS4L'@S1[:UTN"..8+IMT;R)FE+,\S!@SNQY8G>Q.: .+U'1=+L/&OB;3K
M33K6&PN/#"W$MJD*B)I%DD"MMQC(P.<=JZ7X7V-I9_#C0GM;6"!I[.*69HHP
MID<J,LV.I]S6W+X?T^?6Y]6EC9[F>R^PR M\IBW%L8]<L>:A\->&;3PKIWV"
MQN;V6V!_=I=3F01*.BIGHOM0!R/Q _Y*5\.O^ONY_P#0$K/O=)B\.ZO=7NN^
M'K?4-.N-6%W'KUK(!<VK/*-BR#AMJMA<J2-O:O0=4\-Z?K&L:3JEVLAN=*D>
M2V*O@ L #D=^@K,?X?Z.]\TQGU$6CW/VIM.%VWV5I=V_<8_][YL9QGM0!U5>
M"Q:!I<7[/+ZT+*$ZJ@,\=Z4!FC9;C"[7ZJ !C XZ^IKWJN>_X0O2/^$,;PIM
MF_LMD*$>9\^"^_[WUH X>^L[S7/'WBN.3PM8:['"MO:QF\NQ$;>-H0Y" HV,
MLS'<,<CVJK>VNI6/B3X26FKNKW\'VJ.5U?>&Q&@!W=^,<UZ#K'@S3M8U%K_[
M5J%C<RQ""=[&Z:'SXQG"OCKC)P>O/6GR^#=&DN]!N%@>(Z$&6Q2-\*@90I!'
M?A10!PNF:+I>M>'/'6JZK:PRZA_:-^GVJ109;<1#$85NJ[0 1BNU^'O_ "3C
MPW_V#;?_ -%BH+WX>Z+>ZC>W32W\45^V^\LX;IDM[A\8W.@ZDX&>QQR#6_I6
MFV^C:3::9:!A;6D*PQ!SD[5&!D]^!0!Y]%IMC%\8?$EW'IMH]U!I,-S"Q@4L
M)B7RP./O' R>IK!;1=*7X!CQ"((?[9^S#4/[2VC[1]IW[MWF?>SNXZ^U>G7/
MA.PN/%,7B)9[RWODC6)Q!.429%)(61?X@":S1\-]"$H7??\ ]GB?[0-+^U-]
MD#[MV?+]-W.W.W/:@#JK5WEM(9)5VR-&K,/0D<UY-H7AC0M7T+Q[=:E96]S.
M=6U"/SID#- JDD;"?N\G=QCDUZ]7'7'PUT2<WP2YU.WCU">2:]BM[QD2Y+DE
M@X';DCC!P<9H X+2)M4U[4] ^U:#::^8?#-M*L-_<B-5:1F#RX9&#,0BC./Y
MUZ1X"TW4='\,BQU&&. Q7$WV>&.;S1%"7)1-V!G:#MZ=JFU3P=IFHM92127>
MG3V4/V>"?3YS"ZQ<?N\C@KP.".,<5I:/I%GH6EQ:=81LD$62-S%F9B269F/)
M))))/K0!POB+_DO'@W_KQN__ $!JPM(_X]/C%_UUN?\ T4]>G7?AO3[WQ-I_
MB"99/M]A')%"0^%"N"#D=^M5H/!NDV\>OI&LV-=9VO<R=2RE3M].": /+]/%
MW=:%\--/CTFWU:!K">X-E<SB**21%0*6RK E0[$ COGM5G4M'U*PTJ/2]1T^
MWT[1]6\3V:?V?;W/FI'$XS)'D!<*SH#C 'S5Z')X'TA]"TS28VNH%TO'V*Y@
MG*3PG!'#CU!((/!K-USPG9:?X*OK*UTFZUIYIUN9U>\*W,SAES(LA_C4 $#C
M[N* ,>^T[1O#?Q;TN>R@BLH/['NYIX+= B*%V?.%' ) QGOM'I6%96PM+GP/
MJ-EX:L])M;G4D\B[-WYE[<1RQR$^: @SN!R<N<<5M^'/#_\ :/C:+4QI>LQ6
M%OI\MO/<:VQ,]T\A4;,,2=BJI]!ECZDUO1_#/1([>WB-UJK_ &-T:R=[UF:T
M"GA8O[H['J2 .>!0!D_#K_D?OB'_ -A&+_T%J](KGD\(Z?9KXAEM$E,^MAC<
MAI2 6VE1M./EZ]:T=!L)=*\.Z9ITTGFRVMI% \F<[F5 I/XD4 </<_\ )Q=G
M_P!BXW_HYJY&+P_I9^ .H:PUE"^IK]HFCNV4&6)DN&"[&ZJ!CH..3ZFO7W\-
MZ>_BR/Q*RR?VC':&S4[_ )?+W%NGKD]:KKX.TE?!\OA<+-_9LJR*P\SY\.Y=
MOF^K&@#F);V+P?\ $:XU&Z;R].UW2S<2MV%Q;+EOSB)/OMK%LK.)/ ^ER:KI
M+:GJ_B;5O[1%B9O+CDD8-(JR$@_NUC4$J0>1TKT+Q+X/TCQ9IEOI^JQ2-#!(
M)$,<A1@=I4C([$$@CO4VN>&['7K.V@G:>W:TE$UM-:2>5)"P!&5(]B1CI@T
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MBP@5Y@AE$;8! 8\DY[5Y]:V\EL_@74+70-,TFRN-2C-K(ETTM[)')'(3YAV
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MRM(9KYI[>TLYS*EN&5=R@[5Q\P+8QQNH ZJ>XAM8'GN)HX84&7DD8*JCU)/
MKG8?%D5SXTCTFVEM)M.?2GO_ +7'(&&5E"8R#C&":S/B)''=WWA'3KI0]A=:
MR@N(V&5DVQNRJP[@L!P>N*PM7TW3].^)>LI8016_F^$IY)8H5"KN\P#=@<9(
M 'X"@#U WEJMO'<&YA$,FW9(7&UMWW<'H<]O6HI=4T^"7RIK^UCD\Q8MCS*#
MO;[JX)ZGL.IKS/470?!OP0"P!:;20O/4[D/]#5[P]HVGZA\7/&MY>VD-S+:2
MV1M_.0,(F,()90>C?*O/48H [&PU*Z-WJQU&XTM;2VE A:WG)=$P<^=GA35V
M+5=.GOGLHK^UDNT&YH$F4R*/4KG(KQEO^0;\9O\ KHW_ * U=%JVBZ;H[_#Z
MZL+.&"Z.IQ1/.B 22*\$A?<W5MQ&3GJ: /1)-5TZ&\-G+?VJ704N86F4/M R
M3MSG&.]68Y$FC22-U>-P&5E.0P/0@^E>/V>D:5J7PP\8:MJ5O"VI/<ZA++=.
MH\V*2-F" -U& J@ >N.]>C^#/^1&\/\ _8-MO_12T %[XKTG3_$=GH5Q<HMY
M=1O(N74! NWALG(+;N!CG!JCH/C&VOEU'^U+FRL7M]5N;"!7F"&41MM!^8\D
M]\5BZUIUC<?&S06FL[>4MI=P[%XE;+*R;2<CJ.Q[5AZ=X?TJ]\(_$6\N[""X
MN3J6J!998PS(%W%0I/W<')X[G- 'JU[J-CIL(FO[RWM8B=H>>544GTR34Z.L
MB*Z,&1AE64Y!'J*\<L_[4U3Q#H"II&GZP8?"MK,D6I7!15:0D2.OR/ECM4$X
M''UKOO 6EW^C>&C8WZVT9CNIC!#;3&5(8BY*QAB!G;DKT[4 6]=U+7[&:%=&
M\/1ZHC*3([WZV^P]A@J<US?AOQWXE\2PQW5KX-C6R^T-!),=63*;6VN=NP$X
MY^M>@5P7PA_Y$N;_ +"5W_Z-:@#LGU33X[];![ZV6]896W,RB0CU"YS1/JFG
MVSLEQ?VL3JZH5DF52&;[HY/4]AWKQFRT;7O$'A75)K?1=&^V7&HW$HU:XO2E
MQ#,D[!3CRSMV[0H&[H/>NGTC1K'5/C)XKN-1M(;F2UM[!HTE0.J.8V^8 \;A
MMX/49/K0!WDVM:5;NB3:G9QL\AB4/.H+.."HR>2/2I$U.PDOWL$OK9KQ!N:W
M653(H]2N<BO(H]"TR[\#?$R^NK*">Z74=3V2R(&:/8"R[2?NX;)X[FM"YTFQ
MTVW^&U]:6L4=[+?0K+<A1YLOF0.7+MU8L>3F@#U>F2RQP1/+-(D<:#<SNV H
M]23TI]<[XVT:;7O#C6-O-:I/]HAECCN^89V1PXC<#DJVW!H UH=6TVXLC>0Z
MA:26H.TSI,I0'.,;@<9R1^=6'GACFCB>6-9)<^6C, 7P,G [X%>->)9K:/P?
MXJM)_#L>A:PAT^6ZBMY0\$T?VA0DB8P.S \ \#.<<=GXH=1\2_ J9&\O?$+W
MQY% '5G5-.&H#3S?VHO2,BV\Y?,QU^[G-86F>,+>;4-=@U2XLK&*PU#['"\L
MH3S/W:/SN/7YNU<GX.T/P]JOPSLM8UU;>"\EN6N[G4G98YDN!.<'S3R#D!<9
MZ<58T'P_I6JZ[X^GU"P@NG-^81Y\8?8OD(3MSTSGDCK@>@H ]+!# $$$'D$5
M!<7UI:9^TW4$.$+_ +R0+\HZGGL,CFN;^&4KS?#/PZ\C%F^Q(,D]AP/T%9/B
MC3[+4_BUX4M[^*.:'[%>.(9!E78>60"#P<?>^H![4 =O'JFGRV/VZ.^MGL_^
M?A9E,?7'WLXZTJZG8,EPZWML5MF*SL)5Q$1U#<_*?K7B_BVWATW3/BII]A$D
M%BD=A.L,0VHDK@;\ <#.U2:Z;Q-H.F6#^#=%BLH(],O-44WJA !<NL3,GFG^
M,EADYSDB@#OX=9TNYLWO(-2LY;6,X>=)U9%/NP.!5B:X@MH&GGFCBA49:1V"
MJ![D\5YQJOA[3IOB5/HEK;16]KJ_AZ9;V*! J\2*L<A XW#<0#6-!J%QXK\.
M^$_!=WS>?;&AUA.N(K,_,&_WR(^?>@#T^TO;Z;Q#?VTDNFM8QQQM L,I-P"0
M,F1>@'ICJ*MVFJ:?J#2K97UK<M$<2"&97*'WP>*\QALQJ'Q5^(UB;G[*+G28
M(?M&<>5NA"[OPSFM+PO;KHOB73M,UCPS8Z=JGV*2&TU#39/W-TB;2ZLH (/"
MD!@>^#0!V&@ZA=W&AB\U:?2_-!<R26$Q> *#_>;VZU<L]4T_487FL;^UNHD.
M'>"975?J0>*\*\*JMQ\)_!VGW S87OB00W:'[LB;Y&"-Z@LJ\5W&LV-IH_Q*
MTY=*MH;87NCWJWD<"!%94V&-F XR"2 ?PH [M=9TM[J&V74K-KB90\40G4NZ
MGH5&<D>XJ[7B/]BZ;9_ O0=4ALX5U%)+&=;O8/-#F>,9W]>AP!V  [5[=0!4
MEU33X+V.REOK6.[D^Y \RB1OHN<FL.T\70#Q'XBL-3GL[*UTR:WBBFEE">89
M(@YR6.,Y/&*Y#Q#I:Z'>ZYJNJ:%8ZYH-U="ZN+R*4+>66T("/4JFW(VL".:T
M=$T/2M7^)?CF;4+&WO-KV<:">,.JJULN[ /3.!D^PH [RXU"RL[3[7<WEO!;
M8!\Z60*G/3YB<5SOCKQ<WAKP%=^(],%M>^5Y?EY?=&X:15SE3SU-<%X:>.\\
M(>"-,CT>#5M2 O);9+VX*6\,<<C(6<;6W$!E51M./:LG7A)'\%O'=O)%:P^1
MKWEB&T8M#%\\!*ID#C<6[#DF@#U#4?%MU9^//#6@);PM!JT$TLLASN0HFX!>
MWYUUU>8ZY_R6;X?_ /7E=_\ HHUZ=0!RWAWQC;:G:SMJ5S96<ZZC<6<,;3!3
M*(Y"@(#'))QVK?O=2L=-C62_O;:U1CM5IY50$^@)/6O)]$\/:'?^ _'-U>V=
MM/.;_4M\TJ!GBV,Q4*3RN/O<=SFJ^CMK.MZYIKR:+IVL31>&;%A'J=P4"^9N
MWNHV/DL5 )XZ =Z /:5974,I#*1D$'((I:YKP'IE]H_A.WL-0\@/#+*(T@F,
MJ1QF1BB!B!G:"%Z=JZ6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "L[7-#L/$6E2:;J4326[E6^1R
MC*RG*LK#D$$=:T:Y[QKXJM_!_A>\U64PM-'&3!!)*$,S]E'<]<G':@!NG>"-
M'TW4%U%/M=Q?B!X&NKJZ>:1T;&068G^Z,>G..IJ=O".CMX5A\-&!_P"S(1&$
MC\PY 1@Z_-UZ@53\'^(Y=8TBVFU/4M$DO+ICY46G39 PBL4(9B2ZYR<=L5I:
MYK4>G:+K-Q:RV\M[I]G)<F MDJ0C,NY0<@';[9YH I:QX(T?6M0EO9S>P2W$
M8BNA:7<D*W*#HL@4C=P2/7!Q6A!X?TVUU>'4X+?R[B&R%A'M)"K"&#!0O3J!
M7%7/Q"U2'P;X,UA;6S,^N7]O;7"%6VHLF[)3YL@\<9)KT*WO+6[,HMKF&8PR
M&*7RW#;''56QT(]#0!D3>$-'N--UC3Y('-OK$S3WB^8<NY"@D'MPHZ4_4?"N
ME:II%GIMQ%*L5EL-K+%*R2P,@PK*X.0<5J6]Y;79E%M<PS&&0Q2^6X;8XZJV
M.A'H:;>WUIIMJ]U?74%K;I]Z6>0(H^I/% &-:>"M&M-,U.RV7$_]J1F.]N+B
MX>2:92I7!<G/ )  Z5<N_#FEWWAQ= NK;S=.6)(5C+'("8VD,.01@'/7BK*:
MOILNF'4H]0M'L "QNEF4Q #J=V<5'#KVCW-G'>0:K8R6LD@B29+A"C.>BALX
M+>W6@#-TSP5HVFI?;DN+Z6^B\BXFO[A[B22+!'E[F)PO)X%-TKP-HNDW(N$^
MV73)"UO"+VZDG6")N"B!B0H( 'K@8K>N;RULU1KJYA@61Q&AE<*&<]%&>I/I
M5;^V])&J?V6=3LO[0QG[+YZ^;TS]S.>GM0!ST?PT\/16\,(.H,+=T:T9[Z5F
MM IR%B)/R#Z=<#/04ZY^&WAZY:\.+^%;Z9YKR."]DC2Y+L21(H.".3^!QTK?
MFUO2;:X^SSZG913^:L/E/.H;S&&53!.=Q'0=32#7=(.J_P!EC5++^T/^?7[0
MOF],_<SGI[4 5[CPOI-SJNCZD]MMN-(5TLMC%5C5E"D;1P1@ >U9]YX T*^U
M&>[E2[$=S*)[FTCNI%MYY!CYGB!VL>!GUQSFHK'QM:+J^O6NM7NGZ?#87RVM
ML\TPB,@,2.<EC@G+=J3Q=XKNM!U+PO;V4=O-#J^HI:RN^3A&QRI!'//?(H Z
MZN<U/P1H^JZS)JDIO(KB:-8KE;:[DB2Y1>BR*I 8#)'TXK4N];TFPO(;.\U.
MRM[J;_50S3JCOVX4G)JP]Y:QW<5H]S"MS*I:.%G =P.I"]2!0!D67@[1=/BT
MF.VMW1-)EEEM!YAPC2;MWU'SMQVJS-X;TNYO[^\GMO-DU"U6TN0[$J\0W87'
M3^(UJUR$_P 0-*E7Q';Z==6TM]I%N\BJTJLLS"(R?* <D#HV.AS0 ZS^'.@6
M<]C-_I]P]A*LMF;F]DE^S[<X5 QP%YZ=\#/05-J'@'0M3U"XNYUNU6Z=7N[6
M&ZD2"Y88 ,D8.&Z#/KCG-6- \5:=JMEID<VHV"ZM=6<5P]FDZ[P60,<(3NQS
M^53V5_=R^(M5M9[O2GM+=8S##!(3<Q97+&8$X )Y7':@">'0["#7I]:CB(O9
MX$MW;<<;%)(&.@ZFM&J&GZWI.K/*FFZG97C1'$@MYUD*?7:3BK] 'FNB?#^W
MU)_$CZO'J-K]KUFZ8I!=20K=6Y(*[PI 93EO?DUVH\.:6NJ:?J*6_ESZ?;M;
M6P1B%CC; *[>G\(K!\=^.W\'_9(;32VU.\F26X>!9=GEP1+N>0G!]@!WYKJ[
M&]M]1T^WOK6026]Q$LL;CNK#(/Y&@#'UGP;I6MWYOIGO;:Y:+R)9+*[> S1Y
M)V/M(W#D^_-1WO@?1KM;/R!=Z<]G +6&33[I[=A"/^69*GE>_/>M&W\1:'=L
M5MM9T^9EE6$B.Y1B)#T7@_>.#@=:D;6])2Y6V?4[);AYC L1G7<9, [ ,YW8
M(..O(H R[GP/HDVFZ?90Q7%F-.W"TGM+AXIHMWWL.#D[N^<YZFI(/!NBV]EI
M]I';R;+&\^W1,TK,[3_-EW8G+$[CG-:":WI,NJ-I<>IV3Z@O+6JSJ91]4SG]
M*)];TFUU&+3KC4[*&^EQY=M).JR/GIA2<F@!KZ'82:XVL/$6O&M#9%BQVF(M
MN(QTZ]ZK>&_"^G^%;-[/3'N_LQ.4BGN7E6(<_*@8G:.3P*MWNN:1IOF_;M4L
MK7RMID\^X5-F[.W.3QG!QZX-,?Q%HD<UK"^L:>LMV ULAN4!F!Z%!GY@?:@!
M=;T/3_$.G_8M1A9X@ZR(R.4>-UY5U8$%6'J*HZ;X.TK3%OBOVJYN+Z+R;BZN
M[EYIG3! 7<QR ,G@8K1U#6M*TAHEU+4[.S,QQ&+B=8]Y]MQ&:?=:II]CC[7?
M6UOF,RCS9E3Y!C+<GH,C)]Q0 FE:9:Z+I5KIEDA2UM8Q%$K,6(4<#D]:=J>G
M6VKZ7=Z=>*7MKJ)H95#$$JPP1D=.#65JGC+0M,\,7/B :C:W-C"K%6MYT82N
M 3L4YP6..E:NG:C::M817MC<13P2#(>*0.,]QD<9% &7>^#M'O\ PY8Z'+%,
MMI8>4;1HIF26%HQA&5P<A@._O3=,\&:-I5[->Q1SS75Q;_9IYKF=Y7F3.?G+
M$Y/;/H .@K6U#4[#2;;[3J-[;6<&=OFW$JQKGTR2!FL+6O%2V%_X<%G+:36.
MJ7+QR7&_<HC6)WW*P..J]3D8S0!#%\.- BT'^Q0;\V:3+/;AKV0M:NN=IB;.
M4QD]/6K5CX'T73[BXN42YENKFU:TN+BXN7EDE0G)W,Q))Z#/8  5K:=K&F:Q
M"\VF:C:7L2-M=[:99 I]"5)Q3+#7=(U6>6#3M4LKN6'_ %B6]PLC)]0#Q0!
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MMTN'"%DVX8#/#':N3U..:9XW\6W/ARUT"?3DMKA-2U2"S9I,L/+D!)92I'/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-W+LA8L')B7=B,[AG*X_+B@#$\+Z1I.H^.?'KWUI;W,OVR*)EF0/MC,*],]
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MO+[SXXUC!(AM\R,=K-CH%& ,]J]0T_1;#2[J_N;.$QRW\WGW+;R=[X SR>.
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MC'/!-&]C%Y-M-;W$D,L:8 V[U()& ."34UIX2T.P_LH6MBL0THR&S"NW[LR
MJY//S$@G);/)SUH P/#EM!9?%3Q;!:PI#"]I8RM'&H52V) 3@=\ 5V5[_P >
M%S_UR;^1J"#2+*VUB[U6*$K>W<<<<TF\G<J9VC&<#&X]*N2(LD;1N,JP((]C
M0!\[O_R:]HW_ %_C_P!*7KT'6?\ DO\ X;_[!,_\VKI3X"\.'PK#X9-@?[(A
MD\V.#SY,AMQ?.[=NZDGK6C/X?TRX\0VNO2VY;4K6%H(IM[#:C9R-N<'J>HH
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M;1SU4'!QN.,@XSQ46K^#]&US4H]0O8)C<+%Y+&*XDB$L><[) I =<D\'/4T
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MR%/K@UI5Y_I^B:VGC+0K^]_X1RRBMK>:%8=/D<23PE1A0&4 JK!#[9]Z] H
MS+3Q'HE_<);V>KV-S,\)G5(;A7)C!P7X/3/&:-,\1Z)K3S)I>K6-Z\'^M6WG
M5RGN<'I[UY!HMC%9_LUW=_9P(E[<03>=.%^<IYY1@6'. @Q]!76VNB:TOBC0
M[Z\_X1NRAM;:>)(M/DD$D\)CX4!E *JP1O;\: .MC\6^')KRVLXM=TU[FY4-
M!$ETA:0'H5 /.>WK4VF^(=%UBXGM],U:RO)H/];';SJ[)VY ->.+I-@?V=]$
M?[-&))+FVD:0#Y]S7(4G=USM./IQ7<7UM;:?\7= -M!' ITBZ1Q$@7**T9 P
M.P[4 =3%XET*;6&TB+6+%]24D&U6X4R CJ-N<Y'I5>UU64:_K4-UJFD-96<<
M;B&)\3VP*Y8SY. #U' XKR^6:YGT/PGJ5OI^D:;I%WKUK-9PHSO='?-DEG/&
M6!8D<\'&:N#_ )'SXM?]@N#_ -)C0!Z5#XI\/W&I1Z=#K>GR7LBAT@2Y0NP(
MR" #SD<_3FH;;5)?^$CU>WN=4TEK.TBC=;>-\7%N"N6:;)P >HX'%<!=Z=9V
M?PR\ 2V]O''*M_I<HD51NWN5W'/7)R<_6B'_ )*;\4/^P7;_ /I/0!Z)%XJ\
M/3ZC#I\.MZ=)>3(KQ0)<H7=2,@@ \Y'(]1S4MUXAT:QU*'3;O5K*"^FQY5O+
M.JR/GIA2<\]O6O,9].L[3X/>"IX+>-)ENM,G$@4;@[.FYL]<G)K8\/6FFWLO
MQ"FUB.%W.IRQW#R@;EMUA39R>@ R10!Z#:7EKJ%I'=6=Q%<6\@RDL+AT8>H(
MX-3UQOPH_P"26^'_ /KV_P#9C794 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 51UC1]/U_3)=.U2V
M6XM)<;HV)'(.001@@@CJ*O56O=0L].CCDO;J&W2218D:5PH9V.%49[F@#)TW
MP7H&DW*W5I8E;D1O%Y\D\DCLK[=P9F8EONKUZ8XQ5AO"^C-X=B\/FR!TN(($
MM_,; ",&7G.>" >M+I/B?0M>>=-)U>SO7@_UJP3!BH]3CM[]*+'Q1H6I70MK
M'5[.YF,'VG9%,&/E9QOX[9- %76/!7A_7KXWFH6)>=D$<C1SR1>:@Z*X1@''
MLV:T8]%TZ'5(]2BM42[CM?L:.I("P[MVP+TQD#M533/%WAW6KU[/3-;L;NY0
M$F*&=68@=2 .H]Q6A8ZE9:G8I?6-W#<VCY*S1.&0X)!Y'H01^% %&7PMHL]A
MJEC)9!K;5)3->)YC?O7( )SG(X5>F.E.U#PUH^J:1!I5Y9K):6^SR%WLK1%1
MA2K@A@0.X.:I/K\5YK.AG3==THV%ZLQ\DG=+=[1UA(./E(.>#5Q?%6@/K9T5
M=9L3J8.TVHG7S-WIC/7VZT 16?@_0K#2[_3H+'_1]05DNS)*[R3@KM.Z1B6/
M!(Z\=JMW&A:7=Z%_8EQ9QRZ:(EA^SODC8H 49Z\8&#G/&:JZ3J$USK6M02ZI
MIUS%:R($M[<8EM@021+R>3C(X'0TNG>+_#FKZ@UAIVMV%U=KG]S%.K,<=<>N
M/:@!ND^#M!T2*[CL[ ?Z8NRX:>1YVE3&-I9R25P3QTJ/2/!/A[0[EKBQL"LI
MB,*F6:2;9&>J('8A5]ABGWWC/PSIC[+W7M/MV\UH2LDZ@AUQN4\\8R,^F:L:
MMXGT+0HX'U75[.S6?_5&:8+O'J/4<CGWH RHOAOX4A@\E-,8('5XR;F4M$5.
M0(VW909[*0*6Z^'7A6]DGDFTPYN)6FN ES*@F9FW'> P##))P<@9.!730S17
M$,<T$B2Q2*&1T8%6!Y!!'45D:CXO\.:1J"V&HZW86MVV/W,LZJPSTSGIGWH
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M,^T32X)5!Z].@K+\"^+AK6CVL^IZ[H]U>WK*(X+(;/+<IO,1!9BS 9)Z=.E
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M.Z"*9688Z\#KCOCI4-WXU\,6$J17>OZ="[R-$%>X4'<K;6!YXP00<]Z ./\
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M&&>_/--MO"^B6<6GQ6VGQ1IITC2VH4G]V[ AFZ\DACDG/6@#@O$=[9Z-XO\
M&EW<62W-LV@6[3VP;8)R7D0!B.F00"?2IK:/5;3XH>%[;5&T=)1IUVJ0:;$Z
M>7'B/"L68[ER..!T-=W=>'])O;B\GNK&.62\MA:W!?)\R($D*1T_B/YU0L_
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M8A!;+XBNA&$^Z!MCX'M52\CUV;XLZN-,&DF5-*MEC&I*[?NBTF[9M[;OO?\
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M3_M9V8_"O4_#W_(M:5_UYP_^@"LRY^'_ (5O+^ZO;C1X7FN]QG^=PCLP(+%
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M6[^V;3['Y6/]1M._;C^'9U[=*H:):6Y\'?$AS"A>;4]3$A(R6 4X!]AS^9H
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M4<4RRTC3].N+R>SM(X9;V3S;AE',K^IK,L/&_AO4X+R:TU6)TLX3<3Y5E*1
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M].TW2AI=G90P6(4KY"+A2#USZYR<^N:YG6O$>H6GQ1\+:);3)_9VHP7,DZ[
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MLXY&W.(4 +GU)ZG\: .+^!W_ "2VQ_Z[W'_HUJZSQ9;:?>^$]3M=5NOLEC-
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M:LQP S[=J$^C$=O6L33]/N+KQ+X8O+SQCIMYY*2RV-K:Z<(FFC:+:V&$C84
MJ>G4"N:6&./]EV;8BC="[G ZM]I)S]: .^'C[3CX_D\+;9-Z0*WF^3(<REB-
MGW<8P =V<<XS72W]_:Z783WU].D%K A>25S@*!7%6LL<?QRU)9)%5GT.#8&.
M"W[YNGK6MX_U'^S?"4T@MK2X:6>"W47J;X$9Y54.X[A2=WU H O:'XKT;Q%+
M/%IMTSS0!6DBEA>%PIZ-M=02#CKTJUJVM:=H5JEUJ=TEM \JPK(X.-[' !(Z
M?4\5PFA/<I\8I+>^UN'5+E-#96>*W6$(?.0[, G) .>N0&'K5WXMO;1^&-.>
M\V_95UBS,V[IL\SYL_AF@#H-&\8Z#K][-9Z=?&2YBC\UHI(9(F*9QO4.HW+G
MN,BHM,\=>&M9F:*PU1)BEL;IW\MU1(QU+,0 O7."<XYQBL76IH;KXM>%19R)
M)+%87LER8V!Q"RH$)QV+=*Y#2K23_AER9;*,^;):S22;!RP$S;S[_("/H* /
M2-+\=^'-9OXK*RU M/."T D@DC$X'),;,H#\<_*36II>MZ=K6EC4]/NEFLR7
M'F$%<%20V0P!&"#UKBO&%W87T7@:/2I899)-9M9K582"?(56+L,?PA.#7.:]
M<W/AN[\5>#;(E)O$-Q%+I?M]I.R?Z!2K-[9H [H^)[#4]9\-2Z?XD\JUU$3M
M#9_8R?MX4==[#,>WKVS5P>./#C:U_9(U$?:_/^SC]T_EF7_GGYFW9N[8SG/'
M6N-\0:?!I/Q/^&.G6J[;>UBO(8QZ*L*@?RI?M#^'5CN]+U/3M8\-W.KA&T^X
MB'GV\TEQAO*;^(K(Q;##( Z]Z .PTC58IO$'B*%_$"W:V31;[1K81"P!5C@O
MCY]V,Y/3%-TWQ[X:U?4(;*SU'=-/GR"\$D:3XZ^6[*%?\":\SNHKF:Z^-$=H
M&,QAM\!>I'E/N'Y9KIO%=WI][X:\%1:5+#))+JEB]DL3 D*O+$ =@F<^E '1
MW_Q"\+Z;)<)<ZF0]M*T4ZQV\LAB9<9+;5.T<_>/'7G@UT<$\5S;QW$$BR0RH
M'1T.0RD9!!]"*\\\-0Q?V7\17,:[I-6O%<X^\!"F ?;D_G71?#PD_#CPWD_\
MPV#_ - % #]1\<^'-)U1].O=2$=Q&567$3LD);[H=PI5,Y'WB.M/UCQIX?T&
M]^R:C?\ E3A!(ZI#)((T/1G*J0@X/+8KSCQ=J5W?^%O'%PFH:=I=C#<7%FUE
M'9JTUW(JA=[N3G<W&,#A0#VK9U 2VLVI:UX?UW3C<)80'5=,U"/=%,JQ94[L
M@KE"1GE3WH ]+1TEC62-E=& 964Y!!Z$5@6_CCPY=:P-*AU$-=-*T*?NG$;R
M+G*+(5V,PP> >U:6B7B:AH&G7L5O]FCN+6*58,8\L,H(7\,XKSRQN'\.G1_[
M.U/3M;\,7NJ+#;V\T0%Q:O)(>4;^+:Q).0& SSQ0!U&G^(K*VD\2W5[XC%Y:
MZ;.?.C^R>7]A4 Y3(&9/KSTIX^(GA0WCVIU=%D5&<%XG5) OWMC%=KD>BDFO
M,S_R!/C)_P!?,G_H+5UFNVL U+X:1>2GEQW6$7'"XMR1CZ$#\J .EMO%FCZY
MHVJSZ9JAB-E&XGDDMW5[8[20S1N 3P,CCG%<MXC\6:CIW@WPE?Z5K@OCJ&JV
MUM-??953[1$^_=\A'RYP.F#Q3-0 'BGXE8XW:% 3[GRIJY2^_P"2-_#7_L,V
M?_M2@#UK6?&OA_P_>_9-2OS'.$$KJD,DGE(> SE%(0<=6Q3M7\8^']",0U'4
MHXC+!]HB 1G\Q,@97:#GEEP!R<UQGB'4KNZOO&8@U#3M(MK")()_]#62XO6:
M'<-Q)''S[%&"3S]*I>'DBN?%/PTD<+(8_#+.I/.&\N,9^O)H ]8MKB.[M8;F
M$EHID61"5()4C(X/(_&N8T?Q-86^CZMJ-]XE74+6UU%K=YS:&$6Q+(HAP!\V
M"P^;ON]JZRO ;=%E^$7CR-P&1O%!5@>X-Q;T >OZ7XT\/ZSJITVQO_,N]AD1
M&B=!(@ZLC,H#CW4FI?%GB.W\*>&KW6+A6<01,8XPK'>^"54D X!(QD\"L/Q(
MJI\2_ FU0,&^48'0>0./T%7/B6,_#3Q'C_GPE_E0!)#X[T/_ (1ZRU>YN7B2
MZ(1(Q;RF1Y,9*JFW<V/4#%6O^$PT#^QH-7.I1BPGG6W28JPQ(6VA6&,J<\'(
M&.^*X6]^V7/B;P3)IVL6EB'T>6."XF@%PAEQ$2@&Y<,5[YZ \5E^(=*BB\*7
M*RZU;:S]M\4VS7306WE1I)E%=,;FST!//4F@#T1?B#X7:SM[K^U L-RTBP,T
M$B^88\;MH*Y/WEQZY&,U#_PLKPG]B:[_ +38JCLCQBUE,J%0"VZ/;O4#(Y(Q
MSUJEXIBCD^)W@(.BL%:_901T(A&#3?#4$7_"RO'[^6NYC9*3CJ/(Z4 ;U]XR
MT#3["QO9]0#0WZ[[7R(GF:9< DJJ M@ C)QQGFM/3=2L]8TZ'4-/N$N+68;H
MY$Z'G!^A!!!!Z$5Y-X.LC=>#_!T^F:]#IGB"#3Y_)2XB\R.X@,@WJP)'0JG*
MG(KT'P1JK:QX;6YDM+6VF6XGAF%I_J9)$D96=#W5B"<^_>@"I!X^TZ?Q]<^%
MPL@>&%")/)D^:4LP*?=P   =Q.#FIQ\0?"YU'["-4'F&;[.)?)D\GS<XV>;M
MV9SQC=6 CL/BWXHBBD5+F71;<0 M@ELN!C\2*Y^2ZTX_LUI:HT?G&T6V6 $;
M_M7F ;=O7?OYQU[T >RUSVG^./#FJZHNFV>HB2Y<LL68G5)2OW@CE0KXP?ND
M]*VHMT=BGV@Y98QYAZ\XYKS;1)I?#LGAJSM=3T[7O#5Y<"'3MT0%U:Y1RK*1
MPP4 @D@,,_6@#N5\3Z,WAV77Q>J=+B#E[C8V $8JW&,\$$=*AUGQCH6@/!'J
M-Z4EGC,L<<4+RN4'5RJ*2%]SQ7F/]HVEM^SKJUO-<1K.&O+<Q%AN$AN'(7'7
M.#GZ<UU6@W,%E\3M=&H31Q/-I5B]HTK!<PJ'$F">P8C- %C6?&]O8^)/#4T6
MIQ?V#?VEU-(Z('$I7R_+VX!;.6(P.23C%=+H7B/2O$EM+/I5UYRPR&*56C:-
MXW]&5@"/Q%<+;R:'?^./ MQH<$:Z:+?4WMPL6Q0<H&901W);GOG/>MGPP /B
M5XZ X&^Q/X^10!J^+=273;;37;7?['\[4(H0_P!E$_V@D-^YQ@[=V/O=L5DQ
M^(-3;XT2^'C<#^RUT3[6(=B_ZWS0N[=C/0],XK-^,G_(+\+?]C):?RDHA_Y.
M-G_[%H?^CUH L^!/&,]YX8U[5O$>H1B&PU6X@$SHJ!(EV[1\H&3D_4YKIM)\
M5Z+K<5T]E>_\>@#7"SQ/"T2D$AF5P"%(!YQCBO&-+68_#O49([A+:*+QJ'GG
MEC\Q(D\R/YG7(RH8J2,CI71>*-)U VOB>[N/$]IJ>J+X=EA:UM++R6$);<&8
MB1L]' '^T: .VL_B)X5OY8([?507N)4A@#02)YS,=HV94;AGC<,@9&3S4UYX
MZ\-V&KMIESJ02Y218I"(G,<;MC:KR!=BDY'!(ZUQOBG4-%NM/^'4=G-;RR'5
M[%[98F!*Q 8)XZ#E1]<5B>,=2N[_ ,#^+;Q=0T[3;+[=/;#3H+-3+<2(X4N[
MYSO.W=P.% /O0!W,GB#4U^-$/AX7 _LMM$-V8=B_ZWS2N[=C/0=,XKMJ\U9@
M_P"T3:LI# ^&L@@]?WYKT*SO[34(FEL[F*XC1VC9HG# .IPRG'<'J* ,?5]2
M6U\5Z#9G7?L;71FQ8?91)]MVJ#]_'R;>OOFJ]]\0_"VG/.EQJ>&MY6BG"6\K
M^2RG!W[5.T9_B/!YP>*Y_P :_P#)8/AW_O7W_HI:;X>@B_X1SXC-Y:[I-5U
M.<?> C& ?S/YT =S;:]I=YJC:;;WB27:VZ77EJ#S$W"N#C!!]C5>[\5Z'8S:
ME%=:A'$^F1I)>;E;$(?[F3C!)[ <GTKSN%U\/Z)\./%[-LMX]/@TW4'/_/"6
M)=C,?19 #_P*DL9Y[;P*WB":UM&U#Q5K,4J-?Q[X[9'D"P,PXR$15(Y')'-
M'>6_BW3-9TG5)M'NV:XLH&9TEA>)XSM)4E'4'!QP<8.*Y;1?%=[>_"K0-;U;
MQ(-,O+NX"27?V-9?-/F.HCV 87( Y XQ52TDG'CSQ/!=ZS%J=PGAX*\L<"PA
M2'D.S )R1N!SG^+%<G/_ ,F]>#/^PK%_Z.EH ]FUCQAH6A7\=CJ%Z4NI(_-\
MJ.&25E3.-[;%.U<]S@52\ ZW=:_H-S>W5RMP1J%S%%(@4 QK(0F-O!X Y[UF
M:+<V]G\5O&?VZ:.&22WLI8#*P7,*QL&(SV#9S1\(GMY/!D[VH MFU.[,0 P
MGFMC],4 ='K7BK1O#\T,&HW3+<3@M'!#"\TC*.K;$!./?&*;_P )AX?&BVVL
M?VG#_9]S,L$4^#@R,<!3QE3G@YQCOBL"RDBMOC-K(O75)9])MC9ESC,:N_F!
M?^!$$BN#U*.&^\/:LZ!9-,N_&\7DXY212R*Y'8J6#?K0![+HNN:?XAT\7^F3
MM-;%R@<QLF2/0, <>_2M&C&!@44 %%%% !1110 4444 %%%% !1110 4444
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MSR/,=5*K^)X[U9U+QCH6DSP07-X3-<6_VF".&)Y6F3('R! =Q^8<#G'/0$T
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MFFISZ58RW\>-ET]NC2KCIAB,B@!FLHT?A;4$9R[+92 L?XCL/->47%_IMW\
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MTUK?8(_*-I&5V@DA<8Q@$DX]2:L/HVER:8NFOIMFU@H 6U,"F(8.1A,8Z^U
M'G]_'?Q_%35O*\10:*9M,MGA:>V242QJT@<*6(QM8Y(']X5O^#)-*T/PKI5F
MFMQ7D5Y-+]DG,?E>>S.[E47T&3CV%=!J6BZ5K*1IJFFV=\D9W(MS L@4^HW
MXJ9K"S?[/OM(&^S',&8P?*.,97^[QQQ0!8HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR2 HS*/NYW#(%=(FN:WX:\5SZ?K>IQZI9-I,VHK(MJL+Q-$P#* "<J0>_/%
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MK2-4_M&%#=CRI?F;*%NHRK'G'7%>H?\ "-:#_P! 33?_  %3_"C_ (1K0?\
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M@2W\'O;Z8D%D846]%TQ-S'%(I4!-OR'"@DDG[N.^1ZO6'<^,-!M-,OM2GO\
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M8S7%U"$!R1#O7#$9&#Z&K]CX3O[;P?XHTEY+<W&JW%_+ P8[0)]VS<<<=1G
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M4VX*DCDYZ?E5C^Q?%]SKF@:Q/::/ -*\R'^SX;E]I1TVLX?R^HPN$Q@ =>>
M"BWBOQ,ET?!.Y3XJ-Q\FH>0/*-EG=]IVXVY RFW^]3?$'C-H_%>I:,_C*UT!
M=,AA5#-#&[W<SIO+-N& @!487!R3R.*LM\/]4>R;73>6X\;?:_MBW8+>2H'R
MBWZ9\K9\O3.3FM*?2O$VF>(+_5M%M=,N/[6BA-S!=7#H+>=$V;E8(=Z[< C
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MU2WUM[6VL+BZLK6P6"-HI5B7#&0D;LL<]",>]=/\._\ DF_AO_L'0?\ H H
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MQQW/:KR.LB*Z,&1AE64Y!'J* .(\4>'_ !5KUOJFC;]&N-(OCB.>Z#":T4@
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MC\5^(-%TWQ7!X@=;B\E$[:;*B"T%N7/[L80N&"\[L]?:O1F4,I5AD$8(/>N
MTSPCXJTJRM?#]KK-G#H%K<!TN(U<7AA#[Q#_ '?]G=Z=J (;,Z_XO_X2#4[;
MQ%>:8ME>SV>GVULD9C_=<;Y=RDON;/&1@4OAGQAJ/B#7?"LCR>7;ZAHDUS<0
M*!M,RNBY'<#EL<]ZM-X7\3:5-K-MX>OM,33]5N)+DM=H_FVLD@^<H%X<9^8
MXP3WI)/ ^HZ+)X<N/#%Q9F72+-[%X[\,$FC;:2V4R0VY<],<T 9'B+Q1KEGI
MWCJ6TO2LVG:A916>57$:OY.Y>G(.YNOK6J3K?AWQYH%G-KUUJ<&L1W*SPW*1
MJD<D:!PT>U05'48)/'K5:?X?:O=Z/XFM[K4K62[UF\MKH2!&5$\LQEEQR<?(
M0.O&,]ZZ?6?#]QJ?BGP_JL5PD4>F?:=X(^9O-CV KQC@\\T <?X.UR\O=5MA
MJ'BJZ36EWMJ>AWUNL:@ -Q -H/RG!!#-D9S6'I_C^XN+/3]>3Q%?3ZC<W<9F
MT461^SBW>3:45O+^\J'=NW\D'UKM(_#7B;4=3T8^(+S2IK?29_/2ZMXG6XN&
M",H# _*@.[+!<YQVI=&\.>*M#AM-%M-4TY-#M)]T<_E,UT8 VX0D'Y.GR[^N
M.V: ,[PK_P EP\??]<;'_P!$BK_Q*UO4M$C\,G3KIK<W>NVUK/M4'?$V[<O(
M[X%7]&\*W.F_$'Q)XBDN(7M]52W6*)<[T\M IW=N<=J/''A6Y\4IH:VUQ%#_
M &=JL-])YF?F5,Y48[\T <9J^C75Q\>[.)->U*!I=(DF62/RMT2^8?W:Y0C;
M]03[UZ-XHNY;'PSJ%S!J-MITJ196\N1E(><;B.Y]!W.*S;CPO<S?$VS\4">(
M6T&FM9M"<[RQ<MGTQS5SQAH4_B+PY+86LT<-R)8IX6E4M&7CD5P& YVDK@_6
M@#AM*\3W$6JZQI]AK^IZI:C0YK^.;4;0Q213(0OR$QIN4[@>A QUIJ7WB2Q\
M+^%/%5QXBN9YKZ:RCN;(QQBW:*;:IP NX/\ ,#NSUSP!Q6S/X3\3ZAKCZO>W
MVF>;<Z9<:;-;Q!_+A1\,K(2,LVX<DXX/ XYNW7@^[N/ WA_05N81/ICV+22'
M.U_(*EL<9YV\4 0:3XFN-(U/Q=IVOW32_P!E$ZA;RL "UFZE@!@#.TJRY^E:
M_@:35KCP?87FMSM+?WBFY<%0/+5SN5  .RD#ZYKC?'^F6GB;QWH&EZ?>*UW,
MLD&JQPD-_H*NLC"0C[OSJ%'J6->I@!0   !P * /-H+GQ!X@C\4:W;:_<V0T
MV\N+2QLXTC,#"$8)DRI9MS9Z$8[4[PMXAU:]U'P5#<WKRQW^@R75R& _>2CR
M\,>/]H]/6I+[PQXCTB'Q+#I5_IZ:-JDD]Y(TR.;BW:1?W@3'RG.,@GIGH:I>
M'= U>Y\,>!M?T*>R6\LM*$$D-[N$<L<B(>JY((*CMS0 :[XSU329/&(%[L^S
MZC96=G(T0<6PEC3<^T#+8RS8YYQ]*@L?%.HQW6JZ?X=U>_\ $!;29KJU>]M2
MLD5TA "@[$#!@V0N#RN.]:R_#_4[BV\0M?:K ;_4KNVOK>XBB.()H@I7Y3_"
M&7 YSM]ZV8+#QG=Q7S7^KZ?8RO;>5:I80F1$DSGS6,@R?3:.,$\YP0 <QH]^
MVK:5JHT_QS?W;+8.UQ;W4,<=W:S#!W*-@VKPRD$$<C!K 74-6\+? G0M0T[6
M+KS[B2U"^8L9$*-P47Y?N_7)]Z[JW\,ZYJ>N_P!J>()=+BDCL)K*,:<KDR"7
M;EG+XX&WA>>IYK#G^'GB*^^&]IX4N[W2PUC<0FWGB$F'CC)/S@CANG3B@#9O
M)M3\2>/-1T*VUB[TO3]*M(9)6LP@EFEEW$99E;"A5Z <DUSTWBCQ)_8L%A'J
M2C5+7Q4NC27C0K^^B()#,O3.&7(&.5]ZZS4_#^M6OBJ;Q!X<GL/-N[9+>\MK
M[>$?824=63)! 8C&,$5GQ> +Q--T]9+Z&6_&OIK=_+L*I(W.Y4')  V@9]*
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M<)2^[TQ@XK,E\.^)],O]67P[J&FPV6J3FY9[J-VEM)64!V0#Y7SC< V,'U%
M&9'J.M^*/&D>G0ZM=:5ITV@VVH.ENB>:DCNPP"ZG';/'\/;)K#&H^+)?AYJ_
MB"3Q/<I>:'/<0PK%#&([@0R$%I@5))(XX( P#US7H5KX>N8/'4^OR7*212:9
M%9;2,.75V8L<#&#N[5DKX(O!X!\0>'OM4'GZG/=RQR<[4$KE@#QGC/- &)KO
MB]+OQ3-IUWXBOM"M;6R@F3[#;&5YII06RQ\M_E4!?EXSD\\4VV\2^(O$'_"#
MV\6HO82:I'?1WTJ0 %O)P ZJX^4G!(R,#=T.,5T<_AS7],U@ZIX>N-.,MS9P
MVUY!?!PA:+(212O.<,00>HQR*L?\(UJ<NM^%]2O=2CNIM*BN5NI#'L,S2HH!
M50,  C\L=: .)UZ;5X_#GQ$T"XUV]N8]*M8IX+F01^:\<L3%HG(4 KE3R #@
M]:]$\'V<MEX4TV.6^N+QFMXW$D^W<H*CY1M4# [=_>L?4O!-QJ-QXS8W<21Z
M_9PV\) ),12-U)8=QEATK<\,6NK6.@VUIK+6374"+$&L]VPHJ@ G=SG@T <C
M9G7_ !>WB#4K;Q%>:8MC?3V>GV]LD9CS%QOEW*2^YL\9&!7*>*[NZ\6:'\.-
M=?4;JUDO]3M8WAA";(I<L#*F5)W9SC)(QCBNW;POXFTJ?6;?P]?:8FGZK<27
M1:[1_-M9)!AR@7AQGY@#C!/>C4OA\7T?P?I>FW,:0:!?V]R[3 YE6,'.,?Q$
MG/I0!TMW8W\?A>YLK34;B34!;.D-Y*$\SS,':QP O7';%>;ZQXYUN[\&>&;W
M1[@I?-9R:GJ.U 2T=NH$J$$<;G./PKUVN%\.> 'TC7]=NKRXBGL+Q)(+*W4$
M&"&21Y)%.?5F'3L* (-:\1ZA<Z]JPTJ]9-/TSPZ]XQ100UQ(&,1.1V5"WXUR
MM]-JGB'PK\-;ZZUJ]CN+S4(EE>(1C+E9"),%3\PQ@=N>E=9X8\ W^B^#M;TN
M]OX;K4=1A-N+A00JQK (8@<\\ 9/U-12> M6@\%>%=-LKRR.IZ!=1W*M,'\F
M4J&!!P-P^]Z=J *MGH^H:C\2_%5I!KEY8Q1VMAYL]N(_.E81N%R64@#[Q. ,
MG'0=<=]1UC7]'\"/-?*-4&M7%JUYY0_@$R>9MZ;MHSZ9[8KT/0]!O;'Q/K.M
M7LMNS:E!:(8X=V$>)&#]>Q+<>U8NG> [VR@\/QO=V['3-6N;^0C=\ZR&3"CC
MJ/,'Y&@"A-KVJ>#-3\46=QJ=SJ]O9:.NIVK7H3S%<EU*$HJY4E0>G%%W+XA\
M,:3HGB*Y\17=^US<VT>HVDT<8A*S$*?+"J"I4L,<G..:Z#4_!HU?Q'J]Y=3)
M]AU'1QIC1KG>IWN2WIT<8]Q68GA+Q-J,&D:5KM_ICZ5ID\4QDMD<379B^X'#
M?*@R 6P3G'&* ,"#5FT'X@_%75D0.]G8VLR*>A98"0#[9Q2:[INM6^B^$-0O
M_$%UJ#7>L:>]U#.D81'9PP,6U05 /&"2"#[5TX\!//XC\:7EY<QFR\16L5NJ
M1@[X@L10DYX[Y%4)/!WB_4;+0;#5-3TK[-HUY;7"M;I)ON1$PY?/"G;G@9!)
MZC% "1^(]6;QQ\0+ WK_ &73-/AELX]JXB<P[B1QD\\\YK/2_P#$MEX5\*>*
M[CQ%=3S7LUDES9&.,6[Q3;5. %W!_F!W9ZYX P*Z)/!=XOBKQAJQNH/*URSC
MMX4YW1E8MA+<=,^E277@Z[G\">'] 6YA$^F-8M)(<[7\@J6QQGG:<4 9UK-X
M@\2ZKXDO[/79[&/2;U[*RLXXXS%(\:*6,N5+,&+8X(P.E;OP\U.\UGP!HVHZ
MA.9[NX@WRR$ %CD^G%<G=2?V+KOBRVT_Q-I5G97$GVN_BNT9;BT=XQN:+)"O
MN !!Y /KT/3?#&WEM?AGX?BG1DD^R*Q5A@@')'Z$4 <W9ZU?3^+YK2_\4W.E
MZNNI,D&E75NJVMQ:A\*(R5R[,G.X/G<>E5=*TS5KP^.[FRU^ZTQ+;6+F2%;5
M$^>411G,A93E<!1M&.^<\8Z'5/#/BC6B-,U"_P!+GTI;Y+E;LQ,+M4602*@
M&P$8V[QV[9K3TCPS<:=:^)XI)XF.KW\]U$5S\BO&B -[Y4]* .8N?$DNI>'O
M"UWJ/B6;2%O[ 3SQ:= 9+JXE*KRH"/A!DDX'<"N:\4ZU=:[\)=)N;R=KB:+Q
M"EN9VB\MI5CE=59DP-I( R,#G/ KL+#P7X@T)]$N=)N],>ZM-(32KG[6KE %
M8,)$V\DYSP<9XYJC=_#76;GPJVA-J5I(L>M#48KAPP=T+L[!P!C=ENW% %B[
M_P"3B[#_ +%UO_1S5U'C.]DL/#LDJ:Q%I ,L:/=NF]E0L-PC7!RY&0!@\FJL
MWA6YE^*-MXK%Q"+6+2S8F$YWEC(6SZ8P:L>+]"O=;L]/?39;=+W3K^.]A6Y!
M\J0J&7:V.0,,>1W H X:#Q7?0:-XWM[#6M0O8]-TQ;NRN[ZV,4\;LLF00R)N
M * @[>Y'-2>(-0\2:#\'M1\3/K]Q)JEU!:31CRT$=KND0%4&WG*O@DYSC/%:
M5YX)\1ZA-X@GNM0TYGUS2OL<RJKA;>1=X0)URF'Y)YSDXYP-3Q3X/N]>^%[^
M%8+F&.Y:WMXO.?.S,;(2>!GG8?SH Q?$^N7-MK5E%JGB&_T'2I-/C>WO;:!6
MCDN23N$KLC!0!M(!P#D\U!K?BF1==L-%U/Q1/801:7'=37NEVV\W<SD@%3L<
M*F%+>^X<\5U&I:;XJCD$>E76DW%E):I!):ZC&VV-@""RE!E@P(RK>G!&:R[/
MP5K'AK^R[CP]>V4US;Z:FG727ZNL<RJQ974IDJ06;CG@X[4 ;'@+6KK7?"T=
MS>R&:XBGEMVG,1B\\(Y"R;2!C<NTXQU)KIJP8;+Q+%8:5&^JVL]TESYFH2M!
MM62([B4C Z8RH!/.%Y.36]0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ",H92K
M %2,$'O4=M:V]E;1VUK!'!!&NU(HD"JH] !P!4M% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 5+72]/L;BXN+2QMK>>Y;
M?/)%$JM*WJQ R3]:MT44 -=%D1D=0R,,,K#((]#3+>V@L[:.VMH8X8(E"1QQ
MJ%5%'0 #@"I:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "HKJUM[VVDMKN"*>"0;7BE0,K#
MT(/!J6B@!  JA5   P .U+110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% &?>Z%I&IW,=Q?Z58W4\?W))[='9?H2,BM#I1
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(PV2<L/E/&.O2O0: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>%VT[:$^RFVD\K:.@VYQ3-.T#7-)T][#3['PO;6;YWPQ6TBJ^1@[AGG(XYH
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M E<DJO3L17<WWA34]3U*/4;_ $KPG<WL>-L\MI(SC'3DGMV]*N_V9XD_M/\
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M\SA(T4NH)R&).>@%=-X*\0OXE\/"[G-NUS#/+:SO;-NB=XV*[D.3\K###ZT
M:IU:P76%TDW<0U!H?M MMWSF/.-V/3(Q5RN,EU^Z7XR0>'Q#;?96T4W9E,?[
MW?YI7&[^[@=*YE?&'C*3X?MXT\_3$M[5G+V/V9B;A$E*,=^[Y#@'  /3.><
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MD4:EW8]  ,DT <QH&A7UA-XL:XC4#4M0>>VPX.Y#$B@GTY4US$7A7Q'I.F>
M+JUTZ*\O- BFCNK3[2L9/F1;,JYXXKTNSO+?4+*"]M)5EMIXUEBD7HRD9!'X
M5/0!4U&R35-(N["?*)=0/"^.2 RD'^=>=R:!XLU3PA8^"+[3+:&TA\B"YU5;
MH,LD$3*1LCQN#L$ YP!D\UZ?10!QP\/:@/C"?$?EI_9O]B?8M^\;O-\[?C;U
MQCO6_P"(=/EU;PSJNFPLJRW=G- A;H&="HS[<UI44 ><V&A>(;K2?!4%]I26
M<NAW<8G'VI)-\26YC\P8]6/W>M7/$7@V[\0>)=:D8K'8W_A\:>DVX$K-YKMR
MO7 RIKNJ* .)\.V6M#4K(7OA31],CMHS]INXV21YGQ@&+: 5&<DEN<<8[UI>
M/M'O-?\  VJ:7IZ*]U<1JL:LP4$AU/4^P-=)10 U45/NJ!]!7E^I>$O$,T/B
MW2[?2+&0ZS---'J\TRDK&Z ",KC=D8VCL,Y[8/J5% '#Z%H>L+XXM=<OK-+:
M$>'X[&1/.5RLRR[B..HQSFGZ?I.M:7\2?$%ZNGQSZ5K2V[?:A<*I@,413!0\
MMDXZ>M;VF>*-#UK4+FQTS5+:[N;;)E2%MVW!QUZ=:UZ /)=$\ :UIWPXT"SG
MLK2?5M'U![O['-(ICG1BX9-V" 2KY!/0@5TUI!XCCT_4+NS\-:+ILY:(6]B6
M4O,@/[P22)\H+#A>" >N<\=I10!Q/A#0;RS\2:GK#Z';Z#:W5O%%]AAF5_,D
M5F)E8)\H.&"\<G!)I_Q"\.ZCXA_X1O\ LZ-'^P:U;WD^YPN(DSN(SU//2NSH
MH \[\9Z+KWB%+_2Y/#6FWJRG&G:MYZQM9@@89@<ON5LG*<'CI7H,*-'#&CN7
M95 +GJQQUK.C\2Z#-J/]G1:WIKWV[;]F6Z0R9]-N<YK4H \GE\)>)CX0\5^&
MAID)6\OI+NSNQ=+B4/.C[2O52%!Z^E=GK^C7NH>*_"U_;HIM]/GG>X8L 5#P
MLBX'?DBNEHH \@C\(>*(?"MGH\6A6*SZ;>QW<EW]I0MJ)2</QQE2PY)8]1C'
M.1U.D:9KFF?$G6]1;3$DTS6DMG:X%RH-LT414J4ZMD]QQ74-K.G+K::,UV@U
M)X/M"V_.XQYQN^F1BKU '+?$30[_ ,0^#+FQTQ(Y+P2PS1QR/M#[)%<KGMD
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M\1>(M8:2^M;?2M)U>XL_*%MNDN%7&%W9^7;E3D DY/I75^(O^19U7_KSF_\
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M@90^-W*,.NT5RFG?"^"*X\613S70M=53R+9GO))B$:)5+,&/+!@<$Y.!C.*
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M$[QN5+(>?E; 8>QKHJSM"@OK?1X$U*.SCO#EI4LU*Q*220!GK@8&>^,X%:-
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M*CCGJ<UF:SXSOHM;MM%U/Q%IWA>>'3X[F[E*I+YL[DC8GF<;!M))Z_,!QUH
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MRI&J[2B@ -DXR<#WK<U+PUK^L6GAM[^[L7O=/UA-0N3&&2,1C?\ )'QDD!@
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MF!=OS^9GC.[.,=J -"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M Z6BL>+Q7H,VDV^JQZK;&PN)1#%/OPK.3@+['/K2:-XLT'Q#/-!I.J6]W+"
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA77'P;X<.M_VR='M?[0\SS?.V?Q_W\=-W^UC-:$&DV%MJEUJ4-K&E[=A%GF
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MWOC-:T.G6=O?W-]%;HEU=!%GE ^:0("%S],G\Z .3^%2A/!"QJ $2_O%51T
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M;^WN-0ABDT^%9[L.2!"C?=+'ISC@=:;HGB?1O$7G#2[U9V@QYB%&C=0>A*L
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MQW;W^H65M=Z0-*DM9$F ;,AE1U^4^RDY[5U]1SW$-K$9;B:.*,=7D8*!^)H
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M3#HNGFP23S5MC;)Y8?\ O;<8S[U871],34O[233[5;[9L^TB%1)M]-V,X]J
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M(O\ A//B&_EKN>2U5CCJ/LP./U-=L]C:27-O<O:PM/;!A!(8P6B###!3U&0
M#CTI8[&TAGN)XK:%)KD@SR*@#2D# W'O@<<]J .6^%1)^%WA[/\ SZC^9KL*
MAM+2VL+6.UL[>*WMXAMCBB0*JCT ' J:@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ JO=7UG8A#=W4%N'.%,L@3<?09ZU8KA_%=MJX\2#4/#\]E=7MOI
M^RYTB]&%N(&<G*-_"V5(YX/&>U '83W]G:V@NKB[@BMB 1-)(%0YZ<DXIQO+
M4112FYA$<Q C?>,.3T /?->5V7B"PG\0^&7N+F71=)N] 4:<)O+VK(&P\>Z1
M2,[ F#QD?7%5]6\/Z!8Z5X6M=.N'U"R/BJ-5FF*,,.'+QQLH \O=Q@<9R.U
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MFI1*4AM8&D>60@DA(U!)P!^%9.CWEK>ZQ\0K76C#]M29H_+G('^A"(>7C/\
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MHIGP\&)_& '3_A([G_T".F^*%\&Z[X@70_$48M]0MX1<6ES++]G)5B0?*D#
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MJ_:I(X-.XO$FMY$E@/\ M1D;A^7-<)HTT5C=?"R]OG6*R.BO!'+(<(D[0QD
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M?9:7/&!!?07$<N!S\TCC=]1Q^0H [G5];T_0[6*YOYS''-,EO%M0N7D<X50
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M&H]:\7Z/H-]#8WDL[W<L9E$%M;23N(P<%V"*2%SW-.\'1)#X(T&.-0J+I\&
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MJ-YJ_P /=%O[^=I[N>#=)*V,L=QYXILWC*PU!-=L]&U&T;4--C;!8AP7"%B
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MUUO]G6/E3Q?8K?RYV+S+Y2XD;U88Y/N:E>"&62.22*-WB),;,H)0D8)![<4
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M0W&EW4R6TY:,/%$&Z/)GHN0.><$BM^LW5[34[R-(]/O;*W0AA,MU9FX$@.,
M 2)COGKG/:@#SB&#0O#OBSP_!X&UII1>W?EW>E6]Z;F#[/L8M+M).S:0N#D=
M<5BZ;9)-X,GT75_'#V"B^EM;C2UM(7E$IN"5V\>8Q8E6!'KZ"O1K'PSK6F,[
M6%_X>M"_WC!H1CW?7$_-.;PYKKWZW[:CH#7JC N#H9,@'^]Y^: ,+0-:TG2?
MB7X\34+VWM)6EM9 \\@0.BVZYP3UQGGTW"N<\,ZA<VNA>%=.&I0Z%:WW]H7B
M7TT49=8_.RD<9D!5=RON/!X%=1;^!=?.M:W>7VHZ#<IJ$\4P$^DM,,I&$SM,
MHV'CU;/7(Z5LW7A[7[Z%(;S4]!N(HR&1)M#+JI'0@&?B@#RR6:WO/!6KP->M
M?%_&$#-),JJ\T;&+:Y50!AAD@@ $5Z/XTU6>W\1:#IB:I;Z/%=+<2OJ,L<;,
MFP+\B&0%5+;B22.BU;;P[KSR/(^I:"TDA4NQT,DL5^Z2?/YQV]*=>:#X@U&)
M8K[5-"NHU;<J3Z(S@'UP9^M 'EM_=13_  G^(:+J#WTG]LI-YTJJKRQDVV)=
MJ@#:P!(( !%=9XOO+74/B=\-KFSN8;F!Y;[;+"X=6Q&@X(XKI6T#Q S3LVJ:
M$3.@28G1&_>*!@!OW_(QV--B\.:Y MNL.HZ!&+;/D!-#(\K/7;B?Y<]\4 <]
MX9UK2?#]AXSM-;O+>VN8M6O+B:*=PK2QR89& /+!EP!CTQ6;X+L;BSUGX?07
MT96XBT"Z;:X^9,M'@>QVG%=G<^&]<O;F.YNM0\/SSQ?ZN670BS)]"9\BISI/
MB=IUG;6]&,R*560Z,VY0>H!\_..!0!G^$N/'OCL#I]LM?_29*S_'?_)3OAU_
MU\W?_HM:Z!-)\3Q2R2QZUHR22D&1ET9@7(&!D^?SQ22:/XEFFBFEUG17EA),
M3MHS%D)ZX/G\?A0!D^'(T/Q@\;R%1O6WT]0W< QOD?H/RKG]%UG2M&^%WB/2
M]5N[>+4;>6_BN;:5P))'=W*X4\MN#+@CK7;II'B>.>2=-:T99I0!)(-&8,^.
MF3Y_.*@F\-ZY<7J7LVH>'Y+N/&R=]")=?HQGR* .9\)6<]GX\\-VUZA%U;^#
M8TD##E6$J CZ]J9I\:#P%\4B% +:AJN>.O[H5V']D^)_M'VC^VM&\_9L\S^Q
MFW;<YQGS\XSVIHT7Q(L4T0U?1!'.6:51HK8D+=2P\_G/?- %_P )_P#(G:'_
M -@^#_T6M<%=CX<^(_M6MS7W_".ZS$[I<2+>"SNXG4D'>H;#'C/0YKLTTWQ5
M%&L<>NZ0B* JJNCN  .@ \^J5QX6U>\NUNKF\\.SW*XQ-+H)9QCW,^: .$M;
MO6KVZ\%:KJVO/H\UUI=S M_+;QD._F*RAA(-JEXU#=B<$"EUBQL?^$<MI8-:
M;6TO?%]JUQ<- L:-("J,%V@*P^4<C@G/O7H-WH?B._MS;WFK:'<P'DQS:*SJ
M?P,^*0:#XA%O%;C5="$$)#11_P!B-M0CH5'GX&/:@"A\18SIO]B>+(QAM%O5
M-P1_S[2_NY?RRI_X#7.11-?_  P\=>*YE/FZ[#<RQ9ZBVC1DA'_?()_X%7;R
MZ7XHN(7AFUS1Y(G&&1]'<AAZ$&?FF_V-XE^R_9?[9T7[-L\OR?[&;9MQC;CS
M\8QVH X;1;F'2Y?ACJ6HRI#8'17MEGE8*D<S11D L> 6"L!ZXJ?Q=JNFZQ-I
MVHZ+>+86MEKRQ7FK1P1M'YAA95DR<JX4LJ%CP,^U=?+H'B">R%E-JFA26@ 7
MR'T1BF!T&TSXQ0N@^(4L?L2:KH2VFW;Y T1A'M]-OGXQ0!1\'VML?$^LWR^*
M&UV]\B""Y98$2- "[(-T8"LWS-GN,C/:NWK#T'2-2TDF*6ZTLV04[;>QTTVV
M&)'.?,8>O&/QK:D+B-C&JL^/E#' )]S@X_*@#@=+N([+XK>-;Z:9(+&"QLS<
MRN<*K!&.2?9:[RWN(;NVBN;>5)8)4$D<B'*NI&00>X(K-TW0;>SMKU;A4NIM
M0D:6]=T&V4D!=NTY^4* H!SP.<G)K4CCCAB2*)%2-%"JBC 4#H .PH =1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5&]U>PT^]LK.YN E
MS?.8[>(*6:0@9/ !P .I/ [FKU<+X<_XF_Q.\5:I/\W]FB'3+0'_ )9KM\R0
M_4L1SZ"@#H4\5Z+)I^IWR7C&VTR5X;M_)D_=NGWAC;EL9ZKD4^3Q-I$*Z2SW
M1 U8J++]RY\W< 1V^7@C[V*X"T\9Z[+X)^(&HO>*;K2-1NH+)_*3]VB8VC&,
M-C/?-6K_ ,6ZU!;_  V>.Z ;6GA%_P#NE_>[HT8]OEY)Z8H [W3]8L-4DNXK
M.X$DEG,8+B,JRM&XYP0P!Z'(/0CIFKU<+J?_ !)_C#H<\'RIKMG/:W*CHSP
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MD#;R-Q<!=W)P>F*]0TR:2XTJSGE;=)) CL<8R2H)H M45Y]XTUR[T_6)HO\
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M/.1J,L!N$B\ML&,$C.[&WJ#QG-:%<5=^(-2B^,>G^'TG TR;2'N7AV+DR!V
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ME67/(P0<GVK-G\ ZU_PC*K:C3(=377DUI+-&9;9-N/W0;;GMDG:.2>*]-HH
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M<ZI::!<Z6FGZA=O=I<7.\S6C2',@5 "K\Y*Y(Z\YH [&RN5O;"WNT4JL\2R
M'J PS_6O/AXG\0MXR\?Z?:-]J_LNQAETZU\M>)6AW8X&6RW8FO1U!"@$Y('7
MUKB8/"&L6OC'Q=KEKJ%O;MJ]O!'9N%+M"\<>W+J1@C/N>* (O FK2ZK=F2'Q
M@-9A\C_2K.YMTAN+:;(Y"JJD+]X$,#R!@]:V?'>NW/AOP9J&IV2H;M D<&\9
M =W5%)'L6S^%4-,T+7KKQ=:Z]KL6DVTEI:R6ZC3V=VN"Y7ERRC"C;PO/)/-:
M_B_P_P#\)1X5O]'$_D23H#'+C.QU8,I(]-RB@#BM6TO6-+\:>!TO]=FU:)[Z
M4LT\,:,D@@?[NP#Y3D\')&!SS6(?B5*UD_B!?%(^TK=G;H(ME,9MQ+LVEMN[
MS"GS;MV,\8Q77-X>\7:QXA\/:IK4ND01Z3.[M!9O(WF[HV4OEE&#DC"^A/)X
MJ33- \6Z'&-%TR[TM-&2Z:6*[?>UQ'"TA<Q^7MVD\E0V>G;- '-ZYXYEDU;Q
M"4\6C2)M+F:"QL!;+(MPR("3*2I)#,2H"E< 9K4BUO7?%'BVQL+'5)-*L+SP
M]!J<GE0H\B.[D84NIP>0#G/"\#)S6G+H7BG2=3U@^')M+^QZK/\ :2UX7#VD
MQ4*[*H4B0':& )'/M6E;^'KR+Q[_ &_+<Q2P_P!CI8-P1(T@E+EL 8 (/KU[
M4 <(FJ>,9_!&O:P_B5HKCP_/=01B.UBVW?D,26ERIZCC"XQC/.:NZUXW%SX@
MCT^?Q*WAVVCTZ"Z+PP+))--+D@?,K (H XP"=W6MN+P9?IX*\5:*9[;[1J]S
M>S0/N;8@F)V[N,Y&>< _C2MX<\0:-J<.IZ"VFS32Z?#97EO>2.B%HL[)%95)
M_B8$$<C% &%9>+M:\3VGA/3+74/L-UJ379O;ZWA4L4MSMS&K@@;R5/3@&M'P
M=;WUI\3O%EO?WAO9([2Q"7#(J-(F)2"P7 W#D<  XS@5<U3PWXCF;P]K$%]8
MW.OZ5YHF\]6B@N$E&'4;02N,+@X/3FI_#'AW6K#Q5K>NZS<63R:G#;J(K4MM
MA,>\;1N R,,.>YSP.* *GQ9,X\'0&V"&X&IV?E!_N[O.7&?;-5[A_$>A^+--
MT:7Q)-?1:[;721RS6T2M:7$:;PZ!5 *XS\K9Z=ZW?'/AV\\3^'DT^PN8K:<7
M<$XFD!(4(X8D #D\<"J5MH?B#4/%^GZWXA;3(8=)AF6VBLG=O,DD 5I&+ ;1
MM& O/4\T 8P\<:H_PI^UJ0/%'GC2"FT9%[O\O.,8_P!O&,>U>BVD<L-G!%/,
M9YDC59)2 #(P'+8' R>>*\QTW1H-3^-&H7%C<K/H]CLO[B-,&-=09#&!GH3L
M^8^A(KU2@#SW3]2UK4-7\<V]]+;/:V?[E$0-\BF#< ,_[W)/4^V!6?X1\1ZK
MHOA3P+'/8VITG4$@L XF)G61HR5<C&W:2IXSGH?8;\?AO6[/7/%,]LVGR6>L
MA9(_-D=9%<0B/:<*0!D9SSZ8YR* \&ZZOA;P=I0_LXS:%>07$S&X?;(L2LN%
M_=]3NSSTQWH M:KXWODAU.XT:P%XNG7#0&W\F5I+ED($@1E4JI!R!G.2.U=E
M:7 N[."Y$<D8FC60)*NUUR,X8=B.XKB;?P]XNT#7M3_L*ZTJ71]3NFNV%[YG
MF6DK_?*A>'4GD D?AU/<PQF*".-I&D**%+OU; ZGWH \^\&S'Q!\0_%VJWO[
MR33+D:;9(W(@10=Y4=BYP2?;'2NMU&STS3[^3Q1<*L4MG92QS3!>3#\KD'UQ
MLR/J?6L23PSJFB>+;[7_  Z;2:+4PGV_3[J1H@SJ,"2-PK8.#R",'UK7GTZ]
MUW3[NTUA8;>VN;>2W:WMI3)D.,%BY5><'@ 8'7)XP 8=UXUO]-T+2_$E]96Z
MZ-?-%YJ(Q\ZU27&QV/1NJ[@ ,9X)Q4C>)O$-WXA\1:-IVF:>)=+2!XY9[A]L
M@D5FYPN<_*!CH.>3Q52/PAK5[X0L?"6KO9/I]J\*27D4C;YX(F#(OEE<*QVJ
M"=Q[D9S6E8:%K%EXO\2ZN4L7@U.*!($^T.&4Q*R_-\F!G=VSC'>@#(@^(&JS
MZ+X>\0'2K6/2=4N(+:1#.QG1I&V;AQMVANV<D>G2K<WBGQ/=^(/$&C:/HVG/
M/I0@99+B[8+()$+8X7.XX  Z#G)Z5GQ^"->B^'OA_P / Z:;K3+R&>20W$@1
MUCDWX'[O.3TZ<>]2:/+JD?Q0\;&QM;68F.PW"6=H]K>2V.0AR.N>AZ4 7]+\
M;W6O:!HVI6-@MK'>><+V>Z;,5@8LA@_*YRPP.1ZGTJC)\1;T>!IM>ATVVFFM
MM2.GS*LYV,1,(]Z<<@Y!P2.O4TL7@;5]'7PT-,GLKQ-.>>6\@O&:-)9I3N\U
M=H;E26P".AZCK527P)XD?PIJ^C>?I3O=ZR=0CDWR(-OG"4Y&UL'Y<8YQZF@#
MH+7Q%K1\7W'AZ^LK&*:33S?6<D4SNN X0I)D#G)!R*KZ7XRO]0\(37[VEM%K
M$5\;!['<Q"3^8$"%NO((;.. <]JMRZ/J0^(,'B27[#'80Z6]G*#<-O4EPY;[
MF,#;CDCUXZ5GZ;H]G>_$R^UG3[U9K 6\4TT<3!HFO"KHK@CN(CR/]I30!W*;
MMB[R"V.2!QFN'UCQMJ&C/]HN[*V@@_M-;)+25\7$T1<)YZ\XQDY"XZ=Q7<UY
MC>^!_%-SI&J:?Y^DRO-JJZA%=RO)YDZK*KJDGR_+M P"-PP  !UH V;#4M;N
M/BIJ^GR2VQL+6RMW2,!LA79\GW8X^F /J>DU^YN[/P_J%U8F(74-N\D9F!*@
M@$\@=>E8MOH.L6OCV?7$DL7M;VQA@N02X='C+'Y%Q@@[N[#'OWZ+4;3[?IEW
M9[]GVB%XMV,XW*1G]: /++^[U*[^'_P]O;WR[FZDU7394*L0TA*$_,3W)/)K
MJ(/&MUI]]XBM?$-K;0G2+1+X/9R,XDB8-Q\P!W KCWSVK.'A#Q*_A7PKI4IT
MGS=$O;69BL\@$D< P,'9]YOI@>]7;_P9>ZQXB\0SWIM4TW5],2P!BE9I8RN[
MYL% /XNF>U $]KXKU4Z_IEG/I;2V>H*VZ6W@F'V-P,@2,RX93TW#'/:NFU66
MY@TF[FL_*^TI$S1^:"4R!W Y(KG/#5CXUMQ;6>OW>EO:6@"BXM-YFN@!A=X8
M )V)QG)&.E=3<P_:+6:#.WS$9,^F1B@#S:T\4:O8_"+3-=O[6SU)IA;E_-=@
M?WDBC<1@@D,P..*Z.^\1ZPGC@^&[+3[-M^FM>Q7$T[ 9$BI\P"\ 9/ SGCD<
MUA/X+\22_"^V\*N^E?:+9H$2032!"D4BON)V9R=H&,<=<GH-]M$U9OB)%XAV
M67V5=+-BT?GOOW&0/G[F,<8Z^_M0!S[_ !!U]/"%]KQT>P"Z3<RV^H1FY;,A
MCDVOY7R],<Y;Z8[GH-2\4R_VK/I>F"+[1;VT=Q))-#+(N7W;$Q&,@D*22>G&
M ><84G@G7I/ GB70B=-%SJU[<7$;BX<HBRONP?W><CIP.?:K=[X>\4V'B./7
M_#\NF&:ZM([;4;*\D?RF,>=CHZKG(W$<CI0!TGA?69]?\.VFI76G7&G7$H(E
MM;A2K1L"0>H!(.,@XZ$57N]=GF\3/X?TM8/M4-J+JXFG!9(U9MJ+M!!).">H
MP!WS6IIL5W#8QK?SI/=G+2O&NU,DYPH/.T=!GG YYKG[WP]J-IXX7Q/I'V>8
MW%H+.]M)Y#&&"MN216"M\PZ$$8(H P=>\57NM?#/Q9Y<,=GJ>FI<6=]&7+!<
M(?FC8 9# @C.._I76^&[+_B5:?>7EM9_;4M$BCFB3YA$54[=QYZC)'3@5@WG
M@N_D\)>)K.![0ZKX@DEDF9Y&6*+>H4*"%)8*H'89.3QTKK=(AN;;2+2WNUB6
M>*)8V\ERZD@ 9!(!_2@#B?B%*T'C3P',EO).ZWT^(XMNYOW70;B!^M=)97K:
MIKMUOTB>RNK*U00S707+"4MN V,05S$O?-9WBOP_K.K>)/#NI:<E@8M)G>=E
MN+AT:3<NW VQMCOS6HO_  DDU_$\MOIMM:Q*[,D5V\CS/C"J28EVKDDD\G('
M'6@##T?QAK.IZM/H<NG6UOK%I=E;F(ES&EMMRLRM_%N)  X/7I@FK&K^+KN.
M[U:UTBWCFFTP .LD,K^=(4#^6I0$+\I7DYY.,<9JE=>$M=^WZ5XALI+%/$<<
MS?V@SSN(9X&ZPC"9VC"[<@8()Y)),EQH'BO2?%E]JWAV;2Y+751&]Y:7S2 0
MRJH7?&RCD$ 9!QT_( NV7BRZUNXL["PLC9WTM@M]<I?HW^C!F*JA48)8L&],
M!<]P*K_\);K-M_PC8U+1H[.;5+UK*>!I-QB8!R'4C@J0F0#@\U#J7AGQ)9^)
M+/Q'H5Y97-_]C^Q7\-]NCCG7<7#J5!*D,3@<\<?6QKWAW7M0L=%O(KBRGUC3
MM0%ZT<A:.!QM93&I 8J &&#@YQDCF@"+4?%>JJ?&EE;16L=SH=I'/!.VXAP\
M;OROJ-N.N#5-/$.IZ9X&\)75[:6=\;Z:Q@:21VW() F),$'<^<GJ.<=:LP>$
MM;GU/Q;<7\]@D>O64=NH@+DQ,L3)W R/GZ]\=!G AN?"GB.[\&^'=)D_LH7.
ME75I*Y6>0(R08Q@["26QZ #/>@#;7Q#>Q>/_ /A';R"WCMIK-KJTG4G=-M8!
MDP> RY![\&JS^+IX;33_ #(H?M&J3RK9E$=E\A,GS6 R3E0I ']\<CDB;QAX
M6F\21:9+:W7V._LKD.)U/(B<;)E!QW0G'N!TJ/Q;X9U"_&D7_AVXMK35-'D+
M6R3J?)DC9=KQMCD C'(Z8_$ ":1J5UXIMM:TC5])C3[.XC66>T<VUVC#*L$<
M G!&"N3@@<\TFHZK9>![/0-$CFM[.WFS;1W=V/W4>Q<@-@@9;MR!U],5L:''
MK9ADGUU[1;F3 6WLRQBB S_$V"S'/)P!P!VR8?$&GW>I&"!;'3[_ $UTD2\M
M+QL;\[=C+\K#(PW7'6@"_I,]Y<Z<DM_#%%<%G!6%BR%0Y"L">Q4 _C7)>.(-
M?T_7](\4Z/IPU>+3XIH;C3PV)-K[<R1?[0VX]<<=S6UX,\/2>&/#J:8\NY5F
MEDCC#EU@1G)6-6;DA00,G&:EU&#78]=AO=-^R36@MS'-;7$K1EVW9#*P5L$#
M/4<Y[4 <[H7C'PI<:=X@\6Z>7A>*%7U*T>+9-&\8?&Y?[Q!VYZ';UX-6X?%>
ML#7M/LI-*\^WOXW_ 'L,,RBTD5<A9&9<%3TW #GM5>3P(VLWOB2_U98+.36K
M);'RK1B^Q0#^\9B%W/DCM@!0,FKOAJS\:P_9[7Q!=Z6]K:#'GVF\RW6!A=X8
M +V)QG)'84 <]_PL7Q)_PB(\5CP_9'2[>:1+R-;IC-L64H6C&W!  YS@GG@#
MDW/%FNL-4A5?&2Z/;/9+/;06EL)YY7)/SR*4;$>,  8R<\UD>$-*U3Q!\+9M
M$1;6*RO;JZB>Z\TETB-P^_";<%NH'S8Y![8/1R>&==T_Q+J%UH<FG)9:E;00
M227!?S;41*5S&H!#\'(!(YH Y]_%?B36XOA_%I]_'83:]:W!NY!"KA2D:L74
M,.H^8@=,D9R!6AXDO[O2[VWT^Z\=&P,5BIC$%JLUS<2Y(,DJ>6P"<#A0,G/-
M.T'P+K.GW/@UKN>Q,?AX7<3&)W)FCD0*A *C#>HSCT)K1N_#_B&W\6ZKJ.D3
M:>MMJ\,,<TUP7\ZV,89<HH&'X;(!(YH XV>\U;Q3K/PSU'^V)[&74;:X=A;Q
M1E8Y5A.YU#*?O D8.0!TP>:WU\8ZC9>-_'L-U-YVFZ)I\-U;V^Q1@^3O;Y@,
MG)]2:KV_@;Q/IUAX2:TETF2^\.O/$BRRR".>&1-@8D)E6 [8(]ZUX/ ]Q+XO
M\7:E?RP-I^O6<5J(XF/F*!%L?.1CUQR: ,:XU'Q1H7A33/&-YK[W8E>VDO=.
M:WC6 13,JE8R%W@KO')8YQS5V%_$WB/Q-XJL(/$4NFVFFW,:6I@MXF<EH5;#
M%E/R@G/J=W4 4T>$?%.H:-IOAG5KG2SHUE)#YMU TAGNHX2"BE"-J$[5R=Q]
MJZ70M!N=+U[Q'?S21-%J=U'-"J$Y4+$J$-D=<J>F: &^!-:N?$7@?2-6O-OV
MFX@!E*C + D$X[9QG\:Z*N?\$:%<^&?!FF:-=R127%I&4=X22I.XGC(![^E=
M!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5C^(?$^E>%[:";5)W3[1*
M(8(XXFDDE<_PJJ@DFMBO*/B?ID]QXX\%.FK7L GU QHL7EX@(4?.F4/S'WR/
M:@#U&TNDO;.&ZC614F0.JRQE' (SRIY!]C4U<&VN^*D\27OAG3(-/N9K&R@G
M2[OYF!F#,5)?8H 8[3P!@>O:K1\4ZKJ.F:SJNB06<EMID\L*PS!B]V8O]9M8
M$!.<A<ALXR<9X .RHKA?^$YO=1U+PQ'H]G:O::]:37$<EQ(P:,HJDA@!V+=L
MYQVZU47QAXJDTCQ%(EEI O- FE6X9FD\N=502#8O525/<D XZYX /1:IZAJV
MGZ4L;7]Y#;^:=L8D< N1R0!U/X4:1J"ZMHMAJ2(46[MXYPA.2H=0V/UKC?&,
M'B+1?%=IXNT;3AJ]M%9-9W=@K8E5"^_S(O4] 1WP..X .G=?#_BVQ,3C3]7M
M$<,5.R9 XZ9ZC//ZUJQQI%&L<:*B( JJHP !T %<'I/C7PT?#NN>*=*23?YB
MM>6;IY<JW&!&JLO."3M&1GOUYJ[:^(]>/B.'3GTW[5;7-N[I=I97%M';RJ,[
M)"X.0>S#'/&.: .QHKSW0?%'C/Q%X6BUZTTW2$ADM9G2!GD,CRHY"J,< $ C
M.<YY[X&OI'B>YUS0_#E[9-;--J8WS*8VQ$JJ3)@;L_*V$YSR10!OVNJ6-]>7
MEI;7*2W%DZQW$:]8V(W '\#5RN'7QP]@OC"XU*Q@C31)HT5;=B6G+HI4%B!R
M2RCIQ6H=3U_3=15M4M+232OLDD\]U;97[*Z#.PAF)<$9PP Z=* .DHKA;?QE
MK,\^B746E2W.GZG(BRQ16,ZR6:N,K(TA&QU'&[ &,\$BNX??Y;>65#X.TL,C
M/O0 ZBO,O#WBW4]-\&ZEK6KS0WLQU2:U@B1#&7E,WEHN22 G3MD =ZZ.;Q%J
M.C>*M*TC6%M98-6#K;W-LC1^7,@W%'5F;((Z,".1C'>@#IYIHK>%YII$CB0;
MF=VP%'J2:@TW4K+6-/BO]/N$N+27/ERQG*M@D''X@U:KQCPKXD\0>%OA1H^L
M1Z=8SZ#:[A=+YK?:=AF8%U&-HP3TYR!U'8 ]GHKC-4\7WKW&K0:'"LLFFA5P
M]E/.+B4H)-@:/A.&49.>3TP.>ET:_EU31K.^GLYK*:>)7>VG4AXF(Y4@XZ&@
M"]17+>(]>U32[FY$"65K:06?G1W-YEA<39;]RBAE(.%R3S]X<5K>'-7_ +?\
M-:9J_E>3]MMHYS'G.PLH)&>] %]IXEG2!I%$K@LJ9Y('4X].1^=$,\5Q'YD,
MBR)DKN0Y&0<'GZUC7'A^YE\6)K4.KW$%NUK]FN+)44K-C>4;<>5(,C'CKQ7/
MM>S?#S2='TG4-<6>*XG>!-3OX ([=%3*1L$('., DCN?:@#O:*XK6/%6N:/I
MNAR_8;"ZGU'4Q9$QS,J%69]CKUX9%!R2<9Z&JR>.M1T36-7TWQ79VD;6>G-J
MD$]@S%)H5.&7#<[P<#W]J .^HKB[?Q5K*:WID5QIKS:?>HWGRPV,\?V%@NX;
MW<;74]-P"^N*DLO$6OZKIVE:WIFG6]QIM]<*IML[9H[=B0)BY;:3@!BFWH<9
MXH Z2#5+&ZU*\TZ"Y1[RS"&XA'WH]XRN?J!6?J7C'P]H\K1ZCJL%L5W M)D+
MN499=V,;@/X<Y]JI:7KFH:AXK\3Z1]FL[=].6V,$PW/YGF*S9?ITP.![\FN/
M\-7E_9?"._UJXMM.U'['-?7B17$9!\Q9I2S$G.3UQ@#KUH ]5@GBNK>*X@<2
M0RH'1UZ,I&01^%25R<_BN0#1K*!%2^O['[:["VDG2% $'W$^8Y9P!R  #ST!
MHVWCC4O[.A@O=(:VUBYU,Z=;++')%%.,;O/ 8;MFT$XZY&,\YH ZR+6-.GU>
M72HKV&2_AC\V6!6RR+G&3Z<U>KS_ $L7Z_&N^6_>W=QH$6R2!"@9?/;JI+8.
M<CJ>@/M77Z]K$'A_0;W5KA6>*UB,A1>K'LH]R<#\: -&F2Q1SQ/%*BO&ZE65
MAD,#P017(V_B37O^$BL["33#=6MY#(?M$=E<0+:2J,A9&<$,K= P Y'2L-?B
M!XB'@B#Q6^FZ;]D2[,%U;K(YD9?M!AS&>@(XZ]>>E 'H6FZ5I^CV@M-,L;>S
MMP2WE6\81<GJ<#O5NN1M_$.N0>-!H.HVNGD75C)=VC02/\A1@I1R1S]X'< /
MI7-CXA^*?^$)@\7G1M-;3(I7%Y"DSF8HLS1EH^,< #KUP3@"@#T1=8TY]9;2
M$O86U%(?/:W5LNJ9 W$=N2.M7JX4W$3_ !F@N@X\IO#+2;S_ '?M"G/Y4R?Q
MOJ2^#1XS@M+:31PWF-:;6$_V??M\P/G;NQ\VW;TXW4 =[17*Q>)KP>.;72)U
MM1INH6376GW"JVZ8KC=&<G (!#>X]*@;Q?<QVMFSI$TNIWDL-B8H)''DH&/F
MLJDLV57( Q]Y>1R0 =C4-U=6]C:2W5U-'#;PH7DED;:J*.223T%<7'XXU"QM
M-8.K:5*&M)X(;.X6UEACO3,0J[5<%@58X8#=[9JU9ZQJFHZ[<:%J&F"YTZXL
MV=+TZ;-%"&S@Q2))PV1SP1GIB@#>C\0Z-++8Q1ZI9M)J"&2T43*3.H&24YY_
M"M*N>A\':7!'I$:P0[=,=I8F\E0^\DGAA]U=Q)VK@<#L,'?DWF-O+*A\':6&
M0#VS0!FWOB31].O([2\OXH99)%A&[.T.PRJ%NBL1R 2":EM=$TVRU&XU"VM$
MCO+G'GS G=+CIN/?';/2O.-!U4Z1X?\ &VKZZ+2\L;/6KIY(?()9Y5,83:68
M@#(4#(R..>*ZB^\2:KH&HZ(-9ALWLM6N%L]ULK*UM.X)1223O4X(SA?7% '7
M45Q.D>(_$^LZ[J5I#8:5%;:;J8M;AGFD+-%L5B4XY8;NX [>]=A=/-%:2R6Z
M(\RH2BR,54GW(!Q^5 #YH8KF"2">-9(I%*.CC(92,$$=QBJ^FZ78:-9)9:;9
MP6ELF2L4*!5!/4X'>O.5^(OB2'PCI?C"ZTG3AH<Q07B1RN9XU9]GF+_#@$CC
MDGVSQU%GXAU"Z\0>*-)*6JMI,5O)!+L;#^8C-AAN[;<<'_"@#J:*\\3QYK-S
MHO@^]MM-LF?7I/*=7E8"-BC,,<=/EY/)]C4W_"2>,(_$5IX=ET[1?[0GT^6Z
M,R3R&%660*"05W8P1P,DD]0.: .]HKSVQ^(MV-,N+?4]/ABU^#5H](\B.0^3
M)+)RC@GD)MRWKA?>M9_$U_I/BN'0M6AAG-[:RW%E/:1LGF-&,O$49FYP00<\
M^@H ZRBN*\.^-)=<T]-5BN-.N+);22:[@@#+/:2J 1&X+'/\0SA?N].:XW1O
M'-S+_86J#Q)>WM_J%U"M[I1LB+>.*4XQ&?+&#'N!W;CG!]: /9Z*\OTO6KZY
M\6-:ZAXIN=.UE=0=1I%U;JMM-;!R%$1*@LQ3!#!B<]L5ZA0 5B^(/%>D>&?L
MBZE-*)KQREM!!"\LDI')VJH).,C\ZX2WO/$FN>"=1\;V_B*ZM9D%S<65@D<9
MMQ%$S (X*[F+!#EMPQGCI6;XABN/$'Q$^'6I1ZO?V@U:UGN(EB\O_1/]'1B(
M]R'[V>=V[VQ0!['!*L\$<R!@LBA@'4J0",\@\@^QK#UCQQX9T&]-EJ6KP0W*
MJ&>(!G9 >A;:#M_'%;L,9B@CC:1Y610ID?&YB!U.,#)]J\_"^(?!>NZW<P>'
M6US2M3NS>&:SE47,1*JI0QMC>!MXP>] '>6=Y;:A9Q7=G/'<6TRAXY8V#*P/
M<$5/7E-_XMT6R\/^'[/P[=S:)I>I7<XN)8[=FFM0F6DC$9#;7+D#H0,DCM4,
M7CC48=(U:PTW5)K]Q?V=GINIW=ML<"X.T[E*J&*$-SCGC- 'KA( ))P!69J.
MO6.FV-M>R-)-;W,B1Q/;1F8,6Z'Y<_+[]*Y35M"\1Z9HNN+_ ,)1=W6G-ILD
M@EG$?VF*=?F^4A-I1E!!!Y';UKEI-0U;PM\'?"%S8:Q=&6\N;%"95C/EQ/'S
M$N%'R\=\GWH ]GHKA9Y=4\4>.=9T>#6KO2M/T>& '[$$$DTTJE\EG5OE"@#
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MPY#%+J^H16HF)6(-DLY'7:HR3CV%6]-U.QUC3XK_ $ZZBNK24926)LJ>Q_\
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MX0,9)/ICHJ* "D;.T[0"V. 3@5@7'C+2H/%"^'46[N=1PC2I;6SR+ K?=,C
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M<!BA==IX8J>/J#6A0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q&MRW
M^M?$2V\-0ZI=Z=8P:8=0G>S8))*YDV*NX@X48)XZUV]<IKOAW5I/%%KXCT"[
MLX;Z.U:RGBO8V:.6(MO'W2"&#9^N: //TU?4/#%GXM1M1D^UW'B*"Q-^L'F2
M(C1IF38H.Y]@/ 'WN@[5K:?K;ROX@TJTU+5]4TIM&EN$GU.UDC>&895D#.B;
M@P8''.,&M2#X=WXT[6%N=81]2O-2BU2WNUAP(9T"D?)GE<J1C/W3USS6U;Z3
MXEO;75%US4[(_:K1K:&VLH66*,D$&0EB6+'/3@ #OUH X;PY>K:_!WPC')KL
M^E0SLRR?8X6DN;@ N?+B"JQ!S@D@'@=J%\0ZZOA+7+W3]0U&Y_X1W58YE^V0
MF.>XM B.\4JLH/ 9CD@$@"MVQ\!:OHVA^%H]-U"R;4M"69,W,3&&59<ANAR"
M.,?C5W3-';PK-KU]XBUFPET[5&6:=YU\K$OEA77DXV87@<G'&3UH ;JWB&?4
M/%N@V>E7;K81V;ZQ?/%_RT@QB)?HS$G'HM<;I'C*[GM]&UJ/6]9N]4O+J(W>
MF_8)?L@AD?#*A\H*-BD$-NYVGKFNA^$.@?9/#MWJ4[2S)?OY5F9UPPL8\K""
M.V02WT85J:+X9\3Z,ECI$.MV:Z%8R@QLMN3=20@Y6%B25 Q@%@,D#L>: ,'&
ML>)]&\6:W_;M[;?9;B\M;.SC*_9_+B!7#J1EBQ!R<Y&>,8KL/ '_ "3KPU_V
M#+?_ -%K6'+X+\06XUW3=+U>RAT76)I;B3S8&:X@:4?O%0@[<$YP2.,]#76>
M'-+?0_#&EZ3)*LKV5I%;M(HP&**%R/RH Q/&5_?-J_A[P[87LMBVKW$HFNH0
M/,2**,NP0D$!CP,XXYK(UU_$GA+1)K.+6WN_[1U&VLM-NKI0\]MYK;7+G #X
MY*_7GI71^*?#USK#Z;?Z9=QVNJZ7.9[629"\;!E*NC@$':RGJ.163<^"]9UO
M2=0&MZXO]I3SPW%H;5&^SV+PG*;$8Y.3]XG&<]L4 1*-1\*>.- T[^VM0U*P
MUA9XI$OW5VCEC3>KJP4$ @$$=*X]=1\3K\)X?&W_  DEZVH6\X\NV.WR)$^T
M^7MD7&6)!/.>. .E=_8^'=;O?$UAK?B2\L'?38Y$M+>PB=5WR *TC%R23M&
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M$(VG<-PQZXJG=^#->GTS3[@Z['<:_9ZDVHK+<1L;?+*5,*KG*QA3@8.>,]Z
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M="ZBN#&?++++Y@!&<X[5L-X4U2]\:^'_ !+?W=F)M.M9H9XK>-@KLX(!7))
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M/!Q6[KVNF^\9ZUI]UJ?B*R@TU(8K5='MI7'F/&':20HC9^\H"GC /'- 'J@
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M"@*_!'/'6M:&RU+Q+XX\76$^OZI9V%C);"WBLI_+96>!23NQG /.!P23G/%
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M-1U!8HW%I 8HD2,-M #,Q)^<Y)/H.U='4-Y<I964]U(&,<$;2,%ZD*,G'Y4
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MX;N;'Q9J6O7-Y%+)?6EO \<<14*T8.YADG@D\#MZFNCILCK%&TCG"J"Q/L*
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M<\.JV,=I);K&5QM4!CG/0\\>]==4#7MLM^EBTZ"Z>-I5AS\Q12 6QZ L!^-
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MS^U;:.32KFWN/-^R,1*8<;1M\SY<D<\F@"E92ZL_Q;UR(WXDM[?3[=X[<Q#
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MZ393:=I5O:7%[-?31KB2YFQND;J20.GL.PQ5R@ HHHH **** "BBB@ HHHH
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MHGMGW']XC.2V&Z?*Q'% 'L=%<9XHO+F#5?!*0W,T:SZD$F".0)%\ASAL=1D
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MM[B6^M[XR;F6YM\;)4W':1CC[N,^^:TJ "BBB@ HHHH **** "BBB@ HHHH
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MTV>6_P!1O))(;!"H5Y)I2<<#LN2Q/H* -?X87TVI?#/0+F=BTGV41ECU.PE
M?R45@Z_HEC>_&S0FG%P3)IT\K;+J5!N1D"X"L,#U X/?-=KX8T5/#GA?3-'1
M@_V.W2)G'\3 ?,?Q.35#7?"LVJ>(M,URQU:33[RQ1X21"LJRQN02I#=#QUH
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M;[/NS'O()R0#MZG[M<A\0?#^FWGQ7\$>? [?;Y+I;C$SKN"1+MQ@_+^&,]Z
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MDMM>CR?-9@<1L1G))//K533-#M_%GAK7_$>ISW7]JFYO!:SI<R(;)8F98U0
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M^P7;?^BUKH: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJAG"]@?09S3[KP%YFI:G+9Z[?6-AJK^9?V,*H5E<J%8JQ&Y-P S@Y]Q78T4
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MNPK/T31K+P]HUMI6GHR6UNNU=S;F)))+$]R222?4UH4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
@* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>employementagreement_mil012.jpg
<TEXT>
begin 644 employementagreement_mil012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M\0RV=R@N$REK$AEE+$D! %')X^@[G'-6M#N-9N_M=SJMHEE$\@^R6I96EC0
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MA^[N-2L88O"UOIUU;:M]LEU6 QB-X@Y9L$-YA:13M*D8Y/. * .DLO%5O?\
MBRXT*"UN/]'MVE:YD0HC,KA"J9'S8)Y8<9&!GG&<GC#5+NQ?6--\./>:*K-M
ME6YQ<3(IP7CAVG<."0"P)'0<BM)]-N6\=KJ/E?Z'_9;6YDW#[YE#8QG/0=>E
M8&E_\)1X=\-Q^&K+07N+FU0V]GJ)GB%L8P<))("V\$#&5"G)'!YH W=>\66V
MB7NDV?D27%QJ-S%$$7Y?*1W"^8^1P 6 QU)^AQT%>>:]X+\03W@O;/65FFGU
M*UGE#6B9B2-AC!+?=3EMO<D]R:]"&0H!.3CDT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4KK2-,OKJ&ZN].M+BXA_U4LT"NZ=_E)&1^%7:* "BB
MB@ HHHH **** "F0PQ6T"001)%%&H5(T4*J@=  .@I]% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_:FGK'?VD,<L@%@QG66-MPZ)NSD#ZT =Y)XCTVTUNUT.YN'74[B,O%'Y$F)
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MR-%$;[S'5253,( R>V37&WND72^/Y_ R0DZ-J=_'KSG^%85R98S[-,D?'HU
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M6=SAG."!U.>U)?2*WB!;/7UUQ[5=,M1I5G8-/&D\I#>8&:+'S@[1\Y  Y]Z
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M\1Q:GK^LZ,UN]O=Z8\>X,P(EC=<JZ^W4>Q%>1Z^DFJ>']:6]@U^]\3QWLCO
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MD,C11->^8ZJ2J9@P,GMDUR&A7.G6_A37]!UW1M0NQ'JT\EU;I:R92%YLK,K
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ME '845R=CXFOKV\U#1=7T?\ LS4([$W<:I<B=)(B2I(8 8((P1CO7DKRR?\
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M8;N,?A7J%% 'CD6C_P!J1ZIHWA%=;AT>[TBYCGM=2CF2&WG(41+'YHR#RP8
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M] 3@X^E;^BZH-9TN.^%E=V>]G7R;N/RY!M8KDC/0XR/8BM"B@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9"<!.GJ3D9H7^V[JU\):9J,VK6*R:S<VX,\I2XEM1%(R!RIZ[<+G.<C(.>:
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M-9_--W-:1VNI:0[D"9V3=E%Z!T8'.!]W/I0!Z/J.HVFDV3WE].L%NA56=@2
M68*!QZD@?C5JO&?%NAAOA/;7^H:C+J%]>W]M=RW$=RXB)EE3*H <; I 7TQD
M8-7M<$ \9MX?FTWQ#J&DZ;IT30VVG7#DB21GS)(YD5F("@+DGO0!ZQ4<\\5K
M;RW$[A(HD+NYZ*H&2?RKR5!KE^W@72]5N=5LI)KN^@F,DACGF@2-RF\J?O%
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M75VG9'TIIF2,+D2>9'L.3VQUIE]X=CNO%&G:_#</;W=I&\$H501<0MSL;Z,
MP/8T^_UZ.P\2Z/HK0,[ZFEPZR!L!/*52<COG=^E7[Z>:VL+B>VM6NIXXV:.W
M5@IE8#A03P,],F@#EE\#W=O<306'B2]L]&FNC=/8PQJ&5F;>RI+]Y$+9) YY
M(!&:NKX0A7QIJ/B3[7)YM[8BR:'8-J@$'<#Z\5N6,\US86\]S:M:SR1JTENS
M!C$Q'*DC@XZ9%6* .6C\$P1^'?#NCB]D*:)<07"2;!F4Q9P".V<T:SX)@UFX
MUZ5[V2(ZOIZ6+@(#Y84N=P]3\_Z5T5[>6^G6%Q?7<@BMK>-I99""=J*,D\<]
M!3[>>.ZMHKB%MT4J!T;&,J1D'F@#D;?P+.+[23?Z_<WVFZ1();*S>%%*NJE4
M+N.7V@G'3WS4%Q\/9Y&UJUM_$-U;:/J\LL]Q9) A.^0?/B0\A2>J_49&:[FJ
MFFZG9ZO9_:["<30>8\6\*0-R,48<CLRD9]J .?C\$01ZMX6O_MLA;P_:/:QI
ML&)@T8CR?3IFK6L:!JUWJ?V[2?$=QIC/"(98C L\3 $D,JM]UOF/(Z\9'%=#
M10!QH\ _V?%I;Z!J\^G7MA:FS,[Q+,)XBVXAU.!G=E@1C!)[5<C\(<Z$]QJM
MW=SZ5=27333D,T[NKJ0>R@;S@#@  5=\0>);/P\EJLT-U=75W(8[:TM(O,EF
M(&3@9 P!R22 *KZ'XOM=:U.?2Y+#4--U*&(3&UOX@CM&3C>I4D,,\<'K0!+#
MX:BAU/Q!>BY<MK*QJZ[1B+9'Y?'KGK64/ LEG9Z)_9.LRV.HZ59"Q6Z\A9!-
M#A<JZ'@\J",'@UV-% '+_P#"'&2#11=ZO=W=QIM^;]IY\$S.0X*XZ(OS\ <
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF'^S]1EL3E]V\IM^;IQG=TKE+K2[/Q7\4KVPUF(W-EIFF0/;VSN0GF2,VZ3
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MI?/F>9&'Z8XQG'>MFO,-/\)Z1K_Q$\:P:I;M<6D!LDCMS(P13]G7YL C+
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M64LA8==IYKL P90P((/<&@,& *D$'N* (;*SM].L;>RM(A%;6\:Q11KT55&
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M6&B^)+"X:Y\0:61IXM6U+3H!-',JMQ%(H1R'[AL#J>?3TG<N[;N&[&<9YI:
M.*^%^E2Z9X:O'>TGM(KW4;B[MX+G/FI$S )OSSN(7)SSS6GJ_A--3\26&O0:
MG>6%[:1& F (1+$6#%&#*>XZCFNBI"RKC<P&3@9/4T <_!X0LK?PUJ^AK<7!
MM]4>Y>5R1N4SYW;>,<;CC-5KKP2C26-SIFKWVF7MK9K8FX@$;&:%>@=74J2#
MD@@ C)KJ6947<S!1ZDXI: *6D:9%HVE0:?#+/,D((\VXD+R.222S,>I))-7:
M0,&&5((Z<4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*@M/@OXJT^$L+6P\126UM&6)\N(3(0HSV&37>76EV/BOXG7^G:Y;K=V.G:9
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MU4C85D*DDC&<_*,<US%M\*]+MM+MM'75M7;1H65WTYYD,4S!MWS?)NP3R5!
M)YQ0 _PK(TOQ(\8NXVLT&G,5]"8GK@5MEU'P3X+M6E=([CQ1/$[1L0Q1I+@,
M 1R,C(R*]0U+P5;WVORZQ;ZKJ>G3W$20W2V4JJMPBYV[LJ2" 2,J0<5%:_#_
M $>STW1]/@DNEM])OVO[8;USO)<[6^7E?G/'!X'- '.>)/!L&G7]C);^$TUK
MP[:V;P#389 'M7,A=I41CARV<<'/'%8\\MOKNMZ%86.B77B71+?1!<06EU<H
MA#F4QEI!(0&90FWOC)^M>C:SX5&J:F-1M=8U/2[HPB"1[*1 )4!) 975AD%C
M@C!YJI+X"T]+;3$TV]O],N-.A:"&ZM9%,C1L<LK[U8,"PW<CKR,4 <-'I>HR
M3^$_"GB&RDM]+N-4O9%LI;A9=UO'&9(8W920P!8C!/1!6_X<TBQT3XOZS::=
M&(;;^Q[=U@4_)%F5\JH_A&><#NQK;N? 6G7&BV5@M[J$5Q97!NX-06?-R)F)
M+.6((.[<<C&/:I]#\&V>B:U<ZP+Z_O-0NH%@N)KJ16\S:Q(; 4 'D# P, <=
MZ .?^.)(^$NKX./G@_\ 1R5#?Z+9:[\6K:TU*+[1:+X=61K=C\DC"<@;A_$!
MDG!XS@]J[#Q5X:LO%_AZXT34))X[:<H6:!@KC:P88)!'4#M4B:!:1^)5UT/-
M]J6Q%B%+#9Y>_?G&,[L^_P"% '.?#2%+*#Q+ID&5L['7)X;:+)(BCVHVU?0
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M@5-5N[Z!+J]_Y:W E@<OYC=6R1WZ=J-!\)Z%KT'CRXU6SANIAK-[$CRC<;<
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MZN%;!YXR>M=2D\4DC1)*C2)]Y P)7ZBO"%T?3;/X/>.[FUL;>&<:C=6XECC
M81+.NU,_W1V%=GJ?A[2_#GCCP5/I5I';7$]S/!<S(,/<*8&8^8W5SN .3DYH
M ]$\^'S_ "/-C\[&?+W#=CUQ227,$*EI9HT .TEF Y]*\3OEMGL;3Q%I/AQ8
MHY=<AEBUVYNU^US;K@*WRA<[""RA2P^7M72Z1X7T?Q!XT\<G5[&*]5;R*.-)
MUW+'FW3<R@]&/'S=>!0!Z917(?"RXEN?AAH$DTC2/]FV[F.3A6('Z 5U] !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !7/ZQX2M]6U/\ M&+4]3TV[,(@
MEDL)Q'YJ D@,""."S8(P1D\UT%12W5O;Y\Z>*/:I<[W PHZGGM[T 8VG>$-*
MTJ^T^[LTEC:PLFLH4WY7RV8,2<\ELJ.<]S5>^\#:5?+J6^2[BEO[N*]::*4*
M\,T84(T9QP1M'7/>MQM3T]((IVOK813'$<AE7:Y] <\_A4ES=VUG%YMU<101
MYQOE<*,_4T <W;> =-MK^2_^VZE+=SVKVMU++.&-RC9Y?CJN>,8 QTIK_#S1
M9/"FF>'"UW]ATVX6X@/F#?N5F(R<<C+'M73R7$$-N;B6:-(0-QD9@% ]<]*P
M$\3O<>+KG1K5+>6&/2EOXK@2<.S2.F,CC;\O6@#I*P(_"&F1>%K[PZK3_8;S
MS_-)<;_WK%FP<>K''%7=(O;F;0X;S5?L<,^UFF^SS;X5P3T<XR,8_6KD-W;7
M%O\ :(+B*6#!/F(X9>.O(XH P=1\%V-]<6EW!>ZAIU[;6XM5NK*8)(\0_@;*
MD,,\].#TJ.;P#HLWA1O#W^E);O,+EKA9CYYFW;_-+G.7)[FMF;5+<Z3=7UG/
M#<K!&[YCD#*2HSC(K.\$>(I?%?@[3M<FMTMY+M68Q(Q(7#LO4_2@#7L+0V%A
M#:FYN+HQKCSKA@TC^[$ 9/X5REQ\,M%N8+NUEN]4-C/(\T=G]IQ#;R.Q8O&,
M<'))&20"3@5V;,J*68A5 R23@ 57CU"REM3=1WEN]N#@RK*I0'ZYQ0!F1>%;
M*/Q+:^('FNI=0M[ 6 >1P0\>[=N8 <L3WX^E/L?#.GV'B'6-:B\UKK5EB6Y5
MV!3$:[5P,<<=>M:TDT4*JTLJ(&(4%F R3T%0R:C8PE1+>6Z%G,:AI5&6'51S
MU]J .=TWP!IFF7EI+'>ZG+:64ADL[":YW6]NV" 57&3@$XW$XSQ45[\.-'O;
MRZD:ZU*.RO)_M%UIL5SMMIY,@DLN,\D D @&NJN;NVLHO-NKB*"/.-\KA1GT
MR:<T\*A"TJ#S/N98?-QGCUXYH Q#X2LAXM/B."[OK:Z>-(YX890(9PH(7>N.
M<9[$5=\0:%9>)="N]'U .;6Z4*_EMM88(((/J" ?PJW;7EK>1&6UN89XP<%H
MG# 'TR*+:\M;Q6:UN89U4[6,3A@#Z'% &1IWA2UL-1LM1>^O[R\M+:2U6:[E
M#LZ.X8[L 9(( 'M3+CP7I%W%K4<ZS.NKS)//^\P4D0*%9".5(VJ1[BMJ&]M;
MF62*"YAEDB.)$20,4/H0.E$=[:S7$EO%<PO/']^-9 67ZCJ* ,G1/"]OHMY/
M?-?ZAJ-[-&L1N+^82,L8.0JX  &3GID]ZE\0>';7Q%!;)/<75K-:S">WN;20
M)+$^",@D$<@D$$$<UL5 ;VT618VNH0[/Y:J9!DMUV@>OM0!RDGPTT66'4HFN
MM2*ZG;K!>YN-QG*MN$C$@G?R1GI@XQTK?O-!L[[5])U.8R_:-+,AMPK84[TV
M-N&.>*N+>VKW3VJ7,+7"#+0B0%U'J1U%<=)XYN;KXA/X9TJWT]X;5(I+NZN;
MO:2'(^6-0#N8 ]"1SQQ0!MS>$=)N;G7)KF)YUUN...\C=OE*HI5=N.1P>N>O
MI572_ ]CI^IVM_/J.J:E-9*R6@O[@2+;@C!*@ <XXR<G'>N@6]M7NVM%N83<
MJ,M")!O ]2.M#7MHLBQM=0AV?RPID&2_7;CU]J .3N?AIH]T=2B:]U5+#47D
MEGT]+G$'F/U<+C.<_-C.,@<5MV?ANQLM9AU2(S&XBT]-.7<P*^4K;AQC[V>]
M:*7MI)*D274+2."402 E@.N!WQ1#>VMQ-+#!<PRRQ'$B)(&*'W Z4 <_>>!-
M'OM'U?3)6NA#JEZ;Z9TDPZ394@H<<8*#UK=TZR.GZ?#:&ZN;LQC'GW+AI'YS
MEB ,_E6;XF\1P:%H6JWD,EO->6-H]R+5I0&.U<\@<@>]:MC<&[T^VN64*9HE
MD(';(!H YJ]^'^EWM[=2_;-3@M+R;S[O3X+G;;W#\9++C/.!G! />M-?#-@O
MC!O$X,W]H&R^PXW#R_+W;NF.N1ZT_4O$FF:3J^FZ9=SA+G4&<1 L %VH6);)
MX'&![FKUQ?V=K)''<7<$,DG"+)(%+?0'K0!R&I>#--TCP5K]C9Z9=:K'?W+W
MTMI]H"2/(Q4GRVQP1M! ]1[U@^'](?4?'NBZG;6GB$PZ;!.;F]UY&21RZA$B
M0,!G&6)(&/<FO5:S-=N]0L[.*338[)Y6G1&%W,8EV'J0<'+>@H QA\/-$_L'
M6=&)NFM-7O3>W(,@W>865B <<+E!Q]:FT_P186&M6^J27VI7LEHC)9QWEQYB
M6H88.P8!SCC+$G'>M^>^M+57:XNH(EC +F20+MSTSGIFI8Y$EC62-U=&&593
MD$>H- '.6_@71(+#7;%HYIK?6[F2ZNTE?^-SD[2 "N" 1W&*ET7PE;:/J#:@
M^HZGJ-WY/D)+?W D,4>02J@ #D@9)!)P.:N^(=<MO#FAW.JW:2210!0(XAEW
M9F"JH'J6('XUAV_BW6H-2L;?6_"D^GVU]*((KB*[2Y"2$$J)%4 J#C&>1F@#
M=\0:':>)="N]'OC(+6Z4+(8FVM@$'@X/I535?">GZM8:?;/+=6\NG$&TN[:7
M9-"0NW(;&.1P000?2M9[VUBN4MI+F%+B092)I &;Z#J:+F]M;,(;JYA@#G:I
MED"[CZ#/6@#GX? NEQZ3J]C-/>W4FKQ^7>WEQ,&GD7:5 W8P  3@ 8%=!9VL
M=C8V]I#N\J"-8DW')PHP,_E6?J'B73-,UK3])NKA4NKX2&(;@ H1<DMD\9S@
M>IJ2QN]0FUK4K>YCLEM(?+^S-#,6E;(^;S%Q\O/3UH 2;0;.?Q+:Z\YE^V6U
MN]L@#?)L<@G(QUX'>L[5_!-EJNI3W\>H:GI\UU&L5W]@N/+%RJ\#>"#R 2,C
M!QWK=BO[.:Y>VBNX))X_OQ)("R_4=123:C8VPS/>6\0W^7EY57YO[O)Z^U &
M2_@[26UC0M21)8I-$B>&SC1_D",FP@@C)X]Z=%X2TV+2-;TQ6G^SZS+/-<Y<
M;@TPP^TXX&.G6MVLW7-:@T*P%S-#<3N[B*&WMXR\DTASA5'X'DX  ))H KW'
MA?3[FUT2VD,VS1YHYK;#C)9$*+NXY&"?2L>X^&VEROJ30:EJ]FNISR37J6UT
M%6??U4C:<#J.,'!QDUI:%XLM=8\%1^)YXC96IADFD1VW&-4+!LD=?NDUDV'C
MV\EGTN74_#=QINEZK(L5E>/<(Y+.,QB1!RFX=.3R0#B@#1U+P/IE\=+>VN+W
M2YM,B,%K-I\HC98B "AR""ORCJ.U5F^'&AMH>K:1NO/L^JS1SW+&;<Y=-IW;
MB"<DH"<YR2:A;QGK5UJVJ6>C^$Y-0AT^Y^RR7'V^*(%PJL<*W/1A6EX@\32Z
M%X=MKN2P+:K>-';VVG^8"6N'Z)N'&!SEO12: +.N^&[?7FM9FN[VRN[0L8+J
MRE"2(&&&7D$$' R"#T%9Y\!:2='6P\^^$RW9O1J G_TD7!&#)OQC./EQC&.,
M4^U\4.OB?4-(U+[+;I965O.]QYFU2\A8$?-T *\?6I?$_B1_#MC::MY,=QI'
MG*E[,K?-#&_"RC'#*"1GV.1TH KMX"TN;0-1TJZNK^Z_M&1)+JZGG#32%"I7
MG& !M P !BM>\T.TOM=TS5Y3)]ITY9E@"MA<2 !LC'/"C%:((90RD$'D$=Z1
MW2*-I)'5$499F. ![F@#!N/!ND79UW[3'+*NM&,W2E\ %%"J4QRI& <^HS45
MCX*L[4WDESJ.J:C/=6K69GO;@.\<1ZJN  ,\'."3@<UN1:A93VS7,-Y;R0+]
MZ5)5*CZD'%<GX'\:WOC*XN[E;2QM]+CDDC@ NB]RY1@-S)MP%.3WZXZ]: -B
M;PGIT_A[3-$=I_LFFM;M 0XW9AQLR<<_=&:;%X2LX/%\_B2WN[Z&YN547-O'
M,!!.54HI9<9R >,$=*V;NZ@L;26ZN95BAB4L[L< "N7E\<V\UIX8O--C6:VU
MJ[2 ^8P#0JT;/R 3AOE''O0!K^)_#ECXLT"XT743,+6<J7,+!6^5@PP2#W I
MZ:#9Q^(EUP&7[6ME]A W?+Y>_?TQUSWJ[;7EK>HSVMS#.JG:6B<, ?3BB"]M
M;F22."YAE>(XD6.0,4/H0.E %32=$M-&EU&2U,A;4+MKR;>V?WC*JG'' PHJ
MCK/A"TUG5XM4^W:C972P?9I'LI_+\Z+=NV-P3C).",$9/-=!7(ZEXTN?[=N=
M%\.Z%-K5Y9A3=N)U@A@+#(4NV<MCG ']: )+#X?Z/ILMH;:2[6&SO9+ZVMS(
M#'"[JP95&,[?F)QGK5^\L++2M5O/%+17DUR;-+9XK>,RED5RPVHHR3EC^%5O
M#GBPZU?WFE7^EW&E:O9JLDMI,P<,C<!T=>&7((SZUN0W]G<7$EO#=P231_?C
M20%E^H'(H XOP%H#)K?B#Q9<Z;+I\NL3CR+688DCA4?>8?PL[98CMQ79:EIU
MKJVF7.GWL?F6US&8I$R1E2,'D=/K46I:K;6$$X,\'VI(7E2!I &?:">G7'%5
M-"\01:CX2TO7+YX+,7EM',P>0!%+*#C)H IZ=X)LK.[-U=ZAJ>JRBW>VC.HW
M D$4;XWA0 .N "3D\=:H6_PQTB&&R@DU'5[FWL)HYK*"XN@R6Q1@RA1MZ<8Y
MR<9 (R:[165T#HP96&00<@BEH Y*[^'VGSW^I7UOJ>KV%SJ4F^Z>SN0GF#:%
M"X*D8 '!ZC)YYJ6?P'IGD:?'IUUJ&DO86_V6&6PG",8N#M;<&##(SDC.<G-=
M#<WMI9!#=74, <X7S9 NX^@SUI\EQ##_ *V:-/E+?,P' ZGZ"@#FY? 6E'3=
M/M;:>^LYM/>1[>]MY\7 :0DR$L00V\G)R"#1)X"TB;P\VD2RWKYN1>?;#.?M
M(N <B4/V88QTQCC%=';W5O=P">WGBFA/22-PR_F*P=0\510:[H%A9-;W<.IW
M$T$DL<H;R]D3/QCOQB@#G]/\+/I?Q2@G+:C?PS:+-'<7UZ3)N8RQX0L %'R@
MX4 =SCK5R+X7:,EG#8O?ZO-8VTJ2VEK+=;H[8JX8;!M]L?-G@D#&:[>N)F\;
M:Q-XAU;2M'\)RZD-,E2*687\40)9 XX;GH: +VK>!=/U74;N\6_U.Q-ZJI>Q
M65SY:70 VC>,$YV\94@XK2MO#MA::ZNKP*Z3K8I8*@;Y%B5BP 'KD^M1Z-J^
MI74,TFMZ-_8I5U6,2WD<OF9]UZ?3WK7>:*)D621$9SM0,P&X^@]: .;O/ >C
MWNC:KI<C72PZE?&_E=)</',2IRAQQ@H,=:WM/LSI]A#:FZN+HQC'G7+AI'YZ
ML0!G\J=]MM?M?V3[3#]IQN\GS!OQZ[>M3T >=3:;_P )E\2]*U5M'O+6QT%)
M-UQ>0-";F4D;%13R54@MNZ9Q74:YX6M=;O+>^%Y?:??VZ-&EU8RB.0QM@E#D
M$%<@'D<'IBMVHKFYAL[:2YN)%CAC4L[L> !0!S4W@'2VL=-@MKO4;.?3WD>&
M\@N/WY,G,A9F!W;CR<CZ8J!OAIH;6FH6@FOUMK^2&:>+S\AI8RI$F2"=S%1N
M)//-=)=7=Y#J=C;PZ>\]M/YGGW(E51;X7*Y4\MN/''2KM &+XDTFXU:'35MI
M7C>VU&WNF99-@V(V6!_O KD8]2/2MHC(P>E%8_B;76\.:+)J0TV[U!8F'F16
MJ@NJ=6?DC@ 4 8T?PUT>,QP?:]3;2HY_/CTEKG-JK!MP^7&=H;G:6Q[5I7'A
M*SF\6)XCCN[ZVO/*6&6."8+%.BDD!U(.<9[$5NQR"6))%SM90PR,'!IU '-_
M\(3I7_"$+X2W7/\ 9H0(#O'F8#[^N,=?:C5_!=GJNIRZA'J&IZ=<3Q+#<M87
M C%PBYVAP0>1D@$8.#UKI*I7-W>1:I8VT.GO-:S^9Y]T)546^T97*GEMQXXZ
M=Z *">$]+BU'1;V%)(FT>W>WM(U?Y CJ%(.>3PHYS6Y16'<>(Q;^,K'P\UE+
MF[MI+A;DNNW"8R .O\0ZX_&@#+?X;Z0]OK=I]LU(66L.\D]H)QY2.S!F9!MX
M)*^IZFM[4-#M-3U'2[Z<R>=ILK30;6P"S(4.[CD8)J[<W,-G:RW-Q(L4,2EW
M=CPH'4U+0!Q+_"_1I+)[)K[539B3S;6W^T_)9OOW[HAC@@]-V[ )'<UT.E:!
M:Z1=ZC=023R3:A(DD[2L#EE0(", =E&?>M">YAMO+\Z14\QQ&F3]YCT ]ZEH
M S= T2T\.:%::18F0VUJFR,RMEL9)Y.!ZUI444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %>>^(-+L]6^,&B6]_ EQ;KI-PYAD&Y'(D3&Y3P0"<X/<
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MB693]XH^#&WT*CCZ5WM<UK?@?2=;U-=4\R]T_4PGEF\TZY:"1T_NL1PP^HH
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MZ\N"W1]S!4&QSN(R2P [<USFB6<.O-\+8=37[5"VF79DCE^99 JQ[0P/W@,
MX/H*]'U+P7I>IZS)J<LM[%)/&D5U#!<-'%=*N=HD4?> R1[@X.13=*\$:1H\
M^FRVINC_ &;YXM%DF+"-9<;E'^R-HP.U 'FGB*&/1K?XC:9IJ+96#W.F*T4
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MUJEU:S)?"87<^\R[4W*7( W8W$#/H/2NGUGPY;:Y=Z?<W%Q<QR:?-Y]OY+*
M),$;CD'/!(P>.:6_\.VNHZ]INL2SW*W.G;Q;A& 0;QA\C'.0 /;MB@#@=7U#
M69[#Q?%]LOX/$5M?[-)@MI& :+"&+:@^5P<L6)!QDYP ,7M4TZ:7XB^%+*:^
MNED.E78EF20"0\QY <#CTR,''3'6LR'3S-J>H->)XXTG4;B\EE:#37D-LV6P
MK*^"G*A222.<]!@5VFG^%Y'NM)U?4[Z[DU:RMVA#;DQM;&X, N"3A<D=QQB@
M#SK6VN+OX4^*K6\OKRY_LG7C:6\LMPY<QB>+ =L_/@.1\V>WH*]FMK=+2W2"
M-I65<X,LK2-USRS$D_B:YT^ ])?1]8TN:2[EMM6N#=7(:0 ^:2"74@#!RJG'
M3CI7065HMC:1VZRS2A!_K)I"[L>Y)/4T <1\0+**Z\3>"B\EPN[4VC/E7#Q\
M>4YR-I&#QUZ]LU+I<K^*?$7B?3[B\OK>'2Y8[.V2WN7B9,Q[C*2I!9B3QNR,
M*..3GH]=\.V7B%+,7;W$<EG<"X@EMY3&Z. 1P1V()!JO+X3LO[7DU2SN;RPN
MYH5@N'MI!^_1>%WA@V2!P&&&]Z *?PZUG4-<\'6]SJC"2\BEEMI)@N!,8W*;
M\>^.??-=5573M.M-)T^"PL81#;0+MC0$G ^IY)[DGDFK5 !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !5>YU"RL\_:KNW@PAD/FR!<*.K<GH,]:L5YSXI
MTJSUCXO>&+:_@2XMO[/NG>&1=R28*$!@>" <'![@4 =S/K&F6HMS<:C9Q"Y
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MP%F$:QL@<?Q8;YN<\@&N=UJ(V$7C;2M-MXDLI==TZ-K8-Y46V58MX) ^56.
M2!T)XH ]DM=5TZ^MY+BTO[6X@CSODBF5U3'7)!P*:FKZ9)>)9QZC:/=.H=85
MG4NRD9!"YR1CG-><3Z)K%I<:UJ,^CZ/I%J^@W,$UO871?SF RCE?+4?*-PS_
M +6*I3Z+ING_  Z\!:A:V<,=]]MTN0W00>:S2%=^6ZD')&/3'I0!Z-I_BO2=
M3U_4-%MKE&N[$H'&]<.64MA<')P!SQQ6Q+-%;PO--(D<2#<SNP 4>I)Z5Y_X
M.TZQC^*'CJ5+.W62&>T\MUB4%-T&6P<<9).?6MOXD?\ )-?$?_8/E_\ 030!
MT;W,$8B+S1J)6"Q[G WDC( ]3@56GUK2K4J+C4[*$M(8AYDZKEQU7D]1Z5Q?
MBAT^S_#U=PW-J]LP&>H$$G/ZC\ZQ]+T#2K_P_P#$6[O;&"YN#J>H(LDR!BBJ
MN0%)^[R2>.] 'J-[J-CIL*RW]Y;VL;':'GE5 3Z9)ZUC:#XC;5M0\0PS"".W
MTR[$,<JMPR&)7W$DX_B/X5P_A>&'6_%?A:+5HH[N.#P=!<PI<*'7S795=\'O
M@ 9]ZPKNV6SL_$NEZ7;PR6DWBVUMGMGD\N)D*H3$2 =J;@%Z<#C% 'MEKJFG
MWMJ]U:7UM<6Z9WRQ3*Z+CKD@X&*=!J-E=3-#;WEO-*J+(R1RJS!6Y5B >A['
MO7FTFBZQ9R^)-0N=*TG2;2?0)HI;:PN3)YDB@E'*[% PI=<_2N@^&.C:?IW@
M/1+JVM(DNKJPADGN @\R0E <,W4@9P!V % &WXC\2:=X6TS[?J,NV,R)&J*5
MW.68+P"1G&[)] #6<_B^"/QBVF23V::8-)%_]L:4 9,ICQNSMQ_6LCXOVUO/
MX.@::".1DU&U"ET!(!E4'&?4<&HI]"TNZ^,T%O-86[VUMX>#Q6YC'EJWVA@#
MMZ< G'UH ZS6-4F7PY)J&B76EO(=IAFO)]ML06 .77/;.,=\5<N=4L=/BB?4
M+ZTM?,X4RS*@8^BY/->(^)X8[3X0_$.SMT6*VM_$)2&)!A8U,D!PH[#)/'O7
M<>(-#OIM;M=:L](TS7T334M9],NW59$&XMOC+ J"V2"#C.T<T >@@A@"""#R
M"*IZOJEMHFCWFJ7C;;>TA::0^P&<#W/2J7A"YTZ[\(Z7-I,,L%@8%6&&4DM&
M!QL)))X((Z]JXSXI7USJ>H:/X0L+"?46N)%OM0MH&56:UC8?*2Q  9L=_P"&
M@#H_ _C/_A+[2[,^G/IE_:.@FLY)-[*KH'1LX'!!].QKH)]2L;:ZBM9[VVBN
M)O\ 50R2JKO_ +H)R?PKRV?6M1TCXG:7K][X<O='T[4T72KUYY8F1I"286^1
MC@@Y7)[5J:%H^E:[KWCJYUJV@GG6_P#LWF3*"T,"PH4VD\IU)R,<\T =\=2L
M!%'*;VV\N4,8V\U</M!+8.>< '/IBHI=;TF"TANY=4LH[:?B*9[A DG^ZV<'
M\*\5T>PM]5\-?"FSNU\ZWEN;KS%;I(N')!]0<8([@FNDO=/NI/B3J5EI_AO1
MM0MK+3+>.WMKR7R8X(W:0L8T$;#YB,$X'W0* /3;J^L[&U-U=W4%O;C&999
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M^M 'HDT\-O'YD\J1)D#<[!1DG &3ZDXJ"VU33[VXFM[6^MIYX3B6.*96:/\
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MY9CB))9E1G/^R">?PJW7D$FGZIKWB7QFI\/:1J>Z9+1I+^[,;P1^0A4(/+;
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M-0LOS"2.,XCW ]1A5X]A0![197]GJ-OY]C=P74.<>9!('7/ID<5.S!5+,0%
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M#&3DH2I&5SS@].U-_P"$+T(:)9Z0EH4L[2X2ZB59&R95;<&9LY8YY.>M;]%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS?HBF%9=VS'WMQ ;Y=P4C/>@#I:*Y_5_%MGI,5].;2\NK;3_ /C]FMD5EM^
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M?C*%@2,C'(YSZ5:CU3Q<NCZ1#!I6GS7]S&6FN'N7^SPHJ@@LVW<6;/0#UYH
MZR:>&VC,D\J11CC<[!1^9H,\*SK TJ"9AE8RPW$>H%>/_$K7I?$'P:OY[FV6
MVN[;4EM+F)'WH)(Y=I*M@94\$<=ZV];_ .2_>%_^P7<?^S4 >DT5YI-\0_$!
MT'5->MM"LFTW2;J:"Z$ETRRRK')M)C 4C@8/S'KD8XYUK?Q=K4?B+1;?4])M
M8--UO>+1XYV::(JF\"52H&2HZ*3@]S0!VM%<!)X[U5;*;Q"FE6I\,071@:4W
M#?:619/+:8+MV[0V>"<D#-69?%/B*_\ $FNZ+H6DV,CZ4\6ZXO+AD1P\8<*
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M.Z7<L9::7#C_ &ACCZU[-J4;S:7>11J6=X'50.Y*G%>/GPAK_P#PIGPCH_\
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M$$5[87L=G<?9W+Q.RS1,&0GG!#*>:[?4=0\10K86NBV5@(OL@EEO=1E98@W
M$:A>=QZY/ 'K7GFI>%M<?X<^-=!MO#36L]YJ$5[9V]L$$7EL8?D4@XW*$;=Q
MC/3-=%K>CROXMAN-4\+3>(+,Z9%!91%8WAMYPS;]ZN<+D%/GP>!CVH L7/Q&
MOFT'PQ?V&DQRW.M7#VIMWEP(Y5##[P_AWKR<?=YQ6KI'B35T\6CPYXAMK&*Z
MEL1=V\UF[F.0ABKH-P!R/E/T-<AHGAS6X-/\%V,VDRPOHVL7!N2H41^6?,*N
MF#]P[P!W]JW_ (J";3-(T_Q78JK:AHETKQH3CS4EQ&\8^NY?^^: -WP]XAGU
M[5]>C2WC73].NQ9PS G=+(J@RY[8#$ ?C3/&OB6Y\+Z59W=K9"\EGOH;40EM
MI;><<'U^M3^#=#;P[X3L-.E.ZY6/S+E^I>9SND.>_P Q-8/Q4:X31-%:UC62
MX77+(Q1LVT,V_@$]LGO0!:L/$NNVGBJ+0O$-C8J]Y:R7-G+82.P8QD;XV#@?
M-A@<]*K6OBOQ%;ZOI,.N:;IUK;ZM*T$4,,[//:OL9U$HQALA2#MQ@U3O8-<\
M6>*8M1MM)O=(32]-NXH);W8C/<S*%7:%8_*NW.ZN>L- GMO^$5O+'P+<6EQI
M=U&VIW+QQ?:9V,;(Q5MQ+KN.XDD=1@<' !V^C^.!<>"]4UK5($MKO2'N(;ZW
M1B0LD6> 3ZC:1]:SH/&/B:[U/2M'ATFP34;[2!J+F:1Q';DOC#8R3@$# YR>
MPK%\4Z'<3?$U-"M=ITOQ((;S4H\\H+9LMQV#_NUSW.:[!M,O/^%LQ:J+=OL(
MT-K8S<;1)YZMM^N!F@#GD\=^++CP_K&HP:+I:MH,L\6HB2X?$S19+B' X&W!
MRW<XQQ6S<^+=3U+4++3_  Y;61FET^/49I=0D94CCDX1 %&2QPWL .^:S[/0
MM3C\'?$"S>SD%QJ-[J,EI'QF59(P$(^IK(NO"<=K?Z1J6L^$Y-<M6T2WLY88
MHDEEM9XP?X68<$,1D'@K[T ;3_$&_FM/#_V+28GOM3N[BQFMY)B!!-$&#?,!
MRH9<DXSMZ#/%17OBSQ+%IWBS3;FVTV+6-*L!>13022>5)$RL21D;@Z[#CL3C
MI1;^'[I+SP3-:^'8M*@M;RYGN;6W966W5XG52Q'&3E<XSR?QJ?5M U.]\2^+
MY(;8^5?Z EI;R$@*\N)1M_\ 'A^= %+2?%'B2V\,>$K*4:7)JFKVX:"YNKB3
M88UA1LR'&YI6+=!QU.:[K1+G4[G30VKV,=G>J[(Z12^9&V#@.IZ[6'." 1WK
M@;8SW'@70]+UOP'?WUE:VZ6EW#)'&TT<L<:!9(UW<H?F&X$,/2NF\ V%]IWA
MUX+R*YMXC=2O9VUU+YDL%N3\B,<GD<\9. 0,\4 9?Q%U/Q!8:EX7@T:2VC2Z
MU-(V\R1U+MM<A&VC_5GOWR!6;8S^(U^)'BZ'2+73GNVAL'GENI'$*$1-\JA1
MN)))QTP!SZ5M?$.RU"5O#FHV.GSWXTW5H[F>"WP9#'M8$J"0#R1QFI_#=E>K
MXV\3ZK<64UM;7\5BT'FX!)6)@RG!/*D@&@""P\6ZWKOA'2M2TG2;=;V[EDBN
M#<S$06AC+J[,1\S LF !ZC)KG/%GC+7Y?AMK\]N+2TU/3+U;*[EMIWVE6,>'
MA8#.3YB]>G/M56#PWJ5KH7AJ/5_#]WJ6G6M[J$EYIL2JY+22L879"P#@ GJ>
M-P-0W?A;6G\%>-M&M?#1LGO;F&^LK> 1K%L'DDQC:<;QY;9 &,]"<T >O:<;
M\V$1U-;9;SGS!;,QCZG&"P!Z8_&L?7]0\0P7T-KHME8"(Q-++>ZA*RQ*<@",
M!>2QY.>@ [UK:5?OJ>FQ7<EC=6+29S;W:JLB8)'(!(YQGKT-</XITIY_'2WF
MH^&)O$.G-IZPV406-XH)][%RZN0%R"GSX/ H +CXC7S:#X9OK'28Y;K6;J2S
M:W:7A)5WKPV/N[UZX^[SBK\_B#Q-_:-MH-O;:/\ VRMI]KOI9)9/LT:ERJ*G
M&XEMIZXQ@]:Y;1/#FMV]EX.L)M(DA?1]:N7N60*(O+8R,KIS]SYP!P#[5K^+
MO#=LWC9=<U'PN_B#3Y[%;9HX8DDDMY4=F#;6(^5@Q&1T*B@#KO"^NGQ#H:7L
MEO\ 9[E)9+>X@#;A'+&Y1P#W&1P?0BMFL3PE8K8>'H(UT2#12[-(;&%@PCR3
MC)'&XC&<=_6MN@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKC]>\1Z
MW;^-++PYH]I9.]W8R7/GW1;;"5<#)"G)&#C P<D<@9H ["BN'L/%?B"XT_7;
M)M+LY?$6DW,<#1Q2E+=UD"LLN6.0H4DD<GY>.M49/&OB&UM?$%J8M'O]4TRR
MCU"%[)G,,T19@ZD;B0X"-CDYR.* /1J*Y+6O&+1:%H5WHD<5S<ZY<016B2Y*
MA7&YF8 YPJ D^]9OB/Q?XBT"2]U&>UTF'2K2=4%K-,3=W,65!E0@[1U)"D9X
MYQ0!W275O+<2V\<\3SPA3+&K@L@;.W<.HS@XSUQ3;J]M+"-)+RZAMT=Q&K32
M! S'HH)ZD^E>=12Z_P#\+6\70:#'8"5[:Q>2>^WE$ 1\*%3!).X\YX"GK6'X
MW\0R^)/A[H=W=6ZVU[!XDBM;J%&W*DL;.K8/IQG\: .Y'PVT$7'W[_["+C[2
M-,-V_P!D\S=NSY?3&[G;TSVKKZXK5?$^M3>(=2TS05TE!I<<9G;478&:1UWB
M--I&W"XRQSRPXKHO#NM1>(O#MAK$"&-+N%9=A.2A/5?P.1^% &G17/>+?$-Q
MH5M80Z?;1W&I:E=K:6J2L5C#$$EW(YVJ%)..:R8_%.N:7J]YH^NP:>]T--DU
M"SN+,.L<@3AD96)(()!X/(/:@#MZ*\V@\;^*%T30?$=Y8:6FD:C+;12P(TGG
MH)2%$@.=N,G.W&<$<YKTF@ Z#)ID<L<J[HY%<9QE3FN!\3V__"5?$:P\)WDL
M@T>#3FU*[@C<I]J)D\M$8CG:""<=ZTH/AUHVEZW8ZIX?4Z-- _[^.UXCNH\'
M*.N<=<$'J/Y '7U'-;P7(03PQRA'$B!U!VL#D,,]P>AKA6\5>*-4BUC4]!L]
M+.F:9/+ L=T9/.NS%]\J5.U!D$#(.<<XH;QQJ>JZIH5GX?M+1EUC2VODENRV
M(""OW@IY !(P.^.0* .^HKS.#QCXTO-+UR2#3]&2YT"66*[>1I#'<E!NQ$ <
MK\N.6)Y(J]+XUUC4-4\/V.B6-GG6=)_M 273-BW^X?FV_>&&Q@8))'(&: .^
MHKA[#Q7XAGL=?L'TNSF\1:1/'$8X92EO(L@#)+ECD*%))')^7CK4$'C75;5?
M$5IJ']DW5[INEG4H)K!F,,@P_P C DD$,GKR#VH [^BO/(O&'B:"/PYJNH6.
MF)I.M7$%L(8F?[1"9A\CDD[2,XRN.,XR>M;&@>+7NK;Q NLI#:W6AW,B7(CS
MM,(7>D@!.<,G/X&@#JZ*P_"&JZAKGA6PU74K:*VN+R/SA#'G"HQ)3.>^W!/U
MJKXV\27OAJPTV;3[.*[GO-1ALA%(Q7/F;NA'0Y YY^E '350UG1['7])GTS4
M8?-M9@ RABI!!!!!'(((!!]JYW3O$.O6GBU= \06^GN]S9O=6<VG[U#;" T;
M!SU^8$'(%4K3Q;XBMM;TFVUN#1XH]4F: 6MM*SW%F^QG42')#CY2#C&": -[
M1?!^GZ-J3ZE]IO[Z_,7D+<W]RTSI'G.U<\ $@$]S705QFD>.&E\%:OJ^KPQ6
M]]HTEQ#?01D[1)'G 7/.&&W'UK+/C'Q;+J>B:+!INF+J>I:3]N<S&01V[[QD
M-@DD!3C YW$<@4 >CU!=7MI9"(W=U#!YL@BC\V0+O<]%&>I/I7(-K_B?5M<U
M'3-!BTE!I2QQW4]X)&66=D#%(PI!"@$9)SUZ5R/C+Q!_PD_A;P/J;6_V:9O$
MUO%/!NW>7(C.C#/<9!Q[8H ]=%[:-?-8BZA-VJ>88!(/,"9QNV]<9[U/7FUG
M_P G%:A_V+R_^CEKTF@!&944LS!549))P *9!<0W4$<]O+'-#(H9)(V#*P]0
M1P17!7?B3Q%K">))=)M-..D:7)-9NDQ?S[ET3]X4(^5<9P,@Y([57\-ZAKMK
M\._",.CQ:=%%)IR-/?:BY$46%&U0H8,6;)]AB@#TFBO)-?\ %WB#5?#'AZZT
M][*UN)-?33[O8[E'E2;:-K C,3;"2.I! ]:Z*\\2^(9M8N-(TS^Q([K3K:)[
MV6\9PDLSJ6$<0!! P,[CG&X<4 =S17GJ^/=0UMM"@T1--LY]2L7NRVINQ7<K
M!#$@4C<P;/.>@SBNVTF:^N-+MY=3M$M+UE_?0I('56Z<,.H/4?6@"Y117$ZG
MXEU^;Q3J&C:%'I'FZ?!'*8;Z1A+=EP3B/! 4#&-QSS0!V(NK=KIK59XC<(@=
MH@XWA3P"1UP<'GVJ6O,Y9]=?XL7ZZ1;6D5Y+HELTK7K%HX/WDF5PARS9.."!
MP3GH#J:?XK\0:IX4>XMM-L1J\&HR:?=EY2+: QL0TO)#%< <#G)_&@#M)[B&
MU@DGN)HX88UW/)(P55'J2> *A;4]/1;5FOK8+=D"V)E7$V1D;.?FR#VKSC7/
M$=YK'P_\<Z=J)L9+S3;4JT]@Q,,J/'N4@$D@CD$9/2LC4_\ D%?!O_KK:?\
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M349CNO&P2R1A6&W& ,L#R>F* .RHK@IO&FJZKJ.E66@KI=M+>Z5'J:G4V?\
M>!S@1H%(R1CD\XR.*[/39KNXTVVFO[46EV\8,T <.(WQR PX(SWH M45C^([
MS5K+3XVT:UMIKB294:6ZDVQ6Z<DR/R"0,8P.<D5G^$?$5YK%QJVGZC]B>\TV
M9$:>P8F&570,I&22#U!&3R* .HIDLL<$3RRNL<:*6=W. H'))/84\]#7FOA_
MQAXA\1^!KSQ+?:;I2:5_9MPZP'>SSR(#G()P(SAEP<DXST- 'HMO<P7=NEQ;
M31S0R#*21L&5AZ@C@TL\\-M!)/<2I%#&I9Y)&"JH'4DGH*\\T_QA?R>%O!]M
MHFF:=;ZEKD;F*(JR6UM'&NYSM7G X  (Y/6J7B#Q)K-]HOCGP_J]G:0R:?HI
ME\VV+%9BZO\ ,N>BX X/(.>3UH ]31UD171@R,,JRG((]12UYW8>(_$FD)X6
M.I6>G#2-4>*RCCB9S<0LT9*%B?E.=O( XSU/6G> K_Q)?>*?%0U.XLY+6"_,
M+)'YF481H (P3@)CDCKDDT >A44R7S/)?R=GF[3LW_=SVSCM7E'AOQ?KVD^$
M?$6N:N;:^6+4YX+>"-G#M.9@BH"Q($>2,=P* /6JP]0\*:?JNN6NJ7TMW.;5
MEDAM7G/V=)%Z2>7T+#/4UCP^(/$>D>(-)T_Q)#I;P:JSQ0S6'F+Y,RJ6",')
MW @$ C'(Z5VE !6=K&B6FN16D=WYFVUNXKR/8V/WD9RN?;-<PWB?Q'?>/M5\
M.Z59Z<(-.^S2RW-R7_U<BY90%ZN>W0  YS6?<?$#54LKOQ#%%I1\/VMTT)@:
M1OM<D22>6\J\[1R"0I'('6@#TBBN)N_$?B74M8U>V\,6FFR6^D%8Y6O2^ZYE
M*!RD>W 7 (&3GD]*2\\6:S=:G::5IEM8:?>FP2^O/[58E8-Y*K$ A&6RK9.<
M #OF@#4T_0M%\+7TVIW%_*][?,L'VO4KO>[#)*Q(6Q@9R0HZ^^*Z.O,=<\;B
MX\)>'M2GT>PN+B?78]/G@N5\U+>56D1GC/J"N5/HU=5HOB.XO/%6OZ%?Q0PR
MZ>T<MNR9'FV\BY#')Z@@@]J .DHKSBU^(.J:GI]E)96UA'-J^H7$6FR7+,L:
MVL.<S2<Y)., #&<CFNC\*^(+O5IM3T[4EM1J&FS*DKV;$PRHZAD=<\CC(().
M"IYH Z2BFR,R1.RH78 D(" 6/ISQ7"6'BWQ!;Z]I%IKL.D1IJLCQ"UM)F:>S
M<(S@2')#<*02 ,'UH [VBBN&NO$_B*[\2:OI^AV^D2?V4R*UG=2LMQ=917)0
MY"H/FP"002#G% '<T5PVI^*]<GUK5;/0H])2/2503_VA(P:XE9 _EIM.%PI'
MS'/)Z<56O/'VJ7MUX8M_#MC:2/K]C)<QF[9@L#*%/S%>P!;.!DD <9H [LWM
MH+X6)NH?MAC\T6_F#S"F<;MO7&>,U/7"1ZY)%\5;31[_ $[3/M?]@"ZGU"*(
M^8&$A#(K'GR\@D U3L_'VKR6VG:]<0Z6NA7]U'"D"2-]JACD?9'(QSM/)4E0
M. >IQ0!Z/17#:?XH\1ZQJUXVG6VDRV%GJ+64UF96%VJ*^QI22=H[L%(Y'?-=
MS0 4UW2*-I)&5$499F. !ZDURFJ:_K5SXLD\.^'8K!9;:U6YN[J^#LB;R0B*
MJD$L=I.<X KB?'?B/6-<^$GB$-#9VMSI]RUCJD89VR5=,&(\<,&!^;L2* /6
MK+4++4H3-8WEO=1!BI>"4.H/ID'KR*LUSO@FPN=.\,VT-S;:;;DJK(NGQ%$*
M[%P6!ZMQR?I714 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>=>(;R]L
M/B_I=S9:?)?[-$G\Z"%E$A3SDY3<0"0=O!(XSWXKT6L]]%LW\0Q:X5?[;%;-
M:J=WR^6S!CQZY4<T >:WWAO7=4L];UNYT:;_ (F>K6D\VCF5/-FLX%"[&^;;
MN;&[;GMC-:WAG2;RT\>3Z@OA5=*TF_TY8(XXEA7RBCLW[Y4.-S;N-N[C /?'
MHE5M0LEU&PFLWFN(%E&#);2F.1>?X6'(H \O\ :'<)XWO[.5EETGPK)-;::P
M.?FG.\C/JB$)[;JH:OX1U:\T;Q'IJ^$DN=;N;N>X769S$1)%OW1K&Q.\-M 0
M+@!>N?7U?1-#T_P[IJV&FP&* ,78LQ9G<G+,S'EF/J:T: /.K:77]*\;:[KX
M\,W]QI^I6MFHBBDA\])$1N"I<# W$'!ZXQD9QB:GX*\03^ ["'[!NU2Y\1C5
MKNW213Y"N[L1N) . 5SCOTKV"B@#S/6O#4=IXQUC4[KP3%XD@U-8I+=Q'"S0
M2H@0HWF$84[5.1GOQ7>:':&QT.RMFLK6R=(EWVUH,11,>2J\#C)-:%% '*>-
M])U"\71M4TJW%U>:1?K=?9MX4S1E61U4G@-ALC/'%8\NGZQXG\0W6MS:/<Z=
M;6VD3V5I!=.GG32R\DX5B%4!0.3SFO0Z* /.[SP[JTGPK\-:0EFQO[1M.,\.
M]<IY;(7YS@XP>AKT2BB@#B_%.CZQ:^)]/\6^'[9+VZM[=K.[L6D$9N+=FW#8
MQX#*W//6G6VK>+=>U>Q6#19M!TR&3S+R:^>-Y9U _P!4B*6P">K$CVKLJ* /
M-;6#Q%X7L-=T&S\/7.H"[NKB;3KN&6(1!9B6Q+N8,I4DYP#GM5K0?"-_H7B;
MPRHC\VTT[09+.:X4C;YI=#@#KSACTKT"B@#A=-T+4X--\>126K*^I7MS):#<
MO[U6@55(YXR01SBN<M1JOA_Q1X)B72Y;JZL_#!BN[2)T$@"^4K!<D*2&QQD9
M .#TKUVL^31K.7Q!!K;*_P!MAMWMD.[Y=C,&/'KE10!YK?\ AS7M6M->UN?1
MYE_M/4[.632#*GFS6< "E&(;;N;D[<]L9H?P_JC:EKL]AX1&F66J:!-96T$(
MA0QR .1YJJV S;L#&<<9(YQZU10!PFJZ#J=QX3\%V<5JS7&GW^G2W2;E_=I'
MC>>O./:L+XA:-=3>.=/LM.D58_%,'V'444X810NKF0>_EET_$5ZQ6)IWA73=
M-UNZUE/M,^H7 *F>ZG:4QH3NV)N.$7/84 ;,<:11)'&H5$ 55 P !T%<+\4F
MN4L/#;V<:R7*^(+1HHW;:'8;L GMGIFNUNKRUL8A+=W,-O&75 \KA 68X49/
M<DX [U6U71;/619?;%<_8[N.\AVMC$B9VY]1STH XN>QU[Q1XH?51I=UHT=C
MI5S:VC7;Q^8]S+@;@$9L*NT<YY)K L?#VH6T7A6>R\#&RETBYB;4)/W'VBY;
MRV1F1@WSKEMQ+$$Y&!P:]CHH \E\4:%/<_%&'1;4H=-\0K#>ZI%GE1:MU([!
M_P!VN>Y!KK;C2+Y_BQ8ZPMN3I\>CRV[3;A@2&56"XSGH#VK2T7PKINAWMU?6
M_P!IGO;K ENKN=II"HZ*&8G"CT%;= '!K'K'A+Q5K]S;:#=ZM8ZO)'<PM:21
MAHI0@1D<.RX!V@AAGK7/W_@?74\(^%+1;59[^'Q"FIWZQ.NV(,[NV"2,A=P'
M'7'%>N44 </;:'J2?&J]UUK4C3)-%6V6?<N#)YBG;C.>@/;%=Q16?)KND0VA
MNY-5L4MA,8/.:X0)Y@."F<XW9!&.M '"V]KXC\/MXGT6TT&>]75+V>[LKY)8
MQ"GG#D298,-K9Z Y[5FVGAK4K"'PHVK>%I-:MK/1OLALLQ.+:ZW*=[*[!<%1
MC<,XQ7KE% 'CI\->(K7PI%:C02;G3/$R:H(+9XQ'-#YC.1#R.@;&"!6CJ.@C
M_A)[[7;_ ,!G6XM6MX'2*1+=YK29%VF-][8"D!3E20"#7J!(4$D@ <DGM4%C
MJ%EJEHEWI]W!=VSYV36\@D1L'!PP.#R"* .%U33671M-TW4O %KJ&F?9LM:Z
M;Y9-G<$Y(4,5PIS]Y3G(/K5SP]<ZOX:TGPKHNHV;S2WLL\$DCW(=K50LDL:$
M\[R$7;D''R]:[:HW@BDECE>)&DCSY;E02F1@X/;(H DKSSQSI\VKW-W:77@N
M35&\H?V7J-I)&CPN5_C=F5H\/SD9!'O7H=% '%>'M$UBR\:27VH@RJ=#M+62
MZW B6=&<O[]\YQWKFI_"^K169:\T274;%?$]W?7&G(R$W$#[O+?!8*P#%6VD
M_A7K51W%Q#:6\MQ<S1PP1*7DDD8*J*!DDD\  =Z /)F\-ZT;#QS:V_AD6$>M
M:>C6,%N8E1&5"GEMM8 2'(;@;>3SQS=OO"VM2Z?\,HTL6+Z1);F_&]?W(6-
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M%=5X=\3:A-XFDT'5;S2KZ5[3[9!<Z;E5P&"NC*6;!!92#GD'IQ7*V/A'7I/
M,_AN[T2/S]-U#[=:O/-&\%]B<R;, D@%21\P'7ZUUGA6P*:M-=+X)L/#UNL
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M'(%-M?$WCB^@UZVBCT2.\T*5TFG>*1H[KY ZA%#@H<=22>HQ71:AHUY+\1-
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M749C ;/(&X[L8QCDFO0++5[FY\4ZMI,MHL<-G#;S13B3<91)O!R/X<&,C]:
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M*X)9 3MB52#@$D,3D'@5TE>?_"F*_O?#T_BG55#:GK)1R>G[J- D8^APS?\
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M6_(4LP3#C9_=&0<GVKC]%M?$?B/X/Z1X6BT4BWO8(E;5/M$?E)!O#$[<[]X
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M;F*67</E9RFT8SDYVGH*YC4O!.J7T?B60V$$SOKD&IV=O<,ICNTC1 R-UP&
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M#TF_>.Z;9K%PD#1M;F0MN<']YO"G;C'4#G% &S_PD_B+4/$>JVFDMHV-,NA
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M,J+B%'!:+<,KN';(!I]W?VE@(3=W$<(FE6"+S&QOD;[JCU)]*X*#QK)8Z_\
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M/(!&#CMG% %^BN'O=:\37_CS4?#FD36%I!;V<-S]KN(&E9"Q8%=H9<YP.<\
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MHR22>3G H ]+HJCH\FHR:3;MJT=O'?[2)A;L3&2"1E<\X(P<=LXJ]0 4444
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M34TL=02YGL'D5!.@1EZM\N06#8/'%<AJGA/Q/?VOC"-=%MH!KMA;BWBAG0+
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MDBD8'<VX;.!@ #J,YYP.@GUS6_$/B=M&T*\M]-AM;&&[NKF6W\]RTN=D:J6
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M@D9.3[5"_@O6&^#%_P"&!'%_:<SS%%\P;<-<&0?-_NFKVI:%JNF^*]4U73M
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M3:1 VJ6"V-V!M:!9Q*!CC.X #FLPZ->'XEIKFU/L(T<V9;=\WF&8/C'I@=:
M.5;Q[JVG^'+V'4+G3UU6#7/[&2^E7RX,$!_.==W&$).,XR!2#QW?6ECXFM8]
M;TO6KC3]*;4;2^M%7:<;@4D56(R"%/!Y#5-=^"-5FM]9F2*UDN?^$B75[*&9
MLQSH$5"CG!VY&\=.#BKEUH^NZSX:\1VKZ#IFDM>6#VUI;Q.KRL[*V2\B@*%)
M*X'/0DF@"E/XJ\1:5X2M-8U34-,BFUN6VALDDBV16(D!9GD8M\_RC..!D8Z5
M4N?B!?Z=IGB6WAUO2]:N;#3EO[2^M%7:06*LDBJQ&0<'@\AA71:UX7OK[P9H
M=K!';2:CI#VUPD$Y_=2O&NUHR<' (+#..N*J7?A_6?$?AOQ!8W&C:9H@O+/R
M+6*-A)(7Y):1U  4G:  ">"?:@#7U[7KW3K[PM%!Y>W4[X07&Y<_+Y3MQZ'*
MBN7/B'QEJ&B^)M6L[_3[6'1+V]BBA>T,ANEA8G#'<-HV@#@9)R:N/IOBW7-2
M\+W&H:5:Z?!I-V))T%V)6E_=,I=<   $].2=W;'-W3_#.I6WA#Q;ILB1BXU.
M[U"6V <8*S;MF3VZCZ4 5SXDUOQ'KFEZ7HMS;Z:LND1ZK=7$L'GD>8<)&JY
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M& S<8R,<4OB&]UF[^&7B6YM_%>GZM8_9"T5Y;0J)""K"2)U4[1P5PPY&3D4
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MK0T/[)Y?^A:O;WDN]L?NTSNQZGGI6GINMZ=JT]]!8W'FR6,YM[@;&79(.HY
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MVO >KZCJNC7L>JS)<7FGZC<6$EPD83SO+? ?:. 2,=*72_#$NE^,Y=2B:/\
ML\:1;Z?"FX[P8W8\C&,8([U/X2T*ZT*+65NGB8WNK7-['Y9)Q'(V5!R!SZT
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M&>] 'M-%%>-PZ[XO_P"%6V_CB;Q$YG@PYLA;1"*:,3;#O.W=N(R<J0!QQWH
M]DIKR1Q &1U0,P4;CC)/0?6N(EN=9\3^--:TJRUN?2+'1T@0FVBC>2>:1-^2
M75@%48& .<GFN-US4]:\0:'X:6YU62WO;7Q6NE7+V\*!9)$=MLP# X(V@X^[
MDG(Z8 /:Z*BMHY(;6&*6=IY$0*TK@ R$#EB   3UX&*\RT'7_$4NBZ]XIU+5
MVDLM'FODCL$@0"X$>[:78#(QP !_=R<YH ]2HKR+1O&=P^IZ'&GC!M5GU5O(
MO+46JH+1WC)5XB$'"L N&+9SFM*W\<:E:_"K4KZ]<2^(]/FETQP$ WW>_9&0
MH&.=R-C&.M 'I=4-5UJPT5+5[^8Q+=7,=I"0A;=*YPJ\ XSZGBN,MY?$>M>(
MY/#A\03V0TC3[=[ZZMH8C+<W,H)_B4JJ *3@#O7-:_XAN;GPS8C7+J)I]%\8
MP6EQ=[1&LB1MN$A X7Y6&<<<&@#U#6/"V@^()8I=7TBSO9(AA'GB#,H],^GM
M6G!!%;01P01)%#&H5(T4*J@=  .@KAM(\57^LV.J>,DN!'X;M+>8V=F@4O<^
M6"6ED."5Y4@*,>IKG="\=3M?^'IV\5_VK<:I/'#?:8+54CM_,4X,;!01L;:#
MDG()- 'KQ(52S$ #DD]JHW.M:?:7>G6LUP!+J+LEJ%4L)"%+GD<#Y03DUF>/
M5N&\ ZZUK=R6LL=C-()(U4DA4)*_,#P0,9Z\\8->>+8ZI'I?PQA@U9Y+J=MT
M,\T*?Z.C6?W5"@!MHSC=G)ZYH ]:U/2['6;"2PU*UBNK23!>&5<JV"",CZ@5
M+:VMO8VL5K:01P6\2A8XHE"J@'8 =*\UO/%&L^#I/%MI>:D^K#3]/AO;.6YC
M175I&9-K[  1N /0<9I?#?BUO^$NTK3(O%;>(8M1CE6X#VRQ_9Y43>&0JB_(
M0&&#G''- 'H]]?6NF6,M[?7$=O;0KNDED.%4>I-8$'Q%\&7$R0Q>)M++N<*#
M<*,G\:J_%7_DEWB'_KU/\Q7-:WXQTB\\,C1CX3U:6\U&#[+:176F^2DLI3C#
MO@#'7/7C(H ]6ZC(K,U[Q!IGAG3#J.K7!@M0ZQEPC/\ ,QP!A03UKS[4=8NO
M"]IX5\)ZAX@.D%-,\R]OXXQ)(QC"((T+*P&2222.B^]<[XR\0S:_\']4$]Z+
M]K'68[9+T1^7]ICW*RN5P #AL' QD&@#URY\'^&[S5AJMSH=A+?@AOM#P*6)
M'0DXY(]:VJ\T\3^+@/&5[HTWBEO#UM8VT3JT5NLCW$TF3SN5AL4!>!@DMUJ/
M_A+KK5?"/AV_N_$D.AK=&9+J2"'?<7#QDH/)1E;"D@L>,@$4 >GT5Y*OC/5I
M_"%O<2:M/%:0ZQ-8WNM0V0,BVZ!BDAC*D*6.Q2=O'I5K4_%EUI7AG357Q;:W
M4.I:B8(M;CB1FBMPA=MRJ-ID!4KTQR"1D4 >H45PO@/Q*VJ:OJ^DKK+:S:VJ
M136U\\01RK[@R/A5!*E<Y '#5>\7:GJ(UG0?#VEWAL9M5DF,EVL:NT442;FV
MA@1N)*C)!QSQ0!UE%>;^*;[Q;X/\!ZW=2:M'>2V]Q;_V?=F-!,T;2(KI(NW9
MGD@$#D'/!J?4YO$NERZ)X?\ [?,NIZY>2,]]]F0"UBCCWND28QVP"V>ISF@#
MT&BO-KO6/$WAW4M<T&&\EUJY71FU/39)H4\T,'V,C!  _)5AP#VYIFF:]J4V
MA:S?:!XI'B26&P=TM+BV1+F&Y'3Y%53M//RD9R  >M 'IE%>8:?XM>Q\/ZSK
MEKXM7Q!;V=@\LEK=0)%/#<#[N555*H>001QC@]:@T'QE,GB'1K6+Q4=?;40\
M=W;M;+&()1&75HRJ+A<KMPQ/4&@#U:FNZQHSNP5%!+,QP /4UYMX(UW4=7U*
MT-SXK\S4L-_:FA7=LD+0'!XB&T/\K8Y)8$>];7Q56X/PTUQK>[DMBELY<HJG
MS$P04.0< @]1@^] '8 AE#*001D$=Z6O/=$O=6T/Q)X>TS4-7EO=-U+2G,1F
MBC0I/'M?JBCCRR1S_=S6;X>\?:FNE^)-2UF</&MDVKZ8AC5=MNS2JB< 9^XG
M)Y^>@#T/3] TC2KR[N[#3K:WN;MR]Q-'& \K$Y)8]3R2:T:\TTF[\4:]J=KH
M%QKL]C+8Z3!=:C<P01>=-<2Y(0;E*JJ@'H,FNA\#ZQJ&H6^K:?JLZW%[I.H2
M6;7"H$\] %9'*C@$AN0..* .JHKB]9O-6UCQP/#6G:K+I5O;Z>+VYN((D>61
MF<HB#>" !M))QD\"JVKW>O:3X<L(=<\3V.FRF[:*>_@CW37$0W;/+C*$"1OE
MW  @8.* .NUO6K#P]H]QJNIS&&RMP#+($9MN2%'"@D\D5;@FCN+>.>)MT<BA
MU.,9!&17B_B/7KC6O@SXTAGOWU!;"[2WAO)(?*>6,M"X++@88;B,X&<9K:UC
MQ6MKJ>DZ%-XB?0;1-(BNY+B*%9))78[50;E8 #:2>,G(% 'J5%>41^,M?U/0
M_#8L-2B6[N=:ETR>[^SC9/&JR8E"$<9 5\#'/'3BK=SXBUGP=J?B6RO=4DUB
M*ST4:I:O<Q(CJ^YTV'8%!4E0>G% '?:EJ]EI"VIO9C&+JYCM(?D+;I7.%7@<
M9]3Q5ZO(]>L-?M[+P9>:GKTNHBZUNP>XAE@C18I"V08RB@A1R,'/8\4_QCXM
MO=$NM9O(_%\8N["0-;Z1;6PEB,8"Y2=]A*NWS?Q#'% 'K-%>>W][XCU?XEW?
MA^PUIM.TZ+3H;QG2"-W#%V!5=P_BXR3G&WCKFNQU^'49_#]_'I%R;;4C WV:
M7:K8D RO# C!/'3O0!HT5YS=^-;_ %;X?Z!<:/,+?6];N(K-6V!C!(#^_;:0
M1A0C]1Z5B:QX[G:^\02Q^+?[-N=*N)+>QTW[,KI<&,#)E)0D[VR!M*X'- 'L
M-%><Z[XCDNI-,F?Q9_8-M=Z<EU%;6MN)[EY&YRZE&Q&!@<8R<\UG'Q;XEUFP
M\ "POX[.XUQ;A+N00JPRD?WP&'!&"P'3. <B@#U>BO,=>U74M)UZ'2-3\8W&
MCVZ649M-0DM(BEY<$L'\UV4JN,)\HVYSG->C6!G.GVQNI(9+@Q+YKP_<9L#)
M7V)Z4 6**RO$UU<67AN_N;6^M+&>.(E;J\/[J+_:;Z=AW.*X+1O%ER-7U73K
M3Q'<:S;KHLM_%<W-HL3PRHP7 PBAE.X'H<8ZT >I45Y1'JWBJT\*>&/%EUX@
M>9KR6S2YL/L\8A>.4JI((7<'^8-G.,Y  '%=#H_B:YT[6/%FF^(+KS/[+/V^
MWF**I:S92P' &=A5E)^E ';45SG@6YU>_P#"%EJ&MRE[R]!N=FQ5$4;G*(,
M=%V]><YKHZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N1\3^']9N_%>
MA:_HK6#2Z>D\,L-Z[HK)(%&054\C'2NNHH Y72O#%Y8:7XHM9)H&?5KZZN82
MI.$65%50W'4$<XS67:>$=?T&+0;S2)-.GU"RTF/2[R&Y=TBE5<$,CJI((;=U
M7D-VKOJ* ,_18=4ATQ%UFZAN+]F9I&@3;&N22%7N0!@9/)QDUPTZZVOQ?UJ?
M1/L4DJ:5:K)!>.R(X+R8(902""/0@Y/2O2:KI8VL=]+?);Q+=RHL<DP4;V5<
MX!/<#)_.@#A+?P'JUGI5M>PWMFWB2+59=6=V#"W=Y04>+^\%V$ '&> <5:US
MP[XI\3^"]=TS4[K38KN_5$M8("QAMU4@G+E0S$X/\/'&*[FB@#D/B!X4O?%G
MA./2;*:WBG6XAE+3$A<(<GH"<T:CH6N6/BVY\0>'3I\K7UM'!>6M](\:EHR=
MDBLJMSAB""/QKKZCEGB@56FE2-68("[  L3@#GN3QB@#SYOA_JD6B6]Q;WUH
MWB./6&UEY'5A;R2L"K1\98)L(&>O&:TM'\/>(3X\/B?6IM/4-IK60M;1G81?
MO%<?,RC=G#9/'88XS79T4 <WX[\/7?B?PK-IUA-#%=^;%-$T^=A9'5L-C) .
M.U9L^A^*(M=MO$MDNDG5);+['?V<DT@@=0Y9&20(6R,D<KSFNVHH YWPEX?N
MM%BU&ZU*>&?4]3NVNKEH 1&AP%5$SR555 R>3S5;7]!UC_A)[3Q)X?>R:]CM
M6LKBWO698Y8BP<$,H)5@V>QSGM6YK6L66@:1<:IJ$C1VL !D95+$9(4<#W(J
M_0!PEQX3\23VVF:I+JMI/XCL+V6[C$@86P212K0 @;@NW&&P3D=*9-X/UO6?
M^$AU'5Y;"+4]0TE]+M(;9W:*",ACEG*@L2S G"\ =Z[ZB@#D]3\+7E[HGA:R
MCF@$FDWMI<3%B<.L2X8+QU/;.*S]7\.>*=<9=-U"71YM.2^2YCU##"ZC19 X
M54"[0V!LW!NG.,UWE5-3U.ST;3+C4=0G6"TMT+RR-DA1^')^@H Y"#P'/)X@
M\<7-[<0FQ\1P101B,DR1A8F1BP( _BR,$UGR^$?&>I:9H6F:C=Z.EMH]Y:SB
M2!I"]TL+#[P*X0[03@9RV.0*Z>T\;:3?6=C=0Q:AY-[<BVA+V,JY8@$,05X3
M!'S=/>M]9XFG>!94,R*&>,,-R@YP2.P.#^1H XQM!\5Z1?:O%X=N-*%CJ=RU
MV)KO?YMI(X <JH4K(,C< 2.3SD5I0>';N+XB2>(GGB>V?2$L=O(D,BRERQ&,
M8P?7\*Z6B@#%TV\U*;Q1KEK<^4=/MQ;FT9$(8%D)D5B>"<@'CLPJMXN\/77B
M Z%]FEAC_L_5X+^7S21N2/=D+@'GGOQ[UJ#6+(Z^=$\QOMPM1=E-IQY98IG/
M3J.E7Z .7U[1=7_X2*S\0Z UDUY%;/9SV]Z[)'+$S!AAE!*LK#T.03TK/U_P
MSXDUWPI:17%]I\FMVVHQ:@@*LEN-C[A%D#=@#C<1DUW%% '#S:)XLM_%"^(=
M/&C-<7=A':7UO/+*$C=&9@\;!<L/F(P0*SXOA[JZ:#;6,M_:37$7B4:Q),=R
MAX_,+D8QPYSTZ>]>D5@3>,-)MM*U+4IS<Q6NG7'V>=I+=U.[<%^4$?,,L.1Q
M0 FJ:%<WWC/P_K,<D2V^G1W22HQ.YC*JA=O&.-ISDBC2="N;#QCXBUB22)H-
M3%J(D4G<OE(RMNXQR3Q@FN@HH Y7Q)HFL3^(](UW1?L$MQ913P/!?.Z(5DV_
M,K*K$,-GIR">E<_'X#\0;9H;F]L)TD\06VM&8%U8E=AE3;M( &SY>3P><5Z0
M[B.-G;[J@D_2JFD:M::YI%KJE@[/:W*"2)F4J2#['I0!BZOX7DU;Q=;:E))'
M]A73+FQFCR=Y\TKR.,8PI[URL_@GQG>>#[3PM/>Z.+*P>#RKA&D\RXCB=2JN
MNW"?*.Q;) Z<FO0;'6+74-0O[*%9Q+8LJ2F2%D4E@2-K$8;IVK0H *X#_A!=
M1_X4Y_PAWVBU^W^5L\W<WE9\W?UQGI[5WLLL<,3RRNL<:*69V. H'4D]A7.:
M?\0/"FJ:C%86>MVTMQ*VV)?F42'T5B &/T)H I7>@^(-+\4ZCK7APZ;.NJ11
M+=6]_(\>R2,%5=616R-N 5('3K67=?#[5(_"FF6]E>6DVLVNM+K4TEP&2&>;
M<S,O )4?-@<'I[UZ-10!#:&Y-G";Q8ENB@\U86)0/CG:2 2,],@5RV@^#9+/
MPEK.A:E+$Z:E<7;LT))Q',3CJ!R :ZN2>*%HUEE1#(VQ S ;FP3@>IP"<>U4
MXM8MIM<GTA5G^TP1"9V,+"/:>F'Q@GGH#0!A:#8^,K:73[/4KK2ET^R39)+;
M;VEO %VKN5E C[,<$\C P*SKSP!=7/Q$36%NH!H;W$5_<6ASO:[B1D1AQC;R
MI//5:[ZB@#D-2T+7+'Q;<>(/#IT^5KVV2WO+6^D>-28R=DBLJMR Q!!'XUD3
M?#J]N- M;:XNK.>]EU^/6=19E(B?YLLB#!)&T!1GKCG%>C54U+4[+1].FU#4
M;F.VM(1F260X"C./YD4 <PO@R:T\0:I]BEA7P_K<$@U"R8D-',R[3)%@$?,#
M\P..>>>E+H&F>,M/&F:;>7FE#3-/41M<0!VGNT5=J!E9=L?8D@GD<8S727FK
MV&GZ/+JUU<I'81Q><TQZ;,9S[Y[#O5>R\0V%_J::=$9DNVLTOO*EB*$1,Q4$
MYZ'(/'44 2Z[IQUCP]J6F+((S>6LMN'(SMWJ5S^M<CI7A/Q"(_" U1],1M D
M96^S22-YL7V<Q*?F4?-DY(Z8[UUVJZW8Z*;0W\C11W4ZVZ2[245V^Z&/\.3P
M">,UH4 <7K7@>37-9\033W,<=IJFEQ6497)DCD1G8.1C& 64]>U:&C1>,6U"
M%M<GTJ*TAB*LEEO=KESC#-O4; .3@9Y/6NDHH P?&FB7'B3P;JFCVDD4<]W#
MY:/*2%!R#S@$]O2F>)/#*^(?"9TII?)NHU1[6Y7K!.G*.#UX(_(FGOXOTJ+0
MM1UF8W,5EI\C13M);NK KC)4$98<CD<&G7/BW2+0:(9IW']M.J66(R=Y8 C/
MIP1UH RKW1/$C7.C:]:OIK:[:6KVMY#([K!<(^TG:P7<I#("/E[D>]4?%7A'
MQ)XL\!RZ5?7VG_VG+=I<94,L,2*P(C4[=S8 ZD<D]J[74]1MM(TNZU*\8I;6
ML332L%)(51DG Z\"I;:>.ZM8KB(DQRH'0D8R",B@#E]1T77['Q/=ZWX<.FR_
M;[>.&ZM[]W0!X]VR1616SPQ!7 Z#FJMWX>\41:MHVM6UUIE_J=M8R6=U]K#0
MQG>RMOCV*<$%<8[CO7;T4 >?Z5X<\9Z!%>BRO]*NFEU%[UA/O07(E7YU;"DQ
M[6 *[=V1P:BB\":O';/J44NFVVN#5O[4A@A#?94/E")HR<!OF7)+ =3TKT6B
M@#&T*/Q#NNI]?ELE,C*(+6SRR0J!R2[ %B2?0 8XJEXJT#4-1O-(U?1IK:/5
M=*E=XENMWE2I(NUT8KDC(P00#@CI6M-K%M!K=MI+K.;FYC:1&6%C& O7+XP#
MQT)J;4M0M])TN[U&[8I;6L+32L 20J@DG Z\"@#B=9\)^*/$?A+6;/5-1LA?
M:A/ \%O&S?9[5(W1B Q7<Q;:23CKCI6YXK\/WNJS:5J>DS01:KI5PTT N<^5
M(K*4=&(Y (/4 XQTK?MKB.\M(;F$DQ3(LB$C&01D54TK6+;68[E[59U%O<-;
MOYT+1DLN,XW 9'/4<&@#F(/#?B2YU34_$%Y>V%EK4MB+*Q6U#316Z!MY+%P"
MQ9L9X& .*C3PYXIO=:GURYET?2]333WM+=[$-,'9F5MTI=5RHV8"X.-QYKNZ
MCFGBMH6FGE2*)?O.[!0/J30!P<W@O5O$NH7EUXC32[,S:7-IW_$M9W:3S"IW
MNS*O"[1M7GJ>:U=(M/&OGVT.JWFE0VEO"R-)9AI)+I]N%8AU CQ][ )R>.E;
MAUBR&OKHAD;[<UJ;L)M./+#A"<].I'%7Z .&A\.^)]2UO1+G7VT;;I$IE%[:
M;_/N3L9,%2H$:G=E@"1D#%=!XLT63Q%X3U31XI5BDO+=HD=APK$<9]LULUE:
MOXBT[1+O3;6^E9)=2N!;6P5"VYSV..GU- '(Z]X1\3:_X)T^T:?3+/7["3]S
M-#)(T6PQM$W)7=DJQ.,=0*7Q+\.IM4/AZWTZX@@L;*!+&^23.9K57B<*N ><
MQ=_[QKT*HS/$)U@,J"9E+B/<-Q4$ G'7&2.?<4 <KJNA:W:>+7\1>'C82R7-
MHMK=VMZ[QJVQB4=756((W$$$8Q5WPCX?N="LKV2_N(I]2U&\>]NGA!$8=L *
MF>=H"@#-=#10!R6N:#K4?BJ+Q)X=>Q>Z:S^Q7-M?,Z)(@;>K!E!(8$GMR#6=
M-X7\5++H>K_;[#4=9L9;IYH[HO'!MG &V,JI(";0!D<@GIFN^HH \PU'X?\
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M6FRH@M!;B0KL;"%]Q49W9ZFM%/#?B?4=2T;^WKW2I[?2;D7"7=O$RW-PP5E
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ME \@;A< DX!/)IFD^&_%6B10:+8:GIT6AP7&^.<Q,UT(=^_R<'Y.Y7=Z=LT
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M""#[C(Y'<9%<G?\ AWQGXDL5T?7[[1(]+9T-S)91R^=.J,&V@-\J9(&3S[4
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MJJ/0 <"I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/TUIFL;&VM3.^^4P1*GF-ZM@<GW-6Z** "BBB@ HHHH **** "BBB@ HHHH
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M9W+C;\H&!R3@YJQI'BG3[>"]DO\ Q,FH(VKM81O]D,(@D.-L!P.<?WSP<]:
M.NHJCJ&KV&E26<=[<")[R=;:W7:29)#D@  'T//05FQ^-O#DVM?V1'J:&\,I
M@ \M]AE'5!)C86_V0<T =!117FWB?XBZAH_BN6&RM;>70M*:W36;AU8O$9F(
M&T@X^4;2>#U[4 >DT55O]2LM+TZ;4+ZYCM[2%=[S.V% _P _G7,ZAXXTV_\
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M?I7B+Q-?HLMQN5Y?+P9'\QE551!R< < 9XKHK3Q5H=]HUQJ\.HQ"QMBPN))
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !56[U.PT\H+V^MK8OG:)I53=CTR>:M5Y=\0I-,B^(_A
M=M7TJ34[3['=YMDLS=$GY,'8 >GKVH ]#MM9TN]F$-KJ5G/*1D)%.K,?P!J]
M7$>&)/"UUJK#1O"<NDWJ0LRW4NB&U ' (#E1SSTSR,UG?\)QKN?^$7^S0?\
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ML(I=A\YE5C]W<00&QD4 >H45@>%[C5;BWG:_U+3=4MLJ;2_L5V"52/F#*&8
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MLAG!\R3C=[;5R<^PKG_"NGP_#SQXOAF%_P#B5:Q9I-:$G@74*!91]64!S[T
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M&[@-Z5T.@Z9X@F^(-YXCU:QAL[>?3$M8H4G$C1E9"VUB."3DG(XYQSBNVHH
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M',\:'*J64'C/;FN5M/#GB"Q\>>-=<LTM5_M&WMUT]YVW(TD<84AU!R!D5WH
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M$4<A1F:8ME6.&(P,# ZU3M_#OBL6/A>(:-IEI'H%Q$S0176?M6(VC:0': F
MV<').3G&.;=GHWC3P_97?A[0XK$64MW)-::K)/\ -:Q2.796A*G>PRP'.#D9
MQ0!2T^ZU6P^)WC74+K5%>RTVSMYI8!;#+Q>7*ZH&W?*5R>>=WM4>C?$"[:\T
M"XN?$VB:A_:\Z03Z5:[/,LS("4VD,6;:V%;<._:MJ7PSJP\;Z_*;6&XT;Q!9
M16T]Q]H"26^R-T/R;?FSN[$4OAS2_$MB=*TRZT;1H;>P"I/J2OO:Y1%PI1-H
M*,3M))/&#UH PM3U7Q-XD\">*-=@OK6/2Q%>P0Z>;;)>! R,YDSD.<,0,8X
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M8N]"E\2:9X@CGTV6YCN;)45HG3 9&",1@A@0>O!ZURVA>(;[PS^SQX<OM/\
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MTV]U 323ZJ<&!8H\8**Y W/N3@D@?-UP*S6^(.J_V!,MA>Z=J=_::W;:>+N
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M$BB0(B#HJ@8 _*I* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV&TMF+$E75)%)88X&7'3/>NWHH P_"4.K6OANSL]9M;:WNK6-( +><RJZJH
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M_$&CZE#.(5@\RWOE_P"?BV<!C'[@LJCZ,U)X<\)OH/B#6[[SP]K=3M+90?\
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MVIN#9P&[$8N?+7SA$24#X^;;GG&<XS4U !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% %#^P]*.L_VP=.M3J6S9]K,0,@7&
M,!NO2K]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 53U/2;#6K(V>I6D5U;E@WER+D9!R#[$5<HH BMK6
M"SMUM[:%(HDSM1!@#)R?UYJ6BB@ K'U3PIH&MW276I:1:7-R@VB9XQOQZ;NI
M'M6Q10!#:VEM8VL=M:016\$8PD42!54>P'2IJ** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+9Y.:ZS0[66RT#3;2=0LT%K%'( <X95 //U% %^BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>employementagreement_mil013.jpg
<TEXT>
begin 644 employementagreement_mil013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M\0RV=R@N$REK$AEE+$D! %')X^@[G'-6M#N-9N_M=SJMHEE$\@^R6I96EC0
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MA^[N-2L88O"UOIUU;:M]LEU6 QB-X@Y9L$-YA:13M*D8Y/. * .DLO%5O?\
MBRXT*"UN/]'MVE:YD0HC,KA"J9'S8)Y8<9&!GG&<GC#5+NQ?6--\./>:*K-M
ME6YQ<3(IP7CAVG<."0"P)'0<BM)]-N6\=KJ/E?Z'_9;6YDW#[YE#8QG/0=>E
M8&E_\)1X=\-Q^&K+07N+FU0V]GJ)GB%L8P<))("V\$#&5"G)'!YH W=>\66V
MB7NDV?D27%QJ-S%$$7Y?*1W"^8^1P 6 QU)^AQT%>>:]X+\03W@O;/65FFGU
M*UGE#6B9B2-AC!+?=3EMO<D]R:]"&0H!.3CDT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4KK2-,OKJ&ZN].M+BXA_U4LT"NZ=_E)&1^%7:* "BB
MB@ HHHH **** "F0PQ6T"001)%%&H5(T4*J@=  .@I]% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %<!\1=3OK#Q#X(BL[R>WCNM82*=(I"HE3CY6 ZCV-=_7G?Q)M+FY
M\2>!'@MY94AUI'E:-"P1>.3CH/<T 9?BS7->T;XG3W]C<W$VEZ7IL%Q>Z<K$
MK)"TCK(ZKTWJ &^BFNB\2ZS))K7@B73;Y_L5_?'<87(6>,PLPSCJ.AYI]M:R
MM\7]5FDMW-L^BP1[V0[&/FOE<]"<'I7&R:-JGA[X@^'/#\5I<3Z%#J3WVGW"
MH66WC:-P\+'MM8@KGLU 'LM<-X/U6YL]<\8:+JU[+-_9UY]KAEG<L5MI5WJ
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M\^;O8G"A""">><8SFN8UZ#3/^$U;7=5EUNWTG4]-@^SW-@]Q'MD0L3'(L7S
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M.&1<\,>HQ4W@V2WA\5P6OA>ZUF;0#:R&[MK^.7RK-P5\M8VE 8$Y<%02,#-
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M **** "BBB@"O8V-OIME%9VD?EP1#"KN+'KDY)Y)R2<FK%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 07UHE_87%I))+&D\;1EX7*.H(QE6'(/H:Y>P\$W*
M:GIUWK'B*]U:/3"6LH9HHT"N5*[W*C+L%) )]<UU]% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5C>+-!C\3>%=1T=R%-S"1&_]R0<HWX, ?PK9K*U_2;K6=/^
MR6VKW>F!F_>RVJH7=,$%06!V]>HY&* //_!%OJ'C;1]=\0:E'Y-Y?V']CV^[
M^!40B1@1V:9G/_ 157PKI&AL_A^QF\/>(6UJT>(W*SS70@M9(AGS,LWELNY?
ME"YR".*]2TG2K/1-)M=,L(A%:VT8CC3.>!ZGN3U)]35V@#PC5+2:_P##]VUY
MI6O7OBF&_P#.NW=9S%#$EP&'EC_5L-@&U5!/)/:N_P#"L,S?$?QGJ!MKB.UO
M(].:"66%D$@$+9QN Y&0".H/6NXHH P?&T$MSX#\0001/+-)IUPB1QJ69F,;
M   =37GGB32=1F^#7@RSBT^Z>Z@FL#+"L+%XPJ?-N7&1COGI7L-% '%V5G<K
M\8]5O&MI1;/H\$:SE#L9A(Q*ANF>G%<UJXB&OS7&@Z;KNE>*FOU#Q0Q2FTNT
M\P R2''E%"F3G(8'W%>LT4 <!X;EDTWXG>++.ZL[Q#J,T$]K-]G<PNBP@,?,
M VC!&.3UXJ;X@,XO]!6\74FT!I9O[0&GK*6+;!Y0;ROGV9W=.^,UW-% 'A5Q
M87L&@^)+&P\/ZG'))K-E?6=K)%(Q>',6"7;//RG<"<KSGI777LY\:^.-"^PV
M6H06NF0W;W<]U:20!'EB\M8QO W-R2<9''6O1Z* /'/M-]_PJK_A O['U'_A
M(?(_L[R_LC^3C=M\WS<;-FWYLY_"M3QU9ZOX;U"PUSP_97-[<S:=+H\RV\99
M@Q7=!(0.@#@Y)Z UZ?10!Y;K_@VWT;1O!L<EK>W6FZ-OAO18-(LH$D>#*/+(
M<C>,D#G#'BNB\"V.D1-J=[I&EZG:13R)']HU"28O=! <,%E)95!8@9 S7844
M >8?$W3=5&KVUSH]I<3OK%C)HERT,981*\B%9&QT !EY/3-5M;\/WB^/K?0K
M2PG.AZG-97EQ,L9,48ME<,C'H"WEP"O6** .+T&SN8OBIXONI+:5+>:WL1%,
MR$(Y5'W!3T..,XKF].T?4GN/BQ&+&X#7X9;3=&5$Y,,@&PG[W) X]:]8HH \
M>N;R2?P1X"O(]-U0IHE_:)?QFQE$D>R$JS!-N64$@9 (IU]I^DVWBC6]0UG3
M/$,T6J>5>:>UA]K7S<Q*IB98B-K@K_&!P?:O7Z* //M'T=M/\=^'_LNE3V5A
M!X=DB\MB9! QEC/EE^06'/?M3]*NKCP[>>.M5GTO4+B/^THY(HK: M).OE1K
MF,'&[G/3T-=]10 =J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** ..\9Z_JEMJFC^&] :*+5=6:0_:I4WK:PH,N^WN>< 'C-5;K
MP]XUTF)+W2/%<VJW*,IDLM2AB6*<9Y 9%!C.,D=:B\=+<Z)XL\/>,4M9KFQL
M5FM=06%"[QQ2 8D ')"D<^U6+[XI^'VM43P_,-=U2? MK"SSN<G^\<?(HZDM
MTH U/&_B*7PUX0NK^%,ZA(%@LXAR7N'^5 /7!.?H#67X#UC6!?ZOX9\2W@NM
M7TYTE6XV*GGP2*"K   <'<I_"L7Q!#J7CCXCVNE:;?1V$7AN)+RXF:$7""[D
M^XFTD E5R0>QSQ5;Q%8:[X-\2Z1XWU77(M2MX773[[R[$6^RVD/WF(8Y"N0?
MK0!IPMXB\1?$/Q7IL'BB\TVSTLVH@B@MX7'[R+<V2Z$]1^M6+&_U_0_']KX8
MU#6SK%MJ-E+/%,]ND<UJR=SL #*>V1U^G.1IWAC3?$GQ6\=-?-=_N6L=GV:\
ME@^]!SG8PST'6K/@K3K/P=X^U30+V+?>WRFYTW4IV+RW%O\ Q0EF)^9".@ZC
MGM0!5\:0>+?#$&C20>.-0F-_JT%@XDM+<;5DW9883J,5N:W;:_X5\&>(-3;Q
M5>:A<16+O;F:WA7RG SN&U1G\<BH/BW_ ,>7A/\ [&:R_P#9ZVOB3_R37Q'_
M ->$O_H- &5I/A[Q/J&C6-Z_C[4T>XMXY646=M@%E!Q]SWIWBK4=2T2/PWHK
M^(6M%OYWANM:EBC#C:A95&1L5G/ ..U<;HZ_!7^Q+#[;_8WVO[-'YV\OG?M&
M[/OG-=IJGB7PC#H&D07-I!=>$[Q&@2\,?F6T'E_*BL"#@'! /8K0!J:%I>OZ
M9J[B?76U?198-R/=!!/'+GL44!D(SUY! K#^'GB+5M:\6>.+/4;PSV^G:CY-
MHA11Y2;I!C( )^Z.N>E9WA--#MOB%%!X%N7ET5K25M3BAE:2UCDROE%2<@.?
MFR >@JG\.;^WTKQ/\4M0NWV6]MJ332MZ*K3$_P J -3Q[XA\2/KLFD^$KD13
MZ58/J5\?+5_,Y&R'D'!8!CQSTKI;OQ&NH?#6\\1Z5+L+Z7+=0/P3&XC)&<\9
M!&/J*XSP3X>\6:C977BJ+Q##IEQX@E^UR6\FG+.RQ\B)=Q<<!,8&.]4]+2Y\
M*Z#XX\"W]PLQ@TRXU"PE6/RUDADC;>%7)P%?/&>YH Z?X:^*=2U2S_LCQ%('
MUF.WCO(YMH475M* RR # R"=K8Z$#UK4\"ZM?:O:ZX]].9FMM:N[:(E0-L2/
MA5X'8=^M8%QHUY-X \*^(M%3=K>CZ?!-"@_Y>8C$OF0GV8=/<"K'P@OXM5\.
MZQJ, 80W>MW<\888(5F##/O@T 7_ !9I.OI;ZIJ]AXNOK**&W>:.TCMH&12B
M9QEE+<D9Z]ZS? EGXDUG0=%U^^\8WTHN(TGEM/LL 1AW7(3./QS77>*/^12U
MK_KPG_\ 1;5D?"__ ))CX=_Z\DH K^"-?O=3U;Q;!J-X)$L=7DM[96"KLC &
M%X S]31JNO7T/Q5\.Z/;W8_L^ZL[F2>%0I#LH^4YQD8]C7+>#_!_A[Q'XD\;
M7&L:3;7LT6N2HCRKDJN <?F:G;PUHOAOXU^%XM&TZ"R2:QNVD6(8W$+P30!9
MT)/$WBK5O$SCQA>V$%AK$UG#!#:P, B[2.60G^+'X5O7=IK7AKPAXBO9O$EU
MJ5S'82RV[SP1)Y#I&Y! 50#DXZYZ5YOI8^')\2>+_P#A,?[.^W?V[<>5]I+;
MO+^7&,=L[JZQ;KP/_P *_P#%MGX-ELMHTRXEGCM2>IB8 G/TH L>']%\5:SX
M7TO53X\U&*>\LXK@K]BMF16= V,;,D<^M;'P\\0WWB/PW+-J1ADN[2\FLWGA
M&(Y_+;'F*.P/\\UQ=I\-+75_A5ITVF7-_#JLVF031[K^8Q.^Q6*%"VT*W(X
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M4 %%%% !1110 44C.J#+,%'N<4H((R.10 444$X&3TH **0,IQA@<].>M+0
M444F0"!D9/04 +12 @YP0<=:6@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0+R;4-!L[FY*FX:/;,5& 74[6(';D&M*@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17%^--
M=URP\0^&M&T.:R@DU:2X1Y;J%I OEH'& &'N*KIK_BG0?%NBZ1K[Z7?VVKM)
M'%-91/%)$Z+NRRLS KCTZ?S .\HJAI6LZ?K4,\NGW F6WG>VE^5E*2(<,I#
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M)NFY2>A]Q0!8HKEFO?'(8[="T(KG@G5)1Q_WXI/MWCO_ * .@_\ @UE_^,4
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M - '0?\ P:R__&*/MWCO_H Z#_X-9?\ XQ0!U5%<K]N\=_\ 0!T'_P &LO\
M\8H^W>._^@#H/_@UE_\ C% '545ROV[QW_T =!_\&LO_ ,8H^W>._P#H Z#_
M .#67_XQ0!U5%<K]N\=_] '0?_!K+_\ &*N:7=>*I;Y5U72M*M[3!W26U^\K
M@XXPIB4?K0!O4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGU".X6WDCAMG?RR0IW,0,*GS+\QX_(T =)1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]F*S"J /)MSP.YND.:]@M+*TL+<6]G:PV\(Y$<,81?R'%'V&T^R"T^RP?9@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(Z6$ZPP0$C.Q8]I! Z9.<XJEXINO%6@?#V'^TM4C?4DU2"%;RTRAFA,H +C
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"TEG87T*:LT*Q_:F4HN[@.P R5)&['7!(ZUL44 <#+\.)M3URRU/6]:DO##
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BL#4_#EWJ-^]S%XGUJQ1@ (
M+5H1&N!CC=&QYZ]:I_\ "'7_ /T.WB3_ +[MO_C- '5$!E*L 01@@]ZXJTEO
M_ [/836-S?:!O+6MQ:H9)+52<^6Z#DJ.Q':K3^$;V-"[^./$2J!DLSVP _\
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MC<V !D]> * ):*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** /*_C!!J=YJ?A:TTFYF@O'DNI(?*<C?)'#YB ^N64#\:
MZ&]\<QGX7#Q39KNGN;91;0CDFY<[%3'?#G!^AIWBG3KR[\=>"[NWMI)+>TN+
MIKB15RL0:$@%CVR>*YVP\(:K%\0QIDENP\*V=[)K=NY^Z9G4!8AZ;7,CX^E
M&5X2=] ^&/CB+5T.L?V=?SQ317,I(FVQQ[ADYP"<U;\27$5W<?":Y@MDMH9K
MF*1($.5B4QH0H/H!Q^%3R:#JQ\$?$FU&GW'VB_U.ZEM(]AS,C*@4J.X.#^5.
MU'0=5EM_A8$T^X8Z<\!O $/[C$2 [O3D$4 =%/XIU[4-7U6T\-:19W<&E2"&
MXEN[IHO.EVAC'& C<@$#+8&3^-5XO'UUK<.AIX<L+9[O5;66ZQJ%P8DB6-E1
MTRJL6;<2, =B:K65S?\ @K6O$D$FA:GJ$&HWS:A9S6,/FJY=%#1N<_(0R]3Q
M@UE0^'H])\&Z%HOB?PK=:K&D<L[W&G@RRVEP\A<H F& PV-RG&5Y]: /2M'N
M[N^TJ"XO[!K"[;(EMF</L8$CAAU!QD'T(Z5Y(NJ7NB_&K5]5DN9CI1O[?3+J
M-G)2,30*8WQT&'7!/^U7HW@:#4[;PG:Q:K]I\\/+Y:W;[IEAWMY0D/=@FW-<
MT/",^M:E\1;*]MY(;;57M_LL[K@,RPC#J>^UP/RH I?&?4KN?3!H.G3R0R+:
M3ZG>21,59(8E.P9']Z0J/^ FK]YJUI:7OPXM[O2HKVYO4Q#=2N0]LPB0EEXY
M)S^E9%EH/B+4_ 'BW5M;L)AX@U.Q^QQ6V,N$BCV@ ?[;[VQ[BM#6-$U.;6OA
ME+%8SO'I^[[6P3B#]T@^;TY!'X4 'AQ@OQD^(;,H8"WLR5/?]STK#&I6>K_#
M;P'?6&EPZ7;2>)K;9:0MN6/$\@.#@=2"?QKIM&TJ_M?B=X[U&>TFCLKNWM1;
MSLN%D*Q8;:>^#7$>'M#N/$'P-\%V,%O<31_VXC7'D$AHX?/E#OD<C /7M0!Z
MA;>,TO;[5)[:W5M TN)S<ZF7XDD0$LL2X^8*!RV<9X&:RH_'6N6^G:=K^J:%
M:V^@7\D2JR79:XMTE($<DB[ N#E<@'(SWJK:^&]2TB#6O T4,TGA_4;.?^S+
MO!869=2&AD/7 )RI/TY-4KLZSXB\%Z7X-;P]J5I>JUK#?7$T06WB2%E+NLF<
M/G9P!SS0!VGA_P 3_P!JW.O6M[ EG<:/=M#*N_<&BVADEZ# 9<G'M7(2^,X=
M87P5J5_X=@<ZIJ;I8M)*=UN@.%E''4@9Q].:/B!H6NCQ!-+X?M99$\16(TR^
MDC'%N1(H$S^WEO(OX"KOC#P[<#6/ $.E6,LEEI=^HD,:Y$,2JH!;T&!0!?O?
M%VNW&H:LOAW0[>_M-'D\JY:6Y,<D\H4,T<*A3D@$#DC).*Z^SN/M=E!<^3+#
MYT:R>5,NUTR,X8=B.A%>?6]WJ_@O4O$MK%X>U'4O[1OGO]/FM8@\;/(B@I(V
M1Y>&7J>QKT"Q:Z:PMVODC2[,2F=8B2BOCY@I/;.: )Z*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@#.US23K>F26/]H7MB'^]-9N$DQW&2#P?I3?#V@V/AC0K71M-
M1DM+92$#MN8Y)))/J22?QK3HH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HIDTR6\$DTIQ'&I=CC. !DUS^G^.=!U
M+2I=5BN9XM.C0.;NYM988F!.!M9U ;GC S0!T=%8MMXLT6]TV[O[.\^TPV8_
M?K#$[2)QD9C W<CIQS6O%*LT*2IG:ZAAN!!P>>0>10 ^BBB@ HIDLT4 4RRI
M&&8(I=@,L3@ >Y/:GT %%%% !15#5]:T[0;(7FJ7<=K;EQ&)),X+'H*K:/XJ
MT+7YI(=*U2VNIHUW/$C?.%]=IYQ[T ;%%%% !113))HH=GFRI'O8(NY@-S'H
M!ZGVH ?114%Y>6^GV4]Y=RK#;0(9)9&Z(H&23^% $]%<U;?$'PI>7,-M;ZW;
MR33.L<: -EF)P!T]372T %%%5-4U.TT;2[G4KZ0Q6EM&9)7"EMJCJ<#DT 6Z
M*BMKB*[M8;F%MT4R"1&QC*D9!J6@ HHHH **** "BF0S17$0EAE22,Y 9&!!
MP<'D>]5;S5]/T^]L[.[O(H;F]9DMHW;!E(&2!^8_.@"[1110 4444 %%%% !
M112,RHI9F"J!DDG  H 6BL#6?&>BZ#Y+7\ERL$P0I<QVDLD)WG"CS%4KD^F>
MX]:WZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4M.MM6TJZTV[0M:W4+0RJIVDJPP1D=.#0!S^@R^,#!IXNK30ELO+3>T5U,9
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M:0N1DH< GL.P[5[!7FGC+PKJ3^%+;PMH&F7UY;QSP3+=7%Y&RQJC@[/G?=P
M, #%>ET %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
( !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>employementagreement_mil014.jpg
<TEXT>
begin 644 employementagreement_mil014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M\0RV=R@N$REK$AEE+$D! %')X^@[G'-6M#N-9N_M=SJMHEE$\@^R6I96EC0
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MA^[N-2L88O"UOIUU;:M]LEU6 QB-X@Y9L$-YA:13M*D8Y/. * .DLO%5O?\
MBRXT*"UN/]'MVE:YD0HC,KA"J9'S8)Y8<9&!GG&<GC#5+NQ?6--\./>:*K-M
ME6YQ<3(IP7CAVG<."0"P)'0<BM)]-N6\=KJ/E?Z'_9;6YDW#[YE#8QG/0=>E
M8&E_\)1X=\-Q^&K+07N+FU0V]GJ)GB%L8P<))("V\$#&5"G)'!YH W=>\66V
MB7NDV?D27%QJ-S%$$7Y?*1W"^8^1P 6 QU)^AQT%>>:]X+\03W@O;/65FFGU
M*UGE#6B9B2-AC!+?=3EMO<D]R:]"&0H!.3CDT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4KK2-,OKJ&ZN].M+BXA_U4LT"NZ=_E)&1^%7:* "BB
MB@ HHHH **** "F0PQ6T"001)%%&H5(T4*J@=  .@I]% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %)M&[=@9Z9I:* "BBB@ HHHH ****
M "BBB@ HHHH *0J&Z@'ZTM% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4_BD?.%4X(![X/%)IOC[2=3O[6WC@U"*"]=DLKV>V*073 $X1O< D9 SCC-
M'4T5RMS\0-'M=0F@>&_:UM[@6MQJ"6Y-M#*2!M9_8D G& 3R:=J/CO3=/U:^
MTI++4[Z_LE1Y8+.V\QMC+NW#G&!QUQR1C- '445Q:?%#P_+!9W<,>H2Z=<O'
M&=06U/V>)WP KL>AR0#@$ \$UHZSXSL-&U"2Q^QZC?7$,0GN5L;<R_9XSG#/
MR,9P< 9.!TH Z.BN9O?'>C6<NGQ1_:;R34;4W5FEI"9#.@V\*/7#9YZ $G&*
MQM>^)D%IX%U77--L;PWEC*;:2VNK<JUO-C(,J@\+R.0><B@#OZ*IZ5J']J:;
M%>?9;FU\S/[JZC\N1<''*]NF1[5F:WXML]$U"+3_ +%J%_>O"9S;V%OYKI$#
MC>W( &>!W- &_17,7/C[0K>RTB[$EQ/%JZN;/R(2[2%1G;MZ[CG&,=?2K?A_
MQ39>(9;ZWBM[RTO+%E6XM;V'RY$W#*G&2,$ X(/:@#<HKA];\6_\59X8LM(U
MFUE@O+MXKJ"+8Y=1&Y!SR0,KCCOWKN#R.N* "BO/]*U/Q-JWB'Q5IT.L6T(T
MB:..V:6T#!MZ;_GP1TZ<8K8\ ^*I/%_@VUUJZMTMI7+I*J'Y,HQ!92?X3C\*
M .HHK.M-;TS5))K;3M3M)[B--Q6*17*@]&P#R/?I6'X$UZZU'P9_:>MWL;2)
M<W*23N%C4*DS*.F !@"@#K:*H6FMZ7?6]Q/:ZC:S16Y(G=)5(BP,G=_=XYYI
M;'6=,U.22.QO[:X>(!G6*0,5!Z$CT/8]Z +U%4+36]+O[G[-::C:SS[#((XY
M0S% 0-P ZC) STI(M=TF?4?[/BU*T>\.[$"S*7.W[V!GG'?TH T***Y9?$=U
M?6&N:KIL+7%MIOG0VT$:Y:[EC'S'UQN^4 <G!/.10!U-%<=;^,'FN/#:BRU0
MVNJ))F9K(JPD!  D'_+-3\S9] .<9-2?$'Q1>>%M!%SIMK]JO-WFF+KB"/#3
M.?8+QGU84 =;14%E>0:C86][:R"2WN(UEB<?Q*PR#^1JF_B/1(Y?*?5[%'RP
M :X49*G# 9/)!X/I0!IT5E3>)M!MYVAFUG3XY4D2%D:Y0$.^=JD9ZG!P/:I9
MM=TFWOTL)M3M([MW"+"\RABQ&0N,]2.W6@#0HK/O]=TG2I%34-2M+5FP0)IE
M3@G /)X!/&:6ZUS2;&=H;O4[."58C,R2SJI6,8RQ!/ Y'/O0!?HK&;Q=X<2T
MMKMM>TU;>Z8K!*;I LA!P0ISS@]?2KU_JEAI<0EO[R"V0YP97"YQR<9ZT 6Z
M*SVUW2$CM9&U2S"7?_'LWGKB;O\ )S\WX56/BWP__8UYJ\>KV<]C9Y\^:"42
M!".W&>?0=\T ;-%<:VOZEKEMX<U3PY>6;6MQ+&;ZT*^:Q1PA8;U.$**6)SU.
M!WP9K23Q6)==,ES;7*V\_F:?M@\M9%^;,#$]<#:-X_B)ZX(H ZRBJ&B:Q:Z_
MHEGJUDQ-O=1"1,]1Z@^X.0?<57U>X\O4-*B77(-/=[C)MW5&:\7:?W:[CD<X
M.5YXH UZ*H3:WI5M>"TGU&UCN"ZQB-Y0&+MC:N/[QR,#J<U?H **Q[CQ7X=M
M$=[C7=-B2.7R79[I %DQG:>>N"#BK"Z]I#ZL-*35+-M0*[Q:B=3(5QG.W.>G
M/TH T**SI=>TB"^%E+J=HET7$8B:90V\C(7&?O$=!U-.U+5;'3H]MWJ%O9R2
M*Q0S.!TZM@GD#(SVH OT5R'@+Q#/J7@"UUC6[^%I&EG62Y;;&A"SNB], < "
MNDT_5+#586FT^\@NHT<HS0R!MK#JIQT/L: +=%<I\0-5U+1M"MKS3;H0.;^W
MADS&'W(\JJ1STX)K7M?$FAWWVO[)K%A.+/)N3'<(WD@=VP>!UY/I0!J45GQZ
M[H\NF-J<>JV+Z>IPUTMPAB';E\X_6KZ.LB*Z,&1AE6!R"/6@!:*Y?6?'FEZ-
M?W=I):ZC=?8462]FM+8R1VJL,@R'/]WYN,G'-2:GXWTO3=2ATX17EY>7%J+N
MWALX?,,R$D?+S[$\X&.] '245R\?C[1'\,SZXYNHHK>X-K+;20$3K/D+Y6SN
M^2.!ZUCV_BN;5?B9I%A''J-C'_9]S)<6-Y&8V)W1['(R01][!!/<4 >@457U
M!VCTVZ=&*LL+D$=C@UYYX/\ B/:+X3T ZJFJ2>?'%!-JKVY-OY[<8:3UW<$X
MQGC- 'I=%<QJ_CK3-'U"YM'M=1NC9HLE[+:6QD2T4C(,A^G.!DXYK.U#Q^UM
MXZT[1+73;N[M+FS:X,T$!?S,E-C(<@; &;<?I0!W%%<Q/X^T2#P5'XL9K@Z=
M(0%58\REB^S;MSU!SQ[&M"Z\2Z=:3Z1"SN[:LQ%KL7((";RQ]%"\YH UZ*Y;
M3?'VDZG?VL$<&H107KM'9WL]L4M[E@"<(WN 2,@9QQFDF^(&CPZA);M#?FUB
MN1:2ZBMN3:QS9"["_P#O$*3C /4T =517+7_ (\TZRU6_P!+BL=3O[^Q*>?!
M96WF,%9 X;J!C!'7DGH#BMO1M7LM?T>UU73Y3):7*;XV(P<="".Q!R/PH O4
M5Y]\5M?\0Z'9:./#=PL5W<W3(5,2OYH6-GV?,#C)7''/-=+#XJT^7P2OBG?B
MQ-G]K//(&W)7ZYX^M &Y17E7@KQ5K>J>$_%USXJOIXFLD9RUI&B2VL;0>80F
M!RR@\$YY%.\1:_<0Z)\.Y](U74&MK_5K2)YIWQ+<0MU$F.#GO0!ZG17-ZKXT
ML=-U6;3(;'4M2N[>-9;B/3[;S?(5ON[SD $@$@#)]J;/XZTA=-TR]LEN]2_M
M-6:TALH"\DBK]\X.,;<@'.,$XH Z:BL_1=9M->TU+ZS\T1EF1HYHRDD;J2K*
MRGD$$$5H4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4=:_Y 6H?]>TG
M_H)J]00""",@]0: .0^%G_)+_#W_ %Z#^9KA@H'[+TH  _<.?Q^TFO9D1(T"
M(JJHX"J, 4WR(?)\GRD\K^YM&W\J /-KHJO[0:ET+J/"Y+*!DL/./ '>JWAK
M5K72]8T"P\,^)QJVCWSM&=(GVO/81B-FW!A\ZJI 7:_KCK7J?E1^;YOEKYF-
MN_'./3-,CM+:&9YHK>))9/ONJ ,WU/>@!\TC1022)&TK(I81KC+$#H,]S7CV
ML7GPVUC2;C7XKN/1/$7ELVVVG-O>QW&/NM$I!=MW'(.?6O9*@-C:-<BY-K ;
M@=)3&-P_'K0!Y(6OH?%.FWWB+Q)<>'+B^\/6P:XQ"BO,C,98V,JD!AO#8&.I
M]*B>71M$N_ FH1ZA<W>F2ZG?W+7EY&$)+HV9,!0 FXELX QSTKV*>V@NH_+N
M((YDSG;(@89^AK%UGP_)J?B/P[J221)#I<D[R1L.7#Q% !VXS0!Y_KGB$MXD
M\6>)/#LT%W!8:'!:-<Q@2Q>:9F8GCAMB'<>OH:DT^^L$^)V@M'XKGUM'LKJ+
M[5-)$8?-;RR(XS&JC<0,E<DCY:]6AM;>WA\F&"*.+GY$0!>>O IJ6=K%''''
M;0HD9W(JH %/J!VH \K\*ZC<Z%^SG%J%A&GVB*"9@63>%S.P+D=]H);\*73;
MZP3XHZ T?BJ?6T>SNH?M4TD1A\YO+(CC,:J-Q R5R2/EKU=8HTB\I8U6/&-H
M&!^51I9VL4<:1VT*)&=R*J !3ZCTH \%EO[.;]F"_P!/CNH6O;-@MS;AQYD)
M-[D;EZKGMFNY-]:Z#\2]/U'5[B*TLKWP\EK;W,[A(Q*DF]DW'@$A@>>N*]!%
ME:CS<6T/[TYD_=CYSZGUITUM!<P^5/#'+%_<=0P_(T >+:J\>IZ?XIUFUQ)I
M=_XATY+:0?<F\MHD=U]5+9&1P<5W6O?\E7\'_P#7KJ'_ *#%78^3%Y2Q>4GE
MKC:NT8&.F!2F-&=7**77.UB.1GKB@"&_OK?3-.N;^[D$=O;1-+*Y[*HR?Y5Y
M;X)T3QAJ-I>>*X-8L+"7Q#+]J:"XT\SND0R(EW>8O 3&!CO7K#HLB%'4,IX*
ML,@TJJ%4*H  & !VH \)FL]2T;P3XT^'T["YN;.%=1L3#&4$MLSJ\@1<D@*P
M88R>M=+XB\4:'XA\0^!AH]W#>XU19&> AA"#$^$8C[K'^Z>?E/I7H^H6;7=I
M<)!.;6ZDB:..Z1%9XB1P1GK@\XKD['PEKMSJ^E7.OZCILEMI4C3PQV-JT1N)
MBA022$L0" 2<+W/X4 9?A&SDO-&^(\%L +FXUN_B0]#N,:A>?J:Q?#*:3J-C
MX2M+GQIJ-S=0RV[)HZI 6@FA7)5U6/>BKM*DDCCOS7L:1I'NV(J[CN; QD^I
MIB6MO'</.D$2S/P\BH S?4]30!XE;VNGKH.L:'KOC+4+&4ZA<03Z1"D!DE\R
M8E3&IC,CAPRMD$]3TQ7<^%XQ'\4?&PR698=.7<>I_=/7:-:V[W"W#01-.HPL
MA0%@/8]:>(T5V<(H9L;F Y..F: /%455_9EBP /WJGC_ *_A6IJ!BTSXA^*'
MU+QA<>'4N4M[F#'DA;B-8@AP9$;)5E(P/7IS7JGD0^3Y7E)Y7]S:,=<]*2>U
MM[G9Y\$4NP[E\Q VT^HSTH \S\/6%GI_C+P=;6,EQ+:1Z#<M ]TFV3:TD9&1
M@8.&QC%8WBY&?0/BRJ*2?M%JV .PBB)/Y5[040R"0HN\# ;'('UI/)C^?]VG
M[S[_ ,H^;MSZT 5M*U*QU;3H;S3KN"[MG&%E@D#J2.HR.XKA_$NM@>-[G3=0
M\22Z!8V]A%/#]G$:S7CL[@A6=6)V[0-BC)+5Z###%;Q"*")(HQT1%"@?@*;)
M;0321R20QO)&<HS*"5/L>U 'C/@Z6*9OAK%O#36USJD<R,07BD"N=K@=&P0<
M>]7?%XU ZG\21I0D-V=(LL"/[Q7]YOQCOLW5ZRMO C[UAC5MQ;<% .3U/U-/
M"('9PBAVP"P')Q0!Y;K7B#PYJ&J_#RZTV^LC;I>$(%D7,*&!@%(_AYP,'N*]
M4JO%I]E VZ&TMXVW%\I& =QX)X'7WJP1D8- 'BXT)O%7B'XCVFG:G)!?"ZMV
MA$=PPCD(BY21 <,I(*G(X_2M:^U^+6O@_J,&CV2V>H6$:Q7FD0*%>WV2+YJ!
M/0J'QQ@@_6O2X[.UA??%;0HP_B5 #3Q;P+,9EAC$IZN%&X_C0!PVAWGA7Q%X
MCTW6M-UJ?5-1AMG5=KH/(A8<B5548YP &YSTZ&N-L]0-E\,]'U$2R_V=:>))
MI;^2W <QQ>=-AR,'@,R-T/8U[1#96ENLBPVL,8E.9 D8&\^^.M.2UMXD=(X(
MD1QAE5  WUH \NUJZ\(#1?$WB"WFF\1+-91Q7YCG B<;@$5FC P1G)QR%!SU
M&8UU33I?B5<R7>LV]Y!/X7D1I+/ 0XER4BP3DA<GDDCGH.GJD5G:P6QMX;:&
M. Y!B1 %YZ\#BA;2V0*%MXE"H44! ,*>H'M[4 >7Z?)KVFRPZ)%=VFMQ7&C7
M/]BZK;C;/$H5<+(!\I!/E@,.I%,\+WOA?Q%I?A>&75;J75M-DB\O3 R)+;S(
M-K[E"AM@^;.>"/>O4K>RM;5I&M[:&%I#ES'&%+'WQUI4M+:*XDN([>))Y!AY
M%0!F^IZF@":N%^#Z/%\-;"WGR+F">YCN >HD$[YS[UW59EEI(TW4[R>T8+;7
MLGG30$?=FP 74_[6!D>O/<Y -,D 9/ KC+1;CQ/J^IZI87^GFR0-ID2S6YG#
M(I_>D;9%QN?*GKD1J:[(@,"" 0>"#3(K>&W!$,,<8/78H&?RH \Y^&]XMC8Z
MWX%O+]3=Z)*\4,B-AFMG&Y& R3E<D8YQP*P/#UQHVMZ%X.T>77M#0:3>)<!C
M>()KA5#A$$1Y5GW#<#T]^WK-_I27-A=16;)97<T3I'=Q1 O$S C>/<9S7*P>
M$-4N[ :9K%KX;-KY0A>XM[1C,ZXQD!N$;'?+8/:@"OX?M-,N_BKXW2:"UF=5
ML"JNJL01&22 ?<+^(%<WI5UH.J^&[SPWXHU:[BU:&_E\_3 R)+--YQ=&B^7<
MV[*D$']*]@2TMXI#)'!$LAZLJ '\Z#:6S72W1MXC<*-HE*#>!Z9ZT >6'4M'
M37?&&@>+=9ETXWEP9%CE9$2YM7B5%V,RDDC:1@'.>G.:O0VNGVWQ-\)VT<95
M8M!E6)+K!E4 Q[-V>=P /OP:]%FM+:XECEFMXI)(CF-W0$H?4$]*&M;=Y?->
MWB:3^^4!/YT >/K%I_\ PKWXHLJ6V1J-^ 0%[*I4?]]$D>]:!UVWTOQ?I4VL
MZO)IVGWV@P)9WN4$1D4DR(692 2"A[9P/:O3A8684J+2  ]1Y8Y_2B6QLY[<
M6\MK!) #D1O&"H/TZ4 >4ZCIWA^RM/!%MIG[W37\0%H6N2&$JLDA8KG^ L>.
M,'J."*N7/E'Q%\4[>#9O?28#Y:=2WV>4'@=^GZ5Z9):6TVWS;>)]HP-R X%*
MEK;QRF5((ED.<LJ $Y]Z ,'P'?6M]X%T0VEQ'.(K""-S&P8*XC7*G'<=QVKH
MZ9%%'!&(XHUC0=%08 _"JVIVL]]8R6L,_D"8%))5^^JD<[?]KT)Z=><8H Y'
MX0I(OP^MW;(BENKF2 '_ )YF9\?@>3^-'CYH$\1>"&=HUD_MD $D X\I_P"I
M'Z5V=E9V^GV,%E:1+#;01K'%&O15 P!^5.EM;>=@TT$4C#H70$C\Z /,-4N+
MS1=2O]4TJ[MM6T>35XQ?Z1<#$\%SYB*&A8=3N",%/;I7JE5_L%G]J%U]D@^T
M#.)?+&\9Z\]:L4 >3VL>GM9?%4E;8XEF!.%X'V9>/^^L_C3'-G!X?^%$L9@C
M<W-M\RX!.ZV;?S[MC/O7J8L+,!@+2##=?W8YH-A9D &T@PO0>6.* /%_$^M:
M9<^&/$ M9[?3Q#KZ-+9;MT[R+<1AYI"Q)13C("@ <<G.*ZO2=>L;3XH^)1J]
MY! MU:VDFF33N%26V"'>$8\$;V)([]>U=\UG:L92UM"3+CS"4'SXZ9]:6:TM
MKAXWGMXI6B.Z,N@8H?49Z4 >'Z+JL&F^ O"%Z;IXM(L=8NUOI+8!C;;WF$3,
M"#@ N#R.XQSBO2?"<6@3:QJ^JZ)J$FHR7@B^UW:R*\3NH(4#: NX+UQZC-=0
M+: 6YMQ#&(2"#'M&W!ZC'2E@MX;6%8;>&.*)?NI&H51] * .+^+ C/@D&8+Y
M"ZA:&4O]T)YR9)]L=:AGT^SF^*^A7FBQP 6^GW U%[<#:8F"B%6(XR6W$#T4
M^E=ZRJZ%'4,K#!!&0154V8M=/FATR*VMI"C>4!'B,.1P2HQD9QF@#SS2["YT
M[Q%=> A;O_9+7(U2WD ^1;0L7:'\)@%QW5S7IU8?A_3-4MC+?:[=6MSJLZ)$
MYM8RD4:+G"J&)/)9B3WR., 5N4 >0>*=8:_F\8VE[XBN+">UW6MEH]F(A)=@
MP@AF#*7<,6(XP %/UJ]X.N+>\\<Z#<6\L<R?\(=$H=&##(F4,,CN""#[BO3#
M;0&X%P88S.%VB3:-P'IGKBECMX(<>5#&F!M&U0,#.<?G0!XMJ#"VCU749019
MZ?X\BNKM@,A(@B L?8%E-=*-<TO6_C+HS:7=07D<.E7*O<6[AXRQ:,[0PX)
MP2.VX>M>B^3%M=?+3;)G>-HPV?7UID-I;6ZHL-O%&$!"A$ VYZXQTH CU/\
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MKGC/4;*?[?-;3Z/"D!D=GG8J44QF1@P96W GJ>>*]O2UMX[A[A((EF<8:0(
MS?4]30;6W:Y6Y:"(SJ,"4H-P'IGK0!QWA50OQ'\='JWF6()[G_1Q3OA-_P D
MTTO_ '[C_P!*)*[((BNSJBAF^\0.3]:$C2- D:*BCH%&!0!P_C[_ )&3P-_V
M&?\ VD]<BVGW2>))/AB(F_LJ;4AJH;'RBPSYC1?3SAM_&O9FC1RI=%8J<J2,
MX/M1L3S/,VKOQMW8YQZ9H \E_P"83\8/^V__ *2UEZA_R(OPA_["EA_*O;?)
MBPX\M,2??^4?-]?6D-O"513%'MC(*#:,*1TQZ4 >?:1K.F>%_''C&+7K^WL'
MNIX;RWDNI!&)H?*"_*3][:5(P.:YW1K?3(_#.B3ZEK%SX;OY[F^O-+O25C1(
MI)=WEOO&TAE*MM/7'%>PSVEM=;/M%O%-L.5\Q VT^HSTI9[:"ZB\JXACFCZ[
M)%##\C0!SW@36+W6_#AN+Z>&Z>*YF@CO($V)=HCD+*HZ 'VXX.*Z:D551 B*
M%51@ #  I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *Y'XG:MJ&B?#_4;_2[HVMY&\"QS! VW=,B
MG@@@\$UUU<+\8O\ DF&I_P#76V_]*(Z -/P)KUQK?A9)-28#4[*1[/4. ,31
MG#'T&1AO^!5RG@/QAK7B/XBZFMQ<DZ)/9-=Z=;^6HVQB<Q*V<9^8(6Y/\55/
M&T>I:%XJO].TE&">,X4MT=1Q!<JP21_;,+%L^JULZ/86^E?&1M/M4V6]MX7@
MAC7T59R!_*@#$USQ$A^!NN:IX?U;6]\5R$6ZO9_](1O/0, RGA<$@>QKK;[5
M;*'Q-X.M;N]U9+V\BE,$5O(!;S$1@MYXZMCJ/>O*HO\ DV?Q'_V$6_\ 2B.N
MT\0_\E,^%_\ UQN__1"T :7ASQ.FFV_C74-;U"4VECK<T4?FN7*($3;&@^IX
M4=S6W>^-+:RCTZ/^RM4FU'4(S+#IL42FX5!C+."VU ,CJW4XZYKR^'1M4;7/
M$OB>R8W\>B^))ISH[("LPV+O=3WD"D%?0J<<FNJ?Q)I,7Q"TKQ9->QQZ%JFA
MFUM[V0[8TE$V\HS'A21Z]U([4 ;Z?$/1S90W,L%] 6U%--GBEB"O:S-T\T9X
M7I\PR.16QJGB"STG5-*TZ9)I+K5)FBMTB4'&U=S,V2,*!U//6O/[;1H_'-O\
M0;FS.;#5I(8]/GQA9)8(@/,4]U\P#D==M2_#_49O''B8^)[J-E72]/BT]%88
M NG >X(]"/E6@#8\/>*=$M/#>O:M_:&JRV=EJ4T<[ZBWF.L@VC9$!_!DJ%'J
M:UM%\86VKZJVES:=J.F7XA^T)!?PA&ECS@LI5B#@D9&<C/2O)](@GD^&_B:X
MAB>9;+Q>UW-%&NYFBCDB9\#O@ G\*]4TGQIHGB#7EL=&<:ALMC-+>0 -%""0
M C-V8\G;['- %[Q)K@T+38Y419;NZN([2TB8X#S2'"@^PY)]@:IRZM?:?XIT
MO1Y[>_N8+F!V-[%;@Q&49)$A'^K  &/4L.>#G)^(,<@USP3<G)MH];1)/0,Z
M,J$_CQ^-=U0!YAK_ (TUN+X8W_B&WBOM+U.RN4BD@O+5%4EI$5@H()9!N(#9
MY(/TKLI;+5;:XM#'X@EE+3J&@N(8@)4ZN 54$':"?PKFOC;/!%\+=3CEE1'E
M> (K, 6Q,A.!WXYJZUQX)L-0LM0L;RP>_5_)MXK6Y5WF,GR[ H)SDX.>V,],
MT :L?C'2<:W]I>6S;12?M:7"A2$QN61<$Y5AT/4],5!/XWM8K+2Y8]*U2>\U
M.,S6^GQPKYXC&,NP+!5'*]6[@=>*X7QA:7'C#Q+=:OHEC'=6GAT+%=*2<:HZ
MR+(UOP<$)MSR#\YQBK&MZEINJ>*]#\3?\)%=Z1HNH:2\$.H6[H@642!C'(SJ
MP4D9X..4Q0!V3^.](7P]#JP2[<S7'V-+)8?])-P"08MF>&!!SSC SG%0#XB:
M5'INH75W9ZC9SZ?+#'<V4\2B9/-8+&V Q4J2>H/8UQ1BTS2(M \36E]J-]HT
M>NSW%[?7J@\R1&+SAM51Y>X#YL=\UH^-_$NG^)O!7B(Z-$]W;Z?):22WT*AH
MI=LR.ZHP^]L523V&: .\U/Q!:Z7JNGZ;+#<2W.H+,T"Q*#GRDW,#DCD@\>_I
M7%6'CPZ[X+\27VK6FKZ=:V<MPHN;15CD6-7P%1MQ_>@=>U.O/$FE>(/B?X,.
MD7D=[#"MZ7GA.Z,%H1A=W3=@$D=1QGK7+Q:C9_\ "I?'>D&XC&HV]S?22VQ.
M)$4R\,1Z<CF@#TS1?$^G2W.D:+&U\TMUI4=];SW6"9H\ ?,V>9.03QWS3K_Q
MMI&FZAJUI<M,/[*MH[BZE5,HN\X1!@Y+MV&.XKC]4C.F^ _ WBR,'?HD5J\Y
M R?LTL:QRC\B#_P&LV;2[O4OA7JOB-TN%NM7U&+5I1"N94MDE0H%X.=L2[AP
M: .\M_%1UI;_ $N"VO\ 1-7%FT\ U"V4G:>!(JJQ#!6(RN<\C(YJG;'QB8_#
M3S7\32>8Z:C";+;]HCW?+(3_ ,LB$P=O]XXJAX630=1\80WEAXKU7Q!=VMF^
M'D>*2"))"N59D1<,2H(4G/RGBO1* ,'3-8D7Q%>^';YP]U!"MU;RX ,T#$KD
M@<;E8$''!RIXS@:]Y>VNGVS7-Y<1P0J0"\C8&2< ?4D@ =ZXR[C>7XX::T.<
M0:'*TY']UI0%!_$$_@:M_$/4[/2])TR:\MX'1M4MT2XN"?*M'R2)GP1D+CID
M#)&30!MKXDT5K&YO3JEJEO:MLN'DD">2W7#[L;3[&FVGB?0[[4ETZUU:TFO6
MC\T0)*"Y7&<X^A!KRR;4K'_BZJ-J:W)GTV)XY7"KYP^RL-RX !7. ".O')SS
MJ27.GPWOPJ,4]L@"N!M=1PUJ0?S;CZT =-X]\3PZ/X6UAK/5X[34[6V:1" K
ME7VDJK9! +=@>3GBNBT>:2XT2PGE8M+);1N['N2H)->0IK5G#\+_ !MHNL7,
M4.OI)?-<6\[ 23,VYD=0>6&W;@CH%]*]7\-3Q7/A?2I89%DC:TBPRG(/RB@#
MDH;G7O&^O:NFGZU+HVB:7=-8AK6)&FN9D WDLX(503@8'-:NE-K_ (<_M0^(
M]3BO]&M8/M$.HN@CF4 $NCHHP< 9# <_RY[0]=L? &OZ_HOB.7[#;WNHRZC8
M7LJD0S)+@LF[H&4@\'UJYJ7Q N-0T#Q'?>&+*2XM-/LB\&I,IV2S<[@B$?.%
M');ID8H V]%\;6FL:E#8/IFIZ=-<P&XM?MT*H+B,8R5(8\C<#@X.#TK*C^*%
ME?Z/>:AI6C:Q=0VT$DCRK;J$1T)!0G=U_BXS\OOQ7-6.HZ6/B)X5N+?Q1>:U
M"R7$+WES*IA$SHNV--J@!VP?EZCY16CX$A,GP,NXXHRTDD.H *HR68R2@?CT
MH U]%^( E\%Z1JNI:;?_ &^^$<45M# N^[E,8<M$N[[F,G+$8 YJ^/'NF?V3
M<7DEI?Q7,%REG)ISPC[3YSXV(%!P=P(((.,=Z\XAOM/OO"OP\OX]=EL[+3(?
ML=_>6;KNLY7@4+O+*P497:21_%[UK"W\(/I6KZA<Z]K6H6MQ?6T4FLLZ@031
M@F.6.1%4 *6"EL$9P* .DUCQ=I]WX.URXOHM<TC[ $%TD:B*ZB#$%61@2ISZ
M@^M7KCQ=::7:Z3;6]GJFJ75Y:">&"!%>8Q +F20LP ^\._)/%>>:]J]U?_#3
MQQ9'6AKNG6<4 M=3"*"Y9@6C++\KE<+R/[W-:]YK2P77A_3-3\0SZ%I/]A17
M"2P,J/<S<*4#E3T7!VKR=U '4S?$+18-%TO52MXT&I7!M846',BR@-E&3.=V
M4*X&><?6K>A>+;;6]3N],:PO].O[5%E>WOHU5FC8D!UVLP(R".O6O+]!GADT
M_P )VA>0W-MXMN!/%.<S1D^>R^8.S$$&N\C_ .2W7'_8N1?^E,E &YKVDZEJ
M@@&G:_=:28]V\P0QR>9G&,[U.,8/3UK@_!UMXK\1?VR]QXWU",:=J\]@JI:6
M_P ZQD8)^3J<UZI7!?"[_5>+O^QFO?YK0!1TWQK-I>L^+HKBSUC5A::DS".T
M3S!;0B)#_$P &=V%'/!XKIKKQOIL5EI4]E;WFIRZK%Y]I;6<8,CQ@ ECN("@
M9 .2.3BLCPH!]M\?' R=5D'_ ) CKA=&BBM+/P3J6H:Y>:)I\V@M:K?6[HBK
M*)%?8[.K!0RY(Z9*4 >EW'Q"T2T\/6^M3BZCMI;P6,B-%B2WFR05D7/&"#G&
M?;-$OCJ"*TL7;0]:^VWSR"WTXVZBX94P6<@L JX(ZD=17":I::6OA/2KC3+Z
M_P!1MK[Q=;3/<WP7,S;@C,NU5!0[>#CGFNI\:ZS]D\4:7IM_KTNA:/-:S3O=
M1,J--*K(%B#L#MX8M@<GI0!H3_$31;;0;35YH[U(KF]-@8?(_>Q3C=E'3.<Y
M0C SDD8SFK.D^-++4M2NM.N;*_TJ]MX/M1AU"-4+0YP9%*L00#P>>*\FCU.T
MM=&L_-DN96M/'"7$R7 +7"Q,CLDCKC.2H+=.Q]*Z?6KBW\;>,+T>'+J*]2#P
MW=V\ES;L&C$LV!''N'&>"<4 =9I?CW3]4OK* 6&IVL&H9%C>74 2&ZP"WRG<
M2,J"1N R!Q5J+QAILWA;4/$*QW'V.Q,XE4H-Y\DD-@9P>5..?RKS[PRN@ZH?
M"UJ_BS6[[4()(I5THM$?LLL2'<)5$89%7E>3SD=<U3/B'3=-^%WB_P /W%PJ
MZRLVHH;'_EJ0SNP<+UV[3NW=, T =G/X]N/^$^TW1+?2;Z6SN;#[2TBQ*2=Q
MCVN#NX10S!N^>F<5/HGB+1H)_%MTVHZF8M-NV^VF_DW1P$ DB$#D)QTZ]*Y]
M=1L](^)/A2YU"XCMH+CPY]GBDE.U7E+QD(#Z^U<]]@NM3T3XM6ME$TTYU3>L
M2C)<(P<J!W)"D8H ](L/B!IUU=K;WMAJ>DF6W>Y@;4( BSQH-SE<,>0.2#@X
M[5/HOC2UUF^M[7^R]5LOM41FM);R (EP@P25(8X."#AL'%9Q\>^&M=9+.QB?
M65ELIIKA;6,.;>()RKC@AF^Z%ZDUA^$]8M;/Q)I>F>'?%$FM:)<6\C2VDY62
M33D1,H2X 91G";7YY]J /4JXOQ7JVJV'C3PKIUEJ#0VNJS31W">4C$!$W#:2
MN03WSFNBT/7]+\2::NHZ/>)=VC,4$B CYAU!! (KC/'5]:0?$CP"LMS#&R75
MR6#.!M!BP,^F20* .JNO&/ANQ%Q]IUVPC^S.L<V9U^1CG .._!./:M"?5+"V
MM(KJ6[B6";'E.&R),C(VX^]D<\5YW9W&FMXQ^)CO-:D_9[969F7[OV;##/IG
M /O6+H6NP:'!\/-7U.<#1?['>R-SG=';7!"8WD?=)"E?S]Z /7]/U&RU6T%U
M8745S 25WQMD9!P0?0@]15JN6T_6_"^E:9<:G:-%::=>W_%RJMLNIY, NO'(
M)XW=/E/;FNDN4DDM)DB;;(R,%/H<<4 <YI_BF"[TO4/$EQ<>3HEL\L<!"Y\U
M8V*M(>YRP8*!V&>2>,35O&4M]I'A#6-)O_L\&H:G:0W<(", DBEV1B1D$8'3
M'>H_ T;-\"(K=8V\Y-/NH6CQ\PD!D4C'KD&L"XU72KSX>?#:+[7:RI%J6G1S
M*7! *Q$.ISQP>H[9YH ]5TK7])UQ9VTO4;:\%NVR4PR!MA]_\\TEIXATB_OO
ML5KJ-O+<E/,6-7Y=/[R_WA[C(KS;7C+>>*OB#9:1*CW\^@P*D<3C>[@2 @ ?
MQ8('XBM/P]J?A'Q5J.A7MG>7=WJUD&:*V,C!K+*[9!(   .-O/!.,4 =;XLU
M:ZT309+ZTL[JZ9)$$B6D7FRJA8!F5.Y _#N<@5GR>+6L]>O(K^QU&WT^WT[[
M:MRUO^YV@;GWOV<= OL>N1CJZR/%.DOKWA35M)B<))>6DD*,>@9E(&?;.* ,
M?PU<ZWXKT:#7;C49M,@O!YMK9VT43;(C]TR,ZL68C!XV@9Q[UJZ9=W]A87TG
MB.ZME\BY94N%7RHVBPNPX).#S@\]<X[5SW@#Q/IT/A&PTC4[J'3M5TNW2TN[
M2[D$;H8QMW8)Y4@ @CCFH?'.I,1X:UA5D.B6>L))=RD?+Y>TJLQ_V%8YS[ C
MC!H ["WU[2;J&YEBU"WV6O\ Q\%G"F'C/S@X*\>M5HO%_AR:YM+>+6[%YKP9
MMT$PS(/;ZXX]>U<Q<>1<_%"35K*XA:PAT-XM0G1P8R2^8U8]-V-Q]A]17'0R
MZ;_PI7P.LDEKM_M6SWABN,B7Y\_@>?;K0!ZY9>)]!U%;MK/5[*9;/'VADF7$
M0/0D]AP>>E0Q>,O#4][:V46NZ>]S=C=!&LZDR#H,>N<<>O:N:-S:-\:KN*.:
M$E_#:@JK#YB)V.,>NT_E7&6MKI^K? '1=/T_[.^M22PBT6+'FK<"89;CD$)N
M)/\ ='I0![#>^(M'TV=H+S4;>"1-OF!WP(]W"[ST7/;.,TEYXDT33KJ2VO-6
MLX)XHO.DBDF4,B9 W$=AE@!ZYKROQMJ]A<Z;\0;&*2+3[J-0);8#=/?$1KB4
M@YQ&!@?*!]W)(S6[;ZAIE[\5_#\ZW-M*/^$>D,;EAU,B8(SZC=@]QGM0!V9\
M5^'UTRVU-M8LA8W3;(;@S )(W3:#ZY!XZ\58O]0@0"RCOX;>_NHG-KO&XD@?
M>"_Q 9!(KSWPOI-EXK\%^+M&2>/;)K=[Y+QL#Y+>9NC<8Z8(!%;O@6]U#Q$O
M]LZO:M;W=G$=-\MA_P M5;]^X]F95'_ #0 RW/C3^S?#[R:E$]TMXR7J&QV_
M:[?S,!S_ ,\2(\MCN<#KQ6UI^L21>)KKP[?2>9<);K>6LV #+"6*D$#C<K#!
MQU#*?6MZN%U.-YOC5H1AS^XTFY><C^XSJJY_X%_*@#IO$6N0>'-"NM4G0R"(
M )$IP99&(5$'N6('XU)'<G3-,2;6+V(2L1YC\*@<_P "#J1G@#DGW-<K\54D
M_P"$=TNX&?(MM9LYKCT$8D .?;)6F^/-3&A>*?"6LW^Y=%MYKB.ZEVDK#))&
M%B=L=!]\9[;J .MMM<TN[L)KZ'4+=K6!F6:4R "(KU#Y^Z1W!Q26>L:?JCSP
M65[&\\0'F(#AXP>A*GG!['&#7G?BRYTR?14USP];B;3$URTO=6N;=24N8T/S
ML/[X4A"2..#Z&MB\,.J?%/P[J6D7,4T5M877]H3PN&7R6"^4K,..7W,!_LDT
M 9#^(]?'PG\2ZJ-6D_M+3[R[CBN/)CSMCDV@;=NWI[5Z%+JUGI^GV\U_=)$9
M$!&[JQQDX Y/KQ7DK7MH_P $_&VVYA;.H7P&''.Z8E?S'3UK;U?7+/2/&^DW
M^JZA-::+>Z.L%M?1/^Z68.6968 @;EV\_P"S[4 >@KK6EOI<>II?V[V,N/+G
M60%'R<  CJ<\8'.>*R=9\=:)I'ANYUH7D=Q%"_DA(SR9LX"$=5.2,Y' KA[F
M;1_"]WX6UFP6X'A1=0NWGN9"SH)9HPJ38/(3<7 . .21P1FWXWGT2^^&_B;4
M=!BC>&>>VFN+R$'9.ZS1[B#_ !;5 R1QU[@T =G/JEE=ZUHRVWB*&'S#*PL4
M*,;T;3Z_, I4G(],5?LM<TK46N5LK^"X:U)6<1.&,1]&QT/M7&^(M6TV[^('
MP_N8+VWDB>6]*2*XPP,!4$'N"> >A[4S68+[0_B!(FG1R"#Q5;B!GC'_ ![W
M,?!E]OW)8^YCH [1M?TE;"&^^WP&VG!,,BMN\S'7;CEO7BN;\8^(9D\/:1JN
M@:JA@N-2MH6D@V2+-&\@5AD@X[CC!ZUE^)+ZS\+^/]*DU.XGT[0I-*-G;7,1
MQ'#,KY*,<':"H7_OD>E9GB%- TWP-9/I$K)I]SXBMKA)9Y#B8F52[IN_AR#[
M<$C@YH ]-AUK3+C5)M+AO[>2_A&Z6V5P70>I'4"IK/4+/4!*;2XCG$,ABDV-
MG8XZJ?0CTKB_&IG\/:WIGC/3;9[K"_V?>P0]9HI#^Z(]UD*CZ.:ZW0].;2]'
MM[61Q). 7GD'_+25B6D;\6+'\: ,;6_'=AHNN_V)]@U*^U(VZW"6]E )&=&9
MEX^8=-I))P.G.3BFZEX_T[3;R\B-AJ=S;6#!;Z]MX T-J2 2&.X$X!!.T' /
M-9\*@_'BZ; W#PW& ?\ MX:N/FCTO3[OQ;8:_P"*]7TN2?4+B5=.MFB'VN&8
M J8U:-F<D';P>H[4 :7C_P 2ZA-X[\.Z#:+KT.G3":69M+94DO,1AE\I]V2J
M_P 73OUXKJ;KQ[I^E--!_9^KW4&GH@O[N.$.MKE0V)#NR6"D%MH;'>N?U:UC
ML?BK\-+2(RF."SO(E,OW\+  -WOQS6-<)IFFZEXNLM>\5ZMI+SW\TZ6%NT0%
MW#*J[3&K1L7)Y3 /5<<4 =]J_C[3=*UA-)CLM1U"^EM4NX8K&$2&6-F897YA
MTVDDG QCG)Q2OX\L/^$GF\/6^GZG=7]O-%'.(( RQ*ZJWF,=W" ,,D\]< XK
M!T2RAL/B_;VD/FF.V\(P0QF?_6;1.0-WOP,^]7?"2C_A:'Q ; W&2Q&?;R*
M+W_"P=,^V[/L6H_V?]J^Q_VIY(^R^;NV8W;MV-WR[MNW/>GZAXZLK75+[3X;
M#4[L6 'VVZM80T5L2N[#'<"2!R=H.!7FFD6.D?\ "-Q^&];\6:Y#J"WAM9=$
MMVBW%_.)4JAC+%#P^[.,9.:Z;1O$&F^%]5\::9J\ZQ7]QJ<EW;6[#Y[N.6-
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M/IFK'AB+7(3J::QJ!OHQ=M]DF:V$#>7@?+M'4 Y 8\G!/3% &]@8Q@8]*4#
MP*9--%;023SRI%#&I9Y'8*J@<DDGH*S[/Q!I5_=-:P7B_:%C\WRI%:-C'_?
M8#*_[0R* -%(XX@1&BH"<D*,9-.K"M_&?AN[OH+*VUFTFN9Y7AB2-]V]U&6
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M2L=<TW4KJ6UMKD&YB4.\#HT<@4]&VL =I]<8K0H :T:/MW(IVG*Y'0TH &<
M#/6LI_$VC1WJVCW\8E:?[,#@[/._YY[\;=_^SG/M4EYX@TNPF>*YN@C1E5D(
M1F6,MC:&8#"DY& 2"<CUH T$C2,L415+'+$#&3[TBQ(A<QHB,W)(7J?4^M/K
M.U'7=-TJ01WER$D,;2^6J,["->KE5!(49ZGB@"73=-ATV&1(N7ED,LKD ;F(
M S@<#   'H!5HHC')52?<4RUNH+VUBNK69)K>9 \<D;95U/((/<5B^)]7O\
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MSKET(1.6W1Q_+A,'E<9^[VH [3 SG SZTC1QLZNR*67[K$<CZ5R/Q2O9]/\
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MB%9A70X_ /CG4M-U34K]+RSE@:]U"0%;AU@8+Y1P-P^;;G')&!TKU7K1TZ4
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MS2I&ILIE!9L9)0X'UKF/AUH6B:AX)\-7\L(N[JTM8RGFS/*L$H'.U&)5&'L
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M<:;8/#*4(#@^8>,CW%<,NG,FEZ7J=X^HVFGV?B#4A=3V1=)84E9PLF5&0N0
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M')*65HUQL*E6R23@$'.* /1K_P :-!XAO=!T_1+[4M1M8HIBD+1HA1\\[W8
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MO'B-P^<!6[D8Y]*J2>'4N?%L.O7=PTQM(#%96^W"0%OOOGNS# SQ@<=\UMT
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP:G831R1R*-P1MVQ\ E2?49Q6I0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5P7Q& TK4/#'BH':-,U%8;EST6WG'EN3]#MKO:J:GIEEK.G3:?J-LES:
M3 "2)QPP!R/U H \B\J0?#L>.MA^U?V[_;N,?-Y'F>5M^GD\UL: !JFA^/\
MQ22&&IO<0V[CHUO!&T:$?4AJ]#_LG3_[%_L?[)'_ &=Y'V;[/CY?*V[=OTQQ
M3;31=-L=&&CVMG'%IXC:(6ZCY=K9R/QR?SH \Z\"^"9;[P'H=T/%OB6V$MG&
MXAM[M%C3(Z*"AP/QKEI+<VOP8^(=L9YIC%XAFC\Z9LR/B:$;F..2>IKW6QL;
M;3+&"QLH5AMH$$<4:]%4= *H2>%M#ETR_P!.?386L]0G:XNH3G$LA()8\]<J
M#^% &-#X*N(IXY#XV\2R!&#;'N8BK8/0_N^E8-]I^JZA\9M232M<?2G71K<N
MZ6T<V\>8_&'Z?A6]_P *J\#?]"W9_P#CW^-=%;Z/I]KJ#7\%JB730+;F49R8
MUY5?H,T <)X+M+@>/]83Q-J,]]XCL(]EH\BI'&UDY!$D:*  21ANN" ,UF>
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M=:YBT8'X4_$E<C(U'5,CTH ]7TVZ-YIMK.^T2RP)(RKV+ '\JL[U#A"PW$9
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M1N4'!9<@;AGN,BI/%FH1:3X0UB_GM5NXH+25WMV^[*-I^4^QZ'VK@X1J5O\
M$#P-#J6I:7*Q@N6BM+"U,2V\9@X&XNVY> !P,[3Z4 =>_P 0O"4<D"-KEL#.
MVU#\VT'<5PQQA>01\V*NZQXLT+0+J&VU34HK>>92Z1D%FVCC<0 <+[G KS&W
MMH5_9MUAA$H:47DCG'WF%RX!/N J_D*Z?PU(B_%#Q,;ME$[:=8- 7//DA7WD
M>V_K[T ;/@?7+GQ!I>H75S-',(M3NK>%XP #$DA"=.O'?O73UP7PD:V;PMJ#
M66W[(=7O##MZ;/,.W'MC%=[0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 54O-+L-0GM9[RTBGEM)/-MVD7)C?^\/0^]6Z* "N-\2
M^%E.DQ6VC^']'O;4WAN;O3[I=@E+ Y9'P0CYP<XYYZ5V5% '#>%?"#PSZW=:
MMI5A96^I0Q6D>E6["2.*! PPQ  )8NQ.!76SZ5876E'2[BS@EL#&(C;N@*;!
MT&#Z8'Y5<HH RM+\-:+HEG-::;IEM;P3_P"N1(QB3C'S9^]QQS4>D^$_#^A/
M.^EZ1:6CSKLD:*/!9?[N>P]NE;-% &=_86E?V7!IG]GV_P!AMV5HH-GR(5.5
M('L>:L-I]H^HQZ@UO&;R.-HDF(^94)!*@^A('Y59HH Q;/PCX=T_5WU6ST:S
M@OF+$SI$ P+?>(]">Y'6KL>D:?%:7=K'9PK;W;R/<1A>)6?[Y;USWJ[10!CW
MWA30=3AL8KW2;6>.P %J'3_4@  !?0<#CV%2:5HL6EW^K7:,I;4;H7#*J;0N
M(U3'7D_*23[^U:E% &7K7AO1?$20IK&FV]X(26C,J9*$]<'J,]Z8?"V@G3;G
M3O[(LQ9714S0"(!'*@!3CV"KCTP*UZ* ,:T\)^'["2UDM='LX7M4>.%DB *J
M_P!X9[YR<Y]:BA\%>&;?2KC2XM#LEL;AQ)+ (QM9AT..Q';'2MZB@#+M/#>B
M6&D2Z3:Z7:QZ?-GS;<1@K)GKN!^\3[U!IG@_P[HLL,NFZ/:6TL+,T<D<?S*6
M&T\]>G%;=% %+5=(T_7+%K'5+.*[MF(8QRKD9'0CT/O5!?!OAM551H=B%6W-
MJ%\D8\HG)0CN,DGZDFMRB@#*T7PUHOAU)5TC3;>S\T@R&)<%\=,GJ<5+J^AZ
M7K]JMMJMA!>0JV]5E7.UO4'J#[BM"B@#.M- TBQT>32+73K:'3Y%9)+=(P$<
M,,-D=\CKFK=G9V^GV<-G:0I#;PH$CB085%'0 5-10!S$VK^+DGD6'PG:21!B
M$<ZL%+#/!QY?'TIG]L^,O^A/M/\ P<#_ .-5U5% '*_VSXR_Z$^T_P#!P/\
MXU1_;/C+_H3[3_P<#_XU7544 <K_ &SXR_Z$^T_\' _^-4?VSXR_Z$^T_P#!
MP/\ XU7544 <K_;/C+_H3[3_ ,' _P#C5']L^,O^A/M/_!P/_C5=510!RO\
M;/C+_H3[3_P<#_XU1_;/C+_H3[3_ ,' _P#C5=510!RO]L^,O^A/M/\ P<#_
M .-4?VSXR_Z$^T_\' _^-5U5% '*_P!L^,O^A/M/_!P/_C5']L^,O^A/M/\
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MV]N-L32Q@E5_N^X]CQ6S10!5L=.LM,A>*QM8K>.21I62)=H+L<L<>I-6J**
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MNK.3S(KB)6 8 D!EP6'RGUS0!V-%%% &?%?7CZY/8OIDL=I'$'2^,BE)&/5
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MY@)"DY&,'@#')TX]1UGQ/<>(X=*U'^S9=,E^R6R;$8-,(U<M+N5CMW,%PN.
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MRCF67/7_ %2YS_M4 >O45Y9;>'+77_%WC>SU"XO'L[)K9+6!+J1%B8VR_/\
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M7="O[XR@!RV,8X'&.GO5G4_"]CJGB/2=;F+"XTX.%"]) V,!O4*P##W%;=%
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MWZ4 1WWAR&^U70K]YY%?2'=XU &)-T9CY_ YJI=^#K:[N?$T[74JG7[1+24
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MTJ.K=   OR@ #H*["B@#(O-!BO/$VEZVTSK+I\4\21@#:XEVY)^FW]:UZ**
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M2;G3-1@6>TN4V21MW'U[$'!![$4 6+E;=K29;H1FV*,)1*!L*8YW9XQCKFN
MO+*Q\4?$:/1;K$VA66C1W5O:12%89'>0J'PI 8!5 '89JR?AQ//:#3+[Q=KE
MWHH 4V3O&"Z?W'E"AV7MC/2M;5/!T5S?66H:3?SZ-?V=O]DCEM8T93!P1&R,
M"" 1D>E 'F^KO=66@^(M M;VY2VT[Q#91V4OFEGA21HVV!CDD*2<9SUK:N?"
M.F6OQ/L=(MC=1:9?Z9+-?6PNI"MR\;J%+DMDGYLGGG'/4YZ4?#ZP.@OIKWEW
M++-?IJ-S>.5,L\RNK9/& /E P , 5L3:!!/XJM-?:603VUK):K&,;2KLK$GO
MGY10!Y+>I-9>#?$6D65Y<6\%EXI@M[1A(2UO&SPG:I.> 6/6NGN=+L?!?Q$\
M.'2GFMK;4XKN._1YWD601Q>8LC;B?F!!YZ\TSQUX4AM/#.HI"UQ/_:VNVMU.
MHZIF2-2%*\@ +G-=%:>"1_; U+6-8O=8DBMY+:V6Y6-%A1\!_N*,L0 "Q[4
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M!*[@0#G /7VXH XG^PK71/"W@/7[22X&K37>G137)G<F2.4!6C(SC9@X QP
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M<I_PL;PS_P _%]_X*[K_ .-T?\+'\,_\_%]_X*[K_P"-T =717*?\+'\,_\
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M$TLMO%HMW#=6Z18PQCX53D=/I0!Q/B2PBT[Q'JNH^)[#5C:2SI)9:]I\Y/\
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M!(^8X]  =9117FVG:#8^+O&/BVZUA9)9K&ZCL[)A(RFT01*VZ/!^5BS$Y]J
M/2:S[F\U"/5[&WM],$]C,'-Q>?:%7[.0,J-A&7R>..E>+:;:MJG@WX:V<]S*
M4N=2NHYY(W*M(A,VX9'(W#(X]>*Z?6-/M=&^+?P[TW3HA;V<4-\J0J3@#RB>
M_N: /4LC.,\T5X7#9:UX@TK4-9L?"M[=>()+^=[36!?0IY)CF9415:0,$ 7:
M5QSSUS75V^J)X(\8>*8[[*6-Y9?V[ A;@.HVSH#ZDA3CWH ]))P,FBO'K;2H
M8?"WARQUBPOM6UC6+B?59M-AE6..=V&YC,6( 5 Z #/7'!K.<7'_  A>HZ8(
MYM-2V\6VUO! D^\VBL86VJPXP"S$8Z9H ]RR#T-&1G&>:\PO--LO!?Q!M'T*
MV^S+=:/>27$*LQ69XMC(S GELD\]>:D\'^#M,OO#7AWQ*US/#KDPBO;C45E/
MF3LXRT;YX*'.W;[<4 >EY&<9YHS7AHLM7\16>LZK:>%KZ\UUM0N/L6KK?0I]
MG,<I6-%#2!E5=H!&.<GKFMCQ1I0M=:U/6/%&@WMY83QQ20ZI83[IM*"QJ& 3
M.5"L&?<N>O.: /6J*C@=)+>.2.3S$905?^\".#6/XSU&XTGP3K>H69*W-O92
MR1,/X6"G!_#K^% &YD9QGI6+X5\0+XG\.VVK"W^S><\JB(OOQLD9.N!UVYZ=
MZP/#O@;1].30M8L9IK6_6)6N)UE)-]O3YA+N)W9)W>H(XKSZ'PYIX^!MUXB*
M.=7MC<36MWYC![<I<-@)S\HX)([DF@#WHD#J:*\M\4VVGZ_X@U!#H-[KMW:6
M,2S%[I(;>Q+*S@QY(/F$$,2,X 7D=*R$MV\4W?POM]4GFEBO-)N#=@2%3.!'
M&<,0<\D#/KSZT >TY''/6BO,[+PWI.O?$#7=-U&U\VPT*SLK73K8R,%@5XV8
MLN#][@#=U^7K7*6<EV?"^EZ,(KK5X;SQ+>QW,23K&]XL?F,%9V(&"5#'D9QC
MO0![N#D9% .>E>21^&?$4NE>(M/L/#\ND:9<&UGMM.FOH]LA5\SQ*T;MY:NJ
MJ.PR3ZFNB\ _V1;WVJ6=CI%]H5ZJQ/<Z5<$&-/O 2Q8)4AL$$@\[1QZ@'<T$
M@=3BBO.O%UIIVN>,#9-H-YXANK6R4R6QN$BMK4.S8?+$'S&VGIGA1TH ]%Z#
M)JEJNK6>BV'VV^E\N#S(XMP!.6=@BC ]V%>3:"[^*+3P#HNLR27&GS65W<3Q
M22$BX:)@D8<C[P4'/N<9JQX_\&Z1I/A..WA+S6PUJV:"VD?<MHLCJ'C3N%.,
MX/3/% 'IUQ=ZC'K5G:PZ8)K"5',][]H5?(('RC81ELGC(Z5H9&<9YKS#5K2#
M3?C/X%L;*,0VL5C=JD2D[0 C8K/TSP_IWB?P-KOB?54:36I);V2.\,C"2T\I
MW6-8SGY0NP' _&@#U_I1GC->1:5;)XR\7>'FUL-/%<>$HKJX@+$)-(9%Y8#J
M,L3CIG'I4=GH=[=>'=?T72K;[98Z7XE;&F/<&,36P16, 8]!N?(!XXQ0![#U
MHKCOA^^D+!J=KI=C?Z7)#<*;G2[OC[*Y08V#)&U@,\'!YZ5V-  2 ,DXHKS.
M+P[IOB3XJ>+8=7B^UVL-O9%;5W/EEF1_G(!Y( P#VR:Y:WNKVXL-#\--976M
M:?#K&I6YM%N%1KF*W/[M6=V *C=G!/.P>E 'M&KZM9Z'I-QJ=_+Y=I;KOD<
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M_DEWA[_KU'_H1KL: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN8FBE0_Q*PP1^1JOI-UJ-U!,VIV$5E(L[)$D=P)0\8QM;.!@GGCMBM D#J:
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M&T^V,F+=6QNQM5<L0 "QR<5'K'CBSLO">I:[81?;%L;K[(\;-LW.)EB;!P>
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ME2""R2*ZME7$BE'WKAU96P0O.,@]QDYW/^$ TR+0-/TRSN;RUET^8W%M?1R
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M1?WID&=S;MVX YP0,5WVF^!;&PUQ-9GO]1U'4!;O;-->RJ^^-B#M("@ #'
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MJN]#AES<1<@]C7;:GI&G>%OB-X>DT+3[>R:XTZ_29;>,()O+5&3=C[QSW/-
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M,DXSQ4,7B+QDTJ+)X$V(6 9_[7A.T=SC'-=9'/#,TBQ2QNT;;7"L"5/H?0T
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M=X7L);+3$=+>2=[@H[[MK-U /IQ3/$GA>R\3P6B74UU;RVDXN+>XM)?+DC<
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M1II9IY"\DLC'+.S'J3_2J>M^%+/6]0MM0:\O[*\MXVA$]C/Y3/&Q!*,<'(R
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M!'J*=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MNIH(C#;?;+MYA;H<96,,>.@&>N!C- %O7+.ZC\/:JFB-%;ZE<1NT4KG&9B,
MDGOT ]..PKGO!>M0WVN7ME/!JVF:K#;(9]+U"=YE #$>;$[,0RDD D>@KK]2
MT^'5=.GL;@R"*9=K&-RC#Z$<@^]5;'0K>SU%M1DGGN[TP"W$]P5++$#NVC:
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MV,%YM:VC19T#A ULNXJ#T)P.>O KE[;2+"#X*^&M:2VC.JK>6<@O2H,V?/5
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MU^'^BV=_!<1R7[6]O/\ :+>Q>[=K:&3)(98\X&"20.@/04 <IIKJGPE\=EF
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M8\DDDDD^M7J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!"]Z=0U RW+J/,A,>1'ANJ[0%Q0!VEYXLCM/%MAI[36@TRYTZ6]:[:0 #:R
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MA^QR2C48%@O&FG>1Y@"2"S$YW98_-G/3T%=!->6MO-!#-<PQ2W#%84>0*TA
MR0H/4XYXKDF\<V^A^$(=6U_4]&NII)Q"C:7-^ZDS(%^7<QSM!RW/&#0!>M?
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MU2ZD6WGD&,.\0.UCP.HYQSFNFK+L?$FAZG>R6=AK.GW5U'G?#!<H[C'7@'-
M&I7(M\-/#30SP-;W1@D8O'";R79;,7#DPKNQ&=PSE<>G0XK'B^(KZI\1YO#^
MF:CH$>G6ODAYIY]\EVSXRD.U@-PZ=^:]#EEC@B>65UCC12SNYP% Y))["@"C
MINAV.E3WL]JD@EO762X=Y&<NRH$!Y/HHKD_$VDRV'@T>"?#F@SW,5W;-;1S2
M.#!;*QP6=F;=D9+  '.!3=0^)ME/X/U35]!FLY[FRNUM_)DD#Y4SK%YFU6SM
M8$E3]*ZZRU[1]2O9K*QU6RN;J#/FPPW"NZ8.#D Y'/% "Z'I%OH.A6.DVH_<
MVD*Q*<<M@<D^Y//XT:EHECJ\]A->1%Y+"X%S;D.1MD (!XZ\$\&D37]'EU9M
M*CU6Q;45SNM%N%,HQU^7.:T: ,N_\/:;J>LZ9JUU"SWFF&0VKAR A< -D#@\
M =:\\\1Z%*^JZZL?@O4)[N])-M+:7N+*X8J LDZ%U 93URIZ9YZUU&K>+=1;
MQ'-X>\,Z3'J-_;1K)>37$_E06P;E58@$LQ'. .E3Z#XCU:YUJ;1->T0V%\D/
MGQSV\AFMYTS@X? VL#_">>] $^@^%+72K30Y)AYFHZ7IJV"S*QVE=J[N.G)0
M5+=>$=%O(-9@N+0R1ZR5:]4R-\Y"A01S\N HZ>E6(?$FA7&J-I<.LZ?)J"D@
MVJ7*&0$=1MSG(HOO$FAZ89!?ZSI]J8G6.037*(48C< <G@D<X].: ,E_A]HK
MQ6RB?58Y[>,PK=1ZC,LS1DYV,X;++D\ ].V*Z#3=-M-(TZ#3["!8+6!-D<:D
MG ^IY)]SUJN?$6B+J$&GG5[ 7LZAHK?[0GF2 C(*KG)R.GK3;[Q)H6F&07^L
MZ?:F-Q&XFN40JQ&0#D\$CG'IS0!1U?P3H^LZC)?S"\M[F:,17#V=W)!YZ#HL
MFPC<.<<\XJU_PBVC@Z/LLUB71R6LDC8JL65V]!UX/>K=YK&F:?IZZA>:C:6]
MDP!6XEF58VSTPQ.#GM1'K&F2V,%['J-H]I.RI#.LRE)&)P K9P23P .] %VL
M_3=%L=)N=0N+.(I)?S_:+@ER=SX SSTX X%16WB;0;Q;IK76].F6T4M<F.Z1
MA"!U+8/RCW-7FO;1+$WSW4*V8C\TW!D CV8SNW=,8YSTH P+?P#H%KJ<=[%#
M<;8IS<Q6INI#;12DD[UB)V@Y)/3@GBM"'PWID%GJUK' PAU:62:['F'YVD4*
MQ!SQD =*TXI8YX4FAD22*10R.ARK \@@CJ*;<7,%G;27-S-'!!$I:265@JH!
MU))X H S9?#.ES:?I-B\#&WTF6*6T7S&^1HEVH2<\X![]:HZKX$T+6-0GO+F
M.Z5KD*+N*"ZDBCN@HP/,12 W''/;BMZ2^M(;$WTMU EH$\PSM(!&$QG=NZ8Q
MWJG=^(]#L);:*\UC3[>2Y :!9;E%,H/0KD\@^HH I:OX+T;6;Z"^E2YM[J&'
M[.);*YDMV:+.?+8H1E?:H)/A]X;D\.SZ#]@*Z;-<_:FA25E DR#P0<@9 XZ5
MKZEKVCZ,T2ZIJME9--_JQ<W"QE_IN(S6;?\ C;0].\366@W%_;)<W4329:=%
M$>-NU6R>K[OE'?!H EUOPCI>NWD=Y<?:X+N.,P_:+.ZD@=HR<E&*$97/.#4%
MUX&T.XMK"&&*XL381&&WDL;F2"1(SC*[E()!(!YSSSUK3DU_1XM672I-5L4U
M%\;;1KA1*<]/ESFEOM>T?3+N"TO]5LK6XG_U44\ZHS\XX!.3SQ0 _2M*LM$T
MV'3]/A\JVBSM7<6.22223R22223R2:NUS_@G7;KQ)X5M]4O(X8YY)9T*P@A<
M)*Z#J2>BCOUKH* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *\\^.'_))-8_WH/_1R5Z'6=KFAZ=XD
MTB;2M6M_M%E,5,D>]ESM(8<J0>H% ''&PM;[XR61NH$F$'AP21K(N0K>?C=@
M]\$C\35OX<Q1V\WBZWA18X8O$$XCC48508XB0!V&2:ZE='L$UA=66#%\MK]D
M$NX_ZK=NVXSCKSG&:73])LM+DO7LX?*:]N&NK@[B=\A !;D\<*.!QQ0!RWQ0
M.[PW802_\>5QJ]G#>YZ&$RC<#['@&L_XA6>D:5H>OW>F+%;:\^BR((X&V,UN
M&&YM@X.,_>QD5WFI:;9ZOIT^GZA;I<6DZ[)(G'##_/>LO1_!FA:&UR]I9L\E
MS'Y,TEU,\[-'_<S(2=OMTH Y+Q5I^FZ;H/@J;2+>"*6+5;&.S>%0&9&X89'4
M%,D^O6H-#TC3[O2_B-<7-G#-+)J=[$7D0,=@C4@#/3EB?K77:9X"\.Z1?P7E
MI9R^9;9^S+-<RRI;YX/EHS%4_ 5IVVA:;:0:A#!;[(]1FDGNAO8^8[@!CR>,
M@#IB@#S+PY:0:GKWP[-[$L_E^&6D D&X;@(@"0>N,_GS6=KD+V[>+=.L8;=;
M67Q+IZR02$I 0ZQ%@^T<*S;=V!WKUFS\-:1I\^GS6MIY<FGVAL[4^8Q\N$[?
MEY//W5Y.3Q23>%]&N$U5)K%)$U9E:]5V8B4JH4'KQ@ =,=,]: /.?$>F>(].
MM_$FLRC1+*4^'YH6M]+F<R/A@5D*LB_=&\9]ZZVST7PG!;>&)C#:0S)$$TXH
M0AEW1?,O'WP5R2#D=ZU-(\(Z+HAN7M;:222Y0132W4[W#L@SA-TA)V\GCI5?
M2/ ?AW0]1COK&Q=9XE98/,N))%@#=1&K,0F?8#TH \QC@AC_ &=_$4B11J[3
MW*LRJ 2!<G )KH]-ABO/'?A""_C22WA\,F>U2097S\QJQ /<)74K\/\ PTEM
MJEL+&06VJ$FZ@^TR^6Q+;B57=A<GGY<5;U+PEHVJV5E:W-JX6Q %I)%,\<L.
M!M^612&'  ///>@#ROQ7!%!:?$VQM%$5B+C2W"1?*JS.R>81CH3A"?>NQUK3
M;+3/B1X$6QM(;88O82(4"Y009"G'4 @&N@C\%Z!%H$^B+89L;B433JTKEY9
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MF@#Q2">XU3PKI'PWN'9KU-5;3;T]";2V(D+>P*>4!ZYK073=7U7Q!XXA@L-
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MU1G=E!)*L^WGVQD>AJY-<)X7U;PCXLGDV6.H:;'INI2'H#Y8DB<^^X,N?0T
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MB0/;.*J6'CK0+SPM;^()=2M;>TD"*Y:4'RY2H)CSW89Z 5=_X2G0?["_MO\
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MV<T=DGF7#+)_JT_O'_9]^E $.G^ ?#&ERV\MII862VD66%WFDD:-@"!M+,<
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M2=X<$,&Y.3G)R:NZ/HFG:!9?8],M5MX2YD8!BS.QZLS,26/N2361<>,M,O\
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M^\<)*R_=+H#M<C Y8&NAKS?PWXC^(/B?P[::W967AE+>Y5F2.66=7X8K@X!
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M TJ^73UN;*.0:=(LMH&S^Z=?ND?2I(M&TZ'69]8CM$74)XA#+.,[F0= ?RH
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M+L<XYXR<#- ')ZM'9)\,O 9T]8_-%]IILRF,[R1NQ[D;L_CFGZ)_R4CXI?\
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M$XNB//;3[,V>[J81OW[?;?C/OBE^&>UK/Q&\&#8OK]VUJ5^Z4RN2O^SNW=*
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M_P"+4L$BR)]HMTW*<C*QQJ?R((_"M[QRP;Q?\-&4@@WKX(_W$H ]/I"0H))
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ML:BB.H^8L!\@!]B3CW)K.U5K)OV<M+2Q,?G-;6:6H3&XW6],A?\ :W[L]^M
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M^N:UKT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MUC2K6\:'(C:5,E0>HSUQ[=*-3\*Z#K%E;66H:3:SVUKC[/&8P!%QC"XZ# '
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M=5_9]H-3.I?9X_MIA$!GQ\WEYW;<^F3FN%\*^.':?Q._B&_1+:SUY].M&,6
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MQ9:=9Z<)Q9VT< N)FN)=@QOD;[S'W-9D'@SPU;:O_:T.B627V\R"98AD.>K
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MZXSSBHO[$TO^R#I/]G6O]G,"#:^4/+()R1MZ=>: .'UCGX[>%C_U"KG^M/\
M!US8V=IXY35)(HY(]9NY;L2D ^2P!0G/\)3&*[I]-L9-1AU![.!KV%#'%<%
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M/P@\,PZ9)$T\TNG)IZQD;O-5TSCW #9].:V_"4$1\4>/I#&I=[^-&)'51 F
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M>R>5:VT;2ROM+;549)P.3QZ5SP^(_A4W8MVU,H71GCDDMY%CE"C+!'*[7(]
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M]: *,?CVRD^(,WA;RI\QP(WF_9Y3F4LP*YVX"X .XG!SC-3'XA^&%OS:F_?
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M(/%/BB"ZUU-6G7PI.AE6%(@K L2@"\$@$'N1NK3U2)(OAM\/5C0*%O\ 22H
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M2W1I%QTPQ&>*N)9VT5U-=1V\27$P599E0!W"YVACU.,G&>F:FHH I_V1IO\
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MB@"QD9S(X4'GMS5/Q!XP@T74;?2;6PN]5UBX0RQV5H%W+&#C>[,0$7/&3WH
MZ2BN4TOQMY^MPZ+K6C7NB:C<*S6R7+(\=QMY(21"06 Y(XK0\,>)8/$^G7%U
M#!);O;74MI/#*1NCDC."#C\#^- &W17-^#O&FG^-+6^N+".6-;2Y,!$N,L,
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MA"EE#$$JI/)Q0 ^BL7PEKQ\4>%=/UHVPMC=Q[_)#[]G)&,X&>GI6U0 4444
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M\IYR?IP*FTCPFVD7C7+>(]?OP8RGDWMVLB<]\!1S0!T=>;W7_)Q=C_V+C?\
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MVY[UXI!H]C;_  K\'Z^ENAUG[=8N;]AF<YE"[2_4KM^7;G& *Z31?#6BZ_\
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MXCDM$CBN$#K'NMURP!Z,< 9Z\5A>$99'N_AS%)(TB6]WJUO"[G),:*ZIS[
M?A0![,9HU+AI$&P9;+#Y1ZGTIGVNV_>_Z1%^Z ,GSCY >03Z5Y7XG(;4OBD
M0<:#;@^W[N:K?_"#12_#W2#I%A93WDAM+V]ANCM&I;4)*2-@YY<D9! P!C%
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M!=PSC'.,5<\0:/JFF>#_ !O/)H5MHFF75A$R6=O<K(@G5B&<!0 NY=N>.2M
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M);V][;33Q_?CCE5F7Z@'(H Q+7P/I=O9:M#-/>WD^JP&WN[NZFWS-&5*A0<
M* &. !WJ[=>&=/O-/TFRE\WR=+GAGM\/@[HAA-WJ/6KLVJZ=;8\^_M8LN8QO
MF5<N.J\GK[5)=WMI80^=>74-O%G&^:0(N?3)H GK/O-&M+[5]-U.;S/M&G&0
MP;6P/WB[6R._%6I;NV@M3=37$4=N!N,KN @'KD\8K#M/$HO?&TNBP""6T73(
M[Y+F-]VXM(R8XXQ\M &_-#'<020S(LD4BE'1AD,",$$5RMC\.])L;FR8W>IW
M-K82"6SL;FZ+P6[#[I5<9.W/&XG':NMHH R(/#=A;^*KKQ$GF_;[FW6VDRWR
M;%.1@>O%3ZYHUGXAT6[TG4$9[6Z39(%;!QUR#Z@@&IDU*PDO6LH[VV>Z7[T"
MRJ7'U7.:2XU/3[-7:YOK: (P1C+,J[6(R <G@D<T 9>G>$;/3[W3[QKR_N[J
MPAE@BFNY][%)""=QP,_=&*+GP=H]Y_;?VF*25=9:-KI2Y',:A4*XY4C:#GU&
M:WE974,I#*1D$'((I: ,'1/"EKHM]+?F]U#4+V2(0_:+^X\UDC!SL7@ #/)X
MR>YJ;Q)X;LO%&FI8WTES$D<Z3I);2>6ZNARI#=L&JOC#Q-+X7L;"6WTTZA<7
MU]'8Q0"819=PV#N((_AQ^-5;/7_%TU[!%<^"?L]N\BK+-_:L3^6I/+;0,G Y
MP.M $<?P^ACD5_\ A*/%;;2#AM7D(/U%;=IX?LK.]U>[B\SS=5=7N<MD9"!!
MM].!6C%<0SJS0S1R!&*L48':1U!QWJ&34["*S%Y)?6R6I.!,TJA">GWLXH R
M/^$-TK_A&=/\/_O_ +#8/%)#\_S9C8,N3CGD5S-EX.DU/QCXPNIY]7TSS[J%
M8KBSE,/VB/R$!&2"& .>1R#G!&37H37,"VWVEIXQ!MW^:7&W;ZYZ8J./4;&:
MT%W%>6[VQ.!,LJE,YQ][..O% &)-X%T.6QT*R6&2&WT2X2XLTC?&'3INSG/J
M?6F:IX'T_4M3N=0BOM3T^:\14N_L%SY2W 48&\8/('&1@X[UT<EQ!"RK+-'&
MS E0S $@#)Q]!7/P>+;;6=&U.YT&>T>YLY980+N4)&61MNXE22$)Z'O0!D^,
M;9++P:?!^B>'KJZ^V6IM+9(HC]G@!X#22'A=OWN>216O;^#=/3P%'X2F+M9_
M91;RLAVL_=FSV).3^-;%C=^?;VZ3RVWVUH$EEC@DW 9')7N5ST-3FXA$Y@,T
M?FA-YCW#<%Z9QZ>] &?=Z!97E]I-Y+YGFZ4[/;8; RR%#N]>#4$WA/2;J[UF
MXN86F_MB"."[C=OE9$# 8]#ACS]*T[2_L[]&>SNX+E%.UFAD#@'T.*S?#?B!
M]?@O&FTR[TV>TN3;R070&[[JL&!!(P58&@"KI7@NQTR\-V]]J>H3K UO$]]<
MF7R8VQD)P,9P,DY/ YJ1O!NE/X/@\+GS_P"SH1&J?/\ /\CAUYQZJ*Z"B@#!
ME\)V3^+!XCBN;VWO#&L4T<,VV*=5SMWKCG&?:I]=\.6'B-;%-0\UHK.Z2Z2)
M6PKNOW=X[CGI6O10 5YUK_@_3M"T.VAL-*U:[MH]3:\#:=<8N+ N#EH0!EES
MP4_VL\UZ+10!YGX4\+KJ.J^);N:QU.TTS4K%+ /J)(NKGA_,D;=R/O!1GL.
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ML+_Q'I^N7/FO=:>DB6R%OW:%QAFV_P!['&:OWUE;ZEI]S8W48DM[B)HI4/\
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ME>4!BP+$]3SCZ #M0!OUE^)+FXL_"VKW5H2+F&RFDBQUWA"1^H%:E(RAE*L
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M4"P71FN782J%*\C/)P3R>1GC%0GP'I1T.RT@SWYM;*:.:'=<EF#1X\ODYX7
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MBB/5$S]T' ]^!S0!YG_8>F67P1\/:Q!9PKJ:2V$ZWFP><&,R#[_7 4X S@
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M0"2+POF)%'&1(N !^59$VEZ5'^SO'JT<,(U 6J7HO0H\[[47!W;^N[?QU]J
M/6[O6=+T\2F]U*SMA$5$AFG5-A;E0<GC.#CUQ5N&:*XA2:&1)(G 9'1@58'H
M01U%>>Z)I5GJOQ2\53ZG90W$L5G8 ),@=5+QONX/&?E S]?6M#X4J(_ D4"\
M1PWEW%&O]U1.X 'L* .JO]4T_2H1-J-]:V<3':'N)EC4GTRQ%8_BSQA8^&?"
M-SKJRV]R%B+VR"90)V[!3WZYXSQ6+]DMM4^,M]'J<$5PMGH\+6<<RAE4/(WF
M. >,Y"C/IQ7%:Y9VL?PZ^)%I%;Q&RL-4;[&-@(@+"(NJ?W0&)X'J: /4O!NL
M7VN:"E]J$VER32$$#392Z1@J#M8G^,9Y_"GMXNT=/%@\-M=Q"^^SB;F10,EM
MH3KG>>N,=*F\,6EM9^&].6UMX8%>VB=A$@4,Q09)QU/O7*)86;_'JX=K2!F'
MA^.8,8P2)/M##=_O8 &>M &OX5\:6FL:'97.J7EA9WUW-/'';&8(7"3/&-JL
M<G.T?C6_?:MINE^7_:&H6EIYIVQ_:)ECWGT&2,UXW!H>F-\ -9U!K*%KQC>3
M>>R NK)<.%VMU&-HZ>_J:V#!JVK^/M>\K1M'U;RK&SA U.=D\N-XRQV 1MPS
M%LGCH* /6 00"#D&J-WK6E:>)#>ZG9VPB*B3SIU386Y4')XS@X]<5F^!]/O=
M*\&:98:A-#-<6\9CWP2F1-H8[ &(!.%VCIVKG-,T?3]3^+?C%[^SANO*M;%$
M69 Z@,C[N#QGY0,_7UH [5M:TI+FWMGU.R6XN5#01&=0TH/0J,Y8'VJRES!)
M/+ DT;318,D:L"R9Z9'49[5X7#H]A!^SQ_:26L7V]+A9$N2H,BE+L(N&ZC"@
M >U>B>'3_P 73\;#OY6GG_R')0!K:SXRT30XK&2YOH&6]NEM8RDR8!+8+$D_
M=4@Y/:MB"]M;IREO<PRLJ*Y6.0,0K#*GCL>Q[UXA!;VEYX)\$220PS+)XP9-
MS(&W(TUP2/H<#CV%=_X?1(?BKXLBC541;+3PB*,  "48 ]* .L?5-/BLI+V2
M_M4M8R5>=IE"*0<$%LX&#Q6+XH\4II7@74?$6DRVM\+>'S(F5]\;G('53SU[
M&O/M%GM[KPWI%A'I<&JWMWK]_-91W$YCMU*/(QD? .X!3P,'DBJFI+/!X*^*
M-K-%90&.:)F@L&)@1VBCW;<@')(YX'.: /9-&O7U+0]/OI%59+FVCF95Z LH
M) ]N:2[UK2M/$AO=3L[;RBHD\Z=4V%AE0<GC.#CUQ5?PK_R*&B_]>$'_ *+6
MN0TO2=,U+XP>+WO[6"YDBM;(1I,@< ,C;B >.RC/O[T =Z^H64<4,KW=NL<_
M^J=I !)QGY3GGCGBJ[Z[I$>FIJ+ZK8K8N<+<M<((F.2,!LXZ@CKVKQ9;*"\\
M/>'-)D!?38_&<]K"F>&MPTHV?[I!(^E=O/I>G2?%W3M+EL;8:=9Z')<6=KY2
MB)9FG"NRKC&=N/SH [A=3L'L5OEO;9K1L;9Q*IC.3@8;..3Q4*:]H\AN@FJV
M+&TYN MPA\G_ '^?E_&O'?$]O%:Z5\1]+LU\G3H]1TUXXX?E6.21HC)MQT.<
M'CN:ZC6?#6BQ?%/PE;Q:9:QP-9W8DB2(!)!&(R@8=&P3D9[@'M0!V=]JZS>'
M;C4=%O\ 2Y2$)BN)Y\VV0?XG7M]*E;6;.PTRTN-7U'3[9ID7,AG"Q.Y )V%B
M,CT]J\FUJ"*R\*_%>SM8TAMH[E'2*,;54M%&6P!TR:W#HE_/:>&M8TZQTO6'
M@T.*WFTN^<*=C!3OC)! 8X(.1@@=: /1+O5-/T^T6[O;ZUMK9L8FFF5$.>GS
M$XI9M3T^WL!?SWUM%9D BX>55C(/0[B<5Y);3-J_B+PXGA_0K*2RM]&G>WT_
M59V5+>03^7+@[7RRD;1['BK]OX/UI-)MD":$UU9:Q<7MII+SM):F-TPT0.T$
M,K.Y'RX&10!ZC;75O>VZ7%K/%/ XRDL3AE8>Q'!J*ZU*PL=WVN]MK?;&96\Z
M54P@.-QR>F2!GWKG_ MS9S6&HPP:-_8UU!?.E[9+('1)BJL2A'&TJ5/ '4\9
MK)UC3K34OC/H\=Y D\<>C3R".1=REA*@!(/!QG/UP>U '7/XBT2*VM[F36-/
M2"Y.()6N4"RGT4YPWX5/?ZII^E0K-J-_:V<3':KW$RQJ3Z L17E6E^'='?P_
M\2F?3K=_*O;R*$-&"(5$*N G]WYF)XQSCTJU8.VJKX3M+31;'4]7A\.07$EQ
MJ<["&&.0*.%"MN=BAYP, =>: /39]1L;:Q^W3WEO%9[0WVB255CP>AW$XQ6)
MI_B@:EXTN=(MFMI[!--BO([F%]V\M(ZD9!P1\O:O,_#R1W\'@#3+U()=..K:
MFQA7YH2T9D,0&>JC)VY]!4_BN*+1O$/CYM&1;>0^'8G=8!M",SL&( Z';SQZ
MYH ]=LM7TS4I98K'4;2ZDA.)4@G5RA_V@#Q^-9_C+6Y_#?@_5-8MHHY9K2 R
M(DF=I.1UQS7(Z/X=UF#Q+X=O5TGP_I5K9QR1,;&[9GN(6CP%P8UW88(W)[9K
M;^*?_)+_ !#_ ->A_F* .@M-:TV\N39PZA:27J+NDMHYE:1/JH.1^-/;5],7
M4AIK:C:"_(R+4SKYI'7[F<_I7!ZUHVG:-KW@&33[.&WE%\T)EC0!W5H'W!FZ
MMDC)SWKE=+T;Q#KO@J:>WTO04N9]0EN?[5N+QDN8YUN#AC^[.""H4#=T^M '
MLL^KZ9;3&&?4;2*42)$4DG56#MRJX)ZGL.]*=7TQ=2&FMJ-H+\C(M3.OFD=?
MN9S^E<'H6CV&H_&+QI=7MI#<2VHL#!YJ!Q&S0Y+ 'HWRCGK7*Z7HWB'7?!4L
M]OI>@I<SW\MS_:MS>.EPDZW!PQ_=G!!4*!NZ?6@#UN"^O6\2WMI+/I9L8H5>
M...4FZ5CC)=>@7T-3KKVCO<P6RZM8FXN%#0Q"Y3=(#T*C.2/I7!:9_R73Q9_
MV"(/Y+7-1Z-IUM^SQIVI16<(OU-K<+=;!YH?[0@SNZ\#@>W% 'N59'B;Q)I_
MA30Y]5U&3$46 $# /(Q/"J"1DUKUP7QFABE^%VJM)$CM&T#(64$J?.09'IP2
M/QH TY_&-O%XMM+ 7-B=*FTV:]:],HV@I(J?>SMQ\QS[BNAM]1L;NQ^W6U[;
MS6F"WGQRJT>!U.X''%<+J6BZ9<?%W0[62QMS:P:/<2QP>6/+#>:G\/3^(GZ\
M]:Y+5H7M8O$NDZ?;6_V.;Q591M:NWEPLKI&Q5B =JLP4' [T >S6&IV&JPF;
M3KZVO(@=I>WE610?3*D\U7U_7;+PUH=UJVH.RVUNN2$&68DX"J.Y)( ^M<OX
M:T76;/QO<:E>6&C:9;S:>(9+;3KEG,CJX*2%2BC@%US]!2?%<^3X;TV^E4FS
ML=8L[F\P,_N5D^;/MR* $F\8^+K*P.K7O@@IIB+YDB1:@KW4<?4L8]H!('.T
M-FNL?7-+ATN#4KF^@M;.=%>.6YD$0(89'WL8..U3W.H6=IILFHSW,:6<<1F:
M<M\H3&=V?3%<*C6'B/XM6LLZ1W=BGAY;NP69,KF24AI K#@[0@Z9P: .Z&HV
M+6D=VMY;FVD("3"5=C$G PV<')XJNFOZ-(ER\>KV#+:_\?!6Y0B'_?Y^7\:\
M=UZVBATKQII-JOEZ9'XAL/)2+Y5C9S$9 N/N_,>@Z$UU.H^&]&3XN^'X8],M
M8X#I=P6A2)51]C)LW*!@XW$C/0X/:@#OXM5TZ:Q2]BO[62T<A4G293&Q)P &
MS@G/'UI+/5M-U">:"RU"TN983B6.&97:,_[0!X_&O%]<MK:W\(>.;% +>R3Q
M-;X6/Y!&&: L5QTZD\5U^O6&F^'OB%X,GTVS@L]R7D,XMXPF^!8=V"!U (4C
MWH [B+6-+GU!]/BU*SDO8\[[9)U,BXZY7.13+G7M'L\?:M6L(,R&(>;<HOSC
M&5Y/49''7FO(T1UM?!>IVFAZ7I6G76LV[VCBX:2]=92Q.]BO.Y221N/;TK8T
M70M+O]/^(MS>6,%Q,VJ7D0>5 Q51$I 7/3EB>/;TH ].2[MGN6MDN(FG10[1
M!P653T)'7!]:5;JW:Z>U6>(W"*':(.-ZJ>A(Z@5Y/I[OHME\._%Q8^5/80:3
MJ+D]8Y$!B8GT60#)_P!JNF^'L1U)]:\6R#+:U=G[.3VM8OW<7TSAF_X$* .O
MO;^STVV-S?7<%K IP99Y BC\3Q34U*QDM8;I+VV:WG8+%*LJE)"3@!3G!)/I
M7*^,VCN=?T#38-'M=3U-C/<6XO9V2W@55"L[@!MQ^< #!QDGBO/GMS/X5O\
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M6=P\$JH>J[D()4^AIA\&Z%_PBTWAL69&F3Y\U!(VZ0EMQ9GSN+$C)).:WJ*
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M'YM$^RN;.>87$Y:9VDED#!M[N3N8Y4=3VQTK2N-'LKK6;+5I8B;RR22.!]Q
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MD;7VE<\=>">M9,W@'0)]4>]>&XQ).+J2U%U(+:28'/F-%G:6R >G)&37344
M9]IHMC8ZQJ.JV\16\U'ROM+ER0WEJ53 Z# /:LF7P#H$VJ/>O#<8DG%U):BZ
MD%M),#GS&BSM+9 /3D\UTU% &5%X<TR#Q!>:['"PU"\A6":3><,B]!C.!TJ
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M# !AN0@X( R/:J,7@#P[;L_DVDL<;7$%UY*W#^6)8L;'"YQGY1D]\<YKIZ*
M*$VC6-QK5OJ\D1:\MX7@C?<<!'(+#'0_=%<[_P *O\+^4T!MKIK7?YD5JUY*
M88&W;LQINPASZ=B1T)KL:* "N-?X8^'&N;B=/[2A:XF>>18=2GC4NQRQVJP
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M+%$?1U=+#8S*(0R[6  .#D#'.: ->BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ***S->\0Z3X9TUM0UB]CM;93C<V26/HJCEC[ 4 :=%1V\
M\=U;17$+;HI4#HV,94C(J2@ HHHH **** "BBN<U;QQHFCZC)I\TEU<7D2AY
MHK.TEN#"IY!?8I"Y'//- '1T52TG5[#7=,AU'3+E+FTF!*2+D9P<$$'D$$$$
M'D5=H **** "BBB@ HHHH **** "BBN2O/B5X8L;^[LIKJ[,MI(8IS'83R*C
M#J"RH1W]: .MHJKINI66L:=!J&G7,=S:3KNCEC.0P_SQBK5 !1110 4444 %
M%%037EM;W%O!-/''-<L4A1FP9&"EB .^ "?PH GHHHH ***PM;\8:/H-Y'97
M4EQ+>R)YBVMI;23R;,XW%4!P,]S0!NT5FZ'K^F>([ WFEW/G1*YB<%&1HW'5
M65@"I'H15VYN$M+2:XD!*1(TC!>N ,G% $M%97AOQ!9^*?#]IK5@DR6MT&*+
M,H5QABIR 2.H/>M6@ HHHH **** "BBB@ HK,N]<M;/7]-T:193<ZA'-)"54
M;0(@I;<<Y'WAC@UIT %%8&O^,]#\,WEM::G<3)<7*,\4<-M),6"XR<(I]:30
M_&WA_P 0WKV.G7Y:\1-[6\T,D,FWU"NH)'N* .@HHHH ***IZKJ=IHNE76IW
MTGEVMK&TLKXSA0/0=: +E%<Q8^-8M0TJTU&#0==,%U<)#&#9C=M<9$I&[B/'
M\7Z5T O+9KYK(3QFZ2,2M#N^8(20&QZ$@C\#0!/1110 4444 %%<WK?CO0?#
MUZ]IJ,MVDL:!V,=C-(H4C.=RH1^M1:/\1/#FOWMO:Z=/>2R7 )B9K"=$8 $Y
MWL@7H/6@#J:*S?#^N6OB30K75[)95MKE2R"50&&"1R 3W'K6E0 444A( ))
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M@EU>^L%GGD4Q:=$SW5V!)*?+C*?,O8EAV&.,TR^\1:I9_#SQNEK?:O&VEW,
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MC.2&'('!.!P2><XIMS\.=5N-"O?#Z^(8HM':>2YMD6T_>J[2&4+(V_#(KG.
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M<!FY)!5U#')P10!Z_17FOBO1;_PEX,\37FFZ_J)LS89BAGN'DE@F#<NDI;<
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M-,.Q/OZ^]>7>(]7^S/J>M:=J/B.]O;745"7<0=+"%1*JM 5+;74#*E@#D]Z
M/9J*\ZCTR?Q+\0_%MA>ZOJ<6G6BV9BM[6[>$!WB))RI!'3.!P2<D'BL+2=4U
M3Q!I'@?0KS5;U4OY[X7ES#,8YIH[9F"J7'(S\N2.3B@#TI-6L+SQ1<:*ULS7
MEC;QW7FNBE0'+ ;3G.?E.>/2I+[7;;3]=TG2)8Y6GU/SO)90-J^6FYMW.>G3
M -<?X6TXZ5\5_$%H+NXN85TRU,)N93(Z*6D^4N>6P<X)R<$#M3O'=C)J7CWP
M19QW<UJ)7O0\L#[9 @A!(5NQ(&,CD9XYH ]"HKQ_6=6U+P0_B[2K#4+ZXACL
MK2YLFN)&N)+9II?)8*6R3R0P![BKFD7%Y9:\D6F6_BL:=/8W O'UE)2J2JH:
M.16<G:Q^8$# Y'% 'JE%>+QQ:C9_#'0/&+:]JTNKA[-F+W;F)XWE1"C1YVGY
M6Y)&2><U<UG4YM7\4>(XIO\ A*B;"1;73_['27RH6$:L7?80&8LW1LC 'K0!
MWOB?Q=9>%S813VUW=W=_,8;6UM(PTDC 9/4@ #CJ>]6K369;K4XK)M(U&W#V
MBW)N)HU$2$D?NB0Q_>#/('''6O)_$>GW&L^(/AM=ZN^I6NH:AN6\B6XDB,3K
M$N2B@CRR3G.,$UTD37/_  N:;P\=1OSIH\,@",W3YW>8$\S.<^9C^/K[T >@
MV=]:ZA"TUI.DT:R/$60Y 9&*L/P((_"K%>*>%-+U&+X4-=Z3-J\\TVHN+N&W
MNV\UK=+E]XA!.%<KU(P3SSFNZ\!7.G3PZBFFZIJ=Q%'(@>QU3>9[)MO*DR?/
M@]1G(X.#0!V-9>CZ[;:U-J<5O'*ATZ\:SE,@ W.JJQ*X)XPPZXKE]4AE\2?$
MQM$N+Z^M]-L-+2Z\JSN7@,LSR,H+,A!( 7@9ZFN+BO[[0M%UVQCN]0E>\\8&
MQEN;5=UTT7E*QVX_Y:%4QD=R30![A17DL$GB'[/XAT_PY;>)([62P26T.JB1
M98Y@^)$BDD).60Y&3PPXQ4;^([;0O"WB6^T34M;BOK:S0MI>M>8TMM(S;1,/
M,))'S<X)7(% 'KU0W4YMK.>X$,DQBC9Q%$,N^!G:H[D]!7,Z5X/NM$U.TO+7
MQ!J4\0B9+Z"]G><7+$<.NX_NV!YX&".,5QO@N#4)OA+<^*KW7-4N=2DTJ[2/
M?=,4B5=^T@9^_E,[CSSCI0!Z /%4"3:#!<6%[;3ZRSI%%,BAH2B%R)!GCA>V
M:WJ\6@%[KNB?"P3:C=+<W+S>;=B0F4CR7W88\ABN1GJ,YJWK>JZAX"OO%&G:
M=?WMS -&CO[07<S7#6TK2F$[2Q)(Y#8)/(H ]>K+\1:[;>&M#GU:[CED@A*!
MEB +'<ZH,9('5AWKSO3-0O-%UNUFTVU\6261M+@ZB=9CE,9=(RZ2 N3M8LI4
M@8'S#CBL?6](N9_@S#XDN=9U*?4+Y;6YNQ+<LT,@DF0[!&3M4+D8V@'Y<=":
M /;V.%)P3@=!5'1M2?5]+BO9-/O+!G+ V]X@25<$CD D<XR.>AJY,2()"#@A
M3_*O$M"U;6[_ .$G@V7^VKY+V]UY+:6[,S-(4:252"3G=QC@Y' H ]PK-UO7
M=/\ #VG_ &W4IC'$SK$BHA=Y';HBJH)9CZ"N4TBUE\/_ !1.CV^HZA<6%WH[
M7;17ET\^V59E7<I<DC(;D=*V?&.@7VMVMA/I5U!;ZGIMVMW;&X0M$[!64JX'
M."&/(Y% #]&\9Z7K.I-IBQ7UE?B,RK;7]H]N[H#@LH8?,/I70UPEIXFOHO$-
ME8^+?#,%GJ31S'3[ZWE6>*0JNZ158@-&2HZ'J!7&:+K.JWFGZ/KUK#XLN-:N
M;F*:Y)AE-E)"[C>BK]P(J$X8#.5SF@#VZJYOK4:B-/\ /3[68C.(<_-L!"[O
MID@5Y]9:9>>-[SQ->R:YJ=C<66HRV&GBUN62.W\H* Y0$!R6))W9R..*@M]$
M+?')#=ZA>R7$>@Q7+M'</&CR";:1L#8$9QG9TR: /0-+U-]2-X'TZ]L_L]PT
M ^U(%\X#^-,$Y0]CQ]*T*\6L_$^M6O@[QU<1ZC.UVGB22QM)9G+_ &=7D1!M
MST"AB0.F:Z6\L)?!?B;PR]AJFJ7%OJ-V;&\AO;QYQ*3&S+(-Y.U@5_AP,&@#
MT*2-)8VCD171AAE89!'N*4    8 Z 5XPEIJ%[\--<\23>(-8&H:?->O9&.\
M=5B$4KD J#A\X(^;/& ,8KUNUOU.APZA=.L:?9EGE<\!1MW$_3K0!6U?Q+I6
MA7NF6=_<^7<:E.+>UC"EB[''IT'(Y]Q1KGB"UT);-)8YI[F]G6WMK:  R2L>
MN,D  #)))P *\FU'6-+UF[T?Q5=ZG9"YN=<M%MK=KA-UI9([$;AGY2Q^=L],
MJ.U=G$Z:K\:R[.LD&FZ(KVV#D;YI#N<?55 ^E '2:7JUCKM]J,<=LWG:5=FU
M9Y47[^U6)0Y/&&'ITIUYX@M=/U^PTBZCFB:_5OLUP0/*=UY,><Y#8Y&1@X.#
MGBN!T/PR?$&O^-C+JNI6D::LRP+9730[)#$F9#M(W'[N <@8/'-5-7U2[US]
MGRT\0W4F=4LA%=QS]_.AFV[_ *D _P#?5 'K]<MX7\;1>*YI?L6C:E%:1R21
M&\F$0C+H<%1ARWZ5TT4@EA20# =0V/K7EWPYNDLOA9KES)?C3UCO+YC=E-_D
M\GY]O\1'7'>@#U":W@N4"3PQRJ#D+(H89_&I    !@#M7E7AF]DL?&^B6EFW
MB46NH6EQ]H.M,Y6=T",LB*[$J>3D  8(XK#ACU-/@S;^,Y/$&KOK%L!+$QO'
M\O:)]NQDSAP1U+9//7  H ]QK+T#7;;Q%IK7UK'+'&)Y8,2@ [HW*$\$\94X
MKDH[27Q9\0?$=O=ZGJ5O:Z.MM#:Q6=V\ #R1^8TC;2-QY &<C Z58^$JR)X%
M"S2>9*+^[#OC&YO/?)Q[T :^K^--+TC4CIIAO[Z^1!));Z?9R7#1*>A?:,+G
M'?FM'1-=T_Q%IJW^F3^; 69#E2K(X."K*<%2/0US&I:1XHT3Q3J6O>&XK#48
M-2$1NK&ZD,,@>-=@,<@!'( R&'6L#6?&"S^'$AL=,OM&OKK7%L=5MK*,&Y5B
MAD<H4^\S*H <<X/M0!ZO17CESX@U;PYH_B:72[?7H=.6RB>SDUJ.0M!<-)Y;
M!6DR2,,K8)."#79VO@::PNT-OXCUA[66W>&^BN+N21IF(&V1'+9B8'/*]CCB
M@#:N_$$$>@/J^GVUSJT0.U8K!0[R'?L.T$@'!SGGL:U5;<@;!&1G!ZBO K8W
M.B?LR2:OI^HZA!>S^6?,6[?]WBZVG8,_)D$YQC/>N^O5G\2^/HM!N;^]@TRS
MTB.\DCM+AX&GE=RHW.I#%0%Z9ZF@#O7BCD9&>-6*'<I89VGU'I3Z\;U'5-9L
M='UG0X-8O/-TWQ!9V]K>/(6E$,I1@CM_'C<1SU'!KI+:RE\-?$W2K"UU/4KB
MTU.PN'N(KR[><>9&4(<;B=I.X@XP/:@#T"LG2O$NE:UJ>J:?I]SYUQIDBQ76
M%.U6.> >A^Z0<="*S/'/B/\ L+2H;:WNH+;4M2E^RVLL[A4B)'S2L3QA%R?<
MX'>N7\"RZ'HGBGQ58Z5?6T\,5K9F'9.KM.4B<NV0?F.22Q'<T =W8^(+74M=
MU#2[2.:0Z>%%Q< #RED;GRP<Y+ 8)P,#(R<\5H7<[VUG-.EO+</&A<0Q8WO@
M=%R0,GW(KRK1]2N_#_[/[ZY:2 :I>!KEYR,GSIYMN\^I&X?]\BNRTCPC<:'K
M%O=6FOZE/;&)DO+>^G>X$[<;74L?W; YS@8(.,"@"Y#XHAO_  U;:WI%C>:G
M%/C;!;A!*IY#!@[* 5(((SUK&?QI/KOPXO/$GAV(6S11SMB_3)3R@V?E4D$D
MK@<XYSSC!C\$?Z%XU\<Z/'Q;0WT%W&O96GBW.!^(S^-<_P##G3+[6?@T^FV-
MY;VINI[N&62>W:;]VS.IV@.N&Y&"21QT- 'JEK(TUG!*_P!YXU8X]2*FJEI5
MO>VNFQ0:A<6]Q/&-IDMX6B4@=/E+,<X]ZNT %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5@>,?#;^*
M_#[:9'??8I/.BF2?RO,VE'##Y<C/3UK?HH XW_A'O'&?^1[@_P#!+'_\75P^
M#+6]UG5]1UF4:B;^#['%$\>U+>W[HO)R2>2W'.,8Q735S&@^,X?$>LW]GI^F
M7S6=E/);2Z@X183*F,J!NW'KUQ0!2'@C4(M+T=(?$+'5=&:1;.^EM@^Z%A@Q
MRIN^?@*-P(/R@U-=>#+K4_#\EIJ>O7%QJ?VQ+Z"^2(*+:9,;/+CR0%&.A)SE
MN>:Z>]O+?3K&>]NY5BMK>-I99&Z*JC)/Y"LZY\16MOKNC:4(Y)'U6*:6&5<;
M5$:JQSWY#C% &&W@:\U2UU=?$6O27\VH6?V)?(@\B*"/DY5-S9;=SDGMCI3(
M?!&KW%_H=YK'B47CZ/.)(4BLA$KC85.[YSECD'/08/'.:[>B@#BX? MW;S>)
MX8M:4:9KWGR/;-: O#-*@0L'W<@8^[@?6K"^!X&^&J^#9KLR(MH(%NA'@A@<
MJX7/4, <9[=:Z:[NH[&RGNYL^5!&TCX&3M49/\JXZW^)VG7=M'<6V@^)IH)5
M#QR1Z1*RNIZ$$#!% %W3O ]I;>";OPW?7+WGV[SGO+O:$>621BS/CG!!(QUZ
M"IM&T+7K34(;C5_$S7\-O$8XH(K40!R<?/+\QWM@<=!R3BMRQNUO[""[6&>%
M9D#B.>,QR+GLRGD'VJQ0!D>)]"3Q)X=N]):<VYG"E)@NXQ.K!E;&1G# 'K7-
M:I\-(]0\!:;X:BU:2WELB6^W+#EG+*ZRG;NXWB1^_?O7>5FZ_K$/A[0+[5[B
M-Y8;.%IG2/&Y@.PS0!DZ]X+AUBX\-/#=?98M#NTN(XA%N\P*  F<C' Z\U#)
MX.NU\7:MK%IK"PVNKP)%>6CVH<L4C9%97W#;][)&#G'OQT6DZC'J^C6.IPHR
M17EO'<(C]5#J& .._-7* .2F\$+-X#TWPO\ V@0++[-_I'D_?\EU;[N[C.W'
M7C/>NFO;1+^PN;.0D1SQ-$Q7J P(./SJ>B@#AM,\ WUKI6@:?>ZZEU'HE['<
M6Q6S\LF-$9!&WSGGYL[O;I6MJ/A"VU7Q%>:E=SEX+O2&TJ6V"8RI<L6W9Z\X
MQCWS71T4 <MHGAO7=/N[+^T/$[WMC8H4AMX[40F7Y=H,S!COP/0+SS6KKNFW
MNIV<2Z=JLNFW<,JRQS*F]6QD%73(W*0>F1S@]JU*K7>H6E@]LEU.L374P@A!
M_CD()"C\%)_"@#DF\ SWMKJ,VI:R9=9O)[>X2]M[81+;O!S%MC).<$G.3SD]
M*VM#TG6+.[N+O6=<.H2R(L:10V_D0Q $G(3<V6.>23V K<K.UW6[+PYHUQJN
MHNR6T &[8NYB20  .Y)(% '/^&/ %OX:\2:CJR7KW"7 9+2W,>U;2-Y&E=%.
M3D%FST'2FMX,U6WN;V'2O$LEAI-[<M=2VZ6P,T;.<R"*7<-@8Y/W3C)Q71:%
MK=EXBT6VU;3I"]K<*2A88(P2"".Q!!%:- &%;>'!;^-+WQ%]J+&ZLX[7R-GW
M=C$[MV><YZ8KGK[X=7=[::WI0\0O#HNJ337+6R6H\Q)9#N/[S=R@?YMN 3TS
MCKWU% '.:+X9N--UZYUB[U%;NYN;*"UD"6_E+F,M\P^8]=W3MCK68WP] TDV
M\&JO#?Q:M+JMI>+"#Y,CLQVE2?F7#$'D9]J[:B@#BV\"76H6&IC6]>GN]0O3
M"T=Q#%Y26K1-NC,<>2 0W))//2M;1-(UJTOY;S6=?_M!S$(HX8;;[/"@SDL5
MW-ESZYX' %;U% 'G_CRTGOO&_@B&UNVM+CS[MHYU0-L809&5/4'&".,@GD=:
MG?X>RZC9Z\VMZP;O4=7@2W-Q#;B)+=(SE B;C_$=QR>?:NX*J65BH)7H2.E+
M0!Q7_"*:K'K6G>)-5\31RW6G+(LA^Q".$V[ ;P%W_*W&2^3],"L3PYI^G^)/
MBQJ/BK2Y&FTBVB54E'^JFO"NQG3UVQX4GU->C:?J%IJVGQ7ME,L]K,N8Y%Z,
M.G>K*JJ*%50JCH , 4 8VG^'Q8^*]9US[27.I16\9AV8\OR@PSG/.=WH,8K%
M/P_4_#1_!O\ :1PS,WVOR.F9S-]S=[XZ^_M7:44 <IJ7A75/[<O=4T'75TQ]
M0C1+Q)+03AF0;5D3YEVMMXYR#@<<5:@\+>3XATK5FU":9K#3WL2)AN>;<4.]
MGSU^3T[UT-% '&ZI\/XM4L/%=K)J#HOB"2.3<L7^H*(JCO\ -R@/;T]ZD;P]
MXK46\\/BZ,7:P^3/OT_=!( Q*NL?F#:X!P3DYP..*ZZLK0->@\06MU/;Q21K
M;WDUHPDQDM&Q4D8[$B@!?#NB1>'=!M=*BF>98 V97 !=F8LS8' RS$X[5R-U
M\-;ZYT:]T+_A)&CT>2>2XMH$M!OCD:0R .^[YU5SG&%SQD\5TFH^*;73O%VC
M^'9()FN-425XI5QL01KN.[G//M6]0!@Z)X=ETO7-6U:XOEN;C4TMA*$A\M5:
M*,H2/F/#$YQVZ9/6L)/AU+::+H\&GZR8-3TBZGN;:]-L&4B9F+HT>[E2&QUS
MQFN[HH Y;P_X2NM)\2:AKU]K#7]Y?V\<4P\@1*I0M@J 3@8(&.>A.3FG^)O"
MDVO:OHVIVNJOI]SI33/"RPB3<SJ%Y!(XX.1W!/(ZUNMJ%HFIQZ:TZB\DA:=(
M>YC4A2WTRRC\:LT <5'X ^VVVNMKVIF^OM8C2&2>"'R%@2/F,1KEL$,=V23D
MXJ]I_A_71/))K/B4WR_9GMXHH;00)\V,R.-QWMQQT R>.:L:QXNTW2O#NH:T
MI:[@L)O(F6'[PD#A&7G'()K?H Y&7P,LOP]L?"G]H$"U%N/M/D_>\IU?[N[C
M.W'7C-+J'A/51K.H7^@Z^-,&IA/M<;V@F^=5VB2,[AM;: .<C@'%=;10!R^I
M^#AJ6J^%[XZE-G0G9OWJ^8]QE N6;(P>,DX.<U*GA,)\1)/%OVPDOIOV#[+Y
M73YP^[=GVQC'XUK#5+:5[^*U?[1<6/RS0Q_>#% X7GC)!'YTNE7LNHZ9!=SV
M,]C+("6MKC&^/DC!P2/?\: .1TSP)K&C:5/IUAXI>"W6[-U9;;09B+.S,DGS
M?O5.XC'R^M;7A[P]=Z9J&HZIJ>I)?ZC?B))'BM_)C5(PVU57+'^-B22<Y]JZ
M"B@#E];\+7UUXDA\0:+JZZ;?BV-I/YMJ)XYHMVX97<N&!)(.>]9MM\-Q;Z+?
MVAUJ=[VXU0:M#?&)=\-P O)7.&!*G(X&&(XKNJ* .63PWKL]EJ U#Q5<-?7*
MQK!+9P>1';;&W K'N;<2?O9/(XX%5#X%GU5]1E\3ZJFHRWE@=/'V:U%NL41;
M<2!N8EMP!SG QTKM** .2TGPIK,&J65WK/B:348M/C9+:&.V$ 8LNW?*0QWG
M'T&>:ET;P:-(^'1\)"^,H^RS6_VKRMO^L+<[<]MW3/:NFDD2&)Y9&"HBEF8]
M !U-165Y;ZC8V][:2B6VN(UEBD'1E89!Y]C0!Q?_  KF2/1O"]E;ZW)!-X?+
M-%<+;@F5BI RI;@9/(YR,CC.:L1> C??VW-XCU+^T;O5;5;-I(8/(6"%<D!%
MW-SN.[))YQ6QXJ\467A'1O[2O8IYE:5(8H;=0SR2,<!1D@?K6AIEY/?Z=%<W
M-A/82OG=;3E2Z8)')4D<]>#WH P]+\.ZW'=(^M^)#J5M% T"6\=J(%DW8!:7
MYCO; [8 R3BN>F^&.IW'AM?#4GBISHT#JUK%]B'F*%<,JR/N^<#&!@+V/;%>
MD56N]0M+![9+J=8FNIA!"#_'(02%'X*3^% $[KOC9<XW C-<-I/PV72O"?A_
M0AJIE&D:FNH";[/CS<.S;-N[Y?OXSD].E=-I^O0:AKVL:1'%(LNEF$2.V-K^
M8F\8^@]:U: ,5] #^-(?$7VD@QZ>]EY&SKND5]V[/^SC&._6F>)?#LFNI9S6
M>I3:;J-C*9;:YC4.%)!5E9#PRD'IQ]:NZEJ,]C/8QPZ;<WBW,XB=X=N( ?XW
MR1\OTS6A0!R5AX3U277K/5_$6NKJ<MBKBT@@M!;Q1LZ[6<C<Q8[<CK@9/%0Z
M7X,U;26M;"V\2R)H-I/YL-HEL%FV!MPB,V[E >/NY(XS79T4 <5?^!]2^VZL
M=%\1OIECJ[^9>0"U$C!RH5WB?<-A8 9R#@\BK$G@RX@\6:;KFEZN;86U@FG3
MPSP><9X%?=]XL"K'INYKK:* .(M/AO:1Z%XETFZOI)X=<U"2^+I'Y;0,Q#+M
MY.2K*#GCZ59L_"6J3:WIVI>(=>34_P"S-QM(H;,0+YC+M,C_ #-N;!.,8 S7
M75E6VO07/B>^T)8I!/9V\5P\AQM82%@ .^?E- &1#X)6'P+JGAG[>2+_ .U?
MZ1Y/W/.9F^[GG&[UYQVKH[:S2#3(;&3;-''"L+;EX<!<'(]_2K-% '*ZUX!T
M35AIXAL+"T^RWL5T^RS0^:J$YC/3@Y]_I6;K<:^&/B)I7B$J(]*O;3^R+I@,
M);MOW0L?0$DIGH,BN\K(T#7+;Q-I3WD,#I$)Y8"DH!),;E">.V5S0!SQ\$:S
M9ZAK=WHWB86;:O<&:99+(2B,;0HV?.,,,'D\'(XXK,\4:+;P^&-$^&FDEG:[
M,:3'JT=K&P:65L=,D8'J6P*[N;49XM;MM/73;F2":-G:\7;Y41'16YSD^PJ_
MM7?NVC=C&<<XH 4    8 KQSX>1Z1XD\ :WX2FU.&*]NKR[S"DBF9%W\/LSG
M .#7L=4OM.G0:K'8 PI?2Q-,D87#%%(#-TZ99?SH YF+P=K,FO:3KFH>)$N;
M[3V9-JV(2)X6&'4+ORKG ._)Z#C H_X0%?\ A6'_  A?]I''E^7]K\G_ *:;
M\[-WX=:[.JUEJ%IJ*S-:3K*()G@D*_PR(<,OU!H YN^\):DOB6\UG0M=&FMJ
M$4<=[&]H)PY0$*Z98;6"G'.1TXJ_X/\ #*>$O#Z:3'=O=(DTLHE=<-AW+8/)
MR1G&>];U% '(WOA768=:O=2\/>(_[/6^97N;:YM!<QEPH7>GS*5) &1D@U"/
MA\O]B30OJ\[ZS+?KJ1U0Q+N%RH 4B/IL"C;M]">:U=5\7:;IN@3ZS&6N[>"Z
M6U<0]?,,HB(YQT8\_2M^@#E#X1O-5TK5K+Q+K3ZBNHPB#9!#Y$4"C)!1,M\V
M3DL2>@["C2/"^LP:O:7VM^)9-26QB:.VACMA I+  O+ACO; ]@.N*ZNB@#S?
M_A5UVWP\OO!<OB$/I[LGV-_L0#P*)?,(;Y_GR<#/&,5T&K>%;N;6;36M&U5=
M/U.&U^QR-+;^=%/%G< R[E((;D$'N:W[74+2]GNX;:=9)+27R9U7^!]H;!_!
M@?QJS0!Q/_"O5;17M9M5>6^N-4BU.[O&A'[V1'5MH0'Y5PH4#)Q[UN7F@"[\
M6Z7KOVDH;"">'R=F=_F;>=V>,;?0YS6U10!5O=,L-25%O[&VN@A)03Q*^W/7
M&1Q6)I7@K3-)\1ZKJ\%O:C[<D2)"ELJ>0$4JVTC^]GG@=.]=+10!YKX5T>WN
M?">K_#;6"ZR6)>)"#AI+9V+13)ZXSCV*X-;5CH.IZ9?1:SXD\5&]M],MY!$J
MVXMD (^:27#'><#V Y.*Z_:N_?M&[&,XYQ0RJZE6 (/4$4 <!X/N[:PL]:\9
M:Y<0Z;%KMZ)83=N(]L"KLA!ST)4%L>XJ/X),&^&MNRD$&[N""._[QJ]">-)%
MVNBLOHPR*$C2-=J(JKZ*,"@!U%97AO7H/$NAPZK;12112O(@23&X%'9#T]U-
M:M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %<?\0[R[BT_1].M+J6T_M;58+&:>%MLB1-N9MK=B0N
M,^]=A6/XE\/0^)-*6TDGEMIHIDN;:YBQO@F0Y5QG@_0]030!R4FDQ>'O'>EZ
M'9W-_P#V3KEC=)<6TE[*^QXPI$B.S%D8AB#@CMWK.^#.B6<,&NWR-=>=#K5W
M;H&NI&38-O5"VTM_M$9]ZZ_2?"MU!KXUS6M8;5+^* V]OBW6".%&(+$*"<L<
M#)ST&*G\)>%H_"EIJ-O'=-<"]OY;XEDV[3)CY>O.,=: ,KXM6L=S\,=<+F0&
M& R+LD9.1QS@C(Y/!XKG=0\/0'Q+\/M+AN;V&VDM+YY6%U(96!CA)42$EE!/
M'!X&0,5Z)XBT6'Q'X=O]'GD>.*\A:(NG5<]"/H:Q[#PA=PZAH-]J.LF]N='C
MN(D86RQ"19%11D G&-GXYH X;4=0OO"EKXXTC3+N_-O;7&GQV>96FE@%S@2"
M-G).>NW)X)K<\)BZL_&$,6FZ5XDM-'GM)!=+JS,ZB92I1U+.Q!(W@C@'BMZ^
M\#6>HW/B22YNI=NMK;@A %:!H1A&4]SG#=.U6M%T/5[/4&O=7\1SZFPA\F*)
M8%@B4$@EF52=S\#GMS@#- %WQ)_R*VK_ /7E-_Z :X/P3=^.T\#:$MCI.@R6
M@L(1"\U]*KLFP8+ 1D X[9KT;4;,:AIEW9,Y07$+Q%@,[=RD9_6N,TWP3XIT
MG3+73K+QY+':VL2PQ(=*@;:JC &3R>* (?$D-[J?C[PKI=U>7%K!<V%TU[!9
MW#HLA41G:&&#C/?@XSTS6)IGAP7Q\9:9<:KJS66CW#+IT8OI5,!:(/G<&R^"
M1@,2!SZFNZA\,7!UK1=7O]5>[O--MYX&<P+'Y_F%?F(7A<;1P*EL?#$=E<^(
M9A=,YUF7S&!3'E?NQ'@<\],T >?V<VH>)KOX>07FJ7L<5]H\\E\()VC:XVK%
MU*D$$GJ1S@D=ZAUD2Z5H7Q*\.)<W,^GV=C%<6BW$S2M")4;<FYB21E<@$]ZO
MWOAB;3O%G@;1;'5)8)]/TN[2&\$0.2HB'S(>"""01GOP0>:Z$> #-H?B*UO]
M6DNM1UY0MU?>2$"J%VHJH#@!1GOW/- '.V/FZS'X \-27-S!ILFA+>726\S1
M-/LCC54+*0P4%B2 >>*AU"PU6"7Q?X;T;4;[.G06NJ:7ON'=XG^8M%N)W,K;
M,!23]ZNON/!!_L_P^NGZI)9ZGH=N+>WO!"'#IL5&5T)P0=H.,\$<&ELK"Q\$
MV^J:_KVL^?=7CQF[OI8Q&N%&V-%1<[0,\#DDF@#&N-?;QGJG@RUTNXEAM[B/
M^V;[RI"I6)!A8V(Z@R-M(_V37+RV-S=_#WQ3XAFU?5/[0TV_O6L72\D58!'*
M2!M!PV>1R#Q@#&*ZGX5^'X[*+5]=6":"#4KIS80S@AH;0.S( #]T%G=L>A%;
M"^!HE\'ZUX>^W/LU2:XE:;RQF/SF+$ 9YQF@#GGLI=#\4>"]0AU&_EN=6D>+
M4/-N7>.?,!?.PG:N&' 4 #I7,VVJ:KJFD/X@LM-\57'B)[QY8)XBQL_+68@0
MA-^TIL&#\N<Y->JWWAF.]N_#UP;ID.C2F10$SYO[LQX//'7-9</@B^LYGMK#
MQ+=VFB/=&Z-C%"H=27WLBS9RJ%L\8S@D9H R;;11XG\?^,[34M0U$V-K):""
MV@NY(51FMU);Y2/P'3))P:Y,0-XCT+X:W&JW5Y/<37\EK+*+J1&=4\T Y5A\
MWRCYNOO7KFF: FF^(-<U9;AI&U5X7:,K@1^7&(^#WSC-<ZWPX,7AK0],LM9D
MM[O1KMKJWNS;J^2S.2&0G!'SXZ]J .WBC6&)(USM10HW$DX'J3R:\N^('B/3
M9O'V@Z#?S2KIVGL-3OO*@DEW.,^3&0BD]<L<\8Q7J$"21V\:2R>;(J@/)MV[
MCCDX[9]*Q/#OA>/0M1UK49+IKN]U:Z\^65DV[4 PD8Y/"C./K0!Q?PZ\0Z=#
MXWU_P]82R-IUVYU/3_-@>+:6QYT8#@' ;!&.V:R?LEWJOPGUCQJ=8U*'6IX[
MN=9$NY!''&KNHB6/.T#:O!QD'G.17I6O^%X]:U?1-5CNFM+W2;@RQR*F[?&P
MP\9Y'##'->3Z^=/@T+Q#X9L=;U2,RSS);>'7LP)FF=B5V.,EH2QW#';J>H(!
MT,ME<>(OB%I.D7.IW\6GOX8CN;B*"Y>/S6$N.2#D<D$D<G&,XK*O+R\U:X\2
M7$=EXJGU2SO9[32[BP9OL]OY/RH"H<!LL,MN4Y!KT;3?"OV7Q)9:])<GSX='
M73&@"_+PX<MN^HQC%5+OP7?_ &[46TGQ)<Z98ZG+YUW;Q0*SAR ':*0G,98
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M<F-B6R&&TY'48ZG'!KII?AU!/X9NM+EU.:2ZO+]-0N[YXQNEE5U;[HP%7"@
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MS;2P2%@DJ%&V,5.",'!'(/N.:Y>P\(WQURQU77M>?59=/5Q9QBU6!$9AM9V
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M;=33O9_V9;XB$S*%R@R1@C!]Q0!VT_B 3^'%UC0K.36$DQY44#",R#=M)!?
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M)QD$XSQD]J]&H **P/&MU;VGA&_>YO;NSC=5B\VS7,^68*%C']YB=H^O;K7
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MBJCZW9?:M2M(I/,N].@2>>( C:KABO.,<[&H AU#0(M0\1Z-K+S.LFEB<)&
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M+JPGW>3<PO#)M.#M8$''X&L"V\>Z-=>-IO"L8N!>Q[@)B@\EW559HU;.2P#
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MK-4]!\*2:!KFJWEMJLSV.HW$EV]B\2829]NYP^-W\/3IS7244 %<M'X(MH_
MEYX5%Y,8+H3AI]HW+YKLYP.G&[%=0S!5+,0 !DD]JXD?$NUN1+/I7A[7M5T^
M)BIOK.U4Q/@X)3<P+@>H% %Z_P#!TKZI#JNCZS/I>H+:K:32)"DJ3QKRNY&&
M-P.<$>N*JW/P[LI?"7]B1:A=1W!O!J#:@P5I7N=^\R,,8.3V],5TFBZU8>(=
M)@U33)Q/:3C*M@@@@X((/((.015^@"O8PW%O8PPW5VUW.BX>=D5#(?7:O _"
MLGQ%X<?6Y].O+349=.U#3Y'>"X2-9!AUVNI5N""/RQ6]10!PLOPUBEL=>LWU
MN]DBUN)!=&1$9O.7&9 <#&0/N]!V[5KQ^$;>/5?#U^+J4OHEI):QKM&) R*N
M3Z'Y>WK71T4 <QJOA.YN-:GU71]<N=(N;N)8;ORH4E68+G:V&'RN 2,CMVJ&
MX\$2K>V-YI>OW]C<V]D+"69@L[SQ [ADN#A\Y.[WZ5UM% '#+\-;>'1SI]MJ
M]Y#Y&H'4=.F"JSVDA))&2/G!W-D-US5FR\,Q^'M:NO%VKZY<WMT+!K>XEEB5
M4$88/E50< 8Z#/4FNPHH \W\#:1;ZCXY\0>,K:">+3[EA%8"92GF$JOG3*I&
M0&** >IP:](JEK.HC1]#U#4VC,JV=M)<&,'!8(I;&>V<4[2[X:GI%E?K&8Q=
M0),$)SMW*#C/XT <1XFTRYU+XJZ']EO9[&>+2[EX[F) VUM\8P58$,""1@_A
M@@&KO_"NXWTJ\2?5[J75[J]BOWU,QH'6:+'EX3&W:H&-ON:[6N=D\5QQ_$&'
MPG]D8R2Z>;[[1OX #E=NW'MG.: *-OX%ECUB35KC7KNYO+FS>SO&>) LJ'.W
M:H'R!2<@#KWZFH8OAS;6WA'1M%M-4N8+G1IC/97ZHI=')8G*G@@AR".]:GA+
MQ7'XKBU5X[1K;^S]1EL"&?=O*8^;H,9STKHJ .3TOP8^G:Y>:Y<:S=WNI7=E
M]EEE9$0##9!15P%QP,?CU-:WA>WU"U\+Z;!JLLLM^ENHG:5PSE\<[B.">W%:
MU% &3XDT*+Q'HDNG23R6[%TEBGB +12(P=6 /!P5'%8/_"!32ZH=4N_$-W<7
M\UG-8W4C0H%EA<#"JH&$"D;N.22<GFNTHH YJ?P;;S^$](T W4HBTUK5DE"C
M<_D%2,CWV\U5NO TC:QJ-U8:[>6%GJK![^SBC1A*VW:2KD9C+*,$CZ\<5U]%
M &5X9T*+PSX<L=&AF>:.TC\M9' !89)YQ]:U:** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y3Q_
MIFH:IHEJEC:/?10W:2W=BD_DM=0@-E V1W*M@D [<5U=96O:*VLV\ AU&ZT^
MZMI?.@N;8C*M@C!5@592"<@B@#S.>XTR/0["#1EU2P\OQ18+/IM\2'M&++E%
M!)(1A\W4@Y./2NIUN1Q\4M-B#ML.B7A*YX)WQ\XJ>7X>VUWI%];7NJWUQJ%Y
M<Q7;ZD=B2I+%CRRJJH4!=O3'<U-8^"!!KL>MW^M7VHZDMK):-+,L:J4<@X"H
MH"XQVZ[CG/& #S&VT&UTSX%V/BVWEG77;.WCN8+OSWRF) !&%SC9M^7;CGDG
MFNHEU"XM/C5KTZ%V$'ACSTB).W<'4]*U+;X76]MI-GH9U[4Y=!MV21].?RRL
MK*V[EMNX*6&2N<9Z8K-\.RKKWQIUG6;2WN'TI=(6S:>:W>-&D\Q25&\#/ -
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MZ>0)KAF<8B4G& V""<CC/-6=!\-MI%Y>:A>:G<ZGJ-VJ1RW,ZHF$3.U55
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MTDDDLFIVJVL]N^/+V* ..,\@>M9=K\.XXEL;.YUW4KS1M/E66UTZ;R]BE#E
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M" "I4!W!'&<Y.* .(N-%M]#\ >%_%EI-<'7 U@\MT9W)G64HK1D$X*8; &.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+CIU->;*+:.XT#Q!I&BZA&+O6X0-=O+I/.NXY92K!D!SL() ! P #BM_0?\
MDK'Q+_Z]K3_T0: .R\%>)AXQ\)66NK:&T%UO_<F3?MVNR=<#/W<].];]>?\
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M!9P/.X09)55)('OQ7C-G=7E[X6\$Z++976LVDMSJ FLUG5&N$MW98U9G8 J
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M868LZQS(>A8G&X8% ';:7J=IK.E6NI6,HEM;F,2Q/C&5(].Q]JMUX_J6O_\
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M+,^V[,90J9.<L<MDGOWR,T >J45X;JUN--\&^-=&L)7M;.SUZU6U"L?]'#O
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MX4TVSTKPQI]O8VZP1- DA5>A9E!)_&MF@ HHHH **** "BBB@ HHHH ****
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MH8 Y-:5QXB6'Q=IFAI LB7UM/<?:!)]WRRHQC'.=W7/:MH2(7*!U+KR5!Y%
M&;8:%;:?KNKZM%)*T^J-$TRL1M7RTV#;QGIUR36#+\.M//AS2](M]1O[9M+N
MVO+6[C9/-20L['.5VD?.1C'I78-(B8W.JY.!DXR?2AW2-2SLJJ.I8X% '(7O
M@!;W[5"WB+6$L;X#[=:*\>VX.T*QR4W)N ^8*0#DXQ77+%&L(B"+Y87:%QQC
MIBG%E52S, H&22>*%8,H92"#R".] '%1?#6RCBAT]M7U.30H9A-'I+NAA!#;
M@I;;O* \A2V.!706?AZULO$NIZ['+,USJ,<,<J,1L41@A=O&>YSDFM;(/>DR
M,9R,>M &=X@T6W\1:!>Z/=22QP7<1B=XB P!],@C]*Q;3P);P:KI]U<:MJ5[
M;:82UA97#H8X&V[0<A0SD D L3BMN*[U%M<GMI+")--2$/'>"X!9W[J8\< <
M\YK&O?'%FF@:;K&GQ?:[:^U"*Q7<VS&Z4Q%NAZ$$X[T 1S^ ;>2\NC!K.J6N
MG7EQ]IN=.@D18I)"06(;;O4,1DA6&<FMJQT*VL->U;6(I)6GU,0B5&(VKY2E
M5V\9Z'G)-:2R(Y8(ZL5.#@YP:I:MK-EHEO#/>R%$FN(K:/ R2\C!5'YG\J ,
M$> +"+0K'3K6^OK>:PN9;JTO8V7SHGD9F;^':5.\@@C!'YU9C\'0'P]JVE7>
MI7]X^JJZW5W,Z^8=R;/E  50!T &*L1^(E?QC>:"T"HEO8QWGV@R==[LNW&.
M,;<YSWK;W+MW9&W&<YXQ0!R^I>!--U3PII7AV:YNUM=-:!HI$9=[>4,+N)7'
M/? %3:CX0@OO%<'B&/4;VTN5MQ:SQ0E/+N(0^_8P921R3R"#BNB5U=0R,&4]
M"#D&J%SK-E::Q8Z5-(1=WJR/"H'!$8!;)[?>% &%I_@6.SO+![C7-4OK/3G\
MRRL[ET*0MM*@E@H9]H) W$XK:\0:%9^)=$N-*O\ S!!.!\T3;71@0RLI[$$
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCF,33+*LD;Y 967W4@B@#I**Y[Q=XK@\(V5C=3VDURMW>)9JD/W@S!B,#O\
M=QCWJE+XOU.(6%D/#4QUV\228Z?]KCQ#$C ;WD&5&<K@#/)QVH ZZBN-_P"$
M^$]C9"RT>XGU:ZNI;0Z<\J1F*6($R!G)VX &01G.1BDO_'SZ7IFGW%[X?U"*
M[N]0.G?8SM+^;M8@JWW75L !@<<\XP: .SHKD;+QR$O=2L=?TN71[JQLCJ!5
MIEF62W!(+JR]P1@CW'6ETKQG<W>I:=;:GH-SID6J(S6$TLR/YA"[]KA>48KD
M@'/0C.10!UM%<1#\0Y)_+U"'P_>2>'I+G[,NII(AR=^S?Y0^;R]W&[KCG%-\
M*^*-=U?QMXCTZ\TPQV-E/'&C>=&?(_=@X..6W'GVSB@#N:*XWXD>(]6\.:):
M3:3;&26>]@@:7>@V R+\N&Z[AE<]LYJ:\\7WT>HVVD67A^6[UE[47=S;?:D1
M+9"=HW2'@DD'  [9H ZRBL;PUXBA\2:=+<);RVMQ;7#VMU;38+0RI]Y21P>H
M((Z@BN?UWQ1KME\2='T2RTPS64]M-+(!-&OG8V#=SRNS)X[YH [FBO*-"\5Z
MEH]OXNFM]#N]4M[+6[V6YF%PL8B0$':@;ER "<#U'.376W?C,R2Z=;:%I4NJ
MW=[9"_6/S5A6. XVLS-W). !GH>F* .JHK+\/ZY!XAT>/4((I(26>*6"4 /%
M(C%71L=PP(KC-6M+C7/BQ<Z5+KNKV%E#H\5PL=C>M""YE=22!P>/Y4 >CT5Y
MUIDEUX?^)=GH%KK]]J]C=V,L]S#?3B>2T9"NUP^,@-DC!K0M_B"9VMKXZ)<I
MX?NKH6L.J&9,,Q?8KF/[P1FX#>X..: .UHK@-!\8:W=^+O%-M?Z5*NG::R8\
MN1':$"+=@*OS.7ZC&<9 K2TGQE=W>KV%AJGA^YTH:E$\MB\LR2&3: Q5U7E&
MVG.#GH?2@#K:*\WTOQCHVC>'?%VM6FF74<6G:Q)%=H]P9#+)O16==V=H^8':
M..*W+/QE=/XCL-*U+0+G3H]261K&>29'\PHNXJZKRAV\X.?2@#K**XJ/X@F0
MQ7QT2Y7P]+="TCU0S)@L7\L.8_O",OQN]P<4Z_\ &MQ)>:Q;:;H5S?6.EYBO
M;V.9%V/MW,$0\N5!&<8]LT =G17)_#*1Y?AIX?DD=G=K1268Y)Z]ZZR@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ KSWXA^()8-2L?#Y;4;33[J,S7U]
M96LDK^7G B0HIVLQSENP'J:]"HH Y#2_%&@:?X2GGT?3=1&GZ6J(+6.PDCD(
M)P-BN%+=<D_7-=<#D ^M+10 4444 %%%% !7F.F^"M'U_P ?^,[G7=$CNA]I
MMQ;R7$9P5\A<[3WY':O3JY]O"\S,6_X2371DYP)X\#_QR@#BM'\/3Z=X;\6_
M#Z&R$3FVF?3[M8MJW44JD*'<#!=2=ISSC%-\+VF@7NI:%$EKXGFU.U(EFBO)
M[GR;"1$();S#LZDJ N>OI7;?\(M-_P!#-KW_ '_C_P#B*/\ A%IO^AFU[_O_
M !__ !% 'F%MH&HWGA;QW&MC>&1?$[7L<489))XTE1CY9X.2H.".X&*V[2+3
M9O[3U#PG#XAO-5M-*G^S7>H2W#I'*PXB59CRY(!P!C@9-=I_PBTW_0S:]_W_
M (__ (BC_A%IO^AFU[_O_'_\10!YO8M8)XA\'ZM8PZ_>+!,Z:C>WOVE\320.
MJKM?@'<>2HVKD<\U?T>6UA\2:6/"L>N:?//='^U=%GBE^S01D,9&.X;$(;&"
MC8.>!S7<_P#"+3?]#-KW_?\ C_\ B*/^$6F_Z&;7O^_\?_Q% 'F.@:%HUKI5
MEX;U:U\37&L0W @EL8Y[D6Y DR)AR(O+P _7\,UZ_KMB^J>']2T^)@LEU:RP
M*Q[%D*@_K6=_PBTW_0S:]_W_ (__ (BC_A%IO^AFU[_O_'_\10!Y_>:B^N_#
M+3_ \&G7\>OM':V4]N]I(JV_E,F^1G(V[,(2""<Y%="+6X_X7^UWY$OV;_A&
M_+\[8=F[[1G;NZ9QSBM__A%IO^AFU[_O_'_\11_PBTW_ $,VO?\ ?^/_ .(H
M M>*M%_X2+PKJFCAPC7=L\2.>BL1\I/MG%<GI/Q$33-&@T_7](UBWURVB$,E
MK#822_:'48W1,H*D-C(Y'7\:Z+_A%IO^AFU[_O\ Q_\ Q%'_  BTW_0S:]_W
M_C_^(H XGQX->UGP9X8N-0THP7S:_;S26MN#(88LR;=Q'<+C)Z9I/$@-_P")
M?$=CJL>MW%TT:1Z)96KSQP2*8AEB8R%^^6W%SP!7;_\ "+3?]#-KW_?^/_XB
MC_A%IO\ H9M>_P"_\?\ \10!YU;13WFH?"&6&TNMEE;S0W):!U\EUAC4ALCC
MYE(]\<5OZ59W*>'_ (D(UM*&GU&]:(%#F0&W0 KZ@GCBNF_X1:;_ *&;7O\
MO_'_ /$4?\(M-_T,VO?]_P"/_P"(H Y.]LKH^!/AM$+:8R07VEM,@C.8PL?S
M%AVQWSTJCJ<UK!X@EG\.PZYI?B=]143:>L4IMKL>8 TKC!CVE,MO!!_&NZ_X
M1:;_ *&;7O\ O_'_ /$4?\(M-_T,VO?]_P"/_P"(H T;35H[S5M1TY;:ZC>Q
M,8>62/;')O7<-C9^;'0^AK0I$78BKN+8&,MU/UI: /+?%,FE67Q;2]U[29;W
M3VT-8HV_LYKI1+Y['H%;!QG\_>MO0_$OA"![MM(T>>R=(&FE,>C26^]5YQG8
M-QYX'4UV]% 'D&EV&K:#K\7Q"O-..S693'?6$4&9+&%]HBD  R6^5?,_WNG%
M17>FZ7I>L>);?7(_$C3WE[)<V<.G37(BO8Y%!"J(SLW9RIW8[=J]DHH \TMY
M;?P#XPN;B\L[V'2+[2[2&WDC@>X\EX R^4VP,=V&!!Z'!YINI:U=#7O!WBS5
MM(O-/LA'>PSH(WF>W\P)Y1D55R-P3IC@G!KTVB@#QZ]BOM<L?BA<VVFWJ+?6
MMN;1)8&1YE6$C(4C.3C..O(R >*DURY_M^/X;W6G6]W)%;:K"LY:VD0QE57=
MN# 8 ]>GO7KM% 'E7Q MM7T?Q'=7&AVD\S>)M/&FR&)"1%<!PJ2L1T C=^?]
MFI?%'AJQT6_\+2S#4X]#T^REL)9M.>5)(20A1V\KYMIV$'MDC->H44 <IX$M
M-,BL+Z[TNUU2*&ZN2QFU*21I+G:H42#S"6"D# S@\=.E8GBV>,^.%MM<;6CI
M!L%:R@TXSJMQ<%VWAC#@EL;,!B!R37HU% 'B7A_[1H=KX0U*[TZ_2'1;O4K3
M48UMY)7MS,Y*-P"77@989ZU;O+R37-6^(\UO97*+-X>C2W22%DDE&R8!MA&X
M9.< C.,<<UZ5X@T2;68;8VNJW>F75M+YL4]N003@@AT/RNI!Z&H/#OAG^Q+J
M_O[K4)]1U._*?:+J953*H"$554 *HR?Q)H Y3Q%H\]W\,/"Q^SWK+IK6-S<P
MVA9)Q&L>U]FW#;E#$X'/RUCWV@:7XAT'Q$?#5OKMY<BQ2-+R_GG(FQ*)3#'Y
MQW9_=CD#&6ZU[%10!Y?HD/AV[UB*[TRP\3:G<V=K-*1J$UP4A8IM,)$YVEV!
M(P,].>*9X4DM8/%>F0>%'UN+3)$E.I:;>Q2B"R&S*A3(/E;?@;5)!&>PKU.B
M@#C?BO9W-_\ #'6[>T@DGG,:,(XU+,0LBL< => 35.WO8];^(_A_5K&*X:Q.
MDW2>;);O'AO,C&"& (/!^N.*[ZB@#R35QJEE=^-)[=;^WMIM8L?M$]JC>:+7
MRXQ*T9 R2!D97)'-1Z9;VH\7:I_9-EJPL=1T*2WLY[S[1)]HE5F+8,N2HP1@
M'&<$CJ,^OT4 >=^"/%-EI?PZT&&XMK_SH&MM,GC-JZ&*9R%&=X'RYQDC/45W
MMY!]JL;BW#;?-C9-WID8S27EC;W\<<=S'YB1RI,J[B!O1@RDXZX(!P>X%6*
M/&FOYI/A,O@0:;??\))]G&G&U-K)L!#;?-\S;LV;?FW9KH+=QH?QA=;N.Y\F
M]TBWM;:=;=W1Y%=L@LH(4]^<5Z+10!Y!_9]Y_P ,V367V2?[68)!Y'EG?G[0
M3]W&>G-3:QI^G:7XYUZ[UU]?AAU!8)[*33);D+*5B$;1D0\;P5&-W9J]9HH
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M0R2*593SP0>E=5110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !7*_$#7+[1/#T2Z4R)J>HWD.GVDC
MC(CDE;&XCO@9/UQ755ROQ T.^UOPY&VE!&U/3[N'4+1'.%>2)L[2>V1D?7%
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MZ?'YMV/+FBBSCS#'(LFWZG;C\: ([+Q=J,=]Y'B'P]+I$;6TEU'<+<"XC"H
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M,XKL*\FOA$/$7VC0-,UW2?$SZB@N+>.*7[)<Q^: \DAQY14QY;<"&SCO7K-
M''VGC+4;^^,EKX;FFT87S61O8[A6D#*YC9S#C.P,#DYSCG%07OC^XMCJ-];Z
M#)<:#IMPUO=WXN55P4.)&2+&653G)R.AP#BN=O!$/$:W&@:9KND^)9-23[5;
M)%+]DN(_, DDD./**E,MN!#9QWK/'A_2-/DUC2M9T+Q!?:C-?SM;Q6DMRL%W
M%*Y93N1A$H ;#;L8P<YH ZE?%/B.3XG:AI-MI<=Q8P:>DL<?VM5#99L2YVY^
M;A=O;&:Y>[\1ZYXA^"GBB]U2V$0#3"&=9PQ($Y&S: ,!0 ,]\5TT(.A_&"0R
M65X+.]TJWM;::*W>6,.CME6< A<#!RU<K%%>'X-^*/#7]F:B-4@EN&,1M),2
M!IRR[&QA\@YXS0!VMIXENK'2/#FD:5I?]IZI<:7'<-&]P(4CB5%!9G(/5B
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M<7829F*JY\N/:=V PZL,\XKL1R* "BJ&M:A-I>CW-[;V$]_/&H\NU@&7D8D
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MK%C<?89T:]U)IT6V=TV;%61B')#-DKP .O(KU*B@#QB^N]7OOA=IWA:/PUK
MU.R^QP78:T81JL,B997Z/G:#\N>"3T%>ST44 >/2Z+J5_I/Q"\+C3KV.]O\
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M (?/V'9YGVC.W=TSCG'I7744 >*ZI;ZAI6CB5]/G,S>/?M$$+KL,Z%R5*[L
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MP1W.L-+ TL942IC[RD]1[BN\HH YGXAVEQ??#W7K6T@DGN);-UCBB4LSG'0
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M0_*V=HP <\\X/%>JT4 >3ZK!YOB%KG1O#^MZ3XH.H())+=)/L=S$) &DE?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56O-1
ML=/"&]O;>V#YV^=*J;L=<9/-6:AN+.UNPHN;:&;;]WS$#8^F: *7_"2:%_T&
MM._\"D_QH_X230O^@UIW_@4G^-3?V-I?_0-L_P#OPO\ A1_8VE_] VS_ ._"
M_P"% $/_  DFA?\ 0:T[_P "D_QH_P"$DT+_ *#6G?\ @4G^-3?V-I?_ $#;
M/_OPO^%']C:7_P! VS_[\+_A0!#_ ,))H7_0:T[_ ,"D_P :/^$DT+_H-:=_
MX%)_C4W]C:7_ - VS_[\+_A1_8VE_P#0-L_^_"_X4 0_\))H7_0:T[_P*3_&
MC_A)-"_Z#6G?^!2?XU-_8VE_] VS_P"_"_X4?V-I?_0-L_\ OPO^% $/_"2:
M%_T&M._\"D_QH_X230O^@UIW_@4G^-3?V-I?_0-L_P#OPO\ A1_8VE_] VS_
M ._"_P"% $/_  DFA?\ 0:T[_P "D_QH_P"$DT+_ *#6G?\ @4G^-3?V-I?_
M $#;/_OPO^%']C:7_P! VS_[\+_A0!#_ ,))H7_0:T[_ ,"D_P :/^$DT+_H
M-:=_X%)_C4W]C:7_ - VS_[\+_A1_8VE_P#0-L_^_"_X4 0_\))H7_0:T[_P
M*3_&C_A)-"_Z#6G?^!2?XU-_8VE_] VS_P"_"_X4?V-I?_0-L_\ OPO^% $/
M_"2:%_T&M._\"D_QH_X230O^@UIW_@4G^-3?V-I?_0-L_P#OPO\ A1_8VE_]
M VS_ ._"_P"% $/_  DFA?\ 0:T[_P "D_QH_P"$DT+_ *#6G?\ @4G^-3?V
M-I?_ $#;/_OPO^%']C:7_P! VS_[\+_A0!#_ ,))H7_0:T[_ ,"D_P :/^$D
MT+_H-:=_X%)_C4W]C:7_ - VS_[\+_A1_8VE_P#0-L_^_"_X4 0_\))H7_0:
MT[_P*3_&C_A)-"_Z#6G?^!2?XU-_8VE_] VS_P"_"_X4?V-I?_0-L_\ OPO^
M% $/_"2:%_T&M._\"D_QH_X230O^@UIW_@4G^-3?V-I?_0-L_P#OPO\ A1_8
MVE_] VS_ ._"_P"% $/_  DFA?\ 0:T[_P "D_QH_P"$DT+_ *#6G?\ @4G^
M-3?V-I?_ $#;/_OPO^%']C:7_P! VS_[\+_A0!#_ ,))H7_0:T[_ ,"D_P :
M/^$DT+_H-:=_X%)_C4W]C:7_ - VS_[\+_A1_8VE_P#0-L_^_"_X4 .M-4T_
M4&9;*^M;ED&6$,RN0/?!JW4%O8VEHS&VM8(2W!,<87/Y5/0 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%<[X[C=O!6K2QW-Q \%M),K02%"2JD@$CG&<' ZXYXR" =%14<ZRM;R+
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MV>#?#G'F+O RN>]1Z3XXT76=0AL[9[I'N49[1Y[62*.Z5>28F8 -@<\=N>E
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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E** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>employementagreement_mil015.jpg
<TEXT>
begin 644 employementagreement_mil015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M\0RV=R@N$REK$AEE+$D! %')X^@[G'-6M#N-9N_M=SJMHEE$\@^R6I96EC0
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MA^[N-2L88O"UOIUU;:M]LEU6 QB-X@Y9L$-YA:13M*D8Y/. * .DLO%5O?\
MBRXT*"UN/]'MVE:YD0HC,KA"J9'S8)Y8<9&!GG&<GC#5+NQ?6--\./>:*K-M
ME6YQ<3(IP7CAVG<."0"P)'0<BM)]-N6\=KJ/E?Z'_9;6YDW#[YE#8QG/0=>E
M8&E_\)1X=\-Q^&K+07N+FU0V]GJ)GB%L8P<))("V\$#&5"G)'!YH W=>\66V
MB7NDV?D27%QJ-S%$$7Y?*1W"^8^1P 6 QU)^AQT%>>:]X+\03W@O;/65FFGU
M*UGE#6B9B2-AC!+?=3EMO<D]R:]"&0H!.3CDT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4KK2-,OKJ&ZN].M+BXA_U4LT"NZ=_E)&1^%7:* "BB
MB@ HHHH **** "F0PQ6T"001)%%&H5(T4*J@=  .@I]% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6ZWE])<.K%U)\I%E^8ME5)P,<XZUM:]:7#^&O 2);RLT.J:>TJJA)0!#DGT
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M^\5ZM91> +?P[I 6PU*%'6!KL LH@)$)9E) 4%3N[XQ7IZEBBEEVL1R,YP:
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MTC\NWMXUCC3).U0, 9/)^IJ>BB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7S,I9@ 6)P %)SUK4\%6MW97?C666QES+K,TL"2*4\Y?+3&TG@@D8STKN**
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M>ZE)<[%+D9B"3GDX&20,# YYKT&J]]!-<V,T-O=/:3.I"3HJL8SZ@,"#^(H
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MMKZ.*'3X7.^:7*Y4')Z[0223@8ZT =-17,#QWI(_M998-0BETE"][&;1V,0
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M9GCAUV[@0R.TKM^]V(@SDL2< #WK?M_%^FMJ%]87JS:;=V5O]KFBO H_<?\
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MSR:_%#>%+\D21E9,NTBD;0W7&>..G0 'JUW9V]]"(;F(2QATDVMTW*P93^!
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M=/MI@!*OV=!Y3,/X2S+TZBO3XI8YXEEBD62-AE70Y!'L:?0!Y+_9FO?\(?\
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M\2?ZY8S_ 'MNX<>N*3P]I<-A\0K74M*\)WNF:3<Z;-:!WMRKF7>C[I5R2BD
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M[I/Q$TQ_)=["S\+II_VG'RF195X^N!F@#NTW>6N\ /@;L=,US6MZ_JB>(8-
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M\SSZCJ*RVB #,RXAY'_?)_*@"7QO*L^I_#&9(EB5]2B81KT0%%.!["NP\/\
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MB2VTPP:JSQ0S6#/^YF52P1P_W@0" 1CD=* .SJ*2X@AEBBEFC228E8U9@"Y
MR0!WXYK'\:7=_8>"]8O-,:);J"TDE5I<X 5221CG=@''OBO.I+O7VT_X:75P
MEM>:C))FWQ(X#JUH<-*S9.>26(STXYH ]BHK@E\<ZEHK>([?Q+:V;7&DV<=[
M&]@6"3H^X!</DJVY<?C5O2_$NN0^(-.TSQ!!I8&J1R-;M82,QBD1=YC?=U^7
M)##'W3Q0!V5%<?\ %0D?"_Q"0<'[*?YBN$U&T^$L'AB6:RN].CU1;;,#6%XQ
MN!-M^78%;.[=C^M 'M=%<#!XB\0V^E^&-%$=K_PD-YIXN+N74&8)"J*H8L%P
M2Q9@, CG-8GB?Q?XAO/"\ M/LEG?V^NPZ=?>7*^UGWHR&-A@^6P(R#S@D>M
M'H^F:'::5?:G=VYE,FHSBXGWL" P4+\O' PHJY/>6MJ\*7%S#$\S[(ED<*7;
MT7/4^PKE]5U/Q=;R0P6MMHL.RV$D]W>3,(9923^ZC .X=,[F]1P:Q-2\9P:A
M9^ =2.C6<YUB^B5?M*[VM&.,M&?[P.<&@#TFBN&;Q)XIU/Q!X@TG0['2U_LF
M6-?/O6?$FZ)7"@+WR3D\ #'!SQ#;^/KW6M*\.?V/:V<6HZQ;R7+_ &R1O)MD
MCP')Q@MEB !QZF@#OZB-Q +D6QFC%P4+B+<-Q4'!..N,D<UP<OC_ %"/1S;B
MQM'\0_VLND+$LI-N967>)<_>V;#NQU[5!ITNL-\9K6'6H;1;B/09BLMF6\N1
M3/'V;E2""",GL<\X !Z12;UW[-PW8SC/-<I\1]8O='\'S-IDODW]W/%9P3?\
M\VE<+N^H!./?%4'^$?A4Z:8H[:9-1VY751._VH2_\]-^>3GG'2@#M9KRUMYX
M8)KF&.6<D11NX#2$=0H/7\*FKRWQ=;SVGCOX86]U=-=SQ37"27#*%,K"- 6(
M'0GK6KXD\7>(M .H:E)8:9%I%C*!Y,\Y^U7,7&Z2/!V@<G /)VGI0!VYO+47
M@LS<PBZ*>8("XWE<XW;>N,]ZFKBY]9B7XQVFC?V99-*^C&X%^8_WZCS6'EAO
M[O&<>IK /Q$\3#P<_BW^RM-&E6D[1W,1D?SI568QEH^PQQUSD@].* /4Z:Z+
M+&T;J&1@593T(/:N-MO$OB&T\7:5I>MV-A';:O%,]M]E=VD@:-0Y20GAOE/4
M8Y%1^%?%'B+Q$MCJBV6ER:->.RLEO.3<68P<&3=\K'( (&"">^* .UABCMX8
MX88UCBC4(B(,!0.  .PIK7$"7$=N\T:S2 E(RP#,!U('4XR/SJ6O/?&,NH1?
M$SPF-+@AEO'M+Y4\]BL:<199L<X !X'4X''4 'H5%>?KX]U+3M.\0Q:Q8VKZ
MOI-Q!;HEH[+%<-.%\K!;E>6YZXP:M0>*]9L;^ZTW6HM,DN?[.EO[6:Q=S&_E
MX#QL&YR-RG(Z@GI0!VU-DD2&)Y975(T!9F8X"@=23V%>=Z?X\UY_!@\4WVF6
M"6ES#"MC:QRL)I9W94&XGY50L<CJ<<GTI=4\0ZN-/US0M>336GGT2ZNK:?3W
M8HP5=KHP;G<-RG/<'M0!Z'')'-$DL3J\;J&5U.0P/0@]Q6):^%+&W\1RZ]+/
M>7=\P=83=3%TME8Y98EZ*#P/7 QFN*T3Q/XBT+PEX6U"^L-/&@31VEH0LC_:
M8E=51)6_AP3@E1R 1S76:!XHDOK_ ,0Z?JD<-K<Z/<X;83M:W9=T<G/J,Y^E
M '345@>#=;O/$GAFWUB[MDMA=L\D$:YR(=Q"%L]R #^-;] !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %<KX]TN]U;2M,BL;=IGBU:TG<*0-L:2 LW/H*ZJB@#E9M+O6^*MIJP@8V*
M:-+;M-D8$AF1@N.O0$UR-[X,U&[TS67GTA+SR_%3:K%92E<7EOL5"!DXR06Q
MG'*UZQ10!Y?+X?6]\*^*8]%\#1Z(;G3FM[8,D4=Q<N0<@JA("YVXR>3FMK5M
M&U&XF\#-%:LPT^Z5[K!'[I1 RY//J0.*[.::*V@DGGE2*&)2\DCL%5% R22>
M@ [T12QSQ)+$ZR1NH9'0Y# \@@]Q0!YSXE\.ZM>ZEXYEMK)Y$U#1(K:U(8?O
M9 ),J.?]H=?6DN+?7_$$?A?0[G0+JS_LV\M[J^O)'C,!$(R!&0Q9MS8Z@8[U
MZ!?ZE8:7 )]1O;:SA)VB2XE6-<^F6(%6(Y(YHDEB=7C=0RNIR&!Z$'N* /)(
MO"$6ESW^G3_#ZVUF\EOI9;7494B\EHI'+ RN3N4J&(QM.=HQUKKM%T>\L_B5
MXBU![4QV%Q9VD5O("-K% P8 =>,BNOHH \NU+2K[4_$-K<0^$)]-\0PWZ,^L
M6TB+;O;K(-Q9@VZ3=&,;67.3[5W>E:S+J.JZQ92V1MQI\ZQ+(9 WG!D#AL8^
M7[W3FM:HXX(86E:**.-I7WR%5 +M@#)]3@ 9] * .+\?>'1J6IZ'J\FAKK=K
MI[31W-AM1G9)%7YT#D E61>,]":JVUOJ>G>&;[_A&?!\&B7M_<K!;(!&K11D
M8\^8*<#;EB%!8]/>O0J* /.M$\'WGA.[G\/62SW?AS5;5A).S O:W.S:[')R
M5D'/&<,.PK-\+^&(K!M&TZ?X=6J:E9.BW6K2)$(B(QQ-&X)9G8A2!M&"3G&*
M]7HH \WLSXG\(IK6CZ;X>FOY;J_FNM-O Z?9U$K;L398,NTDYP.>U65&N>'?
M'6L7_P#85SJL6KVUJ$ELF142:)65E?>P*J<@YYX]:[NXN(;2WDN+F:.&")2\
MDDC!511R22> *+>XAN[>.XMIHYH)5#QR1L&5U/0@C@B@#R5?#?B&R\ ^&A)I
M4EQ?Z7XA.H7-K R[FC\V4DID@'(=2!D=:WH7U;P]XLU;6T\/:C>V6NP6TWE6
MYC,UK,D>PQR*7 Y&.02 0:] HH \J3PAKD>E^'I9K/-[)XI_MB^BC<,+9'+D
MC/?:"H..]=#XUMX[VXBM=3\'2:]IABS'+:[#-#-DY'S,I4$;?F4]0<]J[2B@
M#C/#UYJ_A_3O">AZK:23W%Z)HIKA[@,UOL5I$5N#O.T;2<]5[YK8\8V6HZCX
M-U>STERE_-:ND!#;26(Z ]B>F?>M=X(9)HYGBC:6+(C<J"R9ZX/;.!4E 'DU
MGH#_ /"2>'K_ $SP-)H^FP)-:7($<*W!,L>W>^UN44CJ22<DX]<;7GU_3/@G
M=^&KC1GC^PQ+!)J/G1M;RQK* ICPQ8LW P0,9.3VKVRXN[:S6-KFXB@$DBQ(
M97"[G8X51GJ2>@[US"?#?P^ETKA;W[(MQ]I73C=R?91+NW;A%G'WN<=,]J .
M=UOPS!:^,M7U.^\%CQ'!J:0O;O''$[0RH@0HV\C:IVJ=PSWK5M- O;?Q5X2N
M4TF"RM;/3;F.XBM2/*MY'\LA%Z9&0W(':NZHH \R\0>%M8U&'XD1V]F2=52V
M^Q98 3%(5# <\<@CG%6-4EDUG2+"+6_A_>W^GF#:8B(FN8)A@9 WC"D=&5L\
M<@5Z ;B!6*F:,$<$%A4H.1D=* .)\.W6K>&]'\+Z/J5E+--?3S0/))<AVM5
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MXM;W3BL<DB!WW)(@8A201@\YPU>RT4 >777AV\70M.U31_",&F3:?K*7ZZ9
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MQ&957"A3ZYZ<5NZ'ITRW[7.G_#S2]!G@M9-MQ-' &:X(PJH8LG9URQQD'@4
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MY<[LI3C.>V<@=J *EEXN\06VO:1::W_8@74Y6@-G:2%KBR?8SJ'.XAQ\I!(
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M-PP" 2,XZU6T?3M5U7QAJ'B?4--DTV,Z<NG6EK-(C2LN\NSOL)"\D #)Z=J
M,'X$65W%X#L[R2/3A;3B79)%"1<LPF8'S'SAAQQQTQ7H'B&[U.RTAY=(MH)[
MPNJK]HD"11J2 TCG()51DX')QQ6%\+-$U'P[\.=+TK5;?[/>P&;S(MZMMW2N
MPY4D=".]2?$'2KS5=&L5MK ZC#;ZA#<7=@&4?:85SE/F(4\E6P3@[: ,;_A/
M-5L]*\5+<OI-]?:-9)>0SV6[R)58-\K+N)!!0Y^;H1TJT/$_B>RU/P_-JEMI
MBZ9K4XMUAA#^?;.T;.FYB=K?=(. ,=B:YV]\,Z[<?\)5]C\+)8V^M:,L%K!
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M[Y^;L,<'K6?'\1;[4='T&*)M.TS5=1DN([F:\),%MY!VR$#<"Q+%=HSWYZ4
M>ET5YPOQ!OTTBZM0-.O-<CU2'2[>6!C]FF:4!DD."2 %+94$\J1FG^(;OQQI
M_A;Q)'>/ISB#39+F#4[>%D'"MOB,9D+!\#*L./7TH ]$HKS*U\2:UI?AOPII
M<NI:3'?ZI;>:M[<QLL4%ND2'YE+Y>0E@/O ')..*D;XA:C'HMU:Q_P!G7>NQ
MZK#I4$T!/V:5I@&27 )(&TG*Y/*GF@#T)[ZUCO8K)[B);J9&>.$N [JN-Q Z
MD#(S]:GKS6,:W%\7=!@UJ:SN733;MH[FUB:(."8\J4+-@C'4'D$<#%>C7$\=
MK;2W$IQ'$A=SZ #)H DHKS)O&'BR'PC'XWF33/[';;.VFK"_G+;,P ;S=V"^
M"&QMQ6E-XB\2ZCX_U'P]I TZ*UM(;>Y-U<1NQV.#N7 89)XP>  #UXH [NBB
MN4TCQ+>W^G>*KB6. /I-_<VT 52 RQHK*6YY.2<XQ0!U=%><P>,?$>IR>$[2
MPBTY+C6]):\FFEC<I X$9)"ALD?,1MSU(YX-1R^.=;TO2->@U'^SCJ6EZA;V
M9O1&Z6RQS;"LSKN) 4/R,_C0!Z517 :EXE\2:%X.U+5;B;1]0\J6V%G>6JL(
MIEDE5'#)O."-W!#8.1Z&M[6==NM/\7^&])A2)K?4S<B8LI+#RX]Z[3G YZY!
MH Z&BN!\'^)O$/B1K341<Z+/8S.RW5A"&6YL!SC<Q8[F! !!5>N165;^,/&M
M[X.O?%4,>CI:Z>]P7M6AD+7,<3L&(??\AVK@#!R03T.* /4Z*\^OO&MYJ6L-
M9:+J>CZ9%!9073S:H"QF:4%DC50ZX 4 EN?O#BDM_'.I^(K7P[::''9VVHZI
M!-/<2W ,L=LL3;'PJD;R7X'(X&: /0J*\H\9ZAXTC\/Z=#>&QLK@:[;VIFB1
MF2Z4R*8Y% ?*+D$,AY.."!6OJ/BC6O[<ET.WU?0;"YT^UBDN[F]C8+/,X)"1
MIY@*K@9)RQ&X4 >@5!%>VL]W<6D5Q%)<6VWSXE<%H]PRNX=LCD5P4'CG5?$<
M7ANST)+.UOM4@FN+F:X4S1VZPML<*H9=V7X!ST%/\#-J#>/_ !NNJ+!]L1K%
M7: $(^(FPR@DD9&#C)P<C)ZT >@T45YUXJG\0_\ "U/#%II]_:0V\L%U(B2P
M.P^55W;\.-W!^7ICGK0!WUM?6MZ9Q:W$4Q@E,,OEN&\N08RIQT(R./>IZ\ET
M>?Q/;KXXN=#DTV&&TUJ[G;[7$\AG<(A*#:R[!@#GG)/08YZ&Z\3ZO?Z)H6HV
M-UI.CVE_9K=3WFI,&5'95*Q(N]<DY/.<8'K0!W-%>/ZYXHU[7O"WA*_LKJQM
MI;C7X[*X\M'>-Y4E9592'&8CL)*]2".>.?6[83K:PK=/&]P$42O&I56?') )
M) ST&3]: &3WUI;/LGNH(G(SMDD"G'XUF:OINC^+;/\ L^XO'EA#;WCM+QH]
MXP05;802IST/%>>^*G\.I\8ICXCTIM1@_L.+RD%BUUM;SGYVJIQQWKIO#"^&
MIUU&3P?HL6EZBL&T33Z5);J2<[0<A2PRHR : .QM;6"QM(;2UA2&WA01QQH,
M*J@8  J:O/+'QYJFL2Z=H=E9PP^)!,R:M%,C-'9)'C>^ 02'RNSGG=UX-0:K
MXZU7[3KMUIU_H<%KHTSPBRO"?/O6C4&3!WC9SE5^5LD<T >E45P\OB;6/$&M
M1:9X7DLK9%T^*_GNKV%I>)<^7&JJR\X!).:EMO$VO)KGA?2]5TZVL[C48[PW
MD:MOPT(7:T;!N%;.<')Y [4 =G56\U.QT^2VCO+R"W>YE$,"RR!3*YZ*N>I]
MJ\^\8^)-:DT[Q_86<MM;KI-G"T<IC8N5EB8OR&&&X^4]O0U'>Z[J^BZ3X#BO
MDTN_FU'4+>!I&MF_=QLHP5RYQ(/[WZ4 >GT5RVA>);FXUOQ+I6KB"&729Q)&
M\8*AK5UW(QR3DC# D<<=!7,VWQ UF_TO129-+TVXUN6YG@GNU(CM[.,@*64N
M-\C97'('/3B@#T^BN9\&^(Y]<AU*VO);.:\TVZ^SR3V1S#,I571UY.,AL$9.
M"#1XZ\07WAKP_'?Z?!%/<->00"*7.&#R!2,@\'G@]O0T =-17GLFM>-K;Q=%
MX;EET:66^M&NH;M+>15M@K88,F_,G4 <KR<GTJ;3/%'B.[\.:TIATUM9TO4F
ML'G9C%;;1L/G,"V0 KY*@\D<=: .\HKS-?&NOBP\2VUG=Z-K&H:3:Q7L%Q:(
M?*FC);?&RASAP$;&&[CBMO6?&,IT?P[-H(AENM>N(4MA,I94B8;Y'(!!^5 >
M_6@#L:**\X@\1>--9'B.;2QI$$6C7]Q;1K/!([77EX(7AQMX(^;G)/08Y .M
MTCPMI>BZA=ZA;)/)?77$MS<SO-)M!R$!8G"@]AQ6U7G\/C75/$TVA6'AU;2T
MN-0TS^T[F>[C:5;>/(0*J@KN8OD9)' JO<^/=7TW3-7M+]=/CU;3=0M[.6\*
ML+58YL%)V7.0 "<C=U'6@#TBBN!U#Q-XAT/PS/>WEQHURKW,$-KJD(9;<1R,
M%:21 Q("'T;!R.G-.O/%.N:#X:N;R_ET>_DEG@@TV\MV,<$S2L%S(-S;0IR2
M0W(]* .\HKSA?'6I:6VKVMW<Z7K4]MI4FI6TNF@H&V'#1NNYL8)4@@\C/'%6
M;7Q-XAMO#^HZW+<:-KEC%I\EU%)I@9-LJC/E$%FR",\\$8.1S0!WU,BAB@C$
M<,:1H"2%10!R<G@>]<MX3U/7=2=+BZU#1=4TR>#S%N=-!0PR9'[L@NVX8)YX
M(QR.:Z>Y>6*UFD@B\Z949DCW!=[ <#)Z9/&: ):*\]T;Q?JZ^*-)TO5M2T*]
M;4TEWV^G']Y8R(F_:QWMN7 89P.169<>./%Y\"WOC>SATIM-Q(UM8O$_FK$&
M*+(S[L$Y&2N!QT.: /5:JW6IV-C<6T%W>00373^7;I)(%:5O10>I^E<GXBUS
M7K6:,VVHZ#I-H+19EFU)LFYE.<QJN]2J@8RW/7CI69>^-YKM?A[>1Z?9$:Y,
M/-$\>]H"54GRVR,')/- 'I-%< -=\7ZQJWB2STAM*M8](N?+CEN('D,V8U8(
M0'&.2<M[C X)JHOC[4M6M/#(M+G2]'DU>Q>Z:XOT9XS(I5?*C&Y<DDD\GH.E
M 'I5%>7>);OQ@_B+P/ ;G3;*ZN)I_,C6-Y8S*D;_ #'#C<A4@A>H)Y)KU!<[
M1N(+8YQ0 M0W=M%>V<]K,"8IXVC< XRK#!_0UQ/B_P 2:_HUUJ$\%_H-A9V<
M EMX;]MTM^0I9@N'78.-HX))HF\5:]JOB73M)T-+&"*^T5-2,]U&TA@RX'0,
M-W! QQR<YXP0#LM-L+?2M,M-.M%*VUK"D,2DY(50 .>_ JU7F9\>:[8:)->Z
MA#8N-)UP:;JLD4;!3 =N)D!;Y2-ZY!SWKI]2U^\3QSHWA_3TA=9H);R_=U),
M<*X5-N".6<XYST- '2T5'//';6\L\IQ'$A=CZ #)KS9O&/BR+PBGCB5-,_L=
MML[::(7\];8L &\W=@OM(;&W% '>ZIKND:((SJNJ6=B)3B/[3.L>\^V2,UH5
MX[KUIK5_\<]-6*ZTER=*DEM#<6;R(D6\C#+O&7_VA@>U>Q4 17-S!9VLMS<R
MI#!"ADDDD;:J*!DDD] !3HI8YX4EB=7C=0R.IR&!Y!!KQQ9_$-SHWQ1;4;^T
MFMX8[F)T2!U.X6P"E"7(5<=1@\\YK<T_7/$^B6?A*>^_LUM*U.2WL?LL<3B:
M#?&=C&3=AC\O(V@<X&>M '8:)X6TO0+BZN;-)WN[K'G7-S.\TK@=%W.2<#T'
M%;5>7ZA\0M32/5]8M+W1$T[3+F2$:=,?])NDB;;(P;>-I.&VC:<X&>M>FPRI
M/!'-&<I(H93Z@C(H BFO[.V?9/=P1/C.UY IQ^-20SPW";X)4E3IN1@P_2O)
M?$D_A&#XPWI\7)8-;G1X!!]LA\P;_,?..#@XJ?PN="E^(ZWW@B$1:''I\BZI
M+;Q-';/)N'E@ @ N.22!TH ]7JK!J=C=7UU8P7D$MW:[?M$"2 O%N&5W#J,C
MIFO.+/XBZE);:?KTU]HATN]NHXCID9_TJ"*1]B2%M_+#*EEVC@GTJMINKQ:!
M\1/BGJ\R%X[.WM)B@."VV$D#\3Q0!ZU17GVC^,-537='M-5U'0[V/5PR"/3B
M0]G*$+A2=[;U(4C.!SBH9/&.NZ=K>GC4[S0@EYJ*V3Z1"^ZZMU=RJ.7#D,?N
MDC:!@T >CT5P.G^)O$.L:]?+8W&C&*RU%K6729 RW7DJ^TR[]V 2/F VX(XS
MFJ6J^.]5%QKMWIU]H<%IHTSPBQO"?/O&C ,F&WC9SE5^5LD<T >ET5Y[>>-K
MS4]7>ST34]&TV&"S@NFEU0%C,\JET10'7 "X);G[PP*KKX_U#64T".PNM+T=
M]2LY+AI]04RHTJ.(VACPR@G.3G.<8XH ]*HJEI,FH2Z5;OJL,,-^5_?) ^Y-
MV<94GL>OMFKM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %<MX]TC4-5T2T?2H4N+VPU"WOH[=G">=
MY;@E-QX!(SUKJ:* .!AL/$>K^.K?7;W1QI]FFE7%HL+W$<DBNS(06VDCG!QC
M.-O)YP*LOA/66^"EAX<%JO\ :D26P>'S5P"DR,WS9QP >]>D54U/5+'1K"2_
MU*ZBM;2/ >:5L*N2 ,GZD"@#@=0^&Z>(/&GBG4=2M_)6Z@M%TN_1QYD$B*=S
MJ <J0P3KC(&/6K<.F^*-3O\ P?=ZS8QI=:5=7 O98Y4*2*86195 .<,2.,9'
M/&*[U6#*&!R",@U4GU;3[;4[739KN*.]NPS00,V&D"C+8'? H XKQ#X*OO$&
ML^*E8+%::GI$%K;SE@1YJ,[<@<X!*]J2XM/%'BN;0;+5=#&F0:?>Q7MY<M=1
MR+,T62JQJI)PS8.6Q@"O0J* //(_"&JI\5&OO*3_ (1[SSJ8.\?\?9A$)&W.
M>F6SC%'@OPCJND>+]0NM0B1-.LTEMM)Q(&+12SM*QP.5(^1>>PKT.J.JZSIF
MA6GVO5;^WLK<L%$D\@0%O09ZGVH X'_A$-:_X42?#'V5?[6\DIY/FKC/G;_O
M9QT]Z[1-6NCXQDT9K5!:K8+=+<!\L7+E2I7L,#(/?GTK2M;J"^M(;NUF2:WF
M021R(<JZD9!!],5((T$AD"*)& 4MCD@9P,_B?SH AOOM?V"X^P>3]L\IO(\\
M'9OQ\N['.,XSBO/M/\.ZAJ/BJ'4SX7B\.'[+/%?RQSQL+QG4!0%C/(#?-N;!
MXKTFB@#R,Z'XRN? &F^%&T".%M.EMA)=&\C9+A(I5.8P#D' W'=CH1R36GXS
MT76O$+7M@_A2TN+DOC3-;BN$C-JO!5FR?,#*<G"@@X%>DT4 >8:??:WIGQ'\
M:R:=I#:NA-DKQQSI"ZN+<8/SD J><\Y&!P<\00^ ]2TW2O#U]<:3::S?6DMW
M)?Z>S)M?[2V\["_R[D(7KC//->D6FD65EJ>H:C;Q%;K4#&UR^XG>47:O!X&!
MZ5>H \YO/#6K:AX=CNK30-,TC4++58=1L["$HOF+'QME=/EW,&?IP,CGJ:NW
MD7BSQ3I'B"UN],BTFTN=+EM;6UFF261YW5AO9D)"KR!CKWKN:* /+?\ A']:
MNM+\+ZA?>%(KBYT6%K&?3+B>&3SXFC0>8C$E 0R< D'&>E6M0\-ZO?\ AN*Z
ML_#VFZ5J%EJT.HVFG0,B&5(N-LKK\N\@OTX&0,]37I%% '!VEGXDU;XAZ5KU
M_HW]G6%M93V_E/<QR2*[%#D[21@XP,9^[SC(KMKNV2\LY[63/ES1M&V/0C!_
MG4K,%4LQP ,DU5TS5+'6;"._TVZBNK23.R:)LJV"0<'Z@B@#S5]"\6W/@2+P
M%+HZ)&J)9OK NHS$;=6'S!,[]Y48VD8SWKJ=(T*]LOB+KVJO"%L+JSM8;=]X
M.XH&W#&<C&1UKK*IZIJMAHMB]]J=W%:6J$!I96PH).!S]: +E>;KIGBC2IO%
M6E66BI<V^L7<UU;Z@;I%CB\V-5(="=Q*D<8&#ZCK7I%% 'GWAWPQJUAJ7@R:
MYM@B:9H;V=T?,4[)2(L#@\_=/(XXJ8Z3K^G:QXMU"TTNUO8]0N[9X[:>10+F
M%8520#G"MP<;N.*[NB@#R6;P1JM]H'BE-.T2+0H[\6KVFEM.A4S0R;V<["43
M=A5P#VR<5MM;>*->\:>&]8NM#&EVFG"Y$B2W,<K[I(MH8[#C;D #!SR<XKOZ
M* /-H=$UK4_%.CZC<^%;;2-2L[CS+[5K>XCV7*;6#(JJ=[!B0?G'&.M8/AT>
M)[_X87NA:;HJ7,6HS7L$5]]I1$@1YI%?S%)W9'S$;0<Y%>SU1TC2++0]/6PT
M^(Q6RN\@4L6^9V+MR>>K$T <'<^$9M"UU[JW\+VOB2TN+&WM]LIA62"2%2@/
M[WC:R[<X.05Z5:N-#US3+SP]X@T_1K&6[L[66UO=,L76%-LA#?NBV%RK#G.,
MY->@44 ><>(-,\8:_P"&$N;G3X/MUOK$%];:8DR!E@C8?(TF=I<\GKCM27VB
M:@GB2YU^7P7;ZNNJ6L(DM)I8#+9S1@C&YSM*E2,E2>5Z&O1I98X8GEE=8XT4
ML[N<!0.I)["J&D:_I&OQ2RZ1J-M?1Q-L=K>0.%/ID4 <;<Z)KNE:CX<U^PT2
MRFN+6TFM;[3;!UA11(0^8BY"\,.<D9S1I<7B/1;KQOXHU#3((Y;J"&XM;;[2
MI7$43#8S#H1@9/3).,CFO0Z;)&DL;1R(KHPPRL,@CT(H AT^X>[TVUN9(_+D
MFA21D_ND@$BN2\5Z;K*^-?#>OZ7IAU&*RCN89X5G2)E$@4!@7(!'!SWKM:*
M.-T70-1L]*\803P!9-2U&[GM1O4[T>-54]>,D'K7.V?AC6]*E\-W$_AN'61:
MZ#%I[6\D\0%I< @L_P W!!& 2N3\O0UZI10!Y&?"?B>V\)V-F-)BGO-)\1C4
MU2*>-$NXO,=SY>3\GW^C8Z5ZM:2S3V<,MQ;M;3.@9X68,8V(Y4D<''J*FHH
MX'5[7Q)IGQ*FU[2O#_\ :MI-I4=H<7D<)5Q*S'[W)X(_.M6SU[Q3.MS]J\&/
M:F.!GA_XF4,GFR#&U..F?4\#%=!=ZA:6'D?:[B.'[1,L$6\XWR-T4>YP:LT
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M5=R@=\DD]L#GBU:^+=9U;P+HVJB\TG1Y+F62*_OKLCRH/+9U)169=Q9DX!/
M/>MW1-&O++QKXHU.=%%KJ!M3;L&!+>7%M;([<UQUCX/U[2=-\+2OH]OJ<FER
MWWG6+7"* 9I"R2*6^4D#\1NXH DB^(.J1^'_ .U#=:=?6NFZXMAJ%Y;+^[FM
MF"XF3#$*1YBY&2.#72:[XHN;'QCI^D6GE_9X[*?4=3=EW,D"#"!>>"S9_ 5F
M:+X2U.;3_%ND:[:6T=MK4K7"2V\@9$,D2*4"X!RA7AL#. >*7P1X2U>.PU>X
M\5B/^T]0@CL3Y4@<+!'$$!!]68NQ'J: ,S2OB#?N^AZC=ZWH5S!J]Q%"^DVQ
M'GV8E_U9W;R6()4,"HZGIBN\\4ZZGAGPOJ.M21^:+2$R"/.-[=%&>V20*Y+P
MWH>N::ND:3/X8T9$L"L<^K$H_G1H,*R( &$APIRW .>M=7XLT(>)O"FIZ+Y@
MB:[@*)(>BMU4GVR!0!S4FL>+/#EQH=UKMYI]Y::I=QV<]O;VIB:UDD!V%6+G
M>H;@Y&>],BUOQCKRZGJV@/IPL[*\DMK;3YH27O!&VUV,NX!"2&V\8X&:6;3_
M !3XHN-"M-9TFWTZVTV\BO;JX6[67[0\0.U8U R 6P3NQ@#O45OIGC+PY'JN
MC:%I]I-;WEY+<V>I27*J+42MN8/&1EBI+8QD'CI0!>N=7\2:[XFU32M!N;+3
M4TF*$SO=6YG,TTB[PG# *H7&2,G)XJ?3?$6M3>+M*T?4[.&T>?1Y+RY@5@Y2
M9943"L"1MPQ/Y54FT[Q+X<\4ZKJFD:;#K$.KQ0&56N5MVAGC39N.1@JPP>.0
M1TJ&?2?%NG:WH7B VUOK5_%I\MEJ$<<JV_+NKADW#! *X[''- %?7O'>K:7H
M7C.^A2W:31M0@M[93&3E&\K=GGD_.WZ5-K^N^,/#FFZ.99--NM2U75TM5B6%
MECA1XV(0G.3AEY;N,\5F:AX+\2ZCX3\8VT]O;"_UC4(+J"..8% JF(E=QQ]T
M(1D@9QG S76^,M$OM9N?#3V2*RV&LPW<^Y@,1JK@D>I^8<4 8NJ^(]8TS4=.
M\.7?B/1[&_:UDO+O4[F$)&5W[42.-G R><Y;HI/>JT/CW5=5TW2].TZ73SK5
MYJDVG/>1J9+<+"I=YD4-SE-I SU;KQ6QXGT&\/BJT\0V6C6NLJ+-K*XLYW1&
M W[T="XVY!W @XX-4+[P_P"(&M-!UJUTG3(M6TR^EN#IMLXC1H9%*%-^,&0+
MM^; !(H ;H*ZK%\8K^'5YH+B>/0H@EQ!$8Q*GG,02F3M.21U/3/&<5T7BS6[
MO19- 6U$>+_5X;*;>N?W;JY./0_*.:S-"TSQ!-\0;SQ'JUC#9V\^F):Q0).)
M&C*R%L,1P2<DY''(&3BKOCK2-2U33],N-)ACN+S3-2AOUMY)/+$P3<"@8\ D
M,>3Z4 1:OXDO[+QA=:7"(OL\6@S:@NY<MYJR!1SGICM7-Q^+/%]IX/TCQG?S
MZ:VG3_9OM6GQVS!ECD94\Q9-WWLL&V[< '&3C)MW.F^(;OQ!JGB/5-/AL;4^
M'I[-(%N!*Z-N#_,1P2>>F0 !SDUCZ3IOB;Q+\-/#GAQ]-@339H+.2;4A<C'V
M="D@41XW;_E"^G&<\\ 'JNI7#VFE7ES'CS(8'D7(XR%)%<=<^+]3B^&6A^(5
M$'VV]-EYH*'9^]=%? SQPQQ7:7ML+RPN+4MM$T31[O3((_K7EQ\/^,[KP3I/
MAB71[6W72YK7?<_;%<7*12+]Q<97@;CNQTQ@YX -Y]5\4ZSXQ\1:'I5Y86%M
MIGV=DN9K8S,3)'NV[=P'7))[# QWKEM4U_Q!XDT7P'?Q7MM8S7>J^3,BVY=?
M.C,J[_OC*?*?E]QSQ7?:)HUY9>-?%&ISHHM=0-J;=@P);RXMK9';FN0'@_Q#
M8>#_  O';V45SJ&CZQ)>RVOVA4\R-I)3PYXSAU- &[8Z]?'XN3^'9UM7ABT1
M;IITAVR-)YBJ><G"\DX_6L[X+?\ (L:S_P!ANZ_]EK1T_0-6_P"%LS>)[BV2
M&RFT1+4@2AF6;S%8KQU P>>E2?#7P[J/AK0]1M=3C1)9]3GN4".&RC;<'CZ4
M 6O%VIZE82V:6^LZ3HEDX<SW^H%6PPQM1$9U!SDDG/&*YM/'NMWGASP]<6 T
MZ:^OM8DTN609,#[?, E7!SM.Q6Z],@>M:_B+2-5'C:SURST:VUB%;![00S3K
M']GD+AO,^8'@C@X&>*Q-,\(>(K<:3;7=M;D6'B*347N(I0%EBD$A+*O5<%P-
MM %]O%FL^&=3UZQU^XM=26QTC^U8)K>W,!8!F4QLNYNZC!SWK%\0/XIDT[P?
M>:U=V%Q#>ZWI\CPV]L8C:L7# !BQWKU!R <XKH_$/@^\U[Q/K$IV1V5]X>.F
MK,6R5E,C-]WK@ @UE7.E^--;L?#-A>:/:V::1J-I<7,PO%D^T")@"4 ' QEN
M>>@QWH ](NW,5G/(H!*QLP!Z<"O+M)\<Z[/\-O"6J6EMIXO]6U3[$\8B*0@%
MY0" #Q]Q2?Q]:]1NHVELYXTY9XV4?4BO,] \$:WI_@/P7I-Q!$+O2M8%W=*)
M00L>^8Y![G#KQ0!J)XGUGPYK^K:=XANK748+;1WU>.>VMC P5&*M&5W-GM@Y
MJQH=UXWG.D:I>-IUU8:B%>XLX83$]DC+N5@[.?,QP",9YXI^M^$[G6O&%[<2
M )IMWX>FTQI0PW+(\F?N_3FH="7QQ&NC:1=6%G96M@%2\OUN%E%VB+M"QIC*
MEC@DG&,'% '&Z+K=WX<T#XFZM8B,W-OX@E*>8NY>9%4Y'T)KTC7=;N].\3^&
M-.@$?D:E<31S[ER<)"SC![<@5QZ> -9F\,^/M.D$,4VLZG+=V1,@(9=P9=V.
MF2,5J-9>*M>\5>&-4U#1X--M=,FF::+[6LSL7A9=PQQM!P .2<G.,<@&!K>L
M^)O$GPT\1>((KBQ72)H+J*&P-N?,,"EHS(9=W#<%L;<8&.^1MP:_=6OC?P=H
M:0VQMKO26EDD:/,BE4X"MV'%9;^&_&%GX&U;P19:7:R6SBY6UU)KM0&BD9G"
M&/&=_P Q7T&<YXYV3X5U4_$#PGJ_E1_8]-TQ[:Y;S!E7*$  =^>] &6?$_C.
M\\+Z[X@M;K3+>#1[B[5;=[5G-TD+MG+;QL^48X!R03QFMB3Q%KGB#Q%;Z5H-
MQ::?&FF1:A<W%Q;F<YE)V1A0R]@23GZ4VS\+ZI#\.O$^C/$@O=0?4&MU\P8(
MF+[,GMG</I5.#3]8\/>*K*YTVVLM0N9]$@M;NP:]6&6,Q' E&0<IEBIXZ_E0
M!N^!-?U77[36#K$,$5U8ZI+9;(,[0$5.YZ\D\^F*Q->_MR3XQZ';6NJP06_V
M">5(WM2^%W1AP?G&2<#!_A]#5GX6"Y^Q>)GNY(Y)W\073.\6=A;"!MN>P(('
MTJSXATK6D\?:)X@TS3X[^""VFM+B,W"Q,@<J0XSU'!XZT <IH\_BBTT;QGJ.
MCWEA:V^GZQJ$_E7%L96N65BS D,-BX  P"<YZ5M7_CFXOKW2;&TU?2]!%UI4
M>IS7-^ _^LX2-%+*">&).>@%7]-\-ZE;>$_%VGR1H+C4[R_FM@'!#++G9D]N
MOX5ECPIJFDS:)J2:%::R\6BP:;>6<LB*T;Q\JZ,X*D9+ ].Q&: .I\%^(7\2
M^'A=SFW:YAGEM9VMFW1.\;%=R'GY6 ##ZUT-97AVWO+;1HEO[.QL[IF9W@L5
MQ''DG SW(& 3QDYK5H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ J"\OK33K9KF^NH+:!2 99Y BC/
M3D\5/7!?&$HO@%FDB:5!?6I:-5W%QYR\ =\^E '2+XN\-.ZHGB'269C@ 7L9
M)/\ WU3M7\4Z'H%Q;V^JZI;VLUQ_JHY&^9^V0!SCWKD[+4?#-Q?V\"?#K4X'
MDE5%FE\/JB1DD#<S8X ZD]JQ;W3]:E_:""Q:U#'-_8AEBD:R#>7#YY'EXW<G
M_;_2@#T:X\4Z':Z[%HDVJ6ZZG+C9:[LOSTR!TS[UKUXQX775=*^(?Q U*ZUB
M*5=.6VFOB+( W*"%V 7YOW> ,<9S6CHWQ NVO- N+GQ-HNH?VO.D,^E6H026
M9D!*;2&+-M;"MN'?M0!ZM61K?A?1O$9@;5+(3209\J59&C=,]0&0A@#Z9KDK
M#5O&7B*QF\1:+=6/V1;N2.UTJ2 #SXHY"A9IBV58[6(P,#CK4?AN/6)/C#XM
M,NK(UO;I:!X?LPR\;)*R(&W?+M+')YW>U '6^%'\/OH$(\,>1_9:,RIY .W<
M#\W7DG/4FMNO(]%\>ZZ_P^TCQ/<M;>0NK?9]2"0A0+=GV;QZ%25^N:ZO7O%-
MU9>,K73+4I]CM-/GU/5#MRWE*,1JI[$L"?H* .QJ.XN(;6WDN+B:.&&-=SR2
M,%51ZDG@"O*]'^(5V]SH%Y<^)M%OO[7N(X)M(MMGF6?F_<PP8LQ4[0V1W/2N
MO^)7_)-/$?\ UX2_RH U;;Q-H-[.L%KK>FSRL<+'%=QLQ^@!K4KC-,\$>%]7
M\':;#>:#I[^;91%I%MU5\E!R' !!]P:Y[PWKFLV_@._M1K%G!)I.LRZ6^J:F
MXPENC#Y^2 [@$* 2,T >J45XUJ_BG4=8\ ^-K.W\06>H#384(U&VA7%Q#*AW
M1D!L*P((W#VXK7O/$>H:+!X?T&Y\3Z=82W-HUU-J=U B!(UVA(T1FVEB6ZD]
M%)Q0!Z=63K?AK2/$:VZZO9BZ2!MZ1N[!,\?>4$!AP.&!%9G@3Q))XBTN]$UW
M:7DUA>/:-=VF/*N  K+( "0,JPR 3R#5*?4M?\0>+]7TC1M3@TJUTA(5EF:U
M$[S32+OQ@D *%Q[DGK0!UM[?6>DZ?+>7MQ#:VD"Y>61@J(.G7]*BTC6=.UZP
M6^TN[CNK5F*B2/."1UZUXY\0M8U;Q'\&[NYNKB"WFLKXV.HV\<.5FECG50RL
M3E1QNQSUQVKV+2+6^M-.6'4+Z.\G!/[U+<0C'8;03T^M $]_?6NF6$]]>S+#
M:P(9)9&Z*HZDU-'(LL:R(VY' 92.X->()'J[>"_B?-?:LES%'=7<#QBV"%Y%
MCC D!W' VC&W]:ZR+4O$^A7OA:6_U"TN+#5IDLY+%+;:;<M$S(5DSEL;<'(Y
M[ =@#M[+6=.U*]O;.SNTFN+%Q'<QKG,3'H#^1J]7F2>-M9C/Q">.&&9]$E1;
M15AZ @Y9\<MCK]!70^#[_4-0:69O$>F:_IC1J8[FVC$<D<F>495)&,8/.".F
M#0!UE5K74+*^>9+2\M[AX'V3+%*KF-O1L'@\=#6-XZ\1_P#"*^$+[4TPUT%\
MJU3^_,_RH,=^3GZ UP&@Z=#\-_%/AQ5NXY;;6[86&HNL@;-Z"720^NXLZB@#
MV&BN+U#4]>U?QO<Z#HNH6^G0:=:1W%S/);>>TDDA;:@!( 7"DD]:YR7QYXFA
M\%WNHR16O]J6_B+^S?)5?D*!U4J"?7)^:@#U>BO.=;\0:QX>ETG1-4\4:9:W
ME^9IYM4FMUBC@B0+B-$9L,Q9L D] >*SS\2ITT-[;^V=)>]&KKIJZQ\OV;RC
M'YGGD;L9"Y7;NQN'X4 >JJJHH55"J.@ P!2UY1/\0;ZST+Q5';:YIVLW.EV<
M=Y::A;(NUE=BI1U4E=RE>W4,.*OWVJ^--.\0:%:'4=/E&OB5!$;3"V+*@?*D
M-F3"[A@XR1VSP >D45YG+XUUGPW9>,+?5;FUU"YT7[*;:Z:(0+)]H&%$@!P
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M%G%Y5K;1+#%'DG:BC &3R>!WKQJU\1ZIX=^%KZA ENE[+XCFBF5D\Q%W3MN
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MOQKXGM/+,&$L+)Y#A)&@0[V)_N[SC(]#77>'=0N-6\-:7J-W$D5Q=6L<TD:
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MRR\UU-% %33'OI-,MGU.*&*^,8,Z0L617[A2>HJW110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTFTN('*LVH3 QP#S2BM*%8%0X4E>F<BL6P@U"V^*FBVVIQ:-%(VD7*>1IR,
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MO"%RMU8+J"W$L-LEJ\AC21WD55#,.0N2"?84 :>F^(]$UBWGGTW5K*[BM_\
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MV$'#S+,NU6[*3V)) P?45S?PQ\9WWC.QEO[[4=)9W!8:=:(?-M1O('F$L<Y
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MR-Q\S,Q+%N!@YR,#TI+3P9X?L=,OM.@TY1;7Z[;H/([M,,8PSL2Q&"<<\9H
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M*#TQQF@"AX1>+Q+XTUWQ9&PEM(U72]/<="B?/*P]BYQG_9IWBQ4E^(_@:*Z
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M%N@#''HMP]KN[3>:@8K[[/TKH]$\,Z/X=$W]EV8A:<CS9&D:1WQT!9R20,G
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M?0\47WA/0=2TBVTJYTR%K*UP;>-,IY) P"A4@J?H: .$\<P:##I131Q$)?\
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MZ1'<ZK<K9()M54)?-N;]\ I4 \\<$CC%3?V)IG]A+HALXFTQ8!;BV<;E\L#
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M6?GEF+>2""%Y/J!SUI]GHFG:??W]]:VJQ7.H,KW4@))E*C )R>P)Z4 ?/_\
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M:79:UILVGZC;I<6DPQ)$_0\Y'3D$$ Y'3%9$'@7PU;F)HM+17B61 _FN782
M*X9BV7R !\Q/08Z4 <)=65M:_!_P.\$*(Z7>ES*P'(=G0LV?4Y/YUK^&8[&<
M_$1]46-F;5)DN3*!G[.L*;,Y_AVYQ^-=I)X?TJ72K/2WLT-E9F(V\6XX0QXV
M8YSQ@=:IW_@KP[J>L?VM>:7%+>G:'?<P$FW[N]0=KX_V@: ,SX4_\DN\/?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBH+B]M+1X
M$N;F&%IY/*A620*9'Z[5SU/!X% $]%06EY:W]N+BSN8;B DJ)(7#J2"01D<<
M$$'W%$5[:3W4]K#<PR7%OM\Z)) 7CW#(W <C(Y&: )Z*** "BBB@ HHHH **
M** "BBB@ HHHH ***@6\M6O7LEN83=(@D> .-ZH20&*]0"0>?:@">BBB@ HJ
MM<ZC8V<]O!=7EO!-<L4@CEE56E;T4$_,?841ZC8S7\UA%>6[WD"AI;=95,D8
M/0LN<@'MF@"S1110 456O=1L=-2)[Z\M[5)9!%&T\JH'<]%&3R3@\=:LT %%
M5I]1L;6[MK2XO+>&YNBPMX9)55YBHRVQ2<MC(SBK- !1110 4444 %%%5K_4
M;'2[4W6H7EO:6X(4RW$JQH">@R2!0!9HHHH **K)J-C)J$FGI>6[7L:"1[82
MJ9%4]&*YR![U9H **** "BBB@ HHHH **** "BBB@ HHHH **BN;FWLK:2YN
MIXX+>)2\DLKA511U))X I8)X;JWBN+>6.:"5 \<D;!E=2,@@C@@CO0!)15:Z
MU&QL9;>*[O+>WDN9/*@6654,K_W5!/S'V%6: "BBB@ HHJCJ.M:5HZQMJ>IV
M=BLAPAN9UB#'VW$9H O4444 %%%% !1110 45'+<008\Z:.//3>P&?SIL=W;
M3.$CN(78]%5P30!-1110 4444 %%%5K[4;'2[;[3J%Y;VD&X+YMQ*L:Y/09)
MQDT 6:*** "BBB@ HHHH ***:CI("496 )!P<X(ZB@!U%%-5U<$HP8 D9!SR
M.M #J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "N%T?\ XG_Q3UV_N/F@T*..QLE/19)%WRO_ +WW5SZ5
MW5<+X8_XE7Q,\6Z7-\IOC!J=KG_EHA39)CZ,H'XB@#D_"VK^*]'^&L^KZ=#I
MC:9IL]W*]O.KF6Y19W9RK@@)@$@ @\K[XKI?$EW'8>(_"'BVQRJ:C/'IMR.G
MFPSJ6C+?[K $?4UBV>E>,K+X>7OA+_A'2\U^;F.*Z%U%Y<$<TCY,GS;L@,6&
MT'.1WR*U_%MDINO OA2U8R2Q7\-T_M!;)DL?3)VCZF@#T2BBB@ HHHH 9*S)
M$[(AD<*2J @;CZ9-<#IOB_78?$>CV.M3Z')_:CO$]G8N3/8R!"X#G>0X^4J2
M .>G%=EKEK<WV@:E:64ODW<]K+%#)G&QV4A3GV)%>9V/A[6()/"EQ:>"HM.7
M1YU%VBRP>=.3$T;.K!L%03D[CN;/3CD N'QEXQN?#.L>(;2#1X[729[E'AEC
MD+W*0NV2I#83Y1CG.6!Z"NBTOQ9<W7C,Z1=PPQVEYIL6H:;(H(9ATD1R3@L"
M01@#@UEV?AK5HOACXFT=[7%_>OJ!MXO,7Y_-9RG.<#.1U/'>J/C^UO=&\&^'
M-9L@B:[H[PPP1DY,IE01/$,=2<@_\!H ZOPMX@O/$-YKDS10KIEK?-9V3H#O
ME\L8D8G."-^0, =#UKI*R/"VAIX;\,:=I"'<;:$+(_\ ?D/+M^+$G\:UZ /.
M_$7C'7] N;N^N9-#@L+:Z6--.DDW7=Q"65?-5@^ 3DD+MZ#FKLVO>*-2\8ZY
MH.C+I=O'IR6\@NKN)W_UB$[2JL,DD'GC '0YXY+4?!^O3Z!KFDQ>%[>74Y[R
M:Z_MB66(FX0R^8BH<[PQ7"8. !DY[5W'AO3M1C\9>(]8O+%[6#48;(PJ\B,P
M9(V#J=I/*D@>A[9H Q+;Q[K&JZ%X;BL;6RAUW6+B>W<RAF@A\@L)7 !!/W>!
MGOUI_AIM4/Q:UN/5Q;&ZCTFV7S;8,L<J^9(0P5B2O7!&3R.M9MEX6\0Z-I?A
MK4X=,^TW^D:A?/+8K,BM)!<._*L3MW %3@D5O^'+'7I_B!JFOZIIGV&TNM/A
M@MXVF1W3:[$JVTGGG/&1@@9R#0!V]<?XIUCQ!87[I87&AZ=91P>8L^J/DW,O
M.8U =2H  RQS][@<5V%>=ZKH6I'QOJ]V?#D&K)J%O#%97MP\9CLMJD.&5CN
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M #OELG'& >UZU\6ZUK'@?1-6AGTK27NV=+Z]O&S%;["RG8A9=Q9EX&[@=<T
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M]/9R7;R%E6TC94C0@83))+$'/S<9]*U* "BBB@ HHHH **** "BBB@ HHHH
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MG0WDBN5-S')E/LWEJXVGNQQCJ*]&JEI>KZ?K=H;K3;N.Z@#M&9(SD;AU'X4
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MO7W@N\C\0?#][ (]AX>CFAG=V"MM,2(I [YVT =Q"LL=I&L\BRS*@#NJ;0S
M<D#)QD]LUXE=^(M=\1_!G2]4^UVMG+/JL<,R0VV%8"X 3&&&,%03Z].*]Q89
M4CVKR6Q\ >(+/X.6V@>3;MJUK?K=K"9@$<+-OV[N@)% &OJNO:[;>)(_#[>)
M-*TVYCLHYHI[NSPNH2LS JH+@*!M7(!+?-7>V37+V-NUZD279C4S)$Q9%?'S
M!2>2,YQ7&:Y%XDU:V:"^\'Z7J=G<P#;;37:AK67D'<Q4A@?E(9<$<_6NF\-Z
M;<:/X8TO3;NX^T7%K:QPR2Y)W,J@$C/.* .$U7QIJNC:N);OQ!H18ZBEL="B
MVM.(&D"!]^_=OP0Q&W'6L]M/UR;]H"[6/6+5)UT;S4D>PWA83.,1XW_>Y^_G
M\*>?!_BI/"3:!!I.GJ]K>B[:^-R-VH%9_- QMRA(ZEC_  XZ'CJ;3P_J?_"V
M)/$TT,<=E+HBVA'F!F67S Y7'<8SS0!RG@&QUH?$WQI)+JUM(T%S;B[/V'!N
M/W;;=IW_ +O'_ LUA>(M?O/$W[-CZK?) EQ+=*K""/8GRSX&!^%>E>%_#FH:
M5XQ\8:G=)&+;5)X'MBKY)"HP.1VY-<;_ ,*Y\0_\*''A+RH/[6%QYFSSALQY
MV_[WTH Z_5O$%Y:?%3PYH<:0&TO;2>25FCS("JDC:W8<5B:QXTU71=6::Z\0
M:%E=02W_ +"CVM.8&D"!]^_=OP=Q&W K<U;PWJ-Y\4O#NOQ)&;"QM9XIV+X8
M,ZD# []:Y=_!_BE?"<WA^#2=/5X+W[6U^UP-U_BX\U1C;E6/&2Q_AQWX +=C
M=ZM9?%'QE>W6JQO8:=9P32P"UY>'9*ZHIW?*5R<G!W>@IFD>/[UKK0;N[\0Z
M'>IK$\<,NE6A7S;,R@[,,');!VJV1WXQ6F?#VM/XTUNXETZ)]+\0V$-O<2"Y
M >T*QLK#;CY_O=12^&](\0V!TG3+GP]HT,5@%2?5 RN;A$7"F-  RN2%)+'C
MGK0!%X:\2:[KVJ^:FL:22EY)#=Z&\12>VB5V7=NW%BV #RNTY[5Z)7G5UH7B
M'6M;TI]1T'3+>[L+])VURWG :2)&SL5,;QN7Y2I.!D]:ZO0M5O-2O-;ANX88
MUL;\VT+1$G>GEHX)]_GP<>E &+XO\07FD^,/!VGVZ0-#J5U+',9(]S *JD;3
MV/-9Z:OXOUJZ\4)IVH6%C#H]X\4+26OFM-B-6"'YAM SRW).[MCG2\7>'-1U
MCQ?X0U*T2,V^EW4LMR6?!"LJ@8'?H:L:#H-]I[^+#.J :EJ$EQ;X;.4,2*,^
MG*F@#%MO&&L^)HO#5AI$EMI][J>FG4;NXDA,H@1=JX1,C)+MW/ '>L/XFMKG
M_"M/*\0);_:H=8AC2>WX6XC#?+)MR=A/=<]16IIOA3Q#X<L_"VIV-G;WFH:=
MIK:=?637 C\Q&*L"CX(R&7OU!I?%7AKQ=XJ\$/;7HM/[1EU..YCM4D&RV@4\
M)OP-[#DD^_M0!U%GK=W/\0M4T1_+^QVUA!<1X7YM[LX.3Z?**Y=O&VMW&G"U
MM6MEU.\\17&DVTKQ$I#%&S9<KGYB%7ID9)K6U+3_ !!IGCV;7M(TR#4K>]L(
M[66-[H0-"Z.Q#9(.5(;MSQ6%#X*\26FB07*K:3ZS8^()M42+S-D=Q&Y8,H/.
MTD,2,],<T 6=-35[7XQ&'5KJ"\DC\.N8KF*'RMZF=>&3) (.>AP1BLW1_'>O
M7/PS\-ZO;PV/]HZCJZV+)Y6R+:TCJ.!TZ#)^M=%I>E>([SX@OXCU6QM[*V;2
M&LH[=+@2LC>:K#<0 "3\W3@ "L3P_P"!-<T[P!X4T>XBA%WINMQWMP!*"!$)
M'8D'N<,.* -9/$>M^'/$FH:=KU[;:E;1Z/+JL<L-MY#)Y; ,F-S9&""#UK+N
MO$GC;3?"VD^(;BZTV:/5)[4/:I:E3:),ZXPVX[_E.TY Y((Z<]!KWAB?5?%L
MU[,R1Z9+H%SITLI891I'4YQZ;03FN(UB7Q!)X"\.:?=1Z;]C@OK""*\M+OS_
M .T-LBJGEJ ,# W$DG[O3T /::YK6=;O=+\9^'K(^7_9FIB>"0E?F295WIS[
M@,,>U6[+5;RX\6ZMI<L,(M+2"WEAE0DLQDWA@W88*?D?>J?CK1K_ %C08FT@
M1G5;&[AO;,2MM4NC<@GT*EA^- &-X=\<7=]XJUR#4/)328XYIM/D5<$QP2&*
M8D]_FP1[&LNT\9Z[-<_#QKV*T#:^]S),/)Y2, -&%.>#M89/>DUSX>ZTW@OP
MYIVD/$-0M;>2ROG=\ QW"8G8'N=^"!6[XA\)WEWXM\$7FG11C3]%>83 O@HC
M(BJ ._W: .3A76Y&^*+WFK13P0PRQR1"UVES]E^4J=QV@# Q@YZ\5HZ;JOB?
M0=#\&WUQ>64FFW[V=@U@ML0T22( C^;NY88!(P!R<=,U<E\.>((=3\;VL-A!
M-8Z_"[P7?VD*8W,&P(R$9^]CG.,5HZEX:U&Z\+>$M/B2,SZ9>6$UR"^ %AQO
MP>_2@"M%JOBKQ+=Z[<:'J%C86FEW<EE!#-:F4W4D8&\NVX;5+' QSWIV@^.+
MK7]5\*^5''%:ZKID]U/'C)66-D7 /H"6_2F0Z;XI\,7>NVVBZ9:ZA:ZG=R7M
MM/)=B+[-)(!N#J02RAAD;>W%58O!VL>%1X3N-&MHM4?2+.:SNH6G$)D\S:Q=
M201PP/![&@"CX[U[6+OP]\0K.&ZBMX=+\F-,199XI(077.1@DMU[ =*]$\/P
MWT&A6B:A>1W=QY8)ECA\H$'H-N3T'&<\UPESX,\1:IHWCJ.\2TBN]=$3VRI+
MN12L8&PG'; 7..>N*[OP_)J,FBV_]J6"V-VBA&A6<2C@8SN '7TH X#1IFMO
MBQ\29T +QV=JZ[AD9$&>:98>-M?G^'W@S4;2.Q%_K&H_8Y5,6V)03* 0 >,;
M%)QUP?6MFS\*ZI#XW\;:JZ1_9=7M88K4AQDLL6TY';FLW1O!&M67@SP-IDT<
M(N='U075V!(" F9>A[GYUXH LV]_XTD\77_A1M8T\O':QWR:G]A^9$8LOE^5
MOP3N'7/ !ZY&,S5?'FLP_"Z/5Y([-]3AU3[!.3#NB<K*R%@I/&0 ?K79V^BW
MD?Q)OM<94^Q3:7#:HV[YMZR.QX],,*XW5O 6NWGP\N-&BBA-X^N27R@R@#RC
M,S@Y]<$<4 :$RZW)\=5@BU:)+5-&$XB-KN_=&=0T>=WWB5SO[=,57O?&FJZ5
MK=N;SQ!H4CRZFEH^A0;6FCB>38K[P^XN 0Q&W'45N:CI.M6WQ0M/$-A8Q7EE
M-IHTZXS<"-H/WV_S,$'<,=A7+1^$/%4/A.TT2'1]/233;V.[:Z^TC=J)2</_
M '<H2.26/4 8YR #5\)KK<GQ5\8BXU:*6VMGM5>(6N-ZM"60*=WR[=W/!W>U
M9^@>/=8N_AOI5['#9#6-5U0Z=;XBVPQDLWSLH/.%4GKR:Z+1]+US3/B-KFH/
MIT+Z9K2V\C3BY :V:*'85*8RV6 Y'8YKG=#^'^NZ=\.=*L2+9=:TG5?[2@C:
M3,<F&;Y"P'&Y6(SV.* -^+6=?T'Q/%HFLWUMJ,=]8S7%I=1VWDLDD6"R,H8@
MC# @]>U8,'BOQ@G@G2/&=U>:?]EF>W6?3EM3EXY'6,N)-W#9;<!C Z<XYW8]
M(UW7_$\6MZOI\.FQ6-C/;VEJ+D3.\DN SLP  7"@ =>]5IO"&K/\'M.\-".+
M^T8%M0Z^8-O[N5&;GZ*: /0JYOQAJ-_I]K:&UU73=)MY)2MSJ%^5(B7:2 BL
M5#,3@<G@9ZU:M=5O)O%^HZ5)#"+2WM8)XY5)+DN7!#=A]PXK)\6Z1J=QXAT'
M6;#3(-42P$Z/9S3"/!D"[9%+ C(VD>N&XH YU?B!J[>$);NSN-/U&]MM=BTQ
M;F$8ANT9DPPP3M)#@'!."#6H=1\6:=XH.@W6IV-[+J&FSW%G,EIY0@GC*@*1
MN.Y/F'4YK*'@_P 3/#?6]Q;69-QK]KJXEAFP@4>7OC (S\NS /\ %Z"NOO\
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M5.!D[CVQCGCH!IOB;P_XKURYT;3;6_LM9>.=9);KROLLH0(VX8)93@'Y>>U
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M'-Z,WM_<JHV##8$2'Y2Q( YZ#)P:H3?$'5(OAIXBU6UU"UU"[TG4([:&]BB
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M,#CCI0!ZC03@9/2N%U"Z\2Z9X=6\U'Q)I5BUU<HTMQ<0JB6,14DQQY/[U\X
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MQ)G/3"@;.E6I/'MV?#O@^.XUJQTBXUBT:YNM1N$7;&J*O"*Q"[F9@!GH >*
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M53H6P%'/'6KGAJ+4H/BUK<.J74=W-'I-L$N$B\LRIYDA!91P#DD<<'&>,XH
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M$$\ *">G2K] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB,T 7Y6XSM.",^]5=0T3Q+XE\/ZY8W=CIFC+=61M[>*&4RN9#R6>0*N$/ P
M3U/M75Z3KNF:Y]L_LVZ$_P!CN7M;C",NR5?O+R!G&>HXK1H \]_L3Q/J&O:!
MJ5WI6F6=G8++:OI\-T6VQRH%:0-L XP,(!T[\\)HNC>-M&TW3_#-LUA#I]E,
MH_M82[I'ME;(3R2F Y7Y2<X'45Z'10!R.D>&[^RTGQ9;3>5YFJ7]W<6^ULC9
M(BJN[C@Y%:_A739]&\(Z/IEUL^T6EE#!+L.5W*@!P?3(K7HH X--)\5>&[_7
M(M!LK"]M-5NGO89;BZ,36LT@ ?<NT[UR-PP0>HJI>?#V\@\/^!])T^6*4:'J
M=O=W,DC;=ZJ2SE1SR23@5Z/10 =17E$WA#QC%X"O_ UG;Z<;';*EMJ+W)#-$
MSEU0Q[>&YVDYP!SSW]7HH X6XT;Q'I/BY-:TBRLK^.XTR*RGAGNC"8GC8D.#
MM;*_,1C&>*R)? GB'_A";JSWV<^JC7CJR#>4CF'FA\9P=N>?7%>HT4 >9_$U
M=1D\.Z'J4 BL?%$=XL-G"DOF9:8&-T5L#(VG<3@?=KO-"TB#0-!L-)MO]3:0
M+$IQ][ Y)]R<G\:C/AW1SKW]N-I\#:IMV"Y89=1C'&>G''%:E '&ZSI>OV?C
MJ/Q'HME:7Z2Z=]@GMY[DP%")"ZN&VMD<D$8S6+;^!]>&DO#=26CW<GBF/6)&
MC8A/*#(S8R,YX.!].:],HH Y36O#$^K^,;:^<H-/_LJYL9OF^?,I7&!] :Y2
MY\+^-KWP39^%);;3(X=/>W47BW3$W4<4BE0$V_(=J@DDGE<=\CU:B@#A+K1/
M$&D:YK,^B:9IFH6^K2+<*]W-Y9M9M@1B1M.]#M5L @]1[U>/AW43X[T369&M
MV@L],EM9V0;,RL5.57G"\'OQ76T4 5[ZW:[T^YMDD,331-&)!U4D$9_"O-8/
M#'B]=#\-V(TW2K=/#]Q!*(H[H_Z:4!4OG9^[X);!R23VQSZE10!Y)X?'BEK+
MQC::+9V-S%>:W?1I-/<F(VSEMI8KM.]<8/!!SFI$TK4O#?C[P[IVBI!>2Z?X
M::)XII#$)U$J*<-@[3G#<@CC'?->FV.FV>FK<"SMUA%Q.]Q+MS\\C'+,?<T'
M3;-M575#;J;Y(#;K-SD1E@Q7Z9 /X4 >=ZCX'UW6/!_B_P"TK:1:WX@FCD$"
MREHX4CV*B%\<G:IR<=36GJ7A'4[KQ)X$OX_(\G1(Y5N\OSEHE4;1CGD'TKNZ
M* //AHOC#09-:T_P]%I\EIJ=W)=V]]/.5>R:7E\Q[2'P<E>?K3W\/>)++Q+J
M\]G'972:O!!$VI3R;)+4I'L8^6%^;/W@ 0,GFN^HH \MTOPIXNTJ3PM=Q6NG
MM-HFGS64L)NB%N02@7#;?ER%W<@X( [Y%BZ\&Z[J^@>,[B\CM(-7\0)''%;)
M,7CACC7:@+X&2<L3@8YKTJB@#@'\,:QI;>'M3L+*RU"[L=*73;RSGF\M74!2
M&1]I (93U'(/:NK\/Q:G%IF=6CLXKN21G,5F#LC4GY5R<;B!C+8&?2M2B@#C
M?%=CXAU![RPCT72-8TNZB"PB[F\IK9\$$L-C;AT((P1T]ZH0^%M>T3Q-X<U&
MR2WU*.TT9=)NVFG,3##*3*/E.[[IX_6O0:* /*/^$.\6IX1'AR"TTQ$LKQ;M
M;HW!W7Y6<2@,-OR$]V)/('8Y&])H&M#Q]=:H+*UFTW5M.BM+P&Y*O;%=V[ V
M_.,-QT_"NYHH X+P[H_BG28=*T633]'%EIY6-]3WEWGA084"/:-KD;<DL0,$
M\UU'B718_$?AK4=&DD\M;R!H@^,["1P<=\'!K5HH XO3;;QI?3V-GK,=A9:=
M;1-'>/;S><U^2FT8!0>6N?F/.>U8G_"*>+7\&KX$>*P&F@"W.K"Y.\VP;./)
MV_?V_+][%>GT4 <M8^'KJT^(M[K0$0L)=,AM(P&^8,CL3QZ8(KE- E\3P:IX
MV_L*RLKQ)M9EC7S[DPF"3RH_G/RG>N"..#\O?/'JE5;+3;/3WNGM+=8FNYC<
M3E<_/(0 6/OA1^5 '!V?@C5?"L?AR]T,6U]=Z98/87=O-*8A<([!R4;!VD."
M<$<@U!JG@C7=;\-^+YKI;2+6=?$"1VR2EHX(XL!5+X&3]XDXQDUZ;10!R7BO
M1=3NKOP_J6G6MM?2Z5.\CV=Q+Y:R!HRFX-@@,I.1D>M<WJ'@OQ/JNF^,K6[%
M@)->AAFBDCF;;%*@51$05R1A0-_?KCGCU&B@#@9])\2/J.F^)!HNG2:A':/8
MW>FR7>5:/<&1TDV8# @Y!'1NM=5H$.I1:6/[6CLXKMY&<Q68/EQJ3\JY.-Q
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MR0D4",3M#8^=@,<X&:[RB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME_\ "#^)%T36M%"Z8]M)JAU.SE>9_P!\?/6412IMX& 02"><<4 )I/B>_O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M Z2BL'5=4,6JZ$EOK5C;0WDC?N94WM>+@$")@>.N<\]11J/C7PSI+.E_K=G
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M"0VXY8@9PI)&21@UH6GA_2K'4O[1MK)([S[,MKYV26\I<87D]!@4 <3\$?\
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MI-,LYM3@U*2W1KR"-HXICU56QN ^N!^5,BT?3X#?&*U13?L7NL9_>L5"Y/X
M"@#Q\,6C^"Y8DG9W_P"N,==9X6LK:35/B%*\*,\NHM"Y89W(($.T^WS'\ZZS
M_A&=% TH?V?%C21BQZ_N. /EY] .M6K;2[&T>\>WMDC:]D,MP1G]XY 7)_
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M/3K5OPO<6C^-?&[WOEQF1;20+-@8M?(&.O\ "#OSVSF@#I]2\7>']'CCDO\
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MS-^= '?03Q75O'<02)+#*H>.1#E64C((/<$5)7*?#,EOAGX<).?]!C'Z5U=
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MW>TNB&-U$BCJ49@ X]U)J&Y\?^%[34I+"?5D66*40ROY;F*.3IM:0+L4^Q-
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M*&35+KR?/8I$BQM(\A R=J*"QP.N!Q0!(VAZ6^E0Z6UC ;"'9Y=N5^1-A!7
M]B 1]*BN/#6BW6MQ:U/IMN^I1+L2Y*?.!@C&?H34)\8>'QH]KJ[:I"NGW4OD
MQ3MD*7Y^4\?*1M;.<8QS1HWB[0_$%Q<6^FWWF3VZAY8Y(GB8*>C8< E?<<4
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MUU'>6/G,UN8$"MN\Q?DQN&,=0?6IK72I],B@G\->*-/GO[31K:&\@OX#Y-U
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MK&^+V/\ A56N[@2/+CR!_P!=4K?G\/6LVMZ1J*K'%_9<<L<,:1@'#J%P#V4
M'COQZ5HWEE:ZC:/:WMO%<6\F-\4JAE;!R,@^X!H X7Q1/977B'X?KI<D+N;Y
MI8/)(/\ HP@;>1C^'&VLCPS:2'X9>.S8QG[9/>ZH%*#YF;Y@O_UJ]#L/#.AZ
M7J,VH6&D65M>3Y\R>*!5=LG)Y [GD^M7;.PM-/CDCL[:&W221I76) H9V.68
MX[D]30!YGHVG75];^"IKGQ;I36T3Q3:?;6^G^7))MA8&,-YIXV%@>.U8FJ:G
M=W_@S3M4:_TVPT^[UF%H-)M;,*RD70RS2;L[N"S':.3CO7K-AX7T#2]1EU"P
MT:QMKR7.^>&!5<YZ\@=^_K47_"'^&C)>R'0=.+WP(NB;9<RY.3NXYY /U&:
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MKGWJG8^#_#>F.'L="TZW991,&CMU4AP" P.." QQZ9- $WB?_D4]9_Z\9_\
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MCZ\L*ZMIEI?"%MT8N(@^P]\9_"@#QZS,=]H.GB6XCOD?QZ"THC"K+DD[@O(
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M8JBDA1ZGBO#1_P FKS?]?O\ [<BO3X;NVT_XQ7CZA/%!Y^AP?97F<*"JR/O
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M'?AUM9&EB]?SS<?91)]GD\DS=/+\W;LW9XQGKQUK+\5QI%XN\!+&@54OID4
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MGQD\)I:3PS3QV5X96C8-A65=H)'T8_C[URO@ZVT^[\$ZU#?ZHVEN?%DK6EX
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M",]\&@#V/1-=L/$-@;W39))+?>4#O$T>XC'(# $CD8/0UI4 8&!THH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KG?&&A76O6FEQ6IBS:ZK;7<GFG ,<;[F X.3CM715SWC?48-*\
M)7EY<:Q/I$493-[!")7CRX'"D'.<XZ=Z -'3=!TC1VF;3-+LK(S',IMH%CW_
M %P!FK-I96MA:):6=M#;VR A(84"(HZ\ <#K6-J7C'1]&O(]/NIYY+U[=9XX
M(+9Y9)5)(^55!R<@\=@,]*Q=>^)FF6'@UM>TU)KK_2!:B-K:0&.3>%99!C*$
M ]#C)P!G- '3Z?X=T32;J2ZT[1["SN)>'EM[9(V;ZD#-61IE@MO<VZV5L(+I
MG:XC$2[9BWWBPQAB>^>M8UYXVTBR@LWD6_>:\1I(K6*QE:?8IPS-&%W*!ZD"
MG7'CCP[;6&FWSZ@#;:EN^RND;MYA4$E< 9W<8VXSGC&>* -A]/LI$MD>TMV6
MU8-;@Q@B$@8!7CY2 2.*:NE:<CW;I86JM>?\?1$*@S\8^?CYN"1SZUSDOQ#T
M<Z#K.HVZ7AFTJ/=<6DMG*DR$@E"R%<A3C[W0 $G&*SI/&=MJOA+P]JTVIWNB
M/=WMM$VVR;]_*R;C$ Z_ZLY^^...#0!UMAX=T32[>>#3](L+6&X&)HX+=$60
M>C #GJ>M.TO0M(T19%TK2[*Q$IS(+:!8]WUV@9JAK'C'2=%U :?-]KN+SR_.
M:"RM)+AXX\XWL$!VCZTV?QOX=M]+T[4WU%39:BQ6VE1&8.P4DC &0?E(P1G/
M'7B@"]9>'-#TV^DO;'1["UNY,[YX;9$=L]<L!FK26<%I]IEL[6".>=C)(54)
MYKXQEB!R> ,\UDZ5XST75EU#RY9[:33T$EU%>V[V[Q(02'*N =N >?:FZ+XU
MT;7KY;.T>ZCGDB,\(N;22$3QC'SQEU&X<CIZT 4] \/ZJ_B>[\3^(A9KJ#VZ
MV=K;VC,Z6\(;<<NP!9F8Y/ P!76UPWPOUS4M=TC6IM3NFN)+?6;BWB9E VQK
MMVKP!TR:ZC6M<T[P]8K>ZI<"WMC*D7F$$@,QP,XZ#)Z]!0 'P_HS:L-6;2;$
MZB.EV;=/-]/OXS39O#NB7&J)JD^CV$FH(05NGMD,H(Z'<1GBL5/B1X=>>:W,
ME\ETBAX[9["999U)P&B0KN<<=A[]*CU7Q?I&H^ M0UFUUJYTRV@<137:VQ,U
MM('4%3&RYSD@$$=&S0!T<FC:7-JD6J2Z=:/J$2[8[IH5,J#G@/C(ZG\S44/A
MS0[?5&U2'1]/CU!B2UTEL@D)/4[L9YK/U#QCI.BK:07,MY=7$MN)PMM:23/Y
M73S&5%.T9]??TINH>/?#FFP6,TU\62_MS<6GDQ/(9D!4?* .22R\=>: *EMX
M)M;GQ+XCO=;T_3[^TO[B":U2>(2E-D*HQ(8<'([=JL:[X7.J>(_#5PL%JVFZ
M=]I6X@D48*20[%4+C!'MZ4Z_\>Z'IQA6=KUG>V6ZD2&RED:WB89#RA5.P=>O
M/!J74?&V@Z9-:PS7;RRWEO\ :;6.WA>9ITR -@4'<?F!P.V3T!- &IIVCZ9I
M%HUKINGVMG;L2S16\*QJ2>I( Q4>FZ!H^C22R:7I5C9/-_K&MK=8R_UP!FLR
M/QWX?D\.W.N?:Y$L[2807(D@=9(9"RKM9"-P.67MWI!X\T$Z4^I":Y-M]I%K
M#BUD+7,A&0(EQF0$="!C@^E %K4_"^FW_AF^T&"UM[.SO%976&!0 6ZL%QC=
MW!['![5M*H10JC  P!7/)XWT)M%FU4W$R103"VEA>WD6=9CC$9BQOW'(P,<Y
MI8/&VA3:3?:E)<RVT-@0MU'=0/%+$3C:"C -DY&, YSQ0!M16=K \[PVT,;7
M#;YBB &1L8RV.IP ,GTJK<:!HUWID>F7&DV,MA'C9;/;H8TQTPN,#\*SK3QM
MHMW9:C<E[FW_ +-A-Q=0W5K)#+''@G?L8 D$ X(STJ*T^('A^]U.TLH9[C-X
MVRVN'M9%@F?&=JR%=I/![]L=: )O$&ASR^&TTW0;;2HTC=#]BN[<&VEC!R8R
MH!V@^H!P16;X6\+W]GXAFUO4;33-/Q9+8VEAII)CBCWEV))5<DMCH,8%)H?Q
M#L]6U[7;&6"XMK?37^6>6VD1=BQAG,C,,(0<X!P2!FM#2O'6B:Q<&"V:\60P
M-<PK/9RQ?:(AU:+<HWCD=.>: -/^P='_ ++.F?V38_V>6W&U^SIY6<YSLQC.
M>>E8GBO1=5U"_LY[/3=#U6TA1E:RU2/&Q\C$B/L;![$8K)L/B%:^(?"_B"Z>
M:\TA+&2=1>+92'RXE;"O\RX+^J]1W%;S^*M*TCP]H]S=WUQ>-?0QBU,=NSSW
M9*!MPC09R1R>,#/:@!GA;PN^F:)?VVL"TN[C4[N6\O(T3,&Y\#8H8<J%51R.
M<5JVWA[1;+3I=.M=(L(;&;/FV\=NBQOGKN4#!_&L^+QQH,FAWVKFZEBM[!PE
MVDL#I+ Q(&&C(W#J.U)I_CC0]2UJ+2H);A;B=6:V:6UDCCN0O+&)V #@#G@]
M.1Q0!N2V5K.8#-;0R&W??"7C!\ML8ROH<$C(]:@CT;2X=4DU2+3K1-0E7;)=
M+"HE<<<%\9(X'Y"FZ9K=CJ\]_#9RL[V%P;:X!0KMD !(&1SUZCBG:QK%CH.E
MRZEJ,WDVD14.^TG&Y@HX'NPH L7=I;7]K):WEO%<6\@P\4R!U8>A!X-5K#0]
M)TNSDL]/TRSM;63/F0P0*B/D8.0!@\>M9FF>-]$U;6$TNWDN4N98VEMS/:R1
M)<(O5HV8 .!GMVYZ4R+QYH$^K+IZ7$^7G-JER;:06[S#@QK+C86R",9Z\4 =
M!;V\%I;QV]M#'#!$H6..-0JH!T  X IEUI]E?- UW:07#6\@EA,L8<QN.C+G
MH1ZBL.^\=Z!I^JSZ=/<3&2VVBYECMI'AMRPRHDD"E4S[GZUS_B/Q?/+JW@*?
M0[YUTW6+PB3]WCSH\ @$,,CK[4 =]%:6T%Q/<16\4<]P5,TB( TA P-QZG X
M&:J3^']&N=,739])L9;!&WK;/;H8E;).0N, Y)/XFLO3]5MG\:Z]9G7)IGM(
M87EL)(0L=H"@.X/CYMPY/)Q5:'XE^&)_*875RD<\JQ6TLEG*B7!9@@\MBN'&
M2.GUZ4 ;5[X;T/4OL_V[1M/N?LRA8/.MD?R@.@7(X'L*N_8[7[6MW]FA^TI&
M8EFV#>$)!*ANN,@''M6%JOCK0M'U&:RNIK@O;A3=2Q6LDD5J&^[YKJ"J9Z\G
MIS4FJ>--%TG4#IT\L\M]Y*3I;6UL\TDB,6 *A <_=;/ICF@#5?2M.DBNXGL+
M5H[PYN4,*D3'&,N,?-P .?2H;?0-&M5LUM])L8A9%C:B.W1?(W?>V8'RY[XZ
MUR^N_$S3+#PO9ZUIJ37B75TEL@^S2?(?,"R!P!E6 )P#R2.,UV5E=QWUE#=1
M+*L<JAE66-HW ]U8 @^Q% %.^\.:'J=Y'>7^CV%U=1XV33VR.ZXZ8)&:NM:6
MSW<=VUO$US&I1)B@+JIQD ]0#@<>U9&L^+M*T.^CL)_M5Q?21^:+:RM9+B01
MYQO*H#A<\9-1S>./#L&A66M/J*C3KR8013[&QO.>&&,KC:V<XQCF@#4FTC3+
MF.[2?3[25+S'VE7A4B? P-_'S8  Y]*BA\.Z);"V$&CV$?V562#9;(/*5AA@
MO' .3G'7-/T?5[;7--CO[19UAD)"B>%HFX.,[6 .*RM4U*"W\<:#8/K4]O-<
MI.4T]( R76U"26?'R[>HY&: -VSLK73K1+6RMH;:VCSLAAC"(N3DX X'))I)
M-/LYKZ&^EM('NX 5BG:,&2,'J%;J,^U<U=_$GPU9FYWSW<BVDSPW;P6<LBVQ
M1BK&0JI"C(/)ZXXJ+5/B!:6'C'2M$CM[B>*\@>9YXK6608^784*@A@=QR>@X
MSB@#J5TZQ2VGMDL[=;>X+M-$(E"R%_O%AC!SDYSUIK:7I[O:.UC;%[,8M6,2
MY@&,?)Q\O  X]*Q;KQYH%GJLEA+<3YBF6WFN5MI&MX96QA'E VJW(ZGC/.*=
MJ7CC1-,U&ZTZ1[J>^M@IDMK6TDFD"LNX-A0?EQU/09 ZF@#;73[--0?4%M(!
M>O'Y;7 C'F,F<[2W4CVIEOI>GVEG)9VUA:PVLA8O#'"JHQ;KE0,'/>N2USXE
MZ;I]AH%]IZ37UMJ]TD:216TC@1G.[&!G>,8V=>O'!K1MM8MKGQZMFFLW0E?2
MQ<C2GMMJ!"X_>EBN0W.-I/X4 :^FZ%I&C12Q:9I=E91RG,BVT"QA_K@<U%#X
M8T"WM?LL.AZ;';^<+CRDM4"^:.CXQC</7K62OQ%\./=K$+FY\AI_LZWWV23[
M*9<XVB;;LSGC.<>]6-2\<:+I>HW.G2/=3W]L$:2VM;22:3:PR& 4'(QU/09'
MJ* -/5-!TC6Q&-5TNROA$<I]I@63;]-P.*G;3K)DMD:SMREJP:W4Q+B$@8!3
MCY2 2./6L>3QMH*:!9:TET\]I?-LM1!"\DDS\_*J ;LC:<C'&#FL+QCXS67X
M6ZWKGAV\EANK0B,EX2DD$@= RLCC(.&Z$=Z .X^R6WVTWOV>+[48_*,^P;]F
M<[=W7&><4Z>WANH)(+B*.:&12KQR*&5AZ$'@BJVD327.BV$\K;I9+>-W;U)4
M$FLC4]2@@\<:'8/K4]O-<13,FGK &2YVJ22SX^7;U'(S0!JZ7H>DZ)&\>E:9
M9V*2'+K;0+&&/OM S4]I86>GI(EE:06R22&5UAC"!G/5CCJ3ZUS-W\2O#5G]
MH+3W<B6LKPW3PV<LBVY1BI,A52%&0>3UQD5'J?Q M;#QII>A);W,\5W;O,\\
M5K)(/X/+*%00RG<<GH,#.* .JO;"SU*T>TO[6"ZMI/OQ3QAT;Z@\57BT+2(-
M,&FQ:79)8!@PME@41Y!!!VXQG(!SZBLJY\>:!:ZJ]A+<3YBF%O-<K;2-;Q2G
M&$>4#:K<CJ>,\TZ_\<:%IVLRZ1+/.^H1M$K6\-N\C?O 2IX'W< Y/0<9ZB@#
M=>SMI+N*[>WB:YB5ECF9 70-C(!Z@' S]*:MA9H;DK:0*;HYN,1@><<8^?\
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M?FNK\#V<$5[KUY'XA&M3W%TBW,J6ZQ(DB1J,#;\I.W;G'<<\UTTVF:?<:?\
MV?-8VTED%"_9WB4QX'0;2,8I]I9VMA;);6=M#;6Z?=BA0(J_0#@4 <I\2HS!
MH%GKB#]YHM_!?''4QAML@^FQF_*N%_M,:#967Q'D'R7]_?F7U,,B$0 ^W^CQ
M8_WJ]IFABN(7AGC26*12KHZAE8'J"#U%02Z9I\UBEC+8VTEH@ 6W:)3&H'3"
MXQQ0!X]J^D/HFA?"RRFS]I_MJWFN">IED.]\_P# F-=58W5O;_&K7XIYXXI)
M]+M1$KN%,F&?[H/7\*[JXLK6[:%KFVAF:%Q)$9(PQC8=&7/0^XJ.?2]/N;V&
M]N+"UENX!B*>2%6DC_W6(R/PH \A$:)^R]&%4 >2C<#O]I!S^=>TU5_LVQ^P
M?8/L5M]C Q]G\I?+QG/W<8Z\U:H \ZT75M,T+Q/XZBUVZM[>1KI+K%PP'FVY
MA4+MS]X#:PP._%0Z7J&F6WQ+L;_8FG:;?^'(UTT3((54+*6:,#H#M9#CTKO;
M[1M+U.6*6_TVSNY(>8WG@60I]"1Q3[_2]/U6W$&HV-M>0@Y$=Q$LB@^N"#0!
MXWJAAU"U\3WUOMETN[\46"0LO*2E3$LA'8@MQGOBNZUOCXM^%#W-C? _^0JZ
MS^SK$6D=H+*W^S1$&.'REV(0<@A<8&#R*D>V@DN([AX(VGB!6.0H"R ]0#U&
M<#/TH \),]K/^SK<6/G1/-'J&V:$,"R W_\ $.HR#7I'C/49[76O#NEVUW::
M8+MYS_:$T*.8!&@^6/?\H9MQ&3V!XKHQH.CAKAAI-B#<L'G/V9/WK Y!;CYB
M#SSWJ:_TRPU6 0:C96UY"&#".XB6101WP0>: /$#=QFTUBZEU,ZA;6?BRQN[
MRY9%4R6X6,&4JH V9P00,$#-=_XGUO0-3T_Q':6!@N]3CT"X=KF!5DV1%6PA
MD'3)Y"]\9KKUTO3UDED6QMA)+&(I&$*Y= ,!2<<@#MTI+'2--TN%X=/T^TM(
MI#ETMX5C5C[@ 9H Q_ %W;7?@'03;7$4WEZ?;QOY;AMK"-<J<="/2LGQ5-%8
M?$OP??WTBQ6(CO+=9I#A(YG1=H)/ +!6 KL+#3+#2X6AT^QMK2)FWLEO$L:E
MO4@ <T^\LK74+9K:]MH;FW?[T4T8=6^H/% 'D?BF>'4;[XC7NGR)+9QZ#';3
M2Q'*-.!(V,C@D*1GTS7I_AJ)(?"ND11J%1+*$*HZ ;!5B'2=.M]/;3X-/M8K
M)@0;9(56,@]1M Q5I$6-%1%"HH 55& !Z"@#@_BE<6MI'X3N+TJMM%XAMGD9
MNB@+(=Q]AU/TJCK5U;:G\299-.GBG6U\-7(NI(7#*H=QL4D=^"<?C75>*M!N
M-=ET(P-"$L-4BO)A*3\T:JX('!R?F'!XK5LM'TO3898;#3;.UBF.9$@@5%?Z
M@#F@#RJ:U/\ PS9IHAA+0QV]M<3QHN=T8F5Y#CZ;B?QKH?$^IV&L^*O!,6DW
M<%W<+?-=DV[A]EN(F#,<= <J/<UWD-M!;VRV\$,<4"+M6)%"JH] !QBJUAHN
ME:5)))IVF65F\O\ K&MX%C+_ %( S0!YOI&H1Z%<Z%%H>OVFL>'[^^$$&G3Q
MC[3:;MQW(W#80YR'7('&:H:+K.BVOPF\86UQ=6\<XGU)9(7<!Y&=G"8!Y.>
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M 55& !Z 4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'PY_Y)MX;_[!T/\ Z"*Z>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF?6IYY0CR2:JH#,Q123'Q_J\]*Z34K^'2M+N]1N=WD6D+SR;1D[54L<#UP*
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MM5/1=9L]>TR/4+%W,+EE*R(4='4D,K*>0P(((K0/2@"%K2V?SM]O$WGC;-E
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M,>O'(R!D=,T =(T$+S),T2-+&"$<J"R@]<'MFJ;Z1;R>((=98L;B&V>V1<#
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M;""X5H[N>2)GE5#@?NL$ '&[D^HQ6GIVF6VE:1;:79IY=M;0K#&O7"@8'U-
M"Z9J=GK.FP:CI\XGM+A=\4@! 8>N#S5;Q+?7&F>%]6O[2$37-M9RRQ1D9#,J
M$@$=^14^D:7;Z+I%KIMJ7,-O&$5G(+-ZDXP,DY/XU=H \7M]5LCXM\$7LGBV
M;6<R2&X8F$6]N\EM($0!%&UF.0%))XJ]H>KV>CZEHMOX6\2?VAI=]=&%]!N
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M=>N.*T5C1&9E15+'+$#&3[T >/\ @O0D\2^"_B%H[X!NM>O5C8_PR (4;\&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF*\LW5! FZ$NOE +E=I&.221U-5M"U>\N/$\=OJ?BB^L->^VR"72+R!5MIH
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M1R*&(!D.,G&0  1C;WS6E!X<\0ZIKNE7_B6]TUH=*9I8(;&-QYTQ4J'<L>,
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MP0S3Q>3+/"QBPLRL@/'F'G"DX!Z=>OM/"'BNTL_#DJWFC/J.A1O:P@QR^5+
MT:)EN<AQL!XXYJ*\^'>L7N@^*=+N-7M9/[:EBNUG\IE9)U\LL",X\O,8 ZD
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI^G-()&M+:. N!@,54+G'X5>HHH **** "BBB@ HHHH **** "BBB@ HHHH
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M78=/M=5<2W,<MH97BEVA6DB;< "0H^\",C-==#&88(XC(\A10N]SEFP.I]Z
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MKD(N8DBR%AND&'4 C^)!N^HK2L['5/&MUXDOD\0ZGITUCJ,UAI\=K,4AB\H
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M)C? 3YV7HS_[5=;IGAG5'\20Z]XAU.VO+JT@>"TAM+8PQ1!R-[G<S$L0H'4
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M#/D2JZO)@[AD.5'88]ZZ*[\/FZ\8Z9K_ -I"BRMIK?R=F=_F%3G=GC&WT[T
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M3Y'2=D20)+(GF;0<;\*/FZCFO<=-L(]+L(K.*:YF2/.'N9FED.23RS$D]>]
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M4]"R@'\:Z&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN:U[QCIGAW5X+":RU"ZOKF$S*EC9M.Q13@D[><9(H JWWA'55U74KK0O$/\
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M?VTM_8=B]F%\K'G;D1=V<_+]S..>M:7B'7[+PQHLVJZAYIMHF16$*;V)9@H
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MUVY65B67@^Y%9-MX N_+TVPU'Q'/?:-ILL<MM9M;(C,8_P#5B20'YPO'&!G
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M@E"@Y/;&W]:R-*\%:AI,EE:1>)KO^Q+&7S+>Q6)4?:"2L;R@Y9!GI@9  )-
M',6NC-X@L_'%W?ZIJ>ZQU.[2Q6&\DC%N5C5@P"D9.2.#D#' Y.:(LT\1^)?A
ME>ZC-=O<7^DS27#QW4D>YEAC8$;6&TDDYQC/?->CZ=X7CT^RU^V6Z9QJ]W/=
M,Q3'E&1%7 YYQMK(G^'\R6OA?^S=;DL[WP_;M;17!MED$J,BHV4)X.%'?B@#
MMJ\3TV>6VT7XP3P2O%-'>7+))&Q5E(5L$$=#7ME<7%\/88K#Q=:_VC(1XCEE
MD=O*'[C>",#GYL9]J ,&YTZ709_!6LP:EJ,NH:A?P6U\TUT[I.DD3%@8R=H
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MMO92W"O=2#$A.Q2/E3Y<'N:/ 7B==,\)^*=&MS.6T%)[G3Q<PM&[VQ#/'E7
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M,DAB#F-TE7:Z,.<$9/4$$>QK0UC_ ) E_P#]>TG_ *":\E\.*W@WPYX7\90
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M*,P%Z\#7"PX.?+#!2V>G5@*\E\;2V\Y\4ZI8V_B"_O\ 3]WEZC#<"*WTZ2-
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M?4HKN?3-!MWM85@LI;A'NI!B4G8I VI\N#WI? 7B@:9X/\4:1!YS/X?CGN+
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MHU*2';N))('.,G@8':D^)MC!J>J>$+"Z7?;W.IO#(OJK0N#^AH ]!#HT8D#
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M'AC7HO$_AVTUB&!X([C?B-R"1M<KV_W:UZXGX19_X5;HFY@QVRY([_O7KMJ
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M= (I60J'5&SDE2PR,#O0!9L?"T%CIVNV:W,C+J]S<7,C$#,9E4 @>PQ69<>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<.H1JA:+D[B Q&S<5'/I78Z'X:?2M0NM3OM5N=4U*YC2%KB=$3;&A8JBJB@
M98D^I-:&L:18Z]I-QI>I0+/:7"[9$/&>X(/8@X(/8B@"S<K UK,MR$-N482A
M_N[<<Y]L5XSHZS:?\%] \4171@O]&:22U$C$"YA,S*(& Z[UVA?0[<5V3_#J
MXN+7^S;WQAKMUH^-ILW>-6=/[CRA0[+V//(K;O/"=A>WFC.Y=++2#OMK! !#
MO PC$8R=H^Z.U '$Z>3K'PX\7>*[N<R:AJ=C=JT.3BRC1'58,'HPQEN!DGZ5
MB6D\MSX8^'>C/IEYJ=A-ITMS<65K*L9G*! H8LR@J"Y)&>3CCBO2I?!=FT_B
M!H;JX@@UVW:*ZMTQL$A4J95&.&(//8X!-5SX#MHM"T2QLM2N[2[T5=MG?1A#
M(H*[6#*058,.HQV% '$76G:[IGA:_P!4ATV_L(M!U)-2TVUN9U=_LVT>?"2K
M-\GWR 3TQ7417:^+/B78RVDS/I>C:>+HE3A9)[@?NP1WQ&"WMN%:,S6'@GP_
M</JUYJ6JO>S,9&>%II+B1EQL5$7:HPN , ?G57X7>%Y/"W@V**ZB:*]NW-Q-
M&[;FC! "1D_[*!1]0: -/QSXC'A7PA?ZH@W7*IY=K&!DO,WRH ._)SCT!KR&
MYOK?P]X0\-WEAI6O?VQH,_VNYFFTN9%F$G_'R&=EP 03R>RBO9-<\,6WB#4M
M'NKR>;RM+N?M26ZXV2R 85FXS\O)&/6MB>"*ZMY;>=!)#*A1T;HRD8(/X4 <
M'K\EKXL\7^&M(EE:70[NQFU%HTD95NB-@C#8() #EL?3-87CWP=I^E>&+"V$
MT]S:_P!NV_V>&65C]FCD=0\:G.2O&1GIGBNHA^'-O::+I%E9ZQJ%O=Z.TGV&
M_&QI(T?[T; KM9<8&".P]*6;X<65QX>NM.EU*^>]NKQ+^74F*^<9U(VMC&T
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M+FY\5ZKJ,2@@V]PD(0Y'7Y4!X^M3^%+'4M/TRXBU.XN)Y6O)WB-Q*)'$1<[
M2./NX..V<4 ;E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7VI_/N [.XRQW$D94X )/08J^GQ#)U.;1W\,ZQ'K*QK/#8GRBTT1)&\.'V*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?_!Z#P3#')_PDK6T6G-IIB82)(K*K,W& H +;NF.]=KX8B:/XE>--P)'EZ>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !69?
M:]9V&L:?I3"66]OBQCBB7)5%'S2-S\JC@9[D@#-:=<%X9C_M;XA>-K^9W#P-
M#ID#*<-%&(]S;3VRS9_ 4 :4WQ TQ=7U'3;2PU2_ETX'[5):6N^.)@I8J6)
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MP*[F8YR#DGKD=,5I>,/#K^*-#73DN5MR+F&?>R;O]6X;&,CKC%;]% '/^)-
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MXUK444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5Q?Q(UBYTO2=,M[:2]B_M#4([6:2PC+SB+:SMY
M8'.XA,9'3)-=I6+XFT ^(-/ABBNVL[RUN$NK2Y"!_*E3."5/W@02".X)H \U
MO-7U33_#OB^/3V\20Z=%IBW-G<ZJDR2P39(=4D?YB,;6'/'-7]2TW5;#7?":
MP>)=7\S6V>'4"UP61AY7F$QH>(SP0"HXS727?A+6=9\/:W8:SX@6:?4X! A@
MM=D%LHSRL9<DDYY);L!QBM'4/#/V[4O#EY]KV?V-(TFSR\^=F(QXSGY>N>]
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MJQHA8HBJ6.6(&,GU-.HH **** &&*-I%D,:F11@,1R/QI]%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(;!P2!_"#U/84 :]%>6?#_Q?Y/@N3Q#XDU769I)5C+FZM=L)=F8*ML%0;R>
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M61NBJ/Y_2N%N_&_]I>*_"=G8KJ5@MU=2&:"[MFA,\7DN01N'S#<!TZ<9QD4
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M$<[<XSB@#R'0H+F\UK2_AU="1X?#NH27<[L/]9;1X:U!/0Y,@X_Z9U['=?\
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M T%U;Q3PMUCE0,I_ U&VFV+_ 'K*V;]V(N8E/R Y"].F>U ')^+%"^.? @4
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M"I1/H,8% &1X#M+.S\'62:??37UI(9)H[B:+RV</(S$[<# R3C QC&.*Z.D
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MC<Z'*FHZO:I)K#64 M0%2ZD1MI#YSF/(/3%<5-J,GASP_I?Q"*,)-0N;^24
M<E+A6: 'V!AA'XU9UO1CX?L?A5ICC][#JD/G9[R-AG/_ 'T6H ZB+QU<W_BC
MQ-H2Z;>PQZ? !%<>01L?RY&+.V> =J[..:K>$OB+:CPQX<74X]4E:ZB@MWU1
M[<F!KA@!M,F>N[C.,9R,\&JT%_:6?Q'^(-G<W,4-S>6EJUM%(X5I@MN^[8#]
M['?%4[M0OP#\,X '.FGCU\Z.@#7@\9R:9XT\76=Q!JNIK;SVYAM;*$S&"/R%
M+'&0%!8GODG. <&N@G\=:+%HFF:I UQ=KJF!96]M"7FG.,D!>V #G. ,<UG^
M$U'_  L#QVV!DW5H"?\ MV6N$\*7$.D6'PYUG4)%ATR.*_M7N)#B.&21SL+'
MH,[2,F@#OM0\7P:IX.\4/8?;+#4]-L9FD@N8_*G@;RF9&QSP<9!!(XJKX?\
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MW?S:G$\T+0I=%6GOD:%$7:H #*Q^4$#&,4 >D3>)-/BUO3](C9[B[OHFGC$
MW*L0_P"6C'/"G. >YZ56\;>(I/"OA'4-7AMI+B:")C&JIN57P=I?!&$!QDUP
M_P /+&X\$^(!I.OQ(EWK%NDEC<;V81J@YLP23C8#D>H)]*ZSXFHS_#/Q$J*6
M/V)S@#L.30!$_P 1-.LM-TB?4K/48+C4D?R8/LIWNZ*"0JY)^8L OKFK-WXY
ML[4VL0TO6)[V:V%T]E!:;IK>,G&9%S\O((QDDX.!7*SW^GZOXK^&,]E=07<*
MB[4O$X<!UMEX..A'IVI-95-/^)NLRW_BN?P[#>65M);RJ852<1[U==TJD;E)
M!P.?GS0!U]WXWTF#3M,O+9;K4#J@+6<%E"7EE &6.TXP%'7)&*Q?$7Q)BLO"
M<.KZ5974TLMZMFT4MN<P.)%5TD7((;!( [G':L&*\M=(L_"^D6WB:YTK0KJW
MN[S^U+E(HIIF\P,(P73:F?,9ON\@#%<]->VP\ ZY_IDTWV?Q5#<RO=$"80L\
M1660 # 8<YP* /5+KQYIUI>P6#V&JOJ,]H+N.RCM<S%"Q7&,\$;23D@#UYJ@
M?BIH1TPZA'::M+;0DB\:.S)^Q$,5(FY^4C&2!DXYZ$5%97=IJ/QG6\LYX;F"
M3PT#'-$X=6'VD]".#TK#M54?#'XF8 &=0U<G\C0!W.K>+[#2[FWM8K:^U*[N
M(?M"P:?!YKB+IYAY "YX'//;-5[CQ_H5O9Z3=+)<31ZL'^R"&$LSL@Y3;U#9
M^7&.OI7";%LO%-G<7WBB?P]!=^'[06]RIA5)3'NWH6E4C(W*V!C[W>K.F6=A
M;ZW\/3I]W=7MI/=ZE<)/=1A'<O&[%L   $DD<="#0!T]Q\0[3_A']>O8-.U&
M.^TB+?/8W%OME3*ED8@'&PX)R#T!K7\(Z[+XC\,V6I3VD]M-+"AD66(QAF**
M2R DY0D\&N)UQ&DUWXFHBEG;P[$ H&23Y4]=;X U*QU+P+HK6-W!<B"R@AE\
MIPWER+$N4;'1AD<'F@"76?%]EI&J)I:6>H:CJ#1>>UM80>8T<><!FR0 "<@<
MY-<IX^^(?D?#&XUGPX;OSIOW27 @_P"/5Q(JN) WW&Y(&1UJU#J=AX:^*GB.
M76[R"QBU.SM)+.>YD$:.L0=9%#'C()!QUYS7$^(@9O@CXVU)%86>I:VUW:$C
M&^)IX@' /9BI/XT >K>"PX\/)YDFLR/O.Y]7&)B<#I_L^GXU6U?Q]I6CW]W:
MR6NHW"6(4WUQ;6QDBM0PW#>V?[I!. <"NFM_^/:+_<'\J\?\6:R^HP>-+:]\
M17-E<VYEM+/1;01*]POD@AV!4NX;)R00 H- 'H&J>-M,TS5ETH07MY?26JW4
M4%G#YK2QLQ&5YQ_"22<#ISR*BM/B!HMW;Z;,!=1"^O6T\+-#M:&X7/[N09^5
MCCCK7.^$[BWO?B%87-M+'-&?"5N%DC8,/]<P(R/<8/N*IVV@R>(O"?CRRMCM
MO4\0W-Q9N.JSQB-D(].1C\30!Z'>Z]96&N:;H\GF->:B)#"J+D!8QEF8]AR!
M]:EUK6;'P_I4VI:C*8[:+&2%+,Q)P%4#DDD@ 5P_P]OV\::[>^-)H6CC2UBT
MZU1AC:0!).<?]=&"Y_V*TOB<CIH.F:@49[73M7M+R["KG$*/\QQW R#^% %^
MP\;V5Y=RV4NFZK97RV[7,5K=VNR2X1>OEX)#'IQG//2N.^'GB'4O$OC'6[N_
MFUX)!J$]O;VYC"6D,:CA9!VDY_/%:MWJNG^)?B?X5;0[V"_33H;N>[FM9!(D
M221A$4L.,ENW7C-,^$_^M\;?]C-=_P#LM &OXZ\83>$TTCR+">Z>^OXK<E(2
MX"EAN P1\Y&=H[D>U9"^,IK/Q_JD,MOJUU&^FVD]OIL$!>5"V\N2F<*1\H.3
MUP.M3_%6:*UL/#-W.ZQV]OXBLY9I6.%C0%LLQ[#WJ309[>\^*VOW=M+'/#)I
M5DT<L;!E929#D$=0>* -0>.]&?PW:ZW%]JECNIOL\%LD!-P\V2#'L_O JV>W
M&<XK0T+Q%::_'<^1%<V]Q:R>5<6MU'Y<L3$ C</0@@@@D&O(4B:.TTS4)-2F
MTNRMO%&I)/?1!#]G,AD5&.\%0N?E)(XW=J[_ ,#6^FMJVN:A8^(KO79I3#!<
M74JQ^7E%8@(T:A6(#\XSCB@#7U_Q;IOAR\L;.\2ZDN;\2?9HK>$R-(4VY4 <
MY.X8_'. *IQ?$#2'T;5]1FAOK5M(P;VTN(-D\0(RIVYP01R"#S6/XUU&STKX
MD^"+R_D6*V1;\-,_"Q9CC 9CV&3C/;-<MXGNK?6(OB7JVFS)<:>-+M[7[1$V
MZ.65=S-M8<':& ./6@#T%?'^D'2;G5'AU"*RBD2*"1[5A]L9SA1 .LF3QQ]>
MG-6M'\7V.KZC-IKVM]IU_%#YYMK^'RG:+.-Z\D$9X//%<UXP5;+P]X,U)UQI
M^F:A:371 XBB\MD#GV4LM5=:N(/%_CN)?#MW#>"TT2]CGN;:0/&KS!5C0N.-
MV03C/:@#HK+XBZ-?7UK"D&H1VMY-Y%IJ$ML5MKB3G"H_O@XR #CBGR?$#2(]
M0> P7YM([G[))J(MS]E2;.W87S_>(7.,9XS6#X3\9>'X_"?A71FVW6J[8+)M
M.C56GMY47:[NA(**I4DL?PS7):?9:>WA>X\/ZWXTU&SN/MTMK-HT*0F0NTY*
ME%,9D8-E7W GKUXH ]/UCQSINCZA<V;6NHW;6<:RWDEG;&5+52,@R'/IS@9.
M.<4_4_&FFZ?<V-K!!>:G<WL'VF*'3X?-;R>/WAY "\C!SSVK@KO[-IGBKQ?'
MJ_C&ZT$33K=)"H@ NH6A5<IYB$N059<+Z#CFK6C3:5X-\<6 OKXVNFS^&X(+
M&ZU$B+/EN248G #893CB@#0\->.(5L?$6I7L][=PG76M+&!8F:4YCC*Q*AY!
M!W9!QC!S78:%XAM=?CN/)@NK:>UD$<]M=Q>7+&Q 89'H00002#7EVE76@:EI
M'B*YU&]N=.M)_%;RV>H1'RS!(8D*2EB,*K#/+#!WC/6NU\!ZS>ZC)K%E/JT&
MM6UA-&EOJD**HG#)N*G;\I9> 2/44 :/B'QEIGAJ^M;*\CNY;J[C=[>&VA,C
MRE2H*J!R6.X<?7IBJ]]X[L+&1(?[.U:XN!;)=7$%O:%WM(V&1YHS\IX/RC)X
M/%9NOHK?&+P<6 )6SOB,]CM0?U-8.HF+3?B)XHDU+QA<>'8[E+:Y@QY(6XC6
M((V#(C9*LI&!Z].: .XU'QGI5C9:;<0BYU!M37?906,1DDG7:&+ <8 !!).,
M9J!?'VBMH8U-1=EC=?8OL7D'[3]H_P">7E_WL<^F.<XKCM/&F>$=?\'WLUW-
M'H3Z//:6]W?@1>7(SK*HDR $)4$#..E)XGUBPUV;1-<TZ\N-+TFSUB6"?5HH
MXPI9H2@F4L&4IN.S>P[GZT =5?\ BW2]0\(ZW<RRZKI9L$*WB+&(KNVR 00#
MD<@@@\@U>T7Q+IL]SIFC1S7<EQ/I<=]!+<J,S1<#)8=7Y!(QWS7GNLV^FOX(
M\>ZA8^(KO79I+.."XNI!'Y64!*A&C4*Q <YQG'%:.IK_ &5X-\!^+DX_L>*U
M6Z8#_EUFC6.3ZXRK?A0!V=[XTT;3K[5;6YED4Z5;QW%W($RJ!S\B\<ESV '-
M)I7C'3]2N+FVFMK[3+FW@^TO#J,/E,8>GF#D@J#P><COBO.+C3KJ^^%NH^)Y
M//BN-6U2'5IFC4-)%:K,NS ((.V-0_(-6[K3['7%UG^S/%][XCU5-!NHH@HA
M:-%E  4M$@&XE1A2<\'B@"_XB^(2:AIFDOI46K6*7>J6BP74UN8H[J(R@,$;
M/0KS@X)&2.]>B:D[1:7=R(Q5UA=E8=00IKR36/%.AZIX&\&6-A>07%VM]IN^
MWB8,]ML95;>!RF#\O.,D\5ZSJW_('OO^O>3_ -!- '!>$/B/:#PKX?.J)JDG
MVB*&"759+<FW,[ ##2>N[@G&,\9KM=(U^RUJXU*WMO,6;3KDVMQ'*NTA@ 01
MZJ0<@]Z\@;6]+U'X"Z9X=L[F$ZU<QVMM%8!AYWF>:C;MG7&!OW=,8.>:WO'=
MY>>"_%,^KZ=$[GQ%8FP54'_+\O$#'ZJQ'_ : /0="UZR\16<UW8>8;>.XDMQ
M(ZX$A0[2R^JYR,^U<E?3^)=8^(^IZ+IWB632K.SL8)U5+.&;<SE@>77/8=ZZ
MSPUHD/ASPUIVCP8*6D"QEA_$W\3?B<G\:\S\01>#Y?B[JP\7S6L4(TVV^SFX
MN&B!;<^<8(SQB@#N[.VUGPY:7VH:QK]WKD,4)<0)8Q1NN.25" %CCM4\GC+1
MQ9Z-<PRO<C675+)(%W/)D9)QV"C[Q/3O6'X;U/X=:%;:G-X>U&P6..'[1>>3
M=-*1&F?F()/=L<=217*>%(I/#?BFS\1ZM8"TTG7VDBT^-B?^)6TC[U0@G"^;
MU..AXX% '>7_ ,0-(T^_N8)(+^2VLY1#=W\5N6M[9SCAW]LC. <9YQ5C6O&-
MCHVHKIZV>HZC>^3Y[P:?;F9HH\X#-R  2#@=3CI7F7DV%O:^*=+USQE?Z8TF
MI70ETN)(2]Q',Y*F-60N^]6'0GGTQ73:?J.F^#?B%KR:W?QV<%Y863V=Q>.$
M$JPHR.NX\;@2#MZ_-TH ZNP\8:/JEWI<%E,\W]IVLEU;NJ?*40@-G/((+8QC
ML:R/%OC^'0]#\136-M/<7VD;8G!BW1K(\>]&;!'R<C)XZXK"D\1:4OC'PAX@
ME3^R-)N]/O(X6O%6!58LC#/.%W %AD\Y]:PM9O8=7\._%>[LB98)6MVC<#AU
M$*?,/52!D'N.: .XO?$=G<W/A26\GUO3)[ZY9(;5$$:S, ,B93D[.XP>]='H
MNOV6O)>M:>8K65U):3I*NUDD3&?PY!!KSGQ5J5CJNO\ PSNM/NX+J Z@R^9"
MX=<A$R,CN/2H_&UW=^$O$VM6^GJV_P 6V<<5F!VO0RPG'I\DBMG_ &: .R3X
MAZ//IEE>V<%_>&^EECM+>W@W2SB,X=U&<;!CJ2.U;>B:W9^(-.^VV7F!1(T4
MD4R%)(I%.&1U/1@:\YUS18/#/B3PM!_;LVA:9#I4NGQW\8C"B4,C;7,BE5W@
M$YX)*]:ZKP!;:?'INHW6FZM=ZK'=W[RR7=PBJ)) JHQ3:JJ5^4<@8)!H O:W
MXML]$U"/3Q9:AJ%\\)N#;V%OYKI$#C>W( &>!W..E03^.M)6PTRZLXKW4FU.
M-I;6"R@+R,BXW,0<;0"0#DCDXK \2ZV!XWN=-U#Q)+H-C;V$4\ MQ&LUZ[,X
M(5G5BVW:!L49):N7\.3Z%+X0\-I=>))M UJT%Y'#>F1%$;>=F2&7=\A/*-L.
M#T(H ]>T;6+37=+BU"S,GE.64K*A1T96*LK*>00001[5?KF_ VL7NN>&([N^
MDBGE6>:%;J%-B72(Y5957L& SZ>E=)0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2$!@00"#P0:6L
MS7M=M?#VFB\NDFEW2I#%# F^261SA44=R30!>M[:WM4*6\$4*$Y*QH%&?PIP
MBC$IE$:B0C!?')'IFL?0/$UOK\EY;BSO+&]LF47%I>(%D0,,JWRD@@@'!![&
MJ_B/QGI_AF_LK&YMKVXNKY)&MHK2(2-(4VY4#(Y.X>W!)( H WI;6WG>-YH(
MI'C.49T!*GU&>E/\M#()-B[P,!L<X],UR][XZM[25((]&UB[NA:I=W-O;0*S
MVB,,@298 -P?E4D\&G77CO3T%D--LM0UA[RU%XB:?$&*PDX#MN90,GC'7(/%
M '45"+.U#NXMH0TA#.=@RQ'0GUK'L?%VFZCJ&FV=N+@R:C9O>0LT>T!%*@AL
MG(;+#C'8U@^./% D\&^,8M,FNK:^TB-8WF4["'95<%&!ST;VH [HQHSJY12R
MYVL1R,]<4Q;6W6X:X6"(3L,-($&XCT)ZUYTWCK4-)D\$:<--O[_^TK 37$L:
M*[S8@!PA+#+!B&;/8]\UZ%?7UMIMA<7UY*L-M;QM++(W15 R30!.RAE*L 01
M@@]Z:8HRBH8T*I@JNT8&.F*Y;3_'UE>WMA;W&E:MIT>HG;97-[ J1SMC<%!#
M$J2 2 P&:XW3/$.IZ_\ &#4K>YB\2065@;98+.%ECCB+*"S7"AN5)Y'7@T >
ML2VEM/(DDUO%(\9RC.@)4^Q/2I#&C.KE%+KG:Q'(SUQ7)_$#Q9=>$])M)[.Q
MFN9;F[B@#(@94!=00<L/F920OOUK'G\77-I\2&0V6KS)/H<,T6E1*#(LAFDW
M,5W;%(  +$^@ST% 'H@C179U10S8W$#DX]:5E5T*.H92,$$9!%<!XB\9Z)?_
M  YN]:GGUS3[6*X%O.+(B&\@E5PI0\X'.,\]#6YK/C*VTC4I;"/2]4U&:"%9
M[G[# KB!&SM+98<G:W R>.E '0-!"T0B:)#&,80J,#'3BE>*.0J7C5BARI89
MP?44RTNH;ZR@N[=M\$\:RQM@C*L,@X/L:X/Q]K/B"?6;7PUX2N_L^IBTFU"Y
ME$:OMC12(TPP(^=\#U&* .]>V@DF69X(VE4;0Y0%@/3-.\F(QB,QIY:XPNT8
M&.G%8GA[Q39ZUX+M?$<CK#;M;&:X)Z1%0?,!_P!TAORK(A^)NEO_ &<T^EZQ
M:1:G/%!8RW%LJK<>8P 93N.!R#S@XY - '9K&BLS*BAFY8@<GZTPV\#0& PQ
MF$C!C*C:1].E<VGCNPG\2SZ#:Z?J=S>6URL%PT, *0@@$2.V[A/F^O!XXJ.W
M^(.F7-[ BV6HK87%S]D@U1H0+:67)4 -NW8+# 8K@GO0!U*6\,4'D1PQI#C'
MEJH"X],4CVT$EO\ 9W@C:'&/+9 5Q].E<SJ?C_3M,O;V+[!J5S;:>P6^O;:
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MX=3\+?%:\M]WD2R0M&S*1N7R8P&&>Q'(]017MCQI*NV1%=>N&&12X'/ YZT
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M_P#HV.NS\97>BV7B*ZND\37'AK7HK1")'V^3>H-Q4;&!$FT[AQAAFO2=HQC
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%1SW$-K"9KB:.&)>KR,% _$T 244R*6.>)98I%DC895T.01[&G
MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/:_X7TK6]1L]1UH
MB>ST^.1A:7&TV^XXS(X/!( .,\#)KH:X/Q_9:_JFH:99VFAR:IH2YFOH([R.
M#SW!^2-MQ&4'WB._ [4 'PTMHD&OWFF0FW\/W=_OTR$+M78$ =T7LC."17>5
MC>'K_5;R&5-2\/-HRQ;5A0W,<P<<]-GW<8'YULT %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
C%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>employementagreement_mil016.jpg
<TEXT>
begin 644 employementagreement_mil016.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
MSC.!VSQGUK/USQ4NBWE[;FS,WV72)M4W"3;N$9QLZ<9]?TKG/"GA_5+?5-%:
M^LM4B&EVKQ%[FZMS"I*A=L2QC<RG&?FVXP.IK0\5Z#J6I:GJLUI;>9'/X<NK
M&,[U&Z9V!5>3W]>GO0!8A\6ZE;OI\FLZ$EG97\D<,=S!>"<(\GW XV*0"2!D
M9Y(KI[>[MKL2FVGCF$4C12;&!V.O53Z$>E<5+;Z]XAL=)T>XT"?3+2WGMIKJ
MXN;B%MPA97"HL;L22RJ,G&!FNRLY)9!/YMFUMMF95#,I\Q1T?Y2< ^AY]: .
M;L/&KWFI6<;:9Y=A?7D]E;7 N TADBW[M\6/E4^6^#DGID#-7;#Q9;ZCXDO]
M(@M+D)9VXF-P\;*)3O92$4C+ %2-PX)Z9KD]'\+ZC;:MIDAT:2#5X+Z2;4-;
M,R%+N([L@88NV[*84J N/89ZQK&\B\;7>JK;&2V.E)"A5U!>19';: 3QP1R>
M.>M %2U\6:C)=V,%YH#6G]I12/8J]R#(65-^R5=H\LE?0MCH>:;:^+M2.NS:
M;J.AQVJVUHUW<SQWHE$*<[0PVCEL-@9Z*35+PNFN7&O#4O$7AZ^CU"56C6=I
M[=K>RCZ^7&JR%N<#+8R3C. ,#0TO1KY=$\02W=K"VIZI<7+F*X;<C)S'"C%3
M]WRU3..FX]Z (=.\;SSZ'=:UJ.EQ6FGV]G]J8Q7RSR#@,$*!1AB#W/7BFWWC
MBZTBQU)]5T7[/>6EA]OB@2Z#K-&#M(W;1M8$@$8(^88)K!O/"-YKB3+8^'H_
M#H729K1U8Q!;B9BAC7$;'*(4/S'!^;@=:G\2:/KOBNTU:Z&BS6<W]C26$%M/
M-$6FED=6;!5BH4>6H!)&<G@4 =%!XFU&'6(=-UC14LY+F"6:W>"\$ZMY8!8-
M\JE>&&#@BJ.E^.-1NK71+^_T!+73]8:)()HKX3.K2+E-R%%X]<$XK,TWPW<+
MXDL[W2_"TV@0QQ3)>/-=1-]I1D(6,*DCCA]K9.,;?>LC0O!U_;6'AV&W\)3Z
M5J]B]N;C57NX2FU<";"I(Q;>NY<%0/F[8H ]/UC4+C3;-)+6PEOKB258HX8S
M@98_>9L':HZDX_,US\_CB6TLKU;C2E35+2]ALVM1=#RV:4*RL)2H^7:Q)RH(
MVGCO3]7M?$NBZ5=2:+=7^M7MS*J(EP;<"T3)W.HQ&&P. "QR<=LUFP:5*F@0
MQOX.GNC%?K<W46I302SW+%2&F4K(4+@D<,0,<#&!0!L2>*KFVTBVN+C2T:^O
M;D6UE:6UVLHG)4MGS, !0 Q)YP%[YQ4=QXJU32K'59M7T P/8V$E]&UM<&:"
M94!)3S"B[7Z<%>G(S@UA0>&-6MI/[=L-*6VD@U<WUMHYD1<0M!Y,@R"45VRS
MXSC/4\FM'6CXE\2Z'KMI'HSV%I-I5Q!#!=21&>XN'4A<;'944<CD\ENP% &Q
MI>I^(KR>W-YH-G;6DJ[FE343(RC&1\OE#/.!UK3U34K?2--FOKDMY<8&%099
MV)PJJ.[$D #N2*XSP]I$5E>6PB\#ZAI<_EF,WYN;=Q%E<%L"5B?^^36C=>#]
M4FFL95\57DSVDKS)]MMHI1O*A0<*$'RC=C(/WC[8 +">+T?P);>)?L3;[F*-
MH;/S!N>61@J1[L=V8#.*OZ;XBL[[PO%KTK"VMC 99A(?]25SO5O=2"#[BN+T
MKPAXBET7PKH]_=36<.G(;J:X@$.Z.90%BB .\-C<[%L$<#O5B#P3K*7%]I8U
M68:;]N35(+J>**3SI&R7C=%VC D D&% )/M0!JVWCJ.Y\,PZJ-,N5N;F^DL+
M:P9@)))5D9 "3PO"%CG[H!ZXK2TS5]7EU3[!J^B?8V>(RQ7%M.;B%L$ JS;%
M*MR" 1@\X/%<G9^%?$5GHL4\C1W>HV&NSZC!;D+$)D:24,-P) +I*6&>AP#7
M117/B'7;QXS8W.@Z<(&5I96A>Y>4D;2@5G554!N6SG(X[T 6-;\07&GZI::7
M8:>EY>7$$MSB6X$"+'&5#?-M.6RZX&/4D@51C\:-J4&E)H>FM=WNHV8OA%/,
M(4@AX&Z1\-U)P H.<'L,UF:WX8N&U&Q;5+*]\5Z;%;2Q^5*T D29F!WE3Y:$
M;?E!'*_B33=+T?Q!X<ETK59+*35)1IOV"\MH9T,L860O$59RJOM#%3D@G@\T
M =%;^))8M-O;C5])N[*XLY1$\,2-.)BV-IA95'F [@.@(.00,4VR\6P7/@^U
M\0RV=R@N$REK$AEE+$D! %')X^@[G'-6M#N-9N_M=SJMHEE$\@^R6I96EC0
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MA^[N-2L88O"UOIUU;:M]LEU6 QB-X@Y9L$-YA:13M*D8Y/. * .DLO%5O?\
MBRXT*"UN/]'MVE:YD0HC,KA"J9'S8)Y8<9&!GG&<GC#5+NQ?6--\./>:*K-M
ME6YQ<3(IP7CAVG<."0"P)'0<BM)]-N6\=KJ/E?Z'_9;6YDW#[YE#8QG/0=>E
M8&E_\)1X=\-Q^&K+07N+FU0V]GJ)GB%L8P<))("V\$#&5"G)'!YH W=>\66V
MB7NDV?D27%QJ-S%$$7Y?*1W"^8^1P 6 QU)^AQT%>>:]X+\03W@O;/65FFGU
M*UGE#6B9B2-AC!+?=3EMO<D]R:]"&0H!.3CDT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4KK2-,OKJ&ZN].M+BXA_U4LT"NZ=_E)&1^%7:* "BB
MB@ HHHH **** "F0PQ6T"001)%%&H5(T4*J@=  .@I]% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:=8Q^&YKC6;FU:Z>V^UQ(J1*57>7Z98L, ?CBN8\2Z9?W4'Q42"SGD:XBM#
M%C)\W; N=O\ >Q@]*M:MJGA?6K'1[G4(M;LUCMB+;6+.">*2&08#1?*NX'H?
MF!4XXS0!Z'I.H-JFE6]Z]G<V;RKEK>Y3;)&0<$$?4=>A&".M7:Y_P1/JEQX0
ML9=8,S7AWC?/'LD>,.PC9U[,4VDCU-=!0 4444 %%%% !1110 4444 %%%%
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MR1Q-(9UDC57( DC;;A^3M(P,$T >D45R]WXA\01"RMK?PJ\^HSQO+-&;L+!
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M(7#9W9*ME@0K$'!!Q7H/BFSN9]6\$O#;RR+!J6^8HA(C7R'&6QT&2!S79T4
M>.1W=YHWPZ\0^#&T;4YM7 OHH!'9NT<T<K.PE$@&W&'Z9SD8QGBO4/#D;P^%
M])BE1DD2RA5D88*D(,@CL:TZ* .+^*-G<WWA&.&UMI;B3^T+5BD2%SM$JDG
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M@;221C&<UZG10!X]HVGZAHWACX=ZW/IMXZ:0D\5];I S31),I7?Y>-QVD#(
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M<6MI).&98PC1G8#M;*@C/!!KT*@$'H<T >/QZ#JT.@^$Y;C3KA+BX\6?VE/
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MR%N0X0'/F#<<_(" H]Z[;0-.O8=#\<QRVDZ/=:I>R0*T9!E5HU"LH[@D<$4
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M&106VD-UQU%<QJ.AZO?>&M5U,Z5=I-JOB.VO(K0Q$RI C(H9U'W3A22.PZT
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,KQ!H,'B+3X[
M.YEDC2.XBN T>,[HW#@<CH2*U:** "BBB@#G]=\*0>(M0MI=0O[UK" H[::K
M*()G5BP9_EW-SCC./E'%=!110 4444 %%%% !6+XD\/?\))9I9R:I?V=J<K<
M1VCJGVA#C*LQ4D#_ '2.IK:HH AM;6"QLX;2UB6*W@18XXU'"J!@ ?A4U%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!!<65M=RV\D\2R/;2>;"6_@
M?:5S]<,?SJ>BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%-5T9F564LIPP!Y!Z\T .HIJ.DL:R1LKHP#*RG((/0@TZ@ HHHH ****
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M8+1R(P93@\'D=#0!R]CKVK/KOB;2TO;HPVVG17EG->6R+*C-O!^4!<@E00&
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M;<^E &M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*G!YH Z:BN6TCQM#J>HV=G<:1J6F_;XVDL9;Q$"W"J-Q VL2K;?FPP!Q74T
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M*.6WA<AN,=>30![%17+6'C:&[U^TTFYTC4[!KY'DL9KJ- EP$&6P Q93CG#
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M7?M<)M+FQOK*01W-I=!=\9(RIRI(*D<@@U<U;5+;1=)NM2O"XM[:,R/L7<Q
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MRSMUB9C>1S("A0XP1V)Z#'.*H>&HRUS\'VVY"V%Z<XZ?N%KN-7\,^(KN\O\
M^SO%36MC?KB2":T$S0?+M;R6W#;D=B#@\UT&D:9;:+H]GI=H&%O:0K#'N.3A
M1CGWH \V\0Q6.E_$;5KO6_$&J:':7]I;O:W%K-Y<<ICWJZ$[3EAD$#_:-9LV
ME:9H]UX9U!M4U[2-!EL+F);UW$<T<DDPF E.TA0^6(X'05[00#U&:" 1@\T
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M]%/W2>W)%0^$;VT@\4Z;8^%-5U.[T>6*4WNGWBNZZ> N4VLXRAW?+LR>I]*
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M[">/48[:>)F\N6&19,.C;3_7H:MKKUCX?^*M_/J9>&V?1+53<>6S+&V]\!L
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MY:YU.\M8))M\&VX# $[!N^7?\P&<8P<XXKK;[QG/!>?8;/P[J%_>P6R7-]!
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M=H"[3SSGC'6@#L**Y27QK)!I5O)+H5_'JUQ=FRATURH=Y0"Q(?.TQ[06WCC
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M<X3/S$>AQG% '9T5Q^I^.GM?$S^'],T2YU2_^S1W2"&5$0QL2"Q9C@ 8'U+
M"NJN[J&QLY[NYD$<$$;2R.>BJHR3^0H FHKB+;XA2M'IU]?>';VRT7494BMK
MZ26-CF3_ %9>,'**W'/.,C-<G=W6JZW\;9+*]T>^FM;&S22&TCU$1)'^]'^D
M$*P#9'\)R?4<4 >QT5@>.G>+X?\ B.2-V1UTRY*LIP0?+;D&N?\ #?B"\T_X
M>^$H[72[O5M0O;*,*B.%4;4!9GD;A?QY)Z4 =_17'VWC^WE73?/TZXMI+K4W
MTJX1V4_9KA02%)'# XX(]15R'QE9S>/)_"@MY1/%;^;]H)&QF 5C&.^X*ZM]
M* .DHK'\/^((O$*:A)! \<-I?2V:NQ!$IC(#,OMG(_"MB@ HKS7P_P"-M%TC
MP"NL66FWR6+:H;5HGF,T@=G"E@222.<[170:;XPGF\0_V-J^B7&DSR6S7=N\
ML\<BR1J0&R5)VL,@XY^M '545Q5C\07O9+&Z/A^^BT/4)Q!:ZD70[BQ(5FC!
MW*C$<,?49QFL'PYK;Z3XD^*.HW!EG@TZ1)Q%O_A6)V(7/ SB@#U.BL"^\4P6
M.G:%>-;2,NKW5O;1J&&8S*I()]<8K$U?QM--#K\6G:)=W6GZ:);:[U".5%\N
M0)EMJ$[F"Y&2.>N : .ZHKRS2=5T^'2OAA%J,%W<7MY;@6TR7#*J.(D+%QGY
M\Y'7-;MQX_N6GUF'3/#=Y?MI$[Q73+,D:A54-E2Q^8D$_*/3GJ,@';45R%QX
M\ADAT0:-IMQJ=YK%N;J"W5UBV1  EG9CA<;@.^35SPSXMB\2WNJVBV%S9S:9
M(D4Z3XR'9<D<9'!R,YP>HXH Z.BBO+-"\4ZGIEWXQ6TT.]U=;76KB69DG1!%
M'M3"KN/S-\K':/;U% 'J=%<YI_C*PU35-(M+..1X]4T]K^&8X 5%*C:1Z_-^
MAK \9^/;S3O#OBI](LI/MFCR) TY9,(7C#"0!NH!8#'//M0!Z%15'1[J[O=+
M@N+ZR:RN''S0M(KD>ARO'/7\:YNY\<W;:MJ^F:3X<N]2N=*D59]LR1IM9 X(
M+=2<D!1G[ISCC(!V5%<>_P 0+2?2-"NM*L+F_O-;4O9V:LJ-A1ER[$X4+T)Y
MYZ9JAJWCZ]B\+^)'ATB>TUS2(-TUM)+&PC#(2DRMT=>,XZ\$8H [^BL;PKJ-
M_JOANRO-2LVMKF2)&(9T;?E0=_R\#.<X[5RFFSS'X^ZS 99#"NBQ,(RQV@[U
MYQTS0!Z)17FN@>-=%T?X>MK=GIU\EB-2-LT,DYFDW-(%+ DDD<YQ6D?'U]%K
M7]BW'A2_BU.>'S[*#SXF$Z X;<X.V,CJ<D^V3C(!W%%><:_XSTW4?AKKM_K&
MDWL2Z==+:7UA'<;)%D$D>-LB$9'S*<CJ,BK&H^*]:M?'VA:+I^E22V$]D\S#
MSHP91\F&RW(V9.1U;/>@#OZ*XNZ^((MY+N[31;J70K*Y-K<ZFLB!48-M=A'G
M<R*QP6'H< XJU>^,9U\07FDZ3H5UJAT]$>^EBE1!%O&Y54,1O;;S@8ZCF@#J
MJ*XOX4737OPZL+EI'D\R:Y(9R22/M$F.O/3%1#Q3KC?%>;P^NENVG1V*2D^;
M&,;I"/.]<8&-O7C.* .YHKA'^))_L^76XO#][+X:BE*-J:RIDJ&VF019W% >
M_7'.*[I'61%=&#*PR".A% "T5B^+Y9[;P?K%W:W$EO<6UE-/%)&>5=48CKP1
MD=#7.:.+K4/ ND:A-XHOH-1O[.!E<O&5,\BK@;=G0L>GIF@#O:*R9?$NDPZZ
M-$DN'743$TZPF"3YD'5@VW!'T/7BGQ>(--FTB'5$G?[)/@0L87#2D]-J$;FS
MVP.: -.BL>T\4Z->6U].EZ(UT]MMVMPC1/ <9&Y7 (R.AQSVS4:^+M&:6[A:
M>:.>T@%S+#+:RI((NF\(5W,N1U ..] &Y16/_P )3HWD:5/]K/DZLR+92>4^
MV4L,J,XP"1S@XZ50TWQI::CX@UK3?(NH4TPHC226L@#,5+,2=N ,8QG!/;.1
M0!T]%<EI7B;0-)\)Z9=-K=[?6-U*T-O?7,<DKS.7( 8A/7(&0,@<9KH7U.TC
MU&*P=W%S+$TR+Y3XV+C)+8VC&1U/<4 7**Q8/%>C7&HVUBETZS7:LUJ9('1+
M@ 9/ENRA7XYX)XYZ57TRWU+3]=UV[O\ 59IM)?;)"MRJH+<C<7"D?P ;>3W!
M^I .BHK,L=?T_4+M+6!IQ,\)G02VTD8>,$#<"R@'EA^=+K.O:9X>M$NM5NEM
MH7D6-6*DY8G ' /<T :5%<A>>*O#NK_V?Y6O7=J4U9+=! KQF><?\L6RO*-N
M!/0$=ZVM0\1Z7IDT\5S._F6\(GG6*%Y3#&<X9]H.T<'KZ'T- &K17GWB?Q-#
M)>>$M3TS69%TR?4Q#.8VVQ2IY3MSQDC@>U;K>.=%;1-6U.W>YG32P?M4"VLB
MS(0NX91E# $<Y(QCG/!H Z2BLOP[K U[0++41%)$T\*.Z/$Z ,5#';N RO/!
M&0?6M2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "N.^(EM<FPT;4[>VEN4TG5H+V>*%"[F)0RL54<
MD@-G'M78T4 <!K/B@>*?"WBRVTG3[J6PCT:<+>O$\8EF:-QY2(R@M@8)([D"
MN<MY9;+POX#M-8FU6QT,Z<WVO[$)D=IPJ>6CF,;U&"_ QDBO8J* / M7M93\
M*/'6E0:=J,5PVJQW,-M<)))*87:$HQ9LECA3D9)&#FO1;>WF'Q<L9S#)Y(\-
M-&9-IVAO/0[<^N.U=Q10!YE86ERO@CXE1FWE$DU_J;1*4.9 8@ 5'?/;%4KU
M=#BTW0O[6_MO1M4@T>W6VU2PCEW2?+S%\@()4C.UQ_%QWKUJB@#'\*3ZG<^%
M-+FUI"FI/;(UPK+M.['<=CZCL:\^DF^R:O\ $S2IX+E;O48'FM%%NY69!:D$
MA@-O48Z]>.M>LT4 >;:O:W#> O 42V\IDBO]*,B!#E NW)([8[UR_BI9=7TS
MQ=:WRZ]=^(5GN%M+*)YT@CMEY1PJXC92@SSDLW&,FO<:* /-(M5MX/BWINJ2
M)<BQU/P_%:6LWV:0JTWV@G8<+\IP0?FP!WKH?B/IEYJ_@/4K6PA,]TOE3I"O
M63RY%<J/<A2![UU5% '"W'CN?6K6[M_"VFWMQ<)I\\S3S6[Q"WF"?NX]KK\[
MENP/&.]<=8RV']N>#M5MFU^]\BX*ZE>WIN76.62!U"['X!W$Y*C"\ GD5[71
M0!Y99V=R/@GXHMS;3">0ZGMCV'<V9),8'4YXQ6IX?MIT^(T,SP2+&/#%K'O*
M$#<)6RN?7VKOZ* /''T^^@MKS5A8W,L>F^-IKZ:)(B7:#&TNJ]6QNSQV!KHH
M+R/Q=\1]-U/2HYWTW2["X22ZD@>)'EE*@1KO )("DG' KT&B@#@/@]=H/ 5G
MI$D<\-_IH:.ZAF@>,QL9'(&6 !X]"?>F:]J T7XM6&IW5M<M8+HLL4UQ% TB
MPDS*03M!.. /QSTR:]"HH \5U'3+G7X->\3P6NHC3I==L[J-8%>*XEMX(Q&\
MD8X8?>+#H?EKK?!=OH,_B&ZU#1SKMXT5J(#?ZC-,\9#-N,:>;SD;03@8&>M=
M[10!Q/Q%MYKB;PAY4+RB/Q':R/L4G:H5\L?0>]9?C;3[:#QW8ZQJT^K6VE2Z
M<UH;G3I9D,4JR;P'\KG:P)QVRM>E44 >*^*-*MV^'FG/HNGZL(KGQ'%<M]MW
MR32#)4RG=E@I"@_-@\^]:6M66GZ7X]U^[UVYU^T@U!8)[.339KA4F*QB-HR(
MOXP5! /9J]8HH \EN8[32[G0=,ODU_3/#8TLR06D#S>:UTSY,<C0Y8L%/"YQ
MDGTJCI T>'PF-,\1:7J]J+;5[I_M,0F,NGNS,T;&1<L=RG&X;@3UZBO:** /
M%I[>^O\ 3-)U34;K7+K1=-U>>..]0217ALWAVK,=@#D!\@G&2O.,5-J.D6-W
MX8U?5?#EIKE\T%Y9S/->O+(UZD#[R(A(=Q"AF[#)Z9KV.B@#S6XUZ#Q/\2?!
MUSI5O=RV-K]L\VZDM9(T5VAX3Y@.>.>W(%=)X_N-1M?!E]+ICW"3AHP\ELNZ
M5(C(HD9 /X@FXUTU% 'CEF^EVGC7[=I^G:UJ6E7.B7-LCW1GF-[*&1VC7SB<
M J".< G([5J^#YK:#Q7:6GA6\UB;0VMI3>V=]'+Y5DPV^6$:0 J<[AM!/ )[
M5Z=10!R'Q$N;JUT6P,4]Y;V+ZA$FHSV0;S8[8AMQ!4;@-P0$CG!-8/@;[':_
M$#6?LEOJ<=E?6-N]E-?&>0SA&D#MNDR5&6& 2.,$#!KTVB@#C?&D$TWB3P6\
M<3NL>JLSE5)"#R7Y/H*-*@E7XL^(IVB<1/IUFJR%3M8@R9 /?M7944 >*Z>]
MSI_A7P];ZE)JEAHLFI:@=0DM%E23_6.8E8H-ZJQ)Z=>*I7]G))X*^(>FV6G:
MFCSR07=K#<K+)+) !%\^Y\DGY2=I.1T(&,5[O10!YAK^OV,GB[P/XG1;MM'C
M2^BDG%G*2C,BA04V[AD@@<=JQ'TO2=.FU_2]<'B:2]N-0N'@L;&>X$5[%,Q9
M=H4^7R&(;)&,'->U44 <'I%@UI\7+\I;RK;1Z%;0QNP)'RR-\N[N<8KI?%6F
MS:QX2UC3+<@3W=E-#'DX&YD('ZFM>B@#R34-67Q1X*T;PG965\FLM)9QW<$E
MI(GV,1.C2,[$!<#8<8/.1BMJPMIU^/&K7)@D%NVB1H)2AVEO,'&>F:]!HH P
M/',<DW@#Q%%$C/(^F7*JBC)8F-L #N:\]AEDL_#?@2SUF;5;'0SI9^T_8A,C
MM<!4V1N8AO P7P!C)%>PT4 >+6>G32^!?%UK:V-];ZC8:M_:]E!="1I=JB.2
M,[FR69@C#&203BII?M]CX7MO'D>GW+7[:W-?O;^43*+>4- J%>O""(_A7L=%
M '&>''B\$^"_#6GW\5PUQ>21P2&-,[;B;<[%_0;BPS]*[.JUW8V]\;<W"%_L
M\PGC&X@!P" 2!UQGH>^#VJS0!X7X>TZ]3X56$#V=PLH\412&-HF#!?M"G=C'
M3'>NY\4:=/J'Q"TB*-'"2:1?PF4*=J,_E@9/;_ZU=W10!YMX2\6MIWA_0/#*
MZ/?2:Y;B*QNK5H7C6!4&UIFD*E2N!D8/.0!678Z3?W5Y\7;>.UF\R]3R[;*$
M"5C#(!M/?DBO7:* /(KG7HM=TGP-8Z?9W\DMEJ=BUZ7M)$%L44J58L ,Y/;/
M )],S66K#PW9>+_#UW97KZI=7]Y<644=J[BZ2890AP-H'.#DC&*]7HH \82Q
MO,?![_19_P#1XSY_[L_NOW2#YO3\:ZWPQ;S1CQWOAD7S=5G:/<I&\>1& 1ZC
M.:[JB@#QSPXTGAA_!>MZE:7:V#>'VT^9X[=Y#;R[T==ZJ"PS@CIUK5\,^(8K
M36OB%K]U97<5O%+;S&'ROWIC$ P=AP02,-@X(SS@UV>OZ'>:K-9W.GZW=Z7=
MVI;:T0$D<@88(>-N&Z<'J.U5])\'VUAIFJ6M[=3ZC/JSL]_<R'RVFRH3 V8V
MJ%& !TH W[>9;FWBG3.R1 ZYZX(S7E^C>)(/#$_C./4K*^1KC6+B:T*6DCBZ
M)1!L4J",Y ZXZ^QQZFJA%"J % P .PI: /'M'MIO TW@>[UN"XBMHM'GM+B1
M(7D\B5V20*X4$CN/J*KZK#?:SX6^)TT&FWBF\E@DMXI(65Y$$4?S!2,\@9QU
M'0@'BO::* ,W0=5M-:T:WO;)I&A9=H,D31G(X/# &L#PI!+%XO\ &TDD3HDM
M]"8V92 X%N@R#WYKL:* /%_#,5QX>TOP%K]]:70L;:SNK.\*P,S6QD?<CLH!
M;!*X)QQD5>U*"Y\3Q>/M;TZTN6L[G1UL;,M"R-=,JNS,JL 2,L%!QSSBO6J*
M ,#P5JEKJOA+3I+4RXA@C@D$D+QE75%W## 9QZCBN;TZUN%^/>LW)@E%NVBQ
MHLI0[2V]> >F:]#HH \)T33KU/@[%;O9W F_X2*-_+,3;MOVA#G&,XQWKT2_
M@E;XOZ/.(G,*Z1<J9 IV@F2/ SZUV5% 'B7BRPO)?A]\2XH[2=Y)M;C>)%C)
M,B[K?E1CD<'IZ5TFL7*Z/\0_"6I7L5PMF=,FM3+' \@61MA"G:"1FO2:* /$
M8-(TBRMM1T'7$\3S:B]].J:?9SW BNXI)2RNH!$>TJWS9(P0<UTMAJD'@OQM
MXF@U*WO=FHR07%@\-M)-]HQ$$* J#\P*XP<=<UZ310!Q?PHAN8/AU81W=N]O
M<":Y+Q.,%29Y#C]:H7DZ:=\:)&O$N(X=2T:.TMID@=T:7SFRNY00" 0><"O0
MZ* /&8=1>S^$LW@1]/O3XD%O)IRV:VLA#EF*B0/C;LP=V[.*]+T[48+'4K3P
MNZS->0Z:EQYNS]VR*1&<-G[V<'&.A%;=5OL-O_:7]H%";D0^0'+'A,[B .@R
M<9/L/2@#)\;R*G@;758_-+83QQJ.2[M&P"@=R3VKD/#<OA*P\#:%->6,2ZC9
M6=O(XBLC]H$R*N0,+NW$@@^N37IU% 'G7CC3Y/%B1V]DD-OJ^DP?;6DE)V@L
MI!M]PQN5QD.>@&,CYN*>O:^VL:#X7\4P:=?FSL+LOJ5C '2>W#1-&6 7#$*6
M[=0?3->HT4 >3:Y!9:OX;U#7/"6E7MTZW%G<W$LPF$E^L,@8QJ)?F;:!UZ=A
MG%=/;ZUIGC"UO;C1M/EDG;3Y('NY[1H60D<0[G4%N220"0,>XKLJ* /%X-5B
MN/"'PZM(K:^>?3=2M([Q!:29A9(G5@1MY(.>F>.?2NM\/W*:?\1?&4=W'-%]
MIEMKB*1HF$9C6W +;\;0 01UZUW=% 'F/A#05\1? Z+0IMT-P\<RC>I5H91*
MSQL0>1@[6^E7],@UKQ/X!U6]O+=K36=0TU[*.-_E*,J,I/MNE+GZ;?2N_HH
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M_!*D@<D$]J]!\"V6BK=ZG?Z/I^JQ1R>7#]LU&28FY"@GY5F.X*I8C.!DDXH
MV+CQ&EKXSL_#T]LR?;;22XM[G?\ *[H1NCQCJ%(;-8OB/Q99.GBO2I],DN[+
M2=-$UZRS%-Y=21$".02HSG/&:E^(=C<?V=IVNV$$L]]HE['=)'"I9Y(B=DJ
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M#/%/]G>!H9X;.>]O=1UFZAL[0L$9V,KM\Q/W0J@DGMBK%G<Q^!_'.N?:]/U
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M>>=+:UMHB TTSG"J">!W))Z &L_3?%MW)KC:+K6C-IE^]LUU;A;E9XYT4@,
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MM*OPF-^  <^]<[_9^H2>"/ =@-,O5NM,\3(MW%]GD_= 2NQ;)'*88?/TYZT
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MGELQ!+$J<8P,=22W08)H UO#WAE-#N+^]GO[C4=2OV0W-W<!5+!!A555 "J
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MAM=2>R:\LXTOQ)',%8*R,^P;&!9>Q'- '845YCX2\>:RWP]T_5=4TX7=[?W
MM[ )<C==R/(_#?*!&%"]>>%S6VWCPZ79:V?$6F_8+S2;=+IX89_.6>-\A#&V
M%ZLI7! P<4 =G17EVMZOK=[XC\$QZSH:Z:TFJ>;$8KH3C'DOE7^5=K#<..0>
M>>*]1H *ANHI9K2:*"=K>9T94F50QC8CA@#P<=<'BL"Q\6B]T;Q#J/V(I_8]
MU=6_E^;GS?)&<YQ\N?3G'O6:?'UW/<:'9Z?H1N;O6-*&HQ*;H(D1.TE7;;T
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M2WD2.4PNRD+( "4..#@\''O6+X=\,1Z%/>WL]]<:CJ=\RFYO+@*&8*,*JJH
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MVF,81Y"Z%8RQ& 6P>M=M10!Y?X5MX8/%U@?#.FZ[I>G/'*=4LKV*6.VB.WY
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M%DZPFE:A;:6-#:WBGNK9HO,?SU8\,,CKP#@G!.,<UWLX+6\H R2A  ^E244
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M.,&N&E\*W&I:)XGNM+T"[LM*GO+.[L]*=3;R3>2V9F5 08]XX'0DJ.E>ST4
M>4P>&]$UZUUFWT'P_J]I-+I4UNE_J3W"!9)!CR@DS$GH"2!@8'/-;GA[Q5J5
MS'HFC1>'-2ANHT6/4GNX&BBME1,$JY&')8#:%SD'/%=U10!XS)+J5E\./$GA
M!=!U:;5C)>B/9:.8I(W=G#K)C:?E;@ Y)XQ746.GWJ_$_1KQK.<6T?AHPO,8
MSL63S4.PGH&P#QUKOJ* //\ 3M.O4^.>LZ@]G.ME)I$4:7!C(C9PRY4-T)]J
MXJ2RU.?]GO4?#"Z+JHU:Q=5> V<G[S-WO_=G'SC;R=N<5[K2!E8D*P)!P<'I
M0!Y;X@T*RM_%T&JZYI6JW>G7.E0VX>P\\M!-&S':ZPD-A@PP2",@]*?<Z;H,
M'AG2[?4/!>K0:;-)-<*T+2SW-E*6^5FV$R*7&2<$X/!KU"B@#F/ 0U)?#6-2
M:^91<RBT.H#%P;?=^[\S/.['KSC&:Z>BB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N%^+L_V?P%
M(YN)+>,WELLDB2%"$,JAOF'(XS7=5Q?Q2L[N]\%M'9V4]Y*EY;2F&"/>[*LJ
MLV!WX!H Y^QM/A9/J%M%:>(6EN7E588UUN=B[D@* /,YR<<5U-[XWM]$UK4[
M'7H5L8;:V^V6MQOW+=1#AP!@8=3@;>2<@U17QI:JP9? WB96!R"-) Q_X]6?
MXK\-ZGX_UR:'9)IUEH@WV$\T0S<7G!#8(YB7 !_O$GKB@#5E\8ZLFEZ(G]A(
MFNZTSFVL);G:L4:KN+R/MXPN,@ G)Q7/^,M<U.Y\-P#5=$FM+ZPUZQ#1Q,9(
M[D>8K PN0N[/3'8\&K=[=:S=7'A3Q=<:!?"?33<VVI6$41:5/,4*7C7^-0R
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M(MS'ILMJ'RBW)A+.R*WKQM]B10!T \9:EI-Q/;^)M)AM'%A-J$#6=R9UD6(
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M=R281L!<@@C.2.V,U'I&J:]9:_XX&B:/;WIBU,S2M<W)A4CR8\(F%;+'!ZX
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M^!#!&NYW_4 >I-85MXZU:2TLM?FTJU3PU>W201RBX8W"([[$E9=NW:6(X!R
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MD2/+ 28G89*$C!(]."1^-2T ><>'/%-]I'AC2=,N/ _B9Y[2SB@D9+6(J65
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M$7]JV]K(X7SU1P< YP,KNQGO76S:GK_B6PUN!- N-/TYM,EBB6]55N)KEE(
M4*Q 0#C)ZDC% &3I_C:ZMO"7@QM(T*R1M:9H4M(V,<4!"L1C X4$9/!XSCFM
MO2_%&LIK.JZ'K6FVSZI:V0O[8:?(2EU&25VC?@JVX8YXYKB4M-5\/Z%\,+:3
M3I'U&UN9?,M-RASB*0LH).-VW.,G&<<BM>_T[Q#XEU#Q+KMCIUYI<K:&=,T]
M+HK'-*Y9G9L G;SA02?>@#8L?%'B2/6[+2]7LM*CGU.WFDM5MIW8P2HH;RYL
MCT/5?0\5@^%O&/B"S\':AJVJ);7LDNIR6ME$L[[WG><H(R6&%C!/&.BCI3-+
MT7[-XI\,:KI/@:;2K&T,EO=,88EN':2/:';#99%/5B<G<3CUJP>&=7NO!FH^
M'KGP_<27-CJ[:C&L^P6]\GG[_+5MW5D)'( ]: .ZT37]6/B*30=>@L5NVM?M
MEO-8R,T<B!@KJ0PR&4E?J&[59\<7T>F>"-8O9K*"]C@MF=K:<9CD [,/2L?P
M=I>G1:U/=Z=X'_L&%8-GVFXC2*:1R<E BD_*  <DCGH#UK5\?Z?=:KX!UNPL
M86GNI[5DBC7JS'M0!A_\)=J,,/@[3M'TBS\S6M-::.-G,<5MLCC8#@'Y '/
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M;!8;NFXX! SQ6S%HVHW_ ,7GUN33[B#3;GPX+<R2[04D:0,8R 3\P'7J..M
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M)&42O#.T@W)D@$@%3C/.:U_#=W>W_P 7-9NKRQDL@VD6_E02LID1/,?&_:2
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MA).S[\Y)SSSQ6'H_C_7[CP[X/CAM;:[U/59+FSG>8E5#P[AYF1V^7<>/4#%
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M^C>*=;7Q/8:/KG]CR-J%O++&-.D8M;O'M+))DG/#<,,<J>*SO@O_ ,BWK?\
MV';K_P!EH ](HHKA= \4>(]?N5O;6VTF72S>26TUJDK"[ME5V7>^3MS\N2N
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MLD;J\;@,K*<A@>A!IU>=67B+7$O-"\-:-:V+/+X?AO/M%UNVQ$$*<A3\PZ#
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MLE0<\CG&TUH6_B'7])\2Z;I/B6/3'BU-)?L]Q8"11')&N]D<.3D%<X88Z=*
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M0Q%C&;:7!$T>>0?F'!SC!KHM=\2SV'B;0M%LHX9'OC+-<O)DB&VC7+-P>I)
M':@#I:0C((R1GTKSFS\?:O);:=KMQ#I:Z%?W4<*0)(WVJ&.1]D<C'.T\E25
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M[K?=M*X&,[N<^M:] !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M><X!]DHH Y?1-+O;7Q_XJU&: I:7L=D+>3</G*(X;C.1@D=:X:]\':_+\/\
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M7DZ((X@P!8B12>20.@-9D^FZMH/B/2?$5MI4^HQ?V.NFWMM;,GG1%6#JZAF
M89+ C/H:[^B@#RRY\):]JMEK/B V*VVKW.JVNHVFGRRKG9;!0B.P)4,P#=R
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MVK8HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6S[@=X2$*W .1@C'.* ,.T\>:KK>B>%TTNULX=8UQ9F8W 9H;=8>)&P""W.
MHSWY/%2:AXJ\4^';2"YUW3[$6L.IQVMY=PAMDEO( %F0%B4VL0&#9]JR=)\+
M>(= T7PCJ46F?:=0T<W<5U8"=%>2*9R<JQ.W<,*<9YR174)9:KXI\.ZY:^)[
M.+3[2^5HK:UW*\D$>W&YV!*EMWS8'3 YH LW_B"\7QWI7AVPBA=)+:6\OY)
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M'@\KD],G@D#-7-.TW7;[5/!%Y=Z++8+I,=Q#=+)/&Y7,"HK#:QR"P(]>.<4
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MA8+MSGH>N,5EV]EXG\,V.N:%IV@MJ$5Y<W$]A>I<QI'&)B3B4,0PVDGH#D4
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M  '.>*[NN2TC1+VS^(^OZH]N(]/NK.UBMW#+AB@;<-H.1C(ZBNMH \W\4?\
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MM;AMS)#</$'X(VML(W+ST/%<)/X[\0V'A/59I8;*YU?2]:CTQBB,D=PK,F&
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M(/.>@QR =_IVJ6&K0//I]Y#=1)(8F>%PP#CJIQW%6Z\FT[Q[JJ?#J^UNWL+
M7<6MBR6&*(QHZF5$YY^\0QY_2NBAUSQ#HOC"STS7[G3[JTU"TGN(WM;=HC T
M6TLO+-N7#=>#]* .WHKRB\\:>,[?P WC5%THV=P%>*Q,#[X(V<*CE]_SGD9&
M!UR#QBO57#&-@A <CY21D _2@"&]OK73;*6\O;B.WMHANDED;:JCU)JP#D9'
M2O"9I=<N/AE\0YM3U"WN84U"YA*) RMYBR1@L"7.$P.%QQZFN\76?$^D^)=
M@U>33I;'67>'R((65[1Q&74;RQ\S[I!.%]A0!W5%>;:IXRUK1M56:]U/05B.
MHI:_V*C!KKR7D""3>'^_@AMNW&.]2>'I-?F^+_BF*;4K9[*V2U#0_9VR8V61
MD"G?A2"?F.#N]!0!Z#-/%;Q-+/*D4:_>=V"@?4FJG]N:1_T%;'_P(3_&N5^,
M6/\ A5.N9&1MAR/^VR5CPR_#B>>.)? DH9V"@MX;< $G')*<"@#U&BN-U_QA
M-X0U]FUP1CP_<VY:UN8HSOCG0$M$_."6 RO3D8K/O/%FOZ?H.CC4FTW3=6UJ
MZ81_:01%8P!2_P"\RPWN% &,J"S8[<@'H5%>:CXAWECI>MV\D^FZMJ=C-;0V
MEQ:';#<FX.V,L S;2&#;@#T''6M.ZU#QGH%AJ\^I'3K^W@TR:[AO+>$PB*=%
M)$;H7)93U##'0YZT =O37=8T9W8*JC))Z 5R&I>*+^T\.>%+^-(#-JM[8P7
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M;(-;U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9OFSCHIJRECXE\.>*M>ETK1XM1LM8E2YBF:Z6(6TH0(PD!Y*_*#\H)[5WE%
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MG!X&<<=>:[JB@#BM4M-?NO%6GS-I OM%^P[#:2W"(L%SNSOD7)#C;@#&[')
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M?1UU.*VLI[>2,W:0$%V4@Y;/IZ5HZ=KGBJXO!'?^#OL=OM8F5=3BE((4D *
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ML  \Z,?E!Y(W,1]!70:)HU[9>.?%6J3QJMIJ'V3[.P8$MY<95LCJ.3WKIJ*
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MFFM3F*5D; =.3\K#:>O>L6_\.:O::MIFN1:/IFK7"Z<+&]LD*PH&#;P\6\$
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M- '>45P/@W5/$WB/6=4N;G4;>'2],U6ZLA;K; O<A20N7S\H7*]!DD'-=]0
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MDLD]VJMH"JGFI;M)L!#9WF0*0Y[=1BMCPT77XT^/VC"LXM[,J&. 3Y0QD]J
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M>M:=-K<VC1W2-J,,0FD@P<JA. ?3N*\UC\3^,;7P!IOCF\U.T>WVP/<Z:MH
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MP3INE^3Y>A:A:SS%VVYCC&&(XY)ZUOIX^\(22+&GB?2&=B JB\C))/;K714
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MF.&.-DVINQ\Q"H><<DUT_BO1-1N]2T77='$$FH:3+(1;SN42>*1=KKN .T\
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MXC\+M8Z8;<7:W,$Z?:&*H=D@;!(!/;TH S;/7+.XOK>#_A7FLV_F2*GG2Z?
M$CR<;F(<D =347B/Q=J7@O7+G^T$?4-/U&,#25CC =;H<?9V('(;((8^A'.*
MN?:OB1G_ )!?AG_P-G_^-U'JO@=_%>MZC<^(VC:R6 VVEP0.28,X+3DD#$I(
M&,= .^: ,K7?$FK>';/P[I.M^)+73[_41--?:F84VPA #Y<:D;<Y=5!(/ )J
MG:_$&_N-'GTZPU6TU'4&UB#2[755B&QDE7>)&08!90'&!@$J*VVT#Q6+?0=4
MDDT^[U[2/.@</*R1WL#@ DMM)1_E0]",@]C4VJ>'O$FOZ DE[<:?;ZS:ZC'J
M%A%%N:"$Q_=C=L!FR"V6P/O<#B@"EK]SXP\)^&/$-Y+K$6H0P60FM+R2!$FC
MESAE9%&UEQ@@X]N:V?$.M7]AJ'A.&VF")J%^(;D; =R>2[8Y''('2LZ^\/\
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MBVF,BLJJ &R5&"<'CMZULT %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4C,J*68A5 R23@ 4M<-\4W
M>70=*TKS'CM]6UBUL+ID.#Y+L2PSVSMQ^- &G#\0_!T^H"PB\2::UP6VA1.,
M$^@;H3^-=-65>>&M&O=!?1)M-MO[.:/RQ L8"H,8ROH1V(KR[P]K_B2Y\.>
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MC8ZQ)IFF3:):ZAF&&-Y4:0MPI92.1C)(/W>,9)H ]'HKE? .JZAJ>B7D>J7
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M&T>^NUM[=+:(I+'%(>)"5R>/E&,=,G)-;2ZAXBTOQ%X5N;S66NK;7'>.YL3
MBQP$Q&1?+(&[@C'S$YH ]$HKRJTN_&&L^'O$6LQ^)7M7TN]O$LX$M8BDJQ,Q
M D)7)&!MXQC&>35O4_%$FH6FA7DOBI=!M[[3$NQ;VD FN9)6 /*E'Q&.G Y.
M>: /2J*\HE\8>(]1\*^"+BPO8K>^U>]:SN)?(4JP ==^TCCE=^!CGCI6MX@N
M;S1FTS3M0\<O9)Y$C/-';(]Y=2;N#L$; (!W Y.* .SN]7LK'4;"PN)BES?N
MZ6R;"=Y52S<@8' )YJQ=W4-C93WEP^R""-I9&P3A5&2<#D\"O(&U;5_$\7P[
MO([R./4IKR]A-V(1C"))&T@0\!BJD@'C)Z8XK9NKW5M.F\6^&-3U.35(AH3W
M]K<31HDBJ0Z,C;  >0"#CO0!W^DZM9:YI5MJ>GRF6TN4WQ2%2NX?0@$5=KQ;
M2?$YT;X=^!-+_M;^R(M0@E:>^$8D>../G:@((W,649(.!FNV^'_B.36O[7LG
MU+^U(]/N%6"_,0C,T3H&&X  ;E.Y20!G H [.BJFJS75OH][/8PB:\CMY'@B
M/\<@4E5_$X%<!X2U.^UY'6V\<O<W#6C?;;2>UBBN+.;C#(FP8 .00P8=.: /
M2(Y(YD#Q.KH<X93D>E*2%4LQ  &23VKR+P1-J6G?!6TU$^)H[,7!!$][&FVT
M0S,'\O"Y=VR<!L\XILFOWNHZ!XVTNU\27=]!9:4+RWOI;58IAE9-\3 HH(.P
M?,%! 8X.1P >O(ZR(KHP9& *LIR"/44ZO(%UVY\.>$_!>E7/B:6SBU2U$\E^
M\$;/;PI#'B*,!,<E@ S G&>M=9\/_$<FM+J]F^I?VHFGW*I!?^4(S/$Z!AN
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M9(;B/[T,JG*N/H1^6:V:* .$ELOB5=V+:9+?^'X$=?+?4X!*9MO0LL1 4/\
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M?]G=Z=JL_P#".>*=+N=3MM U+3H-.U"Z>Z\VXB9I[1Y#F38OW'YR1NQ@GG-
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MWC SSG%:>J>%M;UK0](@U#4[::_M=6AU":18MD81'+>6@'/ ( )Y.,FM/5]
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MDMUK]SJ-OJUR;.\MYHXQ&DC(S*T6U05 *D8).1[\UR>DZ]/X;TCXE:C:NJ7
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M/K0!J^'/$FG^*=.DOM-:0PQSO WF)M.Y>O%:5S.MK:S7#([K$C.5C7<Q &<
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M6L?PM9-8>&K&%KRZNR85?S+E@S#(!QD <#M6Q0 4444 %%%% !1110 4444
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M:Q[ [=7.<LQ]R23^-9<V@ZI:^,[KQ!ILEG*MY:1VTL%R60H4+$,K*#G[QRI
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MW_M_7A+!9JT5CHEO(3;L=Q\R9D!!SQA6P, \'.:SKGQ1J]U_PJVY^VR1-JK
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M S$MAL'M@9YYK5L?#.LW7B.QUKQ'J=G<R:;'(MG!96S1(&<;6D;<S$MMX &
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M>:%\N&4/C.T[!D>F:ZIO"E_</X>GO]8-W=:9>27<TK0A1*75UVJ ?E4;^.O
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M VDD]^,8K+F\4>,;:P\,B\LK*ROK_4C8W,4L9(8;7*R*0YP"%'R\GW% 'HU
M((R#D5YU-KOB%;7QSI5QJ,!O-(LTN;:^@MMAVO$[XV%B 04(!R>M=)X&6Y'@
M?1&N;@3L]C RD)MVJ8UP#R<GWH Z&BL[7[JZL/#^HWED8A<6]O)+'YR%D)52
M<$ @]O6N!/BWQ9I^C>&/$M])IT^E:D;6*[M(H&62+S@,2!]W)R?NX &<<]:
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MVU;6+0^+)-9BO9A81V=M,]D$BD*K&54;&W!?F)YR>V* /2M>\:6.A:S9Z/\
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M9*R#=C'(4C<.>AR*P=,LDT63X;16,UVD=\6DN$>ZDD#G[&3C#,<#/(4<#TH
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M?QQ27+R&WF0E-R,Q+*"&!QGJ*@?3I-)T3P-XBCU'4)-5O+VPANI9+N1EFCF
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M#!LY_#I5'2_!-[I4EG:P^);W^Q+*7S+>P6-48 $E8VE'S,@S]WN  217844
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M.:W_ !)XPM/#5YIUG-8:C>W6H>;Y$-C )6/E@%LC([,/R-1Z3XP.JZE%9?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "L/Q9H*^(]$^Q"]-E<)-'/;7(4-Y<R,&0[3PW(Z
M5N5D>(_#UKXETQ;.YEG@>*59[>XMVVR02K]UU/J.?S- ',QZ]XFT35M+L_%V
MG:9=6MW=+;6VI:>S#9,P.S?&_()Y&5.!7$QRZKK6EWNN66@^(;GQ&U[,]IJ,
M4Z"",1S%5B"F4?N]J[6!7DD]>M>BVO@N\EU.RO=>\27NL+8R>=;0/#%#&L@!
M =@BC<PR<9Z4UO LD=U<1V?B'4;/2;FZ-U-I\ 0?.6W,%DQO16;D@'N<$9H
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M.SEL=1@%[<QS7>J'5HKB/:'MI\+@KD8(&WH>H)%:6A:'=Z9-=76H:U=ZI=W
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M?3M</)]M$B9='4M@ EL@@<8&*W=,\,7,,]Q-K.NWFL&:W-KY<R)%$(S][Y$
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\5WNH>,_!UJ^G:MHYGNIG:"Y*J+B/R'(SL8@X.,JW()'%:5W\3M.M+?4;_\
MLK59=)L'DBDU&*)#$TB<%5^;<1N^4-C;GOWH [>BN3O/'EI;ZG;:9;:7J-[?
MW5@E_#!;HF6C8D8)+ *1CDGCIR20*SO^%J6#Z3-J<.AZS-;6;,FHE84!LF4X
M97RPR1C)"YP""<9H [VBN;U3QA!9WMO9:?IM]J]W-;B[\JR"?)"3@.Q=E')S
M@9R<&JUQ\0](BL]%N8H+VY&L>8MK'#$"^]!RC*2,-G*^@(.2!S0!UM%<->?$
M,KX?\13QZ+J%OJNC0^9-93K'N4,I9),ARI3@DX.>#Q6[X0UBZU[PQ8ZA>64]
MK/+"A83!1YA**2ZA6/RDDXS@^U &Y17-:KXP2RUF32+#2-0U>^@B6:XCLP@$
M"-G;N9V4;C@D*,DXKDOB+X]F;X5R:OX<6_C-UB,W:!4:S82JK*X+;E8_,HP#
MSW'!H ]2HK!\'P&WT".-H-7A(<Y75K@33GISN#-P>PS^ K)\'ZS>_P!N^+-%
MU>[::73;WSH9),#%K*NY![[<$9H [2BO-?AGXJU;6]5U.+6)F9+V,:GIJ,H&
MRV:21 OX;4/_  *I?#_C*X_L[7/$-^UW>6=SJ[66DVEN@9G53L79T'S-N)).
M!CK0!Z+17'S>+;/4?#?B/[=9ZIILVF6S->VVY5N(T,98-&RL5R0#@@]1VIWA
M[Q7IC+X=TF%=0(U/3?M5G/>$,TBJ!E7;<29,$$]O>@#KJ*YS4?&VE:7JVHV%
MSYP&FV(O;J=5!CC5FPJ=<ESC(&*32?&":AJ/]GWFD:CI5V]N;F".]5!YT8(!
M*E689&1E3@C(H Z2BN6\*>.+;QCLET[2]12R:$R?;)XU6/>" 8P0QRW/;C@C
M.16AXA\26OAZ*U$D%Q=W=Y+Y-K:6JAI)GP2<9(   )))  H V:*Y.+QN+BTU
M2-=%U*+5].17ETV18_-*O]UU._8R\')#=CWQ7-_!B\O]5T :MJ3:W<7=TKM)
M=7ER'MI,2, (DW';@#!^4=^U 'J%%<=XQUC5?[9T?PQH5PEI?:GYDDMXT8?[
M-!&!N8*>"Q) &>*C7PWXIT6_LKG2_$UWJL!F5;VTU8H0T9^\R.B JPZ@<@T
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M* $*P1FRV3TPIZ9JIJ/BVQTW4M3L9H;AI=/TPZG*45<-%EAA<G[WR'K@=.:
M-^BN-M?B+9W-QI1;2-4@T_5)$AM-0EC01/(PRJXW;AG& <8/;CFFZOXZA1M9
MM;/3-3N8-.5HKO4+=%\JWDV9(Y8,VT$$[0<4 =I17G_ASQ<UCX)\*P-;7^L:
MQ?Z>LHA@*M(RJHW2.SL !D@9)Y)K1N_B-HUEH%GJ\T%ZL5Q??8&A\H>;!.-V
M5=<]04(XSG(QG- '7T51T?4)=4TR.[FT^ZT]W)_T>Z"B1<$@9 )'/7KWKGOB
M!K5[I^FV.EZ1,8M8UBZ2TM7 !,0SF23![*H/YB@#KZ*Y#X?:U?:AIE]I>L3&
M76='NWM+IR #*,YCDP.S*1^1KG]"M==\4ZWXH9O%NJV,=AJTMK!#;+$45 %(
M^\A)Z^M 'I]%<1H&LZWIGC*3PEXANH[]I+4WEAJ"1")I4#;61U'&X=<CJ*Y[
MP9:ZOXF\+6NKWOCW5K:XG>8-#&T 50LK(,90GHHH ]8HK*L@FA>'FDOM6FO8
MK:-Y9;VY*[BHRQ)V@#@<<#M7GGA#Q5XA_P"$DTN\UZX;^R?%,<SV$#J +1U8
MM&F1_>CP>>IH ]8HHHH **XGXCWM_;1^';6PU2?3?M^KQVLT\.W<(V1R?O C
MJ!^53:?X<O(-1MYF\=ZM>+&X8V\C0%9 .=IP@.#[4 =A17-?\)QI,=MKLMYY
MUFVB,1=Q3J ^W&490"=RO_#ZGBF77C-8(]-CAT74[G4K^ W*:=&L8FBB&,M(
M6<*O4#KG)QZT =117+R>/-+7P];:M'!>2O<W!M(K%8A]H:X!(,14G 8%6SDX
M &<U6/Q$T^'3M1N+[3M0L[K3I8([FRE1/-7SF"HP(8JRDGJ#V- '8T5D:IXA
MM]+U?3=,>WN)KG4$G: 1!<?ND#$')')!P/?KBN(L/',FM^"/$E_K6GZK9V=I
M+<+Y]JR1R"-7P$1@^?,4=3P/0F@#TZBN8T7Q1ITEWH^B1I>A[O24OK6:Y(;S
M8P%!5FR29 ""?KG-.O\ QSI.FZAK%I<+<8TFWCGNI40,H,APD8YR7;C QW'-
M '2T5SVB^*TU75'TR[TJ_P!*OQ#]I2"\"9EBS@LI1F'!(!!.1D5=US7;;08K
M*2ZCE<7=Y%9IY8!P\C;5)R1QZT :E%9-UXAM;3Q#!HKQS&YFM)+M64#8$0J"
M"<YS\P[5S5O\4=/N;"PU1='U9=&NWCC_ +1>)!%$[D* PW[L!C@L 1GC)H [
MNBN8U#QK#:Z[<Z5::1J6I262))>R6B(5MPPRH.Y@6;'.U03BN=\&>,/LGP[T
M2>X%]JVHZC<7,=K#$=\T^V60YRY "JH&22 !B@#TFBN2F^(.F6OAF^UJ[M;R
MW%A<):WEK(BB6"1F4#/S;2/G5L@D$'BD/CQ?LMLZ^']8-U>3/'9V;1HDLZ*H
M8R_,P"I@C[Q!SVH ZZBO/?$/Q$NK.QT.?3M%U'?>ZHEE/#+$BO&0QW18+ ;V
M .T@E<<Y%:VI^.5T^>2&/0-7O)+>V2ZO5@2/_148$@-EQN; /"YZ4 =917+7
M_CO3;.?2H+>UO;^75K5KJQ2UC!,JC:<?,1@X;.3@  Y(J.'X@Z9_86K:G?6M
M[8/I,HAN[2=%,JN<; H4D-NW#&#SF@#K:*\XN/%%[?\ Q"\(6<MAJFD&0W;R
MVURRA9D\@E2=C%6P1T/(...16YI/CJWU:[LUCT?5(;"^9DL]0EB7R9B 3V8L
MH(4X+ 9H ZNBJ6KZI;:+I-UJ=X7%O;1F1]B[F('8#N3TK%T[QI'=W=S9WND:
MCIEW#:&]6&[5,RP@X)4JQ&0< @D$9% '3T5P]M\3K"YM],OAH^K1Z3J#QQ1Z
MA)&@B21^ K#=NP&^4MC&>YZU?OO&\%MK5YIUKI.I7XT]5-_<6J(4M]PW '+
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M\$_#SPKI(OI=,M!/#;ZG?0@;H59&9R"0=NZ3 W=MU=9_8.L_]#AJ?_@+:_\
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MB@ HHI&940LS!549))P * %HKQNP\5:V-=L_&UQ?3_\ "+ZGJ<FG):,Q\N*
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MWJ00 -O7C.*J^'/%V@Z;X0US6(+2^AMK75)89(I)3/)-/E%PF3_$64 < >U
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M1!DL=IX KG=&^(NEV7A;3;.VT_6;[48+.*+[)!ILP9G5 "-S*% R.N:]&HH
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M1:KI[2*$)* (V2?0"N+\3^9JVA^)H+T:]>>)$NI]EE&\ZV\%NCY5@JXC9?+
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M(+38ZAMQ*@9SQQGC)Z"O8:* "O#E=C\+O$/A_P"S70U2WU?S9(#;N/D-XA#
MXP1CG@].:]QHH X[Q'!+)\1O!,J1.T<;7V]PI(7,&!D]LUYM<S&]T&RO;_\
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M"X\L^48=H=(0>AQ,QX]!6\E^O@[QYXDN=4M;TV6K_9[BUN+>TDG5F2/8T9V
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MNR$ZO]_8597 P05<'H.A%<A9:D\G@7P?8W,>MVNEV;"VUI8+:XBE5EB.Q3M
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MHNEE4U'5_LCJTZ ML>13'R.-VPG=VK3;6+1/B7+;C0Y3KZZ!]I,@NR5*[_\
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M88U20?O!(1M8$ 8P223TQDUW^G6EPOQ@U>[:WE%N^D6Z+,4.PL';(#=,].*
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M4KJ;6L9N00 =^T9R!P#Z^]<[X9M+F%?'7F6\J>?JL[Q;D(\Q3!& 5]1D$9%
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MHJEI%]-J.E6]W<6,UC/(I\RVF^]&P)!&1U''![C!J[0 4444 %%%% !1110
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MK:,\/G%1P@('))QQ63X0^'%['H,=[J'B+7['5-18WM]%:7"QJ)I.2""A.0,
M\]17IU)N7=MW#=C.,\XH X#X?Z5?>$M:UKPJ\5Y-I4;K>Z=>2H2I5_\ 61EP
M NX-SCODG%7?B&MPUOHX>+4)='^VC^TTT\.96BV-MR(_F*;]N<=J[.B@#R?0
M+!K6Y\;6]IH.HV-KJ.G)+8)+#(?,58W0@L<X<L0=A.[!''7$$^DZI'\!-#MO
M[,O&O+.2VFFM5A;S@J3 M\G7('.*]?HH \GUBRTRY\7R>(=6T?79]+U.QB6!
M[6*Y22&6-G!22.,AAN#*06&.#TJS%HC0ZK\/I-/T"\T^TAN;R>:"0M*;??&V
M#(Q)P6)SR>IQ7IP96SM8'!P<'H:6@ KSA/M.G?$OQ>DVG7[1ZQ9VWV2>*V=X
MF,<4@8,X&%.2.O\ 45Z/10!Y;<Z5J+? K1=/6PNC>QK8;[80MYB[9HRV5QD8
M )/IBJ>HZ'IFF>)/$9UK0-<U"2^N?M5B^GM<>7.&108SY3!58,IY;'!'.*]>
MHH I:/9Q:?HMC9P6OV2*"!(TM]^_R@% V[N^.F?:N&L;^Z\(^*O$]M/H^IW0
MU*[6]L)+6V:1)BT:J4+CA"&7^(@8YKT:B@#Q;3;"_L?!G@JTUS3]8&DQ_:QJ
M-K:0S;_-WDP[UC^?9RWMG;FJUUH]\O@;QIIEIX>U&W>34;>_M;7R7<O!F$\-
MR&<!&RH)(.17N =2Y0,"PZC/(I694&68 =,DT >5:Y:Z;J/BR#Q+J>CZY-I%
M[IRP(;>&YCF@ECD<XDCCPX#!N"1CCWKMO!EC:V/AR(6>DW&E13223?9;F5GE
M&YC\SEB2&88)&>,XKH** /./&1^Q?$?1-3NM#U#4]/CT^XB?[+8M<A79EVY
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M_A\H99H2FQS(S;&ST;!Z=: -2U\?6TWPVF\7SVQA\B&1I;0ORLJ,5\O..I8
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MI\S*#NSVSC-<8-#U"+2=?TZU\-WMDD^LV-]:P)"640;HL_,,C<-I+#/'/UH
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M 8\/ZG/J?EW%E;3QP$VTJ2,VV4R_=4!7R0><CI3O&'A35K631K+2K::YCO\
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M [Y)*L0H.W/%9GB:.\T?QQI/B>+3[N_LELYK&Z2SB,DL09E=7"#EAE2#CI0
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M2>"#MQGIS6_?WE[XVUCPU;P:'JEA#I]^NHWLU];&%8RB,!&I/WR6;^'(P,T
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M/F3(L;O'C'990?P-5K3Q?KNM6!GT71;>42ZC<6T%Q/.RPK#$2/-<@$Y9@0%
M_&@#M)IHK>(RSRI%&.KNP4#\33\Y&17F7B7QDDOPPUR_UG0;.[FTV]6RN[%Y
M2\$CB1,,K8R1AU89&:ZFQ\22/XTF\.7%HD*_8([VSE5L^:F=K@CL5./P- '2
M45PDWQ N#)JRV>F).(=4CTC3\R[1<W)&9-QQ\JKSR,_=-23>,]4TJS\00ZQI
MUHFJ:5IYU&-;:9FAN8L-T)4%2&0@@CT- %K4_ %GJ-Y?RIJ^L6=OJ)S>V=K<
M!8ICC:>JDKD#!VD9KJ+6VALK2&TMHUB@@C6.-%Z*H& !] *P_">L:QKUC_:6
MH:=;V5E<QQRV2I,7E96!)+C "Y^4@#/!YYJQX@O]8M$M8=%TV*[N;B0JTEQ(
M4AMU"DEG(!/;  ')- &S17 3_$*\LO#=U>76E1OJ-CJT>F7-O;S;D<L4PT;$
M#.5<$ XYX-7K/Q3K%GXHCTCQ'I]C:I<V<MW;S6EPTH41D;T?<J\@,#D<4 ==
M++'#&9)9%C0=68X _&GUXWXQ\2Z]K_PON=5FT>U@T6_>$VY6X9KB-//38\B[
M=N&P.AR-PZ\U[)0 45Q5EXNUK5?&&IZ-8:5:BUTN[2.[NYYRO[IE##8 .7Y;
MCH,#GFJUOX[U:2TL]?ETFU3PS>7201RBX8W"([^6DS+MV[2Q' .0&!YH [I9
MX7F>))4:6/&] P)7/3([5)7E6D:G;Z-\4_B9J=T2+>TM;2>3;UVK!DX]^*Z/
M3?%.NIJ>DPZ_I-I:6VL!A:M;W#2/#($+B.4%0,E0>5XR,>] '945Q%QXM\06
M%W;7>H:):VVC7&H+8J&N&^U*&?RTE9-NW:3@X!S@BGQ>*]?O]5OSI>CV=UIN
MGWWV*=#=E;IB" SJNW: ,Y +9(% ':45P^H>,=:\W6;O2-(M;K2M%D:*Z>6X
M9)IF10T@B4*1\H./F/)!%=E9W45]907ENVZ&>-98V]589!_(T .$\+3-"LJ&
M51ED##<!ZD5)7 CQ)8V/Q"\5(=&A6?3=+2ZFO(_];.@4-L(QV[5J>&]<\1:G
M):3:AI5@NG7UOY\-S8W9E\KH0D@91DD'JN1D&@#J7=41G=@JJ,EB< "DCDCF
MC62)U=&&593D'\:SO$=Q':>&-6N9K=+F**SFD>!_NR (25/L>E<7I_C26T\,
M>#5TC0+<'6E:.&T278D!"%ASC[N1R<<#. 3Q0!Z/17+^&_$6J7NO:IH6MV5K
M;W]C'%.KVDK/%+')NP1N ((*D'-:^N7U[I^DS7&G:>VH7@*K%;JVT,68#)/9
M1G)/H* -&F/+'%M\R14WL%7<<9)Z >]<8GC>\TG^W(/$MG:Q7&EV*Z@&L)FD
MCFB.X8&X AMR8Y]17/>(=4\1WK>#'UO2K.UANM=M)HC;7#2-$<,=D@91S@]1
MD<'VH ]69@JEF(  R2>U1?:K?]U_I$7[[F+YQ\_^[Z_A7!:GXKUO5;'Q+)I>
MDVDNC::9[.5Y+AEGF9$_>-&H4KA2> 3SCJ*R]*U6TL=/^%-G/I-O=S7EH%AN
M9#\]J5A0DKQWSC\* /5B0 23@#J338IHKB(2PR))&W1T8$'\17G?AS6O$=YX
MI\8Q:E%92:?92!#$+AV\O$((5 5P0W5LXY)ZU'X>\:1P?#?P[<:/H-M!=ZM<
M/:V6FQ2;(D;>^YBV,A0%+' SS0!Z717%1^,-5T^]U/2]=T^TCU"VTU]2MWM)
MF>&>-<AE^9058''KP<U1@\=Z\++0-:O-$LX=%U:6W@&VY8W$9FP%<KMV[<GI
MG."#[  ]#HI'W;&V %L< GC->6^'/&FMZ?HOB[6O$,=O-9Z=J5Q"J07#O()5
M9$6) R@;,G@YSD]* /4Z*XR'Q1X@TW5])MO$NE6%O;:M(8(9;.Y:0P3;2RI(
M&49R 1E>XKLF.U2V"<#.!U- "T5Q-KXL\00:GI(UO1;6RL=6G-O B7+/<6[[
M691*NT#D*?NG@U0D\=>)+G3M=U+3="L7L]$NKF&X-Q=,KSK"3GRP%/.T9R3C
M)P,XH ]%HKE=+\8_;_%,&E26HBM[[3(]2L)RW,JG&]".S#(/'8URGC?QOKCZ
M!XG?1(88+73+V"Q^VF=ED9RR"3: /X695Z]"3VQ0!ZEYL?G"+S%\TKN"9YQZ
MX]*)9HX(FEFD2.->K.P 'XFO-+ZZ\01?%'2_+L+&35Y=!F1D%PWV>+]^IW%]
MNXC '1<Y('3FGZSXR:?X=>)Y]=T*TGN=(N1:W=D92\$QW1D,"1G!#@\C/% '
MI0(90RD$$9!'>EKB;KQ7J,&JZ+H>CZ1;RS7^F&ZC,LQ2.#:4&&P"=H!/09S@
M=\BL/B%>6>@ZO)J.E1'6=.OTT\6MO,3'<2R;?+*L0" =^>1D8- '?T5Q=MXJ
MUZU\7:1X=UO2;.*6_CFE%S:7#/'A%!P-R@[@>O;!!![#JM3U"#2-*O-2NB1;
MVD+SR$#)VJ"3C\!0!:J.6XAA9%EFCC9SA [ %CZ#UKA8_&OB"TM=*UC6=%LK
M?1=2FBB'DW3//;"4XC:0%0I&2,X/&>]<N+/5M7^/%Y]OTO1KQ[.RB:-+B9V6
M"+S 0\>8S^\[XP #WH ]FHK.UZ]N]-T"_OK&V6ZN;:!I8X&8CS"HSMR.YQ6#
MJOCF.V\"Z?XAT^V6ZGU(V\=G:E\>9+*0 A..WS9_W30!U]1F>%9U@,J"5AE8
MRPW$>H%<=XA\4>)-'&IW\.AVC:3I:!YGGN626Y4*&<P@*1@#(^8\D&LC4IDN
M/CQX7FC.4DT>9U/L=Q% 'IE%<;!XVFE^'>J>)S9()++[5B#><-Y+LHYQQG;^
MM.N/%&LWVIKIOA[3K*:YBLHKR[DO)VCCC\S.R-=JDECM8Y/  ]Z .PHK*\-Z
MW'XB\/VNJ1PM 9@P>%CDQNK%77/?#*1GVKE=6U?Q*GQ<TW2K(69T\V$DQCDN
M'7>N^,,S *1O7!VCI@GD9H Z#6_"D6L:C!J4.IZCIE]#$8?/L954O&3G:RLK
M*1GGIFKF@:#9>'-+%A9>:REVEDEF??)+(QRSNW=B:Y.3QMK]W9:IK>CZ+97&
MB:=+*A,UTR3W(B)$C1@*5 R&QD\X[5VNFW\&JZ7::C:DFWNH4GC)Z[6 (_0T
M 6J*X\^-_LUAXNFO;58IO#\C@1A\^=&8P\1Z<%LXQ5;_ (3VY/@BTU;^S475
MKB_73?L#2'"W'G&-E+8[ %NE ';)+'+N\N17V,5;:<X(Z@^](\\,<D<;RHLD
MF=BLP!;'7 [UY5H>K^(=-C\:W&C:79W-O9ZW>7$[W5PT9DP%)2,*IYP,Y.!R
M.O.-C4?%%A>^(?A].='@N&UF.6>VN)C^\M 8D8[>.I# 'Z4 >@TQ98VD:-9%
M,B %E!Y7/3(KB9_&'B"[FU6ZT'0K>^TS2KE[:4-<,MQ<NF/,\I0I'!.!D\D<
M5EV][K1^)WB<:%86\D\UE82,U_(T21 +)P0JEMQSTQV.3V(!Z;16'X0\0-XG
M\.0:E+:_99R\D,T&_<$D1RC 'N,KD?6N*^*$FBKXP\'Q^(K@PZ0ZWOGDS/&I
M(1-N2A!^]B@#U&BO.?",/PTE\01/X9NTFU.)&=%6]GDPN,,=KL0>#Z5:G^(C
MV%GJ=I>Z<!XBM;E;6WTZ.3/VLR?ZET)'W6&23_#M;- '>45R-[XAU^35UT32
M-/T^;48+-+J_DN+ATAB+DA8U(4DDE6.2  ![XJJ?'MQ?:9H:Z3IJ-K&KO-&M
MM<S;8[<PY$Q=@"2%(P,#G(H [BBN(F\9:SIMI"FK:&MO>G5[?3F*2,8)4E(Q
M+$Q ) ST(X(P:U=3\07EOXJM]!LK6"2:YT^>ZCDFD*J'1E4*< \'=R?;I0!O
MS316\1EFD2.->KNP 'XFG@@@$'(/0UXS:^*=2?X$WNO>)=-L=7MB^Z.&69F,
MV;HJ1("N%"G;MP3PHZ5W]AXF<^+X_#T]FD$4VFI>V<JM]\ [73&.JY!^AH Z
M>BN%N?B!,EQK:6FFK<)::A#I5B?-V_:;IP-RDX^54)Y//0UJZ'KVIRZ[<Z#K
MMG:V^H1VZW<4EG*SQ31%BIQN (*L,$>X- '2T5@^)_$$GAU-+F^SK+;76H16
M<[EL>2LA(#^_S;1^-9[>-2OQ(7PM]C'V<P@&[W\B<H9!'C_KF,YS0!UU%<5%
MXNUK4UU :+HL5P8=5?3H999BL05%R\LA )"ALJ ,Y-5W\?7UKI-\EWIUHNLV
MFHPZ:46Y(MF>4*4D,A7(3#Y/&>,=Z .]HK'T*\UNX^U0ZYIUO;30LOES6LQD
MAG4C.5R P(Z$$?0FG>(+[5+&SA&CZ<M[>3S+$!)(4BA!!)D<@$[1CL,Y(H U
M))(X8VDE=411EF8X _&E5E=%=&#*PR&!R"*\P\5:_>:K\-O&NGZG:P6^HZ9%
MY4WV:4R1.'575E) /(/0C@BK*>++_0M#\"Z3INF1WUUJVG!8@\NP*T<,9!)P
M?EY)/L.,T =#JW@R'4M5FU*VUC5M+GN8EBN?L,ZJLRKG&0RM@@$C(P:V=(TF
MST/2;73-/B\JTMD"1IG/'N>Y)Y)]ZYN;Q%XDFU(:-IFFZ;+J=K9QW.HO-<NL
M$;/D+&A"EB3M8Y(  QZTL?BO6-9T32;OP_H\337PD\]KV8K#9F,[65RH)8[@
M5&!S@GB@#L*9YL?G>3YB^;MW;,\XZ9QZ5PS?$"[_ .$?@>/2XFUV;5&TA;7S
MSY(G4G<V_&=@4;NF>U8LVI^(+;XEW<]UI=JVJV?AB:2**WF9HKD"="-I*A@3
M@C!'7'8T >K45Q^H>.XHOA_9>)=/MA=3:@($M+4OC?-(P79GU!SG_=-=>F[8
MN_&['..F: %HK@9/'>JBSF\0II5JWAB&Z,#3&X;[0R+)Y;3!-NW:&SP3D@9J
MQ-XI\17WB37=%T+2+&1])>+=<7EPR(X>)7"@*I.[)(] ![T =M48GA,Y@$J&
M91N,88;@/7%>7:IXUU_6+7P/?Z)!;6\>JW1\R&:Y=<R*L@:-BJG]WD9SU) X
MK:@U<O\ $W5],MM&L%UB+1TF^VM(P\TDC$;$+D)D]<$\=* .XEFBMXFEFD2.
M->KNP 'XFG @@$$$'H17A.IZMKFM_LY:S?ZP8)%E<&&59F>1O],PP<%0 !@!
M<$\#M7HLNOZJMSIN@Z!96D]]_9R7D\EY,T<44?W5'RJ268AOIM- '94P2QF5
MHA(ID4 E,\@'H<5P[>/KRZL-(M].TN+^WM1NY[,VMQ,1';O!GSBS 9*C'&!S
MN%5_"]QJ%Q\5_$ U2UBM[N+3+5'$,A>-_GD(9"0#@@]QP01SUH ]#HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ KFO'VE7.K^#KR.PC+ZA;E+NT4=3+$P=0/<[<?C72T4 >27.
MC>(;/P78^(+/3)V\2+JEQJ,EJ!\X$X="GX(T?_?%3ZAX8;2-/\':??:/>:OH
MMC:21WEI:IYF;DA"KNF1N&?,Z\ FO5** /#=4\,ZRWPT\9:#:^&I[6>YU.*\
MM+6! 8_*8PD*I!P64(=P' (KM_'.GZK;QZ'XCT.QDN]4TIV0VZ#YI8I$VL/?
M#;#^!KNZ* /+M1\"2P_#70+"2P.ISZ=>1:A?VH(W7+-N\X DC+?O&(YYV@4W
M^P+.X\+>*QH/@NXTII]+DMH'G79/<NRME!'DD*#MP2>2>G%>IT4 9OAZ"6U\
M,Z5;SH8Y8K.%'1NJL$ (/XUR_CZQDNM5T&6[TF\U;0XFG^V6=JGF%I"J^4S)
MD;E'S^P)%=Q)(D4;22.J1H"S,QP% ZDFFPSQ7,*302I+$XRKHP96'J".M 'C
MD'A[5(=-U338/#4UBDGB&SU&"&%%\I(,Q9 *G&Y=AW < YP37:>(]%N]3\=:
M-*D,GV,:=?6\TX'RQM($"Y^N#^5=G10!XQ>IXCN?A3%X-3PQJ0U*S6"">4HO
MD,D4BG=&V?G)"C@#N<]*]GI&8*I9B H&23VJ&UO+6^B,EI<PW$8;:6B<. ?3
M([T <IX5TJ[MO$WC.6[MI(H+V]C:!V&!(OE!21^.17&>'/"&GZ;#IVC7G@":
MZU>VG6.;4&^6V:-7_P!>),G)VX.W&<\<=:]EHH \KF\(ZIJGBOXEQM;/#;ZO
M96\-G<.,)(XAQP?0-C-2^%-$TM=8TLP?#Z?3KVW0M=7MR-B02!<?NSD^9EN.
M,#'.>U>E^?#]H^S^;'Y^S?Y6X;MN<9QUQGC-24 >%_\ ".WIT2SDD\'7T_B.
MQU"*[U+49HPSS!9PS>2Y.7R.0!@!0>^ =WQ%93ZIJDMQ8^$M4T_Q2+A!:ZI:
M_+"\888>5P0"-G#(P)'09KU>B@#R"]\*V.GZWKXU'P-<Z[=7MZ]U8W,*YCD$
M@!V2/N'E[6W9)'0Y&:]8L;=+33[:VCA2".&)8UB0Y5   %![@=*GHH \[M]+
MUBU^*OBS6(=+:>&;2XDM3(VR.>15'R;N<<C&<57\+Z:(_&5I=Z%X<U70+(PR
MG58+E?+MY'(&P(FX@L&S\R@#'UKTRHYIX;:/S)Y8XDR%W.P49)P!D^IH S?%
M%O->>$M9MK>-I)YK&>.-%ZLQC8 #\:X30= U:VT_X:)-83(VG&;[8"O^IS Z
MC=Z<D"O4:* .4L-.O(_BAK.H/;NMG-IMM%',1\K,K2$@>XR/SI/B':7M[X;B
MCM;>YNH!>0/>VUJ<2S6P?]XBX()R.P/(R*ZRB@#Q>?PG/?WFO6VD^%I='L-7
MT0V]H/*6,><C,V9@#\A;@#/8#/H-?4;W7/$P\)0)X9U.T_L_5;:XOWN8PJH5
M!4[.3N7DG=TP!ZUZC10!Y=;C6_#]CXI\.Q>']0NY[Z[NI["ZB13;LDW(WN3\
MI4DY&,G'&<U77P[K'F_"@_V?/C2X&6^^7_4'R4'S>G((_"O6:CCGAF>1(I8W
M:)ML@5@2AQG!]#S0!P&EV^HZ=XR\96DVDWQBU5EGM;M(P82!!M(+9X;(QC%8
M.@>&]<TGX>>"KPZ5</?Z%>337%@,"5HI&D5MH)P6 8,!GFO8:* /-KNTU/Q3
MKNJ:VFD7ME:0:%/86T=W&(Y;B:3DD)DD* H'.,DU+J&BZE+\-?!U@EE*UW:3
M:6UQ$!\T8C*;\_3!S7HE% !7D!\/ZQ>Z#XY\,?V7=Q7=UJT^J6=S(@%O,OFQ
MR(H?/WCMZ=N]>MRSPPM&LLL<;2MLC#, 7;K@>IX-24 >>WD^I>--9\.0C0=2
MTVWTV^74+R:^C"!61&"QIR=^6;J.,"NXU)+J32KQ+)PEVT#B!CV?:=I_/%6J
M* /$[+0Y($\+7UIX*U"&^TV[BDU:\FB!N)G*,KE26+2+N.XGITQ[=9IFC:C#
MX&\:6<EG*MQ>7FIO;QD<RK)NV$?7/%=Y#<07(<P31RA'*,48-M8=0<="/2I*
M /+?%=M=Z!\//"WB..';JGAV.V+0N<%T=%BEB^IR/Q6GZUX1U&V^"+Z/;6[W
M>K-Y5W<HF-\LQF667'J?O8^@KLM3\*66LZU:ZC?W-[-':LLD5B9L6WF+G:Y0
M#EAGN<>U;M '$V*WFJ?$?3]>_LR]M+-M$F@;[5%L9)//0A6&3@D*2/:N;\2>
M'-8NO"/Q%MH-.GDGU#48Y+1%7F90(<E?4?*WY5ZU37=(XVDD95102S,<  =R
M: .*L]*OT\=>'KQK606]OH,EO+(1PDA:(A3[\'\JP-9\-:U/)XIO+6P>2:/7
M+/4K2)B%^TK$D>X*3QV8?45ZE!/#=0I-;RI+$XRKQL&5A[$54UK1[+7](N-,
MU",R6TX 8*Q4@@@@@CD$$ @^U '!3ZM=ZQ\5/"$TFDW>GVRP7PC6\55E=O+7
M<=H)PH^4 GJ<_4]OXFTEM=\+:KI*.$>\M)(48] S*0"?;.*SM)\*Z9HVMI>S
M:I?:AJCP-# ^HW0D=(\@L$&![9.,].:Z:@#RZ[.M>)_#NB^%Y/#VHV5Q%/:_
MVA<7"*L$:0LK,4<$[R2HP!Z\XK8T[2;^+XT:QJKVDBV$VE10QW!'RLX8$J#Z
MUW-% !UKRGPYX4U>W\96ND7=G(GAW0+JYO;"9ON3&7!B4>\>^7]*]6IDLL<$
M3RS2+'&@+,[G 4#J23T% 'COB'PW=:F_BVUN_"MSJ>MW<LQT[4)U#016Y0>6
M$<G"L.1M R6(SQR-BTTW4[SXD>$M8_LN[@LX-&>&=IH]IBDY&UO0UZ8K*Z*Z
M,&5AD$'((I: /'I(->L_ 'B/P?%X<U&:^DDO/)N @^SR12.SA@^>20V N,YQ
MTY(L:IX7M+;Q&-3UKPK=ZW:7>FVT:?9HO,DMYHP0RE=PX8%>>F5KUFB@#&\*
MV2:?X:LX$TB/2!M+FQCDWB$L22-W<\Y/N3UKGM>BOK#XHZ-K2:7>WEBVGRV3
MO:1AS$[2*P+#(PN!UKNJ* /++3^VO#7A;5_"4?A[4;RZ>6Z73[F!%,$B3,S*
MSN3\F"YR#Z<9KT#PYI;:'X8TK2G<.]G:10,PZ,54 D?B*TZ* /,O&'AO5;OQ
MW;+8V<DFDZT+9=4D7[J?9I?,&[_>4[?PI8O#FJ'XJ&%[.3_A'X;Q]:2<_<:=
MH5CV#W#%WKTRB@#A=$TF_M]!\;0RVDB27NI7TMNI',J.BA2/8D5A)X=U<7WP
MG<Z?/MTNT=+X[?\ CW8P1KAO3D$?A7JKND<;22,J(H)9F.  .Y--@GAN84FM
MY4EB<95XV#*P]B* /.;&YU[P<-=TFT\.7NHW%UJ$]WIMQ$H-NPF.X"5MPV;6
M)SGJ!Q6WX?T_48/'_B._O+?9'<VEBJ2J#L=T63>%SV!(_.NOHH Y3X>:=>:9
MX9EM[VW>"8W]W($<8.UIG93^((-9OC=;ZT\:^$]9M]&O]3MK%;P3I91J[KO1
M%7@D#KGOVKN+FYM[.!I[J>*"%<;I)7"J,G R34@((!!!!Z$4 <OIGBZ6_P!1
MAM6\(^(+(2$@W%S;1K&G&?F(<G]*Y2_T#Q%K.I3^.XK9[?5]/EVZ3ILH ,EL
MFX.LGH\FYB/[ORUZI4<,\-PA>"6.50Q4E&# $'!''<4 >7Z[H=G<^+#XAUCP
MC?ZK8ZCI\*K'%#OFM)D+91DW# (8<\C*_C5A]'N]%_X1/7]/\,26\.G_ &E+
MO2;-Q++$DX'S+T#$%02!_>.,XS7IE% 'FWB&7Q'XCT#^T1H$\,5AJ]K>6=DX
M NIX8F!<LN< DYPO!P*MV4FIZW\3-.UHZ+?66F1:9/ 'NT".7+QGE<G:..,\
MG!XQC/?5&\\,<T4+RQK++GRT9@&? R<#O@4 >*-HVN3_  $U/PC_ &#J*:K9
MN%"M$-D^;OS,QG/S +R:[3QEINIP:?X>U_2+&2ZU71I5S;)]Z2&1-DB#_P =
M/_ :[NB@#RV\\"W*_"[2+*:Q_M&^MKV+5+^U) :Z=F+3)G(&[#L!_NBMKP5I
M>E0:M=WFE^#IM$A$"Q"YNE\N68DY91'DD*,*=Q(R>@[UW%% &!XVT:37_!>J
MZ="";B2 O;XZ^:GSI_X\HKAETCQ W@U_$CZ3-_PD1UQ=6%CC]YL!$/E_]^<_
MG7JDT\-M'YD\L<4>0-TC!1DG &3ZFI* /)Y_#5WIOA3P?::CI=[J=A$\D^L6
M=LN]Y)I%+ L@(WJLC-D?2F:3IUQI"^);:7P'))I5_<P7 T^.-"HM]BJ=H^Z9
M5(#%,]<D$X&?59[JWM3&+BXBB\UQ''YCA=['HHSU/M4U '#?#[3YK&ZUC[+8
M:EI^@.8?L-GJ#'?&X#>:55B2J'*8!/4'%2?$*RGNSHC2Z==ZEHT5VS:C96@+
M/(OEL(R5!&Y0^"1]..*[6B@#QB3P_J":%X\T^Q\+3Z?%JEM%-86T,:[<!0NP
M[3@2$_,5]SS710Z)J2ZS\,Y392B/3;&>.\;'$#&V10&]/F!%>@Q3PS-(L4L<
MC1-LD",#L;K@^AY'%'GPFX-OYL?GA-YCW#<%SC..N,]Z /-?$_ANQC\<WNKZ
MOX7NM=L;ZUA6)K6/S'@ECW J5W#A@5.>F1VJM?:$(&\."_\ !US)H4=I.6T:
MR(N%M[IW5E,@R WR[N3D D_6O5Z* /%[+0=:TNQCGB\-SQ2:1XC;4?L5NJE7
MMI4*E83G#,@/3CI75:0VJ:O\5!KDFC7MCI8T5[6)[M CL_G(QRH)VY&< \_*
M3Z5WU5;KRKR.XT];QH9WB.3!(!+&&R XZX]CCJ* /+/#NAW(^)4_APA6T/P_
M=2:K;@'(#W"CRHR.VPM,P_"O7:PM(T;2?!]A.1=,#<3>;<WE].&DFD/ +N<>
MP X'M6[0!XSI_@[3]-1]&OO $VIZF+QPEZ?EMYH6D+"1I,_*0AY7&<KTYKN_
M#FG7=IXV\8W<UN\=O=SVK6\C#B0+;JK8^A!%=710!X[;:-K.D^#O EQ)HU[/
M)I.HRRW=K!&&F1&,H!"YY^\/SKH])TS4#\9=3UN2QN(K"XT:*-)9%P-^Y24/
MN._TKOZ9--%;PO--(D<2#<SNP"J/4D]* /%3H^N3? C5O"/]A:BFJVKX :(;
M)\W?F9C;/S +R:V_$'ABV'B33]7U?PU<ZU8/I,=F\=M'YDEO,C%@2@()#!B,
MC."OO7J$4L<T22Q.LD;J&5U.0P/0@]Q4:W5N]T]JEQ$UQ& SQ!P74'H2.HH
M\S?1[G1_^$4\0Z;X4FM(+"XNC<Z5:L)9DCG7:'QGEOE0E03C..<5HZ))K$OC
MCQ%XBFT*\M[673(5LXI@%DE*%SM(!.UB>WH1GTKT&B@"MIUS+>Z9:W4]K):3
M31+(]O(<M$Q&2I]QTJS110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1&XNG *N8VW9D!)+$D@<#'MV&D:+J-OX7\:VLMHZS7VH:A+;(2,R+(/D(^M
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M:_AT^.W@E/DSR3 &)@Q&54@DG/(VFLO6=*U/Q!9^'-8\0^%_M]QI;SV^HZ<
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M&]C68TWB)?BK=Q6-MI[ZG)H5L9Y)7<6\6)9,XP-S9)P!QW)/&#N_$G3K_4-
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M2_$-GIT<^I7K,ALRQ 5HU=I1Z_*(G_2NUT""_MO#NF0:I+YNH1VL:7,F<[I
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M&">8.-NW<<@<G&.0>FM)XHU^_P!>U>WT+3+*>QT=UBN#<2LLMQ)M#LD6!@$
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MC<*@D,6\;PI. V.N,@C-<?JOB77I?%5]HF@QZ2);&WCG,5_(XDNB^XXCVD8
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M7O1;>$=*TB5+V"ZM; I$#<K$P8K.4RGS9< <@9Y[UM^%+ IJT]TG@FP\/0+
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M>,>@!Z\5D:C\0]11-8U>UU+0XK'2[F2%=+G/^DW21'$C!MXVDX;:-IS@9ZT
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M6)6D8*"['"J/<GBK%>#VESKEQ\&]*U"\N8+UI=:@DMH@A1]XO&W!W+'.6QC
M&!ZUZ+8:OXBT_P ;VNAZY<:?=PZA9RW$,EI;M$87C*[D.6;<N&X/!H ZC3M4
ML-6MVN-.O(;J%7,;/"X8!AU&1W%6Z\GTGQ[J'_"OY=5$.EV,KZT; S^25M[=
M"P'FR*#S^8&2*[SPU/K$UM/_ &I=:?>QA@;6]L1M6=".<KN;!!R."0: -RHH
M+F"ZC\RWFCF3.-T;!AGTR*Y;XCZW<:3X5>VT\_\ $UU25=/L5!Y\R3C=[;1D
MY]A6!X2TZ/X>>.?^$5C8_P!EZO9I<6;-_P _,2A9A]64!S0!Z;17$-K?B;6/
M$VM6N@MIT-GHS)$RW43.UW,4#LNX,/+ ! S@\\X/2L.+X@^(KSPOX1O;2TLO
MM^N7L]J\<BL$CPT@0\'(QM!;KG!QB@#U.BO/=0\2ZW;:Q#X=DUW0[&]M[,75
MY?W46$D9G8(D<9D7'"DDY/:JY^(MU?:-H4<%SI=AJ.HS7$,]U</OMX/()61E
M^8;MQV[1G^+VH ]*HKS"Y^(>JVGAW4VB?3=0U/3=2MK0S6V?(N8Y2NUA\QVM
MAB#R0"._2KDNL>-K7Q?!X<EN='EDU"T>YBNUM75;78P# IOS(.0!RO)R?2@#
MT.BO-1X^U:Q\.ZE'?_V>=8M=9&CQW# QV[%@K+*X)RH"DDC/\/7FE_X3G4;"
MW\16DFI:3JUW8:2^IVEW9+B-MN04D0.V"&V]#R&[4 >DT5YXOB3Q58R>&M3U
M)M-;3M:N8;9K.*%A);F5"R-YA8ACQR-H'/'K3? 4FOW'C+Q:U_J-K-;PWPB>
M-+=E)81)M*$N0JXZC!R><T >BU7GOK2VNK:VGN(HY[IF6"-F :0J-Q"CO@ F
MN8\8^(KW2M4T?3+2_P!/TP:AYI:_OXR\:% N(P-RC<VXXR>BGJ:Y_P 13>(7
MUOP(9H[#^V/MEVBO&6,##R7 DQG.-OS;<Y[9[T >GT5P^FZ_XD@U'Q'HMZMC
MJ&HZ=:QW5G+"AMTF$@;"N&8[<,O7/2H?#GBO4)/%L&B7^LZ)JWVJTDG#Z8,&
MVD0J"C#>V00W!.#\IXH ZH>)=$.DS:J-5L_[/@?RY;GS1Y:-D#!;H#D@?C6D
MCK+&LB,&1@&5AT(/>OGR+_DV[Q5_V$W_ /2B*O>=)_Y UC_U[Q_^@B@"Y17E
MY\5>,KSPYKVO6DFDP6^C7-VGDRV[NUTD+-GD.-GRC'0Y(/05KMXEUKQ%KL6E
M>'I;2P2/3H;ZZN;J SE3+DI&JAE[ DDF@#N:*\>\4^)O$&I^"Y(O/M+/4+#7
M8M-OC%&Q65A)&R.GS JIR"0<YY&17K-DEU'90I?313707$LD491&;U"DD@?B
M: "ROK34K5;JRN(KB!BRB2)@RDJ2I&1Z$$?A5BO&/#&I>+-)^&<^LZ<VFC3]
M-FNY3:30LTERBSNTAWA@$P-P VG[O/7%=)?^-KO4=:DLM(UC1M)AM[.&Y:74
MQN,[RJ65%&]<*%P2W)^8<4 >AT5C>$]='B;PM8:OY:QM<(?,16W!74E6 /<;
ME.*X;4/B)J*1:MK-MJ6AQV&FW,D2Z7,?])NHXFVNP;>-K'#%1M/09ZT >I45
MQ&L>.'\+ZQ(^M*C:)=VOG:;<0QG<TJKEH&Y.6;@KTSR*Y_Q7=^,GTGP=+=W5
MC87E]K4*R6Z0.PB+;FC5CO&X*!\PXR>A&.0#U>BO.]2\6ZPVMW^E6FMZ!I\N
MDPQ"9K]<?;+AD#E5'F#8F".?F.3[4D7C;6M>OO#EOH<=G;KK&ER7<DERC2?9
MF5D!X!&X#)&.,D@YXQ0!Z+7'7?@GP>-<B%S$4GOIVN4L3=R"&>5<,S^3NV,1
MP3Q6._CK6],T37;:]BLKK6]/U&'3[9XT:.*=I@AC9ER2,!R2 >U17@UVS^)W
M@Z/7;JSNE6*^D2YMH&A_Y9+N5E+-TX((/.>G'(!Z=39)$AB>61@B(I9F)P !
MU->6V7Q&U"2WT[79M2T1M.OKJ.(Z5&?]*@AD?8CEM_+#*EEVCC/I5VZUSQ-K
MUGXGO--?3X]*TV6XLDM986:6Z\M<2-Y@8!.<A?E/3F@#T&UNK>^M(KJUF2:W
MF0/'+&<JZGD$'N*FKFOAW_R3CPW_ -@V#_T 52T_Q5J%UX5\5:G(D GTJZOH
M;<!3M*PYV;AGD\<]/PH [*BO.T\5^)=4U?0-+TW^SX7U/0EU&>XFA9Q"Y*Y(
M4,-P^; &>^<\8,3>/=9T[2]6L+VWL[CQ#9ZG!IL!C#)#.TX4Q.1DE1@DD _P
M]>: /2:*XRUUCQ!HWBW2]%UZYL;Z'5HYC;W%K;M T4L:AF1E+,"I7.#P>*YF
M'QMXQ;X?P>-I3I2V<1!FL1 Y>9/-V,P??\AZX&#TY/.  >K2Q1S(4EC61"02
MK#(X.1^M/IK$A"RKN(&0,XS7G5AXQUJV\1:/:ZKJ>@W+:E<-;S:;9-F:Q;8S
M+E@YWCY=K':.3Q0!Z/17F)\4^,K[0O$.LV4FDV]OHMW=QB*6W=VNEA8\9#C9
M\HQGG)ST%;FE>+KNY\7V>GW<44=AJVE1W^G, 0V\ >9&QSR0&## '% '945S
M7A?7KW7]5U^0K"-*L[S['9LJG?(R#$K$YP1N.!@=C5#5M;\13_$!O#&CR6-O
M$=*2^-U<0M(8R970@*&&[.%QTQR>>E ':45Y2OC#QK/X0U;7%.D0MH4T\%S$
M8'87C0L=Y4[AY8QT'S'(/08KH=?U[5U>RDL]5T31-/FM!.+G4R&,LAZ1A=ZX
M &"6YZ\"@#M:*\AU3Q#K_B-/A]J&GW=I8C4;AF:)H6D43+'("3AQN3KA?H<U
MJ:IXVU4W^M+8:MH-FFC-Y7V>]_UE]*J!W ^<;%YV@X;G- '=ZCH]EJLUA+=Q
ML[V-P+F AB-L@4J#QUX8\5)'JEA+JDNF1WD+7T,8DDMPXWHIZ,1U KA)_&6O
MZSXCTG2_#BV,,.IZ(FIK/=QLY@RXY(!&[@@8XY.<\8J]IVOWDGQ3UC0WM;-E
MM=,BG$T<6V61SMR"Q/W>>!VH [BJEGJEAJ$]U#9WD,\MI)Y5PD;AC$_]UO0U
MP>G>,=9@\1Z/9ZKJF@W3:G,\$VGV)S-8OL9URP<[Q\NTG Y/%-^&7_(U_$#_
M +#3?UH ])HKE/$>N:JOB+3/#>AM;17MY%+<S75S&9%@A3 R$!&YBS #G K!
MU#QOKNBZ'XNM[T6,NL:%%%-%/'$RQ7$<GW24W$@C# C/I0!Z350ZI8#51I1O
M(?[0,/GBVWCS/+SC=MZXSQFL_P -2:Y<V37FM/: W.V6""W0@P(1G:S$G<W3
M)&!G-8SZ]./C(F@?9K3[.=%^U>?Y7[[=YI7;NS]WVQUH [2L;7/"VE>(9+>:
M^BF6YMMWDW%M.\,L8/4!T(.#Z=*\]'CGQ@/ 2^-&&E_8[><I+9"!]]P@G\LL
M'WX0^@P>F<\XKI;;6O$NF^-=)TK6Y-.GMM8@G>-;6%D:VDB"L5+%CO&&QG Y
M[#I0!TVC:)IWA_3UL=,MQ! &+D;BS.Q.2S,22Q/J36A7E4OC+QC)X7UGQ';G
M2H[72+RXB-N\#LUTD<A!.[?\GR\=#D@]!6S%XA\2V7B3P\NIMI[Z=KID5;>&
M)EDM&$9D4%RQ#\#!.!STH [RBO-M5\9:WHNIB>]U+04A_M!+;^QE8-=>0\@0
M2;@_WL$-MVX J*PU'6K/XG>,KJ\U&V;3=-M8)981;MN,.R5U"'?A6'\1P=WH
M* /3J*\STGQYJ;7.A7=_J>A7-MK,R0MI]F?W]D9%)CRV\[^<*WRC!/%:/A/7
M_$WB37-2:0Z?!I&F:I<V3@1,99PA(7!W87&5)/<YX&* .PT[5+#5[07>G7D-
MW;EBOFPN&7(ZC(J:YN8;.UENKF5(H(4,DDCG"HH&22>P KSGPGXJUG5OAG_:
MMI;:1:7AO7A9V7R;:",/AI&&X9P.<9&34,_B:YU?PGX\TJZU'3=4;3]+>2.^
MT\8259(I."H9@&4H>AZ$4 >EVEW;W]I%=VD\<]O,H>.6-LJZGH0>XJ:N6^&W
M_)-?#G_7A%_Z#74T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+">2[T6PTAY9BT=K:!<K&  /,9?E9^O3@ @5NT4 >;W=UJME\8M2GTS3?[1
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M>5!&Q^:1L9P!WX&?:K5 '!ZWX.E\7>/HY]>LTD\.Z=:%;6)I/]=<.1N<@'(
M  Y[U2\2_"_3[73X=1\':9#:Z]87$=S:D2$"3:WS(Q8XP03^E=_8ZE9ZDDS6
M5S',(96AEVGE)%ZJ1V(]*M4 >>6B:]HWBOQ"=*L+.\CU-H;I]]\B-83&,*1,
MO)*G;N!7K@_6L+P;H6H:EX.^'MU;J)HK#4+BXN)"P7Y"\H# 'KG(Z>M=;KVE
M> ]7U22?5KJP6]"^1,5U$P,RC^"0(Z[L>C9KI=)DTQM/CBTB6U>S@ B06KJR
M( !A1MX&!CB@#DO$.@74/C%M>M_#MKK]O=6:6TUM*T2O$Z,Q5U,G&"&((SG@
M=:K:EX7U&6U\.ZJWA[2;B[T]I_M.D0!$B:.;LA8;=Z[4.3@$ANG%>B44 ><Z
MEX<UC5O"LD,7A[3M*G?5+:>.TMF0,(8Y$8F1A\I;AC@=!@<FM^\T:]F^).EZ
MRD8-C;Z=/;R/N&0[.A QUZ*:Z>B@#S.]\$:K=6^OR?9+:68^($U6S@G=3'<H
MB(I1NNW<-XY'I5J71=4U3P]XD@B\)Z=HANM-DM;6)#$9Y9&5L[G3Y0F=N!GJ
M,G%>A5235]/DUB72$NXFU"*(3/;@_,J$X#$>F30!S.L^']1O-&\'V\,*M+IN
MH6<]T"X&Q(T(8CUP3VIOAO3-9T;QMXC\[30^F:G="[BOEG3"_NPNPI][.1UZ
M5VM% '-^*UU*0011>';37M,D5EN;25D60-QL9?,.PC[P(X/((-<SHG@[6+&Y
M\*2/:I#;V&H7UR]LLX<6<,J.(X@3][&X#C^5>E56EU"TAU"WL)+A%N[A'>*(
MGYG5<;B/ID?G0!P?BCPCK.K:CXMELT0)J.F6UO;EI0OF-&[,Z'N 0=N3Q\U%
MCI&MGQEH>LIX7MM+L+>&:TDM(IHO,B#[#YC;?E*_+@*,GC/? ]%HH \?C\!>
M(5^"VO>&S:)_:EW>M-#%YRX93,C9W9P.%->KZ?$]OIMK#(,/'"B,,]"  :LT
MCNJ(SNP55&2Q. !0!PEEX9U2'X>>*M(>!1>:A+J+6Z>8N&$Q?9SG SD=>E06
MFBZ_X7U>VU:PTH:FESI-M9WMK'<)')%+",!@6(5EP2#SVSS77?\ "3Z!_P!!
MS3/_  +C_P :U: /++_P7K\_@O4I?LT$FMWVM)J[V:S *H5TQ$'. 2%0<],Y
MKTK3Y[FYL(9KNS:SN'7+V[2*YC/IN7@_A5FJUEJ%IJ*S-9W"3""9X)"ASMD4
MX93[@T >7VFB>-++X?WGA)=$A=K]KF-+S[8@2WCFD?.]>I(#$C;GJ.A!K1N?
M"=SH6O37=IX9M/$5I<V5O!MF>))()(5* _O.-K+MSCD%>E>D44 9^AVT]IHE
MI#=6UG;7"Q@RPV2;848\D*/3)_'K7 Q>&-4T>?4-/M?"&DZFMQ>R7%KJ=T8B
MD22/N(E4_.2I+ ;<Y&.E>G44 <)KO@ZZ\9:W/#K :TT2QAV:<D$@#/<,,>>0
MIXV=%!]S5+6-*\7ZGX8\/R76GQ76LZ+J\5S*B3H@O(X]PWJ2<*6# X.,'/M7
M9W?B;1+'5X-)NM5M8M1N"!%;-(/,;/3CKSVK5H \WNM#U.U\0:CJX\&V>L#5
MXH9C%--#OLYUC",C,_#(<*<KGD'BM:T\/ZE%XPT#49+6SB@M=)FM[@6@"1),
M[1MA%/.WY6KI1J^GG63H_P!KB_M$0_:#;Y^?R\XW8],\4:9J^GZS#+-IUW%<
MQPRM!(T9R%=>JGW&10!P.L^"]9OF\57%M'$MQ-J=IJ&G>9(-LIA1,AL?=R58
M<U::P\2^(?&WA_5M1T1=-TZQBNHI8FNDEDS)&!N.WC&0 ,9/4G%>@T4 >9>'
MO#6JZ/#IVB-X0T>46<P1]9E\IED@5LA@@^?S"N!SP#SDBI(])\5:+'XDT33M
M(BNK75+JXN;74#=(BP></F5T/S$J<XQUXY%>CR2)#$\LC!412S,>@ ZFJVFZ
MG9:QI\5_IUS'<VDP)CEC.5;!(./Q!H S_!VG7.D>"]%TZ]0)=6ME%#*H8, R
MJ 1D<&N,;1O%=CI_BOP_9Z/%-!JUS=W%OJ+72*B+..59/O;AD@<8)QR!7IU%
M 'D\,6LZ)XY\,PVNGK=W=GX5$5S:B949@KQJP5C\N0V.I (!YJQ+X,U[5+#5
M]:F@@M-<N=6MM3M;-Y@ZH+<*J([KQE@&R1D#(KT-M(L6UQ-9,/\ IZ6YM5EW
MGB,L&*XSCJ <XS3;K6])L9S!>:I96\P )CFN$1L?0F@#EX+'7?$7C+2-8U72
M/[(M-'CF,<3W*323RRJ$_@) 55SU.23TK+_X0_6O^%%GPO\ 9D_M;R2GE>:N
M,^=O^]G'2N_LM5T[46=;'4+6Z9!EA!,KE?K@\5<H IZI;37FCWMK;R^3/-;O
M'')G[C%2 ?P)KS&T\-^(8K+PL(/"=I8_V'<Q-<(EQ%YEV1&R,ZL. /F+?,<G
M/MSZU10!PMAX:U2#P/XMTR2!1=ZC<:C);)Y@PRS;MF3G SD=>E97CBRN]$^'
M?AW4H"D>NZ&UJMLA.3+(RB)XACKN!/3^[7I]9%UX7T>]UZWUNZM#-?6X'DM)
M*[)&1T8)G:&YZXS[T -\)Z&OASPMIVE;MTD$0\U_[\I^9V_%BQ_&J*:->CXH
MS:X8Q]@;14M!)N&?-$S.1CKT(YKHI+F"*:*&2:-)9B1$C. SD#)VCO@<\5+0
M!Y['X5U=?A]XPTDVZ_;-2N[^6U3S%PZRL2F3G SGOTJ$^']:L/$GVQ= M-5\
M_2[:TAFN)D"V+QA@X(;DJ2P/R9)QBO2*9)+'"F^6143(&YC@<]* /*+?POXG
MTWP]X2":0MS=^'M0E,D"W,:?:(F# 2(2<#[WW3@U?F\/ZKINK:Q/!X/T[6!J
MLHNX9;F2+-K*R*KI)NY*!ER-F>IKTNB@#CK7P]J$'Q(LM7-O;I8PZ ;%S!A4
M6;S5;:J=0N <5GS^%-9F^(7BC5(@L%KJ.C"SM;GS!E9< 9P.1@\YKT&B@#R>
MT\.>(8H/"K0>$[2P71+B,SQ)<1>9<_NVC9U8<8&=V&.6S[<])X(\/:EHNO\
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MO;.9)[:= \<J'(93T(H R?!6F76C>"=&TV]01W5K:1Q2J&# ,!@C(X-;M%%
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M_/)!J.G37$P2.UN$92R-GHI*C![5:OKK7=0^(W@:35K&VL LEV5MH;GSV?\
MT=MTA8  *,J .>ISVH ET7Q;XBNK'7/$%_/:1Z/HD][&]LD'[VZ\K=M^;.$
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M\AC&2%P>H)-;%<T^O:O%K'ARSGTN&W&I"?[6AG\Q[<HFY<$8# ]">V1ZUTM
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M;- &M<ZGXKT'6[+2+W4;+46U>WN%LYUM/),%S''O4$;B&0\^_%9FK?$75AX
M\.ZMI4,+ZG>Q/<74;H2H2"-FN,#/!W*%'UK;@T[7_$/B[1]7UC3(=*M=(69H
MX1="=YYI%V9^4 !0,^Y)Z51\.>!KZQ\8:O+J"Q-HH2XCTY ^2%N9!)*".V"-
MOTH TM1\47<OBB'3],:%K)-&EU.X=DW;@?EA /;)#'W KG--\;:_<> /!NH6
MD5B+_6-0-I(IB*Q*"90" #QC8I..N#ZUH>!_!VLZ/H^M#6#$]_/;QV%L4?</
ML\,6R,D]B26)%5]#\$ZU8>#_  -IL\40N='U,W-V!("%3]]T/<_.M %MO%6M
M>&-5UVQUVZMM32RT<ZM!-#;^02 S*8R-S#J!@^]5;G7O&NCV/AR_OKO3KF+6
M+^T@GBCM3&;02L,A3N.\8R,G!!P>:TO$OA2;5O$6LWEQ+%;Z9=>''T]KAW \
MN0R,VXCT .<^U<OK%SXAN]'\$0:A;Z?#;Q:QIX6>UN_/^W%6&'0 #:FT%CDD
M]/K0![%7D6ISZ-!\7/$)UCPY<:TILK3RUATPWGE'#Y)&#MSQ]<>U>NUP%W9>
M*=(^(&KZUI.A6VIVM_;6\0\R_%N4,8;/!5L_>_2@"YHWV*\TK5&\)^'SX?U$
M1A4DO-(^RB1N2H(P"R\8/IFJ6D>-M3\4:GINEZ=:BTN[?+Z_YT9(M-I*^4O8
ML[ D'LHSS6I'J_C2>QOM_A6SM+I8";3_ (F:S*\I( #?(N ,DGZ8[UDZ;X(U
M+PKJ.F:KI,_VV]F)CU[S9-OVP,2QF&> R,3@?W3B@#(OOB1=I#JFMPZ_H<-M
M874D4>BRE?M%S%&^UFW;PRNV&*@+CIUS6_-K'B/Q%X@U>R\.7]E8VVE+$N^X
MMC,;F9T\S;]X;% *C(R<DU1MO#FNZ*][I=AX>T>]@GO9)[;4[IU(ACD<N5DC
MQN8KE@,'GCD5>N--\2>'?$^M7^@Z7:ZE:ZN(I-DER(#;3(FS)R#N0@*>.>#0
M!;TSQ#K,_C2QT?4K6&U,FB?;;B!"'*3B4(0&!Y7!-<=XZU[6M1\#^,?+O(K=
M--U=+,!8<L\),/&=PP<R9SW QWS70S:1XKTSQ#H^OI!;ZW>+I;:??J)EMOG+
MK)O3(QC((QUQ67>>"/$=_P""/&%A.MH-2U74EOH%27]V0#"VS)'_ $S*Y(&>
M#QF@#I+N_.G>(_"NEZQ90:GJ%T]P(M3$2Q"%EC9CM3+$$J O7\>U6=,\5O>:
MEK]A>645E-HP5G+7&Y9$92ROG:,*0#SSC!XXK.O[+7M6\0^$-7FT;[-_9\MQ
M)>1"Z1_+#QM&H4\;CR&/'YFI_$'A2YU'QCINJV<BQV\D+6>JH?\ EK ")$&.
M_P P*G_9<T 3S>,# MC;36]I:ZG=6OVMK>[O1$D*9  9]I)8DXP%/1N>.:<<
MVG_%'P1<0SV"+F9H)89V++%*A^\K+C>!G<", \=*7Q)IGB&Q\7VGB?P]:0:B
M?LAL;RPEG$)=-Y=71SP""3U[?ITVDMJ4EEYNJQQ0W,C;OL\3[UA7C"[L#<>,
MDXZDXX H R[K7%TS5[/PY9QPS7ILS,@NKGRMZJ0H"G:VYNYX]ZV=/N9;S3;6
MZFMVMI9H4D>!SDQ,0"5)]1G'X5S/B_0$\0W'V74- .HV @#07$$J1SVT^3DJ
M692 1MY!ZCH>VUX9LM1T[PSIMGJUU]JOX8%2>;).]@/4\GTR>O6@#!\9>*)=
M,UC2]%M]6T_2'O(Y9YK^^VE8HTV@*JLR@LQ8=3P >#699^+]>O\ PQ?WFFRV
M&J7FB7YCNOLB[DO[<*K$QX8[7*MTR1N4CO6OXKT*]GU[2]?T_3;74Y+2*6VG
MLKAU3S(WVD,K," RLHZ]03S56YTWQ3>>&&T^WLM/TBXU&Z*3-9L ;.U/4Y_C
MEQD9  &?;) &V'CB76)-4UZPVGPIIEFS^:8R'NY@N]@I/15'!XY;/I65HWCR
M^-_H,MYXAT+4$UB589=.LBOFV3.I9,$.2P! 5L@<FM.S\#S:-<:EH6FJ!X4U
M:R>-XC)\UG,4V$J#U5QR?]H9[T>&]+\06DNE6%WX<T:VCL5"7.HJZR&X"KA3
M&H 96)P26Z<]: (=.UKQEX@T]O$FC26#V!NGCM]*>'#SPI(4+&8L-KG#$#&.
MG6M[P_KEYJ6M^)[2X\ORM-O$A@VK@[3$K\^IRQKG=-TGQIX>TQ_#.CVMF+07
M3M:ZN\X/D0/(7(:$KEG&Y@.QXJVFF>)]&\4>(&TS3[6ZL]9DCFCNY+D)]E<1
MA&WIC+#Y<@#KTX[ '*3ZSXC\20_#>_75;>TFU"61V M-ZK*L<GS$;QD;3C;Q
MSSGM750^*[FV^(OB/3KQ8#8Z9I4=V9$BQ(QP"V3GIUP*R8?!_B+2O#7@8VUE
M!=W^@2NUQ:_:!'O5E9?E<C'&0:UH/"-_=?$#Q%JM]$D>G:KI,=G\L@9@VT!A
MCVYYH SI/$WBW3_"%IXWO;JP?3IO)GFTM+4@QV\C* 5EW9+@,"<C'6M(ZGXI
MUOQ?XCT;2[^RT^VTQH#'<26OG.QDB#;<;@,9R2?H *S'\.>+=1\'6?@>]T^T
MCLHA#;SZJMT")+>)E(VQXW!RJ@<\#GFNKT/1KRP\8^*-2G5!;:C);-;D-DD)
M$%;([<T 2>!]=N/$O@W3M6NXXX[F96658\[=Z.R$C/8E<_C4'B_7-0TZ;1]*
MTCR%U+5[HP1RSH72%%4N[[01N( X&1R:?X!T:\\/^"['3+]46YA:8N$;</FE
M=AS]&%1^,-$U"^GT;5](2*74=(NC.D$S[%F1D*.F[!VD@\'IQ0!GVNI>)(?$
MMWX4O-4M)+N6P%]8ZDMEC:!($='BWX)&1@@CK6%\";2_3P3'=27L#V4DLX6W
M6VVN'\SEC)N^;H>,>G/%=+HNE:Q?^-)O$^LV46G^78_8;6S6<3-@OO=V8# )
M(4 #/ H^&/AW4/"W@BWTK4T1+I)I78(X889R1S]#0!/\2'O8OAWKLMC=+;RQ
MV<K,YCWY7:=P'(P2.A[>E<7/#KL=]\-D2^M;C4)(KGRIWMRB1(;9>JAB6*C/
M<9..E>B^+-*FUSPCJ^E6S(L]W:20QESA=S*0,^V:YC3=%U^ZU#P7>:AIL5D=
M&6XAN$%RLN08 BL,#NV>.U $2^(]=T^T\;Z=J=Q:7UWHE@+NVN5M_+64/$[!
M73)'!3'7D&JA\9ZDWAOP:S:EI^BC6+5I)]0GM]T4;JJE8U4L%4MN/4]%.*U=
M4\+ZG=:AXZFB2,IK&DQVEIEP-TBQRJ0?09=>:CLM)\0Z-X,T#23HFGZQ!!9"
MWO[&655.\ ;65F!5@,,"".X(- '6:$^I2:1"VK26DMWE@9K3/ERKD[7 /3*X
M)&3@]ZTJYOP-HESH'AW[)=116[/<S3I:0N72U1W++$K8&0 ?3&<XKI* "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX@GL;1$WV+NA92N&)958!3N]16I9^.[RW^&&JZOJ8C.MZ5)-93QHN%:Y5]J
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M6PTRXOA)9JB/#)" Q0A"1M8$X)Y^4]:9H?CVY.JZ!]I\5:/JW]K2B&XT^T5
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M/4_'VI>']-U*#3[2WL8+G[0;82R*S%P5 ) YP.3G&WISD '<45YC;>-=?N=
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MGC==RDA20&!#*<<<5#\4;B?_ (1RPTR"9X%UC5+;3II8SAECD;YL'MD#'XT
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M%=6LHP\4JAE/?I0!YW:#6+_XNNVIQVL%P?#LJ"UMYC*L :9=NYRHRS'<>@X
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M999,1SPSNQ*[MIVM@H1QC(KTNB@#%\.QZL(;F;5K2QLGEES#:VAW^4@ &'?
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M/2N@M[*[\$?"YH[,V\FH6-FT[M<9*23<O(3MY.6+=/:@#K+=94MHDGD$DRH
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MQR)%D=_F 'W3N ZYZ\4 9OACQ;<R>+]-TH^*[?Q#%?6TS3>5;I&+>5 I&QE
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M7K1JV&B?RMD8?*Y9MQY!P!77_#_Q+)XBTN_$M]!J#V%Z]J+V!0JW" *RO@<
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MKEE#=>=R@$XY!.<5M-I/BK3-9O\ 5-*L])N'U>*%[J"XN75;:Y1 A96"'>F
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M-O$ZN\0 9Y2ZDD%CC (P!0!Z%17EEKXNU_Q/)X)2POETX:U973WK)"KE7BV
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MQ/ O"QE"NU3C +!CTX%5F\,^+=)EUBQ\.WNFQ:=JEU)=+<W!?S[-Y/\ 6;%
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M5D50-IRFTCYNN1TYXGN_ FI7%AX"@6XM WAV2![HEFQ($15.SY>>1WQ7H%%
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M_ "*@#H:*Y[^QO$/_0UR?^ $5']C>(?^AKD_\ (J .AHKGO[&\0_]#7)_P"
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.5/8_I0!=HHHH **** "BL#Q#XML_#U]IU@]G?7U_J!?[/:V4:L[!!EB=S*
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M@#7774[M+@>+OL\<XE):-#/$-HSVP3QTKU'4O"]KJ/B&PUP7=[:WMFAB!MI
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M"/'_ *LJ54*NWG&!CDYSFL?Q;X/=? VJ6EO)J.KWE]<VK3/</YDCJLT>0 H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ***CGN(+6$S7$T<,0ZO(P4#\30!)
M13(I8YXEEBD62-AE60Y!'L:?0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %<KXMT31+B:#7?$*2W=CIL3 61A,\1=R!YAC )9AT'7 )-=57->(+
MCQ1IVL6E]I%DNJ:886BN;!9$BD5\@K*K-@'C(*DCUH Q/A8MM)!K]YI2K!HE
MQJ!:QLPPS  BA\H#^[RV3L."/09KT"N/\&Z5JL6L^(->U:R33Y-6EA,=BLHD
M,2QIMW,R\%FSDX]!S784 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
4% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>employementagreement_mil017.jpg
<TEXT>
begin 644 employementagreement_mil017.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M\0RV=R@N$REK$AEE+$D! %')X^@[G'-6M#N-9N_M=SJMHEE$\@^R6I96EC0
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MA^[N-2L88O"UOIUU;:M]LEU6 QB-X@Y9L$-YA:13M*D8Y/. * .DLO%5O?\
MBRXT*"UN/]'MVE:YD0HC,KA"J9'S8)Y8<9&!GG&<GC#5+NQ?6--\./>:*K-M
ME6YQ<3(IP7CAVG<."0"P)'0<BM)]-N6\=KJ/E?Z'_9;6YDW#[YE#8QG/0=>E
M8&E_\)1X=\-Q^&K+07N+FU0V]GJ)GB%L8P<))("V\$#&5"G)'!YH W=>\66V
MB7NDV?D27%QJ-S%$$7Y?*1W"^8^1P 6 QU)^AQT%>>:]X+\03W@O;/65FFGU
M*UGE#6B9B2-AC!+?=3EMO<D]R:]"&0H!.3CDT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4KK2-,OKJ&ZN].M+BXA_U4LT"NZ=_E)&1^%7:* "BB
MB@ HHHH **** "F0PQ6T"001)%%&H5(T4*J@=  .@I]% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@A]JOM".MWUE=275YYIDU.:],@G(D(VB,GY<8ZX[>];FBS?\)'\2KKQ%8PW
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M^="PPN!C/'-4+32]0\,:%XZ\%LEW=VITZ>]TVX,6?,$D9#Q_* -P?HH]2<4
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M=%M\@4YF 8$#'78.M 'JE%>::CKROHW@BX\2Z$9;R\U2UCMREX?W<C ;9SM
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M1!XP.]>I44 <CHGBRU71O#L/V'4@;QEL@9+5H_*D6/)WA\''! (SDU)\2_\
MDF?B/_KQD_E71W%E;W4UM--&'>VD,L))/RL5*YQW.&8<^M5/$&CQ>(/#U_I$
MTKQ1WD+0M(@!*@]QF@#@;S4)?%0\(:/:Z9J$5U9W]M>WQFM72*W2%23^\(VM
MN. NTG-8EMX=T:Q@O="UG0?$%]J;7LRQPV\UTMO=122EE?<K")5"M\V<<@YY
MKV:VB6"UBA5MRQH$!]<#%2T <?X;LI[;X@^,97MY8[>7["(9&0A9 L)!VD]<
M'@UPUA;7=EX7\*VNLVNL1:+]HU W\-I%,',AF8PAQ&-^PY8\<$[<U[310!X1
MJ>F7?_"MO'ND6FAZG!-<7\-W:6K0R2,\+&#;ACG<WRMN7)*X.>E=?J[RZ1XZ
M\(:K<65Z]FFG36LDEO;/+Y<C!,!@H)&<?YQ7I'2@$$9!R* /'Y?#6IZMK'Q8
MM8[2:,ZC#;+9R2(529EC?A6/!YP#CIFM#PY9Z!<ZWIT^G^'O$)U"UC>:1K^>
MZ6.TDV%=A\YMK,=Q7Y<\<]*]0HH \HT!;>+Q1I)\+V&NZ699F.KZ9<0RK:0H
M48D_.-@??MV[#@\\8KT31-;AUVVN)H;>X@^SW,ELR7"!6+(<$@ G@]1[5IU!
M:65O8Q/';1A%>1Y6Y)R[L68DGU)- '$7%T?"7Q%U?5;^TO9--U>TMQ'<VUL\
MXCEBW*48("1D,"#C'6N9FT759M"@OWTR[C?4O&<.I"V:(^9#!N"AI%'W>%R<
M],\U[(2!U-% !7F.F:S=^"1X@TF71-2O+^;4KB[TY8+9WCNEE.Y09 "J8)(;
M=C &>:]-!!&0<BEH \[M[^;PCXVUZ^UC3[W[-K,5K/#+9VTERJRI'L>(E%)!
MR 02 "#6/;Z9;6_A=)/%7A_43!J>JW>I;[9)&FTUG;,>1'\ZDCJ1T/!KURB@
M#QR^36#X0TB\N(=7O;+3O%$-S ]S S79LDSAW7&X\D]1G&*N^++C3+^\N=0@
MTSQ%IVO&V1M-OM/MY@;L%-R*X5=O#':5D ( ]*]6HH K:<;HZ9:&^"B\,*>>
M%Z"3:-V/QS7E6D^&=3U+P5\2-+^RS07%_K-Z]J)D*"4':5()ZJ2,9Z5Z]10!
MYCJ6J2^,X/#FD6>E:G!=0ZA;75_]ILY(DM5B.Y@78!221@;2<UM>!;.YM=9\
M9/<6TL*SZR\D32(5$B>6GS+GJ.O(KM** .,^(MM=&RT35+6UFNUTG5H;R>&!
M"\C1 ,K%5')(W9Q[5@W+S^,?'IEL["_@TV70+NS2\N;5X0TCLG9@"  1C(&<
M-CI7J-% 'CUW<WFL_#"S\")H^I1:X8;>PG1[1UBA6-E#2F7&PKM4D$$YR*US
MIU[_ ,+C\1WGV.X^RRZ (HYO*;8[Y'RAL8)]J]*HH \KN=,OV^!&B6(L;DWD
M:V&^W$3>8NV:,ME<9& "3Z8K0T^^N?"?BKQ1;3Z1J5T=2NUO+"2VMFDCF+1J
MI0N!M0AEYW$#!S7HE<QJWA&YOM4N;ZP\2:II9NXUCN8H"CHX48!4.I\ML=UQ
M^= %#X1!A\+M%W !MLN<=/\ 7/7.>(Q$-;O;C1--UW2_%OVI5C%M%*;:^4,
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M=G'XSO\ 76:UT+0]0206<TDT]];O;BWF"_NXP'7#L6ZXX &<FNUHH \/M88
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M;6#/:.-;UJX.IS6TA*-N$JND.>JG8BK[$U-H>F:%<:D\^D^%-:M9H+*8FZU
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MX)E0D!@ >I"Y('?&* ,6?6]5;1-<3Q%X;2&*#3Y)_P!Q=^;#<)M;=&7VJ5;
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MV&W^U[?M/EKYNWIOQSCVSFO(+7P]K#_#WXDV7]FW2W-YJUW+:Q/$5:="5(*
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M'D$5D^(/#\6OP6X-[>65Q:R^=!<VD@5T;!'<$$$$@@@BI/#G_(L:3_UY0_\
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M@1J0K$OQGG  QZUEGQ[+?:1X>?1M-6;4]=5V@M[B;8D(09D9W )PIP.!SD4
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M[<')P.<5RG@OQ/<Z9\/_  Y9Z98+=:IJ][>);0SR>4B*LTKN[D D!1V )YH
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M8Z@'&>E6-0\/ZSXIA\6ZY;:9<6LMU)8MIUK>+Y4DPMCN.Y3]W<20,_C7KE%
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M2Z* /(_&6C79^(2Z'9@?V?XN6)[X*V#&+9@9&QVWQ[5]S7K:JJ*%4 *!@ =
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M^&WA#3TLY6N[.;3&N(@.8Q&4WY^F#FNO\2V<VH^%=7L;90T]S930QJ3C+,A
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M82%&0&V[@#@T :NF:[XE_P"%FZ_;Z@U@NF6%I \R+/(1'&1(P= 5P7/\6<<
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M)9B0![&K-_\ $:[M/#VGWB:0LFHRZQ_8]S9B;[LPWCY&QR"57!/9JY[_ (1
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MVU>SO-6O],AD+75@(S.N.%\P$KSWX%70RMG!!P<'!Z4 +1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(% '=:$-0'A[3AJJ[=2%K&+H;@W[W:-W(X/.>E<G\'BG_"NK6,_\?<=S<K>
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMS=2KJ;:59Q(Z@W<RC+%2>%1<'+'C@UK^'_$3:S-?6=U82Z?J5@ZK<6LCJ^
MXRC*R\,I /X@B@#<HHKB;GXA-&]Y=6V@7UWHEE<&VN=1B=.&5MK%(\[G52<$
MCT.,XH [:BN3OO&-S_;-YIFAZ#<:O)8*C7<B3I$D98;E12Q^9L<X' R.:--\
M?Z=JE_H,,%O.L&M0326\TF!MDB^_$P[,.?R- '645R^J>.-/TG6=2L;B&4Q:
M9IXOKNX3!";FPD8'4NV,@4FG>+[F74DT_5]"N=*N+BW>YM!+,D@F5,;E)4_*
MX# [3^?% '4T5Y_;_$\SZ/I^NGPY?1Z%=/'&]\TL?[IG8)G9G<5#'!;CVR.N
MMKOBZ]TN]O(;+PY>ZA#80B>[N$D2)54@G";C^\8 $D#V&<T =517(WGCN)-2
MTZPTS2[G4I]2T_[?:"-E0,N1]XMPHP<Y/ICDD5@^)/B+J47P_P!8U/3M+FL]
M4T^Z%E=1RR1M]E<E</W#@[UQ@=_04 >F45R-SXOU..Z@TZW\+W,^JFV-W<6@
MNXE$$>\HOSDX8L5. /QQ72:;?#4M,MKT6\]N)XP_DW$921,_PLIZ$4 6J*IZ
MMJ,>D:3=:A+#-,EO&9#% A>1\=E'<FL'3O&%S+J,VG:MH5QI=XMFU["CSI*)
M8U(#<KT8$C(/K0!U5%<#;_$QI]-TS6&\.WL6AWSQ1&^>5/W;R$*,IG<5#'&[
M\0",9TKOQG.NNW^G:9H5WJ4>FA/MT\4J*(RR[MJ*QR[;>2!].M '645QOPIN
M'NOAGH\\DKRLXE.]R23^]?'6NRH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "N$\(9M/'OCJQ<#SVNH+N//\:/$ "/8%2*[
MNL2^\.I<>)K#7[:X:VO;9&@FPNY;B \^6P]FPP/8YZYH \ADF%WHVD:A>CQ!
M>:]::G;W.L><;CRK-5G&X"/_ %9 XP%!.,GM7>ZNXU#XP^%8[?YC9:==W<W'
M1)-L:Y^I!_*N\K%T?PZFF:KJFJSW#7>H:A("\S+M"1KPD2CG"@9^I))H VJ*
M** "BBB@".<9MY /[I_E7BG@:_\  NG^"]+M-=\.A]3BB(N&ET"25BVX]6\L
MYXQWKV^B@#SOQ%?6WB;PM8>&O#M@PAUC,(:2S:*.RMT/SR%& VD8P@XR<$=*
MQ9M)U%/A[KW@/[',][IFR>TEA4K]N@$HE#*P_P"6O!5N^[![UZ]10!Y38Z7H
M'B*YGBT>3Q'>78TZY1;G49[@Q6K2)LV'S3]XYZ+G[M:7A3QB8='\.^'(='OW
MUB%(;.]MY('B6T5%VO*SE=I7Y<@ _-D5Z)10!XR=4_L[P#XP\+/8WSZR\NH>
M7;I:R$/'(782!L;=NUL]><8')&=4W T7QWX1O[Z&X2UDT'[&)5@=P)BR$*=H
M.#]:]1HH \S\%:0;S6_B-9ZA;2+:WVH-'\Z$"1&5@<$]>M4? =GJNJ>(]-MM
M8MIDC\(VDEHLDB%5GG9VC5U)^\!"@Y]6KUJB@#Q&UT;1[.SO?#VN)XGFU)KV
M:-=/M)[@0W44DI974 B,*5;)R1@@YKVU%"(JC. ,#-+10!Q/Q!NI;>;0TN;F
M_M=#EN7&HSV/F"0 1DQJ6C^95+<$CVK@SITT]CXMM],TW4]XO+'5+.WNA*\M
MS!%Y>3NDR23M)"D[AP,#H/<J* .%NO&,7B6QU.QT;3[R>U_LR=Y[N2%X1%)M
MPL05E!9CDYQTQWKDO!^EW_@*PT'Q$5O+VQU.RM[;58Y8]TUF<?NW4 9$:YVE
M>W!Y->ST4 <1X5@ECU+QPSQ.JRZFS1DJ1O'D1C(]17(^&EF\-6W@?7]0M;E;
M!-'EL+IU@=S;.S*ZLZ@%@#M(SCCC->RT4 >5/H\GC7_A.]1MX)X[+4;."VT]
MY8FC::2%682!6 .-Y4 ]\&L^V&HZKX3U#QQ/8W*:BNJ6EY%;F(AS%;A(V 7K
MR&G_ #KV6B@#Q'Q-I%^WP%FF>SG;4M5OEU*>)8R7#2S;L$=>%VC\*V_$=C8Z
M=\0-0U#7+G6[2PO[.#[/<:;+.BF2/<&C?RN=V"I&?4XKU.B@#R:&*T\)ZKX3
MUU=.U2UT0VMW!,+E'FFMGE<2*T@&YAN.?IGG%9VJ07_B:/XB7>GZ9=E9_P"S
M)[1)(61KE(3N.%(SR$.!UY''->U54U2P75-+N;%I[BW$\93SK:0QR)GNK#H1
M0!YUJWB6U\1>-_ [:?;7?V=+V8R37%L\.US _P @W@$G&<XR!QSS6!9:+H]I
MI]SX=UM/$\^IF\EB_L^UGN!#<QO*6610"(PFU@221R#GFO0].\'7<>MV.J:U
MX@N=7ET]'6S1X$B6,LNUG;:/F;;QD^IXKK* /)?%DUC:ZOJ=SHW]N:5XM1U6
M"&WBD>'4B  C,H!C92."201@YZ5ZPA8QJ7 #X&X#H#3J* .+^(5U-;KHJS7-
M_:Z-+>%=2GL=XD5/+8H"4^95+X!(_/FO.[^W7^Q?'5G96&J)'>?8+FR6[6:2
M2:)9$4ON?+=>=I.0".!CCWBB@#CO$\$TOC_P3(D4C1QS7GF.JDA,VY R>W->
M?MJ3:=\&-0\%OI]^^OVL,]L]LMI(05\QF\T/C:5VG(.>3P.HKW&B@"MIX(TV
MU!!!$*9!^@KF?B)<W=KHEB8I[RWLGU")-1GL@WFQVQ#;B"HW ;M@)'(!-=?1
M0!X3J&EB_'C"QT6RU5H]1TNVET]KPSR-=^3([/AI,L,] IQG(('-='KOBBV\
M1Z_X(-C:7BQ)JRM-)<6SP^6YB?$?S@;C][.,@8'/(KTK4+-=0T^XLWEFA6>-
MHS)!(4D3(QE6'0CL:YK3_!=VFK:=?:UXBNM6&F;C9Q20I&%8KMWN5&7;:2,G
MU)H J>#K.8>(_'7F121+<:BNQV4C</)49![UQ?AO2-&CTS2?#^J1^)YM9@GC
MAGTY;BX\A"CY$N"1'Y0P'&#Z8YKVVB@#Q1M+TG3I=>TK7!XFDO;C4+AX+&QG
MN!%>Q3.67:%/E\AB&R1C!S6EXK&DZ??WIL?[>T;Q);6Z1V4EG'(ZZCMC'EA@
MH9) #\AW8(QUQBO6:* *]BUP^GVSWB*ETT2F95Z*^!N _'-<?\5HI7\'1S10
M2S+;:A:SRB)"[!%E!8X')P*[BB@#AM,N$U/XK-JMJDK6,WAZ,1S/"R G[0_'
MS $'V-<S,VH:?HVO,&U"SLI_&$GVZ>U1Q*MH57+J5&X D*-R]B:]?HH \7BM
MH6NO&MMI5GJI@U3P\5T][OSY6NBJS!L&3+#EAA3C/! YKT+P!J=MJ7@G2A;^
M:&M;6*VF66%XRLBQKN&& SCU&1[UTU% %74XGGTF\BC7<[P.J@=R5(%>1:-<
M?;O!'@"QA@NOM.F:S:QWD;VTB&$A)<YR!Q[CCFO9Z* /-O%VC7FL^-M6M+:)
M\W7A*XMHY",*9&EX7=TS5#PO;:!?ZEH4*)XHN=2MB)IH+R>X,5A(B$$N)#MZ
MDJ,9SGTKUBB@ KB;RWF;XT:7<"%S"NBSJ9-IVAC*O&>F<5VU% 'D>JV6G:1X
MR\1RZ[/XAMTOI([FR.FS7"I<CRE1DQ%QO#+CGL1VJSJMEX8TVUT:UO;;7M E
MMM/3[#J%KYAEC!))@9H]V64X.U@0<\=Z]3HH \CEU'4;/5?AWKWB2&Z4QVUY
M'=S"U=F5G51'O1 2K, .,=<^E=-X&MYH?$?C5Y87C$NK;D9E(#KY:\CU%=M1
M0!X=I.CZF_@+Q))#87$D]IXM;4%MO+(>>.-XF.T'KD X]<5WP\6)XJ74-.T7
M3[N>U_L^4R7DL3PJLI&%B"NH+,<DG'3'O79T4 >$:G,=4^!V@:?:6UV]YI]W
M9PW,)MI%:-ESG@CG'J,BNP^(DE_X:URP\7:59S74S6D^FSQ0QEV;<I>$D#L)
M%P3Z-7H]% 'D^L>$/[!\*^#EG-^;?2IV;4I;!W$RF6-@\H*?-@2-SCG:3VKH
M_ MKHQO-5U#2%UB5)/*A:^U*65Q<!02-GF'=A2Q&< 9/&:[6B@ KRWP_XC?P
M5HMWX<GTJ_NM;@OY_LEK' ^+Q))2ZNL@4J%PW))XP<UZE10!YQ8:O#X*\4^)
MTUN&ZBCU&Y2^M)HK:299LQJK1@JI^967&#CJ#64/#VJ6/PHL-3^QRQZQIFH-
MK45KM^=5,K.T1'7)C8Y'KQ7KE% 'DO\ 8&H>(/AMXJU46LW]J:]<&[C@(*2^
M3$Z^3'Z@[$X]WJYH,'AW4==@N-,/B6^N;6UFD,VH37#1VK,NTHPE/WR">%S]
MVO3J* /(YK*Z_P"&=M-M!:S?:!':9A\L[QBX0GCKTYI_B5CJ'B+Q+8:J=<FN
MRBQZ+86DD\<,J&(?-F/"GYRVXN> *]9HH \L\$[[CQ)X3G6"=8X/"?V:5I(6
M39*LD2LAR!SE3^59OB?3KZ?PG\3(X;.>1Y-3AEC58R2ZJ("Q4=P IZ>E>RT4
M >9^)-5\*ZU=6>HW$FMZ;(;8FRUFQAGC9OG(:+ 4G((!VNN#GBNQ\(3ZI=>$
M=,FUI7747@!FWIL8GL67LQ&"1V)-;=% '-^/;C4K7P3J4VDF=;M53YK==TB1
MEU$C(/[P3<1]*X&S_LV+QM;7FE)K,^G7.DW=JE[>M<RB:<F-MH\S)48'7 !.
M1VKV*B@#RBZLKH_ 30K86TWVA1I^Z(1G<,31DY'7BK^G:Q'X/\6^*K34K6]:
M34+Q;VP\FV>070:-5V*5! (9<<XZYZ5Z110!QOPI@GM?AGH\-U"\,Z+*'C=<
M%3YK]J[*BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "L?Q+XAA\-:6MW)!+<S33);6UM%@-/,YPJ
M G@?4] #6Q7'_$.RNYM/T?4;2UENCI.JP7TL$*[I'B7<K;5[L V<>U #K7Q?
MJ7]J2:/J7AXV>JO:O=642WBR1W(7 91)@;6!(R".AS7 R>*M9UGX6Z3K.K6L
M@_XG5LZ312*S3J+ELJ$4#&T * >M=;!=_P#"7?$71]4TZVO%TW2+2Y\RYN+:
M2 222[5$:AP"2 I).,#BN0T5+I_ACH>@G3M034=+UNW-U$]I(NT&[9L@D88;
M>203CO0!Z%I_C&Z/B$Z/KFBMI,CVCWD$INEF5XT(#AMH&UAD''(]ZKZ=X\N+
MJ72[FZT&>ST?5I1%8WKSJS,6!,>^,#*!P..3U&<9J#Q3I-UJGCS38XHI!#+H
M]_;M.$.Q&?8!D] >OY5S'A;2-#(\/Z=<Z+XC?6[22+[3#-/=""UDB&?-RS>4
M4W*"H7.<C H [+2/&UWKGB*]TRQT&9H-/OI+2\O&N%5(]OW6 (RQ//RCIQSS
M785Q?P^M+BUN?%YN+>6'SO$-S+&9$*[T*IAAGJ.#S7:4 >=I\3;R;1+G7+?P
MM<RZ592R1WDWVI R!'(9D0C+@  GIW'.#6S?^,9FU>+2O#^E'5[IK5;R5C<"
M"**)CA,L0<LV#@8Z<UY]HVO[/A3JV@QZ9J$VHWLE_;V20VKNDYDED7.\#:N"
M3G<00%SW%;^G(_@#Q3)/JD%W)87NDV=N+JVMGG5)H%*%&" D9!!!Q@T ;*?$
M%;C2;62TTB>35I[]]-.G23*ACN$5F<-)R,!5)R,YR..:S/%OC3Q'8^%XKBWT
M*:POSJ4-I,))D(&70C8Q&'5P2N[ QSW%9D%C;?V!J-]XET#46T_6-<EOD\J)
M_/L4V!8I65/G4G9VY&X9JEJ4>JW'@*\=%UC4=,L];MI[&2\A<W3VRE"Y*D!V
M ;=@D9P* /8+*6XGLH9;JV^S7#*#)") ^P^FX<&N'TOQ;K4GQ$\2Z??6*QZ1
MIL<):0W"XMT*2/YF ,MO 7C/RXK6N?#]AXLDM]:35->M4DC79%!=S6JD GDQ
M\$$^XKF;BVE/C_QQI4UO=1GQ!I\$-C.+=VB8K!(C9< A<$]R* -S3?'5S=7&
MER7V@36.EZNX2QNWN%=F8J602(!E-R@XY/8'%)I'CNZUO5+^WL_#\QL].NKB
MUO+QKA56-H]V-JXRQ; R!]T,.37*^%=+T*6;P_9R:-XC;6;1HVN8[F:Z$%G)
M&OWR7;RV7</E"YR#TKHO UE<VVC^+EGMIHFFUR_DC#QE2ZL?E89Z@]CWH J)
M\4YO[$TW7YO#-TFAWKI$;E;A6D1VX&(L99=WRYR,]AC&=[2/%E[=>*&T'5M#
M?3+I[4WEN?M*S+)&&"D':/E8$CCGZUQ_]F7_ /PI7PM9_8KG[3%<V)DA\IMZ
M 3*22N,C Y-=3>6MPWQ=TJZ6"4VZ:/<(TP0[ QDC(!/3/!XH P?#WC71]'^'
ML>KZ=HES!9/JGV0VPN&E?<S[2X+9)]=M=)IGBZ]E\2C1-8T*33)Y;5KJV87*
MSB5%(# [1\K#<..?K7G/A[2-2B^%FF6TFG7:3KXGAE:)H&#!!.I+$8SMQSGI
M7;^);?4C\0=+N]/MY'DBTB^6.382BRGR]@)Z#)'>@">Q\;W\NH::FI>&[G3K
M#5)3#9W$TZF3?M9E$D6,IN"G')]\5BZ)XKUC5K/QL==TC.G6,ES&R+=+E D2
MY@&T G/S'?[US5LEN1X3U2/3_$-S?V=[#)K-W=I<N8W*,K*$;@_.>J+@ #GF
MMNP,UM!\2-$ELKU;V\GO;NV'V5RDL;P@*5<#:23QC.: -G2_%]EI_@GPT=&T
M>:2;55\O3]-%QD@ %FW2-_"H!))SVJT/'DEK;:ZFJZ.]EJ>D61OFM1<"19X<
M,0R2 #NI!R!@UR>DV-]HWAOX<ZY/I]XT6DQ317T$<#-+"LJ;=^P#<0I S@9P
M:FUJ.Y\47/B[7["QO!8CPW)IEL9;=XWNI"7<E$8!B!D#IR3Q0!T=OX]NVN]&
M>\\/3VNE:Q*L-I>-<*S;V4LFZ,#*AL'!SGU Z5VU<!K]E=2Z%X#2.VF=X-5L
M7F58R3&HC8$MZ =R:[^@#DKWQ?J#ZUJ&FZ!X??53INT7<INE@579=P1,@[FQ
MC/0#/6N;UWQ9'J>H?#_7M+MKFY2YN+D1VH(5V<PLFQLG PW!/08)JY8ZF/!/
MB3Q/%JEEJ#PZC>"_LIK6SDG$^Z-5,8* X8%<8..N:P+/3-5\.V7@&YNM*NY9
M;>\O;N\A@B,C6ZRJ[<@=P'Z=21@9- '477BJXU/1?%6CZEI;Z7JMEIDDWE"<
M3+)$T;[71P!GD$'C@US6GZGIME\)O 4FKZ?+?^??6\4.VX:,QRDOMD)'W@,'
M@\'-:$QF\2ZUXLUZQL[P6 \/MIMNTUN\;7,G[QSL5@&(&0.G7I6'>:3J3?"G
MX=VHT^[-Q;ZO://$(6WQ*#)DL,9 &1R: /0K_P 7WB>(KS2-'T&;5&T^..2^
MD6X2+R]XRJ*&^^Y49QP.G-5['QY+K'ABQU;2-!NKR:^NI+>&WW[ H1F!>1R,
M(N$[C.2!S5"&^E\*>/O$SWFF:E/#JQM[BRDM+1YA(RQ!&C)484Y7^+ P<Y%<
MAHDMP/!GAH:DNHQ:*^HZA_::Z=YI8/YK^6K&+Y]F[=T[@4 =+XJ\?ZM!\/\
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M$Q)C$* R(!RVPC/R\C'M6G\/VF%_JT5E<ZM<^'46'[%)JB2!UD^;S%0R .4
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M[=Y$\T3$E6*@A>"#DX&*Z_1M;@UM;XPP7$)L[R2SD6= I9DQEAR?E.00>XH
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M)Y%:>@Z)9^'=$M=)L0_V>W4A3(VYF))+,Q[DDDGZU4U3Q7IVD1W4DZ74D5F
MUY)!"9%M@0#\^/8@D#) ()&"*KZG8W6L:IH&JZ5JMY';1-YKK!,OV:>%@#\Z
M]6)'"XZ9S0!TE%8USXFL;:>:/R[F5+>=+>::*+<D<K;<*>_\:Y(&!GDBMDD
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MY/\ D=.E<9!X^U$MH=Y>>'3;:/K,T4$%S]K#2J\@RA:/;PI/0YSC!('2N[H
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M)+=&0@RJZ_*5'<'M0!R_Q&O[[Q)?>!DATZUN-(U*=+B*"XNF07#% P250A
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M$F]5EC.#M; R#P>G>MZN3\"V-W8CQ)]KMY8?/UZZGB\Q2-\;%<,/4''6NLH
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MT,VARR(WJI+$'\C4VC^,].TS3/&^J#18;4:9JLL,BVQ^:\EW!0QXX9F('XT
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M0,%C$I7;MVEL<9S@CZ#L] \3G4[W7[&_@CM+K1[HQR /D-"5W1R\] RY^F*
M.CHK"\'Z]<>)O#<&L3V@M4NF=H(]Q),08A&/N0,_B*W: "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>BD555Q[=?RKNJ* /(_"OAK3[2;1+*;X>RQZO9L@N]0E^6!#&/\ 7(^3O)8
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MCBN7B*_,L0G#%_ICFNR\1:'=:KX[TV189/L1TF]MI9P.(VDV  ^_!_*NTHH
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M'39+LOIUE>2;Y8(=B@@\M@%PQ"YX!H SM2U/Q*/C'8Z7:26?]G_V:\_E22R
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MSS(DF=K$#.#BN:?Q?XAM/#L&IWMEIB3:M/!!I5N)'&PR G,['CA1N(7T(]Z
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MQ\[<%CO^48QTS4\GBO7]/CTB#5=+MX+RZUI=-E9&)BEC*,PEBYR,[0,-TYH
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M<+<$JP4\H PVCL11I-SXEAUKQP= @TW;#JC2N]\7(D/DQ_(H4C!XY)/<<'G
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M2Y19%< \G 8*5Y]>:U;+PW;:O!JMK:>!;7PY%<:;-:_:I8H4F,LB[<*(R?D
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MI+&2#M8=LCBNCHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ@CG!7&>,FN8/Q&U+[$?$0N-%_L07?E?8-Q^V&#S/+\W=NQN_BV;?N]\U/\
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MH(4GF;.6WE#M"],#/8D]JZ'Q%HU_?7_A*6V@WII]^)KD[P-B>2ZYY//)'3-
M&1\-;KQ#>:GXH?5;RSFMX=6G@98XG#"55C'R$N0(\#[N,YYS70^*=0UFR:S3
M3)=,LX)"YN+_ %)LQQ8 VJ$#*69CGG.!BLOP;I^L:)XA\2V=YI3BROM3FU""
M_69"C!P@";<[@W![8XIGBS2;V7QCIFK?\(^-?L8;.6 6IDC'D3,RD28D(&"
M5R,D4 <SX@\6:_K/A#1[FSN-/@G'B"/3[IX0[QRNDP",A# ^6=N2#DD'&?7U
MBU^U+91?;&BDN@@\TPJ51FQSM!)(&?4FO)W\*>)HO"T]H-%C:ZL_$::M%%;S
M1K'<1E]Y6/)&W;TPP'M7I[&\U'09/W3V%Y/;L CL&:%RIQDJ2,@^AH XRW\8
M:_9ZYI,.LR:'LU&[-J^G6LA:YLV*L4+-O(?[N&PHY(Q6+HO_ ",'Q>_W$_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH @O+2&_L;BSN%+07$;12*#C*L,$9^AI+"R@TW3K:QM5*V
M]M$L,2DYPJ@ #)Z\"K%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %<SJO@'P]K.H3WMU:SB6Y 6Z6"ZEB2X &!YBHP#<<<BNFHH 9##%
M;01P01K'%&H1$08"J!@ #L*?110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 C*&4JP!4C!!Z&N8L/A[X:TV_@N[>
MSES;2&6VADNI7A@<_P 21LQ53R>@X[8KJ** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMX94F!.YRZ@D'MQFE_X2Y='\+P:IXCDL4GDG6';I\_FHQ:0(-I;&<9!;TP:
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M,NYU]0,Y(]Z +=%8]KXHTJ\\1WFA0W"F]M$C>0;EP2^[Y5YR6&PY&.,BMB@
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M:SL-4U+48%<7&HO&]P2V02B!%P.W H YSX3NS_#'10[,VQ)(P6.?E65U _
M"NSK/T31K/P]H\&EV"NMK!NV!VW'YF+'GZDUH4 %%%% !1110 4444 %%%%
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MQ=\1?VI;Q7!L]/M$LDG0,%C?>9"H/JP )_"N(UJUME^$/CVV2",VNG:U/%8
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M;TOP_H8T;3;<Q67SY4N68EB2Q+$Y)YJ+0]7:3PO%J>KZGH\N YFN["7_ $7
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MS?,SNWY[Y]NG%=%7.>,O%$GAC3;9K2R^WZE>W*6MG:;]GF.W7)P<  $YQZ4
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MCM8]>E50N J?NX\@>@!R,5Z!7)ZCX!TA_"6JZ#IEI%:Q:B5:0%WVAQM ?KU
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MNO> PL,8!UV($!1R*@6TUJZ^('C**P@T.2/;;0NFI"3(@,((5=O&PL7S[YH
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M9D2"=7*CIG /3WJKH&M"3PN-3U36=)ND0N9+VS?;;A02.I)QCH>>M<YH9O\
M1O$6D:/KVFZ7+,;.6+3=5L,J61%4LCH?NY&#P2,BN!\+JLGPE\%P7 !L9?$R
M)=*WW67S)"H;_9WA>OM0![7I7B70]=BFDTK5K.\2'_6F"8-L]SCI4,?C'PU+
M?VUC'KVG/=7*JT,2W*EI W*XYYSV]:YGQ'''#\4M&:T55FET>^6\V#!,0V>7
MN]MV<5RYL+6V_9WT::&"-)5>RG$@7YA(;A,MGUP2/IQ0![313!-$TK1+(AD4
M L@89 /3(I] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.2^'DT%M*B_LU)!*L*LRD.#G?N!W;L]\YK?HH AL[2&PLX;2W4K#"@1%+%B
M!@<DDGZFJ6G>']*TF^U"]L;*."XU&027;J23*PSR<G_:/3UK3HH Q].\+:)I
M.ASZ+8:?'!IUP'$L"LV&WC#<DYY''6H;KP9X?O=!M-#GTY6TZS97MXA(ZF)E
MS@JP.X'D]^];U% &?I^B:=I=S/<V=L(YIXXHI7WLQ=8UVH#DGH"?ZU4E\(:#
M-HG]C2:;&U@)6G6+<V5D+%BZMG<IR2<@CK6W10!CZ5X6T31;6ZMK&P18[O\
MX^3*S2M-QC#LY+,,$C!/>J-C\/?"VFR0/:Z4JO!*LT)>:1S$RG(V[F.T9_A'
M'MQ7344 8\7A?1H/$4NOQ67EZG,,23+(X#\;<E<[2<<9QFEUOPQH_B(P-J=H
M99(,^5*DKQ.F>H#(0<' R,XXK7HH YZY\#>&[K3[&QDTQ%M[$L;812/&T>[[
MV&5@QW=\GGOFFR^ _#$UG?6;:3$+6^$0N($=U1_+QL^4$ 8VCIC.!G-='10!
MBZUX3T3Q ;9M2LO-DM<B&1)7B= >H#(0<'TSBK.CZ!I>@131:591VD<SB21(
M\X+!0N<=N% X]*T:* .'O_!L>M?$6]O]3L3)IS:9#%#.LQC995DD+!2C!U^5
MASP#FMZ/PEH,6D6>E1Z;&MC9SK<01!F&V13N#YSDG//).>];5% &;K6@:7XA
MM4M]4M%G2-Q)&=S(\;#^)64AE/N#1HV@:7X>M7M]+M%MTD<R2'<SM(Q_B9F)
M9C[DFM*B@#+TCPYI&A37LVEV,=M)?2F:Y9"?WCY)SR>.IX''-0_\(CH/V?5+
M<Z;$T.JRF:]1BQ$SGG=R>#GGC&*VJ* ,"Q\%^'].L[ZUM[#]W?Q&&Y,LTDCR
M1X(VEV8MC!/ />I;GPEH5WH5KHLVGHUA:;?L\8=@8BO *N#N!'J#FMJB@##M
MO!V@6FCWFDPZ<HL[W/VI6D=GFR,?,Y)8\>IJ]=:/87GV'[1;!_L$HFMLL1Y;
MA2H/7G@D<U>HH AN[2WOK26TNX4GMYD*212+E74]016/HW@SP_H%Y]KTZP\N
MXV>4LDDTDK(G]U2[':/88%;U% %+3-)L=&@E@T^W$$<LSSNH).7<Y8\GN:YW
MQGX=D\0:QX9#62W5A;W<KW@9@ J&%U!Y.?O$=.1UKKZ* ,?1_"NBZ"ETNGV(
M3[7C[0\LC2O+@8 9G)) !/&<<U5TSP+X:T?4([ZQTQ8YX<^26E=UASU\M68J
MG_ 0*Z*B@"E8Z38Z;/>36=N(I+V;S[A@2?,DP!GD\< =*R5\!^&5CU.)=+41
M:F2;N,32;)"6W'"[L+SS\N*Z.B@#&U+PIHFK6%G97EB'AL@!;%9'1X<#'RNI
M##@ =>:;'X0T"'09-$CTV-=/ED$LD6YLR.&#!F;.YCE0<D]JVZ* *=SI=E=Z
MC97\\ >ZLBYMY"3F/>NUN,X.1QS3M1TVSU?3YK#4+:.YM)EVR12#(8?YYS5J
MB@#%T7PGHGA^>6XTVR\NXE4(\TDKS2%1T7<Y)"^P.*M:5HFG:(ETFG6JVZW5
MP]U, Q.^5L;FY)ZX'M6A10!QOBCPN?$'C3P]-<V0N-+M[>[6X8OMV,WE[,8(
M8'*G!7ICM6I!X+\/6VAWFC1Z<OV&]):Y1I'9IB<<LY)8G@=ZWJ* *&HZ+IVK
MZ6VF:A:1W%FP \I\\8Z$'J",<$<U7T3POH_AYIWTRS\J6?'FRR2O+(^.@+N2
MQ ],XK7HH R[7PYI%EKMYK=M8QQZE>*$GN 3EP,<8S@?='0<XH_X1S2#J=_J
M+6,;76H0B"Z=B6$L8& I4G&,<=*U** ,'1O!GA_0+LW6G6'ES^68E=YI)2B'
MJJ[V.T<#@8Z4^#PAH%MX<?P]'ID/]DODFV8EER3N)R23G/.<\'I6W10!B:1X
M1T/0VN'L+'9+<)Y<LLDKRR,O]W>[%L>V<5*WAK1V\/Q:$UDITR$($M]S878P
M9><YX(!ZUK44 4H=)L8-6N=4BMPM[<QI'-+DY=4SM&,XXR:NT44 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !112,P52S$ #J30 M%("" 0<@]Q2T %%%% !111
M0 4449H **** "BBFNZ1C+LJCIDG% #J*** "BD9E12S$*H&22< "HK6ZM[V
MV2XM+B*X@?.V6)PZM@X.".#R* )J*,C.,\T4 %%&<]** "BHI[F"V5&N)HX@
M[B-3(X7<QX"C/4GTIL=Y:RW<MI'<PO<P@&6%9 70'D;AU&?>@">BJ3:QIB33
MPMJ-HLMNA>9#.H:-1U+#/ ]S5J&:*XA2:&1)8I%#(Z,&5@>A!'44 /HHHH *
M*@N+RUM&B6YN883,XCB$D@7>YZ*N>I]A4] !1110 444=* "BDW+_>'YU&US
M;I<16[SQ+-*&,<9<!G ZD#J<9&?K0!+14<\\-M \]Q*D4,8W/)(P55'J2>E+
M%+'<0I-#(DD4BAD=&!5E/(((ZB@!]%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !114$%Y:W,LT4%S#+) VV5(Y QC;T8#H?K0!/11
M3)IH[>%YII$CBC4L[NP"JHY))/04 /HIJ.DL:R1LKHP#*RG((/0@TZ@ HHHH
M **** "BBB@ HHJ(7,!NC:B:,W 02&+>-X4G ;'7&01F@"6BBH[BX@M('GN9
MHX84&7DD8*JCU)/ H DHH!! (.0:@MKRUO5D:UN89Q&YC<Q2!MK#JIQT(]*
M)Z*** "BBB@ HHHH **@-Y:B]%D;F$793S!!Y@WE,XW;>N,]Z?<7$-K \]Q-
M'#"@R\DC!54>I)X% $E%-BECFB26)UDC=0R.IR&!Z$'N*=0 4444 %%1SSPV
ML#SW$L<,,8W/)(P55'J2>E+%+'/"DT,BR1.H9'0Y# \@@CJ* 'T444 %%%%
M!145O<P7=NEQ;31S0N,I)$P96'L1P:EH **** "BBB@ HHHH **** "BBB@
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M%(^[]Z['>I3<1@*<X&*['1-(N[+Q_P"([Y[;RK&YMK*.W<$;6,:N& '48R*
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M^CZ=J,!@NX(2LL9()4[B>W'>NHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDQPFYEOD=C+)(I947:1M 7&6.>O2H/A-(\W@CS9(C%(^H7C-&3G83.^1GVH
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MFG>/]<_X1+5-<O[?39HQ>)9:5);AXH[IV?R]YW,<)N/7T5O:@#JO^$(\/?\
M/B__ ($R_P#Q50W/A/PK9K&UU"D DD6)#+>2+N=CA5&7Y)/0=ZQHO'-[H]UJ
M%MKTVEWOD:9+J4,^F%E5A'@/&RLS8;YEP<\@]*P_$5]XIO-*\)WFM1:9]FO=
M:L)5CM%=7MB7#*K%B0_'!(Q@^H/ !W?_  A'A[_GQ?\ \"9?_BJMZ?X9TC2[
MH7-G:M', 5#&9VX/L6(I?$NN0^&O#6H:S/&9$M(3)Y8."YZ!<]LD@?C7,_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KD?B%I.JZMH^FIHUND]W;ZI;7.UW"*%1\DDGL/;)] :ZZB@#A
M[6VUGQ#X]TW6;_19M*LM(M9TC%Q-&[S32[0<!&8;0J]3C.>E<]I>@S-\7+W2
M(V1]#TVY.N>6#G9<S)M5#Z8/F.![BO5+B!;FVEMW9U65"A:-RK $8R".0?<5
MGZ%X=TSPY:RP:="Z^=(99I99&DDE<_Q,[$DG\: +>IPR7&DWD,2[I)('11G&
M25(%>?\ A74?%_A[PKIFCR^!+R:2SMUA:1=0M@&('4#?7I5% '$:W::YXQM]
M,TFZTJ72]+N<S:MOG1FV*WRVX*'G?@$D<!>,Y.*R;CPCKDOA#4_"3V\=U:V$
MT,^CW%PZE)XD<.+>0=<C:4R1@@CTKTVB@#SNT\-IK5OJEFG@>P\-V]SITMK]
MI,4 G,CC;A?*S\@&<DD9XXJWH%YXR":+H\^@I8I9JL>H7TLR21S(B;<0A6W9
M8X.6 V\]:[FB@#R";1?%L/P[UCP3;>'GDD+7/DWYN8A#+&\K2# W;MQW;<$
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M92W=6AGCC,$T:>60^\CY2 #D9QZ5H?#K2-3T3PF+/6(ECO?M=Q*X1@RD/*S
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MBIR#CD$5V=% 'C]IX?\ %^E?!S1O#,&DSFZEEDCU)8+B)9(K<RNS!&+!<LI
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/*K2J?I'!(/^!5W7A,IK/CCQ1XA5A) CQ:7:O_LQKODQ[%W_ /': .WHHHH
MXWQ/XOUWPXM_=CPE)=:79IYC7BZA$FY0,D[#\W'(_"F6GC#Q!<:3/J=SX2:R
MLEL7NXYWOXI V$WJ"J_-S^E7/B3_ ,DT\1_]>$O_ *#39?\ DDK_ /8"/_HB
M@#4T'7K?5](TRXDE@CO+RSBN3;+("R[T#<#KCGK4EK=ZA)K]_;31V8L8E0P/
M',6F8D?-O3'RC/3UKRZ70-+TSP!X#U6TLH8]2-[ICM>!!YS^9M# OU((.,'C
M&!VJW;V,FI_%+XF6$5S]EDN=,MH5G_YYEH  WX9S0!ZE;WEK=EQ;7,,QC.'$
M<@;:?0XZ5/7G'A&VMM&\3V>G:CX5M]%U<V3QP76GR V]ZB%-^<8.X<$!QD9/
M->B32QV\,DTKJD4:EW9C@* ,DF@#C_%_Q$L_".KV=A+92W(>,3W<L; "T@,B
MQB1AW&YNGM79;AMW9&W&<]J\3T._N/$,/B?5[[PCK>HP>(B88)K=8MJ6B@I&
M%WN"#U8\=<&E_M^]O_@C<Z3J!FMM2T^ZM])U$,=KK&947)P?XHS@G//- 'LD
M-_9W(4P7<$H9BJE) V2.2!CO2B]M&E2(74)D<L$02#+%>N!WQWKSK6/#^CZ'
M\3O ITJSM[$RR72/#;H$60+;MABHX)&XC/7YJQ_#.FVUGX,\:>)8;9'UFUNM
M3^RW++EX N_ 0_P\EB<=<T >NQ7EK//)!#<PR2Q<21I("R?4#I0+RU-V;07,
M)N0-QA\P;\>NWK7E7AWP]JR2>%+W3_"VFZ8MJ4::_AOU>2ZA>,APX" L6)#\
MDX(K(\/Z1KNM>$=-U&S\,Z>NIR7:WW]N/?@3M)YV7W#9G!&Y-N[&* /:IM0L
MK8$SWEO$ ^PEY57YO3D]?:G&\M1=BU-S"+EEW"'S!O(]<=<5YA9^'M*UC6?B
M--J5C#=LEP4C\Y _E?Z.I)3/W6/'(Y^4>E9,6CV%K\-_ NMQVT?]K/J&GN]\
M5S,^]P""_4KM.,$XP .U 'LLM[:P7$<$MS#'-+_JXWD 9_H.IHGO+6V#F>YA
MB"*&<R.%V@\ G/05X])I>I>)+GQF1X7L-2GDU&>UCU&YOA%+:A%41A 4)7;P
MXP1DFMJST2/5?BA%%XBMH;R>#PU:M-%*!)$9O,<,V#P2#NP?<T =OK7B72]"
MTN/4;NX4V\LD<<9C8$N7<*".>0-V2?3-:L<B2QK)&ZNC#(93D'\:\)U'3;'_
M (0B^LS:0-;V/C-K:VC:,$0Q&=<HN>BG)XKW.VMK>RMH[:U@C@@C7:D42!54
M>@ X H ;->VMO+'%/<PQ22G$:/(%+GV!ZUB+XG1/&&I:/="""VL[.&Y^T22;
M<F1G&#G@?=_6N3\7Z$]OKFLZU?>&[7Q%I%U;QK-B11=6*HAW>6&ZC^+Y2&R?
MI2Z;I6C>(OB?>3W%M'?V2Z'926Z72^8I#&3#E6SEMO<\\GUH ](-S;K;?:6G
MB$&W=YI<;<>N>F*Q_$GB)-'\':CKUEY-X+6!ID"OE'QVR*\VTP60\,P: =).
MIG_A)KR'3].:;RX<1,[8D)!'EJ,G&#DXXJ"Z2:U\*?%&QDL;/3UBCB?[%92^
M9#$S0@MM.U>N 3P.: .UN_'=Q;1^"&%E$W_"1M&)<N?W.Y%;Y?7[W>NXKQK5
M?]3\'/\ ?@_]$QU[+0!S>A^*X=1DUA;UK:S^Q:K+I\6^4#S=BH0>>YW=!6]<
MW5O9P^;=3Q01YQOE<*,_4UYAX;\+Z%KD_CV;5;*WNI#K%S#NF0,84\M#E<_=
M.23D8/RCTKG]!N-5UR7PE%<:);:\(/#OG);WUP(T#&7RS)\RL&;:J#D?Q$]Z
M /=%970,C!E89!!R"*CN+JWM(C+<SQ0Q@X+R.%'YFN;\ Z7J6CZ#/9ZA;16J
MB]F>UMHI_.6"%CN"!L#@$L.G3%5?'&A7NI7^D:A::;8ZPMAYWF:7>N%68.%
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M^Z-WF\ =@!CDUK:D;S54TY+GP=JQ&GW4=U!MO+48D0$+G][R.3Q27WC'6O\
MA+-1T+1?#*:BUA'#)+,^H+!_K 2."I]#WK6T?5]9G6YDU_1(=&AA4,LGV])@
MW7.<*-N..3ZT 9;O>OXA&MMX.U;[:+-K,'[9:[?++ASQYO7('-95AH"Z=H6E
MZ/;^#=:%IIMXM[;AKZU+"4,6&3YO(RQXKNTU;39+J2U34+1KB)=\D2S*71?4
MC.0/>BWU;3;NTDN[;4+2:VCSOFCF5D7'7+ X% '+7)O9];_ME_!>IR7BV;V0
M5[RUV-&S!B"/,/=1S7GDFB7UY!9:38^"O$L$]K>0S>7>7BR6EHB2!W$#,X4D
M@8!]">0,U[;%JFG3WC6<-_:R72#<T"3*74>I4'-8'AKQ5<ZWXM\4Z1-;Q1Q:
M/-#'$Z9W.'5B=V?IVH L_P!O:S_T)^I?^!5K_P#':Y+4?#4NHZ_>:T/#WBJS
MO;P()VLM8@A#A%"KD++V KT*#5]-NKR2SM]1M)KJ/.^&.96=<>J@Y%3P7,%U
M'YEO-'-'DC=&P89'49% 'G"^'ISIEWI]SH'BN\BN3&VZZUF"1X71MRM&3-\C
M X.1Z"I].T>?3-8@U>+PQXBDU"-'CDN)M3MG:X5L<29EY P, 8 Q7<G5=.";
MSJ%J$PQW><N,+]X]>W?TJ-M>T=+..\;5K%;65ML<QN4".?0-G!- '&Z3HXT6
MSU:TL_!&JB'57=[E7O;5L[@05'[WA<$X'O5W0/#T">&)_"C:#J>F:8\<FZ::
M[B=W+-D_,CLV[D\XZ"NMN[^SL+;[3>7<%O!Q^]FD"+STY)Q2_;;7R89?M,/E
M3$")_,&)">0%/?/M0!)#$L$$<*9VQJ%&3DX Q3ZHPZUI5Q;SSP:G9RPP?ZZ1
M)U98_P#>(/'XU6\-^)-.\4Z-#J>G2;HI1G8Q&].2,, 3@\4 6M7TNVUO1[O2
M[P,;:ZB:*4(V#M(P<&D;2K5M".CD/]D-M]EQN^;9MV]?7%5_$VO6_ACPY?:S
M=*7CM8RPC!P9&/"J/<L0/QJIX/\ %(\5:7//+9/87MI<O:W=F[[VAD4],X&0
M00<X[T 3S^%M-N-$TS2767[+IKP26X#\@PXV9/?H,^M0R>#-%FU36]0F@>63
M6H$M[Q'<[&15V@ =N.]:TNIZ?#>+9RWUM'=,NX0O,H<CUVYSBDDU33XHDEDO
MK9(WC,JNTR@,@ZL#GD<CF@#(T?P=8Z1J*7YO-2O[F*(PP/?W33>2AQD(#TS@
M9/)XZUJ:SI4&N:/=Z7=/*MO=1F*4Q/M8J>H!]QQ^-+-K.EVR6[SZE9Q+<@&!
MGG51*#TVY/S=1TJ2]U"RTV$37UY;VL1.T//*J+GTR30 MC96^FZ?;V-I&([>
MWB6*)!_"JC 'Y"N8\1>$;![?Q#J5OI+:C=ZG:K%<6)N/*2YV?=YQ\K@=#_\
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MX#%65@<AE8<@@C((H X S:_>?%;0YM3M;2UFM]+NY!9VTQF*(=BAG?:OWFP
M .-O4YXK>&KFPLOV>8;B_@FNX+B"03112%'GDEF*[=PZ99@"?2N]T+PKIOA^
M:XN+8W,]W<!5ENKRX:>5U7HNYB2 /05SNA^%_LUKK?@O5+&2;099&N;&9<A1
M%(VXQ9'*NCY(]00>U &;H=K=Z;\5-.AN-)TC2C+HT^;?392^Y5DCV[_D49'(
M!&>]:OA/]U\3_'MO'Q#OL9L#H)&A.[\3A35]/!FCZ3-#K*C4[G4+%7<3FZDE
MGF! S&V3\X^487IGZFCP-HU[86=_JVK1B/5=9NC=W$6<^2N (XL]]J@#ZDT
M4?%(34/&FGZ?::%9ZIJD%C)<!M1G*6\$3.%SM"MN<E<=. #SS7#6-I%J'AOP
MAI]W'"UL/%5S"886+1>6#/\ (I.,IVY'([5ZKK7A+3-=OX+ZY:\AN8HS#YMI
M=/ TD1.3&Q4C*Y&<57M/ F@V,L3VUO+&D-\;^&$3-Y<4Q5@2JYP =QX'% '#
M>*HD\/\ B/Q?_8L$=GO\)^>RVR!!O$DB[\#N%[^U2>(=!T33="^'T]A:6T$J
MZOIT<<L2!6E5L$@D?>S@-SW&:]'F\/Z;<:O/J<T'F7$]G]AEW$E6AW%MI7IU
M)K#M?AIX>M7LVQ?S+8S)-9I<7LDBVQ1@P$8)PHR!^ Q0!I^,M'AU_P 'ZII=
MQ=):QW$!'GN<+&1RK'V! S7">()?%5]J7@NWUFVTZV9-:@<"TN&F:Y*(Q:0
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MMS!0HZ<!C7HO@'2M0T;1KVUOX;2W5K^:6VMK28RQV\;8.P':N,,7XQQFIY_
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M2NK2VL+6&UN?#,C301PJL<A6=0I*@8) )%:/PBM+:W^&6B2PV\4<DT&Z5T0
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M !]*=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"V,:RWC,MHFX$21_N^7[XP.>_>@#V>BN)^+L\EM\,-7ECF>%E,'[R-RI ,R
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M0!G)P.0!GG'6W/C"[O9M*L_#NG0W=YJ%B-1/VN<PQP0'&"Q"L2Q+8  ['TH
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M;E;BV:-H!M49<'[H)!P3UKKO^$-T[_G^UW_P=W?_ ,<H_P"$-T[_ )_M=_\
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MGUP0<>]<9>^%;V[T34Y+G2+FYCMO%TVHM:*"LES;'*DQ\C)PQ88/.W%>OT4
M>17GA2SUKPKXDB\-^%;S39I+:)8)KXO')=,D@D,8CD.0N44;CC);VS6EJ.J:
MEXI\0>$9K;P[J]K;6>H>;>/>6QC\MC$X  /) R<MT^[SS7I=% '-?$#1;OQ#
MX&U/3;$*UVZI)"K' =T=7"Y]]N/QK O[R]\;:QX;MX-#U2PBT^_34+V:^MS$
ML91& C4G[Y+-U7(P,UZ#++'"A>618T! W,<#G@4^@#COA[I]YI\/B07EM+ 9
M]?O)XO,4KOC8C:P]0>QJM\8--OM7^&6IV6G6DUW=2-"4AA0LS8E4G 'L":[J
MB@#SKQC;6%U>QQZIX7UB:>&V7[#JFD*[3*YSE"R8*$'!&[*G-=AX934X_"^E
MIK+;M36UC%T203YFT9R1QG/7'>M6B@#RJSEU7PUX0U?P@/#^J7=\9+J.QF@M
MRT$R3,S(S2?=3&_Y@Q&,59U[0=5\,^'_  EJ>D6<FH:IX?@6TEA@4L9XFBV-
M@=2 P5OSKTRB@#R[4/ ]Q!\+M%L9+*34+JRO(=1O[9&Q)<L23, <C+?.V.>=
MH%1KHFFW'A[Q6^@>$-1L'DT::VBGNQ(LMP[HV8TB<DXR%Y[DX%>JT4 97A>"
M6U\):-;SQM'-%8P(Z,,%6$:@@CU!KF/$2W>G?%#0M9&F7UW8FQFM'DM(#+Y;
MLZD;@.@XZUWE% 'GFEZ5J$7@3QO:R64ZW%W>ZH]O&4.Z57W;"H[@YX]:P9O#
M%O:7NC:CKWAW4=1LY-!M;1ELXY'EMIXP<AD0AL$-C/."O;->O1RQR[O+D5]K
M%6VG.".H/O3Z ,'P?8P6'AN!+?1FT=)'>7[&\ID=-S'EB<_,1@D=B<5P7B+1
MIM3USQ/;ZCX=U#5=0N<)H\S*QM(8C$ #NSM0A]Q/<\8S7K=% 'E&@OJ.@ZKH
MVMRZ#J\MK<:!!ITT<5J3-;SPL?O)P0IR<-TX]#61%I-YXBT7Q#<7&E23O:^+
M1>SZ=&_[QXQ$@:,$$ N%?L>2, UZAKGA:'6KZVU"/4=0TV_MT:);BQE"ED8@
ME6#*RD9 /3K5K0- L_#FG&SLS-)OE:>::=]\DTC'+.[=R?Z4 <WX*TW1XM7O
M+W2?"U]I40A6(7=]YB23$G+((W)(484[N,D\=*F\96M[;>(O#?B2ULKB^ATR
M2>.Y@MDWR^7,@7>J_P 6TJ,@<X-=<MQ \[0+-&9E&6C##<![BI* ."TR"]UW
MQCK'B4Z=>65F-*73;5+N(QRS'<TC-L/(&2 ,]:L_";3KS2OACH]EJ%K+:W40
MEWPS(59<RN1D'V(-=I10!R>K^$=2OO%!UVP\23:?-]F%LJ"TCF")G<=N\'&3
MC/K@>E<7IGA+Q)#\/@\DD]U?V&L?VC:V$L*PDF.X=FP>,^8I+#/'(QQ7KSND
M:,[L%11EF8X 'J:565U#*0RD9!!R"* .#MYKSQ?XXT74ET?4M.T[1HYY&?4(
M#"TLTB[ JJ>2%!8D].E7_B)!>7&@VBV\%[<6@OX6U""RW>;);9.]5"_,>=N0
M.2,UUU% 'D6FV1TG7M<N+#P-=G2M0TV)8;-X=OG!'<2"0-D*Y5B0C<L !P3Q
MM>!K+[)XFNCHNGZSIWATV>&M=15T5;G>,>4DA+ ;=V<<=*]#HH XWQG:7MOK
MWAKQ):V4]]%I4TZW-O;+NE\N:/:75?XMI X'.#5;28KS7?'&I>)CIUY96*:4
MNG6RWD1BEF;>9&;8>0!P!G&:[NB@#B/A'IU[I/PQTBRU&UFM;J/SM\,R%67,
MKD9!]B#47B=;O3_B7X=UI=,OKRR2TN+61[. RF-V*E2P'0<=:[RB@#S_ $?2
M[^'PCXXMY+.=)KO4-1DMT9"#*KCY"H[@]JY^?PQ% ?"VI:[X?U#4+-/#\%A/
M%:)(TMM,@##<B$,0=S ]<$#->P4V21(HVDD=411EF8X 'N: .?\ !=A;6.@?
MZ)H<FC13S/*+660O)R<!WR3M9@ 2N3CI6";B\\*_$'Q#>2Z-J=_9ZS';2V\M
MA;F4+)&GELCX^[G ()P/>N^1TEC62-E=&&593D$>H-.H \7L]*U>#PSHL>N:
M-J;Z=_:][+J=C9H[.VYG,1*KAGCW'/'!X-0W?A[4'\+>/=+T_P -7=D+\07=
MA;B+Y6C4("N1D>9\I)3.<FO;J* /*=<L;36?$&F>)M3\,ZS=:9+I[6;VZV\B
MW%M(LFY6:-2&*D%AGGMZUVG@JPM;'0#]DT.31HIYWE%K-(7D.3@.^2=K$*#M
MR<5T5,,L:RK$TBB1P2J$\L!UP* .$,UUX1\=>(+Z?2=2OK#6%MYH9;"V,Y22
M--C(P7D9P"">.>M<QXA\+ZW+\$]:M_[-G;5=4U)M0-C$N]XQ)<*^W [A0"?3
MFO8Y)$AC:21U1%&69C@ >YH1UD171@R, 593D$>HH 4=!2T44 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5P?Q@D2+P!(TLC1P_;+82LK%<)YJ[N1STS7>5QOQ.L;W4/!IBL+.:\G
M2\MI?)A7+LJ2JQP/H#0!R]A!\'KC4;6&ROHY+N25$A0:A<DLY("CE\=<5UFH
M>.8?#^M:E9>((EM+>&V^UV5PK9%U&.'0 _\ +0$@;>^0:A'CF?(_XH7Q0/?[
M)%_\<K-\3^&=4\>:Y.DGFZ;8Z.-VFS,HS/><$2D'_EFN ,=\DT :3^*M=^PZ
M';#1[:+7M8$DB6LT[".VB0 EI&"Y) 9!@#JV.U12>/KFTTFZCN],C_M^#48]
M,6SBF_=RS2 -&P<C(0JV[D9&"*Q==TZ[\1Q^&M>U_P *W%T;(3VVI:;&NYU+
M!<2QC(WKN3L<X;V-)-X;<^'8-2T#PDVF/8:S#J$=BS@37<48*DE2<(Q#OA2>
MP]<4 ;6H>+_$6@:/K=QK6AV_G6%H+N&>TE=K:<$X*%F4%7'IW!S6UK/B*32[
MSP] ENLG]JW8MV);'ECRV?(]?NXKG-=GU_QOX;\1:?:Z%<6-D^GE+;[>HBGG
MN,YP%W$!, #)QDGTJO<W6K^)-7\'RQ^'-2L[?3[T27;W<80JWDNORC))4'.6
MX'*XSS@ @T#7_$%UIOCRXURVL+JQL9KN-H/M#M\T<2?NE!4#RR,\\')/%:/A
MWQ@L-EX+@32;>RTS6[=TC\ISMMI57<L8&.C ''N*S[*QU2UMOB'HDFCWQDU*
M:]N[2X6,&&59(@JJ&S]XGMBGCPQJDOP4TBS2U>+7=*BAO+:)A\RSQ-N"_4C*
M_P# J -S6?'::1KNK6AM/-LM(TT7EW,K?,)&)$<('JP&<_2I=-\1ZY#KNGZ;
MXBTRSM?[3CD>U>TN&DV.@#-%)E1SMR<CCY37/0>$=3USX>>)WO+8V^M^()I+
MGR)C@QA2!#$Q] J+_P!]&I_"FD:0/$-G<6/@"XTF:WB=IKRZ'E^3(5V[(^3Y
MF<L,C Q]<4 ;NGV:>#X?$.JWU_>'3GE:Z"7,YF,8&2Q7T!/1>> .Y(&Q8ZN;
MR_ELY-/O+2:.)9?WX0JRL2."C,,Y4Y'T]:3Q$BR>'KZ.33CJ,;Q%7M%&3,IX
M91[XS7+^"]*OM&U^ZM;&YU*7PQ]D5H8M21P]O-N_U<9<!BFWZ@<<]: -/Q+X
MGN]&\0^'],MM,GN5U&>17DC:,<)&S;5#,/FR <G P#SGBK6J^*[;2XKV7[%>
MW<=@@>]:V5&%N-N[YLL,D*0Q"Y(!'J*R_&=M>CQ%X3U2VL+F\@L;R4SK;*&=
M0\+(#@D<9(R>U8+VT^A>+M:74_!D^N66JSK=6MS;VT<[1L456BDW$;0"O!SC
MG\@#I+OXA:1;W5O;6]OJ-_+<V)O[<6=L7\Z/C[F<9.#G'L<X/%*OCVRENKZT
MM]*UF>\LX8II;9+3:^V0$C 8CD '.<>@S6;%975O\2-$N/[+>"UAT>2UD-M
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MWE[=_.%!VGGMWYJG?>'-1UZ7XCV,<%Q;'51!]BFFC9$E*1*I&2.!N7'T.>:
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MD@.!NX)VY(!ZD8[UYFOA*?5M,\2:=H&DZCI&C7>GJL5GJ)**UV'W QH6)1<
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MAFN2'W&)&8E5(*#L">G2@#H(?%ES'H7A"PT'2;07VLV2S0V\DI2"UA6)6;)
M)(&Y5  YJ"7XB:G9VOBT7VC0PWGAZVAE:-9RR3,X8_*V!\N ".,\X(XJG!IF
MK:%;> =9&DW=W_9VE?8;^U@ ,T>^*/!"DC.&3!&>]8][%JOB&?XG1KIDT5W=
M6%DL%F2&E VR;0V"1N(YQGC.* .SC\6Z[;:YHL6JZ1:0:;K,C16S17#--"^P
MNHD4J%Y /W2<'N>YHOBO7];GBOK;1[*31);M[4F.Z)N80K,GF.I4+C*Y*@Y
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]H)<[0RY^4#=T!R<8.1GC=M?%>L:?XFFTGQ+:Z?%&=.DU"*:RD=@JQL Z-N
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M\O3K?SGVPQ!"[-.<=5 .0O4D 51OOB!JNCV=]_:5C9-<:3>6RW[V[L8S:3'
ME3/((.00<]#S0!Z+17.:YXDFL/$>@:+90Q33:E)(\S.3B*WC7+/QWR0!VYKF
M_P#A._$4WAR?Q?:Z5I[^'8B\BPM*XNI(%8J9 <;0< L%/;O0!Z$+B W)MA-&
M9U4.8MPW!>F<=<>]2UYE/X@TW2?BGJNM7=P$LAX=MY%8#)?=,VT*.['( 'O6
MO/XKUZWTC33/I5K;ZQK%V8K*SFD($$>TONF8=PJDD+W(% ';45SGAK7K[4-0
MU/2-6AM8]1T\QLSVCEHI8Y 2K+NY'*L"#GD=>:Z.@"&"[MKKS/L]Q%-Y3F.3
MRW#;&'53CH?:IJ\AN/$UX_@+Q]=Z)I^GZ9<6&I75O)+ "C2 #!FRO_+7D'/M
M7I'AF34I?#UE)JQMS=-$I)MV9E*X&"2W.?6@#6HJGJMU<V6E75S9V3WMU'&6
MBMD8*96[+D\#GO7+:=XIUJ'79-(UN'2VG>PDO8)-/E9E4QD!HW#<Y^8<CKS0
M!VM%>9P>/O$I\,Z3XJN=)TZ/1KIX$GB$KFX42.$\Q>-N-QX')(QR,X&U)XE\
M0:CXDU:QT"PT^6TT@I'<-=2NKSRLN\I'M&%P"!EL\F@#K(YHKRV\RVN%>-P0
MLL3!AZ9!Y'!K+\-^&X/#%E/:VUY=W,<UP]P3<E"5=V+-C:J\$GO6'\(W\SX7
MZ.^"-WGG!ZC]])6OXWO-0T_P3K-[I;1+=6]I+*&D)&T*I)(Q_$ #CWQ0!MR7
M$,,D<<LT:/*=L:LP!<XS@#N<4]W6-&=V"HHRS,< #U->0W5YK[:7\.+JZBMK
MO49+D& )*V) UJ=K2,PSGDEB,^V:Z>V\3:L+GQ%HWB"QT][JQT_[;&;4L89X
MF#C:P;D<J0?7- &R-!L=3UR/7QJE[=0X4Q6JW>ZS#+TD"#@L#[D9&<9%;]>9
MZ/XRN#X/\))H^FZ3I]QK/FB*.5C':P!,D@!>23V QWKN]$N-5N-/SK-E%:7J
M2,C+#)OCD /#J>H!'.#R* -&BBO&_%%MJ/C77M?UC29I%'A15BTW83MENT99
M9N._"A,>] 'LE%<C>^.K>+X>6_BJRM_M)NHXA;VX?&Z61@@0GMAC@_0U6A\3
M^)+#Q=H>@:WI^G9U,3.+JSD<H!'&6*X89# XYZ$'MB@#M)8EFB:-RP5A@[6*
MG\QR*(88[>%(88UCBC4*B*,!0.@ ]*\^T;Q]K-_IFI:]=Z=96^AZ6;I+EQ(Q
MFE:(MCRUZ8P%!)/4G'2K^F^*==BU72(-?LM.AM]8#+;FTF9GMY AD$<FX8.5
M#<C'(Z4 =K17GD/CW5Y+&W\1/8Z>/#5Q=+"H$S?:EB:3RUF(QMP20=O4 ]:D
MN/%WB>[U#Q);:-INFE-$EPTMW(X\Y?+#A5"_Q=>3@#Y>N3@ [^BO.8?'NNR6
M&@:_+I5E%H6JW,%MY9F8W,?FG:'/&W;N[=<8Z9P+6H^,=<,NMW>CV&GRZ9HL
MC13K<3,LURR*&D$>!A< X&<Y([4 =Y17#S^+]7U'Q-'HWAZSLI%GTJ'4H[J\
M=E1%=F'S!>2>%P!CJ>>.><\1>,O$=]X(2>U2UL=0M];73+[RY7QYB3*!Y9'.
MQN^><$CF@#UNBH++[6;*'[>(!=[1YH@)*;O]G/./K6/X@U^?0]7T"$P1M9:C
M>&SFE).Z-V0F/';DJ10!OU#/=VUKY?VBXBA\QQ''YCA=['HHSU/M7*:?XUEO
M/B+>^'&M46RB1T@N@QS)-&L32)CIP)1^1KG=3\;_ &_2="U*ZT2PNK>\\3"R
MLC.N[9&'9%G7/1\J<8H ]-%W;-=M:"XB-RJ;S"'&\+Z[>N/>BWN[:\C:2VN(
MIT5BI:)PP##J,CO7GMC_ ,G$ZG_V+Z?^C5I/@I_R*.I_]ABZ_FM 'I-1P7$-
MU"LUO-'-$_*O&P93]"*D/2O%_!WB7Q'X?^$^FZS'IEC+H=BK"9'E<7,D?FD.
MZ #:,$G /4+GC- 'K>JZ>=4TZ2S%[=V7F8_?V<@21<'/!(.,].E1Z'HECX>T
MF'3=.B*6\>3EF+,[$Y9F8\DDDDFN<O\ Q1K=YK6H67ANUTV6/38HVG>]E93,
M[IO$<>T<?*5.X]V'%0CQQ?:Z^C6GABTM6O-0T_\ M&1K]V$=O%D+@A1EF+$C
MM]TF@#NJ*X>X\8ZY#9Z98/HD4/B/4+R6TCAEE/V?$8+/,& W&/: 0,9YQ37\
M9ZOI7_"06&LV=E_:FFZ4^J6[VKMY-Q$ W4-RI#+@\GK0!W5%>;R^.?%-K#H&
MH3Z)I[V.N.D%M!'.PFCED0M&7)&T*<<XR5'J15V+QOJ.CW7B"T\3VMFLNE6"
MZ@DE@S%98CN&W#\AMRX]#GM0!W=%<9IOB;7H=:TJR\06>G11ZLK_ &<V<K,T
M$BIO\N3<,'*AOF'=>E=G0 5%<7,%I"TUS-'#$O5Y&"J/Q-<GJ?B37+CQ!J&E
M^'K73G_LR.-KE[Z5E\R1UW+&FWH=N"6/'S#BN$\>ZI?>+5\!75M;6#Z9J-]%
M)';798YFP<I* ,%!R./?B@#V*74K""U2ZFO;:.WDQLE>50C9Z8).#5D$, 00
M0>017B?B73-;N?B=X3TNYTWP[(D5E.;:S97-J,)\VY=O8CC ["NLN_&>N1PZ
MOJ&FZ=IKZ1HDCPW$<DS+-.8@#+Y0 VJ%Y SG.WM0!Z#17%W'BG6=7UN?3?"=
MMI\HM+6&XN+B_=U4F4%HT4*,Y*C))X&1Q6'JGB'Q==>+O!<=M:P:=]OANI)+
M&[E<?O$0;UDVC! SE?7J<4 >E1W=M+<2V\=Q$\\./-C5P63/3(ZC/O4.J6!U
M/3I;,7EW9F3'[^TD"2K@@\$@XSC'3H:X-O$T]OXD^("Z5H>G_P!H:3;V\WG!
M2)+S]V6PY')( (6MG6?&WV?P?I.KZ5!'<W6L26\-C!(QPSRX.&QSPNXGZ4 ;
MVAZ'8^'=*CT[3XV6%"6+.Q9Y'8Y9F8\EB>2:T:X'4/&FN ZUJ&EV&GRZ3HLK
MPSK/,RSW!C ,OE@#"XY SG)!Z5W%K<Q7MG!=0-NBFC61#ZJ1D?H: )J*Y[Q9
MXAGT*"P@L+6.ZU/4KI;6UBE<J@8@DNY )VJ 2<<UDIXMUG3=1U'2==M+'[=#
MIDFI6LUFS^5,J<,I#<A@<=SD'M0!V]%><P>./$BZ9X?UZ\TO3H]'U66VA:-)
M7-Q'YV ).FW;DYV]<$<YSCT:@ J-+B&666*.:-Y(B!(BL"4)&1D=N.:X3Q]J
M7B*T\3>%+31Y;6.*ZO&!$LCKYCK&_P K[>J8.?J!Z5G:=/XD'C_QK%H=KIS3
MB6T>:6]=Q'G[.N$4*,DGGDXP,=<\ 'J%%<#;>/K[6=&\.'2;*U35-9CED*W<
MA\FV6(XD)*\M\Q  XSGVK?\ "VO7.L17]MJ$$,&I:=<FVN5@<M&QVJZNA/.U
ME8'!Y'- &_14-W=16-E/=SMMA@C:60^BJ,G]!7$:=XSUPMHM_JEAI\6DZU*D
M4"P3,UQ;F0$Q>9D;3G !QC!(ZT =O#=VUQ)+'!<12O"VV14<,4/H0.A^M35Y
MK8^-;/2T\?:B=&M8/[(N]K&V7:]XYR%+G^\20,^]7G\5>*=)U;0+#6]+TT#5
M[D1>;:2N1"-C,48,/O<#!'!^;I@9 .XAN(;@.89HY CE&*,#M8=0<="/2I*\
MAT/5_$NE:-XNO](L-/EL[#6=0GF^URN'FVN698PHP, =3U)QCC-:>M>(?$5Y
MXS\%?V,]I'9:G:S7213R2 /^Z5B) O7 8%??.: .\O88M8L+JS@U&:!MWEO-
M92@2Q,,'&<'!Z=1T-1Z#H-CX<TM;#3T<1[VD>25R\DLC'+.['EF)[UYYHU_X
MDM+SQP^A66GR1V^LSSRO>R./,/E1_(@4=<+U/'(]\>B>']737_#NG:O'&8EO
M;=)_+)SLW*#C/?'2@#2J-[B&.:*%YHUEESY:,P#/@9.!WP*R/%OB#_A&/#=S
MJ:V_VF92D<$&[;YDCL$49[#)&?;-<;>3^(#\3/!$&O6]@K[KUXY;%W*'_1R&
M4AN01QSWSVQ0!VFO^&K/Q"MJT\UU;7-I(9+:ZM)?+EB)&#@\C!'!!!!I= \-
M67AU+DV\ES<7-W();FZNI?,EF8# W-Z <   "N<G\7>(M.U"SGU33=.M]-N]
M06R6V\\F[C#N421OX2"<' Z ]:U/#_BMK[_A((=5CBM+G1;IXYPI.TP[=Z2\
M] R\_@: .GHK"\'ZS>>(?"]GJ]]:I:O>*98X5).(R3L)SW*X/XU>UF[O;'1[
MFYTZQ-]>(O[FV#A-[$X&2>@&<GV!H OU72^M)+M[1+J!KE!EH5D!=1ZE>HZU
MR>F^(_$,VLWN@7<6C/J8LOMEK-:RR& C?L*."-P()'(Z@]J\N\+G7M/^'/BO
MQ!9V^CI<^9>B6_.\78;(W;7 Z#J.>H% 'T+17 V_B/Q%!I_A_25BTV76]0MF
MG,TLLGDQ0(J?._&YG)8# [D\\5#?_$6_T[P\US+ID$FIVNL1Z7=6\,A*/NP0
MT9.#\RLI&>YP>E 'HE%9VBMK#Z<&UR.RCO2Q)2S=F0+V&6 )/KVK1H ****
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MJ/3X_,U&V>.[M%!P3+$X=0/<X(_&NEJ*YNK>SA,UU/%!$"%+RN%7). ,GU)
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MQXFN?%&N'2+FR67P]+I5A:W.T33LVYBQ4$A1NVJ,GWXKTVB@#@M2T/4IM$\
MP1VCM)IU]:27:@C]TJ0.K$_0D#BJ_B;PEJ&O^)?$J)$8[>_\/I:07#'Y3,)'
M8*>_=<_6O0+JZM[*V>YNYXH((QEY97"JH]R>!3XY$FB22-U>-P&5E.0P/0@^
ME 'G7A71[%=;L)(?AS%H\]O&S75[*D2>7)MQB$J27R2>>!C\J]'HHH \OU[P
MS:VWC76-4U'P8WB*#4DA>WDBCC=H9$38R-O8;5(53NZ=:GUWPWJ$P\ +9:-%
M:II^H)/=VUJP,=JN,M@\9 )/2O2:1F"J68@*!DDG@"@#B=9T;4+CXN>&M6AM
M7>PM;.YCFG!&$9E.T'OS7-3^$X--U77(KKP FO7=[?2W5C>E(C$5D.[;*['*
M;6+=CD=*]7M[B"[MX[BVFCF@D&Y)(V#*P]01P10EU;R7,MLD\33PA3)$K@L@
M;H2.HS@X^E '!^1J7@WQ=JE_:>'[K4=.U2VM@B:>4)MY84,80ABOR%=N&[8Z
M57U>+Q,NL>"?$>H:(]W<V27:W]MIFUC$9D4( ';G&,$YQD'VKTFB@#A?#.B:
MA9_%#QKJ=U:,EC?BT%M*V,2[8R&Q]#ZUC>%/".L6?C"WL;^U9-!\/274NERE
M@1,9F&P8_P!A2XY[UZG41NK=;M;0SQ"Y9#(L)<;RH."P7KC)'/O0!Y1<^%(-
M.U?78[KP"FO75]?27=C>[(C&1)\VR5F.4VL6['(Z5ZO:PI;6D,$<21)'&J+'
M']U !C ]A4M% ')>-],U">30]9TRU:\N-(OOM#6JL%:6)D9'"Y(&X!L@$C.*
MQKBPU;Q1KNHZVVD7=A;0:)/86D-WM6:>63DG:&.%&T#D\DUZ*S!1EB /4TBN
MK_=8-]#F@#SZ_P!!U27X:>$]-2S=KRSETUKB+(S&(RF_//;!KT.BB@#B?'MG
MJ/\ :GA?5['3;C4(]-OVDN(;;:9-C1E<@,0#@GUJUX8L+V#Q=XKU"YM)((+^
M6UD@,F,L%@56Z$]#D5U;,%4LQ 4#))/ %0VEY:ZA:I=65S#<V[YVRPN'1L'!
MP1P>010!Y#:>"KFV\.>$KK6/#3:JFGI=P7NG%4>15ED+)(JL0"1@<9SAO:O0
M/!>GP66G7,EOX:AT"*:<F.V7:)'0  -(%X5CSQDX&*Z6B@"GJUB-4T:^T\ML
M%U;R0%O3<I7/ZUYMX5\-VUG<:+9R_#J&WU.R*"\U.1(Q$I0?ZV)P2SLS $#
MQDYQBO5:* /(G\%ZS>Z9\2;5[;[.VIWHN+%Y6 678=XYSP"0!SZU;UO6-5UC
MQ)X(-UH=SI<2:IF1;IT+/)Y+_<",<H!GYCC.1QUKTJ^L;;4["XL;V%9K6XC,
M<L;=&4C!%<[IW@O1= NXM5FO+Z<V$3BW?4;UI$M(\8;;N.%^48)/;O0!EZ9H
M>IP^"/&=E):.MS?7FI26T9(S(LF[81SWS6?>:;K&E7/P\U1-&O+U=)L);:\@
MM=AEC9X(U'#, 1E3GFO3(Y$FB26)U>-P&5E.0P/0@]Q3(KJWGEFBAGBDD@8+
M*B."8R1D!@.AP0>: .1\/Z1?VEOXS6>V=#?:G<36P)'[Q&AC4$?4@C\*T_ U
MC=:9X$T.QO86ANK>SCCEC;JK!>1Q7044 <O\0=&O=;\)30Z;&LM]!-#=01,P
M42-'(K[<GID CZUARR:YXD\=^%=37P_?:=IVGFZ\Y[S8'#O"5'RJQ^4' SW)
MZ<5Z)10!X?%X9U&/0]- \%2MKNG:A#=ZEJ,BQ-+=[)@S>2Y;<Y8<\X  QZ5K
M_$+2[V3Q=I\&F'RO^$KMO[,OTSAD1&5VDP.I$9D4_45ZS6'8^%-/L=?N-<,E
MW=:A,&59+J=I! C')2,'A%SV'I0!L00QVUO'!"@2*-0B*.BJ!@"N<^(%A?:G
MX0N+:P@EN&,L+36T3['GA$BF2-3D<E01UYZ=ZZ>HI[JWM?*^T3Q0^;((H_,<
M+O<]%&>I.#Q0!YSX<TJ6Q^(4&J6/A!M'TBYTY[15CBBC=7#J^^95/ (! ZGC
MG&>*NA^%-:C^$/B;19K)HM0NY;QH(78 N&^[SG'/O7JM% 'D]]HTFK1^&]9U
M/P==WL%A:/87FFW$<;3+D(5E12V& 92.H.#G%37WANXN?"U@NE>$X]'_ .)_
M;71M(M@?R$8?O) . V!T!.!BO4J* "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N ^,?D?\*^
MD^TC-O\ ;;7S1@G*^<N>!R>*[^N0^)6EZCJWA V^EV;7=TEW;S"%752P256/
M+$#H* .6L(OA!<:C:PV>DP_:I)42'_B77"_.2 O)3 YQR>*Z35_')\+:WJ%K
MX@BCCLS;_:=,GA!S<XX:$@G_ %N2N .H/:G?\)=XE_Z)_JG_ (&6W_Q=4/$/
MA/4_'&MW1U!IM-L-,7_B4LCC<]UP?M) /12 %4]?F/% $]UXI\0VUGH-C<6^
MF6FO:L))7$[-Y%I$@!.[G+-\R+@$#)/85 ?B!?0Z3<V\EK93Z_%J<6EQ+!(?
ML\LDH#))GDA=I)(Y/RD9JGJVCZMK</AS6]>\*PZC=Z<)[;4--/E2>:'"CSHM
MQVGE 0"0<,1VI;GPS>W/AV&]TGPI8Z-=V.KPZC;:=%Y<;W"1C&)"GRJY#/CD
M@<<]: +^J>)O%OAO0M=NM7T[3IGLK,75M=VH=8)#G!C96;<&'7@X(/:MK6_$
M-SIE[X;@ABB8:K>"WE+Y^0>4SY7!ZY4=:P=9B\4>-?#_ (@L&T?^RK*;3S%:
MPW;H9Y;C.<DHQ54X YYR<U!.OB3Q%JOA*>3PW<:?;Z9>"2[-Q-$6SY3KE K'
M* G&3@G<,#K0!2\.:QXB.G>/[S5FTZ\MK*XNU,#)(P,D<*?( QQY1 .5ZY)]
M:T=!\97,=EX(+Z=8VFEZY"T3"W0HMO/MW(BC. K8(QZBJ]II&N6L'C[1FT:=
MEU66\N[.[62/RI/,B"JGWMP;([C'O4@\(ZI+\%]-TG[/Y.O:=#%<6R%EREQ$
MVY1G..<%<YQ\U &AK?CR32==UR%+:.73M$TQ;FZ?G>;AS^[B!Z#(YS@]13M)
M\4:S%XBTW2]=;1Y1J<<A@;378F&1%W&-]Q.[*YPPQRIXK-M?!FI:K\//$4.I
M1);:YK\TMU)'(P<1-G]S&6&05"HH_$U:\,:7$-<M9X_AW8Z$UO$QGO&B@#B0
MC&V$QDD@Y;+''% '2>+=<?PWX7OM6CA25[=5VJ[%5!9@H+$=%&[)]@:Q)-6U
M^'PSKMWJ]OHNH6D6FR7-O<69)@GPC$QNC,21P.0<$'M72:\U\FBW#:=8PW]Q
M@?Z),P59ER-ZY/&2N<9XSC/%>>6GAJ\DM_%3Z/X;N-#L+[1Y;=-/EDC7S[HA
ML.J*S*@P0N<C.>G% %ZQ\7ZC+X<\'6FB:=IMOJ6N0-(D;(RVUK'&H9R%4Y[@
M 9'7K23>.]?L!XNM[^PL5N]!T^.Y1HBYCG9@YSR<A<*..H.1D]:I6FAZWH.E
M> ;]-.-Q?:3;2VMUIZSQK*RR(,E"S!6*E <9Y%4;BVUGQ#J_Q&@;3_*OKK1[
M:."S$JLR967:K,#MW'KP<#.,G&: .F7Q3XEL]1\/SZK9Z:NEZU.MND4)?S[=
MW0NFYB=K?=.0 ,>I[TKOX@ZJEK?Z];II)T*QNGA:W>1OM<T<;['D4YVCD,0I
M'('7FMCQ!HNH7D'@U;>V+G3]3@GNAN \M%B=2>3S@D#C/6N6MO"/]E27>EO\
M/M/U>YDO9)+;5)XX#$89)"^96;YPRAB,!3G:,4 =/)XB\0:KXIU33?#T.F?9
M=*6(3R7N\F>1UWA$*G"@*1EB#R>E1_".0R_#FRD9#&SW%VQ0]5)N).*@2#6_
M"WC+7I['0)M3L=8,,UN]O+&@AE2,(RR;F&%X!R ?H:T_AOI.I:)X(M+#5HA%
M?)-<-(H8$?-,[ C'8@@_C0!D:S?>(_\ A<&DV%G<V:V1L)9A%(),,NZ,.6 .
M"W'RGH,FL+1-4\3Z7H7BW4='M],-GI^KZA/*+S>7GVN68)M("X X)SD]AC)Z
MCQ!9:K:_$G1=>M-*GU"S6RELYO(= T3,ZD,0S#*\'I4.G>']4@\#^,-/DM"M
MU?W6I26T>]?WBR[O+.<X&<CKCWH 2[\41W'CCP/"FEV4BZO:37"7,T>Z>W'E
M;\(W;.<'UJ31?%'B/7-0DN+.#2)=.BOWM)[,2,+R!%D*&1B3MSQNVXZ'@DUG
M)X8UD>+/AU>&R;[/I.G20WK[U_<N8 H&,Y//'&:CU#2-2U;Q#93KX1.GZ[;W
MZ/)K=O+&L+VZR?,20V]]T8V[&7J?04 >GUY+XNTJ?XD>+-4TVTF:.W\.V9\B
M1&P#J#X9>?\ 9"@'T)->H:E/<VVEW4]G;&ZNHXF:& $#S' X7)( R<5P'A;X
M5:6N@PW'B*"YFUR[+7-_(E]-'F5R6(PCA>,XR.N* -73_'L,GPM/BVXB)EMK
M5C<P#Y2)T^5D]LN/R(JE-XH\7Z/=^'HM9L=*9-8O8[<M:^8/L^Y22C!C\S<<
M,..#QTK&N? -]I]MXP\-:=%Y7A[5;075G/+/E;>Y& R,6);#%0VXYP!4FO:K
MKFJWW@@:AHCZ:B:U 9!)/'(99/+?F/83\@&[DXZCB@#:TCQ9X@U?Q!K,*VVF
MP:3HU_+!<SR;S))&J@@( <;AR23QR,#K533_ ![J\D>D:O>1Z2-'U6YCA2VA
MD8W5NLIQ$[G.ULDKD #&[OBM3PKX?O+9O&$6H0-#%J>JSRPMN!WQ/&J[A@\=
M#UYKG?#/A@Z:-(TJ?X>:=]NLG1+G6)(H/+=$Z2HPS(9&P#@@8)Y- %R[^(&K
M);:AKMNFDG0["Y>%K:21OM<T<;[))%.=HY#$*0<@=>:T)O$GB74O%FMZ'H,&
MEJNGQ6\JW-X)"I$B%MI"D9)(Z\8 [YKGK?PC_94MYIC_  ^T_5[F2^DEMM4G
MC@,1ADD+_O6;YPRAB,!3G:,5U^@Z/>6/C[Q5J$MMY=E>1V2VS@C#^7&X8  Y
M&"1UH YB/XA>)I?!UGXQ.FZ;%I'F1Q7-LS.T[9D$3NC [5 <G (/ SGM6SJO
MBO6I=<U:QT/^QTCTE4$O]H.P:YE9-^Q-I&T!2HW'/)Z<5C#PIK?_  HE/#WV
M%O[5#J3;^8N<?:Q)USC[O/6I-7\,K8^+-;OI_ \'B2+4S'-:RE(&:&0($:-S
M(054E0V1GJ>* +X\<ZKK&IZ':>'[.SVZMI)OUDNRQ%N0R@[@I^8#)&!C)QR!
M6#XK\6^))?AQXH5S9VFJ:3>+:74UL9 KQMLVO%SE6.\=2>AKJ-/T"^M?&^BW
MPTZWM;.WT.2VE6UP(8IFDC;8@X..&P<=JPO$'A'6]0\/?$&UM[/,VIWL,]DI
MD4><J+$3CGCE&'.* /1]-%^-/B_M1K9KSGS#;*PCZG& Q)Z8_'-1:[J1T;0-
M1U00M.;.VDG\I3@OM4MC\<5EQ>)+YK_0;:?0I[0:GYZRB>9-]L8UW+E5)#;L
M'G/'&>3BMK4VO$TNZ;3HH9KP1,88YCA'?' )[ ]* .4TKQ+KD>FS:SK']CW6
MC+8O>?:M+D;]T4 8HP9CNR,X(QRO(&15#_A+_%.GZ1IGB/5[/2ET:]DA$EO
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M1110 4444 %%%% !1110 5RGQ!T:_P!=\/V]KIT(FF34+:9E+A<(D@9CDD=
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M8L=Y!)(XXJ])X2URZA\;Z!+IH6UUB[DOK343,ABW$(51DSO^\G/&.OX^I44
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MAJVE6:17=K?G3K@239$3^:L99"!\_P!X8/'7/;!M^(_$-_I_C'P5I[V5FO\
M:<UPL^\>:T6Q5(\M^,9SSQ6$_@_Q&_@?Q3I TVUBGN=7-_9HER"LB^=')M'
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MN-'G6&Y@\U9-Q<*8]K< [MP SC!ZT[3/&]O>>*4T">*W6XFMS<6\MK=BXC<
M_,K$ %6'7&",=ZY^_P#"&M:M+XV5(?L3ZE<6MUIT\DB,-\"I@,%)(RR>G0_A
M73^'M0\4ZBZ?VWHD&D)"O[S;=+.9WQCY0OW5ZGDYZ#U- &GKUE=ZCH-]9V-P
MMO=30LD4K D*Q'?'..W'-8<&C>)1J6@W-Q<Z0T-O;-!J$"0,%R1U@';/ .>P
M]\5UM(Q(4D L0.@ZF@#R+PE#X=M]=\:KJ.BBY\O69/+V:2]R$7:IP"B,!SGB
MM;Q9<?V1\%;NX\/6WV6VN+0SJH?8;=9VWD* /^FA '&/PJUX5M-<T'5/$L]S
MX?NI(]2U)[N Q3P$A"  &S(,'CWJ3Q5IVO:_\.=5TV/25BO+L^5;6BS1@0QJ
MRXW-G'(4GC.,@=LT 8_C.RDL/[!O;?1+2VNK[4[*RN3%<G$L2R;EB8;0"IVC
M)QP..16W)K.F^'=0U.+3]/T^'5)$2\U")[X0JSD$*%)!W.0OH!T)/-2>,+#5
MM8L_#WV+2I6DM-5MKVX1I8E*)&26&=V">>,<>XJM>VGBC0O&EYK>C:0FJV&K
M0PBYM6NDAEMY8P5# M\I4J>0.X_, TM.\<V>N6.CRZ1;M/<ZI"\\4$K>7Y21
MG:YD8 X 8A> <D\<9(R->\::S'H-I<6FCO9W3:U%IMPETY7'[U03&=OSHPX#
M8'!)QQ4FM:5XIMM<T7Q3I]I;W]_!!+:WVGK.(PT4C!@(W; RA &3C=CM4OB;
M3/$6O>&+:8V,(OX-3MKU+!9U.V.-U)3S#@%C@G/3G'.,D O3:K;CQWI5A=Z&
M@U26QFEAO"ZL(P-NY%.-W)(YP/QI=-\8F]T_7YY]/%K/HTSPS6[S;F8JH;(P
MOW6!&T]_2J]SI^KW7Q"T+6&TTK:VUE/#.RS(=CR%2 .03C;R<?3-)?>%+N3X
MA1:K;.BZ7>0)_:<7>26!@T!'OS@^R8[T 6[_ ,7"RN!8^39KJ26RW,T%S?+"
MB!LA5#E3N8E6[8XY(R,W_"_B.T\5^';76;))(XIP08Y!\R,I*LI^A!KGM7LO
M$NB>-YM?T+38]6L]0MHX+RT-PL,D;QEMCJS<$88@BNNTTWS6,;ZBL273Y9XX
MFW+'D\*#@;L# SCDY/'2@#A/BA86=WJ_@O[3:03>9KD43^9&&W(58E3GJ.!Q
M4?Q&T>#PMX<D\5^&HX],U#3'CD9+8>7%<QEPK)(@PK#!SG&>.#6KX[TO5M4U
M'PU+INFO=)INI)>SD2QIE5!&T;F&3S]/>F^*-&UKQS:1Z+-:?V5HLDB/?/+*
MKSS*I#"-%0E5!(&6+?A0!<N_&,R0S2V>DO-';Z:FHS232F%-K D(C;2&?"GC
M@=.?3/U#QCJ-QJW@O^Q[2-['6TDN/WTVQV @+A#A2!C(.>>1CWJ/6]$UVZU_
M4H%TR&^TF73E@TXO<*D=G(%8,60Y)8Y&& .  ,C)JG:>'O$=KI_@&X_LJ)[G
M0XW@N;872@X:#RM^[IP1D@9./6@#8UOXA6FDIJ,L,-O<QZ8^RZ0WBQRD@ L(
MD(^?:#W*Y((&<5/'X;TG6]9_X2B&%&CU'3# Y\QP;J.0*0&'10%';GYNV.<N
MSM?%_A?Q!JT&GZ/;ZKI>IW;7L4YO%A-K(X&]7!!++D9&T$_GQWENLJ6T2SR"
M294 =PNT,V.3CMS0!F>&-"A\-:!!I5OQ%$SLJ!BPC#.6V*6Y(7=@9]*UZ**
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M2[GL+Q[1[JS(\JX "LLBX)QE6&1DX(- '4U5T[4;/5K"*^L+A+BUF!,<J=&
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MU#*>H(R*=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/XB.L+9Q/I%I
M:7I$G^DVER^SSHB""%;! .2#R,$ BMBB@#RZ/P/JTEG-)%IMGIBW&NV>H+IL
M$P9((XBN]L@!=S;2< 8Z5T?B'PWJ&J^++6^MI%BMTTJ[LVEW?,DDNW:0/;!-
M==10!Y9;^&_%2Z;X8@30M-M$T"XA=X8[H$W95&1G!"X488M@Y))[8YOV'@[5
MK<_$,R)#_P 3TO\ 8L2=<QNHW>G+"O1** .?\#Z1=:#X)TC2KX(+JUMUCD"-
MN&1Z&N>M]/\ %WA_7O$U]I^E6FH0:I=B6W1KL1-&1&J[FR#E21R."-O?/'H-
M% 'F5IX$U+PW8^'+BSL[/6+K3[2:UO;69P@E$KB4M&S @%7SU R#VKM?#<&H
M0Z:[:G9V-E<2RLXM[(96-/X59N-S8ZD #\JV** .,;2-:L?B?/K5K90W6FZA
M916TTAN CVY1F).T@[A@]JRSX,U<_!#_ (139#_:GD[-OF?)GSM_WOI7H]%
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M@MX9A/((U@8L#$#\A.>Y'6M"BB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6L7U%,[K1;A3*,=?ESFN&LM"UV/6_#M\8O#5E#90RI EA-)YEQ$T1 0!D 8
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M..N*N6FHS/XHU2TEU33)+:WBC=;2,_Z1!E02TO.,'J.!Q0!QGC.V\6^,;/\
MX1R7PC;Q6;3133WC:DK(45@Q1/D#!CC&<<9-=6E_XHCC5$\,V"HH 51JF !Z
M?ZJKVE>)=#UV::'2M7LKV2'F1+>=7*CUP#T]ZU: .>_M+Q5_T+=C_P"#4_\
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MR72M*H,"D9!?GY00,\T <S>6>L:AJNFZG<^$;![S32YM)/[88>5O 5N!%@Y
M'4&M+^TO%7_0MV/_ (-3_P#&JNZ1XET/7S*-(U:SOFB_UBP3*Y7W(';WKG?
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MBO0[>%;:VB@0DK$@0$^@&*HZWX?TKQ':Q6VKV274,,RSQHY(VN,@'@CU/YT
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MF;[0<ROYGFXQO\S=OW8XSG..*T=&T'3/#]H]MIEL((W<R2$NSL['C<S,26/
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M"!GTRS'\34_P;Q_PJG1/I/\ ^CI* .ZK"?QIX9CUC^R7URR6^\SRC"91D/\
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MY/XYTS3=)MM.34HK&:Z^W7Z-((8BRH5159<DG&3D8 KS#6Y#+\'+XF:&8?\
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MTYH ?K?AS1_$EJMMK&G07D2'<GFKRA]5(Y'X&F:%X6T/PTDBZ/ID%IYIS(Z
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M6^=GN@%_UK, I+>N0 *SK_P9X;U2VM+>]T:TFBLXQ%;JR8\M ,;01SC@<=*
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MNQWC3DK_ '<GM[=*FT;P[H_AY)TTC3H+))VWR+"NT,?I^- &G7">*R%^*?@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ[M;6[N!'/="0P)M)+[%W/C [#FO/OB7>:%-X<\3I9")M4@6Q:_EC0\)YZE
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M<>,_*!T&>V:D\=<>,/ C2_\ 'O\ VI(#GIYAA;9^.<U%=RVD7QWL/M+(LKZ
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M87'S>6"IDQU&!VKH-0&HW7Q6$ND:S860GT*)K66>U\]98Q*Y8)AU]4)Z\8H
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MOQ,R3ZY\2);,AH$\-"*Z*<CS]LI /N$Q7H/A"2.7P9HC1NKC[! ,J<_\LUH
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M5#?=.QE#$'UQCUJMHWQ%TF]\&V>O7[26IF\N-HA;RDM,RYV1C;F3V*@C@^E
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MN"_EJ=JY+?,W7GKBNHU3Q?HFD0V<EQ=/)]M3S+9+6%YWE3 )8*@)VX(YZ<T
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MYN;F&WBCGN2K3R*@#2%1M!8]\  53E\.Z+/HXTB72K-]-4Y6U:%3&IR3D+C
M.23^-/UG6]/T"Q%YJ,YBB9Q&@5&=G<]%55!+$\\ =JH1>-/#\NAW&L?;]EG;
M2>5-YL3I)')QA#&1NW'(P,9.1B@"_8:'I.E:<VGV&FVMM9OG?!%$%1\C!R.^
M1ZT[2=%TS0K1K72;"WLK=G,AC@C"*6( )P.^ /RK!O?B%HL/AG5=8MGGD;3D
M/FVTEM+'*KE24#(5W*#_ 'B,=\\5J^&=>@\2:#:ZG"LB>:B^8KQ.FU]H) W
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M_P!K\VPM9/M@ N=\*GSP!@;^/FP.!FFZ9HVF:+;M!I>G6ME"S;F2VA6,$^I
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MI?[Q88P<YYSUKE_%/AW5?$2P>'XXK"U\,DQ&Z96/G.B$'RD0+M4':HSGIVH
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M/:JE[X<T/4KZ.^OM'L+J[CQLGFMD=UQTP2,T >7>&+*6/7OAA'?1GSX=%N6
M<<I\J;?H0IQ736,\,/QOUE)941Y=(MA&K, 7_>-T]:[=[*UDO(KN2VA:YA5E
MCF:,%T!Z@-U .!G%07.C:7>:A;ZA<Z=:37MO_J;B2%6DC[_*Q&1^% 'D:11I
M^R\^U%&86<X'4_:<Y^M>TC[H^E5/[(TW^S/[,_L^T^P8Q]E\E?*QG.-F,=>>
MG6KE '@)4-\-?B@I&0?$4H(_[;1UZ1XI18_'_@((H4+<W:J ,8'V9N/TKI_[
M$TG[/<V_]EV7D74AEN(OLZ;9G)!+.,88Y .3SQ5F6TMI[B">:WBDFMR6AD=
M6C)&"5)Y&1QQVH POB""?ASXDP,_\2RX_P#1;5R*26U[J?PK,;Q3HD4O*L&
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M&4^5CAN<<CC-=IXH4+\1? 6 !B>] QV'V9J &^&_B1I^LV&LWU['-8VVG3S
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MX\*>1;RS,%7S0Z,R@GC.W% '8^#/$<GB#Q!XI*73SV-O<P):JR;#$#"I92"
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M>&DGN-0U*^F9LO+J%I]G8$JI(5=BY3)X//4\G%=/5/2/^0+8?]>\?_H(JY0
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M+'96KSF&/.-[[0<#@^_'2JS_ !$\-IHD.LM>-_9\UZUBDXC)!D&[)_W?E/-
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M2E^&VHWFK?#O1;^_N'N+J: M)*_5CN(YH Z6WMH+2W2WMH8X88QA(XU"JH]
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M9,9VGKN'&,\\5B?"+5]0UW03J6J7^L75W<)OD^U6XCME^9@/)(4 \ 9Y/X4
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MJFEA5GC[_*Q&1^%)-H^F7%B+&?3K26S#;A;O K1@YSG:1C.23^-8.L:UI_\
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M\$DLC=78H"2?QK;H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KA/B\PC\ R2N=L<=[:N['HJB9,D^
MU=W3)H8KB%X9XDEB<89'4,K#T(/6@#A[:YM;_P",L5W:3PW$+>'#Y<T3AU/^
MDX."..U<+XM_Y)C\31_U,7_LUM7MT%E:6NS[/:PQ;$\M?+C"[5SG:,=!GG%#
MV-I)%+$]K T<K;Y$:,$.W')'<\#\J //M;.GQ:Q#=6?BQ/#VNQ:9%O\ M2H8
M+F#+%05? ;#;N5.1GZ5U_A/5)]:\):5J=S;K;S7-LDCQH"%!([ \X/4>QJ_=
M:;87PC%W96UP(SE/.B5]GTR.*M 8&!TH \U^)7VSQ/K6D>!M+DA62<_VA?-,
MI9%@C/R*X!!(9\#&1T%9OC/3_&.D'3O&-]>Z7=_V!+YKQ65H\4CP.0LJY+L"
M-O/3MFO6!;PK<-<"&,3,NTR!1N(],]<4Z2-)8VCD171@596&00>Q% 'G.D^(
M-'TKXC>)[O4=1MK6#4K.QN[*:>0(LT(C8'83UP>P]:X^S\FY\&>&2L!CAD\=
M B)UP54RR84CMCIBO3=;T77SJD%SHLNC26D<(1+/4;7Y;=P>)(V09'&!M/IP
M15SPQX9CT'0(+"YD2]N%G>ZEG>,#=.[EV91VY8@>U '*^+DFM_B9IETWB!M"
M@GTN6WBO#'$RM()%8QDR J"5P>Q.VN=N+."U;0M6L?%LYLI=<NWN-::VB"1S
M21>6" 5\O860C<!C+GFO9;JSM;Z P7=M#<1$Y,<R!US]#0UI;/:?9&MXFMMN
MWR2@*;?3;TQ0!XUXFM;)_!?C&\A\1R:]///I\%U,88UC!29,!3&H5CA\'&<8
M&:[3Q BGXL^"R5!*VVH$''3Y(_\ $UUR:?91V8LX[.W2U'2%8@$'.?NXQUYJ
M9H8GF25HD:2,$(Y4$KGK@]LT >+^(X9FN/'$T4SP1VNNZ;<3RQH',<:I$6?:
M00=OWL$$<<UJSP6=S+KEY_PF4FOW]OX?N4VQPPB-(G&>7B4#.5! )SC)%>I"
MWA5I66&,-+_K"%'S\8Y]>*AMM-L;."2"ULK:"*3.^.*)55L]<@#F@#S?5$5/
MA?X "J !>:1C'U2M'PK>VL'Q5\<64US#'=3SVC0PNX#R 6XR5!Y.,<XKO#;6
M[11Q&",QQD%$*#"D=,#MCM338VC7BWC6L!NE7:LYC&\#T#=<4 0:U_R M0_Z
M]I/_ $$UX]+K&EW_ , ](T.RNH&U:X6SMH;-6'G>=YJ$G9U' +9]"#WKVYE#
M*58 J1@@]#55-+T^.YCN4L;99XUV)*L*AE7&, XR![4 >:>-[ZZ\$>*[W4M/
MB=O^$DL?LD2H/^7],+$?Q5__ !VO0?#6B0^'/#6G:/#@K:0+&6'\3=6;\6)/
MXUDW/AW5=9\66E_K%S9_V3IDS3V-I;JQ:27!"O*6XRH)P%[G-=70!YO\8_\
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MM;T;4+C5K6;4;&?6I(G22%XD?YP/+ 7.T+O [$9ZUT^H3^&M<BUO4=%D@O\
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MU?\ <Z?=]NE &-X!_P"2=^&_^P9;_P#HM:Z*FQQI%&L<:*B( JJHP !V IU
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%9^J6>H78B%AJK6!7.\B!)-_3'WNF.?SH T**Y[^QO$/_0UR?\
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M;Q#_ -#7)_X 14?V-XA_Z&N3_P  (J .AHKGO[&\0_\ 0UR?^ $5']C>(?\
MH:Y/_ "*@#H:*S=+L=3M))&O]8:_5@ JFW2/:?7Y>M:5 !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:*Q]!\4:7XC%PMA+()[9@MQ;3Q-%-"3TW(P!&?7I6Q0 4444 %%%% !1110
M45FZKK=MI%QID%PDK-J-T+2(Q@$*Y1FRV2.,(>F>U6KR^MM/M_M%W,D,6](]
M[GC<S!5'XL0/QH L45FP:W;7'B&\T5$E%S:017$C$#85D+  '.<_(<\>E:5
M!1110 4444 %%%% !1110 4444 %%%175S!96DUU<RK%! C222,>%4#))^@%
M $M%-CD2:))8V#(ZAE8=P>AIU !114%Y<&SL9[D037!BC9Q# H,DF!G:H) )
M/0<T 3T5@7?BVTL+KP_:W5I>Q3ZVQ6&-D4-"P4,1)\W!&<<9YJ;1O$MGK>J:
MQI]M'.DNE3BWG,B@*S$9RN"<CZXH V:*** "BJ]]?6VFV,U[>S)!;0(7DD<\
M*H[FK% !1110 4457EOK:&\M[.29%N+@.88R>7"XW8^F1^= %BBJ5CJ+7MQ>
M1-87EL+:7R@]P@59O]I,$Y7W.*NT %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSNO+*WG"PS/M"EB-I() &<$ XY!KI-/LHM-TVUL8"QBMH4A0N<G:H &?? H
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M*@T;38[*WDFD52S-)/(7DD9B69F8]222:H?\(GIW]CZUI>^?[/K$L\MR=XW
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M=8D&0P(/R\<#@=<UJWVA6>H:Q8ZG<;S-9Q311H"-C+*%#;ACGA10!Q!O[L>
M?AU-]KG\ZYO--69_,.Z4-'E@Q[Y[YZUBVT^OZN+C6K'2-=GU<:I)Y-VE]&MJ
ML,<Y0P^491\NQ2#E,[B3Z&NRL_AOI=H-.1M1U:X@TR=)[&">X#);E3D*H"C(
M[?-D@< CFK;>![ ZE)<QW^I16LMT+R73XYPMN\V0VXC&[E@&(# $]J .GHJE
M:::EIJ-_>K<7,C7C(S1R2;DCVKMP@_A!QD^IJ[0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !13(Y8Y5+1NKJ"1E3GD=J?0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %<UXOU6Z@M[;1M)?;K&JL8;=^OD(!^\F/LB]/5BH[UTM<
MUK/@JTUC7!K!U/5K*\%N+;=977E#8&+8Z>I_0>E &7\*+.+3O"M[8PEC%;:M
M>0H7.3M65@,GN<"NYKB_AYX5O/#-IJ8O;F]>2XOIW2.>X$J^69&*N,=&8$%N
MY/I7:4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
*%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>employementagreement_mil018.jpg
<TEXT>
begin 644 employementagreement_mil018.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M\0RV=R@N$REK$AEE+$D! %')X^@[G'-6M#N-9N_M=SJMHEE$\@^R6I96EC0
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MA^[N-2L88O"UOIUU;:M]LEU6 QB-X@Y9L$-YA:13M*D8Y/. * .DLO%5O?\
MBRXT*"UN/]'MVE:YD0HC,KA"J9'S8)Y8<9&!GG&<GC#5+NQ?6--\./>:*K-M
ME6YQ<3(IP7CAVG<."0"P)'0<BM)]-N6\=KJ/E?Z'_9;6YDW#[YE#8QG/0=>E
M8&E_\)1X=\-Q^&K+07N+FU0V]GJ)GB%L8P<))("V\$#&5"G)'!YH W=>\66V
MB7NDV?D27%QJ-S%$$7Y?*1W"^8^1P 6 QU)^AQT%>>:]X+\03W@O;/65FFGU
M*UGE#6B9B2-AC!+?=3EMO<D]R:]"&0H!.3CDT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4KK2-,OKJ&ZN].M+BXA_U4LT"NZ=_E)&1^%7:* "BB
MB@ HHHH **** "F0PQ6T"001)%%&H5(T4*J@=  .@I]% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ@^L3W&HF"!+20B2.7<5D#XV[<-GKGC'4BM_PY:7,?CS1IGMY5C7PE%$SLA
M#^:AVD^OM0!?A^(2RZ(UQ_8]R-474CI1TXRIG[3C./,SMV[>=U6)/&DUEH\]
MQJ6@WUKJ$=S':166Y7^TRR8V".3[K YY/&,'/2N5%M8Q6?BM=?T>^N-.G\2L
MYE@C?? /*CVSKM^; 88W+GKZ9K,N[*_U70)6BN-=U/0-+UFVNK:>42)>/ $9
M9MAPKL$+Y!QG@C)Q0!V.H>)KB_\ #WB?3+_39=*U6UTN6?RC,L@>-D<*Z.O7
ME2#TP:B\#:I>6GPP\*2Q6%SJ,EP(H93&W,2L3F1B>H&.?K65:V.B76E^*+S0
MH-=NW_L>6V%[?R3NLNY6/EQB4[B00#P,?-6IX-U6/PQ\,/"JZE;7:O.8;+8L
M1W1R2,0I<'&T9P,^XH [ZN(U>:3Q#\1[+PZ'9=-TVV&I7JJ<>=(6VQ1M_LC!
M<CH<"NWKA=-_T+XTZ[%+P=0TJVN(">XC9D8#\2/SH BUOQM<76G^(TT_0[JX
MTS3UGM;C4$F1=LBH=^V,_,P7/)'H< XK'2XF\/\ A/P/XOBFDV+:V=GJ:%B5
ME@E50'(_O(Y!!Z\D4RTU-O#VA^+?#-QI]_)JL]W>R644=I(ZW*399'#@;0.>
M<D8P:7Q+%)_PH30M':-DO;^+3K**)AAO,+1G&/4!3^5 'K->8>)98KOXJOIN
MI>*;_1M/31HYT6WU'[*K2F9U/7@G'\J]/KRSQ,^D67Q;>\U_1Y;ZP?1(XHF_
MLYKI1)YSGLK8./YT =#H-G8:<+Z\T;Q'J/B*XC@/^B3ZL+A<]1CLK'& 3[T^
M/X@V-WIVB3:?:S7-[JTQACLLA9(BO^M,F?NB/'/X8ZU6T3Q-X0MOMKZ/HT]D
MT=NTTOE:-);F15[ [!N// Z\US.CZ=JWASQ!%X[OM.^3796CO[.&'+Z>DA7R
MG&!DGY1YGN<XXH ZS4O'<MI<:G)9Z%=7VF:2YCO[V.5%\M@ SA$/+[01GIWQ
MFK.I^,)8]4BTS0M)DUF\:U6\D$<Z0I'$QPI+-W;!P/;/%<#<Z7I6F:GXEL]<
MB\2/=7=_-<6EMI\UR(KV.7D*H0[,Y)5MV.G/%;T<UOX#\:W5U>VMY'I%]I=K
M#;S1P//Y3P!E\IM@8Y(8$'H<'F@#H-/\;VVHWN@VT=C<Q/JT5Q(!,-C0-#M#
M*R^N3V],]ZS?%GCBZT_2_%T6EV+M>Z+!&?.+KA3+$6$@!Z[>..]9NIZW<_V[
MX.\6:MI%YI]DJ7L,R>6\SVXD"^49%5<C<$Z8XS@UF7L=[KMG\4+FVTV]5;ZT
MM_LB2P,CS*L+#(4C/.,XZ\C(SQ0!M:AK\4EMX*F\1:-<K?7E_$EOY=V $D(&
M)&V$!@>NTUU>A>)(M;N]8M#;O;7.E79MI8W8'<,!ED'^RP.1]*\\URY_M^#X
M;W.G6]W+';:K L^ZVD0QE57=N# 8 ]>GO5GX@6^KZ-XCNKK0K2>9O$NG_P!F
MR&%"1%<!@J2L1T 1WY_V: -ZV^(@U+3K"?3-&N+JYU*>=+&W\U4\V*(X:9F/
M"K^9Y'K6_P"'=?77K2X9[26SO+2=K:ZM96#-%( #C(X8$,"".H-<-XH\,V.B
MWOA62;^TX]#T^SEL)9M.>5)(20A1V\KYMI*$'MDC-=+X$L],BL;^\TNUU2*&
MZN<F;4I)&DN=JA1(/,.X+@8&<'Y>F,4 :OB#7X_#\%A++ \PN[Z&R4*0-ID;
M:&/L*2XU^.W\5VF@F!S)<VDMT)0PP C*I&/?=^E8OQ*BG.@:?>PV\TZ:?JMI
M>3)"A=_*20%B%')P.:S+;5%\0?%/3=1L+6\.FQZ3<Q+=RVSQ*[EXR0 X!X&.
M<<\XZ&@!T'Q1DFT"U\1#PW>+H4CHD]XTZ Q%GV$A.K*&.">.^,XS6S?^+[E/
M$5UH^D:%<:I)81I)>R).D8BW@E57=]YB!G' Z<UQ1T^\_P"&;(K+[)/]K\A!
MY'EG?G[0#]W&>G-;4.JQ^$?B#XG;4[6],6K&WN+&2WM))A,5B"-&-@.&!'0X
MX- %3P5XK-CX"TLP6MQJ.H:GJ%W':6V\(SXFD8EF;[JJHY].!BMN[^(D.F^&
M]5U/4=,GMKK2KB*"\LFD5BGF%0K*PX92'!!]B*X&QT:<>%_"NIZO::I:VMG?
MZBM\MDTJ36XFD;:_[OYBH*@''9L]*NZ[I6GW/PY\1W&@V&M3?:KNS3S[YI9'
MNQ'*AW(),OM&6&2!T]!0!VK^--26*SC/A:Z34=0FD6RLY+F-3)"B!C*[9PG7
M&TY.:RO$WCC7[2QT"2RT&ZM;B[U=+*XAG>,'(8YC4G((< XD'&.X-:OCT:*\
M>GIKMGJ MM[M'J5B)-]E( ,',?S+N!(S@CCGM7&:A/JC>$]!U"^_M*]L=.\4
MQ317,]LQN&LEW!970+N/)(SC)&#CF@#M]4\7:I8RR1VOA:\NS:VJ7-ZPG2-8
MMP)*(3Q*P .=O'3GFF77CV(7NDVFF:7<ZC-JU@;VT".J K\O#%N%X;.3Z8Y)
M KE-9NH];U_6H]077;CS[>$Z#9VQN8(I5>($LVS: =Y.[S.@'2I?!*2S:WX+
MD%M<HEKX;DM9C+ Z>7*K1 J=P'.0?KB@#HD^(EO%X>U6_P!0TNYM;W3+H6<U
M@'61WF;;L",.&#;Q@_6LBYUS4;KXE^$H=4TJ?2I$AOI'C,ZRQR*8UP=R\$@@
MY!'&1US63KNEZB\WBZ]@L+B;[)K]A?K$D9+3QQ)&7V#^+ ST]*UKG7$\2?$?
MPM>Z58WL]A:07H>XDM7B5G:-<(-X'/RCGIDXSUH WM"\97FM3V$I\-WL&EZB
M"UI?>8D@(VEE,B+S&& X)SR0#C-=5,SI#(\<?F2*I*ID#<<<#)Z9KRKP_+:0
M>)M(3PFNMV:S3-_:NC7,,HMK6/8Q8_.-J,'V@;#@YZ8KUB@#Q;4O%NN:W\*_
M%%YJ5I);)!?E(IUE3Y%6Z0>5A.?E'&[O7>V7C*Z?Q)8Z3J>@76FKJ22/8S23
M(_F;!N*NJ\HVWG!S7G;&4_#3Q;X>^QWG]J1:J\Y@-K)\T;7:$,K8VL".>#TY
MZ5W_ (HMIIO'O@J2.*1HHYKSS'520F;<@9/;F@".'X@F5H+XZ)<KX?GNA:1:
MH94P6+[%<Q_>$9?@-[@XKM:\0\/:'HUOI>G^'-6MO$T^LPW"P36,<]R+?"R9
M$PY$7EX ?K^&:]OH X'2_&&L2_$#Q-I]_8&+2-,CA+2F:/%NNR1_,./F;> O
M'.W';FKVF>.9KRZTPWN@W6GZ?JS;;"[EE1O,8J74.@Y0LH)'7TXKG+J!W\=>
M/M&ECN(IO$&GP1:?)Y#F.0K;R*WS@;5P3W(JKX6L=!NKGP_:M:^)YM6M622X
MM[F>Y\FQEC7EFWG9C(P-N<[N* .ITSQ]-J^HZA!9Z!<O::;<7%O>7C3(J1M%
MNP #RQ;:.!TW#-9Z_%,C2M,UN;PW?1Z)?LD2W8D1G$C#@"(?,1N!7/&>PP1F
M3P5:7$'A[QDDMO+&\NM:BZ!D(+J3P1Z@]C6.]A=_\*?\%VWV2?SXKO3C)%Y9
MW(!(N21U&.] '4VGCETU6^T_7-%GTJ:VL&U)-TR3"2!3ACE>C XXY^M6-!\4
M:AJUU;)>>&[RPMKR SVUR94F0K@'#[?]6Q!! /!Y&<UEZU#.OQ/2[&G37L">
M'+E3&J9$K>:A\O)XRP!&#63X1DM8/%>GV_A2;6AI#PRG4-/OHI1#984; AE&
M5;=QM!(QGTH ]1)P,UQMGXYN9K[3Q>^';RPTW4IS;VEW-(NYGPQ4/%]Y-P4X
MSGMG%=7>M.MC<-:J&N1$QB!Z%\<?KBO$HI+>2U\+:H\?B&\U.TO[>?6KBZ%R
MRV[8(9?+/R_>/&Q3@#WY .YG^(ETT6LS:=X9N[V#1KF:"]E%PD841]2F>7..
M<#VYR:OWWC9?-T>VT33)=4O-4M?ML40E6$1P8!WNS=/O  <Y-9&AVES'X4\>
MQO;RJ\VIZDT2E"#("O! [@]L5D:5*WA74_"&N:G;7::?+X7BTV62.W>0V\PV
M. ZJ"1GD=.HH WO &HS:GXD\9330SV["_A4V\Q!,3"%0R\$C&0>1P>O>NI\0
M:Y:^'-$N-4O!(T4( $<0R\C,0JJH[DD@?C7+^ )9[OQ#XPOY;&YM8KJ^BD@%
MQ$8RZ>2H#8/J #CJ,X.#5[XCZ?>7_A,O8V[W,]G=V]X+>,9:41R*S*!W. <#
MOB@!;3QI-#<74'B'1+C1F@LWO1(TJSQM$GWOF3@,/[OY9JK:^/KDMIESJ7AR
M[T_2M4E2&UO'G1R&D_U?F(.4#?C@D9Q536-=;Q[HNLZ%H.GW;PS:9+NO;B)[
M=4F(PD(#J-Q/.2.!^-9>HZN/%WA_0/#EA8WZ:F+JT:]BEM)(Q9K$P9RS,H7^
M' P><C% &_/X]O'N-9@TOPU=7[:/.T5TPN$C7:%#94M]XG)^4>G)Y%3/XZ-X
MFEKH&CSZI<:A8_V@(C,D CAR!\S-_%DXP/0U6\,6L\3^.O,@D3SM5F:/<A&\
M>1& 1ZC.:Y6T@T:#P;X3A\0VNLZ;<PZ8OV?5;%)5DA?.&B)C!(/ .&&#]: .
MXN/&<WEZ7!8:%>SZMJ$3S"PF98&@1" [2,W &2 ,9SGCBH)?B# FA074>F7+
MZG-?G35TS<HD%R,[E+9VA0!NW=,8/>N*>TNY)_#NO>+GUJ.WDTZ>TFNK3SH9
MHV$VZ%IEB^8;TZC& V,XJS+8VFEV.@^)-+TS61IUMK<ES=_:Q)-</&\9B^T;
M6R^WA3@C..<4 =5#X^E35=0TS4-#GLKRPTM]2E1IE=653@!&'!!]>,$$8K0N
M?%\%MX:T36C:2-'JTMI&D889C\_&"3WQNKBY;\>*_B'K7]G03^5-X4EM[9YH
MFB,Q,IY 8 [<MC) Z'M5*36?[5\%>#=&L]/U%KW3[W35OT>SD06WELJMN+*
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MZ6TJ!"2@4#<2.P'?/2@"U;>(]$TWQ9XXG-E=13Z7;P3WTYF9UF7RBRA$)PI
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M7."0OTKV6B@#S"PL_#OV;6K_ $SPKK>HVPM%MY6O7N&:ZC9\O'''.=QV@;N
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MU<D#:<\D$'/%:E5TL;:/4)K]8@+J:-(GD)))12Q4>P!9CQZU8H \(U.TFO\
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M%)+D-*[+\VWGY2*]FHH X#7-4;7O"D&B>']&NH#J[O9_Z5I[11VD./WDCJP
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M0?-N P"<@'H2#BO2J* /,M:TZ^DO_B@R6=PPN]'MX[<K$Q\YA#,"J<?,<D#
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M[:+*D[I'.%7@=S^%1-?7HU]+$:7(;$V_FF_\U=BODCR]OWLXYSTYH T****
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M@NP4D9/KGK7'^!O TVL_#;2+2[UF_ATF<>;=:9Y:8<B0DKO(WJI(!(SW/3-
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M:1KH'[Y7&W&.-N,8 K0@\((GC"S\37&HSW%_!I@T]MR*JRC<6+D #!))X'%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M77_QNC_A-M%_ZB7_ (*KK_XW70T4 8MGXKTJ_NX[6#[=YLAPOF:=<1K^+,@
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M3;1?^HE_X*KK_P"-T?\ ";:+_P!1+_P577_QNNAHH Y[_A-M%_ZB7_@JNO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N/
MU_PEJ+^)(_$WAK4(++5O)^SW$5U&7@NXP<@. 001V8<]J["B@#C+70/%6J:S
M97WB35K.&VL9/-BL=)$B)+)@@-([') R?E P>]/\+>"DTU=3O-=2SU#5=2O'
MN9I?*W*BGA$7<,X4"NPHH Y*Z\'F#QOI7B+1OLMF(89+6^@";1/"W*XVC&Y6
MYYJQX(\-3^%_#7]EW<T4[FXFE+1@[2'<L!S[&NEHH YCPCX:N_"LNI6$=S%)
MH;SF;3X>=]MNY>/TV9Y'IS1?>&;BZ^(NE>)%GB6WLK.6W>(YWL7/!';%=/10
M!ROCOPWJ/B33]+72Y[6&[T_4X;]#=!BC&/=@';SR2*K[/B7_ ,]_"7_?FY_^
M*KLJ* .3U'2_%MOK4FIZ'J=C*ES"B3V&H^888W4??B*G*YSR,<]:;I'A;488
MM?O=5O+:;5]:C6.3[/&4AA5$*HJY))QN))/7/2NNHH \TLOASK%G\)8O!<>I
MVR2R3%;JY3=CR&D+,%X^\1QSQR:[B'PYHEO;QP1Z38B.-0B@VZG  P.U:=%
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M=)HYML_O! DH?'MDXK:HHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*HV^,O\ GIH/_?N;_P"*KH:* .>V^,O^>F@_]^YO_BJ-OC+_ )Z:#_W[F_\
MBJZ&B@#GMOC+_GIH/_?N;_XJC;XR_P">F@_]^YO_ (JNAHH Y[;XR_YZ:#_W
M[F_^*HV^,O\ GIH/_?N;_P"*KH:* .>V^,O^>F@_]^YO_BJ-OC+_ )Z:#_W[
MF_\ BJZ&B@#GMOC+_GIH/_?N;_XJC;XR_P">F@_]^YO_ (JNAHH Y[;XR_YZ
M:#_W[F_^*HV^,O\ GIH/_?N;_P"*KH:* .>V^,O^>F@_]^YO_BJ-OC+_ )Z:
M#_W[F_\ BJZ&B@#GMOC+_GIH/_?N;_XJGPKXM\^/SI-$\K<-^R.7=MSSC)ZX
MK>HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *B>UMY+B*XD@B:>($1R,@+(#UP>HS4M%
M $-Q9VUWY?VFWAF\IQ)'YB!MC#HPST/O4<VF6%Q>PWLUC;2W<(Q%.\2M(@_V
M6(R/PJU10!6BT^R@MI+:&SMXX)"2\21 *Q/7( P<]Z99Z3ING6SVUCI]K:P/
MDO%!"J*V>N0!@U<HH C@@AM8$@MXHX84&$CC4*JCT '2I*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ***AGNK>VV_:+B*+=T\QPN?S
MH FHJ.&X@N5+031RJ#@E&# '\*DH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "O-/'UM!=>/-!-]X;NM=LXK&YQ;Q6PE7S&:/&2Q"KPIY)KTNN=
MU^\\3:=J=K=:3IL>JZ<8V2YM$E6*97R"KJSD*1C(*\>M %;P-=^'Y[*]M]#T
M?^QY;>?;>6#VZPR1R$#!8+D'(Q@@G(KJZY+PAI.JQZQKWB'6+5+*ZU:2$)9K
M*)##'$A5=S#@L<DG''3FNMH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
6**** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>employementagreement_mil019.jpg
<TEXT>
begin 644 employementagreement_mil019.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M\0RV=R@N$REK$AEE+$D! %')X^@[G'-6M#N-9N_M=SJMHEE$\@^R6I96EC0
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MA^[N-2L88O"UOIUU;:M]LEU6 QB-X@Y9L$-YA:13M*D8Y/. * .DLO%5O?\
MBRXT*"UN/]'MVE:YD0HC,KA"J9'S8)Y8<9&!GG&<GC#5+NQ?6--\./>:*K-M
ME6YQ<3(IP7CAVG<."0"P)'0<BM)]-N6\=KJ/E?Z'_9;6YDW#[YE#8QG/0=>E
M8&E_\)1X=\-Q^&K+07N+FU0V]GJ)GB%L8P<))("V\$#&5"G)'!YH W=>\66V
MB7NDV?D27%QJ-S%$$7Y?*1W"^8^1P 6 QU)^AQT%>>:]X+\03W@O;/65FFGU
M*UGE#6B9B2-AC!+?=3EMO<D]R:]"&0H!.3CDT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4KK2-,OKJ&ZN].M+BXA_U4LT"NZ=_E)&1^%7:* "BB
MB@ HHHH **** "F0PQ6T"001)%%&H5(T4*J@=  .@I]% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MEK7B&2'Q#>Z5:Z9>&PM(K-8\&1$4M))N4E@2W3@8'XT >@45Y+#XM\1:];>
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M8Q)EHU."S*?E'7'4D]>*QO\ A+?$DGP\T:>/45&JGQ"FF27)B&)E$K)\R^X
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M3RF'8),AAL0#H!N &<G YJ__ ,(])_PL(^)OM">4=*%AY.T[MWF^9NSZ=L4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
:HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>employementagreement_mil020.jpg
<TEXT>
begin 644 employementagreement_mil020.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M\0RV=R@N$REK$AEE+$D! %')X^@[G'-6M#N-9N_M=SJMHEE$\@^R6I96EC0
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MA^[N-2L88O"UOIUU;:M]LEU6 QB-X@Y9L$-YA:13M*D8Y/. * .DLO%5O?\
MBRXT*"UN/]'MVE:YD0HC,KA"J9'S8)Y8<9&!GG&<GC#5+NQ?6--\./>:*K-M
ME6YQ<3(IP7CAVG<."0"P)'0<BM)]-N6\=KJ/E?Z'_9;6YDW#[YE#8QG/0=>E
M8&E_\)1X=\-Q^&K+07N+FU0V]GJ)GB%L8P<))("V\$#&5"G)'!YH W=>\66V
MB7NDV?D27%QJ-S%$$7Y?*1W"^8^1P 6 QU)^AQT%>>:]X+\03W@O;/65FFGU
M*UGE#6B9B2-AC!+?=3EMO<D]R:]"&0H!.3CDT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %4KK2-,OKJ&ZN].M+BXA_U4LT"NZ=_E)&1^%7:* "BB
MB@ HHHH **** "F0PQ6T"001)%%&H5(T4*J@=  .@I]% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=EL2N!T/H!71G0_B47WGQ3HN[&,_V9SC_OJE71/B6BA5\5:*JCH!IA _]"H
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M Q@*.Y- 'J=%>,0:AXJO/A=?>+6\47D5W8-</;PQQQ^5(L<K#$H*Y8D C@@
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MAM/M,GEP^:<;V]!^8K3KQ;6;[PUXU\:>)(=<UO3K.RT^T;2K%;FY1#Y[<RS
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MA21G.W/  QDT >FT5Y$/&>KZ=X,O+>\U5_M4'B1]$&IM 'D6('<9"BC#.$!
MXZXIT?BRZM[#Q5:Z7KFH:G;6VBR7UI>WEL4E@F4,&0DHH8?<8<>HH ];J(W$
M N5MC-&)V0NL18;BH."0.N,D<^]>6:I=>)='\%Z1XQ?Q)=S73M://9&.,6S1
MRLH* ;=V<-][=G.>G&"[TR[N?V@1"-<U*%?[$-RIC,>4!GP8AE#\AQG^][T
M>L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8YQ7:T4 >?6O@'4M.\+>&(;&^M5UOP^6,,LB,890X*NC8Y ((YZ@BG:CX/\
M$NLZ=)<:AJ]HVJKJ%O?6MNJN;.'R>B8/S$-DECZXXXKOZ* .'B\->)I?&6F>
M);V^TUIH8I+6>TB5Q&D+%3F-CRSY!R3@=!@8YK:#X+U[1(/$.DB[TZ72=3FN
MKB)RKB='E7 !_AP*]!HH \^L_ &HZ=X3\,VUI?VRZWX?=GAF=&,,H?<'1AP0
M"K=1R,59'A#5]2EUS4]:NK+^T[_3&TRWCM0WDV\1#'DMRQ+,"3@=*[BB@#B]
M8\%W>I?">'PA'=0I=):6UN9V!V$Q%"3ZX.P_G75:DEY)IEU'I\D<=ZT3+ \N
M=J.1P3CL#S5JB@#E_"O@C3/#WAJRTR>UM;NYB3,]Q)"&,LC'<S9(SU)QGMBN
M?U[P);6[>++EKN*R\/:MIP:ZBCB8M!/'TE55'(P,D#DD5Z100",'D4 >/W%[
MJ6M>(? PNM<TG4I5OA-'%I@)#Q+$Q::3))!^Z , #<>O;L_#GA.YT7QMXHUR
M6XADAUAX&BC0'='L5@=W;OVK>L=$TG3)I)M/TNRM)9?]8\%ND;/]2!S5^@#C
M;KP_XDT_6=6N?#=[IL=OJS++,MZCEK>8($+IMX;(53@XY'6GWOA[7[36XM:T
M2^LIKV2Q2SO5U!&5)]A)64>7]ULLW&,8/;%=?10!R%QX6U:]O/"MY?ZG#<W6
MDW$L]U)Y6SS=Z,N$4< #( SV'/-7H/#T\7Q!N_$1FC,$^G1V8B&=P979B?3'
M-=#10!P2^ ;Q=+U:.._@COI=??6[&7866-LJ55QQD8# X[-5ZYT3Q1K6@Z]9
MZS?Z>CW]B]I;6]HC&*(LK R,[#<2=PXZ #N:Z^B@#D-=\(76K?#RS\.17,*7
M$"VJF5@=I\ID)]^=IQ4.L^%M;/Q"MO%>B7.G[AI_V">"]#XV^9OW*5[^Q]/>
MNUHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
?"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Apr. 23, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cartesian Therapeutics, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-1622110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7495 New Horizon Way<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Frederick<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">21703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">348-8698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RNAC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Smaller Reporting Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,381,514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001453687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 118,641<span></span>
</td>
<td class="nump">$ 125,139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">261<span></span>
</td>
<td class="nump">1,115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">3,137<span></span>
</td>
<td class="nump">3,022<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">122,039<span></span>
</td>
<td class="nump">129,276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">11,637<span></span>
</td>
<td class="nump">12,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets, net</a></td>
<td class="nump">5,366<span></span>
</td>
<td class="nump">5,601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">In-process research and development asset</a></td>
<td class="nump">93,900<span></span>
</td>
<td class="nump">93,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">48,163<span></span>
</td>
<td class="nump">48,163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Long-term restricted cash</a></td>
<td class="nump">1,735<span></span>
</td>
<td class="nump">1,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent', window );">Long-term prepaid expenses and other assets</a></td>
<td class="nump">5,551<span></span>
</td>
<td class="nump">5,551<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">288,391<span></span>
</td>
<td class="nump">296,411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,598<span></span>
</td>
<td class="nump">1,288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">10,161<span></span>
</td>
<td class="nump">9,498<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities</a></td>
<td class="nump">4,186<span></span>
</td>
<td class="nump">4,151<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">15,945<span></span>
</td>
<td class="nump">14,937<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities, net of current portion</a></td>
<td class="nump">7,669<span></span>
</td>
<td class="nump">8,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_WarrantsAndRightsOutstandingNoncurrent', window );">Warrant liability</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ContingentValueRightLiabilityNoncurrent', window );">Contingent value right liability</a></td>
<td class="nump">405,900<span></span>
</td>
<td class="nump">392,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities, net</a></td>
<td class="nump">6,948<span></span>
</td>
<td class="nump">6,948<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">436,509<span></span>
</td>
<td class="nump">422,651<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note&#160;14)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, value, issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 350,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 28,544,728 and 26,011,106 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">718,017<span></span>
</td>
<td class="nump">700,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(861,555)<span></span>
</td>
<td class="num">(822,373)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(4,583)<span></span>
</td>
<td class="num">(4,576)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; deficit</a></td>
<td class="num">(148,118)<span></span>
</td>
<td class="num">(126,240)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; deficit</a></td>
<td class="nump">288,391<span></span>
</td>
<td class="nump">296,411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, value, issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, value, issued</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_ContingentValueRightLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Value Right Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_ContingentValueRightLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_WarrantsAndRightsOutstandingNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants And Rights Outstanding, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_WarrantsAndRightsOutstandingNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-41<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478064/805-740-55-13<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-39<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">9,427,168.437<span></span>
</td>
<td class="nump">9,427,168.437<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">350,000,000<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">28,544,728<span></span>
</td>
<td class="nump">26,011,106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">28,544,728<span></span>
</td>
<td class="nump">26,011,106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">134,904.563<span></span>
</td>
<td class="nump">134,904.563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">120,790.402<span></span>
</td>
<td class="nump">120,790.402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">120,790.402<span></span>
</td>
<td class="nump">120,790.402<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">437,927<span></span>
</td>
<td class="nump">437,927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">437,927<span></span>
</td>
<td class="nump">437,927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">437,927<span></span>
</td>
<td class="nump">437,927<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Collaboration and license</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Grant</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">19,463<span></span>
</td>
<td class="nump">14,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">7,114<span></span>
</td>
<td class="nump">8,315<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">26,577<span></span>
</td>
<td class="nump">22,989<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(26,499)<span></span>
</td>
<td class="num">(21,889)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">1,026<span></span>
</td>
<td class="nump">2,015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Gain on change in fair value of warrant liabilities</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">1,818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_FairValueAdjustmentOfContingentValueRightLiability', window );">(Loss) gain on change in fair value of contingent value right liability</a></td>
<td class="num">(13,800)<span></span>
</td>
<td class="nump">346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other (expense) income, net</a></td>
<td class="num">(12,683)<span></span>
</td>
<td class="nump">4,179<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(39,182)<span></span>
</td>
<td class="num">(17,710)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other comprehensive (loss) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="num">$ (39,189)<span></span>
</td>
<td class="num">$ (17,678)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net loss per share allocable to common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (1.46)<span></span>
</td>
<td class="num">$ (0.68)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (1.46)<span></span>
</td>
<td class="num">$ (0.68)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">26,855,158<span></span>
</td>
<td class="nump">25,902,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">26,855,158<span></span>
</td>
<td class="nump">25,902,650<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_FairValueAdjustmentOfContingentValueRightLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Adjustment Of Contingent Value Right Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_FairValueAdjustmentOfContingentValueRightLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueNotFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue that is not accounted for under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueNotFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Stockholders&#8217; Deficit - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Series A Preferred Stock</div></th>
<th class="th"><div>Series B Preferred Stock</div></th>
<th class="th">
<div>Preferred stock </div>
<div>Series A Preferred Stock</div>
</th>
<th class="th">
<div>Preferred stock </div>
<div>Series B Preferred Stock</div>
</th>
<th class="th"><div>Common&#160;stock</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Accumulated deficit</div></th>
<th class="th"><div>Accumulated other comprehensive loss</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, beginning balance (in shares) at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,790.402<span></span>
</td>
<td class="nump">437,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2024</a></td>
<td class="num">$ (6,802)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 689,887<span></span>
</td>
<td class="num">$ (692,071)<span></span>
</td>
<td class="num">$ (4,621)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,767,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of common stock upon vesting of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">2,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(17,710)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,710)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, ending balance (in shares) at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,790.402<span></span>
</td>
<td class="nump">437,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2025</a></td>
<td class="num">$ (21,789)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">692,578<span></span>
</td>
<td class="num">(709,781)<span></span>
</td>
<td class="num">(4,589)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,936,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, beginning balance (in shares) at Dec. 31, 2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">120,790.402<span></span>
</td>
<td class="nump">437,927<span></span>
</td>
<td class="nump">120,790.402<span></span>
</td>
<td class="nump">437,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2025</a></td>
<td class="num">$ (126,240)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">700,706<span></span>
</td>
<td class="num">(822,373)<span></span>
</td>
<td class="num">(4,576)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Dec. 31, 2025</a></td>
<td class="nump">26,011,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,011,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">$ 304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of common stock upon vesting of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock through at the market offering, net of commissions and expenses (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,270,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock through at the market offering, net of commissions and expenses</a></td>
<td class="nump">14,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">2,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (39,182)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39,182)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, ending balance (in shares) at Mar. 31, 2026</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">120,790.402<span></span>
</td>
<td class="nump">437,927<span></span>
</td>
<td class="nump">120,790.402<span></span>
</td>
<td class="nump">437,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2026</a></td>
<td class="num">$ (148,118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 718,017<span></span>
</td>
<td class="num">$ (861,555)<span></span>
</td>
<td class="num">$ (4,583)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Mar. 31, 2026</a></td>
<td class="nump">28,544,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,544,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (39,182)<span></span>
</td>
<td class="num">$ (17,710)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">615<span></span>
</td>
<td class="nump">1,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Non&#8209;cash lease expense</a></td>
<td class="nump">235<span></span>
</td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock&#8209;based compensation expense</a></td>
<td class="nump">2,423<span></span>
</td>
<td class="nump">2,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Gain on change in warrant liability</a></td>
<td class="num">(94)<span></span>
</td>
<td class="num">(1,818)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_FairValueAdjustmentOfContingentValueRightLiability', window );">Loss (gain) on change in fair value of CVR liability</a></td>
<td class="nump">13,800<span></span>
</td>
<td class="num">(346)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">854<span></span>
</td>
<td class="num">(893)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(246)<span></span>
</td>
<td class="num">(5,830)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">310<span></span>
</td>
<td class="nump">1,819<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(850)<span></span>
</td>
<td class="num">(2,178)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(22,135)<span></span>
</td>
<td class="num">(23,108)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(1,075)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(1,075)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Equity offering costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(454)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">279<span></span>
</td>
<td class="nump">183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from at the market offering, net of commissions and expenses</a></td>
<td class="nump">15,392<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_PaymentsForContingentValueRightsDistributions', window );">Distribution of Contingent Value Rights</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7,754)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">15,671<span></span>
</td>
<td class="num">(8,025)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(6,498)<span></span>
</td>
<td class="num">(32,176)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">126,874<span></span>
</td>
<td class="nump">214,279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">120,376<span></span>
</td>
<td class="nump">182,103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash investing and financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchase of property and equipment not yet paid</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_EquityOfferingCostsInAccruedLiabilities', window );">Equity offering costs in accrued liabilities</a></td>
<td class="nump">$ 707<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_EquityOfferingCostsInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Offering Costs In Accrued Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_EquityOfferingCostsInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_FairValueAdjustmentOfContingentValueRightLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Adjustment Of Contingent Value Right Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_FairValueAdjustmentOfContingentValueRightLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_PaymentsForContingentValueRightsDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Contingent Value Rights Distributions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_PaymentsForContingentValueRightsDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Description of the Business</a></td>
<td class="text">Description of the Business<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cartesian Therapeutics, Inc., or the Company, </span><span style="color:#231f20;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">was</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> incorporated in Delaware on December 10, 2007, and is headquartered in Frederick, Maryland. The Company is a late clinical-stage biotechnology company </span><span style="color:#231f20;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">pioneering cell therapy for the treatment of autoimmune diseases. The Company leverages its proprietary technology and manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell&#8217;s genetic material. The Company&#8217;s cell therapies are designed to be dosed repeatedly like conventional drugs, administered in an outpatient setting and given without pre-treatment chemotherapy, which is required with many conventional cell therapies.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">The Company&#8217;s Product Candidates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company aims to provide a personalized approach to treating patients that begins with the collection of a patient&#8217;s cells, which are then used to manufacture the Company&#8217;s cell therapy product candidates. Once a patient&#8217;s cells have expanded in the Company&#8217;s process, mRNA is introduced to deliver a chimeric antigen receptor into the cell. Once the manufacturing process is complete, the product candidate is sent back to the treating physician where they administer six weekly infusions of the Company&#8217;s cell therapy candidate to the patient. The Company&#8217;s product candidates are specifically designed to target and destroy the pathogenic, self-reactive cells that are the underlying cause of the autoimmune disease, with the goal of creating a precision immune reset for the patient.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Descartes-08, the Company&#8217;s lead cell therapy product candidate, is an autologous chimeric antigen receptor T-cell therapy, or CAR-T, product targeting B-cell maturation antigen, or BCMA, in clinical development for the treatment of generalized myasthenia gravis, or MG, and myositis, specifically, moderate to severe multi-refractory dermatomyositis and antisynthetase syndrome. In contrast to conventional DNA-based CAR T-cell therapies, the Company&#8217;s CAR-T administration is designed to not require preconditioning chemotherapy, to be administered in the outpatient setting and does not carry the risk of genomic integration associated with cancerous transformation. Descartes-08 has been granted Orphan Drug Designation and Regenerative Medicine Advanced Therapy Designation by the U.S. Food and Drug Administration, or FDA, for the treatment of MG, and Rare Pediatric Disease Designation for the treatment of juvenile dermatomyositis.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Management&#8217;s Plan</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026, the Company had an accumulated deficit of $861.6 million. The Company anticipates operating losses to continue for the foreseeable future due to, among other things, costs related to research and development of its product candidates and its administrative organization. The future success of the Company is dependent on its ability to develop its product candidates and ultimately upon its ability to attain and sustain profitable operations. The successful development of product candidates requires substantial working capital, which may not be available to the Company on favorable terms or at all.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026, the Company&#8217;s cash, cash equivalents, and restricted cash were $120.4 million, of which $1.7 million was restricted cash related to lease commitments. The Company believes the cash, cash equivalents and restricted cash as of March 31, 2026 will enable it to fund its current planned operations for at least the next 12 months. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Further, the liability associated with the CVR Agreement (as defined below) will be settled solely through cash flow received under the Company&#8217;s License and Development Agreement, or as so amended, the Sobi License, with Swedish Orphan Biovitrum AB (publ.), or Sobi, and any other Gross Proceeds (as defined in the CVR Agreement) net of certain agreed deductions. Under the CVR Agreement, 100% of all milestone payments, royalties and other amounts paid to the Company or controlled entities under the Sobi License, and any other Gross Proceeds will be distributed, net of specified deductions, to holders of the CVRs. There is no obligation to the Company to fund any amount related to the CVR liability. See Note 5, &#8220;Fair Value Measurements&#8221;.</span></div> If the Company is unable to obtain additional funding on a timely basis, it may be forced to significantly curtail, delay, or discontinue one or more of its planned research or development programs or be unable to expand its operations or otherwise capitalize on its commercialization of its product candidates.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480922/205-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481034/205-10-S45-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Basis of presentation and consolidation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Selecta (RUS), LLC, or Selecta (RUS), a Russian limited liability corporation, and Cartesian Bio, LLC, a Delaware limited liability </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">company, which is a variable interest entity for which the Company is the primary beneficiary and have been prepared in conformity with accounting principles generally accepted in the United States of America, or U.S. GAAP. Any reference in these notes to applicable guidance is meant to refer to the authoritative United States generally accepted accounting principles as found in the relevant Accounting Standards Codification, or ASC and Accounting Standards Update, or ASU, of the Financial Accounting Standards Board, or FASB. All significant intercompany accounts and transactions have been eliminated.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements for the three months ended March 31, 2026 and 2025 have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission, or the SEC, for interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. These consolidated financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and the notes thereto for the year ended December 31, 2025 included in the Company&#8217;s Annual Report on Form 10-K that was filed with the SEC on March 9, 2026. The unaudited interim financial statements have been prepared on the same basis as the audited consolidated financial statements. In the opinion of management, the accompanying unaudited interim consolidated financial statements contain all adjustments that are necessary for a fair statement of the Company&#8217;s financial position as of March 31, 2026, the consolidated results of operations for the three months ended March 31, 2026, and cash flows for the three months ended March 31, 2026. Such adjustments are of a normal and recurring nature. The results of operations for the three months ended March 31, 2026 are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2026.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Significant accounting policies</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company disclosed its significant accounting policies in Note 2, &#8220;Summary of Significant Accounting Policies&#8221; included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2025. There have been no material changes to the Company&#8217;s significant accounting policies during the three months ended March 31, 2026.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Not Yet Adopted</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Statement Reporting- Comprehensive Income- Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (ASU 2024-03), which requires public companies to disclose, in interim and annual reporting periods, additional information about certain expenses in notes to financial statements, including purchases of inventory, employee compensation, depreciation, amortization of intangible assets, and selling expenses. This guidance will be effective for the annual period beginning the year ended December 31, 2027 and for interim periods beginning January 1, 2028, with early adoption permitted. The Company is currently evaluating the impact of the standard&#8217;s adoption on its consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2025, the FASB issued ASU 2025-10, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (ASU 2025-10), which establishes authoritative guidance on the recognition, measurement, presentation, and disclosure of government grants. Under ASU 2025-10, government grants are recognized when it is probable that the entity will both comply with the conditions of the grant and the grant will be received. The ASU provides specific accounting models for grants related to assets and grants related to income, including options to recognize government grants as deferred income or as a reduction of the asset&#8217;s cost basis. The ASU also requires enhanced disclosures regarding the nature of government grants, significant terms and conditions, accounting policies applied, and amounts recognized in the financial statements. ASU 2025-10 is effective for fiscal years beginning after December 15, 2028, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-10 on its consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2025, the FASB issued ASU 2025-11, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interim Reporting (Topic 270): Narrow-Scope Improvements</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (ASU 2025-11), which clarifies the guidance in Topic 270 to improve the consistency of interim financial reporting. The ASU provides a comprehensive list of required interim disclosures and introduces a disclosure principle requiring entities to disclose events since the end of the last annual reporting period that have a material impact on the entity. ASU 2025-11 is effective for fiscal years beginning after December 15, 2027, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-11 on its consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text">Goodwill and Indefinite-Lived Intangible Assets<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026, the Company has goodwill of approximately $48.2&#160;million and an indefinite-lived intangible asset of $93.9&#160;million related to Descartes-08 for MG.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes to the carrying value of the Company&#8217;s goodwill or in-process research and development asset related to Descartes-08 for MG during the three months ended March 31, 2026 and 2025.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Indefinite-Lived Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Indefinite-Lived Intangible Assets</a></td>
<td class="text">Goodwill and Indefinite-Lived Intangible Assets<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026, the Company has goodwill of approximately $48.2&#160;million and an indefinite-lived intangible asset of $93.9&#160;million related to Descartes-08 for MG.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes to the carrying value of the Company&#8217;s goodwill or in-process research and development asset related to Descartes-08 for MG during the three months ended March 31, 2026 and 2025.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Allocable to Common Stockholders<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share Allocable to Common Stockholders</a></td>
<td class="text">Net Loss Per Share Allocable to Common Stockholders<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss per share allocable to common stockholders for the three months ended March 31, 2026 and 2025 (in thousands, except share and per-share data):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(39,182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(17,710)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding - basic and diluted</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">26,855,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,902,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net loss per share allocable to common stockholders:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1.46)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.68)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the potential dilutive shares of common stock excluded from the computation of the diluted net loss per share allocable to common stockholders for all periods presented, as the effect would have been anti-dilutive: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options and restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,278,679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,047,628&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">692,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">692,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Series A Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,026,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,026,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">437,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">437,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,435,224&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,204,424&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2026 and December 31, 2025 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds (included in cash equivalents)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">117,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">117,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">117,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">117,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liability</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value right liability</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">405,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">405,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">405,947&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">405,947&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds (included in cash equivalents)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">122,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">122,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">122,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">122,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liability</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value right liability</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">392,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">392,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">392,241&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">392,241&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers within the fair value hierarchy during the three months ended March 31, 2026 or the year ended December 31, 2025.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026 and December 31, 2025, money market funds were classified as cash and cash equivalents on the accompanying consolidated balance sheets as they mature within 90 days from the date of purchase.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026, the Company had restricted cash balances relating to secured letters of credit in connection with its real estate leases. The Company&#8217;s consolidated statements of cash flows include the following as of March 31, 2026 and 2025 (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">118,641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">180,434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Long-term restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">120,376&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">182,103&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrants to Purchase Common Stock</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, the Company issued warrants in connection with an underwritten offering, or the 2022 Warrants. Pursuant to the terms of the 2022 Warrants, the Company could be required to settle the 2022 Warrants in cash in the event of an acquisition of the Company under certain circumstances and, as a result, the 2022 Warrants are required to be measured at fair value and reported as a liability on the balance sheet. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded the fair value of the 2022 Warrants upon issuance using the Black-Scholes valuation model and is required to revalue the 2022 Warrants at each reporting date, with any changes in fair value recorded in the statements of operations and comprehensive loss. The valuation of the 2022 Warrants is classified as Level 3 of the fair value hierarchy due to the need to use assumptions in the valuation that are both significant to the fair value measurement and unobservable, </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">including the stock price volatility and the expected life of the 2022 Warrants. Generally, increases (decreases) in the fair value of the underlying stock and estimated term would result in a directionally similar impact to the fair value measurement. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the 2022 Warrants was determined using the following inputs to the Black-Scholes simulation valuation:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Estimated fair value of the underlying stock. The Company estimates the fair value of the common stock based on the closing stock price at the end of each reporting period.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk-free interest rate. The risk-free interest rate is based on the U.S. Treasury at the valuation date commensurate with the expected remaining life assumption.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Dividend rate. The dividend rate is based on the historical rate, which the Company anticipates will remain at zero.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expected life. The expected life of the 2022 Warrants is assumed to be equivalent to their remaining contractual term which expires on April 11, 2027.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Volatility. The Company estimates stock price volatility based on the Company&#8217;s historical volatility for a period of time commensurate with the expected remaining life of the 2022 Warrants.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Black-Scholes pricing model assumptions used to record the fair value of the 2022 Warrants liability is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.68</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.48</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.03</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.28</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">89.14</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">87.36</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects a roll-forward of fair value for the Company&#8217;s Level 3 warrant liabilities (see Note 9, &#8220;Equity&#8221; to these unaudited consolidated financial statements) for the three months ended March 31, 2026 (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Warrant Liability</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fair value as of December 31, 2025</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fair value as of March 31, 2026</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Value Right</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Company entered into a contingent value rights agreement, or the CVR Agreement, pursuant to which each holder of common stock or a 2022 Warrant in December 2023 was distributed a CVR by the Company. Each CVR entitles its holder to distributions of milestone and royalty payments under the Sobi License, net of deductions. See Note 6, &#8220;Fair Value Measurements&#8221; to the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2025 for further discussion of the terms related to the CVR Agreement. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The CVRs represent financial instruments that are accounted for under the fair value option election in ASC 825, Financial Instruments, or ASC 825. Under the fair value option election, the CVRs are initially measured at the aggregate estimated fair value of the CVRs and will be subsequently remeasured at estimated fair value on a recurring basis at each reporting period date. The estimated fair value of the CVR liability was determined using a Monte Carlo simulation model to estimate future cash flows associated with the legacy assets, including the expected milestone and royalty payments under the Sobi License, net of deductions. Changes in fair value of the CVR liability are presented in the consolidated statements of operations and comprehensive loss. The liability value is based on significant inputs not observable in the market such as estimated cash flows, estimated probabilities of success, and expected volatility of future revenues, which represent a Level 3 measurement within the fair value hierarchy. The significant inputs used to estimate the fair value of the CVR liability, which represented a financial instrument being accounted for under the fair value option, were as follows:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Estimated cash flow dates</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026 - 2038</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026 - 2037</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Estimated probability of success</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">95.0% - 100.0%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">95.0% - 100.0%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility of future revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23.0</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23.0</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects a roll-forward of fair value for the Company&#8217;s Level 3 CVR liability for the three months ended March 31, 2026 (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">CVR Liability</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fair value as of December 31, 2025</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">392,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fair value as of March 31, 2026</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">405,900&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text">Property and Equipment<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consists of the following (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,709&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Construction in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,733)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,637&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,185&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $0.6 million for each of the three months ended March 31, 2026 and 2025, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Accrued Expenses</a></td>
<td class="text">Accrued Expenses<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of the following (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and employee related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration and licensing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued patent fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued research and development costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional and consulting services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued equity offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,498&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains operating leases for manufacturing, laboratory and office space located in Maryland and Massachusetts. In Frederick, Maryland, the Company occupies over 35,000 total square feet of integrated space under a lease agreement, or the Frederick Lease Agreement, and subsequent amendments entered into between February 2024 and June 2025, or the Amended Frederick Lease Agreement. The Amended Fredrick Lease Agreement is set to expire in 2031, carries an aggregate annual base rent of approximately $1.4&#160;million and is subject to annual increases in accordance with the terms of the </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Amended Frederick Lease Agreement. See Note 9, &#8220;Leases&#8221; to the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2025 for further discussion of the Company&#8217;s leases.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2026 and 2025, the components of lease costs were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,001&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The maturity of the Company&#8217;s operating lease liabilities as of March 31, 2026 were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026 (remainder)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,960)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,855&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to operating leases was as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities (in thousands)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,169</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">317</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.7 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.4 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12.2</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11.8</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the Company&#8217;s right-of-use assets and lease liabilities for the three months ended March 31, 2026 and 2025 are reflected in the non-cash lease expense and accrued expenses and other liabilities, respectively, in the consolidated statements of cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Equity</a></td>
<td class="text">Equity<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Equity Financings</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;At the Market&#8221; Sales Agreement</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On December 13, 2024, the Company entered into a Sales Agreement, or the Sales Agreement, with Leerink Partners LLC to sell shares of the Company&#8217;s common stock, from time to time, through an &#8220;at the market&#8221; equity offering program under which Leerink Partners LLC will act as sales agent. The shares of common stock sold pursuant to the Sales Agreement will be issued pursuant to the Company&#8217;s shelf registration statement on Form S-3 (File No. 333-283803), filed on December 13, 2024 with the SEC and related prospectus supplement, filed on January 8, 2025 with the SEC, for aggregate gross sales proceeds of up to $100.0&#160;million. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2026, the Company sold 2,270,712 shares of its common stock pursuant to the Sales Agreement for net proceeds of approximately $14.6 million after commissions and expenses. There were no shares sold pursuant to the Sales Agreement during the three months ended March 31, 2025.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2026, there were no warrants issued, exercised, or cancelled. The following is a summary of the Company&#8217;s warrants as of March 31, 2026:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of Warrants</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Equity<br/>&#160;classified</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Liability classified</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average<br/>exercise price</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,560&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">685,712&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">692,272&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">46.76&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11, &#8220;Equity&#8221; to the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2025 for further discussion of the terms related to the Company&#8217;s warrants.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026, the Company had 120,790.402 shares of Series A Preferred Stock and 437,927 shares of Series B Preferred Stock issued and outstanding, respectively, which are convertible into 4,464,273 shares of common stock. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Reserved Shares</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has authorized shares of common stock for future issuance as of March 31, 2026 as follows:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of warrants</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">692,272&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for future stock incentive awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,641,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">736,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding common stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,542,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Series A Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,026,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">437,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,076,508&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Incentive Plans</a></td>
<td class="text">Stock Incentive Plans<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Company&#8217;s stockholders approved the 2016 Incentive Award Plan, or the 2016 Plan, which initially authorized 40,341 shares of common stock for future issuance under the 2016 Plan. Pursuant to the terms of the 2016 Plan, the Board of Directors is authorized to grant awards with respect to common stock, and may delegate to a committee of one or more members of the Board of Directors or executive officers of the Company the authority to grant options and restricted stock units. The Board of Directors established a Stock Option Committee which is authorized to grant awards to certain employees and consultants subject to conditions and limitations within the 2016 Plan. In January 2026, the number of shares of common stock that may be issued under the 2016 Plan was increased by 1,040,444. As of March 31, 2026, 3,044,044 shares remain available for future issuance under the 2016 Plan.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In September 2018, the Company&#8217;s 2018 Employment Inducement Incentive Award Plan, or the 2018 Inducement Incentive Award Plan, was adopted by the Board of Directors without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Stock Market LLC listing rules, which initially authorized 39,166 shares of its common stock for issuance. As of March 31, 2026, there are 502,296 shares available for future grant under the 2018 Inducement Incentive Award Plan.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 2023, the Company assumed the 2016 Stock Incentive Plan, or the Old Cartesian Plan, of the then private company that merged with the Company in November 2023, or Old Cartesian. . The Old Cartesian Plan permits the granting of options or restricted stock to employees, officers, directors, consultants and advisors to the Company. The unvested common stock options and Series A Preferred Stock options assumed by the Company generally vest over a four-year period. Additionally, the stock options granted have a contractual term of ten years and only full shares can be exercised as per the individual award agreements. As of March 31, 2026, there are 49,149 shares available for future grant under the Old Cartesian Plan. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The outstanding stock options to purchase Old Cartesian common stock were converted into stock options to purchase 776,865 shares of common stock and 14,112.299 shares of Series A Preferred Stock of the Company. The replacement awards that were issued as a part of the assumption of the Old Cartesian Plan resulted in $2.6&#160;million attributed to post-combination </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">service to be recognized as stock-based compensation expense over the remaining terms of the replacement awards, of which $0.1&#160;million and $0.2&#160;million was recognized during the three months ended March 31, 2026 and 2025, respectively as research and development expense in the consolidated statements of operations and comprehensive loss. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense by classification included within the consolidated statements of operations and comprehensive loss, was as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,474&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,423&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,508&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The estimated grant date fair values of stock option awards granted under the 2016 Plan and the 2018 Inducement Incentive Award Plan were calculated using the Black-Scholes option pricing model based on the following weighted-average assumptions: </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.93</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.46</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.20</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">92.71</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">97.44</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average fair value of common stock</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17.46</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The expected term of the Company&#8217;s stock options granted has been determined utilizing the &#8220;simplified&#8221; method for awards that qualify as &#8220;plain-vanilla&#8221; options. Under the simplified method, the expected term is presumed to be the midpoint between the vesting date and the end of the contractual term. The Company utilizes this method due to lack of historical exercise data and the plain nature of its stock-based awards. Expected volatilities are based on the Company&#8217;s historical volatility.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant date fair value of stock options granted during the three months ended March 31, 2026 and 2025 was $5.25 and $14.03, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026, total unrecognized compensation expense related to unvested common stock options was $15.5 million, which is expected to be recognized over a weighted average period of 3.0 years.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the stock option activity under the 2016 Plan, the 2018 Inducement Incentive Award Plan, and the Old Cartesian Plan for options for common stock:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number&#160;of Common Stock Options</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average Exercise Price ($)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average Remaining Contractual Term (in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in&#160;thousands)</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,463,747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13.72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.41</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,962&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,304,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(86,132)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(139,658)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,542,407&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.74</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested at March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,204,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at March 31, 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,139,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.64</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2026, the Company granted 420,650 restricted stock unit awards with a weighted-average fair value of $6.76 per share based on the closing price of the Company&#8217;s common stock on the date of grant under the 2016 Plan, which generally vest over a four-year term. Forfeitures are estimated at the time of grant and are adjusted, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company has estimated a forfeiture rate of 10% for restricted stock unit awards based on historical experience.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized compensation expense related to the restricted stock units was $6.4 million as of March 31, 2026, which is expected to be recognized over a weighted-average period of 3.1 years.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s restricted stock units under the 2016 Plan and the Old Cartesian Plan:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:74.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Grant Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value ($)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">522,498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18.44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">420,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(169,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(37,598)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">736,272&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11.82&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Arrangements</a></td>
<td class="text">Revenue Arrangements<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Collaboration and license revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Swedish Orphan Biovitrum AB (publ.)</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the Company and Sobi entered into the Sobi License, which was subsequently amended in October 2023. Pursuant to the Sobi License, the Company agreed to grant Sobi an exclusive, worldwide (except as to Greater China) license to develop, manufacture and commercialize the Nanoecapsulated Sirolimus plus Pegadricase, or NASP, formerly known as SEL-212, drug candidate , which is currently in development for the treatment of chronic refractory gout. The NASP drug candidate is a pharmaceutical composition containing a combination of a pegylated uricase known as SEL-037, or the Compound, and nanoparticle-encapsulated form of rapamycin, known as ImmTOR. Pursuant to the Sobi License, in consideration of the license, Sobi agreed to pay the Company a one-time, upfront payment of $75.0&#160;million. Sobi has also agreed to make milestone payments totaling up to $630.0&#160;million to the Company upon the achievement of various development and regulatory milestones and, if commercialized, sales thresholds for annual net sales of NASP, and tiered royalty payments ranging from the low double digits on the lowest sales tier to the high teens on the highest sales tier. A more detailed description of the Sobi License and the Company&#8217;s evaluation of this agreement under ASC 606 can be found in Note 13, &#8220;Revenue Arrangements&#8221; to the consolidated financial statements in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2025. Any proceeds received from milestone payments or royalties relating to the Sobi License would be required to be distributed to holders of CVRs, net of certain deductions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On June 28, 2024, Sobi initiated a rolling biologics license application to the FDA for NASP for the potential treatment of chronic refractory gout which resulted in the achievement of a development milestone and a $30.0&#160;million payment obligation from Sobi to the Company. As a result, the development milestone was no longer constrained and $30.0&#160;million was recognized as revenue during the year ended December 31, 2024 as there were no remaining performance obligations under the Sobi License. The proceeds from the achievement of the development milestone were received from Sobi in July 2024 and were included, net of deductions as specified in the CVR Agreement, in the distribution to holders of the CVRs in March 2025.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Grant revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">National Institute of Neurological Disorders and Stroke of the National Institutes of Health</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In June 2024, the Company received funding approval from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health, or NINDS, for an award of $1.5&#160;million granted for the budget period, which ran from June 2024 through May 2025. In June 2025, the Company received funding approval from NINDS for an additional award of $1.5&#160;million granted for the budget period that runs from June 2025 through May 2026. The funding was provided by NINDS to further the Company&#8217;s use of RNA-based CAR-T cells to combat autoantibody-associated autoimmune disorders. Grant funding is to be used solely for manufacturing of RNA-based CAR-T cells and analysis of samples to inform mechanism of action. The award period runs through May 31, 2026. The Company will recognize grant revenue when expenses reimbursable under the grant have been incurred. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026 and December 31, 2025, the Company recorded a receivable of $0.1&#160;million and $0.9&#160;million, respectively, that is subject to reimbursement by NINDS. The Company recognized grant revenue of $0.1&#160;million and $0.7&#160;million during the three months ended March 31, 2026 and 2025, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Transaction Price Allocated to Future Performance Obligations</span></div>Remaining performance obligations represent the transaction price of contracts for which work has not been performed, or has been partially performed. As of March 31, 2026 and December 31, 2025, there were no unsatisfied performance obligations from contracts with customers.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and License Agreements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_CollaborationAndLicenseAgreementsTextBlock', window );">Collaboration and License Agreements</a></td>
<td class="text">Collaboration and License Agreements<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Biogen MA, Inc.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On September 8, 2023, the Company entered into a non-exclusive, sublicensable, worldwide, perpetual patent license agreement, or the Biogen Agreement, with Biogen MA, Inc., or Biogen, to research, develop, make, use, offer, sell and import products or processes containing or using an engineering T-cell modified with an mRNA comprising, or encoding a protein comprising, certain sequences licensed under the Biogen Agreement for the prevention, treatment, palliation and management of autoimmune diseases and disorders, excluding cancers, neoplastic disorders, and paraneoplastic disorders. The Company is not obligated to pay Biogen any expenses, fees, or royalties.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company may terminate the Biogen Agreement for any reason or no reason, and Biogen may terminate the agreement after a notice-and-cure period of 30 days if the Company fails to pay a fee owed to Biogen or for any other material breach of the agreement. The Biogen Agreement will otherwise expire when all claims of all issued patents within the patents and patent applications licensed to the Company under the Biogen Agreement have expired or been finally rendered revoked, invalid or unenforceable by a decision of a court or government agency.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Biogen Agreement encompasses patents and patent applications in the PCT/US2010/026825 patent family, which was filed March 10, 2010. In general, all patents that issue in this family have an expected expiration date of March 10, 2030, subject to potential patent term adjustments and/or extensions. For the U.S. patents and applications in this family, U.S. Patent 9,034,324 was awarded 677 days of patent term adjustment, which would extend the expiration date of this patent to January 16, 2032, absent any challenges to the patent term. The other issued patent in this family was not awarded any patent term adjustment, so its expected expiration date is March 10, 2030.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">National Cancer Institute of the National Institutes of Health</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Effective September 16, 2019, the Company entered into a nonexclusive, worldwide license agreement, or the NCI Agreement, with the U.S. Department of Health and Human Services, represented by the National Cancer Institute of the National Institutes of Health, or NCI.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the NCI Agreement, the Company was granted a license under certain NCI patents and patent applications designated in the agreement, to make, use, sell, offer and import products and processes within the scope of the patents and applications licensed under the NCI Agreement when developing and manufacturing anti-BCMA CAR-T cell products for the </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">treatment of MG pemphigus vulgaris, and immune thrombocytopenic purpura according to methods designated in the NCI Agreement.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s entry into the NCI Agreement, Old Cartesian paid to NCI a one-time $0.1 million license royalty payment. Under the NCI Agreement, the Company is further required to pay NCI a low five-digit annual royalty. The Company must also pay earned royalties on net sales in a low single-digit percentage and pay up to $0.8 million in benchmark royalties upon the Company&#8217;s achievement of designated benchmarks that are based on the commercial development plan agreed between the parties. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the NCI Agreement, the Company must use reasonable commercial efforts to bring licensed products and licensed processes to the point of Practical Application (as defined in the NCI Agreement). Upon the Company&#8217;s first commercial sale, the Company must use reasonable commercial efforts to make licensed products and licensed processes reasonably accessible to the United States public. After the Company&#8217;s first commercial sale, the Company must make reasonable quantities of licensed products or materials produced via licensed processes available to patient assistance programs and develop educational materials detailing the licensed products. Unless the Company obtains a waiver from NCI, the Company must have licensed products and licensed processes manufactured substantially in the United States. Prior to the first commercial sale, upon NCI&#8217;s request, the Company is obligated to provide NCI with commercially reasonable quantities of licensed products made through licensed processes to be used for in vitro research.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company must use reasonable commercial efforts to submit a BLA with respect to a licensed product by the fourth quarter of 2026 and make a first commercial sale of a licensed product by the fourth quarter of 2028.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The NCI Agreement terminates upon the expiration of the last to expire of the patent rights licensed thereunder, if not sooner terminated. The NCI Agreement encompasses patents and patent applications in the PCT/US2013/032029 patent family, which was filed March 15, 2013. In general, all patents that issue in this family have an expected expiration of March 15, 2033, subject to potential patent term adjustments and/or extensions. For the U.S. patents and applications in this family, only two patents were awarded patent term adjustments. U.S. Patent 9,765,342 was awarded 297 days of patent term adjustment, which would extend the expiration date of this patent to January 6, 2034, absent any challenges to the patent term. The other patent, U.S. Patent 10,876,123, was awarded three days of patent term adjustment, but this patent is subject to terminal disclaimers filed against other family members, so this patent will not extend beyond the March 15, 2033 date. The other issued patents in this family were not awarded any patent term adjustment, so the expected expiration date for these patents also remains March 15, 2033. There is also a pending patent application which, if issued, will expire on March 15, 2033, but could also be subject to patent term adjustment and to any potential future terminal disclaimers. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">NCI has the right to terminate the NCI Agreement, after giving written notice and providing a cure period in accordance with its terms, if the Company is in default of a material obligation. The Company has the unilateral right to terminate the agreement in any country or territory by giving NCI 60 days&#8217; written notice. The Company agreed to indemnify NCI against any liability arising out of the Company&#8217;s, sublicensees&#8217; or third parties&#8217; use of the licensed patent rights and licensed products or licensed processes developed in connection with the licensed patent rights.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Shenyang Sunshine Pharmaceutical Co., Ltd</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In May 2014, the Company entered into a license agreement, or the 3SBio License, with Shenyang Sunshine Pharmaceutical Co., Ltd., or 3SBio. The Company has paid to 3SBio an aggregate of $7.0 million in upfront and milestone-based payments under the 3SBio License as of March 31, 2026. The Company is required to make future payments to 3SBio contingent upon the occurrence of events related to the achievement of clinical and regulatory approval milestones of up to an aggregate of $15.0 million for products containing the Company&#8217;s ImmTOR platform.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_CollaborationAndLicenseAgreementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration And License Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_CollaborationAndLicenseAgreementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026, the Company has not recorded any U.S. federal or state income tax benefits for either the net losses the Company has incurred or its earned research and orphan drug credits, due to the uncertainty of realizing a benefit from those items in the future.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2026, the Company was not a party to any litigation that could have a material adverse effect on the Company&#8217;s business, financial position, results of operations or cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Other</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As permitted under Delaware law, the Company indemnifies its officers, directors, consultants and employees for certain events or occurrences that happen by reason of the relationship with, or position held at the Company. Through March 31, </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2026, the Company had not experienced any losses related to these indemnification obligations, and no claims were outstanding. The Company does not expect significant claims related to these indemnification obligations and, consequently, concluded that the fair value of these obligations is negligible, and no related reserves were established.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, as permitted under Delaware law, the Company indemnifies its directors for certain events or occurrences while the director is, or was, serving at the Company&#8217;s request in such capacity. The term of the indemnification is for the director&#8217;s lifetime. The maximum potential amount of future payments the Company could be required to make is unlimited; however, the Company has directors&#8217; insurance coverage that limits its exposure and enables it to recover a portion of any future amounts paid. The Company also has indemnification arrangements under certain of its facility leases that require it to indemnify the landlord against certain costs, expenses, fines, suits, claims, demands, liabilities, and actions directly resulting from certain breaches, violations, or non-performance of any covenant or condition of the Company&#8217;s lease. The term of the indemnification is for the term of the related lease agreement. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited. To date, the Company had not experienced any material losses related to any of its indemnification obligations, and no material claims with respect thereto were outstanding.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents selected financial information with respect to the Company&#8217;s single operating segment for the three months ended March 31, 2026 and 2025 (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration and license revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Descartes-08 for MG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Descartes-08 for dermatomyositis</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Early stage programs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development employee expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development facilities and other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income), net </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(39,182)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(17,710)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> Includes interest income; gain on change in fair value of warrant liabilities; (loss) gain on change in fair value of contingent value right liability; and other expense, net.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated subsequent events through the date on which the consolidated financial statements were issued. The Company has concluded that no subsequent events have occurred that require disclosure.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Presentation and Consolidation</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Basis of presentation and consolidation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Selecta (RUS), LLC, or Selecta (RUS), a Russian limited liability corporation, and Cartesian Bio, LLC, a Delaware limited liability </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">company, which is a variable interest entity for which the Company is the primary beneficiary and have been prepared in conformity with accounting principles generally accepted in the United States of America, or U.S. GAAP. Any reference in these notes to applicable guidance is meant to refer to the authoritative United States generally accepted accounting principles as found in the relevant Accounting Standards Codification, or ASC and Accounting Standards Update, or ASU, of the Financial Accounting Standards Board, or FASB. All significant intercompany accounts and transactions have been eliminated.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements for the three months ended March 31, 2026 and 2025 have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission, or the SEC, for interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. These consolidated financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and the notes thereto for the year ended December 31, 2025 included in the Company&#8217;s Annual Report on Form 10-K that was filed with the SEC on March 9, 2026. The unaudited interim financial statements have been prepared on the same basis as the audited consolidated financial statements. In the opinion of management, the accompanying unaudited interim consolidated financial statements contain all adjustments that are necessary for a fair statement of the Company&#8217;s financial position as of March 31, 2026, the consolidated results of operations for the three months ended March 31, 2026, and cash flows for the three months ended March 31, 2026. Such adjustments are of a normal and recurring nature. The results of operations for the three months ended March 31, 2026 are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2026.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Not Yet Adopted</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Statement Reporting- Comprehensive Income- Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (ASU 2024-03), which requires public companies to disclose, in interim and annual reporting periods, additional information about certain expenses in notes to financial statements, including purchases of inventory, employee compensation, depreciation, amortization of intangible assets, and selling expenses. This guidance will be effective for the annual period beginning the year ended December 31, 2027 and for interim periods beginning January 1, 2028, with early adoption permitted. The Company is currently evaluating the impact of the standard&#8217;s adoption on its consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2025, the FASB issued ASU 2025-10, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (ASU 2025-10), which establishes authoritative guidance on the recognition, measurement, presentation, and disclosure of government grants. Under ASU 2025-10, government grants are recognized when it is probable that the entity will both comply with the conditions of the grant and the grant will be received. The ASU provides specific accounting models for grants related to assets and grants related to income, including options to recognize government grants as deferred income or as a reduction of the asset&#8217;s cost basis. The ASU also requires enhanced disclosures regarding the nature of government grants, significant terms and conditions, accounting policies applied, and amounts recognized in the financial statements. ASU 2025-10 is effective for fiscal years beginning after December 15, 2028, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-10 on its consolidated financial statements and related disclosures.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2025, the FASB issued ASU 2025-11, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interim Reporting (Topic 270): Narrow-Scope Improvements</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (ASU 2025-11), which clarifies the guidance in Topic 270 to improve the consistency of interim financial reporting. The ASU provides a comprehensive list of required interim disclosures and introduces a disclosure principle requiring entities to disclose events since the end of the last annual reporting period that have a material impact on the entity. ASU 2025-11 is effective for fiscal years beginning after December 15, 2027, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-11 on its consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Allocable to Common Stockholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Net Loss Per Share Allocable to Common Stockholders</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss per share allocable to common stockholders for the three months ended March 31, 2026 and 2025 (in thousands, except share and per-share data):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(39,182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(17,710)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding - basic and diluted</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">26,855,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,902,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net loss per share allocable to common stockholders:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1.46)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.68)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Potential Dilutive Shares of Common Stock Excluded from the Computation of the Diluted Net Loss Per Share Allocable to Common Stockholders</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the potential dilutive shares of common stock excluded from the computation of the diluted net loss per share allocable to common stockholders for all periods presented, as the effect would have been anti-dilutive: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options and restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,278,679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,047,628&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">692,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">692,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Series A Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,026,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,026,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">437,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">437,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,435,224&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,204,424&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2026 and December 31, 2025 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds (included in cash equivalents)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">117,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">117,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">117,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">117,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liability</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value right liability</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">405,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">405,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">405,947&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">405,947&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds (included in cash equivalents)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">122,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">122,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">122,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">122,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liability</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value right liability</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">392,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">392,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">392,241&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">392,241&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text">The Company&#8217;s consolidated statements of cash flows include the following as of March 31, 2026 and 2025 (in thousands):<div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">118,641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">180,434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Long-term restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">120,376&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">182,103&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Schedule of Restricted Cash</a></td>
<td class="text">The Company&#8217;s consolidated statements of cash flows include the following as of March 31, 2026 and 2025 (in thousands):<div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">118,641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">180,434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Long-term restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">120,376&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">182,103&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Fair Value Measurement Inputs and Valuation Techniques for 2022 Warrants Liability and CVR Liability</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Black-Scholes pricing model assumptions used to record the fair value of the 2022 Warrants liability is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.68</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.48</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.03</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.28</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">89.14</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">87.36</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>The significant inputs used to estimate the fair value of the CVR liability, which represented a financial instrument being accounted for under the fair value option, were as follows:<div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Estimated cash flow dates</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026 - 2038</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026 - 2037</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Estimated probability of success</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">95.0% - 100.0%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">95.0% - 100.0%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility of future revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23.0</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23.0</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Roll-Forward of Fair Value for the Company&#8217;s Level 3 Warrant Liabilities, CVR Liability and Forward Contract Liabilities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects a roll-forward of fair value for the Company&#8217;s Level 3 warrant liabilities (see Note 9, &#8220;Equity&#8221; to these unaudited consolidated financial statements) for the three months ended March 31, 2026 (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Warrant Liability</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fair value as of December 31, 2025</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fair value as of March 31, 2026</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects a roll-forward of fair value for the Company&#8217;s Level 3 CVR liability for the three months ended March 31, 2026 (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">CVR Liability</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fair value as of December 31, 2025</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">392,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fair value as of March 31, 2026</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">405,900&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consists of the following (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,709&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Construction in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,733)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,637&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,185&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of the following (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and employee related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration and licensing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued patent fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued research and development costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional and consulting services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued equity offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,498&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Components of Lease Costs and Other Information Related to Operating Leases</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2026 and 2025, the components of lease costs were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,001&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to operating leases was as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities (in thousands)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,169</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">317</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.7 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.4 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12.2</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11.8</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Operating Lease Liabilities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The maturity of the Company&#8217;s operating lease liabilities as of March 31, 2026 were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026 (remainder)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,960)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,855&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Warrant Activity</a></td>
<td class="text">The following is a summary of the Company&#8217;s warrants as of March 31, 2026:<div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of Warrants</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Equity<br/>&#160;classified</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Liability classified</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average<br/>exercise price</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,560&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">685,712&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">692,272&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">46.76&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockByClassTextBlock', window );">Schedule of Authorized Shares of Common Stock for Future Issuance</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has authorized shares of common stock for future issuance as of March 31, 2026 as follows:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of warrants</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">692,272&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for future stock incentive awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,641,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">736,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding common stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,542,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Series A Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,026,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">437,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,076,508&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-5<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481142/505-10-45-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-10<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-8<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of Stock-Based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense by classification included within the consolidated statements of operations and comprehensive loss, was as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,474&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,423&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,508&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Weighted Average Assumptions Used</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The estimated grant date fair values of stock option awards granted under the 2016 Plan and the 2018 Inducement Incentive Award Plan were calculated using the Black-Scholes option pricing model based on the following weighted-average assumptions: </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.93</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.46</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.20</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">92.71</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">97.44</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average fair value of common stock</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17.46</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Options Activity</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the stock option activity under the 2016 Plan, the 2018 Inducement Incentive Award Plan, and the Old Cartesian Plan for options for common stock:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number&#160;of Common Stock Options</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average Exercise Price ($)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average Remaining Contractual Term (in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in&#160;thousands)</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,463,747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13.72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.41</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,962&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,304,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(86,132)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(139,658)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,542,407&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.74</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested at March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,204,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at March 31, 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,139,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.64</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Schedule of Restricted Stock Units Activity</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s restricted stock units under the 2016 Plan and the Old Cartesian Plan:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:74.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Grant Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value ($)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">522,498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18.44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">420,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(169,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(37,598)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">736,272&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11.82&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents selected financial information with respect to the Company&#8217;s single operating segment for the three months ended March 31, 2026 and 2025 (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration and license revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Descartes-08 for MG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Descartes-08 for dermatomyositis</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Early stage programs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development employee expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development facilities and other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income), net </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(39,182)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(17,710)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> Includes interest income; gain on change in fair value of warrant liabilities; (loss) gain on change in fair value of contingent value right liability; and other expense, net.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">$ (861,555)<span></span>
</td>
<td class="num">$ (822,373)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale', window );">Cash, cash equivalents, restricted cash and marketable securities</a></td>
<td class="nump">120,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash and cash equivalents</a></td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rnac_OldCartesianMember', window );">Old Cartesian</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed', window );">Contingent value right, percentage of milestone payments, royalties and other amounts to be distributed</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents And Debt Securities, Available-For-Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Value Right, Percentage Of Milestone Payments, Royalties And Other Amounts To Be Distributed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rnac_OldCartesianMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rnac_OldCartesianMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Indefinite-Lived Intangible Assets (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 48,163,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,163,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Intangible assets</a></td>
<td class="nump">93,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment to goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rnac_OldCartesianMember', window );">Old Cartesian</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">48,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rnac_OldCartesianMember', window );">Old Cartesian | Descartes-08 for MG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Intangible assets</a></td>
<td class="nump">$ 93,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-47<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 37: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-41<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478064/805-740-55-13<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-39<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rnac_OldCartesianMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rnac_OldCartesianMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=rnac_Descartes08ForMGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=rnac_Descartes08ForMGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Allocable to Common Stockholders - Schedule of Computation of Basic and Diluted Net Loss Per Share Allocable to Common Stockholders (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (39,182)<span></span>
</td>
<td class="num">$ (17,710)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding - basic (in shares)</a></td>
<td class="nump">26,855,158<span></span>
</td>
<td class="nump">25,902,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">26,855,158<span></span>
</td>
<td class="nump">25,902,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Net loss per share allocable to common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (1.46)<span></span>
</td>
<td class="num">$ (0.68)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (1.46)<span></span>
</td>
<td class="num">$ (0.68)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Allocable to Common Stockholders - Schedule of Potential Dilutive Shares of Common Stock Excluded from the Computation of the Diluted Net Loss Per Share Allocable to Common Stockholders (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Potential common shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total (in shares)</a></td>
<td class="nump">9,435,224<span></span>
</td>
<td class="nump">8,204,424<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Common stock options and restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Potential common shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total (in shares)</a></td>
<td class="nump">4,278,679<span></span>
</td>
<td class="nump">3,047,628<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Potential common shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total (in shares)</a></td>
<td class="nump">692,272<span></span>
</td>
<td class="nump">692,523<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PreferredStockMember', window );">Preferred stock | Series A Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Potential common shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total (in shares)</a></td>
<td class="nump">4,026,346<span></span>
</td>
<td class="nump">4,026,346<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PreferredStockMember', window );">Preferred stock | Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Potential common shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total (in shares)</a></td>
<td class="nump">437,927<span></span>
</td>
<td class="nump">437,927<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">$ 117,674<span></span>
</td>
<td class="nump">$ 122,724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liability</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ContingentValueRightLiability', window );">Contingent value right liability</a></td>
<td class="nump">405,900<span></span>
</td>
<td class="nump">392,100<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">405,947<span></span>
</td>
<td class="nump">392,241<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds (included in cash equivalents)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds (included in cash equivalents)</a></td>
<td class="nump">117,674<span></span>
</td>
<td class="nump">122,724<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">117,674<span></span>
</td>
<td class="nump">122,724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ContingentValueRightLiability', window );">Contingent value right liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Money market funds (included in cash equivalents)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds (included in cash equivalents)</a></td>
<td class="nump">117,674<span></span>
</td>
<td class="nump">122,724<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ContingentValueRightLiability', window );">Contingent value right liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Money market funds (included in cash equivalents)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds (included in cash equivalents)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liability</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ContingentValueRightLiability', window );">Contingent value right liability</a></td>
<td class="nump">405,900<span></span>
</td>
<td class="nump">392,100<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">405,947<span></span>
</td>
<td class="nump">392,241<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Money market funds (included in cash equivalents)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds (included in cash equivalents)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_ContingentValueRightLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Value Right Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_ContingentValueRightLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet', window );">Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Dividend yield | Valuation technique, option pricing model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 118,641<span></span>
</td>
<td class="nump">$ 125,139<span></span>
</td>
<td class="nump">$ 180,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Long-term restricted cash</a></td>
<td class="nump">1,735<span></span>
</td>
<td class="nump">1,735<span></span>
</td>
<td class="nump">1,669<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents, and restricted cash</a></td>
<td class="nump">$ 120,376<span></span>
</td>
<td class="nump">$ 126,874<span></span>
</td>
<td class="nump">$ 182,103<span></span>
</td>
<td class="nump">$ 214,279<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques for Warrants Liability (Details) - Valuation technique, option pricing model<br></strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember', window );">Risk-free interest rate | 2022 Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">0.0368<span></span>
</td>
<td class="nump">0.0348<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember', window );">Dividend yield | 2022 Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember', window );">Expected life (in years) | 2022 Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and rights outstanding, term</a></td>
<td class="text">1 year 10 days<span></span>
</td>
<td class="text">1 year 3 months 10 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember', window );">Expected volatility | 2022 Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">0.8914<span></span>
</td>
<td class="nump">0.8736<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 43<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-43<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rnac_A2022WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rnac_A2022WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Roll-Forward of Fair Value for the Company&#8217;s Level 3 Warrant Liabilities and CVR Liability (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember', window );">Warrant Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="num">(94)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=rnac_ContingentValueRightMember', window );">CVR Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">392,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="nump">13,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 405,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=rnac_ContingentValueRightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=rnac_ContingentValueRightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques for CVR Liability (Details) - Level&#160;3<br></strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Estimated probability of success | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ContingentValueRightLiabilityMeasurementInput', window );">Contingent value right liability, measurement input</a></td>
<td class="nump">0.950<span></span>
</td>
<td class="nump">0.950<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Estimated probability of success | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ContingentValueRightLiabilityMeasurementInput', window );">Contingent value right liability, measurement input</a></td>
<td class="nump">1.000<span></span>
</td>
<td class="nump">1.000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Expected volatility of future revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ContingentValueRightLiabilityMeasurementInput', window );">Contingent value right liability, measurement input</a></td>
<td class="nump">0.230<span></span>
</td>
<td class="nump">0.230<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_ContingentValueRightLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Value Right Liability, Measurement Input</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_ContingentValueRightLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=rnac_ProbabilityOfSuccessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=rnac_ProbabilityOfSuccessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=rnac_MeasurementInputRevenueVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=rnac_MeasurementInputRevenueVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 16,985<span></span>
</td>
<td class="nump">$ 16,918<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation</a></td>
<td class="num">(5,348)<span></span>
</td>
<td class="num">(4,733)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">11,637<span></span>
</td>
<td class="nump">12,185<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rnac_LaboratoryEquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">9,323<span></span>
</td>
<td class="nump">8,419<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">417<span></span>
</td>
<td class="nump">417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">6,709<span></span>
</td>
<td class="nump">4,177<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">269<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in process</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 3,466<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rnac_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rnac_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and employee related expenses</a></td>
<td class="nump">$ 1,319<span></span>
</td>
<td class="nump">$ 3,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_AccruedCollaborationandLicensing', window );">Collaboration and licensing</a></td>
<td class="nump">385<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_AccruedPatentFeesCurrent', window );">Accrued patent fees</a></td>
<td class="nump">195<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_AccruedResearchAndDevelopmentCostsCurrent', window );">Accrued research and development costs</a></td>
<td class="nump">4,858<span></span>
</td>
<td class="nump">2,521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_AccruedAuditFeesCurrent', window );">Accrued professional and consulting services</a></td>
<td class="nump">2,187<span></span>
</td>
<td class="nump">2,059<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_AccruedEquityOfferingCostsCurrent', window );">Accrued equity offering costs</a></td>
<td class="nump">707<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">510<span></span>
</td>
<td class="nump">378<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">$ 10,161<span></span>
</td>
<td class="nump">$ 9,498<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_AccruedAuditFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Audit Fees, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_AccruedAuditFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_AccruedCollaborationandLicensing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Collaboration and Licensing</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_AccruedCollaborationandLicensing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_AccruedEquityOfferingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Equity Offering Costs, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_AccruedEquityOfferingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_AccruedPatentFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of patent fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_AccruedPatentFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_AccruedResearchAndDevelopmentCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of research and development costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_AccruedResearchAndDevelopmentCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - Frederick Lease Agreement<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of office space leased | ft&#178;</a></td>
<td class="nump">35,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_LesseeOperatingLeaseAnnualBaseRent', window );">Aggregate annual base rent | $</a></td>
<td class="nump">$ 1.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_LesseeOperatingLeaseAnnualBaseRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Annual Base Rent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_LesseeOperatingLeaseAnnualBaseRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_LeaseArrangementAxis=rnac_FrederickLeaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_LeaseArrangementAxis=rnac_FrederickLeaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Components of Lease Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 583<span></span>
</td>
<td class="nump">$ 584<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">431<span></span>
</td>
<td class="nump">406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 1,018<span></span>
</td>
<td class="nump">$ 1,001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Maturity of Operating Lease Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2026 (remainder)</a></td>
<td class="nump">$ 3,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2027</a></td>
<td class="nump">4,554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2028</a></td>
<td class="nump">2,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2029</a></td>
<td class="nump">1,630<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2030</a></td>
<td class="nump">1,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="nump">852<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">14,815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="num">(2,960)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 11,855<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, To Be Paid, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Other Information Related to Operating Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in the measurement of lease liabilities:</a></td>
<td class="nump">$ 1,169<span></span>
</td>
<td class="nump">$ 317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term</a></td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
<td class="text">4 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">12.20%<span></span>
</td>
<td class="nump">11.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - &#8220;At the Market&#8221; Sales Agreement - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 13, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock- at-the-market offering</a></td>
<td class="nump">$ 15,392<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rnac_AtTheMarketOfferingMember', window );">At-The-Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_SaleOfStockAggregateMaximumGrossSalesProceeds', window );">Aggregate maximum gross sales proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares)</a></td>
<td class="nump">2,270,712<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock- at-the-market offering</a></td>
<td class="nump">$ 14,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_SaleOfStockAggregateMaximumGrossSalesProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Aggregate Maximum Gross Sales Proceeds</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_SaleOfStockAggregateMaximumGrossSalesProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rnac_AtTheMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rnac_AtTheMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Warrants - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2026 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ClassOfWarrantOrRightOutstandingWarrantsIssued', window );">Warrants issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ClassOfWarrantOrRightOutstandingWarrantsExercised', window );">Warrants exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ClassOfWarrantOrRightOutstandingWarrantsCancelled', window );">Warrants cancelled (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_ClassOfWarrantOrRightOutstandingWarrantsCancelled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant Or Right, Outstanding, Warrants Cancelled</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_ClassOfWarrantOrRightOutstandingWarrantsCancelled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_ClassOfWarrantOrRightOutstandingWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant Or Right, Outstanding, Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_ClassOfWarrantOrRightOutstandingWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_ClassOfWarrantOrRightOutstandingWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant Or Right, Outstanding, Warrants Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_ClassOfWarrantOrRightOutstandingWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity - Schedule of Warranty Activity (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ClassOfWarrantOrRightRollForward', window );"><strong>Number of Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants, outstanding (in shares)</a></td>
<td class="nump">692,272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward', window );"><strong>Weighted-average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 46.76<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember', window );">Warrant Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ClassOfWarrantOrRightRollForward', window );"><strong>Number of Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants, outstanding (in shares)</a></td>
<td class="nump">685,712<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ClassOfWarrantOrRightRollForward', window );"><strong>Number of Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants, outstanding (in shares)</a></td>
<td class="nump">6,560<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_ClassOfWarrantOrRightRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_ClassOfWarrantOrRightRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity - Preferred Stock - Narrative (Details) - shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">120,790.402<span></span>
</td>
<td class="nump">120,790.402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">120,790.402<span></span>
</td>
<td class="nump">120,790.402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Convertible preferred stock, common stock issuable upon conversion (in shares)</a></td>
<td class="nump">4,464,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">437,927<span></span>
</td>
<td class="nump">437,927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">437,927<span></span>
</td>
<td class="nump">437,927<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleSharesIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleSharesIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity - Schedule of Authorized Shares of Common Stock for Future Issuance (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="nump">13,076,508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember', window );">Shares available for future stock incentive awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="nump">3,641,284<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rnac_RestrictedStockUnitsUnvestedMember', window );">Unvested restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="nump">736,272<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Outstanding common stock options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="nump">3,542,407<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="nump">4,026,346<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="nump">437,927<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="nump">692,272<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rnac_RestrictedStockUnitsUnvestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rnac_RestrictedStockUnitsUnvestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Nov. 13, 2023</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,076,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock&#8209;based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,423<span></span>
</td>
<td class="nump">$ 2,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value of stock options (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.25<span></span>
</td>
<td class="nump">$ 14.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Outstanding Series A Preferred Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,542,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">420,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate', window );">Estimated forfeitures rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common&#160;stock | Outstanding Series A Preferred Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense related to unvested employee stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rnac_StockIncentivePlan2016Member', window );">2016 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares authorized for grants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease', window );">Number of shares authorized, increase (in shares)</a></td>
<td class="nump">1,040,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,044,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rnac_EmploymentInducementIncentiveAwardPlanMember', window );">Employment Inducement Incentive Award Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares authorized for grants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">502,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rnac_OldCartesianPlanMember', window );">Old Cartesian Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares authorized for grants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense related to unvested employee stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock&#8209;based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rnac_OldCartesianPlanMember', window );">Old Cartesian Plan | Old Cartestian | Common&#160;stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based compensation arrangement by share-based payment award, options, outstanding, number (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">776,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rnac_OldCartesianPlanMember', window );">Old Cartesian Plan | Old Cartestian | Preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based compensation arrangement by share-based payment award, options, outstanding, number (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,112.299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of forfeitures rate of the stock options based on the historical trends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant, Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rnac_StockIncentivePlan2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rnac_StockIncentivePlan2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rnac_EmploymentInducementIncentiveAwardPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rnac_EmploymentInducementIncentiveAwardPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rnac_OldCartesianPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rnac_OldCartesianPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rnac_OldCartestianMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rnac_OldCartestianMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans - Schedule of Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 2,423<span></span>
</td>
<td class="nump">$ 2,508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">949<span></span>
</td>
<td class="nump">1,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 1,474<span></span>
</td>
<td class="nump">$ 1,233<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans - Schedule of Weighted Average Assumptions Used (Details) - Options - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">3.93%<span></span>
</td>
<td class="nump">4.46%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">5 years 11 months 19 days<span></span>
</td>
<td class="text">6 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">92.71%<span></span>
</td>
<td class="nump">97.44%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue', window );">Weighted-average fair value of common stock (in dollars per share)</a></td>
<td class="nump">$ 6.81<span></span>
</td>
<td class="nump">$ 17.46<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighed-average fair value relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans - Schedule of Stock Option Activity (Details) - 2016 Plan, 2018 Inducement Incentive Award Plan and Old Cartesian Plan - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number&#160;of Common Stock Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">2,463,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">1,304,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(86,132)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(139,658)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">3,542,407<span></span>
</td>
<td class="nump">2,463,747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Vested (in shares)</a></td>
<td class="nump">1,204,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest (in shares)</a></td>
<td class="nump">3,139,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-average Exercise Price ($)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 13.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">6.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">15.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">11.34<span></span>
</td>
<td class="nump">$ 13.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice', window );">Vested (in dollars per share)</a></td>
<td class="nump">11.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest (in dollars per share)</a></td>
<td class="nump">$ 11.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted-average Remaining Contractual Term (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, term</a></td>
<td class="text">7 years 8 months 26 days<span></span>
</td>
<td class="text">6 years 4 months 28 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm', window );">Vested, term</a></td>
<td class="text">5 years 1 month 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest, term</a></td>
<td class="text">7 years 7 months 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding</a></td>
<td class="nump">$ 2,002<span></span>
</td>
<td class="nump">$ 2,962<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue', window );">Vested</a></td>
<td class="nump">1,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest</a></td>
<td class="nump">$ 2,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>n/a</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>n/a</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested, Outstanding, Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested, Outstanding, Weighted Average Remaining Contractual Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rnac_A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rnac_A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans - Schedule of Restricted Stock Units Activity (Details) - Restricted Stock Units (RSUs)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2026 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at beginning of period (in shares) | shares</a></td>
<td class="nump">522,498<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">420,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(169,278)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(37,598)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at end of period (in shares) | shares</a></td>
<td class="nump">736,272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-average Grant Date Fair Value ($)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at beginning of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 18.44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">6.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">18.59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">16.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 11.82<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Arrangements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 28, 2024</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag', window );">Government Assistance Current Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</a></td>
<td class="text">receivable<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">receivable<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Grant</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Unsatisfied performance obligation</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GovernmentAssistanceTypeAxis=rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember', window );">National Institute of Neurological Disorders and Stroke of the National Institutes of Health Funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GovernmentAssistanceAwardAmount', window );">Government assistance, award amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_GovernmentAssistancePotentialAdditionalAwardAmount', window );">Government assistance, potential additional award amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GovernmentAssistanceAmountCumulativeCurrent', window );">Government assistance, asset, current</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Grant</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rnac_SwedishOrphanBiovitrumABSOBIMember', window );">SOBI | License</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount', window );">Future contingent additional payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 630,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Government Assistance Current Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_GovernmentAssistancePotentialAdditionalAwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Government Assistance, Potential Additional Award Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_GovernmentAssistancePotentialAdditionalAwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Variable Consideration Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GovernmentAssistanceAmountCumulativeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset from government assistance, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483507/832-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GovernmentAssistanceAmountCumulativeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GovernmentAssistanceAwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of government assistance awarded that comprises amount received, receivable, and to be received unless condition for government assistance is not met. Includes, but is not limited to, government grant, assistance, incentive, award, subsidy, and loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483507/832-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GovernmentAssistanceAwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueNotFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue that is not accounted for under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueNotFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GovernmentAssistanceTypeAxis=rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GovernmentAssistanceTypeAxis=rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rnac_SwedishOrphanBiovitrumABSOBIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rnac_SwedishOrphanBiovitrumABSOBIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaboration and License Agreements - Biogen M.A., Inc. - Narrative (Details)<br></strong></div></th>
<th class="th"><div>Sep. 08, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=rnac_BiogenM.A.Inc.Member', window );">Biogen M.A., Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination', window );">Written notice for agreement termination</a></td>
<td class="text">30 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Written Notice Period For Termination</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_CollaborativeArrangementWrittenNoticePeriodForTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=rnac_BiogenM.A.Inc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=rnac_BiogenM.A.Inc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaboration and License Agreements - National Cancer Institute of the National Institutes of Health - Narrative (Details) - NCI Agreement<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 16, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_LicenseAndOptionAgreementRoyaltyPayment', window );">License and option agreement, royalty payment</a></td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum', window );">License and option agreement, benchmark royalties, maximum</a></td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination', window );">Written notice for agreement termination</a></td>
<td class="text">60 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_CollaborativeArrangementWrittenNoticePeriodForTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Written Notice Period For Termination</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_CollaborativeArrangementWrittenNoticePeriodForTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License And Option Agreement, Benchmark Royalties, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_LicenseAndOptionAgreementRoyaltyPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License And Option Agreement, Royalty Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_LicenseAndOptionAgreementRoyaltyPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=rnac_NationalCancerInstituteAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=rnac_NationalCancerInstituteAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and License Agreements - Shenyang Sunshine Pharmaceutical Co., Ltd - Narrative (Details) - 3SBio License<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid', window );">Aggregate amount of upfront and milestone-based payments</a></td>
<td class="nump">$ 7.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform', window );">Aggregate amount for future payments upon achievement of clinical and regulatory approval milestones for products containing ImmTOR platform</a></td>
<td class="nump">$ 15.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate Amount For Future Payments Upon Achievement Of Clinical And Regulatory Approval Milestones For Products Containing ImmTOR Platform</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate Amount Of Upfront And Milestone Based Payments Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=rnac_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=rnac_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2026 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_NumberOfReportableSegmentsNotDisclosedFlag', window );">Number of reportable segments not disclosed flag</a></td>
<td class="text">segment<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_NumberOfReportableSegmentsNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Reportable Segments Not Disclosed Flag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_NumberOfReportableSegmentsNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Collaboration and license revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Grant revenue</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">19,463<span></span>
</td>
<td class="nump">14,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">7,114<span></span>
</td>
<td class="nump">8,315<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(39,182)<span></span>
</td>
<td class="num">(17,710)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rnac_OperatingSegmentMember', window );">Operating Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Collaboration and license revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Grant revenue</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">7,114<span></span>
</td>
<td class="nump">8,315<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rnac_NonoperatingIncomeExpenseAdjusted', window );">Other expense (income), net</a></td>
<td class="nump">12,683<span></span>
</td>
<td class="num">(4,179)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(39,182)<span></span>
</td>
<td class="num">(17,710)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rnac_OperatingSegmentMember', window );">Operating Segment | Descartes-08 for MG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">12,135<span></span>
</td>
<td class="nump">7,036<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rnac_OperatingSegmentMember', window );">Operating Segment | Descartes-08 for dermatomyositis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">227<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rnac_OperatingSegmentMember', window );">Operating Segment | Early stage programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">355<span></span>
</td>
<td class="nump">990<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rnac_OperatingSegmentMember', window );">Operating Segment | Research and development employee expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">3,828<span></span>
</td>
<td class="nump">3,702<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rnac_OperatingSegmentMember', window );">Operating Segment | Research and development stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">949<span></span>
</td>
<td class="nump">1,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rnac_OperatingSegmentMember', window );">Operating Segment | Research and development facilities and other expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 1,969<span></span>
</td>
<td class="nump">$ 1,671<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rnac_NonoperatingIncomeExpenseAdjusted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nonoperating Income (Expense), Adjusted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rnac_NonoperatingIncomeExpenseAdjusted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rnac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueNotFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue that is not accounted for under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueNotFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rnac_OperatingSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rnac_OperatingSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=rnac_Descartes08ForMGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=rnac_Descartes08ForMGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=rnac_Descartes08ForDermatomyositisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=rnac_Descartes08ForDermatomyositisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=rnac_EarlyStageProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=rnac_EarlyStageProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=rnac_ResearchAndDevelopmentEmployeeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=rnac_ResearchAndDevelopmentEmployeeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=rnac_ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=rnac_ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=rnac_ResearchAndDevelopmentFacilitiesAndOtherExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=rnac_ResearchAndDevelopmentFacilitiesAndOtherExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>168</ContextCount>
  <ElementCount>261</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>64</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>9952151 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952152 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952153 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952154 - Statement - Consolidated Statements of Changes in Stockholders??? Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit</Role>
      <ShortName>Consolidated Statements of Changes in Stockholders??? Deficit</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952155 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952156 - Disclosure - Description of the Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/DescriptionoftheBusiness</Role>
      <ShortName>Description of the Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Goodwill and Indefinite-Lived Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssets</Role>
      <ShortName>Goodwill and Indefinite-Lived Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Net Loss Per Share Allocable to Common Stockholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholders</Role>
      <ShortName>Net Loss Per Share Allocable to Common Stockholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/PropertyandEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/AccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/Equity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Stock Incentive Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/StockIncentivePlans</Role>
      <ShortName>Stock Incentive Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Revenue Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/RevenueArrangements</Role>
      <ShortName>Revenue Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Collaboration and License Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreements</Role>
      <ShortName>Collaboration and License Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952171 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.cartesiantherapeutics.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Net Loss Per Share Allocable to Common Stockholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersTables</Role>
      <ShortName>Net Loss Per Share Allocable to Common Stockholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholders</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cartesiantherapeutics.com/role/FairValueMeasurements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cartesiantherapeutics.com/role/PropertyandEquipment</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/AccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cartesiantherapeutics.com/role/AccruedExpenses</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cartesiantherapeutics.com/role/Leases</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/EquityTables</Role>
      <ShortName>Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cartesiantherapeutics.com/role/Equity</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Stock Incentive Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/StockIncentivePlansTables</Role>
      <ShortName>Stock Incentive Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cartesiantherapeutics.com/role/StockIncentivePlans</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cartesiantherapeutics.com/role/SegmentReporting</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Description of the Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/DescriptionoftheBusinessDetails</Role>
      <ShortName>Description of the Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cartesiantherapeutics.com/role/DescriptionoftheBusiness</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Goodwill and Indefinite-Lived Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Indefinite-Lived Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssets</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Net Loss Per Share Allocable to Common Stockholders - Schedule of Computation of Basic and Diluted Net Loss Per Share Allocable to Common Stockholders (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofComputationofBasicandDilutedNetLossPerShareAllocabletoCommonStockholdersDetails</Role>
      <ShortName>Net Loss Per Share Allocable to Common Stockholders - Schedule of Computation of Basic and Diluted Net Loss Per Share Allocable to Common Stockholders (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Net Loss Per Share Allocable to Common Stockholders - Schedule of Potential Dilutive Shares of Common Stock Excluded from the Computation of the Diluted Net Loss Per Share Allocable to Common Stockholders (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails</Role>
      <ShortName>Net Loss Per Share Allocable to Common Stockholders - Schedule of Potential Dilutive Shares of Common Stock Excluded from the Computation of the Diluted Net Loss Per Share Allocable to Common Stockholders (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Fair Value Measurements - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofCashCashEquivalentsandRestrictedCashDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques for Warrants Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques for Warrants Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Fair Value Measurements - Schedule of Roll-Forward of Fair Value for the Company???s Level 3 Warrant Liabilities and CVR Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofRollForwardofFairValuefortheCompanysLevel3WarrantLiabilitiesandCVRLiabilityDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Roll-Forward of Fair Value for the Company???s Level 3 Warrant Liabilities and CVR Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques for CVR Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques for CVR Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment - Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Property and Equipment - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/PropertyandEquipmentNarrativeDetails</Role>
      <ShortName>Property and Equipment - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cartesiantherapeutics.com/role/AccruedExpensesTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Leases - Schedule of Components of Lease Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/LeasesScheduleofComponentsofLeaseCostsDetails</Role>
      <ShortName>Leases - Schedule of Components of Lease Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Leases - Schedule of Maturity of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Schedule of Maturity of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Leases - Schedule of Other Information Related to Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/LeasesScheduleofOtherInformationRelatedtoOperatingLeasesDetails</Role>
      <ShortName>Leases - Schedule of Other Information Related to Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Equity - ???At the Market??? Sales Agreement - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/EquityAttheMarketSalesAgreementNarrativeDetails</Role>
      <ShortName>Equity - ???At the Market??? Sales Agreement - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Equity - Warrants - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/EquityWarrantsNarrativeDetails</Role>
      <ShortName>Equity - Warrants - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Equity - Schedule of Warranty Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/EquityScheduleofWarrantyActivityDetails</Role>
      <ShortName>Equity - Schedule of Warranty Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Equity - Preferred Stock - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/EquityPreferredStockNarrativeDetails</Role>
      <ShortName>Equity - Preferred Stock - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - Equity - Schedule of Authorized Shares of Common Stock for Future Issuance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails</Role>
      <ShortName>Equity - Schedule of Authorized Shares of Common Stock for Future Issuance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Stock Incentive Plans - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails</Role>
      <ShortName>Stock Incentive Plans - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Stock Incentive Plans - Schedule of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock Incentive Plans - Schedule of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Stock Incentive Plans - Schedule of Weighted Average Assumptions Used (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofWeightedAverageAssumptionsUsedDetails</Role>
      <ShortName>Stock Incentive Plans - Schedule of Weighted Average Assumptions Used (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Stock Incentive Plans - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails</Role>
      <ShortName>Stock Incentive Plans - Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - Stock Incentive Plans - Schedule of Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Stock Incentive Plans - Schedule of Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - Revenue Arrangements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails</Role>
      <ShortName>Revenue Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cartesiantherapeutics.com/role/RevenueArrangements</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9955548 - Disclosure - Collaboration and License Agreements - Biogen M.A., Inc. - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsBiogenMAIncNarrativeDetails</Role>
      <ShortName>Collaboration and License Agreements - Biogen M.A., Inc. - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9955549 - Disclosure - Collaboration and License Agreements - National Cancer Institute of the National Institutes of Health - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsNationalCancerInstituteoftheNationalInstitutesofHealthNarrativeDetails</Role>
      <ShortName>Collaboration and License Agreements - National Cancer Institute of the National Institutes of Health - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9955550 - Disclosure - Collaboration and License Agreements - Shenyang Sunshine Pharmaceutical Co., Ltd - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsShenyangSunshinePharmaceuticalCoLtdNarrativeDetails</Role>
      <ShortName>Collaboration and License Agreements - Shenyang Sunshine Pharmaceutical Co., Ltd - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9955551 - Disclosure - Segment Reporting - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/SegmentReportingNarrativeDetails</Role>
      <ShortName>Segment Reporting - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="rnac-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9955552 - Disclosure - Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails</Role>
      <ShortName>Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="rnac-20260331.htm">rnac-20260331.htm</File>
    <File>rnac-20260331.xsd</File>
    <File>rnac-20260331_cal.xml</File>
    <File>rnac-20260331_def.xml</File>
    <File>rnac-20260331_lab.xml</File>
    <File>rnac-20260331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="514">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>103
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "rnac-20260331.htm": {
   "nsprefix": "rnac",
   "nsuri": "http://www.cartesiantherapeutics.com/20260331",
   "dts": {
    "inline": {
     "local": [
      "rnac-20260331.htm"
     ]
    },
    "schema": {
     "local": [
      "rnac-20260331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "rnac-20260331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "rnac-20260331_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "rnac-20260331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rnac-20260331_pre.xml"
     ]
    }
   },
   "keyStandard": 224,
   "keyCustom": 37,
   "axisStandard": 23,
   "axisCustom": 1,
   "memberStandard": 31,
   "memberCustom": 26,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/dei/2025": 5,
    "http://fasb.org/us-gaap/2025": 1
   },
   "contextCount": 168,
   "entityCount": 1,
   "segmentCount": 64,
   "elementCount": 550,
   "unitCount": 6,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 514,
    "http://xbrl.sec.gov/dei/2025": 29,
    "http://xbrl.sec.gov/ecd/2025": 4
   },
   "report": {
    "R1": {
     "role": "http://www.cartesiantherapeutics.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets",
     "longName": "9952151 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "9952152 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
     "longName": "9952153 - Statement - Consolidated Statements of Operations and Comprehensive Loss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit",
     "longName": "9952154 - Statement - Consolidated Statements of Changes in Stockholders\u2019 Deficit",
     "shortName": "Consolidated Statements of Changes in Stockholders\u2019 Deficit",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-26",
      "name": "us-gaap:PreferredStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-26",
      "name": "us-gaap:PreferredStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows",
     "longName": "9952155 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.cartesiantherapeutics.com/role/DescriptionoftheBusiness",
     "longName": "9952156 - Disclosure - Description of the Business",
     "shortName": "Description of the Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.cartesiantherapeutics.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "9952157 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssets",
     "longName": "9952158 - Disclosure - Goodwill and Indefinite-Lived Intangible Assets",
     "shortName": "Goodwill and Indefinite-Lived Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R10": {
     "role": "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholders",
     "longName": "9952159 - Disclosure - Net Loss Per Share Allocable to Common Stockholders",
     "shortName": "Net Loss Per Share Allocable to Common Stockholders",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.cartesiantherapeutics.com/role/FairValueMeasurements",
     "longName": "9952160 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.cartesiantherapeutics.com/role/PropertyandEquipment",
     "longName": "9952161 - Disclosure - Property and Equipment",
     "shortName": "Property and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.cartesiantherapeutics.com/role/AccruedExpenses",
     "longName": "9952162 - Disclosure - Accrued Expenses",
     "shortName": "Accrued Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.cartesiantherapeutics.com/role/Leases",
     "longName": "9952163 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.cartesiantherapeutics.com/role/Equity",
     "longName": "9952164 - Disclosure - Equity",
     "shortName": "Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.cartesiantherapeutics.com/role/StockIncentivePlans",
     "longName": "9952165 - Disclosure - Stock Incentive Plans",
     "shortName": "Stock Incentive Plans",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.cartesiantherapeutics.com/role/RevenueArrangements",
     "longName": "9952166 - Disclosure - Revenue Arrangements",
     "shortName": "Revenue Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreements",
     "longName": "9952167 - Disclosure - Collaboration and License Agreements",
     "shortName": "Collaboration and License Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "rnac:CollaborationAndLicenseAgreementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "rnac:CollaborationAndLicenseAgreementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.cartesiantherapeutics.com/role/IncomeTaxes",
     "longName": "9952168 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.cartesiantherapeutics.com/role/CommitmentsandContingencies",
     "longName": "9952169 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.cartesiantherapeutics.com/role/SegmentReporting",
     "longName": "9952170 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.cartesiantherapeutics.com/role/SubsequentEvents",
     "longName": "9952171 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.cartesiantherapeutics.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersTables",
     "longName": "9955512 - Disclosure - Net Loss Per Share Allocable to Common Stockholders (Tables)",
     "shortName": "Net Loss Per Share Allocable to Common Stockholders (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsTables",
     "longName": "9955513 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentTables",
     "longName": "9955514 - Disclosure - Property and Equipment (Tables)",
     "shortName": "Property and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.cartesiantherapeutics.com/role/AccruedExpensesTables",
     "longName": "9955515 - Disclosure - Accrued Expenses (Tables)",
     "shortName": "Accrued Expenses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.cartesiantherapeutics.com/role/LeasesTables",
     "longName": "9955516 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.cartesiantherapeutics.com/role/EquityTables",
     "longName": "9955517 - Disclosure - Equity (Tables)",
     "shortName": "Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.cartesiantherapeutics.com/role/StockIncentivePlansTables",
     "longName": "9955518 - Disclosure - Stock Incentive Plans (Tables)",
     "shortName": "Stock Incentive Plans (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.cartesiantherapeutics.com/role/SegmentReportingTables",
     "longName": "9955519 - Disclosure - Segment Reporting (Tables)",
     "shortName": "Segment Reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.cartesiantherapeutics.com/role/DescriptionoftheBusinessDetails",
     "longName": "9955520 - Disclosure - Description of the Business (Details)",
     "shortName": "Description of the Business (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "rnac:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssetsDetails",
     "longName": "9955521 - Disclosure - Goodwill and Indefinite-Lived Intangible Assets (Details)",
     "shortName": "Goodwill and Indefinite-Lived Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-47",
      "name": "us-gaap:ImpairmentOfIntangibleAssetsFinitelived",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofComputationofBasicandDilutedNetLossPerShareAllocabletoCommonStockholdersDetails",
     "longName": "9955522 - Disclosure - Net Loss Per Share Allocable to Common Stockholders - Schedule of Computation of Basic and Diluted Net Loss Per Share Allocable to Common Stockholders (Details)",
     "shortName": "Net Loss Per Share Allocable to Common Stockholders - Schedule of Computation of Basic and Diluted Net Loss Per Share Allocable to Common Stockholders (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R36": {
     "role": "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails",
     "longName": "9955523 - Disclosure - Net Loss Per Share Allocable to Common Stockholders - Schedule of Potential Dilutive Shares of Common Stock Excluded from the Computation of the Diluted Net Loss Per Share Allocable to Common Stockholders (Details)",
     "shortName": "Net Loss Per Share Allocable to Common Stockholders - Schedule of Potential Dilutive Shares of Common Stock Excluded from the Computation of the Diluted Net Loss Per Share Allocable to Common Stockholders (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
     "longName": "9955524 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "shortName": "Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsNarrativeDetails",
     "longName": "9955525 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofCashCashEquivalentsandRestrictedCashDetails",
     "longName": "9955526 - Disclosure - Fair Value Measurements - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)",
     "shortName": "Fair Value Measurements - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-43",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails",
     "longName": "9955527 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques for Warrants Liability (Details)",
     "shortName": "Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques for Warrants Liability (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-73",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-73",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofRollForwardofFairValuefortheCompanysLevel3WarrantLiabilitiesandCVRLiabilityDetails",
     "longName": "9955528 - Disclosure - Fair Value Measurements - Schedule of Roll-Forward of Fair Value for the Company\u2019s Level 3 Warrant Liabilities and CVR Liability (Details)",
     "shortName": "Fair Value Measurements - Schedule of Roll-Forward of Fair Value for the Company\u2019s Level 3 Warrant Liabilities and CVR Liability (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-81",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-81",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails",
     "longName": "9955529 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques for CVR Liability (Details)",
     "shortName": "Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques for CVR Liability (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-84",
      "name": "rnac:ContingentValueRightLiabilityMeasurementInput",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-84",
      "name": "rnac:ContingentValueRightLiabilityMeasurementInput",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails",
     "longName": "9955530 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)",
     "shortName": "Property and Equipment - Schedule of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentNarrativeDetails",
     "longName": "9955531 - Disclosure - Property and Equipment - Narrative (Details)",
     "shortName": "Property and Equipment - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails",
     "longName": "9955532 - Disclosure - Accrued Expenses (Details)",
     "shortName": "Accrued Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.cartesiantherapeutics.com/role/LeasesNarrativeDetails",
     "longName": "9955533 - Disclosure - Leases - Narrative (Details)",
     "shortName": "Leases - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-105",
      "name": "us-gaap:AreaOfRealEstateProperty",
      "unitRef": "sqft",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-105",
      "name": "us-gaap:AreaOfRealEstateProperty",
      "unitRef": "sqft",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.cartesiantherapeutics.com/role/LeasesScheduleofComponentsofLeaseCostsDetails",
     "longName": "9955534 - Disclosure - Leases - Schedule of Components of Lease Costs (Details)",
     "shortName": "Leases - Schedule of Components of Lease Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails",
     "longName": "9955535 - Disclosure - Leases - Schedule of Maturity of Operating Lease Liabilities (Details)",
     "shortName": "Leases - Schedule of Maturity of Operating Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.cartesiantherapeutics.com/role/LeasesScheduleofOtherInformationRelatedtoOperatingLeasesDetails",
     "longName": "9955536 - Disclosure - Leases - Schedule of Other Information Related to Operating Leases (Details)",
     "shortName": "Leases - Schedule of Other Information Related to Operating Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.cartesiantherapeutics.com/role/EquityAttheMarketSalesAgreementNarrativeDetails",
     "longName": "9955537 - Disclosure - Equity - \u201cAt the Market\u201d Sales Agreement - Narrative (Details)",
     "shortName": "Equity - \u201cAt the Market\u201d Sales Agreement - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProceedsFromIssuanceOfCommonStock",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-107",
      "name": "rnac:SaleOfStockAggregateMaximumGrossSalesProceeds",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.cartesiantherapeutics.com/role/EquityWarrantsNarrativeDetails",
     "longName": "9955538 - Disclosure - Equity - Warrants - Narrative (Details)",
     "shortName": "Equity - Warrants - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "rnac:ClassOfWarrantOrRightOutstandingWarrantsIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "rnac:ClassOfWarrantOrRightOutstandingWarrantsIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.cartesiantherapeutics.com/role/EquityScheduleofWarrantyActivityDetails",
     "longName": "9955539 - Disclosure - Equity - Schedule of Warranty Activity (Details)",
     "shortName": "Equity - Schedule of Warranty Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.cartesiantherapeutics.com/role/EquityPreferredStockNarrativeDetails",
     "longName": "9955540 - Disclosure - Equity - Preferred Stock - Narrative (Details)",
     "shortName": "Equity - Preferred Stock - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PreferredStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "us-gaap:PreferredStockSharesIssued",
       "us-gaap:PreferredStockSharesIssued",
       "us-gaap:PreferredStockSharesOutstanding",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:PreferredStockConvertibleSharesIssuable",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.cartesiantherapeutics.com/role/EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails",
     "longName": "9955541 - Disclosure - Equity - Schedule of Authorized Shares of Common Stock for Future Issuance (Details)",
     "shortName": "Equity - Schedule of Authorized Shares of Common Stock for Future Issuance (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-111",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails",
     "longName": "9955542 - Disclosure - Stock Incentive Plans - Narrative (Details)",
     "shortName": "Stock Incentive Plans - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockBasedCompensationExpenseDetails",
     "longName": "9955543 - Disclosure - Stock Incentive Plans - Schedule of Stock-Based Compensation Expense (Details)",
     "shortName": "Stock Incentive Plans - Schedule of Stock-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-127",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofWeightedAverageAssumptionsUsedDetails",
     "longName": "9955544 - Disclosure - Stock Incentive Plans - Schedule of Weighted Average Assumptions Used (Details)",
     "shortName": "Stock Incentive Plans - Schedule of Weighted Average Assumptions Used (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-131",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-131",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails",
     "longName": "9955545 - Disclosure - Stock Incentive Plans - Schedule of Stock Option Activity (Details)",
     "shortName": "Stock Incentive Plans - Schedule of Stock Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-135",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-137",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails",
     "longName": "9955546 - Disclosure - Stock Incentive Plans - Schedule of Restricted Stock Units Activity (Details)",
     "shortName": "Stock Incentive Plans - Schedule of Restricted Stock Units Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-141",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-141",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails",
     "longName": "9955547 - Disclosure - Revenue Arrangements (Details)",
     "shortName": "Revenue Arrangements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "rnac:GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "rnac:GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "rnac:GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "rnac:GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsBiogenMAIncNarrativeDetails",
     "longName": "9955548 - Disclosure - Collaboration and License Agreements - Biogen M.A., Inc. - Narrative (Details)",
     "shortName": "Collaboration and License Agreements - Biogen M.A., Inc. - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-151",
      "name": "rnac:CollaborativeArrangementWrittenNoticePeriodForTermination",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-151",
      "name": "rnac:CollaborativeArrangementWrittenNoticePeriodForTermination",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsNationalCancerInstituteoftheNationalInstitutesofHealthNarrativeDetails",
     "longName": "9955549 - Disclosure - Collaboration and License Agreements - National Cancer Institute of the National Institutes of Health - Narrative (Details)",
     "shortName": "Collaboration and License Agreements - National Cancer Institute of the National Institutes of Health - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-152",
      "name": "rnac:LicenseAndOptionAgreementRoyaltyPayment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-152",
      "name": "rnac:LicenseAndOptionAgreementRoyaltyPayment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsShenyangSunshinePharmaceuticalCoLtdNarrativeDetails",
     "longName": "9955550 - Disclosure - Collaboration and License Agreements - Shenyang Sunshine Pharmaceutical Co., Ltd - Narrative (Details)",
     "shortName": "Collaboration and License Agreements - Shenyang Sunshine Pharmaceutical Co., Ltd - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-153",
      "name": "rnac:AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-153",
      "name": "rnac:AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.cartesiantherapeutics.com/role/SegmentReportingNarrativeDetails",
     "longName": "9955551 - Disclosure - Segment Reporting - Narrative (Details)",
     "shortName": "Segment Reporting - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "rnac:NumberOfReportableSegmentsNotDisclosedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "rnac:NumberOfReportableSegmentsNotDisclosedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails",
     "longName": "9955552 - Disclosure - Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details)",
     "shortName": "Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-155",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20260331.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "rnac_A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2016 Plan, 2018 Inducement Incentive Award Plan and Old Cartesian Plan",
        "label": "2016 Plan, 2018 Inducement Incentive Award Plan and Old Cartesian Plan [Member]",
        "documentation": "2016 Plan, 2018 Inducement Incentive Award Plan and Old Cartesian Plan"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_A2022WarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "A2022WarrantsMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022 Warrants",
        "label": "2022 Warrants [Member]",
        "documentation": "2022 Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/AccruedExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Expenses",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r352"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r747"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r935"
     ]
    },
    "rnac_AccruedAuditFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "AccruedAuditFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued professional and consulting services",
        "label": "Accrued Audit Fees, Current",
        "documentation": "Accrued Audit Fees, Current"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_AccruedCollaborationandLicensing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "AccruedCollaborationandLicensing",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration and licensing",
        "label": "Accrued Collaboration and Licensing",
        "documentation": "Accrued Collaboration and Licensing"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_AccruedEquityOfferingCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "AccruedEquityOfferingCostsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued equity offering costs",
        "label": "Accrued Equity Offering Costs, Current",
        "documentation": "Accrued Equity Offering Costs, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued expenses and other current liabilities",
        "label": "Accrued Liabilities and Other Liabilities",
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Accrued expenses",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "rnac_AccruedPatentFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "AccruedPatentFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued patent fees",
        "label": "Accrued Patent Fees Current",
        "documentation": "Carrying value as of the balance sheet date of patent fees."
       }
      }
     },
     "auth_ref": []
    },
    "rnac_AccruedResearchAndDevelopmentCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "AccruedResearchAndDevelopmentCostsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued research and development costs",
        "label": "Accrued Research And Development Costs Current",
        "documentation": "Carrying value as of the balance sheet date of research and development costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: Accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r104",
      "r539"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r16",
      "r53",
      "r110",
      "r536",
      "r572",
      "r573",
      "r1008"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accumulated other comprehensive loss",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r7",
      "r16",
      "r441",
      "r444",
      "r508",
      "r568",
      "r569",
      "r869",
      "r870",
      "r871",
      "r922",
      "r923",
      "r924",
      "r925"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r747",
      "r1063"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r586",
      "r922",
      "r923",
      "r924",
      "r925",
      "r1009",
      "r1065"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r313"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform",
     "crdr": "debit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsShenyangSunshinePharmaceuticalCoLtdNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate amount for future payments upon achievement of clinical and regulatory approval milestones for products containing ImmTOR platform",
        "label": "Aggregate Amount For Future Payments Upon Achievement Of Clinical And Regulatory Approval Milestones For Products Containing ImmTOR Platform",
        "documentation": "Aggregate Amount For Future Payments Upon Achievement Of Clinical And Regulatory Approval Milestones For Products Containing ImmTOR Platform"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsShenyangSunshinePharmaceuticalCoLtdNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate amount of upfront and milestone-based payments",
        "label": "Aggregate Amount Of Upfront And Milestone Based Payments Paid",
        "documentation": "Aggregate Amount Of Upfront And Milestone Based Payments Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r849"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r775",
      "r785",
      "r795",
      "r827"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r778",
      "r788",
      "r798",
      "r830"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r850"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r779",
      "r789",
      "r799",
      "r823",
      "r831",
      "r835",
      "r843"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock\u2011based compensation expense",
        "verboseLabel": "Total stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r343",
      "r349",
      "r350"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Potential common shares",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "us-gaap_AreaOfRealEstateProperty": {
     "xbrltype": "areaItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AreaOfRealEstateProperty",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Area of office space leased",
        "label": "Area of Real Estate Property",
        "documentation": "Area of a real estate property."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsBiogenMAIncNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsNationalCancerInstituteoftheNationalInstitutesofHealthNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsShenyangSunshinePharmaceuticalCoLtdNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r84",
      "r106",
      "r127",
      "r128",
      "r129",
      "r164",
      "r173",
      "r191",
      "r195",
      "r203",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r431",
      "r433",
      "r479",
      "r524",
      "r525",
      "r530",
      "r621",
      "r693",
      "r694",
      "r702",
      "r747",
      "r753",
      "r754",
      "r766",
      "r957",
      "r958",
      "r1021"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r111",
      "r127",
      "r128",
      "r129",
      "r203",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r431",
      "r433",
      "r479",
      "r747",
      "r957",
      "r958",
      "r1021"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r456",
      "r738"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets:",
        "label": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_AtTheMarketOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "AtTheMarketOfferingMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityAttheMarketSalesAgreementNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-The-Market Offering",
        "label": "At-The-Market Offering [Member]",
        "documentation": "At-The-Market Offering [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofWeightedAverageAssumptionsUsedDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r835"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r835"
     ]
    },
    "rnac_BiogenM.A.Inc.Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "BiogenM.A.Inc.Member",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsBiogenMAIncNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Biogen M.A., Inc.",
        "label": "Biogen M.A., Inc. [Member]",
        "documentation": "Biogen M.A., Inc."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/DescriptionoftheBusinessDetails",
      "http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssetsDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination [Domain]",
        "label": "Business Combination [Domain]",
        "documentation": "Business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r576",
      "r717",
      "r718",
      "r999",
      "r1001",
      "r1002"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/DescriptionoftheBusinessDetails",
      "http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssetsDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination [Axis]",
        "label": "Business Combination [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r576",
      "r717",
      "r718",
      "r999",
      "r1001",
      "r1002"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination [Line Items]",
        "label": "Business Combination [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r375",
      "r376",
      "r377",
      "r378",
      "r384",
      "r385",
      "r386",
      "r387",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r422",
      "r423",
      "r424",
      "r427",
      "r723",
      "r727",
      "r999",
      "r1001",
      "r1002"
     ]
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of property and equipment not yet paid",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r22"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r102",
      "r674"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Axis]",
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market funds (included in cash equivalents)",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r476",
      "r477",
      "r478",
      "r1010",
      "r1011"
     ]
    },
    "us-gaap_CashAndCashEquivalentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsLineItems",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/DescriptionoftheBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Line Items]",
        "label": "Cash and Cash Equivalents [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "totalLabel": "Total cash, cash equivalents, and restricted cash",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r60",
      "r124"
     ]
    },
    "rnac_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale",
     "crdr": "debit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/DescriptionoftheBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash, cash equivalents, restricted cash and marketable securities",
        "label": "Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents And Debt Securities, Available-For-Sale",
        "documentation": "Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents And Debt Securities, Available-For-Sale"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net change in cash, cash equivalents, and restricted cash",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation",
        "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r60"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r811"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r809"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets",
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit",
      "http://www.cartesiantherapeutics.com/role/EquityPreferredStockNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r107",
      "r108",
      "r109",
      "r127",
      "r129",
      "r154",
      "r155",
      "r157",
      "r159",
      "r166",
      "r167",
      "r203",
      "r240",
      "r242",
      "r243",
      "r244",
      "r247",
      "r248",
      "r253",
      "r254",
      "r256",
      "r257",
      "r259",
      "r262",
      "r265",
      "r266",
      "r270",
      "r273",
      "r280",
      "r479",
      "r580",
      "r581",
      "r582",
      "r583",
      "r586",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r609",
      "r629",
      "r647",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r853",
      "r918",
      "r919",
      "r926"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityAttheMarketSalesAgreementNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/EquityPreferredStockNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r108",
      "r109",
      "r166",
      "r256",
      "r265",
      "r266",
      "r268",
      "r270",
      "r273",
      "r278",
      "r280",
      "r439",
      "r580",
      "r581",
      "r582",
      "r583",
      "r703",
      "r853",
      "r916",
      "r918"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Axis]",
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Domain]",
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price (in dollars per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r131",
      "r281"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Line Items]",
        "label": "Class of Warrant or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of warrants, outstanding (in shares)",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "rnac_ClassOfWarrantOrRightOutstandingWarrantsCancelled": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ClassOfWarrantOrRightOutstandingWarrantsCancelled",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityWarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants cancelled (in shares)",
        "label": "Class of Warrant Or Right, Outstanding, Warrants Cancelled",
        "documentation": "Class of Warrant Or Right, Outstanding, Warrants Cancelled"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_ClassOfWarrantOrRightOutstandingWarrantsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ClassOfWarrantOrRightOutstandingWarrantsExercised",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityWarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants exercised (in shares)",
        "label": "Class of Warrant Or Right, Outstanding, Warrants Exercised",
        "documentation": "Class of Warrant Or Right, Outstanding, Warrants Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_ClassOfWarrantOrRightOutstandingWarrantsIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ClassOfWarrantOrRightOutstandingWarrantsIssued",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityWarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants issued (in shares)",
        "label": "Class of Warrant Or Right, Outstanding, Warrants Issued",
        "documentation": "Class of Warrant Or Right, Outstanding, Warrants Issued"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_ClassOfWarrantOrRightRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ClassOfWarrantOrRightRollForward",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Warrants",
        "label": "Class Of Warrant Or Right [Roll Forward]",
        "documentation": "Class Of Warrant Or Right"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Table]",
        "label": "Class of Warrant or Right [Table]",
        "documentation": "Disclosure of information about warrant or right issued that give holder right to purchase security from issuer at specific price within certain time frame."
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "rnac_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average exercise price",
        "label": "Class Of Warrant Or Right Weighted Average Exercise Price [Roll Forward]",
        "documentation": "Class Of Warrant Or Right Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "rnac_CollaborationAndLicenseAgreementsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "CollaborationAndLicenseAgreementsTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration and License Agreements",
        "label": "Collaboration And License Agreements [Text Block]",
        "documentation": "Collaboration And License Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_CollaborativeArrangementWrittenNoticePeriodForTermination": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "CollaborativeArrangementWrittenNoticePeriodForTermination",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsBiogenMAIncNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsNationalCancerInstituteoftheNationalInstitutesofHealthNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written notice for agreement termination",
        "label": "Collaborative Arrangement, Written Notice Period For Termination",
        "documentation": "Collaborative Arrangement, Written Notice Period For Termination"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsBiogenMAIncNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsNationalCancerInstituteoftheNationalInstitutesofHealthNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsShenyangSunshinePharmaceuticalCoLtdNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note\u00a014)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r78",
      "r532",
      "r608"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r234",
      "r235",
      "r667",
      "r952",
      "r954"
     ]
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total (in shares)",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common\u00a0stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r756",
      "r757",
      "r758",
      "r760",
      "r761",
      "r762",
      "r763",
      "r922",
      "r923",
      "r925",
      "r1009",
      "r1062",
      "r1065"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r609"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "periodStartLabel": "Common stock, beginning balance (in shares)",
        "periodEndLabel": "Common stock, ending balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r47",
      "r609",
      "r627",
      "r1065",
      "r1066"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.0001 par value; 350,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 28,544,728 and 26,011,106 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r254",
      "r261",
      "r535",
      "r747"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r820"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r113",
      "r115",
      "r120",
      "r522",
      "r543",
      "r544"
     ]
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer equipment and software",
        "label": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation and Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r685"
     ]
    },
    "us-gaap_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in process",
        "label": "Construction in Progress [Member]",
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": []
    },
    "rnac_ContingentValueRightLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ContingentValueRightLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent value right liability",
        "label": "Contingent Value Right Liability",
        "documentation": "Contingent Value Right Liability"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_ContingentValueRightLiabilityMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ContingentValueRightLiabilityMeasurementInput",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent value right liability, measurement input",
        "label": "Contingent Value Right Liability, Measurement Input",
        "documentation": "Contingent Value Right Liability, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_ContingentValueRightLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ContingentValueRightLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent value right liability",
        "label": "Contingent Value Right Liability, Noncurrent",
        "documentation": "Contingent Value Right Liability, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_ContingentValueRightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ContingentValueRightMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofRollForwardofFairValuefortheCompanysLevel3WarrantLiabilitiesandCVRLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "CVR Liability",
        "label": "Contingent Value Right [Member]",
        "documentation": "Contingent Value Right"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/DescriptionoftheBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent value right, percentage of milestone payments, royalties and other amounts to be distributed",
        "label": "Contingent Value Right, Percentage Of Milestone Payments, Royalties And Other Amounts To Be Distributed",
        "documentation": "Contingent Value Right, Percentage Of Milestone Payments, Royalties And Other Amounts To Be Distributed"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract liability",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r283",
      "r284",
      "r286",
      "r297"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognized",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r298"
     ]
    },
    "us-gaap_CostOfRevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostOfRevenueAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Cost of Revenue [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r127",
      "r133",
      "r134",
      "r249",
      "r268",
      "r509",
      "r517",
      "r529",
      "r675",
      "r676",
      "r677",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r1004",
      "r1005",
      "r1006",
      "r1007"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities, net",
        "label": "Deferred Income Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r356",
      "r357",
      "r531"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depreciation expense",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r27",
      "r122",
      "r678",
      "r679",
      "r681",
      "r683"
     ]
    },
    "rnac_Descartes08ForDermatomyositisMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "Descartes08ForDermatomyositisMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Descartes-08 for dermatomyositis",
        "label": "Descartes-08 For Dermatomyositis [Member]",
        "documentation": "Descartes-08 For Dermatomyositis"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_Descartes08ForMGMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "Descartes08ForMGMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssetsDetails",
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Descartes-08 for MG",
        "label": "Descartes-08 For MG [Member]",
        "documentation": "Descartes-08 For MG"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Line Items]",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r296",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r296",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlans"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Incentive Plans",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r311",
      "r315",
      "r344",
      "r345",
      "r347",
      "r720"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restricted Stock Units Activity",
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "documentation": "Tabular disclosure of share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r967"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r802"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "rnac_EarlyStageProgramsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "EarlyStageProgramsMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Early stage programs",
        "label": "Early Stage Programs [Member]",
        "documentation": "Early Stage Programs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share allocable to common stockholders:",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofComputationofBasicandDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r121",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r152",
      "r154",
      "r157",
      "r158",
      "r159",
      "r163",
      "r252",
      "r348",
      "r373",
      "r429",
      "r452",
      "r453",
      "r523",
      "r545",
      "r686"
     ]
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasicAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofComputationofBasicandDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share allocable to common stockholders:",
        "label": "Earnings Per Share, Basic [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofComputationofBasicandDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r121",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r154",
      "r157",
      "r158",
      "r159",
      "r163",
      "r252",
      "r348",
      "r373",
      "r429",
      "r452",
      "r453",
      "r523",
      "r545",
      "r686"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholders"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share Allocable to Common Stockholders",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r160",
      "r161",
      "r162"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate changes on cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r483"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payroll and employee related expenses",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r994"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average period",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation expense",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r995"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation expense related to unvested employee stock options",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r995"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofWeightedAverageAssumptionsUsedDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Outstanding common stock options",
        "terseLabel": "Outstanding Series A Preferred Stock options",
        "netLabel": "Options",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993"
     ]
    },
    "rnac_EmploymentInducementIncentiveAwardPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "EmploymentInducementIncentiveAwardPlanMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employment Inducement Incentive Award Plan",
        "label": "Employment Inducement Incentive Award Plan [Member]",
        "documentation": "Employment Inducement Incentive Award Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Smaller Reporting Company",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r848"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r848"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r848"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit",
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails",
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofWarrantyActivityDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r92",
      "r93",
      "r94",
      "r116",
      "r117",
      "r118",
      "r135",
      "r136",
      "r137",
      "r139",
      "r146",
      "r148",
      "r150",
      "r165",
      "r204",
      "r205",
      "r227",
      "r251",
      "r282",
      "r348",
      "r364",
      "r365",
      "r370",
      "r371",
      "r372",
      "r374",
      "r428",
      "r429",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r451",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491",
      "r493",
      "r508",
      "r542",
      "r568",
      "r569",
      "r570",
      "r586",
      "r647"
     ]
    },
    "rnac_EquityOfferingCostsInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "EquityOfferingCostsInAccruedLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity offering costs in accrued liabilities",
        "label": "Equity Offering Costs In Accrued Liabilities",
        "documentation": "Equity Offering Costs In Accrued Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r775",
      "r785",
      "r795",
      "r827"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r772",
      "r782",
      "r792",
      "r824"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "rnac_FairValueAdjustmentOfContingentValueRightLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "FairValueAdjustmentOfContingentValueRightLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 3.0
      },
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "(Loss) gain on change in fair value of contingent value right liability",
        "terseLabel": "Loss (gain) on change in fair value of CVR liability",
        "label": "Fair Value Adjustment Of Contingent Value Right Liability",
        "documentation": "Fair Value Adjustment Of Contingent Value Right Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gain on change in fair value of warrant liabilities",
        "terseLabel": "Gain on change in warrant liability",
        "label": "Fair Value Adjustment of Warrants",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r456",
      "r469",
      "r738"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r456",
      "r469",
      "r738"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r458",
      "r459",
      "r723",
      "r726",
      "r741"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r458",
      "r459",
      "r723",
      "r726",
      "r741"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value Measurement Inputs and Valuation Techniques for 2022 Warrants Liability and CVR Liability",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r458",
      "r741"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r454",
      "r456",
      "r457",
      "r458",
      "r459",
      "r468",
      "r469",
      "r471",
      "r476",
      "r512",
      "r513",
      "r514",
      "r671",
      "r700",
      "r701",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r738",
      "r741",
      "r745"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofWarrantyActivityDetails",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofRollForwardofFairValuefortheCompanysLevel3WarrantLiabilitiesandCVRLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability Class [Axis]",
        "label": "Liability Class [Axis]",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r470"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r464",
      "r466",
      "r467",
      "r468",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r520",
      "r738",
      "r742"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a01",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r301",
      "r306",
      "r307",
      "r456",
      "r469",
      "r476",
      "r512",
      "r671",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r738",
      "r745"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a02",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r301",
      "r306",
      "r307",
      "r309",
      "r456",
      "r457",
      "r469",
      "r476",
      "r513",
      "r671",
      "r700",
      "r701",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r738",
      "r745"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a03",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r456",
      "r457",
      "r458",
      "r459",
      "r469",
      "r476",
      "r514",
      "r671",
      "r700",
      "r701",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r738",
      "r741",
      "r745"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofWarrantyActivityDetails",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofRollForwardofFairValuefortheCompanysLevel3WarrantLiabilitiesandCVRLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value by Liability Class [Domain]",
        "label": "Fair Value by Liability Class [Domain]",
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r470"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofRollForwardofFairValuefortheCompanysLevel3WarrantLiabilitiesandCVRLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofRollForwardofFairValuefortheCompanysLevel3WarrantLiabilitiesandCVRLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofRollForwardofFairValuefortheCompanysLevel3WarrantLiabilitiesandCVRLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Disclosure of information about financial instrument liability measured at fair value on recurring basis using unobservable input."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r470"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Roll-Forward of Fair Value for the Company\u2019s Level 3 Warrant Liabilities, CVR Liability and Forward Contract Liabilities",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r465",
      "r470"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
     "crdr": "debit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers, net",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net",
        "documentation": "Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy."
       }
      }
     },
     "auth_ref": [
      "r1015",
      "r1016"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "crdr": "credit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofRollForwardofFairValuefortheCompanysLevel3WarrantLiabilitiesandCVRLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Change in fair value",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r461",
      "r470"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet",
     "crdr": "credit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net",
        "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy."
       }
      }
     },
     "auth_ref": [
      "r1015",
      "r1016"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofRollForwardofFairValuefortheCompanysLevel3WarrantLiabilitiesandCVRLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r470"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r454",
      "r456",
      "r457",
      "r458",
      "r459",
      "r468",
      "r469",
      "r471",
      "r476",
      "r512",
      "r513",
      "r514",
      "r671",
      "r700",
      "r701",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r738",
      "r741",
      "r745"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non\u2011cash lease expense",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r499",
      "r746"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r779",
      "r789",
      "r799",
      "r831"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r779",
      "r789",
      "r799",
      "r831"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r779",
      "r789",
      "r799",
      "r831"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r779",
      "r789",
      "r799",
      "r831"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r779",
      "r789",
      "r799",
      "r831"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "rnac_FrederickLeaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "FrederickLeaseAgreementMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Frederick Lease Agreement",
        "label": "Frederick Lease Agreement [Member]",
        "documentation": "Frederick Lease Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and fixtures",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r631"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets",
      "http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r207",
      "r521",
      "r694",
      "r699",
      "r723",
      "r724",
      "r725",
      "r734",
      "r739",
      "r747",
      "r938",
      "r939",
      "r1003"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssets",
      "http://www.cartesiantherapeutics.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets",
        "verboseLabel": "Goodwill and Indefinite-Lived Intangible Assets",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r937",
      "r940"
     ]
    },
    "us-gaap_GovernmentAssistanceAmountCumulativeCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GovernmentAssistanceAmountCumulativeCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government assistance, asset, current",
        "label": "Government Assistance, Asset, Current",
        "documentation": "Amount of asset from government assistance, classified as current."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "us-gaap_GovernmentAssistanceAwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GovernmentAssistanceAwardAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government assistance, award amount",
        "label": "Government Assistance, Award Amount",
        "documentation": "Amount of government assistance awarded that comprises amount received, receivable, and to be received unless condition for government assistance is not met. Includes, but is not limited to, government grant, assistance, incentive, award, subsidy, and loan."
       }
      }
     },
     "auth_ref": [
      "r1018"
     ]
    },
    "rnac_GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government Assistance Current Statement Of Financial Position Extensible Enumeration Not Disclosed Flag",
        "label": "Government Assistance Current Statement Of Financial Position Extensible Enumeration Not Disclosed Flag",
        "documentation": "Government Assistance Current Statement Of Financial Position Extensible Enumeration Not Disclosed Flag"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_GovernmentAssistancePotentialAdditionalAwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "GovernmentAssistancePotentialAdditionalAwardAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government assistance, potential additional award amount",
        "label": "Government Assistance, Potential Additional Award Amount",
        "documentation": "Government Assistance, Potential Additional Award Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GovernmentAssistanceTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GovernmentAssistanceTypeAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government Assistance, Type [Axis]",
        "label": "Government Assistance, Type [Axis]",
        "documentation": "Information by type of government assistance."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "us-gaap_GovernmentAssistanceTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GovernmentAssistanceTypeDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government Assistance, Type [Domain]",
        "label": "Government Assistance, Type [Domain]",
        "documentation": "Type of government assistance."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "crdr": "debit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment to goodwill",
        "label": "Impairment of Intangible Assets, Finite-Lived",
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r915",
      "r951"
     ]
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InProcessResearchAndDevelopmentMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "In Process Research and Development",
        "label": "In Process Research and Development [Member]",
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process."
       }
      }
     },
     "auth_ref": [
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950"
     ]
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r230",
      "r231",
      "r435",
      "r436",
      "r437",
      "r438",
      "r461",
      "r465",
      "r470",
      "r480",
      "r481",
      "r482",
      "r565",
      "r567",
      "r632",
      "r670",
      "r671",
      "r723",
      "r725",
      "r736",
      "r737",
      "r740",
      "r745",
      "r998",
      "r1000",
      "r1033"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r230",
      "r231",
      "r435",
      "r436",
      "r437",
      "r438",
      "r461",
      "r465",
      "r470",
      "r480",
      "r481",
      "r482",
      "r565",
      "r567",
      "r632",
      "r670",
      "r671",
      "r723",
      "r725",
      "r736",
      "r737",
      "r740",
      "r745",
      "r998",
      "r1000",
      "r1033"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r130",
      "r355",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r366",
      "r367",
      "r368",
      "r369",
      "r528",
      "r575",
      "r585",
      "r722"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other liabilities",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r914"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-Lived Intangible Assets [Axis]",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r223",
      "r225",
      "r673",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets",
      "http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "In-process research and development asset",
        "netLabel": "Intangible assets",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r225",
      "r673"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r223",
      "r225",
      "r673",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r779",
      "r789",
      "r799",
      "r823",
      "r831",
      "r835",
      "r843"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r771",
      "r847"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r771",
      "r847"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r771",
      "r847"
     ]
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Investment Income, Interest",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r176",
      "r195",
      "r693",
      "r872"
     ]
    },
    "rnac_LaboratoryEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "LaboratoryEquipmentMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Laboratory equipment",
        "label": "Laboratory Equipment [Member]",
        "documentation": "Represents information pertaining to laboratory equipment."
       }
      }
     },
     "auth_ref": []
    },
    "rnac_LeaseArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "LeaseArrangementAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Arrangement [Axis]",
        "label": "Lease Arrangement [Axis]",
        "documentation": "Lease Arrangement [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_LeaseArrangementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "LeaseArrangementDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Arrangement [Domain]",
        "label": "Lease Arrangement [Domain]",
        "documentation": "[Domain] for Lease Arrangement [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofComponentsofLeaseCostsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofComponentsofLeaseCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease cost",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r498",
      "r746"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Lease Costs and Other Information Related to Operating Leases",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1019"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r507"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases [Abstract]",
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_LesseeOperatingLeaseAnnualBaseRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "LesseeOperatingLeaseAnnualBaseRent",
     "crdr": "debit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate annual base rent",
        "label": "Lessee, Operating Lease, Annual Base Rent",
        "documentation": "Lessee, Operating Lease, Annual Base Rent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturity of Operating Lease Liabilities",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1020"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total future minimum lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r506",
      "r917",
      "r921",
      "r1030"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r506",
      "r917",
      "r921",
      "r1030"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2030",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r506",
      "r917",
      "r921",
      "r1030"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r506",
      "r917",
      "r921",
      "r1030"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r506",
      "r917",
      "r921",
      "r1030"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026 (remainder)",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r1020"
     ]
    },
    "rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four",
        "documentation": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: Imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r506"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r127",
      "r128",
      "r129",
      "r203",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r432",
      "r433",
      "r434",
      "r479",
      "r607",
      "r687",
      "r702",
      "r766",
      "r957",
      "r1021",
      "r1022"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 deficit",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r79",
      "r538",
      "r747",
      "r753",
      "r754",
      "r916",
      "r920",
      "r936",
      "r1017"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and stockholders\u2019 deficit",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r101",
      "r127",
      "r128",
      "r129",
      "r203",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r432",
      "r433",
      "r434",
      "r479",
      "r747",
      "r957",
      "r1021",
      "r1022"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r456",
      "r1010"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities:",
        "label": "Liabilities, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsShenyangSunshinePharmaceuticalCoLtdNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "3SBio License",
        "label": "License Agreement With Shenyang Sunshine Pharmaceutical Company Limited [Member]",
        "documentation": "Represents information pertaining to License agreement with Shenyang Sunshine Pharmaceutical co., ltd."
       }
      }
     },
     "auth_ref": []
    },
    "rnac_LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum",
     "crdr": "credit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsNationalCancerInstituteoftheNationalInstitutesofHealthNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License and option agreement, benchmark royalties, maximum",
        "label": "License And Option Agreement, Benchmark Royalties, Maximum",
        "documentation": "License And Option Agreement, Benchmark Royalties, Maximum"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_LicenseAndOptionAgreementRoyaltyPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "LicenseAndOptionAgreementRoyaltyPayment",
     "crdr": "credit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsNationalCancerInstituteoftheNationalInstitutesofHealthNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License and option agreement, royalty payment",
        "label": "License And Option Agreement, Royalty Payment",
        "documentation": "License And Option Agreement, Royalty Payment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LicenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LicenseMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License",
        "label": "License [Member]",
        "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark."
       }
      }
     },
     "auth_ref": [
      "r963",
      "r964"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r168",
      "r236",
      "r237",
      "r238",
      "r239",
      "r310",
      "r339",
      "r340",
      "r341",
      "r351",
      "r459",
      "r518",
      "r564",
      "r566",
      "r574",
      "r599",
      "r600",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r663",
      "r664",
      "r665",
      "r666",
      "r668",
      "r669",
      "r698",
      "r703",
      "r719",
      "r723",
      "r726",
      "r727",
      "r741",
      "r742",
      "r743",
      "r744",
      "r749",
      "r959",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputExpectedDividendRateMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend yield",
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r1012",
      "r1013",
      "r1014"
     ]
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputExpectedTermMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected life (in years)",
        "label": "Measurement Input, Expected Term [Member]",
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r1012",
      "r1013",
      "r1014"
     ]
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Measurement Input, Price Volatility [Member]",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r741",
      "r1012",
      "r1013",
      "r1014"
     ]
    },
    "rnac_MeasurementInputRevenueVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "MeasurementInputRevenueVolatilityMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility of future revenues",
        "label": "Measurement Input, Revenue Volatility [Member]",
        "documentation": "Measurement Input, Revenue Volatility"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r341",
      "r1012",
      "r1013",
      "r1014"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Axis]",
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r457",
      "r458",
      "r459",
      "r723",
      "r726",
      "r727",
      "r741"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Domain]",
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r458",
      "r459",
      "r723",
      "r726",
      "r727",
      "r741"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r168",
      "r236",
      "r237",
      "r238",
      "r239",
      "r310",
      "r339",
      "r340",
      "r341",
      "r351",
      "r459",
      "r518",
      "r564",
      "r566",
      "r574",
      "r599",
      "r600",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r663",
      "r664",
      "r665",
      "r666",
      "r668",
      "r669",
      "r698",
      "r703",
      "r719",
      "r723",
      "r726",
      "r727",
      "r741",
      "r742",
      "r743",
      "r749",
      "r959",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market funds (included in cash equivalents)",
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r965",
      "r966"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r842"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "rnac_NationalCancerInstituteAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "NationalCancerInstituteAgreementMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsNationalCancerInstituteoftheNationalInstitutesofHealthNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NCI Agreement",
        "label": "National Cancer Institute Agreement [Member]",
        "documentation": "National Cancer Institute Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "National Institute of Neurological Disorders and Stroke of the National Institutes of Health Funding",
        "label": "National Institute Of Neurological Disorders And Stroke Of The National Institutes Of Health Funding [Member]",
        "documentation": "National Institute Of Neurological Disorders And Stroke Of The National Institutes Of Health Funding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Continuing Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Continuing Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r61",
      "r62"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Continuing Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit",
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofComputationofBasicandDilutedNetLossPerShareAllocabletoCommonStockholdersDetails",
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net loss",
        "netLabel": "Net loss",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r62",
      "r80",
      "r94",
      "r99",
      "r112",
      "r114",
      "r118",
      "r127",
      "r128",
      "r129",
      "r132",
      "r138",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r149",
      "r150",
      "r156",
      "r203",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r252",
      "r255",
      "r258",
      "r263",
      "r348",
      "r373",
      "r429",
      "r453",
      "r479",
      "r541",
      "r628",
      "r645",
      "r646",
      "r680",
      "r682",
      "r684",
      "r764",
      "r957"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofComputationofBasicandDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator:",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recent Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r779",
      "r789",
      "r799",
      "r823",
      "r831"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r806"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r842"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r842"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash investing and financing activities",
        "label": "Noncash Investing and Financing Items [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other (expense) income, net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other (expense) income:",
        "label": "Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_NonoperatingIncomeExpenseAdjusted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "NonoperatingIncomeExpenseAdjusted",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other expense (income), net",
        "label": "Nonoperating Income (Expense), Adjusted",
        "documentation": "Nonoperating Income (Expense), Adjusted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SegmentReportingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r694",
      "r930"
     ]
    },
    "rnac_NumberOfReportableSegmentsNotDisclosedFlag": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "NumberOfReportableSegmentsNotDisclosedFlag",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SegmentReportingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments not disclosed flag",
        "label": "Number Of Reportable Segments Not Disclosed Flag",
        "documentation": "Number Of Reportable Segments Not Disclosed Flag"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OfficeEquipmentMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office equipment",
        "label": "Office Equipment [Member]",
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine."
       }
      }
     },
     "auth_ref": []
    },
    "rnac_OldCartesianMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "OldCartesianMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/DescriptionoftheBusinessDetails",
      "http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Old Cartesian",
        "label": "Old Cartesian [Member]",
        "documentation": "Old Cartesian"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_OldCartesianPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "OldCartesianPlanMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Old Cartesian Plan",
        "label": "Old Cartesian Plan [Member]",
        "documentation": "Old Cartesian Plan"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_OldCartestianMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "OldCartestianMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Old Cartestian",
        "label": "Old Cartestian [Member]",
        "documentation": "Old Cartestian"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r684"
     ]
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating loss",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r680",
      "r684",
      "r688",
      "r929",
      "r931",
      "r932",
      "r933",
      "r934"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofComponentsofLeaseCostsDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofComponentsofLeaseCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease cost",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r500",
      "r746"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total operating lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r495"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r495"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease liabilities, net of current portion",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r495"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofOtherInformationRelatedtoOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r503"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets, net",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r494"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofOtherInformationRelatedtoOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted-average discount rate",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r505",
      "r746"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofOtherInformationRelatedtoOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining lease term",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r504",
      "r746"
     ]
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeasedAssetsLineItems",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Leased Assets [Line Items]",
        "label": "Operating Leased Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "rnac_OperatingSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "OperatingSegmentMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Segment",
        "label": "Operating Segment [Member]",
        "documentation": "Operating Segment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/DescriptionoftheBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of the Business",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r95",
      "r96",
      "r97",
      "r577",
      "r578"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit",
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Foreign currency translation adjustment",
        "terseLabel": "Currency translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r542"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossTaxAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive (loss) income:",
        "label": "Other Comprehensive Income (Loss), Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Other Depreciation and Amortization",
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r27",
      "r55"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other expense, net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r735"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r777",
      "r787",
      "r797",
      "r829"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r780",
      "r790",
      "r800",
      "r832"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r780",
      "r790",
      "r800",
      "r832"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables and Accruals [Abstract]",
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_PaymentsForContingentValueRightsDistributions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "PaymentsForContingentValueRightsDistributions",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Distribution of Contingent Value Rights",
        "label": "Payments For Contingent Value Rights Distributions",
        "documentation": "Payments For Contingent Value Rights Distributions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Equity offering costs",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r806"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r806"
     ]
    },
    "us-gaap_PreferredStockConvertibleSharesIssuable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockConvertibleSharesIssuable",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityPreferredStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, common stock issuable upon conversion (in shares)",
        "label": "Preferred Stock, Convertible, Shares Issuable",
        "documentation": "Number of common shares issuable upon conversion of preferred stock."
       }
      }
     },
     "auth_ref": [
      "r267"
     ]
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit",
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock",
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r756",
      "r757",
      "r760",
      "r761",
      "r762",
      "r763",
      "r1062",
      "r1065"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, par value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r265"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r609"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.cartesiantherapeutics.com/role/EquityPreferredStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r265"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit",
      "http://www.cartesiantherapeutics.com/role/EquityPreferredStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares outstanding (in shares)",
        "periodStartLabel": "Preferred stock, beginning balance (in shares)",
        "periodEndLabel": "Preferred stock, ending balance (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r609",
      "r627",
      "r1065",
      "r1066"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, value, issued",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r254",
      "r260",
      "r534",
      "r747"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseAndOtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term prepaid expenses and other assets",
        "label": "Prepaid Expense and Other Assets, Noncurrent",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r856"
     ]
    },
    "rnac_ProbabilityOfSuccessMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ProbabilityOfSuccessMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated probability of success",
        "label": "Probability Of Success [Member]",
        "documentation": "Probability Of Success"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cartesiantherapeutics.com/role/EquityAttheMarketSalesAgreementNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Proceeds from at the market offering, net of commissions and expenses",
        "terseLabel": "Net proceeds from issuance of common stock- at-the-market offering",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of stock options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r11"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r198",
      "r519",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r672",
      "r679",
      "r682",
      "r684",
      "r704",
      "r705",
      "r748",
      "r749",
      "r750",
      "r752",
      "r755",
      "r854",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r955",
      "r956",
      "r1032",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r198",
      "r519",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r672",
      "r679",
      "r682",
      "r684",
      "r704",
      "r705",
      "r748",
      "r749",
      "r750",
      "r752",
      "r755",
      "r854",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r955",
      "r956",
      "r1032",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Abstract]",
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r507"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/PropertyandEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r86",
      "r88",
      "r89"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total property and equipment",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r103",
      "r540"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets",
      "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r507",
      "r527",
      "r540",
      "r747"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r507"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r168",
      "r236",
      "r237",
      "r238",
      "r239",
      "r300",
      "r310",
      "r339",
      "r340",
      "r341",
      "r347",
      "r351",
      "r459",
      "r515",
      "r516",
      "r518",
      "r564",
      "r566",
      "r574",
      "r599",
      "r600",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r663",
      "r664",
      "r665",
      "r666",
      "r668",
      "r669",
      "r698",
      "r703",
      "r719",
      "r723",
      "r726",
      "r727",
      "r741",
      "r742",
      "r743",
      "r744",
      "r749",
      "r758",
      "r953",
      "r959",
      "r1013",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforCVRLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r168",
      "r236",
      "r237",
      "r238",
      "r239",
      "r300",
      "r310",
      "r339",
      "r340",
      "r341",
      "r347",
      "r351",
      "r459",
      "r515",
      "r516",
      "r518",
      "r564",
      "r566",
      "r574",
      "r599",
      "r600",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r663",
      "r664",
      "r665",
      "r666",
      "r668",
      "r669",
      "r698",
      "r703",
      "r719",
      "r723",
      "r726",
      "r727",
      "r741",
      "r742",
      "r743",
      "r744",
      "r749",
      "r758",
      "r953",
      "r959",
      "r1013",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r772",
      "r782",
      "r792",
      "r824"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r127",
      "r133",
      "r134",
      "r249",
      "r268",
      "r509",
      "r517",
      "r529",
      "r675",
      "r676",
      "r677",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r1004",
      "r1005",
      "r1006",
      "r1007"
     ]
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]",
        "documentation": "Information by form of arrangement related to research and development."
       }
      }
     },
     "auth_ref": [
      "r354",
      "r997"
     ]
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]",
        "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others."
       }
      }
     },
     "auth_ref": [
      "r354",
      "r997"
     ]
    },
    "rnac_ResearchAndDevelopmentEmployeeExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ResearchAndDevelopmentEmployeeExpensesMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development employee expenses",
        "label": "Research And Development, Employee Expenses [Member]",
        "documentation": "Research And Development, Employee Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r353",
      "r670",
      "r680",
      "r681",
      "r693",
      "r1029"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "rnac_ResearchAndDevelopmentFacilitiesAndOtherExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ResearchAndDevelopmentFacilitiesAndOtherExpensesMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development facilities and other expenses",
        "label": "Research And Development, Facilities And Other Expenses [Member]",
        "documentation": "Research And Development, Facilities And Other Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development stock-based compensation expense",
        "label": "Research And Development, Share Based Payment Arrangement, Expense [Member]",
        "documentation": "Research And Development, Share Based Payment Arrangement, Expense"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r773",
      "r783",
      "r793",
      "r825"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r774",
      "r784",
      "r794",
      "r826"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r781",
      "r791",
      "r801",
      "r833"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashAndCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/DescriptionoftheBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash and cash equivalents",
        "label": "Restricted Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r75",
      "r102",
      "r124",
      "r533"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Domain]",
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashAndCashEquivalentsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Long-term restricted cash",
        "terseLabel": "Long-term restricted cash",
        "label": "Restricted Cash and Cash Equivalent, Noncurrent",
        "documentation": "Amount of cash and cash equivalent restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r85",
      "r124"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units (RSUs)",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993"
     ]
    },
    "rnac_RestrictedStockUnitsUnvestedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "RestrictedStockUnitsUnvestedMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unvested restricted stock units",
        "label": "Restricted Stock Units, Unvested [Member]",
        "documentation": "Restricted Stock Units, Unvested"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets",
      "http://www.cartesiantherapeutics.com/role/DescriptionoftheBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r70",
      "r537",
      "r571",
      "r573",
      "r584",
      "r610",
      "r747"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r93",
      "r94",
      "r135",
      "r136",
      "r137",
      "r139",
      "r146",
      "r148",
      "r150",
      "r204",
      "r205",
      "r227",
      "r251",
      "r348",
      "r364",
      "r365",
      "r370",
      "r371",
      "r372",
      "r374",
      "r428",
      "r429",
      "r440",
      "r442",
      "r443",
      "r445",
      "r451",
      "r491",
      "r493",
      "r568",
      "r570",
      "r586",
      "r1065"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer [Abstract]",
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration and license",
        "verboseLabel": "Collaboration and license revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r82",
      "r164",
      "r174",
      "r175",
      "r189",
      "r195",
      "r198",
      "r200",
      "r201",
      "r294",
      "r295",
      "r296",
      "r519",
      "r680",
      "r684"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/RevenueArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Arrangements",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r285",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r296",
      "r299"
     ]
    },
    "us-gaap_RevenueNotFromContractWithCustomer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueNotFromContractWithCustomer",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails",
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant",
        "verboseLabel": "Grant revenue",
        "label": "Revenue Not from Contract with Customer",
        "documentation": "Amount of revenue that is not accounted for under Topic 606."
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueRemainingPerformanceObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsatisfied performance obligation",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "rnac_RevenueRemainingPerformanceObligationVariableConsiderationAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "RevenueRemainingPerformanceObligationVariableConsiderationAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future contingent additional payments",
        "label": "Revenue, Remaining Performance Obligation, Variable Consideration Amount",
        "documentation": "Revenue, Remaining Performance Obligation, Variable Consideration Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total revenues",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r82",
      "r119",
      "r127",
      "r128",
      "r129",
      "r164",
      "r174",
      "r175",
      "r189",
      "r195",
      "r198",
      "r200",
      "r201",
      "r203",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r479",
      "r524",
      "r526",
      "r693",
      "r735",
      "r753",
      "r754",
      "r957"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue:",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r842"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r842"
     ]
    },
    "rnac_SaleOfStockAggregateMaximumGrossSalesProceeds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "SaleOfStockAggregateMaximumGrossSalesProceeds",
     "crdr": "debit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityAttheMarketSalesAgreementNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate maximum gross sales proceeds",
        "label": "Sale Of Stock, Aggregate Maximum Gross Sales Proceeds",
        "documentation": "Sale Of Stock, Aggregate Maximum Gross Sales Proceeds"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityAttheMarketSalesAgreementNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityAttheMarketSalesAgreementNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, number of shares issued in transaction (in shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/AccruedExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Expenses",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Potential Dilutive Shares of Common Stock Excluded from the Computation of the Diluted Net Loss Per Share Allocable to Common Stockholders",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/GoodwillandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination [Table]",
        "label": "Business Combination [Table]",
        "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r375",
      "r376",
      "r377",
      "r378",
      "r384",
      "r385",
      "r386",
      "r387",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r422",
      "r423",
      "r424",
      "r427",
      "r723",
      "r727",
      "r999",
      "r1001",
      "r1002"
     ]
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfCashAndCashEquivalentsTable",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/DescriptionoftheBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash and Cash Equivalents [Table]",
        "label": "Cash and Cash Equivalent [Table]",
        "documentation": "Disclosure of information about cash and cash equivalent by type. Excludes restricted cash and cash equivalent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash and Cash Equivalents",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "documentation": "Tabular disclosure of the components of cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsBiogenMAIncNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsNationalCancerInstituteoftheNationalInstitutesofHealthNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsShenyangSunshinePharmaceuticalCoLtdNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Computation of Basic and Diluted Net Loss Per Share Allocable to Common Stockholders",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1010",
      "r1011"
     ]
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Operating Leased Assets [Table]",
        "label": "Schedule of Operating Leased Assets [Table]",
        "documentation": "Disclosure of information about long-lived, depreciable assets that are subject to operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r507"
     ]
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restricted Cash",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r75",
      "r1031"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r26"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r26"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofWeightedAverageAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r314",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r347"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Options Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r10",
      "r71"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Weighted Average Assumptions Used",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityAttheMarketSalesAgreementNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/EquityPreferredStockNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class [Table]",
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r68",
      "r69",
      "r70",
      "r107",
      "r108",
      "r109",
      "r166",
      "r265",
      "r266",
      "r268",
      "r270",
      "r273",
      "r278",
      "r280",
      "r439",
      "r580",
      "r581",
      "r582",
      "r583",
      "r703",
      "r853",
      "r916",
      "r918"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockByClassTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Authorized Shares of Common Stock for Future Issuance",
        "label": "Schedule of Stock by Class [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r46",
      "r47",
      "r68",
      "r69",
      "r70"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Warrant Activity",
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r82",
      "r83",
      "r84",
      "r164",
      "r170",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r196",
      "r197",
      "r201",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r226",
      "r232",
      "r233",
      "r421",
      "r424",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r690",
      "r693",
      "r694",
      "r699",
      "r751",
      "r1032",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r164",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r185",
      "r187",
      "r188",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r201",
      "r689",
      "r691",
      "r692",
      "r693",
      "r695",
      "r696",
      "r697"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeriesAPreferredStockMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets",
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit",
      "http://www.cartesiantherapeutics.com/role/EquityPreferredStockNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails",
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A Preferred Stock",
        "label": "Series A Preferred Stock [Member]",
        "documentation": "Series A preferred stock."
       }
      }
     },
     "auth_ref": [
      "r857",
      "r858",
      "r960",
      "r961"
     ]
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeriesBPreferredStockMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets",
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit",
      "http://www.cartesiantherapeutics.com/role/EquityPreferredStockNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails",
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series B Preferred Stock",
        "label": "Series B Preferred Stock [Member]",
        "documentation": "Series B preferred stock."
       }
      }
     },
     "auth_ref": [
      "r857",
      "r858",
      "r960",
      "r961"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock\u2011based compensation expense",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award vesting term",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unvested at beginning of period (in shares)",
        "periodEndLabel": "Unvested at end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r328"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unvested at beginning of period (in dollars per share)",
        "periodEndLabel": "Unvested at end of period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r328"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average Grant Date Fair Value ($)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofWeightedAverageAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofWeightedAverageAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r339"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofWeightedAverageAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r341"
     ]
    },
    "rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofWeightedAverageAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average fair value of common stock (in dollars per share)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Weighted Average Fair Value",
        "documentation": "Weighed-average fair value relating to the share-based payment award."
       }
      }
     },
     "auth_ref": []
    },
    "rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated forfeitures rate",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award Forfeitures Rate",
        "documentation": "Represents the percentage of forfeitures rate of the stock options based on the historical trends."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofWeightedAverageAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r314",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r347"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares authorized for grants (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares authorized, increase (in shares)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant, Increase (Decrease)",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant, Increase (Decrease)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r325"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average grant date fair value of stock options (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r333"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Intrinsic Value [Abstract]",
        "documentation": "n/a"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation arrangement by share-based payment award, options, outstanding, number (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r320"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number\u00a0of Common Stock Options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in dollars per share)",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r320"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average Exercise Price ($)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average Remaining Contractual Term (in years)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term [Abstract]",
        "documentation": "n/a"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Vested and expected to vest",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r335"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Vested and expected to vest (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r335"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Vested and expected to vest (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r335"
     ]
    },
    "rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested, Outstanding, Intrinsic Value",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested, Outstanding, Intrinsic Value"
       }
      }
     },
     "auth_ref": []
    },
    "rnac_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested, term",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested, Outstanding, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofRestrictedStockUnitsActivityDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofWeightedAverageAssumptionsUsedDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r324"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r325"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award expiration term",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r721"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofWeightedAverageAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r338"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding, term",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest, term",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r335"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares",
        "documentation": "Number of options vested."
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "rnac_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Vested (in dollars per share)",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Exercise Price",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofComponentsofLeaseCostsDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofComponentsofLeaseCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term lease cost",
        "label": "Short-Term Lease, Cost",
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less."
       }
      }
     },
     "auth_ref": [
      "r501",
      "r746"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r126"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r82",
      "r83",
      "r84",
      "r98",
      "r164",
      "r170",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r196",
      "r197",
      "r201",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r226",
      "r229",
      "r232",
      "r233",
      "r421",
      "r424",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r690",
      "r693",
      "r694",
      "r699",
      "r751",
      "r1032",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets",
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit",
      "http://www.cartesiantherapeutics.com/role/EquityPreferredStockNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r107",
      "r108",
      "r109",
      "r127",
      "r129",
      "r154",
      "r155",
      "r157",
      "r159",
      "r166",
      "r167",
      "r203",
      "r240",
      "r242",
      "r243",
      "r244",
      "r247",
      "r248",
      "r253",
      "r254",
      "r256",
      "r257",
      "r259",
      "r262",
      "r265",
      "r266",
      "r270",
      "r273",
      "r280",
      "r479",
      "r580",
      "r581",
      "r582",
      "r583",
      "r586",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r609",
      "r629",
      "r647",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r853",
      "r918",
      "r919",
      "r926"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit",
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails",
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofWarrantyActivityDetails",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r47",
      "r50",
      "r51",
      "r92",
      "r93",
      "r94",
      "r116",
      "r117",
      "r118",
      "r135",
      "r136",
      "r137",
      "r139",
      "r146",
      "r148",
      "r150",
      "r165",
      "r204",
      "r205",
      "r227",
      "r251",
      "r282",
      "r348",
      "r364",
      "r365",
      "r370",
      "r371",
      "r372",
      "r374",
      "r428",
      "r429",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r451",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491",
      "r493",
      "r508",
      "r542",
      "r568",
      "r569",
      "r570",
      "r586",
      "r647"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets",
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r136",
      "r137",
      "r165",
      "r253",
      "r254",
      "r256",
      "r259",
      "r493",
      "r519",
      "r579",
      "r587",
      "r598",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r609",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r630",
      "r631",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r647",
      "r682",
      "r684",
      "r759",
      "r1064"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets",
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r136",
      "r137",
      "r165",
      "r202",
      "r253",
      "r254",
      "r256",
      "r259",
      "r493",
      "r519",
      "r579",
      "r587",
      "r598",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r609",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r630",
      "r631",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r647",
      "r682",
      "r684",
      "r759",
      "r1064"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r776",
      "r786",
      "r796",
      "r828"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993"
     ]
    },
    "us-gaap_StockCompensationPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockCompensationPlanMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails",
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock options and restricted stock units",
        "terseLabel": "Shares available for future stock incentive awards",
        "label": "Share-Based Payment Arrangement [Member]",
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares."
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "rnac_StockIncentivePlan2016Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "StockIncentivePlan2016Member",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2016 Plan",
        "label": "Stock Incentive Plan 2016 [Member]",
        "documentation": "Represents the information pertaining to the 2016 stock incentive plan, which provides for the granting of stock based awards to employees, directors, and consultants under terms and provisions established by the board of directors."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock through at the market offering, net of commissions and expenses (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r46",
      "r47",
      "r70",
      "r580",
      "r647",
      "r658"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon vesting of restricted stock units (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r70"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit",
      "http://www.cartesiantherapeutics.com/role/StockIncentivePlansScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon exercise of options (in shares)",
        "negatedLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r46",
      "r47",
      "r70",
      "r324"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock through at the market offering, net of commissions and expenses",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r46",
      "r47",
      "r70",
      "r586",
      "r647",
      "r658",
      "r765"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon exercise of options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r47",
      "r50",
      "r51",
      "r70"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets",
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 deficit",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r50",
      "r51",
      "r63",
      "r611",
      "r627",
      "r648",
      "r649",
      "r747",
      "r766",
      "r916",
      "r919",
      "r920",
      "r936",
      "r1017",
      "r1065"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 deficit:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/Equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r264",
      "r266",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r279",
      "r282",
      "r439",
      "r450",
      "r650",
      "r651",
      "r662"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events [Abstract]",
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r510",
      "r511"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityAttheMarketSalesAgreementNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "rnac_SwedishOrphanBiovitrumABSOBIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "SwedishOrphanBiovitrumABSOBIMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/RevenueArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SOBI",
        "label": "Swedish Orphan Biovitrum AB (SOBI) [Member]",
        "documentation": "Swedish Orphan Biovitrum AB (SOBI)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsBiogenMAIncNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsNationalCancerInstituteoftheNationalInstitutesofHealthNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/CollaborationandLicenseAgreementsShenyangSunshinePharmaceuticalCoLtdNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r840"
     ]
    },
    "us-gaap_ValuationTechniqueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationTechniqueAxis",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Approach and Technique [Axis]",
        "label": "Valuation Approach and Technique [Axis]",
        "documentation": "Information by valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r458",
      "r723",
      "r727",
      "r741",
      "r1014"
     ]
    },
    "us-gaap_ValuationTechniqueDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationTechniqueDomain",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Approach and Technique [Domain]",
        "label": "Valuation Approach and Technique [Domain]",
        "documentation": "Valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r458",
      "r723",
      "r727",
      "r741",
      "r1014"
     ]
    },
    "us-gaap_ValuationTechniqueOptionPricingModelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationTechniqueOptionPricingModelMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation technique, option pricing model",
        "label": "Valuation Technique, Option Pricing Model [Member]",
        "documentation": "Valuation technique calculating price of option."
       }
      }
     },
     "auth_ref": [
      "r741",
      "r1012",
      "r1013",
      "r1014"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofComponentsofLeaseCostsDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/LeasesScheduleofComponentsofLeaseCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable lease cost",
        "label": "Variable Lease, Cost",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r502",
      "r746"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r810"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantMember",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofAuthorizedSharesofCommonStockforFutureIssuanceDetails",
      "http://www.cartesiantherapeutics.com/role/EquityScheduleofWarrantyActivityDetails",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofRollForwardofFairValuefortheCompanysLevel3WarrantLiabilitiesandCVRLiabilityDetails",
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofPotentialDilutiveSharesofCommonStockExcludedfromtheComputationoftheDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants to purchase common stock",
        "netLabel": "Warrant Liability",
        "verboseLabel": "Exercise of warrants",
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r756",
      "r757",
      "r760",
      "r761",
      "r762",
      "r763"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrant liability",
        "label": "Warrants and Rights Outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": [
      "r1012",
      "r1013",
      "r1014"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants and rights outstanding, measurement input",
        "label": "Warrants and Rights Outstanding, Measurement Input",
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur."
       }
      }
     },
     "auth_ref": [
      "r1012",
      "r1013",
      "r1014"
     ]
    },
    "rnac_WarrantsAndRightsOutstandingNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.cartesiantherapeutics.com/20260331",
     "localname": "WarrantsAndRightsOutstandingNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liability",
        "label": "Warrants And Rights Outstanding, Noncurrent",
        "documentation": "Warrants And Rights Outstanding, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesforWarrantsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants and rights outstanding, term",
        "label": "Warrants and Rights Outstanding, Term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1012",
      "r1013",
      "r1014"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofComputationofBasicandDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Diluted (in shares)",
        "terseLabel": "Weighted-average common shares outstanding - diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r159"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofComputationofBasicandDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average common shares outstanding:",
        "verboseLabel": "Denominator:",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cartesiantherapeutics.com/role/NetLossPerShareAllocabletoCommonStockholdersScheduleofComputationofBasicandDilutedNetLossPerShareAllocabletoCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted-average common shares outstanding - basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r159"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r808"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481034/205-10-S45-5"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-3"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-4"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-11"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-7"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482804/825-20-50-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483507/832-10-50-3"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "39",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-39"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478064/805-740-55-13"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "184",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r858": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r861": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r862": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(r)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(s)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(t)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(u)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-30"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-31"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-32"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-33"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-4"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483507/832-10-50-3"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>104
<FILENAME>0001453687-26-000082-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001453687-26-000082-xbrl.zip
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M=7+;X"E;N*K84A)JU(#,<WC?+H>.LX*:V,9&\LQ0=^I2MDEF_#G<Q=12!RM
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MXN.2GP$%A,%<R/;*%>BH%3N&),9. ON;%7L@20$PMB",'/,&-/+BVIC"]P3
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M3]L6B=1/6(W%%C[ ;%JZS5LV_;!JX^_DJL_PD[U]_U/!_P-02P,$%     @
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MTMFC3EY3;)EN15;OK![0-YYMHCG:V(_='_<_<W_LWCW$,Y@V%M%*R6,9*HO
M)6<_H1"N]#5ST3AZ&ZNTF=<>]P L<VS"K1"/I,90H;K1>"PAGV.R"T A$QG*
M=/B?.JQ9%(@_*@GQ'>*K(G([L+V7W@:?8YM*/82$NZG]IXU$) 7\4]>->3LZ
M$?R6"H&OX:X4N.[#O0^9;5F?Y/6Z<_2;KS4!SF-,-&(>WQL14O<LF (WH[5H
M^&ID4(I,E<-)L)53ILZK:S?W+Z?2;.Y3SU%0$HT :L#VPL4\O.?>(=5N;OA\
M+(NQRL:"DG+!1_6K,%VG"9&7F9H*C$Y2Y7,#OP<B./VS5*S6-J[P-K:NLZU'
M0V! Z"9LG?'2B,'LQPE26)GQZ4 6SFQNTLG]=]U@=S*F/(@B5K_N=E[UP_5Q
MS?%QZ[!]2"<V5N-?/%NX/LQIN<.<?1NOCO5ZK</CWL;A=BO8./88VX-6^^CS
M<^WU6T>=SE9L]YTAO#%@;E/RXLU.=V<VH0Z50:>\8\']PP2*GA6+J_*KQHT[
M??,A,H=<K?%?RGR7RGQ>O/G@7J]8)Z*_7T:Q<VQN,]9M-]Q9](ORUNKU>>KY
M\]3O1,$>RIB[WCN._(( _5["[O] F;IY<%U>"0GI92J;B?9C /2YH&R3;CM;
MN?P)I-_<9H[90%JL$FUAQ8M4BH2]G[>EUWY+_%>4OW!EUH/RL1;AZ^)R]Q?_
M1AR07 'GWBHZ]]TN9\T>:ODKM%(9=Q ]\ =-8['R7=HB/;IM4GLQA8?(D97=
M/&735U$;/W*KK_Y[NWWWG=^?4$L#!!0    ( (DXGEP1+>>=,P4  & F   6
M    97AH:6)I=#,R,5\S,S$R,#(V+FAT;>U:;5/C-A#^WE^Q#=,[F$F,7_*>
M'#,AA"DS+7 D-]=^ZBBVC-6S)5>6@?37=R7;7*ZY7-,K7 ,$&$_LE7;WV1=)
M#_$P4DE\-(PH"8Z^&W[?:,")\/.$<@6^I$31 /*,\6MX']#L S0:Y:BQ2!>2
M74<*7-MMPWLA/[ ;4L@54S$]JO0,#XO[X:$Q,IR+8'$T#-@-L.!-C77;GD]:
M=MBB';?I]^@\\+J$$-_W>BYU"/G-J>%4'%[,R=0BIF]J">.-B&K[?:^=JL$M
M"U34=VS[AYH9=S0,!5=H3.+DXF.A8U43D=>H;"Z4$DG?<5&9HG>J06)VS?L&
M8O& \0#1]-M>JFJ%^DJ%+V(A^WNV^1EH22,D"8L7_=<SEM ,SNDM7(F$\-?U
MC$H6%F,R]B=%E]&@N;TMX'101<PXK> YKL8TN8O8G"GP7,OY%- 2E"6_?725
MRF_OYWAR-3L[/1N/9F<7YW#Y[FKZ;G0^@]D%;+/73A?>65-K;,%T,C:>.U[+
MKF^SRZ,IC$XN+F>3D^4H;[/'56A[=ALN3F'VXP2FHZOCT?EDVKCXY:?)KS :
MS[3$M6UW<R#KFO,SO;^VZ_4*4CY1(C6WRUJ=[N.V?/.S\3KCX O.J:^8X'#+
M5 0JHO V)Q)AQPNXHJF0"E!X*F0"CMUX"R*$L99GC'"81522E.:*^5D=SKAO
MP;Y6\6JOZ[KV8"R2E/"%N7,&!Q *:2RDZ*\(@"+X 'XFTH_ <^K%.D\R"%F,
MS^_]F5(_ETPQQ$QX ),[/R+\FN(&D20LR[3O^*='!KB; +I$T<EE/PH<E1MU
MH 0MXA@])$<G9(;91I,B#)F/=Y6L]-^HG"\ 18J%Z$<=TEQF.<%L*0%+O5V&
MTO0V:B!&'K$,/G!QBZ"NZ:N]5G?P]463DB# O;(1T[#<EY;+J/'_U)%CO=IS
MVO9@]3K;I)R6([U)A:S/+(1YC'9\5!;K<KDO(4G_R)FD^K!@DOLQ4?OD -"F
MT]H/#BIGE@KNOMA&OM)BI^<UZ[I&26)\PW3V!KHLGUE*W2^FE'',4T),"'$%
M483I[F%%$Y99#@G3.4\ES734ZUI,XAAP&KI$8LQ)EF(:LKJ9%3).N*^?H\*
M&=6ZVW%4'A=)$U@4QN;?^]/ZI^#K4!O@F\=ZH\5=ZVV9*8K,8UI)YT+BFM+
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M)92DC9Q)YQ-DV41#VFA2WJV!PZJA+$E VG!/WDG@L"HP2Q)X3_&8 JG?+$E
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MH< MG>^[$;@/WL;H4."6SO&=!GQ "5Z3T;SP%J"]<BU\^1/% 49-;QX2UCK
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MUXF+.'Q>)]_,Z\1%+O8W:D5]#./F$GE=S"H-J>R;/&-/V3=Y16K[E7TSYY2
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MZ!-DGV@6:][N(,SA';&@!>4KN#;"_)R4C;$0_18'PF-^C@7UHF(+X"5V+%5
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MP8MZVBU/-BL$QY2U_U[G%-Q2?C\DG+YV#AKSKO[5]65*O>/H*^(CMX3?\/N
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M&:0Y^Y;)\2[)9;YEA:/0P7A <JSK_136^K"7M/=AZO#7:ZZ]HP&!+]D7A+L
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M69:YS$S.7F-=>\$JEDQCOWJIV]J[T_I[RF$'RUYN,ME,;&]))@UQ9O2D=(*
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M]C^R#LED1C_8T[-<4QL?:N-# 4ZJ40IP$FRU26R%_4J8JX$2L8;$?:18YFM
M6-R('*N7/1..QPOGBX*_GPC=(0)TEP!>T;2U9V,]2-2]-X/?(RC[::JU7>IV
MY,XC4^&X_>VRW:AE2RL-TQ++[91.'S)14PY%?SX=\ \8V_VH/;ZA 9!P855
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M!JL?.3%NWJXA)%#1>M4K:.Y?7 N6]&$V-3I]8ABFWC+KNF7WVV;?'K0Z@_[
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M7.=%4B2FMK:9S5*W6:YW,BCNKDI.Y)F<-W7?)"?G.FK1LM[*H-NFJEOQ+AW
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M(QTC(0CF3'@J&";5(/P(^8+4/<>A5J*+23)Z@:[]A'R0JN$A5Q-U<N$C,S%
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M/7W7SGJ.HWZ.EU;E(EA:IFEO:&>I+,+AF14OWJ^8JF73Q;+Y3/!R[;)7I?B
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M"X24L5IY[B^ >\#L=<G:].XPOUZ<?'-Y#.66-O ._O4]:9[&)>3:&+3*3K]
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M$HW;=/3S,.J], /'>W3K,EGO8EAQLTRK^X7K!=<8CSR6&5]\#O0.9DR0_ &
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MH@+Y5G=<'#0#%QLH:9IE DH\XJVGL)B1NCJ]KD));@B%%T1D].JZ;&TCX!\
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MD^TP$5888%I1G#\/%*/37.!@1YNUPS8[QLV.=FS6+-'-E$[&F5CRMIMF%/T
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M*+\7/?5=6=1&81 W###; +W7:>>%Z3(_6AF4",QEHM<Z@7Q!F<5Y0W04-7+
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MV9+RQ(=ESHP0YV_.@I!ZT7+,A<LUK?D<7BQG4<).:;(H']W)GP(+;.994X$
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M[VP/RS=J0]NS?8<=#GW^:@-0 .;.U 81A! :VVZHP7X3@N:]'5(%6L^UAR+
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M2F,=I/</F#E!+D+:+:R/>5PY=V?S((PQ,P:9 S&F.3(5L@_PM(NX)!UP"IH
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M#$3*2QE "[MH M+QG/N,=$5.=F1$@N:WX.1<CG*IWN(3&RP$UB!CLI"^).E
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MJDO4_4$:/D^Y,NI$_.\EJ@Y9]932A>%'GIE)41E_D>8A\]PJ'HC@C(#<2:.
MOOGA!_<4W2 YXHZS?$PYVF,#\>3-W/0:^KW=,1C_E"2R[F/@__ GI_'$CUT/
M9PZ&I*CFW$]T:N[2H@[23PZP1,]>ZH?C.64:::U$%7(N6,6(%$M8+28H\MLN
M"PPK<0DBTDS)+X=SW*?YL"M9K$.F%YNWY+EV%N#-IY*F?J*UR711&L\3CGC:
M=6Y@D@'\;K<<S DB3$GR@,=[N6RD'-BRU>0<.GZ)5PTYE9ME=.B%'-_@CH53
M9H_XA!NE)J=4(!*1UZ<>+X.;>^[HHT+&,+*[W!33Y7(V?!P8^T<9W= *>+F3
M59+@GPY!NI.3JDA>E.I$HW"93)&\U!4;)</_T*H#+72C'Y&,N"V5VLG-&Z4;
MQI1+S)A(4+,#XA>P\7-8&[EC.$&)EUWJ3Z.5F/WAV8M\@G'BXSG&*];H*A-1
M)IS%'@$&(Y0W-D6T:3U#3/> H[<6GY2*#1L$38>[YG(.:LEM48<$PL0HK$QW
M _R0QSQ-TJY]&L!Y:38R\5SNN'><9";\VYB8Z+@\JM#O&LUN=OT.20; X[AS
M8N8</@"IC-I3\EY_7,3M/!W3[Q#*A'B,<T^(0"+*BDTS\E92A4H(LG 08 7D
M%2 %G:6<)HK!1!>N__1'\B_+/$B,?!:O 03AQ/9%2GPF(H1X7DM7TIQ=D_#/
M0P-!@=>PG\RAW(8DE GUB_20T:2B_I5-P0,N+>9\.+*!'(3KZIV#VM/M'TRP
M0E05&*^-P=)@3^9R%Y=M2#M=/>*4=XOV5WI7H7B102])[Q8W*]"ZP@R49[A"
M06$',5SN+H?K1Q@")!E63C%-[7I,40^Z&[*TORBU7M?MCF>)R,L9,JZ#3%7X
MHG*Y]X4@^ES8L+ID]:2@T9D$3,'JHRDO5X)G6Z1G"X]8S)RI3Y$4)O/U5@XJ
M_#P1E5*XR*90%@MGN>0"5,?&]AVL2 0+$TSVE77L*!-',OP5Z*3W;@1\*(O&
M]M; GAM0('M@PU-WGMUX$ZPFA1'93=+5F.4H>]Q1F8DR8#YC&(&2!!%X0\QY
MQKP>5-KX!I=E&I59X7"D<ADE,Q["B1X"^3"D)'E-JW#W8]-+-V47;#@^F$_4
MDI2>)U&_)KWK**F$?@3:X?=%,@.,NR%BNH3#,>0###6PJKD!RC-W +^20^<)
MD.[Q2-XDZ7!.>;?\5/!HO'0LA:NWN8; ]B(LU F';>6$1B+S2=S-0MM?G+<\
MS1>X$H!L T:6*M7+%V/6<(K"#9F<G[P)^)')K*DGBBMJ^0T C.9"!24I+*Z%
M2.Q)FXA?3?4G#;I"@3E%F""5EZSY="38"KDH<MQD1=7E)IN(*O!,)&"UXNX
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MQRJ?8]LV?^U!L[OE4'M85+/7[E5L3<_:I/&Y%M5KMOI5 U2_.1AT'QRI;DT
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MX,2/@A6+)2C?/]O69^8(:T)<_/F7_P!02P,$%     @ B3B>7!@_!'<L%0
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MQL-%47\?4D8S#<_O%F.+]7A:AM_K<EJ9=Z*5WB9[%8&4"E1RN6E1!H5L&'9
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M#I/4PU%"=!G&U:2:MKF_'V$#J.@L<4)J E+JU/FRD(#MM.R -!CO!9<;F(K
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M]P,(501?$DO+@D2F@S/&B:*/<I"C0A4/Z$@_?FZ>JGLT;BZZ>!7O=_MJ<I*
M.VO3:/)%&90$T&7ZKBA9B5TRWD,W!I-*]XC8_M!L.E]ARY<<H5^3/&?-HA[D
M-W\-83:".BZVU.WD_B;5W2^#;;_\YWIBWT&^7R:IXA<[K:;/H;75Z*BJF)X1
MH9?4G%."2/4X"TQ?VDY+9#^J,Z)O2.J(BC*G35!*3.#2E67D5A;(4]Y&,!C+
M[N[MBGOTFMDT-*,4A!8:(A0BC57L7N\-;C"+/!S2="[GZ$5)?5S5L0<F"I$8
MPR@I+:4J7SK$T-W<[8A.[>\RD3A;LGGX[&K63MLT>Z5IJ:/G'*MWCB?'3M @
M@P/CL/VA;7@&,S(02;(Z/-#T@1/^WC]Y..'AW*>.>DT*Y5FI0RY9,+NL_^YF
M!A-9Z$'MR$(>C!NYQG.VJ[YR?R[C(:V?VST\6C)(KB#>FB;;9!Z)%4KD/&_K
M"^%YJ=#/OL1;"Q\NK2.O[DZB@>A(OIZ \$@-Y:6F18%_VC#F=>K#WSDXB'Y(
MM[#O4B7JIF$7U67[+'D$M\D\S.>456B%X43SPN>[?U02@2\U>I++7L &8Z0?
MCF#X"CR?.5_F2-I[Z9%?;=:Z;T^PWL<WAFZLD?J-9)LW9JJ^@<ZDQ)PG3AE&
M2D5%*<%([[$78]OP(*1DK7_V/YK5TSI2;S63Q.GH\T4843@;N _8$9KMB 9C
M0=%(LB;]"DLCF!=&SL99T!#NG]"1_CV"-4=U[)?JG=$K2[12BI224\-B*"7#
M]LZPL _G]-3>J/<@:CZ?=;VK^UE>\'."Z=SP)'2[N ]BK+V)3E'4NBLHLQM>
M*N("SQ=!%][ZTN?Z*_PQNQ[,R=O52;OU+20&S5F^N[?1IMZ:2(F3PBACC8\.
MN[<[00W&Z.&0I+/KBZH4G(CK74^?U:/T3;VXXG.^F>CS4?W=(# P0XR@0-+L
M9J@.-$UT>M<TLE=+@UG2X2H?7\JHBG^;F#AI7\*63D(RK#&]6!-$!%70X ]1
M>*>%P:1']:?HTZ2*JN#U5YW.*ZLV8 NZ()H:0:B+41FOI5V]2F6[QG<W.9B<
MH?XH@"QW5$Y<SD*UC9W"I<6688* +85RJ:]ZSQ.3-C0PF$.T^M/W23)%U6Y>
MGK2W5S%"3O;9QCAA:5I/6R#4\Y(;;ETIW2%ZWMS48 ["ZD_C2'+&/?QU:W>#
M@\3"0%4^NK_DQ)31$*G36MD50C/T)*3MB X\VNJQ4*0'=9PO=# _3?3^]G$]
MOJDGBS.\Y]_-:7Y"1.&P!M ##2?T#RG^\*65COE7C#B:&,!MFB6 4^G18X1?
M&D>[SF)C=X0IB<W;3;+TN9C)1P[H1TMW4 PF@G"<FC=>9'&<F-%,RS]M4^7C
MJS;WRB7?M30Y#YX50EI3:O2#Q#L@!A,QP%'V:4)&/+JY;MKWT(PWXK#!$,.]
M(SH*1QD#97E 5G87Q6#"!CC:/E',#^<2_&K;69,<WSI^.SO=\W$0_8,#6NO=
M63BVYVB>PW0*L+[IV^4Q!<^[.1].>.(\2"(BI>D[!J+ 'J[[8CLY7WY;.[]/
M0C6='[>8MY)\^NGE.+];%8A);KRA1A/.5'+C#8L\PCD%L@GH@+R7'JBV.@/V
MKTN\I?5ZD)T9NRCS9?&1@'5>NY)Z&M'O*5P/94"^T!FH@Z&/QV!!_Z3GM:&I
MO0%9T=7>/[ =Y:4GQE)/@HK!45L&3]&KKX9@1Y?MO(.QK9+ FZOX,DW&=O0_
M8)O.!!Q$DDHL21IG/(1"<A/PPQ;'HGWT%G4KZ0ZRJ'A:Q:M^W%,H;]+(?_\)
M1A_AUSK-,IWD0,IM0JL%T0%HM+HLN,>N"SD6ZZ,WS/@,/%6C9^=?'B'O/]6=
MG$,!:6T.CG@/9: R,H=?CGL8Q $%20;$MF/T]S D2ZSI>L;6),]8<Q)=,$QR
MZ:+&3LT[&.1@,CB&1[2#=?@@5'M9SSI6WQL@CJ99%Z+SBE*OK'XH.[K$.)C4
MD<$1[6 -XF29;(7XOOX%WMHJ7,86FDT@10!BG9"D2+(HE/1<!K97VLGA;0\F
M#Z57^IQ#,>>+E_P&'[(TWL%-KL&8?/@:.UC]YM4DULU"_.[V[LL3-A]P&D:/
MH/0@#[R+U]=>><T8)0IT)%JK0(0PLN324,FPBX6W7#A^5/7]FI3-NZ*4U=X5
MI2*6&4\ @E)1*UDH[%CO5D"#NB3B2!:L*9I'T@":3_4NX9C,H-.O"#E%/W+"
MK=1I*<&<[^' A47;@XDA8&KZ"+&B*?4?,$D3[2C7^85Q-<E'N*?N?X1-3/,^
M]2R!<L9*4Y@B6(8]UG= .G!A_RA&.Z86<'S;-_6D7OI/BTXNKX"<WW"[N$\D
M4)M6<U1$D3 %0[3PEA@%"93E*GJZERN[LZG!K+!/5W@/LMW3&[W[/+^XY [_
M_-W_ U!+ P04    " ").)Y<$6Q#P%I)  ![& 0 %0   ')N86,M,C R-C S
M,S%?9&5F+GAM;.V]6W,;.;(N^KY^19_>KP?3N%\F]JP=\JV7(]R60^Z>V>=I
M E>+:RB6ITBZK?7K#XJ49(JL*A9%H*I(:6*B3=VJOLS\ &0F$HG__7^^WTQ_
M^N;+^:28_>UG]!?X\T]^9@LWF7WYV\]__/X.R)__SW_^QW_\[_\'@/_[ZNK#
M3V\*N[SQL\5/KTNO%][]].=D<?W3XMK_](^B_-?DF_[ITU0O0E'> /"?JS][
M77R]+2=?KA<_88CY_:_=_[3\*T3*.H<ID %!(%" 0-M@@)%:<$HEELK^OU_^
M*K27S" %.,$24*09,-!"H!27Q%F)B.6KATXGLW_]M?J/T7/_4Q1O-E]]^;>?
MKQ>+KW_]Y9<___SS+]]-.?U+47[Y!4-(?KG_[9_O?OW[SN__25:_C912OZQ^
M^O"K\TG=+\;'HE_^[V\?/MMK?Z/!9#9?Z)G]\8+X>K=X^,---.R7]0_CK\XG
M?YVO_OY#8?5B9:"](OS4^!O55^#^UT#U+8 P(.@OW^?NY__\CY]^6FM.E[8L
MIO[*AY_N/OYQ]7X7Z62V^,5-;GZY^YU?]'0:$:^>L+C]ZO_V\WQR\W7J[[]W
M7?K0B/Y>Y H4J^#\K^IIOQR-Z3H"*>W2>!"_ZV<5Q1-BK'OZ\9@?G@6<#WHY
M721$O/OLI'B+&SU)J>"=1R= NWH0N/$WQI<IH3YZ[@;.>Y#;"*M'6ETN_'RB
M9W'V+/57OUQ,[/POMKCY987U=3&;%].)JV;95WI:31^?K[U?S/?C+F?:@FJV
MA60]OO]7\\,VP$963&:3:J+Y$+^\>V*%)0-L_WWA9\ZO9YY[ -/"/OJE:37O
M%0^&FFKCIZOO_G,Y!U^T_OK/SXOXGFH]BHC]^_AQ_L^']41!28'@$ $-71RE
M2E!(.0G!PETSS^]I$_3<K Q]]XIH<,Q^\=/%_/X[E6;79F]&L59K KE^UV;J
MMV7"3 .)) -<.LD#ABA@E4NF%8+'\OP@RD5Y+]G=$#MHI0AE<9/4GHLBF1K7
MEHJ@?_ZI*)TOHW,4?[0:]W^UTV+NW=]^7I1+_^.;Q6P16?UVNGIA')C^2_4A
M&1->3_5\?AD^+PK[KXOODQW%8*Z!QDH +XQG#ID@G,Y%BFTP"?G1LFJW\.4)
M!F[BRE&*KJ/-D0S8Q/-FM=!T0O3/+0<B$05VT22T?:/WTV+YX\Q59-'U,"S0
M,7(R\9/2@@H>",?,G:CU'_F2(S)^FXHS&/VS+R=^?O$I&L^7I7<K:+^MO,QM
M:)I28+SDP!!/G X(>VI23__-<%+2H,Y)W^7 L=;:GOX3J7J7!3 -"UYU@4:%
M LI2"0C$<4I"1MKTGF$SG#-AP?&JSC 77,SG,8JZ,/-%J>UB&PV$D9/"<>"H
MU%I('[#%B0W_&$'_MDX<'!RAT R#?(WF]3*R;K9H H4I A+ZL/KD%<0V^-3#
MNQ9(_\8^QCJUACY&M3G\.3V_OIBYZI^W_UY.ONEI!#>_6+S697D[F7WYNYXN
M=P(:JAW0(C@@N4$DQ)E'Z]3)C$[ AN+#44;<=O>26R#'K&]ML8RPKKSU$6(,
M<C_ZQ9T6=OP2Q(!A5@$:D".8(>X%23T[M. Y!U(DT_<N%_"Q7(A>R5<]<6^_
M?XUADH_4O:Q2L(]TL U1* Z4] 0$J"B!6B.H4[L%'6"= S-2:W^7("2I#[$S
M<Q$+-+(28 (5]$A)&&1.W^$<C/YTC>Z:EQX__HNOOES<?IKJ*-[,5:O6U\H?
MCE/4-C:B"5 L*. "H<90+[!-;>TV/"?M,"93=(9%X#(BTXOHGGSP>NZOJL**
MR_!'G) J\7>DQC$>4L(#K8DV)GXT2B1F02N@DZ9!.E5GF.O?S^ZTZ3],OGGW
M?K;0LR^3Z*^L%?#VNYTNJRJ>7XO"_3F93G=X&P@P5@>@K&"0.QT83$V-0S&>
M-%NR&B3#:M*$@T(/I"8&0.\,"X(QF'P?\2P,_B0%[AJ2'6O(*Q^%F=B%=_41
M[<=B9AL<&*N!EMX!:SW'T LM"4]LZN[H3IH,F8RP2Q>>,XIL1DFLB<M;5 :3
M6$D:%%':]AA(G@E-,BA_ER(B31RYC4)Z"#33'C!A+,%02$Y2[R^OWWS2)GZ"
M\G9-*(\UX8>)-I-IU)J?1Y:MMK&NBVE\]KR:E!:W3:)*+8'FE@'CI'**$1U\
MZAQB5VPGO\.4Q0@9DLP;./<D3R -P$##0. B2!8<-"%UE4$SFOX)D<>"S30Y
M1OT9=Q\^Z=LJ%=Z4YN05*B> Q$AYB+S4-&3:=WB,9%!"'&6KAFV'(Q2=Q_SE
MTKO'@V#EL6Q\:\=98088 R$0"CF&H84X>0E*)V#G1([$9LB>E[P'=MN4.G<(
M2"\-\"1P%Z=+8D/J?:EV1&?#CH2*SY"FW!5Z9S\&NTA4;8%!W.,XQVG/4B<A
M=E&<C?F/5'"&Q&(#(9O#6R@<4 )%QYH3H;6SV!G:SV0P9%JA%]\RK3$2KAO5
M&;5__D.7I:Z*;F9NM;TROUPNJI.R59[\,<0X!FP @A$#A)<,2,TYD!PI!!DB
MG&UEJ'=/P!WPOC.C0BY-)UPM5A!?%[.*J!'&JO)J!;,#83TDP.#XB1O%,>48
MJNV=[@8V='SA.=(AAZXS+"5O[LJPW\]L<>-_U]\W-/-X+QY1'7U>!X&A4@+G
M-798:\0%2[R0[(%T9F3)88@,6V#U<= *BI$*2$KC^*<^6**@UA3E<R_/U/Y/
M57"&_:O7Q<W-9''CUXO9PT1F:Z"I^,D8[@#V'@6*C4,P>;ET,YPSY4(J V38
MN.HD\7J&,G&&XIX"A#CCC,1OJ-33PIAV-GIA1B+U9]@.>WR@:[NR?P4)1IH:
M'B2(03=DG$,NDS>*J($QQ"97&BOM;FT?I>(<9VSB3%7,FO$$XH%R1H+@(0M*
M,J-"CO5A$\/9V/LHY69(0%\XMU*DGG[2D^BHOM9?)PL]W8:%(OVT@3&$"3&(
M<08[KE+;O '*V9@^A:HSY)JO_"(JQ;NWNIQ%EV1^8>WR9CFM.A'%^&5B)SM2
M5QWGC,86(.N]%PQ:*%)[ ?M1G0TO$AL@0T)A ]%J RU.8E]+?UVUG?CFU\'M
MAV)>A;27(4:Y.W"%!B98'SU;'P+'@B"=8:?[$(AG0YZ<ILF0<MC5PC8BZG75
M<\ "[SA3VBHG4>IMC5T49\.'(Q6<(?.P+X;:QN<1 C)( YCTEA.J@D*ISV#M
MPW2FD6924^Q21=VU1?QE2VL?XI=YFSM^TE7>_=K'7]<=.JH>T.GQ\9-[:_O8
M(E ?/2#7*<HX1TAL571)">68:.AMZGV!'GM KF3"A !=G67%QD/(">:"/X,>
MD/OMV;D'Y'XUGE(/R)4T<1D$.F $B-<:(XB)]-F:G8Z^!V0' S^A!^1^1??=
M_:\9T4L/R"[F.J0-8'==#\("7S7.UY43)1E5T2W63*0^U7M"/2!S&+]5Q8/U
M@%PGW @#,01B(!!*!,+>29BZE/)T>D!VL-:3>D#N5_5@/2!7T!@R0%H4H2%>
MG2XUTN/DWN[)](!\*@N.5W6&N> QIAA:79:K:="M=F ^^?+S=0RW=G;A68@H
M'06&!6^Q42C.B5EW-IN0C>Q$W^'!1 8#9)@L'J-<09I?+!?713GY'^]VTFC,
M $69!]!(2B*EH3*IS_6V(SHS6ARE\.RSQAK=^_E\N8O,R.J40)S4' ^&&*Z\
M2-Y$NAG-6=+@"8K.TSIP!]E&!?ANHC[$I9)B@*V6.CB"5?*$V1Y(9TF&IZH\
MPV;Y1OE&UV7,2PF,J%J=F4!58(JKY(?V.L Z>6:D5GV&??(-B/M6,V0P4(;@
MJH.5H?&3E2+UGG@+G'-BPU&JSK#'O0.M?C'C5@#). 46.4BQA%#)[ PX$Y<A
MA8HS%=D_@M6R<MDJKM9Q@F(HAC=.0Z-,ZM90;7C.CP-/579C17T_&]D/:ID7
MX?6UGGV)?S?;W)N_KW<[<EN[\WMR;G(_3=C>MKR=T"!ZDQ1X$Y#2.E ILFT/
M?^AGRQLA!)1P$' MD:1.6VI2^Y]CW?)NM>=A6]ZM:AS=EO>ZGJ<J!BQFJR-'
M-3L\RI*J$;\!.,"@'=+,J=0K4"N@<6Y]MQNZB3-'*SQ#!FL+4WV2OQ94IAWP
M6D #;X(?;[@BE]:'HH2+'IB*Q@-2,Z.Y,!B3U/4P/5*AZX[X,$QH57;VM';]
M!IU1%ABA*,"4(ZZ#1<*FKH<8QR9H A.U)C"?H-\,.UL;H5+#CJR,$L* @=6T
MVHW5C.F:6]U3!:/G8^WC-)NC^6#](;-Z<%P;H(E'@&)-@^<V8)[Z(%<KH'.@
M0#J-9]C!VCY;5H^JRHP8%ZJK61&VE GD9.X#?>=#@ 0ZSG&KU?Z#8?5 ,7%
M*HP (E9)K#SGR8LA.X,[!W[DL42&[:O.M:&25.TPO8GS&67<,$682G]&[Z0*
MYI^6-3A*T1F6B_TU@;6(7@KFNYCKX)KI3KH>I&">N  D$Q) Q;T)O&I4D3I/
M?FH%\XF-WZKB80OFV?HV!PV85EP$Q#"3J4L?3ZQ@OMU:3R^8;U7UL 7S6!)@
MD%$@$*8%M9@'G[KJ\<0*YI_ @N-5G6$NB$YI634^?N/7_[Y_M$6[]I"OBNGT
M75'^J<N=L@N% S !64 (1L$B:H)+G4TZ$.(8JQT.VIS,:9*>:NE;ZC-HU3X[
M5'TN-,<1H4?&I/8G1E<YF]6DQY75MMHCA_.QMQ5%U0Y322H \QQ[HA55*/UF
M]?!]0/HDQ9%:SQ%_'E#3Y775%I%#X"A7@6C-D4X>@XRJ@*Y/;B2S1(;4Y@K5
MNN+SS;*,@#Y%5ZIP:YRK'UY^K2PQ?_O=EW8RWRT,)9@!10,&2%A'*,48)[_"
M]7"4Y\VHS%;+D@^M1;PZ<M )L'8&:"$PP,YY%8.W(&7J5E8'@WR6+$MDLUP=
M\9J&Q8_[D==IITH]OY;%?">68"1&GI);8 RU4HJ@&4^>DGD2TF=)MY36RW!.
MH17U1__GZD<KE(YKHP%13%9I3145H^):#^,B;PWRE/>Z:#X@>\:<>IIU<ET:
MT##1-H*T-&K$*QV#2X>H#$&*#)VV.@![E@PZPC89+A>X</^]G*\OQ/B]:"BB
M67'>1&VY:M/<S^:Z^J4K'[4UGRS\9U]^FUB_EN[*V^++VHKU;?2#CY\" LIZ
M2%70DN#4=W3GENF\:3LJ1C2V-SWBBL>6!LU1?W[R9;:^C-+>_E[J*)I=V7;F
M5E]-5Y+^T%%32V="%-"0FRI>HD1R+(U)W84@CR3GS>X16+\F<WMTIC\"^2''
M3A[942 5P8 3*@VD+!";^NS9(P#G3:&GZ[K&\ED:Y+1D"8W6P&@E@=7$(NPX
MA)EO"MJ3LLVQ3<%D%)*Q *PR5L)0K2BIMS[W;5/D3;L;[( DA ->=0;G0D*2
MY7:X]K1[OJ/9;_S<EI-5DJ@(\5=>+>>3F9_/WU15OM/YXP'5[13VOD>F/G!]
MD B)SE:_UO/KZEZ[^$_%R6]Z6KEQC_:^'=(( AY852X)'=!,1->+Q<@5!Q*9
ME#I?M0?2T9.!O?9N.?67H?Y%NV6B<5$6$E57 SL 89P:-!=6L>1=)KL Z^N,
M=DI>[(2YR2TPEG/<]R/VPJ[CFLHP=R6'F]JRP@!E. 0V+JS"2^=T\H9C#5 &
MJ\).;_,BO>XSE$C4P:H^EM[_*$;;"S!3I?9><,,4;B<Q90=Z'&^',1!&4P:4
MES& L-Q&YRYP[5/G]P<BRIX:[U'PI%7]"?FQNLG^<AHGSCLG\D?-Z28<PVBU
MV4XC,(Z4M(:X[:M^=SW=AF?W'Y4GUGZ13G49BBV[72"XB1#&3Q$;!P%!Q2H?
M*WB=>*B/\0;'G-YH8BLDY,F*MI7,6W+_V)^^T\OC;VS\9OS9&V\6G[U=ENOK
MP[[%2+)RM=X5Y6>]]K@>#0$+@0H4 H.%#IA9Q(GK-'ODQ7D>E!N;03-X+SNB
M; FPC4]@ 8PP$C"%*:ON0Z4^=:9Y'Z;S(%<6"R2L%5Z3/\;=<9*-.%8[>U>3
M+]>+3S&*C-_07V)P^-MD&N$7,_])WZXV%*^*6SV]N_APM1-S<5,L5QN-K_R;
M226I62[6U6";0D62 R.] MKK:I-0<&5HMWDL$\+S(-EXC-A8GYPOQ?QK4;@_
M)].IGKGWL[OG^P^3;SY^N="S+Y,X#5_,YWYQ3-+Y\)>D3D,?*6:BQ'1-)+!-
M7<R 1M( (14&6L$ &(-0.0B=P*F/-+;A29>2KGG+_-7MQE>U>3)E.3"(A!@)
M$61=0%JYU"VI#\785Z(Z&4^:L]09C'(:">L'Q>DHD-2$ 4A<$-@[1E%J@HTV
M89W#_ ?EKKN98<!49#O E]SUP:9\8D[R,#N,@3 4:V X<L!1+;'&7%'9QT[8
MV'/7/?&D5?V]Y:X?X%B*@+30 R1]]/:Y(X+M=9A/+G?=4?N=<M?=5)<A=[TG
M,GAU^YO^[Z)<M=ZHHS7TM.JAX #ACL?0SD1RIQ[W!T)\%HY&3K-E.%>^!^X/
ML!_U3<,@JX6<R25Y MQAG)2L-#B,<LELF*6?SM'0D>! $E3=9\2@A5QK:5/O
MV(V&=GM<GA-C7:OI4CM'5>WG:H6'\EU1_O9K_2JOJ0;*.08X]=+$1<!(#CLY
M2/7/'Z+L/K-=BK1*S>(Z?2H+&]?Y*S_W\<G7JTV];WY:?*U2.O4@A61 &6.!
M"IAJ)YCV)+W#U '8^5(FGWTR+$WW2?IM'%X&H)6F@!.CN*-&")JZW]+]NT<1
M8J5)]CY)G?V'56^_V^FR.DW1A!>AB)=C SA62B/-=?"I.SP?BO&,:)+5/#D<
MV)NO>E)6L]9EV ;[;B7'M))C)YF@-) *Q?#5,5(58%OM4T\B':&=$WDR&*,Q
MYLZW"_[1+ZICC/=W-U],*QI&01;%QO&ONV-N][F-(GPJ%E'PB9Z^F4SC [_Y
M]0&Q(FS\T7KX>%?9)+Z[.G.[7.B'XU"KO_3ND/<?L0]_BF*FK@0X11WDJ$6X
MB.*X>V$>2N_N97@79=@0X#+<5Y+>XWXT?6RF[J1%P 0>1SI%/A#E+):IB]]2
M84]7XW DHMHDJ%42& PM8%0JXJG6024_OYM4@K[J(P;A;G,M1>_&'TNEQ9&"
MO[JM?\#.C095!XG@@7%* >$,"3JN:MHGOQXLGSC#;\3T3]+MCCHC(4N.B^YJ
MD3U.W>S%EVG_9A^V839K1D.&3B0]TI(C8)QG"L@0P3JH&/:(.Y1\;WH8INW9
MGSD7HK4:,%<7_,VV9I^FFV4:F]"PI$!B*8&+(;U6&@844F\'ML#I/YN2UG9U
M_1(3*#Y#(O<?NBSUYF;!(S 4 PFI I!IZPS75<_BQ"QX!.#,[/YTY0YQ,7=U
MLQ@V0%9["<9:@46TE<*I#3Z.RY:RVOUH56<H4>IVSYRI[AXE<<ES&G@JM4:*
M$D;3M_H>V^6;XXFITABJ_\L[FQ"]7-[9Q5R'W=_85=?]7]Y9E1A$HFMF!2",
M$ @-LD:F7D1.ZO+.],9O5?& EW=6T.(G8U5<W)QDWA*H7?H.="=T>>=>:SWQ
M\LY]JA[P\LY5/8H'"@L$?*!6.Q7]I>3U':=T>>?36'"\JGM+4W5VD-9'ZG<.
M![C(8F@U0)Q2@Q4/+OE-1DF CR52Z7ECK'^C-\Y?^2I&WNE)N>H4\9O7\V6Y
M6M@WZ@76%3!ZYCY,M)E,5QJX^TVG%P]_7,ST5:6AZEZ,5WH^.::X(S.BU'48
M?2HP4<G$PUO7X"YJP5W.'@#%7_A8S,I'^!J'6%R3XY3/*'!64H\%102G[GB8
M5(!CUX848&HCZ  ],#Y((%E03'OJ3/+$5#+P?95,#,?=[>5A&+N/I63B0?I7
MMP\?_VL2)\C27M]^J"KRZT)"@0.0GH2X$GM*B-"2,9&+TJW(ADJZ#<2:)NZF
MLUX&K[MV:=W%VQ!ZU('-E)<[".@P*;L<%F\B539SC8UC6LLXYA '3F$:EPP4
M'$E]_=D(N+4G(3AV:K5:*2>EWL]B=#A?:0 U[(=B%I40-1%-Q1$2DFJ9NG=3
M"YS^ _N,AFRBS)%6R)!3K(.&ZZ&9ZHP;"Q!@1C&!)D#$50\$P<^3($^Q0D\S
M"*F'IB@'6FL'8K#B6;!<<M7'#$*>)T&>8H4<V]*U[6/KEEGL$)!!.$ M<C#&
M!=+ZY!N3C6B>=Y25R$H9^+.O#W7]=QM6SSKLF0*M8W /$W>EXL"!C<23&W"
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M1^B.-T#J1JAUETO=Z^-V!YG 0#J" 68L:$U%T+CC=85MKSDKBR?6:N_+S4X
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M!V3U<2E#%!BM5S%%#%5\_)E G:*]QE?T']DEMT:17)49BF2J7GG+A2_WPE)
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MN$PT992(A'')42$ZF5I#PZDQVS=&I[HV_#&0=%F!U7-?K2^%J+]#C!B@O8(
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ME-90.:*$[C4^"BL@B3: 0NVMD2:(]'<+CJF<:G0L2F6L71Z1'@NRC%1 !8P
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M!29("+A5R*'  A[/H:^N0HV0T9G#G5'19.SCH$K$50T!WTR^39R?N3H!M85
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MTWJ- NZT1D8,2$3B?S!GG$AI0ACQ<8''PISN:I&"=?GJK(Z@S.BCG7;9&!=
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M#&C+^^M'"*J:NE @,8\1MI$2&^^H$CQQ'- %5[J,9<O;7MU;H3[90#!0U&J
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MC,Q_O((;O<2&PTQWWZ[^8_3<_^=__/]02P,$%     @ B3B>7(#,J"[9X0
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M%R2<',RG<O=X_TOQE+,D7' 5I-$!=+L_&%UTES\R._;+U<WE(/L;X/@8%5_
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MB6ZHU5&9<30ND\J&=KL$EN]C=U3 H^WKCC\)]ZA=%G5.G^QZ[?!+6;HNT"-
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M>8G_FOPM%QCP!F9A)]C@+? C>1E*5;KC2:QC$@MG,%-,=U6V9YAVFH3$3>(
M"QV#0%1U7Y#V// <]@$7_PO0#^@$3 6O3U4C!;Q(50$2_$X5(K2JVU4AFLO>
MLT)@.+AQ!;U\LO%@?2$^KLJOHP40/7H<BS#V#&RE9NI'H1E&0I&C(L26-!6\
MDPFGKL) '.(&M@LGH7&".8 !<8H1&)50O>X?DGHME1\5>D+3Q]^!7VE>E)_)
MBB0-27\AF&4% H(GCKVK64<[OQ7J":..,CCVX:C<\Y>7IXH,4T19:4$WE5,B
M25U2'AUPL?O)*7&&5Y.3SVDH+]H?$MZOR=\(KNXHM ?UOE)6:,;Q8\-RT\B+
MO3@(8E#Y8# 'FM65?A>1PEJA1S$46TFU(@/3:FB=4,82XCPM5!9T"HXEBH(>
MI?]V2H).P0,J"#HYD$3U%UX>Z_'^E^(IORCJM *%)AU_6_<%!:\+=Y<_,BWX
MY>KFDKGVZIS*"XE&&A%\?C4_76:@DWU"7*711]."R95K.3[D<G5:)D7:*= R
M_:1DD0NZ%:O( Z'3]4PNBZ1\)%>DX;&%^[>1GI7153S AFU'Q'>B./-<ZTO#
M,FS$5O$)6B!]W% 4_D#;-*!D2!^MRAJ8_3.%E=AJK0@!^&Y[*W9+%7W_B8K_
MPQFBY+L(X3-TWC15'J\;7K6;KM0WN%*2ZP>07E45C E*R];!F!?YH!*&P"LG
M-M*[68TUTPLBWXB2C!A^& =VG)(LLL0SI(_3T+S6[K:=8V0E6\X-4)G69D6R
MPK3X4,Q36^P-Y)5LLR<GMX)6>]/3+-]O[U @X9Y[@U=?I^_>(>^CO?>./"JW
M>^A<#&PV+XNG=7-'A]FOD,4= !;]"4>1@2F"7F"3R(Y %;+&"&FV+0.RB--%
MC+!4=:Q1J,1V#BH @!D<.=G!FX(YP13M"$;)++H=F!-V?R\P^SS\--T->84?
MA9KD[KVB6=\8"?'S\5"4^4.QI!122H,F!0$=>8^P+77.'8ZSV.'V"//#$^VQ
M/RNM9'&QKJHC=8!LQZ9GVL@VW,3TL9E&B9VX2@I:= 0A'YA478M/6NI8]'")
M+4GJ( #NA"?\RQUQ[>4M]H346^6B)_86BEWL"2Y8\V+_+<GL.)Q7O^'5>C,N
M*R;6FI#TNK@E":5"2;_#=5[_6I1Q3:IGYLO@2R?+I2T2^A8_=ASM@\=,0VR;
M1FC3_\F\+#73E$2^+53P42>3N@-$!NU0;LO5ROA85MRC2__-Q$%<'AX0WSR0
M/EF%I>I9P5]KJH7/=+*<30W5@>!4(7^[W>HG#[OO!V<A@>R27[[_GI;O0<SV
MO?8LPRSF=A+/AFCWU^YTH@NTX1EQIL_0D.WN +#+N-;^?CH!5I6FJ(/%97,:
M-8)\D "IDY:$/_2*#X57ET7=Y,VZ(=?9%5E3],I[%MK\/J_Y4/5YD7YNJO(?
M].]W#^3@K?HZ^Q^"5\W#QW614OZ/NU5=TS9"Q_(-DD2A9X86MFQQMZI65K6?
MZ%HNT(8-MJH,V4<;_OGRT$K 'F)KS>'KO%QW*P?J! 'X/_7.NH#;^,W,)6P%
M.3*-UZ/3>+Z=1OK0W<@T7N]/HXP_6^]\ MSB;V9>Y;SK2\RO(G_](DA/NOWU
M<K#<[<$B2.Y<0BQ#\:1V'SS=X-.F,\U!)*-KQ%[J&FEBX]CS7<_W,HE6'[M4
M-*_!FRX7717!3P+]:@ 0B9V83A8<MF#)R"S;U..X3&H;>NS1>(UF'L?%'&GD
M,?*PG&J^[^HNMM$0=_C;X QQ10[<NQ'[*?--P[5L$L=)2%(+U%YXAIYF=>VI
MHP9_&[IXSU!!!#,!1($34UV%<,"4>(-$%[3$ZACN>)>N)@ !:[.@F(KT>H[:
MHAHN*/J^KHN^!B]F]+[;Q7[,:[HON"%57J8?Z>\.%N20[M"P;<9&EB99E. H
M"$Q7M*;1*!7=&M[112UAU%)&G+1XB:-QC*;56IGD0&66$1I4^&A6**GZ1^.C
M+E8&:5:P836D^8=E&JZPZYQ!><GWY2/.BX-[U="BRIC$AAUD7NR8L1-FXO6*
MCM/0K(KM1>JP<.8?+5V(%V($'0%WT.DRPY10I[B0KB<GBRWGYNB%Y7=91[!0
M%-LD(.-T+Y/CKR[8NF22]]U.)=./GI#N0YJ',H6W>3[^NF8SLIL!PTE+Y/GL
M23QM/Q0)"[,?1^34T9QY6JS3\GSVQEP^T>>X4$<S?48>E:EJF"35FJ1M 8WK
MC.[;Z0Q>E'53#V*DTIC$OF%Y<40WUGYLQ-A+C#3V?9<$MF6E@-J#<^1TZV-+
M'Y&VS$O9<8 2Q@*D#MLL; *+O%(P@/K:X="5N^F)(TY]/EQ*!A!(^3B5P$@6
M>3L-(&#Y-5%YIXNDS8ZR8"DS48EV"XX)OR49*+:NBIQ5,#LOTH_Y-_93??QB
MWB*F$3D.-7IFXL2NFT4XC$'A7J.D-%NX#6%^:YYUI($!5.,XB7D&U4@/,VF[
M@O=4-?1&FA=.52#1.*%EPX%F!3X(ZIE_0V*OPB(#J4&@=H '#/%RZ<>:$_*L
MY,3UC3B+8L-SHL#&D65::2J\3YDDI?M:;D,;/?, RXIWGN\]_H+%S@40$]BB
M*,,!ILL#"-H84TY8H$TA% + ID09%'(;$FE(8%L1(2DGMR'3(RRW!1&29&?[
M(?:&W-:C/;J-I$%:<<@N*[!A)KZ;9&&$LTS(5AT=?1F7AFR^XRX08ML):?&D
MG!@ZLAF/2J!HF[ []J([@Z-B[6\&CC\DJ4:L,4J]O];;863@!)N&&46A8WI!
MDOD>I )).RQ(<62+C6!."J@SK=2"R@*6!:@ETP+ 56.'7U4ZT0ZZK#+L"'*@
M!;M_E:W*LZ+_+%DJU?/0N<X"XZXHER-_OJ,_U3AA^XWZTU@(6T9B([2=T$BS
MR'53VTM=![0(J61.^Q9[P,O.50\[.P[_?=T\$);>A NT^]()T7(J)U',)KS6
MU$!W_<O,BD2!(O7P*:MHI)"UA4L@J0?UL&:2!AH2GHO/#[@B,:Y)RI(D"1V<
MC3V@&+]L'^G*)/)MT_439^(W4C<D_9VP$PE)SY])A>_)AV^D2O*:W%1Y<E!:
M-<.V@9T@-9S0<FP[Q8%I^F*I[ MQ#+$C4KGP+0OH^[Q *9OHJD9/U&K4C.T?
M !Z$!29/P!/SMB8$9M@Y8P;G# VYW['I,6MZMWVN$P%Q&5CQ6"[%&6KE.$.]
M)*@3!?6R("[,VYI?@)OI;<VSG*_J+<TWS/VU'/J3/K0%V%C.$;<<ICO>O 7)
MRAWFKDC#.AO<5.5SGI+TW<NO-0N9OBR>*>6\N#^G&Y!G'C/=.B;7]'=='0W*
MWEA'DA [!O93;$16E"6.E08X '4D4<.6[@,<Z]*1\2X=[&M#><\=PAOV8*<R
M1;,A=AY;'F/@28S!VW/'+/7WC$&*\@]HPR/JF&35=39,H@V76KJGJ,5-T1%,
M$5.+'K[4 KE_[%(\.CQ-A![@6/[GYY?'N%SM6\C$3@V<69[A14EFA5EF658H
MFAJR,[)F(]?10BTQ\0207>FG+=)),L&,BJ XH-2.HZQ+I7/LCK18"L=1 89I
M&\<?T-^PY2.=QGW-(:YIX#1V#=<R/=?,S,!-046PH QH5C#;=$Q][5HX@F+[
M 9VXP)14JED+8^EU>K4,P7B%5BV<_)OMU#($YY1&+3OCR%D>?M)Z-W$8>_>R
M?61X&&MC05F%AXH[(FKN^K][P,7.,>VR:!/:]HYK/[/"<^]Q0S95IO:;OCJ^
M0W]RL9$Z09:8<9!@#*I _68DTVPK%7A3WQQDHETIWPJ_NCVT[P0]=N^.>>RZ
M2/F!M,-KNCU_'CU*=HF^1SQ[7'#$)!^4F538@O.M3:>J?I]O1JYEFXN^&;%'
MEMJWQZ!D[%6;G3&HY7!>I)REP:_V0[,">EH(S22DZZL9.SA-TB@"EM06HJO]
M-G&3.?:-32%IBQ*6W, E;7**?-EM,63%%BOE:,$6DAZF83E9AE2[%(B4](4'
MD$$D5A5?)D1SV? S" P'T6F@E^$.N0]%PQJTIRG]=.H+EMU5W95?B_W=N&U&
M1AC''DLN#4B49+$3.J*NN1$:FO?%+574D3U#%SROM$*,M+C+;@R?>>>= JEA
M&BXE,,BI-R.2E'MO;,S%''TS0@U=?G./RBW?'[*,),UU]N%;\L!V'K=T:W!=
M,#\]^W^VUWC&*[;+N*6[BBIGG:+9'Z@=V/W%X,D#S[H9L'+&CN%AGW@D\U*?
M@+(F-?"H6_TYQZR@(.EX1A4[N+0_UZR">D(9@NT'=$R5V.[AE2< :(DVV/?L
M(L8OPYSQ<,;_%VU9.4-;)KLGV-9D[Y<[+QR[V52W<]&(MJ)]C@X.%]T5:81X
M?P^EDQ2\7,Y528^%Y14ISY_OV;GS/&G6>+5Z86[[\\=&M&S.S#":K2NE;MQ\
MN$97]/][[]"N>ZICA]]&H//'<BU:M4($HVF;J1@>F.U3BPRH"H^@S%+5>.;&
M7JPJCZ"0P^H\HJ_(;=_:6IJ?&VI4F"_H$YLB.L\'!?>XUR5*/"/.K,CP,S<C
M(<9I$@M5OQ2BIEGINZ*N&^*HIPZL22>&G-B^2!D>0+?\!@.ZR>EPZ6F?H7>8
M/IR0>5C &Q,A<15M,:9I+;I9$!)[?]D7>TE.Z;<; UXW^]<BI[N'S[\>KUE#
M[,S !-N&B;&;I;YEIA&H!OTD-<U*/]B$MY79.77T/:5? Z\7IT$3TW=E4,#T
M?1(%#:5LA,14I.?3M!;5<R&Q]_5<["7X1GU_J_!;>\W3]< "U[D4'$ZS.D]L
M19_K'[O;@(XG\?VZ*%3S^W8-*,$T'0*0ADJ:0/FE]O*B-!;;TP.%'N[MH:^>
M4MUB<U_[/J^35<D(C"5[8#,QL(L=(T[-V+:2D,2>4/MN88J:[41+_R\RY3"F
M8!*\*E4I//":E),^&[91W9+7DCHA+*S2"AQ3]%ZA.(> ^,?K=HB\*'LK^N&1
M5/=Y<?]S57YM'KHNN@>:'F(C"N/0L(F;."0SG22)8#>C1^DL<SO:DT8M[;Y5
M,/1^]#A2HG>D)\LO=4\*%5WBIG12L!-N2X^/N_"-Z:1PA[>FTX_++<M= ^OC
MI^X8NT;LVK%A^I'C9TY S,2$+,$[HVM6QXY6S4+XG^@S#ZS305(^/M)-:,U.
M-;"%>!(8W[6,R&3_Q)$745#H;^TO!6ETP1*UL/04H*! JTN*@9#:1ACXMA%Y
M.#%=UTF#!,/"WZ2_#ZDPMTU6?9FAK]W7<@H>8CLQ:1EA)KF?:?6.E*,"*-I)
M[8Z]Z*[IJ%C[.Z3C#\GNABZX->(N%AX56U^OF[K!O)_G0=U,;!G8HRKFF]@G
M:4!LDWBP3=$4N67V1BT'K;_OK VPK]& "^@F:1) T;V2*EBDMDS2B$CLG40$
M/6$+-3G\PCLI$5$/-U1";RV<%-:%OP\XN5KOK;[M-:@7&V&$8R--HBAS";;H
M;FV1Y*XQ#C6;E&%!G63H8<2[:3SUX+FG+HT'MVD\99^H4VYY/T,%YYYG?_%W
MH7<RVJ?:=U(J#XGH>A!X@>4EF9W%7YYX8L3G!E>"N\Y7G?!];H6G_1VA1YZ"
M'3+C[DKX[4Z4Z='S4D)GRTF\U QLU_4LNYNH#T7ZIYFFGE? XI:^T1D2VZ._
M*N:P?82";,9-ON+UT RVC+^!5,0Y3%\[I7"4OS]':N <O,I2_&8)2=PG/Q3W
ME\5'YJX^KZ^SW^JFN'_?7&<W5?6WZL,_FY?SKU5:TU^GE\7%<Y7^K>J.ZJ(7
MS)+CZ[YQ;@/ J54=W*G@FODQ?NL*5O&,8OKO&VJ_J[9R19>TS.>B'N0F7Y3/
MA#489P\![J=EH9^VP$NA#C.R^@!7Z)]1 9W<Y;<LT>5NPT^$9>=Z_-2Q)/NY
M];=RE\43M:"?R#-9V0>.6+[MC,W4P&'F&[%%,#L@>*DO5/1+@)9FR\9)_<>_
M6[[Y5QO8QVT"'[%-GR*I899E:T_.4$OW#''*R-;1SFU>1%7]W"8H+=O0;5[D
M@XYN J](%$:_XALEO+I@9Z**E3K(FW5#SN\KPO=-(W=NQ#3BT(V-Q#'#, @(
MB<3\.@":FI7ZZN(2;2@"BE4+ C:MW9I@@&EY3Q^U#* -!UM<YK5=&B! 16[U
M0,E5U18 3%$5;)C$DY6L!8=:KAHU3+:=BM+ 5T\-^>^2 \=SKML"*Y;/[L R
MBCVVZ;XF]'Q+,NK_.$'-AG 0\LX2I7E&+O^!;%F0C?\?05!LZZ,2%YAEW$](
M9I#L92;K2 &8%E-Y%L (N5=*!)@6?CP78.8]N/N&FI6</GE7I3?E*D]R4M]4
M97)5-N=I^40)@A,"A ?4K.@='Z@O ]QSPS]OQA))><-FRAGJ6!/WO(BC-N]J
MT0(8S )(8*4A20 ,A)2G1)S*8JX1L.!#7PC\9;F-PKMUG1>DKL\3:G?JG#N<
MV8]T,W*0%-Q&RX2V$4:)8[B.&T<Q">,H"R [A5F*FBU(3Y_=Z<1Y<4I.\#QX
M8IL$I9# ;(0<&N#]@;"$BC8(\_06W2$(B[^_11!_4;8>0$JRO,@;\BE_9D4@
M&_IQY/&*M D+'[XEJS5;.WXNR_1KOCKH@A#$V(AQ2O_I>B9.O#0B'K!$ (P!
M[=L+XXDMC%0AZ%.$XMENG%/FJ2J?VA 7QAFT>,"),">Q@>/,-%(_]I,PLC#Q
M/?$H:"T@RP9*;ZE+=3$&0REF@G5^A]!=6\^)P5E! \!:9M#W&W90S\]X^(=$
MV08Y*)15<@"27[BX@QPXA_4>),>1<(_?=I:,GC#?;^W882C!-M#@0UN>]O@E
M&/93(_)BWZ 2)(EM.:[G"K5X5L&,?C_2<://\UJ.Q41VE7P!ON53IT/ *[\@
MR&"G5(LOY0P-6.L"M-%>%-66OS/4<2CCS3\5<8";?T'DY?S_I\^ HNL!14A-
MWAN<2F.Y"P5%:.S<-*@:4^YH(9B"PY<4.PZ-,,I"PX\CG-IQ9%FQ4%ZR"#'=
M(6.#Q,>S+AAW&/8N'Z,+0= ,32-._<P(4]\.;#/-TBR$1ZZKPE$Z"'T7S5A=
M2#H(S)0>MQ*'&+;M!B;!6>1G!!I=KA9*<*#X+I!$4=CX"6EAJG&!;3R.98.=
MJ4T'@PBHZ*ST^HEA$*'WST :D\(V@4;GZ=_7=</6MNNLSUL_*'GGVP8.DLCP
MB>UX7FA;B<]RS.\Q=[3#@_N.$87Y5/9("W_F/V.JV:Q:^":L-F-A<,\\K':;
MC"W?9 0$K),1(S;]Q,A<+W;BS,&A)Q<N*8VH_+I^".4^>, 4_VGHQ(RG,D!@
MUG,0F[TES+ZGGK2&0,HI"56'4AZE]3K!E%-BCX933KXD9T%OZ =PA1_)^;?\
M(%HH\BP#.V9 ]3H*$RL.$A-6,&PXN&8U9J00HX7^8-2 -WP[*(BIJ*QL,(T4
M%@NL@,?X5Z1O.T,OJE['A-K7IJ//2+A;^[ZG'\NJ;?QP3__%U?26M5:KW^<L
M["=>\YRM@U(O-KM0\^B2F5E.9MFQ0X_"@+T(G(-E-B9#DFSAV/+5K2LM9P"G
M'@QF :>I>M3D-+MC U$^QF!".[QH PW@]]0&GIR74R&(,*^F% Z3/DS8B,MY
M+*4DW?%/RHT #X:\(24L.77S@NZ]R8=K\>#$K133MDQ: *"9^G"M.,/R@&FI
M0,#M*(L%^ATP/@SD._RCW'[\BO*!ZX?+XKE-BSTOTH]Y@8N$_GS9D,=ZK+HO
M\5+Z$_8-$L:Q96=1DIF@WN3"E#5K"VM6PV/Z\YX3?DN;];P@RD+^+.'3$(=6
M[ 2@!3"8=G8LH,L=J#9<(,Z&E@K!8.$5G2W$Z2YZ\ ##L7\J@0\@&PG("+#U
MN&U%<EE0%:6_8>8D->,,TQ,)=HS ,1,C=&S+()F3Q('MN&[HPR+^CA/2'MG7
MDJ'6@U&%!IV-@"-F$%2(#-/_+<6NX0_+@6Z)J@P4FQ9+64#8")F% [^FA3T,
M\)IY7KJ!5T5P3=Z3]K^71==1LKB_P$]Y@U=C^P#+]XV0^*[A^G::)6[D$R<!
M=O,2)*W[QKWKBLK\\ST'72PI7^8&EQO G@  =$4U7P=F,%LP\-@W);HE[(//
M5P1=D=XXL-_SU,";JGS.4Y*RLE;?_UKSHBH_H W+K,4(VV&],&O2"H2^[T7[
M@<W']M%./"U[##BJZKJ,B1)>NN48$) C_<>@(TB6ZV37O9=UO2;I^W5%A[_A
M\0W\V,__UA6SZDM(IP=E&SS3"#T+&[:-0S--0AS"$I# '.C>F5!6>%1&F>U4
M44?K)QY?NBVEW575!%;Z P,N9MJTP@BS<&V7LY87U#*#6F[.^@HP[2,=2VC#
MD\(B?+)PJ"JR!Z:_;!$]67@.BN1)#P1W'+Y_3M/ZNKIN'JH/57%?WZ37Q:8.
MU57#?O^UOLU6":M(==>L6-D^YLR4J(>G@)1F,_4^9UN#(JTI?%UGL0^X8L%Y
M==MQC!JKW;IL1=FT#WYE]NN69"N2=(7:[DJV-]BIJIEQ3[U,P3P5TS3O4UUX
MAF 6<.G)4>SZ58BME--8!?W%W,T*P1HZJE4.NW E]VT<#%T7'GO[_\0_Z-_*
M%1V&16O=XH8<%/S&L1&GL6E85H:#U'<#DB:PSBH+< VQ&Y+]6EJRZ'E#=Z%R
MTH"I$]R6OJWI &YD3R\Y/0S5VPK2)N_P*=[*@I@P;Z ,-1SYURY,#>#XSU&J
M&CX%RHI72Y"6K8G6X+P@:;\Q&NFU965&E)J>D3FQ%V/?<3)H);1C9#1OSL^3
M9/VX7K'@+,02BY,<6*%@!!PQFWNZR# SV=/;[G%U-#6?DDE9';.C1!:N7C8E
MZ&'-LLFG)6.-*_)$#RE=]N%YD?*#29L)?[&N*FHJ]M4T2HD1IG3WEKBQ%69I
M$F,'E%H@0%-W]$_+09]!WMY=E/SLEK0,2!7($ %33*T50P33\1Z=/NV;@=,>
M;/NNQQT+"B.?Q>55%1 M0''9.&EQ" ["IP&O+GP^;#T?K-1JQ6-)V[;K=P^X
MZ)R%5R6_K27I;;E:T4,M>VG?XMC$-Z*04(N39([CAM@V ]B]PZ+LZP[&:EMY
ME5F72[G0<5%N)C6?'+7/S^*'R,Y5.!"IL[T-%6K;U6@C5]_3:/L]H#^8K*@3
M5N&^['5FZ;4/G'+,_SG.GB=-C+)CZ&E<2"YHR0-)URMRG='S6[4FZ:=MY,H=
MCE=D6W#VH&!&8$3$B@UL16;LV$F4N*#MKSAIS0M)SP@S'1TK_9X/NJB(HRFX
M(&C!"&C,C\ S8 /]P1E!2JOVRLNORDR*$U[6Q($!.3!/\!%D6V"?IRG]KNJ;
MLF[PZO_-GR[*E!PDZ">F$7MQ:,2^Y]J$.($GEALP34:SR6@)HX[R&6II(TH<
M,>K05M='@9JV$.K$AUD#6<DE6EI/"79"*^NCPR[<PGI*M,/6U9-/PV-*6-%_
MW/"MR'M"/_['KN@RZW(G&BPR-89FW1N01CNT>9L^\9B-21CF@S%4(0#U.TL)
M#PJ%$)%,*L9A<N#%@A=$Q!M&)0@]+Y&D_RE/N)NJ[[KS>]X\?'X@Q0N=[\_K
MHG[("W)##PJ/."'K)D\PCW? Q<NG_#&GAX"1RZ,X,Z(XM(R0L :!2>S'GI"/
M2"%/F@V \_E=7J*.54#FN2+ ITW#*\$(LR(=?X,&98Q#U+.(>A[1+I.HXQ)U
M;,H40E4T"8"Z ,M/AFQ9U"=6\)UYNO(B*RD_W*X_D8K==[& XF;SU2.\F;FO
M0C.7E#^>H563_JBHR(!:4">K#R@BM5Q9 K78[-0K4#RTG,_H?5XGJ[)>5_0,
M.71QW1)^^W]!MZDU]W#% P_7:')X&&(C2BS+,,TH=4GH^XX-BG8XC1W=OB7N
MX8['*AJ+Y";IF ,Q[]-RR,I?+TB""O9$J<%"D7?J1&86]5BI 6[?BZ5H5,FZ
MTKA^V&N4=]!(;_<7Q_M>VK9E!#8F1I3ZEH$#QR=A9IM18DN433Z%)XBJRM=5
MIC3/#EIB\JB*:K]W9C.HNUQFJ*4)K!.L<I)BVS8B/Z+_0Q(WC' 6N Z\'/.R
M4P2OUPR:(,)"A=[ U! O,<+8B0PKCA+/]3T_3/&7AB60O+%IV?(D/"5M'DQR
M=&+.CLW,DA,AMHE8#%[8'J+]V/>ZT9ZA+2>H?8)AO/?+G1?:LF%K9JBZ=.6R
M4%C(6P5XJBI]G\3+LJ7 5<!V4"M<R:"2U_287=CQY%)6'_0ZNZ.[W9I5FRJ+
MXTTR'1,;8>9:1F8[+)@\##T?5&MCGJ3NHQ-N[YS;O&FY]I@"N E>Q"M% WC<
M@0$!OV07EDW5Y?H\P64OU84!.+A,%W]3.BX](U5%TD&/@C;U?'\?%&:9@<V4
M[H,RQTH#.W9Q @U''R&E6=$WA/<ZV.1M-07I3B$3V(DIO1I$8,J^!6.G44A7
M6D)II/F,;.H"S,<(+1U7/B/PD7#RN3<D*L$6=7&>_KW^_)Q<U VP*.R1=W7K
M)BEJ'KB[J>!4H\^D>LX3@IB3!5 \]IC@\]?LI\H,U+X9<577FYT03J[T[+$!
MEZM".R'.3D':J>?DULE?"&;.P+;8W=.ZZ=,W^ZH4+'GS^(6Y9?D&C@/?<#W7
M]@/3<<(4E%0A3EJSKO8$T4M.5D"7#  _L;53#RHP;1[P@#@3@QST#5B,$0W)
MFW#Y%:VW ,*+KK]P0/;78XD18,:DKAJZZ)?I.FEJ>ICO#']]>,!F^VT?9T:<
M!99!0B=P,R^)8UNH!_$D%>U;;4Z7>[7Z=0UVLI[&:-HV*),<NJ66$%I8X86$
MFM)M.L! K^F_MCH]/?8BZBLD7J^I8@^?V$_OW<OFQ__)2<7:R[Y\8LUE]_I$
M<2U-6()*YM-3L>5XD4-",_%=J?YODV0UJ^V@HLJ&-O^<K\Y_DVHJ)0BFV%*O
M'B*8?I^"CGQS."%A57>)FR;Z.NWBA( 8[1LG]K:L\XP59VY>6%NMAMHCYH_G
M#:A_KLKZH*6<34P#VUYF),0.W,2WXI#$, ?:%#G-)J*]*7SJ6."?/^GI0]UF
MDZB)NLY480%>ZSG=,\0I<QPVM,\0IZ[2B28BI3)'VB2QA9UI(H(?.M2$WI*(
MI;\]VF?^(TZZQ+:^%D2?UGG<%6"GIA$1SS$RQPT\UXQLPD()!&/GY7C0;!9Z
MIK@BI%NV4+;A:U#TA8"R7D]!?MJ*+(0GS+1LH*2$T8 C5O!N@^7YID9,SY9,
MD+PDJ("@>/W@R@;!2X&L**K]-%0FH]@EAUXN:OTTV7>BU$\<2L+^2]=<Z"HK
M_,;+*@R:O_].6/\_DIX_TSWI/;DECVT.!@OW81&D:[RZ(]7C_A[2C$TC#./(
MB%WLVG'H.J;K":\@KR6%YC7HMZY "\N= QC!5YM3@;7ISS!3L-5-J&3/N\F2
M/9NB//V$#^0[0[V$J!,1;61$ R'1W9_D(P&LM7^&CT5NM?Y3?#2P+<!K3];D
M)N+5F%MN&_+:^.]L9%Z=F=.*.Y2DOBJ;6^8'J@CKND6IOFQ+$$F4>I@>4?]9
M=E/[(*6<\ 825<L+ZIF1J_\P@]3TCD ?2. #ZK8V!,.'<H%N]_!!?R@MU"0G
M^\G5(V;(O$HM"3'1QRI+"+XMYP@?E'C:>-NW&73[;C"7I 8.8M^PL\PS[<2S
M4L>%9-1,DP-9"=F4F4$#1ICW>P8J,>^W.@!@%F! =Z<-PY:V.M^WF(R*?-\S
MQ!;U?8L)ON_[%GSKU"J.[]9U7I"Z/D^H(:ESO@MY]S+X%R_QMG]+[F;8"".;
M:GSDAJ'K!K9-A$I!R3*@>:?0,\$.)7%?(*FM4PA-(($B*V8@=.(%,QE24)U0
MQQ$FK_)JCH+D7ZFF(PR<\<J.P''DC,YU=8^+_%_\BZ'GE[I<Y6E[/BK2F[:2
M#?_G==9UB\>KS_UVYU@U$.Y C>W8P*[E&;%'0C..<&39H&A<)5QI-D]#'GD&
MZ99+?ADWY),E?FTX15M6I2N'J)DV,3.W^&3 ;-]2\P VETIQ4V1#U?"TJ&%5
M"N.^M54[.-S1PSQ2Y]QCM'IA_35_JR_*SZ1MH=E%2H-=/9 Q-=O(77=RQU/;
M2/2Y_G%3B:[G#G7LB;M_0/C-.X!T00>S:)*H:7 *R> AY18"$5K,,20C_M U
M)/6^=)1D0DA:?Z0"'._&OE\,!R=&'-B>X6>N;Z:>ZYHA-%!RFJ)FV]+31VS.
M=MK;MUWOI9K<S\,HMF=2"@[,>NSBHKU?O;"DZ@(H9^@M'4,I)OZ1,$K!%V4B
M:7AS>RI T>3/A$5JVJ;E'X^7=#W/"",GI?^T(B^-$C?+A%*@9BEI-@",$ \0
MAD0:3 $SK=I*Q86I=*O$&[)<:,3%EPA+G(0 $A"A"(J3Z^PV#V2BUB[[*X>J
M717R#8A/=+PS]/4A3QY8Q#W+/JQY?WKVQGV%646H^^URTE;_Q&W3>SHN>7Q:
ME2^$^>C3O*)+>EEUQ;RHY:C7JP8SWM9%RKI=D>JQC=#EA&INB]FU4;S*ZP<Z
M;/S"J<8E'9V1W(RHJM*OR&1-!RU,#;!@8(& '+N7_R(OP%NC7+"&#A7!QYJA
M!.RG("(&SAR?6&GB>;Z0'WY_8-V',]X"A-("=CO9D7W:9IXB$?#,)"8,J(')
M,<ZE6I;L#+18DY)C[ _;DAS].]R%P4-E[A[O_Z?\^DOQE%\4=4K_#75:3(^B
M61,X<727/_)P-<H"^N7JYI+[$NFJ4$ULEZ%HS+L@U $!4Z!9##2X%\1DE7(H
MS R]F M!3,2ATT#P#0E%7:WN*LP"V :Q;WW6B:B:3HRA6TE7*]31'D:F"A[P
M9P$0T$Q%L@/U<D1LQ46,1(234\2I@9=30P'Q=I10Y'FX"G[X)UURO](3Q'GZ
M]X\%>)$<>5VSXG5-?,_;H\^@J-89^EB635%"^G6-(3"O?@J$AVF>@-P:UL09
M,:5T<&S,Q=1O1JBAYLT]"E<Z'DO(([P?RA5]Y;8I?JMO"*E^KLKU$U@)!8?3
MK)1M@.2 #71+FG55H-]JQ)A!G!MQO10%:5Y/-> #TULQ:#2H+E!R*546I;&8
M:@.%'JHZ]%7)L,I- Y'I](]X,OV#%3KH*I7=E>Q7\'P0Z\!1E+I&F-B)$5JV
M@XGI8#N,0 &;;T8TS=:N9;2MA]+7_FM*Q/JH0S)2WQYNHI&F;X9AC9<<(FF(
M,20-L:T;,_A>?N/?R^OE)K[=Z505HOMV!%LV^/?MR#URW?P&.91;S@_[W5^L
MJXIR>W"O31=6[,26X9KTEVD4NV9F0A*@1BF!%CMX[E-'%UC'9QX?L:5&B=1
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M-!>X?KAIBW*D[UY^I;IX65P_$;:W*^[/$[K#XQ%*^R>NC/A&F!#/<*+0].W
MC=T0%/,G3EIS$"!E!"64$[1FBV=>H+)G >$-#["-#0!6L=V)'K" [AB&4<\!
MNWS[_M<6L!_0A@_4,?)RQFKHK-8\EY:I-?<2LLC#[M%RO)00>&,!!T?1[@!
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MGA,;09:PJAYV8J2A&WAADK@6$>^7+D93LXGH2]>LNEK?+X"BR8*@39L"35#
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M4,R?YB5EI"5WVX/D5][DI;\#ABT)JJ=);!EX1?!AIG_+*$->Y$A<3YZ)M78
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MFP]5Q>_L'QM1*SPZ@&;#.J"+SKL,.((H^;(@Y;K>NQ-X+->BO:"G49DW:TH
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MU?;[;S4.LKVLM.VBF!GQKO8&II06;HM\RIAN5JE.'].&[]NDDNEF_VA:F7;
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M<SE,R8)TRXL%5\ZT'":GGV0Y\IS$Y7BP]5BG+VCSA^*:NX[V>QI?'KY18N.
M>!$[?.W M:SMUO.%[& Y\)K%LH6'HA9@U7RK:KA5"';<DN2KP,5;*[=@HMUK
M(GC;-!&\:&!\9.@1)ZU,!%SFM3)3[IZO@:DP=X T3R8]!?!5UW,B2%-\YE^0
M7T5"97^E3/7OHI+&E:OTEW17%K\T Z&&<V5M,\3$B5T<D]!SG&@;)X&XCIZ'
MIUDIM\!0?L0$%94S_\!Q 2@4 =8)J&&U#('IW1/L)IY10=^@(X\D'*,"7 'H
M5;7<D5.D<UQ2I"[%29W4CP++K*<0Q6DZTX" U^#>UF_E/^_RZ#:_+_*/1;E[
MJCZ&GVGYF,7@<>\B:^D.X5:?9-U /<O1_;>OZ(0*JG$1=\@*,6?>.ZN:+S"U
M)L(2#7/@(41+>7.% *SFVH60V_7S@MZ3N822XI'_CSN-7LB>=X,\Z1/^AZLT
M/O]%Y\FJ*BDLF\;X/%_VA>SV/+;_*<N_L6<NK:'$3##9;BULFM0WXB2Q;$>H
M1' %7#5K'H[.AMUMBT=$3UAMNH95]4?N9WVJYCQ4.1+%$5_(Y4WOIHI<E]_-
M5@'OUM4N\?^BC]U=ZE@UU1\9BKW?=5ZH_LYI0"<B-NA(!F9T8$[(^]E3R.W]
MW>RMY%7_G>PQT#^P"M>GG0EZ45C1\[ *+\_=%.N 5.6&OFBY_?$[S:-=02LK
M\6NVWS.X/ #=:XY-"/LIM'BU"O5\BX9)))Z2O@03W<[I!@M,FO;]M,$#/7-$
MECI61=DMZZC6P$09G_5MW[W:'XS0(M=<27[C^*$&08AK91&CESJS-3!\B5];
M@O$ZW=I [L ]W*( WMC9#>3#O-\;NN ;C WNNN;/L?U*^=0E]GO>RY+G+1S(
M_I[F3V.Y1_'6P"$A%'M^Y"9!9+N!6#NH-Z9C[:/JB _J((0X1E6 ]962'!1?
M?<,O0.#\^W/L*]!%IW#6[7DT\_(,F/A6H+EP;_VMK#@,>9UO1LX 2/\_\DY&
M%R_GDM:IQ@O0^_,,/%Z^!TIG(2M Y[T-9ZQRLHN;]([FNRSNC5_T*0XC:N/$
M]RP[,2P[\MWW,7[Q'''-1DK;'A:<X;7Z!DZ;'.]Y6S38&$KF(M84\:8\-4U_
MAJ&'P[OP[L<:7J#]'S*X<'@SUAM-. +_O9U$QR&V X=157<;Q28FGF%A/[*I
M14S'36+(Z*,W($%(_RT>FW0^_O>=G4_];7WK(TINE][Y*77Z!OY4!]7H7KS[
MLZJ/^7_(<36Z):L/TQU 029@.#5JJ#-6]B9]/O2<MELSP$%H)]AW'-]U;++=
M.EOQ""$$M.Z$GIFA>1OT=$*(*1&&$21Z!6*R2%Q0%^N @<"9\6*;[F!B=*.5
M:Y @GR[N24;U%'(1&,^38<1T  ^TXHH1.QE*ST-T4BO BW0_--_0_W_@C3;R
M_>M7RKMH7OJ>?.)BWS9\'#B&05SJNBX5:K,S 4.SCFVAHB-85,,5K]8=8\ZT
MRE1$,DPWPJD%E>W.T"-5N3NVYFK%NS-$=>MWYQZ5G*)0%+0L!N:7]T:+FQ0'
MQM;%\=;W@L@VB>62W\NL)'NQ:_8H)) 0'N$)?Y;W_!5$*NC 20BCO!&[LBJA
M&":#-<A-=[;9":S"$0=SE*D::3 *9]T1!G/D]D86S+X@<7%I^GM?'>)=^8G2
MXKK?:)L+JFO[[)RT;>Q&46@;IN>04+P=W0@0S0=EV][^.<\26A3,EN0BF\9\
MM'=QV%=]I0N:O^PB4"'!&,<$[AL*^ "4W(8%%43$06[0]4S7;'&* 7<%!93+
MW0ID. "S_F=(F[3SQ]Y=SZ*?P?[,=I][5LY8.(UNKO3;5=H=-M#<".+;]"M/
M],Z9S+('OF1IWO[S1U+L"OY^]5W<T^@QW?WK0(NJG>IHUUW7M9CA85$<!;$9
M4^([@5@)^JI8:U:0W6ZTG;.]=TVNIX(<L44G=*LVG^RSMDX]((Z7N>JEZU^_
M0H?/K_M=B!E=[VZW8<> Y.;J;$F\*D<5&8[KX+RJ$;KJ-EP:M.L"A]?Y7S_R
M($-\1VG^4YX=GC^EX/+^B25TN^)KR(B#1A5L'K_+RC2#M%>=8L&TZE1(/=";
M/D&XAII] 1JE2O6GUEVM0E^ N&YAOLCC,#$L\O+WK_29;?5C=U##=79(F4P\
MD[Q\Y2WG/F0\,[)W:?793ULOQGZ2;#V/!B2)A8HA0%"UA]1.0*M^A>BW&JY@
MRCF,@],RK8TOT'@9F"7"(BU%XI1]P1;LV!;L7R<QA\%:1>BER&]5@-S+<K?&
M+P?>Q.<V.8Z>^D8?JC!_KR%D9&'B6Q9V[<!P/-,/'-A-;Q229L&OX?*[678<
M@U8TH&$WJ7%>B=U^E'  )N(GXD\SX+[-$0^^A,P2INCB, YG56-_EMQ+ WW^
M!3GA_4R9P4]'IL8U23S%AP/].R7Y_1]9[UQW(^Q[Q, )=>RM$2>Q$8,*!H#P
M-0LZ^UQ\F$!#^2<FYAJY A/^&I%-=P)M;_QCF:&0HCNRBS>((X081NH4@R0K
M%*D+*/15E8@D:RY5B^PR$K-1XG_<9W<TX_F#$C?XD==UQZ[B?QR*LO+2W6?H
M[N/M66:OS$U^C WSMW@%' !&K02)UW";GZ%5;H3*R)KKC5"9)NILA,K,HPOJ
M.<+Y)-Y064FD=6DSF G%81A%F$1^0MVM[05)!"XR7)<&S3KFK.J=O?\D4<VQ
M\J:*&3+O?*M@RE!!=<?B/@>*BSS>9FM4%GNL3,'Z11]OLT6#Q1]OA,I[JUP\
M+["\(&=@ -Y%72.-'!SZ)D]]"$/?"J(P"NSW6&0_2YGF4[%;A1]G^SW)"\1N
M*77%X[LI>(1^#8"#\SW@^ZZ/4\F2_H$35],LR'>[G>^^WA)*UW](-:;D=KY5
M=P%Q!%6U?AUN[UHW#$BV.#1"!UM6%"9>;,6Q(YX9/0=MM1A3F[^WM)FHBLZL
M;]Q]56UW594=5-]'EU2=75"5=#I]1]U,I3J6+N]*REUY]WG,5.]-&M_ORKWP
M*/#SMS2KGPJ&N O[@J)YS[4\,3!=<I\3?L?LVI ;9A_&NY==7/E0)ND$.:B'
M29+R2U\LM9H[>IB$KA=ZY FX#!PST:IZO<KX>,SV[-VO97KU5(H*Q<PRFJ7D
ME,B(ZK+##@+H*RT/.;N]//$D&W%1FF/,O&PIY E,V!2P R1Q@H1*B>#<VJO)
MI""172$5?47.D7;/7KM-.@KUZONNN*SB,1,#!R:?^.O:AA$3VZ()*+=K$(KV
MA,X]0R'C<>\7>N9VX(48W7]WO KG+_W&T12T3*<9*N876LPFH&FNG4-@5\HD
M!Q2Y-89AK.IBF"3S\KH__3#\L.:C7M@MGJ_$;_/5]REX0 ^\JEF*.Q#1!\JC
MI[NT=B1R!/XJ?A(/43U_^BXD&":/T[0JD[49NJ0.V*'U5CM4)XCI'J13C\&E
MZ$N6WM'L"\V:4;F"$G3QFFZ_4Y9BGM?SY>.MN*1<4C8O)0N(@DE(AY[YB<<@
M@1@A04H8+M=:31!&B.@*P=@C*X=A^X'CF[3,=VFQBR[#JE5:D1U:S (U71S:
MMNLFD>6$CE")D79,UTL>6BDF.KLU8K;LNV X3+MH2P$Z$O!N(H^B3'[K2.(L
MGG^.R* HNY5%^H0!2NK]0UCLXAW)7_D$R-NDFN,]Y#F(MUL<NDG 2\-,TXK-
MV(I@Z:!CD#3K70Z-Q^OJ">4RCH!Q'@DJ4!64 Q4@A&BXLIHC2)6R&86SKK*8
M([<G[+,O+ A.\8)0<&R*OZ3[AL) 2$2F*G+F+R;2E,#D9BXN-4FD7%BJ2]"R
MJ%2UTOI!J2X!@S&ILP<T74^*L?.S^@]WO%VE\1W;Z^'F!_R$2TSV4^B$V#9#
MQTPLWW 2M5.5))#4++058,0A YLD:-T81?<2S>R&:18(I]7?'A:P8JV+@PR*
M[^O.L(#)X.O"$EAZ2]"_T._E_1]T_T)_SM+RL==>@E(7AY9%L1_0) S9CT8"
M<@#)(J)9E;(OWM-3E-[CJ)A^7(-/,!TH5:9^FRITLRSER<KUZCTTWF7A^ABS
M9"O81]>#WYH^_JM\O?HCCXNK^!\%++XS\*IF#=*4250:O$"GFF[!%.,Q>N<O
M5PM)A2F!42H5QX$FB)*Z9@VMM]IE:X*8[I5KZC'94Y\)*<]2NGEZSK.7VO9H
M/JR+^Y-A)MB/MQ;VJ>79P=:W0P+R$$[ TBQY1\AHUP$-/<W'.25Z8"NA'WHF
MMZ1WH2J410!URD[7<4@K'Z"S)/?/R/E7)+)ZTR+],4U*KA<D.KJ,O*Y9*._8
MM8?'['ZD*4UVY=E9(=//98P)\^>C OIA0BE&NH9N+C.4RJ7LCJRY7JKN-%%G
M*;HSC\H=HA]V!7EXR/DD6;:KM\E7^D+3 [-]4WI3TJ?>%=GR0AS$KH\MSW0<
M)S8M$]:!<0Z@9LD]!\_C4 T"Z#>. JIP #H:9WDH=L:JY Q,IA<R!7S>BE*J
MZ-"=!;?JR2M*_.7Q*_R>G")H:T:OTKBJ6^N&]>=FGE)BX"#Q'>Q:S-1V;2_9
MAJ!^%!#@FA7$<?8%3T^O)IX6*.OFV4@./97BLYCBT,4]F!(Y8UR-QWF"DH:)
MG4LXH$BY@$"OJFADF'*I=*36@%\".JM^I1&[6^2O/+@ J.H;7T&SOCC/X0-6
M[DW0/6_ZJR$9)N0=F*@%BB L )G\\Q1*6?T3RZYF^,^3UK7]!9Y>.;>Z.^[E
M\%0G G[\_DRCDL8?>$H*91J#E+T<:R=.<!"Y$;8H)6%HTXAX\>^,H##3GF4M
MBC-$?+J8 ^SM&AAZW=%]O%+*M?".B1D=[VH78$I,00IV9PA7AXP-:@E!QRWF
MI+R#7&PHU]\Z)UL8W_>59Z&*_<IRM,& )<^1MNCM-KE)H^R)IWAP3'/ZR/V%
M+[3Y;5A4#1HO3P42.)B08(O-[98FOAUYG@/+;X/!UVP3'K'AKI0S-%"-!_JM
MQ02:TP;DLZ NU\<]H&96P3BX4I4C7Y6*!$)?5^')L::GOB27D:D[K\WCV^1C
MGG,0I\G:HOY8T67TB<'Q9L6D@,'/4IH=BGV3F'!IM)PP4^RMA?)!LJ9; ,"*
M1=[BY)Y7?0/>DSMAV][&?]N5C]>'HF3BDA\SE!I?,$?C(=W]F_8:&U(CQJ$9
M!3B*33/9.B0DQ(<<L##PFL_7-CJ1'P'"3E$@+\4.47T<@BF/%@_T!T,$M9B<
M)3*V_/LZSS_P82K'!D5G*1#XJD>I'&,N3U+)561ZIS)(.W:[2,OJ_E"Y?_O9
M5=4(K]C 86R[V/"WCF]O7=/=FF(^G1E(VCTQ$B/-YY@SK2T4$@Q7"S7,QF_1
M]$>=2Z8"T0[IB:J$!Y+=4 =YH:H5ZBQATTU0QU]?L?WI+ WGC4_G'Y<S>NX8
MIVB>T[@J4QW6/E[B8=]S/&PFKF.2+?$-WX28-D- =.>/M2!1P6'"K)=!IHC9
M*$M)A:F<$Y5-K;?RQ,TI>A29%(,@5C4<IHB\- \FGX7?IG].GW?\*G._>Z+Q
MIZRZVC 1_[0G#Z*!V8DE- O9SU_N;KJWXPH#E&3Y^?UYNEL*B"7S?@5%W(#)
M(801Z#>.BR+O@0"U4DZ#J757\Q4($-=U$8@\+C$/LRI5N68;2^^S%@2P$\/4
M&II%%-:889+8>=E312=,^)IBH@HLGQ_#]Y]7$EX(9:&IEX,(T7*#,*<67F\:
MI@!Y9R,Q19Z7LU6OHHAGOA1WY)6$>\K^F1]HW%XN=Y3G4%4M;CN_.NW_]8&=
MVFEY2OV_<.#YS,H-?#O"8;0-^9ALCVQ!*99JT=.L%QKLJG!Z6E!@N9/BG1 S
MK=^.OT!]U.")&D0WJ&5V![%-E<19-V3N_+JCKS:H05EQI8=>=BJZ$RA&;M7;
MA![&7MY#-$%1Y,8\>OR^,)[5L"XK1@/#QB3>VMB@L>=1ZL0.<<0G08D!U:Q%
M.VZNE\JVK]+9T5Z1OW.(BY+.SX6\4>()[<1'3EAH8-%"'^E"5JETF )9MMR-
M.D$[V*<ZM-;;.E@GJ)OUMDZ]*Z$TCXTPOM$'_K4,>UZIL<5!N"68D"1P KKU
M(KH5UI'#,#2KQ%-[EP8J0,!'F"*@\I:3"M-P/2IEPCPCY +4UW*RY;25^";#
M5-(T/9,::.35]13.-.YG^F7FT94+#6;'B3*-]T*+DL+':%LF[_1EF'CK4=L,
M+<?V(O?WYVHLZ;>2Y*78S?H]D 81JDL"A>7JEP8;1$H4TH==RF>N\QRU>L5W
M/F5;_CM)0H.=<[&-$RN(J&<FD9&0YCOYF,;_R5])2Y[4-\++'_X#OPXQ?]![
M0%6?A;'>Y/4CM?])(]?A6_C6]3@J2?ISE.QHV,3U9JQ+X"81?'QX*)M\YR]9
M^7=:MO/$: SNXR2RENZ@0]-=@YYR[L]U&T,,,<S0"35 [%*$5P(Q3,5L L8.
MX!S2T @*P@.YT*8(@/5"G !RST*=D/?D+G5-OG$Q4-97&<ZQN\6^'28X,6S7
M##S3"Q,#$K2\!*!9 S3@! <^CG)!S$!<0AM,;%M(6HKGQLA09+#TEE_5>!@C
M[O(@'WU.PO?Z@181NYK3PO _9?D')K)L!YY>LV)7[CKM3>,@=!V<4#/"GF,S
M.7-- YNF[5E>XH=>("1GH@ UR]T1 VSX55Y:?(X$P&LIPCT!CZUBGL#D]8P=
M##RZ@"_CS17A"\"UJY@_<G[>.3XI<OL":)WT 8NLLYY#&$#5F7<8\IYD(M6I
MH>A]=A7'._Y1D#WONW^37I/G73NA/KR\.7VE[%[$$*'?:/ZRB^A=Y7EJRJ'X
M X/N/8>8V-^&!$<&<2(G-*W0 EDINA'6K'VK5'%<X8:BKC5/Z^PK8/*5[MT3
MLZ[>TYX +UEW-]>;8<?9^>2O*.<-F9L\[J)$'105YF&MQ$=5F5FZT5TW5VLE
MYO>RM]:"*W= W*1W>1;1HOA*"\K>?KQ*XP_, M]GS^?)"K%)+!<3TP^QY[L&
M)A'3\F9$O2")G9@D 43+"T'5K*IO4M0@@5HLJDS-#AXP;2W&2C&5JYQ!,+TI
MP!L-%6@@HA4I.3&8JVHJ$!LNU0WL9>GL_,/384]*6N>=#G2?^9P5Q1=:WB;W
MY'LO'=0,,&$Z [M^$IB.:5)J$V#Z/02^;E?W"1N454&WZ*S9TIZA LZY!_%7
MT(K3QS6@4=9A6!VE'.Q.]0/'YB\;Q!#BD6^&DM*,>!E>J$MY!T%?.Z==AC4#
M2>M2RZR<$=6$^'ZMXGM,5;;M_.XS_JM.J]ACN.9\+'NO@)[])XP"@GW/#XB?
M)([G)2NU9%U*"T3BI1J$_-IDLS!#@K:]/<L,\>#J2JDKB[=;3-7^*;80IK05
M)*D<TU ZW\''SG? ?[TY;W-_"I(>Z7PWB2FJ]NJMLU$6T_'G2$%1M5W*\DZ4
M(21W9!Z35GY\/18\7.])45Q]W_4F%47$QX'GV#CT/&=KFA'['ZCEW20TS0;Z
M$2"J(*+?.$Q@K]AI;HF="LIX -/<0/+!"E2(+$5*;AK6JHI(B.Q+92'VDJ0-
M7%<8U$/ >Z/&PBT.8W;[WFZCT*5V;+D.:&CGV>JZ@R@U+/:IUN"@?9W/&"%H
ML<F2![2BA"F#VS%#%*BR+<[67O>\'R*K=P8//B3K$.=WTV.3Y<^<\?Q 'S@5
MMV:$0]-TV=$8!;X76X3]'\P-/@I+N_.[\K&<>H2WL*5.QRF>B?J[E7 "*(W=
M#ND-1UK(&_0C80]'5/EY*4"J,M_V.*25/=JS)/?]V/.O2)Z3T2.-#WMZFUR3
M@KO'^?_Q)/ 7LJ^B=+S)0J\\=QOC(-HF>&NY7D""((G\!'1^BD#5?:XV.%0#
M 1CXZ@9>_=!!!/U6H0(]<X68*G@6JV853"N,<6:6,? C&T*HJJ-<".:Z1SR$
M#;VC'_2R7%T&GQ9\%?^C^/8271=M'!=0BS'TONZ@U-%QULZ8[N0AH":AH$IU
M@95=#+)B6JQ5<0$89!)F@,) M@BITE44@XNN6CDQ1=9EM<3DLPL]5IUAF<7Q
ME_]G1W,>[WX=O@#;U,2AY_@X-@/+=!/'W3JQE =+!+IFZ>Y,3#L"KHZL+U>_
M2EZ:8<P%.KQ4LPRF"I9Q2]X?!J%:M7],"/;;^,L@;!GUGX$6@:F;(B]__WF7
M[IX.3\.M>IRM@WV2$&R'-/!#(XX-6TB5]%;6K"8:6&**H$_VM) O(@8FP T8
MA0?U*/)3<LA>ZL@@^]=)_OKKK2);HV2T<C/^P.+,KP_T.:?1KKJ5LY_WM+J>
MI_'54Y:7NW]7O[_+LV>:EZ]W;#M+'N)B=GF5AG99-F!Z ?8-8N$M#0P2;EUJ
M4/_WM#+@XGNIS+!%^ E]RT']+?>P%(_,T*+X*^JF0\4=I*5SQI;MC-C1OBJC
M%V>9=5'<H".2E1'017.#6D393QS5NG?K$5LM"6A*^*<^,VT96F^5LJ:$F1.Y
M;&K6EYU:5Y2W25,>.S;]U:,1#LS0Q21*(LN.C3#R0?><02B:#953D[FF3*H
MEHT/LT9,E2TF&.A>Y"Z'+#G.C=-11SY)DK+Q<$,P5IX"-T%F?]C;U,-PQ^!U
M]HWNJX2=YBX"&1,Q^+)F(>/I221]12UDU(">'I @2/>\"W QR5 QDZ$6Y.F;
MI$C*S3>\XFH^ODF"N@Z^Z0=5C"<;3*Z./!,'CN]C.XE<P_.,,/2%>N1.P- L
M=!?#R39U\_ -VA7% 3II=8A#8D?<0KIADG<QJ6Q3N]XVZ&::Y(7SRG2DU Y!
M>,-I99-IJ%./P@^W^SR^RO-O-#KD]82!AX>K%[+;7SV5HD?<Q!*KQ;XJ@#P
M*'Z\35$^?\@I(AHF</<YX6G"YR7M)QS0 #_XK?>@XCXK2+34:3BU[FIGH@!Q
MW9-1Y'$E(Y&N>Z,VZMGD=HS]V'/9?TA,0IM&;APN&&UTO<IPC>,<G><:ZJ(1
M1=="XS/4T0MV2UV,#+I6->I!C"0]8WNNUYSZ($;HS!B=RZ?EI/+HN?C,^X<T
MY1W%9<6S:_*(46AAWS)\XA*:N#$H^WH8C.X+(\]_>B:[>KPE>:J_VUT:[0\Q
ML^YV*2H?*7HZ1>*X6V-?]5'9GR81 3TY(PP5$^;E;(()\\EO50'<M!5O"KIE
MB9&D2)A'@*PJS-.$7@KSS-.2F:'<=+YZ/GEXJW$PQ;>KK]_$D[Z$%],LO?68
MZ"X"]:"A OW <"B@S>)G62,FH4JY A/6.89H:&@B3*VJY,Y9>.LF=HJ2WTOJ
M%'Y1(J%SO__XG=GGY>Z%7K-+T4.6LU,*F-0YL89N4WF_1T?8Z 0<D,8YQ8#Y
M*ZXJVH%F\PC9JI,W!8B32^"<6GB])$X!\LX2.46>EPUF/CUEZ;BO=YNP.ZQA
M^-CU0K(E?AP9B0>+8YX#T!]=8>!:+^__-/[+, R36<]Y[?'];V2[QH;]CO^O
M'M=2('(H'QE'_\U[(13<>/ZY:K1EFQO$.YXV';>BBMWM;]W_1I:_<1UGXUE^
M]82UW1BFN3&-;;MN[5RN_IB=RL@!,#:(+<.KT=F^[P5'6XYNK)AAL&2[P)$A
MOE-ZG=-CY"@+OEXLOW+<=9BX?LAUY#EYE;&K$_AYG4<[N3$Z&W<[-/2[3@"W
M#!S$B8=]VZ9Q$&Q=(P F1D# KZ!N&F3J6J4N.G"!!;!57)SU, LN[*-\ZHS@
MUC1Y6XX-"I4$ /CJ*@3.F"$%([&*G/JYF/[SY<"/S-ODPVY_8+^M>KP4G:XM
MEY[YP#1Q:,0A^X]+;$(MQS)B6&<P( 80J9+JY]4 KJ;1U:8'T*NPD*6F%;.?
M# \G@1<F)G$<)P(UDM3(4 F=WF*#23.2+6ILRMJJZYIR&,5K\UY,[VOD*$SQ
M]^;;U:AP"[C&XKS16(.@.LTOR0A%JA\*?57=+\F:2^4ONXQRX_,RVF.9W-)T
M#6Q9Q H\,XA# HKV3,!:V:R,SLRE'[YD)?U?_\/<&O]M.D!U,\6_Q2;E&]F/
MJ]B)ZQF%[\8"E##W%CB$OV3I3VSU)I.1CV3)=U5K/O#<Q?F5-(LO0P#_='5U
M=TQV[> @[B 68,B\FU@M+V!".\4&#3,4Q4F5<AT+++^: UF<U*X;&?"6Q(RW
MJRC*#[S[YI[]*LNK>!%3U9]W$6_\T+\U>-1FQW.4X,2/W"CP;+*-A1Q!0M"T
M'] =N-6)M&\A P:8S;)L6KZ5,P(8"ZHAHSXO/NO@!6"2FTJ>R(UQ6\(;V"0W
M45HGQ[C-+K+>##=1>LX&N F_)'?I^/' %J%%<175DX!&^A!:#L$D]D-,#7<;
M&Z83)-2!7#A&X&C692U4WD\\W*7R[0?'V"1VKU! /$Q_R= -OE',4*7H-C$&
M9=6;Q RIE[>(N<=AHAK3W>\?V46D?/WV1/;[=O%+$0U- Q.;61ZN&1+3L\+0
M#5T1$1U97[-HUA!1!9+FZ"M]YN7-Z0-JRNK$Y'.,-]-RJ8!BF#QVB44MN.62
M.$/'Q%V O5D+'_OA)'-CZZTB:S/$M#(V]YAD:6"3WGF;5+%D'JOGG5EY16]/
MT$AH\_'--OO)=6+3<@++=24ZB4S!%/H4%W<'X6T#V&>9)0G-N>A%'#2P8G"*
M<6*GXV(^R-40-E K=WV5M]D"KEKV*?2\B="GJIQP"M2Z=84"1/<*#$7>6=)R
M^YY\/P5M1]M;^ X._=#%6SNDU Y"XD5"YZ@ +,UG:M-@FH$^RSN8;_\ YIF8
M9"OB!$RPI9D@V69[DCRE;;:'(;U!F^U)DH?;;$^_HJ*>?RJ67P7-3#/F@AW@
MK6GXAFV%I@EKL#T#3[-P]^K\!X+VTJ%Z("L=-\ ^B6+L)21*W,"F)O%^?ZZF
M!W\K25ZNSM!+V/)L#>G#+DTY-\.F/?]:7*5;&Q,G,7#B!VX<$]/?ABU7/Z;Q
M&_&TA2S/45I_G-K9*6ANJF,0T.*\[%K1SQ+1U;I"=S+('+0W;&DAG.PA^AK<
M>?.A\;/?YR2MO4&UMZ-G>;HA]BD)<4 2:C'2'2<2ZO<T!43SJ=2"12>XC2]'
MW($SRI]Y+XX*JF%2+$$PR)\S1Y&44V=TT=4\.W-D==T[L\_*F8M?:'F:"GSL
M4W*?=6H('K,]6Z_XD12[:.Q^&"4V#N-HBTUW:WO;,$G\K9"4+L1#=V('8WG.
MOTM@-;TL5\4.ZQ5X!1-_/BK\;'IXI^--F:%NY4^#&!_SQ(?*ZKB!+F2/HM-?
M%HM5K8*%K+JT%I8N)U%5S">Z_I+&^?[UH=/]1[Q=UN@"FC4+ TD93'X%.($%
M%!./TCVM0I21#%,0%4@T2+/2EEBSI,D5$8^NNEX%\1QA9^7#LP_+V0IU9(2'
M(K-T?.(INZH'D1_CK9%L36L;N(%G0BR!02BZXZYUS.<(5'*8RS"#Q [UQ63#
M)!).,?@<GJ1(T2D[#&/5,W22S,L3<OIA^5OT7>N5^D#*7DV_9R8XM., .]0.
M26"&GK4UH%?H,PAKW9]KH.@C+Y9G8.&WYW.^B%^=I:F5O#>+$BIU:QXD9M&5
M^7S%U>_+@P0-79:''Y1(=N8C0R@][WYUE:8'LF>6+/W:=(2,3>(%V#5=CYV#
ML8U)[)B8QC9W7'EF8 E%3 7A:1;!4_-24H%%(>\O-]DP48IKTR*I@1<P :UA
M;U"OXUR- +_%4O15.5< N<]JN2.7_;R<2[ <:'&:)[.@!999+P]:G*:S3&C
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M([:742'XFE1TB7MM3V/D+IM-\&N1%]B8;&U>@>?X46P$;F+8@'A2'X)FH:]
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M(HV;])H\[TJROSPWW9C@,(AC]E.8> [U;8N PEXC<'2GTQRAHF<&%N]2%-6
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M^_>[?!?U2O0BXC!3R"&8F(YO4#.*8E@2XKKHZPZ'-+#4])%9>6<%?5SO=K^
M_J].VZ[S*1D=4E#XB@;[>W%ZN(U74<1;?#4T56.+*ZHVJ*4+-80=GT(5:0I=
M8V^R):K<9NLBOZY+[4TVIN=N>QLLEL9TKKGV#+.\&G;0Q;8>TA>-_+F3CE_<
M#Q65NXZ/">\<&7J$Y]G8<9R YABH1U&WT=S%XZPE,C<;N_^N)QR7CR1%YR_-
M=2!::R^A<9BWV"&@^:Y_<Q;$6E3S3WFL11F";Q1K4<W@\5B+<D@2,T_YH7+_
M]/!A5T2B]^O1]_2)9)U%<K][XMX[#G.?\4I5U1?J6<KD1H(.KKC>9- I@LX&
MA$X^^$97X9^J]%Z9>W#B5?W=7!P;;D #ZIHA@66*K(>[[@@C1^2]7($!.[K2
M_5?//KWAY;<FZ,]Y\X5OQGNY]@(P_W/=>>%;HOS"*X'"LB$)7^F>1V?[4\(N
MPS=Q2''@!@2[;IR86RMP+1-6_SD'4?/AP+C-7MU7EQO:X(+R&AG)45_S3!33
M[$I9 ]/'+6C<<F)H=I_ZT0"SE"IN]C\.[TW:]\^2/]:0?_Y%V3:)O$RE?.49
MTB6[EO%HT3-73J=+R&"J,M<,CA?CT'-#3!V#!$D2.98-,D AP'4KB0:52DL<
M\8 V/@3P4DQ!Z.(03%>T6&RJ.H?RG$>=ZZKB*=]+F*"L'R( ],I-$>%,Z7=&
ME%A#0^I;8P\5'P[T4L<8MH=#/_&Q']E>&(2N9QE;2"6J*&"0?I$M3$T.)1>3
MIUVZ>SH\H3U'!CTW2"C,;^LR5$S1Z& 33,F(9+&5&0K9C8[L%(X)@5*^1J):
M%^S[R4T;8 8H'6WH?4FO6Z=0ARNM\O5+5M)IDZ5J8.4Z6QQL0X)-8MFV34GD
MF*"9",*0=:=]5+"!GBUAK@GZI73P GB+J<!JLCO ]*ERU C#7=?- F5'STD"
M7D"RS04MZY)[7O)WJ0&"),"$WUR"B%+#=SPOX%YS0&N+[NJ:K8:VAQ6P:\44
M_>R:AH/0V&([]DD2>J;KAP%$ \K3+]_#2R']AF7AP(P\;$4!,RE=:CLV_3VE
MI2[JC]40Y?JTB^EQZ1V%Z6I.4-N0A$/Z"[HJRWP7'LJV#/>.J'4Z#1*FJC')
MV=KK-B,9(JO7@&3P(7@ _3Z/K_+\X_?G75[YM#^04GBRV]"[VM-A6V"(0Q.?
MWS9(Y[3\J" 1)D+W.8GYS:B;HR-*,2A)8(HLJ1R!P0572Q&8(J>;(3#YG&2Q
M3)8697ZHLEENTKL\>V#[.]*DSZ(.]ETK9@:*89,D<FT_ LUWF *F/>/O!)H'
M9I_SC!<< >MBII@E=IBI8@%,,"^I;^%JF#(O0J"J2I@I4.N6P0@0W:N!$7E'
M3JBKO,BK*,H/<Q'42JQ=7K#B)W@;4,=*J$^" )3^.PU.LV!7P&%B/,,>,4%6
M1S1,E.N<UP:PYJBH&(V*I'D&V*KR+$;XI40+OJ4IDV\L@Z/ZSZ^TX [/.GW#
M[$V5"Q/LAXZ#C<CU(\]A6B!46[(&0$ZSOJA365]JD(@M\*0X_PZR#X*.S#?B
M+DPQB630S230U7O3(-SDSJV8&B?!QK5RWR"HO:_D-@FF@K/79& HSD?Y0ON3
M"5P7$YO]Q_.\F 1;F]I;X*S.<6!KYIO0%JY$BV((PPSBXB A/@Y(;'AV;(=Q
M3""^;V4,@[O"UV&8V'FAB@TP_3^9A;/A/0Y72+GI4*@[Q8:#>A\I-1VBA5-H
MNN](&J3T@2_TE3YG>=U&.LGRI^D)H68UH(DW7#&,V/$#T_*=$&1H"@#5K!H;
M%- 1!]1!8D'3%2%^"AJ,BKD$- 27,PANVP$H5F6SB8!<UQ8#,*%G8T'>E5,8
M7^D+30_T2U;6;2S3:K#,WW;EX_6A*+.G,X=S%0RUG0B'-/(Q<1+?]:E%# IJ
MS30/4K.RJ.HF8'I C$VQ29BA9%E!C#T_=G 8,/U*$]/9VC;QS(#\_D+S,'L;
M1G5!PUB%\AH1Y2P34YQJV0!3FPULQ("WW85K\.@/!A^U"*C3F>+$*M*8 @!7
MU9?B#+C4EH W9>^9W:'P=8_QJT/YF.6[?]/XTJPBCH$)<3QL;'W?C&+#-!-0
M#=0T..UWS09X.W&WF;-+C@C(#]>=X:/H?4H5=Z WJI8QS0C=IM?\";;*&Y4(
MC<KN5)/ 5KY5B1#>OU<)O26;SW(59\]RV2S=-W5[TAM04IDL9Q1.B^%RXF!B
M-Y3%(D:K1 [+$$D+,EC.EELY?V6(E'[VRN!3<#GAGN"KJ#R0_?Z5%US\6APS
MRDYYXH*2([*6]O24;L"DP:6J)$$OQ7^A4VZBN)P)<6A>\E0S!R:+PGQ1G&,/
MI5Q*9(4 K";$$'*[8@UZ3\X:9JOEO%3G ZW__R:]BJJ^T<57&M'=RU!3.V(X
MS";V VPEQ'6\.+)X(CV\#[T(;*'O?W';^18NNR.W@&'&L! ;Q4QB95R1T@HM
M=/1#"Y\/T41'!GV=9Q#80(90K,A,%@*YJK$,8<*ER0QZ5V+Z)+^%,[.-66N_
MDOV!?N4M2NYHSN>LD0=ZF_R\VU-VP4QI6^?W-7LE>YZ@<Y7&=>I.U7V^N,]^
MY%4_=>[_P&6;V#A(#((#UPD2&@2>Z\3"DRIU8:G=/FG11B\<;Y1SQ#>\BU6#
M.A^ ]=0B?RP:WJ"\Q;\*"-:C;TE-0E,O&Y^H (QWU+;=TPKPW6PBU(XZ[E^%
M,OI:[]\):W2;H"/>;6(.V[\CZHCAWG3<;+!']QGZD4^Q>U?[!QCE^1[V46[L
MYUOO)VQ4J&X^3XX5U09\O1&DNOEW-JY4.S#9=(.<@SAWO W7J=!DBX/(CW%@
MA[;I$2]A7P0LRV 4EO;D@KP2373A^X6F$HSS2LR^5\0!V"$U1KR&*A4!^I2E
M"8Q#6CD[8);D?E+ _"LP:8[I[O>/3+^4KTU6_#'AX!L[ 0^]X4R.$V)"28#=
M*/#MP#<]7RP#8 Z09CFN0;<5&9U4F!JZF#C/,FM:EE6R ";(LM0+B[$H:1-N
M.;9$+;[LAY/4SBZ\BLB*DM?*J_#S<D?OS^RZ?LB;N>7/A_+C]V<:U3ZLI^$3
M.."'+Z$!=JA-MP[9&NR/D!-X'J1N 6X HOTNH57\^962'!I^%N"<V'FLEA\P
M:>[ 1A5P/MVGX0Z'K^%X%B=7T2DM '#5PUJ< 9=G-N!-R7$%Q?4^*^A]]G/Z
MO./=<>HY)(*QMO$5=$>K*\"H@LR=Q?>[IZJIQ\]?[FZZ(PW$ VP3S)@/JZGA
M TR015F@;GR*&*7R4QV&EUUWM,,D:;WY#M-/2S>4XI,4[_+L91?3^,?77PH:
MWZ2?=BE)(V8$7$7E[J4N1:WN]@?VNZ8'7I865V%19:_U<O6)A?V$^MA,3,(.
M=,-)(@/8B4D!6KH=VWQ$:++/_BCJI,NDQ0Z1(WK@%D<J=D/,+EB?QT"_,V=O
MBQVO_OR!(\B4SU_0$4?4(/FZ02<DT1%+]%N+ID(#0RW?U/5L4H'4VLV>%#)R
MH$N4RM4ENVFT[4+'N[9%IH%]QR38LPB-0IK8=FQ"*A<'8( 4'[Q@\=3'%M[%
M;8@C8OIJ(9TPY7,B\:ROF\+^&./4J&J*,0!AW4X8XR3VVE],/"I;,52274KC
MCR1/V;K%510=G@[5I($/--E%N]XT$+*U,'$B'X>F[<51%+MF[, JAN9 ZKZG
MG "BN(8(+8:999J8K*IE!4QT6]BH!8Y^Z#*F@:]0E,6)558,,PMPY6(840;T
MBV&$WUP^ ?>4#GJ=%>6G+.]W?N@.<MQ7.\^>ODV&NTCP58H?J_KHZBHVVIH[
MLDWL;]D_72LPHBV)?,L$=7-X$RITARL;FGCR3Q4<&NK_\K&>820_*7>]/1<,
MCK[WG02&78<:\IR0YK>RHNK<PY%J?$-(3T?SMV2LAD&\Z]'P9K-Z5]^FJ7&^
MZR,C.Q^"'8X<A]NDN<J2_5U6[*JV1GUW7'7^.!%EYP\UL17[O$F;;[BPYJLB
M0'4?%RT*_+PX(H%:+$0\/?+\%-3MBKD$5,7+&20Q1D*<8F43) 1 KCP\0IP)
M_;D1@'?A,;>_YQ_3^%/^*]G?)A__5;Y>_9''Q4]Y6L8WZ?5+'O\]OSV419P^
M7*7Q+^E+4<9-9%DP(B>[OF9=\7=*<DS3&'TBN[Q)<F5"T4Q4:4)9[6#E7<J,
ME!?*,\;X>ZA\)"5B&AUQU$N25O6<//^<$4 +X43E1>R?CP&NP7F8_M'+=(6)
M BK8)Q5VE :Z6E!R*5NZ(<O%:\'5W<?O-#J4NQ=ZS;3J0Y:_7GW?%:*Z;/!E
M[9E"#4S4 OVKN'89IG9>=2PF%*87^C0R4X1!5"3)D]1(B>GPBJO)X"1!70&;
M?E"B"JYI/WW'EDO+3W2TZ7M"8AZQ\G!@NDX<.5'BB<U9FH2BWS=>=3U_KN"B
MA(K&YJ=9,RUNR@B&B5Q+:PT2<9BS#=X!- .JI%30+EGE1/+\E5L1=<TA*;@Q
M4CY2%!+V7$11\4AIB6*&&?]+Y[/X+T652W.T3U8>C;Z\7N70'/YGE3^S#TOH
M(R;@6<XY_'IL/3J<,NS8#O:#,& *R4NHZV]=4RQE>!J,9HUT@GMJ^@L0SW'N
M".@D)33#E%*'W-. [5FK'D(W0"\IH5].,7VES^ROW(G(;D&GWJ:\U2[9I=5@
M@0SM![X-57IIEO9)Q33^]GJ::9:",]4T__1"3^SUGA3%;5(%L2H;_$(]>7:,
M0SNA.#(,,_*L)/0<4$7#*"3="8X<W#$^-V>V YD$]*DN(1VFJ&!4R_M,QRA2
M[2CMP7D;[^@8N:,NT=$7X&6#C3'R:5=$9,\=3A_3N.H>=R&IH6MCGP0)N^,$
M9D"H3;U N&1P#(AN(6TJY6JXM3N-009TUIODT+28JJ(;**$R)(,*!.=HDBH.
M'%UTM<+ .;*Z18&SSRZ8117.#V0)+P>R<+=RY56^*HK#4]4'L.@6*)F]^E_*
MA-F,?.R:X=;;TM (?!O6VEH?LA#AD&J)?2RSXV.JI(L0->Z6X/G_+G8 IIX4
M3+/JQ% Z^%\43RH>;Z65RRJ'7>E!=/W15UH9/C@(2R]$R0:-3\\,0AT#OV&7
MZ?1A%^XY,%H6G]B%N*3[W4N_E9KG!9A8082WQ&&_3FB2Q*!&+8)P-5MO)RSX
MM?\AR^(_=OL]L#>C( ?%-*X&OL#49X<E[!)V0@'5.&Q0C07^S-%0V*011K>J
M/HV"4-=MU0AC1:];(_!UB4!O&T^^2;\=GI[R5Z[3BC*]#_>?LOSJ>1_N_Y[#
M4ED 2^J.5#T\Y%6CUSI;HKK53"15'#NPU8T[ZN0*3@+)7\_-CWOQMJ]0)D^K
M%HW\A:D6O:Q5G*,BP3&Y>#< SGI1<#CQ9[%QB=<E(E3-+)>O]*EVW=_1O/+H
M,_)NP_WNH?HX?B7YCG\>?&C[+FX*3.LOJU<W;WDX#"T7AY00QXX=W["%QJDK
MP4:S7OMT* \Y1=&I_22)XRK3D>R/35\!@:#%S!>(DZW)4I@J:S#;H"-NJ(,<
M.F&W02U^Z S!1KFMR7! @&Y-QLO&\31O "RJIXIAD\&_Q4#6BQ&JXL=9*%'9
MHI*3O<@K7Y@W2ZWR+<A^J -+5?+A6UOLTZV+D]CPMX$1)+Z?@,9ZC</2?$ZT
MD*O\WQ:V='W'%,_$+L2*. %3[]),@$_OFB=/U>BN"4CKSNV:)[DWM$O@E04!
M$9D)]?5-Y29E6%3'5U$U4+Y_).EM[:7[DC7)\W^CO!$SC:]>F#9ZH-7=AU]]
MCJZ]K]F>V\5\U4N3-*(6#ETOP6:PC4CLF;%#86.7WQ=]FI57BPHF-2XC%\T?
M_J=,(.;]<!$2O7D_6+_KD$_C>.C0W'38+QG5Z+:- !T)WZ"6='0U^:UI*?Q[
MGQNK,LKTCJA;/S3UCHB?BF>]0S17-@*^'+@/JRE"+ZY>R&[/[12&587N94Z$
MG]CL6N#%.$QBUPXB*[(34(\C78AJ/I9KZ-R_VQ\0S&YPZ('C4,C/"M:V?YK/
M686[LOJ!>=K3=K9QBWZUI14![^#$$V3Q6Q]=<VC^.<X@068K.TQ$X4EVC^0G
M$SN.LO/N>$U3I,N;FF&[F)AQA(/(W1J^Y5GN5BAX( 9.LX:N;5U:P]J@E );
MU\WP2DR/JN, 3!O6Q'<!']M.-K!5=IX4(E)5$\II8.OVHQ0BO->:4NRMA34D
M]Y=S:+FUYIH^]@W7Q3[Q?<LW$]?TY I'UNB2?VI ,]<#7H05@H:/-(% <T68
M-OEZD+F^]HN*0%;L;C]-V&BYAXIN]E?Q/PY%6=WJ[K.OE".ZV]/C3&G>5O8^
M&^H*?>P_>^H*/199L0B[/1$CP8'O.887!D;@@IIIZ4!2=TK2"66>IIBW2/-C
MNNH!S7_+?XYXS_9#W:8=G0ZS4S]\P?X66C=43+6\]3;!%-0)6[X51W2[4^[9
M[R=:ZI\:7K<M];4X#G5R59'.U(+BJII7)Y,O];=66"L[TQH'8'5U*V[2.YKO
MLGDO8,]J"PD./&KB*#1<QS><F-KK^-CD\%\I(H;:B%CE:ZL;;R0\2O'2IEX6
M5;UM5A-1^>+B;+\G><&+XVN_W%IN.<DO0;.W3O_^KN[$.\:U:J*XV5"3)1K>
M>@<>OF7;\M:./TGL_QS^P&5;H\Q-N!"-!042['@N/GZ/]@]LQ:_/.6^^=YD0
M+5DG(;RRYO/EO,%DQQSAU9+1_E"UDFP&W7?2^)541HAS=_IDT,]8F&*7Y"EO
MK[5>60283\NJ(\3!K5\D 6;%8*T$?!4U,X&_[HI_?LHIO4F9^-.B_,J48*_1
M5^5[\=PM)K;M81H&+G5]WTYB4#*:.&C-6HL#Q@F#S.2F!HURX88=$HP4LTSU
ML >F>P9&!G,T$,<#M8@@CLD*PX/G&:!IB/ $X#<=)CS/D+FAP@(KR*D5/L:/
M>P_^MBL?K]F!E3W1_/..A+L].\MZ/4Q="X<6L;#A^%84FYZS)2!-,@E-L_)H
M8:-]"Q"F-Z8Y):8JE-$/TPY'TO]@<%$+>(,^SW("K N$*%0D_M.P5I5X(;(O
MA5SLI:4CO+JM*&C)<_%;&#M:-'HFODV_TNB0Y\Q$9?>P73$ZFJO6 W:"P\ +
M<1)8CALX81@ZH#822K'3':'MC-RJD:S*2SIHHA9/1,JSPN@4$73$'%6HRP[E
M4K&+@HZVM]H;H!NMLRTGGF]FMXAMRL66K#1A2R$WE4_.4H';&TW$4LC6\4E7
M*H%(9K7E#R3=_;N9DI46V7X7UXZT-+ZK6^,VD[6.(W&.20(%GWN_SSB2@RJ=
MQU^B[1;[$37P-HPB+XPCF@0N* ].,8*:M?H'6D3YKO(PMCW.?SP4NY2"1S.K
MWA@Q+?V6[(8IZBZFU<#Y$ZZ5ENYB>SZ%ZX0P.F',M+4./:V+GZHR E6CMVX.
MH2;F]K(.=<&1F0O2=LVIB]AODU^>&6/2DJ'R\V[/KO!9>A;R*.[(KE=':M@Q
M#GS3P6%B.(E%(T/PPBV/@NZDJ&,S(5(AQ27^4*-5:8.G%C%<]=23:7$BQ_EI
MM;L./X'92T=6UOB@VP0U&"&&$CKBA,Z"R 7B:&GG)V3>B6Z^RO4JT<-?X#B4
M):R9GI4BM?**@U264'X^96712I(YM6FYBW?[:M+4-WXKJ&X*=1B0QI\8J3P\
M=&B/HW:2^QVM)^CV&UUQ&]V,F58,V+G@6X10TW)-.P2Y791@I?F N,]*9OI)
MUQ2J8;R8#;XZ.X'G0P<]=,(/M0@B+G&H@V+5R:]!DB<4U2E(&V4ME[3P357^
MJA*<UDU85<G&7H:JTL7EE.A%KL]YV6!GYNE T4%E/5MFA'TO2K#M68GK1XS'
M1&CDGBP"*R6%'MND1-G34]8J2I2=$ (6#"QE=&R'F-A)@EW'L4A$J.UZ$6QH
M@$Y62XT"^$#3[(G=$IDJT\U-L=-&)X=@!TLOQ[175-Y!9X,^<#7"AQ%KJ(R0
M98JB4P,,?M4#0I8YEV>!]#IR:O_H;!?PL?^29F%!\Q?N:J\3)9IBBEWM!"+[
MZ+"O?ASNUE47IP5;3$*#X,0@R=8CWC;<@LX)[1AK/EBZ\3/!H-D&=0FI<X[0
M.2D;U"$&_<;)00T]P"I7_5^$F I^5_L,T]GO:(O!2GXUMBLZ%?3CN^HQLAK[
M+\^=]0##:P6N]ONK^!_W&;\%P6H!^F_J=KDSH;RH1>[FFXMG\ _0/*TWEY,+
M]'A,4ZHXIWZ<,JF<^8'E5LN)'R>EF_,^\11\NN05VZ*8;].G/7FX]'2&6Q/[
M=FCCR/0"UW8BAU#AD9)G*^N6K186XL#$)T>>4S\M18MH @J0&#F@J9"#J$N-
M@CQ?:;7YCX,$=(<^#C\@$3/^2/+]Z[>2W;'N\NPA)T_%\.AVXD:8$"O"D6>Y
M9F";/OM_X;#P&!3-HE*!106'BYX;P( HY"AO! *W*BB&"5)-; 42M3!EYK:/
M4@T(KZJ@7BZ".L0%18'1.:(F8Y^C+Z\7WIS#_RR".?NPA*ZYW<?7)"]I4>Y(
M.JQFMK:'0Y.$V(FW+O4-WX@B(JQF!@!HUC ,(CJ!!$C9$"\$U,I""F$:Y9PX
M&5TR1"5 C2RD5DZ#"&XI3'=,4#*I-H;>6T]C3&!]IBRFGI-SR'ZF14'IL?7,
M9W8%I\5H<0@E/B:617$2Q79"7!+$!-3)91J<9AU20X.Y)V?X(^9;5$<U3*_4
M<#>=5E8U:$UYMF)D*G+$S0!;U8LF1OBE"TSP+;C_ZCZ/K_*<CR+F,4ZFDGD3
M#5$7UN#+NO."3M"J;C;B;JMA4N<]5XNIA GB?4ZJ#A'=-D#"1(,<5Y.$2?FN
MAE=<S7TU25#7@S7]H-SI^(660YW:F@SS;J>VR[CCUH]P$ <V=FW;IXZQ=</
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M:QG8MPTGMK<D-!T75C4 10'RI4M5#?1*-.(&"8E&A6#^BND G3R#:8<+E_-
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M4QKWPI-&N,6A:X78->W0" W?L@"INR#0NKWC+0+HJ<8 /7 44,%QX'-_*B0
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M#2GDBCEDL=&(<T(A&&\P[Q9<-KVY'18J/KPL(M)*LO*?F'B3OK,5*9-DS[3
M B50$P$J<DF[;3T;7MP.%!6?9I80:%686!6<[&0"M$<.N$>424\T89ITM!6-
MKVZ'BXJ/,LL(M8YX,[$QL^.WDP __B=L!<S$I4_<Y*TU(T)*&4&5R(K:>&T[
M1%1_<ME%F,70\&^_;@GQ7?I&H:+MR7PZ'H5<H?_"CG/I>=INP6+^G(NV1=Q-
M#^NCJ+L5X1V+O&_GZ(NUW_ZVS(?+!N(ZOAE-TLM&R4I,5V5=35!SQB"K64 @
M\ZU84 [+?<51T<[=$@GW+UTM-Q@OY@_?>5IWQ]!UJDG9>L=GZ[8O_ZFP2!.=
M7*4.6D:*27Q:UJ6Y7%(P3 EY;TAX,#H%Q#V@_]FB_N78SN?7<;DAO_HQVG*D
M5%IDJ5$(E ,1B(LJ[+M(ZX2;36(J@= )&FX"2R=Q5X";=?I?36_L:"LMG5J,
MK,M))U9Q)2.35.P+7$X!S#85E2"EFWJG165= 5H^I0 =YE<?'EZ_9.4WV%GZ
MQ'D*V+5$C@$+-J8]/M^7YG.2G6DF9UC\=-7TIK4I)/9J$/2B#2M<&60\UXAA
M"M$2IWWY"*>9G&$ZI?2*H.YBKP%!#[8Y;6+@;?JXG?.$";(X  I&<<PEB]'O
M2RWN%.(\4C$L7OJ(;4X3< 40N9K/TX:T\2@")Q.I@D2!:VN5ADC]OL2 4^#Q
MG()*@ID3]3DM)MQJH'%_1]'$!.4D5V+&Y2<PF/H(I3W/3D*&!4H7S>X$21<Q
M5X"5EW;^]6H2\C^O_W$[^F['B9GYU>*EG<WN1I,O?['CV^V<;!N053$@+1UA
M,3E1:TL[GU:$U8"E3@#8W#T5U\;)$/L.,S<M99"\STU&YA_!0V(J.>_WL&C(
MU+5$Y*YV!O%( J."2%#[TA!.LDM[Z!DVQ"D/J6*RK\!8I=#^FQV%US^^P60.
M::%<Y_/[9S+;NH$W$AD-#$5L.,/6$FQ+!T(MR!JF!V%_J"JMB0K M9=XSCRR
MQ&M$&388B-$X[FL$TCE:&J9#88]FZ&3IG@Z-Z<*."]F=Z3>8+>X^C&T2QR1D
MW_PM[S:2*=UJ7V$9,B(:%"+CSG%0U)=&RCYZ:O!?1<+K8D*OP+9<)TYL+F![
M!W8.'W,?^NOXYV0XL[BVI$333M4H0-8RZUSZZ/;V23X%07L)JL%9%8%0.;%7
M@*&<)Q)'D]$"WHV^0WB;5#+Y,DKQW$I@KW_X\6U.2/[3=!I^'XVW:JK3S@ Y
M;R,R7@DL@XT"EX;5L336X.6*(*U7Y50 OB:Z.0:D+7,(0W B*B%P\9OVH\!2
M/(&\!["<),P*0/ 1$O,COX"P^YSB_73B&P(\;Y'5$)#W("D&9?7>7LZGP*0]
M=<-T_.T!2#TII(HSHWT[S&:^F'?)B2?Q"4V-YM$P8_<U7"J]W3\29,6SV7N)
MPXLKH@);MJ)_J]<88&2%!224\XQBI24KG0>T>O,P+8)[NP4Y2I 5[.C?C:P;
MC4>+G'(R664*?)V.D]#GV7PN[II$HZU&5GJ!7- FF%P\OG=$Q2D :4M;)9?Q
M96Y<>U%(!79FC:\#QVF81^2P$RA*%;6( ;M8.IFLF9IA;]+ZT7XSQ+JHH@)0
M/=SI?+!W^4*GZ<!=9BZ"0IH2 YB MGQ?%X N-VG/*:D&3)WTW'"1UD'H=4!G
M=IO>^FS!+2.ZM6]M!7/"(><P1LJ0("CVF!;/4FQ%V+ NKS]@%59)%1NXYX>O
M#ZS<-5T!!8(T:(> 11F286<^EKZGW4_1L*?>/6&KH!*J -6VF+9N)6E("R//
M.R(2:++'%D3IHZ9M*H8]R.X)/!V%7<$VKP'^S<<66(7<%RQM7"13U@9/@]M7
MUU[0#!UY='0.+]=?+%Y6,8.:IERJ_+>_VEF>O98EMKQF7.\0])RIM.)\1$HP
MEPO^!=)62J0E,00+PJ38N#W9+H0^XGW5N+3R0.I+Z@.&Z$N67DXG>5DDLI>Y
MGDNV6BP/R/WJ:/HDG9&42XK-9M9) Y):OK :!]<3E/J0>P7;O5?WK\UC_V[@
ML_VQ)LGG>32$VSQ[!R/'M48!+ W46B+5OAYQI[B_ R0->\M[%N=74BD58&SW
M+G5)NM,&:9X[VG"(GAEL+=_7/*IC,#[LQ>ZY#S&/$G8%P7CNHCA:W,#*83\:
M7+^#%9,^.2<#H@ D<NH"P<4+3)K)&?;N]BPX*J6,"NQ/*PFM+*E+EE0"1X1(
M(05+WS"ES5''^[K>KGS/@JI"JJ@ 5,^KR#?KKI8LX+0DG(P:216QD!)+7;P$
M>P<90Q?:EM'P=I)))W%7@)BU)L$[Z8\,D E.HPA81*.%,[$/G[9.P] I KU@
MI9.@*P#*50C+CEYV_,&.TB;@I?TV2C'6)ALD0=TZG+:6,6TN@Z-!FM)X:2!E
MV'.CGF!30NP5H.<C+.QH N&UG4U2R#:_\O[VYG:<6Q6F?>7(C[:D%$F2DJ4>
M$0\ 2F"/5>FHYS!5PQX@]82IPLJH %YK'"ROH/-HA!E\A<E\]!U6!Q;OIO-\
M3'$=/]L?6^PIBUSTD'8-$*.DBA';0\[),20.>Z#4ES'K44T5H'!;:IL<<+"Y
M*91'$*0PUIN@2>F+NFTJACU@Z@E+'85=P<G2H;WM)C] "-)1.R0T>,FXB8:4
MKM$]1%,K*!7O83W4665WM12#V2 =KS\LM?(5TJ^G\/H92QW;7S]_\AE[8>]A
M:9C&V$L,"1N1QLF]X6RE?')RFI;W"P,VQEYR21E#-O=?H XPEHQ*)?]O8^PC
MD-"Z,?9A<5<1+AUNY;MD)'EO9",EB(&UE&#*]-Z!]/\,C;%;:/B$QMB'Q5T!
M;O8V8%VYY.C2=C7[>RVX2=&?%:ITTX!+;(S=0KW'-,8^+.L*T-*N0_/J$"W/
M.")<H,@X4WGTE<;%QU-<9&/L%IH^J3'V8;%7@Z!#'9I7WILXI#U)K!"9J]6=
M!EHZ$^DR&V.?BJ#N8J\!0?NJ3E=9,,HC3;W)JX%+RBP&7QPXE](8NT-L<YJ
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M!#/=%;UY,-)9ZA5 ITU#<F<\<LIP1+DDTD9/E"^=9EO?"($"ZMW;I_($65>
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M"B$M*.0T&&3!>L!<2>-X._O9$X7#WL;V9SEK4.A%7%H\S(RU>69L2!'09+2
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M'"(J6 [W76RW[PB:K@A\8,BPZ%$(6JGTR3$H?N]^B*A*3FS.#YC-B_6BVJL
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MUO(43)XEYCI$:&UFL!<0M3&1135Z07?A'Q[HNZ]>*94@>."Y?=V"'\/.6:[
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MSVL&.P;G6J9U)B+B"B"%L,H'7=KR7>@Q^%Z]=S@&WROR"GSH404J"B<[+4)
M. I!M<2@=.F4YHJ+P8JIO4LUV%X=5 "H5F4L0D,**B&F+QG3:;V%Y/A[L;*7
M6PVV7]&G5(/ME7H%T-F;V8QM^H2]0-&F[8A/!IOZTLWR*\I!+Z#08_+&]TJW
M8+?[T\%QE=-I/J=?WK56B++(>8H1D9X)K[5@L30XGA%P,0>51SFBTV5<@?58
M[BM>V#F$O&I@,K]71P+]EZ71G;^X>_J=^X$W2XZ?V)Z$#V,[R:UQ=R^X(!2R
M.(_RPM+E_FO<T.(-RWO@8UA;U@%6FY'2T#JN >>KHY4G]C,[NZTZ!XXTEQXY
M!X9R9[$EQ?=[S>0,'&P-CI6M,+^,XH9.=O\(:0L]\HO[4[X_3T:+^9\GW]-W
M(>QF)P6OR'(ID)"4*\XI=KI=1[7#[QK8$]<"LCXT4X&Q>WWS;3R] UCR<_TM
M"W<W(UX39(DGB$H"7 =C5/GTU29BACW&KP:#9956Q:[CB-PA0PW2S#K$L07O
MM(O*EDZ:Z)JRQ?]I,%A*<178P".RCYPVR$1*$..<*VE!4E\\5[ECTI?X)\-@
M=\55@,%65\6:^SPR4:=/RA-@F*3-735I8_WYWYY.8[K+O ;@/-WROK3?1@L[
M7MW_IE 59M\AO-F\^MW*M!,6&6DYBEI@:WRT$4HG_QQ-Y 6DENT'QB;4>M72
M161P+)E_.\FC8$??(7N!(E,(VCRV?/;%T<P4RJW(<W7'T]PH9SFNXM$)?X2Q
M762_/%_,E\AR:RYXU[Q?2G$"E;1I<YH^<94[LVKIG2W=?J$;Q05S-TX.7C8=
MS5)TG'EDA:!I>5JAJ?0AFN*!8"GBA[6F9\3LGCR2,ZJ_@JC@(<A^N! (V4>A
M0()($L0AA<(RQ=E,$T.<95OC%[JG9ZZ]OYJ<DG-"8#-O\U1]5(2EIPW;.O5.
M6Z2IUX@S+(D1 3,HW1FTIKNVTS79 (D3Q#KT!<5V]$,QD4\;[W5&B A(!Q"(
MNTB95<EF"W4HJ#OXECHP<(KJIGW(<6A K ZDL[U\.PFW'E:?[OE:FM#G5W'K
MC!F2["BXM&7W0H>@@C>^W6C.8]XZ["U6*<#T)N>A 70]#B\?=ES-+#!*D(Z2
M(N\,,]HP+D@[6[+[^<,>:Y4"10'951!EO+B=CR8PGU_Y?]R.YJ.E$G:X6&\U
MTD1A9#@-)MA(@)4^K6H@I9J4M 'CV!):JA1L^>,,&E:CBH!L^CI?XQO#G.0<
M2B?Z'"1JV*"GB.I;P.ET/53CQ!:C)BL<.2!M)$$B17"$6Q64T,=YL*>'UX>'
M#KK;Z=%.%&0%%N9@)<(Z,U;@G!S.4'1& U,R:"B>V="Y[.<<]WL#NK9R&JL
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M.7=)N-,*:/%&#"* :1  3F*!0B)C$9M.4&R<D%TB&H.]'9UZ8.  H72NNYK
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MF7?&W40[FTN:41AN9T%VHMOI7.OLS<IHTV>M44&!3E8B40(H15S]-T*)=_0
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M FA" A!%OA]PEB _<N:)KVGASSZ*?0:&8$P^G[4A^%#8O+OY]!) O!"!B*+
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MR-Z4@AYF6?FL5'_W3(HI8?-QE*N?_ZCX42X+^LS#PLW 8'6Y< W@)QP@YA$
M2>1Q1+F0V'QIM+.Z!D@"#$CB^X"Q)(@8]&EDOD'/YS5 2XX>_QJ@$7\'HABM
MPH@)]Y73%<3Z.9#T?1B1B)ON0?"WO 9H9D>?:X!&J!S@V\"@8R )0'[(0.)1
MB!'QH/C,AQU("K/7 (T(V3Z@;;ME^N7C(<]L^D*RMQ_I-*T$KQ<Y(KK">I(
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M,#(V,#,S,5]C86PN>&UL4$L! A0#%     @ B3B>7!%L0\!:20  >Q@$ !4
M             ( !X(L! ')N86,M,C R-C S,S%?9&5F+GAM;%!+ 0(4 Q0
M   ( (DXGER S*@NV>$  +W&"0 5              "  6W5 0!R;F%C+3(P
M,C8P,S,Q7VQA8BYX;6Q02P$"% ,4    " ").)Y<7\/M8AA[  !U^P8 %0
M            @ %YMP( <FYA8RTR,#(V,#,S,5]P<F4N>&UL4$L%!@     *
-  H H (  ,0R P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>rnac-20260331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:rnac="http://www.cartesiantherapeutics.com/20260331"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="rnac-20260331.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
        </entity>
        <period>
            <instant>2026-04-23</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rnac:OldCartesianMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rnac:OldCartesianMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rnac:OldCartesianMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">rnac:Descartes08ForMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rnac:A2022WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rnac:A2022WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rnac:A2022WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rnac:A2022WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rnac:A2022WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rnac:A2022WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rnac:A2022WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rnac:A2022WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">rnac:ProbabilityOfSuccessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">rnac:ProbabilityOfSuccessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">rnac:ProbabilityOfSuccessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">rnac:ProbabilityOfSuccessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">rnac:MeasurementInputRevenueVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">rnac:MeasurementInputRevenueVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">rnac:ContingentValueRightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">rnac:ContingentValueRightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">rnac:ContingentValueRightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rnac:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rnac:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rnac:LeaseArrangementAxis">rnac:FrederickLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rnac:LeaseArrangementAxis">rnac:FrederickLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rnac:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-13</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rnac:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rnac:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rnac:RestrictedStockUnitsUnvestedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:StockIncentivePlan2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-06-30</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:StockIncentivePlan2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-01-31</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:StockIncentivePlan2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:EmploymentInducementIncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:EmploymentInducementIncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:OldCartesianPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:OldCartesianPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rnac:OldCartestianMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:OldCartesianPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-13</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rnac:OldCartestianMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:OldCartesianPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-13</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:OldCartesianPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-13</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:OldCartesianPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rnac:A2016Plan2018InducementIncentiveAwardPlanAndOldCartesianPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rnac:SwedishOrphanBiovitrumABSOBIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rnac:SwedishOrphanBiovitrumABSOBIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-28</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rnac:SwedishOrphanBiovitrumABSOBIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GovernmentAssistanceTypeAxis">rnac:NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GovernmentAssistanceTypeAxis">rnac:NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GovernmentAssistanceTypeAxis">rnac:NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GovernmentAssistanceTypeAxis">rnac:NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GovernmentAssistanceTypeAxis">rnac:NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GovernmentAssistanceTypeAxis">rnac:NationalInstituteOfNeurologicalDisordersAndStrokeOfTheNationalInstitutesOfHealthFundingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">rnac:BiogenM.A.Inc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-08</startDate>
            <endDate>2023-09-08</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">rnac:NationalCancerInstituteAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-16</startDate>
            <endDate>2019-09-16</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">rnac:LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">rnac:LicenseAgreementWithShenyangSunshinePharmaceuticalCompanyLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:Descartes08ForMGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:Descartes08ForMGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:Descartes08ForDermatomyositisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:Descartes08ForDermatomyositisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:EarlyStageProgramsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:EarlyStageProgramsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:ResearchAndDevelopmentEmployeeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:ResearchAndDevelopmentEmployeeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:ResearchAndDevelopmentShareBasedPaymentArrangementExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:ResearchAndDevelopmentFacilitiesAndOtherExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">rnac:ResearchAndDevelopmentFacilitiesAndOtherExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rnac:OperatingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="segment">
        <measure>rnac:segment</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-25">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-26">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-27">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-28">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-29">0001453687</dei:EntityCentralIndexKey>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-607"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2026-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-37798</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">Cartesian Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">26-1622110</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">7495 New Horizon Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Frederick</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">21703</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">301</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">348-8698</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-15">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-16">RNAC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-17">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-23">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-24" unitRef="shares">29381514</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-30" unitRef="usd">118641000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-31" unitRef="usd">125139000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-3" decimals="-3" id="f-32" unitRef="usd">261000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-3" id="f-33" unitRef="usd">1115000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-34" unitRef="usd">3137000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-35" unitRef="usd">3022000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-3" id="f-36" unitRef="usd">122039000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-37" unitRef="usd">129276000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-38" unitRef="usd">11637000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-39" unitRef="usd">12185000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-3" id="f-40" unitRef="usd">5366000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-41" unitRef="usd">5601000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-3" decimals="-3" id="f-42" unitRef="usd">93900000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-4" decimals="-3" id="f-43" unitRef="usd">93900000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:Goodwill contextRef="c-3" decimals="-3" id="f-44" unitRef="usd">48163000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-45" unitRef="usd">48163000</us-gaap:Goodwill>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent contextRef="c-3" decimals="-3" id="f-46" unitRef="usd">1735000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent contextRef="c-4" decimals="-3" id="f-47" unitRef="usd">1735000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent contextRef="c-3" decimals="-3" id="f-48" unitRef="usd">5551000</us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-49" unitRef="usd">5551000</us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-3" decimals="-3" id="f-50" unitRef="usd">288391000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-51" unitRef="usd">296411000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-3" decimals="-3" id="f-52" unitRef="usd">1598000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-53" unitRef="usd">1288000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="c-3" decimals="-3" id="f-54" unitRef="usd">10161000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="c-4" decimals="-3" id="f-55" unitRef="usd">9498000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-3" id="f-56" unitRef="usd">4186000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-57" unitRef="usd">4151000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-58" unitRef="usd">15945000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-59" unitRef="usd">14937000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-60" unitRef="usd">7669000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-61" unitRef="usd">8525000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <rnac:WarrantsAndRightsOutstandingNoncurrent contextRef="c-3" decimals="-3" id="f-62" unitRef="usd">47000</rnac:WarrantsAndRightsOutstandingNoncurrent>
    <rnac:WarrantsAndRightsOutstandingNoncurrent contextRef="c-4" decimals="-3" id="f-63" unitRef="usd">141000</rnac:WarrantsAndRightsOutstandingNoncurrent>
    <rnac:ContingentValueRightLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-64" unitRef="usd">405900000</rnac:ContingentValueRightLiabilityNoncurrent>
    <rnac:ContingentValueRightLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-65" unitRef="usd">392100000</rnac:ContingentValueRightLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-3" decimals="-3" id="f-66" unitRef="usd">6948000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-4" decimals="-3" id="f-67" unitRef="usd">6948000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:Liabilities contextRef="c-3" decimals="-3" id="f-68" unitRef="usd">436509000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-69" unitRef="usd">422651000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" id="f-70" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-71" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-72"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-6"
      decimals="INF"
      id="f-73"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-6" decimals="3" id="f-74" unitRef="shares">134904.563</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-5" decimals="3" id="f-75" unitRef="shares">134904.563</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c-5" decimals="3" id="f-76" unitRef="shares">120790.402</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-6" decimals="3" id="f-77" unitRef="shares">120790.402</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-5" decimals="3" id="f-78" unitRef="shares">120790.402</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-6" decimals="3" id="f-79" unitRef="shares">120790.402</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue contextRef="c-6" decimals="-3" id="f-80" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-5" decimals="-3" id="f-81" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-7"
      decimals="INF"
      id="f-82"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-8"
      decimals="INF"
      id="f-83"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-7" decimals="INF" id="f-84" unitRef="shares">437927</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-8" decimals="INF" id="f-85" unitRef="shares">437927</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c-8" decimals="INF" id="f-86" unitRef="shares">437927</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-8" decimals="INF" id="f-87" unitRef="shares">437927</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-7" decimals="INF" id="f-88" unitRef="shares">437927</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-7" decimals="INF" id="f-89" unitRef="shares">437927</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue contextRef="c-8" decimals="-3" id="f-90" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-7" decimals="-3" id="f-91" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-92"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-93"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="3" id="f-94" unitRef="shares">9427168.437</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-3" decimals="3" id="f-95" unitRef="shares">9427168.437</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="3" id="f-96" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-3" decimals="3" id="f-97" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c-4" decimals="3" id="f-98" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-3" decimals="3" id="f-99" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-3" decimals="-3" id="f-100" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-4" decimals="-3" id="f-101" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-102"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-103"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-104" unitRef="shares">350000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-105" unitRef="shares">350000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="INF" id="f-106" unitRef="shares">28544728</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-107" unitRef="shares">28544728</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-108" unitRef="shares">26011106</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-109" unitRef="shares">26011106</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-3" id="f-110" unitRef="usd">3000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-111" unitRef="usd">3000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-3" decimals="-3" id="f-112" unitRef="usd">718017000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-3" id="f-113" unitRef="usd">700706000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-3" id="f-114" unitRef="usd">-861555000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-115" unitRef="usd">-822373000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="-3" id="f-116" unitRef="usd">-4583000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-117" unitRef="usd">-4576000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-118" unitRef="usd">-148118000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-119" unitRef="usd">-126240000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-3" id="f-120" unitRef="usd">288391000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-121" unitRef="usd">296411000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-122" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-9" decimals="-3" id="f-123" unitRef="usd">400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueNotFromContractWithCustomer contextRef="c-1" decimals="-3" id="f-124" unitRef="usd">78000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer contextRef="c-9" decimals="-3" id="f-125" unitRef="usd">700000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:Revenues contextRef="c-1" decimals="-3" id="f-126" unitRef="usd">78000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-9" decimals="-3" id="f-127" unitRef="usd">1100000</us-gaap:Revenues>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-128" unitRef="usd">19463000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-9" decimals="-3" id="f-129" unitRef="usd">14674000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-130" unitRef="usd">7114000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-9" decimals="-3" id="f-131" unitRef="usd">8315000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-3" id="f-132" unitRef="usd">26577000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-9" decimals="-3" id="f-133" unitRef="usd">22989000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-134" unitRef="usd">-26499000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-9" decimals="-3" id="f-135" unitRef="usd">-21889000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest contextRef="c-1" decimals="-3" id="f-136" unitRef="usd">1026000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-9" decimals="-3" id="f-137" unitRef="usd">2015000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-1" decimals="-3" id="f-138" unitRef="usd">-94000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-9" decimals="-3" id="f-139" unitRef="usd">-1818000</us-gaap:FairValueAdjustmentOfWarrants>
    <rnac:FairValueAdjustmentOfContingentValueRightLiability contextRef="c-1" decimals="-3" id="f-140" unitRef="usd">13800000</rnac:FairValueAdjustmentOfContingentValueRightLiability>
    <rnac:FairValueAdjustmentOfContingentValueRightLiability contextRef="c-9" decimals="-3" id="f-141" unitRef="usd">-346000</rnac:FairValueAdjustmentOfContingentValueRightLiability>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-142" unitRef="usd">-3000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-9" decimals="-3" id="f-143" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-144" unitRef="usd">-12683000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-9" decimals="-3" id="f-145" unitRef="usd">4179000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-146" unitRef="usd">-39182000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-9" decimals="-3" id="f-147" unitRef="usd">-17710000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-148" unitRef="usd">-7000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-9" decimals="-3" id="f-149" unitRef="usd">32000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-150" unitRef="usd">-39189000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-9" decimals="-3" id="f-151" unitRef="usd">-17678000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-152" unitRef="usd">-39182000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-9" decimals="-3" id="f-153" unitRef="usd">-17710000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-154"
      unitRef="usdPerShare">-1.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-155"
      unitRef="usdPerShare">-1.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-9"
      decimals="2"
      id="f-156"
      unitRef="usdPerShare">-0.68</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-9"
      decimals="2"
      id="f-157"
      unitRef="usdPerShare">-0.68</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-158" unitRef="shares">26855158</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-159" unitRef="shares">26855158</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-9" decimals="0" id="f-160" unitRef="shares">25902650</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-9" decimals="0" id="f-161" unitRef="shares">25902650</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-10" decimals="3" id="f-162" unitRef="shares">120790.402</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-3" id="f-163" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-11"
      decimals="INF"
      id="f-164"
      unitRef="shares">437927</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="-3" id="f-165" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-12"
      decimals="INF"
      id="f-166"
      unitRef="shares">26011106</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="-3" id="f-167" unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-13" decimals="-3" id="f-168" unitRef="usd">700706000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-14" decimals="-3" id="f-169" unitRef="usd">-822373000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-15" decimals="-3" id="f-170" unitRef="usd">-4576000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-171" unitRef="usd">-126240000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-16"
      decimals="INF"
      id="f-172"
      unitRef="shares">93632</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-17" decimals="-3" id="f-173" unitRef="usd">304000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-1" decimals="-3" id="f-174" unitRef="usd">304000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c-16"
      decimals="INF"
      id="f-175"
      unitRef="shares">169278</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-16"
      decimals="INF"
      id="f-176"
      unitRef="shares">2270712</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-17" decimals="-3" id="f-177" unitRef="usd">14584000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-1" decimals="-3" id="f-178" unitRef="usd">14584000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-17" decimals="-3" id="f-179" unitRef="usd">2423000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-180" unitRef="usd">2423000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-18" decimals="-3" id="f-181" unitRef="usd">-7000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-182" unitRef="usd">-7000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-19" decimals="-3" id="f-183" unitRef="usd">-39182000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-184" unitRef="usd">-39182000</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-20" decimals="3" id="f-185" unitRef="shares">120790.402</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-3" id="f-186" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-21"
      decimals="INF"
      id="f-187"
      unitRef="shares">437927</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-3" id="f-188" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-22"
      decimals="INF"
      id="f-189"
      unitRef="shares">28544728</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-3" id="f-190" unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="-3" id="f-191" unitRef="usd">718017000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-24" decimals="-3" id="f-192" unitRef="usd">-861555000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="-3" id="f-193" unitRef="usd">-4583000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-194" unitRef="usd">-148118000</us-gaap:StockholdersEquity>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-26" decimals="3" id="f-195" unitRef="shares">120790.402</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="-3" id="f-196" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-27"
      decimals="INF"
      id="f-197"
      unitRef="shares">437927</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-3" id="f-198" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-28"
      decimals="INF"
      id="f-199"
      unitRef="shares">25767369</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-3" id="f-200" unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-3" id="f-201" unitRef="usd">689887000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-3" id="f-202" unitRef="usd">-692071000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-3" id="f-203" unitRef="usd">-4621000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-32" decimals="-3" id="f-204" unitRef="usd">-6802000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-33"
      decimals="INF"
      id="f-205"
      unitRef="shares">55690</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-34" decimals="-3" id="f-206" unitRef="usd">183000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-9" decimals="-3" id="f-207" unitRef="usd">183000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c-33"
      decimals="INF"
      id="f-208"
      unitRef="shares">113042</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-34" decimals="-3" id="f-209" unitRef="usd">2508000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-9" decimals="-3" id="f-210" unitRef="usd">2508000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-35" decimals="-3" id="f-211" unitRef="usd">32000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-9" decimals="-3" id="f-212" unitRef="usd">32000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-36" decimals="-3" id="f-213" unitRef="usd">-17710000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-9" decimals="-3" id="f-214" unitRef="usd">-17710000</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-37" decimals="3" id="f-215" unitRef="shares">120790.402</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-37" decimals="-3" id="f-216" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-38"
      decimals="INF"
      id="f-217"
      unitRef="shares">437927</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-3" id="f-218" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-39"
      decimals="INF"
      id="f-219"
      unitRef="shares">25936101</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-3" id="f-220" unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-40" decimals="-3" id="f-221" unitRef="usd">692578000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-41" decimals="-3" id="f-222" unitRef="usd">-709781000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-42" decimals="-3" id="f-223" unitRef="usd">-4589000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-43" decimals="-3" id="f-224" unitRef="usd">-21789000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-225" unitRef="usd">-39182000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-9" decimals="-3" id="f-226" unitRef="usd">-17710000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherDepreciationAndAmortization contextRef="c-1" decimals="-3" id="f-227" unitRef="usd">615000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization contextRef="c-9" decimals="-3" id="f-228" unitRef="usd">1156000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-1" decimals="-3" id="f-229" unitRef="usd">235000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-9" decimals="-3" id="f-230" unitRef="usd">184000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-231" unitRef="usd">2423000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-9" decimals="-3" id="f-232" unitRef="usd">2508000</us-gaap:ShareBasedCompensation>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-1" decimals="-3" id="f-233" unitRef="usd">-94000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-9" decimals="-3" id="f-234" unitRef="usd">-1818000</us-gaap:FairValueAdjustmentOfWarrants>
    <rnac:FairValueAdjustmentOfContingentValueRightLiability contextRef="c-1" decimals="-3" id="f-235" unitRef="usd">13800000</rnac:FairValueAdjustmentOfContingentValueRightLiability>
    <rnac:FairValueAdjustmentOfContingentValueRightLiability contextRef="c-9" decimals="-3" id="f-236" unitRef="usd">-346000</rnac:FairValueAdjustmentOfContingentValueRightLiability>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-3" id="f-237" unitRef="usd">-854000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-9" decimals="-3" id="f-238" unitRef="usd">893000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-239" unitRef="usd">246000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-9" decimals="-3" id="f-240" unitRef="usd">5830000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-3" id="f-241" unitRef="usd">310000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-9" decimals="-3" id="f-242" unitRef="usd">1819000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c-1" decimals="-3" id="f-243" unitRef="usd">-850000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c-9" decimals="-3" id="f-244" unitRef="usd">-2178000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-245" unitRef="usd">-22135000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-9" decimals="-3" id="f-246" unitRef="usd">-23108000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-247" unitRef="usd">27000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-9" decimals="-3" id="f-248" unitRef="usd">1075000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-249" unitRef="usd">-27000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-9" decimals="-3" id="f-250" unitRef="usd">-1075000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-1" decimals="-3" id="f-251" unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-9" decimals="-3" id="f-252" unitRef="usd">454000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="-3" id="f-253" unitRef="usd">279000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-9" decimals="-3" id="f-254" unitRef="usd">183000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1" decimals="-3" id="f-255" unitRef="usd">15392000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-9" decimals="-3" id="f-256" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <rnac:PaymentsForContingentValueRightsDistributions contextRef="c-1" decimals="-3" id="f-257" unitRef="usd">0</rnac:PaymentsForContingentValueRightsDistributions>
    <rnac:PaymentsForContingentValueRightsDistributions contextRef="c-9" decimals="-3" id="f-258" unitRef="usd">7754000</rnac:PaymentsForContingentValueRightsDistributions>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-259" unitRef="usd">15671000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-9" decimals="-3" id="f-260" unitRef="usd">-8025000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-3" id="f-261" unitRef="usd">-7000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-9" decimals="-3" id="f-262" unitRef="usd">32000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-263" unitRef="usd">-6498000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-9" decimals="-3" id="f-264" unitRef="usd">-32176000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-265" unitRef="usd">126874000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-32" decimals="-3" id="f-266" unitRef="usd">214279000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-267" unitRef="usd">120376000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-43" decimals="-3" id="f-268" unitRef="usd">182103000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-3" id="f-269" unitRef="usd">59000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-9" decimals="-3" id="f-270" unitRef="usd">535000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <rnac:EquityOfferingCostsInAccruedLiabilities contextRef="c-1" decimals="-3" id="f-271" unitRef="usd">707000</rnac:EquityOfferingCostsInAccruedLiabilities>
    <rnac:EquityOfferingCostsInAccruedLiabilities contextRef="c-9" decimals="-3" id="f-272" unitRef="usd">0</rnac:EquityOfferingCostsInAccruedLiabilities>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-273">Description of the Business&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cartesian Therapeutics, Inc., or the Company, &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;was&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; incorporated in Delaware on December 10, 2007, and is headquartered in Frederick, Maryland. The Company is a late clinical-stage biotechnology company &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;pioneering cell therapy for the treatment of autoimmune diseases. The Company leverages its proprietary technology and manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell&#x2019;s genetic material. The Company&#x2019;s cell therapies are designed to be dosed repeatedly like conventional drugs, administered in an outpatient setting and given without pre-treatment chemotherapy, which is required with many conventional cell therapies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;The Company&#x2019;s Product Candidates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company aims to provide a personalized approach to treating patients that begins with the collection of a patient&#x2019;s cells, which are then used to manufacture the Company&#x2019;s cell therapy product candidates. Once a patient&#x2019;s cells have expanded in the Company&#x2019;s process, mRNA is introduced to deliver a chimeric antigen receptor into the cell. Once the manufacturing process is complete, the product candidate is sent back to the treating physician where they administer six weekly infusions of the Company&#x2019;s cell therapy candidate to the patient. The Company&#x2019;s product candidates are specifically designed to target and destroy the pathogenic, self-reactive cells that are the underlying cause of the autoimmune disease, with the goal of creating a precision immune reset for the patient.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Descartes-08, the Company&#x2019;s lead cell therapy product candidate, is an autologous chimeric antigen receptor T-cell therapy, or CAR-T, product targeting B-cell maturation antigen, or BCMA, in clinical development for the treatment of generalized myasthenia gravis, or MG, and myositis, specifically, moderate to severe multi-refractory dermatomyositis and antisynthetase syndrome. In contrast to conventional DNA-based CAR T-cell therapies, the Company&#x2019;s CAR-T administration is designed to not require preconditioning chemotherapy, to be administered in the outpatient setting and does not carry the risk of genomic integration associated with cancerous transformation. Descartes-08 has been granted Orphan Drug Designation and Regenerative Medicine Advanced Therapy Designation by the U.S. Food and Drug Administration, or FDA, for the treatment of MG, and Rare Pediatric Disease Designation for the treatment of juvenile dermatomyositis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liquidity and Management&#x2019;s Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2026, the Company had an accumulated deficit of $861.6 million. The Company anticipates operating losses to continue for the foreseeable future due to, among other things, costs related to research and development of its product candidates and its administrative organization. The future success of the Company is dependent on its ability to develop its product candidates and ultimately upon its ability to attain and sustain profitable operations. The successful development of product candidates requires substantial working capital, which may not be available to the Company on favorable terms or at all.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2026, the Company&#x2019;s cash, cash equivalents, and restricted cash were $120.4 million, of which $1.7 million was restricted cash related to lease commitments. The Company believes the cash, cash equivalents and restricted cash as of March 31, 2026 will enable it to fund its current planned operations for at least the next 12 months. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Further, the liability associated with the CVR Agreement (as defined below) will be settled solely through cash flow received under the Company&#x2019;s License and Development Agreement, or as so amended, the Sobi License, with Swedish Orphan Biovitrum AB (publ.), or Sobi, and any other Gross Proceeds (as defined in the CVR Agreement) net of certain agreed deductions. Under the CVR Agreement, 100% of all milestone payments, royalties and other amounts paid to the Company or controlled entities under the Sobi License, and any other Gross Proceeds will be distributed, net of specified deductions, to holders of the CVRs. There is no obligation to the Company to fund any amount related to the CVR liability. See Note 5, &#x201c;Fair Value Measurements&#x201d;.&lt;/span&gt;&lt;/div&gt; If the Company is unable to obtain additional funding on a timely basis, it may be forced to significantly curtail, delay, or discontinue one or more of its planned research or development programs or be unable to expand its operations or otherwise capitalize on its commercialization of its product candidates.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-5" id="f-274" unitRef="usd">-861600000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <rnac:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale contextRef="c-3" decimals="-5" id="f-275" unitRef="usd">120400000</rnac:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-3" decimals="-5" id="f-276" unitRef="usd">1700000</us-gaap:RestrictedCashAndCashEquivalents>
    <rnac:ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed
      contextRef="c-44"
      decimals="INF"
      id="f-277"
      unitRef="number">1</rnac:ContingentValueRightPercentageOfMilestonePaymentsRoyaltiesAndOtherAmountsToBeDistributed>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-278">Summary of Significant Accounting Policies&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of presentation and consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Selecta (RUS), LLC, or Selecta (RUS), a Russian limited liability corporation, and Cartesian Bio, LLC, a Delaware limited liability &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;company, which is a variable interest entity for which the Company is the primary beneficiary and have been prepared in conformity with accounting principles generally accepted in the United States of America, or U.S. GAAP. Any reference in these notes to applicable guidance is meant to refer to the authoritative United States generally accepted accounting principles as found in the relevant Accounting Standards Codification, or ASC and Accounting Standards Update, or ASU, of the Financial Accounting Standards Board, or FASB. All significant intercompany accounts and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited consolidated financial statements for the three months ended March 31, 2026 and 2025 have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission, or the SEC, for interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. These consolidated financial statements should be read in conjunction with the Company&#x2019;s audited consolidated financial statements and the notes thereto for the year ended December 31, 2025 included in the Company&#x2019;s Annual Report on Form 10-K that was filed with the SEC on March 9, 2026. The unaudited interim financial statements have been prepared on the same basis as the audited consolidated financial statements. In the opinion of management, the accompanying unaudited interim consolidated financial statements contain all adjustments that are necessary for a fair statement of the Company&#x2019;s financial position as of March 31, 2026, the consolidated results of operations for the three months ended March 31, 2026, and cash flows for the three months ended March 31, 2026. Such adjustments are of a normal and recurring nature. The results of operations for the three months ended March 31, 2026 are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Significant accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company disclosed its significant accounting policies in Note 2, &#x201c;Summary of Significant Accounting Policies&#x201d; included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2025. There have been no material changes to the Company&#x2019;s significant accounting policies during the three months ended March 31, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Statement Reporting- Comprehensive Income- Expense Disaggregation Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASU 2024-03), which requires public companies to disclose, in interim and annual reporting periods, additional information about certain expenses in notes to financial statements, including purchases of inventory, employee compensation, depreciation, amortization of intangible assets, and selling expenses. This guidance will be effective for the annual period beginning the year ended December 31, 2027 and for interim periods beginning January 1, 2028, with early adoption permitted. The Company is currently evaluating the impact of the standard&#x2019;s adoption on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2025, the FASB issued ASU 2025-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASU 2025-10), which establishes authoritative guidance on the recognition, measurement, presentation, and disclosure of government grants. Under ASU 2025-10, government grants are recognized when it is probable that the entity will both comply with the conditions of the grant and the grant will be received. The ASU provides specific accounting models for grants related to assets and grants related to income, including options to recognize government grants as deferred income or as a reduction of the asset&#x2019;s cost basis. The ASU also requires enhanced disclosures regarding the nature of government grants, significant terms and conditions, accounting policies applied, and amounts recognized in the financial statements. ASU 2025-10 is effective for fiscal years beginning after December 15, 2028, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-10 on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2025, the FASB issued ASU 2025-11, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interim Reporting (Topic 270): Narrow-Scope Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASU 2025-11), which clarifies the guidance in Topic 270 to improve the consistency of interim financial reporting. The ASU provides a comprehensive list of required interim disclosures and introduces a disclosure principle requiring entities to disclose events since the end of the last annual reporting period that have a material impact on the entity. ASU 2025-11 is effective for fiscal years beginning after December 15, 2027, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-11 on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-279">&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of presentation and consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Selecta (RUS), LLC, or Selecta (RUS), a Russian limited liability corporation, and Cartesian Bio, LLC, a Delaware limited liability &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;company, which is a variable interest entity for which the Company is the primary beneficiary and have been prepared in conformity with accounting principles generally accepted in the United States of America, or U.S. GAAP. Any reference in these notes to applicable guidance is meant to refer to the authoritative United States generally accepted accounting principles as found in the relevant Accounting Standards Codification, or ASC and Accounting Standards Update, or ASU, of the Financial Accounting Standards Board, or FASB. All significant intercompany accounts and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited consolidated financial statements for the three months ended March 31, 2026 and 2025 have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission, or the SEC, for interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. These consolidated financial statements should be read in conjunction with the Company&#x2019;s audited consolidated financial statements and the notes thereto for the year ended December 31, 2025 included in the Company&#x2019;s Annual Report on Form 10-K that was filed with the SEC on March 9, 2026. The unaudited interim financial statements have been prepared on the same basis as the audited consolidated financial statements. In the opinion of management, the accompanying unaudited interim consolidated financial statements contain all adjustments that are necessary for a fair statement of the Company&#x2019;s financial position as of March 31, 2026, the consolidated results of operations for the three months ended March 31, 2026, and cash flows for the three months ended March 31, 2026. Such adjustments are of a normal and recurring nature. The results of operations for the three months ended March 31, 2026 are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2026.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-280">&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Statement Reporting- Comprehensive Income- Expense Disaggregation Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASU 2024-03), which requires public companies to disclose, in interim and annual reporting periods, additional information about certain expenses in notes to financial statements, including purchases of inventory, employee compensation, depreciation, amortization of intangible assets, and selling expenses. This guidance will be effective for the annual period beginning the year ended December 31, 2027 and for interim periods beginning January 1, 2028, with early adoption permitted. The Company is currently evaluating the impact of the standard&#x2019;s adoption on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2025, the FASB issued ASU 2025-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASU 2025-10), which establishes authoritative guidance on the recognition, measurement, presentation, and disclosure of government grants. Under ASU 2025-10, government grants are recognized when it is probable that the entity will both comply with the conditions of the grant and the grant will be received. The ASU provides specific accounting models for grants related to assets and grants related to income, including options to recognize government grants as deferred income or as a reduction of the asset&#x2019;s cost basis. The ASU also requires enhanced disclosures regarding the nature of government grants, significant terms and conditions, accounting policies applied, and amounts recognized in the financial statements. ASU 2025-10 is effective for fiscal years beginning after December 15, 2028, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-10 on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2025, the FASB issued ASU 2025-11, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interim Reporting (Topic 270): Narrow-Scope Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASU 2025-11), which clarifies the guidance in Topic 270 to improve the consistency of interim financial reporting. The ASU provides a comprehensive list of required interim disclosures and introduces a disclosure principle requiring entities to disclose events since the end of the last annual reporting period that have a material impact on the entity. ASU 2025-11 is effective for fiscal years beginning after December 15, 2027, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-11 on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-281">Goodwill and Indefinite-Lived Intangible Assets&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2026, the Company has goodwill of approximately $48.2&#160;million and an indefinite-lived intangible asset of $93.9&#160;million related to Descartes-08 for MG.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no changes to the carrying value of the Company&#x2019;s goodwill or in-process research and development asset related to Descartes-08 for MG during the three months ended March 31, 2026 and 2025.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:Goodwill contextRef="c-45" decimals="-5" id="f-282" unitRef="usd">48200000</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-46" decimals="-5" id="f-283" unitRef="usd">93900000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-47" decimals="INF" id="f-284" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-48" decimals="INF" id="f-285" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-286">Net Loss Per Share Allocable to Common Stockholders&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net loss per share allocable to common stockholders for the three months ended March 31, 2026 and 2025 (in thousands, except share and per-share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,710)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding - basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,855,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,902,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net loss per share allocable to common stockholders:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the potential dilutive shares of common stock excluded from the computation of the diluted net loss per share allocable to common stockholders for all periods presented, as the effect would have been anti-dilutive: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock options and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,278,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,047,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,026,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,026,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,435,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,204,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-287">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net loss per share allocable to common stockholders for the three months ended March 31, 2026 and 2025 (in thousands, except share and per-share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,710)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding - basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,855,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,902,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net loss per share allocable to common stockholders:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-288" unitRef="usd">-39182000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-9" decimals="-3" id="f-289" unitRef="usd">-17710000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-290" unitRef="shares">26855158</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-291" unitRef="shares">26855158</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-9" decimals="0" id="f-292" unitRef="shares">25902650</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-9" decimals="0" id="f-293" unitRef="shares">25902650</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-294"
      unitRef="usdPerShare">-1.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-295"
      unitRef="usdPerShare">-1.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-9"
      decimals="2"
      id="f-296"
      unitRef="usdPerShare">-0.68</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-9"
      decimals="2"
      id="f-297"
      unitRef="usdPerShare">-0.68</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-298">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the potential dilutive shares of common stock excluded from the computation of the diluted net loss per share allocable to common stockholders for all periods presented, as the effect would have been anti-dilutive: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock options and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,278,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,047,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,026,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,026,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,435,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,204,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-49" decimals="0" id="f-299" unitRef="shares">4278679</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-50" decimals="0" id="f-300" unitRef="shares">3047628</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-51" decimals="0" id="f-301" unitRef="shares">692272</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-52" decimals="0" id="f-302" unitRef="shares">692523</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-53" decimals="0" id="f-303" unitRef="shares">4026346</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-54" decimals="0" id="f-304" unitRef="shares">4026346</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-55" decimals="0" id="f-305" unitRef="shares">437927</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-56" decimals="0" id="f-306" unitRef="shares">437927</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="0" id="f-307" unitRef="shares">9435224</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-9" decimals="0" id="f-308" unitRef="shares">8204424</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-309">Fair Value Measurements&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the Company&#x2019;s assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2026 and December 31, 2025 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds (included in cash equivalents)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent value right liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds (included in cash equivalents)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent value right liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers within the fair value hierarchy during the three months ended March 31, 2026 or the year ended December 31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash, Cash Equivalents, and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2026 and December 31, 2025, money market funds were classified as cash and cash equivalents on the accompanying consolidated balance sheets as they mature within 90 days from the date of purchase.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2026, the Company had restricted cash balances relating to secured letters of credit in connection with its real estate leases. The Company&#x2019;s consolidated statements of cash flows include the following as of March 31, 2026 and 2025 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Warrants to Purchase Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2022, the Company issued warrants in connection with an underwritten offering, or the 2022 Warrants. Pursuant to the terms of the 2022 Warrants, the Company could be required to settle the 2022 Warrants in cash in the event of an acquisition of the Company under certain circumstances and, as a result, the 2022 Warrants are required to be measured at fair value and reported as a liability on the balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded the fair value of the 2022 Warrants upon issuance using the Black-Scholes valuation model and is required to revalue the 2022 Warrants at each reporting date, with any changes in fair value recorded in the statements of operations and comprehensive loss. The valuation of the 2022 Warrants is classified as Level 3 of the fair value hierarchy due to the need to use assumptions in the valuation that are both significant to the fair value measurement and unobservable, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;including the stock price volatility and the expected life of the 2022 Warrants. Generally, increases (decreases) in the fair value of the underlying stock and estimated term would result in a directionally similar impact to the fair value measurement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the 2022 Warrants was determined using the following inputs to the Black-Scholes simulation valuation:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Estimated fair value of the underlying stock. The Company estimates the fair value of the common stock based on the closing stock price at the end of each reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Risk-free interest rate. The risk-free interest rate is based on the U.S. Treasury at the valuation date commensurate with the expected remaining life assumption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Dividend rate. The dividend rate is based on the historical rate, which the Company anticipates will remain at zero.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Expected life. The expected life of the 2022 Warrants is assumed to be equivalent to their remaining contractual term which expires on April 11, 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Volatility. The Company estimates stock price volatility based on the Company&#x2019;s historical volatility for a period of time commensurate with the expected remaining life of the 2022 Warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the Black-Scholes pricing model assumptions used to record the fair value of the 2022 Warrants liability is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.68&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.48&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.03&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.28&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.14&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.36&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reflects a roll-forward of fair value for the Company&#x2019;s Level 3 warrant liabilities (see Note 9, &#x201c;Equity&#x201d; to these unaudited consolidated financial statements) for the three months ended March 31, 2026 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:87.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Warrant Liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value as of December 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value as of March 31, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent Value Right&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the Company entered into a contingent value rights agreement, or the CVR Agreement, pursuant to which each holder of common stock or a 2022 Warrant in December 2023 was distributed a CVR by the Company. Each CVR entitles its holder to distributions of milestone and royalty payments under the Sobi License, net of deductions. See Note 6, &#x201c;Fair Value Measurements&#x201d; to the consolidated financial statements included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2025 for further discussion of the terms related to the CVR Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The CVRs represent financial instruments that are accounted for under the fair value option election in ASC 825, Financial Instruments, or ASC 825. Under the fair value option election, the CVRs are initially measured at the aggregate estimated fair value of the CVRs and will be subsequently remeasured at estimated fair value on a recurring basis at each reporting period date. The estimated fair value of the CVR liability was determined using a Monte Carlo simulation model to estimate future cash flows associated with the legacy assets, including the expected milestone and royalty payments under the Sobi License, net of deductions. Changes in fair value of the CVR liability are presented in the consolidated statements of operations and comprehensive loss. The liability value is based on significant inputs not observable in the market such as estimated cash flows, estimated probabilities of success, and expected volatility of future revenues, which represent a Level 3 measurement within the fair value hierarchy. The significant inputs used to estimate the fair value of the CVR liability, which represented a financial instrument being accounted for under the fair value option, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated cash flow dates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 - 2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 - 2037&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated probability of success&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.0% - 100.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.0% - 100.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility of future revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reflects a roll-forward of fair value for the Company&#x2019;s Level 3 CVR liability for the three months ended March 31, 2026 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:87.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;CVR Liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value as of December 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value as of March 31, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c-1" id="f-310">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the Company&#x2019;s assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2026 and December 31, 2025 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds (included in cash equivalents)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent value right liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds (included in cash equivalents)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent value right liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-57" decimals="-3" id="f-311" unitRef="usd">117674000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-58" decimals="-3" id="f-312" unitRef="usd">117674000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-59" decimals="-3" id="f-313" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-60" decimals="-3" id="f-314" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-3" decimals="-3" id="f-315" unitRef="usd">117674000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-61" decimals="-3" id="f-316" unitRef="usd">117674000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-62" decimals="-3" id="f-317" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-63" decimals="-3" id="f-318" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-3" decimals="-3" id="f-319" unitRef="usd">47000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-61" decimals="-3" id="f-320" unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-62" decimals="-3" id="f-321" unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-63" decimals="-3" id="f-322" unitRef="usd">47000</us-gaap:WarrantsAndRightsOutstanding>
    <rnac:ContingentValueRightLiability contextRef="c-3" decimals="-3" id="f-323" unitRef="usd">405900000</rnac:ContingentValueRightLiability>
    <rnac:ContingentValueRightLiability contextRef="c-61" decimals="-3" id="f-324" unitRef="usd">0</rnac:ContingentValueRightLiability>
    <rnac:ContingentValueRightLiability contextRef="c-62" decimals="-3" id="f-325" unitRef="usd">0</rnac:ContingentValueRightLiability>
    <rnac:ContingentValueRightLiability contextRef="c-63" decimals="-3" id="f-326" unitRef="usd">405900000</rnac:ContingentValueRightLiability>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-3" decimals="-3" id="f-327" unitRef="usd">405947000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-61" decimals="-3" id="f-328" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-62" decimals="-3" id="f-329" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-63" decimals="-3" id="f-330" unitRef="usd">405947000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-64" decimals="-3" id="f-331" unitRef="usd">122724000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-65" decimals="-3" id="f-332" unitRef="usd">122724000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-66" decimals="-3" id="f-333" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-67" decimals="-3" id="f-334" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-4" decimals="-3" id="f-335" unitRef="usd">122724000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-68" decimals="-3" id="f-336" unitRef="usd">122724000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-69" decimals="-3" id="f-337" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-70" decimals="-3" id="f-338" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-4" decimals="-3" id="f-339" unitRef="usd">141000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-68" decimals="-3" id="f-340" unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-69" decimals="-3" id="f-341" unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-70" decimals="-3" id="f-342" unitRef="usd">141000</us-gaap:WarrantsAndRightsOutstanding>
    <rnac:ContingentValueRightLiability contextRef="c-4" decimals="-3" id="f-343" unitRef="usd">392100000</rnac:ContingentValueRightLiability>
    <rnac:ContingentValueRightLiability contextRef="c-68" decimals="-3" id="f-344" unitRef="usd">0</rnac:ContingentValueRightLiability>
    <rnac:ContingentValueRightLiability contextRef="c-69" decimals="-3" id="f-345" unitRef="usd">0</rnac:ContingentValueRightLiability>
    <rnac:ContingentValueRightLiability contextRef="c-70" decimals="-3" id="f-346" unitRef="usd">392100000</rnac:ContingentValueRightLiability>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-4" decimals="-3" id="f-347" unitRef="usd">392241000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-68" decimals="-3" id="f-348" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-69" decimals="-3" id="f-349" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-70" decimals="-3" id="f-350" unitRef="usd">392241000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet contextRef="c-1" decimals="INF" id="f-351" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet contextRef="c-1" decimals="INF" id="f-352" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet contextRef="c-71" decimals="INF" id="f-353" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet contextRef="c-71" decimals="INF" id="f-354" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock contextRef="c-1" id="f-356">The Company&#x2019;s consolidated statements of cash flows include the following as of March 31, 2026 and 2025 (in thousands):&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="c-1" id="f-355">The Company&#x2019;s consolidated statements of cash flows include the following as of March 31, 2026 and 2025 (in thousands):&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-357" unitRef="usd">118641000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-43" decimals="-3" id="f-358" unitRef="usd">180434000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent contextRef="c-3" decimals="-3" id="f-359" unitRef="usd">1735000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent contextRef="c-43" decimals="-3" id="f-360" unitRef="usd">1669000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-361" unitRef="usd">120376000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-43" decimals="-3" id="f-362" unitRef="usd">182103000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c-72"
      decimals="INF"
      id="f-363"
      unitRef="number">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="c-1" id="f-364">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the Black-Scholes pricing model assumptions used to record the fair value of the 2022 Warrants liability is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.68&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.48&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.03&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.28&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.14&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.36&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The significant inputs used to estimate the fair value of the CVR liability, which represented a financial instrument being accounted for under the fair value option, were as follows:&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated cash flow dates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 - 2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 - 2037&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated probability of success&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.0% - 100.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.0% - 100.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility of future revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-73" decimals="4" id="f-365" unitRef="number">0.0368</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-74" decimals="4" id="f-366" unitRef="number">0.0348</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-75" decimals="4" id="f-367" unitRef="number">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-76" decimals="4" id="f-368" unitRef="number">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-77" id="f-369">P1Y10D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-78" id="f-370">P1Y3M10D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-79" decimals="4" id="f-371" unitRef="number">0.8914</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-80" decimals="4" id="f-372" unitRef="number">0.8736</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c-1" id="f-373">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reflects a roll-forward of fair value for the Company&#x2019;s Level 3 warrant liabilities (see Note 9, &#x201c;Equity&#x201d; to these unaudited consolidated financial statements) for the three months ended March 31, 2026 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:87.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Warrant Liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value as of December 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value as of March 31, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reflects a roll-forward of fair value for the Company&#x2019;s Level 3 CVR liability for the three months ended March 31, 2026 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:87.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;CVR Liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value as of December 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value as of March 31, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-81" decimals="-3" id="f-374" unitRef="usd">141000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-82" decimals="-3" id="f-375" unitRef="usd">-94000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-83" decimals="-3" id="f-376" unitRef="usd">47000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <rnac:ContingentValueRightLiabilityMeasurementInput contextRef="c-84" decimals="3" id="f-377" unitRef="number">0.950</rnac:ContingentValueRightLiabilityMeasurementInput>
    <rnac:ContingentValueRightLiabilityMeasurementInput contextRef="c-85" decimals="3" id="f-378" unitRef="number">1.000</rnac:ContingentValueRightLiabilityMeasurementInput>
    <rnac:ContingentValueRightLiabilityMeasurementInput contextRef="c-86" decimals="3" id="f-379" unitRef="number">0.950</rnac:ContingentValueRightLiabilityMeasurementInput>
    <rnac:ContingentValueRightLiabilityMeasurementInput contextRef="c-87" decimals="3" id="f-380" unitRef="number">1.000</rnac:ContingentValueRightLiabilityMeasurementInput>
    <rnac:ContingentValueRightLiabilityMeasurementInput contextRef="c-88" decimals="3" id="f-381" unitRef="number">0.230</rnac:ContingentValueRightLiabilityMeasurementInput>
    <rnac:ContingentValueRightLiabilityMeasurementInput contextRef="c-89" decimals="3" id="f-382" unitRef="number">0.230</rnac:ContingentValueRightLiabilityMeasurementInput>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-90" decimals="-3" id="f-383" unitRef="usd">392100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-91" decimals="-3" id="f-384" unitRef="usd">13800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-92" decimals="-3" id="f-385" unitRef="usd">405900000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c-1" id="f-386">Property and Equipment&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,733)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense was $0.6 million for each of the three months ended March 31, 2026 and 2025, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-387">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,733)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-93" decimals="-3" id="f-388" unitRef="usd">9323000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-94" decimals="-3" id="f-389" unitRef="usd">8419000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-95" decimals="-3" id="f-390" unitRef="usd">417000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-96" decimals="-3" id="f-391" unitRef="usd">417000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-97" decimals="-3" id="f-392" unitRef="usd">6709000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-98" decimals="-3" id="f-393" unitRef="usd">4177000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-99" decimals="-3" id="f-394" unitRef="usd">307000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-100" decimals="-3" id="f-395" unitRef="usd">269000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-101" decimals="-3" id="f-396" unitRef="usd">170000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-102" decimals="-3" id="f-397" unitRef="usd">170000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-103" decimals="-3" id="f-398" unitRef="usd">59000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-104" decimals="-3" id="f-399" unitRef="usd">3466000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-3" decimals="-3" id="f-400" unitRef="usd">16985000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-4" decimals="-3" id="f-401" unitRef="usd">16918000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-3" decimals="-3" id="f-402" unitRef="usd">5348000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-403" unitRef="usd">4733000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-404" unitRef="usd">11637000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-405" unitRef="usd">12185000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c-1" decimals="-5" id="f-406" unitRef="usd">600000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-9" decimals="-5" id="f-407" unitRef="usd">600000</us-gaap:Depreciation>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="c-1" id="f-408">Accrued Expenses&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and employee related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Collaboration and licensing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued patent fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued research and development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional and consulting services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued equity offering costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-409">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and employee related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Collaboration and licensing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued patent fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued research and development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional and consulting services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued equity offering costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-410" unitRef="usd">1319000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-411" unitRef="usd">3985000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <rnac:AccruedCollaborationandLicensing contextRef="c-3" decimals="-3" id="f-412" unitRef="usd">385000</rnac:AccruedCollaborationandLicensing>
    <rnac:AccruedCollaborationandLicensing contextRef="c-4" decimals="-3" id="f-413" unitRef="usd">320000</rnac:AccruedCollaborationandLicensing>
    <rnac:AccruedPatentFeesCurrent contextRef="c-3" decimals="-3" id="f-414" unitRef="usd">195000</rnac:AccruedPatentFeesCurrent>
    <rnac:AccruedPatentFeesCurrent contextRef="c-4" decimals="-3" id="f-415" unitRef="usd">205000</rnac:AccruedPatentFeesCurrent>
    <rnac:AccruedResearchAndDevelopmentCostsCurrent contextRef="c-3" decimals="-3" id="f-416" unitRef="usd">4858000</rnac:AccruedResearchAndDevelopmentCostsCurrent>
    <rnac:AccruedResearchAndDevelopmentCostsCurrent contextRef="c-4" decimals="-3" id="f-417" unitRef="usd">2521000</rnac:AccruedResearchAndDevelopmentCostsCurrent>
    <rnac:AccruedAuditFeesCurrent contextRef="c-3" decimals="-3" id="f-418" unitRef="usd">2187000</rnac:AccruedAuditFeesCurrent>
    <rnac:AccruedAuditFeesCurrent contextRef="c-4" decimals="-3" id="f-419" unitRef="usd">2059000</rnac:AccruedAuditFeesCurrent>
    <rnac:AccruedEquityOfferingCostsCurrent contextRef="c-3" decimals="-3" id="f-420" unitRef="usd">707000</rnac:AccruedEquityOfferingCostsCurrent>
    <rnac:AccruedEquityOfferingCostsCurrent contextRef="c-4" decimals="-3" id="f-421" unitRef="usd">30000</rnac:AccruedEquityOfferingCostsCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-422" unitRef="usd">510000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-423" unitRef="usd">378000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-424" unitRef="usd">10161000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-425" unitRef="usd">9498000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-426">Leases&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains operating leases for manufacturing, laboratory and office space located in Maryland and Massachusetts. In Frederick, Maryland, the Company occupies over 35,000 total square feet of integrated space under a lease agreement, or the Frederick Lease Agreement, and subsequent amendments entered into between February 2024 and June 2025, or the Amended Frederick Lease Agreement. The Amended Fredrick Lease Agreement is set to expire in 2031, carries an aggregate annual base rent of approximately $1.4&#160;million and is subject to annual increases in accordance with the terms of the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amended Frederick Lease Agreement. See Note 9, &#x201c;Leases&#x201d; to the consolidated financial statements included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2025 for further discussion of the Company&#x2019;s leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2026 and 2025, the components of lease costs were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity of the Company&#x2019;s operating lease liabilities as of March 31, 2026 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:87.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 (remainder)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,960)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to operating leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities (in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,169&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the Company&#x2019;s right-of-use assets and lease liabilities for the three months ended March 31, 2026 and 2025 are reflected in the non-cash lease expense and accrued expenses and other liabilities, respectively, in the consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:AreaOfRealEstateProperty contextRef="c-105" decimals="0" id="f-427" unitRef="sqft">35000</us-gaap:AreaOfRealEstateProperty>
    <rnac:LesseeOperatingLeaseAnnualBaseRent contextRef="c-106" decimals="-5" id="f-428" unitRef="usd">1400000</rnac:LesseeOperatingLeaseAnnualBaseRent>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-429">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2026 and 2025, the components of lease costs were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to operating leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities (in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,169&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-3" id="f-430" unitRef="usd">583000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-9" decimals="-3" id="f-431" unitRef="usd">584000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-1" decimals="-3" id="f-432" unitRef="usd">431000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-9" decimals="-3" id="f-433" unitRef="usd">406000</us-gaap:VariableLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c-1" decimals="-3" id="f-434" unitRef="usd">4000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c-9" decimals="-3" id="f-435" unitRef="usd">11000</us-gaap:ShortTermLeaseCost>
    <us-gaap:LeaseCost contextRef="c-1" decimals="-3" id="f-436" unitRef="usd">1018000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-9" decimals="-3" id="f-437" unitRef="usd">1001000</us-gaap:LeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-438">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity of the Company&#x2019;s operating lease liabilities as of March 31, 2026 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:87.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 (remainder)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,960)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c-3" decimals="-3" id="f-439" unitRef="usd">3571000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-3" decimals="-3" id="f-440" unitRef="usd">4554000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-3" decimals="-3" id="f-441" unitRef="usd">2529000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-3" decimals="-3" id="f-442" unitRef="usd">1630000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-3" decimals="-3" id="f-443" unitRef="usd">1679000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <rnac:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour contextRef="c-3" decimals="-3" id="f-444" unitRef="usd">852000</rnac:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-3" decimals="-3" id="f-445" unitRef="usd">14815000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-3" decimals="-3" id="f-446" unitRef="usd">2960000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-3" decimals="-3" id="f-447" unitRef="usd">11855000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-3" id="f-448" unitRef="usd">1169000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-9" decimals="-3" id="f-449" unitRef="usd">317000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-3" id="f-450">P3Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-43" id="f-451">P4Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-3" decimals="3" id="f-452" unitRef="number">0.122</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-43" decimals="3" id="f-453" unitRef="number">0.118</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-454">Equity&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Equity Financings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;At the Market&#x201d; Sales Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 13, 2024, the Company entered into a Sales Agreement, or the Sales Agreement, with Leerink Partners LLC to sell shares of the Company&#x2019;s common stock, from time to time, through an &#x201c;at the market&#x201d; equity offering program under which Leerink Partners LLC will act as sales agent. The shares of common stock sold pursuant to the Sales Agreement will be issued pursuant to the Company&#x2019;s shelf registration statement on Form S-3 (File No. 333-283803), filed on December 13, 2024 with the SEC and related prospectus supplement, filed on January 8, 2025 with the SEC, for aggregate gross sales proceeds of up to $100.0&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March 31, 2026, the Company sold 2,270,712 shares of its common stock pursuant to the Sales Agreement for net proceeds of approximately $14.6 million after commissions and expenses. There were no shares sold pursuant to the Sales Agreement during the three months ended March 31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March 31, 2026, there were no warrants issued, exercised, or cancelled. The following is a summary of the Company&#x2019;s warrants as of March 31, 2026:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;&#160;classified&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability classified&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average&lt;br/&gt;exercise price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 11, &#x201c;Equity&#x201d; to the consolidated financial statements included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2025 for further discussion of the terms related to the Company&#x2019;s warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2026, the Company had 120,790.402 shares of Series A Preferred Stock and 437,927 shares of Series B Preferred Stock issued and outstanding, respectively, which are convertible into 4,464,273 shares of common stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reserved Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has authorized shares of common stock for future issuance as of March 31, 2026 as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:87.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares available for future stock incentive awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,641,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding common stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,542,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,026,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,076,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <rnac:SaleOfStockAggregateMaximumGrossSalesProceeds contextRef="c-107" decimals="-5" id="f-455" unitRef="usd">100000000.0</rnac:SaleOfStockAggregateMaximumGrossSalesProceeds>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-108"
      decimals="INF"
      id="f-456"
      unitRef="shares">2270712</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-108" decimals="-5" id="f-457" unitRef="usd">14600000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-109"
      decimals="INF"
      id="f-458"
      unitRef="shares">0</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <rnac:ClassOfWarrantOrRightOutstandingWarrantsIssued contextRef="c-1" decimals="INF" id="f-459" unitRef="shares">0</rnac:ClassOfWarrantOrRightOutstandingWarrantsIssued>
    <rnac:ClassOfWarrantOrRightOutstandingWarrantsCancelled contextRef="c-1" decimals="INF" id="f-460" unitRef="shares">0</rnac:ClassOfWarrantOrRightOutstandingWarrantsCancelled>
    <rnac:ClassOfWarrantOrRightOutstandingWarrantsExercised contextRef="c-1" decimals="INF" id="f-461" unitRef="shares">0</rnac:ClassOfWarrantOrRightOutstandingWarrantsExercised>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="c-1" id="f-462">The following is a summary of the Company&#x2019;s warrants as of March 31, 2026:&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;&#160;classified&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability classified&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average&lt;br/&gt;exercise price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-110" decimals="0" id="f-463" unitRef="shares">6560</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-83" decimals="0" id="f-464" unitRef="shares">685712</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-3" decimals="0" id="f-465" unitRef="shares">692272</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-3"
      decimals="2"
      id="f-466"
      unitRef="usdPerShare">46.76</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:PreferredStockSharesIssued contextRef="c-6" decimals="3" id="f-467" unitRef="shares">120790.402</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-6" decimals="3" id="f-468" unitRef="shares">120790.402</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-8" decimals="INF" id="f-469" unitRef="shares">437927</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-8" decimals="INF" id="f-470" unitRef="shares">437927</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockConvertibleSharesIssuable contextRef="c-6" decimals="INF" id="f-471" unitRef="shares">4464273</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:ScheduleOfStockByClassTextBlock contextRef="c-1" id="f-472">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has authorized shares of common stock for future issuance as of March 31, 2026 as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:87.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares available for future stock incentive awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,641,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding common stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,542,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,026,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,076,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockByClassTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-110"
      decimals="INF"
      id="f-473"
      unitRef="shares">692272</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-111"
      decimals="INF"
      id="f-474"
      unitRef="shares">3641284</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-112"
      decimals="INF"
      id="f-475"
      unitRef="shares">736272</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-113"
      decimals="INF"
      id="f-476"
      unitRef="shares">3542407</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-114"
      decimals="INF"
      id="f-477"
      unitRef="shares">4026346</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-115"
      decimals="INF"
      id="f-478"
      unitRef="shares">437927</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-3" decimals="INF" id="f-479" unitRef="shares">13076508</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-480">Stock Incentive Plans&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Company&#x2019;s stockholders approved the 2016 Incentive Award Plan, or the 2016 Plan, which initially authorized 40,341 shares of common stock for future issuance under the 2016 Plan. Pursuant to the terms of the 2016 Plan, the Board of Directors is authorized to grant awards with respect to common stock, and may delegate to a committee of one or more members of the Board of Directors or executive officers of the Company the authority to grant options and restricted stock units. The Board of Directors established a Stock Option Committee which is authorized to grant awards to certain employees and consultants subject to conditions and limitations within the 2016 Plan. In January 2026, the number of shares of common stock that may be issued under the 2016 Plan was increased by 1,040,444. As of March 31, 2026, 3,044,044 shares remain available for future issuance under the 2016 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2018, the Company&#x2019;s 2018 Employment Inducement Incentive Award Plan, or the 2018 Inducement Incentive Award Plan, was adopted by the Board of Directors without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Stock Market LLC listing rules, which initially authorized 39,166 shares of its common stock for issuance. As of March 31, 2026, there are 502,296 shares available for future grant under the 2018 Inducement Incentive Award Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 2023, the Company assumed the 2016 Stock Incentive Plan, or the Old Cartesian Plan, of the then private company that merged with the Company in November 2023, or Old Cartesian. . The Old Cartesian Plan permits the granting of options or restricted stock to employees, officers, directors, consultants and advisors to the Company. The unvested common stock options and Series A Preferred Stock options assumed by the Company generally vest over a four-year period. Additionally, the stock options granted have a contractual term of ten years and only full shares can be exercised as per the individual award agreements. As of March 31, 2026, there are 49,149 shares available for future grant under the Old Cartesian Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The outstanding stock options to purchase Old Cartesian common stock were converted into stock options to purchase 776,865 shares of common stock and 14,112.299 shares of Series A Preferred Stock of the Company. The replacement awards that were issued as a part of the assumption of the Old Cartesian Plan resulted in $2.6&#160;million attributed to post-combination &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;service to be recognized as stock-based compensation expense over the remaining terms of the replacement awards, of which $0.1&#160;million and $0.2&#160;million was recognized during the three months ended March 31, 2026 and 2025, respectively as research and development expense in the consolidated statements of operations and comprehensive loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense by classification included within the consolidated statements of operations and comprehensive loss, was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated grant date fair values of stock option awards granted under the 2016 Plan and the 2018 Inducement Incentive Award Plan were calculated using the Black-Scholes option pricing model based on the following weighted-average assumptions: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.93&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.46&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.71&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.44&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average fair value of common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.46&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The expected term of the Company&#x2019;s stock options granted has been determined utilizing the &#x201c;simplified&#x201d; method for awards that qualify as &#x201c;plain-vanilla&#x201d; options. Under the simplified method, the expected term is presumed to be the midpoint between the vesting date and the end of the contractual term. The Company utilizes this method due to lack of historical exercise data and the plain nature of its stock-based awards. Expected volatilities are based on the Company&#x2019;s historical volatility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average grant date fair value of stock options granted during the three months ended March 31, 2026 and 2025 was $5.25 and $14.03, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2026, total unrecognized compensation expense related to unvested common stock options was $15.5 million, which is expected to be recognized over a weighted average period of 3.0 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the stock option activity under the 2016 Plan, the 2018 Inducement Incentive Award Plan, and the Old Cartesian Plan for options for common stock:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&#160;of Common Stock Options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average Exercise Price ($)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average Remaining Contractual Term (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value (in&#160;thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,463,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.41&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,304,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86,132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,542,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.74&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,204,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest at March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,139,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.64&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March 31, 2026, the Company granted 420,650 restricted stock unit awards with a weighted-average fair value of $6.76 per share based on the closing price of the Company&#x2019;s common stock on the date of grant under the 2016 Plan, which generally vest over a four-year term. Forfeitures are estimated at the time of grant and are adjusted, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company has estimated a forfeiture rate of 10% for restricted stock unit awards based on historical experience.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrecognized compensation expense related to the restricted stock units was $6.4 million as of March 31, 2026, which is expected to be recognized over a weighted-average period of 3.1 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s restricted stock units under the 2016 Plan and the Old Cartesian Plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.782%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.664%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.666%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Grant Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value ($)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at March 31, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-116"
      decimals="INF"
      id="f-481"
      unitRef="shares">40341</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <rnac:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease
      contextRef="c-117"
      decimals="INF"
      id="f-482"
      unitRef="shares">1040444</rnac:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseDecrease>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-118"
      decimals="INF"
      id="f-483"
      unitRef="shares">3044044</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-119"
      decimals="INF"
      id="f-484"
      unitRef="shares">39166</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-120"
      decimals="INF"
      id="f-485"
      unitRef="shares">502296</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-121" id="f-486">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-121" id="f-487">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-122"
      decimals="INF"
      id="f-488"
      unitRef="shares">49149</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-123"
      decimals="INF"
      id="f-489"
      unitRef="shares">776865</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-124" decimals="3" id="f-490" unitRef="shares">14112.299</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c-125" decimals="-5" id="f-491" unitRef="usd">2600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-121" decimals="-5" id="f-492" unitRef="usd">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-126" decimals="-5" id="f-493" unitRef="usd">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock contextRef="c-1" id="f-494">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense by classification included within the consolidated statements of operations and comprehensive loss, was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-127" decimals="-3" id="f-495" unitRef="usd">949000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-128" decimals="-3" id="f-496" unitRef="usd">1275000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-129" decimals="-3" id="f-497" unitRef="usd">1474000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-130" decimals="-3" id="f-498" unitRef="usd">1233000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-499" unitRef="usd">2423000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-9" decimals="-3" id="f-500" unitRef="usd">2508000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-501">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated grant date fair values of stock option awards granted under the 2016 Plan and the 2018 Inducement Incentive Award Plan were calculated using the Black-Scholes option pricing model based on the following weighted-average assumptions: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.93&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.46&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.71&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.44&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average fair value of common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.46&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-131" decimals="4" id="f-502" unitRef="number">0.0393</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-132" decimals="4" id="f-503" unitRef="number">0.0446</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-131"
      decimals="INF"
      id="f-504"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-132"
      decimals="INF"
      id="f-505"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-131" id="f-506">P5Y11M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-132" id="f-507">P6Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-131" decimals="4" id="f-508" unitRef="number">0.9271</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-132" decimals="4" id="f-509" unitRef="number">0.9744</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <rnac:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue
      contextRef="c-131"
      decimals="2"
      id="f-510"
      unitRef="usdPerShare">6.81</rnac:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue>
    <rnac:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue
      contextRef="c-132"
      decimals="2"
      id="f-511"
      unitRef="usdPerShare">17.46</rnac:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-1"
      decimals="2"
      id="f-512"
      unitRef="usdPerShare">5.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-9"
      decimals="2"
      id="f-513"
      unitRef="usdPerShare">14.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c-133" decimals="-5" id="f-514" unitRef="usd">15500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-134" id="f-515">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-516">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the stock option activity under the 2016 Plan, the 2018 Inducement Incentive Award Plan, and the Old Cartesian Plan for options for common stock:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&#160;of Common Stock Options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average Exercise Price ($)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average Remaining Contractual Term (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value (in&#160;thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,463,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.41&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,304,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86,132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,542,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.74&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,204,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest at March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,139,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.64&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-135"
      decimals="INF"
      id="f-517"
      unitRef="shares">2463747</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-135"
      decimals="2"
      id="f-518"
      unitRef="usdPerShare">13.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-136" id="f-519">P6Y4M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-135" decimals="-3" id="f-520" unitRef="usd">2962000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-137"
      decimals="INF"
      id="f-521"
      unitRef="shares">1304450</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-137"
      decimals="2"
      id="f-522"
      unitRef="usdPerShare">6.81</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-137"
      decimals="INF"
      id="f-523"
      unitRef="shares">86132</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-137"
      decimals="2"
      id="f-524"
      unitRef="usdPerShare">3.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-137"
      decimals="INF"
      id="f-525"
      unitRef="shares">139658</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-137"
      decimals="2"
      id="f-526"
      unitRef="usdPerShare">15.90</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-138"
      decimals="INF"
      id="f-527"
      unitRef="shares">3542407</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-138"
      decimals="2"
      id="f-528"
      unitRef="usdPerShare">11.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-137" id="f-529">P7Y8M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-138" decimals="-3" id="f-530" unitRef="usd">2002000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="c-137"
      decimals="INF"
      id="f-531"
      unitRef="shares">1204110</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <rnac:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice
      contextRef="c-137"
      decimals="2"
      id="f-532"
      unitRef="usdPerShare">11.35</rnac:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedWeightedAverageExercisePrice>
    <rnac:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm contextRef="c-137" id="f-533">P5Y1M9D</rnac:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm>
    <rnac:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue contextRef="c-138" decimals="-3" id="f-534" unitRef="usd">1926000</rnac:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="c-138"
      decimals="INF"
      id="f-535"
      unitRef="shares">3139038</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c-138"
      decimals="2"
      id="f-536"
      unitRef="usdPerShare">11.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="c-137" id="f-537">P7Y7M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="c-138" decimals="-3" id="f-538" unitRef="usd">2002000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-139"
      decimals="INF"
      id="f-539"
      unitRef="shares">420650</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-139"
      decimals="2"
      id="f-540"
      unitRef="usdPerShare">6.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-139" id="f-541">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <rnac:ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate contextRef="c-139" decimals="2" id="f-542" unitRef="number">0.10</rnac:ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresRate>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="c-140" decimals="-5" id="f-543" unitRef="usd">6400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-139" id="f-544">P3Y1M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="c-1" id="f-545">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s restricted stock units under the 2016 Plan and the Old Cartesian Plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.782%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.664%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.666%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Grant Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value ($)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at March 31, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-141"
      decimals="INF"
      id="f-546"
      unitRef="shares">522498</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-141"
      decimals="2"
      id="f-547"
      unitRef="usdPerShare">18.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-139"
      decimals="INF"
      id="f-548"
      unitRef="shares">420650</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-139"
      decimals="2"
      id="f-549"
      unitRef="usdPerShare">6.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-139"
      decimals="INF"
      id="f-550"
      unitRef="shares">169278</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-139"
      decimals="2"
      id="f-551"
      unitRef="usdPerShare">18.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-139"
      decimals="INF"
      id="f-552"
      unitRef="shares">37598</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-139"
      decimals="2"
      id="f-553"
      unitRef="usdPerShare">16.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-140"
      decimals="INF"
      id="f-554"
      unitRef="shares">736272</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-140"
      decimals="2"
      id="f-555"
      unitRef="usdPerShare">11.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-556">Revenue Arrangements&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Collaboration and license revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Swedish Orphan Biovitrum AB (publ.)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2020, the Company and Sobi entered into the Sobi License, which was subsequently amended in October 2023. Pursuant to the Sobi License, the Company agreed to grant Sobi an exclusive, worldwide (except as to Greater China) license to develop, manufacture and commercialize the Nanoecapsulated Sirolimus plus Pegadricase, or NASP, formerly known as SEL-212, drug candidate , which is currently in development for the treatment of chronic refractory gout. The NASP drug candidate is a pharmaceutical composition containing a combination of a pegylated uricase known as SEL-037, or the Compound, and nanoparticle-encapsulated form of rapamycin, known as ImmTOR. Pursuant to the Sobi License, in consideration of the license, Sobi agreed to pay the Company a one-time, upfront payment of $75.0&#160;million. Sobi has also agreed to make milestone payments totaling up to $630.0&#160;million to the Company upon the achievement of various development and regulatory milestones and, if commercialized, sales thresholds for annual net sales of NASP, and tiered royalty payments ranging from the low double digits on the lowest sales tier to the high teens on the highest sales tier. A more detailed description of the Sobi License and the Company&#x2019;s evaluation of this agreement under ASC 606 can be found in Note 13, &#x201c;Revenue Arrangements&#x201d; to the consolidated financial statements in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2025. Any proceeds received from milestone payments or royalties relating to the Sobi License would be required to be distributed to holders of CVRs, net of certain deductions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 28, 2024, Sobi initiated a rolling biologics license application to the FDA for NASP for the potential treatment of chronic refractory gout which resulted in the achievement of a development milestone and a $30.0&#160;million payment obligation from Sobi to the Company. As a result, the development milestone was no longer constrained and $30.0&#160;million was recognized as revenue during the year ended December 31, 2024 as there were no remaining performance obligations under the Sobi License. The proceeds from the achievement of the development milestone were received from Sobi in July 2024 and were included, net of deductions as specified in the CVR Agreement, in the distribution to holders of the CVRs in March 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Grant revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;National Institute of Neurological Disorders and Stroke of the National Institutes of Health&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2024, the Company received funding approval from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health, or NINDS, for an award of $1.5&#160;million granted for the budget period, which ran from June 2024 through May 2025. In June 2025, the Company received funding approval from NINDS for an additional award of $1.5&#160;million granted for the budget period that runs from June 2025 through May 2026. The funding was provided by NINDS to further the Company&#x2019;s use of RNA-based CAR-T cells to combat autoantibody-associated autoimmune disorders. Grant funding is to be used solely for manufacturing of RNA-based CAR-T cells and analysis of samples to inform mechanism of action. The award period runs through May 31, 2026. The Company will recognize grant revenue when expenses reimbursable under the grant have been incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2026 and December 31, 2025, the Company recorded a receivable of $0.1&#160;million and $0.9&#160;million, respectively, that is subject to reimbursement by NINDS. The Company recognized grant revenue of $0.1&#160;million and $0.7&#160;million during the three months ended March 31, 2026 and 2025, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Transaction Price Allocated to Future Performance Obligations&lt;/span&gt;&lt;/div&gt;Remaining performance obligations represent the transaction price of contracts for which work has not been performed, or has been partially performed. As of March 31, 2026 and December 31, 2025, there were no unsatisfied performance obligations from contracts with customers.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:ContractWithCustomerLiability contextRef="c-142" decimals="-5" id="f-557" unitRef="usd">75000000.0</us-gaap:ContractWithCustomerLiability>
    <rnac:RevenueRemainingPerformanceObligationVariableConsiderationAmount contextRef="c-142" decimals="-5" id="f-558" unitRef="usd">630000000.0</rnac:RevenueRemainingPerformanceObligationVariableConsiderationAmount>
    <us-gaap:ContractWithCustomerLiability contextRef="c-143" decimals="-5" id="f-559" unitRef="usd">30000000.0</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-144" decimals="-5" id="f-560" unitRef="usd">30000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:GovernmentAssistanceAwardAmount contextRef="c-145" decimals="-5" id="f-561" unitRef="usd">1500000</us-gaap:GovernmentAssistanceAwardAmount>
    <rnac:GovernmentAssistancePotentialAdditionalAwardAmount contextRef="c-146" decimals="-5" id="f-562" unitRef="usd">1500000</rnac:GovernmentAssistancePotentialAdditionalAwardAmount>
    <rnac:GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag contextRef="c-71" id="f-563">receivable</rnac:GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag>
    <rnac:GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag contextRef="c-1" id="f-564">receivable</rnac:GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag>
    <us-gaap:GovernmentAssistanceAmountCumulativeCurrent contextRef="c-147" decimals="-5" id="f-565" unitRef="usd">100000</us-gaap:GovernmentAssistanceAmountCumulativeCurrent>
    <us-gaap:GovernmentAssistanceAmountCumulativeCurrent contextRef="c-148" decimals="-5" id="f-566" unitRef="usd">900000</us-gaap:GovernmentAssistanceAmountCumulativeCurrent>
    <us-gaap:RevenueNotFromContractWithCustomer contextRef="c-149" decimals="-5" id="f-567" unitRef="usd">100000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer contextRef="c-150" decimals="-5" id="f-568" unitRef="usd">700000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-3" decimals="-5" id="f-569" unitRef="usd">0</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-4" decimals="-5" id="f-570" unitRef="usd">0</us-gaap:RevenueRemainingPerformanceObligation>
    <rnac:CollaborationAndLicenseAgreementsTextBlock contextRef="c-1" id="f-571">Collaboration and License Agreements&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Biogen MA, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 8, 2023, the Company entered into a non-exclusive, sublicensable, worldwide, perpetual patent license agreement, or the Biogen Agreement, with Biogen MA, Inc., or Biogen, to research, develop, make, use, offer, sell and import products or processes containing or using an engineering T-cell modified with an mRNA comprising, or encoding a protein comprising, certain sequences licensed under the Biogen Agreement for the prevention, treatment, palliation and management of autoimmune diseases and disorders, excluding cancers, neoplastic disorders, and paraneoplastic disorders. The Company is not obligated to pay Biogen any expenses, fees, or royalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may terminate the Biogen Agreement for any reason or no reason, and Biogen may terminate the agreement after a notice-and-cure period of 30 days if the Company fails to pay a fee owed to Biogen or for any other material breach of the agreement. The Biogen Agreement will otherwise expire when all claims of all issued patents within the patents and patent applications licensed to the Company under the Biogen Agreement have expired or been finally rendered revoked, invalid or unenforceable by a decision of a court or government agency.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Biogen Agreement encompasses patents and patent applications in the PCT/US2010/026825 patent family, which was filed March 10, 2010. In general, all patents that issue in this family have an expected expiration date of March 10, 2030, subject to potential patent term adjustments and/or extensions. For the U.S. patents and applications in this family, U.S. Patent 9,034,324 was awarded 677 days of patent term adjustment, which would extend the expiration date of this patent to January 16, 2032, absent any challenges to the patent term. The other issued patent in this family was not awarded any patent term adjustment, so its expected expiration date is March 10, 2030.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;National Cancer Institute of the National Institutes of Health&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective September 16, 2019, the Company entered into a nonexclusive, worldwide license agreement, or the NCI Agreement, with the U.S. Department of Health and Human Services, represented by the National Cancer Institute of the National Institutes of Health, or NCI.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the NCI Agreement, the Company was granted a license under certain NCI patents and patent applications designated in the agreement, to make, use, sell, offer and import products and processes within the scope of the patents and applications licensed under the NCI Agreement when developing and manufacturing anti-BCMA CAR-T cell products for the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;treatment of MG pemphigus vulgaris, and immune thrombocytopenic purpura according to methods designated in the NCI Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Company&#x2019;s entry into the NCI Agreement, Old Cartesian paid to NCI a one-time $0.1 million license royalty payment. Under the NCI Agreement, the Company is further required to pay NCI a low five-digit annual royalty. The Company must also pay earned royalties on net sales in a low single-digit percentage and pay up to $0.8 million in benchmark royalties upon the Company&#x2019;s achievement of designated benchmarks that are based on the commercial development plan agreed between the parties. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the NCI Agreement, the Company must use reasonable commercial efforts to bring licensed products and licensed processes to the point of Practical Application (as defined in the NCI Agreement). Upon the Company&#x2019;s first commercial sale, the Company must use reasonable commercial efforts to make licensed products and licensed processes reasonably accessible to the United States public. After the Company&#x2019;s first commercial sale, the Company must make reasonable quantities of licensed products or materials produced via licensed processes available to patient assistance programs and develop educational materials detailing the licensed products. Unless the Company obtains a waiver from NCI, the Company must have licensed products and licensed processes manufactured substantially in the United States. Prior to the first commercial sale, upon NCI&#x2019;s request, the Company is obligated to provide NCI with commercially reasonable quantities of licensed products made through licensed processes to be used for in vitro research.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, the Company must use reasonable commercial efforts to submit a BLA with respect to a licensed product by the fourth quarter of 2026 and make a first commercial sale of a licensed product by the fourth quarter of 2028.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The NCI Agreement terminates upon the expiration of the last to expire of the patent rights licensed thereunder, if not sooner terminated. The NCI Agreement encompasses patents and patent applications in the PCT/US2013/032029 patent family, which was filed March 15, 2013. In general, all patents that issue in this family have an expected expiration of March 15, 2033, subject to potential patent term adjustments and/or extensions. For the U.S. patents and applications in this family, only two patents were awarded patent term adjustments. U.S. Patent 9,765,342 was awarded 297 days of patent term adjustment, which would extend the expiration date of this patent to January 6, 2034, absent any challenges to the patent term. The other patent, U.S. Patent 10,876,123, was awarded three days of patent term adjustment, but this patent is subject to terminal disclaimers filed against other family members, so this patent will not extend beyond the March 15, 2033 date. The other issued patents in this family were not awarded any patent term adjustment, so the expected expiration date for these patents also remains March 15, 2033. There is also a pending patent application which, if issued, will expire on March 15, 2033, but could also be subject to patent term adjustment and to any potential future terminal disclaimers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;NCI has the right to terminate the NCI Agreement, after giving written notice and providing a cure period in accordance with its terms, if the Company is in default of a material obligation. The Company has the unilateral right to terminate the agreement in any country or territory by giving NCI 60 days&#x2019; written notice. The Company agreed to indemnify NCI against any liability arising out of the Company&#x2019;s, sublicensees&#x2019; or third parties&#x2019; use of the licensed patent rights and licensed products or licensed processes developed in connection with the licensed patent rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shenyang Sunshine Pharmaceutical Co., Ltd&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2014, the Company entered into a license agreement, or the 3SBio License, with Shenyang Sunshine Pharmaceutical Co., Ltd., or 3SBio. The Company has paid to 3SBio an aggregate of $7.0 million in upfront and milestone-based payments under the 3SBio License as of March 31, 2026. The Company is required to make future payments to 3SBio contingent upon the occurrence of events related to the achievement of clinical and regulatory approval milestones of up to an aggregate of $15.0 million for products containing the Company&#x2019;s ImmTOR platform.&lt;/span&gt;&lt;/div&gt;</rnac:CollaborationAndLicenseAgreementsTextBlock>
    <rnac:CollaborativeArrangementWrittenNoticePeriodForTermination contextRef="c-151" id="f-572">P30D</rnac:CollaborativeArrangementWrittenNoticePeriodForTermination>
    <rnac:LicenseAndOptionAgreementRoyaltyPayment contextRef="c-152" decimals="-5" id="f-573" unitRef="usd">100000</rnac:LicenseAndOptionAgreementRoyaltyPayment>
    <rnac:LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum contextRef="c-152" decimals="-5" id="f-574" unitRef="usd">800000</rnac:LicenseAndOptionAgreementBenchmarkRoyaltiesMaximum>
    <rnac:CollaborativeArrangementWrittenNoticePeriodForTermination contextRef="c-152" id="f-575">P60D</rnac:CollaborativeArrangementWrittenNoticePeriodForTermination>
    <rnac:AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid contextRef="c-153" decimals="-5" id="f-576" unitRef="usd">7000000.0</rnac:AggregateAmountOfUpfrontAndMilestoneBasedPaymentsPaid>
    <rnac:AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform contextRef="c-154" decimals="-5" id="f-577" unitRef="usd">15000000.0</rnac:AggregateAmountForFuturePaymentsUponAchievementOfClinicalAndRegulatoryApprovalMilestonesForProductsContainingImmTORPlatform>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-578">Income Taxes&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2026, the Company has not recorded any U.S. federal or state income tax benefits for either the net losses the Company has incurred or its earned research and orphan drug credits, due to the uncertainty of realizing a benefit from those items in the future.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-579">Commitments and Contingencies&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2026, the Company was not a party to any litigation that could have a material adverse effect on the Company&#x2019;s business, financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As permitted under Delaware law, the Company indemnifies its officers, directors, consultants and employees for certain events or occurrences that happen by reason of the relationship with, or position held at the Company. Through March 31, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026, the Company had not experienced any losses related to these indemnification obligations, and no claims were outstanding. The Company does not expect significant claims related to these indemnification obligations and, consequently, concluded that the fair value of these obligations is negligible, and no related reserves were established.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, as permitted under Delaware law, the Company indemnifies its directors for certain events or occurrences while the director is, or was, serving at the Company&#x2019;s request in such capacity. The term of the indemnification is for the director&#x2019;s lifetime. The maximum potential amount of future payments the Company could be required to make is unlimited; however, the Company has directors&#x2019; insurance coverage that limits its exposure and enables it to recover a portion of any future amounts paid. The Company also has indemnification arrangements under certain of its facility leases that require it to indemnify the landlord against certain costs, expenses, fines, suits, claims, demands, liabilities, and actions directly resulting from certain breaches, violations, or non-performance of any covenant or condition of the Company&#x2019;s lease. The term of the indemnification is for the term of the related lease agreement. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited. To date, the Company had not experienced any material losses related to any of its indemnification obligations, and no material claims with respect thereto were outstanding.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-580">Segment Reporting&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents selected financial information with respect to the Company&#x2019;s single operating segment for the three months ended March 31, 2026 and 2025 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Collaboration and license revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Descartes-08 for MG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Descartes-08 for dermatomyositis&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Early stage programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development employee expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development facilities and other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income), net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,710)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt; Includes interest income; gain on change in fair value of warrant liabilities; (loss) gain on change in fair value of contingent value right liability; and other expense, net.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-581">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents selected financial information with respect to the Company&#x2019;s single operating segment for the three months ended March 31, 2026 and 2025 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Collaboration and license revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Descartes-08 for MG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Descartes-08 for dermatomyositis&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Early stage programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development employee expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development facilities and other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income), net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,710)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt; Includes interest income; gain on change in fair value of warrant liabilities; (loss) gain on change in fair value of contingent value right liability; and other expense, net.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <rnac:NumberOfReportableSegmentsNotDisclosedFlag contextRef="c-1" id="f-582">segment</rnac:NumberOfReportableSegmentsNotDisclosedFlag>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-155" decimals="-3" id="f-583" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-156" decimals="-3" id="f-584" unitRef="usd">400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueNotFromContractWithCustomer contextRef="c-155" decimals="-3" id="f-585" unitRef="usd">78000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer contextRef="c-156" decimals="-3" id="f-586" unitRef="usd">700000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:Revenues contextRef="c-155" decimals="-3" id="f-587" unitRef="usd">78000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-156" decimals="-3" id="f-588" unitRef="usd">1100000</us-gaap:Revenues>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-157" decimals="-3" id="f-589" unitRef="usd">12135000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-158" decimals="-3" id="f-590" unitRef="usd">7036000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-159" decimals="-3" id="f-591" unitRef="usd">227000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-160" decimals="-3" id="f-592" unitRef="usd">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-161" decimals="-3" id="f-593" unitRef="usd">355000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-162" decimals="-3" id="f-594" unitRef="usd">990000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-163" decimals="-3" id="f-595" unitRef="usd">3828000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-164" decimals="-3" id="f-596" unitRef="usd">3702000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-165" decimals="-3" id="f-597" unitRef="usd">949000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-166" decimals="-3" id="f-598" unitRef="usd">1275000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-167" decimals="-3" id="f-599" unitRef="usd">1969000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-168" decimals="-3" id="f-600" unitRef="usd">1671000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-155" decimals="-3" id="f-601" unitRef="usd">7114000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-156" decimals="-3" id="f-602" unitRef="usd">8315000</us-gaap:GeneralAndAdministrativeExpense>
    <rnac:NonoperatingIncomeExpenseAdjusted contextRef="c-155" decimals="-3" id="f-603" unitRef="usd">-12683000</rnac:NonoperatingIncomeExpenseAdjusted>
    <rnac:NonoperatingIncomeExpenseAdjusted contextRef="c-156" decimals="-3" id="f-604" unitRef="usd">4179000</rnac:NonoperatingIncomeExpenseAdjusted>
    <us-gaap:NetIncomeLoss contextRef="c-155" decimals="-3" id="f-605" unitRef="usd">-39182000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-156" decimals="-3" id="f-606" unitRef="usd">-17710000</us-gaap:NetIncomeLoss>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-608">Subsequent Events&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has evaluated subsequent events through the date on which the consolidated financial statements were issued. The Company has concluded that no subsequent events have occurred that require disclosure.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-1" id="f-609">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-1" id="f-610">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-1" id="f-611">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-1" id="f-612">false</ecd:Rule10b51ArrTrmntdFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
